Citrus Sinensis ID: 010859

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------50
Protein Sequence
MCIIQSHGREMLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQNP
Secondary Structure (PSIPRED)
ccccccccHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEEEEEEEccccEEEEEEEcccccEEEEEEccHHHHHHHHHHHHHHHHHHHHHHcccccEEcEEEEEcccccEEEEEEEccccccHHHHHHcccccccccHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEEccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccHHHHHHHHHHHccccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcccHHHHcccccccEEEEEEEcccEEEEcccccEEEEEEEccccccccEEEccccccEEEEccccEEEEEcccccHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
ccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccHHHEEEEEEEEEEccEEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEcccHccEEEccccccccccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccHHHHccHHHccccHHHHHccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccHHcccccccccccccccEcccccccccccHHHHHHHHHHcccccEEEEccHHHHHcccccccccccccccccccccEEEEEccccEEEEEccccHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
mciiqshgREMLAMEKDFdsklriegnnnsstncptvqrsksfafrapqehfsiqdfelgkiygvgsyskvvrakkidtgTVYALKIMDKKFITKENKTAYVKLERIVLdqldhpgvvrlFFTFQDTFSLYMALesceggelfdqitskghlsedeARFYTAEVVDALEYIHSmglihrdikpenllltadghikiadfgsvkpmqdsritvlpnaasddkactfvgtaayvppevlnsspatfgndlwALGCTLyqmlsgtspfkdtsEWLIFQRIIArdirfpnyfSDAARDLIDRLldvdpsgrpgagpggyavlkmhpffkgidwknirgqtppklasepmvqsgegddvhdsswnpshigdisakindgnggasssegsITRLAsidsfdskwqqfldpgeSVLMISMVKKLQKLTSKKVQLIltnkpkliyvdpsklvvkgniiwsdnsndlsiqvsspshfkivtpkkvlSFEDAKQRASQWKKAIEALQNP
Flexible Loop (DISEMBL)
mciiqshgremLAMEKDFDSKLRiegnnnsstncptVQRSKSFAFRAPQEHfsiqdfelgkiYGVGsyskvvrakkidtgtvyalkimdkkfitkenKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKvqliltnkpkliyvdpsKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQNP
Low Complexity Region (SEG)
MCIIQSHGREMLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSdaardlidrlldvdPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQNP
Disordered region (IsUnstruct)
*******************************************AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDP*****AGPGGYAVLKMHPFFKGIDWKNIR*********************************************************IDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV****HFKIVTP**************************
Disordered Region (DISOPRED)
********************************************************FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD***********DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHD*********************************************LDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQ**
Disordered Region (DISEMBL)
MCIIQSHGREMLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP*****************DSSWNPSHIGDISAKINDG*********SITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFE*******************
Disordered Region (DISPRO)
MCIIQSHGREMLAMEKDFDSKL****************************HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKI*************ITRLASI*SFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQN*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MCIIQSHGREMLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQNP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	499	2.2.26 [Sep-21-2011]
Q4V3C8	486	3-phosphoinositide-depend	yes	no	0.971	0.997	0.840	0.0
Q9XF67	491	3-phosphoinositide-depend	no	no	0.971	0.987	0.825	0.0
Q9Z2A0	559	3-phosphoinositide-depend	yes	no	0.861	0.769	0.385	3e-85
O55173	559	3-phosphoinositide-depend	yes	no	0.861	0.769	0.383	7e-85
O15530	556	3-phosphoinositide-depend	yes	no	0.861	0.773	0.383	1e-84
Q6A1A2	396	Putative 3-phosphoinositi	no	no	0.595	0.75	0.469	2e-74
Q54PK9	908	3-phosphoinositide-depend	yes	no	0.563	0.309	0.416	5e-62
Q12701	592	Serine/threonine-protein	yes	no	0.561	0.472	0.424	2e-59
P34102	910	Protein kinase 3 OS=Dicty	no	no	0.565	0.309	0.390	6e-59
Q12236	1081	Serine/threonine-protein	yes	no	0.565	0.260	0.398	4e-58

>sp|Q4V3C8|PDPK2_ARATH 3-phosphoinositide-dependent protein kinase 2 OS=Arabidopsis thaliana GN=PDPK2 PE=1 SV=1

 Score =  844 bits (2181), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/488 (84%), Positives = 441/488 (90%), Gaps = 3/488 (0%)

Query: 11  MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 70
           ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 71  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 130
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 190
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query: 191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 250
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 251 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 311 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 370
           G  GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S  
Sbjct: 299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVL 357

Query: 371 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 430
            NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct: 358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query: 431 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 490
           NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct: 418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query: 491 KAIEALQN 498
           KAIE LQN
Sbjct: 478 KAIETLQN 485

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9XF67|PDPK1_ARATH 3-phosphoinositide-dependent protein kinase 1 OS=Arabidopsis thaliana GN=PDPK1 PE=1 SV=1

 Score =  837 bits (2161), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/493 (82%), Positives = 441/493 (89%), Gaps = 8/493 (1%)

Query: 11  MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 70
           MLAMEK+FDSKL ++GN   S+N   V RSKSF+F+APQE+F+  DFE GKIYGVGSYSK
Sbjct: 1   MLAMEKEFDSKLVLQGN---SSNGANVSRSKSFSFKAPQENFTSHDFEFGKIYGVGSYSK 57

Query: 71  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 130
           VVRAKK +TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+++L+FTFQDT SL
Sbjct: 58  VVRAKKKETGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIIKLYFTFQDTSSL 117

Query: 131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 190
           YMALESCEGGELFDQIT KG LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT+
Sbjct: 118 YMALESCEGGELFDQITRKGRLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTS 177

Query: 191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 250
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 178 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 237

Query: 251 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD +PS RPGA
Sbjct: 238 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTEPSRRPGA 297

Query: 311 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSG--EGDDVHDSSWNPSHIGDIS 368
           G  GY  LK HPFF G+DWKN+R QTPPKLA +P  Q+   E DD H S WN +HIGD  
Sbjct: 298 GSEGYVALKRHPFFNGVDWKNLRSQTPPKLAPDPASQTASPERDDTHGSPWNLTHIGDSL 357

Query: 369 AKINDGNGG---ASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKV 425
           A  N+G+     +S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKV
Sbjct: 358 ATQNEGHSAPPTSSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKV 417

Query: 426 QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQR 485
           QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDL++ V+SPSHFKI TPKKVLSFEDAKQR
Sbjct: 418 QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLNVVVTSPSHFKICTPKKVLSFEDAKQR 477

Query: 486 ASQWKKAIEALQN 498
           AS WKKAIE LQN
Sbjct: 478 ASVWKKAIETLQN 490

May couple lipid signals to the activation-loop phosphorylation of several protein kinases of the so-called AGC kinase family. Interacts via its pleckstrin homology domain with phosphatidic acid, PtdIns3P and PtdIns(3,4)P2 and to a lesser extent with PtdIns(4,5)P2 and PtdIns4P. May play a general role in signaling processes controlling the pathogen/stress response, polar auxin transport and development. Transphosphorylates the AGC protein kinases OXI1/AGC2-1, PK1/S6K1, PK19/S6K2 and PID resulting in their activation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Z2A0|PDPK1_MOUSE 3-phosphoinositide-dependent protein kinase 1 OS=Mus musculus GN=Pdpk1 PE=1 SV=2

 Score =  316 bits (809), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 183/475 (38%), Positives = 257/475 (54%), Gaps = 45/475 (9%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 83  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 254

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYHFPEKFFPKARD 314

Query: 295 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
           L+++LL +D + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct: 315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFETITWENLHQQTPPKLTAYLPAMSEDDED 374

Query: 354 VHDSSWN--------------------------PSHIG-DISAKINDGNGGA-----SSS 381
            + +  N                          P   G +I   I+D +  +       S
Sbjct: 375 CYGNYDNLLSQFGFMQVSSSSSSHSLSTVETSLPQRSGSNIEQYIHDLDTNSFELDLQFS 434

Query: 382 EGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS 441
           E     L    +  + W QF++    +L +  V K + L +++ QL+LT  P L YVDP 
Sbjct: 435 EDEKRLLLEKQAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPV 493

Query: 442 KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEAL 496
             V+KG I W   S +L  +  +   F + TP +     D    A +W + I+ +
Sbjct: 494 NKVLKGEIPW---SQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEV 545

Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O55173|PDPK1_RAT 3-phosphoinositide-dependent protein kinase 1 OS=Rattus norvegicus GN=Pdpk1 PE=1 SV=2

 Score =  315 bits (806), Expect = 7e-85,   Method: Compositional matrix adjust.
 Identities = 182/475 (38%), Positives = 256/475 (53%), Gaps = 45/475 (9%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 83  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPDSKQARANSFVGTAQYVSP 254

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 314

Query: 295 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
           L+++LL +D + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct: 315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESITWENLHQQTPPKLTAYLPAMSEDDED 374

Query: 354 VH---------------------------DSSWNPSHIGDISAKINDGNGGASS-----S 381
            +                           D+S       +I   I+D +  +       S
Sbjct: 375 CYGNYDNLLSQFGCMQVSSSSSSHSLSAVDASLPQRSGSNIEQYIHDLDTNSFELDLQFS 434

Query: 382 EGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS 441
           E     L    +  + W QF++    +L +  V K + L +++ QL+LT  P L YVDP 
Sbjct: 435 EDEKRLLLEKQAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPV 493

Query: 442 KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEAL 496
             V+KG I W   S +L  +  +   F + TP +     D    A +W + I+ +
Sbjct: 494 NKVLKGEIPW---SQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEV 545

Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O15530|PDPK1_HUMAN 3-phosphoinositide-dependent protein kinase 1 OS=Homo sapiens GN=PDPK1 PE=1 SV=1

 Score =  314 bits (804), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 182/475 (38%), Positives = 257/475 (54%), Gaps = 45/475 (9%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 80  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 139

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 140 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 199

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 200 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 251

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 252 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 311

Query: 295 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
           L+++LL +D + R G     GY  LK HPFF+ + W+N+  QTPPKL +     S + +D
Sbjct: 312 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDED 371

Query: 354 VHDSSWN--------------------------PSHIG-DISAKINDGNGGASS-----S 381
            + +  N                          P   G +I   I+D +  +       S
Sbjct: 372 CYGNYDNLLSQFGCMQVSSSSSSHSLSASDTGLPQRSGSNIEQYIHDLDSNSFELDLQFS 431

Query: 382 EGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS 441
           E     L    +  + W QF++    +L +  V K + L +++ QL+LT  P L YVDP 
Sbjct: 432 EDEKRLLLEKQAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPV 490

Query: 442 KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEAL 496
             V+KG I W   S +L  +  +   F + TP +     D    A +W + I+ +
Sbjct: 491 NKVLKGEIPW---SQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEV 542

Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages. Isoform 3 is catalytically inactive.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6A1A2|PDPK2_HUMAN Putative 3-phosphoinositide-dependent protein kinase 2 OS=Homo sapiens GN=PDPK2 PE=5 SV=1

 Score =  280 bits (715), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 144/307 (46%), Positives = 193/307 (62%), Gaps = 10/307 (3%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 53  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 112

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 113 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 172

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D +I+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 173 GIIHRDLKPENILLNEDMYIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 224

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 225 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 284

Query: 295 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL-ASEPMVQSGEGD 352
           L+++LL +D + R G     GY  LK HPFF+ + W+N+  QTPPKL A  P +   + D
Sbjct: 285 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDED 344

Query: 353 DVHDSSW 359
              + SW
Sbjct: 345 CYGNVSW 351

Phosphorylates and activates not only PKB/AKT, but also PKA, PKC-zeta, RPS6KA1 and RPS6KB1. May play a general role in signaling processes and in development.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54PK9|PDPKB_DICDI 3-phosphoinositide-dependent protein kinase B OS=Dictyostelium discoideum GN=pdkB PE=3 SV=1

 Score =  239 bits (609), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 123/295 (41%), Positives = 174/295 (58%), Gaps = 14/295 (4%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S  DF+  +  G G+Y KV    + +T  ++A KI++KK I KE K  YV  E+ +LD L
Sbjct: 267 SRSDFDFIRTIGKGAYGKVKLVIEKETQLIFASKILNKKLIIKEKKAKYVNTEKTILDSL 326

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           D+P +V+LF+TFQD  +LY  LE C  G+L   +   G  S D  RFY AE++ ALEY+H
Sbjct: 327 DNPNIVKLFYTFQDENNLYFILEYCPNGDLLGALKKAGCFSIDVVRFYAAEILIALEYLH 386

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
             G+ HRD+KPEN+LL  + H+K++DFGS K +       + +     ++ +F GTA YV
Sbjct: 387 GKGIAHRDLKPENILLGKNQHLKLSDFGSAKQLS------IGSHHKGSRSGSFCGTAEYV 440

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA 292
            PE+L    A    D+W+ GC LYQ++SG  PFK  +E+  F  I  R+  +P+ F    
Sbjct: 441 CPELLTEKSAGVEADIWSYGCLLYQLVSGKLPFKGFNEYQTFLLITKREFSYPDNFDKCC 500

Query: 293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI-DWKNIRGQTPPKLASEPMV 346
            +LID+LLD+DP  RP       + +K H FF  I DW +I  QTPP +  E MV
Sbjct: 501 MNLIDQLLDLDPYKRPTI-----SEIKNHEFFSSIQDWSSIPSQTPPPI--EQMV 548

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q12701|KSG1_SCHPO Serine/threonine-protein kinase ksg1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ksg1 PE=1 SV=2

 Score =  230 bits (587), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 123/290 (42%), Positives = 168/290 (57%), Gaps = 10/290 (3%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           + DF+ G+I G GSYS V+ A +  T   YA+K++DK+ I KE K  YV +E+  L  L 
Sbjct: 96  VSDFKFGEILGEGSYSTVLTATENSTKREYAIKVLDKRHIIKEKKEKYVNIEKEALCILS 155

Query: 114 -HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HPG ++LF+TFQD  +LY  L     GEL D I   G  +E  A++Y A +VD+++Y+H
Sbjct: 156 KHPGFIKLFYTFQDAHNLYFVLSLARNGELLDYINKLGRFNEICAQYYAALIVDSIDYMH 215

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK----ACTFVGT 228
             G+IHRD+KPEN+LL  +   KI DFGS K +  S  +   +    DK    + +FVGT
Sbjct: 216 GRGVIHRDLKPENILLDDNMRTKITDFGSAKILNSSHGSHEEDTHHADKPQAHSRSFVGT 275

Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
           A YV PEVL+   A   +D+WA GC L+QML+G  PF   +E+L FQ I+      P   
Sbjct: 276 ARYVSPEVLSDKIAGTASDIWAFGCILFQMLAGKPPFVAGNEYLTFQSILHLSYEIPPDI 335

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
           SD A DLI +LL +DP  R          +  HPFF GI + N   + PP
Sbjct: 336 SDVASDLIKKLLVLDPKDRLTVDE-----IHQHPFFNGIKFDNTLWELPP 380

Involved in the control of cell cycle arrest via a phosphoinositide signaling pathway.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P34102|PK3_DICDI Protein kinase 3 OS=Dictyostelium discoideum GN=pkgC PE=3 SV=2

 Score =  228 bits (582), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 114/292 (39%), Positives = 179/292 (61%), Gaps = 10/292 (3%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
            +I DFEL K+ GVGS+ +V   ++ DTG  YA+K+++KK + K+ + A+   E++VL  
Sbjct: 493 LTIDDFELLKVLGVGSFGRVYLVRRKDTGKFYAMKVLNKKDMLKKKQIAHTNTEKMVLST 552

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +DHP +VRL F FQ+   L+M ++   GGELF  +   G   E+ A+FY AEV+ +L Y+
Sbjct: 553 MDHPFIVRLHFAFQNEDFLFMCMDYVPGGELFHHLQKAGKFPEELAKFYIAEVICSLHYL 612

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL---PNAASDDKACTFVGT 228
           HS  +I+RDIKPEN+LL  +GHIK+ DFG    +  S IT +    N      A TF GT
Sbjct: 613 HSNNIIYRDIKPENILLDEEGHIKLTDFG----LSKSGITSVVGSKNGGEGGFATTFCGT 668

Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+ PE++  +      D W++G  L++ML+G SPF  ++   +++ +I  ++R P + 
Sbjct: 669 PEYLAPEIITGAGHGKAADWWSVGILLFEMLTGRSPFLASNRNDMYKSMIQGNLRMPMFL 728

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
           S  A+DL+++LL  DP+ R G+   G+  +  HPFF+ I W+ +  +  TPP
Sbjct: 729 SSDAQDLLEKLLVPDPNKRLGST-QGFEEISSHPFFELIPWRMLESKMITPP 779

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q12236|PKH2_YEAST Serine/threonine-protein kinase PKH2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=PKH2 PE=1 SV=1

 Score =  226 bits (575), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 116/291 (39%), Positives = 179/291 (61%), Gaps = 9/291 (3%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I+DF+ G + G G+YS V+ A  IDT   YA K+++K+++ ++ K  YV +E+  L +L+
Sbjct: 176 IKDFKFGSVIGDGAYSTVMLATSIDTKKRYAAKVLNKEYLIRQKKVKYVSIEKTALQKLN 235

Query: 114 H-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P VVRLF TFQD  SLY  LE    G+    +   G L E  AR+Y A+++DA++Y+H
Sbjct: 236 NSPSVVRLFSTFQDESSLYFLLEYAPNGDFLSLMKKYGSLDETCARYYAAQIIDAIDYLH 295

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV-LPNAASDDKACTFVGTAAY 231
           S G+IHRDIKPEN+LL  +  IK+ DFG+ K +  +  +V  P      ++ +FVGTA Y
Sbjct: 296 SNGIIHRDIKPENILLDGEMKIKLTDFGTAKLLNPTNNSVSKPEYDLSTRSKSFVGTAEY 355

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 291
           V PE+LN S   +  D+WA GC L+QM++G  PFK T+E+L FQ+++     F   F   
Sbjct: 356 VSPELLNDSFTDYRCDIWAFGCILFQMIAGKPPFKATNEYLTFQKVMKVQYAFTPGFPLI 415

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN--IRGQTPPKL 340
            RDL+ ++L  +   R        + +K H FFK +++K+  +  +TPP++
Sbjct: 416 IRDLVKKILVKNLDRR-----LTISQIKEHHFFKDLNFKDGSVWSKTPPEI 461

Serine/threonine-protein kinase which is part sphingolipid-mediated signaling pathway that is required for the internalization step of endocytosis by regulating eisosome assembly and organization, and modulating the organization of the plasma membrane. Phosphorylates and activates PKC1. Activates YPK1 and YPK2, 2 components of signaling cascade required for maintenance of cell wall integrity. Required for stress-induced P-body assembly and regulates global mRNA decay at the deadenylation step.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	499
255586617	506	3-phosphoinositide-dependent protein kin	0.977	0.964	0.857	0.0
297829596	486	hypothetical protein ARALYDRAFT_897238 [	0.971	0.997	0.844	0.0
350539745	494	3-phosphoinositide-dependent protein kin	0.959	0.969	0.856	0.0
225449645	502	PREDICTED: 3-phosphoinositide-dependent	0.965	0.960	0.833	0.0
224109900	496	predicted protein [Populus trichocarpa]	0.977	0.983	0.846	0.0
30681369	486	3-phosphoinositide-dependent protein kin	0.971	0.997	0.840	0.0
110743925	486	3-phosphoinositide-dependent protein kin	0.971	0.997	0.840	0.0
356535531	491	PREDICTED: 3-phosphoinositide-dependent	0.977	0.993	0.855	0.0
12322773	483	putative 3-phosphoinositide-dependent pr	0.965	0.997	0.841	0.0
296090372	468	unnamed protein product [Vitis vinifera]	0.919	0.980	0.879	0.0

>gi|255586617|ref|XP_002533941.1| 3-phosphoinositide-dependent protein kinase-1, putative [Ricinus communis] gi|223526096|gb|EEF28448.1| 3-phosphoinositide-dependent protein kinase-1, putative [Ricinus communis]

 Score =  874 bits (2259), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 433/505 (85%), Positives = 459/505 (90%), Gaps = 17/505 (3%)

Query: 11  MLAMEKDFDSKLRIEGNNNSSTN--------------CPTVQRSKSFAFRAPQEHFSIQD 56
           MLAMEKDFDSKLRI+ +NNSS++                 VQRSKSFAFRAPQE+FSIQD
Sbjct: 1   MLAMEKDFDSKLRIQSSNNSSSSSSISSNHNNNNNNNIGNVQRSKSFAFRAPQENFSIQD 60

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           FELGKIYGVGSYSKVVRAKK DTG VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG
Sbjct: 61  FELGKIYGVGSYSKVVRAKKKDTGMVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 120

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +VRLFFTFQD+FSLYMALESCEGGELFDQIT KG LSEDEARFY AEVVDALEYIH MGL
Sbjct: 121 IVRLFFTFQDSFSLYMALESCEGGELFDQITRKGRLSEDEARFYAAEVVDALEYIHGMGL 180

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           IHRDIKPENLLLTADGHIK+ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV
Sbjct: 181 IHRDIKPENLLLTADGHIKVADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 240

Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLI 296
           LNSSPATFGNDLWALGCTLYQMLSGTSPFKD SEWLIFQRIIARDIRFPNYFS+ ARD+I
Sbjct: 241 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDASEWLIFQRIIARDIRFPNYFSEEARDII 300

Query: 297 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHD 356
           DRLLD+DPS RPGAGP GYA LK+HPFFKGI+WKN+R +TPPKLA E M QSG+G+   D
Sbjct: 301 DRLLDIDPSRRPGAGPEGYAALKIHPFFKGINWKNLREETPPKLALEAMTQSGDGELDPD 360

Query: 357 SSWNPSHIGDISAKINDGNGGASSS---EGSITRLASIDSFDSKWQQFLDPGESVLMISM 413
           ++WNP+HIGD SA+ NDG GG SS+    GSITRLASIDSFDSKWQQFLDPGESVLMISM
Sbjct: 361 ATWNPTHIGDGSARQNDGTGGPSSTAEASGSITRLASIDSFDSKWQQFLDPGESVLMISM 420

Query: 414 VKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTP 473
           VKKLQKLTSKKVQLILTNKPKLIYVDPSKL+VKGNIIWSDNSNDLS+QVSSPSHFKI TP
Sbjct: 421 VKKLQKLTSKKVQLILTNKPKLIYVDPSKLLVKGNIIWSDNSNDLSVQVSSPSHFKIFTP 480

Query: 474 KKVLSFEDAKQRASQWKKAIEALQN 498
           KKV+SFEDAKQRA QWKKAIE+LQN
Sbjct: 481 KKVMSFEDAKQRAWQWKKAIESLQN 505

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297829596|ref|XP_002882680.1| hypothetical protein ARALYDRAFT_897238 [Arabidopsis lyrata subsp. lyrata] gi|297328520|gb|EFH58939.1| hypothetical protein ARALYDRAFT_897238 [Arabidopsis lyrata subsp. lyrata]

 Score =  850 bits (2196), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 412/488 (84%), Positives = 443/488 (90%), Gaps = 3/488 (0%)

Query: 11  MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 70
           ML MEK+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMEKEFDSKLSLQGN--SSSNGATISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 71  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 130
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 190
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT+
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTS 178

Query: 191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 250
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 251 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 311 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 370
           G  GYA LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S  
Sbjct: 299 GSEGYASLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVL 357

Query: 371 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 430
            NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct: 358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query: 431 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 490
           NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct: 418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query: 491 KAIEALQN 498
           KAIE LQN
Sbjct: 478 KAIETLQN 485

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350539745|ref|NP_001234519.1| 3-phosphoinositide-dependent protein kinase-1 [Solanum lycopersicum] gi|57168305|gb|AAW38936.1| 3-phosphoinositide-dependent protein kinase-1 [Solanum lycopersicum]

 Score =  850 bits (2195), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/489 (85%), Positives = 443/489 (90%), Gaps = 10/489 (2%)

Query: 14  MEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVR 73
           ME++FD+KL+I+ NN+++T     QRSKSFAFRAPQE+F+IQDFELGKIYGVGSYSKVVR
Sbjct: 11  MEQEFDAKLKIQ-NNSANT-----QRSKSFAFRAPQENFTIQDFELGKIYGVGSYSKVVR 64

Query: 74  AKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 133
           AKK DT  VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA
Sbjct: 65  AKKKDTANVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 124

Query: 134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 193
           LESCEGGELFDQIT KG LSEDEARFY AEVVDALEYIHSMGLIHRDIKPENLLLT+DGH
Sbjct: 125 LESCEGGELFDQITRKGRLSEDEARFYAAEVVDALEYIHSMGLIHRDIKPENLLLTSDGH 184

Query: 194 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 253
           IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC
Sbjct: 185 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 244

Query: 254 TLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 313
           TLYQMLSGTSPFKD SEWLIFQRIIARDIRFPNYFS+ ARD+ID+LLDVDPS RPGAGP 
Sbjct: 245 TLYQMLSGTSPFKDASEWLIFQRIIARDIRFPNYFSNEARDIIDQLLDVDPSRRPGAGPD 304

Query: 314 GYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGD-DVHDSSWNPSHIGDISAKIN 372
           GYA LK HPFF GIDW+N+R QTPP+LA EP   S     D  D SWNPSHIGD S + N
Sbjct: 305 GYASLKNHPFFSGIDWENLRLQTPPRLAMEPKAPSTHSSGDEQDPSWNPSHIGDGSVRPN 364

Query: 373 DGNGGASS---SEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLIL 429
           DGNG A+S   +  SITRLASIDSFDSKW+QFLDPGESVLMISMVKKLQKLTSKKVQLIL
Sbjct: 365 DGNGAAASVSEAGNSITRLASIDSFDSKWKQFLDPGESVLMISMVKKLQKLTSKKVQLIL 424

Query: 430 TNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQW 489
           TNKPKLIYVDPSKLV+KGNIIWSDN NDLSIQV+SPS FKI TPKKV+SFEDAK RA QW
Sbjct: 425 TNKPKLIYVDPSKLVIKGNIIWSDNPNDLSIQVTSPSQFKICTPKKVMSFEDAKNRAQQW 484

Query: 490 KKAIEALQN 498
           KKAIEALQN
Sbjct: 485 KKAIEALQN 493

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225449645|ref|XP_002262670.1| PREDICTED: 3-phosphoinositide-dependent protein kinase 1-like [Vitis vinifera]

 Score =  850 bits (2195), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 420/504 (83%), Positives = 445/504 (88%), Gaps = 22/504 (4%)

Query: 14  MEKDFDSKLRIEGNNNSSTNCPT----------------VQRSKSFAFRAPQEHFSIQDF 57
           MEKDFDSKLRI+ N+++                      VQRSKSFAFRAPQE+F+IQDF
Sbjct: 1   MEKDFDSKLRIQSNSSNGGTAGGGGGGGGGGGGGGGAGAVQRSKSFAFRAPQENFTIQDF 60

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 117
           ELGKIYGVGSYSKVVRA+K DTG VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG+
Sbjct: 61  ELGKIYGVGSYSKVVRARKKDTGIVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGI 120

Query: 118 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
           VRLFFTFQDTFSLYMALESCEGGELFDQIT KG LSE+EARFY AEVVDALEYIHS+GLI
Sbjct: 121 VRLFFTFQDTFSLYMALESCEGGELFDQITRKGRLSENEARFYAAEVVDALEYIHSLGLI 180

Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           HRDIKPENLLLTADGHIKIADFGSVKPMQDS ITVLPNAASDDKACTFVGTAAYVPPEVL
Sbjct: 181 HRDIKPENLLLTADGHIKIADFGSVKPMQDSLITVLPNAASDDKACTFVGTAAYVPPEVL 240

Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID 297
           NSSPATFGNDLWALGCTLYQMLSGTSPFKD SEWLIFQRIIARDIRFPNYFSD ARDLID
Sbjct: 241 NSSPATFGNDLWALGCTLYQMLSGTSPFKDASEWLIFQRIIARDIRFPNYFSDEARDLID 300

Query: 298 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDS 357
           RLLD +PS RPGAG  GYA LKMHPFF G+DWKN+R QTPPKLA E    S EGDD  D 
Sbjct: 301 RLLDTEPSRRPGAGRDGYASLKMHPFFNGVDWKNLRSQTPPKLAME--AHSSEGDDGQD- 357

Query: 358 SWNPSHIGDISAKINDGNGGASSSE---GSITRLASIDSFDSKWQQFLDPGESVLMISMV 414
           SWNP+HIGD SA+ NDGN GA+SS    GS+TRLASIDSFDSKWQQFL+ GESVLMISMV
Sbjct: 358 SWNPAHIGDGSARQNDGNSGATSSSEAPGSVTRLASIDSFDSKWQQFLEQGESVLMISMV 417

Query: 415 KKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK 474
           KK+QKLT+KKVQLILTNKPKLIYVDP+KL+VKGNIIWSDN NDLSIQV+SPSHFKI TPK
Sbjct: 418 KKIQKLTNKKVQLILTNKPKLIYVDPAKLMVKGNIIWSDNPNDLSIQVTSPSHFKICTPK 477

Query: 475 KVLSFEDAKQRASQWKKAIEALQN 498
           KV+SFED+KQRA QWKKAIE LQN
Sbjct: 478 KVMSFEDSKQRAWQWKKAIEGLQN 501

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224109900|ref|XP_002315349.1| predicted protein [Populus trichocarpa] gi|222864389|gb|EEF01520.1| predicted protein [Populus trichocarpa]

 Score =  847 bits (2189), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/495 (84%), Positives = 445/495 (89%), Gaps = 7/495 (1%)

Query: 11  MLAMEKDFDSKLRIEGNNN----SSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVG 66
           ML ME++FDSKLRI+  ++    S+ N  +VQRSKSFAFRAPQE+F+I DFELGKIYGVG
Sbjct: 1   MLEMEREFDSKLRIQSGDHPSSSSNNNNGSVQRSKSFAFRAPQENFTIHDFELGKIYGVG 60

Query: 67  SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD 126
           SYSKVVRAKK DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG+VRLFFTFQD
Sbjct: 61  SYSKVVRAKKKDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGIVRLFFTFQD 120

Query: 127 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL 186
            +SLYMALESCEGGELFDQIT KG LSEDEA FY AEVVDALEYIHSMGLIHRDIKPENL
Sbjct: 121 NYSLYMALESCEGGELFDQITRKGRLSEDEACFYAAEVVDALEYIHSMGLIHRDIKPENL 180

Query: 187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN 246
           LLTA+GHIKIADFGSVKPMQDS ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN
Sbjct: 181 LLTAEGHIKIADFGSVKPMQDSCITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN 240

Query: 247 DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSG 306
           DLWALGCTLYQMLSGTSPFKD SEWLIFQRIIARDIRFP+YFS  ARDLID LLD+DPS 
Sbjct: 241 DLWALGCTLYQMLSGTSPFKDASEWLIFQRIIARDIRFPDYFSGEARDLIDHLLDIDPSR 300

Query: 307 RPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGD 366
           RPGAG GGYA LK HPFF+G+DWKN+RG+TPPKL SEPMVQSG+ D    S +NP+  GD
Sbjct: 301 RPGAGRGGYAELKNHPFFEGVDWKNLRGETPPKLVSEPMVQSGDSDHDSGSPYNPTRAGD 360

Query: 367 ISAKINDGNGGASSSE---GSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSK 423
            S   NDGN G SSS      ITRLASIDSFDSKWQQFLDPGESVLMI+MVKKLQKLTSK
Sbjct: 361 SSLTQNDGNAGVSSSAEATAHITRLASIDSFDSKWQQFLDPGESVLMIAMVKKLQKLTSK 420

Query: 424 KVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAK 483
           KVQLILTNKPKLIYVDPSKLVVKGNIIWSDNS+DLS+QV+SPSHFKI TPKKV SFEDAK
Sbjct: 421 KVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSDDLSVQVTSPSHFKICTPKKVRSFEDAK 480

Query: 484 QRASQWKKAIEALQN 498
           QRA QWKKAIE+LQN
Sbjct: 481 QRAWQWKKAIESLQN 495

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30681369|ref|NP_187665.2| 3-phosphoinositide-dependent protein kinase [Arabidopsis thaliana] gi|75316154|sp|Q4V3C8.1|PDPK2_ARATH RecName: Full=3-phosphoinositide-dependent protein kinase 2; Short=AtPDK2 gi|66792634|gb|AAY56419.1| At3g10540 [Arabidopsis thaliana] gi|95147296|gb|ABF57283.1| At3g10540 [Arabidopsis thaliana] gi|332641402|gb|AEE74923.1| 3-phosphoinositide-dependent protein kinase [Arabidopsis thaliana]

 Score =  844 bits (2181), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/488 (84%), Positives = 441/488 (90%), Gaps = 3/488 (0%)

Query: 11  MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 70
           ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 71  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 130
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 190
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query: 191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 250
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 251 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 311 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 370
           G  GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S  
Sbjct: 299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVL 357

Query: 371 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 430
            NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct: 358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query: 431 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 490
           NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct: 418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query: 491 KAIEALQN 498
           KAIE LQN
Sbjct: 478 KAIETLQN 485

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110743925|dbj|BAE99796.1| 3-phosphoinositide-dependent protein kinase-1 like [Arabidopsis thaliana]

 Score =  843 bits (2179), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/488 (84%), Positives = 440/488 (90%), Gaps = 3/488 (0%)

Query: 11  MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 70
           ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 71  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 130
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 190
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query: 191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 250
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 251 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIEFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 311 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 370
           G  GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S  
Sbjct: 299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVL 357

Query: 371 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 430
            NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct: 358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query: 431 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 490
           NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct: 418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query: 491 KAIEALQN 498
           KAIE LQN
Sbjct: 478 KAIETLQN 485

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356535531|ref|XP_003536298.1| PREDICTED: 3-phosphoinositide-dependent protein kinase 2-like [Glycine max]

 Score =  842 bits (2174), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/490 (85%), Positives = 451/490 (92%), Gaps = 2/490 (0%)

Query: 11  MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 70
           ML MEKDFDSKL+I+GN++SS     VQRSKSFAFRAPQE+++IQDFELGKIYGVGSYSK
Sbjct: 1   MLEMEKDFDSKLKIQGNSSSSNGAGNVQRSKSFAFRAPQENYTIQDFELGKIYGVGSYSK 60

Query: 71  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 130
           VVRAKK DTG VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG+VRL+FTFQD+FSL
Sbjct: 61  VVRAKKKDTGIVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGIVRLYFTFQDSFSL 120

Query: 131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 190
           YMALESCEGGELFDQIT KG LSE+EARFY AEV+DALEYIH++G+IHRDIKPENLLLTA
Sbjct: 121 YMALESCEGGELFDQITRKGRLSENEARFYAAEVIDALEYIHNLGVIHRDIKPENLLLTA 180

Query: 191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 250
           +GHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 181 EGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240

Query: 251 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
           LGCTLYQMLSGTSPFKD SEWLIFQRIIAR++RFP+YFSD ARDLIDRLLD+DPS RPGA
Sbjct: 241 LGCTLYQMLSGTSPFKDASEWLIFQRIIARELRFPDYFSDEARDLIDRLLDLDPSRRPGA 300

Query: 311 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 370
           GP GYA+LK HPFFKG+DW N+R Q PPKLA EP  QS   DDVHDSSW+PSHIGD SA 
Sbjct: 301 GPDGYAILKSHPFFKGVDWDNLRAQIPPKLAPEPGTQSPASDDVHDSSWSPSHIGDGSAA 360

Query: 371 INDGNGGASSSEGS--ITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLI 428
                 GA+SSEG+  ITRLASIDSFDSKWQQFL+PGESVLMISMVKKLQKLTSKKVQLI
Sbjct: 361 SVRQPDGATSSEGTGHITRLASIDSFDSKWQQFLEPGESVLMISMVKKLQKLTSKKVQLI 420

Query: 429 LTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQ 488
           LTNKPKLIYVDPSKL+VKGNIIWSDN NDLSIQV+SPS+FKI TPKKV+SFEDAKQRA Q
Sbjct: 421 LTNKPKLIYVDPSKLIVKGNIIWSDNPNDLSIQVASPSNFKICTPKKVMSFEDAKQRAWQ 480

Query: 489 WKKAIEALQN 498
           WKKAIE LQN
Sbjct: 481 WKKAIEGLQN 490

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|12322773|gb|AAG51370.1|AC011560_2 putative 3-phosphoinositide-dependent protein kinase-1; 57432-54928 [Arabidopsis thaliana] gi|8567784|gb|AAF76356.1| 3-phosphoinositide-dependent protein kinase-1, putative [Arabidopsis thaliana]

 Score =  840 bits (2170), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/485 (84%), Positives = 439/485 (90%), Gaps = 3/485 (0%)

Query: 14  MEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVR 73
           M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSKVVR
Sbjct: 1   MDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSKVVR 58

Query: 74  AKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 133
           AKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SLYMA
Sbjct: 59  AKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSLYMA 118

Query: 134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 193
           LESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT DGH
Sbjct: 119 LESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTLDGH 178

Query: 194 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 253
           IKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC
Sbjct: 179 IKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 238

Query: 254 TLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 313
           TLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGAG  
Sbjct: 239 TLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGAGSE 298

Query: 314 GYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKIND 373
           GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S   ND
Sbjct: 299 GYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVLQND 357

Query: 374 GNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKP 433
           G+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILTNKP
Sbjct: 358 GHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILTNKP 417

Query: 434 KLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAI 493
           +LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWKKAI
Sbjct: 418 RLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWKKAI 477

Query: 494 EALQN 498
           E LQN
Sbjct: 478 ETLQN 482

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296090372|emb|CBI40191.3| unnamed protein product [Vitis vinifera]

 Score =  840 bits (2169), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/463 (87%), Positives = 428/463 (92%), Gaps = 4/463 (0%)

Query: 39  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK 98
           RSKSFAFRAPQE+F+IQDFELGKIYGVGSYSKVVRA+K DTG VYALKIMDKKFITKENK
Sbjct: 6   RSKSFAFRAPQENFTIQDFELGKIYGVGSYSKVVRARKKDTGIVYALKIMDKKFITKENK 65

Query: 99  TAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR 158
           TAYVKLERIVLDQLDHPG+VRLFFTFQDTFSLYMALESCEGGELFDQIT KG LSE+EAR
Sbjct: 66  TAYVKLERIVLDQLDHPGIVRLFFTFQDTFSLYMALESCEGGELFDQITRKGRLSENEAR 125

Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
           FY AEVVDALEYIHS+GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS ITVLPNAAS
Sbjct: 126 FYAAEVVDALEYIHSLGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSLITVLPNAAS 185

Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 278
           DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD SEWLIFQRII
Sbjct: 186 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDASEWLIFQRII 245

Query: 279 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
           ARDIRFPNYFSD ARDLIDRLLD +PS RPGAG  GYA LKMHPFF G+DWKN+R QTPP
Sbjct: 246 ARDIRFPNYFSDEARDLIDRLLDTEPSRRPGAGRDGYASLKMHPFFNGVDWKNLRSQTPP 305

Query: 339 KLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSE---GSITRLASIDSFD 395
           KLA E M  S EGDD  D SWNP+HIGD SA+ NDGN GA+SS    GS+TRLASIDSFD
Sbjct: 306 KLAMEAMAHSSEGDDGQD-SWNPAHIGDGSARQNDGNSGATSSSEAPGSVTRLASIDSFD 364

Query: 396 SKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNS 455
           SKWQQFL+ GESVLMISMVKK+QKLT+KKVQLILTNKPKLIYVDP+KL+VKGNIIWSDN 
Sbjct: 365 SKWQQFLEQGESVLMISMVKKIQKLTNKKVQLILTNKPKLIYVDPAKLMVKGNIIWSDNP 424

Query: 456 NDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQN 498
           NDLSIQV+SPSHFKI TPKKV+SFED+KQRA QWKKAIE LQN
Sbjct: 425 NDLSIQVTSPSHFKICTPKKVMSFEDSKQRAWQWKKAIEGLQN 467

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	499
TAIR|locus:2075740	486	AT3G10540 [Arabidopsis thalian	0.971	0.997	0.815	7.8e-213
TAIR|locus:2184357	491	PDK1 "3'-phosphoinositide-depe	0.971	0.987	0.803	2.1e-210
UNIPROTKB|F1Q2Y3	558	PDPK1 "Uncharacterized protein	0.655	0.586	0.421	1.5e-77
MGI|MGI:1338068	559	Pdpk1 "3-phosphoinositide depe	0.647	0.577	0.426	5.9e-76
UNIPROTKB|Q5F3U4	556	PDPK1 "Uncharacterized protein	0.729	0.654	0.398	7.5e-76
UNIPROTKB|E9PER6	529	PDPK1 "3-phosphoinositide-depe	0.641	0.604	0.424	9.6e-76
UNIPROTKB|O15530	556	PDPK1 "3-phosphoinositide-depe	0.641	0.575	0.424	9.6e-76
RGD|620307	559	Pdpk1 "3-phosphoinositide depe	0.647	0.577	0.423	9.6e-76
UNIPROTKB|O55173	559	Pdpk1 "3-phosphoinositide-depe	0.647	0.577	0.423	9.6e-76
ZFIN|ZDB-GENE-061013-109	536	pdpk1a "3-phosphoinositide dep	0.607	0.565	0.444	1.6e-75

TAIR|locus:2075740 AT3G10540 [Arabidopsis thaliana (taxid:3702)]

 Score = 2057 (729.2 bits), Expect = 7.8e-213, P = 7.8e-213
 Identities = 398/488 (81%), Positives = 428/488 (87%)

Query:    11 MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 70
             ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct:     1 MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query:    71 VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 130
             VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct:    59 VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query:   131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 190
             YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct:   119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query:   191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 250
             DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct:   179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query:   251 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGA 310
             LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS              PS RPGA
Sbjct:   239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query:   311 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 370
             G  GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS   +    S WNP+H+GD S  
Sbjct:   299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSASPER-DGSPWNPTHVGDTSVL 357

Query:   371 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 430
              NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct:   358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query:   431 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 490
             NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct:   418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query:   491 KAIEALQN 498
             KAIE LQN
Sbjct:   478 KAIETLQN 485

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2184357 PDK1 "3'-phosphoinositide-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2034 (721.1 bits), Expect = 2.1e-210, P = 2.1e-210
 Identities = 396/493 (80%), Positives = 429/493 (87%)

Query:    11 MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 70
             MLAMEK+FDSKL ++GN+++  N   V RSKSF+F+APQE+F+  DFE GKIYGVGSYSK
Sbjct:     1 MLAMEKEFDSKLVLQGNSSNGAN---VSRSKSFSFKAPQENFTSHDFEFGKIYGVGSYSK 57

Query:    71 VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 130
             VVRAKK +TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+++L+FTFQDT SL
Sbjct:    58 VVRAKKKETGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIIKLYFTFQDTSSL 117

Query:   131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 190
             YMALESCEGGELFDQIT KG LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT+
Sbjct:   118 YMALESCEGGELFDQITRKGRLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTS 177

Query:   191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 250
             DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct:   178 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 237

Query:   251 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGA 310
             LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS              PS RPGA
Sbjct:   238 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTEPSRRPGA 297

Query:   311 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQ--SGEGDDVHDSSWNPSHIGDIS 368
             G  GY  LK HPFF G+DWKN+R QTPPKLA +P  Q  S E DD H S WN +HIGD  
Sbjct:   298 GSEGYVALKRHPFFNGVDWKNLRSQTPPKLAPDPASQTASPERDDTHGSPWNLTHIGDSL 357

Query:   369 AKINDGNGG---ASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKV 425
             A  N+G+     +S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKV
Sbjct:   358 ATQNEGHSAPPTSSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKV 417

Query:   426 QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQR 485
             QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDL++ V+SPSHFKI TPKKVLSFEDAKQR
Sbjct:   418 QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLNVVVTSPSHFKICTPKKVLSFEDAKQR 477

Query:   486 ASQWKKAIEALQN 498
             AS WKKAIE LQN
Sbjct:   478 ASVWKKAIETLQN 490

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IGI

GO:0035091 "phosphatidylinositol binding" evidence=IDA

GO:0070300 "phosphatidic acid binding" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045860 "positive regulation of protein kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|F1Q2Y3 PDPK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 669 (240.6 bits), Expect = 1.5e-77, Sum P(2) = 1.5e-77
 Identities = 142/337 (42%), Positives = 198/337 (58%)

Query:    55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    82 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 141

Query:   115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   142 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEMVSALEYLHGK 201

Query:   175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   202 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 253

Query:   235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   254 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 313

Query:   295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
                       + R G    GGY+ L+ HPFF+ I W+N++ QTPPKL +     S + +D
Sbjct:   314 LVEKLLVLDATKRLGCEEMGGYSPLRAHPFFESITWENLQHQTPPKLTAYLPAMSEDDED 373

Query:   354 VHDSSWNP-SHIGDISAKINDGNGGASSSEGSITRLA 389
              + +  N  S  G +    +  +   S+S+  + ++A
Sbjct:   374 CYGNYDNLLSQFGCMQVSSSSSSHSLSASDAGLPQMA 410

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=IEA

GO:0043304 "regulation of mast cell degranulation" evidence=IEA

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA

GO:0032869 "cellular response to insulin stimulus" evidence=IEA

GO:0032148 "activation of protein kinase B activity" evidence=IEA

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA

GO:0010594 "regulation of endothelial cell migration" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEA

GO:0006469 "negative regulation of protein kinase activity" evidence=IEA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:1338068 Pdpk1 "3-phosphoinositide dependent protein kinase 1" [Mus musculus (taxid:10090)]

 Score = 657 (236.3 bits), Expect = 5.9e-76, Sum P(2) = 5.9e-76
 Identities = 142/333 (42%), Positives = 192/333 (57%)

Query:    55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    83 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query:   115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query:   175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 254

Query:   235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYHFPEKFFPKARD 314

Query:   295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
                       + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct:   315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFETITWENLHQQTPPKLTAYLPAMSEDDED 374

Query:   354 VHDSSWNP-SHIGDISAKINDGNGGASSSEGSI 385
              + +  N  S  G +    +  +   S+ E S+
Sbjct:   375 CYGNYDNLLSQFGFMQVSSSSSSHSLSTVETSL 407

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=ISO;IDA

GO:0005158 "insulin receptor binding" evidence=ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO;IDA

GO:0005829 "cytosol" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0006469 "negative regulation of protein kinase activity" evidence=ISO

GO:0006972 "hyperosmotic response" evidence=IDA

GO:0007165 "signal transduction" evidence=TAS

GO:0010594 "regulation of endothelial cell migration" evidence=IMP

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IMP

GO:0016020 "membrane" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IDA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030054 "cell junction" evidence=IEA

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=ISO

GO:0032148 "activation of protein kinase B activity" evidence=ISO

GO:0032869 "cellular response to insulin stimulus" evidence=ISO

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IMP

GO:0042981 "regulation of apoptotic process" evidence=ISO

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=ISO

GO:0043304 "regulation of mast cell degranulation" evidence=IMP

GO:0048041 "focal adhesion assembly" evidence=ISO

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=ISO

UNIPROTKB|Q5F3U4 PDPK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 656 (236.0 bits), Expect = 7.5e-76, Sum P(2) = 7.5e-76
 Identities = 154/386 (39%), Positives = 212/386 (54%)

Query:    25 EGNNNSSTNCPTVQRSKSF----AFRAPQEHFSI-QDFELGKIYGVGSYSKVVRAKKIDT 79
             +G+N  ST   +   S S       + PQ       DF+ GKI G GS+S VV A+++ +
Sbjct:    48 QGSNMESTAAESRSSSNSLPQHTGQQPPQPRKKRPDDFKFGKILGEGSFSTVVLARELTS 107

Query:    80 GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG 139
                YA+KI++K+ I KENK  YV  ER V+ +LDHP  V+L+FTFQD   LY  L   + 
Sbjct:   108 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 167

Query:   140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 199
             GEL   I   G   E   RFYTAE+V ALEY+H  G+IHRD+KPEN+LL  D HI+I DF
Sbjct:   168 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 227

Query:   200 GSVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 258
             G+ K +  DSR           +A +FVGTA YV PE+L    A   +DLWALGC +YQ+
Sbjct:   228 GTAKVLSADSR---------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 278

Query:   259 LSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAV 317
             ++G  PF+  +E+LIFQ+II  +  FP  F                + R G    GGY  
Sbjct:   279 VAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAKDLVEKLLVLDATKRLGCEEMGGYGP 338

Query:   318 LKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNP-SHIGDISAKINDGNG 376
             LK HPFF+ I W+N+  QTPPKL +     S + +D + +  N  S  G +       +G
Sbjct:   339 LKAHPFFESIVWENLHLQTPPKLTAYLPAMSEDDEDCYGNYDNLLSQFGCMQV-----SG 393

Query:   377 GASSSEGSITRLASIDSFDSKWQQFL 402
              ASS   S+   ++  +     +Q++
Sbjct:   394 SASSHSLSVPETSTPQTSGGNIEQYI 419

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E9PER6 PDPK1 "3-phosphoinositide-dependent protein kinase 1" [Homo sapiens (taxid:9606)]

 Score = 655 (235.6 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 140/330 (42%), Positives = 191/330 (57%)

Query:    55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    53 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 112

Query:   115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   113 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 172

Query:   175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   173 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 224

Query:   235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   225 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 284

Query:   295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
                       + R G     GY  LK HPFF+ + W+N+  QTPPKL +     S + +D
Sbjct:   285 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDED 344

Query:   354 VHDSSWNP-SHIGDISAKINDGNGGASSSE 382
              + +  N  S  G +    +  +   S+S+
Sbjct:   345 CYGNYDNLLSQFGCMQVSSSSSSHSLSASD 374

GO:0005524 "ATP binding" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IEA

GO:0005158 "insulin receptor binding" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEA

GO:0010594 "regulation of endothelial cell migration" evidence=IEA

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA

GO:0043304 "regulation of mast cell degranulation" evidence=IEA

GO:0048041 "focal adhesion assembly" evidence=IEA

UNIPROTKB|O15530 PDPK1 "3-phosphoinositide-dependent protein kinase 1" [Homo sapiens (taxid:9606)]

 Score = 655 (235.6 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 140/330 (42%), Positives = 191/330 (57%)

Query:    55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    80 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 139

Query:   115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   140 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 199

Query:   175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   200 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 251

Query:   235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   252 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 311

Query:   295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
                       + R G     GY  LK HPFF+ + W+N+  QTPPKL +     S + +D
Sbjct:   312 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDED 371

Query:   354 VHDSSWNP-SHIGDISAKINDGNGGASSSE 382
              + +  N  S  G +    +  +   S+S+
Sbjct:   372 CYGNYDNLLSQFGCMQVSSSSSSHSLSASD 401

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0005158 "insulin receptor binding" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEA

GO:0010594 "regulation of endothelial cell migration" evidence=IEA

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA

GO:0043304 "regulation of mast cell degranulation" evidence=IEA

GO:0048041 "focal adhesion assembly" evidence=IEA

GO:0005925 "focal adhesion" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=IDA

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IMP

GO:0042981 "regulation of apoptotic process" evidence=IMP

GO:0030036 "actin cytoskeleton organization" evidence=TAS

GO:0035556 "intracellular signal transduction" evidence=IDA

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007268 "synaptic transmission" evidence=TAS

GO:0007596 "blood coagulation" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0016301 "kinase activity" evidence=EXP

GO:0030168 "platelet activation" evidence=TAS

GO:0031295 "T cell costimulation" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

GO:0050852 "T cell receptor signaling pathway" evidence=TAS

GO:0032869 "cellular response to insulin stimulus" evidence=IMP

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=IMP

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IDA

GO:0032148 "activation of protein kinase B activity" evidence=IDA

GO:0006469 "negative regulation of protein kinase activity" evidence=IDA

RGD|620307 Pdpk1 "3-phosphoinositide dependent protein kinase-1" [Rattus norvegicus (taxid:10116)]

 Score = 655 (235.6 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 141/333 (42%), Positives = 192/333 (57%)

Query:    55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    83 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query:   115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query:   175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPDSKQARANSFVGTAQYVSP 254

Query:   235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 314

Query:   295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
                       + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct:   315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESITWENLHQQTPPKLTAYLPAMSEDDED 374

Query:   354 VHDSSWNP-SHIGDISAKINDGNGGASSSEGSI 385
              + +  N  S  G +    +  +   S+ + S+
Sbjct:   375 CYGNYDNLLSQFGCMQVSSSSSSHSLSAVDASL 407

GO:0003323 "type B pancreatic cell development" evidence=IEA;ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=ISO;IDA;TAS

GO:0005158 "insulin receptor binding" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005829 "cytosol" evidence=IDA

GO:0005886 "plasma membrane" evidence=ISO;IDA;TAS

GO:0005925 "focal adhesion" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0006469 "negative regulation of protein kinase activity" evidence=IEA;ISO

GO:0006972 "hyperosmotic response" evidence=IEA;ISO

GO:0010594 "regulation of endothelial cell migration" evidence=IEA;ISO

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA;ISO

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA;ISO

GO:0016301 "kinase activity" evidence=ISO

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA;ISO

GO:0019901 "protein kinase binding" evidence=IDA

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=IEA;ISO

GO:0032148 "activation of protein kinase B activity" evidence=IEA;ISO

GO:0032869 "cellular response to insulin stimulus" evidence=IEA;ISO

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA;ISO

GO:0035556 "intracellular signal transduction" evidence=IEA;ISO

GO:0042981 "regulation of apoptotic process" evidence=ISO

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA;ISO

GO:0043304 "regulation of mast cell degranulation" evidence=IEA;ISO

GO:0048041 "focal adhesion assembly" evidence=IMP

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=IEA;ISO

UNIPROTKB|O55173 Pdpk1 "3-phosphoinositide-dependent protein kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 655 (235.6 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 141/333 (42%), Positives = 192/333 (57%)

Query:    55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    83 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query:   115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query:   175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPDSKQARANSFVGTAQYVSP 254

Query:   235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 314

Query:   295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
                       + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct:   315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESITWENLHQQTPPKLTAYLPAMSEDDED 374

Query:   354 VHDSSWNP-SHIGDISAKINDGNGGASSSEGSI 385
              + +  N  S  G +    +  +   S+ + S+
Sbjct:   375 CYGNYDNLLSQFGCMQVSSSSSSHSLSAVDASL 407

GO:0005524 "ATP binding" evidence=IEA

ZFIN|ZDB-GENE-061013-109 pdpk1a "3-phosphoinositide dependent protein kinase-1a" [Danio rerio (taxid:7955)]

 Score = 655 (235.6 bits), Expect = 1.6e-75, Sum P(2) = 1.6e-75
 Identities = 140/315 (44%), Positives = 188/315 (59%)

Query:    40 SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT 99
             S + A + PQ  F  +DF  GKI G GS+S VV AK++ TG  YA+KI++K  I KENK 
Sbjct:    61 SSTPALKPPQS-FKKEDFSFGKILGEGSFSTVVLAKELATGKEYAMKILEKNHIRKENKA 119

Query:   100 AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF 159
              YV  E+ +L  +DHP  V+LFFTFQD+  LY AL   + GEL   I   G   E   RF
Sbjct:   120 HYVIREKDILSCIDHPFFVKLFFTFQDSQKLYFALSYAKNGELLRYIRKIGSFDETCTRF 179

Query:   160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
             YTAE+V ALEY+H++G+IHRD+KPEN+LL  D HI+I DFG+ K +           ++ 
Sbjct:   180 YTAEIVCALEYLHTVGIIHRDLKPENILLCEDMHIQITDFGTAKQLSSD--------SAQ 231

Query:   220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 279
              +A +FVGTA YV PE+L    A   +DLWA+GC +YQ+++G  PF+  +E+LIFQ+II 
Sbjct:   232 TRANSFVGTAQYVSPELLTEKSACKSSDLWAMGCIIYQLVAGLPPFRAGNEYLIFQKIIK 291

Query:   280 RDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPP 338
              +  FP  F               P  R G    GG+  LK H FF+ + W+N+  QTPP
Sbjct:   292 LEYEFPEKFFPKAKDLVQRLLSLDPRKRLGCEEMGGFGPLKGHMFFETVSWENLPLQTPP 351

Query:   339 KLASEPMVQSGEGDD 353
             KL   P + +   DD
Sbjct:   352 KLT--PYLPAMAEDD 364

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9XF67	PDPK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.8255	0.9719	0.9877	no	no
Q4V3C8	PDPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.8401	0.9719	0.9979	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	499
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-132
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-105
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-99
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-95
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-86
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-84
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-83
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-79
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-76
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-74
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-72
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-69
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-68
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-68
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-66
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-66
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-65
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-64
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-64
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-64
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-64
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-63
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-62
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-62
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-61
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-61
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-59
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-59
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-59
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-58
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-57
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-57
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-57
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-56
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-56
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-56
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-56
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-55
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-55
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-54
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-54
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-54
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-53
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-53
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-53
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-52
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-51
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-51
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-51
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-51
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-51
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-50
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-50
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-50
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-50
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-49
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-49
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-49
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-49
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-49
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-48
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-47
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-47
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-47
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-46
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-46
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-45
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-45
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-44
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-44
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-43
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-43
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-41
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-39
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-39
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-39
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-38
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-38
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-37
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-37
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-36
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-36
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-36
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-36
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-36
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-36
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-36
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-35
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-34
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-34
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-34
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-34
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-33
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-33
cd01262	107	cd01262, PH_PDK1, 3-Phosphoinositide dependent pro	1e-32
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-32
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-32
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-32
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-31
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-31
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-30
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-30
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-30
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-29
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-28
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-28
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-28
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-28
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-28
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-27
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-27
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-27
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-27
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-27
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-27
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-26
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-26
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-26
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-26
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-25
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-25
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-25
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-25
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-25
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-25
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-24
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-24
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-24
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-23
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-23
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-23
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-23
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-22
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-22
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-22
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-21
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-21
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-21
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-20
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-20
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-20
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-19
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-19
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-18
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-18
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-18
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-17
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-16
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-09
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-08
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-08
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-05
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-05
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	0.001
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.002

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  384 bits (989), Expect = e-132
 Identities = 134/281 (47%), Positives = 179/281 (63%), Gaps = 12/281 (4%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD- 113
            DF+ GKI G GS+S VV AK+ +T   YA+KI+DK+ + KE K  YVK+E+ VL +L+ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HPG+++L++TFQD  +LY  LE    GEL   I   G L E   RFY AE++ ALEY+HS
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPM----------QDSRITVLPNAASDDKAC 223
            G+IHRD+KPEN+LL  D HIKI DFG+ K +           D+         +  +  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
           +FVGTA YV PE+LN  PA   +DLWALGC +YQML+G  PF+ ++E+L FQ+I+  +  
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           FP  F   A+DLI++LL +DP  R G    GY  LK HPFF
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  312 bits (803), Expect = e-105
 Identities = 113/261 (43%), Positives = 158/261 (60%), Gaps = 12/261 (4%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+ KV+  +K DTG +YA+K++ KK I K  +  +   ER +L +++HP +V+L + 
Sbjct: 2   GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           FQ    LY+ LE   GGELF  ++ +G  SE+ ARFY AE+V ALEY+HS+G+I+RD+KP
Sbjct: 62  FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           EN+LL ADGHIK+ DFG  K            ++   +  TF GT  Y+ PEVL      
Sbjct: 122 ENILLDADGHIKLTDFGLAK----------ELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171

Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVD 303
              D W+LG  LY+ML+G  PF       I+++I+   +RFP + S  ARDLI  LL  D
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKD 231

Query: 304 PSGRPGAGPGGYAVLKMHPFF 324
           P+ R G+G      +K HPFF
Sbjct: 232 PTKRLGSGG--AEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  299 bits (767), Expect = 7e-99
 Identities = 114/278 (41%), Positives = 162/278 (58%), Gaps = 13/278 (4%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            DFE  K  G GS+ +V+  +   +G  YALKI+ K  I K  +  +V  E+ +L  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +V L+ +FQD  +LY+ +E   GGELF  +   G   E  ARFY A+VV ALEY+HS+
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            +++RD+KPENLLL +DG+IKI DFG  K     R+          +  T  GT  Y+ P
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK-----RV--------KGRTYTLCGTPEYLAP 167

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 294
           E++ S       D WALG  +Y+ML+G  PF D +   I+++I+   +RFP++FS  A+D
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKD 227

Query: 295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
           LI  LL VD + R G    G   +K HP+F GIDW  +
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  287 bits (738), Expect = 5e-95
 Identities = 110/272 (40%), Positives = 155/272 (56%), Gaps = 22/272 (8%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +E+ +  G GS+ KV  A+   TG + A+K++ KK I K+ +      E  +L +L HP 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR--EIKILKKLKHPN 58

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +VRL+  F+D   LY+ +E CEGG+LFD +  +G LSEDEARFY  +++ ALEY+HS G+
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           +HRD+KPEN+LL  DGH+K+ADFG  + +              +K  TFVGT  Y+ PEV
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDP-----------GEKLTTFVGTPEYMAPEV 167

Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDIRFPNY---FSDAA 292
           L         D+W+LG  LY++L+G  PF  D     +F++I      FP      S  A
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227

Query: 293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           +DLI +LL  DP  R  A          HPFF
Sbjct: 228 KDLIRKLLVKDPEKRLTAEE-----ALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  264 bits (678), Expect = 8e-86
 Identities = 113/266 (42%), Positives = 157/266 (59%), Gaps = 6/266 (2%)

Query: 66  GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ 125
           G+Y +V  AKK  TG +YA+K++ K  + ++N+   V  ER +L Q   P VV+L+++FQ
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 126 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN 185
              +LY+ +E   GG+L   + + G L ED AR Y AE+V ALEY+HS G+IHRD+KP+N
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 186 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 245
           +L+ ++GH+K+ DFG  K     R   L +   +DK    VGT  Y+ PEV+     +  
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK--RIVGTPDYIAPEVILGQGHSKT 181

Query: 246 NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF--SDAARDLIDRLLDVD 303
            D W+LGC LY+ L G  PF   +   IFQ I+   I +P     SD A DLI +LL  D
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPD 241

Query: 304 PSGRPGAGPGGYAVLKMHPFFKGIDW 329
           P  R GA       +K HPFFKGIDW
Sbjct: 242 PEKRLGA--KSIEEIKNHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  263 bits (674), Expect = 4e-84
 Identities = 132/349 (37%), Positives = 186/349 (53%), Gaps = 37/349 (10%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DFE+ K+ G G++ +V   +  DTG VYA+K++ K  + K N+ A+V+ ER +L   D P
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            +V+L+++FQD   LY+ +E   GG+L + +  K    E+ ARFY AE+V AL+ +H +G
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---------RITVL----PNAASDDK- 221
            IHRDIKP+N+L+ ADGHIK+ADFG  K M  +            +L          D  
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181

Query: 222 -----ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 276
                A + VGT  Y+ PEVL  +P     D W+LG  LY+ML G  PF   +    + +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241

Query: 277 IIA--RDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
           II     +RFP     S  A DLI RLL  DP  R G+    +  +K HPFFKGIDW+N+
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGS----FEEIKSHPFFKGIDWENL 296

Query: 333 RGQTPPKLASEPMVQSGEGD-----DVHDSSWNPSHIGDISAKINDGNG 376
           R   PP +   P + S   D     D  D      ++   S K+N G  
Sbjct: 297 RETKPPFV---PEL-SSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQ 341

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  261 bits (668), Expect = 1e-83
 Identities = 118/309 (38%), Positives = 172/309 (55%), Gaps = 24/309 (7%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + F+  K+ G G   +V   +   TG ++ALK++DKK + K NK   V  E+ +L  LDH
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIH 172
           P +  L+ +FQ    L + ++ C GGELF   Q      LSE+ ARFY AEV+ ALEY+H
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADF-----GSVKP-------------MQDSRITVLP 214
            +G+++RD+KPEN+LL   GHI ++DF       V+P                + I    
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 215 NAASDD-KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 273
            +     ++ +FVGT  Y+ PEV++        D W LG  LY+ML GT+PFK ++    
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240

Query: 274 FQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 331
           F  I+ +++ FP     S +ARDLI +LL  DPS R G+   G A +K HPFF+G++W  
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK-RGAAEIKQHPFFRGVNWAL 299

Query: 332 IRGQTPPKL 340
           IR  TPP +
Sbjct: 300 IRHTTPPII 308

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  247 bits (632), Expect = 5e-79
 Identities = 102/270 (37%), Positives = 154/270 (57%), Gaps = 15/270 (5%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           GVG + +V   K       +ALK + K+ I +  +  ++  E+ +L++ +HP +V+L+ T
Sbjct: 2   GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRT 61

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           F+D   +YM +E C GGEL+  +  +G   E  ARFY A VV A EY+H+ G+I+RD+KP
Sbjct: 62  FKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKP 121

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           ENLLL ++G++K+ DFG  K ++  +           K  TF GT  YV PE++ +    
Sbjct: 122 ENLLLDSNGYVKLVDFGFAKKLKSGQ-----------KTWTFCGTPEYVAPEIILNKGYD 170

Query: 244 FGNDLWALGCTLYQMLSGTSPFK--DTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRL 299
           F  D W+LG  LY++L+G  PF   D     I+  I+  +  + FPNY   AA+DLI +L
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL 230

Query: 300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDW 329
           L  +P  R G   GG   +K H +F G DW
Sbjct: 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  240 bits (615), Expect = 1e-76
 Identities = 106/276 (38%), Positives = 153/276 (55%), Gaps = 24/276 (8%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +EL +  G GS+  V +AK   TG + A+KI+ K+   K  K    + E  +L +L HP 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +VRL   F+D   LY+ +E CEGG+LFD ++  G LSEDEA+    +++  LEY+HS G+
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           IHRD+KPEN+LL  +G +KIADFG  K +            S     TFVGT  Y+ PEV
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL----------LKSSSSLTTFVGTPWYMAPEV 169

Query: 237 LN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRIIARDIRFPNYF---- 288
           L   +      D+W+LG  LY++L+G  PF   +      + +RI+   + F        
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG 229

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           S+ A+DLI + L+ DPS RP A       +  HP+F
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTA-----EEILQHPWF 260

Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  236 bits (604), Expect = 5e-74
 Identities = 114/299 (38%), Positives = 166/299 (55%), Gaps = 15/299 (5%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           + DFE+G+  G GS+ +V  AK   TG  YA+K + K+ I K  +  +V  E+ +L +L 
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +V +  +FQD   +Y  LE   GGELF  +   G    D A+FY AE+V A EY+HS
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             +I+RD+KPENLLL   GH+K+ DFG  K     ++         D+  T  GT  Y+ 
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVP--------DRTFTLCGTPEYLA 183

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 293
           PEV+ S       D W +G  LY+ ++G  PF D + + I+++I+A  ++FPN+F   AR
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRAR 243

Query: 294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGD 352
           DL+  LL  D + R G   GG A +K HP+F G +W  +  +  P  A  P+     GD
Sbjct: 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP--APIPVRVKSPGD 300

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  230 bits (589), Expect = 3e-72
 Identities = 110/300 (36%), Positives = 164/300 (54%), Gaps = 19/300 (6%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            D E  K  G G++ +V   +   +   YALK+M    + +  +  +V  E+ VL ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P ++RLF+T  D   LYM +E   GGELF  + + G  S     FY +E+V ALEY+HS 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            +++RD+KPEN+LL  +GHIK+ DFG  K ++             D+  T  GT  Y+ P
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------------DRTWTLCGTPEYLAP 167

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 294
           EV+ S       D WALG  +Y+ML G  PF D + + I+++I+A  + FP +    A+D
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKD 227

Query: 295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMVQSGEGD 352
           LI +LL VD + R G    G   +K H +FK +DW ++  R   PP +   P V S +GD
Sbjct: 228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIV---PKV-SHDGD 283

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  224 bits (573), Expect = 7e-69
 Identities = 116/317 (36%), Positives = 174/317 (54%), Gaps = 39/317 (12%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DFE  K+ G G++ +V   +K DTG +YA+K + K  + ++ + A+V+ ER +L + D+P
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            VV+L+++FQD   LY+ +E   GG++   +  K   +E+E RFY AE + A++ IH +G
Sbjct: 62  WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT--------VLPNAASD-------- 219
            IHRDIKP+NLLL A GHIK++DFG    ++ S  T         LP+   D        
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181

Query: 220 -DKACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-- 265
             KA T+           VGT  Y+ PEV   +      D W+LG  +Y+ML G  PF  
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241

Query: 266 KDTSEWLIFQRII--ARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 321
            +  E   +++II     ++FP+    S  A+DLI RL   +   R G    G   +K H
Sbjct: 242 DNPQE--TYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGN--NGVNEIKSH 296

Query: 322 PFFKGIDWKNIRGQTPP 338
           PFFKG+DW++IR +  P
Sbjct: 297 PFFKGVDWEHIRERPAP 313

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  220 bits (563), Expect = 2e-68
 Identities = 109/294 (37%), Positives = 167/294 (56%), Gaps = 22/294 (7%)

Query: 56  DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLERIVLDQ 111
           +FEL ++ G G+Y KV   +K+   D G +YA+K++ K  I ++ KTA + + ER VL+ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 112 LDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           +   P +V L + FQ    L++ L+   GGELF  +  + H +E E R Y AE+V AL++
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H +G+I+RDIK EN+LL ++GH+ + DFG  K            A  +++A +F GT  
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL---------AEEEERAYSFCGTIE 171

Query: 231 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRF 284
           Y+ PEV+           D W+LG   +++L+G SPF    +  S+  I +RI+     F
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF 231

Query: 285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
           P   S  ARD I +LL+ DP  R GA   G   +K HPFF+GIDW ++  +  P
Sbjct: 232 PKTMSAEARDFIQKLLEKDPKKRLGA--NGADEIKNHPFFQGIDWDDLAAKRIP 283

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  218 bits (556), Expect = 9e-68
 Identities = 104/269 (38%), Positives = 150/269 (55%), Gaps = 21/269 (7%)

Query: 66  GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVRLFFTF 124
           G++  V  AKK  TG  +A+K++ K  +  +N+   VK ER I++ Q + P V +L+++F
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 125 QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE 184
           Q    LY+ +E   GG+    I + G L ED A+ Y AEVV  +E +H  G+IHRDIKPE
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126

Query: 185 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF 244
           NLL+   GH+K+ DFG       SR  +            FVGT  Y+ PE +       
Sbjct: 127 NLLIDQTGHLKLTDFGL------SRNGLENK--------KFVGTPDYLAPETILGVGDDK 172

Query: 245 GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDLIDRLL 300
            +D W+LGC +++ L G  PF   +   +F  I++R I +P     + S  A DLI+RLL
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232

Query: 301 DVDPSGRPGAGPGGYAVLKMHPFFKGIDW 329
            +DP+ R GA   GY  +K HPFFK I+W
Sbjct: 233 CMDPAKRLGA--NGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  216 bits (551), Expect = 3e-66
 Identities = 116/305 (38%), Positives = 172/305 (56%), Gaps = 23/305 (7%)

Query: 61  KIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK-TAYVKLERIVLDQLDHPG 116
           K+ G G Y KV + +K+   DTG ++A+K++ K  I +  K TA+ K ER +L+ + HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +V L + FQ    LY+ LE   GGELF  +  +G   ED A FY +E+  ALE++H  G+
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVK-PMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           I+RD+KPEN+LL A GH+K+ DFG  K  + +  +T            TF GT  Y+ PE
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT-----------HTFCGTIEYMAPE 170

Query: 236 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL 295
           +L  S      D W+LG  +Y ML+G  PF   +      +I+   +  P Y +  ARDL
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDL 230

Query: 296 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI---RGQTPPKLASEPMVQSGEGD 352
           + +LL  +PS R GAGPG  A ++ HPFF+ ++W ++   + + P K    P++QS E  
Sbjct: 231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFK----PLLQSEEDV 286

Query: 353 DVHDS 357
              DS
Sbjct: 287 SQFDS 291

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  216 bits (551), Expect = 3e-66
 Identities = 100/270 (37%), Positives = 146/270 (54%), Gaps = 11/270 (4%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR 119
           K+ G GS+ KV+ A+   T  +YA+K++ K  I +++       E+ VL     HP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L   FQ    L+  +E   GG+L   I   G   E  ARFY AE+V  L+++H  G+I+R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+K +N+LL ++GHIKIADFG  K                    TF GT  Y+ PE+L+ 
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKE----------GILGGVTTSTFCGTPDYIAPEILSY 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 299
            P     D WALG  LY+ML+G SPF+   E  +FQ I+  ++R+P + S  A+ ++   
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF 230

Query: 300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDW 329
           L  +P  R G  P G   +K HPFF+ IDW
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  213 bits (545), Expect = 3e-65
 Identities = 117/293 (39%), Positives = 155/293 (52%), Gaps = 30/293 (10%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DF++    G G Y +V  AKK DTG + ALK M K  + K N+  +V  ER +L      
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            +V+L + FQD   LY+A+E   GG+    + + G LSED ARFY AE+ +A++ +H +G
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
            IHRD+KPEN L+ A GHIK+ DFG  K                  A + VG+  Y+ PE
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-------------GIVTYANSVVGSPDYMAPE 168

Query: 236 VLNSSPATFGNDLWALGCTLYQMLSGTSPF-----KDTSEWL-----IFQRIIARDIRFP 285
           VL      F  D W+LGC LY+ L G  PF      +T E L       QR +  D RF 
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF- 227

Query: 286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
              SD A DLI +L++ DPS R     G    +K HPFFK +DW  +R   PP
Sbjct: 228 -NLSDEAWDLITKLIN-DPSRR----FGSLEDIKNHPFFKEVDWNELRELKPP 274

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  211 bits (539), Expect = 2e-64
 Identities = 106/283 (37%), Positives = 152/283 (53%), Gaps = 18/283 (6%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVR 119
           K+ G GS+ KV+ AK    G  YA+K++ KK I K+ +  ++  ER VL   + HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L ++FQ    LY  L+   GGELF  +  +    E  ARFY AE+  AL Y+HS+ +I+R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+KPEN+LL + GH+ + DFG  K                    TF GT  Y+ PEVL  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK----------EGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDAARDLID 297
            P     D W LG  LY+ML G  PF  +DT+E  ++  I+ + +R     S +AR L++
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MYDNILNKPLRLKPNISVSARHLLE 228

Query: 298 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
            LL  D + R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 229 GLLQKDRTKRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  208 bits (532), Expect = 4e-64
 Identities = 94/271 (34%), Positives = 148/271 (54%), Gaps = 17/271 (6%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           FEL ++ G G++ KV   +K DT  ++A+K M+K+   ++     V  ER +L +L+HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +V L+++FQD  ++Y+ ++   GG+L   ++ K   SE++ +F+  E+V ALEY+HS G+
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           IHRDIKP+N+LL   GH+ I DF     +    +T            +  GT  Y+ PEV
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-----------STSGTPGYMAPEV 170

Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFK---DTSEWLIFQRIIARDIRFPNYFSDAAR 293
           L     +   D W+LG T Y+ L G  P++    T    I  +    D+ +P  +S  A 
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI 230

Query: 294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           D I++LL+ DP  R G        LK HP+F
Sbjct: 231 DAINKLLERDPQKRLGDNL---KDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  210 bits (535), Expect = 5e-64
 Identities = 111/277 (40%), Positives = 154/277 (55%), Gaps = 14/277 (5%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+ KV++ +K DT  +YALK + K  I   ++  +   ER VL Q++ P +V L F+
Sbjct: 2   GKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFS 61

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           FQ    LY+ L    GGELF  +  +G      ARFYTAE++ ALE +H   +I+RD+KP
Sbjct: 62  FQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKP 121

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           EN+LL   GHI + DFG  K           N   DDK  TF GT  Y+ PE+L     T
Sbjct: 122 ENILLDYQGHIALCDFGLCK----------LNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVD 303
              D W LG  LY+ML+G  PF D +   ++++I+   +RFP+ F   A+DL+  LL  D
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD 231

Query: 304 PSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
           P+ R G    G   +K HPFF  + WK +  +G  PP
Sbjct: 232 PTRRLGY--NGAQEIKNHPFFSQLSWKKLLMKGIQPP 266

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  210 bits (535), Expect = 7e-64
 Identities = 105/289 (36%), Positives = 153/289 (52%), Gaps = 13/289 (4%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
            ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL Y+HS  +++RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +K ENL+L  DGHIKI DFG  K             +      TF GT  Y+ PEVL  +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK----------EGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 300
                 D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A+ L+  LL
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL 230

Query: 301 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEPMVQS 348
             DP  R G GP     +  H FF  I+W+++ + +  P    +P V S
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPF--KPQVTS 277

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  206 bits (526), Expect = 3e-63
 Identities = 75/258 (29%), Positives = 140/258 (54%), Gaps = 16/258 (6%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            +E+ K  G GS+ KV   ++   G +Y LK +D   ++++ +   +  E  +L +L+HP
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHP 59

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYI 171
            +++ + +F++   L + +E  +GG+L  +I  +        E++   +  ++  AL+Y+
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  ++HRDIKP+N+ LT++G +K+ DFG  K +            + D A T VGT  Y
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS----------TVDLAKTVVGTPYY 169

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYFSD 290
           + PE+  + P  + +D+W+LGC LY++ +   PF+  +   +  +I+       P+ +S 
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSS 229

Query: 291 AARDLIDRLLDVDPSGRP 308
             R+L+  LL  DP  RP
Sbjct: 230 ELRNLVSSLLQKDPEERP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  206 bits (526), Expect = 2e-62
 Identities = 107/304 (35%), Positives = 177/304 (58%), Gaps = 26/304 (8%)

Query: 56  DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLERIVLDQ 111
           +FEL K+ G G+Y KV   +K+   DTG +YA+K++ K  + ++ KT  + + ER VL+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 112 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           +   P +V L + FQ    L++ L+   GGE+F  +  + + SEDE RFY+ E++ ALE+
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H +G+++RDIK EN+LL ++GH+ + DFG  K                ++  +F GT  
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE---------KERTYSFCGTIE 171

Query: 231 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRF 284
           Y+ PE++       G   D W+LG  ++++L+G SPF    +  ++  + +RI+  D  F
Sbjct: 172 YMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230

Query: 285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI---RGQTP--PK 339
           P++    A+DL+ +LL  DP  R GAGP G + +K HPFFKG+DW+ +   +   P  P 
Sbjct: 231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPS 290

Query: 340 LASE 343
           + +E
Sbjct: 291 IRNE 294

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  203 bits (519), Expect = 3e-62
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 21/275 (7%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           ++  G++ G GS+  V  A   DTG + A+K ++    ++E   A  + E  +L  L HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER-EIRILSSLQHP 59

Query: 116 GVVRLFFTFQDTF--SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            +VR + + +D    +L + LE   GG L   +   G L E   R YT ++++ L Y+HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
            G++HRDIK  N+L+ +DG +K+ADFG  K + D                +  GT  ++ 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG--------SVRGTPYWMA 171

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE--WLIFQRIIARDI--RFPNYFS 289
           PEV+         D+W+LGCT+ +M +G  P+ +       ++ +I +       P + S
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-KIGSSGEPPEIPEHLS 230

Query: 290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           + A+D + + L  DP  RP A       L  HPF 
Sbjct: 231 EEAKDFLRKCLRRDPKKRPTA-----DELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  202 bits (515), Expect = 5e-61
 Identities = 107/284 (37%), Positives = 164/284 (57%), Gaps = 19/284 (6%)

Query: 61  KIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 117
           K+ G GS+ KV   +KI   D G +YA+K++ KK   K       K+ER +L +++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 118 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
           V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS+G+I
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           +RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ PEV+
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMAPEVV 170

Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDAARDL 295
           N    T   D W+ G  +++ML+G+ PF  KD  E +    I+   +  P + S  A+ L
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM--TMILKAKLGMPQFLSPEAQSL 228

Query: 296 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW-KNIRGQTPP 338
           +  L   +P+ R GAGP G   +K HPFF  IDW K  R +  P
Sbjct: 229 LRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  203 bits (519), Expect = 8e-61
 Identities = 107/318 (33%), Positives = 156/318 (49%), Gaps = 40/318 (12%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           F   K  G+G++ +V   +K+DT  +YA+K + K  +   N+ A+VK ER +L + D+  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           VV+L+++FQD  +LY  ++   GG++   +   G   ED ARFY AE+  A+E +H MG 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 177 IHRDIKPENLLLTADGHIKIADFG----------------SVKPMQDS------------ 208
           IHRDIKP+N+L+  DGHIK+ DFG                     QDS            
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 209 -RITVLPNAASDD----KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS 263
            R+  L            A + VGT  Y+ PEVL  +  T   D W++G  LY+ML G  
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 264 PFKDTSEWLIFQRII--ARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK 319
           PF   +      ++I     +  P+    S  A DLI RL       R   G  G   +K
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDR--LGKNGADEIK 299

Query: 320 MHPFFKGIDWKNIRGQTP 337
            HPFFKGID+ ++  +  
Sbjct: 300 AHPFFKGIDFASLIRRQK 317

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  197 bits (503), Expect = 3e-59
 Identities = 104/280 (37%), Positives = 150/280 (53%), Gaps = 12/280 (4%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
            + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+HS  +++RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           IK ENL+L  DGHIKI DFG  K       T+           TF GT  Y+ PEVL  +
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMK----------TFCGTPEYLAPEVLEDN 170

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 300
                 D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A+ L+  LL
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 230

Query: 301 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
             DP  R G GP     +  H FF  I+W+++  +   PP
Sbjct: 231 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  198 bits (506), Expect = 5e-59
 Identities = 116/332 (34%), Positives = 173/332 (52%), Gaps = 47/332 (14%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF   K+ G G++ +V   +K DTG +YA+K + K  + K+++ A+VK ER VL + D 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P VV L+++FQD   LY+ +E   GG+L   +      SED  RFY AE V A+E +H +
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFG---------------------SVKPMQDSRITVL 213
           G IHRDIKP+N+L+   GHIK++DFG                     S K   D+R +V 
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 214 PNA-----ASDDKACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 257
            ++     +S D+  T+           VGT  Y+ PE+          D W+LG  +++
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 258 MLSGTSPFKDTSEWLIFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPG 313
            L G  PF   +    +++II     + FP+  + S  A DLI RL+  +   R   G G
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENR--LGRG 297

Query: 314 GYAVLKMHPFFKGIDWKNIRG-QTP--PKLAS 342
           G   +K HPFF+G+DW  IR  + P  P+L S
Sbjct: 298 GAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKS 329

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  196 bits (501), Expect = 8e-59
 Identities = 103/295 (34%), Positives = 152/295 (51%), Gaps = 26/295 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF++  + G G + +V   ++  TG +YA+K+M K  +  +   ++ + ER +L   + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS 173
           P + +L + FQD  +LY+ +E   GG+L   +   +    ED A+FY AE+V A+  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           MG +HRDIKPEN+L+   GHIK+ADFGS   +  +   V             VGT  Y+ 
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLP--------VGTPDYIA 171

Query: 234 PEVLNS----SPATFG--NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--RDIRFP 285
           PEVL +       T+G   D W+LG   Y+M+ G SPF + +    +  I+   R ++FP
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231

Query: 286 N--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
                S    DLI  LL      R      GY  L  HPFF  IDW NIR   PP
Sbjct: 232 EDPKVSSDFLDLIQSLL-CGQKERL-----GYEGLCCHPFFSKIDWNNIRNSLPP 280

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  194 bits (495), Expect = 2e-58
 Identities = 101/294 (34%), Positives = 165/294 (56%), Gaps = 20/294 (6%)

Query: 56  DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLERIVLDQ 111
           +FEL K+ G G+Y KV   +K+   D+G +YA+K++ K  I ++ KT  + + ER VL+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 112 LDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           +   P +V L + FQ    L++ L+   GGELF  ++ +    E E + Y+ E+V ALE+
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H +G+I+RDIK EN+LL ++GH+ + DFG  K                ++A +F GT  
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH---------EDEVERAYSFCGTIE 171

Query: 231 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRF 284
           Y+ P+++           D W++G  +Y++L+G SPF    +  S+  I +RI+  +  +
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 231

Query: 285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
           P   S  A+D+I RLL  DP  R G GP     +K HPFF+ I+W ++  +  P
Sbjct: 232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  193 bits (493), Expect = 1e-57
 Identities = 115/296 (38%), Positives = 165/296 (55%), Gaps = 25/296 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            DFE+ K+ G G++ +V   K  +TG VYA+KI++K  + K  +TA  + ER VL   D 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHS 173
             +  L + FQD  +LY+ ++   GG+L   ++     L ED ARFY AE+V A++ +H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +G +HRDIKP+N+LL  +GHI++ADFGS ++ + D   TV  N A        VGT  Y+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVA--------VGTPDYI 170

Query: 233 PPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFP 285
            PE+L +     G      D W+LG  +Y+ML G +PF   S    + +I+      +FP
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230

Query: 286 NY---FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
                 S+ A+DLI RL+   P  R   G  G    K HPFF+GIDW NIR  T P
Sbjct: 231 PDVTDVSEEAKDLIRRLI-CSPETR--LGRNGLQDFKDHPFFEGIDWDNIRNSTAP 283

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  192 bits (488), Expect = 6e-57
 Identities = 117/330 (35%), Positives = 174/330 (52%), Gaps = 28/330 (8%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ---LDHPGVVRL 120
           G G++ +V + +K DT  +YA+K++ KK I  + + A+   ER +L +    + P +V L
Sbjct: 2   GKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGL 61

Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
            F+FQ    LY+  +   GGELF  +  +G  SED A+FY AE+V ALE++H   +++RD
Sbjct: 62  KFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRD 121

Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNS 239
           +KPEN+LL A GHI + DFG  K           N   +    TF GT  Y+ PEV L+ 
Sbjct: 122 LKPENILLDATGHIALCDFGLSK----------ANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFP-NYFSDAARDLI 296
              T   D W+LG  +++M  G SPF  +DT +  +++ I    +RFP N  SD  R  +
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MYRNIAFGKVRFPKNVLSDEGRQFV 229

Query: 297 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPPKLASEPMVQSGEGDDV 354
             LL+ +P  R GA       LK HPFF  IDW  +  +  TPP    +P+V S E    
Sbjct: 230 KGLLNRNPQHRLGAHRDAVE-LKEHPFFADIDWDLLSKKQITPP---FKPIVDSDEDVSN 285

Query: 355 HDSSWNPSHIGDISAKIND---GNGGASSS 381
            D  +  S + +      +   G  GA+S+
Sbjct: 286 FDPEFTNSSLLNAGIVPWEDVPGLPGANST 315

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  191 bits (486), Expect = 9e-57
 Identities = 107/291 (36%), Positives = 156/291 (53%), Gaps = 20/291 (6%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 119
           K+ G GS+ KV+ A+   T   +A+K + K  + +++      +ER VL    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           LF TFQ    L+  +E   GG+L   I S G   E  ARFY AE++  L+++H  G+I+R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+K +N+LL  DGHIKIADFG  K           N   + KA TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK----------ENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 299
                  D W+ G  LY+ML G SPF    E  +F  I+     FP + S  A+D + +L
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL 230

Query: 300 LDVDPSGRPG-AGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEPMVQS 348
            + DP+ R G  G      ++ HPFF+GIDW+ + + + PP    +P V+S
Sbjct: 231 FERDPTKRLGVDGD-----IRQHPFFRGIDWERLEKREIPPPF--KPKVKS 274

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  190 bits (484), Expect = 2e-56
 Identities = 101/286 (35%), Positives = 145/286 (50%), Gaps = 13/286 (4%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DF    + G GS+ KV+ A++  T  +YA+KI+ K  I +++      +E+ VL     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 116 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             + +L   FQ    LY  +E   GG+L   I   G   E  A FY AE+   L ++HS 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+I+RD+K +N++L A+GHIKIADFG  K           N        TF GT  Y+ P
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKE----------NIFGGKTTRTFCGTPDYIAP 170

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 294
           E++   P     D WA G  LY+ML+G  PF    E  +FQ I+  ++ +P   S  A  
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS 230

Query: 295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
           +   LL   P+ R G GP G   ++ H FF+ IDW+ +  R   PP
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPP 276

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  190 bits (485), Expect = 2e-56
 Identities = 103/311 (33%), Positives = 163/311 (52%), Gaps = 28/311 (9%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR 119
           ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +   +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL ++H  G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+K +N+LL A+GHIK+ D+G  K                D   TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK----------EGIRPGDTTSTFCGTPNYIAPEILRG 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIARDIRFPNYFS 289
               F  D WALG  +++M++G SPF          ++T ++L FQ I+ + IR P   S
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL-FQVILEKQIRIPRSLS 229

Query: 290 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMV 346
             A  ++   L+ DP  R G  P  G+  +K HPFF+ IDW  +  +   PP    +P +
Sbjct: 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP---YKPNI 286

Query: 347 QSGEGDDVHDS 357
           +S    D  D 
Sbjct: 287 ESDRDLDNFDP 297

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  190 bits (483), Expect = 2e-56
 Identities = 106/281 (37%), Positives = 151/281 (53%), Gaps = 13/281 (4%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHR 179
            ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+HS   +++R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+K ENL+L  DGHIKI DFG  K       T+           TF GT  Y+ PEVL  
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------TFCGTPEYLAPEVLED 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 299
           +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A+ L+  L
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL 230

Query: 300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
           L  DP  R G GP     +  H FF GI W+++  +   PP
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPP 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  189 bits (480), Expect = 8e-56
 Identities = 103/280 (36%), Positives = 155/280 (55%), Gaps = 12/280 (4%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           K+ G G++ KV+  ++  +G  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
            ++FQ    L   +E   GGELF  ++ +   SED  RFY AE+V AL+Y+HS  +++RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +K ENL+L  DGHIKI DFG  K         + +AA+     TF GT  Y+ PEVL  +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEG-------ITDAATMK---TFCGTPEYLAPEVLEDN 170

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 300
                 D W LG  +Y+M+ G  PF +     +F+ I+  DI+FP   S  A+ L+  LL
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL 230

Query: 301 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
             DP+ R G GP     +  H FF G++W+++  +   PP
Sbjct: 231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  187 bits (478), Expect = 2e-55
 Identities = 96/287 (33%), Positives = 144/287 (50%), Gaps = 16/287 (5%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 113
           F    + G G + KV+ A+   TG +YA+K + K  I   ++   +  E+ + +  +   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +V LF  FQ    +   +E   GG+L   I      SE  A FY A VV  L+Y+H 
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHE 119

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             +++RD+K +NLLL  +G +KIADFG  K                D+  TF GT  ++ 
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKE----------GMGFGDRTSTFCGTPEFLA 169

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 293
           PEVL  +  T   D W LG  +Y+ML G SPF    E  +F  I+  ++R+P + S  A 
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI 229

Query: 294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
            ++ RLL  +P  R G+G      +K  PFF+ I+W ++  R   PP
Sbjct: 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPP 276

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  184 bits (469), Expect = 2e-55
 Identities = 83/250 (33%), Positives = 124/250 (49%), Gaps = 46/250 (18%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G +  V  A+   TG   A+KI+ K+  +   +    ++E  +L +L+HP +V+L+  
Sbjct: 2   GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIE--ILKKLNHPNIVKLYGV 59

Query: 124 FQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
           F+D   LY+ +E CEGG L D +    G LSEDE      ++++ LEY+HS G+IHRD+K
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 183 PENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NSS 240
           PEN+LL +D G +K+ADFG  K +                  T VGT AY+ PEVL    
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTS----------DKSLLKTIVGTPAYMAPEVLLGKG 169

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 300
             +  +D+W+LG  LY++                                  +DLI ++L
Sbjct: 170 YYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKML 198

Query: 301 DVDPSGRPGA 310
             DP  RP A
Sbjct: 199 QKDPEKRPSA 208

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  187 bits (476), Expect = 3e-55
 Identities = 103/281 (36%), Positives = 151/281 (53%), Gaps = 14/281 (4%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVR 119
           K+ G GS+ KV+ AK+   G+ YA+K++ KK I K+ +  ++  ER ++L  L HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L ++FQ    LY  L+   GGELF  +  +    E  ARFY AEV  A+ Y+HS+ +I+R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+KPEN+LL + GH+ + DFG  K               ++   TF GT  Y+ PEVL  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK----------EGVEPEETTSTFCGTPEYLAPEVLRK 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 299
            P     D W LG  LY+ML G  PF       ++  I+ + ++ P   + AA DL+  L
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL 230

Query: 300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
           L  D   R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 231 LHKDQRRRLGA-KADFLEIKNHVFFSPINWDDLYHKRITPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  183 bits (466), Expect = 2e-54
 Identities = 87/283 (30%), Positives = 143/283 (50%), Gaps = 19/283 (6%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G + +V   +   TG +YA K +DKK + K         E+ +L+++    +V L + 
Sbjct: 2   GKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYA 61

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
           F+    L + +    GG+L   I + G     E  A FY A+++  LE++H   +++RD+
Sbjct: 62  FETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDL 121

Query: 182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 241
           KPEN+LL   G+++I+D G    ++  +           K     GT  Y+ PEVL    
Sbjct: 122 KPENVLLDDHGNVRISDLGLAVELKGGK-----------KIKGRAGTPGYMAPEVLQGEV 170

Query: 242 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSDAARDLID 297
             F  D +ALGCTLY+M++G SPF+   E +    + +R +   + +P+ FS  A+DL +
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCE 230

Query: 298 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
            LL  DP  R G   G    ++ HP FK ++W+ +      PP
Sbjct: 231 ALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  184 bits (469), Expect = 3e-54
 Identities = 102/308 (33%), Positives = 164/308 (53%), Gaps = 21/308 (6%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 119
           ++ G GS+ KV+ A+  ++G +YA+K++ K  I +++       E+ +L    +HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L+  FQ    L+  +E   GG+L   I       E  ARFY AE+  AL ++H  G+I+R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+K +N+LL  +GH K+ADFG  K    +  T            TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT----------TSTFCGTPDYIAPEILQE 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 299
                  D WA+G  LY+ML G +PF+  +E  +F+ I+  ++ +P + S  A D++   
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF 230

Query: 300 LDVDPSGRPGA-GPGGYAVLKMHPFFKGIDWK--NIRGQTPPKLASEPMVQSGEGDDVHD 356
           +  +P+ R G+   GG   +  HPFFK +DW+  N R   PP     P ++S E  DV  
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPP---FRPRIKSRE--DV-- 283

Query: 357 SSWNPSHI 364
           S+++P  I
Sbjct: 284 SNFDPDFI 291

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  183 bits (466), Expect = 6e-54
 Identities = 112/300 (37%), Positives = 159/300 (53%), Gaps = 15/300 (5%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DFE  K+   G+Y  V   +  +T   +A+K ++K+ +   N+   V +ER +L   ++P
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            VV +F +F+    L M +E  EGG+    + + G L  D AR Y AE V ALEY+H+ G
Sbjct: 62  FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV-----GTAA 230
           ++HRD+KP+NLL+T+ GHIK+ DFG  K    S  T L     +     F+     GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDIRFP---N 286
           Y+ PEV+         D WA+G  LY+ L G  PF  DT E L F ++I+ DI +P    
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIEWPEGDE 240

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP---PKLASE 343
                A+DLI RLL  +P  R G   GG   +K H FF G+DW  +  Q     P+L SE
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGT--GGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESE 298

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  183 bits (466), Expect = 3e-53
 Identities = 107/297 (36%), Positives = 156/297 (52%), Gaps = 25/297 (8%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
             +DF++ K+ G G++ +V   +   +  VYA+K++ K  + K + +A+   ER ++   
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           +   +V+L + FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IH
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIH 159

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           SMG IHRD+KP+N+LL   GH+K+ADFG+   M  + +     A         VGT  Y+
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA---------VGTPDYI 210

Query: 233 PPEVLNSSPAT--FGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFP- 285
            PEVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP 
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270

Query: 286 -NYFSDAARDLIDRLLDVDPSGRPGA-GPGGYAVLKMHPFFKGIDWK--NIRGQTPP 338
               S  A+DLI   L    + R    G  G   +K HPFFK   W   NIR    P
Sbjct: 271 DIEISKQAKDLICAFL----TDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAP 323

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  181 bits (460), Expect = 6e-53
 Identities = 100/281 (35%), Positives = 153/281 (54%), Gaps = 14/281 (4%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVR 119
           K+ G GS+ KV+ A+       YA+K++ KK I K+ +  ++  ER ++L  + HP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L F+FQ    LY  L+   GGELF  +  +    E  ARFY AE+  AL Y+HS+ +++R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+KPEN+LL + GHI + DFG  K        +  N  +     TF GT  Y+ PEVL+ 
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKE------NIEHNGTTS----TFCGTPEYLAPEVLHK 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 299
            P     D W LG  LY+ML G  PF   +   ++  I+ + ++     +++AR L++ L
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 230

Query: 300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
           L  D + R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 231 LQKDRTKRLGA-KDDFMEIKNHIFFSPINWDDLINKKITPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  181 bits (460), Expect = 7e-53
 Identities = 98/283 (34%), Positives = 145/283 (51%), Gaps = 15/283 (5%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDHPGVVR 119
           K+ G GS+ KV+ A+   T  VYA+K++ K  I +++       E RI+     HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L   FQ    L+  +E   GG+L  QI       E  +RFY AEV  AL ++H  G+I+R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+K +N+LL A+GH K+ADFG  K              +     TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK----------EGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 299
                  D WALG  +Y+M++G  PF+  +E  +F+ I+  D+ +P + S  A  ++   
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF 230

Query: 300 LDVDPSGRPGAGP--GGYAVLKMHPFFKGIDWKNI--RGQTPP 338
           +  +P+ R G     GG   +K HPFFK IDW  +  R   PP
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPP 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  181 bits (460), Expect = 2e-52
 Identities = 108/307 (35%), Positives = 167/307 (54%), Gaps = 32/307 (10%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DFE  K+ G G++ +V   +K DTG +YA+KI+ K  + ++ + A+++ ER +L + D  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            VV++F++FQD  +LY+ +E   GG++   +  K  LSE+  +FY AE V A++ IH +G
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT--------------VLPNAASDDK 221
            IHRDIKP+NLLL A GH+K++DFG    ++ +  T                 N  S  K
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 222 ACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           A T+           VGT  Y+ PEV   +      D W+LG  +Y+ML G  PF   + 
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 271 WLIFQRII--ARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
              +++++     + FP     S+ A+DLI R    D   R G+   G   +K HPFF+G
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS--NGVEEIKSHPFFEG 298

Query: 327 IDWKNIR 333
           +DW +IR
Sbjct: 299 VDWGHIR 305

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  178 bits (452), Expect = 1e-51
 Identities = 109/296 (36%), Positives = 161/296 (54%), Gaps = 25/296 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            DFE+ K+ G G++ +V   K   T  +YA+KI++K  + K  +TA  + ER VL   D 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS 173
             +  L + FQD   LY+ ++   GG+L   ++  +  L ED ARFY AE+V A+  IH 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +  +HRDIKP+N+LL  +GHI++ADFGS +K  QD  +          ++   VGT  Y+
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV----------QSSVAVGTPDYI 170

Query: 233 PPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FP 285
            PE+L +     G      D W+LG  +Y+ML G +PF   S    + +I+  + R  FP
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230

Query: 286 NYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
           ++ +D    A+DLI RL+    S     G  G    K H FF+GIDW+NIR    P
Sbjct: 231 SHITDVSEEAKDLIQRLI---CSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAP 283

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  177 bits (450), Expect = 2e-51
 Identities = 98/282 (34%), Positives = 152/282 (53%), Gaps = 17/282 (6%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVR 119
           K+ G GS+ KV+ AK+   G  YA+K++ KK +    +  ++  ER ++L  + HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L ++FQ T  LY  L+   GGELF  +  +    E  ARFY AE+  AL Y+HS+ +++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+KPEN+LL + GH+ + DFG  K             A  D   TF GT  Y+ PEV+  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK----------EGIAQSDTTTTFCGTPEYLAPEVIRK 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDAARDLID 297
            P     D W LG  LY+ML G  PF  +D +E  ++  I+ + +      S  A  +++
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MYDNILHKPLVLRPGASLTAWSILE 228

Query: 298 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPP 338
            LL+ D   R GA    +  ++ HPFF+ + W ++ + + PP
Sbjct: 229 ELLEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  177 bits (449), Expect = 3e-51
 Identities = 107/312 (34%), Positives = 167/312 (53%), Gaps = 28/312 (8%)

Query: 61  KIYGVGSYSKV--VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGV 117
           ++ G GSY+KV  VR KK D   +YA+K++ K+ +  +    +V+ E+ V +Q   +P +
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFL 58

Query: 118 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
           V L   FQ T  L++ +E   GG+L   +  +  L E+ ARFY AE+  AL ++H  G+I
Sbjct: 59  VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118

Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           +RD+K +N+LL ADGHIK+ D+G  K                D   TF GT  Y+ PE+L
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK----------EGLGPGDTTSTFCGTPNYIAPEIL 168

Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFK--------DTSEWLIFQRIIARDIRFPNYFS 289
                 F  D WALG  +++M++G SPF         +T ++L FQ I+ + IR P + S
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL-FQVILEKPIRIPRFLS 227

Query: 290 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEPMVQ 347
             A  ++   L+ DP  R G  P  G++ +K H FF+ IDW  + + Q  P    +P + 
Sbjct: 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPF--KPQIT 285

Query: 348 SGEGDDVHDSSW 359
              G +  D+ +
Sbjct: 286 DDYGLENFDTQF 297

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  175 bits (446), Expect = 5e-51
 Identities = 97/281 (34%), Positives = 150/281 (53%), Gaps = 17/281 (6%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 119
           K+ G GS+ KV+ A+    G  +A+K + K  +  ++      +E+ VL    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L+ TFQ    L+  +E   GG+L   I  KG      A FY AE+V  L+++HS G+I+R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+K +N++L  DGHIKIADFG  K           N   D++A TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK----------ENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 299
              TF  D W+ G  LY+ML G SPF    E  +F+ I      +P + +  ++D++++L
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL 230

Query: 300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 338
            + DP+ R G        ++ HPFFK I+W  +  +   PP
Sbjct: 231 FERDPTRRLGV----VGNIRGHPFFKTINWTALEKRELDPP 267

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  173 bits (441), Expect = 8e-51
 Identities = 86/274 (31%), Positives = 140/274 (51%), Gaps = 27/274 (9%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            FE+ +  G G + +V +A+   TG   A+K++  K  +KE K   +  E  +L +  HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIIN-EIQILKKCKHP 57

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
            +V+ + ++     L++ +E C GG L D + S    L+E +  +   E++  LEY+HS 
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRDIK  N+LLT+DG +K+ DFG    + D++              T VGT  ++ P
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-----------TMVGTPYWMAP 166

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD----IRFPNYFS 289
           EV+N  P  +  D+W+LG T  ++  G  P+ +      +F   IA +    +R P  +S
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--KIATNGPPGLRNPEKWS 224

Query: 290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
           D  +D + + L  +P  RP A       L  HPF
Sbjct: 225 DEFKDFLKKCLQKNPEKRPTA-----EQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  175 bits (445), Expect = 1e-50
 Identities = 103/318 (32%), Positives = 167/318 (52%), Gaps = 28/318 (8%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR 119
           ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q  +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y+H  G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+K +N+LL ++GHIK+ D+G  K                D   TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIARDIRFPNYFS 289
               F  D WALG  +++M++G SPF          ++T ++L FQ I+ + IR P   S
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEKQIRIPRSLS 229

Query: 290 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ--TPPKLASEPMV 346
             A  ++   L+ DP  R G  P  G+A ++ HPFF+ +DW  +  +   PP    +P +
Sbjct: 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPP---FKPNI 286

Query: 347 QSGEGDDVHDSSWNPSHI 364
               G D  D+ +    +
Sbjct: 287 SGEFGLDNFDAQFTNEPV 304

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  174 bits (441), Expect = 3e-50
 Identities = 101/287 (35%), Positives = 147/287 (51%), Gaps = 15/287 (5%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DF    + G GS+ KV+ A++  T  +YA+KI+ K  + +++      +E+ VL   D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 116 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             + +L   FQ    LY  +E   GG+L   I   G   E +A FY AE+   L ++H  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDDKACTFVGTAAYVP 233
           G+I+RD+K +N++L ++GHIKIADFG  K  M D   T            TF GT  Y+ 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR-----------TFCGTPDYIA 169

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 293
           PE++   P     D WA G  LY+ML+G  PF    E  +FQ I+  ++ +P   S  A 
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAV 229

Query: 294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
            +   L+   PS R G GP G   ++ H FF+ IDW  +  R   PP
Sbjct: 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPP 276

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  172 bits (438), Expect = 8e-50
 Identities = 100/291 (34%), Positives = 149/291 (51%), Gaps = 20/291 (6%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 119
           K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ VL    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L+ TFQ   +L+  +E   GG+L   I S        A FY AE++  L+++HS G+++R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+K +N+LL  DGHIKIADFG  K           N   D K CTF GT  Y+ PE+L  
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCK----------ENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 299
                  D W+ G  LY+ML G SPF    E  +FQ I   +  +P + +  A+D++ +L
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL 230

Query: 300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMVQS 348
              +P  R G        ++ HPFF+ IDW  +  R   PP    +P V+S
Sbjct: 231 FVREPERRLGVK----GDIRQHPFFREIDWSALEEREIEPP---FKPKVKS 274

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  174 bits (442), Expect = 9e-50
 Identities = 109/368 (29%), Positives = 161/368 (43%), Gaps = 28/368 (7%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            + + +  G GS+ +V  A+        ALK++ KK  +K  +      E  +L  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 116 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYI 171
             +V+L+  FQD  SLY+ +E  +GG L D +   G    LSE EA F  A+++ ALEY+
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 172 HSMGLIHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           HS G+IHRDIKPEN+LL  DG  +K+ DFG  K + D   T    A       T VGT  
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA----LPSTSVGTPG 173

Query: 231 YVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--------- 278
           Y+ PEVL   + + A+  +D+W+LG TLY++L+G  PF+         + +         
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233

Query: 279 ----ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG 334
                     P   S AA DL+ +LL  DP  R  +       L  H   K  D  ++  
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293

Query: 335 QTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSF 394
                     +  S E      +S   S         N     A +   S    +S    
Sbjct: 294 PDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLL 353

Query: 395 DSKWQQFL 402
            +   +  
Sbjct: 354 STASSKRS 361

Length = 384

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  174 bits (442), Expect = 1e-49
 Identities = 114/324 (35%), Positives = 163/324 (50%), Gaps = 45/324 (13%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           F   K  G+G++ +V  A+K+DT  +YA+K + KK +   N+ A+VK ER +L + D+  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           VVRL+++FQD  +LY  ++   GG++   +   G   ED ARFY AE+  A+E +H MG 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVK----------------PMQDS------------ 208
           IHRDIKP+N+L+  DGHIK+ DFG                     QDS            
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 209 -----RITVLP-NAASDDKAC---TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 259
                R+  L   AA   + C   + VGT  Y+ PEVL  +  T   D W++G  LY+ML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 260 SGTSPFKDTSEWLIFQRII----ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGY 315
            G  PF   +      ++I    +  I      S  A DLI +L    P  R   G  G 
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDR--LGKNGA 299

Query: 316 AVLKMHPFFKGIDW-KNIRGQTPP 338
             +K HPFFK ID+  ++R Q+ P
Sbjct: 300 DEIKAHPFFKTIDFSSDLRQQSAP 323

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  171 bits (434), Expect = 1e-49
 Identities = 95/296 (32%), Positives = 150/296 (50%), Gaps = 20/296 (6%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 174
           VV L + ++   +L + L    GG+L   I + G+   DE R  FY AE+   LE +H  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 175 GLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
            +++RD+KPEN+LL   GHI+I+D G +V+  +   I               VGT  Y+ 
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR------------GRVGTVGYMA 169

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFS 289
           PEV+ +   TF  D W LGC +Y+M+ G SPF+   E +    + +R+      +   FS
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS 229

Query: 290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEP 344
           +AAR +  +LL  DP  R G    G   +K HPFF+  ++K +  G   P    +P
Sbjct: 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  172 bits (437), Expect = 1e-49
 Identities = 107/296 (36%), Positives = 162/296 (54%), Gaps = 25/296 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DFE+ K+ G G++ +V   K  +   V+A+KI++K  + K  +TA  + ER VL   D+
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS 173
             +  L + FQD  +LY+ ++   GG+L   ++  +  L ED ARFY AE+V A++ +H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +  +HRDIKP+N+L+  +GHI++ADFGS +K M+D  +          ++   VGT  Y+
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----------QSSVAVGTPDYI 170

Query: 233 PPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FP 285
            PE+L +     G      D W+LG  +Y+ML G +PF   S    + +I+    R  FP
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230

Query: 286 NYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
              +D    A+DLI RL+    S     G  G    K HPFF GIDW NIR    P
Sbjct: 231 AQVTDVSEDAKDLIRRLI---CSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAP 283

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  172 bits (437), Expect = 3e-49
 Identities = 106/308 (34%), Positives = 168/308 (54%), Gaps = 32/308 (10%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DFE  K+ G G++ +V   +K DTG VYA+KI+ K  + ++ +  +++ ER +L + D 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             VV++F++FQD  +LY+ +E   GG++   +  K  L+E+E +FY AE V A++ IH +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT--------VLP------NAASDD 220
           G IHRDIKP+NLLL + GH+K++DFG    ++ +  T         LP      N  S  
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 221 KACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
           KA T+           VGT  Y+ PEV   +      D W+LG  +Y+ML G  PF   +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 270 EWLIFQRII--ARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
               +++++     + FP     S+ A+DLI R            G  G   +K +PFF+
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC---CEWEHRIGAPGVEEIKTNPFFE 297

Query: 326 GIDWKNIR 333
           G+DW++IR
Sbjct: 298 GVDWEHIR 305

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  170 bits (432), Expect = 8e-49
 Identities = 99/279 (35%), Positives = 146/279 (52%), Gaps = 13/279 (4%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DF    + G GS+ KV+ A++  T  +YA+KI+ K  + +++      +E+ VL     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 116 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             + +L   FQ    LY  +E   GG+L  QI   G   E  A FY AE+   L ++HS 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDDKACTFVGTAAYVP 233
           G+I+RD+K +N++L ++GHIKIADFG  K  M D   T            TF GT  Y+ 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-----------TFCGTPDYIA 169

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 293
           PE++   P     D WA G  LY+ML+G +PF+   E  +FQ I+  ++ +P   S  A 
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 229

Query: 294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
            +   L+   P  R G GP G   +K H FF+ IDW+ +
Sbjct: 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  171 bits (435), Expect = 1e-48
 Identities = 114/358 (31%), Positives = 169/358 (47%), Gaps = 62/358 (17%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           K  G+G++ +V  A K+DT  +YA+K + KK +   N+ A+VK ER +L + D+  VV+L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +++FQD  +LY  ++   GG++   +       E  ARFY AE+  A+E +H MG IHRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 181 IKPENLLLTADGHIKIADFG-----------------------SVKPMQ----------- 206
           IKP+N+L+  DGHIK+ DFG                       S++P             
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 207 DSRITVLPNAASDDKAC---TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS 263
           D   T+   A    + C   + VGT  Y+ PEVL     T   D W++G  L++ML G  
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246

Query: 264 PFKDTSEWLIFQRII--ARDIRFPNY--FSDAARDLIDRLL--DVDPSGRPGAGPGGYAV 317
           PF   +      ++I     +  P     S  A DLI +L     +  GR GA       
Sbjct: 247 PFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD----- 301

Query: 318 LKMHPFFKGIDWK-NIRGQTPPKLA--SEPM---------VQSGEGDDVHDSS--WNP 361
           +K HPFF  +D+  +IR Q  P +   S PM          +S   D   DS+  W+ 
Sbjct: 302 IKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDT 359

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  164 bits (418), Expect = 1e-47
 Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 17/270 (6%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           +++LG + G G++  V +   ++TG   A+K +  + I +E   + +  E  +L  L HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            +V+   + + + SLY+ LE  E G L   I   G   E     Y  +V+  L Y+H  G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           +IHRDIK  N+L T DG +K+ADFG    + D                + VGT  ++ PE
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLND----------VSKDDASVVGTPYWMAPE 169

Query: 236 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARD 294
           V+  S A+  +D+W+LGCT+ ++L+G  P+ D +      RI+  D    P   S   +D
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD 229

Query: 295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
            + +    DP+ RP A      +LK HP+ 
Sbjct: 230 FLMQCFQKDPNLRPTAK----QLLK-HPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  167 bits (425), Expect = 3e-47
 Identities = 109/294 (37%), Positives = 158/294 (53%), Gaps = 23/294 (7%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 212

Query: 235 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFP--N 286
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP  N
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 338
             S  A++LI   L  D   R   G  G   +K H FFK     W+ +R    P
Sbjct: 273 DISKEAKNLICAFL-TDREVR--LGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 323

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  165 bits (419), Expect = 9e-47
 Identities = 94/279 (33%), Positives = 144/279 (51%), Gaps = 14/279 (5%)

Query: 55  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +DF   +  G GS+ +V+ A  K +     A+K  +K  I K+ +  +V  ER +L+ ++
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP  V L+ +F+D   LY+ LE   GGE F  +        D   FY A++V   EY+ S
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + +++RD+KPENLLL  DG IK+ DFG  K +             D +  T  GT  Y+ 
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-------------DTRTYTLCGTPEYIA 196

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 293
           PE+L +       D W LG  +Y++L G  PF      LI+Q+I+   I FP +  +  +
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK 256

Query: 294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
            L+ +LL  D + R G    G   +K HP+F  IDW ++
Sbjct: 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295

Length = 340

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  165 bits (420), Expect = 1e-46
 Identities = 114/315 (36%), Positives = 172/315 (54%), Gaps = 28/315 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+++ K+ G G++ +V   +   +  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P VV+LF  FQD   LYM +E   GG+L + + S   + E  A+FYTAEVV AL+ IHSM
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           GLIHRD+KP+N+LL   GH+K+ADFG+   M ++ +          +  T VGT  Y+ P
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV---------RCDTAVGTPDYISP 212

Query: 235 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPN-- 286
           EVL S      +G   D W++G  L++ML G +PF   S    + +I+     + FP   
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG--IDWKNIR---GQTPPKLA 341
             S  A++LI   L  D   R   G  G   +K HPFFK    +W NIR       P+L+
Sbjct: 273 EISKHAKNLICAFL-TDREVR--LGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELS 329

Query: 342 SEPMVQSGEGDDVHD 356
           S+  + S   DD+ D
Sbjct: 330 SD--IDSSNFDDIED 342

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  161 bits (408), Expect = 6e-46
 Identities = 98/287 (34%), Positives = 147/287 (51%), Gaps = 20/287 (6%)

Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVV 118
           I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L  +   D P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            + + F     L   L+   GG+L   ++  G  SE E RFY AE++  LE++H+  +++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 238
           RD+KP N+LL   GH++I+D G            L    S  K    VGT  Y+ PEVL 
Sbjct: 121 RDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVGTHGYMAPEVLQ 168

Query: 239 SSPATFGN-DLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDIRFPNYFSDAARD 294
              A   + D ++LGC L+++L G SPF   K   +  I +  +   +  P+ FS   R 
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228

Query: 295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKL 340
           L++ LL  D + R G    G   +K HPFF+ +DW+ +  Q  PP L
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPL 275

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  159 bits (404), Expect = 2e-45
 Identities = 100/292 (34%), Positives = 146/292 (50%), Gaps = 23/292 (7%)

Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVV 118
           I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L  +   D P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            + + F     L   L+   GG+L   ++  G  SE E RFY  E++  LE++H+  +++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 238
           RD+KP N+LL   GH++I+D G            L    S  K    VGT  Y+ PEVL 
Sbjct: 121 RDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVGTHGYMAPEVLQ 168

Query: 239 SSPATFGNDLW-ALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARDIRFPNYFSDAA 292
              A   +  W +LGC L+++L G SPF     KD  E  I +  +  ++  P+ FS   
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTVNVELPDSFSPEL 226

Query: 293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 344
           + L++ LL  D S R G    G   +K H FFKGIDW+ +  Q  P     P
Sbjct: 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPP 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  158 bits (401), Expect = 6e-45
 Identities = 90/280 (32%), Positives = 128/280 (45%), Gaps = 25/280 (8%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDH 114
           D E  K+ G GS   V + +   TG +YALK +       E     +  E + +    + 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSC-ES 58

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P VV+ +  F     + + LE  +GG L D +   G + E    +   +++  L+Y+H+ 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 175 -GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             +IHRDIKP NLL+ + G +KIADFG  K        VL N  + D+  TFVGT  Y+ 
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLEN--TLDQCNTFVGTVTYMS 168

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDIRF--PNYF 288
           PE +     ++  D+W+LG TL +   G  PF      S + + Q I            F
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 328
           S   RD I   L  DP  RP A     A L  HPF K  D
Sbjct: 229 SPEFRDFISACLQKDPKKRPSA-----AELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  158 bits (400), Expect = 1e-44
 Identities = 93/296 (31%), Positives = 152/296 (51%), Gaps = 20/296 (6%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           F   ++ G G + +V   +   TG +YA K ++KK I K    +    E+ +L++++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSM 174
           VV L + ++   +L + L    GG+L   I + G+    E+ A FY AE++  LE +H  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 175 GLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++RD+KPEN+LL   GHI+I+D G +VK         +P     +     VGT  Y+ 
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVK---------IPEG---ESIRGRVGTVGYMA 169

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFS 289
           PEVLN+   T   D W LGC +Y+M+ G SPF+   E +    + +R++  +  +   FS
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS 229

Query: 290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEP 344
           + A+ +   LL  DP  R G    G   +K HPFF+ +++K +  G   P    +P
Sbjct: 230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  157 bits (398), Expect = 1e-44
 Identities = 85/276 (30%), Positives = 135/276 (48%), Gaps = 25/276 (9%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDH 114
           + G   G G++ KV  A  +DTG + A+K +      ++N    +K    E  VL+ L H
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR----IQDNDPKTIKEIADEMKVLELLKH 58

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +V+ +        +Y+ +E C GG L + +     L E   R YT ++++ L Y+HS 
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G++HRDIKP N+ L  +G IK+ DFG    ++++  T+     S        GT AY+ P
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS------LAGTPAYMAP 172

Query: 235 EVLNSSPAT--FGN-DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD---IRFPNY 287
           EV+            D+W+LGC + +M +G  P+ +  +E+ I   + A     I     
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
            S   +D +DR L+ DP  RP A     + L  HPF
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTA-----SELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  155 bits (392), Expect = 1e-43
 Identities = 91/287 (31%), Positives = 146/287 (50%), Gaps = 21/287 (7%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSMGLIH 178
            + ++   +L + L    GG+L   I + G+   DE R  FY AE+   LE +    +++
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 179 RDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           RD+KPEN+LL   GHI+I+D G +V+  +   +               VGT  Y+ PEV+
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVR------------GRVGTVGYMAPEVI 173

Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSDAAR 293
           N+   TF  D W LGC +Y+M+ G SPF+   E +    + +R+      +   FS+ A+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233

Query: 294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 338
            +   LL  +P  R G    G A +K HP FK I++K +      PP
Sbjct: 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  153 bits (387), Expect = 7e-43
 Identities = 95/296 (32%), Positives = 150/296 (50%), Gaps = 20/296 (6%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           F   ++ G G + +V   +   TG +YA K ++KK I K    +    E+ +L++++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 174
           VV L + ++   +L + L    GG+L   I   G    +E R  FY AE+   LE +H  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 175 GLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
            +++RD+KPEN+LL   GHI+I+D G +V   +   I               VGT  Y+ 
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK------------GRVGTVGYMA 169

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDIR--FPNYFS 289
           PEV+ +   TF  D WALGC LY+M++G SPF+   + +  + +  + ++++  +   FS
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFS 229

Query: 290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEP 344
             AR L   LL  DP  R G   GG   +K HP FK I++K +  G   P    +P
Sbjct: 230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  149 bits (378), Expect = 1e-41
 Identities = 84/283 (29%), Positives = 142/283 (50%), Gaps = 18/283 (6%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L + 
Sbjct: 2   GKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYA 61

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGLIHR 179
           FQ    L + +    GG+L   I +         E  A FYTA+++  LE++H   +I+R
Sbjct: 62  FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR 121

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+KPEN+LL  DG+++I+D G    ++D +           K   + GT  ++ PE+L  
Sbjct: 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQ----------SKTKGYAGTPGFMAPELLQG 171

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSDAARDL 295
               F  D +ALG TLY+M++   PF+   E +    + QRI+   + +P+ FS A++  
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSF 231

Query: 296 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
            + LL  DP  R G   G    L+ HP F+ ++W+ +     P
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLP 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  147 bits (374), Expect = 5e-41
 Identities = 75/267 (28%), Positives = 131/267 (49%), Gaps = 23/267 (8%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           D+E+ +  G GS+  V + ++   G +   K +D   +T++ K   V  E  +L +L HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELKHP 59

Query: 116 GVVRLFFTFQDTFS--LYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALE 169
            +VR +    D  +  LY+ +E CEGG+L   I      + ++ E+       +++ AL 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 170 YIH-----SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
             H        ++HRD+KP N+ L A+ ++K+ DFG  K +                A T
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS----------SFAKT 169

Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI-IARDIR 283
           +VGT  Y+ PE LN       +D+W+LGC +Y++ + + PF   ++  +  +I   +  R
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR 229

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRPGA 310
            P  +S    ++I  +L+VDP  RP  
Sbjct: 230 IPYRYSSELNEVIKSMLNVDPDKRPST 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  142 bits (360), Expect = 3e-39
 Identities = 83/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)

Query: 60  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLDHPGV 117
           G++ G GS+  V     +D G  +A+K +      +  + A  +LE+ +  L +L HP +
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 118 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
           V+   T ++  +LY+ LE   GG L   +   G   E   R YT +++  LEY+H    +
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           HRDIK  N+L+  +G +K+ADFG  K     ++     A S      F G+  ++ PEV+
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKS------FKGSPYWMAPEVI 173

Query: 238 NSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--RFPNYFSDAARD 294
                     D+W+LGCT+ +M +G  P+          +I         P++ SD A+D
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233

Query: 295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
            I + L  DPS RP A     A L  HPF
Sbjct: 234 FILKCLQRDPSLRPTA-----AELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  142 bits (361), Expect = 6e-39
 Identities = 84/287 (29%), Positives = 138/287 (48%), Gaps = 38/287 (13%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E +  ++ E  KI G G+  +V +A    TG   A+K M    + K+NK   +  E +
Sbjct: 17  PRELY--KNLE--KI-GEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIIN-EIL 67

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVD 166
           ++    HP +V  + ++     L++ +E  +GG L D IT +   ++E +  +   EV+ 
Sbjct: 68  IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKAC 223
            LEY+HS  +IHRDIK +N+LL+ DG +K+ADFG    +   +  R +V           
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV----------- 176

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIAR-- 280
             VGT  ++ PEV+         D+W+LG    +M  G  P  ++     +F   I    
Sbjct: 177 --VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL--ITTKG 232

Query: 281 --DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
              ++ P  +S   +D +++ L  DP  RP A       L  HPF K
Sbjct: 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSA-----EELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  141 bits (358), Expect = 7e-39
 Identities = 72/259 (27%), Positives = 123/259 (47%), Gaps = 18/259 (6%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DF++ K  G GSY  V + K++     YALK +D   ++++ +   V   RI L  ++HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRI-LASVNHP 59

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYI 171
            ++     F D   L + +E    G+L   I+     +  + E E      +++  L+ +
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H   ++HRD+K  N+LL A+  +KI D G  K                + A T +GT  Y
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISK------------VLKKNMAKTQIGTPHY 167

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFPNYFSD 290
           + PEV    P ++ +D+W+LGC LY+M +   PF+  S   +  ++   +    P  +S 
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ 227

Query: 291 AARDLIDRLLDVDPSGRPG 309
             ++ I  +L V P  RP 
Sbjct: 228 DLQNFIRSMLQVKPKLRPN 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 3e-38
 Identities = 84/273 (30%), Positives = 127/273 (46%), Gaps = 20/273 (7%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + F L +  G GS+ +V +A    T  V A+K++D +    E++   ++ E   L Q   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRS 58

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P + + + +F     L++ +E C GG   D +   G L E    F   EV+  LEY+H  
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEE 117

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G IHRDIK  N+LL+ +G +K+ADFG    +  +            K  TFVGT  ++ P
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS----------KRNTFVGTPFWMAP 167

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAA 292
           EV+  S      D+W+LG T  ++  G  P  D     +   I   +      N FS   
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF 227

Query: 293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           +D +   L+ DP  RP A      +LK H F K
Sbjct: 228 KDFVSLCLNKDPKERPSA----KELLK-HKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 6e-38
 Identities = 86/279 (30%), Positives = 131/279 (46%), Gaps = 29/279 (10%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+EL +  G G+Y  V +A+ I TG + A+K++    +   +    ++ E  +L +  H
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIH 172
           P +V  F ++     L++ +E C GG L D  Q+T +G LSE +  +   E +  L Y+H
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH 118

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
             G IHRDIK  N+LLT DG +K+ADFG       +++T     A+  K  +F+GT  ++
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGV-----SAQLT-----ATIAKRKSFIGTPYWM 168

Query: 233 PPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---- 285
            PEV             D+WALG T  ++     P  D         I   +   P    
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228

Query: 286 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
              +S    D I + L  DP  RP A       L  HPF
Sbjct: 229 KEKWSPVFHDFIKKCLTKDPKKRPTA-----TKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  138 bits (349), Expect = 1e-37
 Identities = 78/259 (30%), Positives = 122/259 (47%), Gaps = 16/259 (6%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DFE+    G GS+  V +  +     VYA+K +D   + +  +   +   R VL +LD  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSS 59

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEA-RFYTAEVVDALEYIH 172
            ++R + +F D   L + +E  E G+L   +       L ED+  RF+  +++  L ++H
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S  ++HRDIK  NL L A  ++KI D G  K + D+  T   N        T VGT  Y+
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFAN--------TIVGTPYYL 168

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFPNYFSDA 291
            PE+    P    +D+WALG  LY+  +G  PF   ++  +  +II          +S  
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQ 228

Query: 292 ARDLIDRLLDVDPSGRPGA 310
              LID+ L  D   RP  
Sbjct: 229 LAQLIDQCLTKDYRQRPDT 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  136 bits (344), Expect = 8e-37
 Identities = 85/292 (29%), Positives = 125/292 (42%), Gaps = 49/292 (16%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-------KFITKENKTAYVKLERIV 108
           D+EL ++ GVG+ + V  A  +      A+K +D          + KE +          
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQA--------- 52

Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK---GHLSEDEARFYTAEVV 165
           + Q +HP VV+ + +F     L++ +    GG L D + S    G L E        EV+
Sbjct: 53  MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS----VKPMQDSRITVLPNAASDDK 221
             LEY+HS G IHRDIK  N+LL  DG +KIADFG           +R            
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR----------KV 162

Query: 222 ACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
             TFVGT  ++ PEV+       F  D+W+ G T  ++ +G +P+       +    +  
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN 222

Query: 281 DIRFPNY--------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           D   P+         +S + R +I   L  DPS RP A       L  H FF
Sbjct: 223 D--PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTA-----EELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 2e-36
 Identities = 81/271 (29%), Positives = 136/271 (50%), Gaps = 29/271 (10%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++ KV +A+  +TG   A KI+    I  E +     +E  +L +  HP +V L+  
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
           +     L++ +E C+GG L   +      L+E + R+   ++++AL ++HS  +IHRD+K
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 183 PENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--- 238
             N+LLT DG +K+ADFG S K           N ++  K  TF+GT  ++ PEV+    
Sbjct: 131 AGNILLTLDGDVKLADFGVSAK-----------NKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 239 --SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDAAR 293
              +P  +  D+W+LG TL ++     P  + +   +  +I+  +   +  P+ +S +  
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239

Query: 294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           D +   L  DP  RP A     A L  HPF 
Sbjct: 240 DFLKSCLVKDPDDRPTA-----AELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  135 bits (341), Expect = 2e-36
 Identities = 80/283 (28%), Positives = 151/283 (53%), Gaps = 20/283 (7%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G + +V   +  +TG +YA K +DKK + K++      LE+ +L++++ P +V L + 
Sbjct: 2   GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA 61

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSMGLIHRDI 181
           F+    L + +    GG+L   I + G    +  R   Y+A++   + ++HSM +++RD+
Sbjct: 62  FESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDM 121

Query: 182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 241
           KPEN+LL   G+ +++D G    ++D +           +A    GT  Y+ PE+L   P
Sbjct: 122 KPENVLLDDQGNCRLSDLGLAVELKDGKTIT-------QRA----GTNGYMAPEILKEEP 170

Query: 242 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNY-FSDAARDLI 296
            ++  D +A+GC++Y+M++G +PFKD  E +    + +R +  +++F +  F++ ++D+ 
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDIC 230

Query: 297 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPP 338
              L   P  R G+        K H FFK I++  +  G  PP
Sbjct: 231 RLFLAKKPEDRLGSREKNDDPRK-HEFFKTINFPRLEAGLIPP 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  134 bits (338), Expect = 3e-36
 Identities = 79/261 (30%), Positives = 139/261 (53%), Gaps = 21/261 (8%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLD 113
            + + ++ G GS+ + +  + +++   YA+K   + K     E+     + E ++L ++ 
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS----RKEAVLLAKMK 56

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHL-SEDEARFYTAEVVDALEYI 171
           HP +V    +F+    LY+ +E C+GG+L  +I   +G L  ED    +  ++   +++I
Sbjct: 57  HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H   ++HRDIK +N+ LT +G +K+ DFGS      +R+   P A     ACT+VGT  Y
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGS------ARLLTSPGAY----ACTYVGTPYY 166

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--LIFQRIIARDIRFPNYFS 289
           VPPE+  + P    +D+W+LGC LY++ +   PF+  S W  LI +         P+++S
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-WKNLILKVCQGSYKPLPSHYS 225

Query: 290 DAARDLIDRLLDVDPSGRPGA 310
              R LI ++   +P  RP A
Sbjct: 226 YELRSLIKQMFKRNPRSRPSA 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 3e-36
 Identities = 87/308 (28%), Positives = 136/308 (44%), Gaps = 65/308 (21%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQL-DH 114
           +++ K  G G++  V  A+  +TG + A+K M KKF + E     + L  +  L +L +H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE---CMNLREVKSLRKLNEH 57

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIH 172
           P +V+L   F++   LY   E  EG  L+  +        SE   R    +++  L +IH
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR-ITVLPNAASDDKACTFVGTAAY 231
             G  HRD+KPENLL++    +KIADFG  + ++     T             +V T  Y
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT------------DYVSTRWY 164

Query: 232 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI----- 277
             PE+L      SSP     D+WALGC + ++ +    F  +SE    + I   +     
Sbjct: 165 RAPEILLRSTSYSSP----VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK 220

Query: 278 --------IARD--IRFPNY--------FSDAARDLID---RLLDVDPSGRPGAGPGGYA 316
                   +A     RFP +          +A+ + ID    +L  DP  RP A      
Sbjct: 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS----Q 276

Query: 317 VLKMHPFF 324
            L+ HP+F
Sbjct: 277 ALQ-HPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 4e-36
 Identities = 85/303 (28%), Positives = 126/303 (41%), Gaps = 57/303 (18%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDHP 115
           LG + G G+Y  V++ +   TG + A+K    KF   E+     K    E  VL QL H 
Sbjct: 6   LGVV-GEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            +V L   F+    LY+  E  E   L     S G L  D  R Y  +++ A+ Y HS  
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPP 234
           +IHRDIKPEN+L++  G +K+ DFG  + ++          A      T +V T  Y  P
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALR----------ARPASPLTDYVATRWYRAP 170

Query: 235 EVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQ-------------- 275
           E+L          D+WA+GC + ++L G   F   S+    +LI +              
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230

Query: 276 --------------RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 321
                         +  + + R+P   S  A D +   L +DP  R          L  H
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-----DELLQH 285

Query: 322 PFF 324
           P+F
Sbjct: 286 PYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 5e-36
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 56/301 (18%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGV 117
           LGKI G G+Y  V +A+   TG + A+K +  +F ++   KTA  +++  +L +L+HP +
Sbjct: 4   LGKI-GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK--LLKELNHPNI 60

Query: 118 VRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
           ++L   F+    LY+  E  +    +L      +  L E   + Y  +++  L + HS G
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIK--DRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPP 234
           ++HRD+KPENLL+  +G +K+ADFG  +           +  S  +  T +V T  Y  P
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLAR-----------SFGSPVRPYTHYVVTRWYRAP 167

Query: 235 EVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI------------ 277
           E+L      +   D+W++GC   ++LS    F   SE    + IF+ +            
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227

Query: 278 -IARD--IRFPNY--------FSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
            +AR+    FP          F +A   A DL+ ++L  DP  R  A       L  HP+
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA----EQALA-HPY 282

Query: 324 F 324
           F
Sbjct: 283 F 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 5e-36
 Identities = 83/301 (27%), Positives = 133/301 (44%), Gaps = 57/301 (18%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN---KTAYVKLERI-VLDQLDH 114
           L K+ G G+Y  V +A+   TG + ALK +  +   +E     TA   L  I +L +L H
Sbjct: 4   LEKL-GEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTA---LREISLLKELKH 57

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHS 173
           P +V+L         LY+  E C+  +L   +    G LS +  +    +++  L Y HS
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRD+KP+N+L+  DG +K+ADFG       +R   +P      +    V T  Y  
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGL------ARAFGIPLRTYTHE----VVTLWYRA 166

Query: 234 PEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQ------------- 275
           PE+L  S   +   D+W++GC   +M++G   F   SE    + IFQ             
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226

Query: 276 -RIIARDIRFPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
            ++      FP +                 DL+ ++L  +P+ R  A       LK HP+
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA----KEALK-HPY 281

Query: 324 F 324
           F
Sbjct: 282 F 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  131 bits (330), Expect = 7e-35
 Identities = 84/279 (30%), Positives = 136/279 (48%), Gaps = 50/279 (17%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK------IMDKKFITKENKTAYVKLERI 107
           + +F++ K  G G +S V +A  +  G V ALK      +MD K   +++    + L   
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK--ARQDCLKEIDL--- 55

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------Y 160
            L QLDHP V++   +F +   L + LE  + G+L   I    H  + +          Y
Sbjct: 56  -LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK---HFKKQKRLIPERTIWKY 111

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-----SVKPMQDSRITVLPN 215
             ++  ALE++HS  ++HRDIKP N+ +TA G +K+ D G     S K            
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--------- 162

Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--I 273
                 A + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF      L  +
Sbjct: 163 ------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216

Query: 274 FQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRP 308
            ++I   D  +P    +++S+  RDL+ R ++ DP  RP
Sbjct: 217 CKKIEKCD--YPPLPADHYSEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 1e-34
 Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 74/303 (24%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY-------VKLERIVL 109
           +E     G G+Y +V +A+   TG + ALK    K   +  K  +       +KL    L
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK----KIRMENEKEGFPITAIREIKL----L 52

Query: 110 DQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQ---ITSKG-HLSEDEARFYTAE 163
            +L HP +VRL    T +   S+YM  E  +     D    + S     +E + + Y  +
Sbjct: 53  QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQ 108

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +++ L+Y+HS G++HRDIK  N+L+  DG +K+ADFG  +P          N        
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR------- 161

Query: 224 TFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQ 275
             V T  Y PPE+L       P     D+W++GC L ++  G   F+ ++E      IF+
Sbjct: 162 --VITLWYRPPELLLGATRYGPEV---DMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216

Query: 276 ----------------------------RIIARDIRFPNYFSDAARDLIDRLLDVDPSGR 307
                                       +   R+  F +    +A DL+D+LL +DP  R
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLRE-FFKHLIDPSALDLLDKLLTLDPKKR 275

Query: 308 PGA 310
             A
Sbjct: 276 ISA 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  129 bits (326), Expect = 2e-34
 Identities = 80/275 (29%), Positives = 129/275 (46%), Gaps = 26/275 (9%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + F++ +  G GSY  V +A   +TG V A+K++    + ++ +   +  E  +L Q D 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQE--IIKEISILKQCDS 57

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIH 172
           P +V+ + ++     L++ +E C  G + D  +IT+K  L+E+E      + +  LEY+H
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH 116

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S   IHRDIK  N+LL  +G  K+ADFG    + D+            K  T +GT  ++
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM----------AKRNTVIGTPFWM 166

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFS 289
            PEV+         D+W+LG T  +M  G  P+ D         I  +    +  P  +S
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWS 226

Query: 290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
               D + + L  DP  RP A       L  HPF 
Sbjct: 227 PEFNDFVKKCLVKDPEERPSA-----IQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 4e-34
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 19/252 (7%)

Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH---PGVV 118
           + G G+Y  V R K + TG V ALKI++    T ++  + ++ E  +L QL     P + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIIN--LDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
           + + ++     L++ +E  EGG +   +   G ++E        EV+ AL+YIH +G+IH
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124

Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 238
           RDIK  N+L+T  G++K+ DFG    +  +            K  TFVGT  ++ PEV+ 
Sbjct: 125 RDIKAANILVTNTGNVKLCDFGVAALLNQNS----------SKRSTFVGTPYWMAPEVIT 174

Query: 239 SSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFP-NYFSDAARDL 295
                    D+W+LG T+Y+M +G  P+ D   +     I  ++  R   N +S   R+ 
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234

Query: 296 IDRLLDVDPSGR 307
           +   LD +P  R
Sbjct: 235 VAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  128 bits (322), Expect = 6e-34
 Identities = 82/257 (31%), Positives = 133/257 (51%), Gaps = 17/257 (6%)

Query: 57  FELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           +E+ K  G GS+ K+  AK K D+      +I   K   KE + +  K E I+L ++ HP
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAKMKHP 59

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHL-SEDEARFYTAEVVDALEYIHS 173
            +V  F +FQ+   L++ +E C+GG+L  +I   +G L SED+   +  ++   L++IH 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 174 MGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
             ++HRDIK +N+ L+ +G + K+ DFG  + + DS           + A T VGT  Y+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM----------ELAYTCVGTPYYL 169

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARDIRFPNYFSDA 291
            PE+  + P     D+W+LGC LY++ +   PF+  +   L+ +            FS  
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD 229

Query: 292 ARDLIDRLLDVDPSGRP 308
            R LI +L  V P  RP
Sbjct: 230 LRSLISQLFKVSPRDRP 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (322), Expect = 8e-34
 Identities = 75/273 (27%), Positives = 134/273 (49%), Gaps = 16/273 (5%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLD 113
           ++  GK+ G G++ +V     +DTG   A+K +     + E K     LE  +  L  L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  +V+ +   +D  +L + +E   GG + DQ+ + G L+E   R YT ++++ +EY+HS
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRDIK  N+L  + G++K+ DFG+ K +Q          +S     +  GT  ++ 
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC-------SSGTGMKSVTGTPYWMS 175

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--RFPNYFSDA 291
           PEV++        D+W++GCT+ +ML+   P+ +        +I  +    + P++ S  
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           AR+ + R    +   RP A       L  H F 
Sbjct: 236 ARNFLRRTFVENAKKRPSA-----EELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  127 bits (321), Expect = 1e-33
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 13/209 (6%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E ++L  L HP ++  +  F D  +L + +E   GG L+D+I         E+   +Y  
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++V A+ YIH  G++HRDIK  N+ LT  G IK+ DFG  K +                A
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM----------A 158

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD- 281
            T VGT  Y+ PE+       F +D+WALGC LY++L+    F  T+   +  +I+  + 
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY 218

Query: 282 IRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
               + +S     L+  LL  DP  RP A
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTA 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  126 bits (318), Expect = 3e-33
 Identities = 79/258 (30%), Positives = 138/258 (53%), Gaps = 25/258 (9%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAYVKLERIVLDQLDHPGV 117
           + KI G GS+ K +  K  + G  Y +K I   K   KE + +  + E  VL  + HP +
Sbjct: 5   VKKI-GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES--RKEVAVLSNMKHPNI 61

Query: 118 VRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHL-SEDEARFYTAEVVDALEYIHSMG 175
           V+   +F++  +LY+ ++ CEGG+L+ +I + +G L  ED+   +  ++  AL+++H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           ++HRDIK +N+ LT DG IK+ DFG  +        VL +     + C  +GT  Y+ PE
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIAR--------VLNSTVELARTC--IGTPYYLSPE 171

Query: 236 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----FPNYFSD 290
           +  + P    +D+WALGC LY+M +    F+  +     + ++ + IR       +++S 
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKIIRGSYPPVSSHYSY 227

Query: 291 AARDLIDRLLDVDPSGRP 308
             R+L+ +L   +P  RP
Sbjct: 228 DLRNLVSQLFKRNPRDRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|241293 cd01262, PH_PDK1, 3-Phosphoinositide dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain

 Score =  119 bits (301), Expect = 1e-32
 Identities = 43/106 (40%), Positives = 58/106 (54%), Gaps = 3/106 (2%)

Query: 392 DSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIW 451
                 W  FL  GE +L + +V K + L +KK QLILT+ P+L YVDP K+V+KG I W
Sbjct: 1   QQQSENWWHFLVNGELILKMGLVDKRKGLFAKKRQLILTDGPRLYYVDPVKMVLKGEIPW 60

Query: 452 SDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQ 497
           S     L  +V +   F I TP +    ED +  A +W KAIE + 
Sbjct: 61  SPE---LRPEVKNFKTFFIHTPNRTYYLEDPEGNAKKWCKAIEEVL 103

PDK1 plays an important role in insulin and growth factor signalling cascades. It phosphorylates and activates many AGC (cAMP-dependent, cGMP-dependent, protein kinase C (PKC)) family of protein kinases members, including protein kinase B (PKB, also known as Akt), p70 ribosomal S6-kinase (S6K), serum and glucocorticoid responsive kinase (SGK), p90 ribosomal S6 kinase (RSK), and PKC. PDK1 contains an N-terminal serine/threonine kinase domain followed by a PH domain. Following binding of the PH domain to PtdIns(3,4,5)P3 and PtdIns(3,4)P2, PDK1 activates these enzymes by phosphorylating a Ser/Thr residue in their activation loop. PH domains have diverse functions, but in general are involved in targeting proteins to the appropriate cellular location or in the interaction with a binding partner. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. Less than 10% of PH domains bind phosphoinositide phosphates (PIPs) with high affinity and specificity. PH domains are distinguished from other PIP-binding domains by their specific high-affinity binding to PIPs with two vicinal phosphate groups: PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3 which results in targeting some PH domain proteins to the plasma membrane. A few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes. Length = 107

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  125 bits (315), Expect = 2e-32
 Identities = 79/267 (29%), Positives = 132/267 (49%), Gaps = 26/267 (9%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A    TG   A+K MD   + K+ +   +  E +++    HP +V ++ +
Sbjct: 28  GEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL ++H+ G+IHRDIK 
Sbjct: 85  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT+DG +K++DFG    +       +P   S       VGT  ++ PEV++  P  
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKE----VPRRKS------LVGTPYWMAPEVISRLPYG 193

Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 298
              D+W+LG  + +M+ G  P+ +       +RI  RD     ++  +  S   R  +DR
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--RDNLPPKLKNLHKVSPRLRSFLDR 251

Query: 299 LLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           +L  DP+ R  A     A L  HPF  
Sbjct: 252 MLVRDPAQRATA-----AELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  124 bits (313), Expect = 2e-32
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 24/277 (8%)

Query: 60  GKIYGVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAY--VKLERIVLDQLDHPG 116
           G+  G G++S   +A+ + TGT+ A+K +   +  + E +     ++ E  ++ +L+HP 
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           ++R+     +     + +E   GG +   ++  G   E     YT +++  L Y+H   +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 177 IHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           IHRD+K  NLL+ + G  ++IADFG+   +  ++ T      + +     +GT A++ PE
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARL-AAKGT-----GAGEFQGQLLGTIAFMAPE 178

Query: 236 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDI---RFPNYF 288
           VL         D+W++GC + +M +   P+          LIF+  IA        P + 
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK--IASATTAPSIPEHL 236

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           S   RD+  R L++ P  RP +       L  HP F+
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPS-----RELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  123 bits (312), Expect = 3e-32
 Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 30/284 (10%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            D E     G G+   V +     TG + A+K +  +      K    +L+  +L + + 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD--ILHKCNS 58

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIH 172
           P +V  +  F +   + + +E  +GG L D+I    +G + E         V+  L Y+H
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 173 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
               +IHRD+KP N+L+ + G IK+ DFG    + +S             A TFVGT++Y
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS------------LAKTFVGTSSY 165

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK--DTSEWLIF---QRIIARDI-RFP 285
           + PE +  +  +  +D+W+LG +L ++ +G  P+   +     IF   Q I+     R P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP 225

Query: 286 N-YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 328
           +  FS   +D ++  L  DP  RP      Y  L  HPF K  +
Sbjct: 226 SGKFSPDFQDFVNLCLIKDPRERP-----SYKELLEHPFIKKYE 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  123 bits (309), Expect = 1e-31
 Identities = 87/276 (31%), Positives = 143/276 (51%), Gaps = 33/276 (11%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++ KV +AK  +TG + A K+++ K  ++E    Y+ +E  +L   +HP +V+L   
Sbjct: 21  GDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYM-VEIEILATCNHPYIVKLLGA 77

Query: 124 FQDTFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           F     L++ +E C GG + D I     +G L+E + +    ++++AL+Y+HSM +IHRD
Sbjct: 78  FYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 181 IKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV--- 236
           +K  N+LLT DG IK+ADFG S K           N  +  +  +F+GT  ++ PEV   
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAK-----------NVKTLQRRDSFIGTPYWMAPEVVMC 184

Query: 237 --LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDA 291
             +  +P  +  D+W+LG TL +M     P  + +   +  +I   +   +  P+ +S  
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 327
            RD +   LD  P  RP A     A L  HPF   +
Sbjct: 245 FRDFLKTALDKHPETRPSA-----AQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  121 bits (306), Expect = 3e-31
 Identities = 87/302 (28%), Positives = 128/302 (42%), Gaps = 55/302 (18%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPG 116
            LG+I G G++  V +AK  +TG   ALK +  +    E       L  I  L    HP 
Sbjct: 4   ILGRI-GEGAHGIVFKAKDRETGETVALKKVALR--RLEGGIPNQALREIKALQACQHPY 60

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMG 175
           VV+L   F       + +E     +L + +  +   L E + + Y   ++  + Y+H+ G
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           ++HRD+KP NLL++ADG +KIADFG  +         L +          V T  Y  PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQ--------VATRWYRAPE 170

Query: 236 VLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ--RII-------------- 278
           +L  +     G DLWA+GC   ++L+G+  F   ++  I Q   +               
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGL 228

Query: 279 -----ARDIRFPN--------YFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 322
                   I FP          F DA   A DL+  LL  DPS R  A     A    HP
Sbjct: 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-----AEALRHP 283

Query: 323 FF 324
           +F
Sbjct: 284 YF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 1e-30
 Identities = 85/293 (29%), Positives = 134/293 (45%), Gaps = 50/293 (17%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDH 114
            FEL ++ G G+Y KV +A+   TG + A+KIMD   I ++ +   +K E  I+    +H
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEE-IKEEYNILRKYSNH 62

Query: 115 PGVVRLFFTFQDTF----------SLYMALESCEGGELFDQI----TSKGHLSEDEARFY 160
           P +     TF   F           L++ +E C GG + D +         L E+   + 
Sbjct: 63  PNIA----TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 220
             E +  L Y+H   +IHRDIK +N+LLT +  +K+ DFG V    DS +          
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG-VSAQLDSTLG--------- 168

Query: 221 KACTFVGTAAYVPPEVL--NSSP-ATFGN--DLWALGCTLYQMLSGTSPFKDTSEW-LIF 274
           +  TF+GT  ++ PEV+  +  P A++    D+W+LG T  ++  G  P  D      +F
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF 228

Query: 275 QRIIARD----IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
           +  I R+    ++ P  +S    D I   L  +   RP         L  HPF
Sbjct: 229 K--IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE-----LLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  118 bits (297), Expect = 3e-30
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 32/281 (11%)

Query: 60  GKIYGVGSYSKVVRAKKIDTGTVYALK-------IMDKKFITKENKTAYVKLERIVLDQL 112
           G++ G G+Y +V  A  + TG + A+K       I  +    +++    ++ E   L  L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 113 DHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           DH  +V+   F T ++  S++  LE   GG +   + + G   E   RF+T +V++ L Y
Sbjct: 66  DHLNIVQYLGFETTEEYLSIF--LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +HS G++HRD+K +NLL+ ADG  KI+DFG  K   D           +D+  +  G+  
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD--------IYDNDQNMSMQGSVF 175

Query: 231 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--- 285
           ++ PEV++S    +    D+W+LGC + +M +G  P+ D        ++  +    P   
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235

Query: 286 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
                 S  A D ++    ++P  RP A       L  HPF
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTA-----RELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 4e-30
 Identities = 77/308 (25%), Positives = 128/308 (41%), Gaps = 61/308 (19%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV----LDQL 112
           +E     G G+Y  V +A+ ++TG   ALK +  +    E       L  I     L+  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESF 58

Query: 113 DHPGVVRLF--FTFQDT---FSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEVV 165
           +HP +VRL        T     L +  E  +        +    G L  +  +    +++
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLL 117

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ-DSRITVLPNAASDDKACT 224
             ++++HS  ++HRD+KP+N+L+T+DG +KIADFG  +    +  +T            +
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT------------S 165

Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRI--- 277
            V T  Y  PEVL  S      D+W++GC   ++      F+ TSE      IF  I   
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225

Query: 278 ----------IARDIRFPNYF-----------SDAARDLIDRLLDVDPSGRPGAGPGGYA 316
                     + R   FP+Y             +   DL+ ++L  +P  R  A    + 
Sbjct: 226 SEEEWPRNVSLPRS-SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA----FE 280

Query: 317 VLKMHPFF 324
            L+ HP+F
Sbjct: 281 ALQ-HPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  114 bits (287), Expect = 5e-29
 Identities = 75/257 (29%), Positives = 133/257 (51%), Gaps = 25/257 (9%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G GSY +V   +    G  Y +K ++ +  ++  + A  + E  +L QL HP +V  
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKA-AEQEAQLLSQLKHPNIV-- 62

Query: 121 FFTFQDTFS-----LYMALESCEGGELFDQIT-SKGHL-SEDEARFYTAEVVDALEYIHS 173
              +++++      LY+ +  CEGG+L+ ++   KG L  E++   +  ++  AL+Y+H 
Sbjct: 63  --AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRD+K +N+ LT    IK+ D G  +        VL N    D A T +GT  Y+ 
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIAR--------VLEN--QCDMASTLIGTPYYMS 170

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDA 291
           PE+ ++ P  + +D+WALGC +Y+M +    F  KD +  L+++ I  +    P  +S  
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIEGKLPPMPKDYSPE 229

Query: 292 ARDLIDRLLDVDPSGRP 308
             +LI  +L   P  RP
Sbjct: 230 LGELIATMLSKRPEKRP 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  114 bits (286), Expect = 8e-29
 Identities = 75/259 (28%), Positives = 131/259 (50%), Gaps = 22/259 (8%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +E  ++ G G++  V   ++     +  +K +  + +TK+ + A  + E  VL  L HP 
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHPN 60

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSM 174
           ++  +  F +  +L + +E   GG L + I  + +  L ED    +  +++ AL ++H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 175 GLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            ++HRD+K +N+LL  D H   +KI DFG  K +           +S  KA T VGT  Y
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISKIL-----------SSKSKAYTVVGTPCY 167

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--NYFS 289
           + PE+    P    +D+WALGC LY++ S    F+  +   +  +I+      P  + +S
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYS 226

Query: 290 DAARDLIDRLLDVDPSGRP 308
              R LI  +L++DPS RP
Sbjct: 227 PDLRQLILSMLNLDPSKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  114 bits (286), Expect = 1e-28
 Identities = 81/271 (29%), Positives = 137/271 (50%), Gaps = 34/271 (12%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK------IMDKKFITKENKTAYVKLERI 107
           + +F + K  G G +S+V RA  +  G   ALK      +MD K   + +    + L   
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDL--- 55

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----TSKGHLSEDEARFYTAE 163
            L QL+HP V++ + +F +   L + LE  + G+L   I      K  + E     Y  +
Sbjct: 56  -LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +  ALE++HS  ++HRDIKP N+ +TA G +K+ D G +     S+ T          A 
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-LGRFFSSKTTA---------AH 164

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARD 281
           + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF     + + + ++I   D
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 224

Query: 282 IRFP----NYFSDAARDLIDRLLDVDPSGRP 308
             +P    +++S+  R L++  ++ DP  RP
Sbjct: 225 --YPPLPSDHYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  113 bits (285), Expect = 1e-28
 Identities = 86/286 (30%), Positives = 135/286 (47%), Gaps = 31/286 (10%)

Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
           R PQE     DFEL +  G G+Y  V +A+ ++TG + A+K++    +      A V+ E
Sbjct: 5   RNPQE-----DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQE 56

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
            I++    H  +V  F ++     L++ +E C GG L D     G LSE +  + + E +
Sbjct: 57  IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL 116

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             L Y+HS G +HRDIK  N+LLT +GH+K+ADFG       ++IT     A+  K  +F
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV-----SAQIT-----ATIAKRKSF 166

Query: 226 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
           +GT  ++ PEV         N   D+WA+G T  ++     P  D         +   + 
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226

Query: 283 RFPNY-----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
           + P       +S++    +   L  +P  RP A       L  HPF
Sbjct: 227 QPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEK-----LLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (283), Expect = 3e-28
 Identities = 75/273 (27%), Positives = 133/273 (48%), Gaps = 20/273 (7%)

Query: 60  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL------ERIVLDQLD 113
           G + G GS+  V       +G + A+K ++   ++  +K     +      E  +L +L 
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  +V+   +  D   L + LE   GG +   + + G   E   R +  +++  L Y+H+
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
            G+IHRDIK  N+L+   G IKI+DFG  K ++ +      +  ++    +  G+  ++ 
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN----SLSTKTNGARPSLQGSVFWMA 180

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIR--FPNYFSD 290
           PEV+  +  T   D+W+LGC + +ML+G  PF D ++   IF+  I  +     P+  S 
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--IGENASPEIPSNISS 238

Query: 291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
            A D +++  ++D + RP A     A L  HPF
Sbjct: 239 EAIDFLEKTFEIDHNKRPTA-----AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  114 bits (288), Expect = 3e-28
 Identities = 84/299 (28%), Positives = 129/299 (43%), Gaps = 59/299 (19%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQL 112
           + +E+ +  G G+Y  V +A    T  V ALK   K F    N T   +  R  + L +L
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63

Query: 113 -DHPGVVRLFFTF-----QDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEV 164
            DHP +V+L         +D   +Y+  E  E     D   +     L +   R+   ++
Sbjct: 64  GDHPNIVKLLNVIKAENDKD---IYLVFEYMET----DLHAVIRANILEDVHKRYIMYQL 116

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           + AL+YIHS  +IHRD+KP N+LL +D  +K+ADFG  + + +          +D     
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD----- 171

Query: 225 FVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE------------- 270
           +V T  Y  PE+L  S   T G D+W++GC L +ML G   F  TS              
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 271 --------------WLIFQRIIARDIR-----FPNYFSDAARDLIDRLLDVDPSGRPGA 310
                           +   + +R  +      P   SD A DL+ +LL  +P+ R  A
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA-SDDALDLLKKLLVFNPNKRLTA 289

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  113 bits (283), Expect = 4e-28
 Identities = 79/266 (29%), Positives = 135/266 (50%), Gaps = 26/266 (9%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A++  +G   A+K+MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 30  GEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  +GG L D I S+  L+E++       V+ AL Y+HS G+IHRDIK 
Sbjct: 87  YLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT DG +K++DFG    +       +P      K  + VGT  ++ PEV++ +P  
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKD----VP------KRKSLVGTPYWMAPEVISRTPYG 195

Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 298
              D+W+LG  + +M+ G  P+   S     +R+  RD     ++  +  S   RD ++R
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--RDSPPPKLKNAHKISPVLRDFLER 253

Query: 299 LLDVDPSGRPGAGPGGYAVLKMHPFF 324
           +L  +P  R  A       L  HPF 
Sbjct: 254 MLTREPQERATAQE-----LLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  112 bits (281), Expect = 5e-28
 Identities = 80/264 (30%), Positives = 127/264 (48%), Gaps = 19/264 (7%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 2   PEELFT----KLERI-GKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIEDIQQEIT 54

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL Q D P + R + ++     L++ +E   GG   D +   G L E        E++  
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKG 113

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 114 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNTFVG 163

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPN 286
           T  ++ PEV+  S   F  D+W+LG T  ++  G  P  D     +   I          
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG 223

Query: 287 YFSDAARDLIDRLLDVDPSGRPGA 310
            +S   ++ ++  L+ DP  RP A
Sbjct: 224 QYSKPFKEFVEACLNKDPRFRPTA 247

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  112 bits (281), Expect = 6e-28
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTA 162
           I+ +QL HP +VR + TF +   LY+ ++  EG  L +   S    K   +E+       
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 163 EVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
           ++V AL Y+H    ++HRD+ P N++L  D  + I DFG  K  Q       P +    K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-------PES----K 169

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--A 279
             + VGT  Y  PE++ + P     D+WA GC LYQM +   PF  T+   +  +I+   
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229

Query: 280 RDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
            +      +S+   D+I   L  D   RP
Sbjct: 230 YEPLPEGMYSEDVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  112 bits (280), Expect = 6e-28
 Identities = 76/272 (27%), Positives = 140/272 (51%), Gaps = 23/272 (8%)

Query: 60  GKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVKLERIVLDQLDHPGV 117
           GK+ G G++ +V     +DTG   A K +  D +      + + ++ E  +L  L H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 118 VRLFFTFQD----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           V+ +   +D    T +++M  E   GG + DQ+ + G L+E   R YT ++++ + Y+HS
Sbjct: 67  VQYYGCLRDRAEKTLTIFM--EYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRDIK  N+L  + G++K+ DFG+ K     R+  +  + +  ++ T  GT  ++ 
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK-----RLQTICMSGTGIRSVT--GTPYWMS 177

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDA 291
           PEV++        D+W+LGCT+ +ML+   P+ +        +I  +  + + P++ S+ 
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
           ARD +  +  V+   RP A       L  HPF
Sbjct: 238 ARDFLGCIF-VEARHRPSAEE-----LLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  111 bits (279), Expect = 7e-28
 Identities = 76/263 (28%), Positives = 137/263 (52%), Gaps = 18/263 (6%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVKLERIVLDQLD 113
           ++ LGK+ G G++ +V      DTG   A+K +  D +      +   ++ E  +L  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 114 HPGVVRLFFTFQD----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
           H  +V+ +   +D    T S++M  E   GG + DQ+ S G L+E+  R YT ++++ + 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFM--EHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+HS  ++HRDIK  N+L  + G++K+ DFG+ K     R+  +  + +  K+ T  GT 
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK-----RLQTICLSGTGMKSVT--GTP 173

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNY 287
            ++ PEV++        D+W++GCT+ +ML+   P+ +        +I  +  +   P +
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233

Query: 288 FSDAARDLIDRLLDVDPSGRPGA 310
            SD  RD + R+  V+   RP A
Sbjct: 234 VSDHCRDFLKRIF-VEAKLRPSA 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  109 bits (275), Expect = 2e-27
 Identities = 73/245 (29%), Positives = 121/245 (49%), Gaps = 22/245 (8%)

Query: 85  LKIMDKK----FITKE-NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG 139
           L +MD +    FI K   K++    ER+ +     P +V L        S+++ L+  EG
Sbjct: 10  LLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69

Query: 140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 199
           G+L+  I+   ++ E+  + + AE+V AL+ +H  G++ RD+ P N+LL   GHI++  F
Sbjct: 70  GKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYF 129

Query: 200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 259
                ++DS          D +A   +    Y  PEV   S  T   D W+LG  L+++L
Sbjct: 130 SRWSEVEDS---------CDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 260 SGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK 319
           +G +  +     +        +I  P + S+ AR L+ +LL  +P+ R GAG  G   +K
Sbjct: 177 TGKTLVECHPSGI--NTHTTLNI--PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232

Query: 320 MHPFF 324
            HPFF
Sbjct: 233 SHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  113 bits (285), Expect = 3e-27
 Identities = 85/270 (31%), Positives = 129/270 (47%), Gaps = 23/270 (8%)

Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI--TKENKTAYVK 103
             P+EH  +    L  + G    +    A +   G+    K++  KF+    E + AY +
Sbjct: 62  NNPREHMYV----LTTLVGRNPTTAAFVATR---GSDPKEKVV-AKFVMLNDERQAAYAR 113

Query: 104 LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHL--SEDEARF 159
            E   L   DH G+V+ F  F+    L + +E   GG+L  QI    K HL   E E   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
              ++V AL+ +HS  ++HRD+K  N+ L   G IK+ DFG  K   DS         S 
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS--------VSL 225

Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII- 278
           D A +F GT  Y+ PE+      +   D+W+LG  LY++L+   PFK  S+  I Q+++ 
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285

Query: 279 ARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
            +   FP   S   + L+D LL  +P+ RP
Sbjct: 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRP 315

Length = 478

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  115 bits (289), Expect = 3e-27
 Identities = 51/148 (34%), Positives = 89/148 (60%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           SI++F + K    G++ KV   +K +   +YA+K++ K  +  +N    V+ ER  L   
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
             P +V L+++ Q   ++Y+ +E   GG++   +   G+  E+ A  Y +EV  AL+Y+H
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG 200
             G+IHRD+KP+N+L++ +GHIK+ DFG
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFG 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  108 bits (272), Expect = 7e-27
 Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 34/274 (12%)

Query: 54  IQDFELGKIYGVGSYSKVVRA------KKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           + +F++ K  G G +S+V RA      K +    V   ++MD K   +++    + L   
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEIDL--- 55

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAE 163
            L QL+HP V++   +F +   L + LE  + G+L   I      K  + E     Y  +
Sbjct: 56  -LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +  A+E++HS  ++HRDIKP N+ +TA G +K+ D G +     S+ T          A 
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-LGRFFSSKTTA---------AH 164

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IFQRIIARD 281
           + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF      L  + Q+I   D
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD 224

Query: 282 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAG 311
             +P     ++S+  R+L+   +  DP  RP  G
Sbjct: 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIG 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  109 bits (274), Expect = 8e-27
 Identities = 88/302 (29%), Positives = 136/302 (45%), Gaps = 59/302 (19%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGV 117
           LGKI G G++S+V++A+   TG  YA+K M K F + E        E   L +L  HP +
Sbjct: 4   LGKI-GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR--EIQALRRLSPHPNI 60

Query: 118 VRLFFTFQD--TFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSM 174
           +RL     D  T  L +  E  +   L++ I   K  L E   + Y  +++ +L+++H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+ HRDIKPEN+L+  D  +K+ADFGS + +  S+    P          ++ T  Y  P
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGI-YSK---PPYTE-------YISTRWYRAP 167

Query: 235 E-VLNSSPATFGNDLWALGCTLYQMLS------GT--------------SPFKDTSEWLI 273
           E +L         D+WA+GC  +++LS      GT              +P  D      
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP--DAEVLKK 225

Query: 274 FQRIIARDIRFPN-----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 322
           F++    +  FP+             S    DL+ +LL  DP  R  A       L+ HP
Sbjct: 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA----KQALR-HP 280

Query: 323 FF 324
           +F
Sbjct: 281 YF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  108 bits (272), Expect = 9e-27
 Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 27/268 (10%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 2   PEELFT----KLERI-GKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIT 54

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL Q D P V + + ++     L++ +E   GG   D + + G   E +      E++  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKG 113

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNTFVG 163

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-- 285
           T  ++ PEV+  S      D+W+LG T  ++  G  P  D        R++    +    
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----MRVLFLIPKNNPP 219

Query: 286 ---NYFSDAARDLIDRLLDVDPSGRPGA 310
                FS   ++ ID  L+ DPS RP A
Sbjct: 220 TLTGEFSKPFKEFIDACLNKDPSFRPTA 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  109 bits (275), Expect = 2e-26
 Identities = 81/323 (25%), Positives = 131/323 (40%), Gaps = 81/323 (25%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--------IMDKKFITKENKTAYVKLERIV 108
           +EL K  G G+Y  V  A    TG   A+K        ++D K I +E     +KL    
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-----IKL---- 52

Query: 109 LDQLDHPGVVRLFFTF----QDTFS-LYMALESCEGGELFDQ-----ITSKGHLSEDEAR 158
           L  L H  ++ L         + F+ +Y+  E      L +      I S   L++D  +
Sbjct: 53  LRHLRHENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQ 106

Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
           ++  +++  L+Y+HS  +IHRD+KP N+L+ ++  +KI DFG       +R         
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL------ARGVDPDEDEK 160

Query: 219 DDKACT-FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----L 272
                T +V T  Y  PE+ L+SS  T   D+W++GC   ++L+    F          L
Sbjct: 161 GFL--TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218

Query: 273 IF-----------QRII---------------ARDI--RFPNYFSDAARDLIDRLLDVDP 304
           I            + I                 + +   FP   S  A DL++++L  DP
Sbjct: 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA-SPEAIDLLEKMLVFDP 277

Query: 305 SGRPGAGPGGYAVLKMHPFFKGI 327
             R  A       L  HP+   +
Sbjct: 278 KKRITAD----EALA-HPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  107 bits (269), Expect = 3e-26
 Identities = 82/292 (28%), Positives = 134/292 (45%), Gaps = 48/292 (16%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDH 114
           EL ++ G G+   V + +  +TG ++ALK      IT +      K    E  +      
Sbjct: 5   ELSRL-GEGAGGSVTKCRLKNTGMIFALKT-----ITTDPNPDLQKQILRELEINKSCKS 58

Query: 115 PGVVRLFFTFQD--TFSLYMALESCEGGEL---FDQITSKGHLSEDEARFYTAE-VVDAL 168
           P +V+ +  F D  + S+ +A+E CEGG L   + ++  +G    ++     AE V+  L
Sbjct: 59  PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y+HS  +IHRDIKP N+LLT  G +K+ DFG            +     +  A TF GT
Sbjct: 119 SYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG------------VSGELVNSLAGTFTGT 166

Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDIRFPN- 286
           + Y+ PE +   P +  +D+W+LG TL ++     PF  +    L    +++  +  PN 
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP 226

Query: 287 ----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKG 326
                      +S+  +D I + L+ DP+ RP           M  HP+ K 
Sbjct: 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPW-------DMLEHPWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (267), Expect = 4e-26
 Identities = 74/257 (28%), Positives = 123/257 (47%), Gaps = 22/257 (8%)

Query: 64  GVGSYSKV--VRAKKIDTGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVVR 119
           G GS+  V  V+ KK        LK++ +  +     N+T     E  +L +LDHP +V+
Sbjct: 9   GKGSFGTVYLVKDKKAVAEE--RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMG 175
              +F +  +  +  E CEG +L  ++    H    LSE++   +  +++  + Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           ++HRD+K +N+ L  +  +KI DFG       SR+ +     S D A TF GT  Y+ PE
Sbjct: 127 ILHRDLKAKNIFLK-NNLLKIGDFGV------SRLLM----GSCDLATTFTGTPYYMSPE 175

Query: 236 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAARD 294
            L        +D+W+LGC LY+M      F+  +   +  RI+       P  +S     
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235

Query: 295 LIDRLLDVDPSGRPGAG 311
           ++  +L+ DPS RP A 
Sbjct: 236 IMQSMLNKDPSLRPSAA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  107 bits (268), Expect = 4e-26
 Identities = 89/304 (29%), Positives = 133/304 (43%), Gaps = 61/304 (20%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDHP 115
           LG + G GSY  V++ K  +TG + A+K    KF+  E+     K+   E  +L QL H 
Sbjct: 6   LGLV-GEGSYGMVMKCKHKETGQIVAIK----KFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            +V L   F+    LY+  E  +   L D       L E   R Y  +++  +E+ HS  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPP 234
           +IHRDIKPEN+L++  G +K+ DFG  + +           A+  +  T +V T  Y  P
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTL-----------AAPGEVYTDYVATRWYRAP 169

Query: 235 EVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE------------------WLIF 274
           E+L      +G   D+WA+GC + +ML+G   F   S+                    IF
Sbjct: 170 ELLVGDT-KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228

Query: 275 QR--------------IIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM 320
           Q+              I   + RFP   S    DL  + L +DP  RP +     + L  
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSS-----SQLLH 282

Query: 321 HPFF 324
           H FF
Sbjct: 283 HEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  106 bits (266), Expect = 6e-26
 Identities = 85/297 (28%), Positives = 146/297 (49%), Gaps = 36/297 (12%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E + I    +G++ G G++ KV +A+  +TG + A K++D K  ++E    Y+ +E  
Sbjct: 3   PEEFWEI----IGEL-GDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYM-VEID 54

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVV 165
           +L   DHP +V+L   F    +L++ +E C GG + D +  +    L+E + R    + +
Sbjct: 55  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTL 113

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACT 224
           +AL Y+H   +IHRD+K  N+L T DG IK+ADFG S K           N  +  +  +
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK-----------NTRTIQRRDS 162

Query: 225 FVGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 279
           F+GT  ++ PEV+        P  +  D+W+LG TL +M     P  + +   +  +I  
Sbjct: 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222

Query: 280 RD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 333
            +   +  P+ +S   +D + + L+ +   R          L  HPF      K IR
Sbjct: 223 SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTT-----TQLLQHPFVTVNSNKPIR 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (265), Expect = 7e-26
 Identities = 78/261 (29%), Positives = 130/261 (49%), Gaps = 28/261 (10%)

Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRL 120
           + G G+Y  V  A+ + T     ++I  K+   ++++      E I L   L H  +V+ 
Sbjct: 15  VLGKGTYGIVYAARDLST----QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70

Query: 121 F--FTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEA--RFYTAEVVDALEYIHSMG 175
               +    F ++M  E   GG L   + SK G L ++E    FYT ++++ L+Y+H   
Sbjct: 71  LGSDSENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 176 LIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           ++HRDIK +N+L+ T  G +KI+DFG+ K +          A  +    TF GT  Y+ P
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----------AGINPCTETFTGTLQYMAP 178

Query: 235 EVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE--WLIFQRIIARD-IRFPNYFS 289
           EV++  P  +G   D+W+LGCT+ +M +G  PF +  E    +F+  + +     P   S
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238

Query: 290 DAARDLIDRLLDVDPSGRPGA 310
             A++ I R  + DP  R  A
Sbjct: 239 AEAKNFILRCFEPDPDKRASA 259

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  106 bits (266), Expect = 8e-26
 Identities = 76/268 (28%), Positives = 123/268 (45%), Gaps = 28/268 (10%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+   V  A  + TG   A+K M+   + ++ K   +  E +V+ +  HP +V    +
Sbjct: 28  GQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E   GG L D +T +  + E +      E + ALE++HS  +IHRDIK 
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 143

Query: 184 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 190

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDLID 297
                 D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD ++
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250

Query: 298 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           R L++D   R  A       L  HPF K
Sbjct: 251 RCLEMDVEKRGSAKE-----LLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  106 bits (265), Expect = 1e-25
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 37/282 (13%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 117
           ELGK    G+Y  V +     TG   A+K  + +    E+K   + +E  +L +   P +
Sbjct: 8   ELGK----GNYGSVYKVLHRPTGVTMAMK--EIRLELDESKFNQIIMELDILHKAVSPYI 61

Query: 118 VRLFFTFQDTFSLYMALESCEGG---ELFDQITSKGHLSEDEARFYTAEVVDALEYI-HS 173
           V  +  F    ++YM +E  + G   +L+    +   + ED  R  T  VV  L+++   
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             +IHRD+KP N+L+  +G +K+ DFG    +  S             A T +G  +Y+ 
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL------------AKTNIGCQSYMA 169

Query: 234 PEVLNSSPA------TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA----RDIR 283
           PE + S         T  +D+W+LG ++ +M  G  P+   +   IF ++ A        
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            P+ +SD A+D + + L+  P+ RP      YA L  HP+  
Sbjct: 230 LPSGYSDDAQDFVAKCLNKIPNRRP-----TYAQLLEHPWLV 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  106 bits (265), Expect = 1e-25
 Identities = 80/267 (29%), Positives = 132/267 (49%), Gaps = 26/267 (9%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A +  TG   A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 31  GEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL Y+H+ G+IHRDIK 
Sbjct: 88  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT+DG IK++DFG    +       +P      K  + VGT  ++ PEV++  P  
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKE----VP------KRKSLVGTPYWMAPEVISRLPYG 196

Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 298
              D+W+LG  + +M+ G  P+ +       +RI  RD     ++  +  S   R  +D 
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--RDNLPPRVKDSHKVSSVLRGFLDL 254

Query: 299 LLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           +L  +PS R  A       L  HPF K
Sbjct: 255 MLVREPSQRATA-----QELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  105 bits (263), Expect = 2e-25
 Identities = 79/264 (29%), Positives = 129/264 (48%), Gaps = 19/264 (7%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 2   PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEIT 54

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 113

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNTFVG 163

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPN 286
           T  ++ PEV+  S      D+W+LG T  ++  G  P  +     +   I   +      
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG 223

Query: 287 YFSDAARDLIDRLLDVDPSGRPGA 310
            +S   ++ ++  L+ +PS RP A
Sbjct: 224 NYSKPLKEFVEACLNKEPSFRPTA 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  104 bits (261), Expect = 2e-25
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 21/225 (9%)

Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
           R PQ      D+EL +  G G+Y  V +A+ + TG + A+KI+    +   +  + ++ E
Sbjct: 5   RNPQ-----HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQE 56

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ +  H  +V  F ++     L++ +E C GG L D     G LSE +  +   E +
Sbjct: 57  IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL 116

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             L Y+HS G +HRDIK  N+LLT +G +K+ADFG       ++IT     A+  K  +F
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA-----AKIT-----ATIAKRKSF 166

Query: 226 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 267
           +GT  ++ PEV         N   D+WA+G T  ++     P  D
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  105 bits (263), Expect = 3e-25
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 40/290 (13%)

Query: 52  FSIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
             + D E LG+I G G+  +V + +   TG V A+K M +    +ENK   + L+ +VL 
Sbjct: 12  ADLNDLENLGEI-GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD-VVLK 69

Query: 111 QLDHPGVVRLFFTFQDTFSLYMALE---SCEGGELFDQIT--SKGHLSEDEARFYTAEVV 165
             D P +V+ +  F     +++ +E   +C      D++    +G + ED     T  +V
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELMSTC-----LDKLLKRIQGPIPEDILGKMTVAIV 124

Query: 166 DALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
            AL Y+    G+IHRD+KP N+LL A G++K+ DFG    + DS+      A +    C 
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK------AKTRSAGC- 177

Query: 225 FVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRII 278
               AAY+ PE +   P          D+W+LG +L ++ +G  P+K+  +E+ +  +I+
Sbjct: 178 ----AAYMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232

Query: 279 ARDIRFPNY---FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
             +         FS      +D  L  D   RP      Y  L  HPF +
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP-----KYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (260), Expect = 3e-25
 Identities = 77/276 (27%), Positives = 138/276 (50%), Gaps = 23/276 (8%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM----DKKFITKENKTAYVKLERIVLDQ 111
           ++ LGK+ G G++ +V      DTG   A+K +    D +  +KE      +++  +L  
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQ--LLKN 60

Query: 112 LDHPGVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
           L H  +V+ +   +D     L + +E   GG + DQ+ + G L+E+  R YT +++  + 
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+HS  ++HRDIK  N+L  + G++K+ DFG+ K     RI  +  + +  K+ T  GT 
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTGIKSVT--GTP 173

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--RFPNY 287
            ++ PEV++        D+W++ CT+ +ML+   P+ +        +I  +      P+ 
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
            SDA RD + ++  V+   RP         L  HPF
Sbjct: 234 VSDACRDFLKQIF-VEEKRRP-----TAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  104 bits (261), Expect = 4e-25
 Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 36/268 (13%)

Query: 66  GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF 124
           G + KV   K   T  ++  KI+  K         +  +E +V   + D+P  ++L+++ 
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKAK--------NFNAIEPMVHQLMKDNPNFIKLYYSV 78

Query: 125 Q--DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
                  L M  +  + G+LFD +  +G LSE E +    ++V+AL  +H   +IH DIK
Sbjct: 79  TTLKGHVLIM--DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136

Query: 183 PENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 241
            EN+L   A   I + D+G  K +                   + GT  Y  PE +    
Sbjct: 137 LENVLYDRAKDRIYLCDYGLCKII--------------GTPSCYDGTLDYFSPEKIKGHN 182

Query: 242 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRIIARDIRFPNYFSDAARDLID 297
                D WA+G   Y++L+G  PFK+  +  +      +   + + F    S  A D + 
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ 242

Query: 298 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            +L  + + R       Y  +  HPF K
Sbjct: 243 SMLKYNINYRLTN----YNEIIKHPFLK 266

Length = 267

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  102 bits (256), Expect = 1e-24
 Identities = 60/271 (22%), Positives = 111/271 (40%), Gaps = 44/271 (16%)

Query: 58  ELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKL----ERIVL 109
            LGK  G G++ +V + K            A+K +      KE+ +         E  ++
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL------KEDASEQQIEEFLREARIM 55

Query: 110 DQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDA 167
            +LDHP VV+L     ++   LY+ +E  EGG+L   +  ++  LS  +   +  ++   
Sbjct: 56  RKLDHPNVVKLLGVCTEEE-PLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG--------SVKPMQDSRITVLPNAASD 219
           +EY+ S   IHRD+   N L+  +  +KI+DFG             +  ++ +       
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI------- 167

Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII 278
                      ++ PE L     T  +D+W+ G  L+++ + G  P+   S   + + + 
Sbjct: 168 ----------RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK 217

Query: 279 ARD-IRFPNYFSDAARDLIDRLLDVDPSGRP 308
               +  P        DL+ +    DP  RP
Sbjct: 218 NGYRLPQPPNCPPELYDLMLQCWAEDPEDRP 248

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  102 bits (257), Expect = 2e-24
 Identities = 85/312 (27%), Positives = 131/312 (41%), Gaps = 61/312 (19%)

Query: 53  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKI--MDKKFITKENKTAYVKLERIVL 109
           S+ +FE L +I G G+Y  V RA+   +G + ALK   MD +   ++        E  +L
Sbjct: 5   SVTEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNE---RDGIPISSLREITLL 60

Query: 110 DQLDHPGVVRL--FFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEVV 165
             L HP +V L      +   S+++ +E CE     L D + +    SE + +    +++
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLL 118

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             L+Y+H   +IHRD+K  NLLLT  G +KIADFG  +        + P           
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK---------- 168

Query: 226 VGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-------------- 270
           V T  Y  PE+L   +  T   D+WA+GC L ++L+        SE              
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228

Query: 271 ----WLIF------QRIIARD-------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 313
               W  F       +             +FP + S+A   L++ LL  DP  R  A   
Sbjct: 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAE-- 285

Query: 314 GYAVLKMHPFFK 325
               L+   +FK
Sbjct: 286 --EALE-SSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  101 bits (254), Expect = 4e-24
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDHP 115
           L KI G GSY  V + +  +TG + A+K    KF+  E+     K+   E  +L QL HP
Sbjct: 6   LSKI-GEGSYGVVFKCRNRETGQIVAIK----KFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            +V L   F+    L++  E C+   L +   +   + E   +    + + A+ + H   
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
            IHRD+KPEN+L+T  G IK+ DFG       +RI   P     D    +V T  Y  PE
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGF------ARILTGPGDDYTD----YVATRWYRAPE 170

Query: 236 VL-----NSSPATFGNDLWALGCTLYQMLSG 261
           +L        P     D+WA+GC   ++L+G
Sbjct: 171 LLVGDTQYGPPV----DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  100 bits (252), Expect = 5e-24
 Identities = 55/268 (20%), Positives = 110/268 (41%), Gaps = 37/268 (13%)

Query: 58  ELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
            LGK  G G++ +V +              A+K + K+  +++    +++ E  ++ +LD
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLR-EARIMRKLD 59

Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEY 170
           HP +V+L     ++   L + +E   GG+L D +       LS  +   +  ++   +EY
Sbjct: 60  HPNIVKLLGVCTEEE-PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFG--------SVKPMQDSRITVLPNAASDDKA 222
           + S   IHRD+   N L+  +  +KI+DFG            ++  ++ +          
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI---------- 168

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD 281
                   ++ PE L     T  +D+W+ G  L+++ + G  P+   S   + + +    
Sbjct: 169 -------RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY 221

Query: 282 IR-FPNYFSDAARDLIDRLLDVDPSGRP 308
               P         L+ +    DP  RP
Sbjct: 222 RLPKPPNCPPELYKLMLQCWAEDPEDRP 249

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  100 bits (251), Expect = 1e-23
 Identities = 84/293 (28%), Positives = 135/293 (46%), Gaps = 34/293 (11%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+   V  A  + TG   A+K ++   + K+ K   +  E +V+ +L +P +V    +
Sbjct: 28  GQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--EVVDALEYIHSMGLIHRDI 181
           F     L++ +E   GG L D +T       DEA+      E + ALE++H+  +IHRDI
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDI 141

Query: 182 KPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 238
           K +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+ 
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVT 188

Query: 239 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDL 295
                   D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD 
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248

Query: 296 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQS 348
           ++R L++D   R     G    L  HPF K    K +   TP  LA++  ++S
Sbjct: 249 LNRCLEMDVEKR-----GSAKELLQHPFLKLA--KPLSSLTPLILAAKEAMKS 294

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 99.3 bits (247), Expect = 3e-23
 Identities = 68/228 (29%), Positives = 116/228 (50%), Gaps = 34/228 (14%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           FEL ++ G G+Y +V + + + TG + A+K+MD      E++   +KLE  +L +  H  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHH- 72

Query: 117 VVRLFFTFQDTF----------SLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTAEV 164
             R   T+   F           L++ +E C  G + D +  +KG+ L ED   +   E+
Sbjct: 73  --RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           +  L ++H+  +IHRDIK +N+LLT +  +K+ DFG V    D  +          +  T
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV---------GRRNT 180

Query: 225 FVGTAAYVPPEVL--NSSPAT---FGNDLWALGCTLYQMLSGTSPFKD 267
           F+GT  ++ PEV+  + +P     + +D+W+LG T  +M  G  P  D
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  100 bits (250), Expect = 3e-23
 Identities = 88/305 (28%), Positives = 134/305 (43%), Gaps = 69/305 (22%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF- 121
           G G+Y +V  A    TG   A+K + + F +  + K  Y +L   +L  +DH  V+ L  
Sbjct: 24  GSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR--LLKHMDHENVIGLLD 81

Query: 122 -FT-------FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            FT       FQD   L   L    G +L + I     LS+D  +F   +++  L+YIHS
Sbjct: 82  VFTPASSLEDFQD-VYLVTHLM---GADL-NNIVKCQKLSDDHIQFLVYQILRGLKYIHS 136

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
            G+IHRD+KP N+ +  D  +KI DFG       +R T       DD+   +V T  Y  
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGL------ARHT-------DDEMTGYVATRWYRA 183

Query: 234 PEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDT----------------SEWLIFQR 276
           PE+ LN        D+W++GC + ++L+G + F  +                 E L+ Q+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL-QK 242

Query: 277 IIARDIR-------------FPNYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKM 320
           I +   R             F   FS A   A DL++++L +DP  R  A          
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA-----LA 297

Query: 321 HPFFK 325
           HP+  
Sbjct: 298 HPYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  101 bits (254), Expect = 4e-23
 Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 22/266 (8%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           + ++ G G+   V+ AK++  G  +A+K++D + +++ +K    + E   L   D   +V
Sbjct: 36  ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNR-AQAEVCCLLNCDFFSIV 94

Query: 119 RLF--FTFQD------TFSLYMALESCEGGELFDQITSKGHLS----EDEARFYTAEVVD 166
           +    F  +D         + + L+    G+L  +I S+   +    E EA     +V+ 
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           A+ ++HS  +IHRDIK  N+LL ++G +K+ DFG  K        +     SDD   TF 
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK--------MYAATVSDDVGRTFC 206

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RDIRFP 285
           GT  YV PE+    P +   D+++LG  LY++L+   PF   +   +  + +A R    P
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266

Query: 286 NYFSDAARDLIDRLLDVDPSGRPGAG 311
              S   ++++  LL  DP  RP + 
Sbjct: 267 PSISPEMQEIVTALLSSDPKRRPSSS 292

Length = 496

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 99.0 bits (246), Expect = 4e-23
 Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 28/268 (10%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+   V  A  I TG   A+K M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 28  GQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E   GG L D +T    + E +      E + AL+++HS  +IHRDIK 
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKS 143

Query: 184 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 190

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDLID 297
                 D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD ++
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250

Query: 298 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           R L++D   R     G    L  HPF K
Sbjct: 251 RCLEMDVDRR-----GSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 98.6 bits (245), Expect = 5e-23
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 26/266 (9%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 29  GEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 86  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT DG +K++DFG    +       +P   S       VGT  ++ PE+++  P  
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKE----VPRRKS------LVGTPYWMAPELISRLPYG 194

Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 298
              D+W+LG  + +M+ G  P+ +       + I  RD     ++  +  S + +  +DR
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPKLKNLHKVSPSLKGFLDR 252

Query: 299 LLDVDPSGRPGAGPGGYAVLKMHPFF 324
           LL  DP+ R  A     A L  HPF 
Sbjct: 253 LLVRDPAQRATA-----AELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 96.1 bits (239), Expect = 2e-22
 Identities = 74/260 (28%), Positives = 124/260 (47%), Gaps = 17/260 (6%)

Query: 60  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA----YVKLERIV--LDQLD 113
           G++ G G+Y  V      + G + A+K ++   +   N  A    Y KL+  V  L  L 
Sbjct: 5   GEVLGKGAYGTVY-CGLTNQGQLIAVKQVE---LDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  +V+   T  D  ++ + +E   GG +   +   G L E     YT +++D + Y+H+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRDIK  N++L  +G IK+ DFG  + +      V  +    +   +  GT  ++ 
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL----AWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDI--RFPNYFSD 290
           PEV+N S     +D+W++GCT+++M +G  P         +F     R +  R P+ FS 
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236

Query: 291 AARDLIDRLLDVDPSGRPGA 310
           AA D +   L  D   RP A
Sbjct: 237 AAIDFVTSCLTRDQHERPSA 256

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 63/298 (21%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDT--GTVYALK----IMDKKFITKENKTAYVKLERIVLD 110
           +EL K  G G+Y  V  A+  +T      A+K    +  KK + K        L  + L 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR------ALRELKLL 55

Query: 111 QL--DHPGVVRLF---FTFQDTFS---LYMALESCEGGELFDQITSKGHLSEDEARFYTA 162
           +    H  +  L+     F   F+   LY  L   +   L   I S   L++   + +  
Sbjct: 56  RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD---LHQIIRSGQPLTDAHFQSFIY 112

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +++  L+YIHS  ++HRD+KP NLL+ AD  +KI DFG  +           N   +   
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS-------ENPGENAGF 165

Query: 223 CT-FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFK--DTSEWL------ 272
            T +V T  Y  PE+ L+    T   D+W++GC L ++L     FK  D  + L      
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225

Query: 273 -------IFQRI-------------IARDIRFPNYFSDA---ARDLIDRLLDVDPSGR 307
                     RI                   F + F +A   A DL+++LL  DP+ R
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKR 283

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 95.6 bits (238), Expect = 5e-22
 Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 40/296 (13%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQ 111
           +D E     G G+   V + K I TGTV     M KK +    K++  K    E  ++ +
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTV-----MAKKVVHIGAKSSVRKQILRELQIMHE 59

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEY 170
              P +V  +  F +  ++ M +E  + G L D+I  K G +  +        VV+ L Y
Sbjct: 60  CRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTY 118

Query: 171 IHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           ++++  ++HRDIKP N+L+ + G IK+ DFG            L N+ +D    TFVGT+
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE--------LINSIAD----TFVGTS 166

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-----------IFQRII 278
            Y+ PE +     T  +D+W+LG ++ ++  G  PF  ++              + Q+I+
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226

Query: 279 ARDI-RFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
                R P + F +  RD +D  L  DP+ RP        +  M PF + +   N+
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQ----QLCAMPPFIQALRASNV 278

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 95.2 bits (236), Expect = 8e-22
 Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 28/268 (10%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144

Query: 184 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 191

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDLID 297
                 D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD ++
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 298 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           R LD+D   R     G    L  H F K
Sbjct: 252 RCLDMDVEKR-----GSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 63/191 (32%), Positives = 88/191 (46%), Gaps = 41/191 (21%)

Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D  +++  +++  L+YIHS  ++HRD+KP NLLL  +  +KI DFG       +RI
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGL------ARI 155

Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF--KD 267
              P          +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F  KD
Sbjct: 156 AD-PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214

Query: 268 TSE--WLIFQ-----------RII---ARD-IR-------------FPNYFSDAARDLID 297
                 LI              II   AR+ I+             FPN     A DL+D
Sbjct: 215 YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNA-DPKALDLLD 273

Query: 298 RLLDVDPSGRP 308
           ++L  +P  R 
Sbjct: 274 KMLTFNPHKRI 284

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 82/310 (26%), Positives = 121/310 (39%), Gaps = 80/310 (25%)

Query: 49  QEHFSIQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYV 102
            E FS  D E  K++      G GS+  V  A+ + T  V A+K M     +   K +  
Sbjct: 5   AELFSKDDPE--KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-----SYSGKQSNE 57

Query: 103 KLERIV-----LDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSED 155
           K + I+     L QL HP  +     +    + ++ +E C G   ++ +    K  L E 
Sbjct: 58  KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEV 115

Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           E        +  L Y+HS   IHRDIK  N+LLT  G +K+ADFGS              
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGS-------------- 161

Query: 216 AASDDKACTFVGTAAYVPPEV---LNSSPATFGNDLWALGCT------------------ 254
           A+    A +FVGT  ++ PEV   ++        D+W+LG T                  
Sbjct: 162 ASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221

Query: 255 -LYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 313
            LY +    SP   +++W                 SD  R+ +D  L   P  RP +   
Sbjct: 222 ALYHIAQNDSPTLSSNDW-----------------SDYFRNFVDSCLQKIPQDRPSS--- 261

Query: 314 GYAVLKMHPF 323
               L  H F
Sbjct: 262 --EELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 81/317 (25%), Positives = 128/317 (40%), Gaps = 65/317 (20%)

Query: 57  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VL 109
           F++G  Y      G G+Y  V  A    +G   A+K +   F       A   L  + +L
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP--TLAKRTLRELKIL 58

Query: 110 DQLDHPGVVRL---FFTFQDTF-SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
               H  ++ +          F  +Y+ ++  E  +L   I S   L+E+  R++  +++
Sbjct: 59  RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLL 117

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             L+YIHS  +IHRD+KP NLL+  D  ++I DFG  + +          ++S  +   F
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL----------SSSPTEHKYF 167

Query: 226 ----VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTS--PFKDTSEWL------ 272
               V T  Y  PE+L S P  T   D+W++GC   +ML      P K+    L      
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227

Query: 273 -------IFQRIIARDIR-----FPN--------YFSDA---ARDLIDRLLDVDPSGRPG 309
                  +  RI +  +R      P          F  A   A DL+ ++L  DP  R  
Sbjct: 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT 287

Query: 310 AGPGGYAVLKMHPFFKG 326
                 A+   HPF   
Sbjct: 288 VEQ---ALQ--HPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 71/228 (31%), Positives = 117/228 (51%), Gaps = 34/228 (14%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           FEL ++ G G+Y +V + + + TG + A+K+MD   +T + +   +K E  +L +  H  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSHH- 62

Query: 117 VVRLFFTFQDTF----------SLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTAEV 164
             R   T+   F           L++ +E C  G + D I  +KG+ L E+   +   E+
Sbjct: 63  --RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           +  L ++H   +IHRDIK +N+LLT +  +K+ DFG V    D  +          +  T
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV---------GRRNT 170

Query: 225 FVGTAAYVPPEVL--NSSP-AT--FGNDLWALGCTLYQMLSGTSPFKD 267
           F+GT  ++ PEV+  + +P AT  F +DLW+LG T  +M  G  P  D
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 96.1 bits (239), Expect = 5e-21
 Identities = 46/116 (39%), Positives = 65/116 (56%), Gaps = 8/116 (6%)

Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 285
           +GT  Y+ PE+L   P     D WALG  L++ L+G  PF D +   +FQ I+ RDI +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 286 N---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
                 S  A++ I+ LL +DP+ R G        LK HP F G+DW+N++ QT P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKE-----LKQHPLFHGVDWENLQNQTMP 651

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 92.3 bits (230), Expect = 8e-21
 Identities = 85/320 (26%), Positives = 131/320 (40%), Gaps = 77/320 (24%)

Query: 53  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKK---F-ITKENKTAYVKLE 105
           S+ ++E L +I   G+Y  V RA+   TG + ALK   M+K+   F IT         L 
Sbjct: 3   SVDEYEKLNRIEE-GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--------LR 53

Query: 106 RI-VLDQLDHPGVVRL----FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARF 159
            I +L +L HP +V +      +  D   +YM +E  E  +L   + T K    + E + 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC 110

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
              +++  + ++H   ++HRD+K  NLLL   G +KI DFG  +                
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL---- 166

Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE------- 270
                 V T  Y  PE+L  +   +    D+W++GC   ++L+    F   SE       
Sbjct: 167 ------VVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219

Query: 271 -----------WLIFQRIIA--------------RDIRFPNYF-SDAARDLIDRLLDVDP 304
                      W  F  +                R  +FP    SD   DL++RLL  DP
Sbjct: 220 FKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDP 278

Query: 305 SGRPGAGPGGYAVLKMHPFF 324
           + R  A       LK HP+F
Sbjct: 279 AKRISA----EDALK-HPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 89/307 (28%), Positives = 136/307 (44%), Gaps = 60/307 (19%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKE--NKTAYVKLERI-VLDQ 111
           +E GK  G G+Y+ V +A+  +TG + A+K +   ++   K+  N TA   L  I +L +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA---LREIKLLQE 58

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEY 170
           L HP ++ L   F    ++ +  E  E  +L   I  K   L+  + + Y    +  LEY
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +HS  ++HRD+KP NLL+ +DG +K+ADFG       +R    PN     K    V T  
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGL------ARSFGSPN----RKMTHQVVTRW 167

Query: 231 YVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF------------------------ 265
           Y  PE+L  +     G D+W++GC   ++L    PF                        
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEEN 226

Query: 266 -------KDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVL 318
                   D  E+  F     + I FP   SD A DL+ RLL ++P+ R  A        
Sbjct: 227 WPGVTSLPDYVEFKPFPPTPLKQI-FPAA-SDDALDLLQRLLTLNPNKRITA-----RQA 279

Query: 319 KMHPFFK 325
             HP+F 
Sbjct: 280 LEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 82/326 (25%), Positives = 132/326 (40%), Gaps = 74/326 (22%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-----TAYVKLERI 107
            ++D+E+    G G++ +V +A++I TG V ALK    K +    K     TA   L  I
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK----KILMHNEKDGFPITA---LREI 58

Query: 108 -VLDQLDHPGVVRLFFTFQD-------------TFSLYMALESCEGGELFDQITSKGHLS 153
            +L +L HP VV L     +               + YM  +    G L +       L+
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENP---SVKLT 113

Query: 154 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV- 212
           E + + Y  ++++ + Y+H   ++HRDIK  N+L+   G +KIADFG  +P         
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173

Query: 213 LPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
                   K    V T  Y PPE+L      + A    D+W +GC   +M +     +  
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV---DIWGIGCVFAEMFTRRPILQGK 230

Query: 269 SEW----LIFQRI-IARDIRFPNY-----------FSDAAR--------------DLIDR 298
           S+     LIF+      +  +P +           F++  R              DL+ +
Sbjct: 231 SDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSK 290

Query: 299 LLDVDPSGRPGAGPGGYAVLKMHPFF 324
           LL +DP  R  A          HP+F
Sbjct: 291 LLSLDPYKRLTASDA-----LEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 44/269 (16%)

Query: 64  GVGSYSKVVRAK---KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           G G++ +V + K   K    T  A+K + K+  ++E +  ++K E  V+ +L HP VVRL
Sbjct: 4   GEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLK-EARVMKKLGHPNVVRL 61

Query: 121 F-FTFQDTFSLYMALESCEGGEL---------FDQITSKGHLSEDEARFYTAEVVDALEY 170
                ++   LY+ LE  EGG+L               K  LS  +   +  ++   +EY
Sbjct: 62  LGVCTEEE-PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           + S   +HRD+   N L+  D  +KI+DFG    +  SR     +   DD      G   
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFG----L--SR-----DVYDDDYYRKKTGGKL 169

Query: 231 YV---PPEVLNS---SPATFGNDLWALGCTLYQMLS-GTSPF--KDTSEWLIFQRIIA-- 279
            +    PE L     +  +   D+W+ G  L+++ + G +P+      E  + + +    
Sbjct: 170 PIRWMAPESLKDGIFTSKS---DVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLRKGY 224

Query: 280 RDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
           R +  P Y  D   +L+     +DP  RP
Sbjct: 225 R-LPKPEYCPDELYELMLSCWQLDPEDRP 252

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 84/313 (26%), Positives = 139/313 (44%), Gaps = 49/313 (15%)

Query: 28  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI 87
            +SS++  +   +   A  A +   S+ + E     G G+   V +     TG +YALK+
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAK---SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKV 106

Query: 88  MD-------KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG 140
           +        ++ I +E +         +L  ++HP VV+    F     + + LE  +GG
Sbjct: 107 IYGNHEDTVRRQICREIE---------ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157

Query: 141 ELFD-QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 199
            L    I  +  L+ D AR    +++  + Y+H   ++HRDIKP NLL+ +  ++KIADF
Sbjct: 158 SLEGTHIADEQFLA-DVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212

Query: 200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT-----FGNDLWALGCT 254
           G       SRI     A + D   + VGT AY+ PE +N+         +  D+W+LG +
Sbjct: 213 GV------SRIL----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262

Query: 255 LYQMLSGTSPFK--DTSEW--LIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
           + +   G  PF      +W  L+    +++    P   S   R  I   L  +P+ R  A
Sbjct: 263 ILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSA 322

Query: 311 GPGGYAVLKMHPF 323
                  L  HPF
Sbjct: 323 -----MQLLQHPF 330

Length = 353

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 57/297 (19%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 122
           G G+Y  V +A+   TG V ALK +  +  T+        +  I +L +L+HP +V+L  
Sbjct: 9   GEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 123 TFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
                  LY+  E   +  + F   +    +     + Y  +++  L + HS  ++HRD+
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126

Query: 182 KPENLLLTADGHIKIADFGSVK----PMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 236
           KP+NLL+  +G IK+ADFG  +    P++     V+              T  Y  PE+ 
Sbjct: 127 KPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--------------TLWYRAPEIL 172

Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD-------IRFP 285
           L     +   D+W+LGC   +M++  + F   SE    + IF+ +   D          P
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 286 NY------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           +Y                    +  RDL+ ++L  DP+ R  A     A L  HPFF
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK----AALA-HPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 14/216 (6%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           FE+  + G G+Y  V++ +  +T  + A+K        +E K   ++ E  +L  L    
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61

Query: 117 VVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           +V L   F+    LY+  E  E    EL +++ +   +  ++ R Y  +++ A+ + H  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHKN 119

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            ++HRDIKPENLL++ +  +K+ DFG  + + +          S+     +V T  Y  P
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE---------GSNANYTEYVATRWYRSP 170

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           E+L  +P     D+W++GC L ++  G   F   SE
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 90.2 bits (224), Expect = 8e-20
 Identities = 84/324 (25%), Positives = 139/324 (42%), Gaps = 82/324 (25%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--------IMDKKFITKENKTAYVKLERIV 108
           +++ ++ G GSY  V  A    TG   A+K        + D   I +E     +KL R+ 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILRE-----IKLLRL- 55

Query: 109 LDQLDHPGVVRLFF--------TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 160
              L HP +V +           F+D + ++  +ES    +L   I +   L+ +  +F+
Sbjct: 56  ---LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFF 108

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM-QDSRITVLPNAASD 219
             +++ AL+YIH+  + HRD+KP+N+L  AD  +KI DFG  +    D+   +     +D
Sbjct: 109 LYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WTD 165

Query: 220 DKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTS--PFKD----- 267
                +V T  Y  PE+  S     +PA    D+W++GC   ++L+G    P K+     
Sbjct: 166 -----YVATRWYRAPELCGSFFSKYTPAI---DIWSIGCIFAEVLTGKPLFPGKNVVHQL 217

Query: 268 --------TSEWLIFQRI-------------IARDIRFPNYFSDA---ARDLIDRLLDVD 303
                   T       R+               + + F   F +A   A  L++RLL  D
Sbjct: 218 DLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD 277

Query: 304 PSGRPGAGPGGYAVLKMHPFFKGI 327
           P  RP A           P+FKG+
Sbjct: 278 PKDRPTA-----EEALADPYFKGL 296

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 87.9 bits (219), Expect = 1e-19
 Identities = 63/269 (23%), Positives = 113/269 (42%), Gaps = 37/269 (13%)

Query: 57  FELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            ELGK  G G++ +V +         T T  A+K + K+  ++E +  +++ E  ++ +L
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLE-EASIMKKL 58

Query: 113 DHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 169
            HP +VRL    T  +   LY+  E   GG+L D +      L+  +      ++   +E
Sbjct: 59  SHPNIVRLLGVCTQGE--PLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFV 226
           Y+ S   +HRD+   N L+T +  +KI+DFG    +      R                 
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR----------------K 160

Query: 227 GTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 280
                +P     PE L     T  +D+W+ G  L+++ + G  P+   S   + + +   
Sbjct: 161 RGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220

Query: 281 D-IRFPNYFSDAARDLIDRLLDVDPSGRP 308
             +  P    D   +L+ +    DP  RP
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRP 249

Length = 258

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 81/302 (26%), Positives = 125/302 (41%), Gaps = 67/302 (22%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           L KI G G++ +V +A+   T  + ALK  +M+ +   KE        E  +L  L H  
Sbjct: 17  LAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHEN 72

Query: 117 VVRL----------FFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 164
           VV L          +  ++ +F  Y+  E CE     L      K  LSE +       +
Sbjct: 73  VVNLIEICRTKATPYNRYKGSF--YLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMKML 128

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL------ARAFSLSKNSKPNRYTN 182

Query: 225 FVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--- 277
            V T  Y PPE+L    +  P     D+W  GC + +M + +   +  +E      I   
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPI---DMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239

Query: 278 ---IARDI-------------------------RFPNYFSDA-ARDLIDRLLDVDPSGRP 308
              I  ++                         R   Y  D  A DLID+LL +DP+ R 
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299

Query: 309 GA 310
            A
Sbjct: 300 DA 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 91.8 bits (228), Expect = 2e-19
 Identities = 72/293 (24%), Positives = 124/293 (42%), Gaps = 37/293 (12%)

Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSLYMALE 135
            TG   A+K++      +E++ A  + E  +  +L HP +V L  + +      L+   E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFE 59

Query: 136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG--- 192
              G  L + + + G L   E      +V+DAL   H+ G++HRD+KP+N++++  G   
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119

Query: 193 HIKIADFGSVKPMQDSRITVLPNAASDD-----KACTFVGTAAYVPPEVLNSSPATFGND 247
           H K+ DFG          T+LP     D     +    +GT  Y  PE L   P T  +D
Sbjct: 120 HAKVLDFGIG--------TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 248 LWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV---D 303
           L+A G    + L+G    +  S   +++Q++   D+  P +   A   L   L      D
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI--AGHPLGQVLRKALNKD 229

Query: 304 PSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP------PKLASEPMVQSGE 350
           P  R  + P       +   F+ ++   + G          +  + P+V SG 
Sbjct: 230 PRQRAASAP------ALAERFRALELCALVGILRMGEGAGREAIAAPLVASGT 276

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 83/308 (26%), Positives = 131/308 (42%), Gaps = 69/308 (22%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK----TAYVKLERIV 108
            +  F++    G G+Y +V +A+  DTG + ALK   K  +  E +    TA  +++  +
Sbjct: 5   CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIK--I 59

Query: 109 LDQLDHPGVVRLFFTF----------QDTFSLYMALESCEGGELFDQITSK-GHLSEDEA 157
           L QL+H  +V L              +D  + Y+  E  +  +L   + S   H SED  
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118

Query: 158 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
           + +  ++++ L Y H    +HRDIK  N+LL   G IK+ADFG  +         L N+ 
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR---------LYNSE 169

Query: 218 SDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 273
                   V T  Y PPE+L       PA    D+W+ GC L ++ +    F+   E   
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAI---DVWSCGCILGELFTKKPIFQANQELAQ 226

Query: 274 FQRIIAR------------DIRFPNY----------------FS---DAARDLIDRLLDV 302
            + +I+R             I+ P +                FS     A DL+D +L +
Sbjct: 227 LE-LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL 285

Query: 303 DPSGRPGA 310
           DPS R  A
Sbjct: 286 DPSKRCTA 293

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 87.3 bits (216), Expect = 7e-19
 Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 31/214 (14%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQLDHPGVVRLF- 121
           G G+Y  V  A    TG   A+K + + F ++   K AY +L   +L  + H  V+ L  
Sbjct: 24  GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR--LLKHMKHENVIGLLD 81

Query: 122 -FT-------FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            FT       F D F L M     + G+L         LSED  +F   +++  L+YIH+
Sbjct: 82  VFTPDLSLDRFHD-FYLVMPFMGTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHA 136

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
            G+IHRD+KP NL +  D  +KI DFG  +              +D +   +V T  Y  
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------QTDSEMTGYVVTRWYRA 183

Query: 234 PEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
           PEV LN    T   D+W++GC + +ML+G   FK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 86.3 bits (214), Expect = 9e-19
 Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 58/303 (19%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALK---IMDKKFITKENKTAYVKLERIVLDQLDH 114
           +L KI G G+Y  V +AK  +T  + ALK   + D      E   +    E  +L +L H
Sbjct: 4   KLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDDD----EGVPSSALREICLLKELKH 58

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
             +VRL+        L +  E C+    + FD  +  G +  +  + +  +++  L + H
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S  ++HRD+KP+NLL+  +G +K+ADFG  +      I V   +A        V T  Y 
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVRCYSAE-------VVTLWYR 166

Query: 233 PPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF---KDTSEWL--IFQRI--------- 277
           PP+VL  +   +   D+W+ GC   ++ +   P     D  + L  IF+ +         
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226

Query: 278 ----IARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 321
               +     +P Y             +   RDL+  LL  +P  R  A       L+ H
Sbjct: 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE----EALQ-H 281

Query: 322 PFF 324
           P+F
Sbjct: 282 PYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 75/294 (25%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT-AYVKLERI-VLDQLDHPGVVRL- 120
           G G+Y  V  AK  +T    A+K +   F   +N+  A   L  I +L  LDH  V+ + 
Sbjct: 14  GRGAYGIVCSAKNSETNEKVAIKKIANAF---DNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 121 -------FFTFQDTFSLYMALESCEGGELFDQ-----ITSKGHLSEDEARFYTAEVVDAL 168
                     F D + +Y         EL D      I S   LS+D  +++  +++  L
Sbjct: 71  DIMPPPHREAFNDVYIVY---------ELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           +YIHS  ++HRD+KP NLLL A+  +KI DFG  +            +   D    +V T
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR----------TTSEKGDFMTEYVVT 171

Query: 229 AAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIAR----- 280
             Y  PE+ LN S  T   D+W++GC   ++L     F  KD    L   ++I       
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLGSP 228

Query: 281 ---DIRF-------------PNY--------FSDA---ARDLIDRLLDVDPSGR 307
              D+ F             P          F  A   A DL++++L  DPS R
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 36/272 (13%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 115
           +E+ +  G G+Y KV +      G+  A+KI+D      E     ++ E  +L  L DHP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILKALSDHP 75

Query: 116 GVVRLFFTF-----QDTFSLYMALESCEGGELFDQITSKGHLSEDE------ARFYTAEV 164
            VV+ +  +     ++   L++ LE C GG + D +  KG L   E        +   E 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           +  L+++H    IHRD+K  N+LLT +G +K+ DFG    +  +R+          +  T
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL----------RRNT 183

Query: 225 FVGTAAYVPPEVLNSSP---ATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 279
            VGT  ++ PEV+       +T+    D+W+LG T  ++  G  P  D        +I  
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243

Query: 280 R---DIRFPNYFSDAARDLIDRLLDVDPSGRP 308
                +  P  +S+   D I + L  D   RP
Sbjct: 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP 275

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 27/216 (12%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G      IM +K I  E K A    +  E  VL + 
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGL-----IMARKLIHLEIKPAIRNQIIRELKVLHEC 56

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 171
           + P +V  +  F     + + +E  +GG L DQ+  K G + E+     +  V+  L Y+
Sbjct: 57  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYL 115

Query: 172 ---HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
              H   ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT
Sbjct: 116 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGT 161

Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
            +Y+ PE L  +  T  +D+W+LG +L +M  G  P
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 85.7 bits (212), Expect = 3e-18
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 32/214 (14%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQLDHPGVVRLF- 121
           G G+Y  V  A    TG   A+K + + F ++   K AY +L   +L  + H  V+ L  
Sbjct: 24  GSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYREL--TLLKHMQHENVIGLLD 81

Query: 122 -FT-------FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            FT       FQD F L M     +  ++         LSED+ ++   +++  L+YIHS
Sbjct: 82  VFTSAVSGDEFQD-FYLVMPYMQTDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHS 135

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
            G+IHRD+KP NL +  D  +KI DFG  +              +D +   +V T  Y  
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------HADAEMTGYVVTRWYRA 182

Query: 234 PEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
           PEV LN        D+W++GC + +ML+G + FK
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 48/281 (17%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFF 122
           G G+Y+ V + +   TG + ALK +    +  E  T    +  I L  +L H  +VRL  
Sbjct: 9   GEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 123 TFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
                  L +  E  +    +  D    +G L  +  + +T +++  + + H   ++HRD
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125

Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLP-NAASDDKACTFVGTAAYVPPEVL-N 238
           +KP+NLL+   G +K+ADFG       +R   +P N  S++     V T  Y  P+VL  
Sbjct: 126 LKPQNLLINKRGELKLADFGL------ARAFGIPVNTFSNE-----VVTLWYRAPDVLLG 174

Query: 239 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIF-------QRIIARDIRFPNY 287
           S   +   D+W++GC + +M++G   F  T+       IF       +       + P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 288 FSDAAR------------------DLIDRLLDVDPSGRPGA 310
                R                  DL+ RLL ++P  R  A
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA 275

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 84/295 (28%), Positives = 130/295 (44%), Gaps = 40/295 (13%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G      IM +K I  E K A    +  E  VL + 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 171
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 119

Query: 172 HSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------MANSFVGTRS 167

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEW-LIFQRIIARDIRFPNY 287
           Y+ PE L  +  +  +D+W++G +L +M  G  P    D  E  L+F   +  D      
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD------ 221

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 342
              A  +   R     P GRP +  G  +   M   F+ +D+  I  + PPKL S
Sbjct: 222 --PAESETSPR---PRPPGRPLSSYGPDSRPPM-AIFELLDY--IVNEPPPKLPS 268

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 63/315 (20%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
              +GK +       + + K   T T+ A+K   K  +   +K     L  E I   QL 
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKP--TNTLVAVK---KINLDSCSKEDLKLLQQEIITSRQLQ 57

Query: 114 HPGVVRLFFTFQDTFSLY-----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           HP ++    +F     LY     MA  SCE  +L      +G L E    F   +V++AL
Sbjct: 58  HPNILPYVTSFIVDSELYVVSPLMAYGSCE--DLLKTHFPEG-LPELAIAFILKDVLNAL 114

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM--QDSRITVLPNAASDDKACTFV 226
           +YIHS G IHR +K  ++LL+ DG + ++       M     R  V+      D   + V
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV-----HDFPKSSV 169

Query: 227 GTAAYVPPEVL--NSSPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRI------ 277
               ++ PEVL  N       +D++++G T  ++ +G  PFKD  +  ++ +++      
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC 229

Query: 278 ---------------------------IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
                                       + D  +   FS+     ++  L  DP  RP A
Sbjct: 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289

Query: 311 GPGGYAVLKMHPFFK 325
                + L  H FFK
Sbjct: 290 -----SQLLNHSFFK 299

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 86.4 bits (214), Expect = 8e-18
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 40/285 (14%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQL 112
           +Q +++ ++ G G   +V  A         ALK + +        K  +++  +I  D L
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAAD-L 59

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEG---GELFDQITSKGHLSEDEAR----------F 159
            HPG+V ++    D   +Y  +   EG     L   +  K  LS++ A           F
Sbjct: 60  IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
           +   +   +EY+HS G++HRD+KP+N+LL   G + I D+G+    +     +L     +
Sbjct: 120 HK--ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 220 DKAC--------TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTS 269
              C          VGT  Y+ PE L   PA+   D++ALG  LYQML+ + P+  K   
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Query: 270 EWLIFQRIIA-------RDIRFPNYFSDAARDLIDRLLDVDPSGR 307
           +      I++       R+I  P + S  A     + L VDP+ R
Sbjct: 238 KISYRDVILSPIEVAPYREI--PPFLSQIAM----KALAVDPAER 276

Length = 932

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 71/252 (28%), Positives = 103/252 (40%), Gaps = 19/252 (7%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+  V  A    T  V A+K M         K   +  E   L QL HP  +     
Sbjct: 30  GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGC 89

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRDIK 
Sbjct: 90  YLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 149

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 240
            N+LLT  G +K+ADFGS              A+    A +FVGT  ++ PEV   ++  
Sbjct: 150 GNILLTEPGQVKLADFGS--------------ASKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDR 298
                 D+W+LG T  ++     P  + +       I   D      N ++D+ R  +D 
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255

Query: 299 LLDVDPSGRPGA 310
            L   P  RP +
Sbjct: 256 CLQKIPQERPAS 267

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 78/281 (27%), Positives = 131/281 (46%), Gaps = 36/281 (12%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 117
           ELG+    G+Y  V + + + TGT+ A+K +     ++E K   + L+ I +  +D P  
Sbjct: 8   ELGR----GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD-ISMRSVDCPYT 62

Query: 118 VRLF---FTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHS 173
           V  +   F   D + + M +      + + ++  KG  + ED        +V ALEY+HS
Sbjct: 63  VTFYGALFREGDVW-ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 174 -MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
            + +IHRD+KP N+L+  +G +K+ DFG    + DS        A    A    G   Y+
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-------VAKTIDA----GCKPYM 170

Query: 233 PPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDIRFP 285
            PE +N      G    +D+W+LG T+ ++ +G  P+   K   + L  Q +     + P
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-QVVEEPSPQLP 229

Query: 286 N-YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
              FS   +D +++ L  +   RP      Y  L  HPFF+
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERP-----NYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLDQLDHPGVVRL-- 120
           G GSY+ V + K    G + ALK++    + +E  T +  + E  +L  L H  +V L  
Sbjct: 14  GEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
               ++T +L       +  +  D+    G L  +  + +  +++  L YIH   ++HRD
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRD 128

Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNS 239
           +KP+NLL++  G +K+ADFG       +R   +P+    ++  T      Y PP+V L S
Sbjct: 129 LKPQNLLISDTGELKLADFGL------ARAKSVPSHTYSNEVVTL----WYRPPDVLLGS 178

Query: 240 SPATFGNDLWALGCTLYQMLSGTSPF 265
           +  +   D+W +GC   +M+ G + F
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 82/304 (26%), Positives = 130/304 (42%), Gaps = 62/304 (20%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI----VLDQLDH 114
           + KI G G+Y  V +A+   TG + ALK      I  E +   V    I    +L +L+H
Sbjct: 4   VEKI-GEGTYGVVYKARDKLTGEIVALKK-----IRLETEDEGVPSTAIREISLLKELNH 57

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 172
           P +VRL         LY+  E  +  +L   + S      D      Y  +++  + Y H
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF-VGTAAY 231
           S  ++HRD+KP+NLL+  +G +K+ADFG       +R   +P      +  T  V T  Y
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGL------ARAFGVPV-----RTYTHEVVTLWY 165

Query: 232 VPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD---- 281
             PE+L  S   +T   D+W++GC   +M++    F   SE    + IF+ +   D    
Sbjct: 166 RAPEILLGSRQYST-PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224

Query: 282 ----------IRFPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM 320
                       FP +             +   DL+ ++L  DP+ R  A     A+   
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA---KAALQ-- 279

Query: 321 HPFF 324
           HP+F
Sbjct: 280 HPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 75/286 (26%), Positives = 125/286 (43%), Gaps = 61/286 (21%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFF 122
           G+G++  V  A+   TG   A+K + K F T    K  Y +L+  +L  L H  ++ L  
Sbjct: 19  GMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK--LLKHLRHENIISL-- 74

Query: 123 TFQDTF-----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
              D F      +Y   E   G +L   +TS+  L +   +++  +++  L+Y+HS G++
Sbjct: 75  --SDIFISPLEDIYFVTE-LLGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVV 130

Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 236
           HRD+KP N+L+  +  +KI DFG  +  QD ++T             +V T  Y  PE+ 
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARI-QDPQMT------------GYVSTRYYRAPEIM 177

Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTS--PFKD-------TSEWL------IFQRIIARD 281
           L         D+W+ GC   +ML G    P KD        ++ L      +   I + +
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237

Query: 282 I-----------------RFPNYFSDAARDLIDRLLDVDPSGRPGA 310
                             +F N    +A DL++++L  DP  R  A
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISA 282

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 76/287 (26%), Positives = 121/287 (42%), Gaps = 37/287 (12%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 115
           +E+ +  G G+Y KV +      G++ A+KI+D      E     ++ E  +L  L +HP
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNILQSLPNHP 79

Query: 116 GVVRLFFTF--QDTFS---LYMALESCEGG---ELFDQITSKGH-LSEDEARFYTAEVVD 166
            VV+ +  F   D      L++ LE C GG   EL   +   G  L E    +     + 
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            L+++H+  +IHRD+K  N+LLT +G +K+ DFG    +  +R+          +  T V
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL----------RRNTSV 189

Query: 227 GTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRII 278
           GT  ++ PEV+              D+W+LG T  ++  G  P  D           R  
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249

Query: 279 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
              +  P  +  +    I + L  D   RP         L  HPF K
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSV-----THLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 26  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 83

Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 143

Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 190

Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 19/250 (7%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+  V  A+ +    V A+K M         K   +  E   L +L HP  ++    
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRD+K 
Sbjct: 84  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 240
            N+LL+  G +K+ DFGS   M                A  FVGT  ++ PEV   ++  
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMA--------------PANXFVGTPYWMAPEVILAMDEG 189

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDR 298
                 D+W+LG T  ++     P  + +       I   +       ++S+  R+ +D 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249

Query: 299 LLDVDPSGRP 308
            L   P  RP
Sbjct: 250 CLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 71/287 (24%), Positives = 120/287 (41%), Gaps = 32/287 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           QD +  +I G G+   V +A  + T  + A+K++      +  K    +LE  +L + D 
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE--ILYKCDS 58

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P ++  +  F     + +  E  +GG L         + E         VV  L Y+ S+
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            ++HRD+KP N+L+   G +K+ DFG    + +S             A T+VGT AY+ P
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------------IAKTYVGTNAYMAP 162

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSP----FKDTSEWL---IFQRIIARDI-RFP- 285
           E ++       +D+W+LG +  ++  G  P     K+    +   + Q I+  D    P 
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222

Query: 286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
             FS+     I + +   P  RP         L  HPF    +  N 
Sbjct: 223 GQFSEKFVHFITQCMRKQPKERPAP-----ENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 84.8 bits (209), Expect = 3e-17
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 52/303 (17%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           + ++E+ K  G G + +V   K   T   +  K +  + + +  K+  V +E  V+ +L 
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK 70

Query: 114 HPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDA 167
           H  +VR    F +  +  LY+ +E C+ G+L   I       G + E      T +++ A
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 168 LEYIHSMG-------LIHRDIKPENLLL-TADGHI----------------KIADFGSVK 203
           L Y H++        ++HRD+KP+N+ L T   HI                KI DFG  K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSG 261
                      N   +  A + VGT  Y  PE+L     ++ +  D+WALGC +Y++ SG
Sbjct: 191 -----------NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 262 TSPFKDTSEWLIFQRIIARDIRFPNY----FSDAARDLIDRLLDVDPSGRPGAGPG-GYA 316
            +PF   +    F ++I+   R P+      S     LI  LL++    RP A    GY 
Sbjct: 240 KTPFHKANN---FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296

Query: 317 VLK 319
           ++K
Sbjct: 297 IIK 299

Length = 1021

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 69/238 (28%), Positives = 101/238 (42%), Gaps = 55/238 (23%)

Query: 59  LGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKL------ERIVLD 110
            G I G G+Y +V +A  K    G  YA+K    KF  K +K  Y  +      E  +L 
Sbjct: 5   EGCI-GRGTYGRVYKAKRKNGKDGKEYAIK----KF--KGDKEQYTGISQSACREIALLR 57

Query: 111 QLDHPGVVRL---FFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEV- 164
           +L H  VV L   F    D  S+Y+  +  E     D  QI  K H          + V 
Sbjct: 58  ELKHENVVSLVEVFLEHADK-SVYLLFDYAE----HDLWQII-KFHRQAKRVSIPPSMVK 111

Query: 165 ------VDALEYIHSMGLIHRDIKPENLLLTADGH----IKIADFGSVKPMQDSRITVLP 214
                 ++ + Y+HS  ++HRD+KP N+L+  +G     +KI D G       +R+   P
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL------ARLFNAP 165

Query: 215 NA--ASDDKACTFVGTAAYVPPEVLNSS----PATFGNDLWALGCTLYQMLSGTSPFK 266
               A  D     V T  Y  PE+L  +     A    D+WA+GC   ++L+    FK
Sbjct: 166 LKPLADLDPV---VVTIWYRAPELLLGARHYTKAI---DIWAIGCIFAELLTLEPIFK 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.3 bits (200), Expect = 6e-17
 Identities = 69/250 (27%), Positives = 104/250 (41%), Gaps = 19/250 (7%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+  V  A+ + T  V A+K M         K   +  E   L ++ HP  +     
Sbjct: 34  GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGC 93

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRDIK 
Sbjct: 94  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 153

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 240
            N+LLT  G +K+ADFGS              A+    A +FVGT  ++ PEV   ++  
Sbjct: 154 GNILLTEPGQVKLADFGS--------------ASIASPANSFVGTPYWMAPEVILAMDEG 199

Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDR 298
                 D+W+LG T  ++     P  + +       I   +      N +SD  R+ +D 
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 259

Query: 299 LLDVDPSGRP 308
            L   P  RP
Sbjct: 260 CLQKIPQDRP 269

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI----VLDQLDHPG 116
           KI G G+Y  V + +   TG + A+K      I  E++   V    I    +L +L HP 
Sbjct: 7   KI-GEGTYGVVYKGRNKKTGQIVAMKK-----IRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 117 VVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           +V L         LY+  E  S +  +  D +    ++  +  + Y  +++  + + HS 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            ++HRD+KP+NLL+   G IK+ADFG       +R   +P      +    V T  Y  P
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGL------ARAFGIPVRVYTHE----VVTLWYRAP 170

Query: 235 EVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           EVL  SP  +   D+W++G    +M +    F   SE
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 68/233 (29%), Positives = 105/233 (45%), Gaps = 48/233 (20%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLDQLDHPGVVRL-- 120
           G GSY+ V + +   TG + ALK +    +  E    +  + E  +L  L H  +V L  
Sbjct: 14  GEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 121 ----------FFTFQDT-FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
                      F + DT    YM  + C GG           LS    R +  +++  L 
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYM--DDCGGG-----------LSMHNVRLFLFQLLRGLA 117

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP-NAASDDKACTFVGT 228
           Y H   ++HRD+KP+NLL++  G +K+ADFG       +R   +P    S++     V T
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGL------ARAKSVPSKTYSNE-----VVT 166

Query: 229 AAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF---KDTSEWL--IFQ 275
             Y PP+VL  S+  +   D+W +GC  Y+M +G   F    D  + L  IF+
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 16/210 (7%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 117
           +L K+ G G+Y+ V + +   T  + ALK  + +   +E        E  +L  L H  +
Sbjct: 9   KLDKL-GEGTYATVFKGRSKLTENLVALK--EIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 118 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSMGL 176
           V L         L +  E  +  +L   + + G+L S    + +  +++  L Y H   +
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           +HRD+KP+NLL+   G +K+ADFG       +R   +P     ++    V T  Y PP+V
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGL------ARAKSVPTKTYSNE----VVTLWYRPPDV 174

Query: 237 -LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            L S+  +   D+W +GC LY+M +G   F
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 65/295 (22%), Positives = 120/295 (40%), Gaps = 49/295 (16%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMD----KKFITKENKTA------YVKLERI- 107
            G   G G+Y KV +A    TG + A+K +        +TK+ +        +  L  + 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 108 VLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
           +++++ H  ++ L   +   D  +L M + +    +L   +  K  L+E + +    +++
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMA---SDLKKVVDRKIRLTESQVKCILLQIL 129

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG----SVKPMQDSRITVLPNAASDDK 221
           + L  +H    +HRD+ P N+ + + G  KIADFG       P     ++        ++
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 222 ACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE---------- 270
             + V T  Y  PE+L  +    F  D+W++GC   ++L+G   F   +E          
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249

Query: 271 --------W-------LIFQRIIARDIRFPNYF---SDAARDLIDRLLDVDPSGR 307
                   W       L  +    +       F   SD A DL+  LL ++P  R
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304

Length = 335

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.4 bits (191), Expect = 5e-16
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALE 169
           LDH  ++RL+        L M  E    G L D++   + GH        Y  ++ + + 
Sbjct: 53  LDHENLIRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 227
           Y+ S   IHRD+   N+LL +D  +KI DFG ++  P  +    +  +         F  
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH-----LKVPF-- 164

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF-- 284
             A+  PE L +   +  +D+W  G TL++M + G  P+   S   I ++I     R   
Sbjct: 165 --AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER 222

Query: 285 PNYFSDAARDLIDRLLDVDPSGRP 308
           P        +++ +    +P+ RP
Sbjct: 223 PEACPQDIYNVMLQCWAHNPADRP 246

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 78.6 bits (193), Expect = 6e-16
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  + H  V+ L  
Sbjct: 24  GSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHMKHENVIGLLD 81

Query: 123 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
            F      + F+    + +  G +L + I     LS++  +F   +++  L+YIHS G+I
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140

Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 236
           HRD+KP N+ +  D  ++I DFG  +              +DD+   +V T  Y  PE+ 
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLAR-------------QADDEMTGYVATRWYRAPEIM 187

Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           LN        D+W++GC + ++L G + F
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 44/297 (14%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 117
           +LG+I G G++  V +     +GT+ A+K +      KE K   + L+ ++    D P +
Sbjct: 8   DLGEI-GRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYI 65

Query: 118 VRLF---FTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYI- 171
           V+ +   F   D + + M L      + +  +    K  + E+         V AL Y+ 
Sbjct: 66  VKFYGALFREGDCW-ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
             + +IHRD+KP N+LL  +G+IK+ DFG    + DS       A + D  C       Y
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI------AKTRDAGCR-----PY 173

Query: 232 VPPEVLNSSPAT---FGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQR----------I 277
           + PE ++ S        +D+W+LG TLY++ +G  P+    +W  +F +          I
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY---PKWNSVFDQLTQVVKGDPPI 230

Query: 278 IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG 334
           ++        FS +  + I+  L  D S RP      Y  L  HPF K  + +N+  
Sbjct: 231 LSNSEER--EFSPSFVNFINLCLIKDESKRP-----KYKELLEHPFIKDYEERNVDV 280

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 38/294 (12%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQ 111
            DFE     G G+   V + +   +G      IM +K I  E K A    +  E  VL +
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHE 59

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
            + P +V  +  F     + + +E  +GG L   +     + E+     +  V+  L Y+
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119

Query: 172 HSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------MANSFVGTRS 167

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEW-LIFQR-IIARDIRFPN 286
           Y+ PE L  +  +  +D+W++G +L ++  G  P    D  E   IF R ++  +   P+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
             S   R          P GRP +G G  +   M   F+ +D+  I  + PPKL
Sbjct: 228 SISPRPR----------PPGRPVSGHGMDSRPAM-AIFELLDY--IVNEPPPKL 268

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL----DQLDHPGVVR 119
           GVG+Y  V +A+   +G   ALK +  +  T E+      +  + L    +  DHP +VR
Sbjct: 9   GVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 120 LF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           L        T ++T  + +  E  +       D++   G L  +  +    + +  L+++
Sbjct: 67  LMDVCATSRTDRET-KVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFL 124

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  Y
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTP----------VVVTLWY 173

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             PEVL  S      D+W++GC   +M      F   SE
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 75/296 (25%), Positives = 116/296 (39%), Gaps = 53/296 (17%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GSY+ V +      G + ALK++  K  T+E        E  +L  L H  +V L   
Sbjct: 14  GEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
                +L    E          I   G L     R +  +++  L YIH   ++HRD+KP
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKP 131

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPA 242
           +NLL++  G +K+ADFG       +R   +P+     +    V T  Y PP+VL  ++  
Sbjct: 132 QNLLISYLGELKLADFGL------ARAKSIPSQTYSSE----VVTLWYRPPDVLLGATDY 181

Query: 243 TFGNDLWALGCTLYQMLSGTSPFKDTSE--------WLIFQRIIARDI-----RFPNYFS 289
           +   D+W  GC   +ML G   F   S+        W +   +   D      + PNY  
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG-VPTEDTWPGVSKLPNYKP 240

Query: 290 D---------------------AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
           +                      A DL  ++L + P  R  A         +HP+F
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA-----LLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 86/359 (23%), Positives = 136/359 (37%), Gaps = 72/359 (20%)

Query: 57  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           F+LG  Y      G GS   V  A   D     A+K   K  +T      +   E  ++ 
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIR 57

Query: 111 QLDHPGVVRLFFTF-------QDTFSLYMALES-CEGGELFD----QITSKGHLSEDEAR 158
           +LDH  +V+++           +       L S     E  +     +  +G LSE+ AR
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117

Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAA 217
            +  +++  L+YIHS  ++HRD+KP N+ + T D  +KI DFG       +RI V P+ +
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL------ARI-VDPHYS 170

Query: 218 SDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEW---- 271
                   + T  Y  P +L  SP  +    D+WA GC   +ML+G   F    E     
Sbjct: 171 HKGYLSEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229

Query: 272 LIF--------------QRIIARDIRFPNYF------------SDAARDLIDRLLDVDPS 305
           LI                 +I   +R                 +  A D ++++L  +P 
Sbjct: 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM 289

Query: 306 GRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHI 364
            R  A         MHP+     +     +  P  +  P     E DD+   +   S I
Sbjct: 290 DRLTAEEA-----LMHPYMS--CYSCPFDE--PV-SLHPFHIEDELDDILLMTEIHSII 338

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 65/252 (25%), Positives = 110/252 (43%), Gaps = 15/252 (5%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++ +V   +     T  A+K   ++ +  + K  +++  RI L Q  HP +VRL   
Sbjct: 4   GRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARI-LKQYSHPNIVRLIGV 61

Query: 124 FQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
                 +Y+ +E  +GG+    + ++G  L   E           +EY+ S   IHRD+ 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 183 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 242
             N L+T    +KI+DFG  +  +D     +  +    K      TA    PE LN    
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDG----VYASTGGMKQIPVKWTA----PEALNYGRY 173

Query: 243 TFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRL 299
           +  +D+W+ G  L++  S G  P+ + S     +  I + +R   P    DA   L++R 
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQGVRLPCPELCPDAVYRLMERC 232

Query: 300 LDVDPSGRPGAG 311
            + DP  RP   
Sbjct: 233 WEYDPGQRPSFS 244

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 74.1 bits (182), Expect = 6e-15
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 14/208 (6%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAE 163
           E  V+ +L HP +V+L+        LY+  E  E G L + +  + G LS+D       +
Sbjct: 49  EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           V + +EY+     IHRD+   N L+++ G +K++DFG  + + D   T    A    K  
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS 168

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI 282
                    PPEV N S  +  +D+W+ G  ++++ + G  PF+  S + +   +I+R  
Sbjct: 169 ---------PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-EMISRGF 218

Query: 283 RF--PNYFSDAARDLIDRLLDVDPSGRP 308
           R   P   S    +++       P GRP
Sbjct: 219 RLYRPKLASMTVYEVMYSCWHEKPEGRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 109
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 58

Query: 110 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 161
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 116

Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 167

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 168 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 25/270 (9%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           F   +   GK  G G++ KVV A      K D     A+K++     + E +    +L+ 
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK- 90

Query: 107 IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAE 163
            ++  L +H  +V L         + +  E C  G+L + +  K    L+ ++   ++ +
Sbjct: 91  -IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRITVLPNAASDDK 221
           V   + ++ S   IHRD+   N+LLT  G I KI DFG  +  M DS   V  NA    K
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 280
                    ++ PE + +   TF +D+W+ G  L+++ S G++P+        F ++I  
Sbjct: 209 ---------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259

Query: 281 DIRF--PNYFSDAARDLIDRLLDVDPSGRP 308
             R   P +      D++    D DP  RP
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRP 289

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN----KTAYVKLERI---- 107
           D E  +  G G++  V        G   ALK M   F   +N    K  + +L+ +    
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFK 57

Query: 108 ---VLDQLD--HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 162
              VL  LD   P  +  F   ++ + +   ++S    +L   I S   LS D  + +  
Sbjct: 58  HDNVLSALDILQPPHIDPF---EEIYVVTELMQS----DLHKIIVSPQPLSSDHVKVFLY 110

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +++  L+Y+HS G++HRDIKP NLL+ ++  +KI DFG            L      D++
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFG------------LARVEEPDES 158

Query: 223 CTF---VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSG 261
                 V T  Y  PE+L  S   T   D+W++GC   ++L  
Sbjct: 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 15/208 (7%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+Y+ V + +   T  + ALK  + +   +E        E  +L  L H  +V L   
Sbjct: 15  GEGTYATVFKGRSKLTENLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
                SL +  E  +  +L   +   G+ +S    + +  +++  L Y H   ++HRD+K
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131

Query: 183 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSP 241
           P+NLL+   G +K+ADFG       +R   +P     ++    V T  Y PP+V L SS 
Sbjct: 132 PQNLLINERGELKLADFGL------ARAKSVPTKTYSNE----VVTLWYRPPDVLLGSSE 181

Query: 242 ATFGNDLWALGCTLYQMLSGTSPFKDTS 269
            +   D+W +GC  ++M SG   F  ++
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 73/297 (24%)

Query: 65  VGSYSKVVRAKKIDT--GTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF 121
           +GS ++ +     DT  G   A+K + + F  + + K AY +L  ++L  ++H  ++ L 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYREL--VLLKCVNHKNIISLL 86

Query: 122 --FTFQDTFS----LYMALESCEGGELFD-QITSKGHLSEDEAR--FYTAEVVDALEYIH 172
             FT Q +      +Y+ +E      L D  +    H+  D  R  +   +++  ++++H
Sbjct: 87  NVFTPQKSLEEFQDVYLVME------LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S G+IHRD+KP N+++ +D  +KI DFG  +            A ++     +V T  Y 
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TACTNFMMTPYVVTRYYR 189

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEW-----------LIFQRII 278
            PEV+         D+W++GC + +++ G+  F+ T    +W             F   +
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249

Query: 279 ARDIR-----------------FPNYF-----------SDAARDLIDRLLDVDPSGR 307
              +R                 FP++            +  ARDL+ ++L +DP  R
Sbjct: 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 28/255 (10%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++  V +   +   T  A+K   +  +  + K  +++   I L Q DHP +V+L   
Sbjct: 4   GKGNFGDVYKGV-LKGNTEVAVKTC-RSTLPPDLKRKFLQEAEI-LKQYDHPNIVKLIGV 60

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE----VVDA---LEYIHSMGL 176
                 +Y+ +E   GG L         L + + R    +     +DA   +EY+ S   
Sbjct: 61  CVQKQPIYIVMELVPGGSLLT------FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           IHRD+   N L+  +  +KI+DFG  +  +    TV    +   K      TA    PE 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV----SDGLKQIPIKWTA----PEA 166

Query: 237 LNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAAR 293
           LN    T  +D+W+ G  L++  S G +P+   S     +R I    R   P    +   
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIY 225

Query: 294 DLIDRLLDVDPSGRP 308
            L+ +    DP  RP
Sbjct: 226 RLMLQCWAYDPENRP 240

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+Y+ V + +   T  + ALK  + +   +E        E  +L  L H  +V L   
Sbjct: 15  GEGTYATVYKGRSKLTDNLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 124 FQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
                SL +  E  +    +  D   +  ++     + +  +++  L Y H   ++HRD+
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLRGLNYCHRRKVLHRDL 130

Query: 182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSS 240
           KP+NLL+   G +K+ADFG       +R   +P     ++    V T  Y PP++ L S+
Sbjct: 131 KPQNLLINERGELKLADFGL------ARAKSIPTKTYSNE----VVTLWYRPPDILLGST 180

Query: 241 PATFGNDLWALGCTLYQMLSGTSPF 265
             +   D+W +GC  Y+M +G   F
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 75/301 (24%), Positives = 128/301 (42%), Gaps = 72/301 (23%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQL 112
           + ++LG I G GS+  V  A  IDT    A+K  + D +         Y   E +++  L
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---------YKNRELLIMKNL 116

Query: 113 DHPGVVRLF-FTFQDTF-----SLYMALESCEGGELFDQITSK--GHLSEDE-------A 157
           +H  ++ L  + + + F     ++++ +      E   Q   K   H + +         
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVM----EFIPQTVHKYMKHYARNNHALPLFLV 172

Query: 158 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITVLPNA 216
           + Y+ ++  AL YIHS  + HRD+KP+NLL+  + H +K+ DFGS K           N 
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----------NL 221

Query: 217 ASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ 275
            +  ++ +++ +  Y  PE+ L ++  T   DLW+LGC + +M+ G   F   S      
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281

Query: 276 RIIA-----------------RDIRFPNYFS------------DAARDLIDRLLDVDPSG 306
           RII                   DI+FP+               D A + I + L  +P  
Sbjct: 282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLK 341

Query: 307 R 307
           R
Sbjct: 342 R 342

Length = 440

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 28/265 (10%)

Query: 55  QDFELGKIYGVGSYSKV---VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           +D  LG+  G G +  V   V     +     A+K   K   +   +  +++ E  ++ Q
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQ-EAYIMRQ 63

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALE 169
            DHP +V+L     +   +++ +E    GEL  + Q  +K  L       Y+ ++  AL 
Sbjct: 64  FDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALA 121

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+ S   +HRDI   N+L+++   +K+ DFG  + ++D          S  KA       
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE---------SYYKASKGKLPI 172

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-----DIR 283
            ++ PE +N    T  +D+W  G  ++++L  G  PF    + +    +I R      + 
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF----QGVKNNDVIGRIENGERLP 228

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRP 308
            P         L+ +    DPS RP
Sbjct: 229 MPPNCPPTLYSLMTKCWAYDPSKRP 253

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 40/224 (17%)

Query: 56  DFELGKIYGVGSYSKVVRAK---KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           +    K  G G +  V   K   KID     A+K++ +  +++++     K    V+ +L
Sbjct: 5   ELTFLKELGSGQFGVVHLGKWRGKIDV----AIKMIREGAMSEDDFIEEAK----VMMKL 56

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA-------EVV 165
            HP +V+L+        +++  E    G L +      +L E + +  T        +V 
Sbjct: 57  SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN------YLRERKGKLGTEWLLDMCSDVC 110

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +A+EY+ S G IHRD+   N L+  D  +K++DFG       +R  +      DD+  + 
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGL------ARYVL------DDQYTSS 158

Query: 226 VGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
            GT     + PPEV + S  +  +D+W+ G  ++++ S G  P+
Sbjct: 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 81/316 (25%), Positives = 127/316 (40%), Gaps = 72/316 (22%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DH 114
           +E  +  G G+Y KV +A+  +TG + ALK    +    E       L  I L Q+  + 
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 115 PGVVRLF---FTFQDT--FSLYMALESCEGGELFDQITSKGH-----LSEDEARFYTAEV 164
             +VRL       +     SLY+  E  +  +L   + S G      L     + +  ++
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +  + + H  G++HRD+KP+NLL+    G +KIAD G        R   +P      K+ 
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL------GRAFSIPV-----KSY 168

Query: 224 TF-VGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE------- 270
           T  + T  Y  PEVL      S+P     D+W++GC   +M      F   SE       
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224

Query: 271 --------------------WLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 308
                               W  F +   +D+    P+  S    DL+ ++L  DP+ R 
Sbjct: 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRI 283

Query: 309 GAGPGGYAVLKMHPFF 324
            A     A L  HP+F
Sbjct: 284 SA----KAALT-HPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 82/305 (26%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDHPGVVR 119
           K  G G+   V  A    TG   A+K + + F      K AY +L  +++  ++H  ++ 
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL--VLMKLVNHKNIIG 79

Query: 120 LF--FTFQDTFS----LYMALESCEGGELFD----QITSKGHLSEDEAR--FYTAEVVDA 167
           L   FT Q +      +Y+ +E      L D    Q+     +  D  R  +   +++  
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVME------LMDANLCQVI---QMDLDHERMSYLLYQMLCG 130

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FV 226
           ++++HS G+IHRD+KP N+++ +D  +KI DFG            L   A      T +V
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------LARTAGTSFMMTPYV 178

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEW------------ 271
            T  Y  PEV+         D+W++GC + +M+ GT  F  T    +W            
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238

Query: 272 ----------------------LIFQRIIARDIRFPNYFSDA-------ARDLIDRLLDV 302
                                   F+ +   D+ FP             ARDL+ ++L +
Sbjct: 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFP-DVLFPPDSESHNKLKASQARDLLSKMLVI 297

Query: 303 DPSGR 307
           DP  R
Sbjct: 298 DPEKR 302

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 42/226 (18%)

Query: 53  SIQDFELGKIYGVGSYSKVV----RAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ER 106
           + ++ +LG   G G +  V+    R +K+      A+K +      K++ TA      E 
Sbjct: 4   NSKELKLGATIGKGEFGDVMLGDYRGQKV------AVKCL------KDDSTAAQAFLAEA 51

Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEV 164
            V+  L HP +V+L         LY+  E    G L D + S+G   ++  +   +  +V
Sbjct: 52  SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV----LPNAASDD 220
            + +EY+     +HRD+   N+L++ D   K++DFG  K   ++        LP      
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLP------ 162

Query: 221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                     +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 163 --------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 38/105 (36%), Positives = 51/105 (48%), Gaps = 9/105 (8%)

Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           + R    +++ A+EYIH   LIHRDIK EN+ L  DG I + DFG+  P +  R      
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA---- 323

Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 260
                    +VGT A   PE+L         D+W+ G  L  MLS
Sbjct: 324 -----FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 32/225 (14%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLD 110
            ++Q   LG+I G G +  V++ +   TG   A+K +      K + TA   L E  V+ 
Sbjct: 3   LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNI------KCDVTAQAFLEETAVMT 54

Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDAL 168
           +L H  +VRL         LY+ +E    G L + + ++G       +   ++ +V + +
Sbjct: 55  KLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG--SVKPMQ-DSRITVLPNAASDDKACTF 225
           EY+ S  L+HRD+   N+L++ DG  K++DFG   V  M  D+  + LP           
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN--SKLP----------- 160

Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
                +  PE L     +  +D+W+ G  L+++ S G +P+   S
Sbjct: 161 ---VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 62/264 (23%), Positives = 115/264 (43%), Gaps = 29/264 (10%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLD 110
            ++++ +L +  G G +  V+       G   A+K +      K + TA   L E  V+ 
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI------KNDATAQAFLAEASVMT 54

Query: 111 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDA 167
           QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +A
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV-LPNAASDDKACTFV 226
           +EY+ +   +HRD+   N+L++ D   K++DFG  K    ++ T  LP            
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------------ 162

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI-IARDIRF 284
               +  PE L     +  +D+W+ G  L+++ S G  P+       +  R+     +  
Sbjct: 163 --VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 220

Query: 285 PNYFSDAARDLIDRLLDVDPSGRP 308
           P+       D++ +   +D + RP
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRP 244

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 29/112 (25%), Positives = 55/112 (49%), Gaps = 17/112 (15%)

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
           +++++   ++Y+ S   IHRD+   N+L+ ++  +KI+DFG            L     +
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG------------LAKVLPE 161

Query: 220 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
           DK   +V      P     PE L +S  +  +D+W+ G TLY++ +   P +
Sbjct: 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)

Query: 64  GVGSYSKVV----RAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR 119
           G G++  VV      K      V A+K + ++ I    K  +++ E  V+ QLDHP +VR
Sbjct: 4   GHGNFGSVVKGVYLMKSGKEVEV-AVKTLKQEHI-AAGKKEFLR-EASVMAQLDHPCIVR 60

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L    +    L + +E    G L   +  +  +   + +    +V   + Y+ S   +HR
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----P 234
           D+   N+LL      KI+DFG  + +          A SD    T   TA   P     P
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL---------GAGSDYYRAT---TAGRWPLKWYAP 167

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 267
           E +N    +  +D+W+ G TL++  S G  P+ +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 13/164 (7%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTA 162
           E  ++ QL HP +VRL+        +Y+  E  E G L D + T +G  L+ ++     A
Sbjct: 51  EANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++ + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K 
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK- 168

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 169 --------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 12/168 (7%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  ++  L H  +VRL+        +Y+  E    G L D + S   G +   +   ++A
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++ + + YI     IHRD++  N+L++     KIADFG  + ++D+  T    A    K 
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 169

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
                   +  PE +N    T  +D+W+ G  LY++++ G  P+   S
Sbjct: 170 --------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 46/191 (24%), Positives = 94/191 (49%), Gaps = 21/191 (10%)

Query: 84  ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF 143
           A+K + +  +++E+       E  V+ +L HP +V+L+    +   + +  E  E G L 
Sbjct: 32  AIKTIREGAMSEED----FIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87

Query: 144 DQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 202
           D +   +G  S++       +V + + Y+ S  +IHRD+   N L+  +  +K++DFG  
Sbjct: 88  DYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGM- 146

Query: 203 KPMQDSRITVLPNAASDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQML 259
                +R  +      DD+  +  GT     +  PEV + S  +  +D+W+ G  ++++ 
Sbjct: 147 -----TRFVL------DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVF 195

Query: 260 S-GTSPFKDTS 269
           S G +P+++ S
Sbjct: 196 SEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  +L  ++HP +++L  TF       + L   +  +L+  + +K +++  +       V
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           + A++Y+H   +IHRDIK EN+ +   G + + DFG+            P   + +K   
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGA---------ACFPVDINANKYYG 242

Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KD------TSEWLIFQR 276
           + GT A   PE+L   P     D+W+ G  L++M +       KD       S+  I + 
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI-KL 301

Query: 277 IIARDIRFPNYFSDAARDLIDRL---LDVDPSGRPGAGP 312
           II R    PN F   A+  +D +   L    S +PG+ P
Sbjct: 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRP 340

Length = 391

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 12/191 (6%)

Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
            TG + A+K + K+   ++N + + K E  +L  L H  +V+     + Q    L + +E
Sbjct: 31  GTGEMVAVKTL-KRECGQQNTSGWKK-EINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88

Query: 136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 195
               G L D +  K  L+  +   +  ++ + + Y+HS   IHRD+   N+LL  D  +K
Sbjct: 89  YVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVK 147

Query: 196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 255
           I DFG  K + +           D  +  F     +   E L  +  ++ +D+W+ G TL
Sbjct: 148 IGDFGLAKAVPEGHEYY--RVREDGDSPVF-----WYAVECLKENKFSYASDVWSFGVTL 200

Query: 256 YQMLSGTSPFK 266
           Y++L+     +
Sbjct: 201 YELLTHCDSKQ 211

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 29/173 (16%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 163
           E  V+ +L H  +V+L+        +Y+  E    G L + +   G       RF  ++ 
Sbjct: 49  EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK------RFQPSQL 102

Query: 164 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
                 V + + Y+ S   IHRD+   N L+   G +K++DFG            L    
Sbjct: 103 LEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG------------LSRYV 150

Query: 218 SDDKACTFVGTAAYV---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
            DD+  + VG+   V   PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 151 LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 22/205 (10%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           + + K    GS  +V  A K        LKI  K             +E ++L  ++HP 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPS 118

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMG 175
           V+R+  T        M L      +L+  +T +   L  D+A     ++++ L Y+H+  
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           +IHRD+K EN+ +     + I D G+ +          P  A         GT     PE
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQ---------FPVVAPAFLG--LAGTVETNAPE 226

Query: 236 VLNSSPATFGNDLWALGCTLYQMLS 260
           VL         D+W+ G  L++ML+
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 21/259 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A++  E  V+  L H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVE---AFLA-EANVMKTLQH 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 172
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 61  DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
               IHRD++  N+L++A    KIADFG  + ++D+  T    A    K         + 
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---------WT 170

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPNYFS-- 289
            PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P   +  
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPRPENCP 229

Query: 290 DAARDLIDRLLDVDPSGRP 308
           +   +++ R     P  RP
Sbjct: 230 EELYNIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 13/160 (8%)

Query: 108 VLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
           +L  + H  ++ L   + ++ T  + M    C+   LF  +   G L  ++A      ++
Sbjct: 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD---LFTYVDRSGPLPLEQAITIQRRLL 195

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +AL Y+H  G+IHRD+K EN+ L    +  + DFG+   +     T         +   +
Sbjct: 196 EALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT--------PQCYGW 247

Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            GT     PE+L   P     D+W+ G  L++M       
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 17/252 (6%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G G++ +V +    D   V A+K   K+ + +E K  ++   RI L Q DHP +V+L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVKTC-KEDLPQELKIKFLSEARI-LKQYDHPNIVKL 57

Query: 121 FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
                    +Y+ +E   GG+    +   K  L   +   +  +    + Y+ S   IHR
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117

Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
           D+   N L+  +  +KI+DFG  +   D   +     +S  K      TA    PE LN 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SSGLKQIPIKWTA----PEALNY 168

Query: 240 SPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLI 296
              +  +D+W+ G  L++  S G  P+   +     ++ + +  R   P    D    ++
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVM 227

Query: 297 DRLLDVDPSGRP 308
            R  D  P  RP
Sbjct: 228 QRCWDYKPENRP 239

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.9 bits (147), Expect = 4e-10
 Identities = 62/273 (22%), Positives = 120/273 (43%), Gaps = 65/273 (23%)

Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q +      +Y+ +E 
Sbjct: 46  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103

Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 104 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160

Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 161 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209

Query: 257 QMLSGTS--PFKD-TSEW--LI---------FQRIIARDIR-------------FPNYFS 289
           +M+      P +D   +W  +I         F + +   +R             FP  F 
Sbjct: 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269

Query: 290 DA---------------ARDLIDRLLDVDPSGR 307
           D+               ARDL+ ++L +DP+ R
Sbjct: 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 40/171 (23%), Positives = 70/171 (40%), Gaps = 32/171 (18%)

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------- 159
           ++ +L H  +V+L+    +   +Y+  E    G L D       L   E +         
Sbjct: 54  IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVD 107

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAAS 218
             A++ + + Y+ S   IHRD+   N+L+  +  + KIADFG            L     
Sbjct: 108 MAAQIAEGMAYLESRNYIHRDLAARNILV-GENLVCKIADFG------------LARLIE 154

Query: 219 DDKACTFVGTA---AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           DD+     G      +  PE  N    T  +D+W+ G  L ++++ G  P+
Sbjct: 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 18/234 (7%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           ++F L +  G G + +V      +   V A+KI+  K      +  + K E   L +L H
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKIL--KSDDLLKQQDFQK-EVQALKRLRH 61

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 172
             ++ LF        +Y+  E  E G L   + S        A       +V + + Y+ 
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
               IHRD+   N+L+  D   K+ADFG  + +++          S DK   +  TA   
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL------SSDKKIPYKWTA--- 172

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFP 285
            PE  +    +  +D+W+ G  LY+M + G  P+   +   ++ + I    R P
Sbjct: 173 -PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ-ITAGYRMP 224

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +++ A++YIH  G+IHRDIK EN+L+     I + DFG+    + S  T      +    
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA---- 323

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 257
               GT     PEVL   P T   D+W+ G  +++
Sbjct: 324 ----GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 16/188 (8%)

Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG   A+K +  +  +  N  A +K E  +L  L H  +V+     T      + + +E
Sbjct: 31  NTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88

Query: 136 SCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L + +  +K  ++  +   Y  ++   ++Y+ S   +HRD+   N+L+ ++  +
Sbjct: 89  FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 148

Query: 195 KIADFGSVKPMQDSR--ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 252
           KI DFG  K ++  +   TV      DD        A    PE L  S     +D+W+ G
Sbjct: 149 KIGDFGLTKAIETDKEYYTV-----KDDLDSPVFWYA----PECLIQSKFYIASDVWSFG 199

Query: 253 CTLYQMLS 260
            TLY++L+
Sbjct: 200 VTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 47/192 (24%), Positives = 93/192 (48%), Gaps = 23/192 (11%)

Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q +      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167

Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216

Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 52/267 (19%), Positives = 101/267 (37%), Gaps = 32/267 (11%)

Query: 61  KIYGVGSYSKVV--RAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQLDHPG 116
              G G + +V   +AK I+      L ++ K       EN  +  + E  +  +L H  
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETL-VLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69

Query: 117 VVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVD-------A 167
           VVRL    ++    YM LE  + G+L  F + T             T + V         
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++++ +   +HRD+   N L+++   +K++               L     + +      
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLS------------LSKDVYNSEYYKLRN 177

Query: 228 TAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR 283
                 ++ PE +     +  +D+W+ G  ++++ + G  PF   S+  +  R+ A  + 
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237

Query: 284 F--PNYFSDAARDLIDRLLDVDPSGRP 308
              P         L+ R   V+P  RP
Sbjct: 238 LPVPEGCPSRLYKLMTRCWAVNPKDRP 264

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 66/305 (21%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK----TAYVKLERIVLDQLDHPGVVR 119
           G G+Y  V +A+   T    ALK   K  + +E++    TA  ++   +L ++ H  +VR
Sbjct: 11  GEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAIREIS--LLKEMQHGNIVR 65

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE--ARFYTAEVVDALEYIHSMGLI 177
           L         LY+  E  +  +L   + S    +++    + Y  +++  + Y HS  ++
Sbjct: 66  LQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124

Query: 178 HRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           HRD+KP+NLL+      +K+ADFG       +R   +P      +    V T  Y  PE+
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGL------ARAFGIPVRTFTHE----VVTLWYRAPEI 174

Query: 237 L-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD------ 281
           L      S+P     D+W++GC   +M++    F   SE    + IF+ +   +      
Sbjct: 175 LLGSRHYSTPV----DIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230

Query: 282 -IRFPNYFS------------------DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 322
               P+Y S                   A  DL+ ++L +DPS R  A     A L+ H 
Sbjct: 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITAR----AALE-HE 285

Query: 323 FFKGI 327
           +FK +
Sbjct: 286 YFKDL 290

Length = 294

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 23/43 (53%), Positives = 32/43 (74%)

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 205
           +V+  L  +H +G++HRDIKPENLL+T DG +KI DFG+   M
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359

Length = 507

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 46/258 (17%)

Query: 64  GVGSYSKVVRAKKIDTG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV--- 118
           G G+Y  V +AK+ D      YALK ++   I+          E  +L +L HP V+   
Sbjct: 10  GRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-----ACREIALLRELKHPNVIALQ 64

Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQI----TSKGH-----LSEDEARFYTAEVVDALE 169
           ++F +  D   +++  +  E  +L+  I     SK +     L     +    +++D + 
Sbjct: 65  KVFLSHSDR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 170 YIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           Y+H+  ++HRD+KP N+L+  +    G +KIAD G  +        + P A  D    TF
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADLDPVVVTF 179

Query: 226 VGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
                Y  PE +L +   T   D+WA+GC   ++L+    F    E          DI+ 
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------DIKT 225

Query: 285 PNYFSDAARDLIDRLLDV 302
            N F     D +DR+  V
Sbjct: 226 SNPFH---HDQLDRIFSV 240

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 46/258 (17%)

Query: 64  GVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL- 120
           G G+Y  V +AK+ D      YALK ++   I+          E  +L +L HP V+ L 
Sbjct: 10  GRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-----ACREIALLRELKHPNVISLQ 64

Query: 121 --FFTFQDTFSLYMALESCEGGELFDQI----TSKGH-----LSEDEARFYTAEVVDALE 169
             F +  D   +++  +  E  +L+  I     SK +     L     +    +++D + 
Sbjct: 65  KVFLSHADR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 170 YIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           Y+H+  ++HRD+KP N+L+  +    G +KIAD G  +        + P A  D    TF
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADLDPVVVTF 179

Query: 226 VGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
                Y  PE +L +   T   D+WA+GC   ++L+    F    E          DI+ 
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------DIKT 225

Query: 285 PNYFSDAARDLIDRLLDV 302
            N +     D +DR+ +V
Sbjct: 226 SNPYH---HDQLDRIFNV 240

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 50/232 (21%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER-------IVLD 110
           K+ G G + +V   +         LK+  K+ I    K  K  Y + +R        ++ 
Sbjct: 10  KVIGAGEFGEVCSGR---------LKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-- 168
           Q DHP ++ L      +  + +  E  E G L         L + + +F   ++V  L  
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLVGMLRG 114

Query: 169 -----EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
                +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA      
Sbjct: 115 IASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEAA------ 163

Query: 224 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
            +      +P     PE +     T  +D+W+ G  +++++S G  P+ + S
Sbjct: 164 -YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 24/201 (11%)

Query: 72  VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY 131
           +R K+ID   +  LK  ++K +  E        E  ++ QLD+P +VR+    +   +L 
Sbjct: 18  MRKKQIDVA-IKVLKNENEKSVRDEMMR-----EAEIMHQLDNPYIVRMIGVCEAE-ALM 70

Query: 132 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 190
           + +E   GG L   ++ K   ++         +V   ++Y+     +HRD+   N+LL  
Sbjct: 71  LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130

Query: 191 DGHIKIADFGSVKPMQDSRITVLPNAASDD---KACTFVG-TAAYVPPEVLNSSPATFGN 246
             + KI+DFG  K +            +DD   KA +       +  PE +N    +  +
Sbjct: 131 QHYAKISDFGLSKAL-----------GADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179

Query: 247 DLWALGCTLYQMLS-GTSPFK 266
           D+W+ G T+++  S G  P+K
Sbjct: 180 DVWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 12/164 (7%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE-ARFYTA- 162
           E  V+ ++ HP +V+L          Y+  E    G L D +        +     Y A 
Sbjct: 52  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 170

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 171 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 37/233 (15%)

Query: 55  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +D +   + G G++ +V+RA  K D   + A   M K+F ++ +   +     ++     
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEA---------------- 157
           HP ++ L    ++   LY+A+E    G L D +     L  D A                
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 158 -RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVL 213
            +F  ++V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  L
Sbjct: 122 LQF-ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180

Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           P                ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 181 P--------------VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 63/289 (21%), Positives = 121/289 (41%), Gaps = 51/289 (17%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKL--ERIV 108
           +  LGK  G G + KVV+A           T  A+K++ +      + +    L  E  +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNL 56

Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSEDEARFYTA- 162
           L Q++HP V++L+        L + +E  + G L  F + + K    +L  D  R  +  
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 163 ------------------EVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVK 203
                             ++   ++Y+  M L+HRD+   N+L+ A+G   KI+DFG  +
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 204 PM--QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 260
            +  +DS +       S  +         ++  E L     T  +D+W+ G  L+++++ 
Sbjct: 176 DVYEEDSYVK-----RSKGRI-----PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 225

Query: 261 GTSPFKDTSEWLIFQRI-IARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
           G +P+   +   +F  +     +  P   S+   +L+      +P  RP
Sbjct: 226 GGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 37/232 (15%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++     
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 66

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDEA 157
           HP ++ L    +    LY+A+E    G L D +                ++   LS  + 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 158 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLP 214
             + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                           ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 187 --------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 26/145 (17%)

Query: 149 KGHLSEDEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 201
           + +L +   R        Y +++   +EY+ S   +HRD+   N+L+ ++  +KI DFG 
Sbjct: 95  RDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154

Query: 202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLY 256
            K        VLP     DK    V      P     PE L  S  +  +D+W+ G  LY
Sbjct: 155 TK--------VLPQ----DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202

Query: 257 QMLSGTSPFKDTSEWLIFQRIIARD 281
           ++ + +   K  S    F R++  D
Sbjct: 203 ELFTYSD--KSCSPPAEFMRMMGND 225

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 45/246 (18%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER-------IVLD 110
           ++ G G + +V R +         LK+  K+ I    K  K+ Y + +R        ++ 
Sbjct: 10  EVIGAGEFGEVCRGR---------LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 60

Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-- 168
           Q DHP ++ L      +  + +  E  E G L         L +++ +F   ++V  L  
Sbjct: 61  QFDHPNIIHLEGVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRG 114

Query: 169 -----EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
                +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D          SD    
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD--------TSDPTYT 166

Query: 224 TFVGTAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA 279
           + +G      +  PE +     T  +D+W+ G  +++++S G  P+ D S   +    I 
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN-AIE 225

Query: 280 RDIRFP 285
           +D R P
Sbjct: 226 QDYRLP 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 16/209 (7%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTA 162
           E  ++ +L H  +V L+    +   +Y+  E    G L D +      +L   +     A
Sbjct: 51  EAQIMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++ D + YI  M  IHRD++  N+L+  +   KIADFG  + ++D+  T    A    K 
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD 281
                   +  PE       T  +D+W+ G  L ++++ G  P+       + ++ + R 
Sbjct: 169 --------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERG 219

Query: 282 IRF--PNYFSDAARDLIDRLLDVDPSGRP 308
            R   P    ++  +L+      DP  RP
Sbjct: 220 YRMPCPQGCPESLHELMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 36/230 (15%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK--KFITKENKTAYVKLERIVL- 109
           S Q F++  + G G++ KVV A         A+KI+    K+ T++ K     +E++   
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-TRDAKIEIQFMEKVRQA 185

Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGE-LFDQITSKGHLSEDEARFYTAEVVDAL 168
           D  D   ++++   FQ+  + +M +   + G  L D I   G  S         +   AL
Sbjct: 186 DPADRFPLMKIQRYFQNE-TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244

Query: 169 EYIHS-MGLIHRDIKPENLLL-TADG---------------HIKIADFGSVKPMQDSRIT 211
           +Y H+ + L+H D+KPEN+L+ T+D                 ++I D G     + SR  
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA 304

Query: 212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 261
           +             V T  Y  PEV+      +  D+W++GC +Y++ +G
Sbjct: 305 I-------------VSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 37/226 (16%)

Query: 62  IYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           + G G++ +V++A+ K D   + A     K++ +K++   +     ++     HP ++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEA-----------------RFYTAE 163
               +    LY+A+E    G L D +     L  D A                  F  A+
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF-AAD 120

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLPNAASDD 220
           V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP      
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP------ 174

Query: 221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                     ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 175 --------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 30/215 (13%)

Query: 64  GVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLERI----VLDQLDHPGV 117
           G G++  V +   K   +    A+KI+       +N    +K E +    V+ QLD+P +
Sbjct: 4   GSGNFGTVKKGMYKMKKSEKTVAVKIL-----KNDNNDPALKDELLREANVMQQLDNPYI 58

Query: 118 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
           VR+     +  S  + +E  E G L   +    H++E        +V   ++Y+     +
Sbjct: 59  VRMI-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP---- 233
           HRD+   N+LL    + KI+DFG            L  A   D+      T    P    
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFG------------LSKALGADENYYKAKTHGKWPVKWY 165

Query: 234 -PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
            PE +N    +  +D+W+ G  +++  S G  P+K
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 43/203 (21%)

Query: 84  ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF 143
           A+KI+ +    K  +  ++K E  +L +L  P ++RL     D   L M  E  E G+L 
Sbjct: 50  AVKIL-RPDANKNARNDFLK-EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL- 106

Query: 144 DQITSKGHLSEDEAR--------------------FYTAEVVDALEYIHSMGLIHRDIKP 183
           +Q  S  HL + E                          ++   ++Y+ S+  +HRD+  
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLAT 166

Query: 184 ENLLLTADGHIKIADFGSVKPMQDS---RI---TVLPNAASDDKACTFVGTAAYVPPEVL 237
            N L+  +  IKIADFG  + +      RI    VLP                ++  E +
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP--------------IRWMAWECI 212

Query: 238 NSSPATFGNDLWALGCTLYQMLS 260
                T  +D+WA G TL+++L 
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 54/235 (22%), Positives = 89/235 (37%), Gaps = 48/235 (20%)

Query: 58  ELGKIYGVGSYSKV----VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
            L +  G G++ +V     R +  D      + +        E   +   +E +++ + +
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDA-VELQVAVKTLPESCSEQDESDFLMEALIMSKFN 67

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR-------------FY 160
           H  +VRL     +    ++ LE   GG+L      K  L E+  R             F 
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFC 121

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDS---RI---T 211
             +V    +Y+     IHRDI   N LLT  G     KIADFG  + +  +   R     
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           +LP                ++PPE       T   D+W+ G  L+++ S G  P+
Sbjct: 182 MLP--------------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 20/184 (10%)

Query: 136 SCEGGELFDQITSKGHLSEDEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLL 188
           S   G   DQ  +   L EDE          ++ +V   + ++ S   IHRD+   N+LL
Sbjct: 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL 247

Query: 189 TADGHIKIADFGSVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGND 247
           T     KI DFG  + ++ DS   V  NA    K         ++ PE + +   TF +D
Sbjct: 248 THGRITKICDFGLARDIRNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESD 298

Query: 248 LWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDP 304
           +W+ G  L+++ S G+SP+        F ++I    R   P        D++    D DP
Sbjct: 299 VWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADP 358

Query: 305 SGRP 308
             RP
Sbjct: 359 LKRP 362

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 12/195 (6%)

Query: 79  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE 138
           TG    ++ ++ +  T E  T +++ E  V    +HP +V    TF     L++      
Sbjct: 24  TGEYVTVRRINLEACTNEMVT-FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82

Query: 139 GGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            G   D I +     +SE    +    V+ AL+YIH MG +HR +K  ++L++ DG + +
Sbjct: 83  YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 142

Query: 197 ADFGSVKPM--QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDLWALG 252
           +   S   M     R+ V+      D     V    ++ PEVL  +   +   +D++++G
Sbjct: 143 SGLRSNLSMINHGQRLRVV-----HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 197

Query: 253 CTLYQMLSGTSPFKD 267
            T  ++ +G  PFKD
Sbjct: 198 ITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 63/299 (21%), Positives = 106/299 (35%), Gaps = 65/299 (21%)

Query: 57  FELGKIYGVGSYSKVVRAK-KIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQLD 113
            +LGKI G G +  V+  +   D G+    A+K M     T      ++  E   +   D
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFD 59

Query: 114 HPGVVRL---------------------FFTFQD--TFSLYMALESCEGGELFDQITSKG 150
           HP V++L                     F    D  +F LY  L                
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-----------GLPE 108

Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM----- 205
            L       +  ++   +EY+ +   IHRD+   N +L  D  + +ADFG  K +     
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168

Query: 206 -QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
            +  RI  +P                ++  E L     T  +D+WA G T++++ + G +
Sbjct: 169 YRQGRIAKMP--------------VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214

Query: 264 PFKDTSEWLIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 321
           P+       I+  +     ++ P    D   DL+      DP  RP      +  L+  
Sbjct: 215 PYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRP-----TFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 53/240 (22%), Positives = 98/240 (40%), Gaps = 50/240 (20%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLERI-------VLD 110
           K+ G G + +V R           LK+  +K +    K  K  Y + +R        ++ 
Sbjct: 11  KVIGAGEFGEVFRG---------ILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG 61

Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-- 168
           Q  H  ++RL           +  E  E G L D+     +L + +  F + ++V  L  
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DK-----YLRDHDGEFSSYQLVGMLRG 115

Query: 169 -----EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
                +Y+  M  +HRD+   N+L+ ++   K++DFG            L     DD   
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFG------------LSRVLEDDPEG 163

Query: 224 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 277
           T+  +   +P     PE +     T  +D+W+ G  +++++S G  P+ D S   + + I
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 54/242 (22%), Positives = 99/242 (40%), Gaps = 33/242 (13%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAK-------KIDTGTVYALKIMDKKFITKENKTA 100
           P+  FS     LGK  G G + +VV A+       K       A+K++      K+    
Sbjct: 8   PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 67

Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 68  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 126

Query: 150 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + +++  F      T +V   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186

Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 187 VN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238

Query: 264 PF 265
           P+
Sbjct: 239 PY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 13/175 (7%)

Query: 138 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA 197
           E       I     LS  +   ++ +V + +E++ S   +HRD+   N+L+     +KI 
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281

Query: 198 DFGSVKP-MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
           DFG  +  M+DS      N  S  K  TF+      P  + N+   T  +D+W+ G  L+
Sbjct: 282 DFGLARDIMRDS------NYIS--KGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLW 332

Query: 257 QMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 308
           ++ + G +P+ +      F   I R  R   P + SD   +++ +  +     RP
Sbjct: 333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP 387

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 45/244 (18%)

Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK 149
           +K  T + K  ++K E  ++   +HP +V+L          Y+ +E  EGG+L   +   
Sbjct: 35  RKGATDQEKKEFLK-EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDA 93

Query: 150 GHLSEDEARFYTA------------EVVDALEYIHSMGLIHRDIKPENLLLTADGH---- 193
                   RF               +V     Y+  M  IHRD+   N L++  G+    
Sbjct: 94  -----RVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148

Query: 194 -IKIADFGSVKPMQDSRI------TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN 246
            +KI DFG  + +  S         +LP                ++ PE L     T  +
Sbjct: 149 VVKIGDFGLARDIYKSDYYRKEGEGLLP--------------VRWMAPESLLDGKFTTQS 194

Query: 247 DLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDP 304
           D+W+ G  ++++L+ G  P+   +   + Q + A   ++ P    D    L+      DP
Sbjct: 195 DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDP 254

Query: 305 SGRP 308
           S RP
Sbjct: 255 SERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 33/242 (13%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+   S     LGK  G G + +VV A+ I       +     A+K++      K+    
Sbjct: 5   PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64

Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG---------- 150
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 65  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDT 123

Query: 151 -HLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             L E++  F        +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + 
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  L+++ + G S
Sbjct: 184 VH--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235

Query: 264 PF 265
           P+
Sbjct: 236 PY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 54/259 (20%), Positives = 101/259 (38%), Gaps = 69/259 (26%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 102
           P+         LGK  G G++ +VV+A+ +        +  A+K++      K++ T   
Sbjct: 5   PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML------KDDAT--- 55

Query: 103 KLERIVLDQL----------DHPGVVRLFFTFQDTFSLYMALESCEGGELFD-------- 144
             E+ + D +           H  ++ L         LY+ +E    G L D        
Sbjct: 56  --EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPP 113

Query: 145 --------QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
                       +  L++ +   +  +V   +E++ S   IHRD+   N+L+T D  +KI
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKI 173

Query: 197 ADFGSVKPMQ---------DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGND 247
           ADFG  + +          + R+ V                  ++ PE L     T  +D
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPV-----------------KWMAPEALFDRVYTHQSD 216

Query: 248 LWALGCTLYQMLS-GTSPF 265
           +W+ G  L+++ + G SP+
Sbjct: 217 VWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)

Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHPGVV 118
           K+ G G++  V +   +  G    + +  K         A V+   E +++  +DHP +V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 119 RLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           RL       T  L   L     G L D +   K ++       +  ++   + Y+    L
Sbjct: 73  RLLGVCLSPTIQLVTQL--MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA---AYVP 233
           +HRD+   N+L+ +  H+KI DFG  + ++            D+K     G      ++ 
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLE-----------GDEKEYNADGGKMPIKWMA 179

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
            E ++    T  +D+W+ G T++++++ G  P+
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 23/223 (10%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVL 109
               +    K+ G G +  V +   I  G    + +  K    +  +  + ++    + +
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDAL 168
             LDH  +VRL        SL +  +    G L D +   +  L       +  ++   +
Sbjct: 64  GSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y+    ++HR++   N+LL +D  ++IADFG           +L     DDK   +  +
Sbjct: 123 YYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD--------LLY---PDDK--KYFYS 169

Query: 229 AAYVPPEVLNSSPATFG-----NDLWALGCTLYQMLS-GTSPF 265
               P + +      FG     +D+W+ G T+++M+S G  P+
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 34/221 (15%)

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARF----YTAEVVD 166
           L+HP V++      ++    + LE C  G+L + + S +G +++   +        EV  
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV--KPMQDSRITVLPNAASDDKACT 224
            L ++H    IH D+   N  LTAD  +KI D+G    +  +D  IT       D  A  
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT------KDCHAVP 165

Query: 225 FVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKDTS-EWLIFQ 275
               A    PE++            T  +++W+LG T++++ +    P+ D S E ++ Q
Sbjct: 166 LRWLA----PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ 221

Query: 276 RIIARDIRFPNYFSDAARDLIDRLLDV------DPSGRPGA 310
            +  +DI+ P           DR  +V      DP  RP A
Sbjct: 222 VVREQDIKLPK--PQLDLKYSDRWYEVMQFCWLDPETRPTA 260

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 37/185 (20%)

Query: 97  NKTA---YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLS 153
           NK A   ++K  +I + +L  P ++RL      +  L M  E  E G+L +Q  S+    
Sbjct: 59  NKNARNDFLKEIKI-MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQ 116

Query: 154 EDEA------------RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 201
           E                F   ++   ++Y+ S+  +HRD+   N L+  +  IKIADFG 
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 202 VKPMQDS---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 255
            + +      RI    VLP                ++  E +     T  +D+WA G TL
Sbjct: 177 SRNLYSGDYYRIQGRAVLP--------------IRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 256 YQMLS 260
           +++L+
Sbjct: 223 WEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 39/245 (15%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAK-------KIDTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G + +VVRA+       + D     A+K++      K+    
Sbjct: 5   PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL 64

Query: 101 YVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK---------- 149
             ++E + ++ +  H  ++ L         LY+ +E    G L + + ++          
Sbjct: 65  ISEMELMKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122

Query: 150 -GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK 203
              + E++  F        +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  +
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 204 PMQDSRITVLPNAASDDKACTFVG--TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 260
            + D           D    T  G     ++ PE L     T  +D+W+ G  ++++ + 
Sbjct: 183 GVHD----------IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232

Query: 261 GTSPF 265
           G SP+
Sbjct: 233 GGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 39/273 (14%)

Query: 59  LGKIYGVGSYSKVVRAK--KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           LGK  G G +  V+  +  + D+    A+K M     T+     ++  E + + + DHP 
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLS-EAVCMKEFDHPN 61

Query: 117 VVRLF-FTFQDTFSL----------YMALESCEGGELFDQITSKG-HLSEDEARFYTAEV 164
           V+RL     Q   S           +M         L+ ++     +L       +  ++
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM------QDSRITVLPNAAS 218
              +EY+ S   IHRD+   N +L  + ++ +ADFG  K +      +  RI  +P    
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP---- 177

Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK--DTSEWLIFQ 275
                       ++  E L     T  +D+W+ G T++++ + G +P+   + SE   + 
Sbjct: 178 ----------VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Query: 276 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
           R   R ++ P    D    L+     ++P  RP
Sbjct: 228 RQGNR-LKQPPDCLDGLYSLMSSCWLLNPKDRP 259

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 33/186 (17%)

Query: 93  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG---------ELF 143
           +TK  +  ++K E  ++ +L +P ++RL         L M  E  E G         E+ 
Sbjct: 56  VTKTARNDFLK-EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIE 114

Query: 144 DQITSKGHL---SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
              T   ++   S     +   ++   ++Y+ S+  +HRD+   N L+     IKIADFG
Sbjct: 115 STFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG 174

Query: 201 SVKPMQDS---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCT 254
             + +      RI    VLP                ++  E +     T  +D+WA G T
Sbjct: 175 MSRNLYSGDYYRIQGRAVLP--------------IRWMAWESILLGKFTTASDVWAFGVT 220

Query: 255 LYQMLS 260
           L++M +
Sbjct: 221 LWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 28/191 (14%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF----- 159
           E  ++ +L H  +V+L+    +   +Y+  E    G L D       L + E R      
Sbjct: 51  EAQIMKKLRHDKLVQLYAVVSEE-PIYIVTEYMSKGSLLD------FLKDGEGRALKLPN 103

Query: 160 ---YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPN 215
                A+V   + YI  M  IHRD++  N+L+  DG + KIADFG  + ++D+  T    
Sbjct: 104 LVDMAAQVAAGMAYIERMNYIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQG 162

Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF 274
           A    K         +  PE       T  +D+W+ G  L ++++ G  P+   +   + 
Sbjct: 163 AKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213

Query: 275 QRIIARDIRFP 285
           ++ + R  R P
Sbjct: 214 EQ-VERGYRMP 223

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 34/210 (16%)

Query: 80  GTVY--ALKIMDKKFIT---KENKTAYVKLERI-------VLDQLDHPGVVRLFFTFQDT 127
           G V    LK+  KK I    K  K      +R+       ++ Q DHP ++RL      +
Sbjct: 18  GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77

Query: 128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-------EYIHSMGLIHRD 180
             + +  E  E G L         L E++ +F   ++V  L       +Y+  M  +HRD
Sbjct: 78  RPVMIITEYMENGSL------DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRD 131

Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +   N+L+ ++   K++DFG       SR      A    K         +  PE +   
Sbjct: 132 LAARNILVNSNLVCKVSDFGL------SRRLEDSEATYTTKGGKI--PIRWTAPEAIAYR 183

Query: 241 PATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             T  +D+W+ G  +++++S G  P+ D S
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 18/205 (8%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G + +V       T  V A+K +    ++ E   A+++ E  V+ +L H  +V+L+  
Sbjct: 15  GQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAV 69

Query: 124 FQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
             +   +Y+  E    G L D +  +   +L   +     A++   + Y+  M  +HRD+
Sbjct: 70  VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128

Query: 182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 241
           +  N+L+  +   K+ADFG  + ++D+  T    A    K         +  PE      
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK---------WTAPEAALYGR 179

Query: 242 ATFGNDLWALGCTLYQMLS-GTSPF 265
            T  +D+W+ G  L ++ + G  P+
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 53/252 (21%), Positives = 99/252 (39%), Gaps = 39/252 (15%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI--V 108
           H   +D  L +  G G++ KV  A+  +        ++  K +      A    +R   +
Sbjct: 1   HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 60

Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF----------------DQITSKGHL 152
           L  L H  +V+ +    D   L M  E  + G+L                     +KG L
Sbjct: 61  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120

Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---R 209
              +     +++   + Y+ S   +HRD+   N L+ A+  +KI DFG  + +  +   R
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180

Query: 210 I---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           +   T+LP                ++PPE +     T  +D+W+ G  L+++ + G  P+
Sbjct: 181 VGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Query: 266 KDTSEWLIFQRI 277
              S   + + I
Sbjct: 227 FQLSNTEVIECI 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 58/281 (20%), Positives = 113/281 (40%), Gaps = 50/281 (17%)

Query: 57  FELGKIYGVGSYSKVVRAK-KIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           F LG++ G G +  V  A+ K + G+    A+K++     +  +   +++ E   + + D
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59

Query: 114 HPGVVRL---------------------FFTFQDTFSLYMALESCEGGELFDQITSKGHL 152
           HP V++L                     F    D  +  +   S  G E F        L
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM--SRIGEEPFT-------L 110

Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 212
                  +  ++   +EY+ S   IHRD+   N +L  +  + +ADFG  K +       
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY------ 164

Query: 213 LPNAASDD---KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT 268
                S D   + C       ++  E L  +  T  +D+WA G T++++++ G +P+   
Sbjct: 165 -----SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219

Query: 269 SEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRP 308
               I+  +I  + ++ P    +   +L+ +    +P  RP
Sbjct: 220 ENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRP 260

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 53/283 (18%)

Query: 56  DFELGKIYGVGSYSKVVR--AKKIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLD 110
              L +  G GS+  V    AK +  G      A+K +++    +E    ++  E  V+ 
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEFLN-EASVMK 64

Query: 111 QLDHPGVVRLF---FTFQDTFSL--YMALESCEGGELFDQITSKGHLSEDEA-------- 157
           + +   VVRL     T Q T  +   MA      G+L   +  +    E E         
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAK-----GDLKSYL--RSRRPEAENNPGLGPPT 117

Query: 158 --RFY--TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---RI 210
             +F    AE+ D + Y+ +   +HRD+   N ++  D  +KI DFG  + + ++   R 
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 211 T---VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
               +LP                ++ PE L     T  +D+W+ G  L++M +    P++
Sbjct: 178 GGKGLLP--------------VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223

Query: 267 DTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRP 308
             S   + + +I       P    D   +L+      +P  RP
Sbjct: 224 GLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 31/224 (13%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDH 114
            E  K+ G G++  V +   I  G    + +  K    + +  A  ++  E  V+  +DH
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 115 PGVVRLF-FTFQDTFSL---YMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 169
           P VVRL          L    M L     G L D +   K ++       +  ++   + 
Sbjct: 69  PHVVRLLGICLSSQVQLITQLMPL-----GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+    L+HRD+   N+L+    H+KI DFG  K        +L     D+K   +    
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK--------LLD---VDEK--EYHAEG 170

Query: 230 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 267
             VP      E +     T  +D+W+ G T++++++ G  P++ 
Sbjct: 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 40/202 (19%), Positives = 81/202 (40%), Gaps = 38/202 (18%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-----------------T 147
           E  ++ +L HP +V L         + M  E    G+L + +                 T
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 148 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 207
            K  L   +      ++   +EY+ S   +H+D+   N+L+    H+KI+D G  + +  
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 208 S---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 260
           +   R+   ++LP                ++PPE +     +  +D+W+ G  L+++ S 
Sbjct: 177 ADYYRVQPKSLLP--------------IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222

Query: 261 GTSPFKDTSEWLIFQRIIARDI 282
           G  P+   S   + + +  R +
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 16/160 (10%)

Query: 154 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRIT 211
           +D  RF +++V   ++++ S   IHRD+   N+LLT DG + KI DFG  +  M DS   
Sbjct: 212 DDLLRF-SSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYV 269

Query: 212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE 270
           V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G SP+     
Sbjct: 270 VKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320

Query: 271 WLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 308
              F +++ R  +   P++       ++    +++P+ RP
Sbjct: 321 NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 35/164 (21%), Positives = 72/164 (43%), Gaps = 12/164 (7%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTA 162
           E  ++ +L HP +++L+        +Y+  E  + G L +  Q  +   L   +     A
Sbjct: 51  EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +V   + Y+ +   IHRD+   N+L+  +   K+ADFG  + +++        A    K 
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK- 169

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE    +  +  +D+W+ G  L ++++ G  P+
Sbjct: 170 --------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 50/222 (22%), Positives = 98/222 (44%), Gaps = 26/222 (11%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 117
           E+G+  G  + + V  A+   TGT+  ++I D +  T+E+  A    E ++     HP +
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQN-EVVLSHFFRHPNI 61

Query: 118 VRLFFTFQD-----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           +  +  F         S +MA  S     L      +G +SE          +  L Y+H
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSAN--SLLKTYFPEG-MSEALIGNILFGALRGLNYLH 118

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGS----VKPMQDSRITV-LPNAASDDKACTFVG 227
             G IHR+IK  ++L++ DG + ++        V+  Q +++    P  ++         
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST--------S 170

Query: 228 TAAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKD 267
              ++ PE+L      +   +D++++G T  ++ +G  PF+D
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 29/222 (13%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           +F+  K+ G G++  V +   I  G       A+K + +    K NK   +  E  V+  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMAS 65

Query: 112 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 169
           +D+P V RL       T  L   L     G L D +   K ++       +  ++   + 
Sbjct: 66  VDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+    L+HRD+   N+L+    H+KI DFG  K +            +D+K   +    
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GADEKE--YHAEG 170

Query: 230 AYVPP-----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             VP      E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 18/153 (11%)

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +V   +EY+ S   +HRD+   N +L     +K+ADFG  + + D     + N       
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH------ 159

Query: 223 CTFVGTAAYVPP-----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR 276
                T A +P      E L +   T  +D+W+ G  L+++++ G  P+ D   + I   
Sbjct: 160 -----TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214

Query: 277 II-ARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
           ++  R +  P Y  D   +++       P  RP
Sbjct: 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRP 247

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 13/168 (7%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E + L Q DH  +VRL        ++ +  E    G L D    K  G L   +      
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLP 114

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
            +   ++Y+  MG +H+ +    +L+ +D   KI+ F     +Q+ +   +    S    
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKS- 170

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
                   +  PE +     +  +D+W+ G  +++++S G  P+ D S
Sbjct: 171 -----PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 13/153 (8%)

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAAS 218
           +T +V   +E++ S   +HRD+   N+LL     +KI DFG  +  M DS      N  S
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDS------NYVS 295

Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 277
             K  TF+    ++ PE +  +  T  +D+W+ G  L+++ S G +P+        F   
Sbjct: 296 --KGSTFL-PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352

Query: 278 IARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 308
           I    R   P++ +    D++ +  + +P  RP
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 38/195 (19%), Positives = 83/195 (42%), Gaps = 37/195 (18%)

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--------- 162
           L HP +++      +     +  E CE G+L      K +LS+++     +         
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDL------KSYLSQEQWHRRNSQLLLLQRMA 105

Query: 163 -EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP--MQDSRITVLPNAASD 219
            E+   + ++H    +H D+   N  LT+D  +K+ D+G + P   ++  I       ++
Sbjct: 106 CEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYG-IGPSRYKEDYIE------TE 158

Query: 220 DKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQML-SGTSPFKDTSEW 271
           D  C       ++ PE++         +  T  +++WALG TL+++  +   P+   S+ 
Sbjct: 159 DDKCV---PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215

Query: 272 LIFQRIIA-RDIRFP 285
            +   +I  + ++  
Sbjct: 216 EVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 51/240 (21%)

Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G + +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-----------GHLSEDEARFY 160
             H  ++ L         LY+ +E    G L + + ++             + E++  F 
Sbjct: 82  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 161 -----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV---------KPMQ 206
                  +V   +EY+ S   IHRD+   N+L+T D  +KIADFG           K   
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           + R+ V                  ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 201 NGRLPV-----------------KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 17/155 (10%)

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
           Y+ +V   +E++ S   IHRD+   N+LL+ +  +KI DFG  + +        P+    
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD-----PDYVRK 238

Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII 278
             A        ++ PE +     T  +D+W+ G  L+++ S G SP+        F R +
Sbjct: 239 GDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295

Query: 279 ARDIRF--PNYFSDAARDLIDRLLDV---DPSGRP 308
               R   P+Y +    ++   +LD    +PS RP
Sbjct: 296 KEGTRMRAPDYTTP---EMYQTMLDCWHGEPSQRP 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 17/155 (10%)

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM-QDSRITVLPNAAS 218
           Y+ +V   +E++ S   IHRD+   N+LL+ +  +KI DFG  + + +D       +A  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF-QR 276
             K         ++ PE +     T  +D+W+ G  L+++ S G SP+        F QR
Sbjct: 239 PLK---------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289

Query: 277 IIARD---IRFPNYFSDAARDLIDRLLDVDPSGRP 308
           +  +D   +R P   +     ++      DP  RP
Sbjct: 290 L--KDGTRMRAPENATPEIYRIMLACWQGDPKERP 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 38/159 (23%), Positives = 63/159 (39%), Gaps = 31/159 (19%)

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGH-------IKIADFGSVKPMQDSRITVLPN 215
           ++  AL Y+    L+H ++  +N+L+   G        IK++D G         ITVL  
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-------IPITVLSR 161

Query: 216 AASDDKACTFVGTAAYVPPE---VLNSSPATFGNDLWALGCTLYQMLS-GTSPFK--DTS 269
               ++         ++ PE      +S      D W+ G TL ++ S G  P     +S
Sbjct: 162 EERVER-------IPWIAPECIRNGQASLTIAA-DKWSFGTTLLEICSNGEEPLSTLSSS 213

Query: 270 EWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
           E   F +      R P        +LI++    DP+ RP
Sbjct: 214 EKERFYQ---DQHRLPMPDCAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 50/243 (20%), Positives = 98/243 (40%), Gaps = 38/243 (15%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI--V 108
           H   +D  L    G G++ KV  A+  +        ++  K + + +++A    +R   +
Sbjct: 1   HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 60

Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF---------------DQITSKGHLS 153
           L  L H  +VR +    +   L M  E    G+L                 +  + G L+
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120

Query: 154 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---RI 210
             +     +++   + Y+ S+  +HRD+   N L+     +KI DFG  + +  +   R+
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 211 ---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
              T+LP                ++PPE +     T  +D+W+ G  L+++ + G  P+ 
Sbjct: 181 GGRTMLP--------------IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226

Query: 267 DTS 269
             S
Sbjct: 227 QLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 26/116 (22%), Positives = 50/116 (43%), Gaps = 29/116 (25%)

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS---- 218
           ++   + Y+H  G+IH+DI   N ++  +  +KI D                NA S    
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD----------------NALSRDLF 168

Query: 219 -DDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 267
             D  C  +G     P      E L +   +  +D+W+ G  L+++++ G +P+ +
Sbjct: 169 PMDYHC--LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 40/185 (21%), Positives = 77/185 (41%), Gaps = 34/185 (18%)

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-------------H 151
           E  +L  L H  +V+ +    +   L M  E  + G+L   + + G              
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS--- 208
           L++ +      ++   + Y+ S   +HRD+   N L+  +  +KI DFG  + +  +   
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 209 RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP 264
           R+   T+LP                ++PPE +     T  +D+W+LG  L+++ + G  P
Sbjct: 177 RVGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Query: 265 FKDTS 269
           +   S
Sbjct: 223 WYQLS 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 51/260 (19%), Positives = 98/260 (37%), Gaps = 44/260 (16%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 105
              +      +  G G++ KV + +     +  + T  A+K + +    K  +    + E
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL----------------FDQITSK 149
             ++  L HP +V L           M  E    G+L                    T K
Sbjct: 61  --LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 150 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS- 208
             L   +      ++   +EY+ S   +HRD+   N L+     +KI+DFG  + +  + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178

Query: 209 --RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GT 262
             R+   ++LP                ++PPE +     T  +D+W+ G  L+++ S G 
Sbjct: 179 YYRVQSKSLLP--------------VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224

Query: 263 SPFKDTSEWLIFQRIIARDI 282
            P+   S   + + I +R +
Sbjct: 225 QPYYGFSNQEVIEMIRSRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 50/245 (20%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKL- 104
           H       L +  G G++ KV        G  Y L+  + K +      KE  +   +  
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFL------GECYHLEPENDKELVAVKTLKETASNDARKD 54

Query: 105 ---ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS------------- 148
              E  +L    H  +V+ +    +     M  E  E G+L   + S             
Sbjct: 55  FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 149 -KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 207
             G L+  +      ++   + Y+ S   +HRD+   N L+  D  +KI DFG  + +  
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174

Query: 208 S---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 260
           +   R+   T+LP                ++PPE +     T  +D+W+ G  L+++ + 
Sbjct: 175 TDYYRVGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220

Query: 261 GTSPF 265
           G  P+
Sbjct: 221 GKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.2 bits (102), Expect = 7e-05
 Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 23/113 (20%)

Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT 211
           L+E+E     A  +  L  +     +HR  K  N+LLT DG +K+   GSV         
Sbjct: 14  LNEEEI---WAVCLQCLGALRE---LHRQAKSGNILLTWDGLLKL--DGSV--------A 57

Query: 212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
                 S            ++ PEV+     T   D+++LG TLY+ L    P
Sbjct: 58  FKTPEQSR-------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 48/217 (22%), Positives = 89/217 (41%), Gaps = 29/217 (13%)

Query: 61  KIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           K+ G G++  V +   I  G       A+K++ +    K NK   +  E  V+  +  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSPY 70

Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 174
           V RL       T  L   L     G L D +  +K  +   +   +  ++   + Y+  +
Sbjct: 71  VCRLLGICLTSTVQLVTQLMPY--GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            L+HRD+   N+L+ +  H+KI DFG  + +             D     +      VP 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLL-------------DIDETEYHADGGKVPI 175

Query: 235 -----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                E +     T  +D+W+ G T++++++ G  P+
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 30/149 (20%), Positives = 65/149 (43%), Gaps = 10/149 (6%)

Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
            E+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++            K
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--------RK 177

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 280
               +    ++ PE L     T  +D+W+ G  L+++ +    P++  S   + + ++  
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237

Query: 281 D-IRFPNYFSDAARDLIDRLLDVDPSGRP 308
             +  P+   D   +L+      +P  RP
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 59/284 (20%), Positives = 109/284 (38%), Gaps = 55/284 (19%)

Query: 64  GVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKL----ERIVLDQLDH 114
           G G++ +V +A+       +  T+ A+K++      KE  +A ++     E  ++ + DH
Sbjct: 14  GQGAFGRVFQARAPGLLPYEPFTMVAVKML------KEEASADMQADFQREAALMAEFDH 67

Query: 115 PGVVRLF------------FTFQDTFSLYMALESC----------EGGELFDQITSKGHL 152
           P +V+L             F +     L   L                       +   L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 212
           S  E      +V   + Y+     +HRD+   N L+  +  +KIADFG  + +  +    
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 186

Query: 213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEW 271
               AS++ A        ++PPE +  +  T  +D+WA G  L+++ S G  P+   +  
Sbjct: 187 ---KASENDAIPI----RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238

Query: 272 LIFQRIIA--RD---IRFPNYFSDAARDLIDRLLDVDPSGRPGA 310
              + +I   RD   +  P+       +L+       PS RP  
Sbjct: 239 ---EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF 279

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 28/201 (13%)

Query: 71  VVRAKKIDTGTVYALKIM--DKKFITKE-NKTAYVKLERIV-LDQLDHPGVVRLFFTFQD 126
           + R KK   G  Y  K +    +F+ KE N    +    I  + +L HP +V+L    + 
Sbjct: 698 ISRGKK---GASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS 754

Query: 127 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH---SMGLIHRDIKP 183
               Y+  E  EG  L + + +   LS +  R     +  AL ++H   S  ++  ++ P
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811

Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           E ++      I   D       +      LP     D  C    ++AYV PE   +   T
Sbjct: 812 EKII------IDGKD-------EPHLRLSLPGLLCTDTKCFI--SSAYVAPETRETKDIT 856

Query: 244 FGNDLWALGCTLYQMLSGTSP 264
             +D++  G  L ++L+G SP
Sbjct: 857 EKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 26/110 (23%), Positives = 51/110 (46%), Gaps = 9/110 (8%)

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 220
            AE+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++            
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------R 176

Query: 221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           K    +    ++ PE L     T  +D+W+ G  L+++ S    P++  S
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 16/42 (38%), Positives = 25/42 (59%)

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 202
             +++  LEYIH  G+ H DIKPEN+++  +    I D+G  
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 16/40 (40%), Positives = 29/40 (72%), Gaps = 1/40 (2%)

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGS 201
           +++ AL+ +HS G++HRD+KP+N++ +   G  KI D G+
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGA 302

Length = 566

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 37/158 (23%)

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGH--------IKIADFGSVKPMQDSRITVLPNAAS 218
           AL ++   GL H ++  +N+LL  +          IK++D G         ITVLP    
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG-------ISITVLPKEIL 164

Query: 219 DDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSG-TSPFK--DTSEWLIF 274
            ++         +VPPE + N    +   D W+ G TL+++ SG   P    D+ + L F
Sbjct: 165 LER-------IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF 217

Query: 275 ----QRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
                ++ A     P +   A   LI++ +D +P  RP
Sbjct: 218 YEDRHQLPA-----PKWTELAN--LINQCMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 33/136 (24%), Positives = 62/136 (45%), Gaps = 34/136 (25%)

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG--SVKPMQDSRITVLPNAASDD 220
           E+   L ++H    IH D+   N LLTAD  +KI D+G    K  +D  +T       D 
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT------PDQ 161

Query: 221 KACTFVGTAAYVP-----PEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKD 267
                     +VP     PE+++           T  +++W+LG T++++   G+ P++ 
Sbjct: 162 L---------WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212

Query: 268 TSEWLIFQRIIARDIR 283
            S+    ++++   +R
Sbjct: 213 LSD----EQVLTYTVR 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 34/197 (17%)

Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           F +  SL    E  EG EL+ +  +   L       Y+ +V   +E++ S   IHRD+  
Sbjct: 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLIS-----YSFQVARGMEFLASRKCIHRDLAA 201

Query: 184 ENLLLTADGHIKIADFGSVKPMQ---------DSRITVLPNAASDDKACTFVGTAAYVPP 234
            N+LL+ +  +KI DFG  + +          D+R+ +                  ++ P
Sbjct: 202 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL-----------------KWMAP 244

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDA 291
           E +     T  +D+W+ G  L+++ S G SP+        F R +    R   P Y +  
Sbjct: 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPE 304

Query: 292 ARDLIDRLLDVDPSGRP 308
              ++      +P  RP
Sbjct: 305 IYSIMLDCWHNNPEDRP 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 39/203 (19%), Positives = 78/203 (38%), Gaps = 37/203 (18%)

Query: 103 KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF----------------DQI 146
           K E ++  +L HP +V L         L M    C   +L                 D  
Sbjct: 56  KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115

Query: 147 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 206
           T K  L   +      ++   +E++ S  ++H+D+   N+L+    ++KI+D G  + + 
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 207 DSRI------TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 260
            +        ++LP                ++ PE +     +  +D+W+ G  L+++ S
Sbjct: 176 AADYYKLMGNSLLP--------------IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Query: 261 -GTSPFKDTSEWLIFQRIIARDI 282
            G  P+   S   + + I  R +
Sbjct: 222 YGLQPYCGYSNQDVIEMIRNRQV 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 15/107 (14%)

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT------ 161
           +L +L  P + RL         L M +E  E G+L +Q   K H++E             
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQK-HVAETSGLACNSKSLSF 129

Query: 162 -------AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 201
                   ++   + Y+ S+  +HRD+   N L+  +  IKIADFG 
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 27/212 (12%)

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA-EVVD 166
           ++ Q+ H  +V L+          M  E  E G L   +  K  +     +F  A ++  
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADG-------HIKIADFGSVKPMQDSRITVLPNAASD 219
           AL Y+    L+H ++  +N+LL  +G        IK++D G         ITVL      
Sbjct: 117 ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG-------IPITVLSRQECV 169

Query: 220 DKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQM-LSGTSPFKDTSEWLI-FQR 276
           ++         ++ PE V +S   +   D W+ G TL+++  +G  P KD +  L   +R
Sbjct: 170 ER-------IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--LAEKER 220

Query: 277 IIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
                            DL+   ++ DP+ RP
Sbjct: 221 FYEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	499
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
PF14593	104	PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A.	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd01262	89	PH_PDK1 3-Phosphoinositide dependent protein kinas	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
smart00090	237	RIO RIO-like kinase.	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.66
cd01251	103	PH_centaurin_alpha Centaurin alpha Pleckstrin homo	99.66
cd01264	101	PH_melted Melted pleckstrin homology (PH) domain.	99.6
cd01233	100	Unc104 Unc-104 pleckstrin homology (PH) domain. Un	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
KOG1243	690	consensus Protein kinase [General function predict	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
cd01265	95	PH_PARIS-1 PARIS-1 pleckstrin homology (PH) domain	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
cd01238	106	PH_Tec Tec pleckstrin homology (PH) domain. Tec pl	99.49
cd01257	101	PH_IRS Insulin receptor substrate (IRS) pleckstrin	99.48
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.47
cd01247	91	PH_GPBP Goodpasture antigen binding protein (GPBP)	99.46
cd01236	104	PH_outspread Outspread Pleckstrin homology (PH) do	99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
cd01235	101	PH_SETbf Set binding factor Pleckstrin Homology (P	99.42
cd01266	108	PH_Gab Gab (Grb2-associated binder) pleckstrin hom	99.41
cd01260	96	PH_CNK Connector enhancer of KSR (Kinase suppresso	99.4
cd01241	102	PH_Akt Akt pleckstrin homology (PH) domain. Akt pl	99.36
cd01244	98	PH_RasGAP_CG9209 RAS_GTPase activating protein (GA	99.36
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.33
cd01252	125	PH_cytohesin Cytohesin Pleckstrin homology (PH) do	99.27
cd01245	98	PH_RasGAP_CG5898 RAS GTPase-activating protein (GA	99.23
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.2
KOG3087	229	consensus Serine/threonine protein kinase [General	99.18
cd01254	121	PH_PLD Phospholipase D (PLD) pleckstrin homology (	99.18
cd01246	91	PH_oxysterol_bp Oxysterol binding protein (OSBP) P	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
cd01250	94	PH_centaurin Centaurin Pleckstrin homology (PH) do	99.04
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.98
PF15409	89	PH_8: Pleckstrin homology domain	98.95
cd01219	101	PH_FGD FGD (faciogenital dysplasia protein) plecks	98.86
PF00169	104	PH: PH domain; InterPro: IPR001849 The pleckstrin	98.86
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.79
COG4248	637	Uncharacterized protein with protein kinase and he	98.74
KOG0930	395	consensus Guanine nucleotide exchange factor Cytoh	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.66
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.64
cd01220	99	PH_CDEP Chondrocyte-derived ezrin-like domain cont	98.63
cd01263	122	PH_anillin Anillin Pleckstrin homology (PH) domain	98.62
cd01237	106	Unc112 Unc-112 pleckstrin homology (PH) domain. Un	98.62
PRK09902	216	hypothetical protein; Provisional	98.6
PF15413	112	PH_11: Pleckstrin homology domain; PDB: 3MDB_D 3FE	98.6
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.48
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.45
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.36
KOG1090	1732	consensus Predicted dual-specificity phosphatase [	98.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.34
cd01253	104	PH_beta_spectrin Beta-spectrin pleckstrin homology	98.34
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.31
smart00233	102	PH Pleckstrin homology domain. Domain commonly fou	98.29
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.25
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.14
PLN02876	822	acyl-CoA dehydrogenase	98.06
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.06
cd01218	104	PH_phafin2 Phafin2 Pleckstrin Homology (PH) domain	98.03
cd00821	96	PH Pleckstrin homology (PH) domain. Pleckstrin hom	98.01

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-103  Score=786.01  Aligned_cols=438  Identities=47%  Similarity=0.778  Sum_probs=386.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCe
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~  129 (499)
                      .....||.|++.||+|+|++|++|+++++++.|||||+.|+++.++++..++.+|+.+|.+| +||+|++||.+|+|+..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            67889999999999999999999999999999999999999999999999999999999999 89999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+|+||+++|+|.++|++.|.|++.++++|++||+.||+|||++||||||||||||||+.|||+||+|||.|+.+.+..
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998765


Q ss_pred             cccc---CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010859          210 ITVL---PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  286 (499)
Q Consensus       210 ~~~~---~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~  286 (499)
                      ....   .......+..+||||+.|++||+|.+...+..+||||||||||+|+.|.+||.+.+++.++++|+..++.||+
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence            4311   1111223357899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCCCCCCCccCCCCCCCCCCCCCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGD  366 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (499)
                      ++++.++|||+++|..||.+|+|+     ++|++||||.+|+|++++.++||.+.++.+..+.+.++.....|.....+.
T Consensus       309 ~fp~~a~dLv~KLLv~dp~~Rlt~-----~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~~~~s~e~~s~~~~~~~~~~~  383 (604)
T KOG0592|consen  309 GFPEDARDLIKKLLVRDPSDRLTS-----QQIKAHPFFEGVDWENLWQQTPPKLQPYKPATSISPEYYSAYTPLEPGLDE  383 (604)
T ss_pred             CCCHHHHHHHHHHHccCccccccH-----HHHhhCcccccCChhhhhhcCCCcccCCCCcccCCcccCcccccccCCccc
Confidence            999999999999999999999999     889999999999999999999999999988776655544333221111111


Q ss_pred             -------------------------ccccccCCCCCCCCCCCcccccccc--cccCcccccccCCCceEEEEEeeehhhh
Q 010859          367 -------------------------ISAKINDGNGGASSSEGSITRLASI--DSFDSKWQQFLDPGESVLMISMVKKLQK  419 (499)
Q Consensus       367 -------------------------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~g~~~k~~g  419 (499)
                                               ..+.....++.++.......|+.++  ++.++.||+|++ |++|+++|.+.|++|
T Consensus       384 ~~~~~~~~~~S~s~~~psn~~~~~~~~~~~~~~~~~~s~~~~~~~R~q~le~~~~~~~w~~f~~-~~~i~k~~~l~k~~~  462 (604)
T KOG0592|consen  384 RALFQVPSSASQSSALPSNVTHNGDKVAQPVAPSASSSESKNDTARLQSLESQSKDNPWHQFLE-GSLILKEGALEKRQG  462 (604)
T ss_pred             cccccccccccccccCCCcccccccchhhccccccccccCcchhhhhhhccccccCccHHHhhh-hhhHHhHHHHHhhhh
Confidence                                     0000000111111111222344443  347888999998 999999999999999


Q ss_pred             hhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEcCCccHHHHHHHHHHhc
Q 010859          420 LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQ  497 (499)
Q Consensus       420 ~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d~~~~~~~W~~~i~~~~  497 (499)
                      +|.|||+|+||++||++|+||.++++||||||+++   +.++.+++++|+|+||+|+|++.|+++.|..||++|+++.
T Consensus       463 lf~rkr~lllTn~~rll~~~~~~~~lk~eip~~~~---~~~e~~n~~~~~i~TP~k~~~l~d~~~~as~w~~ai~~~~  537 (604)
T KOG0592|consen  463 LFARKRMLLLTNGPRLLYVDPQNLVLKGEIPWSPD---LRVELKNSSTFFIHTPNKVYYLEDPEQRASVWCKAIETVR  537 (604)
T ss_pred             hhhceeEEEecCCCeEEEEecccceeccccccCcc---cceeeccCcceEEECCccceeccCcccchhHHHHhhhhhh
Confidence            99999999999999999999999999999999996   9999999999999999999999999999999999999874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-68  Score=512.37  Aligned_cols=281  Identities=42%  Similarity=0.763  Sum_probs=260.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|+++++||+|+||+||+++.++|++.||+|+|+|..+.+.+....+..|+.+|.+++||+||+++..||+...+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            46689999999999999999999999999999999999999999888899999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|+||+.||+|+.++.+++.|+|+.+++|+++|+.||.|||++||+|||||||||||+.+||++|+|||+|+..-.   
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~---  177 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK---  177 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999985432   


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC-CCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYFS  289 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~~  289 (499)
                             ......++|||+.|||||++.+.+|+.++|+||||+++|+|++|.+||.+.+...+.++|......+ |..++
T Consensus       178 -------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls  250 (357)
T KOG0598|consen  178 -------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLS  250 (357)
T ss_pred             -------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCC
Confidence                   2345567999999999999999999999999999999999999999999999999999999999554 55599


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLAS  342 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~-~~~p~~~~  342 (499)
                      .++++||+++|..||++|+++ ..+.+++++||||.+|+|+.+.. ...|++.|
T Consensus       251 ~~ardll~~LL~rdp~~RLg~-~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P  303 (357)
T KOG0598|consen  251 EEARDLLKKLLKRDPRQRLGG-PGDAEEIKRHPFFKGINWEKLLAKKLSPPFKP  303 (357)
T ss_pred             HHHHHHHHHHhccCHHHhcCC-CCChHHhhcCcccccCCHHHHHhcCCCCCeec
Confidence            999999999999999999983 45779999999999999999865 44554444

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-66  Score=486.95  Aligned_cols=271  Identities=43%  Similarity=0.769  Sum_probs=261.9

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ..++||++++.||.|+||.|.+++++.+|..||+|++++..+.+....+.+.+|+.+|+.+.||++++++++|.+..++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +||||.+||+|+.++.+.++|++..+++|++||+.||+|||+++|++|||||||||||.+|++||+|||+|+...     
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-----  195 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-----  195 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999753     


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChH
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  291 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  291 (499)
                              .+..+.||||.|+|||++..++++.++|+||||+++|||++|.+||.+.+...++++|+.+++.||..++++
T Consensus       196 --------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~  267 (355)
T KOG0616|consen  196 --------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSD  267 (355)
T ss_pred             --------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHH
Confidence                    345688999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ++|||+++|+.|-.+|.+.-..|.++|++||||++++|..+..+
T Consensus       268 ~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r  311 (355)
T KOG0616|consen  268 AKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR  311 (355)
T ss_pred             HHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence            99999999999999998887778899999999999999998665

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-64  Score=508.16  Aligned_cols=289  Identities=42%  Similarity=0.735  Sum_probs=260.5

Q ss_pred             CCCCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           47 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        47 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      ..+.+++.+||+++++||+|+||.||+|+.+.||..||+|++.|......+....+..|+.+|...++|+||+||..||+
T Consensus       133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD  212 (550)
T KOG0605|consen  133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD  212 (550)
T ss_pred             hccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence            34457789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          127 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      ..++||||||++|||+..+|.+.+.|+++.+++|+++++.|++.||++|+|||||||+|+||+.+||+||+|||++..+.
T Consensus       213 ~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999996543


Q ss_pred             Ccccc---------------ccCCCCC----------------------CCCccccccCccCCCccccCCCCCCCCCcch
Q 010859          207 DSRIT---------------VLPNAAS----------------------DDKACTFVGTAAYVPPEVLNSSPATFGNDLW  249 (499)
Q Consensus       207 ~~~~~---------------~~~~~~~----------------------~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiw  249 (499)
                      .....               ..+....                      ...+.+.+|||.|||||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            21100               0000000                      1123457999999999999999999999999


Q ss_pred             hhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCCCC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       250 slG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      |||||+||||.|.+||.+.++.+++++|+...  +.+|.  .++++++|||.+||+ ||++|+++  .|+++|+.||||+
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~--~G~~EIK~HPfF~  449 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS--KGAEEIKKHPFFK  449 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc--ccHHHHhcCCccc
Confidence            99999999999999999999999999999866  67776  478999999999999 99999995  6899999999999


Q ss_pred             CCCcccccCCCCC
Q 010859          326 GIDWKNIRGQTPP  338 (499)
Q Consensus       326 ~i~~~~~~~~~~p  338 (499)
                      +|+|+.+....+|
T Consensus       450 ~v~W~~l~~~~ap  462 (550)
T KOG0605|consen  450 GVDWDHLREMPAP  462 (550)
T ss_pred             cCCcchhhcCCCC
Confidence            9999999987754

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-63  Score=507.64  Aligned_cols=282  Identities=37%  Similarity=0.664  Sum_probs=263.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCe
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFS  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~  129 (499)
                      .+.+++|.++++||+|+||+|++|..+.+++.||||+++|..+......+..+.|+.|+.... ||+++++|+.||+..+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            788999999999999999999999999999999999999999999999999999999998885 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||+.||++. ++.+.+.|++..+++|+++|+.||.|||++||||||||.+|||||.+||+||+|||+++..-   
T Consensus       444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m---  519 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM---  519 (694)
T ss_pred             EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC---
Confidence            99999999999954 44455689999999999999999999999999999999999999999999999999998532   


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  289 (499)
                             ....+.++|||||.|||||++.+..|+.++|+|||||+|||||.|..||.+.++.+++..|+..++.+|..+|
T Consensus       520 -------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls  592 (694)
T KOG0694|consen  520 -------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS  592 (694)
T ss_pred             -------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence                   2345778999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLASE  343 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~-~~~p~~~~~  343 (499)
                      .++.+++++||.++|++|+++.+.+.++|+.||||+.|+|+.|.+ +..|++.|.
T Consensus       593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~  647 (694)
T KOG0694|consen  593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPT  647 (694)
T ss_pred             HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcc
Confidence            999999999999999999999998899999999999999999865 445555543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-61  Score=487.50  Aligned_cols=258  Identities=35%  Similarity=0.706  Sum_probs=248.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      .+|..++.||+|||+.||.+++.++|+.||+|++.+..+.+....+.+.+|+++.+.|+|||||++|.+|+|..++|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |+|..++|..++++.+.++|.++++|+.||+.||.|||+++|+|||||..|+||+++.+|||+|||+|..+...      
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~------  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD------  171 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc------
Confidence            99999999999999999999999999999999999999999999999999999999999999999999877542      


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  294 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  294 (499)
                          ..+..+.||||.|.|||++....++..+||||+||++|-||+|++||...+-.+++.+|...++.+|..++.++++
T Consensus       172 ----~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~d  247 (592)
T KOG0575|consen  172 ----GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKD  247 (592)
T ss_pred             ----ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHH
Confidence                3567799999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCC-CCC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFF-KGI  327 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff-~~i  327 (499)
                      ||.+||+.||.+||++     ++++.|+|| ++.
T Consensus       248 LI~~lL~~~P~~Rpsl-----~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSL-----DEVLDHPFFKSGF  276 (592)
T ss_pred             HHHHHhcCCcccCCCH-----HHHhcCHhhhCCC
Confidence            9999999999999999     899999999 444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-61  Score=469.79  Aligned_cols=260  Identities=38%  Similarity=0.581  Sum_probs=235.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch----hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      ..+.|.+.+.||+|+||.|-+|.++.||+.||||++.+.....    ......+.+|+++|++|+|||||+++++|....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4577999999999999999999999999999999999887665    335566889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC---CCEEEEecCCcccc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPM  205 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~---~~vkL~DFG~a~~~  205 (499)
                      ..|+||||++||+|++.+..++.+.+...+.++.||+.||.|||++||+||||||+|||+..+   ..+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999877   68999999999986


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCC---CCCCCcchhhhHHHHHHhcCCCCCCCCCHHH-HHHHHHhcC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARD  281 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~---~~~~sDiwslG~ilyelltG~~Pf~~~~~~~-~~~~i~~~~  281 (499)
                      ..           .....++||||.|+|||++.+..   +..++|+|||||+||-+++|.+||.+..... ..+.|..+.
T Consensus       330 g~-----------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~  398 (475)
T KOG0615|consen  330 GE-----------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR  398 (475)
T ss_pred             cc-----------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence            53           34566899999999999997665   3457899999999999999999998876555 778899988


Q ss_pred             CCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          282 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       282 ~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      +.|-    ..++.++.+||.+||+.||++||++     +++++||||+.++
T Consensus       399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~-----~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSA-----DEALNHPWFKDAP  444 (475)
T ss_pred             ccccChhhhhhhHHHHHHHHHhhEeCcccCcCH-----HHHhcChhhhccc
Confidence            8764    3589999999999999999999999     8899999999765

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6e-60  Score=461.02  Aligned_cols=291  Identities=36%  Similarity=0.636  Sum_probs=261.5

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..+..++|++++.||.|.-|+||+|+.+.++..+|+|+|+|..+...++...++.|.+||..++||++..||..|+.+..
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            45677899999999999999999999999999999999999999988999999999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 LYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .|+|||||+||+|..+.+++  +.|+++.+++|+++++.||+|||..|||+||||||||||.++|||.|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999999998876  4699999999999999999999999999999999999999999999999999865421


Q ss_pred             ccccc----------------------------c-C-----------------CCCCCCCccccccCccCCCccccCCCC
Q 010859          208 SRITV----------------------------L-P-----------------NAASDDKACTFVGTAAYVPPEVLNSSP  241 (499)
Q Consensus       208 ~~~~~----------------------------~-~-----------------~~~~~~~~~~~~Gt~~Y~aPE~l~~~~  241 (499)
                      ...-.                            . .                 ......+..+||||-.|+|||++.|..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            10000                            0 0                 012234567899999999999999999


Q ss_pred             CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 010859          242 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  319 (499)
Q Consensus       242 ~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~  319 (499)
                      .+.++|+|+||++||||+.|..||.+.+..+++.+|+...+.||.  .++.+++|||+++|.+||.+|++... |.++|+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~r-GA~eIK  390 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKR-GAAEIK  390 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcccc-chHHhh
Confidence            999999999999999999999999999999999999999999997  46899999999999999999999753 679999


Q ss_pred             cCCCCCCCCcccccCCCCCCCC
Q 010859          320 MHPFFKGIDWKNIRGQTPPKLA  341 (499)
Q Consensus       320 ~Hpff~~i~~~~~~~~~~p~~~  341 (499)
                      +||||+|++|.=++...||.++
T Consensus       391 ~HpFF~gVnWaLir~~~PP~iP  412 (459)
T KOG0610|consen  391 RHPFFEGVNWALIRCARPPEIP  412 (459)
T ss_pred             cCccccCCChhheeccCCCcCC
Confidence            9999999999977777777543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-59  Score=441.60  Aligned_cols=285  Identities=36%  Similarity=0.653  Sum_probs=265.9

Q ss_pred             CCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           49 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      ..++.+++|.++++||+|.||.|.+|+.+.||+.||||+++|+.+........-..|-.+|+..+||++..|...||...
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD  241 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence            35678999999999999999999999999999999999999998888888888888999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||+.||+|+-++.+...|+|+.+++|-++|+.||.|||+++||.||||.+|.|++.+||+||+|||+++.--. 
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-  320 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-  320 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence            9999999999999999999998999999999999999999999999999999999999999999999999999985321 


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  288 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  288 (499)
                               ......+|||||.|.|||++.+..|+.++|+|.+||++|||++|++||...+...++..|+..++.||..+
T Consensus       321 ---------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~l  391 (516)
T KOG0690|consen  321 ---------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTL  391 (516)
T ss_pred             ---------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccC
Confidence                     23456689999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc-CCCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASE  343 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~-~~~~p~~~~~  343 (499)
                      +++++.|+..+|.+||.+|++.+.....++..|+||.+++|+... +..+|++.|.
T Consensus       392 s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPq  447 (516)
T KOG0690|consen  392 SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQ  447 (516)
T ss_pred             CHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCC
Confidence            999999999999999999999988888999999999999999864 4556665543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6e-57  Score=436.51  Aligned_cols=259  Identities=31%  Similarity=0.508  Sum_probs=238.1

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe-
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS-  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~-  129 (499)
                      .++.++.+.++.||+|+.|+||+|+++.|++.+|+|++..  ...+.....+.+|+++++.++||+||++|+.|..+.. 
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            4566799999999999999999999999999999999933  3456677788999999999999999999999999984 


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ++++||||+||+|.+++.+.++++|.....++.+++.||.|||. ++||||||||+|||++..|.|||||||.++.+.++
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999999999999999999999999999999999999995 99999999999999999999999999999877542


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC-----CHHHHHHHHHh-cCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----SEWLIFQRIIA-RDI  282 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~-----~~~~~~~~i~~-~~~  282 (499)
                                  .+.+|+||..|||||.+.+..|+.++||||||+.+.||++|+.||...     +..+++..|+. ..+
T Consensus       233 ------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP  300 (364)
T KOG0581|consen  233 ------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP  300 (364)
T ss_pred             ------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC
Confidence                        456899999999999999999999999999999999999999999875     66788888888 556


Q ss_pred             CCCCC-CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          283 RFPNY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       283 ~~p~~-~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      .+|.. +|+++++||..||++||.+|+++     .+|++|||++...
T Consensus       301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~-----~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  301 RLPEGEFSPEFRSFVSCCLRKDPSERPSA-----KQLLQHPFIKKFE  342 (364)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCcccCCCH-----HHHhcCHHHhhcc
Confidence            78887 99999999999999999999998     8999999998543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-55  Score=449.88  Aligned_cols=265  Identities=34%  Similarity=0.595  Sum_probs=247.4

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..+-|++++.||.|+-|.|-+|++..||+..|||++.+.....+.....+++|+-+|+.+.||||+++|+++++...+|+
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            45779999999999999999999999999999999998865666667779999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |+||++||.|++++.++|+|++.++..++.||+.|+.|||..+|+||||||||+||+..+.|||+|||+|..-.++    
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g----  165 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG----  165 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC----
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999764432    


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChH
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  291 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  291 (499)
                             ....+.||+|.|.|||++.|.+| +.++||||.|||||.||+|++||.+.|...++.++..+.+.+|..+|++
T Consensus       166 -------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~e  238 (786)
T KOG0588|consen  166 -------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSE  238 (786)
T ss_pred             -------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHH
Confidence                   34457899999999999999987 7899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                      +++||.+||..||.+|+|.     ++|++|||+.+..-....
T Consensus       239 aQdLLr~ml~VDp~~RiT~-----~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  239 AQDLLRRMLDVDPSTRITT-----EEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HHHHHHHHhccCccccccH-----HHHhhCchhhcCCCCChh
Confidence            9999999999999999998     999999999987654444

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-55  Score=443.42  Aligned_cols=260  Identities=39%  Similarity=0.703  Sum_probs=239.9

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh--hHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF  128 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~  128 (499)
                      .....|++++.||+|+||.|++|.+..+|..||+|+++++.....  .....+.+|+.+++++. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            456899999999999999999999999999999998887644322  34566778999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-CCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-~~vkL~DFG~a~~~~~  207 (499)
                      .+|+|||||.||+|++++.+.+++.|..++.++.||+.|++|||++||+||||||||||++.+ +++||+|||++.... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence            999999999999999999999999999999999999999999999999999999999999999 999999999998753 


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCC-C-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-A-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p  285 (499)
                               .......++|||+.|+|||++.+.. | +.++||||+|++||.|++|+.||...+...++.+|..+.+.+|
T Consensus       173 ---------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p  243 (370)
T KOG0583|consen  173 ---------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP  243 (370)
T ss_pred             ---------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC
Confidence                     1234556899999999999999877 7 5889999999999999999999999999999999999999999


Q ss_pred             CCC-ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          286 NYF-SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       286 ~~~-~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ..+ ++++++||.+||+.||.+|+++     .++++||||+.
T Consensus       244 ~~~~S~~~~~Li~~mL~~~P~~R~t~-----~~i~~h~w~~~  280 (370)
T KOG0583|consen  244 SYLLSPEARSLIEKMLVPDPSTRITL-----LEILEHPWFQK  280 (370)
T ss_pred             CCcCCHHHHHHHHHHcCCCcccCCCH-----HHHhhChhhcc
Confidence            999 9999999999999999999998     88999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-55  Score=426.03  Aligned_cols=257  Identities=33%  Similarity=0.581  Sum_probs=233.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ...+|.+.+.||+|+||+||+|+++.++..||||.+.+.... .+..+.+..|+.+|+.++|||||++++++.+.+++|+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            368999999999999999999999999999999999887653 3456667889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC------CCEEEEecCCccccC
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD------GHIKIADFGSVKPMQ  206 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~------~~vkL~DFG~a~~~~  206 (499)
                      |||||.||||.+++.+.+.++|..++.++.||+.||++||+++||||||||.||||+.+      -.+||+|||+|+.+.
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999875      358999999999886


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC---
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---  283 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~---  283 (499)
                      +.           ....+.||++.|||||++....|+.|+|+||+|+|||+|++|++||...+..+++..+..+...   
T Consensus       167 ~~-----------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~  235 (429)
T KOG0595|consen  167 PG-----------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV  235 (429)
T ss_pred             ch-----------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc
Confidence            53           3456899999999999999999999999999999999999999999999999998887766543   


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +|..+++...+|+..+|+.+|..|.+.     .+-..|+|...
T Consensus       236 ~~~~~s~~~~~Ll~~ll~~~~~~~~~~-----~~~~~~~~l~~  273 (429)
T KOG0595|consen  236 LPAELSNPLRELLISLLQRNPKDRISF-----EDFFDHPFLAA  273 (429)
T ss_pred             hhhhccCchhhhhhHHHhcCccccCch-----HHhhhhhhccc
Confidence            455688889999999999999999876     77788888754

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-55  Score=428.36  Aligned_cols=285  Identities=35%  Similarity=0.627  Sum_probs=263.1

Q ss_pred             CCCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010859           48 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD  126 (499)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~  126 (499)
                      ....+...||.++.+||+|+||.|.+|..+.|.+.||||+++|..+......+--..|..+|.... -|++++++..||.
T Consensus       342 ~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT  421 (683)
T KOG0696|consen  342 KRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT  421 (683)
T ss_pred             cccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence            334667789999999999999999999999999999999999998888877777778998988775 5799999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          127 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      -+.+|+||||+.||+|-.+|++-|+|-|..+.+|+++|+-||-+||++||+.||||.+|||++.+|||||+|||+++.--
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998422


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  286 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~  286 (499)
                                .......+|||||.|+|||++...+|+.++|+||+||+||||+.|++||.+.++.++++.|...+..+|.
T Consensus       502 ----------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK  571 (683)
T KOG0696|consen  502 ----------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK  571 (683)
T ss_pred             ----------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc
Confidence                      2345567899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLAS  342 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~-~~~p~~~~  342 (499)
                      .+|.++.++++.+|.+.|.+|++++..+-.++..||||+.|||+.+.. ..+|++.|
T Consensus       572 slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkP  628 (683)
T KOG0696|consen  572 SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKP  628 (683)
T ss_pred             cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCC
Confidence            999999999999999999999999987889999999999999999865 34454444

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-55  Score=432.89  Aligned_cols=287  Identities=32%  Similarity=0.592  Sum_probs=261.6

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ...+.+.|..-++||+|+||.||-|+.+.||+.||+|.++|+.+.+........+|+.+|.+++.++||.+-..|+..+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            45678899999999999999999999999999999999999988888888888899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 LYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +++||..|+||||.-+|-+.|  .|++..+++|+++|+.||++||..+||.|||||+|||+|+.|||+|+|+|+|..+..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999999998876  699999999999999999999999999999999999999999999999999987754


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH----HHHHHHHHhcCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIR  283 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~----~~~~~~i~~~~~~  283 (499)
                      .           ......+||.+|||||++.+..|+.+.|+|||||+||+|+.|+.||+...+    .++-++++.....
T Consensus       340 g-----------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e  408 (591)
T KOG0986|consen  340 G-----------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE  408 (591)
T ss_pred             C-----------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh
Confidence            3           233345999999999999999999999999999999999999999987544    3555677778888


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCCCCccC
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLASEPMVQ  347 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~-~~~p~~~~~~~~~  347 (499)
                      +|+.+|+++++|.+.+|++||.+|+++...+.+++++||||++++|..+.. ..+|++.|.+...
T Consensus       409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aV  473 (591)
T KOG0986|consen  409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAV  473 (591)
T ss_pred             cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcccc
Confidence            999999999999999999999999999988889999999999999999865 5566677666443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-53  Score=430.78  Aligned_cols=273  Identities=40%  Similarity=0.741  Sum_probs=250.7

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..+.+++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR   92 (329)
T ss_pred             CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence            45667899999999999999999999999999999999987655444555667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999999764321 


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  289 (499)
                                  ..+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+....+.+|..++
T Consensus       172 ------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~  239 (329)
T PTZ00263        172 ------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD  239 (329)
T ss_pred             ------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCC
Confidence                        22468999999999999999999999999999999999999999999998889999999999999999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ..+++||.+||+.||.+|+++...++++++.||||++++|+.+...
T Consensus       240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~  285 (329)
T PTZ00263        240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYAR  285 (329)
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhC
Confidence            9999999999999999999977677899999999999999987643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.9e-55  Score=409.76  Aligned_cols=257  Identities=28%  Similarity=0.490  Sum_probs=222.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ++.|+.+..+|+|+||+||+|++++||+.||||.+--..- ...-..-..+|+.+|+.++|||+|.|.++|.....+|+|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            4679999999999999999999999999999998854322 222334456799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      +|||+. ++.+.+.+. ..++.+.++.|++|++.|+.|||+++++|||||||||||+.+|.+||||||+|+.+...    
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p----  154 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP----  154 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC----
Confidence            999987 666767665 45999999999999999999999999999999999999999999999999999987632    


Q ss_pred             cCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-----------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-----------  280 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-----------  280 (499)
                            ....+.++.|.+|+|||++.+ ..|+.++||||+||++.||++|.+.|.+.++.+++..|...           
T Consensus       155 ------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  155 ------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             ------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence                  234557899999999999877 77999999999999999999999999999998887766541           


Q ss_pred             --------CCCCCC------------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          281 --------DIRFPN------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       281 --------~~~~p~------------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                              ...+|.            .++..+.||+++||..||.+|+++     ++++.||||.++
T Consensus       229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc-----~qll~H~yFd~~  290 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC-----EQLLHHPYFDGF  290 (396)
T ss_pred             hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH-----HHHhcChHHHHH
Confidence                    112221            256789999999999999999999     899999999754

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-55  Score=469.43  Aligned_cols=279  Identities=40%  Similarity=0.679  Sum_probs=256.1

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      .+...+||+++++||+|+||.|.+++++.|++.||+|+++|-...+......+..|+.+|.-.+.+-|++++..|+|+.+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            35667899999999999999999999999999999999999877777788889999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||++||||..++.+.++++++.+++|+++|+.||.-||+.|.|||||||+||||+..|||||+|||.+-.+... 
T Consensus       150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d-  228 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-  228 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999876543 


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccC----C-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLN----S-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DI  282 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~----~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~  282 (499)
                              +.-.....||||.|.|||+|.    + +.|+..+|+|||||++|||+.|..||...+--+++-+|+.-  .+
T Consensus       229 --------G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l  300 (1317)
T KOG0612|consen  229 --------GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL  300 (1317)
T ss_pred             --------CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc
Confidence                    234455779999999999984    3 56899999999999999999999999999999999999875  78


Q ss_pred             CCC--CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCCC
Q 010859          283 RFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL  340 (499)
Q Consensus       283 ~~p--~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p~~  340 (499)
                      .||  ..+|.++++||.++| -+|..|++-  .|+++++.||||.|++|++++...||..
T Consensus       301 ~FP~~~~VSeeakdLI~~ll-~~~e~RLgr--ngiedik~HpFF~g~~W~~iR~~~pP~v  357 (1317)
T KOG0612|consen  301 SFPDETDVSEEAKDLIEALL-CDREVRLGR--NGIEDIKNHPFFEGIDWDNIRESVPPVV  357 (1317)
T ss_pred             CCCcccccCHHHHHHHHHHh-cChhhhccc--ccHHHHHhCccccCCChhhhhhcCCCCC
Confidence            899  468999999999999 578999975  5789999999999999999998887754

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-54  Score=429.39  Aligned_cols=258  Identities=33%  Similarity=0.507  Sum_probs=229.1

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC-
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF-  128 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~-  128 (499)
                      ...+++|.+++.||.|+||.||+|+.+.+|..||||.|+++....++  ..-.+|+..|++|+ |||||+|++++.+.. 
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            34578999999999999999999999999999999999887665443  33456999999998 999999999999988 


Q ss_pred             eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .+|+|||||+. +|+++++.+ ..|++..++.|+.||+.||+|+|.+|++|||+||||||+..+..|||+|||+|+.+..
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            99999999976 999999866 4599999999999999999999999999999999999999889999999999998754


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh-------
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-------  279 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~-------  279 (499)
                      .           ...+.++.|.+|+|||+|. ...|+.+.||||+|||++|+++-++.|.|.++.+++.+|+.       
T Consensus       163 k-----------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  163 K-----------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             C-----------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence            3           3445789999999999975 56699999999999999999999999999999999888875       


Q ss_pred             ------------cCCCCCC-----------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          280 ------------RDIRFPN-----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       280 ------------~~~~~p~-----------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                  .++.||.           ..+.++.+||.+||.+||.+||||     +++++||||+.-
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA-----~~al~~pffq~~  297 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA-----SQALQHPFFQVG  297 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH-----HHHhcCcccccc
Confidence                        2344442           368999999999999999999999     889999999843

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-55  Score=407.88  Aligned_cols=250  Identities=31%  Similarity=0.540  Sum_probs=224.4

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEE-EEEcC-
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF-TFQDT-  127 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~-~~~~~-  127 (499)
                      ...+..+|++++.||+|+||+||+|++..+|..+|.|.+.-..+. .+....+..|+.+|+.|+|||||++|. .|.++ 
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            355678999999999999999999999999999999999855444 445556667999999999999999997 55444 


Q ss_pred             CeEEEEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--cEeeecCCCCeeeCCCCCEEEEec
Q 010859          128 FSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHS--MG--LIHRDIKPENLLLTADGHIKIADF  199 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~--~g--IiHrDlKp~NILl~~~~~vkL~DF  199 (499)
                      ..+++|||||.+|||.+.|+.    ...++|..++.++.|++.||.+||.  ..  |+||||||.||+|+.+|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            449999999999999998864    3469999999999999999999998  44  999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  279 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~  279 (499)
                      |+++.+...          ...+.+++|||.|||||++.+.+|+.++|||||||++|||+.-++||.+.+-..+.++|..
T Consensus       173 GL~r~l~s~----------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q  242 (375)
T KOG0591|consen  173 GLGRFLSSK----------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ  242 (375)
T ss_pred             hhHhHhcch----------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc
Confidence            999987653          2445689999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCC-CC-CCCChHHHHHHHHhhccCCCCCCCC
Q 010859          280 RDIR-FP-NYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       280 ~~~~-~p-~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ++++ +| +.+|.++..||..|+..||..||+.
T Consensus       243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            9886 77 6799999999999999999999975

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-53  Score=418.86  Aligned_cols=267  Identities=38%  Similarity=0.665  Sum_probs=244.3

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997654444444566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....       
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-------  153 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-------  153 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-------
Confidence            9999999999999888999999999999999999999999999999999999999999999999999875432       


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  294 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  294 (499)
                            .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....++.+......+|..++..+++
T Consensus       154 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  227 (291)
T cd05612         154 ------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKD  227 (291)
T ss_pred             ------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHH
Confidence                  12246799999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      ||++||+.||.+|++....++++++.||||..++|..+..
T Consensus       228 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  267 (291)
T cd05612         228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ  267 (291)
T ss_pred             HHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhc
Confidence            9999999999999986656679999999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.9e-52  Score=421.12  Aligned_cols=265  Identities=38%  Similarity=0.660  Sum_probs=239.4

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  140 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg  140 (499)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+..|..+++.++||||+++++.|++...+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765444445556778999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 010859          141 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  220 (499)
Q Consensus       141 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~  220 (499)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....          ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~----------~~  150 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD----------GA  150 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----------CC
Confidence            99999998889999999999999999999999999999999999999999999999999998753211          12


Q ss_pred             CccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhh
Q 010859          221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL  300 (499)
Q Consensus       221 ~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL  300 (499)
                      ....++||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||.+||
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            23357899999999999999999999999999999999999999999988888888888889999999999999999999


Q ss_pred             ccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          301 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       301 ~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      +.||++||+....+..++++||||.+++|..+...
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~  265 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQK  265 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence            99999999765556699999999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-54  Score=392.10  Aligned_cols=259  Identities=35%  Similarity=0.577  Sum_probs=246.8

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..++++||++++.||+|-||.||+|+.+.++..||+|++.|+.+........+.+|+++-..|+||||+++|++|.|...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            56889999999999999999999999999999999999999998888888899999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 LYMALESCEGGELFDQIT--SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~--~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +|+++||+..|+|+..+.  ..+++++..+..|+.|++.||.|||..+|+||||||+|+|++.+|.+||+|||.+..-. 
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999999999  66789999999999999999999999999999999999999999999999999986432 


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  287 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~  287 (499)
                                 ..+..+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..+++++|.+.++.+|..
T Consensus       176 -----------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~  244 (281)
T KOG0580|consen  176 -----------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPST  244 (281)
T ss_pred             -----------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcc
Confidence                       345668999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ++.+++|||.+||..+|.+|...     .+++.|||..
T Consensus       245 is~~a~dlI~~ll~~~p~~r~~l-----~~v~~hpwI~  277 (281)
T KOG0580|consen  245 ISGGAADLISRLLVKNPIERLAL-----TEVMDHPWIV  277 (281)
T ss_pred             cChhHHHHHHHHhccCccccccH-----HHHhhhHHHH
Confidence            99999999999999999999987     8899999975

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.6e-52  Score=421.45  Aligned_cols=272  Identities=34%  Similarity=0.615  Sum_probs=246.3

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCC-ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTG-TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~-~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ....++|++.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|..+++.++||||+++++++.+...
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            456789999999999999999999977655 6899999987655555556667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+..  
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--  183 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--  183 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999976432  


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  289 (499)
                                 ...+.+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+.....+.+......+|..++
T Consensus       184 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  252 (340)
T PTZ00426        184 -----------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD  252 (340)
T ss_pred             -----------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence                       123568999999999999988999999999999999999999999999998889999999889999999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      +.+.+||++||+.||.+|++....+++++++||||.+++|..+...
T Consensus       253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~  298 (340)
T PTZ00426        253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHK  298 (340)
T ss_pred             HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence            9999999999999999998655556799999999999999876543

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-51  Score=414.13  Aligned_cols=270  Identities=36%  Similarity=0.643  Sum_probs=243.2

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCeEEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP-GVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +|++++.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+.|+ +|++++++|.+...+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            689999999999999999999999999999999876554445556677788899888764 6888999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....      
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~------  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG------  154 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC------
Confidence            99999999999998888999999999999999999999999999999999999999999999999998643211      


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  294 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  294 (499)
                          .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....+.+......+|..++.++.+
T Consensus       155 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T cd05587         155 ----GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (324)
T ss_pred             ----CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence                1223356899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ||.+||..||.+|+++.....+++++||||++++|..+...
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~  271 (324)
T cd05587         231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERR  271 (324)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence            99999999999999987667789999999999999887654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.9e-51  Score=421.88  Aligned_cols=279  Identities=37%  Similarity=0.667  Sum_probs=237.7

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||+||+|++..+++.||+|++.+...........+..|+.+++.++||||+++++.+++...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999998765544555567788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc--
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--  212 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--  212 (499)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+.......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999998654321100  


Q ss_pred             ------cCCC-----------------CCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC
Q 010859          213 ------LPNA-----------------ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  269 (499)
Q Consensus       213 ------~~~~-----------------~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~  269 (499)
                            .+..                 .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                  0000                 00111235689999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhc--CCCCCC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC
Q 010859          270 EWLIFQRIIAR--DIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  336 (499)
Q Consensus       270 ~~~~~~~i~~~--~~~~p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~  336 (499)
                      ....+.++...  ...+|.  .+++++++||.+|+. +|.+|++.  .+++++++||||++++|+.+....
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r--~~~~ei~~hp~f~~~~~~~~~~~~  308 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA--PGVEEIKTNPFFEGVDWEHIRERP  308 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhCCCCCCCCCHHHHHhCC
Confidence            88888888763  455665  368999999999886 66666542  234999999999999999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-52  Score=413.77  Aligned_cols=270  Identities=39%  Similarity=0.650  Sum_probs=233.0

Q ss_pred             CCCCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh-----------hHHHHHHHHHHHHHhCCCC
Q 010859           47 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------NKTAYVKLERIVLDQLDHP  115 (499)
Q Consensus        47 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp  115 (499)
                      .......++.|++++.||+|.||.|-+|++..+++.||||++.|....+.           ...+.+.+|+.+|++|.||
T Consensus        89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            34456678999999999999999999999999999999999987644332           1245789999999999999


Q ss_pred             CccEEEEEEEc--CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC
Q 010859          116 GVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  193 (499)
Q Consensus       116 ~Iv~l~~~~~~--~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~  193 (499)
                      |||+|+++..+  ...+|||+|||..|.+...-....-+++.+++.|+.+++.||+|||.+||+||||||+|+||+.+|+
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence            99999999976  4579999999999988554333222999999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCC----CCCCCcchhhhHHHHHHhcCCCCCCCCC
Q 010859          194 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTS  269 (499)
Q Consensus       194 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----~~~~sDiwslG~ilyelltG~~Pf~~~~  269 (499)
                      +||+|||.+.......     ....+......+|||.|+|||.+.+..    .+.+.|||||||+||.|+.|+.||-+..
T Consensus       249 VKIsDFGVs~~~~~~~-----~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGS-----DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             EEeeccceeeecccCC-----ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            9999999997664331     112223334479999999999987632    4678899999999999999999999999


Q ss_pred             HHHHHHHHHhcCCCCCCC--CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          270 EWLIFQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       270 ~~~~~~~i~~~~~~~p~~--~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ..+++.+|+...+.||..  +.++++|||.+||++||++|++.     .+++.|||...
T Consensus       324 ~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l-----~~ik~Hpwvt~  377 (576)
T KOG0585|consen  324 ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL-----PDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeeh-----hhheecceecc
Confidence            999999999999999986  79999999999999999999998     88999999863

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.4e-53  Score=425.62  Aligned_cols=256  Identities=31%  Similarity=0.579  Sum_probs=239.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|.+.+.||+|+||.||+|+.+.|.+.||+|.+.|... .++....+.+|+.+++.++|||||.+++.|+....+++|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            4689999999999999999999999999999999987643 345567788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      +|||.| +|+.++...+.++|+.++.++.+++.||.|||+++|+|||+||.|||+...|++|+||||+|+.+...     
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-----  153 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-----  153 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-----
Confidence            999987 99999999999999999999999999999999999999999999999999999999999999976542     


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHH
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR  293 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  293 (499)
                           .....+.-|||.|||||++.+.+|+..+|+||||||+|||++|++||...+..++...|.......|...+..++
T Consensus       154 -----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~  228 (808)
T KOG0597|consen  154 -----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFV  228 (808)
T ss_pred             -----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHH
Confidence                 234456789999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       294 ~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .|++.+|.+||.+|++=     .+++.|||.++
T Consensus       229 nfl~gLL~kdP~~RltW-----~~Ll~HpF~k~  256 (808)
T KOG0597|consen  229 NFLQGLLIKDPAQRLTW-----TDLLGHPFWKG  256 (808)
T ss_pred             HHHHHHhhcChhhcccH-----HHHhcChHHhh
Confidence            99999999999999976     88999999875

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3e-51  Score=413.58  Aligned_cols=271  Identities=35%  Similarity=0.629  Sum_probs=243.8

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +|++++.||+|+||.||+|++..+++.||+|++.+..............|..++..+ .||+|+++++++.+...+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            689999999999999999999999999999999876544444455566677777776 5899999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....      
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~------  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD------  154 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC------
Confidence            99999999999988888999999999999999999999999999999999999999999999999998743221      


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  294 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  294 (499)
                          .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....+.+......+|..++.++.+
T Consensus       155 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  230 (323)
T cd05616         155 ----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  230 (323)
T ss_pred             ----CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence                1223356899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  336 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~  336 (499)
                      ||.+||+.||.+|+++...+..++++||||+.++|+.+....
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~  272 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE  272 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence            999999999999999876677999999999999999886543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.6e-51  Score=406.53  Aligned_cols=275  Identities=32%  Similarity=0.566  Sum_probs=237.3

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      .|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++|++|+++++++.+...+|+|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            48899999999999999999999999999999987655444444556789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......     
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-----  155 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence            99999998887643  35899999999999999999999999999999999999999999999999998764321     


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH----HHHHHHHhcCCCCCCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~  289 (499)
                            ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..    .....+......++..++
T Consensus       156 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (285)
T cd05631         156 ------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFS  229 (285)
T ss_pred             ------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCC
Confidence                  1122457999999999999999999999999999999999999999876542    233344455567788899


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLA  341 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~  341 (499)
                      .++.+||++||+.||.+||++.+.+.+++++||||.+++|+.+... .+|++.
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~  282 (285)
T cd05631         230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFC  282 (285)
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCC
Confidence            9999999999999999999987777899999999999999998764 334443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-51  Score=420.12  Aligned_cols=281  Identities=39%  Similarity=0.693  Sum_probs=239.4

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++.|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            48999999999999999999999999999999998764444455566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.........
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999765432110000


Q ss_pred             CC----------------------------CCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCC
Q 010859          215 NA----------------------------ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK  266 (499)
Q Consensus       215 ~~----------------------------~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~  266 (499)
                      ..                            .......+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence            00                            00001224689999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcC--CCCCC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          267 DTSEWLIFQRIIARD--IRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       267 ~~~~~~~~~~i~~~~--~~~p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                      +.+.......+....  +.+|.  .+++++++||.+||. +|.+|++.  .++++++.||||++++|+.+....+|
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~--~~~~~ll~h~~~~~~~~~~~~~~~~~  313 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHPFFKGVDWEHIRERPAP  313 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHhhcCCC
Confidence            998888777776543  34444  468999999999996 99999984  23499999999999999987765544

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-52  Score=412.55  Aligned_cols=258  Identities=30%  Similarity=0.496  Sum_probs=227.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--Ce
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FS  129 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~--~~  129 (499)
                      ...+.|+.++.||+|+||.||+|++..||+.||+|.+.... .++.......+|+.+|++|+||||++|.+...+.  ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            44678999999999999999999999999999999998764 3455667778899999999999999999988765  78


Q ss_pred             EEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|+|+|||+. ||.-++...+ +|++.+++.|+.||+.||+|||++||+|||||.+||||+.+|.+||+|||+|+++...
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999999987 9998887753 6999999999999999999999999999999999999999999999999999987654


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  280 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-------  280 (499)
                      .         ....+..|-|.+|+|||+|.|. .|+.++|+||+||||.||++|++.|.+.++.+++.+|.+.       
T Consensus       272 ~---------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~  342 (560)
T KOG0600|consen  272 G---------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED  342 (560)
T ss_pred             C---------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence            3         2235567899999999998875 4999999999999999999999999999999999888761       


Q ss_pred             ---CCCCC-------------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          281 ---DIRFP-------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       281 ---~~~~p-------------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                         ...+|                   ..++..+.+|+..||..||.+|.||     .+++.|+||.
T Consensus       343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA-----~~aL~seyF~  404 (560)
T KOG0600|consen  343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA-----SSALQSEYFT  404 (560)
T ss_pred             ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH-----HHHhcCcccc
Confidence               01122                   2378999999999999999999999     8899999995

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.5e-51  Score=412.21  Aligned_cols=264  Identities=38%  Similarity=0.666  Sum_probs=238.5

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  140 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg  140 (499)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|..+++.++||||+++++.+.+...+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765555555566778999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 010859          141 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  220 (499)
Q Consensus       141 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~  220 (499)
                      +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          ..
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~----------~~  150 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD----------AA  150 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------cc
Confidence            99999988888999999999999999999999999999999999999999999999999998753211          11


Q ss_pred             CccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhh
Q 010859          221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL  300 (499)
Q Consensus       221 ~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL  300 (499)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||++||
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHc
Confidence            22356899999999999998999999999999999999999999999888888888888888999999999999999999


Q ss_pred             ccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          301 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       301 ~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      +.||.+|++....+++++++||||.+++|..+..
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~  264 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYD  264 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            9999999976555679999999999999987754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-50  Score=408.31  Aligned_cols=264  Identities=34%  Similarity=0.657  Sum_probs=236.6

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||+||+|+++.+++.||+|++.+..............|..++..+ +||||++++++|.+...+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876544444455566677777766 799999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~----------~  150 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN----------G  150 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC----------C
Confidence            999999998888999999999999999999999999999999999999999999999999998753211          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......+|..++.++.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (320)
T cd05590         151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF  230 (320)
T ss_pred             CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            22335689999999999999999999999999999999999999999999999999999988899999999999999999


Q ss_pred             hccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccC
Q 010859          300 LDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       300 L~~dP~~R~~~~~-~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      |+.||.+||++.+ .+.++++.||||.+++|+.+..
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~  266 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNR  266 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999999855 5678999999999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-50  Score=407.71  Aligned_cols=260  Identities=41%  Similarity=0.696  Sum_probs=235.1

Q ss_pred             eeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCh
Q 010859           63 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  142 (499)
Q Consensus        63 LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L  142 (499)
                      ||+|+||.||+|++..+++.||+|++.+...........+..|..+++.++||||+++++++.+...+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999876544444556677799999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 010859          143 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  222 (499)
Q Consensus       143 ~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~  222 (499)
                      .+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----------~~~~  150 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD----------DDKT  150 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC----------CCcc
Confidence            999998889999999999999999999999999999999999999999999999999998753221          1223


Q ss_pred             cccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhcc
Q 010859          223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV  302 (499)
Q Consensus       223 ~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~  302 (499)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....++.+......+|..+++++.+||.+||+.
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCC
Confidence            35689999999999999999999999999999999999999999999888899999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          303 DPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       303 dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      ||.+||++.  +..+++.||||...+|..+..
T Consensus       231 dp~~R~~~~--~~~e~l~hp~~~~~~~~~~~~  260 (312)
T cd05585         231 DPTRRLGYN--GAQEIKNHPFFSQLSWKKLLM  260 (312)
T ss_pred             CHHHcCCCC--CHHHHHcCCCcCCCCHHHHHh
Confidence            999999863  458999999999999987643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.3e-51  Score=410.17  Aligned_cols=270  Identities=35%  Similarity=0.642  Sum_probs=243.0

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +|++.+.||+|+||+||+|+++.+|+.||+|++.+..............|..+++.+. |++|++++++|++...+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            5889999999999999999999999999999998765444444555667888888875 578889999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....      
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~------  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD------  154 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC------
Confidence            99999999999998888999999999999999999999999999999999999999999999999998753221      


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  294 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  294 (499)
                          .......+||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+.....+.+......+|..++.++.+
T Consensus       155 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  230 (323)
T cd05615         155 ----GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (323)
T ss_pred             ----CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence                1123356799999999999998999999999999999999999999999999889999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |+.+||+.||.+|+++.+...+++++||||++++|..+...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~  271 (323)
T cd05615         231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENR  271 (323)
T ss_pred             HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcC
Confidence            99999999999999988777899999999999999987654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.7e-51  Score=417.81  Aligned_cols=279  Identities=38%  Similarity=0.678  Sum_probs=239.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++..++||+|+++++.|++...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765444555667788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc-
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL-  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~-  213 (499)
                      |||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+........ 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999876533211000 


Q ss_pred             -------CC-----------------CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC
Q 010859          214 -------PN-----------------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  269 (499)
Q Consensus       214 -------~~-----------------~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~  269 (499)
                             +.                 ........+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                   00                 000112235689999999999999999999999999999999999999999998


Q ss_pred             HHHHHHHHHhc--CCCCCCC--CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC
Q 010859          270 EWLIFQRIIAR--DIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  336 (499)
Q Consensus       270 ~~~~~~~i~~~--~~~~p~~--~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~  336 (499)
                      ....+.++...  .+.+|..  +++++++||.+|+ .||.+|+++  .+++++++||||.+++|..+....
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~~~~~~~~  308 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS--NGVEEIKSHPFFEGVDWGHIRERP  308 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCC--CCHHHHhcCCCCCCCCHHHHhcCC
Confidence            88888887753  3455553  7899999999987 599999986  356999999999999999986553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-51  Score=420.02  Aligned_cols=282  Identities=38%  Similarity=0.655  Sum_probs=237.1

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||++++++|++...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999997765444455667888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc--
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--  212 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--  212 (499)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999997432211000  


Q ss_pred             ---cCC--CC------------------------------CCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHH
Q 010859          213 ---LPN--AA------------------------------SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  257 (499)
Q Consensus       213 ---~~~--~~------------------------------~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilye  257 (499)
                         ...  ..                              ........+||+.|+|||++.+..++.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence               000  00                              0001123689999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCCHHHHHHHHHh--cCCCCCC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          258 MLSGTSPFKDTSEWLIFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       258 lltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                      |++|.+||.+.+....+..+..  ..+.+|.  .++.++++||.+||+ +|.+|++.  .+..+++.||||++++|+.+.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r--~~~~~~l~hp~~~~~~~~~~~  317 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR--GGAHEIKSHPFFRGVDWDTIR  317 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHc
Confidence            9999999999888887777765  3455565  478999999999997 88887633  234999999999999999887


Q ss_pred             CCCCCC
Q 010859          334 GQTPPK  339 (499)
Q Consensus       334 ~~~~p~  339 (499)
                      ...+|.
T Consensus       318 ~~~~~~  323 (377)
T cd05629         318 QIRAPF  323 (377)
T ss_pred             cCCCCc
Confidence            655443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-53  Score=390.32  Aligned_cols=257  Identities=33%  Similarity=0.587  Sum_probs=235.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..+.|++-++||+|.|+.|+++.+..||+.||+|+++....... ..+.+.+|+.+-+.|+|||||+|++++......|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            34679999999999999999999999999999999987766555 55668889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC---CCEEEEecCCccccCCcc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~---~~vkL~DFG~a~~~~~~~  209 (499)
                      |+|++.|++|..-|.+.-.++|..+-.++.||++||.|+|.+||+|||+||+|+|+-..   --+||+|||+|..+..  
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~--  165 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND--  165 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC--
Confidence            99999999998887776678999999999999999999999999999999999999654   3599999999987652  


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC---
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---  286 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~---  286 (499)
                               ......++|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+...+++.|..+.+.+|.   
T Consensus       166 ---------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w  236 (355)
T KOG0033|consen  166 ---------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW  236 (355)
T ss_pred             ---------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence                     34556789999999999999999999999999999999999999999999999999999999998875   


Q ss_pred             -CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 -YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 -~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                       .+++++++||++||..||.+|+|+     .+.++|||..+
T Consensus       237 ~~is~~Ak~LvrrML~~dP~kRIta-----~EAL~HpWi~~  272 (355)
T KOG0033|consen  237 DTVTPEAKSLIRRMLTVNPKKRITA-----DEALKHPWICN  272 (355)
T ss_pred             CcCCHHHHHHHHHHhccChhhhccH-----HHHhCCchhcc
Confidence             578999999999999999999999     78999999975

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-50  Score=418.47  Aligned_cols=279  Identities=35%  Similarity=0.565  Sum_probs=234.6

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      .|++++.||+|+||+||+|++..+++.||+|++.+...........+..|+.+++.++||||+++++++.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            68999999999999999999999999999999987665555566778889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc--
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL--  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~--  213 (499)
                      ||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+........  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999865421100000  


Q ss_pred             -------C----------------------------CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHH
Q 010859          214 -------P----------------------------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM  258 (499)
Q Consensus       214 -------~----------------------------~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyel  258 (499)
                             .                            .........+++||+.|+|||++.+..++.++|||||||++|+|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el  241 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM  241 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence                   0                            00001122457899999999999998999999999999999999


Q ss_pred             hcCCCCCCCCCHHHHHHHHHh--cCCCCCC--CCChHHHHHHHHhhccCC--CCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 010859          259 LSGTSPFKDTSEWLIFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDP--SGRPGAGPGGYAVLKMHPFFKGIDWKNI  332 (499)
Q Consensus       259 ltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~Li~~lL~~dP--~~R~~~~~~~~~~l~~Hpff~~i~~~~~  332 (499)
                      ++|.+||...+.......+..  ....+|.  .+++++++||.+||..++  ..|+++     +++++||||++++|...
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~-----~~~l~hp~f~~~~~~~~  316 (381)
T cd05626         242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA-----DDIKAHPFFSEVDFSSD  316 (381)
T ss_pred             HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH-----HHHhcCcccCCCChhHH
Confidence            999999998887776666654  3344554  579999999999776544  459988     89999999999999875


Q ss_pred             cCCCCCC
Q 010859          333 RGQTPPK  339 (499)
Q Consensus       333 ~~~~~p~  339 (499)
                      ....+++
T Consensus       317 ~~~~~~~  323 (381)
T cd05626         317 IRTQPAP  323 (381)
T ss_pred             hhcCCCC
Confidence            5444433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-50  Score=407.83  Aligned_cols=267  Identities=35%  Similarity=0.619  Sum_probs=238.5

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHH---HhCCCCCccEEEEEEEcCCeEEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL---DQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      |++++.||+|+||.||+|.+..+|+.||||++.+...........+..|+.++   +.++||||+++++++.+...+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78999999999999999999999999999999876544444455566676654   566899999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||++||+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....     
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-----  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-----  154 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-----
Confidence            999999999988765 46999999999999999999999999999999999999999999999999998743221     


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHH
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR  293 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  293 (499)
                           ......++||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+......+|..++.++.
T Consensus       155 -----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  229 (324)
T cd05589         155 -----GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI  229 (324)
T ss_pred             -----CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence                 122346789999999999999999999999999999999999999999999988889999988999999999999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       294 ~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      +||.+||+.||.+||++.+...+++++||||++++|..+..
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~  270 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLA  270 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHh
Confidence            99999999999999998887889999999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-50  Score=409.51  Aligned_cols=264  Identities=38%  Similarity=0.659  Sum_probs=238.3

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  140 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg  140 (499)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|..+++.++||||+++++.|.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765444445556677999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 010859          141 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  220 (499)
Q Consensus       141 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~  220 (499)
                      +|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~----------~~  150 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----------GA  150 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----------CC
Confidence            99999988888999999999999999999999999999999999999999999999999998753211          11


Q ss_pred             CccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhh
Q 010859          221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL  300 (499)
Q Consensus       221 ~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL  300 (499)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||.+||
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05595         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            22356899999999999999999999999999999999999999999988888888888889999999999999999999


Q ss_pred             ccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          301 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       301 ~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      +.||.+|++.......++++||||.+++|..+..
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  264 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ  264 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999977666779999999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.6e-50  Score=407.14  Aligned_cols=264  Identities=39%  Similarity=0.671  Sum_probs=237.2

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  140 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg  140 (499)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+..|..+++.++||||+++++.|.+...+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765544445556677899999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          141 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       141 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      +|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~----------~  150 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD----------G  150 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC----------C
Confidence            999999888889999999999999999999997 79999999999999999999999999998743211          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  230 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL  230 (325)
T ss_pred             cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            12235679999999999999999999999999999999999999999999888888888888999999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      |+.||.+|++....+..++++||||.++.|.....
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~  265 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYE  265 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99999999976555679999999999999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.4e-50  Score=423.86  Aligned_cols=393  Identities=25%  Similarity=0.353  Sum_probs=285.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCC-CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t-~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ...|.+.+.||+|+||.||+|.+..+ +..||+|.+...   .......+..|+.+|+.++||||++++++|.....+|+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            34599999999999999999999887 788999976443   33344567789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          133 ALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ||||++||+|.+++..    ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999999987753    356899999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNY  287 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~  287 (499)
                      .        ......+++||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+..+.. .+|..
T Consensus       223 ~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  294 (478)
T PTZ00267        223 V--------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP  294 (478)
T ss_pred             c--------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            1        11223467899999999999999999999999999999999999999999888888888776654 46778


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc--ccccCCCCCCCCCCCccCCCCCCCCCCCCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW--KNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIG  365 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (499)
                      ++.++.+||.+||..||++||++     ++++.|||++.+.-  ..+.... ..       .+.  .+.          .
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~-----~~~l~~~~~~~~~~~~~~~~~~~-~~-------~~~--~~~----------~  349 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTT-----QQLLHTEFLKYVANLFQDIVRHS-ET-------ISP--HDR----------E  349 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCH-----HHHHhCHHHHHHHHHHHHHhhhh-hh-------cCh--hhH----------H
Confidence            99999999999999999999998     88999999864321  1110000 00       000  000          0


Q ss_pred             CccccccCCCCCCCCCCCcccccccccccCcccccccCCCceEEEEEeeehhhh-hhhccceEEeecCCeEEE-ECCCC-
Q 010859          366 DISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQK-LTSKKVQLILTNKPKLIY-VDPSK-  442 (499)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~g~~~k~~g-~~~k~r~~ilt~~p~l~y-~d~~~-  442 (499)
                      .............  ......+.      ..       ....+.+.|++.|... .-||+|+|.+.++..... ..... 
T Consensus       350 ~~~~~~~~~~~~~--~~~~~~~~------~~-------v~sDv~~~G~l~k~~~~~~wk~ry~~l~~~~l~~~~~~~~~~  414 (478)
T PTZ00267        350 EILRQLQESGERA--PPPSSIRY------GV-------VTSDVTHGGYLYKYSSDMRWKKRYFYIGNGQLRISLSENPEN  414 (478)
T ss_pred             HHHHHHhhccccC--CCCcceec------ce-------ecCCcccceEEeccCCCcchhhheEEecCCceEEEecccccc
Confidence            0000000000000  00000000      00       0123467888888776 349999999987555543 32211 


Q ss_pred             -CeeeeeeeccCCCCceEE----EEcCCCcEEEEc--CCceEEEEcCCccHHHHHHHHHHhc
Q 010859          443 -LVVKGNIIWSDNSNDLSI----QVSSPSHFKIVT--PKKVLSFEDAKQRASQWKKAIEALQ  497 (499)
Q Consensus       443 -~~~kg~i~~~~~~~~~~~----~~~~~~~f~i~~--p~r~y~~~d~~~~~~~W~~~i~~~~  497 (499)
                       ......+.+.....+..+    ..+.++.|.|.|  -.|+|+..+.+.++++|+++|++++
T Consensus       415 ~~~~~~~~~l~~~~~v~pv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~W~~~~~~~~  476 (478)
T PTZ00267        415 DGVAPKSVNLETVNDVFPVPEVYSQKHPNQLVLWFNNGQKIIAYAKTAEDRDQWISKFQRAC  476 (478)
T ss_pred             CCCCCccccHHHhcccccccHHhcCCCCceEEEEecCCcEEEEecCChHHHHHHHHHHHHHh
Confidence             000011122111111222    335688999976  3477777788899999999999976

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.5e-50  Score=416.39  Aligned_cols=279  Identities=38%  Similarity=0.601  Sum_probs=235.4

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++++.||+|+||+||+|++..+++.||+|++.+...........+..|+.+++.++||||+++++.|++...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            69999999999999999999999999999999987655555566778889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc--c
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--L  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~  213 (499)
                      ||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.......  .
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~  161 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence            99999999999888889999999999999999999999999999999999999999999999999986432110000  0


Q ss_pred             C-----------------------------------CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHH
Q 010859          214 P-----------------------------------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM  258 (499)
Q Consensus       214 ~-----------------------------------~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyel  258 (499)
                      .                                   .........+.+||+.|+|||++.+..++.++|||||||++|+|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el  241 (382)
T cd05625         162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  241 (382)
T ss_pred             cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence            0                                   00001112356899999999999999999999999999999999


Q ss_pred             hcCCCCCCCCCHHHHHHHHHhc--CCCCC--CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          259 LSGTSPFKDTSEWLIFQRIIAR--DIRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       259 ltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      ++|++||.+.+......++...  ...+|  ..+++++.+||.+|+ .+|.+|++.  .+.+++++||||++++|.....
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~~~~~~  318 (382)
T cd05625         242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK--NGADEIKAHPFFKTIDFSSDLR  318 (382)
T ss_pred             HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC--CCHHHHhcCCCcCCcChHHHHh
Confidence            9999999998887777776653  33444  357999999999986 599999984  2459999999999999987544


Q ss_pred             CCC
Q 010859          335 QTP  337 (499)
Q Consensus       335 ~~~  337 (499)
                      +.+
T Consensus       319 ~~~  321 (382)
T cd05625         319 QQS  321 (382)
T ss_pred             cCC
Confidence            433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.7e-50  Score=404.53  Aligned_cols=264  Identities=36%  Similarity=0.628  Sum_probs=236.6

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      ++||+|+||.||+|++..+++.||+|++.+..............|..++..+ +||||++++++|.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999876554444555566788888765 799999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~----------~  150 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN----------G  150 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998753221          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....++.+......+|..++.++.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~  230 (321)
T cd05591         151 VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF  230 (321)
T ss_pred             ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            22335689999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCC--CCHHHHhcCCCCCCCCcccccC
Q 010859          300 LDVDPSGRPGAGP--GGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       300 L~~dP~~R~~~~~--~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      |+.||.+|+++.+  .+.+++++||||.+++|..+..
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~  267 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ  267 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence            9999999997654  2679999999999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-53  Score=418.35  Aligned_cols=283  Identities=36%  Similarity=0.659  Sum_probs=264.4

Q ss_pred             CCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           49 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      .....+.+++.+..||-|+||.|-++........+|+|+++|.++......+.+..|+.+|..+..|+||++|-+|.++.
T Consensus       414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            34566789999999999999999999988777779999999999999999999999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ++|++||-|-||+|+..+...|.|++..+++|++.+++|++|||++|||.|||||||.+++.+|.+||.|||+|+.+...
T Consensus       494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988654


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~  286 (499)
                      .           ...+|||||.|+|||++.++..+.++|.||||+++|||++|.+||.+.++..+++.|+++  ...||.
T Consensus       574 ~-----------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr  642 (732)
T KOG0614|consen  574 R-----------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR  642 (732)
T ss_pred             C-----------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc
Confidence            3           455899999999999999999999999999999999999999999999999999999986  467999


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC-CCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKLAS  342 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~-~p~~~~  342 (499)
                      .++..+.+||+++...+|.+|++...+++.+|++|.||.++||+.+...+ +|++.+
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~  699 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIP  699 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccc
Confidence            99999999999999999999999888999999999999999999997654 444443

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.5e-50  Score=413.52  Aligned_cols=277  Identities=37%  Similarity=0.611  Sum_probs=233.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.|++...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997765444455666788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc--
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--  212 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--  212 (499)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|..+.......  
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999986432110000  


Q ss_pred             -----------cCC--------------------CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcC
Q 010859          213 -----------LPN--------------------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG  261 (499)
Q Consensus       213 -----------~~~--------------------~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG  261 (499)
                                 ...                    .........++||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                       000                    0000112356899999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhc--CCCCC--CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          262 TSPFKDTSEWLIFQRIIAR--DIRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       262 ~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      +.||.+.+.......+...  .+.+|  ..+++++.+||.+|+ .+|.+|++..  +++++++||||++++|..+..
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~--t~~ell~h~~~~~~~~~~~~~  314 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN--GADEIKAHPFFKGIDFASLIR  314 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC--CHHHHhCCCCcCCCCHHHHhh
Confidence            9999998887776666543  23333  358999999999977 5999999431  349999999999999988753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.7e-50  Score=406.81  Aligned_cols=264  Identities=36%  Similarity=0.700  Sum_probs=233.2

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      ++||+|+||.||+|++..+++.||+|++.+...........+..|..+++.+ +||||++++++|.+...+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4799999999999999999999999999877655555566677899999888 799999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----------~  150 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----------G  150 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC----------C
Confidence            999999988889999999999999999999999999999999999999999999999999998742111          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC---------CHHHHHHHHHhcCCCCCCCCCh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---------SEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                      ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...         ......+.+......+|..++.
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~  230 (329)
T cd05588         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            2234578999999999999999999999999999999999999999631         2234566777788889999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~-~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      ++.+||.+||+.||.+|+++.. .+++++++||||..++|..+..
T Consensus       231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~  275 (329)
T cd05588         231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ  275 (329)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence            9999999999999999999743 4679999999999999987754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.6e-51  Score=388.54  Aligned_cols=258  Identities=27%  Similarity=0.390  Sum_probs=225.9

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCe
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFS  129 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~--~~~~  129 (499)
                      .++++|+.+..|++|+||.||+|+++.|++.||+|.++.+. .++...-.-.+|+.+|.+++|||||.+-.+..  +-+.
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            35678999999999999999999999999999999987654 34444445667999999999999999988775  3456


Q ss_pred             EEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|+|||||+. ||..++...+ +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+.+.
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999999987 9999998875 8999999999999999999999999999999999999999999999999999987654


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  280 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-------  280 (499)
                      .          ...+..+-|.+|+|||+|.+.. |+.++|+||+|||+.||+++++.|.+.++..++.+|...       
T Consensus       231 ~----------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~  300 (419)
T KOG0663|consen  231 L----------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA  300 (419)
T ss_pred             c----------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence            2          2344678999999999988765 999999999999999999999999999999999988761       


Q ss_pred             ------------CCCCC------------CC-CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 ------------DIRFP------------NY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ------------~~~~p------------~~-~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                  ...||            .. ++....+|+..+|..||.+|.||     ++.++|+||..
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA-----~~~L~h~~F~e  366 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA-----EDGLKHEYFRE  366 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH-----HHhhccccccc
Confidence                        12222            11 56889999999999999999999     78999999985

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-50  Score=411.46  Aligned_cols=278  Identities=44%  Similarity=0.753  Sum_probs=241.1

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||+||+|++..+|+.||+|++.+...........+..|+.++..++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998765544455667788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||+++++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.........
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999866543200000


Q ss_pred             -------------------CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHH
Q 010859          215 -------------------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ  275 (499)
Q Consensus       215 -------------------~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~  275 (499)
                                         ...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                               0000122345689999999999999999999999999999999999999999998888888


Q ss_pred             HHHh--cCCCCCCC--CChHHHHHHHHhhccCCCCCCC-CCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          276 RIIA--RDIRFPNY--FSDAARDLIDRLLDVDPSGRPG-AGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       276 ~i~~--~~~~~p~~--~~~~~~~Li~~lL~~dP~~R~~-~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                      ++..  ....+|..  +++++.+||.+||. ||.+|++ +     +++++||||++++|+......+|
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~-----~~ll~hp~~~~~~~~~~~~~~~~  302 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSF-----EEIKSHPFFKGIDWENLRETKPP  302 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCH-----HHHhcCCCcCCCCHHHHhhCCCC
Confidence            8877  55556654  59999999999997 9999998 7     89999999999999987744433

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-51  Score=400.82  Aligned_cols=259  Identities=33%  Similarity=0.582  Sum_probs=221.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--eEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SLY  131 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~--~l~  131 (499)
                      ..++..++.||+|+||.||++.+.++|..+|||.+......   ....+.+|+.+|++++|||||++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            45789999999999999999999999999999998766211   2566888999999999999999999754444  699


Q ss_pred             EEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-CCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~  209 (499)
                      +.|||+++|+|.+++.+.+ +|+|..++.|..||+.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999987 8999999999999999999999999999999999999999 7999999999998765311


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHhcC--CCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD--IRFP  285 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~-~~~~~~~~~i~~~~--~~~p  285 (499)
                             ........+.||+.|||||++... ....++|||||||++.||+||.+||.. .......-.+....  +.+|
T Consensus       173 -------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip  245 (313)
T KOG0198|consen  173 -------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIP  245 (313)
T ss_pred             -------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCC
Confidence                   112334468999999999999853 344699999999999999999999987 34334334444333  6789


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ..+|.++++||.+||..||++||||     +++++|||.+..
T Consensus       246 ~~ls~~a~~Fl~~C~~~~p~~Rpta-----~eLL~hpf~~~~  282 (313)
T KOG0198|consen  246 DSLSDEAKDFLRKCFKRDPEKRPTA-----EELLEHPFLKQN  282 (313)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCH-----HHHhhChhhhcc
Confidence            9999999999999999999999999     899999999753

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-51  Score=399.55  Aligned_cols=257  Identities=32%  Similarity=0.536  Sum_probs=241.9

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ....+|++.+.||+|.||.|-+|++...|+.||||.++|..+..++....+.+|+++|..|+||||+++|.+|+....+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            34578999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +||||..+|+|++|+.+.+.|+|.+++.++.||+.|+.|||+++++|||||.+|||++.++++||+|||++-.+..    
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~----  205 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD----  205 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc----
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999876543    


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                             .....+|||+|.|.+||+++|.+| ++.+|-||||++||-|+.|..||.+.+...+..+|..+.|.-|.. |.
T Consensus       206 -------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PS  277 (668)
T KOG0611|consen  206 -------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PS  277 (668)
T ss_pred             -------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-Cc
Confidence                   334568999999999999999998 678999999999999999999999999999999999999887775 77


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ++.-||+.||-.||++|.|+     +++-.|-|..
T Consensus       278 dA~gLIRwmLmVNP~RRATi-----eDiAsHWWvN  307 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPERRATI-----EDIASHWWVN  307 (668)
T ss_pred             hHHHHHHHHHhcCcccchhH-----HHHhhhheee
Confidence            89999999999999999988     8899999973

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-50  Score=404.50  Aligned_cols=266  Identities=39%  Similarity=0.674  Sum_probs=236.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+..|+.+++.++||||+++++++++...+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765544455566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....       
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-------  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-------  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence            9999999999999888899999999999999999999999999999999999999999999999999875432       


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCCCC------
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN------  286 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------  286 (499)
                            .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+....  +..|.      
T Consensus       154 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  227 (333)
T cd05600         154 ------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF  227 (333)
T ss_pred             ------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcccc
Confidence                  2235689999999999999999999999999999999999999999988877777665432  22222      


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                      .++.++.+||.+||..+|.+||++     +++++||||.+++|..+....+|
T Consensus       228 ~~s~~~~~li~~~l~~~~~rr~s~-----~~ll~h~~~~~~~~~~~~~~~~~  274 (333)
T cd05600         228 NLSDEAWDLITKLINDPSRRFGSL-----EDIKNHPFFKEVDWNELRELKPP  274 (333)
T ss_pred             ccCHHHHHHHHHHhhChhhhcCCH-----HHHHhCcccCCCCHHHHhhCCCC
Confidence            458999999999999999999988     89999999999999988744443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-49  Score=402.10  Aligned_cols=264  Identities=38%  Similarity=0.676  Sum_probs=233.7

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||+||+|++..+|+.||+|++.+...........+..|.. +++.++||||+++++.+.+...+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999998764443333334444544 56789999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~----------~  150 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----------S  150 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC----------C
Confidence            999999998888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......++..++.++.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (323)
T cd05575         151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL  230 (323)
T ss_pred             CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            22335689999999999999999999999999999999999999999999888888998888888889999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |+.||.+||++.+ .+.++++||||..++|..+...
T Consensus       231 l~~~p~~R~~~~~-~~~~il~~~~~~~~~~~~~~~~  265 (323)
T cd05575         231 LQKDRTKRLGAKD-DFLEIKNHVFFSSINWDDLVNK  265 (323)
T ss_pred             hhcCHHhCCCCCC-CHHHHHcCCCcCCCCHHHHhhc
Confidence            9999999999864 6789999999999999887543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-51  Score=388.98  Aligned_cols=283  Identities=35%  Similarity=0.689  Sum_probs=257.8

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      ..+.++||.++++||+|+|+.|.+++.+.|.+.||+|+++|+.+.......-++.|..+.... +||++|.++..|+.+.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            456789999999999999999999999999999999999999888887888888899888776 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+++|.||++||+|--++.++.+++|+.+++|.++|+.||.|||++||+.||||.+|+|++..||+||+|+|.++.--  
T Consensus       325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--  402 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--  402 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999998522  


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCC--------CCCHHHHHHHHHhc
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK--------DTSEWLIFQRIIAR  280 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~--------~~~~~~~~~~i~~~  280 (499)
                              ......++|||||.|.|||++.+..|+.++|+|+||++++||+.|+.||.        ..++.-++|-|+..
T Consensus       403 --------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek  474 (593)
T KOG0695|consen  403 --------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK  474 (593)
T ss_pred             --------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence                    22456679999999999999999999999999999999999999999996        23445578999999


Q ss_pred             CCCCCCCCChHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 010859          281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  342 (499)
Q Consensus       281 ~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~-~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~  342 (499)
                      ..++|..+|-.+..+++..|.+||.+|+++.. .++++++.|+||+.|||+.+..+ ..|++.|
T Consensus       475 qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p  538 (593)
T KOG0695|consen  475 QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQP  538 (593)
T ss_pred             cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCC
Confidence            99999999999999999999999999999875 68999999999999999998653 3444433

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-49  Score=403.64  Aligned_cols=264  Identities=36%  Similarity=0.707  Sum_probs=231.6

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999877555555556677788887766 899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....          .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~----------~  150 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----------G  150 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC---------CCHHHHHHHHHhcCCCCCCCCCh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---------TSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                      .....++||+.|+|||++.+..++.++|+|||||++|+|++|+.||..         .......+.+......+|..++.
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~  230 (329)
T cd05618         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCH
Confidence            223357899999999999999999999999999999999999999952         12334556677788889999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~-~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      ++.+||.+||+.||.+||++.. .+++++++||||++++|+.+..
T Consensus       231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~  275 (329)
T cd05618         231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ  275 (329)
T ss_pred             HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHc
Confidence            9999999999999999999753 4679999999999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.3e-50  Score=404.10  Aligned_cols=269  Identities=36%  Similarity=0.658  Sum_probs=235.4

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+..|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765544455667788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+++|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+....    
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~----  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK----  156 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC----
Confidence            999999999999876 679999999999999999999999999999999999999999999999999998654321    


Q ss_pred             CCCCCCCCccccccCccCCCccccC------CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFP  285 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~------~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p  285 (499)
                           .......+||+.|+|||++.      ...++.++|||||||++|+|++|+.||...+....+.++....  ..+|
T Consensus       157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  231 (330)
T cd05601         157 -----MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP  231 (330)
T ss_pred             -----ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC
Confidence                 11122457999999999986      4567889999999999999999999999988877777776532  3444


Q ss_pred             C--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          286 N--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       286 ~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                      .  .++.++.+||.+||+ +|.+||++     ++++.||||..++|..+....+|
T Consensus       232 ~~~~~~~~~~~li~~ll~-~p~~R~t~-----~~l~~h~~~~~~~~~~~~~~~~~  280 (330)
T cd05601         232 EDPKVSSDFLDLIQSLLC-GQKERLGY-----EGLCCHPFFSKIDWNNIRNSLPP  280 (330)
T ss_pred             CCCCCCHHHHHHHHHHcc-ChhhCCCH-----HHHhCCCCcCCCCHHHHhhCCCC
Confidence            4  579999999999998 99999998     88999999999999988765544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-49  Score=400.44  Aligned_cols=260  Identities=36%  Similarity=0.675  Sum_probs=230.5

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||.||+|+++.+|+.||+|++.+..............|..++.. ++||||++++++|.+...+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999999999999999987644333344455667777765 4899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....          ..
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~----------~~  150 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----------GD  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc----------CC
Confidence            99999998888899999999999999999999999999999999999999999999999999864221          11


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....+.+......+|..++.++++||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05620         151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL  230 (316)
T ss_pred             CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            22345789999999999999999999999999999999999999999999888888888888888999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      |+.||.+|+++.    +++++||||++++|..+..
T Consensus       231 l~~dP~~R~~~~----~~~~~h~~f~~~~~~~~~~  261 (316)
T cd05620         231 FERDPTRRLGVV----GNIRGHPFFKTINWTALEK  261 (316)
T ss_pred             ccCCHHHcCCCh----HHHHcCCCcCCCCHHHHHh
Confidence            999999999872    5799999999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.7e-50  Score=401.51  Aligned_cols=261  Identities=38%  Similarity=0.717  Sum_probs=231.2

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||.||+|++..+++.||+|++.+..............|..++.. .+||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999987654444444445556666654 4899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~----------~  150 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----------E  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998754221          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..++.++.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL  230 (316)
T ss_pred             CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            22335689999999999999999999999999999999999999999999888888888888888999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |+.||.+||++.    .+++.||||..++|..+...
T Consensus       231 l~~~P~~R~~~~----~~l~~h~~~~~~~~~~~~~~  262 (316)
T cd05592         231 FERDPTKRLGVD----GDIRQHPFFRGIDWERLEKR  262 (316)
T ss_pred             ccCCHHHcCCCh----HHHHcCcccCCCCHHHHHhC
Confidence            999999999872    57999999999999887554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-50  Score=373.87  Aligned_cols=255  Identities=30%  Similarity=0.450  Sum_probs=222.0

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      .+|...+.||+|.||.||+|++..||+.||||.+...... +.......+|+..|+.++|+||+.+.++|.....+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            5788999999999999999999999999999999876333 333445667999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||++. +|...|+.. -.|+...++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.+..    
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~----  155 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN----  155 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC----
Confidence            99976 999988765 458999999999999999999999999999999999999999999999999999876543    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  281 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----------  281 (499)
                            ......+-|.+|+|||++.|.. |+..+||||+|||+.||+.|.+-|.|.++.+++..|...-           
T Consensus       156 ------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  156 ------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             ------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence                  1122238899999999987754 9999999999999999999999999999999988887510           


Q ss_pred             --------CC-CC--------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          282 --------IR-FP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       282 --------~~-~p--------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                              +. +|        ...++++.||+.+||..||.+|+++     .++++|+||+.
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita-----~qaL~~~yf~~  286 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITA-----SQALKHPYFKS  286 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccH-----HHHhcchhhhc
Confidence                    00 11        1246788999999999999999999     88999999985

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-49  Score=399.52  Aligned_cols=264  Identities=38%  Similarity=0.682  Sum_probs=237.6

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||+||+|.+..+++.||+|++.+..............|..+++.+ +||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876554444555666788888877 699999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----------~  150 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG----------G  150 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC----------C
Confidence            999999998888999999999999999999999999999999999999999999999999998642211          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+......+|..++.++.+||++|
T Consensus       151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (318)
T cd05570         151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF  230 (318)
T ss_pred             CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHH
Confidence            22235689999999999999999999999999999999999999999999888888898888899999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      |+.||.+||++.+....+++.||||+.++|.....
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~  265 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLER  265 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99999999999777789999999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-49  Score=401.00  Aligned_cols=266  Identities=36%  Similarity=0.702  Sum_probs=234.4

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|..++.++ +||+|+++++++++...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999887655555566677888888887 699999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----------~  150 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP----------G  150 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998742211          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC-------CCHHHHHHHHHhcCCCCCCCCChHH
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-------TSEWLIFQRIIARDIRFPNYFSDAA  292 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~~~~~  292 (499)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..       .......+.+......+|..++..+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  230 (327)
T cd05617         151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKA  230 (327)
T ss_pred             CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence            223457899999999999999999999999999999999999999953       2234456677777788999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQT  336 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~-~~~~~l~~Hpff~~i~~~~~~~~~  336 (499)
                      .++|.+||+.||.+|+++.. .+++++++||||++++|+.+....
T Consensus       231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~  275 (327)
T cd05617         231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQ  275 (327)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCC
Confidence            99999999999999999754 578999999999999999876543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2e-49  Score=400.67  Aligned_cols=264  Identities=35%  Similarity=0.649  Sum_probs=233.8

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||+||+|++..+|+.||+|++.+...........+..|.. +++.++||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999998764433333444445554 57789999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....          .
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~----------~  150 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ----------S  150 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC----------C
Confidence            999999988889999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....++.+......++...+..+.++|.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~l  230 (325)
T cd05604         151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEEL  230 (325)
T ss_pred             CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHH
Confidence            22335689999999999999999999999999999999999999999999888888988888888888999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |+.||.+||++.+ .+.++++||||.+++|..+...
T Consensus       231 l~~~p~~R~~~~~-~~~~i~~h~~f~~~~~~~~~~~  265 (325)
T cd05604         231 LEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQK  265 (325)
T ss_pred             hccCHHhcCCCCC-CHHHHhcCCCcCCCCHHHHHhC
Confidence            9999999999864 5789999999999999887654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-49  Score=398.95  Aligned_cols=266  Identities=40%  Similarity=0.736  Sum_probs=236.3

Q ss_pred             eeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccch-hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           60 GKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      ++.||+|+||.||+|++.   .+++.||+|++.+..... ......+..|+.+|+.++||||+++++.|.++..+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999874   578999999998654322 2234456779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      |++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....       
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------  153 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-------  153 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-------
Confidence            9999999999998888999999999999999999999999999999999999999999999999998743221       


Q ss_pred             CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL  295 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~L  295 (499)
                         .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+|
T Consensus       154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (323)
T cd05584         154 ---GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDL  230 (323)
T ss_pred             ---CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence               11223467999999999999988999999999999999999999999999988888999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          296 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       296 i~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |.+||+.||++||++.....++++.||||...+|..+...
T Consensus       231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~  270 (323)
T cd05584         231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLAR  270 (323)
T ss_pred             HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcC
Confidence            9999999999999776667799999999999999887543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.8e-49  Score=399.65  Aligned_cols=270  Identities=38%  Similarity=0.734  Sum_probs=233.7

Q ss_pred             CeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccc-hhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l  130 (499)
                      +|++++.||+|+||.||+|++.   .+++.||+|++.+.... .......+..|..+++.+ +||+|++++++|.+...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999874   57899999999765432 223345567789999999 589999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~-  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999987543221 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCC----CHHHHHHHHHhcCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIARDIRFP  285 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~----~~~~~~~~i~~~~~~~p  285 (499)
                              ......++||+.|+|||++.+.. ++.++|||||||++|+|++|..||...    ........+......+|
T Consensus       160 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd05614         160 --------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP  231 (332)
T ss_pred             --------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence                    12233568999999999998754 788999999999999999999999643    33445566777778888


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      ..+++.+.+||.+||+.||++||++...+.+++++||||++.+|..+..
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  280 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALAL  280 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            8999999999999999999999988766779999999999999987754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.3e-49  Score=397.44  Aligned_cols=263  Identities=38%  Similarity=0.678  Sum_probs=232.8

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHH-HHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      ++||+|+||.||+|++..+|+.||+|++.+...........+..|. .+++.++||||+++++.|.+...+|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876544433334444454 467889999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....          .
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----------~  150 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----------E  150 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......+|...+.++.++|.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (321)
T cd05603         151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL  230 (321)
T ss_pred             CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            22335689999999999999899999999999999999999999999999888888898888889999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      |+.||.+|+++.. .+.++++||||..++|..+..
T Consensus       231 l~~~p~~R~~~~~-~~~~~~~~~~~~~~~~~~~~~  264 (321)
T cd05603         231 LHKDQRRRLGAKA-DFLEIKNHVFFSPINWDDLYH  264 (321)
T ss_pred             ccCCHhhcCCCCC-CHHHHhCCCCcCCCCHHHHhc
Confidence            9999999998753 467999999999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=405.68  Aligned_cols=258  Identities=40%  Similarity=0.696  Sum_probs=238.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~  131 (499)
                      ....|++.+.||+|.||.||+|+++.||+.||+|++.+...........+.+|+.+|+.+. |||||.++++|++...+|
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3467999999999999999999999999999999999987776666788999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC----CCEEEEecCCccccCC
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQD  207 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~----~~vkL~DFG~a~~~~~  207 (499)
                      +|||+|.||+|++.+.+. .++|..+..++.|++.|+.|||+.||+||||||||+|+...    +.+|++|||+|.....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999999887 49999999999999999999999999999999999999654    4799999999987654


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC-
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-  286 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~-  286 (499)
                                 .......+||+.|+|||++...+|+..+||||+||++|.|++|.+||.+.++...+.+|..+++.|+. 
T Consensus       192 -----------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~  260 (382)
T KOG0032|consen  192 -----------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSE  260 (382)
T ss_pred             -----------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCC
Confidence                       23456789999999999999999999999999999999999999999999999999999999988764 


Q ss_pred             ---CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          287 ---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       287 ---~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                         .++..+++||++||..||.+|+++     +++++|||+++.
T Consensus       261 ~w~~is~~akd~i~~ll~~dp~~R~ta-----~~~L~HpWi~~~  299 (382)
T KOG0032|consen  261 PWDDISESAKDFIRKLLEFDPRKRLTA-----AQALQHPWIKSI  299 (382)
T ss_pred             CccccCHHHHHHHHHhcccCcccCCCH-----HHHhcCccccCC
Confidence               479999999999999999999999     889999998764

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-49  Score=400.30  Aligned_cols=264  Identities=36%  Similarity=0.674  Sum_probs=232.9

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHH-HHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||+||+|++..+++.||+|++.+...........+..|. .+++.++||||+++++++.+...+|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999999999999999999875443333333333343 457889999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~----------~  150 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH----------N  150 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC----------C
Confidence            999999998888999999999999999999999999999999999999999999999999998753221          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      .....++||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..+......++..++..+.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (325)
T cd05602         151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL  230 (325)
T ss_pred             CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHH
Confidence            22345689999999999999999999999999999999999999999999888888888888888888999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |+.||.+|+++.+ .+.++++|+||..++|+.+...
T Consensus       231 l~~~p~~R~~~~~-~~~~i~~~~~~~~~~~~~~~~~  265 (325)
T cd05602         231 LQKDRTKRLGAKD-DFMEIKNHIFFSPINWDDLINK  265 (325)
T ss_pred             cccCHHHCCCCCC-CHHHHhcCcccCCCCHHHHHhC
Confidence            9999999999865 5779999999999999987643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-50  Score=408.49  Aligned_cols=287  Identities=37%  Similarity=0.614  Sum_probs=249.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      +....-|..++.||-|+||+|.+++..+|...||+|.++|..+...+....++.|+.||...+.+-||+||..|+|..++
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            44556799999999999999999999999999999999999888888999999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc--
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS--  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~--  208 (499)
                      |+||+|++||++-.++.+.|.|.|+.+++|++++..|+++.|..|+|||||||+|||||.+|||||+|||++.-+.-.  
T Consensus       705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998644211  


Q ss_pred             -cccc------c----C-CCC------------------CCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHH
Q 010859          209 -RITV------L----P-NAA------------------SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM  258 (499)
Q Consensus       209 -~~~~------~----~-~~~------------------~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyel  258 (499)
                       .++-      .    + +.+                  ....+...+||+.|+|||++....++..+|+||.|||||+|
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence             1100      0    0 000                  01223457999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCCHHHHHHHHHhc----CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          259 LSGTSPFKDTSEWLIFQRIIAR----DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       259 ltG~~Pf~~~~~~~~~~~i~~~----~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      +.|++||.+.+..++..+++.-    .+.....++.++.+||.++. -+++.|++-.  +.++++.||||++|||.++++
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkn--g~d~vKaHpfFkgIDfsslRk  941 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKN--GADQVKAHPFFKGIDFSSLRK  941 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhccc--chhhhhcCccccccchHhhhh
Confidence            9999999998887776666542    23334579999999999976 5789999873  557899999999999999998


Q ss_pred             CCCCCC
Q 010859          335 QTPPKL  340 (499)
Q Consensus       335 ~~~p~~  340 (499)
                      +..|.+
T Consensus       942 q~ApYI  947 (1034)
T KOG0608|consen  942 QRAPYI  947 (1034)
T ss_pred             ccCCcC
Confidence            877643

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.1e-49  Score=397.00  Aligned_cols=261  Identities=36%  Similarity=0.657  Sum_probs=230.3

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||+||+|++..+++.||+|++.+..............|..++.. ++||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999987644333334445567777765 5899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----------~  150 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----------D  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.....+.+......+|..++.++++||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05619         151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL  230 (316)
T ss_pred             CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            22335689999999999999999999999999999999999999999998888888888777888889999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |+.||.+||++.    ++++.||||..++|..+...
T Consensus       231 l~~~P~~R~~~~----~~l~~h~~~~~~~~~~~~~~  262 (316)
T cd05619         231 FVREPERRLGVK----GDIRQHPFFREIDWSALEER  262 (316)
T ss_pred             hccCHhhcCCCh----HHHHcCcccCCCCHHHHHhC
Confidence            999999999983    47999999999999877543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-50  Score=385.93  Aligned_cols=258  Identities=32%  Similarity=0.485  Sum_probs=221.7

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-----CCe
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-----TFS  129 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-----~~~  129 (499)
                      ..|..++.||+|+||.|+.|.++.||+.||||.+...+ ..........+|+.+|+.++|+||+.+++++..     -..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            34556899999999999999999999999999986543 334445567789999999999999999999975     356


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+|+|+|+ -+|...++.+..|+++.++++++||+.||.|+|+.+|+||||||.|+|++.++.+||+|||+|+..... 
T Consensus       101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-  178 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-  178 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence            999999995 599999998878999999999999999999999999999999999999999999999999999976542 


Q ss_pred             ccccCCCCCCCCccccccCccCCCcccc-CCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--------
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  280 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l-~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--------  280 (499)
                             ......+.++.|.+|+|||++ ....|+.+.||||+|||+.||++|++.|.|.+...+++.|+.-        
T Consensus       179 -------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  179 -------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             -------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence                   123344678999999999996 4567999999999999999999999999999887777766541        


Q ss_pred             ---------------CCCCC--------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          281 ---------------DIRFP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       281 ---------------~~~~p--------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                     ....|        ...++.+.||+++||..||.+|+|+     ++++.||||...
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita-----~eAL~hPYl~~~  316 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA-----EEALAHPYLAPY  316 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH-----HHHhcChhhhhh
Confidence                           11111        2568999999999999999999999     899999999864

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-49  Score=390.62  Aligned_cols=262  Identities=32%  Similarity=0.598  Sum_probs=227.6

Q ss_pred             eeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCh
Q 010859           63 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  142 (499)
Q Consensus        63 LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L  142 (499)
                      ||+|+||+||+|.+..+|+.||+|++.+...........+..|+.+++.++||||++++++|.....+|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999999776544444445567799999999999999999999999999999999999999


Q ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCC
Q 010859          143 FDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  218 (499)
Q Consensus       143 ~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~  218 (499)
                      ..++..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+....         
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---------  151 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---------  151 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence            887743    3569999999999999999999999999999999999999999999999999997654321         


Q ss_pred             CCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH----HHHHHHHHhcCCCCCCCCChHHHH
Q 010859          219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRFPNYFSDAARD  294 (499)
Q Consensus       219 ~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~  294 (499)
                       .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.....    ......+......+|..++.++.+
T Consensus       152 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (280)
T cd05608         152 -SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKS  230 (280)
T ss_pred             -ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHH
Confidence             122346799999999999999999999999999999999999999986543    233445555566778889999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      |+.+||+.||++||+..+.+.+++++||||++++|+.+..
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  270 (280)
T cd05608         231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA  270 (280)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhh
Confidence            9999999999999988777889999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-49  Score=398.86  Aligned_cols=265  Identities=37%  Similarity=0.728  Sum_probs=236.4

Q ss_pred             eeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           60 GKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      ++.||+|+||.||++++.   .+|+.||+|++.+..... ........|+.++++++||||++++++|.+...+|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            367999999999999873   678999999997654322 2233456789999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCC
Q 010859          137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  216 (499)
Q Consensus       137 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~  216 (499)
                      +++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....        
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--------  151 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--------  151 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--------
Confidence            999999999988888999999999999999999999999999999999999999999999999998754321        


Q ss_pred             CCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 010859          217 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLI  296 (499)
Q Consensus       217 ~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li  296 (499)
                        .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||
T Consensus       152 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  229 (318)
T cd05582         152 --EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  229 (318)
T ss_pred             --CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              122335689999999999999889999999999999999999999999999888888888888899999999999999


Q ss_pred             HHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          297 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       297 ~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ++||+.||.+||++.+...++++.||||..++|..+...
T Consensus       230 ~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~  268 (318)
T cd05582         230 RALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRR  268 (318)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhc
Confidence            999999999999998777899999999999999887543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.9e-49  Score=405.02  Aligned_cols=266  Identities=38%  Similarity=0.632  Sum_probs=232.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|+.+++.++||||+++++++.+...+
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45678999999999999999999999999999999999865444444555677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-  196 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-
Confidence            9999999999999988764 68999999999999999999999999999999999999999999999999997653221 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCC----CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSS----PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRF  284 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~----~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~  284 (499)
                              .......+||+.|+|||++.+.    .++.++|||||||++|+|++|++||.+.+....+.++....  +.+
T Consensus       197 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  268 (370)
T cd05596         197 --------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF  268 (370)
T ss_pred             --------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC
Confidence                    1122356899999999998653    37889999999999999999999999998888888887643  556


Q ss_pred             CC--CCChHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          285 PN--YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       285 p~--~~~~~~~~Li~~lL~~dP~~--R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                      |.  .++.++++||.+||+.+|.+  |+++     +++++||||++.+|..
T Consensus       269 ~~~~~~s~~~~~li~~~L~~~p~r~~R~s~-----~ell~h~~~~~~~~~~  314 (370)
T cd05596         269 PDDIEISKQAKDLICAFLTDREVRLGRNGV-----DEIKSHPFFKNDQWTF  314 (370)
T ss_pred             CCcCCCCHHHHHHHHHHccChhhccCCCCH-----HHHhcCcccCCCChhh
Confidence            65  47999999999999999987  8887     8999999999988864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-49  Score=421.52  Aligned_cols=264  Identities=28%  Similarity=0.455  Sum_probs=228.4

Q ss_pred             CCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           49 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      ......++|++.+.||+|+||+||+|++..+|+.||||++....... .....+.+|+.++..++|+||++++..+....
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            33445679999999999999999999999999999999998765433 34455777999999999999999988775332


Q ss_pred             --------eEEEEEeccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEE
Q 010859          129 --------SLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI  196 (499)
Q Consensus       129 --------~l~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL  196 (499)
                              .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence                    478999999999999988653    46899999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHH
Q 010859          197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR  276 (499)
Q Consensus       197 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~  276 (499)
                      +|||+++.+....        ......+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..
T Consensus       185 ~DFGls~~~~~~~--------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~  256 (496)
T PTZ00283        185 GDFGFSKMYAATV--------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK  256 (496)
T ss_pred             EecccCeeccccc--------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999998654321        11223467899999999999999999999999999999999999999999888888777


Q ss_pred             HHhcCC-CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          277 IIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       277 i~~~~~-~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +..... .+|..+++++.+||.+||+.||.+||++     .++++|||++.
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~-----~ell~~p~~~~  302 (496)
T PTZ00283        257 TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSS-----SKLLNMPICKL  302 (496)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-----HHHHhCHHHHH
Confidence            776544 4678899999999999999999999998     88999999875

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9e-49  Score=402.91  Aligned_cols=265  Identities=38%  Similarity=0.644  Sum_probs=228.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.|.++..+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34567999999999999999999999999999999999875544444556677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-  196 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-
Confidence            9999999999999998764 68999999999999999999999999999999999999999999999999998653221 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCC----CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRF  284 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~  284 (499)
                              .....+.+||+.|+|||++.+..    ++.++|+|||||++|+|++|++||.+.+....+.++...  .+.+
T Consensus       197 --------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  268 (370)
T cd05621         197 --------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF  268 (370)
T ss_pred             --------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC
Confidence                    11223668999999999987543    788999999999999999999999999888888888764  3556


Q ss_pred             CC--CCChHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          285 PN--YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       285 p~--~~~~~~~~Li~~lL~~dP~~--R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      |.  .++..+++||.+||+.++.+  |+++     +++++||||++.+|+
T Consensus       269 p~~~~~s~~~~~li~~~L~~~~~r~~R~~~-----~e~l~hp~~~~~~~~  313 (370)
T cd05621         269 PEDVEISKHAKNLICAFLTDREVRLGRNGV-----EEIKQHPFFKNDQWN  313 (370)
T ss_pred             CCcccCCHHHHHHHHHHccCchhccCCCCH-----HHHhcCcccCCCCcC
Confidence            65  46999999999999855443  6666     899999999986664

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-49  Score=398.14  Aligned_cols=262  Identities=38%  Similarity=0.649  Sum_probs=227.9

Q ss_pred             eeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC---CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           63 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        63 LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      ||+|+||+||+|++..+|+.||+|++.+..............|..++..+   +||||+++++.|.+...+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999775544443444444566666554   799999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~----------~  150 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD----------N  150 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC----------C
Confidence            999999998889999999999999999999999999999999999999999999999999998753221          1


Q ss_pred             CCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC-CCChHHHHHHH
Q 010859          220 DKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-YFSDAARDLID  297 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~~~~~~~Li~  297 (499)
                      ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....++.+......+|. .+++++.+||.
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  230 (330)
T cd05586         151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVK  230 (330)
T ss_pred             CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            223356899999999998754 4889999999999999999999999999888888888888888876 47999999999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          298 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       298 ~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      +||+.||.+||++.. +.+++++||||..++|+.+...
T Consensus       231 ~~L~~~P~~R~~~~~-~~~~ll~h~~~~~~~~~~~~~~  267 (330)
T cd05586         231 GLLNRNPQHRLGAHR-DAVELKEHPFFADIDWDLLSKK  267 (330)
T ss_pred             HHcCCCHHHCCCCCC-CHHHHhcCccccCCCHHHHHhC
Confidence            999999999997643 5689999999999999887543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-48  Score=394.98  Aligned_cols=270  Identities=40%  Similarity=0.685  Sum_probs=229.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||+||+|++..+++.||+|++.+...........+..|+.++..++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999998654444445566778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..+....    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG----  156 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC----
Confidence            99999999999976 4579999999999999999999999999999999999999999999999999987653321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCC-----CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN  286 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~  286 (499)
                           .......+||+.|+|||++..     ..++.++|||||||++|+|++|+.||.+.+..+.+..+....  +.+|.
T Consensus       157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  231 (331)
T cd05597         157 -----TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP  231 (331)
T ss_pred             -----CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence                 111223579999999999863     457889999999999999999999999988877777776533  33443


Q ss_pred             ---CCChHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          287 ---YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       287 ---~~~~~~~~Li~~lL~~dP~~--R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                         .++.++++||++||+.++.+  |+++     +++++||||.+++|..+....+|
T Consensus       232 ~~~~~~~~~~~li~~ll~~~~~r~~r~~~-----~~~l~hp~~~~~~~~~~~~~~~~  283 (331)
T cd05597         232 DVTDVSEEAKDLIRRLICSPETRLGRNGL-----QDFKDHPFFEGIDWDNIRNSTAP  283 (331)
T ss_pred             ccCCCCHHHHHHHHHHccCcccccCCCCH-----HHHhcCCCCCCCCHHHHhhCCCC
Confidence               47999999999999764433  5555     99999999999999988765544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-50  Score=399.24  Aligned_cols=260  Identities=31%  Similarity=0.523  Sum_probs=238.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ..=|.+.+.||+|-|++|-+|++.-||+.||||+++|..+... ....+..|+..|+.++|||||+||++......+|+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            3558999999999999999999999999999999999876544 445567799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-CCCEEEEecCCccccCCcccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +|+-++|+|++||.++ ..++|+.++.|++||+.|+.|||+..+|||||||||+.+-+ -|-|||+|||++-.+.+.   
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---  172 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---  172 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc---
Confidence            9999999999999876 45999999999999999999999999999999999988755 589999999998766543   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCC-CCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPAT-FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~-~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                              ....++||+..|-|||+|.|..|+ +++||||||||||.|++|++||...++.+.+-+|+.+.|..|..++.
T Consensus       173 --------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~  244 (864)
T KOG4717|consen  173 --------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSK  244 (864)
T ss_pred             --------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhH
Confidence                    355689999999999999988875 67899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      +++|||..||+.||.+|.+.     ++|..|+|++++|..
T Consensus       245 eCrdLI~sMLvRdPkkRAsl-----EeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  245 ECRDLIQSMLVRDPKKRASL-----EEIVSTSWLQAGDRG  279 (864)
T ss_pred             HHHHHHHHHHhcCchhhccH-----HHHhccccccCCCCC
Confidence            99999999999999999877     999999999998853

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-48  Score=395.57  Aligned_cols=273  Identities=38%  Similarity=0.658  Sum_probs=232.4

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..++|++|+++++++++...+|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999997754444445556778899999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||++||+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+....    
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG----  156 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC----
Confidence            99999999999987 4679999999999999999999999999999999999999999999999999997654321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCC-----CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN  286 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~  286 (499)
                           .......+||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||.+.+....+.++....  +.+|.
T Consensus       157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  231 (331)
T cd05624         157 -----TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS  231 (331)
T ss_pred             -----ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCC
Confidence                 111224579999999999875     457889999999999999999999999988888887777643  34444


Q ss_pred             ---CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCC
Q 010859          287 ---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK  339 (499)
Q Consensus       287 ---~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p~  339 (499)
                         .++.++++||.+||+.++ +|++.  .+++++++||||++++|+.+....+|.
T Consensus       232 ~~~~~~~~~~~li~~ll~~~~-~~~~~--~~~~~~~~h~~f~~~~~~~~~~~~~~~  284 (331)
T cd05624         232 HITDVSEEAKDLIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGIDWENIRNLEAPY  284 (331)
T ss_pred             ccccCCHHHHHHHHHHccCch-hhcCC--CCHHHHhcCCCcCCCCHHHHhhCCCCc
Confidence               368999999999999655 44432  245999999999999999887655443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-48  Score=394.38  Aligned_cols=271  Identities=37%  Similarity=0.654  Sum_probs=231.6

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+..|+.++..++|++|+++++.+++...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997654444445556778899999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+++|+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..+....    
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~----  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG----  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC----
Confidence            99999999999987 4679999999999999999999999999999999999999999999999999987543211    


Q ss_pred             CCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN  286 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~  286 (499)
                           .......+||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+....+.++....  ..+|.
T Consensus       157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  231 (332)
T cd05623         157 -----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA  231 (332)
T ss_pred             -----cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCC
Confidence                 11222457999999999986     3457889999999999999999999999998888888887643  33443


Q ss_pred             ---CCChHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCcccccCCCCCC
Q 010859          287 ---YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK  339 (499)
Q Consensus       287 ---~~~~~~~~Li~~lL~~dP~~--R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p~  339 (499)
                         .+++++++||.+||+.++.+  |+++     +++++||||.+++|+.+....+|.
T Consensus       232 ~~~~~s~~~~~li~~ll~~~~~r~~r~~~-----~~~~~h~~f~~~~~~~~~~~~~~~  284 (332)
T cd05623         232 QVTDVSEDAKDLIRRLICSREHRLGQNGI-----EDFKQHPFFTGIDWDNIRNCEAPY  284 (332)
T ss_pred             ccccCCHHHHHHHHHHccChhhhcCCCCH-----HHHhCCCCcCCCCHHHHhhCCCCc
Confidence               57999999999999875544  3444     999999999999999987655543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-48  Score=386.44  Aligned_cols=268  Identities=33%  Similarity=0.571  Sum_probs=232.9

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      .|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999987655444445556779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.......    
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence            99999999887654  459999999999999999999999999999999999999999999999999987643211    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHH----HHHHHhcCCCCCCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRIIARDIRFPNYFS  289 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~~  289 (499)
                             .....+|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+....    ...+......+|..++
T Consensus       157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd05605         157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS  229 (285)
T ss_pred             -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccC
Confidence                   12245799999999999988899999999999999999999999988765332    2334444556777899


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      ..+.+||.+||..||.+||+..+.+++++++||||...+|+.+..
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05605         230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA  274 (285)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence            999999999999999999977666779999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=403.23  Aligned_cols=252  Identities=32%  Similarity=0.527  Sum_probs=231.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ..|.....||+|+.|.||.|+...+++.||||.|+.....   ..+.+.+|+.+|+..+|+|||.+++.|...+.+++||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            4688889999999999999999999999999999887544   4466888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++||+|.+.+... .++|.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+....     
T Consensus       350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-----  423 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-----  423 (550)
T ss_pred             eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc-----
Confidence            999999999988875 59999999999999999999999999999999999999999999999999998775432     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCCCChH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA  291 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~  291 (499)
                           ....+.+|||.|||||++..+.|+.++||||||+++.||+-|++||-..++...+..|...   .+..|+.+|++
T Consensus       424 -----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~  498 (550)
T KOG0578|consen  424 -----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPE  498 (550)
T ss_pred             -----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHH
Confidence                 3566889999999999999999999999999999999999999999998888877777653   45678899999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ++|||.+||+.|+.+|++|     .+||.||||+
T Consensus       499 ~kdFL~~cL~~dv~~RasA-----~eLL~HpFl~  527 (550)
T KOG0578|consen  499 LKDFLDRCLVVDVEQRASA-----KELLEHPFLK  527 (550)
T ss_pred             HHHHHHHHhhcchhcCCCH-----HHHhcChhhh
Confidence            9999999999999999999     8899999995

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-48  Score=383.23  Aligned_cols=265  Identities=32%  Similarity=0.510  Sum_probs=231.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ....+|++..+||.|..++||+|+.+.+++.||||+++.+.....  ...+.+|...|+.++||||+++++.|..+..+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            346899999999999999999999999999999999987754433  677889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +||.||.+|++.++++..  ..|+|..+..++.++++||.|||++|-||||||+.||||+.+|.|||+|||.+..+....
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999999865  339999999999999999999999999999999999999999999999999987665432


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccC--CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--  285 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~--~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--  285 (499)
                            .....+..+++||+.|||||++.  ...|+.|+||||||++..||.+|..||....+..++-.-+.+.++.|  
T Consensus       181 ------~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  181 ------DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             ------ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence                  11112226889999999999963  45699999999999999999999999998887776655555555433  


Q ss_pred             --------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          286 --------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       286 --------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                              ..++..++.+|..||+.||.+||||     +++++|+||+...-
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptA-----skLlkh~FFk~~k~  301 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTA-----SKLLKHAFFKKAKS  301 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCH-----HHHhccHHHhhccc
Confidence                    2367889999999999999999999     88999999987543

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.9e-48  Score=399.31  Aligned_cols=267  Identities=39%  Similarity=0.647  Sum_probs=228.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            45568999999999999999999999999999999999775444444556677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+.... 
T Consensus       119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-  196 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-  196 (371)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence            9999999999999988764 58999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCC----CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRF  284 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~  284 (499)
                              .....+.+||+.|+|||++.+..    ++.++|||||||++|+|++|.+||.+.+....+.+|....  +.+
T Consensus       197 --------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  268 (371)
T cd05622         197 --------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF  268 (371)
T ss_pred             --------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence                    11223568999999999987543    7889999999999999999999999999888888887643  445


Q ss_pred             CC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          285 PN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       285 p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      |.  .++..+++||.+||. +|..|++.  .+++++++||||++..|.
T Consensus       269 ~~~~~~s~~~~~li~~~L~-~~~~r~~r--~~~~ei~~h~~~~~~~~~  313 (371)
T cd05622         269 PDDNDISKEAKNLICAFLT-DREVRLGR--NGVEEIKRHLFFKNDQWA  313 (371)
T ss_pred             CCcCCCCHHHHHHHHHHcC-ChhhhcCC--CCHHHHhcCcccCCCChh
Confidence            54  589999999999998 66665533  134999999999986553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-50  Score=373.96  Aligned_cols=259  Identities=33%  Similarity=0.547  Sum_probs=231.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch-----hhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~  127 (499)
                      .+.|+-.++||+|..++|-+|.++.||..+|+|++.......     ..-.+.-..|+.+|+++ .||+|+++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356888899999999999999999999999999997532221     12234445688899887 799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+++|+|.|+.|+|++++...-.++|..++.++.|+++|++|||.++|+||||||||||++++.++||+|||+|..+.+
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999999998899999999999999999999999999999999999999999999999999998755


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccC------CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  281 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~------~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~  281 (499)
                      .           ......||||+|.|||.+.      ...|+..+|+||+|+|+|-|+.|.+||.......++..|..+.
T Consensus       176 G-----------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk  244 (411)
T KOG0599|consen  176 G-----------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK  244 (411)
T ss_pred             c-----------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence            3           3556789999999999984      3458889999999999999999999999999899999999999


Q ss_pred             CCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          282 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       282 ~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      ++|.    ..++.+++|||.+||+.||.+|+|+     ++.+.||||..+-
T Consensus       245 yqF~speWadis~~~KdLIsrlLqVdp~~Rita-----ke~LaHpff~q~~  290 (411)
T KOG0599|consen  245 YQFRSPEWADISATVKDLISRLLQVDPTKRITA-----KEALAHPFFIQIA  290 (411)
T ss_pred             cccCCcchhhccccHHHHHHHHHeeCchhcccH-----HHHhcChHHHHHH
Confidence            9885    3589999999999999999999999     8899999997543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-48  Score=376.31  Aligned_cols=258  Identities=29%  Similarity=0.471  Sum_probs=223.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCC----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTF----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-Iv~l~~~~~~~~----  128 (499)
                      +..|+.++.||+|+||+||+|+.+.+|+.||+|.+...... +.......+|+.+|+.++|+| |++|++++.+.+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            56788999999999999999999999999999999876432 334555678999999999999 999999999877    


Q ss_pred             --eEEEEEeccCCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          129 --SLYMALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       129 --~l~lv~E~~~gg~L~~~i~~~~----~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                        .+|+|+||++. +|..++...+    .++...++.++.||+.||+|||++||+||||||.||||+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              89999999975 9999998765    4788899999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-  280 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-  280 (499)
                      +.+.-..          .....-++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+.++..+..+|... 
T Consensus       168 ra~~ip~----------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l  237 (323)
T KOG0594|consen  168 RAFSIPM----------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL  237 (323)
T ss_pred             HHhcCCc----------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence            9654221          224456899999999999887 6899999999999999999999999999998888888751 


Q ss_pred             -----------------CCCCCC------------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          281 -----------------DIRFPN------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       281 -----------------~~~~p~------------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                                       ...||.            ..++++.+|+.+||+.+|.+|++|     +.++.||||....
T Consensus       238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa-----~~al~h~yf~~~~  309 (323)
T KOG0594|consen  238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA-----KGALTHPYFSELP  309 (323)
T ss_pred             CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH-----HHHhcChhhcccc
Confidence                             111221            123589999999999999999999     8899999998753

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.2e-47  Score=377.15  Aligned_cols=267  Identities=42%  Similarity=0.731  Sum_probs=243.4

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765555555667788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++......      
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------  154 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------  154 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence            99999999999998889999999999999999999999999999999999999999999999999998765321      


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  294 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  294 (499)
                             ....+|++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.....+.+......+|..++..+++
T Consensus       155 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  227 (290)
T cd05580         155 -------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKD  227 (290)
T ss_pred             -------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHH
Confidence                   2345789999999999888889999999999999999999999998887778888888888899999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      +|.+||+.||.+|++....+++++++||||+.++|..+..
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  267 (290)
T cd05580         228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQ  267 (290)
T ss_pred             HHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhh
Confidence            9999999999999976666779999999999999988754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.7e-48  Score=380.58  Aligned_cols=255  Identities=27%  Similarity=0.436  Sum_probs=215.6

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++...... ......+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            4799999999999999999999999999999999765332 223455677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++++.|..+....+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..+....     
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-----  154 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-----  154 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-----
Confidence            999987766555555679999999999999999999999999999999999999999999999999998653321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-------------
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-------------  281 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-------------  281 (499)
                          ........||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+.......+....             
T Consensus       155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         155 ----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence                112234679999999999998889999999999999999999999999877655443332211             


Q ss_pred             ------CCCC-------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 ------IRFP-------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 ------~~~p-------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                            ..+|             ..++.++.+||.+||+.||++||++     +++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~-----~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT-----EQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH-----HHHhcCCCC
Confidence                  0111             2367889999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.9e-47  Score=377.73  Aligned_cols=275  Identities=33%  Similarity=0.558  Sum_probs=231.4

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++|++|+.+++.+.+...+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47889999999999999999999999999999987655444444556779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......     
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-----  155 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----  155 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence            99999999988654  35899999999999999999999999999999999999999999999999998654321     


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH---HHHHHH-HhcCCCCCCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRI-IARDIRFPNYFS  289 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~---~~~~~i-~~~~~~~p~~~~  289 (499)
                            .......||..|+|||++.+..++.++|+|||||++|+|++|+.||......   .....+ ......++..++
T Consensus       156 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd05630         156 ------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFS  229 (285)
T ss_pred             ------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCC
Confidence                  1122357999999999999989999999999999999999999999875432   222222 222335677889


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLA  341 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~-~~~p~~~  341 (499)
                      +++.+||.+||+.||.+|||+...+++++++||||.+++|..+.. +.+|++.
T Consensus       230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~  282 (285)
T cd05630         230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFK  282 (285)
T ss_pred             HHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCC
Confidence            999999999999999999997655679999999999999997654 3334433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-47  Score=379.03  Aligned_cols=254  Identities=25%  Similarity=0.408  Sum_probs=214.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .+++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            36789999999999999999999999999999999865432  2223445679999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9999975 9999887654 47999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---------
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---------  281 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~---------  281 (499)
                              .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....         
T Consensus       158 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07871         158 --------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP  229 (288)
T ss_pred             --------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence                    12234578999999999865 568899999999999999999999999887766555443210         


Q ss_pred             ----------CCCC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 ----------IRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 ----------~~~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                                +.+|           ..++.++++||.+||+.||.+|||+     +++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~-----~~~l~hp~f  288 (288)
T cd07871         230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA-----EAALRHSYF  288 (288)
T ss_pred             ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH-----HHHhcCCCC
Confidence                      1111           2467899999999999999999999     899999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2e-47  Score=381.91  Aligned_cols=258  Identities=26%  Similarity=0.430  Sum_probs=212.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....  ........+|+.+++.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999875432  12233456799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---  157 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---  157 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence            99996 5888877654 569999999999999999999999999999999999999999999999999987542211   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHhc--C-------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIAR--D-------  281 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~~~--~-------  281 (499)
                             ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+. .....+...  .       
T Consensus       158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         158 -------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             -------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence                   12234578999999999865 45788999999999999999999999876442 222222210  0       


Q ss_pred             --CC------------CC---------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          282 --IR------------FP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       282 --~~------------~p---------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                        ..            .|         ..+++++.+||.+||+.||.+|||+     +++++||||+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~-----~~~l~h~~f~~~~~  296 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA-----QAALSHEYFSDLPP  296 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH-----HHHhcCcccccCCh
Confidence              00            01         0245789999999999999999998     89999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.8e-47  Score=375.16  Aligned_cols=261  Identities=29%  Similarity=0.576  Sum_probs=221.1

Q ss_pred             eeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCh
Q 010859           63 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  142 (499)
Q Consensus        63 LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L  142 (499)
                      ||+|+||.||+++++.+|+.||+|.+.+..............|+++++.++||||+++++.+.+...+|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999999765444333344456699999999999999999999999999999999999999


Q ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 010859          143 FDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  220 (499)
Q Consensus       143 ~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~  220 (499)
                      .+++...+  .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......           
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----------  149 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----------  149 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence            98886543  48899999999999999999999999999999999999999999999999987653321           


Q ss_pred             CccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH----HHHHHHHHhcCCCCC-CCCChHHHHH
Q 010859          221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRFP-NYFSDAARDL  295 (499)
Q Consensus       221 ~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~~~~~~~L  295 (499)
                      ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.....    ......+......++ ..++.++++|
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  229 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDI  229 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHH
Confidence            11234689999999999988899999999999999999999999976533    333444444444433 4689999999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          296 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       296 i~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |.+||+.||.+||++.+. .++++.||||++++|..+...
T Consensus       230 i~~~L~~~P~~R~~~~~~-~~~~~~h~~f~~~~~~~~~~~  268 (277)
T cd05607         230 CRLFLAKKPEDRLGSREK-NDDPRKHEFFKTINFPRLEAG  268 (277)
T ss_pred             HHHHhccCHhhCCCCccc-hhhhhcChhhcCCCHHHHhcC
Confidence            999999999999999652 477889999999999888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-46  Score=373.52  Aligned_cols=268  Identities=32%  Similarity=0.580  Sum_probs=233.1

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+...+|++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            37889999999999999999999999999999987655555445566779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......     
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-----  155 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-----  155 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence            99999999888654  36999999999999999999999999999999999999999999999999998654321     


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHH----HHHhcCCCCCCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ----RIIARDIRFPNYFS  289 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~----~i~~~~~~~p~~~~  289 (499)
                            .......|+..|+|||++.+..++.++|+|||||++|+|++|..||.+..+.....    .+......++..++
T Consensus       156 ------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd05632         156 ------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS  229 (285)
T ss_pred             ------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCC
Confidence                  11224579999999999998889999999999999999999999998876644333    33344456677899


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      .++.+|+.+||+.||.+||++.+.++++++.||||+.++|+.+..
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05632         230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEA  274 (285)
T ss_pred             HHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhc
Confidence            999999999999999999998877789999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-46  Score=377.66  Aligned_cols=285  Identities=41%  Similarity=0.693  Sum_probs=244.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|..+++.++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998776555445666788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          135 ESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       135 E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||+.|++|.+++.+.  ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998764  569999999999999999999999999999999999999999999999999987653321100


Q ss_pred             cC-------------------CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHH
Q 010859          213 LP-------------------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI  273 (499)
Q Consensus       213 ~~-------------------~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~  273 (499)
                      ..                   ..........++||..|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence            00                   00011233456899999999999998899999999999999999999999999888888


Q ss_pred             HHHHHhcCCCCCCC--CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCCC
Q 010859          274 FQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL  340 (499)
Q Consensus       274 ~~~i~~~~~~~p~~--~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p~~  340 (499)
                      +..+......+|..  ++.++.++|.+||+.||++||++.. +.++++.||||++++|..+....+|..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~-~~~~ll~~~~~~~~~~~~~~~~~~~~~  308 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR-GAAEIKQHPFFRGVNWALIRHTTPPII  308 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchh-hHHHHHcCchhhcCChhhcccCCCCCC
Confidence            88888777777665  6999999999999999999999322 238999999999999999888666554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.1e-48  Score=373.58  Aligned_cols=250  Identities=32%  Similarity=0.547  Sum_probs=214.9

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-----CCe
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-----TFS  129 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-----~~~  129 (499)
                      -.|+-.+++|.|+||.||.|...++++.||||.+-.+.-       +-.+|.++|+.++|||||+|..+|..     +-+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            468999999999999999999999999999998754422       34468999999999999999888752     225


Q ss_pred             EEEEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-CCEEEEecCCccc
Q 010859          130 LYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKP  204 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-~~vkL~DFG~a~~  204 (499)
                      +.+||||++. +|.++++.    +.+++.-.++-|.+||+.||.|||+.||+||||||.|+|+|.+ |.+||||||+|+.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            6789999986 99998884    4679999999999999999999999999999999999999987 8999999999998


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---  280 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---  280 (499)
                      +....           ...++..|..|+|||++.|. .|+.+.||||.||++.||+-|++.|.|.+...++..|++.   
T Consensus       176 L~~~e-----------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  176 LVKGE-----------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             eccCC-----------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            76532           33578899999999998765 5999999999999999999999999999988887777651   


Q ss_pred             --------------CCCCC------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          281 --------------DIRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       281 --------------~~~~p------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                                    +..+|            ...++++.+|+.++|+.+|.+|.++     .+++.||||....
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~-----~~~l~h~fFdelr  313 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA-----LEALAHPFFDELR  313 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH-----HHHhcchhhHHhh
Confidence                          12222            3468999999999999999999999     8899999998643

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-48  Score=388.38  Aligned_cols=256  Identities=28%  Similarity=0.500  Sum_probs=236.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe-EEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS-LYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~-l~l  132 (499)
                      +++|++++.+|+|+||.+++++++..++.|++|.+........... ....|..+++++.|||||.+++.|..++. ++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~-~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR-SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH-HHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            5789999999999999999999999999999999987765544433 56779999999999999999999998888 999


Q ss_pred             EEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||+||+||+|.+.|.+.+  .|+|+.+..++.|++.||.|||+++|+|||||+.|||++.++.|||+|||+|+.+.+.. 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-  160 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-  160 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence            999999999999998653  59999999999999999999999999999999999999999999999999999886542 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFS  289 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~  289 (499)
                               ....+.+||+.||+||++.+.+|+.++|||||||++|||++-+++|.+.+...+..+|.... .+.|..++
T Consensus       161 ---------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys  231 (426)
T KOG0589|consen  161 ---------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYS  231 (426)
T ss_pred             ---------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCcccc
Confidence                     35668999999999999999999999999999999999999999999999999999999887 67889999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      .+++.||+.||..+|..||++     .+|+.+|...
T Consensus       232 ~el~~lv~~~l~~~P~~RPsa-----~~LL~~P~l~  262 (426)
T KOG0589|consen  232 SELRSLVKSMLRKNPEHRPSA-----LELLRRPHLL  262 (426)
T ss_pred             HHHHHHHHHHhhcCCccCCCH-----HHHhhChhhh
Confidence            999999999999999999999     8899998876

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-46  Score=381.98  Aligned_cols=260  Identities=28%  Similarity=0.475  Sum_probs=212.9

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----CeE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----FSL  130 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-----~~l  130 (499)
                      +|++.+.||+|+||.||+|.+..+|..||||.+...... ......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            589999999999999999999999999999998654222 22334567899999999999999999887543     358


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999995 69999998888899999999999999999999999999999999999999999999999999975432110


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCC--CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--------
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  280 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--------  280 (499)
                             ........+||+.|+|||++.+  ..++.++|||||||++|+|++|++||.+.+.......+...        
T Consensus       159 -------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         159 -------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             -------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence                   1112235689999999999876  57889999999999999999999999877654333222110        


Q ss_pred             ------------------CC--CCC---CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          281 ------------------DI--RFP---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       281 ------------------~~--~~p---~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                        ..  .+.   ..+++++.+||.+||+.||++||++     +++++||||+++..
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~e~l~hp~f~~~~~  298 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA-----EEALADPYFKGLAK  298 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH-----HHHhcCchhhhcCc
Confidence                              00  000   2367889999999999999999998     89999999987553

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.9e-47  Score=388.67  Aligned_cols=251  Identities=30%  Similarity=0.492  Sum_probs=216.2

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-C-----CCccEEEEEEEcCCe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-H-----PGVVRLFFTFQDTFS  129 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----p~Iv~l~~~~~~~~~  129 (499)
                      +|++.++||+|+||+|.+|.+..|++.||||+++...    ........|+.+|..|+ |     -|||+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            5899999999999999999999999999999997653    23344556888888886 3     489999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC--CEEEEecCCcccc
Q 010859          130 LYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG--HIKIADFGSVKPM  205 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~--~vkL~DFG~a~~~  205 (499)
                      +|||+|.+. .+|+++++.+.  .|+...++.++.||+.||.+||++||||+|||||||||..-+  .|||+|||+|...
T Consensus       263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999999996 59999999773  489999999999999999999999999999999999997654  6999999999854


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC----
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----  281 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~----  281 (499)
                      .             ....+++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.|.++.+++..|+.-.    
T Consensus       342 ~-------------q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp  408 (586)
T KOG0667|consen  342 S-------------QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP  408 (586)
T ss_pred             C-------------CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence            3             33448899999999999999999999999999999999999999999999999998887510    


Q ss_pred             ------------------------------------------------CCCCC-----------CCChHHHHHHHHhhcc
Q 010859          282 ------------------------------------------------IRFPN-----------YFSDAARDLIDRLLDV  302 (499)
Q Consensus       282 ------------------------------------------------~~~p~-----------~~~~~~~~Li~~lL~~  302 (499)
                                                                      ...|.           .-...+.|||.+||++
T Consensus       409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~  488 (586)
T KOG0667|consen  409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW  488 (586)
T ss_pred             HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence                                                            00110           0124579999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          303 DPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       303 dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      ||.+|+|+     .++++||||++...
T Consensus       489 dP~~R~tp-----~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  489 DPAERITP-----AQALNHPFLTGTSL  510 (586)
T ss_pred             CchhcCCH-----HHHhcCcccccccc
Confidence            99999999     88999999996543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.8e-46  Score=377.02  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=219.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++++.||+|+||.||+|++..+|..||+|++....  .......+.+|+.+++.++||||+++++++.+...+|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4689999999999999999999999999999999987642  23344567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||+++|+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+...   
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence            999999999999999888899999999999999999999986 6999999999999999999999999998754321   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH-------------
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-------------  278 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~-------------  278 (499)
                               .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.             
T Consensus       158 ---------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (331)
T cd06649         158 ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS  228 (331)
T ss_pred             ---------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence                     1234679999999999999999999999999999999999999997665433321111             


Q ss_pred             ---------------------------------hc-CCCCC-CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 010859          279 ---------------------------------AR-DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  323 (499)
Q Consensus       279 ---------------------------------~~-~~~~p-~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpf  323 (499)
                                                       .. ....+ ..+++++++||.+||+.||++||++     +++++|||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~-----~ell~h~~  303 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL-----KMLMNHTF  303 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH-----HHHhcChH
Confidence                                             00 01111 2468899999999999999999998     89999999


Q ss_pred             CCCCC
Q 010859          324 FKGID  328 (499)
Q Consensus       324 f~~i~  328 (499)
                      |+...
T Consensus       304 ~~~~~  308 (331)
T cd06649         304 IKRSE  308 (331)
T ss_pred             Hhhcc
Confidence            98644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.6e-46  Score=394.51  Aligned_cols=253  Identities=28%  Similarity=0.454  Sum_probs=210.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  126 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~------  126 (499)
                      ...+|++++.||+|+||.||+|.+..+++.||||++....       ....+|+.+|+.++||||++++++|..      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3468999999999999999999999999999999885432       123468999999999999999887743      


Q ss_pred             --CCeEEEEEeccCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEec
Q 010859          127 --TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADF  199 (499)
Q Consensus       127 --~~~l~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DF  199 (499)
                        ...+++||||+++ +|.+++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence              2357899999975 7777664    345799999999999999999999999999999999999999765 6999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  278 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~  278 (499)
                      |+|+.+...           ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+.++.
T Consensus       216 Gla~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  284 (440)
T PTZ00036        216 GSAKNLLAG-----------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII  284 (440)
T ss_pred             ccchhccCC-----------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999865322           122356889999999998664 68999999999999999999999999887766655554


Q ss_pred             hc-----------------CC------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          279 AR-----------------DI------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       279 ~~-----------------~~------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      ..                 ..            .+|...++++.+||.+||+.||.+|||+     .++++||||..+..
T Consensus       285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta-----~e~l~hp~f~~~~~  359 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP-----IEALADPFFDDLRD  359 (440)
T ss_pred             HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH-----HHHhCChhHHhhhc
Confidence            31                 11            1344578899999999999999999999     88999999987654

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-46  Score=384.85  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=210.2

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ....+|++++.||+|+||.||+|.+..+++.||+|....         ..+.+|+.+++.++||||++++++|......|
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            445789999999999999999999999999999996432         23567999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +|||++. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....   
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~---  235 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI---  235 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc---
Confidence            9999995 699999988888999999999999999999999999999999999999999999999999998753221   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC-------HHHHHHHHHhcC---
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-------EWLIFQRIIARD---  281 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~-------~~~~~~~i~~~~---  281 (499)
                            .......++||+.|+|||++.+..++.++|||||||++|+|++|..||....       ....+..+....   
T Consensus       236 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~  309 (391)
T PHA03212        236 ------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH  309 (391)
T ss_pred             ------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence                  1122335689999999999999999999999999999999999998875321       111222221110   


Q ss_pred             -----------------------CCCC---------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          282 -----------------------IRFP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       282 -----------------------~~~p---------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                             ...|         ..++.++.+||.+||+.||.+|||+     +++++||||+.+
T Consensus       310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta-----~elL~hp~f~~~  382 (391)
T PHA03212        310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA-----EALLDFAAFQDI  382 (391)
T ss_pred             hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH-----HHHhcChhhccC
Confidence                                   0001         1246789999999999999999999     899999999864

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-45  Score=364.49  Aligned_cols=262  Identities=35%  Similarity=0.607  Sum_probs=219.0

Q ss_pred             EeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHH---hCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010859           62 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD---QLDHPGVVRLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        62 ~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~---~l~hp~Iv~l~~~~~~~~~l~lv~E~~~  138 (499)
                      .||+|+||.||+|.+..+++.||+|.+.+.............+|..+++   ..+||+|+.+++++...+..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999998765543333333344444443   3479999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCC
Q 010859          139 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  218 (499)
Q Consensus       139 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~  218 (499)
                      +++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......          
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----------  150 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----------  150 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----------
Confidence            9999999988888999999999999999999999999999999999999999999999999998654321          


Q ss_pred             CCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHhcCCCCCCCCChHHHH
Q 010859          219 DDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFPNYFSDAARD  294 (499)
Q Consensus       219 ~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~  294 (499)
                        ......||..|+|||++. +..++.++|+||+||++|+|++|..||....   .....+........+|..++.++.+
T Consensus       151 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd05633         151 --KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS  228 (279)
T ss_pred             --CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHH
Confidence              112347999999999986 4568899999999999999999999997532   2223333334456678889999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      +|.+||..||.+|++....+++++++||||++++|.....+
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~  269 (279)
T cd05633         229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ  269 (279)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcC
Confidence            99999999999999866556799999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-48  Score=381.47  Aligned_cols=256  Identities=31%  Similarity=0.494  Sum_probs=228.4

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ..|.....||+|+||.||+|.+..|++.||+|+++.+..  +...+.++.|+.+|..++++||.++|+.|-....++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            457778999999999999999999999999999987643  345677888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |||.||++.+.+...+.++|.++..++.+++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+....     
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~-----  165 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV-----  165 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh-----
Confidence            999999999999998878999999999999999999999999999999999999999999999999998765432     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCChHHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAAR  293 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~  293 (499)
                           .+..+|+|||.|||||++....|+.++||||||++.|||++|.+||....+...+..|-+..+ .+...+++.++
T Consensus       166 -----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~k  240 (467)
T KOG0201|consen  166 -----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFK  240 (467)
T ss_pred             -----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHH
Confidence                 334789999999999999998999999999999999999999999998877444444443322 33457899999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       294 ~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      +||..||++||+.||+|     .+|++|+|.+..
T Consensus       241 EFV~~CL~k~P~~RpsA-----~~LLKh~FIk~a  269 (467)
T KOG0201|consen  241 EFVEACLDKNPEFRPSA-----KELLKHKFIKRA  269 (467)
T ss_pred             HHHHHHhhcCcccCcCH-----HHHhhhHHHHhc
Confidence            99999999999999999     889999999864

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-47  Score=358.74  Aligned_cols=260  Identities=33%  Similarity=0.531  Sum_probs=226.6

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccC
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~E~~~  138 (499)
                      .++||+|+|+.|--|....||.+||||+++|.   .......+.+|++++..+ .|+||++|+++|+++...|+|||.+.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            45789999999999999999999999999886   334567788999999988 59999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC---EEEEecCCccccCCccccccCC
Q 010859          139 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       139 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~---vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      ||.|..+|.++..|+|.++..+..+|+.||.|||.+||.||||||||||-....+   ||||||.++.-+.... ...  
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~-~~s--  236 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN-DCS--  236 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC-CCC--
Confidence            9999999999999999999999999999999999999999999999999876654   8999999876543221 111  


Q ss_pred             CCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCC---------------HHHHHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTS---------------EWLIFQ  275 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~---------------~~~~~~  275 (499)
                      ..+.....+.||++.|||||+..     ...|+.++|+||||+|||-||+|.+||.+.-               ...++.
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence            22345566789999999999963     3458999999999999999999999998642               255788


Q ss_pred             HHHhcCCCCCC----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          276 RIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       276 ~i~~~~~~~p~----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      .|..+.++||+    .+|.+++|||..+|..|+..|+++     ..+++|||++.+.-+
T Consensus       317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa-----~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA-----AQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh-----hhccCCccccccchh
Confidence            89999999997    489999999999999999999999     889999999987644

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-45  Score=375.53  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=213.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++++.||+|+||.||+|++..+|+.||||++....  .......+.+|+.+++.++|+||+++++++.+...+
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            345678999999999999999999999999999999986542  233345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||+++|+|...    ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.... 
T Consensus       148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            999999999998653    346788889999999999999999999999999999999999999999999998654221 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCC-----CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH--H-HHHHH-HhcC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--L-IFQRI-IARD  281 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~--~-~~~~i-~~~~  281 (499)
                               ......+||..|+|||++..     ...+.++|||||||++|+|++|+.||......  . ....+ ....
T Consensus       223 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  293 (353)
T PLN00034        223 ---------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP  293 (353)
T ss_pred             ---------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC
Confidence                     11234679999999999743     33456899999999999999999999743321  1 12222 2233


Q ss_pred             CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          282 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       282 ~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ...+..++.++++||.+||..||++||++     .++++||||.+.
T Consensus       294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~ell~hp~~~~~  334 (353)
T PLN00034        294 PEAPATASREFRHFISCCLQREPAKRWSA-----MQLLQHPFILRA  334 (353)
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCH-----HHHhcCcccccC
Confidence            45567789999999999999999999998     899999999863

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-46  Score=383.78  Aligned_cols=259  Identities=33%  Similarity=0.546  Sum_probs=241.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ......|.+.+.||+|.|+.|.+|++..|+..||||++++.......... +.+|+++|+.++|||||++|.+......+
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            44567899999999999999999999999999999999998766655444 78899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||+.+|++++++.+++++.+..++.++.|++.|++|||+++|+|||||++||||+.++.+||+|||++..+...  
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--  208 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--  208 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999877543  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  289 (499)
                               ....++||++.|.|||++.+..| ++.+|+||||++||.|+.|.+||.+.+-.+...+.+.+.+.+|..++
T Consensus       209 ---------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms  279 (596)
T KOG0586|consen  209 ---------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMS  279 (596)
T ss_pred             ---------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceee
Confidence                     34558999999999999998875 68899999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .++++||+++|.++|.+|+++     ++++.|.|...
T Consensus       280 ~dce~lLrk~lvl~Pskr~~~-----dqim~~~W~n~  311 (596)
T KOG0586|consen  280 CDCEDLLRKFLVLNPSKRGPC-----DQIMKDRWRND  311 (596)
T ss_pred             chhHHHHHHhhccCccccCCH-----HHhhhhcccch
Confidence            999999999999999999998     88999999863

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.5e-45  Score=364.15  Aligned_cols=280  Identities=37%  Similarity=0.581  Sum_probs=236.9

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++||||+++++.+.....+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987664433344456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998742211100000


Q ss_pred             -----CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC---
Q 010859          215 -----NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---  286 (499)
Q Consensus       215 -----~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~---  286 (499)
                           ............|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.....+.+.......|.   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                 000011112357889999999998888999999999999999999999999988887777777776555443   


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  336 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~  336 (499)
                      .++.++.+||.+||+.||++||++.  +..++++||||.+.+|..+....
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~~--~~~~ll~~~~~~~~~~~~~~~~~  288 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGTG--GAFEVKQHRFFLGLDWNGLLRQK  288 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCcc--CHHHHHhCccccCCCHHHHhhcC
Confidence            5789999999999999999999973  45899999999999998876543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.5e-46  Score=380.82  Aligned_cols=258  Identities=28%  Similarity=0.391  Sum_probs=218.1

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----eE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----SL  130 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----~l  130 (499)
                      +|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+..     .+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            58899999999999999999999999999999865422 2223445778999999999999999999998776     79


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-  157 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-  157 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence            99999996 5899998888889999999999999999999999999999999999999999999999999997643221 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---------
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---------  280 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---------  280 (499)
                              .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+...         
T Consensus       158 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         158 --------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             --------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence                    1122345789999999998774 4788999999999999999999999988876665554321         


Q ss_pred             --------------C---------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          281 --------------D---------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       281 --------------~---------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                    .         +.+....++++.+||.+||+.||.+|||+     +++++||||.+..+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~~~~~~  296 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA-----ADALAHPYLDEGRL  296 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH-----HHHhcCHhhCCCcc
Confidence                          1         12234468899999999999999999998     88999999998654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-45  Score=364.34  Aligned_cols=252  Identities=28%  Similarity=0.435  Sum_probs=208.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcC-CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC---CCCCccEEEEEEE-----
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQ-----  125 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~-t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~Iv~l~~~~~-----  125 (499)
                      ++|++++.||+|+||.||+|++.. +|..||+|++........ ......+|..+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999864 478899999876533222 222344566666655   6999999999885     


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          126 DTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      ....+|+||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456999999997 5999988754  358999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-  282 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-  282 (499)
                      .....           .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+..... 
T Consensus       159 ~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~  227 (290)
T cd07862         159 IYSFQ-----------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  227 (290)
T ss_pred             eccCC-----------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            64321           122356799999999999988999999999999999999999999999888777777654210 


Q ss_pred             ----C----------------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          283 ----R----------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       283 ----~----------------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                          .                      +...++..+++||.+||+.||++||++     .++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~~~l~hp~f  290 (290)
T cd07862         228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYF  290 (290)
T ss_pred             CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH-----HHHhcCCCC
Confidence                0                      112467889999999999999999999     889999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.2e-45  Score=375.06  Aligned_cols=253  Identities=23%  Similarity=0.428  Sum_probs=210.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|..+++.++||||++++++|....     
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            57999999999999999999999999999999999765332 233445667999999999999999999986543     


Q ss_pred             -eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 -~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                       .+|+||||+++ +|.+.+..  .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence             57999999975 67776653  489999999999999999999999999999999999999999999999999875422


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-------
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  280 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-------  280 (499)
                      .           .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...       
T Consensus       176 ~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         176 N-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             C-----------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            1           1223467899999999999999999999999999999999999999987654443322211       


Q ss_pred             ---------------CCCC--------------------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          281 ---------------DIRF--------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       281 ---------------~~~~--------------------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                     ...+                    +...++++++||.+||+.||++|||+     +++++||||.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~~  319 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV-----DEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH-----HHHhcCchhh
Confidence                           1111                    11246789999999999999999998     8999999997


Q ss_pred             C
Q 010859          326 G  326 (499)
Q Consensus       326 ~  326 (499)
                      .
T Consensus       320 ~  320 (359)
T cd07876         320 V  320 (359)
T ss_pred             h
Confidence            4

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3e-45  Score=361.24  Aligned_cols=261  Identities=33%  Similarity=0.602  Sum_probs=226.3

Q ss_pred             eeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCh
Q 010859           63 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  142 (499)
Q Consensus        63 LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L  142 (499)
                      ||+|+||+||+|.+..+|+.||+|++.+...........+..|..+++.++||||++++++|......|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999999876544444445556799999999999999999999999999999999999999


Q ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 010859          143 FDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  220 (499)
Q Consensus       143 ~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~  220 (499)
                      .+++.+.+  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+......           .
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-----------~  149 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-----------K  149 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-----------C
Confidence            99998765  6999999999999999999999999999999999999999999999999998754321           1


Q ss_pred             CccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH----HHHHHHHHhcCCCCCCCCChHHHHHH
Q 010859          221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRFPNYFSDAARDLI  296 (499)
Q Consensus       221 ~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~Li  296 (499)
                      ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....    ....+.+......+|..+++.+.++|
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC  229 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHH
Confidence            11234688899999999888899999999999999999999999987654    23333444455667788899999999


Q ss_pred             HHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          297 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       297 ~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      .+||+.||.+||+..+.+..+++.||||..++|..+..
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~  267 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEA  267 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhc
Confidence            99999999999988877889999999999999987743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.6e-45  Score=387.68  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=204.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC------CCCccEEEEEEEcC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD------HPGVVRLFFTFQDT  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~Iv~l~~~~~~~  127 (499)
                      .++|++++.||+|+||+||+|.+..+++.||||++....    ........|+.+++.+.      |+++++++.+|...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            468999999999999999999999999999999986431    11222344666666554      45689999998764


Q ss_pred             -CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCC-------------
Q 010859          128 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADG-------------  192 (499)
Q Consensus       128 -~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~-------------  192 (499)
                       ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999998 67999999888899999999999999999999998 5999999999999998765             


Q ss_pred             ---CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC
Q 010859          193 ---HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  269 (499)
Q Consensus       193 ---~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~  269 (499)
                         .+||+|||.+....             .....++||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+
T Consensus       283 ~~~~vkl~DfG~~~~~~-------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER-------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             CCceEEECCCCccccCc-------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence               49999999875321             12235789999999999999999999999999999999999999999887


Q ss_pred             HHHHHHHHHhcCCCCCC------------------------------------------CCChHHHHHHHHhhccCCCCC
Q 010859          270 EWLIFQRIIARDIRFPN------------------------------------------YFSDAARDLIDRLLDVDPSGR  307 (499)
Q Consensus       270 ~~~~~~~i~~~~~~~p~------------------------------------------~~~~~~~~Li~~lL~~dP~~R  307 (499)
                      ....+..+......+|.                                          ..++.+.|||.+||+.||.+|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            76555444332111110                                          013557899999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCC
Q 010859          308 PGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       308 ~~~~~~~~~~l~~Hpff~~  326 (499)
                      |++     +++++||||..
T Consensus       430 ~ta-----~e~L~Hp~~~~  443 (467)
T PTZ00284        430 LNA-----RQMTTHPYVLK  443 (467)
T ss_pred             CCH-----HHHhcCccccc
Confidence            999     89999999985

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-45  Score=354.12  Aligned_cols=258  Identities=28%  Similarity=0.489  Sum_probs=223.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh--hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ++|++.+.||+|++|.||.|.+..+++.||+|.+........  .....+.+|+.++++++||||+++++++.+...+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999999999876533222  223457789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++.+.....  
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~--  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS--  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc--
Confidence            999999999999999888899999999999999999999999999999999999999999999999999876533211  


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCh
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYFSD  290 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~  290 (499)
                           .........|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...  ...+|..++.
T Consensus       160 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (263)
T cd06625         160 -----SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP  234 (263)
T ss_pred             -----ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCH
Confidence                 011112456889999999999988999999999999999999999999887666555554433  4457788999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ++.+||.+||..+|.+||++     .++++||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~-----~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSA-----EELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCH-----HHHhhCCCC
Confidence            99999999999999999988     899999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.3e-45  Score=355.42  Aligned_cols=257  Identities=39%  Similarity=0.738  Sum_probs=229.9

Q ss_pred             eeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCh
Q 010859           63 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  142 (499)
Q Consensus        63 LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L  142 (499)
                      ||.|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999876555444556788899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 010859          143 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  222 (499)
Q Consensus       143 ~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~  222 (499)
                      .+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......           ..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----------~~  149 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----------KT  149 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------cc
Confidence            9999888789999999999999999999999999999999999999999999999999987654321           22


Q ss_pred             cccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC--HHHHHHHHH--hcCCCCCCCCChHHHHHHHH
Q 010859          223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRII--ARDIRFPNYFSDAARDLIDR  298 (499)
Q Consensus       223 ~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~~~~~~~Li~~  298 (499)
                      ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||....  .....+.+.  .....+|...++++.++|.+
T Consensus       150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  229 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ  229 (262)
T ss_pred             ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHH
Confidence            34578999999999988889999999999999999999999998776  666666666  45677888889999999999


Q ss_pred             hhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          299 LLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       299 lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      ||+.||.+||+..+.+++++++||||++.+|+
T Consensus       230 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         230 LLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             HccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            99999999999666677999999999999986

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.3e-45  Score=366.15  Aligned_cols=257  Identities=24%  Similarity=0.399  Sum_probs=214.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .+++|++.+.||+|+||.||+|++..+++.||+|.+.......  ......+|+.++++++||||+++++++.++..+|+
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            3578999999999999999999999999999999987553222  22345679999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  158 (309)
T cd07872          82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--  158 (309)
T ss_pred             EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence            9999975 888887665 458999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc----------
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR----------  280 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~----------  280 (499)
                              .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+...          
T Consensus       159 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  230 (309)
T cd07872         159 --------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP  230 (309)
T ss_pred             --------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence                    11224578999999999865 45888999999999999999999999887765554444321          


Q ss_pred             ---------CCCCC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          281 ---------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       281 ---------~~~~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                               ...+|           ..++.++++||.+||+.||.+|||+     +++++||||+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~~~~~  292 (309)
T cd07872         231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA-----EEAMKHAYFRSL  292 (309)
T ss_pred             hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH-----HHHhcChhhhhc
Confidence                     11112           2468899999999999999999998     899999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-44  Score=357.58  Aligned_cols=264  Identities=34%  Similarity=0.581  Sum_probs=221.9

Q ss_pred             EeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHH---HHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010859           62 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER---IVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        62 ~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~---~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~  138 (499)
                      +||+|+||.||+|.+..+++.||+|++.+..............|.   ..++...||+|++++++|.+...+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999876544332222233333   34445689999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCC
Q 010859          139 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  218 (499)
Q Consensus       139 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~  218 (499)
                      ||+|.+++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+...          
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----------  150 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----------  150 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----------
Confidence            9999999988888999999999999999999999999999999999999999999999999998754321          


Q ss_pred             CCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCC---CHHHHHHHHHhcCCCCCCCCChHHHH
Q 010859          219 DDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARDIRFPNYFSDAARD  294 (499)
Q Consensus       219 ~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~~~~~~~  294 (499)
                        .....+|+..|+|||++.+. .++.++|+||+||++|+|++|+.||.+.   ........+......+|..++.++.+
T Consensus       151 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (278)
T cd05606         151 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS  228 (278)
T ss_pred             --CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHH
Confidence              12245799999999998754 6889999999999999999999999876   33444444555567788889999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP  337 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~  337 (499)
                      +|.+||..+|.+||.....++.++++||||++++|..+.....
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~  271 (278)
T cd05606         229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKY  271 (278)
T ss_pred             HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhccc
Confidence            9999999999999966555669999999999999998765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.5e-45  Score=359.88  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=207.6

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC---CCCCccEEEEEEEc-----C
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQD-----T  127 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~Iv~l~~~~~~-----~  127 (499)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+........ ......+|..+++.+   +||||+++++++.+     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            58999999999999999999999999999999876432221 122344566666554   79999999998864     3


Q ss_pred             CeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          128 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      ..++++|||+.+ +|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            568999999975 898888764  34899999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC----
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----  281 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~----  281 (499)
                      ...           .......||..|+|||++.+..++.++|||||||++|+|++|++||.+.+......++....    
T Consensus       159 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07863         159 SCQ-----------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  227 (288)
T ss_pred             cCc-----------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence            321           11224578999999999998889999999999999999999999999887766666554310    


Q ss_pred             -------CC----------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 -------IR----------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 -------~~----------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                             ..                +...++.++.+||.+||+.||.+||++     .+++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~l~hp~f  288 (288)
T cd07863         228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA-----FRALQHPFF  288 (288)
T ss_pred             hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH-----HHHhcCCCC
Confidence                   00                112467889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-45  Score=368.58  Aligned_cols=249  Identities=29%  Similarity=0.462  Sum_probs=217.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCce-EEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV-YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-  128 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~-vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-  128 (499)
                      .+...+..+.+.||+|+||+||++...  |+. ||+|++......... ...+.+|+.+|.+++|||||++++++.+.. 
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            444567788888999999999999985  445 999999876555554 677889999999999999999999999887 


Q ss_pred             eEEEEEeccCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeeecCCCCeeeCCCC-CEEEEecCCccc
Q 010859          129 SLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMG-LIHRDIKPENLLLTADG-HIKIADFGSVKP  204 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~~LH~~g-IiHrDlKp~NILl~~~~-~vkL~DFG~a~~  204 (499)
                      .+.+||||+++|+|.+++..  .+.++...+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            79999999999999999987  578999999999999999999999999 99999999999999998 999999999987


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccC--CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh--c
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--R  280 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~--~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~--~  280 (499)
                      .....          .......||+.|||||++.  ...|+.++||||||+++|||+||+.||.+.........+..  .
T Consensus       194 ~~~~~----------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~  263 (362)
T KOG0192|consen  194 KVISK----------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL  263 (362)
T ss_pred             ecccc----------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence            54321          1222368999999999999  66899999999999999999999999999988666666553  3


Q ss_pred             CCCCCCCCChHHHHHHHHhhccCCCCCCCCCC
Q 010859          281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP  312 (499)
Q Consensus       281 ~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~  312 (499)
                      .+.+|...++.+..|+.+||..||.+||+..+
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~e  295 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLE  295 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHH
Confidence            45678889999999999999999999998843

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.9e-45  Score=372.85  Aligned_cols=253  Identities=24%  Similarity=0.408  Sum_probs=212.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~------  127 (499)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.+.... ......+.+|+.+++.++||||+++++++...      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            57999999999999999999999999999999998765332 22334566799999999999999999988643      


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            358999999975 78777754  489999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-----  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-----  282 (499)
                      .           .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++...-.     
T Consensus       179 ~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         179 S-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             C-----------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            1           122346799999999999999999999999999999999999999998887666655543100     


Q ss_pred             -----------------C--------------C------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          283 -----------------R--------------F------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       283 -----------------~--------------~------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                       .              +      +...+.++++||.+||+.||.+|||+     +++++||||.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~-----~e~L~hp~~~  322 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-----DEALQHPYIN  322 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH-----HHHhcCcccc
Confidence                             0              0      01134678999999999999999999     8999999997


Q ss_pred             C
Q 010859          326 G  326 (499)
Q Consensus       326 ~  326 (499)
                      .
T Consensus       323 ~  323 (364)
T cd07875         323 V  323 (364)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.9e-45  Score=368.10  Aligned_cols=256  Identities=26%  Similarity=0.446  Sum_probs=217.4

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|++....  .......+.+|+.+++.++||||++++++|.+...+|+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            3579999999999999999999999999999999987642  23344567789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+...   
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  157 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence            999999999999999888899999999999999999999975 7999999999999999999999999998754321   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH--------------
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--------------  277 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i--------------  277 (499)
                               .....+||..|+|||++.+..++.++|+|||||++|+|++|+.||...........+              
T Consensus       158 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (333)
T cd06650         158 ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS  228 (333)
T ss_pred             ---------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence                     122457999999999999888999999999999999999999999865543321111              


Q ss_pred             ------------------------------Hhc-CCCCC-CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          278 ------------------------------IAR-DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       278 ------------------------------~~~-~~~~p-~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                                    ... ...++ ..++.++++||.+||+.||++||++     ++++.||||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~-----~ell~h~~~~  303 (333)
T cd06650         229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL-----KQLMVHAFIK  303 (333)
T ss_pred             cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH-----HHHhhCHHHh
Confidence                                          000 11111 1367889999999999999999998     8999999997


Q ss_pred             CC
Q 010859          326 GI  327 (499)
Q Consensus       326 ~i  327 (499)
                      ..
T Consensus       304 ~~  305 (333)
T cd06650         304 RS  305 (333)
T ss_pred             cC
Confidence            53

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-44  Score=369.87  Aligned_cols=254  Identities=22%  Similarity=0.399  Sum_probs=210.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-----  127 (499)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|..+++.++||||++++++|...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            357999999999999999999999999999999998765332 23344566799999999999999999998643     


Q ss_pred             -CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 -~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                       ..+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence             357999999975 77777754  48999999999999999999999999999999999999999999999999997543


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc------
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR------  280 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~------  280 (499)
                      ..           .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...      
T Consensus       171 ~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         171 TS-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             Cc-----------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            21           1223467999999999999999999999999999999999999999987755444333221      


Q ss_pred             ----------------C-----CC---------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          281 ----------------D-----IR---------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       281 ----------------~-----~~---------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                                      .     ..               .+...+.++++||.+||+.||++|||+     .++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~-----~ell~hp~~  314 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DEALQHPYI  314 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH-----HHHhcCcch
Confidence                            0     00               112235678999999999999999999     899999999


Q ss_pred             CC
Q 010859          325 KG  326 (499)
Q Consensus       325 ~~  326 (499)
                      ..
T Consensus       315 ~~  316 (355)
T cd07874         315 NV  316 (355)
T ss_pred             hc
Confidence            73

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-44  Score=352.48  Aligned_cols=254  Identities=40%  Similarity=0.701  Sum_probs=219.1

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHH-HHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQLDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      +.||+|+||.||+|.+..+|+.||+|++.+..............|..+ ....+||||+++++++.....+|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            578999999999999999999999999876543322223333445444 4455899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      ++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||+++....            
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------------  149 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------------  149 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------------
Confidence            99999998888899999999999999999999999999999999999999999999999999875321            


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----CCCChHHHHH
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDL  295 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~L  295 (499)
                        .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+....+..+......++    ..+++++.++
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL  227 (260)
T ss_pred             --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHH
Confidence              2245688999999999888889999999999999999999999998888777777766554433    3578999999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          296 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       296 i~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      |.+||+.||++||++.  ++++++.||||..++|+
T Consensus       228 i~~~l~~~p~~R~~~~--~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         228 INRLLCMDPAKRLGAN--GYQEIKSHPFFKSINWD  260 (260)
T ss_pred             HHHHccCCHHHccCCC--cHHHHHcChHhhcCCCC
Confidence            9999999999999984  56899999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-44  Score=373.97  Aligned_cols=258  Identities=21%  Similarity=0.323  Sum_probs=214.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEc--CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ..+|++++.||+|+||.||+|...  .++..||+|.+....        ...+|+.+|+.++||||+++++.|.....+|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999864  356889999875431        2456999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ++||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+....  
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~--  239 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP--  239 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc--
Confidence            9999996 5899999877889999999999999999999999999999999999999999999999999997654321  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH---HHHHHHHHhc--------
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIAR--------  280 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~---~~~~~~i~~~--------  280 (499)
                            .......++||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...   ...+..+...        
T Consensus       240 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        240 ------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ------ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence                  11223357899999999999999999999999999999999999999976432   1222222210        


Q ss_pred             ---------------------CCCCC-----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          281 ---------------------DIRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       281 ---------------------~~~~p-----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                                           .+..|     ..++.++.+||.+||+.||++||++     .+++.||||....|+.++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa-----~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA-----QDILSLPLFTKEPINLLN  387 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH-----HHHhhCchhhccchhhhc
Confidence                                 01111     1356789999999999999999999     899999999988877654

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-45  Score=356.77  Aligned_cols=252  Identities=38%  Similarity=0.679  Sum_probs=215.5

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      |++++.||+|+||+||+|.+..+++.||+|++.......... ....+|..++++++||||+++++++.+...+|+||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~-~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEER-EENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHH-HHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccccc-chhhhhhhccccccccccccccccccccccccccccc
Confidence            899999999999999999999999999999998875443332 2334589999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCC
Q 010859          137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  216 (499)
Q Consensus       137 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~  216 (499)
                      +++++|.+++...+.+++..+..++.||+.||.+||++||+||||||+||+++.++.++|+|||.+.....         
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---------  150 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---------  150 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------
Confidence            99999999999778899999999999999999999999999999999999999999999999999875411         


Q ss_pred             CCCCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHhcCCCCC----CCC
Q 010859          217 ASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFP----NYF  288 (499)
Q Consensus       217 ~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p----~~~  288 (499)
                       .........||..|+|||++. +..++.++|+||||+++|+|++|..||...+   ......+........+    ...
T Consensus       151 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T PF00069_consen  151 -NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREK  229 (260)
T ss_dssp             -TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTS
T ss_pred             -cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchh
Confidence             122334567899999999998 8889999999999999999999999999873   3333333333222211    122


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +.++.+||.+||+.||++||++     .++++||||
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~-----~~l~~~~~~  260 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSA-----EELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTH-----HHHHTSGGG
T ss_pred             HHHHHHHHHHHccCChhHCcCH-----HHHhcCCCC
Confidence            4899999999999999999998     999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-44  Score=368.12  Aligned_cols=253  Identities=25%  Similarity=0.442  Sum_probs=210.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~------  127 (499)
                      .++|++++.||+|+||+||+|.+..+++.||+|++.+.... ......+.+|+.+++.++||||++++++|...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            46899999999999999999999999999999998765322 22334466799999999999999999888643      


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|++|+++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            4579999998 6799887754 5699999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  281 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----  281 (499)
                                   ....++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....     
T Consensus       171 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         171 -------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             -------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence                         2235689999999999876 568899999999999999999999998877655544443211     


Q ss_pred             ------------------CCCC--------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          282 ------------------IRFP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       282 ------------------~~~p--------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                        ...|        ...++.+.+||.+||+.||.+|||+     .++++||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~-----~ell~hp~~~~~  304 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA-----SEALAHPYFSQY  304 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcchhcc
Confidence                              0011        2356778999999999999999998     899999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.6e-44  Score=345.97  Aligned_cols=253  Identities=27%  Similarity=0.561  Sum_probs=219.6

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCeEEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSLYMAL  134 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-~~~l~lv~  134 (499)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+........ ....+.+|..+++.++|||++++++.+.. ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH-HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            58999999999999999999999999999999876543322 33456778999999999999999998864 55789999


Q ss_pred             eccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          135 ESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       135 E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||+++++|.+++...  ..+++.+++.++.|++.||.+||++||+||||||+||+++.++.++|+|||++..+....   
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~---  156 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---  156 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence            999999999998763  458999999999999999999999999999999999999999999999999987653221   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCChH
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDA  291 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~  291 (499)
                             .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..+.. ..|..++++
T Consensus       157 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (257)
T cd08223         157 -------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPE  229 (257)
T ss_pred             -------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHH
Confidence                   122346789999999999998999999999999999999999999998877666666665544 456778999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +.+||.+||+.||.+||++     .+++.||||
T Consensus       230 ~~~li~~~l~~~p~~Rp~~-----~~~l~~~~~  257 (257)
T cd08223         230 LGELIATMLSKRPEKRPSV-----KSILRQPYI  257 (257)
T ss_pred             HHHHHHHHhccCcccCCCH-----HHHhcCCCC
Confidence            9999999999999999998     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-44  Score=353.95  Aligned_cols=269  Identities=49%  Similarity=0.873  Sum_probs=239.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+++.+. ||||+++++++.+...+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998766655666677888999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999987654321100


Q ss_pred             C----------CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Q 010859          214 P----------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR  283 (499)
Q Consensus       214 ~----------~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~  283 (499)
                      .          ..........+.|+..|+|||++.+..++.++|+|||||+++++++|+.||...+....++.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence            0          000112334567899999999998888999999999999999999999999999888888888888889


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +|..+++.+.+||.+||+.||.+||++.+ +++++++||||
T Consensus       241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~-~~~~ll~~~~~  280 (280)
T cd05581         241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF  280 (280)
T ss_pred             CCCccCHHHHHHHHHHhcCCHhhCCCccc-CHHHHhcCCCC
Confidence            99999999999999999999999999965 67899999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.2e-44  Score=355.77  Aligned_cols=262  Identities=31%  Similarity=0.521  Sum_probs=223.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +.|++++.||.|+||.||+|++..+++.||+|++...   .......+..|+.+++.++||||+++++.+..+..+|+||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            5699999999999999999999999999999998654   2334455677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+++++|..++.+ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......     
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-----  163 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-----  163 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-----
Confidence            99999999887764 356899999999999999999999999999999999999999999999999998653221     


Q ss_pred             CCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---CCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFP  285 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p  285 (499)
                           ........|++.|+|||++.     ...++.++|+|||||++|+|++|.+||...+......++....   ...|
T Consensus       164 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T cd06644         164 -----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP  238 (292)
T ss_pred             -----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCC
Confidence                 11223567899999999984     3456788999999999999999999998877665555554432   2345


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      ..++.++.+||.+||..||++||++     +++++||||..++|.....
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~~~~~~  282 (292)
T cd06644         239 SKWSMEFRDFLKTALDKHPETRPSA-----AQLLEHPFVSSVTSNRPLR  282 (292)
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCH-----HHHhcCccccccccchhHH
Confidence            6788999999999999999999988     8999999999998876443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.1e-44  Score=348.74  Aligned_cols=263  Identities=42%  Similarity=0.720  Sum_probs=229.9

Q ss_pred             eeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCh
Q 010859           63 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  142 (499)
Q Consensus        63 LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L  142 (499)
                      ||.|+||.||+|.+..+|+.||+|++.+...........+.+|..++++++||||+++++.+......|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999776554445566788899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 010859          143 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  222 (499)
Q Consensus       143 ~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~  222 (499)
                      .+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++...........  .......
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--NDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc--ccccccc
Confidence            99999878899999999999999999999999999999999999999999999999999875432211000  0001122


Q ss_pred             cccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC--ChHHHHHHHHhh
Q 010859          223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF--SDAARDLIDRLL  300 (499)
Q Consensus       223 ~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--~~~~~~Li~~lL  300 (499)
                      ....++..|+|||.+.+...+.++|+|||||++|+|++|..||........+..+......+|...  +..+.+||.+||
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  238 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL  238 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHh
Confidence            345788999999999888899999999999999999999999999888888888887777777766  999999999999


Q ss_pred             ccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          301 DVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       301 ~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      +.+|.+||++.  .+.++++||||++++|
T Consensus       239 ~~~p~~Rpt~~--~~~~~l~~~~~~~~~~  265 (265)
T cd05579         239 VPDPEKRLGAK--SIEEIKNHPFFKGIDW  265 (265)
T ss_pred             cCCHhhcCCCc--cHHHHhcCccccCCCC
Confidence            99999999984  4688999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.5e-44  Score=348.22  Aligned_cols=260  Identities=28%  Similarity=0.514  Sum_probs=223.3

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh------hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE------NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~------~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+........      .....+.+|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            47889999999999999999999999999999876543321      233567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      .+++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.++.+....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998765321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                      ...    ........+.|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+... ...+|..+
T Consensus       161 ~~~----~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06628         161 LST----KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI  236 (267)
T ss_pred             ccC----CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCccc
Confidence            110    0111223467899999999999888999999999999999999999999887665555444432 44577789


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +..+.++|++||+.||.+||++     .++++||||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~  267 (267)
T cd06628         237 SSEAIDFLEKTFEIDHNKRPTA-----AELLKHPFL  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCH-----HHHhhCCCC
Confidence            9999999999999999999988     899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.4e-44  Score=349.43  Aligned_cols=255  Identities=36%  Similarity=0.644  Sum_probs=226.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||++++..+.+...+|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999987655554556678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      |+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......      
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------  154 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------  154 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence            99999999999888789999999999999999999999999999999999999999999999999987653321      


Q ss_pred             CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHhcCCCCCCCCChHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFPNYFSDAA  292 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~  292 (499)
                           ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+   .....+........+|..++.++
T Consensus       155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd05578         155 -----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEA  229 (258)
T ss_pred             -----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHH
Confidence                 1224568899999999998889999999999999999999999998776   34444444446677888899999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .++|.+||..||.+||++.   ..++++||||
T Consensus       230 ~~~i~~~l~~~p~~R~~~~---~~~l~~~~~~  258 (258)
T cd05578         230 IDAINKLLERDPQKRLGDN---LKDLKNHPYF  258 (258)
T ss_pred             HHHHHHHccCChhHcCCcc---HHHHhcCCCC
Confidence            9999999999999999883   5789999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.7e-44  Score=355.59  Aligned_cols=258  Identities=23%  Similarity=0.406  Sum_probs=215.4

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .+++|++.+.||+|+||.||+|.+..+++.||+|.+......  .....+.+|+.+++.++||||+++++++.+...+|+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            367899999999999999999999999999999998754322  223345679999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......  
T Consensus        82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            999997 4898888754 568999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc----------
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR----------  280 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~----------  280 (499)
                              .......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+...          
T Consensus       159 --------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  230 (301)
T cd07873         159 --------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP  230 (301)
T ss_pred             --------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence                    112234678999999998654 4788999999999999999999999987765554443321          


Q ss_pred             ---------CCCCC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          281 ---------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       281 ---------~~~~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                               ...+|           ..+++++++||.+||+.||.+|||+     +++++||||+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-----~eil~h~~f~~~~  293 (301)
T cd07873         231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA-----EEAMKHPYFHCLG  293 (301)
T ss_pred             hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH-----HHHhcCccccccc
Confidence                     11112           2468889999999999999999998     8999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-43  Score=355.99  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=215.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.+..++..+|+|.+....  .......+.+|+++++.++||||+++++.|.+...+|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999986542  2334455777999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++......     
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  153 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----  153 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence            999999999999988889999999999999999999997 69999999999999999999999999998654221     


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-------------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  280 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-------------  280 (499)
                             ....++|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...             
T Consensus       154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence                   123568999999999998888999999999999999999999999765533322111110             


Q ss_pred             ------------------------CCCCC-CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 ------------------------DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ------------------------~~~~p-~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                              ....| ..++.++++||.+||..||++||++     +++++||||.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~~~~~~  292 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL-----KELTKHPFIKR  292 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhhh
Confidence                                    01111 1367889999999999999999998     89999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-44  Score=363.39  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=203.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEE-----cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~  125 (499)
                      +..++|++++.||+|+||.||+|.+     ..++..||+|++....  .......+.+|..+++.+ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            4457899999999999999999985     2456789999986542  222345577899999999 8999999999887


Q ss_pred             cC-CeEEEEEeccCCCChHHHHhhc-------------------------------------------------------
Q 010859          126 DT-FSLYMALESCEGGELFDQITSK-------------------------------------------------------  149 (499)
Q Consensus       126 ~~-~~l~lv~E~~~gg~L~~~i~~~-------------------------------------------------------  149 (499)
                      .. ..+|+||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4689999999999999988753                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 010859          150 -------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  222 (499)
Q Consensus       150 -------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~  222 (499)
                             ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....        ....
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~--------~~~~  233 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--------YVRK  233 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc--------hhcc
Confidence                   2377889999999999999999999999999999999999999999999999986532210        1112


Q ss_pred             cccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHH-HHHHHhc-CCCCCCCCChHHHHHHHHh
Q 010859          223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLI-FQRIIAR-DIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       223 ~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~-~~~i~~~-~~~~p~~~~~~~~~Li~~l  299 (499)
                      .+..+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...... .+.+... ....|...++++.+||.+|
T Consensus       234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  313 (338)
T cd05102         234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLAC  313 (338)
T ss_pred             cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            23456788999999999999999999999999999997 9999987654333 3333332 3456778899999999999


Q ss_pred             hccCCCCCCCC
Q 010859          300 LDVDPSGRPGA  310 (499)
Q Consensus       300 L~~dP~~R~~~  310 (499)
                      |+.||.+||++
T Consensus       314 l~~dp~~RPs~  324 (338)
T cd05102         314 WQGDPKERPTF  324 (338)
T ss_pred             ccCChhhCcCH
Confidence            99999999998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-45  Score=342.94  Aligned_cols=251  Identities=32%  Similarity=0.527  Sum_probs=216.2

Q ss_pred             CCCCeeee-eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHH-HHhCCCCCccEEEEEEE----c
Q 010859           53 SIQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQLDHPGVVRLFFTFQ----D  126 (499)
Q Consensus        53 ~~~~y~~~-~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~Iv~l~~~~~----~  126 (499)
                      ..+||.+- ++||-|-.|.|..|.++.||+.||+|++...        ....+|+++ +..-.|||||+++++|+    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            45778765 5789999999999999999999999987432        123456654 34447999999998875    4


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC---CCEEEEecCC
Q 010859          127 TFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGS  201 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~---~~vkL~DFG~  201 (499)
                      ..++.+|||.++||+|+..|..++.  |+|.++..|+.||..|+.|||+.+|.||||||||+|.+.+   ..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            5679999999999999999998865  9999999999999999999999999999999999999764   4699999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH----HHHHHHH
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI  277 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~----~~~~~~i  277 (499)
                      |+.-..           .....+.|-||.|+|||++....|+..+|+||||||+|-|++|.+||.....    ..+..+|
T Consensus       211 AK~t~~-----------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI  279 (400)
T KOG0604|consen  211 AKETQE-----------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI  279 (400)
T ss_pred             ccccCC-----------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh
Confidence            986432           2334467889999999999999999999999999999999999999976533    3467889


Q ss_pred             HhcCCCCCC----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          278 IARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       278 ~~~~~~~p~----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ..+.+.||+    .+|.+++|+|++||..+|.+|+|+     +++++|||..+.
T Consensus       280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI-----~~~m~hpwi~~~  328 (400)
T KOG0604|consen  280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTI-----EEVMDHPWINQY  328 (400)
T ss_pred             hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeH-----HHhhcCchhccc
Confidence            999999996    479999999999999999999998     889999999753

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.2e-43  Score=350.05  Aligned_cols=270  Identities=36%  Similarity=0.708  Sum_probs=230.0

Q ss_pred             CeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccch-hhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l  130 (499)
                      +|++.+.||.|+||.||+|.+.   .+|..||+|++....... ......+.+|+.+++.+ +|+||+++++.|+.+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999985   478999999987643322 22345567799999999 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999987653321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCC--CCCCCCcchhhhHHHHHHhcCCCCCCCCC----HHHHHHHHHhcCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQRIIARDIRF  284 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDiwslG~ilyelltG~~Pf~~~~----~~~~~~~i~~~~~~~  284 (499)
                              ........|+..|+|||.+.+.  .++.++|+|||||++|+|++|..||....    .....+.+......+
T Consensus       160 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (290)
T cd05613         160 --------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  231 (290)
T ss_pred             --------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC
Confidence                    1122346789999999998753  46788999999999999999999997432    234445555566677


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      |..+++.+.+|+.+||+.||.+||++...+.++++.||||..++|+.+..
T Consensus       232 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  281 (290)
T cd05613         232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAA  281 (290)
T ss_pred             CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhh
Confidence            88899999999999999999999987766789999999999999988754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.3e-44  Score=349.34  Aligned_cols=253  Identities=31%  Similarity=0.519  Sum_probs=214.9

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|..+++.++||||+++++.+.+...+|+
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            3468999999999999999999999999999999986542   2223446678899999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......   
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI---  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc---
Confidence            99999999999999888899999999999999999999999999999999999999999999999999987553211   


Q ss_pred             cCCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  285 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----  285 (499)
                             .......|+..|+|||++.   ...++.++|+|||||++|+|++|..||...........+.......+    
T Consensus       161 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06645         161 -------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD  233 (267)
T ss_pred             -------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence                   1223457999999999974   45578899999999999999999999976654443333333332222    


Q ss_pred             -CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 010859          286 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  323 (499)
Q Consensus       286 -~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpf  323 (499)
                       ..++..+.+||.+||+.+|++||++     +++++|||
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~R~~~-----~~ll~~~~  267 (267)
T cd06645         234 KMKWSNSFHHFVKMALTKNPKKRPTA-----EKLLQHPF  267 (267)
T ss_pred             cCCCCHHHHHHHHHHccCCchhCcCH-----HHHhcCCC
Confidence             2467889999999999999999988     89999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-43  Score=357.24  Aligned_cols=247  Identities=27%  Similarity=0.402  Sum_probs=194.7

Q ss_pred             eeEeeecCceEEEEEEEc--CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEEEEEe
Q 010859           60 GKIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLYMALE  135 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~~~l~lv~E  135 (499)
                      ++.||+|+||+||+|+++  .+++.||+|.+.....     .....+|+.+++.++||||+++++.|..  ...+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            568999999999999976  4678999999865432     2235679999999999999999999854  567899999


Q ss_pred             ccCCCChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee----CCCCCEEEEecCCc
Q 010859          136 SCEGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSV  202 (499)
Q Consensus       136 ~~~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl----~~~~~vkL~DFG~a  202 (499)
                      |+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            9964 888877532         248999999999999999999999999999999999999    45678999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHH---------H
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW---------L  272 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~---------~  272 (499)
                      +.+.....       ........+||+.|+|||++.+. .++.++|||||||++|+|++|++||....+.         .
T Consensus       160 ~~~~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07868         160 RLFNSPLK-------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  232 (317)
T ss_pred             eccCCCCc-------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence            86543211       11223356899999999998764 5899999999999999999999999754321         1


Q ss_pred             HHHHHHhcC----------------------------CC----------CCCCCChHHHHHHHHhhccCCCCCCCCCCCC
Q 010859          273 IFQRIIARD----------------------------IR----------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGG  314 (499)
Q Consensus       273 ~~~~i~~~~----------------------------~~----------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~  314 (499)
                      .+..+....                            ..          .....+.++.+||.+||+.||.+|||+    
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~----  308 (317)
T cd07868         233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS----  308 (317)
T ss_pred             HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCH----
Confidence            122221100                            00          001235678999999999999999999    


Q ss_pred             HHHHhcCCCC
Q 010859          315 YAVLKMHPFF  324 (499)
Q Consensus       315 ~~~l~~Hpff  324 (499)
                       +++++||||
T Consensus       309 -~e~l~hp~f  317 (317)
T cd07868         309 -EQAMQDPYF  317 (317)
T ss_pred             -HHHhcCCCC
Confidence             899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.4e-43  Score=341.34  Aligned_cols=253  Identities=30%  Similarity=0.478  Sum_probs=222.8

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+........ ....+..|..+++.++||||+++++++.+....|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH-HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            68999999999999999999999999999999876544433 34557779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.+....    
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~----  155 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT----  155 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence            99999999998764  568999999999999999999999999999999999999999999999999988654321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCChHH
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAA  292 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~  292 (499)
                            .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..... .++..++.++
T Consensus       156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08529         156 ------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQL  229 (256)
T ss_pred             ------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHH
Confidence                  112245789999999999998899999999999999999999999998887777777666543 3455789999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .++|.+||+.+|++||++     .+++.|||+
T Consensus       230 ~~~i~~~l~~~p~~Rp~~-----~~ll~~~~~  256 (256)
T cd08529         230 AQLIDQCLTKDYRQRPDT-----FQLLRNPSL  256 (256)
T ss_pred             HHHHHHHccCCcccCcCH-----HHHhhCCCC
Confidence            999999999999999998     889999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=373.84  Aligned_cols=258  Identities=31%  Similarity=0.521  Sum_probs=229.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +-|+|+..||.|+||.||+|.+++|+-.-|.|++...   .+...+...-|+++|..++||+||+|++.|-.++.++++.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            4588999999999999999999999999999998754   3444555666999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||.||-...++-.- ..|++.+++.+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+.....      
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~------  182 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS------  182 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh------
Confidence            999999998877665 4599999999999999999999999999999999999999999999999999865332      


Q ss_pred             CCCCCCCCccccccCccCCCcccc-----CCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC---CC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FP  285 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l-----~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~---~p  285 (499)
                          ......+|+|||.|||||++     .+.+|+.++||||||++|.+|..+.+|-...+....+-+|.+..++   -|
T Consensus       183 ----t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP  258 (1187)
T KOG0579|consen  183 ----TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP  258 (1187)
T ss_pred             ----HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc
Confidence                12345589999999999996     5678999999999999999999999999999998888888776543   57


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      ..|+..+.||+.+||.+||..||++     ++|++||||.+++-+
T Consensus       259 S~Ws~~F~DfLk~cL~Knp~~Rp~a-----aqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  259 SHWSRSFSDFLKRCLVKNPRNRPPA-----AQLLKHPFVQNAPSN  298 (1187)
T ss_pred             chhhhHHHHHHHHHHhcCCccCCCH-----HHHhhCcccccCCcc
Confidence            8899999999999999999999999     899999999987654

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-43  Score=358.66  Aligned_cols=262  Identities=25%  Similarity=0.392  Sum_probs=211.0

Q ss_pred             eeeeEeeec--CceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           58 ELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        58 ~~~~~LG~G--~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +++++||+|  +||+||++.++.+|+.||+|.+...... ......+.+|+.+++.++||||++++++|.++..+|+|||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            357889999  7899999999999999999998765432 3345667789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+++|+|.+++...  +.+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||.+.......... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~-  158 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL-  158 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc-
Confidence            99999999998753  458999999999999999999999999999999999999999999999998765432211000 


Q ss_pred             CCCCCCCCccccccCccCCCccccCC--CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC--------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--------  283 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------  283 (499)
                        ..........+++..|+|||++.+  ..++.++|||||||++|+|++|+.||..................        
T Consensus       159 --~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         159 --RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             --cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence              000111123467888999999976  45889999999999999999999999876554433332221110        


Q ss_pred             --------------------------------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          284 --------------------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       284 --------------------------------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                                            +...+++++.+||.+||+.||++|||+     +++++||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~ell~~p~f~  311 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA-----STLLNHSFFK  311 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH-----HHHhcChhhh
Confidence                                                  112356789999999999999999999     8999999998


Q ss_pred             CCC
Q 010859          326 GID  328 (499)
Q Consensus       326 ~i~  328 (499)
                      .+.
T Consensus       312 ~~~  314 (327)
T cd08227         312 QIK  314 (327)
T ss_pred             hcc
Confidence            654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-43  Score=344.15  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=219.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc---hhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      +|++++.||.|+||.||+|.+ .+|+.+|+|.+......   .......+.+|+.+++.++|+||+++++++.+...+|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999986 57899999998754322   12234557789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      +|||+++++|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987653221110


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCCCC
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFS  289 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~  289 (499)
                          ..........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...   ...+|..++
T Consensus       160 ----~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         160 ----THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             ----cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence                0011223457899999999999888999999999999999999999999877655544444332   235677889


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .++.++|.+||..+|.+||++     .++++||||
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~-----~~~l~~~~~  265 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSA-----LQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCH-----HHHhcCCCC
Confidence            999999999999999999988     899999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=350.12  Aligned_cols=257  Identities=30%  Similarity=0.534  Sum_probs=222.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||.|+||.||+|.+..++..||+|++...   .......+..|+.++++++||||+++++.+.+...+|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            36799999999999999999999999999999998643   333445577799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......    
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~----  156 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST----  156 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc----
Confidence            9999999999998764 46999999999999999999999999999999999999999999999999998654321    


Q ss_pred             cCCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---CCC
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF  284 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~  284 (499)
                            ........||+.|+|||++.     ...++.++|+|||||++|+|++|++||.+.+.......+....   +..
T Consensus       157 ------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (280)
T cd06611         157 ------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ  230 (280)
T ss_pred             ------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC
Confidence                  11223567899999999974     3456789999999999999999999999887766666665543   334


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      |..++.++.+||.+||+.+|.+||++     +++++||||....
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~~~  269 (280)
T cd06611         231 PSKWSSSFNDFLKSCLVKDPDDRPTA-----AELLKHPFVSDQS  269 (280)
T ss_pred             cccCCHHHHHHHHHHhccChhhCcCH-----HHHhcChhhcccc
Confidence            66789999999999999999999998     8999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.1e-43  Score=343.79  Aligned_cols=258  Identities=29%  Similarity=0.509  Sum_probs=218.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch--hhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSL  130 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~~~l  130 (499)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+.......  ......+.+|+.+++.++||||+++++.+.+  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999987553222  2234567789999999999999999998875  4678


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |++|||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999876532110


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh--cCCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--RDIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~  288 (499)
                             .........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+..  ....+|..+
T Consensus       162 -------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (266)
T cd06651         162 -------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI  234 (266)
T ss_pred             -------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhc
Confidence                   01112235688999999999988899999999999999999999999987765554444433  234567778


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ++.+++|| +||..+|++||++     +++++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~-----~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSA-----EELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCH-----HHHhcCcccc
Confidence            99999999 5667899999988     8999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.6e-43  Score=386.24  Aligned_cols=151  Identities=34%  Similarity=0.592  Sum_probs=141.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||.||+|.+..+++.||||++.+...........+..|+.+++.++||||++++.++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            68999999999999999999999999999999999876555555567788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      |||+.|++|.+++...+.+++..++.|+.||+.||.|||.+||+||||||+||||+.++++||+|||+++.
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~  153 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV  153 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4e-43  Score=346.64  Aligned_cols=251  Identities=26%  Similarity=0.448  Sum_probs=211.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+..  .......+.+|+.++++++||||+++++.+......++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            47899999999999999999999999999999987653  2223445778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||+++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..+...      
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------  148 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------  148 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------
Confidence            99999988654    35789999999999999999999999999999999999999999999999998754321      


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH-------HHHHHHHHhcC-CCC-C
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-------WLIFQRIIARD-IRF-P  285 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~-------~~~~~~i~~~~-~~~-p  285 (499)
                            .....+||..|+|||++.+..++.++|+|||||++|+|++|..||.....       ....+.+.... ... .
T Consensus       149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (279)
T cd06619         149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV  222 (279)
T ss_pred             ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC
Confidence                  22346899999999999998999999999999999999999999965321       12223332222 122 2


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      ..+++++.+||.+||+.||.+||++     ++++.||||...+
T Consensus       223 ~~~~~~~~~li~~~l~~~P~~Rp~~-----~eil~~~~~~~~~  260 (279)
T cd06619         223 GQFSEKFVHFITQCMRKQPKERPAP-----ENLMDHPFIVQYN  260 (279)
T ss_pred             CcCCHHHHHHHHHHhhCChhhCCCH-----HHHhcCccccccc
Confidence            3478899999999999999999988     8899999998653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6e-43  Score=342.23  Aligned_cols=258  Identities=29%  Similarity=0.504  Sum_probs=218.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc--hhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSL  130 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~~~l  130 (499)
                      .+|++.+.||+|+||.||.|.+..+|..||+|.+......  .......+.+|+.+++.+.||||+++++.+.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5899999999999999999999999999999998643221  22334567889999999999999999999876  3578


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |++|||+++++|.+++.+.+.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999886533211


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~  288 (499)
                             .........|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+...  ...+|..+
T Consensus       162 -------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06652         162 -------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHV  234 (265)
T ss_pred             -------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhh
Confidence                   011223456899999999998888999999999999999999999999877655555444432  23456778


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      +..+.++|.+||. +|++||++     ++++.|||++
T Consensus       235 ~~~~~~~i~~~l~-~p~~Rp~~-----~~il~~~~~~  265 (265)
T cd06652         235 SDHCRDFLKRIFV-EAKLRPSA-----DELLRHTFVH  265 (265)
T ss_pred             CHHHHHHHHHHhc-ChhhCCCH-----HHHhcCcccC
Confidence            8999999999995 99999998     8999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.9e-43  Score=347.81  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=209.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|+||.||+|++..++..||+|++..... .+.....+..|+.+++.++||||+++++++.++..+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            68999999999999999999999999999999865432 22233556779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          136 SCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       136 ~~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |++ ++|.+++...   +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......   
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence            997 5888887643   468999999999999999999999999999999999999999999999999987543211   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC----------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----------  281 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~----------  281 (499)
                             .......|++.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+.......+....          
T Consensus       156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         156 -------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             -------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence                   111234678999999998654 47889999999999999999999998876644333222100          


Q ss_pred             --------C-----------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 --------I-----------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 --------~-----------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                              .           .....+++++.+||.+||+.||.+||++     .+++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~~ll~~~~~  285 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA-----KKALNHPYF  285 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH-----HHHhcCCCC
Confidence                    0           0123478999999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.8e-43  Score=347.01  Aligned_cols=252  Identities=29%  Similarity=0.516  Sum_probs=216.9

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      |++.+.||+|+||.||+|.+..++..+|+|.+....   ......+.+|+.+++.++||||+++++.+......|+||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            688999999999999999999999999999986542   23345567799999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          137 CEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       137 ~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      +++++|..++.+ .+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......      
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~------  157 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------  157 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc------
Confidence            999999888765 4579999999999999999999999999999999999999999999999999987543211      


Q ss_pred             CCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCC
Q 010859          216 AASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNY  287 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~  287 (499)
                          .......||..|+|||++.     +..++.++|+|||||++|+|++|.+||...+.......+...   ....|..
T Consensus       158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd06643         158 ----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR  233 (282)
T ss_pred             ----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccc
Confidence                1223457899999999984     445778999999999999999999999988776665555443   2335667


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ++.++.+||.+||..||.+||++     +++++||||..
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~  267 (282)
T cd06643         234 WSSEFKDFLKKCLEKNVDARWTT-----TQLLQHPFVTV  267 (282)
T ss_pred             cCHHHHHHHHHHccCChhhCcCH-----HHHhcCCCEec
Confidence            89999999999999999999998     89999999974

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-43  Score=345.80  Aligned_cols=252  Identities=29%  Similarity=0.469  Sum_probs=213.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ..+|++++.||+|+||.||+|++..+++.||+|++.....   .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            4689999999999999999999999999999999865422   2234567799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+....    
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~----  160 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI----  160 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc----
Confidence            9999999999999888889999999999999999999999999999999999999999999999999997653211    


Q ss_pred             CCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC-----C
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-----P  285 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-----p  285 (499)
                            .......|+..|+|||.+.   ...++.++|+|||||++|+|++|..||...........+....+..     +
T Consensus       161 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06646         161 ------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK  234 (267)
T ss_pred             ------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence                  1223457899999999984   3447789999999999999999999997665443333332222222     2


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  323 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpf  323 (499)
                      ..++..+.+||.+||..||++||++     +++++|+|
T Consensus       235 ~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~l~  267 (267)
T cd06646         235 TKWSSTFHNFVKISLTKNPKKRPTA-----ERLLTHLF  267 (267)
T ss_pred             cccCHHHHHHHHHHhhCChhhCcCH-----HHHhcCCC
Confidence            3578899999999999999999998     88999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-43  Score=361.94  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=203.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ....+|++++.||+|+||.||+|.+..+++.||+|+..+..         ...|..+++.++||||+++++++......|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            33467999999999999999999999999999999854332         234888999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||++. ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            9999996 588888865 456999999999999999999999999999999999999999999999999998743211  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCC-CCCCCH---------HHHHHHHHhc
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSE---------WLIFQRIIAR  280 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~P-f~~~~~---------~~~~~~i~~~  280 (499)
                               .......||+.|+|||++.+..++.++|||||||++|+|+++..| |.....         ...+..+...
T Consensus       211 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~  281 (357)
T PHA03209        211 ---------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST  281 (357)
T ss_pred             ---------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHH
Confidence                     122346799999999999999999999999999999999985444 443211         1111111111


Q ss_pred             ----CCCCC------------------------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 ----DIRFP------------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ----~~~~p------------------------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                          ...+|                              ..++.++.+||.+||+.||.+|||+     +++++||||+.
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta-----~e~l~hp~f~~  356 (357)
T PHA03209        282 LKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA-----EEILNYPMFAQ  356 (357)
T ss_pred             hccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH-----HHHhcCchhcc
Confidence                01111                              1356778899999999999999999     89999999985


Q ss_pred             C
Q 010859          327 I  327 (499)
Q Consensus       327 i  327 (499)
                      +
T Consensus       357 ~  357 (357)
T PHA03209        357 L  357 (357)
T ss_pred             C
Confidence            3

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.3e-43  Score=345.30  Aligned_cols=254  Identities=27%  Similarity=0.435  Sum_probs=213.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            47999999999999999999999999999999986543221 22344667999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++++.|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+....     
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-----  154 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG-----  154 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc-----
Confidence            999998888877777789999999999999999999999999999999999999999999999999998654321     


Q ss_pred             CCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-------------
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  280 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-------------  280 (499)
                           .......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+...             
T Consensus       155 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         155 -----DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             -----ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence                 11224568889999999876 45788999999999999999999999887765544333210             


Q ss_pred             ------CCCCC------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          281 ------DIRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       281 ------~~~~p------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                            ....|            ..++..+.+||.+||+.||++||++     .+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~eil~~~~f  286 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC-----EELLEHPYF  286 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH-----HHHhcCCCC
Confidence                  00111            2467889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-43  Score=344.77  Aligned_cols=259  Identities=26%  Similarity=0.481  Sum_probs=219.0

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch---hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK---ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      +|+.++.||+|+||.||+|.+..+++.||+|++.......   ......+..|+.+++.++||||+++++++.+...+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4888999999999999999999999999999987543222   2234567789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||++|++|.+++.+.+++++..+..++.||+.||.|||++|++||||+|+||+++.++ .++|+|||.+..+......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998876 5999999998776432100


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH---H--hcCCCCCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---I--ARDIRFPN  286 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i---~--~~~~~~p~  286 (499)
                            .........||..|+|||++.+..++.++|+|||||++|+|++|..||...........+   .  .....+|.
T Consensus       161 ------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd06630         161 ------AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE  234 (268)
T ss_pred             ------CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch
Confidence                  111223457899999999998888999999999999999999999999754432222222   1  22345677


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      .+++++.+++.+||..+|.+||++     .++++||||+
T Consensus       235 ~~~~~~~~~i~~~l~~~p~~R~~~-----~~ll~~~~~~  268 (268)
T cd06630         235 HLSPGLRDVTLRCLELQPEDRPPS-----RELLKHPVFR  268 (268)
T ss_pred             hhCHHHHHHHHHHcCCCcccCcCH-----HHHhcCcccC
Confidence            789999999999999999999998     8999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.2e-43  Score=347.77  Aligned_cols=269  Identities=38%  Similarity=0.721  Sum_probs=228.1

Q ss_pred             CeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccch-hhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l  130 (499)
                      +|++.+.||+|+||.||+|++.   .+++.||+|++.+..... ......+..|..++.++ +||||+++++.+.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   467899999987643322 23345567799999999 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||+.+|+|.+++...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++.+.... 
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence            9999999999999999887789999999999999999999999999999999999999999999999999987653321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCC--CCCCCcchhhhHHHHHHhcCCCCCCCCC----HHHHHHHHHhcCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQRIIARDIRF  284 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--~~~~sDiwslG~ilyelltG~~Pf~~~~----~~~~~~~i~~~~~~~  284 (499)
                              ........|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||....    .....+.+.......
T Consensus       160 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd05583         160 --------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF  231 (288)
T ss_pred             --------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC
Confidence                    11223457899999999987655  7889999999999999999999996432    234445566666778


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |..++..+.++|.+||+.||++|||+.  ++.++++||||++++|+.+...
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~--~~~~~l~~~~~~~~~~~~~~~~  280 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGAN--GADEIKNHPFFQGIDWDDLAAK  280 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcc--hHHHHhcCcccccCCHHHHhhh
Confidence            888999999999999999999999984  4688999999999999877543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-43  Score=348.77  Aligned_cols=242  Identities=17%  Similarity=0.242  Sum_probs=209.6

Q ss_pred             CCCeeee--eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----C
Q 010859           54 IQDFELG--KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----T  127 (499)
Q Consensus        54 ~~~y~~~--~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~----~  127 (499)
                      ..+++..  ..||+|++|.||+|..  +|+.||||++.+...........+.+|+.+|++++||||+++++++.+    .
T Consensus        17 ~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         17 SDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             HHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            3444444  6799999999999988  789999999976644443445667789999999999999999999876    4


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      ..+++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+.
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            5789999999999999999988889999999999999999999998 499999999999999999999999999987543


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCC--CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DI  282 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~  282 (499)
                      ..             ....+||..|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+....+..+...  .+
T Consensus       175 ~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~  241 (283)
T PHA02988        175 SP-------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL  241 (283)
T ss_pred             cc-------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            21             123478999999999976  67899999999999999999999999998888887777654  44


Q ss_pred             CCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          283 RFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       283 ~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .+|...++++++|+.+||+.||++||++
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~  269 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNI  269 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCH
Confidence            5666789999999999999999999998

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8e-43  Score=340.58  Aligned_cols=257  Identities=32%  Similarity=0.519  Sum_probs=220.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||.|+||+||+|....++..+|+|++.......  ....+.+|+.+++.++|+||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999999999999999987654333  4456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          135 ESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       135 E~~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      |++++++|.+++...   +.+++..+..++.|++.||.|||++||+||||+|+||++++++.++|+|||++..+......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   45899999999999999999999999999999999999999999999999998766543211


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-CC----
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FP----  285 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p----  285 (499)
                            ........+|+..|+|||++... .++.++|+|||||++|+|++|+.||...+....+.++...... ++    
T Consensus       159 ------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06610         159 ------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD  232 (267)
T ss_pred             ------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccc
Confidence                  01123456799999999998776 7899999999999999999999999887776666655544321 22    


Q ss_pred             -CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          286 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       286 -~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                       ..+++++.+|+.+||+.||++||++     ++++.||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTA-----EELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCH-----HHHhhCCCC
Confidence             2568899999999999999999998     899999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.4e-43  Score=348.09  Aligned_cols=254  Identities=29%  Similarity=0.477  Sum_probs=221.1

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      .+|++.+.||.|+||.||+|.+..+|+.||+|.+.....   .....+.+|..+++.++||||+++++.+.+...+|+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            579999999999999999999999999999999875432   23455677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||+++++|..++... .+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......     
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-----  169 (296)
T cd06655          96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-----  169 (296)
T ss_pred             EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc-----
Confidence            999999999988754 69999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCCCChH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA  291 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~  291 (499)
                           .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+...   ....|..+++.
T Consensus       170 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06655         170 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI  244 (296)
T ss_pred             -----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHH
Confidence                 1123457899999999999888999999999999999999999999988776555444432   23456678999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      +.+||.+||..||.+||++     .+++.||||+..
T Consensus       245 ~~~li~~~l~~dp~~Rpt~-----~~il~~~~~~~~  275 (296)
T cd06655         245 FRDFLNRCLEMDVEKRGSA-----KELLQHPFLKLA  275 (296)
T ss_pred             HHHHHHHHhhcChhhCCCH-----HHHhhChHhhhc
Confidence            9999999999999999988     899999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.6e-43  Score=347.91  Aligned_cols=254  Identities=28%  Similarity=0.456  Sum_probs=218.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.+......   ....+.+|..+++.+.||||+++++.|.+....|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            36899999999999999999999999999999998765432   235567789999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+++++|.+++.. +.+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......    
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~----  170 (296)
T cd06654          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  170 (296)
T ss_pred             ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc----
Confidence            999999999998865 468999999999999999999999999999999999999999999999999987543221    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCh
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  290 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~  290 (499)
                            .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...   ....|..++.
T Consensus       171 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06654         171 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (296)
T ss_pred             ------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCH
Confidence                  1122457899999999999888999999999999999999999999887764433333322   2234567889


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+.+||.+||..||.+||++     .+++.||||..
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~-----~eil~~~~~~~  275 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSA-----KELLQHQFLKI  275 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCH-----HHHhhChhhhc
Confidence            99999999999999999998     89999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=339.17  Aligned_cols=252  Identities=32%  Similarity=0.509  Sum_probs=218.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++.....   .....+..|..+++.++||||+++++.+.+...+|++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            3689999999999999999999999999999999976532   2445677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......   
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---  155 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI---  155 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence            9999999999998876 789999999999999999999999999999999999999999999999999987643211   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCC---CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-----C
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----F  284 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~---~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~  284 (499)
                             .......|+..|+|||++.+.   .++.++|+|||||++|+|++|.+||.+.+.......+....+.     .
T Consensus       156 -------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (262)
T cd06613         156 -------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD  228 (262)
T ss_pred             -------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccc
Confidence                   122346789999999999776   7889999999999999999999999887766555544444222     2


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  323 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpf  323 (499)
                      +..++.++.+||.+||..+|.+||++     .+++.|||
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~~~~  262 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTA-----TKLLQHPF  262 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCH-----HHHhcCCC
Confidence            34567889999999999999999998     88999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=359.65  Aligned_cols=255  Identities=31%  Similarity=0.559  Sum_probs=225.4

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      .++||+|-||+||-|+++.||+.||||+++|..+...+ ...+..|+.+|+.+.||+||.+-+.|+..+.+++|||.+. 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-
Confidence            47899999999999999999999999999987665543 4778889999999999999999999999999999999995 


Q ss_pred             CChHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC---CEEEEecCCccccCCccccccC
Q 010859          140 GELFDQIT--SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       140 g~L~~~i~--~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~---~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |++.+.|-  +.|+|++...++++.||+.||.|||.++|+|+||||||||+....   .+||||||+|+++.+..     
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-----  721 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-----  721 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-----
Confidence            58888775  348899999999999999999999999999999999999997653   69999999999987643     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC----CCCh
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----YFSD  290 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~  290 (499)
                            ...+.+|||.|.|||++..+.|...-|+||+|+|+|--+.|..||....  ++-.+|....+-+|.    .+++
T Consensus       722 ------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~  793 (888)
T KOG4236|consen  722 ------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISP  793 (888)
T ss_pred             ------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCH
Confidence                  3457899999999999999999999999999999999999999997553  355667777788875    4899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC-cccccC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID-WKNIRG  334 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~-~~~~~~  334 (499)
                      ++.|||..+|+..-.+|-+.     +.-+.|||+++.. |.+++.
T Consensus       794 ~AidlIn~LLqVkm~kRysv-----dk~lsh~Wlq~yq~w~DLRe  833 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSV-----DKSLSHPWLQDYQTWLDLRE  833 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcch-----HhhccchhhhcchHHHHHHH
Confidence            99999999999999999988     7789999998753 665553

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.4e-43  Score=346.28  Aligned_cols=266  Identities=22%  Similarity=0.326  Sum_probs=217.9

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcC-----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ..++|++.+.||+|+||.||+|..++     .+..||+|.+.....  ......+.+|..+++.++||||+++++++.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45789999999999999999997653     355899998764422  12233466789999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEE
Q 010859          128 FSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  197 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~----------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~  197 (499)
                      ...|+||||+++|+|.+++.+.          ..++...+..++.||+.||.|||++||+||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999999753          234677889999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHH
Q 010859          198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  276 (499)
Q Consensus       198 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~  276 (499)
                      |||+++.+......        .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+.......
T Consensus       162 Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~  233 (288)
T cd05061         162 DFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF  233 (288)
T ss_pred             cCCccccccccccc--------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99998765332110        11122345778999999998889999999999999999998 8999998887777666


Q ss_pred             HHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc--CCCCCCCCc
Q 010859          277 IIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKGIDW  329 (499)
Q Consensus       277 i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~--Hpff~~i~~  329 (499)
                      +... ...+|...++.+.+++.+||+.||++||++.+ -.+.+.+  ||||++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE-IVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHhhcCCCCCCCCC
Confidence            6554 34567778899999999999999999999843 1122222  999999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.1e-43  Score=386.17  Aligned_cols=261  Identities=28%  Similarity=0.466  Sum_probs=218.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCe
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFS  129 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~~~  129 (499)
                      ...++|++++.||+|+||+||+|.+..++..||+|++....... .....+..|+.+|+.++|||||+++++|.+  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            44689999999999999999999999999999999997654433 334567779999999999999999998854  467


Q ss_pred             EEEEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CcEeeecCCCCeeeCC--------
Q 010859          130 LYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSM-------GLIHRDIKPENLLLTA--------  190 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~-------gIiHrDlKp~NILl~~--------  190 (499)
                      +|+||||+++|+|.++|..    .+.+++..++.|+.||+.||.|||+.       +|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            9999999999999998875    25799999999999999999999985       4999999999999964        


Q ss_pred             ---------CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCC--CCCCCCCcchhhhHHHHHHh
Q 010859          191 ---------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQML  259 (499)
Q Consensus       191 ---------~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDiwslG~ilyell  259 (499)
                               .+.+||+|||++..+...           ......+||+.|+|||++.+  ..++.++||||||||||+|+
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~-----------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIE-----------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccc-----------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence                     235899999999765322           12235689999999999864  45888999999999999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          260 SGTSPFKDTSEWLIFQRIIARDIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       260 tG~~Pf~~~~~~~~~~~i~~~~~~~p-~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      +|..||...+....+..++.....+| ...+.++.+||..||..+|.+||++     .+++.|||+..+..
T Consensus       238 TGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa-----~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        238 SGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA-----LQCLGYQIIKNVGP  303 (1021)
T ss_pred             HCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCH-----HHHhccHHHhhcCC
Confidence            99999987766555444444444444 4578999999999999999999998     88999999987643

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-43  Score=344.20  Aligned_cols=256  Identities=32%  Similarity=0.511  Sum_probs=222.7

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++.....  ......+..|+.+++.++||||+++++.+.+...+|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            478999999999999999999999999999999876532  223345677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||+++++|.+++... ++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++.+....     
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-----  152 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-----  152 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-----
Confidence            999999999998875 79999999999999999999999999999999999999999999999999998764321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCCC-CChHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNY-FSDAA  292 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~~~~~  292 (499)
                           .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.... ..++.. ++.++
T Consensus       153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (274)
T cd06609         153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF  227 (274)
T ss_pred             -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHH
Confidence                 12234678999999999998889999999999999999999999998877665555555442 234444 78999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      .++|.+||..||++||++     +++++||||....
T Consensus       228 ~~~l~~~l~~~p~~Rpt~-----~~il~~~~~~~~~  258 (274)
T cd06609         228 KDFVSLCLNKDPKERPSA-----KELLKHKFIKKAK  258 (274)
T ss_pred             HHHHHHHhhCChhhCcCH-----HHHhhChhhcCCC
Confidence            999999999999999988     8999999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-42  Score=337.81  Aligned_cols=253  Identities=28%  Similarity=0.540  Sum_probs=222.3

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+........ ....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            58999999999999999999999999999999876533322 33456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~----  155 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV----  155 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch----
Confidence            99999999998764  258999999999999999999999999999999999999999999999999987653321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCChHH
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAA  292 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~  292 (499)
                            .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..+.. ..|..++.++
T Consensus       156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08218         156 ------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDL  229 (256)
T ss_pred             ------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence                  112245688999999999988899999999999999999999999998887777777665544 4677889999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .++|.+||+.+|.+||++     .++++||||
T Consensus       230 ~~li~~~l~~~p~~Rp~~-----~~vl~~~~~  256 (256)
T cd08218         230 RNLVSQLFKRNPRDRPSV-----NSILEKNFI  256 (256)
T ss_pred             HHHHHHHhhCChhhCcCH-----HHHhhCcCC
Confidence            999999999999999998     899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-43  Score=347.09  Aligned_cols=254  Identities=29%  Similarity=0.468  Sum_probs=215.6

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||.||+|.+..+|..||+|.+....  .......+.+|..++++++||||+++++.+.....+|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47999999999999999999999999999999986542  2233456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          135 ESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       135 E~~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||+++++|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++..+...  
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999999888763   369999999999999999999996 59999999999999999999999999998754321  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCC------CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHH---HHHhc-
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ---RIIAR-  280 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~------~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~---~i~~~-  280 (499)
                                ......|++.|+|||.+.+..      ++.++|+|||||++|+|++|..||..........   .+... 
T Consensus       157 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  226 (286)
T cd06622         157 ----------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD  226 (286)
T ss_pred             ----------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence                      122346888999999985543      4789999999999999999999997665444333   23332 


Q ss_pred             CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       281 ~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ...+|..++.++.+||.+||+.+|.+||++     ++++.||||...
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~l~~~~~~~~~  268 (286)
T cd06622         227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTY-----AQLLEHPWLVKY  268 (286)
T ss_pred             CCCCCcccCHHHHHHHHHHcccCcccCCCH-----HHHhcChhhhhc
Confidence            345677799999999999999999999988     899999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.8e-43  Score=347.93  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=207.6

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+...... ......+..|+.+++.++||||+++++++.+...+|+++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            489999999999999999999999999999998764322 2223445679999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       136 ~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |+++ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......     
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----  153 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-----  153 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-----
Confidence            9975 88887765 4679999999999999999999999999999999999999999999999999987543221     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCC-CCCCHHHHHHHHHhcC-----------
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARD-----------  281 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf-~~~~~~~~~~~i~~~~-----------  281 (499)
                           .......+++.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+....++.+...-           
T Consensus       154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence                 1122346789999999987644 788999999999999999988885 4444444444432210           


Q ss_pred             -----C-------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 -----I-------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 -----~-------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                           .             .....+++++++||.+||+.||.+|||+     ++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~~il~h~~f  284 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA-----EEALQHPYF  284 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH-----HHHhcCCCC
Confidence                 0             0112467899999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3e-42  Score=335.15  Aligned_cols=253  Identities=28%  Similarity=0.532  Sum_probs=223.3

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++++.||.|+||.||.+++..+++.+++|.+........ ....+.+|+.++++++|+||+++++++.+...++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh-HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            58999999999999999999999999999999876544333 33456679999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......    
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~----  155 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY----  155 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence            99999999999775  468999999999999999999999999999999999999999999999999987653321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-CCCCCChHH
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYFSDAA  292 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~  292 (499)
                            .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..+.+. .+..++.++
T Consensus       156 ------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08221         156 ------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL  229 (256)
T ss_pred             ------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHH
Confidence                  1223467899999999998888899999999999999999999999998888887777765543 345678999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .++|.+||..+|.+||++     +++++|||+
T Consensus       230 ~~~i~~~l~~~p~~R~s~-----~~ll~~~~l  256 (256)
T cd08221         230 ISLVHSLLQQDPEKRPTA-----DEVLDQPLL  256 (256)
T ss_pred             HHHHHHHcccCcccCCCH-----HHHhhCcCC
Confidence            999999999999999988     899999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-43  Score=355.96  Aligned_cols=257  Identities=29%  Similarity=0.452  Sum_probs=211.5

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~  131 (499)
                      .-..|++++.||+||.+.||++...+. +.||+|.+... ........-+.+|+.+|.+| +|.+||+||+|-..++.+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            345699999999999999999987654 45666644322 23455566678899999999 5899999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +||||-+ .||...+.+.+. ++...+++|..|||.|+.++|++||||.||||.|+|+- .|.+||+|||.|..+.+...
T Consensus       437 mvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  437 MVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             EEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            9999865 599999988755 44469999999999999999999999999999999984 78999999999998766542


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCC-----------CCCCCcchhhhHHHHHHhcCCCCCCCCC-HHHHHHHHH
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP-----------ATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRII  278 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-----------~~~~sDiwslG~ilyelltG~~Pf~~~~-~~~~~~~i~  278 (499)
                      .        -...+.+||+.|||||.+....           .+.++||||||||||+|+.|++||.... -+.-+..|.
T Consensus       515 s--------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~  586 (677)
T KOG0596|consen  515 S--------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT  586 (677)
T ss_pred             c--------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence            2        2334679999999999984322           5688999999999999999999997653 455566666


Q ss_pred             hcC--CCCCCCCChH-HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          279 ARD--IRFPNYFSDA-ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       279 ~~~--~~~p~~~~~~-~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ..+  .+||..-+.. +.++++.||..||.+||++     .+||+|||+..
T Consensus       587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si-----~eLLqhpFl~~  632 (677)
T KOG0596|consen  587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSI-----PELLQHPFLQI  632 (677)
T ss_pred             CCCccccccCCCCchHHHHHHHHHHhcCcccCCCc-----HHHhcCccccc
Confidence            654  4777765555 9999999999999999999     88999999975

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.8e-43  Score=348.45  Aligned_cols=254  Identities=29%  Similarity=0.464  Sum_probs=218.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ..+|++++.||+|+||.||+|.+..+++.||+|.+......   ....+.+|..+++.++||||+++++.|......|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            36899999999999999999999999999999998754322   335567789999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......    
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~----  169 (297)
T cd06656          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  169 (297)
T ss_pred             ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc----
Confidence            999999999998865 468999999999999999999999999999999999999999999999999987543321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCh
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  290 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~  290 (499)
                            .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+...   ....|..++.
T Consensus       170 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (297)
T cd06656         170 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSA  243 (297)
T ss_pred             ------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCH
Confidence                  1122457899999999999988999999999999999999999999877654333222221   2234667889


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+++||.+||..||++||++     ++++.||||+.
T Consensus       244 ~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~  274 (297)
T cd06656         244 VFRDFLNRCLEMDVDRRGSA-----KELLQHPFLKL  274 (297)
T ss_pred             HHHHHHHHHccCChhhCcCH-----HHHhcCchhcc
Confidence            99999999999999999998     89999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-42  Score=335.99  Aligned_cols=248  Identities=28%  Similarity=0.575  Sum_probs=216.2

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|+||.||++++..+++.||+|.+.....  ......+..|..+++.++||||+++++.+.+...+|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            68999999999999999999999999999999875432  2234556778999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+++++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......    
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~----  154 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG----  154 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc----
Confidence            99999999988653  458999999999999999999999999999999999999999999999999987653221    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCChHH
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAA  292 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~  292 (499)
                            .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..... .+|..++..+
T Consensus       155 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (255)
T cd08219         155 ------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYEL  228 (255)
T ss_pred             ------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHH
Confidence                  122346789999999999988899999999999999999999999998887777666665544 3667789999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+||.+||+.||.+||++     .+++.
T Consensus       229 ~~li~~~l~~~P~~Rp~~-----~~il~  251 (255)
T cd08219         229 RSLIKQMFKRNPRSRPSA-----TTILS  251 (255)
T ss_pred             HHHHHHHHhCCcccCCCH-----HHHhh
Confidence            999999999999999998     66664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-42  Score=341.18  Aligned_cols=246  Identities=27%  Similarity=0.463  Sum_probs=206.6

Q ss_pred             CCeeeeeEe--eecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010859           55 QDFELGKIY--GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        55 ~~y~~~~~L--G~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ++|++.+.+  |+|+||.||++.++.++..+|+|++........        |......+ +||||+++++.|.....+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            466676666  999999999999999999999999876532211        22222222 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~~  210 (499)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......  
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            9999999999999998887899999999999999999999999999999999999999998 9999999998754321  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH----HHHHHHhcCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPN  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~p~  286 (499)
                                  ....|+..|+|||++.+..++.++|+|||||++|+|++|..||.......    ............+.
T Consensus       164 ------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T PHA03390        164 ------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK  231 (267)
T ss_pred             ------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccc
Confidence                        13468999999999999889999999999999999999999998654322    12222244456667


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+++.+.+||.+||+.||.+||++    ++++++||||.+
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~----~~~~l~h~~~~~  267 (267)
T PHA03390        232 NVSKNANDFVQSMLKYNINYRLTN----YNEIIKHPFLKI  267 (267)
T ss_pred             ccCHHHHHHHHHHhccChhhCCch----HHHHhcCCcccC
Confidence            899999999999999999999964    388999999973

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-42  Score=336.17  Aligned_cols=253  Identities=30%  Similarity=0.544  Sum_probs=220.7

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCeEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSLYMA  133 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~--~~~~l~lv  133 (499)
                      +|++.+.||.|+||.||+|.+..+|..||+|++...... ......+..|+.+++.++||||+++++.+.  ....+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            589999999999999999999999999999998765443 333455777999999999999999998775  45678999


Q ss_pred             EeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          134 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIH-----SMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH-----~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      |||+++++|.+++..    .+++++..++.++.||+.||.|||     +.+++||||||+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999875    357999999999999999999999     99999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-C
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R  283 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~  283 (499)
                      .....          .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.....+.+..... .
T Consensus       160 ~~~~~----------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (265)
T cd08217         160 LGHDS----------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR  229 (265)
T ss_pred             ccCCc----------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC
Confidence            54321          112345789999999999988899999999999999999999999998887776666666544 4


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +|..++.++.+|+.+||+.+|.+||++     +++++|||+
T Consensus       230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~-----~~il~~~~~  265 (265)
T cd08217         230 IPYRYSSELNEVIKSMLNVDPDKRPST-----EELLQLPLI  265 (265)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCH-----HHHhhCCCC
Confidence            677889999999999999999999988     899999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.6e-42  Score=345.85  Aligned_cols=258  Identities=30%  Similarity=0.426  Sum_probs=214.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSL  130 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~--~~l  130 (499)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....... .......+|+.+++.++|+||+++++++.+.  ..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            4689999999999999999999999999999999987543222 2223345699999999999999999998755  569


Q ss_pred             EEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999975 888888753 569999999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--------
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  280 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--------  280 (499)
                                .......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+....+..+...        
T Consensus       163 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07845         163 ----------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI  232 (309)
T ss_pred             ----------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence                      11122346888999999865 45789999999999999999999999998887777666541        


Q ss_pred             -----------CCCCC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          281 -----------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       281 -----------~~~~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                 .+.++           ..+++++.+||.+||+.||++||++     ++++.||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-----~~il~h~~f~~~  296 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA-----EEALESSYFKEK  296 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH-----HHHhcChhhccC
Confidence                       11111           1258889999999999999999998     899999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-42  Score=340.91  Aligned_cols=254  Identities=30%  Similarity=0.467  Sum_probs=214.9

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++....... .....+..|+.+++.++||||+++++++.+...+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            5899999999999999999999999999999997754322 234557779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          136 SCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       136 ~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |+ +++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......     
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-----  153 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-----  153 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-----
Confidence            99 99999998653 569999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC------------
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------------  281 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~------------  281 (499)
                          ........|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.++...+..+...-            
T Consensus       154 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         154 ----PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             ----CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence                0112245789999999998654 46889999999999999999999998887766555544310            


Q ss_pred             -------CCCC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          282 -------IRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       282 -------~~~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                             ..++           ...+.++.+||.+||..||++||++     +++++||||.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~-----~~~l~h~~~~  286 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-----AEALRHPYFT  286 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH-----HHHhhCcCcC
Confidence                   0111           2357889999999999999999998     8999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.2e-42  Score=341.05  Aligned_cols=253  Identities=28%  Similarity=0.481  Sum_probs=212.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT-----  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~-----  127 (499)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+..|..+++++ +|||++++++++...     
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            578999999999999999999999999999999986532    2234566788888888 899999999998643     


Q ss_pred             CeEEEEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          128 FSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      ..+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            468999999999999998763    3568999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCCC-----CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  278 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-----~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~  278 (499)
                      .+....          .......|+..|+|||++...     .++.++|+|||||++|+|++|++||...+.......+.
T Consensus       177 ~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~  246 (291)
T cd06639         177 QLTSTR----------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP  246 (291)
T ss_pred             hccccc----------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence            654321          111235689999999998643     36789999999999999999999998877655555554


Q ss_pred             hcC---CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          279 ARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       279 ~~~---~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ...   ...|..++..+.+||.+||+.+|++||++     .+++.||||+
T Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~il~~~~~~  291 (291)
T cd06639         247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV-----THLLEHPFIK  291 (291)
T ss_pred             cCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCH-----HHHhcCcccC
Confidence            332   23455678899999999999999999998     8999999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-42  Score=365.28  Aligned_cols=250  Identities=26%  Similarity=0.336  Sum_probs=205.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....         ....+|+.+|++++|||||++++++......|+|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4579999999999999999999999999999996322         1245699999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||++. ++|..++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....   
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~---  314 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW---  314 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc---
Confidence            99995 6898888764 569999999999999999999999999999999999999999999999999998653321   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC--------CHHHHHHHHHhcCC--
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT--------SEWLIFQRIIARDI--  282 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~--------~~~~~~~~i~~~~~--  282 (499)
                           ........+||+.|+|||++.+..++.++|||||||++|||++|..|+...        ....+.+.+.....  
T Consensus       315 -----~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        315 -----STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             -----ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence                 111223467999999999999999999999999999999999987654322        12223322222111  


Q ss_pred             -CCCC-------------------------------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          283 -RFPN-------------------------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       283 -~~p~-------------------------------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                       .+|.                               .++.++.+||.+||+.||.+|||+     +++++||||+.
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa-----~elL~hp~f~~  460 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA-----AELLRLPLFQS  460 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH-----HHHhhCcccCC
Confidence             1110                               245689999999999999999999     89999999974

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9e-43  Score=344.44  Aligned_cols=254  Identities=31%  Similarity=0.471  Sum_probs=214.3

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+..... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999999999999999986643332 23445677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++++.|..+....+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+....     
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-----  154 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-----  154 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence            999998888877776679999999999999999999999999999999999999999999999999987653321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC------------
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------------  281 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~------------  281 (499)
                           .......|+..|+|||++.+. .++.++|+|||||++|+|++|++||...+.......+....            
T Consensus       155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         155 -----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             -----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence                 122345789999999998753 47889999999999999999999998776554444433210            


Q ss_pred             -------CCC------------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 -------IRF------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 -------~~~------------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                             ..+            +..++..+.+|+.+||+.+|.+||++     ++++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~~~~  286 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS-----SQLLHHEFF  286 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH-----HHHhcCCCC
Confidence                   011            23568889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2e-42  Score=344.46  Aligned_cols=255  Identities=29%  Similarity=0.451  Sum_probs=215.2

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch--hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+.......  ......+..|+.+++.++|+||+++++++.+...+|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4889999999999999999999999999999997664431  22234456789999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.......   
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN---  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence            9999 889999998776 79999999999999999999999999999999999999999999999999997654321   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---------  282 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~---------  282 (499)
                             .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.++...+.++...-.         
T Consensus       157 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         157 -------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             -------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence                   11223457889999999854 4578899999999999999999999988877666555543100         


Q ss_pred             -------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          283 -------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       283 -------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                         ......+..+.+||.+||..||++||++     ++++.||||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~e~l~~~~~~~  287 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA-----RQALEHPYFSN  287 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH-----HHHhhCccccC
Confidence                               0112347889999999999999999998     89999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=376.00  Aligned_cols=268  Identities=29%  Similarity=0.469  Sum_probs=215.9

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEE-E-----
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTF-Q-----  125 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~-~-----  125 (499)
                      ....++|.+.|.+|||+.||+|++...|..||+|.+-..   .+.....+.+|+.+|+.|+ |+|||.+++.. .     
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            345789999999999999999999998899999987543   6778888999999999996 99999999932 1     


Q ss_pred             c-CCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCCCCCEEEEecC
Q 010859          126 D-TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFG  200 (499)
Q Consensus       126 ~-~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~~~~vkL~DFG  200 (499)
                      . ...++|.||||.||.|.++++.+  ..|+|.++..|++++++|+.+||.+.  |||||||-|||||+.+|++||||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence            1 24588999999999999999854  56999999999999999999999998  9999999999999999999999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCccCCCcccc---CCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010859          201 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  277 (499)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l---~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i  277 (499)
                      .|...-...... .........-...-|+.|+|||++   .+.+.+.|+|||||||+||.|+....||.....    -.|
T Consensus       192 Satt~~~~~~~~-~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI  266 (738)
T KOG1989|consen  192 SATTKILSPTSA-QEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI  266 (738)
T ss_pred             ccccccCCCccH-HHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence            986432111000 000000011123569999999996   578899999999999999999999999987743    357


Q ss_pred             HhcCCCCCC--CCChHHHHHHHHhhccCCCCCCCCCC--CCHHHH-hcCCCCCCCC
Q 010859          278 IARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVL-KMHPFFKGID  328 (499)
Q Consensus       278 ~~~~~~~p~--~~~~~~~~Li~~lL~~dP~~R~~~~~--~~~~~l-~~Hpff~~i~  328 (499)
                      +.+.|.||.  .++..+++||+.||+.||.+||++-+  ..+.++ -.++++.++.
T Consensus       267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence            889999997  68999999999999999999999844  111111 2456666554

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.7e-42  Score=340.02  Aligned_cols=251  Identities=29%  Similarity=0.483  Sum_probs=210.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc------C
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD------T  127 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~------~  127 (499)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++.....    ....+..|+.+++++ +||||++++++|..      .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            568999999999999999999999999999999875421    224466788888888 79999999999875      3


Q ss_pred             CeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          128 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      ..+|++|||+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999998864  46899999999999999999999999999999999999999999999999998754


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~  280 (499)
                      ...          ........|++.|+|||++.     +..++.++|+|||||++|+|++|..||...........+...
T Consensus       162 ~~~----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~  231 (272)
T cd06637         162 DRT----------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  231 (272)
T ss_pred             ccc----------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC
Confidence            321          11233567999999999986     345788999999999999999999999876655544443332


Q ss_pred             CC--CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          281 DI--RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       281 ~~--~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ..  ..+..++.++.+||.+||..||.+||++     .+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~~~~~  272 (272)
T cd06637         232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTT-----EQLMKHPFI  272 (272)
T ss_pred             CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCH-----HHHhhCCCC
Confidence            21  1234578999999999999999999998     899999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-42  Score=342.44  Aligned_cols=254  Identities=20%  Similarity=0.340  Sum_probs=216.1

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCC-----ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~-----~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      +..++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            34679999999999999999999986655     689999886442  22334557789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC
Q 010859          127 TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  190 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~  190 (499)
                      ....|++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999999764                45788999999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCC
Q 010859          191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  269 (499)
Q Consensus       191 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~  269 (499)
                      ++.++|+|||+++.......        ........+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADY--------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             CCcEEECCCcceeecccccc--------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999999875432211        111223467889999999988889999999999999999998 999999988


Q ss_pred             HHHHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          270 EWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       270 ~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .......+.... ...|..+++++.+|+.+||+.||.+||++     .++++
T Consensus       232 ~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~-----~~i~~  278 (283)
T cd05048         232 NQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRF-----KDIHT  278 (283)
T ss_pred             HHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            877777776544 34567899999999999999999999998     66664

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.8e-42  Score=336.33  Aligned_cols=251  Identities=31%  Similarity=0.490  Sum_probs=217.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||+|+||.||+|....+++.||+|.+.....     ...+.+|..+++.++||||+++++.+.+...+|++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            3689999999999999999999999999999999865421     45677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      +||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......   
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~---  153 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM---  153 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence            999999999999875 3568999999999999999999999999999999999999999999999999988654321   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh---cCCCCCCCCC
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---RDIRFPNYFS  289 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~---~~~~~p~~~~  289 (499)
                             .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..   .....+..++
T Consensus       154 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (256)
T cd06612         154 -------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWS  226 (256)
T ss_pred             -------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcC
Confidence                   122345688999999999998999999999999999999999999987766544333322   2233455678


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .++.++|.+||+.||.+||++     .+++.||||
T Consensus       227 ~~~~~~i~~~l~~~P~~Rps~-----~~il~~~~~  256 (256)
T cd06612         227 PEFNDFVKKCLVKDPEERPSA-----IQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHHHhcChhhCcCH-----HHHhcCCCC
Confidence            899999999999999999998     899999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.9e-42  Score=332.61  Aligned_cols=252  Identities=28%  Similarity=0.500  Sum_probs=220.8

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+........ ....+..|..+++.++||||+++++.+.....+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH-HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            58999999999999999999999999999999987644333 34567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEecCCccccCCccccc
Q 010859          136 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       136 ~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||+|+||+++.++ .+||+|||.+.......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence            99999999999764  3489999999999999999999999999999999999998654 57999999998653321   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCChH
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSDA  291 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~  291 (499)
                              ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+.... ..+|..++.+
T Consensus       157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd08220         157 --------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD  228 (256)
T ss_pred             --------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHH
Confidence                    1224578999999999998889999999999999999999999999887766666665543 4567789999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +.++|.+||..||.+||++     .++++||||
T Consensus       229 l~~li~~~l~~~p~~Rpt~-----~~ll~~p~~  256 (256)
T cd08220         229 LRQLILSMLNLDPSKRPQL-----SQIMAQPIC  256 (256)
T ss_pred             HHHHHHHHccCChhhCCCH-----HHHhhCCCC
Confidence            9999999999999999998     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3e-42  Score=337.97  Aligned_cols=247  Identities=17%  Similarity=0.306  Sum_probs=209.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ...+|++.+.||+|+||.||+|..+   ..+..||+|.+.....  ......+.+|..+++.++||||+++++++.....
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            3568999999999999999999875   4567899999875422  2234557779999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999998764 57999999999999999999999999999999999999999999999999987643221


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ..         .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.....+.+... ....|.
T Consensus       161 ~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (266)
T cd05064         161 AI---------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR  231 (266)
T ss_pred             ch---------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC
Confidence            10         01112345678999999999999999999999999999775 99999998887777766554 345677


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .++..+.+++.+||+.+|.+||++
T Consensus       232 ~~~~~~~~li~~c~~~~p~~RP~~  255 (266)
T cd05064         232 NCPNLLHQLMLDCWQKERGERPRF  255 (266)
T ss_pred             CCCHHHHHHHHHHcCCCchhCCCH
Confidence            889999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-42  Score=334.16  Aligned_cols=257  Identities=28%  Similarity=0.495  Sum_probs=219.9

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCccc--chhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSL  130 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~--~~l  130 (499)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+.....  ........+.+|+.+++.++||||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            589999999999999999999999999999998864321  1233445677899999999999999999998764  568


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +++|||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC-  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc-
Confidence            9999999999999999887789999999999999999999999999999999999999999999999999998653211 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~  288 (499)
                            ........+.|+..|+|||.+.+..++.++|+|||||++|+|++|++||..........++...  ...+|..+
T Consensus       161 ------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~  234 (264)
T cd06653         161 ------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV  234 (264)
T ss_pred             ------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCccc
Confidence                  0111223467899999999999888999999999999999999999999887766655555433  34578899


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ++++.++|.+||+ +|.+||++     .+++.|||.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~-----~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTA-----EFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccH-----HHHhcCCCC
Confidence            9999999999999 57999999     889999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.3e-42  Score=333.74  Aligned_cols=253  Identities=32%  Similarity=0.536  Sum_probs=219.0

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc--hhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+......  .......+.+|+.+++.++||||+++++++.+...+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            478889999999999999999989999999998654321  122345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.......    
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----  156 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987653321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCh
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--RDIRFPNYFSD  290 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~  290 (499)
                             ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||...........+..  ....+|..+++
T Consensus       157 -------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd06632         157 -------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD  229 (258)
T ss_pred             -------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence                   123457899999999987766 88999999999999999999999987765554444443  23346777899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ++.+|+.+||+.+|.+||++     .+++.|||+
T Consensus       230 ~~~~li~~~l~~~p~~Rp~~-----~~~l~~~~~  258 (258)
T cd06632         230 EAKDFILKCLQRDPSLRPTA-----AELLEHPFV  258 (258)
T ss_pred             HHHHHHHHHhhcCcccCcCH-----HHHhcCCCC
Confidence            99999999999999999988     899999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.4e-42  Score=348.47  Aligned_cols=247  Identities=27%  Similarity=0.421  Sum_probs=193.8

Q ss_pred             eeEeeecCceEEEEEEEcC--CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCeEEEEEe
Q 010859           60 GKIYGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSLYMALE  135 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~--t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~--~~~~l~lv~E  135 (499)
                      +..||+|+||.||+|+++.  ++..||+|.+.....     ...+.+|..+++.++||||+++++++.  ....+|+|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            4689999999999999764  668999999865422     233567999999999999999999885  4567999999


Q ss_pred             ccCCCChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee----CCCCCEEEEecCCc
Q 010859          136 SCEGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSV  202 (499)
Q Consensus       136 ~~~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl----~~~~~vkL~DFG~a  202 (499)
                      |+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9975 888877522         248899999999999999999999999999999999999    45679999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH---------
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWL---------  272 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~---------  272 (499)
                      +.......       ........+||+.|+|||++.+. .++.++|||||||++|+|++|++||....+..         
T Consensus       160 ~~~~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07867         160 RLFNSPLK-------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD  232 (317)
T ss_pred             eccCCCcc-------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHH
Confidence            86643221       11223356889999999998764 57899999999999999999999997543210         


Q ss_pred             HHHHHHhc----------------------------CC----------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCC
Q 010859          273 IFQRIIAR----------------------------DI----------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGG  314 (499)
Q Consensus       273 ~~~~i~~~----------------------------~~----------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~  314 (499)
                      ....+...                            ..          ......+..+.+||.+||+.||.+|||+    
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~----  308 (317)
T cd07867         233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS----  308 (317)
T ss_pred             HHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH----
Confidence            11111100                            00          0011235678899999999999999999    


Q ss_pred             HHHHhcCCCC
Q 010859          315 YAVLKMHPFF  324 (499)
Q Consensus       315 ~~~l~~Hpff  324 (499)
                       +++++||||
T Consensus       309 -~e~l~hp~f  317 (317)
T cd07867         309 -EQALQDPYF  317 (317)
T ss_pred             -HHHhcCCCC
Confidence             899999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=333.28  Aligned_cols=250  Identities=45%  Similarity=0.805  Sum_probs=226.6

Q ss_pred             eeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCh
Q 010859           63 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  142 (499)
Q Consensus        63 LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L  142 (499)
                      ||.|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+++...+|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999999999999999887666555667788899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 010859          143 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  222 (499)
Q Consensus       143 ~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~  222 (499)
                      .+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......          ...
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------~~~  150 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------SRT  150 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC----------Ccc
Confidence            9999988789999999999999999999999999999999999999999999999999987653321          122


Q ss_pred             cccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhcc
Q 010859          223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV  302 (499)
Q Consensus       223 ~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~  302 (499)
                      ....|+..|+|||.+.+...+.++|+|||||++|+|++|..||...+.....+.+....+.+|..++..+.++|++||..
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcC
Confidence            34578999999999998888999999999999999999999998888777778888888889999999999999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCC
Q 010859          303 DPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       303 dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ||++||++.+  .+++++||||
T Consensus       231 ~p~~R~~~~~--~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGG--AEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCccc--HHHHHhCCCC
Confidence            9999999854  5789999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.2e-42  Score=336.73  Aligned_cols=256  Identities=30%  Similarity=0.531  Sum_probs=214.7

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch-------hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-------ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      .|.+.+.||.|+||.||+|.+..+|+.||+|.+.......       ......+..|..+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5889999999999999999999999999999886432111       112345677999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999998754321


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCC--CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRF  284 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~  284 (499)
                      .        .........|+..|+|||.+....  ++.++|+||||+++|+|++|..||...........+...  ...+
T Consensus       162 ~--------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (272)
T cd06629         162 Y--------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI  233 (272)
T ss_pred             c--------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence            1        111223457899999999987654  788999999999999999999999766554444333222  2233


Q ss_pred             CC----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          285 PN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       285 p~----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      |.    .++.++.+||.+||..||.+||++     +++++||||
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~  272 (272)
T cd06629         234 PPDVSMNLSPVALDFLNACFTINPDNRPTA-----RELLQHPFI  272 (272)
T ss_pred             CccccccCCHHHHHHHHHHhcCChhhCCCH-----HHHhhCCCC
Confidence            33    458899999999999999999988     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-42  Score=358.41  Aligned_cols=250  Identities=22%  Similarity=0.391  Sum_probs=206.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCC-----CceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  124 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t-----~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~  124 (499)
                      .+..++|++++.||+|+||.||+|++..+     +..||+|++.....  ......+.+|+.+++.+ +||||+++++.+
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            34567899999999999999999996544     35799999875532  22345677899999999 899999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhc-------------------------------------------------------
Q 010859          125 QDTFSLYMALESCEGGELFDQITSK-------------------------------------------------------  149 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~-------------------------------------------------------  149 (499)
                      .....+|+|||||++|+|.+++.+.                                                       
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            9999999999999999999988542                                                       


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          150 ---------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       150 ---------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                                     .++++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+.....    
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----  267 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----  267 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----
Confidence                           2478889999999999999999999999999999999999999999999999976532210    


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc--CCCCCCCCChH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDA  291 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~  291 (499)
                          .....+..++..|+|||++.+..++.++|||||||++|+|++ |+.||........+..+...  ....|...+++
T Consensus       268 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (374)
T cd05106         268 ----YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE  343 (374)
T ss_pred             ----eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence                011122345678999999998899999999999999999997 99999876554444444433  34456678999


Q ss_pred             HHHHHHHhhccCCCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~  310 (499)
                      +.++|.+||+.||.+||++
T Consensus       344 l~~li~~cl~~dp~~RPs~  362 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTF  362 (374)
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            9999999999999999998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.4e-42  Score=334.79  Aligned_cols=257  Identities=34%  Similarity=0.548  Sum_probs=223.9

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|++|.||+|++..+++.||+|++......  .....+..|...+.+++||||+++++++.....+|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            4799999999999999999999999999999998765332  34556778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.......    
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~----  154 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL----  154 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC----
Confidence            999999999999988889999999999999999999999 999999999999999999999999999987654321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHhc-CCCCCCC-C
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIAR-DIRFPNY-F  288 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~---~~~~~~~i~~~-~~~~p~~-~  288 (499)
                            .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....   .......+... ...++.. +
T Consensus       155 ------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (264)
T cd06623         155 ------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF  228 (264)
T ss_pred             ------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccC
Confidence                  11124578999999999999899999999999999999999999998773   44444444432 3345555 8


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      +..+.++|.+||..+|++||++     .++++||||+.++
T Consensus       229 ~~~l~~li~~~l~~~p~~R~~~-----~~ll~~~~~~~~~  263 (264)
T cd06623         229 SPEFRDFISACLQKDPKKRPSA-----AELLQHPFIKKAD  263 (264)
T ss_pred             CHHHHHHHHHHccCChhhCCCH-----HHHHhCHHHHhcc
Confidence            8999999999999999999998     8999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.5e-42  Score=338.27  Aligned_cols=256  Identities=25%  Similarity=0.445  Sum_probs=208.4

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ++|++.+.||+|+||.||+|++..+|+.||+|.+.+...... ... +..|.. .++.++||||+++++++.....+|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~-~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKR-LLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHH-HHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            489999999999999999999999999999999976543322 222 333444 46778999999999999999999999


Q ss_pred             EeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          134 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |||++ |+|.+++..    ...+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++..+...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99997 588777654    24689999999999999999999997 9999999999999999999999999998764321


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC----CCCCCCCcchhhhHHHHHHhcCCCCCCCC-CHHHHHHHHHh-cCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIA-RDI  282 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~----~~~~~~sDiwslG~ilyelltG~~Pf~~~-~~~~~~~~i~~-~~~  282 (499)
                                 .......|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||... +.......+.. ...
T Consensus       158 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd06617         158 -----------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP  226 (283)
T ss_pred             -----------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC
Confidence                       11123568899999999865    44688999999999999999999999753 23333333333 233


Q ss_pred             CCC-CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          283 RFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       283 ~~p-~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      .+| ..+|.++.+||.+||..+|.+||++     +++++||||.....
T Consensus       227 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~  269 (283)
T cd06617         227 QLPAEKFSPEFQDFVNKCLKKNYKERPNY-----PELLQHPFFELHLS  269 (283)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCH-----HHHhcCchhhhccc
Confidence            444 3578999999999999999999988     89999999987543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.7e-42  Score=351.55  Aligned_cols=253  Identities=25%  Similarity=0.430  Sum_probs=211.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~------  127 (499)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.++++++||||++++++|...      
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            47899999999999999999999999999999998654322 22334466799999999999999999998644      


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|+||||+.+ +|.+.+...  +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            357999999965 888888754  89999999999999999999999999999999999999999999999999976532


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC------
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  281 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~------  281 (499)
                      ..           ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....+.++...-      
T Consensus       171 ~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         171 SF-----------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             CC-----------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            21           1224578999999999999999999999999999999999999998877655544443210      


Q ss_pred             ----------------C--------------CC-------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 ----------------I--------------RF-------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 ----------------~--------------~~-------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                                      .              .+       +...+..+++||.+||+.||++||++     .+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~eiL~~~~~  314 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV-----DDALQHPYI  314 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH-----HHHhcChhH
Confidence                            0              00       11245678999999999999999998     889999999


Q ss_pred             CC
Q 010859          325 KG  326 (499)
Q Consensus       325 ~~  326 (499)
                      +.
T Consensus       315 ~~  316 (353)
T cd07850         315 NV  316 (353)
T ss_pred             hh
Confidence            83

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-42  Score=342.23  Aligned_cols=255  Identities=29%  Similarity=0.458  Sum_probs=218.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++++.||+|+||+||+|.+..+|+.||+|++....  .......+.+|+.+++.++||||+++++.+.+...+|+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            4578999999999999999999999999999999986542  23345667889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||+++++|.+++.+.+.+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++......   
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            99999999999999888889999999999999999999997 69999999999999999999999999998654221   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-----------HHHHHHHhc
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-----------LIFQRIIAR  280 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-----------~~~~~i~~~  280 (499)
                               .....+|+..|+|||++.+..++.++|+|||||++|+|++|..||......           .....+...
T Consensus       158 ---------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd06620         158 ---------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE  228 (284)
T ss_pred             ---------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence                     112457999999999998888999999999999999999999999865542           223333332


Q ss_pred             -CCCCCCC-CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 -DIRFPNY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 -~~~~p~~-~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                       ...++.. ++.++.+||.+||+.||.+||++     +++++||||..
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~e~~~~~~~~~  271 (284)
T cd06620         229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTP-----QQLCAMPPFIQ  271 (284)
T ss_pred             cCCCCCchhcCHHHHHHHHHHhcCCcccCcCH-----HHHhcCccccc
Confidence             2233333 78899999999999999999998     89999999953

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.6e-42  Score=339.59  Aligned_cols=253  Identities=29%  Similarity=0.486  Sum_probs=210.4

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE-----c
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ-----D  126 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~-----~  126 (499)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|..+++.+ +||||+++++++.     +
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            4579999999999999999999999999999999875432    1224466788889898 6999999999873     4


Q ss_pred             CCeEEEEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          127 TFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      ...+|+||||++|++|.+++..    ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            5679999999999999987753    356899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCC-----CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  277 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i  277 (499)
                      ..+....          .......|++.|+|||++..     ..++.++|+|||||++|+|++|+.||...+.......+
T Consensus       172 ~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~  241 (286)
T cd06638         172 AQLTSTR----------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI  241 (286)
T ss_pred             eecccCC----------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence            7653221          12224569999999999853     44788999999999999999999999877654444333


Q ss_pred             Hhc---CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          278 IAR---DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       278 ~~~---~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ...   ....|..++.++.+||.+||+.||++||++     .++++|+||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~~~~  286 (286)
T cd06638         242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTV-----SDLLQHVFI  286 (286)
T ss_pred             cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCH-----HHHhhcccC
Confidence            222   222455678899999999999999999998     899999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=336.64  Aligned_cols=252  Identities=30%  Similarity=0.510  Sum_probs=212.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~----  128 (499)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.....    ....+.+|..+++++ +||||+++++.+.+..    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            4799999999999999999999999999999999876432    234577899999998 7999999999997644    


Q ss_pred             --eEEEEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          129 --SLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       129 --~l~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                        .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence              58999999999999998865    357999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCC-----CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  277 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i  277 (499)
                      .......          .......|+..|+|||++..     ..++.++|||||||++|+|++|.+||...........+
T Consensus       161 ~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  230 (275)
T cd06608         161 AQLDSTL----------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI  230 (275)
T ss_pred             eecccch----------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence            7543221          12234578999999999753     34678899999999999999999999876665555555


Q ss_pred             HhcC---CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          278 IARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       278 ~~~~---~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ....   ...+..++.++++||.+||..||++||++     ++++.|||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~~ll~~~~~  275 (275)
T cd06608         231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM-----EELLEHPFI  275 (275)
T ss_pred             hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCH-----HHHhcCCCC
Confidence            4432   22234578899999999999999999998     899999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.7e-42  Score=343.22  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=204.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcC----------------CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKID----------------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG  116 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~----------------t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~  116 (499)
                      ..++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++++++|||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence            45789999999999999999998642                34579999986542  2334456778999999999999


Q ss_pred             ccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcE
Q 010859          117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-------------------HLSEDEARFYTAEVVDALEYIHSMGLI  177 (499)
Q Consensus       117 Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~-------------------~l~e~~~~~i~~qil~aL~~LH~~gIi  177 (499)
                      |+++++++.+....|+||||+++|+|.+++....                   .+++..+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886532                   367788999999999999999999999


Q ss_pred             eeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHH
Q 010859          178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  257 (499)
Q Consensus       178 HrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilye  257 (499)
                      ||||||+|||++.++.+||+|||+++.+.....        ........++..|+|||++.+..++.++|||||||++|+
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  232 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE  232 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCce--------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence            999999999999999999999999976533211        011223456789999999988889999999999999999


Q ss_pred             Hhc--CCCCCCCCCHHHHHHHHHh--------cCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          258 MLS--GTSPFKDTSEWLIFQRIIA--------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       258 llt--G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |++  +..||...+.......+..        .....|..++..+.+|+.+||+.||.+||++
T Consensus       233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence            986  6788987776655444322        1123456788999999999999999999998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-42  Score=339.19  Aligned_cols=255  Identities=31%  Similarity=0.469  Sum_probs=215.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++.+.+...+|++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            4799999999999999999999999999999998654322 223456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++++.|..+..+...+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.......     
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~-----  154 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP-----  154 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc-----
Confidence            999987776666666779999999999999999999999999999999999999999999999999987654322     


Q ss_pred             CCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC------------
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------------  281 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~------------  281 (499)
                          ......++|+..|+|||++.+. .++.++|+|||||++|+|++|++||.+.+.......+....            
T Consensus       155 ----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         155 ----ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             ----cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence                1122346789999999999888 78999999999999999999999998776554433322100            


Q ss_pred             --------------------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 --------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 --------------------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                                          ..+|..++.++.+||.+||..+|++||++     +++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~f  288 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-----DELLQHPYF  288 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH-----HHHhcCCCC
Confidence                                01344468999999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-42  Score=339.08  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=206.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.+......  .......+|+.+++.++||||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            57899999999999999999999999999999998754322  1223355799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+.+ +|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......   
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---  157 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS---  157 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC---
Confidence            999985 999988764 468999999999999999999999999999999999999999999999999986432111   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCC-HHHHHHHHHhc----------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIAR----------  280 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~-~~~~~~~i~~~----------  280 (499)
                             .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. .......+...          
T Consensus       158 -------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         158 -------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP  230 (291)
T ss_pred             -------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence                   11123357889999999875 457889999999999999999999997765 22222222110          


Q ss_pred             ---------CCCC-----------CCCCC--hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          281 ---------DIRF-----------PNYFS--DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       281 ---------~~~~-----------p~~~~--~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                               ...+           ...++  .++.++|.+||+.||.+||++     .+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~-----~e~l~~~~f  291 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA-----AEAMKHPYF  291 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH-----HHHhcCCCC
Confidence                     0000           01234  788999999999999999998     889999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.7e-42  Score=355.54  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=207.7

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEE-----cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~  125 (499)
                      +..++|++++.||+|+||.||+|+.     ..++..||+|++......  .....+.+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            4456899999999999999999974     456778999998644322  2335577899999999 8999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcC-------------------------------------------------------
Q 010859          126 DTFSLYMALESCEGGELFDQITSKG-------------------------------------------------------  150 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~-------------------------------------------------------  150 (499)
                      +....|+|||||++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999886431                                                       


Q ss_pred             --------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          151 --------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       151 --------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                                          .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                                367888999999999999999999999999999999999999999999999986543211


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC--CCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD--IRFPNY  287 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~  287 (499)
                              ........++..|+|||++.+..++.++|||||||++|+|++ |..||........+.+.....  ...|..
T Consensus       270 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (375)
T cd05104         270 --------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC  341 (375)
T ss_pred             --------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCC
Confidence                    011123345678999999999999999999999999999998 999998765444333333332  334566


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+.++.+||.+||+.||++||++     .++++
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~-----~eil~  369 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTF-----KQIVQ  369 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCH-----HHHHH
Confidence            78999999999999999999998     55653

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=362.93  Aligned_cols=248  Identities=30%  Similarity=0.540  Sum_probs=215.8

Q ss_pred             EeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCC
Q 010859           62 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGE  141 (499)
Q Consensus        62 ~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~  141 (499)
                      +||+|.||+||.|++..|....|||.+..+.   .....-+..|+.+.+.|+|.|||++.+.+..++++-+.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            6999999999999999999999999886442   2233457779999999999999999999999999999999999999


Q ss_pred             hHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-CCCEEEEecCCccccCCccccccCCCC
Q 010859          142 LFDQITSK-GHL--SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAA  217 (499)
Q Consensus       142 L~~~i~~~-~~l--~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~  217 (499)
                      |.+++... |++  +|..+-+|..||++||.|||++.|||||||-+|+||+. .|.+||.|||.++.+..-         
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi---------  729 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI---------  729 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC---------
Confidence            99999865 788  89999999999999999999999999999999999974 689999999999876432         


Q ss_pred             CCCCccccccCccCCCccccCCC--CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH--HHH-HHHhcCCCCCCCCChHH
Q 010859          218 SDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IFQ-RIIARDIRFPNYFSDAA  292 (499)
Q Consensus       218 ~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~--~~~-~i~~~~~~~p~~~~~~~  292 (499)
                       ..-..+|.||..|||||++..+  .|+.++|||||||++.||.||++||.......  +++ -+.+..+++|..++.++
T Consensus       730 -nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaea  808 (1226)
T KOG4279|consen  730 -NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEA  808 (1226)
T ss_pred             -CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHH
Confidence             2344589999999999999755  48999999999999999999999997543322  222 23346778999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      +.||.+|+.+||.+||+|     .+++..||++.-
T Consensus       809 k~FilrcFepd~~~R~sA-----~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  809 KNFILRCFEPDPCDRPSA-----KDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHcCCCcccCccH-----HHhccCcccccC
Confidence            999999999999999999     889999999753

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.8e-42  Score=337.84  Aligned_cols=252  Identities=28%  Similarity=0.493  Sum_probs=210.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE------c
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ------D  126 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~------~  126 (499)
                      .+.|++.+.||.|+||.||+|.+..+++.||+|++....    .....+..|+.+++++ +||||++++++|.      .
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            468999999999999999999999999999999986542    2234466788888888 7999999999985      3


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          127 TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      ...+|++|||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            56799999999999999988753  4588999999999999999999999999999999999999999999999999875


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  279 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~  279 (499)
                      ....          ........|++.|+|||++.     +..++.++|+|||||++|+|++|..||...........+..
T Consensus       171 ~~~~----------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  240 (282)
T cd06636         171 LDRT----------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  240 (282)
T ss_pred             hhcc----------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence            4321          11223567999999999985     34578899999999999999999999987665444433333


Q ss_pred             cCC-C-CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          280 RDI-R-FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       280 ~~~-~-~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ... . .+..++.++.+||.+||..||.+||++     .+|++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-----~ell~~~~~  282 (282)
T cd06636         241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPST-----EQLLKHPFI  282 (282)
T ss_pred             CCCCCCcccccCHHHHHHHHHHhCCChhhCcCH-----HHHhcCCCC
Confidence            221 1 223578999999999999999999998     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.6e-42  Score=339.24  Aligned_cols=252  Identities=29%  Similarity=0.452  Sum_probs=210.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++++.||.|+||.||+|++..+|+.||||.+...... ......+..|+.++++++||||+++++++.+....|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            589999999999999999999999999999998654322 2233456779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+. ++|..++..  .+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..+....    
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~----  154 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----  154 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence            996 589888865  3568999999999999999999999999999999999999999999999999987553221    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  281 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----------  281 (499)
                            .......+++.|+|||++.+.. ++.++|+|||||++|+|+||+.||.+.++.....++....           
T Consensus       155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         155 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence                  1122345788999999987644 6888999999999999999999998877665544433210           


Q ss_pred             -------CCC-----------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 -------IRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 -------~~~-----------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                             ..+           ...++++++++|.+||+.||.+||++     ++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~~l~~~~f  284 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA-----KAALAHPFF  284 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH-----HHHhcCCCC
Confidence                   011           12467889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.9e-42  Score=339.01  Aligned_cols=257  Identities=31%  Similarity=0.465  Sum_probs=221.1

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ..|+..+.||.|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.+.||||+++++.+.+....|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468889999999999999999999999999999875532  233456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||++|++|.+++.. +++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----  155 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-----  155 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-----
Confidence            99999999998875 579999999999999999999999999999999999999999999999999987653321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCCCCCCCChHHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAAR  293 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~  293 (499)
                           .......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+... ...++..++..+.
T Consensus       156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06640         156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK  230 (277)
T ss_pred             -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHH
Confidence                 1122456889999999999888999999999999999999999999887766555444332 2344556788999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       294 ~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      +||.+||+.+|++||++     ++++.||||.....
T Consensus       231 ~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~  261 (277)
T cd06640         231 EFIDACLNKDPSFRPTA-----KELLKHKFIVKNAK  261 (277)
T ss_pred             HHHHHHcccCcccCcCH-----HHHHhChHhhhcch
Confidence            99999999999999988     89999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2e-41  Score=330.36  Aligned_cols=257  Identities=32%  Similarity=0.595  Sum_probs=218.6

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...... ......+..|..+++.++|+||+++++.+.+...+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            589999999999999999999999999999999766443 3456678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      |+++++|.+++.+.+.+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++.........    
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~----  155 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT----  155 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc----
Confidence            9999999999988878999999999999999999999999999999999999999999999999999876443211    


Q ss_pred             CCCCCCccccccCccCCCccccCCCC---CCCCCcchhhhHHHHHHhcCCCCCCCCC-HHHHHHHHHh-cCCCCCCCC--
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIA-RDIRFPNYF--  288 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~---~~~~sDiwslG~ilyelltG~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~--  288 (499)
                        .........|+..|+|||++.+..   .+.++|+|||||++|+|++|+.||.... .......+.. ....+|...  
T Consensus       156 --~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         156 --MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             --ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccccc
Confidence              011122356889999999998766   8899999999999999999999997653 3333333332 234455544  


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +..+.+||.+||+.+|.+||++     ++++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~-----~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTA-----SELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCH-----HHHhcCCCC
Confidence            8999999999999999999998     889999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.9e-42  Score=338.53  Aligned_cols=248  Identities=21%  Similarity=0.344  Sum_probs=212.0

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ..++|.+.+.||+|+||.||++.+.     .++..+|+|.+...   .......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4578999999999999999999863     34567999988654   223345577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCE
Q 010859          128 FSLYMALESCEGGELFDQITSKG-------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI  194 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~-------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~v  194 (499)
                      ..+|+||||+++++|.+++...+             .+++..+..++.||+.||+|||++|++||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999997543             38999999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHH
Q 010859          195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLI  273 (499)
Q Consensus       195 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~  273 (499)
                      ||+|||+++.......        ........++..|+|||++.+..++.++|+|||||++|+|++ |.+||...+....
T Consensus       160 kl~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~  231 (288)
T cd05093         160 KIGDFGMSRDVYSTDY--------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  231 (288)
T ss_pred             EeccCCccccccCCce--------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999976533211        011123456788999999998889999999999999999998 9999998887777


Q ss_pred             HHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          274 FQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       274 ~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      ...+.... ...+..++.++.+|+.+||+.||.+||++.
T Consensus       232 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  270 (288)
T cd05093         232 IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIK  270 (288)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            77777654 345667899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.5e-42  Score=337.23  Aligned_cols=253  Identities=28%  Similarity=0.486  Sum_probs=218.4

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.++.+++.+|+|.+......  .....+.+|+.+++.++||||+++++.+.....+|+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            4789999999999999999999999999999998775432  34455677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          135 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       135 E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+.......   
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence            999999999999876 789999999999999999999999 999999999999999999999999999987543211   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC-----CHHHHHHHHHhc-CCCCCC
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----SEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~  286 (499)
                               .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...     ......+.+... ....|.
T Consensus       156 ---------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (265)
T cd06605         156 ---------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS  226 (265)
T ss_pred             ---------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh
Confidence                     11267899999999999999999999999999999999999999764     233344444433 233444


Q ss_pred             C-CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 Y-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~-~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      . ++.++.++|.+||..||.+||++     .+++.||||+.
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~-----~~ll~~~~~~~  262 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSY-----KELLEHPFIKK  262 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCH-----HHHhhCchhhc
Confidence            4 88999999999999999999998     88999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.4e-42  Score=340.12  Aligned_cols=254  Identities=28%  Similarity=0.428  Sum_probs=213.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLY  131 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~--~~l~  131 (499)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++...  ..+|
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            46899999999999999999999999999999999755333 22333456789999999999999999998877  8999


Q ss_pred             EEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  160 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-  160 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence            99999975 9999887653 59999999999999999999999999999999999999999999999999988654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---------
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---------  280 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---------  280 (499)
                               .......+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||...+......++...         
T Consensus       161 ---------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
T cd07843         161 ---------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW  231 (293)
T ss_pred             ---------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence                     1122346788999999987654 688999999999999999999999987766555544321         


Q ss_pred             ----------------------CCCCCCC-CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          281 ----------------------DIRFPNY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       281 ----------------------~~~~p~~-~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                                            ...+|.. +++.+.+||.+||+.||++||++     ++++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~ell~~~~f  293 (293)
T cd07843         232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA-----EDALKHPYF  293 (293)
T ss_pred             HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH-----HHHhcCCCC
Confidence                                  0123333 68889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.3e-42  Score=342.00  Aligned_cols=252  Identities=24%  Similarity=0.390  Sum_probs=209.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceE--EEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~v--AiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      +..++|++.+.||+|+||.||+|.+..++..+  |+|.+..  .........+.+|+.++.++ +||||+++++++.+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            45689999999999999999999998888654  6666542  22233445677799999999 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC
Q 010859          129 SLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG  192 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~  192 (499)
                      .+|+||||+++++|.+++.+.+                .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999997543                478999999999999999999999999999999999999999


Q ss_pred             CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHH
Q 010859          193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEW  271 (499)
Q Consensus       193 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~  271 (499)
                      .+||+|||++......           .......++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..
T Consensus       162 ~~kl~dfg~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  230 (303)
T cd05088         162 VAKIADFGLSRGQEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  230 (303)
T ss_pred             cEEeCccccCcccchh-----------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence            9999999998632110           01112234667999999988889999999999999999998 99999888777


Q ss_pred             HHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          272 LIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       272 ~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      .....+... ....|..+++++.+||.+||+.+|++||++     ++++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~il~~  276 (303)
T cd05088         231 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILVS  276 (303)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            766665443 234566788999999999999999999998     556543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.3e-41  Score=335.28  Aligned_cols=252  Identities=30%  Similarity=0.487  Sum_probs=217.9

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      .|...+.||+|++|.||++.+..+++.+|+|++...   .......+.+|+.+++.++||||+++++++......|+++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            466678999999999999999999999999988643   22234456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      |++|++|.+++.. +++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+......       
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~-------  168 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-------  168 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-------
Confidence            9999999999887 67999999999999999999999999999999999999999999999999987654321       


Q ss_pred             CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC---CCCCCChHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPNYFSDAA  292 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~  292 (499)
                         ........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+......   .+..++..+
T Consensus       169 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (285)
T cd06648         169 ---VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRL  245 (285)
T ss_pred             ---CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHH
Confidence               11223457899999999999888999999999999999999999999888777666666654322   233478899


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+||.+||..+|++||++     .++++||||+.
T Consensus       246 ~~li~~~l~~~p~~Rpt~-----~~il~~~~~~~  274 (285)
T cd06648         246 RSFLDRMLVRDPAQRATA-----AELLNHPFLAK  274 (285)
T ss_pred             HHHHHHHcccChhhCcCH-----HHHccCccccc
Confidence            999999999999999998     88999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-41  Score=332.11  Aligned_cols=245  Identities=21%  Similarity=0.345  Sum_probs=212.0

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.....+|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            4568999999999999999999999999999999986542    223456779999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999998754  3589999999999999999999999999999999999999999999999999986543221


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                      .         ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.....+.+... ...+|..+
T Consensus       160 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (263)
T cd05052         160 T---------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGC  230 (263)
T ss_pred             e---------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence            1         1112234668999999998899999999999999999998 99999988877776666543 45677889


Q ss_pred             ChHHHHHHHHhhccCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +.++.++|.+||+.||++||++
T Consensus       231 ~~~~~~li~~cl~~~p~~Rp~~  252 (263)
T cd05052         231 PPKVYELMRACWQWNPSDRPSF  252 (263)
T ss_pred             CHHHHHHHHHHccCCcccCCCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.5e-41  Score=339.35  Aligned_cols=258  Identities=28%  Similarity=0.410  Sum_probs=207.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      +++|++.+.||+|+||.||+|.+..+++.||+|.+...... ........+|+.++++++||||+++++++.+..     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            57899999999999999999999999999999998654322 222234456889999999999999999886543     


Q ss_pred             ---eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          129 ---SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       129 ---~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                         ..|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence               46999999965 888877655 3689999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--  281 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--  281 (499)
                      +......      .........++..|+|||++.+.. ++.++|+|||||++|+|++|++||.+.+.......+....  
T Consensus       169 ~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         169 FSLSKNS------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             ccCCccc------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            5432211      011223456889999999986644 6889999999999999999999998877654433322211  


Q ss_pred             -----------------CCCCC-------------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 -----------------IRFPN-------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 -----------------~~~p~-------------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                                       ..+|.             ..+..+.+||.+||..||.+||++     +++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~-----~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA-----DTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH-----HHHhcCCCC
Confidence                             11111             125678899999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=326.31  Aligned_cols=253  Identities=32%  Similarity=0.587  Sum_probs=223.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|..++++++|||++++++++.+....|++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            589999999999999999999999999999999776443 2344567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      |+++++|.+++...+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......      
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~------  153 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS------  153 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc------
Confidence            99999999999988889999999999999999999999999999999999999999999999999998664322      


Q ss_pred             CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH-hcCCCCCCCCChHHHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFPNYFSDAARD  294 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~  294 (499)
                          .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+......++. .....+|..++..+.+
T Consensus       154 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (254)
T cd06627         154 ----KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD  229 (254)
T ss_pred             ----ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence                11234578999999999988888999999999999999999999998776655444443 4445677889999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +|.+||..+|++||++     ++++.||||
T Consensus       230 ~i~~~l~~~p~~R~~~-----~~~l~~~~~  254 (254)
T cd06627         230 FLMQCFQKDPNLRPTA-----KQLLKHPWI  254 (254)
T ss_pred             HHHHHHhCChhhCcCH-----HHHhcCCCC
Confidence            9999999999999998     899999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2e-41  Score=336.23  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=205.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++......  .....+.+|..+++.++|+||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            36899999999999999999999999999999998655322  2223456789999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+. ++|.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++......   
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  157 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS---  157 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---
Confidence            99996 577776654 3568899999999999999999999999999999999999999999999999987543211   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHhcC---------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD---------  281 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~~~~---------  281 (499)
                             .......+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.. +.+..+....         
T Consensus       158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         158 -------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             -------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence                   112234678999999998754 4788899999999999999999999865532 2222221100         


Q ss_pred             --------------CCCCC---------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 --------------IRFPN---------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 --------------~~~p~---------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                                    ...+.         ..+.++.+|+.+||+.||.+|||+     .+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~-----~~~l~h~~~  291 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA-----QDALLHPYF  291 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH-----HHHhcCCCC
Confidence                          00000         125689999999999999999998     889999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.2e-42  Score=347.23  Aligned_cols=260  Identities=26%  Similarity=0.417  Sum_probs=213.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE----cCCeE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DTFSL  130 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~----~~~~l  130 (499)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+|+.++||||++++++|.    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            6899999999999999999999999999999998765322 223445667999999999999999998876    34578


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999996 59999998878899999999999999999999999999999999999999999999999999976543221


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---------
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---------  280 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---------  280 (499)
                      .      ........+|+..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.......+...         
T Consensus       163 ~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         163 E------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             C------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            1      1112234578999999999865 45889999999999999999999999877654433322210         


Q ss_pred             -----------------CCCC-----CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          281 -----------------DIRF-----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       281 -----------------~~~~-----p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                       ....     ....+.++.++|.+||+.||.+||++     ++++.||||.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~~l~~~~~~~~  300 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV-----EQALQHPFLAQY  300 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH-----HHHHhChhhhhc
Confidence                             0001     13468899999999999999999998     889999999854

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-42  Score=366.99  Aligned_cols=264  Identities=25%  Similarity=0.367  Sum_probs=202.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCC-CceEEEEE--------------EeCcccchhhHHHHHHHHHHHHHhCCCCCcc
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKI--------------MDKKFITKENKTAYVKLERIVLDQLDHPGVV  118 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t-~~~vAiK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv  118 (499)
                      .++|++++.||+|+||+||+|..+.. +...+.|.              +.+...........+.+|+.+|+.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            57899999999999999999986543 22233221              1111111222345577899999999999999


Q ss_pred             EEEEEEEcCCeEEEEEeccCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC
Q 010859          119 RLFFTFQDTFSLYMALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  193 (499)
Q Consensus       119 ~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~  193 (499)
                      ++++++.+....|+|++++. ++|..++...     .......++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            99999999999999999995 5888776543     23456788899999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCC-CCCC--CH
Q 010859          194 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDT--SE  270 (499)
Q Consensus       194 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~P-f~~~--~~  270 (499)
                      +||+|||+++.+....         ......++||..|+|||++.+..++.++|||||||++|+|++|..+ |...  +.
T Consensus       306 vkL~DFGla~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        306 IVLGDFGTAMPFEKER---------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             EEEEeCCCceecCccc---------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            9999999998654321         1223357899999999999999999999999999999999998764 4322  22


Q ss_pred             HHHHHHHHhc----CCCCC----------------------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHH
Q 010859          271 WLIFQRIIAR----DIRFP----------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVL  318 (499)
Q Consensus       271 ~~~~~~i~~~----~~~~p----------------------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l  318 (499)
                      ...+.+++..    ...+|                            ..++.++.++|.+||+.||.+||++     +++
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa-----~el  451 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA-----AEL  451 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH-----HHH
Confidence            2222222210    00111                            1356778899999999999999999     899


Q ss_pred             hcCCCCCCCCcccc
Q 010859          319 KMHPFFKGIDWKNI  332 (499)
Q Consensus       319 ~~Hpff~~i~~~~~  332 (499)
                      +.||||.+...+.+
T Consensus       452 L~hp~f~~~~~~~~  465 (501)
T PHA03210        452 LALPLFSAEEEEEI  465 (501)
T ss_pred             hhChhhhcCCchHH
Confidence            99999998765543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-41  Score=334.60  Aligned_cols=248  Identities=31%  Similarity=0.510  Sum_probs=205.5

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC--CeEEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDT--FSLYMA  133 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~--~~l~lv  133 (499)
                      |++.+.||+|+||.||+|.+..+++.||+|++.+......  ......|..+++++. ||||+++++++.+.  +.+|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6889999999999999999999999999999876432222  122345777888884 99999999999987  899999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++ +|.+.+... +.+++..+..++.|++.||.|||+.||+||||+|+||+++. +.+||+|||+++.+....   
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP---  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence            999975 888887753 56899999999999999999999999999999999999999 999999999997653221   


Q ss_pred             cCCCCCCCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh------------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA------------  279 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~------------  279 (499)
                              ......++..|+|||.+. +..++.++|+|||||++|+|++|.+||.+.+.......+..            
T Consensus       154 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
T cd07831         154 --------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK  225 (282)
T ss_pred             --------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence                    112356889999999764 45578899999999999999999999998877665544432            


Q ss_pred             ------cCCCCC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          280 ------RDIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       280 ------~~~~~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                            ..+.+|           ..++.++.+||.+||..||++||++     ++++.||||
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~-----~~~l~~~~~  282 (282)
T cd07831         226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA-----KQALRHPYF  282 (282)
T ss_pred             hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH-----HHHhhCCCC
Confidence                  112222           2467899999999999999999998     899999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.6e-41  Score=335.55  Aligned_cols=253  Identities=18%  Similarity=0.333  Sum_probs=212.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEc----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKI----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      ...+|++.+.||+|+||.||+|...    .++..||+|.+....  .......+.+|..+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            4578999999999999999999863    456789999986432  2233456778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC
Q 010859          129 SLYMALESCEGGELFDQITSK-----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  191 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~-----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~  191 (499)
                      ..|+||||+++++|.+++...                 ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999998532                 237888999999999999999999999999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCH
Q 010859          192 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  270 (499)
Q Consensus       192 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~  270 (499)
                      +.+||+|||+++.......        ........++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05090         161 LHVKISDLGLSREIYSADY--------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN  232 (283)
T ss_pred             CcEEeccccccccccCCcc--------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999986543221        112234456788999999988889999999999999999998 9999988877


Q ss_pred             HHHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          271 WLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       271 ~~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ....+.+.... +..|..+++.+.+++.+||+.||.+||++     .++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-----~~i~~  278 (283)
T cd05090         233 QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRF-----KDIHT  278 (283)
T ss_pred             HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-----HHHHH
Confidence            66666555433 45677889999999999999999999988     55654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4e-42  Score=342.15  Aligned_cols=253  Identities=30%  Similarity=0.483  Sum_probs=216.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +.|.....||+|+||.||++.+..++..||||.+....   ......+.+|..+++.++||||+++++.+......|+||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            45666788999999999999999999999999986532   334455778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......      
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~------  171 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------  171 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc------
Confidence            99999999988754 46999999999999999999999999999999999999999999999999998754321      


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCCCChH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA  291 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~  291 (499)
                          ........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...   ....+..++..
T Consensus       172 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T cd06658         172 ----VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSV  247 (292)
T ss_pred             ----cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHH
Confidence                11223467899999999999888999999999999999999999999988776665554432   12223357889


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +.++|.+||..||.+||++     +++++||||..
T Consensus       248 ~~~li~~~l~~~P~~Rpt~-----~~il~~~~~~~  277 (292)
T cd06658         248 LRGFLDLMLVREPSQRATA-----QELLQHPFLKL  277 (292)
T ss_pred             HHHHHHHHccCChhHCcCH-----HHHhhChhhhc
Confidence            9999999999999999998     89999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=354.48  Aligned_cols=251  Identities=29%  Similarity=0.409  Sum_probs=222.8

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      -|.-++.||.|+||.||.|++..+.+.||||.|....-....+-..+..|+..|+.+.|||+|.+.+.|-.+...++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            47788999999999999999999999999999987655555566667789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          136 SCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       136 ~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||-| +-.+++.-+ +++-+.++..|..+.+.||.|||+++.||||||..|||+++.|.|||+|||.|....+       
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------  178 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------  178 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-------
Confidence            9964 777777543 5699999999999999999999999999999999999999999999999999987543       


Q ss_pred             CCCCCCCccccccCccCCCcccc---CCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCC-CCCC
Q 010859          215 NAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFP-NYFS  289 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l---~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p-~~~~  289 (499)
                             +.+|+|||.|||||++   ..+.|+-++||||||++..+|.-.++|+...+....+..|-..+. .++ ..|+
T Consensus       179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS  251 (948)
T KOG0577|consen  179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS  251 (948)
T ss_pred             -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhH
Confidence                   4489999999999997   456799999999999999999999999999888777777766543 333 4589


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ..++.||..||++-|.+|||+     ++++.|+|...
T Consensus       252 ~~F~~Fvd~CLqKipqeRpts-----e~ll~H~fv~R  283 (948)
T KOG0577|consen  252 DYFRNFVDSCLQKIPQERPTS-----EELLKHRFVLR  283 (948)
T ss_pred             HHHHHHHHHHHhhCcccCCcH-----HHHhhcchhcc
Confidence            999999999999999999999     89999999864

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-41  Score=334.56  Aligned_cols=253  Identities=30%  Similarity=0.485  Sum_probs=219.3

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      -|++.+.||+|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            47889999999999999999999999999999865432  2234567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      |+++++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+....      
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~------  155 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ------  155 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch------
Confidence            9999999998875 468999999999999999999999999999999999999999999999999987653321      


Q ss_pred             CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCChHHHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARD  294 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~  294 (499)
                          .......|+..|+|||.+.+...+.++|+|||||++|+|++|..||...+.......+.... ..++..++.++.+
T Consensus       156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T cd06641         156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE  231 (277)
T ss_pred             ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHH
Confidence                11234578999999999988888999999999999999999999998877766665554432 3356678899999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +|.+||+.+|.+||++     .++++||||..
T Consensus       232 ~i~~~l~~~p~~Rp~~-----~~~l~~~~~~~  258 (277)
T cd06641         232 FVEACLNKEPSFRPTA-----KELLKHKFIVR  258 (277)
T ss_pred             HHHHHccCChhhCcCH-----HHHHhCHHHhh
Confidence            9999999999999988     88999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=348.88  Aligned_cols=245  Identities=22%  Similarity=0.387  Sum_probs=213.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +....+.+++.||+|-||.||+|.... ...||+|.+.......    ..+.+|+++|++|+|++||++++++..+..+|
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            334567889999999999999999854 3489999987653333    33557999999999999999999999988999


Q ss_pred             EEEeccCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |||||++.|+|.+++..  .+.+...+...++.||++|++||+++++|||||-..||||+++..+||+|||+|+....+.
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999999999997  4569999999999999999999999999999999999999999999999999999655544


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      ++...+.         --..-|.|||.+....++.+|||||||++|+||+| |+.||.+.+..+..+.+.++ .++-|+.
T Consensus       358 Y~~~~~~---------kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~  428 (468)
T KOG0197|consen  358 YTASEGG---------KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEG  428 (468)
T ss_pred             eeecCCC---------CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCC
Confidence            3321110         11346999999999999999999999999999999 99999999999999888765 4567889


Q ss_pred             CChHHHHHHHHhhccCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +|+++.+++..|+..+|++|||.
T Consensus       429 CP~~vY~lM~~CW~~~P~~RPtF  451 (468)
T KOG0197|consen  429 CPDEVYELMKSCWHEDPEDRPTF  451 (468)
T ss_pred             CCHHHHHHHHHHhhCCcccCCCH
Confidence            99999999999999999999998

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.6e-42  Score=336.03  Aligned_cols=248  Identities=20%  Similarity=0.315  Sum_probs=211.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcC-----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ..++|.+.+.||+|+||.||+|.+..     ++..||+|++.....  ......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            35689999999999999999998753     468899999865422  22345677899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC
Q 010859          128 FSLYMALESCEGGELFDQITSKG--------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  193 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~--------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~  193 (499)
                      ...|+||||+++++|.+++...+              .+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997643              4789999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHH
Q 010859          194 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL  272 (499)
Q Consensus       194 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~  272 (499)
                      +||+|||+++.+.....        ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus       161 ~kl~d~g~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~  232 (280)
T cd05049         161 VKIGDFGMSRDVYTTDY--------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE  232 (280)
T ss_pred             EEECCcccceecccCcc--------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999875432211        011123456788999999999999999999999999999998 999998888877


Q ss_pred             HHHHHHhcCCC-CCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          273 IFQRIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       273 ~~~~i~~~~~~-~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ....+..+... .|..++..+.+|+.+||+.||++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  271 (280)
T cd05049         233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI  271 (280)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            77777665443 456789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3e-41  Score=337.95  Aligned_cols=252  Identities=30%  Similarity=0.410  Sum_probs=215.0

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ..|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+....|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            46999999999999999999999999999999987654444444456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+.| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....      
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~------  167 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------  167 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC------
Confidence            99974 77777654 45699999999999999999999999999999999999999999999999999865422      


Q ss_pred             CCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCC-CCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRF-PNYF  288 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~  288 (499)
                              ...+.|+..|+|||++.   ...++.++|||||||++|+|++|..||.+.+.......+.... ..+ +..+
T Consensus       168 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (307)
T cd06607         168 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW  239 (307)
T ss_pred             --------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhh
Confidence                    12457889999999974   4568889999999999999999999998887766555444332 222 3357


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +..+.+||.+||..||.+||++     .+++.||||..
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~  272 (307)
T cd06607         240 SDYFRNFVDSCLQKIPQDRPSS-----EELLKHRFVLR  272 (307)
T ss_pred             CHHHHHHHHHHhcCChhhCcCH-----HHHhcChhhcc
Confidence            8899999999999999999998     88999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.6e-41  Score=330.18  Aligned_cols=252  Identities=29%  Similarity=0.508  Sum_probs=209.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +.+.....||+|+||.||+|.+..++..||+|.+....   ......+.+|+.+++.++|+||+++++++......|++|
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34445568999999999999999999999999886542   223456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-CCCEEEEecCCccccCCccc
Q 010859          135 ESCEGGELFDQITSK-GHL--SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       135 E~~~gg~L~~~i~~~-~~l--~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||+++++|.+++... +.+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++....... 
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-  163 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-  163 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-
Confidence            999999999998764 456  88999999999999999999999999999999999976 6799999999987553211 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCC--CCCCCcchhhhHHHHHHhcCCCCCCCCCHHH--HHH-HHHhcCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IFQ-RIIARDIRFP  285 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--~~~~sDiwslG~ilyelltG~~Pf~~~~~~~--~~~-~i~~~~~~~p  285 (499)
                               .......|+..|+|||++.+..  ++.++|+||||+++|+|++|+.||.......  ... ........+|
T Consensus       164 ---------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd06624         164 ---------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP  234 (268)
T ss_pred             ---------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC
Confidence                     1122346899999999986643  7889999999999999999999997643221  111 1223445678


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ..+++++.+|+.+||+.+|.+||++     .+++.||||
T Consensus       235 ~~~~~~~~~li~~~l~~~p~~Rpt~-----~~ll~~~~~  268 (268)
T cd06624         235 ESLSAEAKNFILRCFEPDPDKRASA-----HDLLQDPFL  268 (268)
T ss_pred             cccCHHHHHHHHHHcCCCchhCCCH-----HHHHhCCCC
Confidence            8899999999999999999999998     899999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.4e-41  Score=335.97  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=208.7

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCe----
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFS----  129 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~----  129 (499)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.+. ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            4799999999999999999999999999999998654322 223345667999999995 6999999999987665    


Q ss_pred             -EEEEEeccCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-CCCEEEEecCCc
Q 010859          130 -LYMALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSV  202 (499)
Q Consensus       130 -l~lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-~~~vkL~DFG~a  202 (499)
                       +|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999986 898887643     35799999999999999999999999999999999999998 889999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  281 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~  281 (499)
                      +.+....          .......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.++.....++....
T Consensus       159 ~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  228 (295)
T cd07837         159 RAFSIPV----------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL  228 (295)
T ss_pred             eecCCCc----------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            7553211          11122357889999998865 457899999999999999999999999887766555443310


Q ss_pred             C-----------------CCC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          282 I-----------------RFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       282 ~-----------------~~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      .                 .+|           ..++.++.+||.+||..||.+||++     ++++.||||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~-----~eil~~~~~~  295 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA-----KAALTHPYFD  295 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH-----HHHhcCCCcC
Confidence            0                 011           2478899999999999999999998     8999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=343.96  Aligned_cols=258  Identities=25%  Similarity=0.416  Sum_probs=208.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-----~  128 (499)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...  ........+..|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            36899999999999999999999999999999998542  1222344466799999999999999999877544     3


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+++||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            58999999975 88887755 46999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh--------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------  279 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~--------  279 (499)
                      ..       ........+||+.|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.......+..        
T Consensus       160 ~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         160 HD-------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             cc-------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            11       0112234678999999998654 5688999999999999999999999987654433322211        


Q ss_pred             -------c-----------CCC-----CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          280 -------R-----------DIR-----FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       280 -------~-----------~~~-----~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                             .           ...     .....++++.+||.+||+.||.+||++     .++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~e~l~hp~~~~~  298 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV-----EEALAHPYLEQY  298 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH-----HHHhcCcccccc
Confidence                   0           000     012457889999999999999999998     899999999854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.2e-43  Score=332.99  Aligned_cols=260  Identities=28%  Similarity=0.417  Sum_probs=209.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCc----eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TF  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-~~  128 (499)
                      +..|++++.||+|.||.||+|..++++-    .||||.++.+.-..... ...-+|+.+++.++|||++.|..+|-. +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            4679999999999999999997766543    78999886553322222 234569999999999999999999876 88


Q ss_pred             eEEEEEeccCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC----CCEEEEec
Q 010859          129 SLYMALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADF  199 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~----~~vkL~DF  199 (499)
                      .+++++||++. +|...|+-+     ..++...++.+++||++|+.|||++=|+||||||.|||+..+    |.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999987 999998744     348999999999999999999999999999999999999988    89999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCH--------
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSE--------  270 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~--------  270 (499)
                      |+|+.+.+.-...       -.....+.|.+|+|||++.|.. |+.+.||||+|||+.||+|-.+.|.+..+        
T Consensus       181 GlaR~~~~plkpl-------~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf  253 (438)
T KOG0666|consen  181 GLARLFNNPLKPL-------ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF  253 (438)
T ss_pred             cHHHHhhcccccc-------ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence            9999886532111       1122468899999999988765 89999999999999999999999986432        


Q ss_pred             -HHHHHHHHhcC-----------CCCCC--------------------------CCChHHHHHHHHhhccCCCCCCCCCC
Q 010859          271 -WLIFQRIIARD-----------IRFPN--------------------------YFSDAARDLIDRLLDVDPSGRPGAGP  312 (499)
Q Consensus       271 -~~~~~~i~~~~-----------~~~p~--------------------------~~~~~~~~Li~~lL~~dP~~R~~~~~  312 (499)
                       ..++++|...-           -.+|+                          .-++.+.+|+.+||+.||.+|+|+  
T Consensus       254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta--  331 (438)
T KOG0666|consen  254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA--  331 (438)
T ss_pred             hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH--
Confidence             23445554310           00111                          124558999999999999999999  


Q ss_pred             CCHHHHhcCCCCCCC
Q 010859          313 GGYAVLKMHPFFKGI  327 (499)
Q Consensus       313 ~~~~~l~~Hpff~~i  327 (499)
                         +++++|+||..-
T Consensus       332 ---~qAleh~yF~~d  343 (438)
T KOG0666|consen  332 ---EQALEHPYFTED  343 (438)
T ss_pred             ---HHHhcccccccC
Confidence               889999999853

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-41  Score=329.42  Aligned_cols=247  Identities=25%  Similarity=0.405  Sum_probs=210.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||+|+||.||+|..+. +..+|+|.+......    ...+..|+.++++++||||+++++++.+...+|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            4689999999999999999998764 568999987654322    23467799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++.......  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--  155 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--  155 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce--
Confidence            9999999999998753 5689999999999999999999999999999999999999999999999999876532211  


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCCh
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSD  290 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~  290 (499)
                             .......++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+.......+.... ...|...+.
T Consensus       156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  228 (256)
T cd05114         156 -------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASM  228 (256)
T ss_pred             -------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence                   01112245668999999998889999999999999999999 999999988888877777643 345677889


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLK  319 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~  319 (499)
                      ++.+|+.+||+.||.+||++     ++++
T Consensus       229 ~~~~li~~c~~~~p~~Rps~-----~~l~  252 (256)
T cd05114         229 TVYEVMYSCWHEKPEGRPTF-----AELL  252 (256)
T ss_pred             HHHHHHHHHccCCcccCcCH-----HHHH
Confidence            99999999999999999998     5565

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-43  Score=305.58  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=218.0

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +.|.-.+.||+|.||+||+|++++|++.||+|.++.... .+.-.....+|+-+|+.++|.|||+++++...+..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            456777899999999999999999999999999876532 3334455678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||.. +|..+... +|.++.+.++.++.|++.||.|+|++++.||||||.|.||+.+|.+||+|||+|+.+.-.-    
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv----  155 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----  155 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce----
Confidence            99975 89888875 4779999999999999999999999999999999999999999999999999998764321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC----------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD----------  281 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~----------  281 (499)
                            .-.+.-+.|.+|++|.++.+.. |+.+.|+||-|||+.|+.. |++.|.+.+-..++.+|...-          
T Consensus       156 ------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             ------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence                  1112347799999999988765 8889999999999999987 899999999888888887521          


Q ss_pred             ------C----CCC---------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          282 ------I----RFP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       282 ------~----~~p---------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                            +    .+|         +.++...+||++++|.-+|..|++|     ++.++||||.+.
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisa-----eaalqhpyf~d~  289 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA-----EAALQHPYFSDF  289 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH-----HHHhcCcccccc
Confidence                  0    011         1245668999999999999999999     889999999854

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=355.06  Aligned_cols=244  Identities=35%  Similarity=0.551  Sum_probs=212.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHH-HhCCCCCccEEEEEEEcCCeEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ..++|++...+|.|+||.|-.+.+..+++.+++|++.+....       ..+|..++ ..-+||||+++++++.+...+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence            468899999999999999999999999999999999876211       22355444 4448999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee-CCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl-~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||++.|+.|.+.+.....+. .++..|++||+.|+.|||++|++||||||+|||+ +..|+++|+|||.++.....  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999999999888876555 8888999999999999999999999999999999 68899999999999865432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHhcCCCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~  289 (499)
                                 ..+-+-|..|+|||++....|+.++||||||++||+||+|+.||...... ++..+|..+.+  ...+|
T Consensus       470 -----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~--s~~vS  536 (612)
T KOG0603|consen  470 -----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF--SECVS  536 (612)
T ss_pred             -----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc--ccccC
Confidence                       22446788999999999999999999999999999999999999866544 66666655443  38899


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .++++||++||+.||.+||++     .+++.||||
T Consensus       537 ~~AKdLl~~LL~~dP~~Rl~~-----~~i~~h~w~  566 (612)
T KOG0603|consen  537 DEAKDLLQQLLQVDPALRLGA-----DEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHHhccCChhhCcCh-----hhhccCcch
Confidence            999999999999999999999     789999999

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-41  Score=337.67  Aligned_cols=258  Identities=26%  Similarity=0.373  Sum_probs=212.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ......+.+|..+++.++||||+++++++.+....|+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            36899999999999999999999999999999998654322 22334566799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-CCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |||++ ++|.+++.....  +++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++....... 
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-  157 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-  157 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence            99996 588888865433  588999999999999999999999999999999999985 4579999999997543211 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--------
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--------  281 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--------  281 (499)
                               .......|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+......++....        
T Consensus       158 ---------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (294)
T PLN00009        158 ---------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW  228 (294)
T ss_pred             ---------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence                     11123467899999999866 457889999999999999999999998877665554443210        


Q ss_pred             -------------CC--------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          282 -------------IR--------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       282 -------------~~--------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                                   ..        ....+++++.++|.+||+.||++||++     .++++||||++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-----~~~l~~~~~~~~~  291 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA-----RAALEHEYFKDLG  291 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH-----HHHhcCchHhHHh
Confidence                         00        123468899999999999999999988     8899999998653

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-45  Score=341.33  Aligned_cols=254  Identities=29%  Similarity=0.454  Sum_probs=223.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +-|.++..||+|+||.||+|.++++|+.+|||.+...     .....+..|+.+|+.++.|++|++|+.|..+..+++||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            3588999999999999999999999999999987543     33455677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||..|+..+.+.. +++|+|+++..++...+.||+|||...-+|||||..|||++.+|+.||+|||.|..+...     
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-----  182 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-----  182 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-----
Confidence            99999999999874 467999999999999999999999999999999999999999999999999999866432     


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCh
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  290 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~  290 (499)
                           -....+..|||.|||||++..-.|+.++||||||++..||.-|++||.+-.+....-.|-..   .+.-|+.++.
T Consensus       183 -----MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  183 -----MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSS  257 (502)
T ss_pred             -----HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhh
Confidence                 23445789999999999999999999999999999999999999999877664433333222   2345678999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      ++.|||++||.++|++|-||     -.|++|||.++..
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA-----~~L~~H~FiknA~  290 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTA-----LRLCEHTFIKNAP  290 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHH-----HHHhhhhhhcCCC
Confidence            99999999999999999998     8899999998654

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.9e-42  Score=340.15  Aligned_cols=253  Identities=29%  Similarity=0.490  Sum_probs=216.8

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      -|.....||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.+++.++||||+++++.+......|++||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            45566689999999999999999999999999865422   223456779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      |+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+....      
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~------  171 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------  171 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc------
Confidence            9999999887765 469999999999999999999999999999999999999999999999999987543221      


Q ss_pred             CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---CCCCCCCChHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDAA  292 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~  292 (499)
                          ......+|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+....   ...+..++.++
T Consensus       172 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  247 (297)
T cd06659         172 ----PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVL  247 (297)
T ss_pred             ----ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHH
Confidence                12234679999999999998889999999999999999999999998887766665554432   22344678899


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      .++|.+||+.+|.+||++     +++++||||...
T Consensus       248 ~~~i~~~l~~~P~~Rps~-----~~ll~~~~~~~~  277 (297)
T cd06659         248 RDFLERMLTREPQERATA-----QELLDHPFLLQT  277 (297)
T ss_pred             HHHHHHHhcCCcccCcCH-----HHHhhChhhccC
Confidence            999999999999999988     899999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-41  Score=371.32  Aligned_cols=258  Identities=26%  Similarity=0.344  Sum_probs=208.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+....|+|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            46899999999999999999999999999999999765544444456677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          134 LESCEGGELFDQITSK-----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-----------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      |||++||+|.+++...           ..++...+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988642           23556778899999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCC--------CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHH
Q 010859          203 KPMQDSRITVLPN--------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF  274 (499)
Q Consensus       203 ~~~~~~~~~~~~~--------~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~  274 (499)
                      +............        ..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            8763211000000        00011223468999999999999999999999999999999999999999876544332


Q ss_pred             HHH-HhcCCCC--CCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          275 QRI-IARDIRF--PNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       275 ~~i-~~~~~~~--p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      ... .......  ...+++.+.+++.+||..||++|+++.
T Consensus       241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~  280 (932)
T PRK13184        241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSV  280 (932)
T ss_pred             hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHH
Confidence            221 1111111  135788999999999999999999863

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-41  Score=343.92  Aligned_cols=253  Identities=28%  Similarity=0.446  Sum_probs=212.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      .++|++++.||+|+||.||+|.+..+|..||+|++.+... .......+.+|+.+++.++||||++++++|....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4689999999999999999999999999999999865432 2333445678999999999999999999997654     


Q ss_pred             -eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 -~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                       ..|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence             469999999 6799888765 5799999999999999999999999999999999999999999999999999875422


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC---
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---  283 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~---  283 (499)
                                   ......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+......   
T Consensus       171 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         171 -------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             -------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence                         1124567899999999876 45788999999999999999999999987765555544332111   


Q ss_pred             ----------------------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          284 ----------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       284 ----------------------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                                  +...+++++.++|.+||+.||.+||++     .+++.||||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~-----~~~l~~~~~~~~  304 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA-----AEALAHPYFEEF  304 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH-----HHHhcCccHhhh
Confidence                                        123568889999999999999999998     889999999864

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.7e-41  Score=330.46  Aligned_cols=251  Identities=29%  Similarity=0.481  Sum_probs=211.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|++..+++.||||.+.............+..|+.+++.++||||+++++++.+....|++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            68999999999999999999999999999999887654444445556778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          135 ESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       135 E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||+++|+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-  160 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-  160 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence            99999999988753    3458999999999999999999999999999999999999999999999999987654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC--HHHHHHHHHhcCC-CC-CC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRIIARDI-RF-PN  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~--~~~~~~~i~~~~~-~~-p~  286 (499)
                               .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||....  .....+.+....+ .. +.
T Consensus       161 ---------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd08228         161 ---------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTE  231 (267)
T ss_pred             ---------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChh
Confidence                     11124568899999999998889999999999999999999999996543  2344444433222 12 23


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .++..+.++|.+||..+|++||++     +++++
T Consensus       232 ~~~~~~~~li~~cl~~~p~~Rp~~-----~~vl~  260 (267)
T cd08228         232 HYSEKLRELVSMCIYPDPDQRPDI-----GYVHQ  260 (267)
T ss_pred             hcCHHHHHHHHHHCCCCcccCcCH-----HHHHH
Confidence            577899999999999999999998     56654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-41  Score=328.82  Aligned_cols=253  Identities=31%  Similarity=0.570  Sum_probs=217.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|+||.||+|.+..+|..+|+|.+....... .....+.+|+.+++.++||||+++++.+.+...+|+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5899999999999999999999999999999987653322 233456779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC-EEEEecCCccccCCccccc
Q 010859          136 SCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~-vkL~DFG~a~~~~~~~~~~  212 (499)
                      |+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++.++. +||+|||.+.......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---  156 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM---  156 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence            999999999987653  4799999999999999999999999999999999999998864 6999999987654321   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCChH
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDA  291 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~  291 (499)
                             .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..... ..+..++.+
T Consensus       157 -------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (257)
T cd08225         157 -------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD  229 (257)
T ss_pred             -------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHH
Confidence                   112235689999999999888899999999999999999999999988776666555544332 345668899


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +.++|.+||..+|++||++     .+++.||||
T Consensus       230 ~~~~i~~~l~~~p~~Rpt~-----~~ll~~~~~  257 (257)
T cd08225         230 LRSLISQLFKVSPRDRPSI-----TSILKRPFL  257 (257)
T ss_pred             HHHHHHHHhccChhhCcCH-----HHHhhCCCC
Confidence            9999999999999999998     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.4e-42  Score=340.34  Aligned_cols=257  Identities=30%  Similarity=0.475  Sum_probs=219.9

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            457888999999999999999999999999999875432  223456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+....     
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-----  155 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-----  155 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-----
Confidence            99999999998865 569999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCCCCCCCChHHH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAAR  293 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~  293 (499)
                           .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+... ...++..++.++.
T Consensus       156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06642         156 -----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFK  230 (277)
T ss_pred             -----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHH
Confidence                 1122356889999999999988999999999999999999999999876665555444332 2334556788999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       294 ~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      ++|.+||+.+|++||++     .++++||||....+
T Consensus       231 ~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~  261 (277)
T cd06642         231 EFVEACLNKDPRFRPTA-----KELLKHKFITRYTK  261 (277)
T ss_pred             HHHHHHccCCcccCcCH-----HHHHHhHHHHHHhh
Confidence            99999999999999998     88999999975443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.6e-41  Score=333.68  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=210.3

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||.|++|.||+|++..+|+.||+|++......  .....+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999998765322  223445678999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          136 SCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       136 ~~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......   
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~---  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence            9985 898888754   358999999999999999999999999999999999999999999999999987543211   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC----------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----------  281 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~----------  281 (499)
                             .......+|..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+......++....          
T Consensus       155 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07836         155 -------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPG  227 (284)
T ss_pred             -------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHH
Confidence                   111234678899999998664 46889999999999999999999999887665555443210          


Q ss_pred             --------CCC-----------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 --------IRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 --------~~~-----------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                              ..+           .+..+.+++++|.+||+.||.+||++     +++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-----~~~l~~~~f  284 (284)
T cd07836         228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA-----HDALQHPWF  284 (284)
T ss_pred             HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH-----HHHhcCCCC
Confidence                    011           12457889999999999999999988     899999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=386.74  Aligned_cols=259  Identities=32%  Similarity=0.568  Sum_probs=227.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      .+++-+..||.|.||.||-|.+.+||...|+|-+.-.... ......+.+|..++..++|||+|++|++-.+.+.+||.|
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3577888999999999999999999999999987654333 444556788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |||+||+|.+.+...+..+|...+.|..|++.||.|||++|||||||||+||+++.+|.+|++|||.|..+.+...+.  
T Consensus      1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~-- 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM-- 1391 (1509)
T ss_pred             HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC--
Confidence            999999999999988889999999999999999999999999999999999999999999999999999887653221  


Q ss_pred             CCCCCCCccccccCccCCCccccCCC---CCCCCCcchhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHhc-CCCCCCCCC
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR-DIRFPNYFS  289 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~---~~~~~sDiwslG~ilyelltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~~  289 (499)
                          +......+||+.|||||++.+.   +...++|||||||++.||+||+.||.. .+++.++.++-.+ .+++|..++
T Consensus      1392 ----~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls 1467 (1509)
T KOG4645|consen 1392 ----PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLS 1467 (1509)
T ss_pred             ----CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhh
Confidence                2334478999999999999654   467889999999999999999999975 4677777776655 577999999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ++.+|||+.||+.||.+|.++     .+|++|-|=+
T Consensus      1468 ~~g~dFle~Cl~~dP~~Rw~~-----~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTA-----SQLLEHAFGK 1498 (1509)
T ss_pred             HhHHHHHHHHHhcCchhhhHH-----HHHHHhhccc
Confidence            999999999999999999988     7899999865

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.2e-41  Score=324.28  Aligned_cols=253  Identities=31%  Similarity=0.603  Sum_probs=222.8

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|.+.+.||.|+||.||+|.+..++..||+|++...... ......+..|..+++.++|||++++++.+.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            589999999999999999999999999999999765433 2334456779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          136 SCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       136 ~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      |+++++|.+++.+.    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--  157 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence            99999999998764    679999999999999999999999999999999999999999999999999987653321  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCh
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSD  290 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~  290 (499)
                              .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+.... ..+|..++.
T Consensus       158 --------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd08215         158 --------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSS  229 (258)
T ss_pred             --------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCH
Confidence                    12234578999999999998889999999999999999999999998887777666665543 345667899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ++.+++.+||..+|++||++     .++++||||
T Consensus       230 ~~~~~i~~~l~~~p~~Rp~~-----~~ll~~~~~  258 (258)
T cd08215         230 ELRNLVSSLLQKDPEERPSI-----AQILQSPFI  258 (258)
T ss_pred             HHHHHHHHHcCCChhhCcCH-----HHHhcCCCC
Confidence            99999999999999999999     889999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-41  Score=343.86  Aligned_cols=256  Identities=28%  Similarity=0.432  Sum_probs=212.0

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----Ce
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----FS  129 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-----~~  129 (499)
                      .+|++.+.||+|+||+||+|++..+++.||||.+........ ......+|+.+++.++||||+++++++...     ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc-hhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            579999999999999999999999999999999876433222 233456799999999999999999887644     35


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            899999996 6999999888889999999999999999999999999999999999999999999999999997653221


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--------
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  280 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--------  280 (499)
                                .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.......+...        
T Consensus       163 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07858         163 ----------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED  232 (337)
T ss_pred             ----------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence                      12234578999999998864 46889999999999999999999999876543333222110        


Q ss_pred             --------------------CC---CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          281 --------------------DI---RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       281 --------------------~~---~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                          ..   ...+.+++++.+||.+||+.||++||++     +++++||||..+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~-----~ell~h~~~~~~  297 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV-----EEALAHPYLASL  297 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH-----HHHHcCcchhhh
Confidence                                00   0123578999999999999999999988     899999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-41  Score=331.15  Aligned_cols=254  Identities=20%  Similarity=0.324  Sum_probs=214.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCC-----CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t-----~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      +..++|++.+.||+|+||.||+|.++..     +..||+|.+.....  ......+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            3467999999999999999999998754     48899999865422  2233456679999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEE
Q 010859          127 TFSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI  196 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~----------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL  196 (499)
                      ....|+||||+++|+|.+++...          +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            99999999999999999998653          23678899999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHH
Q 010859          197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ  275 (499)
Q Consensus       197 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~  275 (499)
                      +|||+++.+......        .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+.....+
T Consensus       161 ~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  232 (277)
T cd05032         161 GDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK  232 (277)
T ss_pred             CCcccchhhccCccc--------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence            999998765432210        11223457889999999988889999999999999999998 999999888777776


Q ss_pred             HHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          276 RIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       276 ~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+... ...+|..++.++.+||.+||+.+|++||++     .++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~l~~  273 (277)
T cd05032         233 FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTF-----LEIVS  273 (277)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCH-----HHHHH
Confidence            66643 345788889999999999999999999988     55653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.7e-42  Score=328.86  Aligned_cols=234  Identities=30%  Similarity=0.486  Sum_probs=200.9

Q ss_pred             cCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCChHHH
Q 010859           66 GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQ  145 (499)
Q Consensus        66 G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~  145 (499)
                      |.||.||+|+++.+++.||+|.+.+..        ....|...+....||||+++++++.+....|+||||++||+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999999999999999986642        122344444556799999999999999999999999999999999


Q ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCcccc
Q 010859          146 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF  225 (499)
Q Consensus       146 i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~  225 (499)
                      +.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+......             ....
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-------------~~~~  142 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-------------CDGE  142 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-------------cccC
Confidence            988878999999999999999999999999999999999999999999999999987654321             1234


Q ss_pred             ccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhccCCC
Q 010859          226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPS  305 (499)
Q Consensus       226 ~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~  305 (499)
                      .++..|+|||.+.+..++.++|+||+||++|+|++|+.||........    ......+|..+++.+++||.+||+.||+
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~  218 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPT  218 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHH
Confidence            567789999999888899999999999999999999999865432110    1123457788999999999999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCC
Q 010859          306 GRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       306 ~R~~~~~~~~~~l~~Hpff  324 (499)
                      +|+++++.+++++++||||
T Consensus       219 ~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         219 ERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HhcCCCccchHHHHcCCCC
Confidence            9999988889999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.1e-41  Score=323.68  Aligned_cols=255  Identities=32%  Similarity=0.564  Sum_probs=221.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMA  133 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~--~~l~lv  133 (499)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++...... ......+.+|..++++++||||+++++.+.+.  ..+|++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999999999999998766433 33456677899999999999999999999988  899999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      +||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  157 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG--  157 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence            999999999999988878999999999999999999999999999999999999999999999999998866443210  


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC-HHHHHHHHH--hcCCCCCCCCCh
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRII--ARDIRFPNYFSD  290 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~~~  290 (499)
                            .......++..|+|||.+.+...+.++|+|||||++|+|++|..||.... .......+.  .....+|..++.
T Consensus       158 ------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd06606         158 ------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE  231 (260)
T ss_pred             ------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCH
Confidence                  01234578899999999988889999999999999999999999998776 333333333  234557778899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .+.+||.+||+.||++||++     .+++.||||
T Consensus       232 ~l~~~i~~~l~~~p~~Rp~~-----~~ll~~~~~  260 (260)
T cd06606         232 EAKDFLRKCLRRDPKKRPTA-----DELLQHPFL  260 (260)
T ss_pred             HHHHHHHHhCcCChhhCCCH-----HHHhhCCCC
Confidence            99999999999999999988     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=338.95  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=206.7

Q ss_pred             CeeeeeEeeecCceEEEEEEEcC--CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLY  131 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~--t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~--~~l~  131 (499)
                      .|++.+.||+|+||.||+|.+..  +++.||+|.+.............+.+|+.+++.++||||+++++++.+.  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48999999999999999999988  8999999999875322233344567789999999999999999999988  8899


Q ss_pred             EEEeccCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC----CCCEEEEecCCc
Q 010859          132 MALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA----DGHIKIADFGSV  202 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~----~~~vkL~DFG~a  202 (499)
                      +||||+++ +|.+.+...     ..+++..++.++.||+.||.|||+.||+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 777766532     36899999999999999999999999999999999999999    899999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH---------
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWL---------  272 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~---------  272 (499)
                      ..+......       .......+||+.|+|||++.+. .++.++|+|||||++|+|++|++||.+.....         
T Consensus       160 ~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
T cd07842         160 RLFNAPLKP-------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD  232 (316)
T ss_pred             cccCCCccc-------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence            865432210       1122345789999999988664 57889999999999999999999998654322         


Q ss_pred             HHHHHHh--------------------------cCCCCC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCH
Q 010859          273 IFQRIIA--------------------------RDIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGY  315 (499)
Q Consensus       273 ~~~~i~~--------------------------~~~~~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~  315 (499)
                      ....+..                          ....++           ...+.++.++|.+||+.||++||++     
T Consensus       233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-----  307 (316)
T cd07842         233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA-----  307 (316)
T ss_pred             HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH-----
Confidence            1111110                          011111           1466789999999999999999998     


Q ss_pred             HHHhcCCCC
Q 010859          316 AVLKMHPFF  324 (499)
Q Consensus       316 ~~l~~Hpff  324 (499)
                      .+++.||||
T Consensus       308 ~eil~~~~f  316 (316)
T cd07842         308 EEALEHPYF  316 (316)
T ss_pred             HHHhcCCCC
Confidence            899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.7e-41  Score=337.68  Aligned_cols=255  Identities=29%  Similarity=0.465  Sum_probs=217.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||+|+||.||++.+..++..||+|.+....   ......+.+|+.+++.++||||+++++++......|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            478999999999999999999999999999999986432   22345567789999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      +||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......    
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~----  169 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  169 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc----
Confidence            9999999999998764 58999999999999999999999999999999999999999999999999987543321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh-cC--CCCCCCCCh
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RD--IRFPNYFSD  290 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~-~~--~~~p~~~~~  290 (499)
                            .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+.. ..  ...+..++.
T Consensus       170 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd06647         170 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  243 (293)
T ss_pred             ------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCH
Confidence                  122345789999999999888899999999999999999999999987765443332221 11  223445788


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      .+.+||.+||..+|.+||++     .+++.||||+..
T Consensus       244 ~l~~li~~~l~~~p~~Rp~~-----~~il~h~~~~~~  275 (293)
T cd06647         244 IFRDFLNRCLEMDVEKRGSA-----KELLQHPFLKIA  275 (293)
T ss_pred             HHHHHHHHHccCChhhCcCH-----HHHhcCHHHhcC
Confidence            99999999999999999988     899999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.5e-41  Score=327.11  Aligned_cols=240  Identities=25%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  140 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg  140 (499)
                      +.||+|+||.||+|++..+++.||+|.+....  .......+.+|..+++.++||||+++++++.+...+|+||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            36899999999999999999999999876432  2334456778999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          141 ELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       141 ~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      +|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........        
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--------  150 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--------  150 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc--------
Confidence            9999997654 5899999999999999999999999999999999999999999999999998754321100        


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCChHHHHHHH
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  297 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~  297 (499)
                      .......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+... ...+|..++..+.+|+.
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  230 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLME  230 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHH
Confidence            00011123457999999998889999999999999999997 99999877766555554432 44567788999999999


Q ss_pred             HhhccCCCCCCCC
Q 010859          298 RLLDVDPSGRPGA  310 (499)
Q Consensus       298 ~lL~~dP~~R~~~  310 (499)
                      +||+.||++||++
T Consensus       231 ~~l~~~p~~Rps~  243 (252)
T cd05084         231 RCWEYDPGQRPSF  243 (252)
T ss_pred             HHcCCChhhCcCH
Confidence            9999999999998

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.7e-41  Score=331.28  Aligned_cols=255  Identities=29%  Similarity=0.472  Sum_probs=212.0

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLYM  132 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~~~l~l  132 (499)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+.....  ......+.+|+++++.++||||++++++|.+  ...+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            479999999999999999999999999999999876532  2334557789999999999999999998864  447999


Q ss_pred             EEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          133 ALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ||||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999887653    345899999999999999999999999999999999999999999999999998754321


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC-----CHHHHHHHHHhcC-C
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----SEWLIFQRIIARD-I  282 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~-----~~~~~~~~i~~~~-~  282 (499)
                                  ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...     ........+.... .
T Consensus       159 ------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd06621         159 ------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP  226 (287)
T ss_pred             ------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch
Confidence                        112356788999999999889999999999999999999999999865     2233333333311 1


Q ss_pred             CCC------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          283 RFP------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       283 ~~p------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      .++      ..+++++.+||.+||..+|.+||++     .+++.||||....
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~eil~~~~~~~~~  273 (287)
T cd06621         227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTP-----WDMLEHPWIKAQM  273 (287)
T ss_pred             hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCH-----HHHHhCccccccc
Confidence            122      1356789999999999999999998     8999999997543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.8e-41  Score=332.67  Aligned_cols=258  Identities=29%  Similarity=0.483  Sum_probs=223.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .+.|++.+.||+|+||.||+|.+..++..||+|++.....    ....+..|+.+++.++|+||+++++.+.....+|++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            4569999999999999999999998999999999976532    345567799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      +||+++++|.+++...+ .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......   
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---  170 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK---  170 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch---
Confidence            99999999999999876 89999999999999999999999999999999999999999999999999986543221   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---CCCCCCC
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFPNYFS  289 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~  289 (499)
                             .......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.....   ..+..++
T Consensus       171 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd06614         171 -------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS  243 (286)
T ss_pred             -------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCC
Confidence                   112245688999999999988899999999999999999999999998777655555544322   2233478


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      .++.+||.+||+.+|.+||++     .++++||||....|.
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~-----~~il~~~~~~~~~~~  279 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSA-----EELLQHPFLKKACPK  279 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCH-----HHHhhChHhhccCch
Confidence            999999999999999999988     899999999985553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.8e-41  Score=331.23  Aligned_cols=254  Identities=21%  Similarity=0.370  Sum_probs=212.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcC-----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+..|..+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            35789999999999999999999987     78899999875432  222334567799999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC---CEEEE
Q 010859          128 FSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIA  197 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~-------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~---~vkL~  197 (499)
                      ...|+||||++|++|.+++.+.+       .+++..+..++.||+.||.|||++|++||||||+||+++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999997653       489999999999999999999999999999999999998765   59999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHH
Q 010859          198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  276 (499)
Q Consensus       198 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~  276 (499)
                      |||+++.+......        .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......
T Consensus       162 dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~  233 (277)
T cd05036         162 DFGMARDIYRASYY--------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF  233 (277)
T ss_pred             cCccccccCCccce--------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999866332111        01112234568999999998889999999999999999997 9999998877766655


Q ss_pred             HHh-cCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          277 IIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       277 i~~-~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      +.. ....+|..++..+.+++.+||+.+|++||++     +++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~-----~~vl~~  274 (277)
T cd05036         234 VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF-----ATILER  274 (277)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHHH
Confidence            543 3445677889999999999999999999998     777765

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-41  Score=336.44  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=210.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .++|+..+.||+|+||.||++.+..+++.||+|.+.+....  .....+..|..++.++. ||||+++++++.++...++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            46788899999999999999999999999999998765332  33445677888888885 9999999999999999999


Q ss_pred             EEeccCCCChHHHH---h--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          133 ALESCEGGELFDQI---T--SKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       133 v~E~~~gg~L~~~i---~--~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      +|||+.+ +|.++.   .  ..+.+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++..+.
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999864 554432   2  23579999999999999999999997 499999999999999999999999999987543


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCC---CCCCCCcchhhhHHHHHHhcCCCCCCCCCH-HHHHHHHHhcC-
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIARD-  281 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~---~~~~~sDiwslG~ilyelltG~~Pf~~~~~-~~~~~~i~~~~-  281 (499)
                      ...           ......|+..|+|||++.+.   .++.++|+|||||++|+|++|++||..... .....++.... 
T Consensus       160 ~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  228 (288)
T cd06616         160 DSI-----------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP  228 (288)
T ss_pred             cCC-----------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCC
Confidence            211           11234688999999999776   688999999999999999999999976542 22223332222 


Q ss_pred             CCC----CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          282 IRF----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       282 ~~~----p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                      ..+    +..++.++.+||.+||+.||.+||++     ++++.||||+...|.+
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~i~~~~~~~~~~~~~  277 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKY-----KELLEHPFIKDYEERN  277 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhhchhhcc
Confidence            122    23478999999999999999999988     8999999999876654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.5e-41  Score=330.70  Aligned_cols=253  Identities=19%  Similarity=0.306  Sum_probs=210.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++......  .....+.+|..+++.++||||+++++++.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3568999999999999999999864     24578999988543221  2233466789999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEE
Q 010859          128 FSLYMALESCEGGELFDQITSKG----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  197 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~----------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~  197 (499)
                      ...++||||+++|+|.+++.+..          .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999987532          35778899999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHH
Q 010859          198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  276 (499)
Q Consensus       198 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~  276 (499)
                      |||+++.+......        .......+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......
T Consensus       162 dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~  233 (277)
T cd05062         162 DFGMTRDIYETDYY--------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF  233 (277)
T ss_pred             CCCCccccCCccee--------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99998765432211        01112356788999999998889999999999999999999 7999998887777666


Q ss_pred             HHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          277 IIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       277 i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      +.... ..+|...+..+.+++.+||+.||++||++     .++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~  273 (277)
T cd05062         234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIIS  273 (277)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            65544 35677889999999999999999999998     66654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.2e-41  Score=327.06  Aligned_cols=245  Identities=22%  Similarity=0.350  Sum_probs=208.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++++.||+|+||.||+|.+. ++..||+|.+.....    ....+.+|..+++.++||||+++++.+.+....|
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            45679999999999999999999975 567899998765322    2355778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999998753  468899999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      .         .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+.......+... ....+..
T Consensus       158 ~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05072         158 Y---------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN  228 (261)
T ss_pred             e---------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            1         11112346678999999998889999999999999999998 99999988777666665543 2334456


Q ss_pred             CChHHHHHHHHhhccCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ++.++.+|+.+||..+|++||++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~  251 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTF  251 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCH
Confidence            88999999999999999999998

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-41  Score=341.66  Aligned_cols=258  Identities=27%  Similarity=0.410  Sum_probs=218.8

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----eE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----SL  130 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----~l  130 (499)
                      +|++.+.||+|+||.||+|++..+++.||+|.+..... .......+..|+.+++.++||||+++++++.+..     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            58999999999999999999999999999999876432 2233455777999999999999999999988775     79


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |++|||+++ +|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            999999974 8999998878899999999999999999999999999999999999999999999999999986543221


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC------
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR------  283 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~------  283 (499)
                      .       ........||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+....+..+......      
T Consensus       159 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         159 E-------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             c-------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            0       1122345789999999999887 7899999999999999999999999988876666555542110      


Q ss_pred             -------------------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          284 -------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       284 -------------------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                               ....++.++.+||.+||+.+|.+||++     ++++.||||+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~~~~~~~  295 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA-----DEALAHPYLAQL  295 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH-----HHHHhCccHHhh
Confidence                                     112368889999999999999999998     899999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-41  Score=327.14  Aligned_cols=253  Identities=19%  Similarity=0.308  Sum_probs=212.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCC---CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..++|++.+.||+|+||.||+|..+.+   ...||+|++....  .......+..|..+++.++||||+++++.+.+...
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            357899999999999999999998754   4579999886543  22234456679999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|++|||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+...
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999998764 56899999999999999999999999999999999999999999999999999876421


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ..        ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+... ....|.
T Consensus       160 ~~--------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (266)
T cd05033         160 EA--------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM  231 (266)
T ss_pred             cc--------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            10        001112235678999999998899999999999999999998 99999887777776666553 334566


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ..+..+.+|+.+||+.+|++||++     .++++
T Consensus       232 ~~~~~l~~li~~cl~~~p~~Rp~~-----~ei~~  260 (266)
T cd05033         232 DCPSALYQLMLDCWQKDRNERPTF-----SQIVS  260 (266)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence            789999999999999999999998     55654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-41  Score=331.54  Aligned_cols=255  Identities=30%  Similarity=0.535  Sum_probs=214.8

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+.   |||++++++++.+....|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            58889999999999999999999999999999875432  223445677888888886   9999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+....   
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence            9999999999998866 479999999999999999999999999999999999999999999999999987654321   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCC-CCC
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPN-YFS  289 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~~  289 (499)
                             .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+.... ..++. .++
T Consensus       156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (277)
T cd06917         156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS  228 (277)
T ss_pred             -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCC
Confidence                   12234578999999999865 457889999999999999999999998876554443332221 22333 378


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      .++.+++.+||+.||.+||++     .+++.||||+...
T Consensus       229 ~~~~~~i~~~l~~~p~~R~~~-----~~il~~~~~~~~~  262 (277)
T cd06917         229 KLLREFVAACLDEEPKERLSA-----EELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHHHHHcCCCcccCcCH-----HHHhhChHhhccc
Confidence            899999999999999999998     8899999997643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-41  Score=331.49  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=210.0

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      |++.+.||.|++|.||+|.+..+|..||+|++....... .....+.+|+.+++.++||||+++++++.+....|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            678899999999999999999999999999987653322 2234466799999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          137 CEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       137 ~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      ++ ++|.+++....  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..+....     
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----  153 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-----  153 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence            95 59999988765  69999999999999999999999999999999999999999999999999987543211     


Q ss_pred             CCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC------------
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------------  281 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~------------  281 (499)
                           .......+++.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+......++....            
T Consensus       154 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         154 -----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             -----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence                 111233578899999988664 46889999999999999999999998877655444433210            


Q ss_pred             -----------------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 -----------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 -----------------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                                       ......++.++.++|.+||+.||.+||++     ++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~il~~~~~  283 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA-----KAALQHPYF  283 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH-----HHHhcCCCC
Confidence                             00123567899999999999999999988     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=326.96  Aligned_cols=248  Identities=23%  Similarity=0.372  Sum_probs=209.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|++.+....    ...+..|+.+++.++||||+++++++.+....|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            457999999999999999999886 4678999998654332    23456689999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........ 
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            9999999999998764 46899999999999999999999999999999999999999999999999998765322100 


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCh
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSD  290 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  290 (499)
                              ......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+... ....|...+.
T Consensus       157 --------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05059         157 --------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPT  228 (256)
T ss_pred             --------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCH
Confidence                    0111223457999999998899999999999999999999 89999888777666666543 3456777899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ++.+++.+||..+|++||++     .++++
T Consensus       229 ~~~~li~~cl~~~p~~Rpt~-----~~~l~  253 (256)
T cd05059         229 EVYTIMYSCWHEKPEDRPAF-----KKLLS  253 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            99999999999999999998     66654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-40  Score=324.56  Aligned_cols=246  Identities=32%  Similarity=0.532  Sum_probs=209.7

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.++++++|+||+++++.+.+....++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999987654444444566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          135 ESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       135 E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||+++++|..++..    ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+.... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-  160 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-  160 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence            99999999998864    2458999999999999999999999999999999999999999999999999987543221 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC--HHHHHHHHHhcCC-CCCC-
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRIIARDI-RFPN-  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~--~~~~~~~i~~~~~-~~p~-  286 (499)
                               .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||....  .......+..+.. ..|. 
T Consensus       161 ---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd08224         161 ---------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD  231 (267)
T ss_pred             ---------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChh
Confidence                     11234578999999999998889999999999999999999999996543  2233344433322 3444 


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .++..+.++|.+||..+|++||++
T Consensus       232 ~~~~~~~~~i~~cl~~~p~~Rp~~  255 (267)
T cd08224         232 HYSEELRDLVSRCINPDPEKRPDI  255 (267)
T ss_pred             hcCHHHHHHHHHHcCCCcccCCCH
Confidence            688899999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-41  Score=324.39  Aligned_cols=246  Identities=26%  Similarity=0.424  Sum_probs=214.3

Q ss_pred             eEeeecCceEEEEEEEcCC---CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010859           61 KIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  137 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~  137 (499)
                      +.||+|+||.||+|.+...   +..||+|++.......  ....+..|..+++.++|+||+++++++.+...+++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4689999999999999866   8999999987654332  4566788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          138 EGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       138 ~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ++++|.+++...         ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         67999999999999999999999999999999999999999999999999999876443


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ..        ........++..|+|||.+....++.++|+|||||++|+|++ |..||.........+.+... ....|.
T Consensus       159 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd00192         159 DY--------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPE  230 (262)
T ss_pred             cc--------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            21        112234567889999999988889999999999999999999 69999998887777777643 345677


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      .++.++.+++.+||+.+|.+||++     +++++|
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~-----~~l~~~  260 (262)
T cd00192         231 YCPDELYELMLSCWQLDPEDRPTF-----SELVER  260 (262)
T ss_pred             cCChHHHHHHHHHccCCcccCcCH-----HHHHHh
Confidence            889999999999999999999998     667654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-41  Score=329.24  Aligned_cols=246  Identities=31%  Similarity=0.522  Sum_probs=209.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++.+.||+|+||.||+|++..+++.||||.+.+...........+.+|..+++.++||||+++++++.+....|++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            67999999999999999999999999999999887654444444566778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          135 ESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       135 E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||+++++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-  160 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence            99999999998863    3468999999999999999999999999999999999999999999999999987653221 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH--HHHHHHHHhcCCC-C-CC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE--WLIFQRIIARDIR-F-PN  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~--~~~~~~i~~~~~~-~-p~  286 (499)
                               .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+...  ....+.+....+. . +.
T Consensus       161 ---------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd08229         161 ---------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD  231 (267)
T ss_pred             ---------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcc
Confidence                     112245789999999999998899999999999999999999999976543  2333444433221 2 24


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .++.++.+||.+||..||++||++
T Consensus       232 ~~~~~~~~li~~~l~~~p~~Rpt~  255 (267)
T cd08229         232 HYSEELRQLVNMCINPDPEKRPDI  255 (267)
T ss_pred             cccHHHHHHHHHhcCCCcccCCCH
Confidence            578899999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.1e-41  Score=331.67  Aligned_cols=257  Identities=23%  Similarity=0.374  Sum_probs=214.5

Q ss_pred             CCCCCCCCeeeeeEeeecCceEEEEEEEcCCC-----ceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEE
Q 010859           49 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFF  122 (499)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~-----~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~  122 (499)
                      ...+..++|++.+.||+|+||.||++.....+     ..+|+|.+.....  ......+.+|+.+++.+ +||||+++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            34566789999999999999999999986543     7899999875422  22334567799999999 7999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCe
Q 010859          123 TFQDTFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  186 (499)
Q Consensus       123 ~~~~~~~l~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NI  186 (499)
                      ++.....+|++|||+++|+|.+++...                +.+++..+..++.||+.||.|||++||+||||||+||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            999999999999999999999998642                4588999999999999999999999999999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCC
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  265 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf  265 (499)
                      |++.++.+||+|||+++.+......        .......++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  235 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYY--------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  235 (293)
T ss_pred             EEcCCCeEEeCccccccccccccce--------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence            9999999999999999865432211        01112234678999999998899999999999999999997 99999


Q ss_pred             CCCCHHHHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          266 KDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       266 ~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+.+....++.+.... ...|...+.++.+|+.+||..||++|||+     .++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~eil~  286 (293)
T cd05053         236 PGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF-----KQLVE  286 (293)
T ss_pred             CCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-----HHHHH
Confidence            9888777776665543 35667788999999999999999999998     56654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.3e-41  Score=325.42  Aligned_cols=240  Identities=22%  Similarity=0.325  Sum_probs=203.5

Q ss_pred             EeeecCceEEEEEEE--cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           62 IYGVGSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        62 ~LG~G~~g~Vy~a~~--~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      .||+|+||.||+|..  ..++..+|+|++..... .......+..|..+++.++||||+++++++.. ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            689999999999965  46788999999865432 23345567789999999999999999998764 467899999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       140 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      |+|.+++...+.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++..+......       .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~-------~  152 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY-------Y  152 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe-------e
Confidence            999999988888999999999999999999999999999999999999999999999999999865432210       0


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCChHHHHHHH
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARDLID  297 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~  297 (499)
                      .......++..|+|||.+....++.++|+|||||++|+|++ |..||.+.+.....+.+.... ...|..+++++.+||.
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMK  232 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            01112245678999999988889999999999999999998 999999888877777766543 4677889999999999


Q ss_pred             HhhccCCCCCCCC
Q 010859          298 RLLDVDPSGRPGA  310 (499)
Q Consensus       298 ~lL~~dP~~R~~~  310 (499)
                      +||+.||++||++
T Consensus       233 ~~~~~~p~~Rp~~  245 (257)
T cd05116         233 LCWTYGVDERPGF  245 (257)
T ss_pred             HHhccCchhCcCH
Confidence            9999999999998

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.6e-41  Score=332.87  Aligned_cols=253  Identities=19%  Similarity=0.321  Sum_probs=214.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCC-----CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t-----~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ...+|++.+.||+|+||.||+|.+..+     +..||+|++....  .......+..|..++..++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            456899999999999999999997643     5789999986542  222345577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC
Q 010859          128 FSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  191 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~  191 (499)
                      ..+++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999988532                347888999999999999999999999999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCH
Q 010859          192 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  270 (499)
Q Consensus       192 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~  270 (499)
                      +.+||+|||+++.+.....        ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         161 LNVKISDLGLFREVYAADY--------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             CceEecccccccccccchh--------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999886533211        111223456789999999988889999999999999999998 9999999888


Q ss_pred             HHHHHHHHhcCC-CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          271 WLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       271 ~~~~~~i~~~~~-~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ......+..... .+|..++..+.+|+.+||+.+|.+||++     ++++.
T Consensus       233 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~-----~~i~~  278 (283)
T cd05091         233 QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF-----KDIHS  278 (283)
T ss_pred             HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCH-----HHHHH
Confidence            888877777654 4578899999999999999999999998     66654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.6e-41  Score=336.13  Aligned_cols=254  Identities=19%  Similarity=0.304  Sum_probs=208.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCce----EEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTV----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~----vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      +...+|++.+.||+|+||.||+|++..++..    ||+|++....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            3457899999999999999999998766664    8999886432  223345577799999999999999999988765


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                       ..++++||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             578999999999999999875 468999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  284 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  284 (499)
                      .....        .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.......+.+... ....
T Consensus       161 ~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (316)
T cd05108         161 ADEKE--------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ  232 (316)
T ss_pred             CCCcc--------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence            32211        11112234678999999999999999999999999999997 99999887765544333322 2344


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      |..++.++.+++.+||..||.+||++     .+++.+
T Consensus       233 ~~~~~~~~~~li~~cl~~~p~~Rps~-----~~l~~~  264 (316)
T cd05108         233 PPICTIDVYMIMVKCWMIDADSRPKF-----RELIIE  264 (316)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            56788999999999999999999998     555543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-40  Score=332.41  Aligned_cols=244  Identities=24%  Similarity=0.388  Sum_probs=204.9

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCc--eEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGT--VYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~--~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ++|++.++||+|+||.||+|.+..++.  .+|+|.+...  ........+.+|..+++++ +||||+++++++.+...+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999987775  4688876532  2222344567799999888 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEE
Q 010859          132 MALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  195 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vk  195 (499)
                      ++|||+++++|.+++.+..                .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999997542                488899999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHH
Q 010859          196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  274 (499)
Q Consensus       196 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~  274 (499)
                      |+|||++......           ........+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.....
T Consensus       160 l~dfg~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~  228 (297)
T cd05089         160 IADFGLSRGEEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY  228 (297)
T ss_pred             ECCcCCCccccce-----------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999998632111           01111223457999999998889999999999999999997 99999988887777


Q ss_pred             HHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          275 QRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       275 ~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      ..+... ....|..++.++.+||.+||+.+|.+||++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  266 (297)
T cd05089         229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFA  266 (297)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            776654 3346677899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.7e-41  Score=340.06  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=209.0

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-------
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-------  127 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-------  127 (499)
                      .+|++.+.||.|+||.||+|.+..+|+.||+|.+.....   .....+.+|+.+++.++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            689999999999999999999999999999999866532   3345567799999999999999999776543       


Q ss_pred             -------CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-CCCEEEEec
Q 010859          128 -------FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADF  199 (499)
Q Consensus       128 -------~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-~~~vkL~DF  199 (499)
                             ..+|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                   36899999997 489888765 46999999999999999999999999999999999999975 457899999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  278 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~  278 (499)
                      |++..+......       ........|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.++......+.
T Consensus       160 g~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         160 GLARIVDPHYSH-------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             ccceecCCcccc-------ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999765432100       111123468899999998754 568889999999999999999999998877665555443


Q ss_pred             hcCC------------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          279 ARDI------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       279 ~~~~------------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ....                              .+...++.++.+||.+||+.||.+||++     .+++.||||+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~h~~~~~~  306 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA-----EEALMHPYMSCY  306 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH-----HHHhCCCccccc
Confidence            2110                              0123478899999999999999999998     889999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=323.80  Aligned_cols=244  Identities=19%  Similarity=0.318  Sum_probs=207.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++.+.||+|+||.||+|.+.. ++.||+|.+......    ...+.+|..++++++||||+++++++.....+|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            45789999999999999999999754 578999998654322    3446779999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999999997654  689999999999999999999999999999999999999999999999999987642210


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                               .......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+.......+... ....+...
T Consensus       159 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  229 (261)
T cd05068         159 ---------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGC  229 (261)
T ss_pred             ---------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence                     00111223457999999998899999999999999999999 99999988877776666543 23456678


Q ss_pred             ChHHHHHHHHhhccCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +..+.+++.+||+.+|.+||++
T Consensus       230 ~~~~~~li~~~l~~~P~~Rp~~  251 (261)
T cd05068         230 PKELYDIMLDCWKEDPDDRPTF  251 (261)
T ss_pred             CHHHHHHHHHHhhcCcccCCCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.9e-41  Score=342.02  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=204.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcC-----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc-
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD-  126 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~-  126 (499)
                      .++|++++.||+|+||.||+|....     +++.||+|++.....  ......+..|+.+++++ +||||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            4589999999999999999997543     457899999865422  22234466788999999 89999999998764 


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc---------------------------------------------------------
Q 010859          127 TFSLYMALESCEGGELFDQITSK---------------------------------------------------------  149 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~---------------------------------------------------------  149 (499)
                      ...+|++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            56799999999999999988542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCcccc
Q 010859          150 ----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF  225 (499)
Q Consensus       150 ----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~  225 (499)
                          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+.....        .......
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--------~~~~~~~  235 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--------YVRKGDA  235 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc--------hhhccCC
Confidence                2578999999999999999999999999999999999999999999999999986543211        1112234


Q ss_pred             ccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc--CCCCCCCCChHHHHHHHHhhcc
Q 010859          226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDV  302 (499)
Q Consensus       226 ~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~Li~~lL~~  302 (499)
                      .++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+......  ....|...++++.+++.+||+.
T Consensus       236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~  315 (337)
T cd05054         236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHN  315 (337)
T ss_pred             CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence            56778999999999999999999999999999998 99999876544433333322  3345677899999999999999


Q ss_pred             CCCCCCCCCCCCHHHHhc
Q 010859          303 DPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       303 dP~~R~~~~~~~~~~l~~  320 (499)
                      +|++||++     +++++
T Consensus       316 ~p~~RPs~-----~ell~  328 (337)
T cd05054         316 NPEDRPTF-----SELVE  328 (337)
T ss_pred             ChhhCcCH-----HHHHH
Confidence            99999998     55654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.8e-41  Score=331.71  Aligned_cols=249  Identities=21%  Similarity=0.296  Sum_probs=209.7

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCC----------------ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTG----------------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP  115 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~----------------~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  115 (499)
                      +..++|++++.||+|+||.||+|.+..++                ..||+|.+......  .....+.+|+.+++.++||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCC
Confidence            34578999999999999999999887644                56899998755322  3345677899999999999


Q ss_pred             CccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCC
Q 010859          116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE  184 (499)
Q Consensus       116 ~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~-----------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~  184 (499)
                      ||+++++++.++...+++|||+++++|.+++.+..           .+++..+..++.|++.||.|||++||+||||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999999999999999999999998765           6899999999999999999999999999999999


Q ss_pred             CeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc--CC
Q 010859          185 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GT  262 (499)
Q Consensus       185 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt--G~  262 (499)
                      ||+++.++.++|+|||+++.......        ........++..|+|||.+.+..++.++|||||||++|+|++  |.
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  231 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDY--------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE  231 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcc--------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence            99999999999999999876543221        111224467789999999988889999999999999999998  78


Q ss_pred             CCCCCCCHHHHHHHHHhc--------CCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          263 SPFKDTSEWLIFQRIIAR--------DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       263 ~Pf~~~~~~~~~~~i~~~--------~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .||...+....+..+...        ....|..++.++.+|+.+||+.||.+||++
T Consensus       232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~  287 (296)
T cd05051         232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF  287 (296)
T ss_pred             CCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence            899887776666555432        123455678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.5e-41  Score=334.50  Aligned_cols=264  Identities=28%  Similarity=0.448  Sum_probs=211.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  126 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-------  126 (499)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....... .......+|..+++.++||||+++++.+.+       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            689999999999999999999999999999999987653222 122345678999999999999999988743       


Q ss_pred             -CCeEEEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          127 -TFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       127 -~~~l~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                       ...+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence             3357999999975 77777664 35799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCC-CCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Q 010859          205 MQDSRITVLPN-AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  282 (499)
Q Consensus       205 ~~~~~~~~~~~-~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~  282 (499)
                      ........... ...........|++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            54332111100 0012233456789999999987654 578899999999999999999999998887666555543110


Q ss_pred             C-----------------------CC-------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          283 R-----------------------FP-------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       283 ~-----------------------~p-------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .                       .|       ..+++++.+||.+||+.||.+||++     .+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~-----~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA-----SDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH-----HHHhcCCCC
Confidence            0                       00       1245778999999999999999998     899999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.5e-41  Score=327.20  Aligned_cols=243  Identities=21%  Similarity=0.352  Sum_probs=211.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ..+|++++.||.|+||.||+|.+.. +..+|+|++.....   .....+..|+.+++.++||||+++++++.+....|+|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            4689999999999999999999988 89999999876532   2234577799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          134 LESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      |||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+........ 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            9999999999999753  4589999999999999999999999999999999999999999999999999976533211 


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  289 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~  289 (499)
                               ......++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+....+..+... ....|...+
T Consensus       160 ---------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05148         160 ---------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP  230 (261)
T ss_pred             ---------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCC
Confidence                     1113345678999999998889999999999999999998 89999988877777766643 345667889


Q ss_pred             hHHHHHHHHhhccCCCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +++.+++.+||+.||.+||++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~  251 (261)
T cd05148         231 QEIYKIMLECWAAEPEDRPSF  251 (261)
T ss_pred             HHHHHHHHHHcCCCchhCcCH
Confidence            999999999999999999998

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-40  Score=330.54  Aligned_cols=249  Identities=20%  Similarity=0.329  Sum_probs=210.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ...+|.+.+.||+|+||.||+|++.     .++..+|+|.+....   ......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            4578999999999999999999864     345678999875432   22334577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC
Q 010859          128 FSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  191 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~  191 (499)
                      ...++||||+++++|.+++...+                .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997543                38899999999999999999999999999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCH
Q 010859          192 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  270 (499)
Q Consensus       192 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~  270 (499)
                      +.++|+|||++........        ........|+..|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDY--------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             CcEEECCCCcccccCCCce--------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999976543211        111224467889999999999899999999999999999998 9999988887


Q ss_pred             HHHHHHHHhcCC-CCCCCCChHHHHHHHHhhccCCCCCCCCCC
Q 010859          271 WLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGP  312 (499)
Q Consensus       271 ~~~~~~i~~~~~-~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~  312 (499)
                      ....+.+..... ..+..++..+.+|+.+||+.||.+||++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  274 (291)
T cd05094         232 TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKE  274 (291)
T ss_pred             HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHH
Confidence            777766665443 345678899999999999999999999843

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-40  Score=329.16  Aligned_cols=247  Identities=21%  Similarity=0.332  Sum_probs=209.9

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ...+|.+.+.||+|+||.||+|...     .++..+|+|.+...   .......+.+|..+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            3468999999999999999999753     35678999987643   233445678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC
Q 010859          128 FSLYMALESCEGGELFDQITSKG---------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG  192 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~---------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~  192 (499)
                      ...|++|||+++++|.+++...+               .+++..+..++.||+.||.|||++||+||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999987653               488999999999999999999999999999999999999999


Q ss_pred             CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHH
Q 010859          193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEW  271 (499)
Q Consensus       193 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~  271 (499)
                      .+||+|||++........        ........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......
T Consensus       160 ~~kL~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  231 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDY--------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT  231 (280)
T ss_pred             CEEECCCCceeEcCCCce--------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence            999999999875432211        011123446788999999999999999999999999999998 99999888777


Q ss_pred             HHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          272 LIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       272 ~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .....+... ....|..+++.+.+||.+||+.||.+||++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~  271 (280)
T cd05092         232 EAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVI  271 (280)
T ss_pred             HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            766666554 345677889999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-40  Score=324.72  Aligned_cols=248  Identities=21%  Similarity=0.317  Sum_probs=210.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ..+|++++.||+|+||.||+|.... +..+|+|.+......    ...+.+|..+++.++||||+++++++.+...+|++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            5689999999999999999998754 456999988654322    24467799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+.+|+|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++.......  
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--  155 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--  155 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence            9999999999999764 4689999999999999999999999999999999999999999999999999876533211  


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCCh
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSD  290 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~  290 (499)
                             .......++..|+|||++.+..++.++|+|||||++|+|++ |..||...+.......+.... ...|...+.
T Consensus       156 -------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05113         156 -------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE  228 (256)
T ss_pred             -------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCH
Confidence                   01112345678999999998889999999999999999998 999999888777777666543 334667889


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+.+++.+||+.||.+||++     .+++.
T Consensus       229 ~~~~li~~cl~~~p~~Rp~~-----~~ll~  253 (256)
T cd05113         229 KVYAIMYSCWHEKAEERPTF-----QQLLS  253 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCH-----HHHHH
Confidence            99999999999999999998     66664

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.3e-41  Score=346.64  Aligned_cols=251  Identities=22%  Similarity=0.361  Sum_probs=206.5

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCC-----CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTF  124 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t-----~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~  124 (499)
                      .+..++|++++.||+|+||.||+|.+...     +..||||++....  .......+.+|+.+++.+. ||||+++++++
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            44567899999999999999999987533     4579999986542  2333456778999999996 99999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhc-------------------------------------------------------
Q 010859          125 QDTFSLYMALESCEGGELFDQITSK-------------------------------------------------------  149 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~-------------------------------------------------------  149 (499)
                      .+...+|+|||||++|+|.+++.+.                                                       
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999999999887642                                                       


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee
Q 010859          150 -----------------------------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL  188 (499)
Q Consensus       150 -----------------------------------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl  188 (499)
                                                               ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                     137788889999999999999999999999999999999


Q ss_pred             CCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCC
Q 010859          189 TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD  267 (499)
Q Consensus       189 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~  267 (499)
                      +.++.+||+|||+++.+.....        ........++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSN--------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             eCCCEEEEEeCCcceecccccc--------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            9999999999999986533211        112223467889999999999899999999999999999997 9999987


Q ss_pred             CCHHHHHHHHHhc--CCCCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          268 TSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       268 ~~~~~~~~~i~~~--~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      ......+......  ....|..++.++.+|+.+||+.||++||++.
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  388 (400)
T cd05105         343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL  388 (400)
T ss_pred             cchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence            6544333333333  3445677899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.4e-40  Score=331.54  Aligned_cols=251  Identities=30%  Similarity=0.410  Sum_probs=213.7

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      |...+.||+|+||+||+|++..+|..||+|++.............+..|..+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            67778899999999999999999999999999766544444445677799999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          137 CEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       137 ~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      +. |+|.+.+.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....         
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---------  172 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---------  172 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---------
Confidence            96 478777765 4568999999999999999999999999999999999999999999999999985321         


Q ss_pred             CCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCh
Q 010859          216 AASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYFSD  290 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~  290 (499)
                           ......|+..|+|||++.   ...++.++|+|||||++|+|++|.+||...+.......+......  ....++.
T Consensus       173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (313)
T cd06633         173 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD  247 (313)
T ss_pred             -----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence                 122467899999999984   456788999999999999999999999887766655555443222  2235778


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      .+++||.+||+.+|.+||++     ++++.||||+..
T Consensus       248 ~l~~li~~~l~~~P~~Rp~~-----~~~l~~~~~~~~  279 (313)
T cd06633         248 SFRGFVDYCLQKIPQERPAS-----AELLRHDFVRRD  279 (313)
T ss_pred             HHHHHHHHHccCChhhCcCH-----HHHhcCcccCCC
Confidence            89999999999999999998     899999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.3e-40  Score=333.43  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=207.9

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcC-------CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFT  123 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~  123 (499)
                      ...++|.+++.||+|+||.||+|++..       ++..+|+|.+....  .+.....+..|+.+++.+ +||||++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            335789999999999999999998743       23579999987542  223344567789999999 79999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCee
Q 010859          124 FQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  187 (499)
Q Consensus       124 ~~~~~~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NIL  187 (499)
                      +.....+|+||||+++|+|.+++...+                .++...+..++.|++.||+|||++|++||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997642                4788999999999999999999999999999999999


Q ss_pred             eCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCC
Q 010859          188 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  266 (499)
Q Consensus       188 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~  266 (499)
                      ++.++.+||+|||+++........        .......++..|+|||++.+..++.++|+|||||++|+|++ |..||.
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             EcCCCcEEECCCcccccccccchh--------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999998765322100        01111234568999999998889999999999999999998 999998


Q ss_pred             CCCHHHHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          267 DTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       267 ~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      +.+.......+.... ..+|..++.++.+||.+||..+|.+||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  290 (307)
T cd05098         245 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK  290 (307)
T ss_pred             cCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHH
Confidence            877766666655443 356778899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.9e-40  Score=327.14  Aligned_cols=252  Identities=18%  Similarity=0.308  Sum_probs=209.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCc----eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      +..++|++.+.||+|+||+||+|++..+|+    .||+|++....  .......+.+|..+++.++||||+++++++...
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            456799999999999999999999887776    48999986542  222345577788999999999999999988754


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                       ..+++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             578999999999999999764 569999999999999999999999999999999999999999999999999998664


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  284 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  284 (499)
                      .....        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+... ....
T Consensus       161 ~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05109         161 IDETE--------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ  232 (279)
T ss_pred             cccce--------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence            32211        01112235678999999998889999999999999999998 99999887766655544443 2345


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  319 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~  319 (499)
                      +..++.++.++|.+||..||++||++     .+++
T Consensus       233 ~~~~~~~~~~li~~~l~~dp~~Rp~~-----~~l~  262 (279)
T cd05109         233 PPICTIDVYMIMVKCWMIDSECRPRF-----RELV  262 (279)
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCH-----HHHH
Confidence            66789999999999999999999999     5565

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-40  Score=326.73  Aligned_cols=250  Identities=21%  Similarity=0.360  Sum_probs=205.8

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCc--eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------CC
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGT--VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------TF  128 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~--~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~------~~  128 (499)
                      |.+++.||+|+||.||+|++..++.  .+|+|.+...... ......+..|..+++.++||||+++++.+..      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3578899999999999999987775  6999988665332 3345567779999999999999999987642      22


Q ss_pred             eEEEEEeccCCCChHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          129 SLYMALESCEGGELFDQITS------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~------~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      ..+++|||+.+|+|.+++..      ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            57999999999999988742      234899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD  281 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~  281 (499)
                      +.+......        .......+++.|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.........+....
T Consensus       160 ~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  231 (272)
T cd05075         160 KKIYNGDYY--------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN  231 (272)
T ss_pred             cccCcccce--------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            865432210        01123346778999999999999999999999999999999 899999887777766666543


Q ss_pred             -CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          282 -IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       282 -~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                       ...+..++..+.++|.+||+.||.+||++     .++++
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~l~~  266 (272)
T cd05075         232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSF-----ETLRC  266 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence             35667789999999999999999999998     55653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=325.85  Aligned_cols=250  Identities=22%  Similarity=0.352  Sum_probs=207.6

Q ss_pred             eeeeeEeeecCceEEEEEEEcCC---CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      |++++.||+|+||.||+|....+   +..||+|.+...... ......+..|..+++.++||||+++++++....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            67899999999999999997653   478999998754332 333456778999999999999999998875544     


Q ss_pred             -eEEEEEeccCCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          129 -SLYMALESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       129 -~l~lv~E~~~gg~L~~~i~~~------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                       ..+++|||+++|+|..++...      ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence             389999999999999888532      3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~  280 (499)
                      ++........        .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+.....+.+...
T Consensus       160 ~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~  231 (273)
T cd05035         160 SKKIYSGDYY--------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG  231 (273)
T ss_pred             eeeccccccc--------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9865432211        01112335678999999998889999999999999999999 99999988877777766653


Q ss_pred             -CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          281 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       281 -~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                       ....|..++.++.+++.+||+.||++||++     .+++.
T Consensus       232 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~e~~~  267 (273)
T cd05035         232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTF-----TKLRE  267 (273)
T ss_pred             CCCCCCcCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence             455678899999999999999999999988     55654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4e-41  Score=340.40  Aligned_cols=258  Identities=22%  Similarity=0.339  Sum_probs=205.0

Q ss_pred             eEeeec--CceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010859           61 KIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        61 ~~LG~G--~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~  138 (499)
                      ..||+|  +||+||+|++..+|+.||+|++....... .....+.+|..+++.++||||++++++|+....+|+||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            356666  99999999999999999999987654332 334667889999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCC
Q 010859          139 GGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  216 (499)
Q Consensus       139 gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~  216 (499)
                      +++|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+..........   .
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~---~  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA---K  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc---c
Confidence            99999998864  348999999999999999999999999999999999999999999999998654332111000   0


Q ss_pred             CCCCCccccccCccCCCccccCCC--CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC------------
Q 010859          217 ASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI------------  282 (499)
Q Consensus       217 ~~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~------------  282 (499)
                      ..........++..|+|||++.+.  .++.++|||||||++|+|++|.+||.+.........+.....            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence            000011123456779999999764  478899999999999999999999987765444433322111            


Q ss_pred             -----------------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          283 -----------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       283 -----------------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                                         ..+..+++.+.+||.+||+.||++|||+     +++++||||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta-----~e~l~~~~~~~~  314 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA-----SSLLSHAFFKQV  314 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH-----HHHhhCHHHHHH
Confidence                                               1122356789999999999999999999     899999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.7e-40  Score=317.74  Aligned_cols=249  Identities=32%  Similarity=0.595  Sum_probs=215.6

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|++|.||+|.+..+++.+++|++.....   .....+.+|..+++.++||+|+++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            68999999999999999999999999999999876533   344567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          136 SCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       136 ~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |+++++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+.......     
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-----  152 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-----  152 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc-----
Confidence            99999999998876 579999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh-cCCCCCC--CCChH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RDIRFPN--YFSDA  291 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~-~~~~~p~--~~~~~  291 (499)
                            ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+.. ....++.  .++..
T Consensus       153 ------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (253)
T cd05122         153 ------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE  226 (253)
T ss_pred             ------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHH
Confidence                  02356789999999999988899999999999999999999999988755444333332 2222333  34899


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  323 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpf  323 (499)
                      +.++|.+||+.||++||++     ++++.|||
T Consensus       227 ~~~~i~~~l~~~p~~R~t~-----~~~l~~~~  253 (253)
T cd05122         227 FKDFLKKCLQKNPEKRPTA-----EQLLKHPF  253 (253)
T ss_pred             HHHHHHHHccCChhhCCCH-----HHHhcCCC
Confidence            9999999999999999998     89999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-40  Score=339.04  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=208.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------C
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------F  128 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~------~  128 (499)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.... +.....+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            6899999999999999999999999999999998764322 22334466799999999999999999988654      3


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||+.+ +|..++.  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.... 
T Consensus        94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-  169 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-  169 (342)
T ss_pred             eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence            46999999964 7776653  3589999999999999999999999999999999999999999999999999875321 


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  281 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~------  281 (499)
                                  ......||..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+....      
T Consensus       170 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (342)
T cd07879         170 ------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE  237 (342)
T ss_pred             ------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence                        1224578899999999876 458889999999999999999999999877655444433210      


Q ss_pred             -----------------CCCC--------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          282 -----------------IRFP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       282 -----------------~~~p--------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                       ..++        ...+.++.+||.+||+.||.+||++     ++++.||||+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~-----~e~l~h~~f~~~~~  305 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA-----TEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCcchhhccc
Confidence                             0011        2367889999999999999999998     89999999997653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.7e-40  Score=322.04  Aligned_cols=251  Identities=28%  Similarity=0.494  Sum_probs=220.0

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+........ ....+..|..+++.++||||+++++++.+....|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH-HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            58999999999999999999999999999999976554433 33455678899999999999999999999999999999


Q ss_pred             ccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          136 SCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       136 ~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      |+++++|.+++.+    ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            9999999998876    356899999999999999999999999999999999999999999999999999765432   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCh
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSD  290 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~  290 (499)
                               ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+....+ ..+..++.
T Consensus       157 ---------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd08530         157 ---------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ  227 (256)
T ss_pred             ---------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCH
Confidence                     11234688899999999998899999999999999999999999998887766666655443 35667899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +++++|.+||..+|++||++     .+++.||+.
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~-----~~~l~~p~~  256 (256)
T cd08530         228 DLQNFIRSMLQVKPKLRPNC-----DKILASPAV  256 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCH-----HHHhcCCCC
Confidence            99999999999999999998     899999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-40  Score=337.15  Aligned_cols=266  Identities=24%  Similarity=0.367  Sum_probs=215.3

Q ss_pred             CCee-eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhh-----------HHHHHHHHHHHHHhCCCCCccEEEE
Q 010859           55 QDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-----------KTAYVKLERIVLDQLDHPGVVRLFF  122 (499)
Q Consensus        55 ~~y~-~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~Iv~l~~  122 (499)
                      ++|. +.+.||+|+||+||+|.+..+++.||+|++.........           ....+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 567899999999999999999999999998765333211           1123567999999999999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          123 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       123 ~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      ++......|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999997 599999988888999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCC----CCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010859          203 KPMQDSRITVLPNA----ASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  277 (499)
Q Consensus       203 ~~~~~~~~~~~~~~----~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i  277 (499)
                      ..............    ..........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+.......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            86652211100000    011122334678899999998764 4688999999999999999999999988877666555


Q ss_pred             HhcCC-----C-----------------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          278 IARDI-----R-----------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       278 ~~~~~-----~-----------------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .....     .                       .....+.++.+||.+||+.+|++||++     ++++.||||++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~~~l~~~~~~~  318 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA-----KEALKHEYFKS  318 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH-----HHHhcCcccCC
Confidence            43110     0                       012357889999999999999999998     89999999985

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-40  Score=324.50  Aligned_cols=243  Identities=21%  Similarity=0.334  Sum_probs=206.1

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++.+.||+|+||.||+|.+. ++..+|+|.+......    ...+.+|+.++++++||||+++++++.. ...|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence            4578999999999999999999875 5677999998764332    2347789999999999999999998854 56899


Q ss_pred             EEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999998753  3589999999999999999999999999999999999999999999999999976533211


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                               .......++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+.......+... ....|...
T Consensus       158 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd05070         158 ---------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDC  228 (260)
T ss_pred             ---------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence                     11112345678999999988889999999999999999999 99999988877777666543 44567778


Q ss_pred             ChHHHHHHHHhhccCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +.++.+|+.+||..||.+|||+
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~  250 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTF  250 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=9.6e-42  Score=368.87  Aligned_cols=262  Identities=32%  Similarity=0.509  Sum_probs=210.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEE------------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF------------  121 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~------------  121 (499)
                      ..||+.+++||+||||.||+|+++-+|+.||||.+....  ....-..+.+|+.+|.+|+|||||++|            
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            578999999999999999999999999999999998765  344556688899999999999999999            


Q ss_pred             ------------------------------------------------E----------------------E------E-
Q 010859          122 ------------------------------------------------F----------------------T------F-  124 (499)
Q Consensus       122 ------------------------------------------------~----------------------~------~-  124 (499)
                                                                      .                      .      . 
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                      0      0 


Q ss_pred             ------------------------------EcCCeEEEEEeccCCCChHHHHhhcCCC-CHHHHHHHHHHHHHHHHHHHH
Q 010859          125 ------------------------------QDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHS  173 (499)
Q Consensus       125 ------------------------------~~~~~l~lv~E~~~gg~L~~~i~~~~~l-~e~~~~~i~~qil~aL~~LH~  173 (499)
                                                    +....+||-||||+.-.|.+++.++... ....++.+++||++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                          0013589999999986666666665433 478999999999999999999


Q ss_pred             CCcEeeecCCCCeeeCCCCCEEEEecCCccccCC----cccccc----CCCCCCCCccccccCccCCCccccCCCC---C
Q 010859          174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD----SRITVL----PNAASDDKACTFVGTAAYVPPEVLNSSP---A  242 (499)
Q Consensus       174 ~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~----~~~~~~----~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~---~  242 (499)
                      .|||||||||.||++++++.|||+|||+|.....    ......    -........++.+||..|+|||++.+..   |
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            9999999999999999999999999999987321    000000    0111233566789999999999997655   9


Q ss_pred             CCCCcchhhhHHHHHHhcCCCCCCCCCH-HHHHHHHHhcCCCCCCCC----ChHHHHHHHHhhccCCCCCCCCCCCCHHH
Q 010859          243 TFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIARDIRFPNYF----SDAARDLIDRLLDVDPSGRPGAGPGGYAV  317 (499)
Q Consensus       243 ~~~sDiwslG~ilyelltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~----~~~~~~Li~~lL~~dP~~R~~~~~~~~~~  317 (499)
                      +.|+||||||+|+|||+.   ||...-+ ..++..+..+.+++|..+    -+.-+.+|+.||+.||++||||     .+
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA-----~e  867 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA-----TE  867 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH-----HH
Confidence            999999999999999984   6865544 345566666666666332    3556899999999999999999     89


Q ss_pred             HhcCCCCC
Q 010859          318 LKMHPFFK  325 (499)
Q Consensus       318 l~~Hpff~  325 (499)
                      |+++.||-
T Consensus       868 LL~s~llp  875 (1351)
T KOG1035|consen  868 LLNSELLP  875 (1351)
T ss_pred             HhhccCCC
Confidence            99999986

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-40  Score=338.84  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=208.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~------  127 (499)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.++++++||||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            47899999999999999999999999999999998764322 22234566799999999999999999988643      


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|++++++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3478899887 6799887765 4699999999999999999999999999999999999999999999999999875321


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~----  282 (499)
                                   ......||..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.......+.....    
T Consensus       173 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (345)
T cd07877         173 -------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  239 (345)
T ss_pred             -------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence                         1224578999999999866 5678899999999999999999999987766554444332110    


Q ss_pred             -------------------CCC--------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          283 -------------------RFP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       283 -------------------~~p--------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                         ..|        ...++++.+||.+||+.||.+||++     .+++.||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~f~~  305 (345)
T cd07877         240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQ  305 (345)
T ss_pred             HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH-----HHHhcChhhhh
Confidence                               111        1357889999999999999999998     89999999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.3e-40  Score=332.11  Aligned_cols=252  Identities=29%  Similarity=0.405  Sum_probs=215.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ..|...+.||+|+||.||+|++..++..||+|++.............+..|+.+++.++|||++++++++.+....|+||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34889999999999999999999999999999997654444444556778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....      
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence            99975 78777754 45689999999999999999999999999999999999999999999999999864322      


Q ss_pred             CCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC--CCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYF  288 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~  288 (499)
                              .....|++.|+|||++.   ...++.++|+|||||++|+|++|..||...+.......+......  .+..+
T Consensus       178 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (317)
T cd06635         178 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW  249 (317)
T ss_pred             --------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccc
Confidence                    12456889999999973   456888999999999999999999999887776666666554332  23457


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ++.+++||.+||+.+|.+||++     +++++|+|+..
T Consensus       250 ~~~l~~li~~~l~~~p~~Rpt~-----~~il~~~~~~~  282 (317)
T cd06635         250 SDYFRNFVDSCLQKIPQDRPTS-----EELLKHMFVLR  282 (317)
T ss_pred             cHHHHHHHHHHccCCcccCcCH-----HHHHhChhhhc
Confidence            8899999999999999999988     89999999953

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.1e-40  Score=331.36  Aligned_cols=251  Identities=23%  Similarity=0.380  Sum_probs=210.0

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEE-----cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFT  123 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~  123 (499)
                      ..+..++|++.+.||+|+||.||+|.+     ..++..||+|.+.....  ......+.+|..+++++ +||||+++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            456678999999999999999999986     34566899998865422  22345677899999999 79999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          124 FQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       124 ~~~~~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                      +.....+|++|||+.+|+|.+++....  .+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999999997643  389999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~  280 (499)
                      ++.+......        .......++..|+|||++.+..++.++|||||||++|+|++ |..||........+.+....
T Consensus       188 ~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~  259 (302)
T cd05055         188 ARDIMNDSNY--------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE  259 (302)
T ss_pred             cccccCCCce--------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence            9765332100        11123456788999999999899999999999999999998 99999887766555555443


Q ss_pred             CC--CCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          281 DI--RFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       281 ~~--~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..  ..|...+.++.+|+.+||..+|++||++
T Consensus       260 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  291 (302)
T cd05055         260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTF  291 (302)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            32  3455678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.3e-40  Score=323.90  Aligned_cols=243  Identities=20%  Similarity=0.340  Sum_probs=205.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++.+.||+|+||.||+|++..+ ..||+|++.+....    ...+.+|+.+++.++||||+++++.+.+ ...|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            346899999999999999999998765 46999998764332    2346779999999999999999998754 46899


Q ss_pred             EEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.++.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999999763  3589999999999999999999999999999999999999999999999999976543221


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                               .......++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.........+... ....+..+
T Consensus       158 ---------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (262)
T cd05071         158 ---------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC  228 (262)
T ss_pred             ---------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCcccc
Confidence                     11112346778999999988889999999999999999999 99999988777766666543 23445678


Q ss_pred             ChHHHHHHHHhhccCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +..+.+||.+||+.||++||++
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~  250 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTF  250 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=326.26  Aligned_cols=250  Identities=28%  Similarity=0.465  Sum_probs=208.4

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC---CCCCccEEEEEEEcCCe----
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQDTFS----  129 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~Iv~l~~~~~~~~~----  129 (499)
                      |++.+.||+|+||.||+|++..+++.||+|++...... ......+..|..+++.+   +||||+++++++.+...    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            78899999999999999999999999999999754332 22233444576666555   69999999999988776    


Q ss_pred             -EEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          130 -LYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       130 -l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                       +|++|||+.+ +|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999975 8988887643  58999999999999999999999999999999999999999999999999987653


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  281 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----  281 (499)
                      ...           ......++..|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+...++....     
T Consensus       159 ~~~-----------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07838         159 FEM-----------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE  227 (287)
T ss_pred             CCc-----------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence            321           1123457899999999998889999999999999999999999999988877776665421     


Q ss_pred             CC-----------CC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 IR-----------FP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 ~~-----------~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ..           ++           ..+++.+.+||.+||+.||.+||++     ++++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-----~~il~~~~~  287 (287)
T cd07838         228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA-----FEALQHPYF  287 (287)
T ss_pred             HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH-----HHHhcCcCC
Confidence            00           01           1246788999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.1e-40  Score=334.46  Aligned_cols=258  Identities=28%  Similarity=0.405  Sum_probs=209.3

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCC--CceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE----cCC
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDT--GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ----DTF  128 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t--~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~----~~~  128 (499)
                      +|++.+.||+|+||.||+|.+..+  +..||+|.+..... ..........|..+++++ +||||+++++.+.    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999988  99999999865422 222334456788899988 5999999998643    235


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|++++|+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            6899999986 599999988888999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  281 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~------  281 (499)
                      ...      .......++||..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+....      
T Consensus       159 ~~~------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         159 PGE------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             ccc------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            211      1112235689999999998765 568899999999999999999999998876554444333210      


Q ss_pred             ----------------------CCC---CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          282 ----------------------IRF---PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       282 ----------------------~~~---p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                            ..+   ....+..+.+||.+||+.||.+||++     .+++.||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~~ll~~~~~~~  297 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-----EEALEHPYLAI  297 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH-----HHHhcChhhhh
Confidence                                  011   12357889999999999999999998     88999999973

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-40  Score=331.19  Aligned_cols=251  Identities=29%  Similarity=0.473  Sum_probs=214.0

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      |.....||+|+||.||++....+|+.||+|.+...   .......+.+|..+++.++||||+++++.|......|+||||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            44457899999999999999999999999987543   223445577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCC
Q 010859          137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  216 (499)
Q Consensus       137 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~  216 (499)
                      +++++|.+++.. +.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......       
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------  170 (292)
T cd06657          99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------  170 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-------
Confidence            999999987754 468999999999999999999999999999999999999999999999999986543211       


Q ss_pred             CCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---CCCCCCCChHHH
Q 010859          217 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDAAR  293 (499)
Q Consensus       217 ~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~  293 (499)
                         .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.........+....   ......++..+.
T Consensus       171 ---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (292)
T cd06657         171 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK  247 (292)
T ss_pred             ---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHH
Confidence               11234578999999999988888999999999999999999999999877766555443322   223345789999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       294 ~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +++.+||+.||.+||++     .+++.||||..
T Consensus       248 ~li~~~l~~~P~~R~~~-----~~ll~~~~~~~  275 (292)
T cd06657         248 GFLDRLLVRDPAQRATA-----AELLKHPFLAK  275 (292)
T ss_pred             HHHHHHHhCCcccCcCH-----HHHhcChHHhc
Confidence            99999999999999998     88999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.2e-40  Score=323.47  Aligned_cols=248  Identities=20%  Similarity=0.333  Sum_probs=207.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCc---eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .++|++++.||+|+||.||+|+++.++.   .+|+|.+.....  ......+..|..+++.++||||+++++++.+...+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4689999999999999999999875544   799998865432  22345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+++++|.+++.+. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..+....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999999765 468999999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      ..       ........++..|+|||.+.+..++.++|+|||||++|++++ |..||...+.......+... ....+..
T Consensus       161 ~~-------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd05066         161 EA-------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMD  233 (267)
T ss_pred             ce-------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCC
Confidence            00       001112234568999999998889999999999999999886 99999888776666666543 2334456


Q ss_pred             CChHHHHHHHHhhccCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +++.+.+++.+||+.+|.+||++
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~  256 (267)
T cd05066         234 CPAALHQLMLDCWQKDRNERPKF  256 (267)
T ss_pred             CCHHHHHHHHHHcccCchhCCCH
Confidence            78999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=326.20  Aligned_cols=252  Identities=31%  Similarity=0.497  Sum_probs=211.4

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEEEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMAL  134 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~--~~l~lv~  134 (499)
                      |++.+.||+|+||.||+|.+..+|+.+|+|++.... ........+..|..+++.++|||++++++++.+.  ..+|+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            788999999999999999999999999999998764 2233334566799999999999999999999988  8999999


Q ss_pred             eccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........   
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~---  155 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS---  155 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc---
Confidence            99975 899888765 5799999999999999999999999999999999999999999999999999876543220   


Q ss_pred             CCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC----------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----------  282 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~----------  282 (499)
                            .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....          
T Consensus       156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence                  11223457889999998765 4578899999999999999999999998877665555443100          


Q ss_pred             ---------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          283 ---------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       283 ---------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                                           .+...++.++.++|.+||..+|.+||++     ++++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~~l~~~~~  287 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA-----DQALQHEYF  287 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH-----HHHhhCcCC
Confidence                                 0111138899999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=320.87  Aligned_cols=240  Identities=21%  Similarity=0.347  Sum_probs=201.7

Q ss_pred             eEeeecCceEEEEEEEcCCC---ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010859           61 KIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  137 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~  137 (499)
                      +.||+|+||.||+|....++   ..||+|.+......  .....+..|..+++.++||||+++++++.. ...++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence            47999999999999876554   78999998766443  234456779999999999999999998764 4689999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCC
Q 010859          138 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  217 (499)
Q Consensus       138 ~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  217 (499)
                      ++|+|.+++...+.+++..+..++.|++.||.|||.+|++||||||+|||++.++.+||+|||+++........      
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~------  151 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY------  151 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc------
Confidence            99999999998888999999999999999999999999999999999999999999999999999865432110      


Q ss_pred             CCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCChHHHHH
Q 010859          218 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARDL  295 (499)
Q Consensus       218 ~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~L  295 (499)
                       ........++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+.... ...|..++..+.++
T Consensus       152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  230 (257)
T cd05060         152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSI  230 (257)
T ss_pred             -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence             001111224567999999998899999999999999999998 999998887766666655443 35677789999999


Q ss_pred             HHHhhccCCCCCCCC
Q 010859          296 IDRLLDVDPSGRPGA  310 (499)
Q Consensus       296 i~~lL~~dP~~R~~~  310 (499)
                      |.+||..+|++||++
T Consensus       231 i~~cl~~~p~~Rp~~  245 (257)
T cd05060         231 MLSCWKYRPEDRPTF  245 (257)
T ss_pred             HHHHhcCChhhCcCH
Confidence            999999999999998

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.8e-40  Score=330.40  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=208.6

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcC-------CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFF  122 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~  122 (499)
                      .+..++|.+++.||+|+||.||+|++..       ....+|+|.+.....  ......+..|+.+++.+ +||||+++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            3456789999999999999999998642       345799998865422  22344567789999999 6999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCe
Q 010859          123 TFQDTFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  186 (499)
Q Consensus       123 ~~~~~~~l~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NI  186 (499)
                      ++.+...+|++|||+++|+|.+++...                ..++...+..++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            999999999999999999999999753                2478899999999999999999999999999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCC
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  265 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf  265 (499)
                      |++.++.+||+|||+++........        .......++..|+|||++.+..++.++|+|||||++|+|++ |..||
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYY--------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             EEcCCCcEEEccccccccccccccc--------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence            9999999999999999865432110        01111234568999999998889999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          266 KDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       266 ~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      .+.+....+..+.... ..+|..++.++.+||.+||..||.+||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  284 (314)
T cd05099         238 PGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK  284 (314)
T ss_pred             CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            9888777777666543 356777899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-40  Score=319.55  Aligned_cols=239  Identities=22%  Similarity=0.390  Sum_probs=207.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++.+.||.|+||.||+|...  |+.||+|.+.....    ....+..|..+++.++|+||+++++.+.+....|+
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            4678999999999999999999874  78999999865532    34556779999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.++...... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            999999999999998765  69999999999999999999999999999999999999999999999999997653211 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                                  ....++..|+|||.+....++.++|+|||||++|+|++ |..||...+.......+... ....|..+
T Consensus       157 ------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  224 (256)
T cd05039         157 ------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGC  224 (256)
T ss_pred             ------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCC
Confidence                        12234567999999988889999999999999999997 99999888776666555443 33456778


Q ss_pred             ChHHHHHHHHhhccCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ++++.++|.+||..+|++||++
T Consensus       225 ~~~~~~li~~~l~~~p~~Rp~~  246 (256)
T cd05039         225 PPEVYKVMKDCWELDPAKRPTF  246 (256)
T ss_pred             CHHHHHHHHHHhccChhhCcCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.7e-40  Score=320.80  Aligned_cols=238  Identities=24%  Similarity=0.412  Sum_probs=203.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEE-EcCCeEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF-QDTFSLY  131 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~-~~~~~l~  131 (499)
                      ...+|++.+.||+|+||.||++..  .|..||+|.+....     ....+.+|..+++.++|+|++++++++ .+...+|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            457899999999999999999976  47889999885432     234567799999999999999999865 5567799


Q ss_pred             EEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      ++|||+++++|.+++.+.+  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... 
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  155 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  155 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence            9999999999999997653  3889999999999999999999999999999999999999999999999998754321 


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                                  .....++..|+|||++.+..++.++|||||||++|+|++ |++||...+.......+... ....++.
T Consensus       156 ------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05082         156 ------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  223 (256)
T ss_pred             ------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence                        112344668999999998889999999999999999997 99999888776666665543 3345677


Q ss_pred             CChHHHHHHHHhhccCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +++.+.++|.+||+.+|++||++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~  246 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSF  246 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCH
Confidence            89999999999999999999998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-40  Score=320.41  Aligned_cols=245  Identities=22%  Similarity=0.356  Sum_probs=210.1

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++.+.||+|+||.||+|.+. .+..||+|.+......    ...+.+|+.+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            44689999999999999999999976 4578999998754332    345777999999999999999999999989999


Q ss_pred             EEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +||||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999999999765  368999999999999999999999999999999999999999999999999987654321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      .         .......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+.....+.+... ....|..
T Consensus       158 ~---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05034         158 Y---------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN  228 (261)
T ss_pred             h---------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            1         01112234578999999998889999999999999999998 99999988887777776654 3455667


Q ss_pred             CChHHHHHHHHhhccCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .+.++.+++.+||+.+|.+||++
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rp~~  251 (261)
T cd05034         229 CPEELYDLMLQCWDKDPEERPTF  251 (261)
T ss_pred             CCHHHHHHHHHHcccCcccCCCH
Confidence            89999999999999999999988

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.7e-40  Score=320.85  Aligned_cols=243  Identities=22%  Similarity=0.362  Sum_probs=205.9

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++++.||+|+||.||+|... +++.||+|.+......    ...+.+|+.++++++||||+++++++.+ ...|+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYI   77 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEE
Confidence            4578999999999999999999865 4688999998755432    3456779999999999999999998754 56899


Q ss_pred             EEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||+.+++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999999988754  3589999999999999999999999999999999999999999999999999876542211


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                               .......++..|+|||++.+..++.++|+|||||++|+|++ |++||.+.+.....+.+... ....|...
T Consensus       158 ---------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd05067         158 ---------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNC  228 (260)
T ss_pred             ---------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Confidence                     11123346778999999998889999999999999999999 99999988876666655443 23456778


Q ss_pred             ChHHHHHHHHhhccCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +.++.++|.+||..+|++||++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~  250 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTF  250 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCH
Confidence            8999999999999999999998

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=313.41  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=211.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ..+++.+++..||.|+.|+|++++.+.+|...|||.|.+.....+.  ..+.+...++.. -+.|+||+.|++|..+..+
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~--kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV  166 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN--KRILMDLDVVLKSHDCPYIVQCFGYFITNTDV  166 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH--HHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence            4456788899999999999999999999999999999876443333  334445554433 3589999999999999999


Q ss_pred             EEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ++.||.|.- -+..++.+ .++++|..+-.+...++.||.||. .+||+|||+||+|||++..|.+||||||.+..+..+
T Consensus       167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            999999842 44455543 367999999999999999999997 568999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC---CCCCCCCcchhhhHHHHHHhcCCCCCCCC-CHHHHHHHHHhcCCC-
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIARDIR-  283 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~~~~sDiwslG~ilyelltG~~Pf~~~-~~~~~~~~i~~~~~~-  283 (499)
                      .           .+....|-+.|||||.+.-   ..|+..+||||||++++||.||+.||.+. .+.+++-+|+...++ 
T Consensus       246 k-----------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~  314 (391)
T KOG0983|consen  246 K-----------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL  314 (391)
T ss_pred             c-----------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC
Confidence            2           2234578999999999864   35889999999999999999999999884 567777888775543 


Q ss_pred             CC--CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          284 FP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       284 ~p--~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +|  .+||+++.+|+..||++|+.+||..     .+|++|||...
T Consensus       315 L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y-----~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  315 LPGHMGFSPDFQSFVKDCLTKDHRKRPKY-----NKLLEHPFIKR  354 (391)
T ss_pred             CCcccCcCHHHHHHHHHHhhcCcccCcch-----HHHhcCcceee
Confidence            22  2589999999999999999999965     89999999974

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4e-40  Score=330.21  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=213.3

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ..|...+.||+|+||.||+|++..++..+|+|.+.............+..|..+++.++|+|++++++++......|+||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45888999999999999999999999999999987543333334445667999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+. |+|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......     
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence            9997 588777654 456899999999999999999999999999999999999999999999999998754321     


Q ss_pred             CCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC--CCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYF  288 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~  288 (499)
                               ....|++.|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+......  .+..+
T Consensus       169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (308)
T cd06634         169 ---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW  239 (308)
T ss_pred             ---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccc
Confidence                     2456889999999974   345788999999999999999999999877665554444443322  23468


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +..+.+||.+||..+|.+||++     +++++|||+..
T Consensus       240 ~~~~~~li~~cl~~~P~~Rp~~-----~~ll~~~~~~~  272 (308)
T cd06634         240 SEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVLR  272 (308)
T ss_pred             cHHHHHHHHHHhhCCcccCCCH-----HHHhhCccccc
Confidence            8999999999999999999988     89999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3e-40  Score=329.15  Aligned_cols=256  Identities=29%  Similarity=0.424  Sum_probs=210.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----  128 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~----  128 (499)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+..|..+++.++||||+++++++.+..    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            467899999999999999999999999999999998765322 222344567899999999999999999887654    


Q ss_pred             ------eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          129 ------SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       129 ------~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                            .+|+|+||+++ +|...+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                  79999999986 777777654 4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~  280 (499)
                      +..+.....         .......++..|+|||++.+. .++.++|||||||++|+|++|++||...+.......+...
T Consensus       163 ~~~~~~~~~---------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~  233 (302)
T cd07864         163 ARLYNSEES---------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL  233 (302)
T ss_pred             cccccCCcc---------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            876543210         111123567889999988654 4788999999999999999999999887765555444331


Q ss_pred             CC------------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          281 DI------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       281 ~~------------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ..                              .....++..+.+||.+||+.||.+||++     ++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~~~~  302 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA-----EEALNSPWL  302 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH-----HHHhcCCCC
Confidence            00                              0112468899999999999999999998     899999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-42  Score=331.39  Aligned_cols=251  Identities=26%  Similarity=0.464  Sum_probs=208.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC--C----CccEEEEEEEcC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--P----GVVRLFFTFQDT  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p----~Iv~l~~~~~~~  127 (499)
                      .++|++++.||+|.||.|..|.+.+++..||||+++.-    ....+....|+++|.++.+  |    -+|++.++|.-.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            57899999999999999999999999999999998542    2334556678899999832  3    267788889999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC---------------
Q 010859          128 FSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---------------  190 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~---------------  190 (499)
                      +++++|+|.+ |-++++++.+++  +++...++.+++||+.+++|||+++++|-||||||||+.+               
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999998 569999998864  6899999999999999999999999999999999999843               


Q ss_pred             -----CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCC
Q 010859          191 -----DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF  265 (499)
Q Consensus       191 -----~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf  265 (499)
                           +-.|+|+|||.|....             ..+.+.+.|..|+|||++.+-+++.++||||+||||+|+++|...|
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~-------------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDH-------------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             eccCCCcceEEEecCCcceec-------------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence                 2258999999997532             3346789999999999999999999999999999999999999999


Q ss_pred             CCCCHHH---HHHHHHhc------------------CCCCCCC-------------------------CChHHHHHHHHh
Q 010859          266 KDTSEWL---IFQRIIAR------------------DIRFPNY-------------------------FSDAARDLIDRL  299 (499)
Q Consensus       266 ~~~~~~~---~~~~i~~~------------------~~~~p~~-------------------------~~~~~~~Li~~l  299 (499)
                      +..++.+   ++++|+..                  .+..|+.                         -..++.|||++|
T Consensus       310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            9877655   44555431                  1111111                         123478999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      |..||.+|+|+     .|++.||||...
T Consensus       390 L~fDP~~RiTl-----~EAL~HpFF~~~  412 (415)
T KOG0671|consen  390 LEFDPARRITL-----REALSHPFFARL  412 (415)
T ss_pred             HccCccccccH-----HHHhcCHHhhcC
Confidence            99999999999     889999999853

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-40  Score=338.30  Aligned_cols=252  Identities=28%  Similarity=0.466  Sum_probs=211.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS----  129 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~----  129 (499)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+++.+.||||+++++++.....    
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            468999999999999999999999999999999986543222 233446679999999999999999988866554    


Q ss_pred             --EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 --LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 --l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                        +|+|+||+ +++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence              99999999 5699998876 4699999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~----  282 (499)
                      .             .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.....    
T Consensus       171 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         171 E-------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             c-------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            1             234578899999999865 4678899999999999999999999988777665555443210    


Q ss_pred             ---------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          283 ---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       283 ---------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                                 .....++.++.+||.+||+.||.+||++     .+++.||||..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~-----~ell~h~~~~~  303 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA-----AEALAHPYLAE  303 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH-----HHHhcCCCccc
Confidence                                       0112358899999999999999999998     88999999984

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.4e-40  Score=321.54  Aligned_cols=250  Identities=20%  Similarity=0.334  Sum_probs=208.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCc---eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ..+|++.+.||+|+||.||+|.++.+++   .||+|++.+..  .......+..|..+++.++||||+++++++.+...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            5689999999999999999999987765   59999986542  233445678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999998764 568999999999999999999999999999999999999999999999999987654322


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      ...     .........++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.......+... ....|..
T Consensus       161 ~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  235 (269)
T cd05065         161 SDP-----TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD  235 (269)
T ss_pred             ccc-----ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCccc
Confidence            100     0000011112457999999998899999999999999999886 99999888877766666432 2344567


Q ss_pred             CChHHHHHHHHhhccCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ++..+.+++.+||+.+|++||++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~  258 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKF  258 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCH
Confidence            88999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-40  Score=328.16  Aligned_cols=251  Identities=22%  Similarity=0.374  Sum_probs=210.3

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEc-------CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLF  121 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~  121 (499)
                      ..+..++|.+.+.||+|+||.||+|+..       .++..||+|.+....  .......+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            4566789999999999999999999853       234579999886542  223345577899999999 899999999


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCC
Q 010859          122 FTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  185 (499)
Q Consensus       122 ~~~~~~~~l~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~N  185 (499)
                      +.+.....+|++|||+++|+|.+++.+.                ..++...+..++.||+.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            9999999999999999999999998764                236788899999999999999999999999999999


Q ss_pred             eeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCC
Q 010859          186 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  264 (499)
Q Consensus       186 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~P  264 (499)
                      |+++.++.+||+|||+++.+.....        ........+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  239 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDY--------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  239 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccc--------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999986543221        111122346778999999998889999999999999999998 8999


Q ss_pred             CCCCCHHHHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          265 FKDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       265 f~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |.+.+.....+.+.... ...|..++.++.+||.+||..+|.+||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~  286 (304)
T cd05101         240 YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF  286 (304)
T ss_pred             cccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCH
Confidence            99888877777665432 34567789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.9e-40  Score=334.35  Aligned_cols=262  Identities=31%  Similarity=0.480  Sum_probs=214.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc--CCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD--TFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~--~~~  129 (499)
                      ..++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+...... ....+..|+.+++.+ +||||+++++++..  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            35789999999999999999999999999999999865432222 234456799999999 99999999999864  346


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||+.+ +|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus        84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            8999999974 999988775 78999999999999999999999999999999999999999999999999998654322


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC------
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI------  282 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~------  282 (499)
                      ..     ........+.||..|+|||++.+ ..++.++|+|||||++|+|++|++||.+........++.....      
T Consensus       162 ~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         162 EN-----PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cc-----ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            11     01122335679999999998754 4578899999999999999999999987766554444322110      


Q ss_pred             -------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          283 -------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       283 -------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                               .....++.++.+||.+||+.||++||++     .++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~-----~~il~~~~~~~~  301 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA-----EEALEHPYVAQF  301 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH-----HHHhhChhhhhh
Confidence                                     0112368899999999999999999998     889999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.2e-40  Score=332.33  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=201.4

Q ss_pred             CceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCChHHHH
Q 010859           67 SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI  146 (499)
Q Consensus        67 ~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i  146 (499)
                      ++|.||.++...+++.||+|++....... .....+..|+.+++.++||||++++++|.+....|++|||+++|+|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            44566777777799999999997753333 34566888999999999999999999999999999999999999999998


Q ss_pred             hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccc
Q 010859          147 TSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT  224 (499)
Q Consensus       147 ~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~  224 (499)
                      ...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+..+........   ........
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~---~~~~~~~~  167 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR---VVHDFPKS  167 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc---cccccccc
Confidence            764  4589999999999999999999999999999999999999999999999999876543221100   00111234


Q ss_pred             cccCccCCCccccCCC--CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHH-HHHHhc---------------------
Q 010859          225 FVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF-QRIIAR---------------------  280 (499)
Q Consensus       225 ~~Gt~~Y~aPE~l~~~--~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~-~~i~~~---------------------  280 (499)
                      ..++..|+|||++...  .++.++|+||+||++|+|++|..||......... +.+...                     
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
T cd08216         168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR  247 (314)
T ss_pred             ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence            5678899999998763  5788999999999999999999999876544332 222110                     


Q ss_pred             ------------CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          281 ------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       281 ------------~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                                  ....+..++.++.+|+.+||+.||++||++     +++++||||+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~p~~~~~~  302 (314)
T cd08216         248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA-----SQLLNHSFFKQCK  302 (314)
T ss_pred             ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH-----HHHhcCchHhhhc
Confidence                        001112345789999999999999999998     8999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-41  Score=347.28  Aligned_cols=251  Identities=22%  Similarity=0.416  Sum_probs=217.7

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCccc-chhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe--EEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS--LYMA  133 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~--l~lv  133 (499)
                      .++..+||+|+|-+||+|.|..+|-.||---+....+ ........+..|+.+|+.|+|||||++|+++.+...  +-+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            3567789999999999999999999998544332222 234456778889999999999999999999987655  8999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCCC-CCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~~-~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|.+.+|+|..|+++.++++...++.++.||+.||.|||++.  |+|||||.+||||+.+ |.|||+|+|+|..+...  
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--  199 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--  199 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence            999999999999999999999999999999999999999996  9999999999999876 89999999999876532  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHhcCCC--CCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDIR--FPNY  287 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~  287 (499)
                                .+...+|||.|||||++. ..|+..+||||||+.+.||+|+..||.. .+..++++++..+..+  |-.-
T Consensus       200 ----------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV  268 (632)
T KOG0584|consen  200 ----------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV  268 (632)
T ss_pred             ----------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc
Confidence                      344589999999999998 6799999999999999999999999975 5677788888876432  2233


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      -.+++++||.+||.. ...||++     .+||+||||..
T Consensus       269 ~dPevr~fIekCl~~-~~~R~sa-----~eLL~d~Ff~~  301 (632)
T KOG0584|consen  269 KDPEVREFIEKCLAT-KSERLSA-----KELLKDPFFDE  301 (632)
T ss_pred             CCHHHHHHHHHHhcC-chhccCH-----HHHhhChhhcc
Confidence            478999999999999 9999999     88999999985

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.5e-40  Score=320.27  Aligned_cols=249  Identities=20%  Similarity=0.321  Sum_probs=207.9

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCc---eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..++|+..+.||+|+||.||+|.+..++.   .+|+|.+.....  ......+..|+.+++.++||||+++++++.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            45689999999999999999999987665   799998865422  2233456779999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .|+||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999998764 57899999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ...       .........+..|+|||++.+..++.++|+|||||++|+|++ |..||...+.......+... ....+.
T Consensus       161 ~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  233 (268)
T cd05063         161 PEG-------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPM  233 (268)
T ss_pred             ccc-------ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCC
Confidence            100       000011223457999999988889999999999999999997 99999888877777766543 233445


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..+.++.+|+.+||+.+|++||++
T Consensus       234 ~~~~~~~~li~~c~~~~p~~Rp~~  257 (268)
T cd05063         234 DCPSAVYQLMLQCWQQDRARRPRF  257 (268)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCH
Confidence            678999999999999999999988

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1e-39  Score=330.39  Aligned_cols=253  Identities=27%  Similarity=0.435  Sum_probs=208.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCeEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSLY  131 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-~~~l~  131 (499)
                      ..++|++.+.||.|+||.||+|.+..+++.||+|++.+.... ......+..|+.+++.++||||++++++|.. ....|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            357899999999999999999999999999999998765322 2233456679999999999999999999875 56799


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ++|||+ +++|..++.. +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....    
T Consensus        87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----  160 (328)
T ss_pred             EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence            999999 5688887765 4689999999999999999999999999999999999999999999999999874321    


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc----------
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR----------  280 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~----------  280 (499)
                               ......++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.......+...          
T Consensus       161 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         161 ---------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ---------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence                     1224578899999999765 56889999999999999999999999876653322211110          


Q ss_pred             ----------------CCCCC-----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 ----------------DIRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ----------------~~~~p-----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                      ....|     ..++.++.++|.+||+.+|++||++     ++++.||||..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~ell~~~~~~~  293 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA-----AEALAHPYLAP  293 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCCcccc
Confidence                            00111     2467899999999999999999998     89999999973

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=324.77  Aligned_cols=251  Identities=29%  Similarity=0.490  Sum_probs=211.8

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      |++.+.||+|+||.||+|++..+++.||+|++.... ........+..|+.+++.++||||+++++++.+...+|+||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999997764 2233344566789999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          137 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       137 ~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      ++ ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......      
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~------  152 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL------  152 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc------
Confidence            97 4999999876 579999999999999999999999999999999999999999999999999987653321      


Q ss_pred             CCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--------------
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------------  280 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--------------  280 (499)
                          .......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+......++...              
T Consensus       153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         153 ----RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             ----cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence                112234567889999998766 7889999999999999999999999888766555444321              


Q ss_pred             ----CCCCC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          281 ----DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       281 ----~~~~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                          ...+|           ..++..+.++|.+||+.||++||++     ++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~~l~~p~~  282 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA-----KEALKHPYF  282 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCH-----HHHhhCcCC
Confidence                11111           1247889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6e-40  Score=322.61  Aligned_cols=251  Identities=21%  Similarity=0.330  Sum_probs=212.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCC-----CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t-----~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      .++|++.+.||+|+||.||+|+.+.+     .+.||+|.+....  .......+.+|+.++++++||||+++++++.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            47899999999999999999997643     4679999876532  2223456778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEec
Q 010859          129 SLYMALESCEGGELFDQITSKG---------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  199 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~---------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DF  199 (499)
                      ..|+||||+++|+|.+++....         .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998765         6899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHH
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII  278 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~  278 (499)
                      |++.......         ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.
T Consensus       162 ~~~~~~~~~~---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~  232 (275)
T cd05046         162 SLSKDVYNSE---------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ  232 (275)
T ss_pred             ccccccCccc---------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence            9987443211         111223456788999999988888999999999999999998 899998877777777666


Q ss_pred             hcCC--CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          279 ARDI--RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       279 ~~~~--~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ....  ..+..++..+.+++.+||+.||.+||++     .+++.
T Consensus       233 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~-----~~~l~  271 (275)
T cd05046         233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSF-----SELVS  271 (275)
T ss_pred             cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCH-----HHHHH
Confidence            5543  3456789999999999999999999998     56654

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.7e-40  Score=322.32  Aligned_cols=253  Identities=29%  Similarity=0.502  Sum_probs=214.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc--hhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +|.+.+.||+|+||.||+|.+..++..+++|++......  ..........|..+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            589999999999999999999888888888887543321  122334456688899999999999999999999999999


Q ss_pred             EeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          134 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988763    356999999999999999999999999999999999999974 679999999987653321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYF  288 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~  288 (499)
                                .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+.... ..+|..+
T Consensus       160 ----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd08222         160 ----------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETY  229 (260)
T ss_pred             ----------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchh
Confidence                      12234568899999999988888999999999999999999999998877766666665443 3456778


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +.++.++|.+||..||++||++     ++++.||||
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~  260 (260)
T cd08222         230 SRQLNSIMQSMLNKDPSLRPSA-----AEILRNPFI  260 (260)
T ss_pred             cHHHHHHHHHHhcCChhhCcCH-----HHHhhCCCC
Confidence            9999999999999999999998     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=325.05  Aligned_cols=251  Identities=29%  Similarity=0.493  Sum_probs=212.2

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      |++.+.||+|++|.||+|.+..+|+.+|+|.+...... ......+..|..++++++||||+++++++.+...+|+||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            67889999999999999999999999999998765433 23345667799999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          137 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       137 ~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      +++ +|.+++... +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......      
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------  152 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------  152 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------
Confidence            975 888888764 579999999999999999999999999999999999999999999999999987654321      


Q ss_pred             CCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-------------
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-------------  281 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-------------  281 (499)
                          .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+......++....             
T Consensus       153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence                111234688899999998776 78999999999999999999999998887766555443210             


Q ss_pred             ------CCC-----------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 ------IRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 ------~~~-----------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                            ..+           ...++.++.+||.+||..||.+||++     .+++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~ll~~~~~  283 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA-----EQALAHPYF  283 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH-----HHHhhCCCC
Confidence                  011           12367889999999999999999998     899999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.1e-40  Score=324.60  Aligned_cols=248  Identities=21%  Similarity=0.339  Sum_probs=208.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcC-----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|++.....  ......+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            35789999999999999999999753     678999999865432  22334577799999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCC
Q 010859          128 FSLYMALESCEGGELFDQITSKG----------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  185 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~----------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~N  185 (499)
                      ..+|++|||+++|+|.+++....                      .+++..+..++.||+.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999987431                      37788899999999999999999999999999999


Q ss_pred             eeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCC
Q 010859          186 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  264 (499)
Q Consensus       186 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~P  264 (499)
                      |+++.++.++|+|||++..+......        .......++..|+|||.+.+..++.++|+|||||++|+|++ |..|
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p  232 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYY--------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP  232 (288)
T ss_pred             eEecCCCceEECccccceecccCccc--------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999998754322110        01112234667999999998899999999999999999997 8899


Q ss_pred             CCCCCHHHHHHHHHhcCC-CCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          265 FKDTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       265 f~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |.+.+..+....+..... ..|..++.++.+||.+||+.||.+||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  279 (288)
T cd05050         233 YYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF  279 (288)
T ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence            988887777776665543 3567789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.8e-40  Score=318.78  Aligned_cols=242  Identities=21%  Similarity=0.345  Sum_probs=203.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++...||+|+||.||+|.+..+ ..+|+|.+.....    ....+.+|+.+++.++|||++++++++.. ...|++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence            46799999999999999999988665 4699998765432    22446679999999999999999988854 568999


Q ss_pred             EeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          134 LESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      |||+.+++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence            9999999999999764  3478999999999999999999999999999999999999999999999999976543211 


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  289 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~  289 (499)
                              .......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.........+... ...+|..++
T Consensus       158 --------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd05069         158 --------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCP  229 (260)
T ss_pred             --------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence                    11112346778999999988889999999999999999999 99999988877766666543 334567789


Q ss_pred             hHHHHHHHHhhccCCCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..+.+|+.+||..||.+||++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~  250 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTF  250 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCH
Confidence            999999999999999999988

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-40  Score=326.33  Aligned_cols=248  Identities=20%  Similarity=0.300  Sum_probs=204.5

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCC--------------ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCcc
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTG--------------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV  118 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~--------------~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv  118 (499)
                      ..++|++.+.||+|+||.||+|++..++              ..||+|.+....  .......+.+|+.++++++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            3568999999999999999999876432              358999986542  233445678899999999999999


Q ss_pred             EEEEEEEcCCeEEEEEeccCCCChHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCe
Q 010859          119 RLFFTFQDTFSLYMALESCEGGELFDQITSKG------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  186 (499)
Q Consensus       119 ~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NI  186 (499)
                      ++++++.....+|+||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999886532            368889999999999999999999999999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc--CCCC
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GTSP  264 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt--G~~P  264 (499)
                      +++.++.+||+|||++..+.....        ........++..|+|||++.+..++.++|+|||||++|+|++  |..|
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p  232 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDY--------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP  232 (295)
T ss_pred             EEcCCCcEEecccccccccccCcc--------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999876532211        111223456778999999988889999999999999999988  7789


Q ss_pred             CCCCCHHHHHHHHHh--------cCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          265 FKDTSEWLIFQRIIA--------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       265 f~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |...+.......+..        .....+..+++.+.+|+.+||+.||.+||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~  286 (295)
T cd05097         233 YSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF  286 (295)
T ss_pred             CcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            988776665544432        1122355678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-39  Score=316.82  Aligned_cols=248  Identities=22%  Similarity=0.368  Sum_probs=210.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|.+......    ...+..|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            468999999999999999999885 4678999988654332    23466799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++++|.+++... +.++++.++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  155 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--  155 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc--
Confidence            9999999999998764 5689999999999999999999999999999999999999999999999999875432211  


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCh
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSD  290 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  290 (499)
                             .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.........+.+... ....|...+.
T Consensus       156 -------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05112         156 -------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQ  228 (256)
T ss_pred             -------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCH
Confidence                   01112335678999999998889999999999999999998 99999988877777776654 3344667899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ++.+|+.+||+.+|++||++     .++++
T Consensus       229 ~~~~l~~~~l~~~p~~Rp~~-----~~~l~  253 (256)
T cd05112         229 SVYELMQHCWKERPEDRPSF-----SLLLH  253 (256)
T ss_pred             HHHHHHHHHcccChhhCCCH-----HHHHH
Confidence            99999999999999999998     66654

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-39  Score=321.72  Aligned_cols=248  Identities=19%  Similarity=0.309  Sum_probs=202.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCce----EEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTV----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~----vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      +..++|++++.||+|+||+||+|.+..++..    +|+|.+....  .......+..|..+++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-   80 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-   80 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence            4467999999999999999999999888775    5666653221  11223445667778899999999999998754 


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      ...++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            4678999999999999999764 568999999999999999999999999999999999999999999999999997653


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRF  284 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~  284 (499)
                      ....        ........|+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.......+.+..+. ...
T Consensus       161 ~~~~--------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05111         161 PDDK--------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ  232 (279)
T ss_pred             CCCc--------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence            3211        111223456778999999998889999999999999999998 999998877665544444333 334


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |...+.++.+++.+||..||++||++
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rps~  258 (279)
T cd05111         233 PQICTIDVYMVMVKCWMIDENVRPTF  258 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            55678899999999999999999998

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9e-40  Score=324.33  Aligned_cols=246  Identities=22%  Similarity=0.365  Sum_probs=205.1

Q ss_pred             CeeeeeEeeecCceEEEEEEEcC-----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+.....  ......+.+|+.+++.++||||+++++.+......
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            58899999999999999998753     235788998765432  22335577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCe
Q 010859          131 YMALESCEGGELFDQITSK------------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  186 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NI  186 (499)
                      |++|||+.+++|.+++...                        ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2478899999999999999999999999999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCC
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  265 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf  265 (499)
                      |+++++.+||+|||+++........        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  230 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSY--------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  230 (290)
T ss_pred             EEcCCCcEEeccccccccccCccch--------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence            9999999999999998765332110        11123345678999999988889999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          266 KDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       266 ~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      .+.......+.+... ....|..++.++.+|+.+||+.+|.+||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~  277 (290)
T cd05045         231 PGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA  277 (290)
T ss_pred             CCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence            988877766655432 3345677899999999999999999999983

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-39  Score=317.92  Aligned_cols=239  Identities=20%  Similarity=0.302  Sum_probs=198.5

Q ss_pred             EeeecCceEEEEEEEc--CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           62 IYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        62 ~LG~G~~g~Vy~a~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      .||+|+||.||+|...  .++..||+|++....  .......+.+|..+++.++||||++++++++. ...|+||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            3899999999999875  456679999986542  23344567789999999999999999998864 478999999999


Q ss_pred             CChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCC
Q 010859          140 GELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  218 (499)
Q Consensus       140 g~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~  218 (499)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+......       
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~-------  151 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-------  151 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc-------
Confidence            999999875 457999999999999999999999999999999999999999999999999998754332110       


Q ss_pred             CCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCChHHHHHH
Q 010859          219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLI  296 (499)
Q Consensus       219 ~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li  296 (499)
                      ........++..|+|||.+....++.++|+|||||++|+|++ |..||...........+..+ ...+|...++++.+||
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05115         152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALM  231 (257)
T ss_pred             eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            000111223578999999988889999999999999999996 99999988777666655543 3456778899999999


Q ss_pred             HHhhccCCCCCCCC
Q 010859          297 DRLLDVDPSGRPGA  310 (499)
Q Consensus       297 ~~lL~~dP~~R~~~  310 (499)
                      .+||..||++||+.
T Consensus       232 ~~c~~~~~~~Rp~~  245 (257)
T cd05115         232 KDCWIYKWEDRPNF  245 (257)
T ss_pred             HHHcCCChhhCcCH
Confidence            99999999999998

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.5e-40  Score=331.22  Aligned_cols=257  Identities=23%  Similarity=0.356  Sum_probs=211.4

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCC-------CceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLF  121 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t-------~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~  121 (499)
                      ..+...+|++++.||+|+||.||+|++...       +..||+|++....  .......+.+|+.+++++ +||||++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            344556899999999999999999986532       2368999876432  222345677799999999 799999999


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCC
Q 010859          122 FTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  185 (499)
Q Consensus       122 ~~~~~~~~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~N  185 (499)
                      +++.....+|++|||+++|+|.+++.+..                .++...+..++.||+.||.|||++||+||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            99999999999999999999999987532                36778889999999999999999999999999999


Q ss_pred             eeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCC
Q 010859          186 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  264 (499)
Q Consensus       186 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~P  264 (499)
                      ||++.++.+||+|||+++........        .......++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYY--------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             EEEcCCCcEEECCcccceeccccccc--------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence            99999999999999999865432111        01112234568999999999999999999999999999998 8999


Q ss_pred             CCCCCHHHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          265 FKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       265 f~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      |.+.+.......+... ....|..++.++.+||.+||+.+|.+||++     .+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~ell~~  289 (334)
T cd05100         237 YPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTF-----KQLVED  289 (334)
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-----HHHHHH
Confidence            9988877777666553 335667789999999999999999999998     566653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-39  Score=317.36  Aligned_cols=240  Identities=24%  Similarity=0.411  Sum_probs=204.1

Q ss_pred             eEeeecCceEEEEEEEcC-CCc--eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010859           61 KIYGVGSYSKVVRAKKID-TGT--VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  137 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~-t~~--~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~  137 (499)
                      +.||+|+||.||+|.+.. .++  .||+|.+......  .....+..|..++++++||||+++++.+.+ ..+++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999865 333  6999999776543  445667789999999999999999999988 8999999999


Q ss_pred             CCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          138 EGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       138 ~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      ++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+......    
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~----  153 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH----  153 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence            9999999997764  6899999999999999999999999999999999999999999999999999876432110    


Q ss_pred             CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc--CCCCCCCCChHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAA  292 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~  292 (499)
                         ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+...  ....|..++..+
T Consensus       154 ---~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd05040         154 ---YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDI  230 (257)
T ss_pred             ---eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHH
Confidence               011113457788999999999899999999999999999998 99999888877776666542  334566788999


Q ss_pred             HHHHHHhhccCCCCCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~  310 (499)
                      .+++.+||+.+|++||++
T Consensus       231 ~~li~~~l~~~p~~Rps~  248 (257)
T cd05040         231 YNVMLQCWAHNPADRPTF  248 (257)
T ss_pred             HHHHHHHCCCCcccCCCH
Confidence            999999999999999998

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=319.66  Aligned_cols=250  Identities=20%  Similarity=0.313  Sum_probs=210.9

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCc----eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      +...+|++++.||+|+||.||+|.++.+|+    .+|+|.+.+...  ......+.+|..++++++||||+++++++.. 
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            345789999999999999999999887765    589998765532  3344557779999999999999999999887 


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      ...++||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999999874 469999999999999999999999999999999999999999999999999998664


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  284 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  284 (499)
                      ......        ......++..|+|||.+....++.++|+|||||++|++++ |+.||.+.......+.+... ....
T Consensus       161 ~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05057         161 VDEKEY--------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ  232 (279)
T ss_pred             Ccccce--------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence            322110        0111223568999999988889999999999999999998 99999998877777766654 3456


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGP  312 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~  312 (499)
                      |...+.++.+++.+||..||.+||++.+
T Consensus       233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~  260 (279)
T cd05057         233 PPICTIDVYMVLVKCWMIDAESRPTFKE  260 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            6778899999999999999999999843

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=314.90  Aligned_cols=244  Identities=23%  Similarity=0.359  Sum_probs=206.3

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  140 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg  140 (499)
                      +.||+|+||.||+|.+.. ++.||+|.+......  .....+..|+.+++.++||||+++++++.+....|+||||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            468999999999999988 999999998765432  33456778999999999999999999999999999999999999


Q ss_pred             ChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          141 ELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       141 ~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........        
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--------  149 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT--------  149 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce--------
Confidence            999998653 56899999999999999999999999999999999999999999999999998755322111        


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCChHHHHHHH
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  297 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~  297 (499)
                      .......++..|+|||++.+..++.++|+|||||++|+|++ |..||...........+... ....|..++.++.+++.
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  229 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML  229 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence            01112234667999999998889999999999999999999 89999888776666665543 34567788999999999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHhc
Q 010859          298 RLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       298 ~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      +||+.+|.+||++     .++++
T Consensus       230 ~~l~~~p~~Rp~~-----~ell~  247 (251)
T cd05041         230 QCWAYDPENRPSF-----SEIYN  247 (251)
T ss_pred             HHhccChhhCcCH-----HHHHH
Confidence            9999999999998     66653

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.1e-40  Score=322.12  Aligned_cols=237  Identities=20%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             eEeeecCceEEEEEEEcCCCce-------EEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTV-------YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~-------vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +.||+|+||.||+|.+..++..       +|+|.+....   ......+..|..+++.++||||+++++++......++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            3689999999999998765544       8888875432   22344566788899999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC--------EEEEecCCccc
Q 010859          134 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--------IKIADFGSVKP  204 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~--------vkL~DFG~a~~  204 (499)
                      |||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.        ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 5899999999999999999999999999999999999987765        69999998864


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcC-CCCCCCCCHHHHHHHHHhcCC
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSG-TSPFKDTSEWLIFQRIIARDI  282 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG-~~Pf~~~~~~~~~~~i~~~~~  282 (499)
                      ...              .....|+..|+|||++.+ ..++.++|+|||||++|+|++| .+||...+.... ..+.....
T Consensus       158 ~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~  222 (258)
T cd05078         158 VLP--------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRH  222 (258)
T ss_pred             cCC--------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccc
Confidence            322              124568889999999976 4578999999999999999998 567766555443 33445566


Q ss_pred             CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       283 ~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+|...+.++.+||.+||+.||++||++     +++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~  255 (258)
T cd05078         223 QLPAPKWTELANLINQCMDYEPDFRPSF-----RAIIR  255 (258)
T ss_pred             cCCCCCcHHHHHHHHHHhccChhhCCCH-----HHHHH
Confidence            7888888999999999999999999998     66664

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=339.64  Aligned_cols=237  Identities=24%  Similarity=0.460  Sum_probs=206.2

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      ..-++-||.|+-|.||+|+..  ++.||||.++.          .-+.++..|++|+||||+.+.+++...-.++|||||
T Consensus       126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             hhhhhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            344677999999999999874  68999997531          123477889999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCC
Q 010859          137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  216 (499)
Q Consensus       137 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~  216 (499)
                      |..|.|..+++....++......+..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.++.+..-        
T Consensus       194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--------  265 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--------  265 (904)
T ss_pred             cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--------
Confidence            999999999999999999999999999999999999999999999999999999999999999999876432        


Q ss_pred             CCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh--cCCCCCCCCChHHHH
Q 010859          217 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--RDIRFPNYFSDAARD  294 (499)
Q Consensus       217 ~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~  294 (499)
                         ....+|+||..|||||++...+++.++|||||||+|||||||..||.+.+...++--+-.  ..+..|...|+.++-
T Consensus       266 ---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfkl  342 (904)
T KOG4721|consen  266 ---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKL  342 (904)
T ss_pred             ---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHH
Confidence               334579999999999999999999999999999999999999999987665433222111  245678899999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ||+.||+-.|..||+.     .+++.|
T Consensus       343 L~Kqcw~sKpRNRPSF-----rqil~H  364 (904)
T KOG4721|consen  343 LLKQCWNSKPRNRPSF-----RQILLH  364 (904)
T ss_pred             HHHHHHhcCCCCCccH-----HHHHHH
Confidence            9999999999999987     555555

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-39  Score=320.25  Aligned_cols=246  Identities=21%  Similarity=0.329  Sum_probs=197.2

Q ss_pred             CCe-eeeeEeeecCceEEEEEE----EcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--C
Q 010859           55 QDF-ELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--T  127 (499)
Q Consensus        55 ~~y-~~~~~LG~G~~g~Vy~a~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~  127 (499)
                      ++| ++.+.||+|+||+||++.    ...++..||+|++.....  ......+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            344 999999999999998865    345788999999865422  2234456779999999999999999998765  4


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|++|||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+..
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999998764 599999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH--------------H
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--------------I  273 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~--------------~  273 (499)
                      ....       ........++..|+|||.+.+..++.++|||||||++|+|++|..||.......              .
T Consensus       160 ~~~~-------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05080         160 GHEY-------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR  232 (283)
T ss_pred             cchh-------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence            2210       001112345677999999988889999999999999999999999986543210              0


Q ss_pred             HHHHHh--cCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          274 FQRIIA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       274 ~~~i~~--~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ......  .....|..++.++.+++.+||+.||++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~  271 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF  271 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCH
Confidence            111111  1223466788999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.8e-39  Score=323.21  Aligned_cols=257  Identities=28%  Similarity=0.463  Sum_probs=208.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCe
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~  129 (499)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|.+.+.....  ....+..|..++..+ .||||+++++++.+...
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            456789999999999999999999999999999999997653222  223344455555555 59999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 LYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +|++|||+.+ +|.+++.. .+.+++..+..++.||+.||.|||+ +||+||||+|+||+++.++.+||+|||++..+..
T Consensus        89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9999999854 77777665 3579999999999999999999997 6999999999999999999999999999875532


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCC----CCCCCcchhhhHHHHHHhcCCCCCCCCCH-HHHHHHHHhcC-
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIARD-  281 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----~~~~sDiwslG~ilyelltG~~Pf~~~~~-~~~~~~i~~~~-  281 (499)
                      ..           ......|+..|+|||.+.+..    ++.++|+|||||++|+|++|+.||..... .+....+.... 
T Consensus       168 ~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  236 (296)
T cd06618         168 SK-----------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP  236 (296)
T ss_pred             CC-----------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC
Confidence            21           112335788999999987553    78899999999999999999999976432 34444444432 


Q ss_pred             CCCC--CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          282 IRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       282 ~~~p--~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ..++  ..++.++.+||.+||..||.+||++     ++++.||||..
T Consensus       237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~  278 (296)
T cd06618         237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKY-----RELLQHPFIRR  278 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCH-----HHHhcChhhhc
Confidence            2233  2478899999999999999999998     89999999984

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-39  Score=323.69  Aligned_cols=247  Identities=20%  Similarity=0.320  Sum_probs=202.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcC----------------CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCc
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKID----------------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV  117 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~----------------t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I  117 (499)
                      .++|++.+.||+|+||.||+|.+..                ++..+|+|++....  .......+.+|+.+++.++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            4679999999999999999986543                34579999986542  23334567789999999999999


Q ss_pred             cEEEEEEEcCCeEEEEEeccCCCChHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCe
Q 010859          118 VRLFFTFQDTFSLYMALESCEGGELFDQITSKG-----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  186 (499)
Q Consensus       118 v~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~-----------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NI  186 (499)
                      +++++++.+...+|+||||+++++|.+++....           .+++..+..++.||+.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999987642           367789999999999999999999999999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc--CCCC
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GTSP  264 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt--G~~P  264 (499)
                      |++.++.++|+|||+++.+.....        ........++..|+|||...+..++.++|+|||||++|+|++  |..|
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p  233 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDY--------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP  233 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcc--------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence            999999999999999876533211        011123345678999999888889999999999999999998  7899


Q ss_pred             CCCCCHHHHHHHHHh--------cCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          265 FKDTSEWLIFQRIIA--------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       265 f~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |...+..........        .....|..+++.+.+|+.+||+.||.+||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  287 (296)
T cd05095         234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF  287 (296)
T ss_pred             ccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            987766554433211        1223456688999999999999999999998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.9e-39  Score=314.53  Aligned_cols=244  Identities=22%  Similarity=0.348  Sum_probs=205.2

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++.+.||+|+||.||+|.+. .+..+|+|.+...    ......+.+|+.+++.++|+||+++++.+.+ ...|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            34679999999999999999999865 4567999987643    2233456779999999999999999999988 7789


Q ss_pred             EEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      ++|||+++++|.+++.+.  ..++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999764  357888999999999999999999999999999999999999999999999987654321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      .         .......++..|+|||++....++.++|+|||||++|+|++ |..||.+.+.......+... ....+..
T Consensus       157 ~---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd05073         157 Y---------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN  227 (260)
T ss_pred             c---------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCccc
Confidence            1         11112345678999999998889999999999999999999 99999988777666655543 2344567


Q ss_pred             CChHHHHHHHHhhccCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .+.++.+++.+||+.+|++||++
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~  250 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTF  250 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCH
Confidence            88999999999999999999987

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.2e-40  Score=338.81  Aligned_cols=255  Identities=21%  Similarity=0.347  Sum_probs=208.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTF  124 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~  124 (499)
                      .+..++|.+++.||+|+||.||+|++.     .++..||+|++.....  ......+..|+.+|.++. ||||+++++++
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            344567999999999999999999964     3567899999975432  222345778999999997 99999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhcC------------------------------------------------------
Q 010859          125 QDTFSLYMALESCEGGELFDQITSKG------------------------------------------------------  150 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~~------------------------------------------------------  150 (499)
                      .....+|+|||||++|+|.+++.+.+                                                      
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            99999999999999999999986532                                                      


Q ss_pred             --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCe
Q 010859          151 --------------------------------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  186 (499)
Q Consensus       151 --------------------------------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NI  186 (499)
                                                                  .++...+..++.||+.||.|||+.||+||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni  270 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV  270 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence                                                        256777889999999999999999999999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCC
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  265 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf  265 (499)
                      |++.++.+||+|||+++.+.....        ........|+..|+|||.+.+..++.++|+|||||++|+|++ |..||
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSN--------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccc--------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999976432210        011223467889999999998889999999999999999998 89999


Q ss_pred             CCCCHHHHHHHHHhcC--CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          266 KDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       266 ~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ................  ...|..++.++.+|+.+||..+|.+||++     ++|+.
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-----~ell~  394 (401)
T cd05107         343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDF-----SQLVH  394 (401)
T ss_pred             CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            8765555444433332  45677789999999999999999999998     55653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=320.86  Aligned_cols=249  Identities=33%  Similarity=0.515  Sum_probs=207.5

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEe
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      |++.+.||+|+||+||+|....+++.||||.+.......  ......+|...++++. ||||+++++++.+....|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            688999999999999999999999999999987653321  2223445888888998 9999999999999999999999


Q ss_pred             ccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          136 SCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+ +|+|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......     
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-----  152 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-----  152 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence            99 779999888764  7899999999999999999999999999999999999999999999999998754321     


Q ss_pred             CCCCCCCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  281 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----------  281 (499)
                            .......|+..|+|||++. ...++.++|+||||+++++|++|++||...+......++...-           
T Consensus       153 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd07830         153 ------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG  226 (283)
T ss_pred             ------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence                  1122456889999999875 4457899999999999999999999998877655554443210           


Q ss_pred             --------CCC-----------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          282 --------IRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       282 --------~~~-----------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                              ..+           ....+.++.+||.+||+.||++||++     ++++.||||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-----~ei~~~~~~  283 (283)
T cd07830         227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA-----SQALQHPYF  283 (283)
T ss_pred             hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH-----HHHhhCCCC
Confidence                    000           11236889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=318.38  Aligned_cols=237  Identities=25%  Similarity=0.388  Sum_probs=197.7

Q ss_pred             eEeeecCceEEEEEEEcCCCce--EEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEecc
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESC  137 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~--vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~E~~  137 (499)
                      ++||+|+||.||+|++..++..  +|+|.+....  .......+..|+.++.++ +||||+++++++.....+|+||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            3689999999999999888764  5888775321  223344567799999999 7999999999999999999999999


Q ss_pred             CCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          138 EGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       138 ~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                      ++|+|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999987542                478999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~  280 (499)
                      +......           ........+..|+|||++....++.++|+|||||++|+|++ |..||.+.+.....+.+...
T Consensus       159 ~~~~~~~-----------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~  227 (270)
T cd05047         159 SRGQEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  227 (270)
T ss_pred             ccccchh-----------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC
Confidence            8532110           01111234567999999988889999999999999999997 99999888777766666543


Q ss_pred             -CCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          281 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       281 -~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                       ....|...+.++.+|+.+||..||.+||++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  258 (270)
T cd05047         228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSF  258 (270)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccChhhCCCH
Confidence             334566788999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=310.33  Aligned_cols=259  Identities=28%  Similarity=0.419  Sum_probs=207.1

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----  126 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~----  126 (499)
                      .+...+|++.+.||+|||+-||+++...++..||+|.+....   ....+...+|++.-++++|||+++++++...    
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            345578999999999999999999999999999999987653   3455678889999999999999999876533    


Q ss_pred             -CCeEEEEEeccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCCCCCEEEEec
Q 010859          127 -TFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADF  199 (499)
Q Consensus       127 -~~~l~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~~~~vkL~DF  199 (499)
                       ....|++++|...|+|.+.+...    ..++|.++..|+.+|++||++||+..  .+||||||.|||+++++.++|.||
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence             34599999999999999998754    36999999999999999999999999  999999999999999999999999


Q ss_pred             CCccccCCccccccCCC--CCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH--H
Q 010859          200 GSVKPMQDSRITVLPNA--ASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--L  272 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~--~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~--~  272 (499)
                      |++....-.   .....  ..-.....-..|..|+|||++.   +...+.++|||||||+||.|+.|..||...-..  .
T Consensus       174 GS~~~a~i~---i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  174 GSATQAPIQ---IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             cCccccceE---eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            998754211   10000  0001111224588999999985   445789999999999999999999999632110  0


Q ss_pred             HHHHHHhcCCCCCC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          273 IFQRIIARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       273 ~~~~i~~~~~~~p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      +.-.+...++.+|+  .+|..+.+||+.||+.||.+||++     .+++.
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i-----~~ll~  295 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI-----PELLS  295 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCH-----HHHHH
Confidence            11223445677775  489999999999999999999998     55654

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.4e-39  Score=312.55  Aligned_cols=238  Identities=22%  Similarity=0.400  Sum_probs=200.8

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  140 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg  140 (499)
                      ++||+|+||.||+|... ++..+|+|++....  .......+.+|..+++.++||||+++++.+......++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            36899999999999864 68899999886543  2223345677999999999999999999999999999999999999


Q ss_pred             ChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 010859          141 ELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  219 (499)
Q Consensus       141 ~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~  219 (499)
                      +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........         
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---------  148 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---------  148 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc---------
Confidence            999988754 4589999999999999999999999999999999999999999999999999875332110         


Q ss_pred             CCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCChHHHHHHH
Q 010859          220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  297 (499)
Q Consensus       220 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~  297 (499)
                      .......++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......+... ...+|..++..+.+|+.
T Consensus       149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  228 (250)
T cd05085         149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ  228 (250)
T ss_pred             ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            01112234567999999998889999999999999999998 99999988777666666544 33566778999999999


Q ss_pred             HhhccCCCCCCCC
Q 010859          298 RLLDVDPSGRPGA  310 (499)
Q Consensus       298 ~lL~~dP~~R~~~  310 (499)
                      +||..+|++||++
T Consensus       229 ~~l~~~p~~Rp~~  241 (250)
T cd05085         229 RCWDYKPENRPKF  241 (250)
T ss_pred             HHcccCcccCCCH
Confidence            9999999999988

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-39  Score=332.42  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=204.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEE-----cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~  125 (499)
                      +..++|++++.||+|+||.||+|.+     ..+++.||||++.....  ......+.+|+.++..+ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            3457899999999999999999985     35678999999865432  22345577799999999 6899999998775


Q ss_pred             c-CCeEEEEEeccCCCChHHHHhhc-------------------------------------------------------
Q 010859          126 D-TFSLYMALESCEGGELFDQITSK-------------------------------------------------------  149 (499)
Q Consensus       126 ~-~~~l~lv~E~~~gg~L~~~i~~~-------------------------------------------------------  149 (499)
                      . ...+|++||||++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            4 45789999999999999988642                                                       


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCC
Q 010859          150 ------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  217 (499)
Q Consensus       150 ------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  217 (499)
                                  ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........       
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-------  234 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-------  234 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-------
Confidence                        1367788899999999999999999999999999999999999999999999876532210       


Q ss_pred             CCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHH-HHHHh-cCCCCCCCCChHHHH
Q 010859          218 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF-QRIIA-RDIRFPNYFSDAARD  294 (499)
Q Consensus       218 ~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~-~~i~~-~~~~~p~~~~~~~~~  294 (499)
                       ........++..|+|||++.+..++.++|+|||||++|+|++ |..||......... ..+.. .....|...++++.+
T Consensus       235 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (343)
T cd05103         235 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ  313 (343)
T ss_pred             -hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHH
Confidence             011122345678999999988889999999999999999997 99999875433322 22222 234556678899999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ++.+||+.||.+||++     .++++|
T Consensus       314 ~~~~cl~~~p~~Rps~-----~eil~~  335 (343)
T cd05103         314 TMLDCWHGEPSQRPTF-----SELVEH  335 (343)
T ss_pred             HHHHHccCChhhCcCH-----HHHHHH
Confidence            9999999999999998     667654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.3e-39  Score=316.62  Aligned_cols=246  Identities=24%  Similarity=0.405  Sum_probs=206.5

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCC---CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..++|.+.+.||+|+||.||+|.+..+   ...||+|.+....  .......+.+|..+++.++||||+++++++.+. .
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence            356899999999999999999997654   3568999875542  123345677899999999999999999998764 5


Q ss_pred             EEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .|+||||+++|+|.+++.+.+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999999999999998653 5899999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ...         ......++..|+|||.+....++.++|+|||||++|+|++ |..||.+.+.......+... ....|.
T Consensus       161 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (270)
T cd05056         161 SYY---------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP  231 (270)
T ss_pred             cce---------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            110         1112234568999999988889999999999999999986 99999988877666665543 345677


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .++.++.++|.+||..+|.+||++
T Consensus       232 ~~~~~~~~li~~~l~~~P~~Rpt~  255 (270)
T cd05056         232 NCPPTLYSLMTKCWAYDPSKRPRF  255 (270)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH
Confidence            889999999999999999999998

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.4e-39  Score=318.22  Aligned_cols=250  Identities=16%  Similarity=0.275  Sum_probs=207.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcC----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKID----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-  126 (499)
                      +..++|++.+.||+|+||.||+|.+..    ++..||+|.+...  ........+.+|..+++.++||||+++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            346789999999999999999999876    3588999987543  233345667789999999999999999997654 


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEe
Q 010859          127 TFSLYMALESCEGGELFDQITSK--------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD  198 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~--------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~D  198 (499)
                      ....+++++|+++++|.+++...        ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            57789999999999999998753        3589999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHH
Q 010859          199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI  277 (499)
Q Consensus       199 FG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i  277 (499)
                      ||+++.+.......        ......++..|+|||++.+..++.++|||||||++|++++ |++||...+.......+
T Consensus       161 ~g~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  232 (280)
T cd05043         161 NALSRDLFPMDYHC--------LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL  232 (280)
T ss_pred             CCCcccccCCceEE--------eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            99998654332111        0112345678999999998889999999999999999999 99999888776665554


Q ss_pred             Hhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          278 IAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       278 ~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      ... .+..+..+++++.+++.+||..||++||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  267 (280)
T cd05043         233 KDGYRLAQPINCPDELFAVMACCWALDPEERPSFS  267 (280)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHH
Confidence            443 2234456789999999999999999999983

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.6e-39  Score=312.91  Aligned_cols=248  Identities=23%  Similarity=0.381  Sum_probs=211.6

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCC----ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~----~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      +++.+.||.|+||.||+|.+..++    ..||+|++......  .....+..|+.+++.++||||+++++.+.+....|+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            467889999999999999998776    89999998654222  134567789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||+++++|.+++.....  +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999986544  99999999999999999999999999999999999999999999999999986654321


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~  288 (499)
                      ..         .....+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.....+.+.... ...+...
T Consensus       159 ~~---------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T smart00219      159 YK---------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENC  229 (258)
T ss_pred             cc---------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence            10         001236789999999988889999999999999999998 899999888777777766543 3456678


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      +.++.+++.+||..||.+||++     .++++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~-----~~ll~  256 (258)
T smart00219      230 PPEIYKLMLQCWAEDPEDRPTF-----SELVE  256 (258)
T ss_pred             CHHHHHHHHHHCcCChhhCcCH-----HHHHh
Confidence            9999999999999999999998     66653

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.7e-39  Score=312.72  Aligned_cols=237  Identities=24%  Similarity=0.421  Sum_probs=201.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++.+.||+|+||.||++..  +++.||+|.+....     ....+.+|+.+++.++||||+++++++... ..|+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            357899999999999999999864  78899999985432     234567799999999999999999998765 4799


Q ss_pred             EEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||+.+++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999997653  4899999999999999999999999999999999999999999999999998753211  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                                 ......+..|+|||.+.+..++.++|+|||||++|+|++ |++||...+.......+... ....+..+
T Consensus       154 -----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  222 (254)
T cd05083         154 -----------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGC  222 (254)
T ss_pred             -----------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcC
Confidence                       112234568999999998889999999999999999997 99999988776666555443 23345678


Q ss_pred             ChHHHHHHHHhhccCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +..+.+|+.+||..+|.+||++
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~  244 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSF  244 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCH
Confidence            8999999999999999999988

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=333.69  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=217.3

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCc---e-EEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGT---V-YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~---~-vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      ..+..++-.+.+.||+|+||.||+|+.+..+.   . ||+|....+..........+..|..+|+.++|||||++|++..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            44566788889999999999999999875432   3 8999887644444556667778999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          126 DTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      +...+|+|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            9999999999999999999999987 499999999999999999999999999999999999999999999999999875


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcCCC
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR  283 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~~~  283 (499)
                      -.....          .....--...|+|||.+....++.++||||+||++||+++ |..||.+....+..++|....++
T Consensus       312 ~~~~~~----------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r  381 (474)
T KOG0194|consen  312 GSQYVM----------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR  381 (474)
T ss_pred             Ccceee----------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence            431110          0001123457999999999999999999999999999999 89999999999999999766554


Q ss_pred             --CCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          284 --FPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       284 --~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                        +|...|.++..++.+|+..||+.||++.
T Consensus       382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~  411 (474)
T KOG0194|consen  382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMS  411 (474)
T ss_pred             CCCCCCCHHHHHHHHHHhccCChhhccCHH
Confidence              5677899999999999999999999984

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.1e-39  Score=317.95  Aligned_cols=252  Identities=20%  Similarity=0.314  Sum_probs=201.9

Q ss_pred             CCeeeeeEeeecCceEEEEEEE----cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--C
Q 010859           55 QDFELGKIYGVGSYSKVVRAKK----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--F  128 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~----~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~--~  128 (499)
                      .-|++++.||+|+||.||+|+.    ..++..||+|.+....  .......+.+|+.+++.++||||+++++++.+.  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3578999999999999999984    4678899999986442  233345678899999999999999999998775  6


Q ss_pred             eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..|+||||++|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            789999999999999998765 3589999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH--------------HHH
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE--------------WLI  273 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~--------------~~~  273 (499)
                      ....       ........|+..|+|||++.+..++.++|||||||++|+|+++..|+.....              ...
T Consensus       162 ~~~~-------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05079         162 DKEY-------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR  234 (284)
T ss_pred             Cccc-------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence            2110       0111245677889999999888899999999999999999998776532111              011


Q ss_pred             HHHHHh--cCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          274 FQRIIA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       274 ~~~i~~--~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ......  .....+..++..+.+||.+||+.||.+||++     +++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~  278 (284)
T cd05079         235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTF-----QNLIE  278 (284)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCH-----HHHHH
Confidence            111111  2234466789999999999999999999998     55654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-39  Score=315.67  Aligned_cols=247  Identities=20%  Similarity=0.330  Sum_probs=197.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEE----cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKK----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DT  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~----~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~--~~  127 (499)
                      -.+|++.+.||+|+||.||+|..    ..++..||+|.+...   .......+.+|+.+++.++||||+++++++.  +.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            35899999999999999999984    457899999998654   2334456778999999999999999998764  34


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      ..+|+||||+++++|.+++.+. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            5789999999999999999764 468999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH--------------
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--------------  272 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~--------------  272 (499)
                      ......       .......++..|+|||++.+..++.++|+|||||++|+|++|..|+.......              
T Consensus       160 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05081         160 QDKEYY-------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV  232 (284)
T ss_pred             CCCcce-------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence            321100       00111234456999999998889999999999999999999887765432211              


Q ss_pred             -HHHHHHhc--CCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          273 -IFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       273 -~~~~i~~~--~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                       ....+...  .+..+..++.++.+||.+||..+|++|||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  273 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF  273 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence             01112222  223456788999999999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4e-39  Score=315.52  Aligned_cols=240  Identities=24%  Similarity=0.396  Sum_probs=201.2

Q ss_pred             eEeeecCceEEEEEEEcCCC------ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           61 KIYGVGSYSKVVRAKKIDTG------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~------~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +.||+|+||.||+|++...+      ..+|+|.+.+...  ......+.+|..+++.++||||+++++++.+....|+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999987544      6899998865421  223445677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-----CEEEEecCCc
Q 010859          135 ESCEGGELFDQITSK-------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-----HIKIADFGSV  202 (499)
Q Consensus       135 E~~~gg~L~~~i~~~-------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-----~vkL~DFG~a  202 (499)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998642       3478899999999999999999999999999999999999887     8999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHh-c
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-R  280 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~-~  280 (499)
                      +........        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+.. .
T Consensus       159 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  230 (269)
T cd05044         159 RDIYKSDYY--------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG  230 (269)
T ss_pred             ccccccccc--------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC
Confidence            765432111        11123356788999999998899999999999999999998 9999988877766666544 3


Q ss_pred             CCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       281 ~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .+..+..+|..+.+||.+||+.+|.+||++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  260 (269)
T cd05044         231 RLQKPENCPDKIYQLMTNCWAQDPSERPTF  260 (269)
T ss_pred             ccCCcccchHHHHHHHHHHcCCCcccCCCH
Confidence            456677889999999999999999999988

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.3e-39  Score=319.79  Aligned_cols=248  Identities=18%  Similarity=0.337  Sum_probs=203.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCc----eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      +..++|+..+.||+|+||.||+|.+..+|.    .+|+|.+.....  ......+.+|..+++.++||||+++++.+...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            346789999999999999999999988876    468887754322  22233467789999999999999999998765


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                       ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             4679999999999999987754 58999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  284 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  284 (499)
                      ....        ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+... .+..
T Consensus       161 ~~~~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd05110         161 GDEK--------EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ  232 (303)
T ss_pred             Cccc--------ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence            3211        011122345778999999998899999999999999999997 99999887655544433322 2334


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +...+..+.+++.+||..+|++||++
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rp~~  258 (303)
T cd05110         233 PPICTIDVYMVMVKCWMIDADSRPKF  258 (303)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            55678999999999999999999998

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-39  Score=316.68  Aligned_cols=247  Identities=30%  Similarity=0.503  Sum_probs=203.8

Q ss_pred             eeeeEeeecCceEEEEEEEc----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           58 ELGKIYGVGSYSKVVRAKKI----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        58 ~~~~~LG~G~~g~Vy~a~~~----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .+.+.||.|+||.||+|...    ..+..|+||++...  ........+.+|...+++++||||+++++++.....+++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            46889999999999999998    45678999999442  2333356677799999999999999999999988889999


Q ss_pred             EeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          134 LESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||++|+|.+++...  ..++......++.||+.||.|||+++|+|++|+|+|||++.++.+||+|||++.........
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999986  67999999999999999999999999999999999999999999999999999876322111


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFS  289 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~  289 (499)
                              .......+...|+|||.+.+..++.++||||||+++|||++ |+.||...+.......+.... ..+|..++
T Consensus       160 --------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (259)
T PF07714_consen  160 --------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCP  231 (259)
T ss_dssp             --------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSB
T ss_pred             --------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchh
Confidence                    11223356778999999988889999999999999999999 789999998888777775543 44677899


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLK  319 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~  319 (499)
                      ..+.++|.+||..||.+||++     ++++
T Consensus       232 ~~~~~li~~C~~~~p~~RPs~-----~~i~  256 (259)
T PF07714_consen  232 KDIYSLIQQCWSHDPEKRPSF-----QEIL  256 (259)
T ss_dssp             HHHHHHHHHHT-SSGGGS--H-----HHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCH-----HHHH
Confidence            999999999999999999988     6664

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-38  Score=312.61  Aligned_cols=239  Identities=22%  Similarity=0.360  Sum_probs=190.6

Q ss_pred             eEeeecCceEEEEEEEcC--CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010859           61 KIYGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~--t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~  138 (499)
                      +.||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            368999999999997543  34578888765432  23334556678899999999999999999999999999999999


Q ss_pred             CCChHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          139 GGELFDQITSKG-----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       139 gg~L~~~i~~~~-----~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      +|+|.+++....     .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--  156 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY--  156 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence            999999987642     2467888999999999999999999999999999999999999999999998654322111  


Q ss_pred             CCCCCCCCccccccCccCCCccccCC-------CCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CC--
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DI--  282 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~-------~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~--  282 (499)
                            .......++..|+|||++..       ..++.++|||||||++|+|++ |.+||....+......+... ..  
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05042         157 ------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL  230 (269)
T ss_pred             ------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC
Confidence                  01123356778999999743       356789999999999999999 89999888776655554432 22  


Q ss_pred             ---CCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          283 ---RFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       283 ---~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                         ..+..++....+++..|+ .||++||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~  260 (269)
T cd05042         231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTA  260 (269)
T ss_pred             CCCcccccCCHHHHHHHHHHh-cCcccccCH
Confidence               234467889999999998 599999998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-38  Score=310.50  Aligned_cols=242  Identities=22%  Similarity=0.358  Sum_probs=196.1

Q ss_pred             eEeeecCceEEEEEEEcC---CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCeEEEEEec
Q 010859           61 KIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTFSLYMALES  136 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~---t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~-~~~~l~lv~E~  136 (499)
                      +.||+|+||.||+|.+..   ++..+|+|.+...  ........+.+|..+++.++||||+++++++. .+...|++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999999754   3457999987532  22233456677889999999999999999765 56678999999


Q ss_pred             cCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          137 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       137 ~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      +.+|+|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.+......    
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~----  154 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY----  154 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce----
Confidence            9999999999764 44678888999999999999999999999999999999999999999999999755332110    


Q ss_pred             CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCChHHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAAR  293 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~  293 (499)
                        .........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+... ....|..++..+.
T Consensus       155 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd05058         155 --SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY  232 (262)
T ss_pred             --eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence              0011123356778999999988889999999999999999999 57788877776666655544 2344667889999


Q ss_pred             HHHHHhhccCCCCCCCC
Q 010859          294 DLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       294 ~Li~~lL~~dP~~R~~~  310 (499)
                      +++.+||..+|++||++
T Consensus       233 ~li~~cl~~~p~~Rp~~  249 (262)
T cd05058         233 EVMLSCWHPKPEMRPTF  249 (262)
T ss_pred             HHHHHHcCCChhhCCCH
Confidence            99999999999999998

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.3e-39  Score=316.13  Aligned_cols=237  Identities=20%  Similarity=0.270  Sum_probs=192.9

Q ss_pred             EeeecCceEEEEEEEcCC------------------------CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCc
Q 010859           62 IYGVGSYSKVVRAKKIDT------------------------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV  117 (499)
Q Consensus        62 ~LG~G~~g~Vy~a~~~~t------------------------~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I  117 (499)
                      .||+|+||.||+|....+                        ...||+|++....   ......+.+|..+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            689999999999985322                        2458888875432   2223446668889999999999


Q ss_pred             cEEEEEEEcCCeEEEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC----
Q 010859          118 VRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----  192 (499)
Q Consensus       118 v~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~----  192 (499)
                      +++++++.+....|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999998865 46789999999999999999999999999999999999997654    


Q ss_pred             ---CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHH-hcCCCCCCC
Q 010859          193 ---HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQM-LSGTSPFKD  267 (499)
Q Consensus       193 ---~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyel-ltG~~Pf~~  267 (499)
                         .+|++|||++......              ....++..|+|||.+.+ ..++.++|+|||||++|+| ++|..||..
T Consensus       159 ~~~~~kl~d~g~~~~~~~~--------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR--------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             ccceeeecCCccccccccc--------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence               4899999987543211              12357888999998865 5688999999999999998 479999987


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          268 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       268 ~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ....... ........+|...++++.++|.+||+.+|.+||++     ++++++
T Consensus       225 ~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~~il~~  272 (274)
T cd05076         225 RTPSEKE-RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSF-----RTILRD  272 (274)
T ss_pred             cChHHHH-HHHHhccCCCCCCChHHHHHHHHHcccChhhCcCH-----HHHHHh
Confidence            7654432 33444556777778899999999999999999988     667653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-38  Score=312.04  Aligned_cols=238  Identities=21%  Similarity=0.274  Sum_probs=193.1

Q ss_pred             eEeeecCceEEEEEEEcCC------------CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           61 KIYGVGSYSKVVRAKKIDT------------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t------------~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      +.||+|+||.||+|+....            ...+|+|++...   .......+..|..+++.++||||+++++++.+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3689999999999985322            335888887543   2233345667888999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC-------EEEEecC
Q 010859          129 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-------IKIADFG  200 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~-------vkL~DFG  200 (499)
                      ..++||||+++|+|..++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888754 56999999999999999999999999999999999999987664       8999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHh-cCCCCCCCCCHHHHHHHHH
Q 010859          201 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRII  278 (499)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyell-tG~~Pf~~~~~~~~~~~i~  278 (499)
                      ++.....              .....|+..|+|||.+. +..++.++|||||||++|+|+ +|..||......+. ....
T Consensus       158 ~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~  222 (262)
T cd05077         158 IPITVLS--------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFY  222 (262)
T ss_pred             CCccccC--------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHH
Confidence            9865421              11346788999999986 566899999999999999997 58999887654333 2333


Q ss_pred             hcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          279 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       279 ~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ..........+.++.+||.+||+.||.+||+.     .+|+.+
T Consensus       223 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~-----~~il~~  260 (262)
T cd05077         223 EGQCMLVTPSCKELADLMTHCMNYDPNQRPFF-----RAIMRD  260 (262)
T ss_pred             hcCccCCCCChHHHHHHHHHHcCCChhhCcCH-----HHHHHh
Confidence            44444445567889999999999999999988     677653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.6e-38  Score=310.32  Aligned_cols=239  Identities=20%  Similarity=0.297  Sum_probs=190.5

Q ss_pred             eEeeecCceEEEEEEEc--CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010859           61 KIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~  138 (499)
                      +.||+|+||.||+|...  .++..+|+|.+.....  ......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46899999999999864  3567899998865432  2223456779999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          139 GGELFDQITSKG-----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       139 gg~L~~~i~~~~-----~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      +|+|.+++....     .+++..+..++.|++.||.|||+.|++||||||+||+++.++++||+|||+++........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~--  156 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY--  156 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence            999999987532     3567788899999999999999999999999999999999999999999998754322110  


Q ss_pred             CCCCCCCCccccccCccCCCccccCCC-------CCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHh-cCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDIRF  284 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-------~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~-~~~~~  284 (499)
                            .......|+..|+|||++.+.       .++.++|+|||||++|+|++ |+.||.............. ....+
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05087         157 ------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL  230 (269)
T ss_pred             ------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC
Confidence                  112235678899999998642       35789999999999999996 9999987766554433322 22222


Q ss_pred             -----CCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          285 -----PNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       285 -----p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                           +...+..+.+++++|+ .+|++||++
T Consensus       231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~  260 (269)
T cd05087         231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSA  260 (269)
T ss_pred             CCCccCCCCChHHHHHHHHHh-cCcccCCCH
Confidence                 2346788999999998 689999999

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.9e-38  Score=314.71  Aligned_cols=258  Identities=18%  Similarity=0.212  Sum_probs=194.1

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCC---CceEEEEEEeCcccch--hhHH------HHHHHHHHHHHhCCCCCccEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITK--ENKT------AYVKLERIVLDQLDHPGVVRL  120 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t---~~~vAiK~~~~~~~~~--~~~~------~~~~~E~~~l~~l~hp~Iv~l  120 (499)
                      ....+|++.+.||+|+||.||+|.+..+   +..+|+|+........  +...      .....+...+..+.|++|+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3446899999999999999999999887   6778888643322110  1000      001112234556789999999


Q ss_pred             EEEEEcCC----eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEE
Q 010859          121 FFTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI  196 (499)
Q Consensus       121 ~~~~~~~~----~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL  196 (499)
                      ++......    ..|++|+++.. ++.+.+.....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            98765433    45788888754 77777776666789999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH-HH---
Q 010859          197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WL---  272 (499)
Q Consensus       197 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~-~~---  272 (499)
                      +|||+|+.+........   ..........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+. ..   
T Consensus       168 ~DFGla~~~~~~~~~~~---~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        168 IDYGIASHFIIHGKHIE---YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEcCCceeeccCCcccc---cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            99999987643221110   011222345799999999999999999999999999999999999999987632 11   


Q ss_pred             -----HHHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 010859          273 -----IFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  319 (499)
Q Consensus       273 -----~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~  319 (499)
                           ...++......+ ...+.++.++++.|+..+|++||+.     ++++
T Consensus       245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~-----~~l~  290 (294)
T PHA02882        245 AAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDY-----DALI  290 (294)
T ss_pred             HhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCH-----HHHH
Confidence                 223333333333 3468999999999999999999987     6665

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-41  Score=310.55  Aligned_cols=259  Identities=29%  Similarity=0.435  Sum_probs=213.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE--------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--------  125 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~--------  125 (499)
                      ...|+-...||+|.||.||+|+.+.+|+.||+|++-.+ ..++.......+|+.+|..|+|+|++.+++.+.        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            35678888999999999999999999999999865321 123344445667999999999999998875543        


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          126 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      +...+|+||.+|+. +|..++... -+|+..+++.++.++++||.|+|.+.|+|||+||+|+||+.+|.+||+|||+|+.
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            34459999999987 999988765 5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--C
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--D  281 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~  281 (499)
                      +.....      ....+....+.|.+|++||.+.| ..|+.+.|||+.|||+.+|+++.+-|.+.++..++..|...  .
T Consensus       174 fs~~~n------~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  174 FSTSKN------VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             eecccc------cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            754432      22344556788999999999865 45999999999999999999999999999988877666531  0


Q ss_pred             -----------------C---CCCC-------------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          282 -----------------I---RFPN-------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       282 -----------------~---~~p~-------------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                       .   ++|.             .-++++.||+++||..||.+|+.+     .++++|.||.
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a-----d~alnh~~F~  319 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA-----DQALNHDFFW  319 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch-----Hhhhchhhhh
Confidence                             0   1121             125689999999999999999999     7899999995

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-38  Score=311.20  Aligned_cols=245  Identities=21%  Similarity=0.376  Sum_probs=201.9

Q ss_pred             eeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           57 FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      |.+.+.||+|+||.||+|...   .++..||||++...... ......+.+|..+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            678899999999999999865   35789999998655333 334555778999999999999999999886432     


Q ss_pred             -eEEEEEeccCCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          129 -SLYMALESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       129 -~l~lv~E~~~gg~L~~~i~~~------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                       ..+++++|+.+|+|.+++...      ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             357899999999998877432      2478999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~  280 (499)
                      ++........        .......+++.|++||.+....++.++|||||||++|+|++ |++||.+.+.......+...
T Consensus       160 ~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  231 (273)
T cd05074         160 SKKIYSGDYY--------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG  231 (273)
T ss_pred             cccccCCcce--------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence            9865432110        11123346678999999998889999999999999999999 99999888776666655543


Q ss_pred             -CCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          281 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       281 -~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                       ....+..++..+.+++.+||..+|++||++
T Consensus       232 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~  262 (273)
T cd05074         232 NRLKQPPDCLEDVYELMCQCWSPEPKCRPSF  262 (273)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence             344556788999999999999999999988

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-38  Score=311.84  Aligned_cols=248  Identities=21%  Similarity=0.354  Sum_probs=202.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEc----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--C
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKI----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--T  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~  127 (499)
                      ..+|++.+.||+|+||.||+|...    .++..||+|++......  .....+..|+.+++.+.||||+++++++.+  .
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            467899999999999999999865    34889999998765432  345567889999999999999999999877  6


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      ...|++|||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            68999999999999999997754 59999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH--------------
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--------------  272 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~--------------  272 (499)
                      ......       .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......              
T Consensus       161 ~~~~~~-------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         161 EDKDYY-------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             cCCcce-------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            321110       01112245567999999988889999999999999999999999987543221              


Q ss_pred             HHHHHHhcC--CCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          273 IFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       273 ~~~~i~~~~--~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .........  ...|..++.++.+|+.+||..+|.+||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  273 (284)
T cd05038         234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSF  273 (284)
T ss_pred             HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCH
Confidence            112222222  33455678899999999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=337.53  Aligned_cols=242  Identities=30%  Similarity=0.500  Sum_probs=197.6

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC------
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF------  128 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~------  128 (499)
                      .-+..-+.||+|+||.||+++++.||+.||||.+++....+  ..+...+|+++|++++|||||+++++-++..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            35677889999999999999999999999999998765332  3455667999999999999999998876544      


Q ss_pred             eEEEEEeccCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC--CC--CEEEEecCC
Q 010859          129 SLYMALESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DG--HIKIADFGS  201 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~--~~--~vkL~DFG~  201 (499)
                      .-.+|||||.||||+.++.+.   ..|++.++..++..+..||.|||++||+||||||+||++-.  +|  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            458999999999999999854   34999999999999999999999999999999999999853  34  379999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCC----CHHHHHHH
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQR  276 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~----~~~~~~~~  276 (499)
                      |+.+...           ....+++||+.|.+||++.. +.|+..+|+|||||++|+++||..||...    +.+++...
T Consensus       171 Arel~d~-----------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~  239 (732)
T KOG4250|consen  171 ARELDDN-----------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH  239 (732)
T ss_pred             cccCCCC-----------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence            9987543           35568999999999999984 88999999999999999999999999643    22333333


Q ss_pred             HHh---------------------cCCCCCCCCChH----HHHHHHHhhccCCCCCCC
Q 010859          277 IIA---------------------RDIRFPNYFSDA----ARDLIDRLLDVDPSGRPG  309 (499)
Q Consensus       277 i~~---------------------~~~~~p~~~~~~----~~~Li~~lL~~dP~~R~~  309 (499)
                      +..                     ..+++|..+++.    +-..+..+|..+|.+|-+
T Consensus       240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence            332                     123445555544    446677899999999984

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.9e-38  Score=308.71  Aligned_cols=244  Identities=29%  Similarity=0.515  Sum_probs=204.9

Q ss_pred             CeeeeeEeeecCceEEEEEEEcC-CCceEEEEEEeCccc-------chhhHHHHHHHHHHHHHh-CCCCCccEEEEEEEc
Q 010859           56 DFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFI-------TKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQD  126 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~-t~~~vAiK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~hp~Iv~l~~~~~~  126 (499)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+..|..++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58899999999999999999987 788999998864321       122333445567777664 799999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          127 TFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                      ....|++|||++|++|.+++..    ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999888743    3468999999999999999999996 7899999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  281 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~  281 (499)
                      +.......           ......|+..|+|||.+.+..++.++|+|||||++|+|++|.+||...+.......+....
T Consensus       161 ~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (269)
T cd08528         161 AKQKQPES-----------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV  229 (269)
T ss_pred             eeeccccc-----------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence            97643321           2235578999999999998889999999999999999999999998887766666665544


Q ss_pred             CCC-C-CCCChHHHHHHHHhhccCCCCCCCC
Q 010859          282 IRF-P-NYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       282 ~~~-p-~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ... + ..+++++.+||.+||+.||++||++
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~  260 (269)
T cd08528         230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDI  260 (269)
T ss_pred             CCcCCcccCCHHHHHHHHHHCCCCCccCCCH
Confidence            332 2 2578999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-38  Score=307.69  Aligned_cols=230  Identities=20%  Similarity=0.269  Sum_probs=190.2

Q ss_pred             eEeeecCceEEEEEEEcCCC----------ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           61 KIYGVGSYSKVVRAKKIDTG----------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~----------~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      +.||+|+||.||+|.+..++          ..+++|++.....    ....+.+|..+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999998877          3477787654321    14556778899999999999999999888 778


Q ss_pred             EEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-------CEEEEecCCc
Q 010859          131 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-------HIKIADFGSV  202 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-------~vkL~DFG~a  202 (499)
                      |+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998765 799999999999999999999999999999999999999887       7999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCC--CCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHh
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA  279 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~  279 (499)
                      .....              .....++..|+|||++.+.  .++.++|+|||||++|+|++ |..||...+....... ..
T Consensus       156 ~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-~~  220 (259)
T cd05037         156 ITVLS--------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQ  220 (259)
T ss_pred             ccccc--------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-Hh
Confidence            75432              1134577889999999876  78899999999999999999 6888877653332222 22


Q ss_pred             cCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          280 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       280 ~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .....|......+.++|.+||..+|.+||++
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  251 (259)
T cd05037         221 DQHRLPMPDCAELANLINQCWTYDPTKRPSF  251 (259)
T ss_pred             cCCCCCCCCchHHHHHHHHHhccChhhCCCH
Confidence            3333444445899999999999999999988

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=327.63  Aligned_cols=246  Identities=22%  Similarity=0.368  Sum_probs=206.8

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..+++.++..||+|+||+||+|.+..   .||||+++......+ ..+.+++|+.++++-+|.||+=+.+++..... .
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            445678899999999999999999854   699999998877766 67788999999999999999999999988866 9


Q ss_pred             EEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||+-+|+|-+|+.++.-. .+|....++.|+.||+.|+.|||.++|||||||..|||+.+++.|||+|||++..-..-  
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w--  541 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW--  541 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee--
Confidence            999999999999998743 46999999999999999999999999999999999999999999999999998643211  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR----  283 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~----  283 (499)
                            ..........|...|||||++.   ..+|++.+|||||||++|||+||.+||...+...++-.+-.+.+.    
T Consensus       542 ------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s  615 (678)
T KOG0193|consen  542 ------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS  615 (678)
T ss_pred             ------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence                  1122233456888999999985   457999999999999999999999999976665554444333211    


Q ss_pred             -CCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          284 -FPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       284 -~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                       .-...+.++++|+..|+..++++||..
T Consensus       616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F  643 (678)
T KOG0193|consen  616 KIRSNCPKAMKRLLSDCWKFDREERPLF  643 (678)
T ss_pred             hhhccCHHHHHHHHHHHHhcCcccCccH
Confidence             123467799999999999999999987

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-37  Score=305.86  Aligned_cols=238  Identities=17%  Similarity=0.286  Sum_probs=189.8

Q ss_pred             EeeecCceEEEEEEEcCC--CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           62 IYGVGSYSKVVRAKKIDT--GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        62 ~LG~G~~g~Vy~a~~~~t--~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      .||+|+||.||+|....+  ...+++|.+....  .......+.+|..+++.++||||+++++.+.+...+|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            689999999999976433  3346677665432  223345677788999999999999999999999999999999999


Q ss_pred             CChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          140 GELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       140 g~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      |+|.+++.+.    ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++........     
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-----  154 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-----  154 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-----
Confidence            9999998764    2467778899999999999999999999999999999999999999999999764221110     


Q ss_pred             CCCCCCccccccCccCCCccccCC-------CCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC------
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD------  281 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~-------~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~------  281 (499)
                         .......+|+..|+|||++..       ..++.++|||||||++|+|++ |..||...++...+..+....      
T Consensus       155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (268)
T cd05086         155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK  231 (268)
T ss_pred             ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC
Confidence               111224578899999999753       235778999999999999996 688998877766666554432      


Q ss_pred             CCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          282 IRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       282 ~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..++..+++.+.+++..|+ .+|.+||++
T Consensus       232 ~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~  259 (268)
T cd05086         232 PQLELPYSERWYEVLQFCW-LSPEKRATA  259 (268)
T ss_pred             CccCCCCcHHHHHHHHHHh-hCcccCCCH
Confidence            2334567899999999999 689999998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.4e-38  Score=337.69  Aligned_cols=259  Identities=21%  Similarity=0.292  Sum_probs=184.9

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCC----CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEE--
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDT----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT--  123 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t----~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~--  123 (499)
                      ..+..++|++.+.||+|+||.||+|++..+    +..||+|.+.....     .+....+  .++...+.++..+...  
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFL  199 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhh
Confidence            456778999999999999999999999998    99999998754311     1111111  1222222223222211  


Q ss_pred             ----EEcCCeEEEEEeccCCCChHHHHhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcEee
Q 010859          124 ----FQDTFSLYMALESCEGGELFDQITSKGH--------------------LSEDEARFYTAEVVDALEYIHSMGLIHR  179 (499)
Q Consensus       124 ----~~~~~~l~lv~E~~~gg~L~~~i~~~~~--------------------l~e~~~~~i~~qil~aL~~LH~~gIiHr  179 (499)
                          ......+++||||+.+++|.+++.....                    ..+..++.++.||+.||.|||++||+||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence                2456679999999999999998875421                    1234567899999999999999999999


Q ss_pred             ecCCCCeeeCC-CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCC-----------------
Q 010859          180 DIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-----------------  241 (499)
Q Consensus       180 DlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-----------------  241 (499)
                      ||||+|||++. ++.+||+|||+|+.+....         ......++||+.|+|||.+....                 
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~---------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~  350 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGI---------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV  350 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCcccccccc---------ccCCcccccCCCccChHHhhccCCCCCCccccccccccch
Confidence            99999999986 5899999999998654321         11223578999999999764322                 


Q ss_pred             -----CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh-cCC---------------------CCCCCCChHHHH
Q 010859          242 -----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RDI---------------------RFPNYFSDAARD  294 (499)
Q Consensus       242 -----~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~-~~~---------------------~~p~~~~~~~~~  294 (499)
                           ++.++|||||||+||+|+++..|+.  +....+.+++. ...                     ...+..+.++.+
T Consensus       351 l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d  428 (566)
T PLN03225        351 LWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE  428 (566)
T ss_pred             hccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence                 3345699999999999999776643  22222222221 111                     111122345669


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                      ||.+||+.||.+|||+     +++++||||++.++..
T Consensus       429 Li~~mL~~dP~kR~ta-----~e~L~Hpff~~~~~~~  460 (566)
T PLN03225        429 LLKSMMRFKGRQRISA-----KAALAHPYFDREGLLG  460 (566)
T ss_pred             HHHHHccCCcccCCCH-----HHHhCCcCcCCCCccc
Confidence            9999999999999999     8999999999877753

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.6e-39  Score=324.20  Aligned_cols=251  Identities=27%  Similarity=0.482  Sum_probs=212.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC------CCCccEEEEEEEcC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD------HPGVVRLFFTFQDT  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~Iv~l~~~~~~~  127 (499)
                      -.+|.+....|+|-||+|..|.+..-|..||||+|....+....    =..|+++|++|+      .-++++|+-.|...
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt----Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT----GLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh----hhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            35799999999999999999999999999999999876443322    245888999984      34799999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEecCCcc
Q 010859          128 FSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVK  203 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~---l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~  203 (499)
                      +++|||+|-+. .+|.+++++.|.   |....++.|+.|++.||..|-.+||+|.||||.|||+++.. .+||||||.|.
T Consensus       507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            99999999985 599999998764   88999999999999999999999999999999999999874 68999999997


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR  283 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~  283 (499)
                      ......            ...+..+..|.|||++.|.+|+...|+||+||+||||+||+..|.|.+...++.-.+.....
T Consensus       586 ~~~ene------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  586 FASENE------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             cccccc------------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence            654432            33566788999999999999999999999999999999999999998887776555543333


Q ss_pred             CCCC-----------------------------------------------------CC-------hHHHHHHHHhhccC
Q 010859          284 FPNY-----------------------------------------------------FS-------DAARDLIDRLLDVD  303 (499)
Q Consensus       284 ~p~~-----------------------------------------------------~~-------~~~~~Li~~lL~~d  303 (499)
                      ||..                                                     ++       ..+++||.+||..|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence            3311                                                     11       34889999999999


Q ss_pred             CCCCCCCCCCCHHHHhcCCCCCC
Q 010859          304 PSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       304 P~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      |++|++.     .++|.||||.+
T Consensus       734 P~KRit~-----nqAL~HpFi~~  751 (752)
T KOG0670|consen  734 PEKRITV-----NQALKHPFITE  751 (752)
T ss_pred             hhhcCCH-----HHHhcCCcccC
Confidence            9999998     88999999974

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.8e-39  Score=337.68  Aligned_cols=252  Identities=23%  Similarity=0.396  Sum_probs=220.3

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      .+...+.++.+.||+|+||+||+|+..     .....||||.++..  ...+....+++|+++|..++|||||+|++++.
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            455678899999999999999999864     23567999998655  23446778999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC
Q 010859          126 DTFSLYMALESCEGGELFDQITSKG--------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  191 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~--------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~  191 (499)
                      ..+-+|+|+|||..|||.+++..++              +|+..+...|+.||+.|++||-++.+|||||-..|+||.++
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence            9999999999999999999997442              27889999999999999999999999999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCH
Q 010859          192 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  270 (499)
Q Consensus       192 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~  270 (499)
                      ..|||+|||+++.+-..+++...       . .-.-...|||||.+..+.++.+|||||+||+|||+++ |+.||.+.+.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~-------~-~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn  711 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVR-------G-NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN  711 (774)
T ss_pred             eEEEecccccchhhhhhhhhccc-------C-CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence            99999999999977655443211       0 1122457999999999999999999999999999999 9999999999


Q ss_pred             HHHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCC
Q 010859          271 WLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGP  312 (499)
Q Consensus       271 ~~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~  312 (499)
                      .+.++.|..+. ++.|+..|.++.+|+..|++.+|.+||+..+
T Consensus       712 ~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e  754 (774)
T KOG1026|consen  712 QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKE  754 (774)
T ss_pred             HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence            99999998876 5678999999999999999999999999843

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=317.11  Aligned_cols=264  Identities=31%  Similarity=0.476  Sum_probs=218.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhh----HHHHHHHHHHHHHhCCCCCccEEEEEEE-cCC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN----KTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTF  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~Iv~l~~~~~-~~~  128 (499)
                      .++|-++.+||+|+|+.||+|.+....+.||+|+-.....+++.    ......+|..+.+.|+||.||++|++|. |.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            36799999999999999999999999999999986555444433    3344557999999999999999999996 677


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCC---CCCEEEEecCCcc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTA---DGHIKIADFGSVK  203 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~---~~~vkL~DFG~a~  203 (499)
                      ..|-|+|||+|.+|.-|++.+..++|.+++.|+.||+.||.||....  |||-||||.|||+-.   -|.+||+|||+++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            89999999999999999999999999999999999999999999764  999999999999954   3789999999999


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccC-C---CCCCCCCcchhhhHHHHHHhcCCCCCCCCCH-HHHH--HH
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-S---SPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIF--QR  276 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~---~~~~~~sDiwslG~ilyelltG~~Pf~~~~~-~~~~--~~  276 (499)
                      ++..+.+...   ..-.....+.||.+|++||.+. +   ...+.++||||+|||+|+++.|+-||...-. ..++  ..
T Consensus       622 IMdddSy~~v---dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  622 IMDDDSYNSV---DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hccCCccCcc---cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            9987654321   1223445678999999999874 2   2368899999999999999999999976432 2222  22


Q ss_pred             HH-hcCCCCCC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          277 II-ARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       277 i~-~~~~~~p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      |+ ..+..||.  .+++++++||++||+.--+.|...     .+|.+||||.
T Consensus       699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV-----~qLA~dpyll  745 (775)
T KOG1151|consen  699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDV-----QQLACDPYLL  745 (775)
T ss_pred             hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhH-----HHHccCcccc
Confidence            33 34566764  689999999999999999999866     8899999996

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.3e-38  Score=289.32  Aligned_cols=250  Identities=26%  Similarity=0.488  Sum_probs=207.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC--e
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF--S  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~--~  129 (499)
                      ..++|++++.+|+|-|++||.|.+..+++.++||+++      ..+...+.+|+.+|+.|. ||||++|+++..|..  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            3579999999999999999999999999999999984      335566889999999995 999999999998753  4


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-CCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-~~vkL~DFG~a~~~~~~  208 (499)
                      ..+|+||.++.+...+..   .|+.-.++.|+.|++.||.|||+.||+|||+||.|++|+.. ..++|+|||+|.++.+.
T Consensus       110 paLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            789999999877665543   48999999999999999999999999999999999999965 46999999999887654


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCC-CCCCHHHHHHHHHhc------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIAR------  280 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf-~~~~~~~~~~~i~~~------  280 (499)
                      .           .....+.+..|--||++-+ ..|+.+-|+|||||++..|+..+-|| .|.+...++-+|.+-      
T Consensus       187 ~-----------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  187 K-----------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             c-----------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence            3           2334577889999999865 45888999999999999999988886 566666655554320      


Q ss_pred             -------CCCCC------------------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          281 -------DIRFP------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       281 -------~~~~p------------------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                             ...++                        ...++++.||+.++|..|-.+||||     .+.+.||||..+
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa-----kEam~HpyF~~~  328 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA-----KEAMAHPYFAPV  328 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch-----HHHhcCchHHHH
Confidence                   00111                        1257999999999999999999999     889999999754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=339.19  Aligned_cols=254  Identities=23%  Similarity=0.428  Sum_probs=219.2

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCc-----eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~-----~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      +....-++++.||+|+||.||.|...+...     .||||.+.+  ...+.....+.+|..+|+.++|||||++.+++-+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            445678999999999999999999875433     388888755  3566677788889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEec
Q 010859          127 TFSLYMALESCEGGELFDQITSK-------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  199 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~-------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DF  199 (499)
                      ....++++|||+||||..+|.+.       ..++......++.||+.|+.||+++++|||||-..|+||+....+||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999876       24889999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHH-
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI-  277 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i-  277 (499)
                      |+|+.+....++....        .-.-...|||||.+.+..++.++|||||||+|||+++ |..||.+.+..+++.-. 
T Consensus       847 GlArDiy~~~yyr~~~--------~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~  918 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHG--------EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL  918 (1025)
T ss_pred             chhHhhhhchheeccC--------ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence            9999655444332111        0112347999999999999999999999999999999 99999999998888744 


Q ss_pred             HhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          278 IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       278 ~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ..+.+..|..+|..+.+++..||+.+|++||+.     ..|++
T Consensus       919 ~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F-----~~i~~  956 (1025)
T KOG1095|consen  919 EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSF-----RTIVE  956 (1025)
T ss_pred             hCCccCCCCCCChHHHHHHHHHccCChhhCccH-----HHHHh
Confidence            456788899999999999999999999999987     55654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=327.18  Aligned_cols=254  Identities=30%  Similarity=0.535  Sum_probs=220.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE-----cC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ-----DT  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~-----~~  127 (499)
                      .+.|+|..+||.|.||.||+++.+++|+..|+|++....    ...+.++.|.++|+.+ .|||++.+|++|.     .+
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            467999999999999999999999999999999986543    3345577788888877 6999999999885     35


Q ss_pred             CeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          128 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      +.++||||||.||+.-++++.-  .++.|+.+..|+..++.||.+||.+.++|||||-.|||++.+|.|||+|||.+..+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            6799999999999999998754  57999999999999999999999999999999999999999999999999999866


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCC-----CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~  280 (499)
                      ..          ...+..+++|||.|||||++..     ..|+..+|+||||++..||.-|.+|+-+..+...+-.|-..
T Consensus       174 ds----------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN  243 (953)
T KOG0587|consen  174 DS----------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  243 (953)
T ss_pred             ec----------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence            43          2456778999999999999853     34778899999999999999999999988876666555443


Q ss_pred             C---CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 D---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ~---~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .   +.-|..++.++.+||..||.+|-.+||+.     .+++.|||...
T Consensus       244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~-----~~ll~hpFi~e  287 (953)
T KOG0587|consen  244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPST-----EELLKHPFITE  287 (953)
T ss_pred             CCccccchhhHHHHHHHHHHHHHhhccccCcch-----hhhccCCcccc
Confidence            2   22366789999999999999999999998     78999999973

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=300.42  Aligned_cols=251  Identities=25%  Similarity=0.433  Sum_probs=213.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~------  127 (499)
                      ..+|.-++.+|.|+- .|..|.|.-+++.||+|.+...... ........+|..++..++|+||++++.+|.-.      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            457888999999999 8999999999999999998777333 33345567799999999999999999999643      


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|+|||++.. +|...+..  .++.+.+++++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+.-..
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence            347999999965 99988884  488999999999999999999999999999999999999999999999999985332


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-------
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  280 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-------  280 (499)
                      .           -..+.++.|..|+|||++.+..+...+||||+|||+.||++|...|.|.+...++.++...       
T Consensus       171 ~-----------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  171 D-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             c-----------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            1           2456789999999999999999999999999999999999999999998877776666531       


Q ss_pred             --------------------CCC----CCC-----------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          281 --------------------DIR----FPN-----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       281 --------------------~~~----~p~-----------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                          ...    ||+           .-+..++||+.+||..||++|.++     ++++.||||+
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv-----~daL~HPY~~  314 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV-----DDALRHPYIK  314 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH-----HHHhcCCeee
Confidence                                011    222           124568999999999999999998     8899999998

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=309.74  Aligned_cols=244  Identities=26%  Similarity=0.377  Sum_probs=195.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-eEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-SLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-~l~l  132 (499)
                      .++|.-..+||+|+||.||+|...+ |..||||.+.......   ...+..|+.++.+++|||+|+|++++.+.. ..++
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L  149 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL  149 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence            3688888999999999999999865 4899999876543321   233888999999999999999999999988 5999


Q ss_pred             EEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          133 ALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMG---LIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~g---IiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      |+||+++|+|.+++....  .+++.....|+.+++.||+|||...   |+||||||+|||||++...||+|||+|+....
T Consensus       150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence            999999999999998764  8999999999999999999999854   99999999999999999999999999965432


Q ss_pred             ccccccCCCCCCCCcccc-ccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC---HH--HHH--HHHHh
Q 010859          208 SRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EW--LIF--QRIIA  279 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~-~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~---~~--~~~--~~i~~  279 (499)
                      .          .....+. .||.+|+|||.+..+..+.++||||||++|.||+||+.|.....   +.  ..+  ..+..
T Consensus       230 ~----------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  230 G----------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             c----------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            0          1111122 79999999999998899999999999999999999998887432   11  111  11111


Q ss_pred             c------CCCCC-CCCC-----hHHHHHHHHhhccCCCCCCCCC
Q 010859          280 R------DIRFP-NYFS-----DAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       280 ~------~~~~p-~~~~-----~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      .      +..+. ..++     ..+..+..+|++.+|.+||++.
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~  343 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMS  343 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHH
Confidence            1      11222 2233     1256778899999999999984

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-39  Score=297.37  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=218.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      ..|.+-.+.||.|+||+||.+.+..+|+.||+|.+..- ...-.....+.+|..+|..++|.|++...+..+..+     
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            35777888999999999999999999999999988543 233445566788999999999999999988877543     


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+++|.+.. +|...|.....++.+.++-+++||+.||+|||+.||.||||||.|.|++.+..+||||||+|+.....
T Consensus       131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            37899999965 99999998889999999999999999999999999999999999999999999999999999976543


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh--------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------  279 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~--------  279 (499)
                      .         ......-+.|..|+|||++.|.. |+.+.||||+|||+.||+..+..|...++.+.++.|..        
T Consensus       210 ~---------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E  280 (449)
T KOG0664|consen  210 D---------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE  280 (449)
T ss_pred             h---------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence            2         12233457789999999998765 89999999999999999999999999998888777764        


Q ss_pred             ---------------cCCC---C--------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          280 ---------------RDIR---F--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       280 ---------------~~~~---~--------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                     +...   +        |..-..++.+++..+|..||++|++.     ++.+.|+|......
T Consensus       281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~-----~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV-----EEALQHRYLEEGRL  351 (449)
T ss_pred             HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH-----hhhcccccccccce
Confidence                           1111   1        12234678899999999999999987     78899999876543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=294.84  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=209.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCe
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      .++.++.+-+..||.|+||+|++..++.+|+..|||.++...+.++  +..+..|.+ +++.-+.||||++|+....++.
T Consensus        60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~F~EGd  137 (361)
T KOG1006|consen   60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD  137 (361)
T ss_pred             ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence            4556677788899999999999999999999999999987765443  444555655 4556689999999999999999


Q ss_pred             EEEEEeccCCCChHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          130 LYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~-----~~~~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      .++.||+|.- +|..+.+     +...++|+.+-.+....+.||.||. ...|+|||+||+|||++..|.|||||||.+.
T Consensus       138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG  216 (361)
T KOG1006|consen  138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG  216 (361)
T ss_pred             eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence            9999999963 6654433     3456999999999999999999997 4689999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccC--CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH-HHHHHHHHhc
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIAR  280 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~--~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~-~~~~~~i~~~  280 (499)
                      .+..+-           ..+.-.|-..|||||.+.  +..|+.++|+||||++|||+.||..||+.-+. .+++..+..+
T Consensus       217 qLv~Si-----------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g  285 (361)
T KOG1006|consen  217 QLVDSI-----------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG  285 (361)
T ss_pred             hHHHHH-----------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence            664431           111236888999999985  44589999999999999999999999987543 4445555555


Q ss_pred             CCC---CCC---CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 DIR---FPN---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ~~~---~p~---~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +++   ++.   .++..++.+|.-||.+|-+.||..     .+|+++||++.
T Consensus       286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky-----~~Lk~~~fyr~  332 (361)
T KOG1006|consen  286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKY-----DDLKKFPFYRM  332 (361)
T ss_pred             CCCeecCcccccccCHHHHHHHHHHhhcccccCcch-----hhhhcCchhhh
Confidence            543   232   278899999999999999999976     88999999974

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.2e-36  Score=287.22  Aligned_cols=240  Identities=43%  Similarity=0.755  Sum_probs=208.8

Q ss_pred             CceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCChHHHH
Q 010859           67 SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI  146 (499)
Q Consensus        67 ~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i  146 (499)
                      +||.||+|.+..+|+.+|+|++........  ...+..|...+++++|+||+++++.+......++++||+++++|..++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            689999999999999999999876543321  456778999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccc
Q 010859          147 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV  226 (499)
Q Consensus       147 ~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~  226 (499)
                      .....++...+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+.......           ......
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------~~~~~~  147 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----------LLTTFV  147 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------cccccc
Confidence            887669999999999999999999999999999999999999999999999999998654321           223457


Q ss_pred             cCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHhcCCCCCCC---CChHHHHHHHHhhcc
Q 010859          227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDIRFPNY---FSDAARDLIDRLLDV  302 (499)
Q Consensus       227 Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~~~~~~~Li~~lL~~  302 (499)
                      |+..|+|||.+.+..++.++|+||||+++|+|++|..||.. .+.....+.+.......+..   ++.++.+++.+||..
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  227 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVK  227 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccC
Confidence            88999999999988889999999999999999999999988 55555555555554444333   889999999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCC
Q 010859          303 DPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       303 dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +|++||++     .++++||||
T Consensus       228 ~p~~Rp~~-----~~~~~~~~~  244 (244)
T smart00220      228 DPEKRLTA-----EEALQHPFF  244 (244)
T ss_pred             CchhccCH-----HHHhhCCCC
Confidence            99999988     889999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=298.95  Aligned_cols=134  Identities=28%  Similarity=0.377  Sum_probs=114.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-----C---CCccEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----H---PGVVRLFF  122 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---p~Iv~l~~  122 (499)
                      .+.-.+|.+.+.||.|-|++||+|.|..+.+.||+|+.+...    ...+....|+.+|+.+.     |   .+||+|++
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            355589999999999999999999999999999999986543    33444566888888772     3   46999999


Q ss_pred             EEE----cCCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH-HCCcEeeecCCCCeeeC
Q 010859          123 TFQ----DTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLT  189 (499)
Q Consensus       123 ~~~----~~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDlKp~NILl~  189 (499)
                      .|.    ...+++||+|++ |-+|+.+|...  ..++...++.|+.|||.||.||| .+||||-||||||||+.
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            996    456899999999 66999999865  45999999999999999999999 56999999999999994

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.3e-36  Score=313.45  Aligned_cols=263  Identities=22%  Similarity=0.278  Sum_probs=190.3

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEc----------------CCCceEEEEEEeCcccchh-----------hHHHHH
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKI----------------DTGTVYALKIMDKKFITKE-----------NKTAYV  102 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~----------------~t~~~vAiK~~~~~~~~~~-----------~~~~~~  102 (499)
                      ..+..++|++.++||+|+||+||+|...                ..++.||||.+........           ...+..
T Consensus       140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence            4567889999999999999999999752                2456799999864321100           011122


Q ss_pred             HHHHHHHHhCCCCCc-----cEEEEEEE--------cCCeEEEEEeccCCCChHHHHhhc--------------------
Q 010859          103 KLERIVLDQLDHPGV-----VRLFFTFQ--------DTFSLYMALESCEGGELFDQITSK--------------------  149 (499)
Q Consensus       103 ~~E~~~l~~l~hp~I-----v~l~~~~~--------~~~~l~lv~E~~~gg~L~~~i~~~--------------------  149 (499)
                      ..|..++.+++|.++     ++++++|.        .....++||||+++++|.+++...                    
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            346666777766554     55555553        235689999999999999988642                    


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCcccc
Q 010859          150 ----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF  225 (499)
Q Consensus       150 ----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~  225 (499)
                          ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+....         .......
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---------~~~~~~g  370 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI---------NFNPLYG  370 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC---------ccCcccc
Confidence                124567888999999999999999999999999999999999999999999997543211         0111123


Q ss_pred             ccCccCCCccccCCCC--------------------C--CCCCcchhhhHHHHHHhcCCC-CCCCCCH-----------H
Q 010859          226 VGTAAYVPPEVLNSSP--------------------A--TFGNDLWALGCTLYQMLSGTS-PFKDTSE-----------W  271 (499)
Q Consensus       226 ~Gt~~Y~aPE~l~~~~--------------------~--~~~sDiwslG~ilyelltG~~-Pf~~~~~-----------~  271 (499)
                      .+|+.|+|||++....                    +  ....|+||+|||+|+|++|.+ ||.+...           .
T Consensus       371 ~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~  450 (507)
T PLN03224        371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDL  450 (507)
T ss_pred             CCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchH
Confidence            4589999999975322                    1  124699999999999999886 7754211           1


Q ss_pred             HHHHHHHhcCCCCC--CCCChHHHHHHHHhhccCC---CCCCCCCCCCHHHHhcCCCCCC
Q 010859          272 LIFQRIIARDIRFP--NYFSDAARDLIDRLLDVDP---SGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       272 ~~~~~i~~~~~~~p--~~~~~~~~~Li~~lL~~dP---~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ..+..+....+.++  +..++.++||+.+||..+|   .+|+|+     +++++||||..
T Consensus       451 ~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa-----~eaL~Hp~f~~  505 (507)
T PLN03224        451 NRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV-----GQALSHRFFLP  505 (507)
T ss_pred             HHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCH-----HHHhCCCCcCC
Confidence            11222223344443  5678999999999999876   689999     89999999963

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=324.70  Aligned_cols=245  Identities=33%  Similarity=0.536  Sum_probs=202.1

Q ss_pred             eeeeeEeeecCce-EEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEE
Q 010859           57 FELGKIYGVGSYS-KVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        57 y~~~~~LG~G~~g-~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      |.--+++|.|+-| .||+|..  .|+.||||.+-.      .......+|+..|+.- .|||||++|+.-++..++|++.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            3344567999998 5899987  578999997643      3445678899998887 6999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC---CC--CEEEEecCCcccc
Q 010859          135 ESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DG--HIKIADFGSVKPM  205 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~----l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~---~~--~vkL~DFG~a~~~  205 (499)
                      |.|.. +|.+++...+.    ......+.++.|++.||++||+.+|+||||||.||||+.   ++  .++|+|||+++.+
T Consensus       583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            99976 99999987421    112456889999999999999999999999999999986   34  6899999999998


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcC-CCCCCCCCHHHHHHHHHhcCCCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKDTSEWLIFQRIIARDIRF  284 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG-~~Pf~~~~~~~~~~~i~~~~~~~  284 (499)
                      .....       +-.+..+..||-+|+|||++....-+.++||+||||++|+.++| ..||...-+.  -.+|+.+++..
T Consensus       662 ~~~~s-------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L  732 (903)
T KOG1027|consen  662 AGGKS-------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTL  732 (903)
T ss_pred             CCCcc-------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccce
Confidence            76542       23346677899999999999998888899999999999999995 9999875443  33677766654


Q ss_pred             CC---CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          285 PN---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       285 p~---~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      -.   ....++.|||.+||.+||..||+|     .+++.||||
T Consensus       733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa-----~~VL~HPlF  770 (903)
T KOG1027|consen  733 VHLEPLPDCEAKDLISRMLNPDPQLRPSA-----TDVLNHPLF  770 (903)
T ss_pred             eeeccCchHHHHHHHHHhcCCCcccCCCH-----HHHhCCCcc
Confidence            22   112289999999999999999999     889999999

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=304.47  Aligned_cols=205  Identities=32%  Similarity=0.503  Sum_probs=183.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh-----hHHHHHHHHHHHHHhCC---CCCccEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----NKTAYVKLERIVLDQLD---HPGVVRLFF  122 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~---hp~Iv~l~~  122 (499)
                      .-...+|..++.||+|+||.|++|.++.+...|+||.+.|+.+...     .+...+-.|+++|..++   |+||+++.+
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            3445789999999999999999999999999999999988766532     23344567999999997   999999999


Q ss_pred             EEEcCCeEEEEEecc-CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          123 TFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       123 ~~~~~~~l~lv~E~~-~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                      +|++++++|++||-- +|.+|+++|..+..++|.+++.|+.|++.|+++||++||+|||||-||++++.+|-+||+|||.
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence            999999999999975 4679999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCC
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKD  267 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~  267 (499)
                      |....+..            ...|+||..|.|||++.|..| +..-||||||++||-++...-||..
T Consensus       717 aa~~ksgp------------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSGP------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCCC------------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            97665433            337999999999999999886 6778999999999999999888853

>PF14593 PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A

Probab=100.00  E-value=1.2e-35  Score=243.55  Aligned_cols=100  Identities=49%  Similarity=0.814  Sum_probs=88.8

Q ss_pred             cccccccCCCceEEEEEeeehhhhhhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCc
Q 010859          396 SKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKK  475 (499)
Q Consensus       396 ~~~~~~~~~~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r  475 (499)
                      |+||+|+.+||+|+++|.|.|++|+|+|+|||||||+|||+|+||.+|++||||||++.   ++++.+++++|+|+||+|
T Consensus         1 ~~w~~fl~~ge~Il~~g~v~K~kgl~~kkR~liLTd~PrL~Yvdp~~~~~KGeI~~~~~---l~v~~k~~~~F~I~tp~R   77 (104)
T PF14593_consen    1 NKWHRFLNPGELILKQGYVKKRKGLFAKKRQLILTDGPRLFYVDPKKMVLKGEIPWSKE---LSVEVKSFKTFFIHTPKR   77 (104)
T ss_dssp             -TTGGGTT-T--EEEEEEEEEEETTEEEEEEEEEETTTEEEEEETTTTEEEEEE--STT----EEEECSSSEEEEEETTE
T ss_pred             CchHHhhcCCCeEEEEEEEEEeeceEEEEEEEEEccCCEEEEEECCCCeECcEEecCCc---eEEEEccCCEEEEECCCc
Confidence            57999999999999999999999999999999999999999999999999999999987   999999999999999999


Q ss_pred             eEEEEcCCccHHHHHHHHHHhcC
Q 010859          476 VLSFEDAKQRASQWKKAIEALQN  498 (499)
Q Consensus       476 ~y~~~d~~~~~~~W~~~i~~~~~  498 (499)
                      ||+|+|++++|.+||++|+++++
T Consensus        78 tY~l~d~~~~A~~W~~~I~~~~~  100 (104)
T PF14593_consen   78 TYYLEDPEGNAQQWVEAIEEVKK  100 (104)
T ss_dssp             EEEEE-TTS-HHHHHHHHHHHHH
T ss_pred             EEEEECCCCCHHHHHHHHHHHHH
Confidence            99999999999999999999863

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=298.65  Aligned_cols=245  Identities=22%  Similarity=0.394  Sum_probs=208.3

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCC----CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDT----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t----~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...+.+.||+|-||.||.|.....    .-.||||.+++....  ...+.+..|..+|+.++|||||+|++++.+. .++
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            345567799999999999987543    235899998765433  3366677899999999999999999999765 789


Q ss_pred             EEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||+++-|+|..+++.+ ..|+......|+.||+.||.|||+..+|||||-..|||+....-|||+|||+++.+....+
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            999999999999999876 5699999999999999999999999999999999999999999999999999998876543


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                      +..         +...-..-|||||.++-..++.++|||-|||.+||++. |.-||.+....+.+-.|.++ .++.|+.+
T Consensus       547 Yka---------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC  617 (974)
T KOG4257|consen  547 YKA---------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC  617 (974)
T ss_pred             hhc---------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC
Confidence            311         11112346999999999999999999999999999988 99999998777666666554 57889999


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGP  312 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~  312 (499)
                      |+.+..|..+||..||.+||...+
T Consensus       618 Pp~LYslmskcWayeP~kRPrfte  641 (974)
T KOG4257|consen  618 PPALYSLMSKCWAYEPSKRPRFTE  641 (974)
T ss_pred             ChHHHHHHHHHhccCcccCCcHHH
Confidence            999999999999999999999865

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-35  Score=299.48  Aligned_cols=247  Identities=25%  Similarity=0.417  Sum_probs=213.4

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCC-C--ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDT-G--TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t-~--~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      -.++..+.++||+|+||.|++|.+... |  -.||||.+.......  ....+.+|..+|.+|+|||+++||++..+ ..
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            345678899999999999999998743 3  358999987654433  56678889999999999999999999988 67


Q ss_pred             EEEEEeccCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 LYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +.+|||+|++|+|.+.+.+  .+.|.......|+.||+.|+.||.++++|||||-..|+|+-....|||+|||+.+.+..
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            8999999999999999987  35689999999999999999999999999999999999999999999999999998765


Q ss_pred             cc-ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 010859          208 SR-ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  284 (499)
Q Consensus       208 ~~-~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  284 (499)
                      .. ++...        ...--...|+|||.|+...++.++|+|++||+||||++ |..||.+.+..+++++|-++ .+.-
T Consensus       265 ned~Yvm~--------p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR  336 (1039)
T KOG0199|consen  265 NEDMYVMA--------PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR  336 (1039)
T ss_pred             CCcceEec--------CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC
Confidence            43 11110        01122457999999999999999999999999999999 99999999999999998754 3567


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |..++.++.+++..||..+|.+||+.
T Consensus       337 Pk~csedIY~imk~cWah~paDRptF  362 (1039)
T KOG0199|consen  337 PKYCSEDIYQIMKNCWAHNPADRPTF  362 (1039)
T ss_pred             CCCChHHHHHHHHHhccCCccccccH
Confidence            88999999999999999999999987

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=291.45  Aligned_cols=249  Identities=20%  Similarity=0.292  Sum_probs=210.1

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..+...+++.||+|-||.|.+|.-. .+..||+|.++...  .......+..|+.+|.+|+|||||+|++++..++.+
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            455567889999999999999999864 36899999986542  223356678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ++|+||++.|+|.+++.++.  .+.......++.||+.|++||.+.++|||||.+.|+|++.++++||+|||.++.+-..
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            99999999999999998873  2345566679999999999999999999999999999999999999999999976544


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc--CCCCCCCCCHHHHHHHHHh-------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GTSPFKDTSEWLIFQRIIA-------  279 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt--G~~Pf~~~~~~~~~~~i~~-------  279 (499)
                      .+.        .....++-...|||||.+..+.++.++|+|++|+++||+++  ...||...++++...+...       
T Consensus       691 ~yy--------~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~  762 (807)
T KOG1094|consen  691 DYY--------RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR  762 (807)
T ss_pred             Cce--------eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc
Confidence            322        12234566778999999999999999999999999999765  8899999888777665443       


Q ss_pred             -cCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          280 -RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       280 -~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                       .-+.-|.-++..+.+|+-+|+..|-.+||+.
T Consensus       763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsF  794 (807)
T KOG1094|consen  763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSF  794 (807)
T ss_pred             ceeccCCCcCcHHHHHHHHHHhchhhhcCCCH
Confidence             1234577899999999999999999999987

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=303.78  Aligned_cols=255  Identities=30%  Similarity=0.481  Sum_probs=223.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .+||+++.++|.|+||.||+|+++.+++..|+|+++...   .....-+..|+.+++.++|||||.+++.+-....++++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            479999999999999999999999999999999997652   23334467788899999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||||.||+|.+...-.++++|.++.+..++.+.||+|||+.|=+|||||-.|||+++.|.+|++|||.+..+..      
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita------  164 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA------  164 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh------
Confidence            99999999999888889999999999999999999999999999999999999999999999999999876542      


Q ss_pred             CCCCCCCCccccccCccCCCcccc---CCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC-----
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-----  285 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l---~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-----  285 (499)
                          .-....+|.||+.|||||+-   ....|...+|+|++|++..|+---++|-....+........+..+.-|     
T Consensus       165 ----ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk  240 (829)
T KOG0576|consen  165 ----TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK  240 (829)
T ss_pred             ----hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence                12345579999999999995   456789999999999999999988888776666666555555555544     


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ..+++.+.+|++.+|.++|.+||++     +.++.|||...
T Consensus       241 ~kws~~fh~fvK~altknpKkRpta-----eklL~h~fvs~  276 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTA-----EKLLQHPFVSQ  276 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCCh-----hhheeceeecc
Confidence            3589999999999999999999999     77888999875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.1e-34  Score=285.09  Aligned_cols=263  Identities=27%  Similarity=0.408  Sum_probs=206.5

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcC---CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~---t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      ..+.|.++..||+|+|++||++.+..   ..+.||+|.+...     .....+.+|.++|..+ .+.||+++.+.+..++
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            45689999999999999999999988   7899999987543     3345688899999998 5899999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-CCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-~~vkL~DFG~a~~~~~  207 (499)
                      .+.+||||++..+..++...   ++...++.|+..++.||.++|.+|||||||||+|+|.+.. ++-.|+|||+|.....
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence            99999999999888777654   7799999999999999999999999999999999999854 7889999999973211


Q ss_pred             cc------c----cccC------------------------CCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhh
Q 010859          208 SR------I----TVLP------------------------NAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALG  252 (499)
Q Consensus       208 ~~------~----~~~~------------------------~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG  252 (499)
                      ..      .    ...+                        ............||++|+|||++...+ .+.++||||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence            10      0    0000                        011122334568999999999987655 68899999999


Q ss_pred             HHHHHHhcCCCCCCCCCH-HHHHHHHHh--------------cC---------------------C--------------
Q 010859          253 CTLYQMLSGTSPFKDTSE-WLIFQRIIA--------------RD---------------------I--------------  282 (499)
Q Consensus       253 ~ilyelltG~~Pf~~~~~-~~~~~~i~~--------------~~---------------------~--------------  282 (499)
                      +|+..+++++.||-...+ ......|..              +.                     +              
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            999999999999864322 111111100              00                     0              


Q ss_pred             --CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          283 --RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       283 --~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                        ..-+.++..+.||+++||+.||.+|+||     +++|+||||...+
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitA-----EeALkHpFF~~~~  388 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITA-----EDALKHPFFDEAD  388 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccH-----HHHhcCcCCcchh
Confidence              0112356689999999999999999999     8899999998544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.6e-34  Score=329.22  Aligned_cols=230  Identities=20%  Similarity=0.302  Sum_probs=182.7

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      .|...++||+|+||.||+|++..+|..||+|.+......       ...|+.++++++|||||++++++.+....|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            466678999999999999999999999999988643211       1235778899999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH---SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH---~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |+++|+|.+++..   +++..+..++.|++.||+|||   +.+|+||||||+||+++.++..++. ||.+.....     
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            9999999999863   889999999999999999999   6699999999999999998887775 665543211     


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH----HHHHHHH-H---------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI-I---------  278 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~----~~~~~~i-~---------  278 (499)
                               .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....    .....+. .         
T Consensus       835 ---------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (968)
T PLN00113        835 ---------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI  905 (968)
T ss_pred             ---------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence                     1133689999999999999999999999999999999999999854211    1111110 0         


Q ss_pred             hcC----CCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          279 ARD----IRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       279 ~~~----~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ...    ...+.....++.+++.+||+.||++||++
T Consensus       906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~  941 (968)
T PLN00113        906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA  941 (968)
T ss_pred             CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH
Confidence            000    01111122357789999999999999998

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=285.00  Aligned_cols=243  Identities=21%  Similarity=0.355  Sum_probs=209.7

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      .|......||-|-||.||.+.++...-.||||.++...+    ..+.+..|..+|+.++|||+|+|++++..+--.|||+
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            467778899999999999999999999999998854422    3455677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          135 ESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||..|+|++|+.+..+  ++.-...+++.||..|++||..+++|||||-..|+|+.++..||++|||+++.+..+.++.
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            99999999999987644  6667778889999999999999999999999999999999999999999999987665442


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcCC--CCCCCCC
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI--RFPNYFS  289 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~  289 (499)
                      -..         .--..-|.|||-|....++.++|||+|||+|||+.| |-.||.+.+-.+.+..+ ...+  .-|+++|
T Consensus       423 HAG---------AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-EkgyRM~~PeGCP  492 (1157)
T KOG4278|consen  423 HAG---------AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKGYRMDGPEGCP  492 (1157)
T ss_pred             ccC---------ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hccccccCCCCCC
Confidence            111         011346999999999999999999999999999999 99999998877666544 4444  4589999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      +.+.+|++.||++.|..||+..
T Consensus       493 pkVYeLMraCW~WsPsDRPsFa  514 (1157)
T KOG4278|consen  493 PKVYELMRACWNWSPSDRPSFA  514 (1157)
T ss_pred             HHHHHHHHHHhcCCcccCccHH
Confidence            9999999999999999999873

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=301.70  Aligned_cols=255  Identities=36%  Similarity=0.668  Sum_probs=229.2

Q ss_pred             EeeecCceEEEEEEE---cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEecc
Q 010859           62 IYGVGSYSKVVRAKK---IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESC  137 (499)
Q Consensus        62 ~LG~G~~g~Vy~a~~---~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~lv~E~~  137 (499)
                      ++|+|+||.|++++.   .+.|..||+|++.+......... .-..|+.++..++ ||++|+++..|+.+..+|+++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            479999999998865   35688899999988765554444 4556888888886 999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCC
Q 010859          138 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  217 (499)
Q Consensus       138 ~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  217 (499)
                      .||+|+..+.+...+++...+++.++++.|++++|+.||+|||+|++||+++.+||+++.|||+++......        
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--------  151 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--------  151 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence            999999999998889999999999999999999999999999999999999999999999999998754332        


Q ss_pred             CCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 010859          218 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID  297 (499)
Q Consensus       218 ~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~  297 (499)
                            ..|||..|||||+++  ....++|.||+|++.|+|++|..||.+    ++...|....+.+|..++..+++++.
T Consensus       152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~  219 (612)
T KOG0603|consen  152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFR  219 (612)
T ss_pred             ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHH
Confidence                  118999999999998  667789999999999999999999998    77888999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCC
Q 010859          298 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP  337 (499)
Q Consensus       298 ~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~  337 (499)
                      .++..+|.+|++++-.+..++++|+||..|+|+.+....+
T Consensus       220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~  259 (612)
T KOG0603|consen  220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSR  259 (612)
T ss_pred             HHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCC
Confidence            9999999999999877889999999999999998866543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=293.94  Aligned_cols=250  Identities=21%  Similarity=0.362  Sum_probs=216.5

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCC---ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      .+......+.++||.|-||.||+|+.+..|   ..||||.++...  .+.....+..|..||-+++||||++|-++....
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            455677899999999999999999998766   469999986653  455566677899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      .-+.||.|||++|+|..++.++ |.|+..+...++..|+.|+.||-+.|.|||||-..|||++.+-.+|++|||+++.+.
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            9999999999999999999865 779999999999999999999999999999999999999999999999999999876


Q ss_pred             CccccccCCCCCCCCcccccc--CccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CC
Q 010859          207 DSRITVLPNAASDDKACTFVG--TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DI  282 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~G--t~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~  282 (499)
                      ++.         +....+..|  ...|.|||.+....++.++||||+|+++||.++ |..||.+.++.+.++.|..+ .+
T Consensus       783 dd~---------~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL  853 (996)
T KOG0196|consen  783 DDP---------EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL  853 (996)
T ss_pred             cCC---------CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC
Confidence            543         111112222  357999999999999999999999999999887 99999999999988887654 23


Q ss_pred             CCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          283 RFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       283 ~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      +-|-.+|..+.+|+..|+++|-.+||...
T Consensus       854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~  882 (996)
T KOG0196|consen  854 PPPMDCPAALYQLMLDCWQKDRNRRPKFA  882 (996)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHhhcCCCHH
Confidence            44457899999999999999999999873

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-33  Score=249.28  Aligned_cols=215  Identities=25%  Similarity=0.436  Sum_probs=177.9

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~Iv~l~~~~~~~~~l  130 (499)
                      +..++..-+..||+|+||.|-+.++..+|...|+|.+......  +.+....+|.++..+ ...|++|.+|+.+.++..+
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3456778888999999999999999999999999998766443  334556667776544 5799999999999999999


Q ss_pred             EEEEeccCCCChHHH----HhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          131 YMALESCEGGELFDQ----ITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~----i~~~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      ++.||.|.- +|..+    +++.+.++|..+-.++..++.||.|||++ .++|||+||+||||+.+|++|+||||.+..+
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999999964 77543    45567899999999999999999999965 8999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccC----CCCCCCCCcchhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHhc
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR  280 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~----~~~~~~~sDiwslG~ilyelltG~~Pf~~-~~~~~~~~~i~~~  280 (499)
                      .++-           ..+.-.|--.|||||.+.    ...|+.++||||||+++.||.+++.||.. .++.+++.++...
T Consensus       200 ~dSi-----------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  200 VDSI-----------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             hhhh-----------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            5431           011135778899999975    34689999999999999999999999964 5777777777654

>cd01262 PH_PDK1 3-Phosphoinositide dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain

Probab=100.00  E-value=2.8e-33  Score=218.78  Aligned_cols=89  Identities=63%  Similarity=0.901  Sum_probs=85.0

Q ss_pred             EEEEEeeehhhhhhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEcCCccHH
Q 010859          408 VLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRAS  487 (499)
Q Consensus       408 i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d~~~~~~  487 (499)
                      |+++|.|.|++|+|+|+|+|||||.|||+|+||.+|++||||||+++  +++++.+|+++|+|+||+|||+|+|++++|+
T Consensus         1 Il~~g~v~Kr~glf~kkR~LiLTd~PrL~yvdp~~~~~KgeIp~s~~--~l~v~~~~~~~F~I~Tp~rty~leD~~~~a~   78 (89)
T cd01262           1 ILKIGAVKKRKGLFAKKRQLILTNGPRLIYVDPVKKVVKGEIPWSDV--ELRVEVKNSSHFFVHTPNKVYSFEDPKGRAS   78 (89)
T ss_pred             CceeeeeeehhccccceeeEEEecCceEEEEcCCcCeEEeEeccccc--ceEEEEecCccEEEECCCceEEEECCCCCHH
Confidence            68899999999999999999999999999999999999999999992  3999999999999999999999999999999


Q ss_pred             HHHHHHHHhcC
Q 010859          488 QWKKAIEALQN  498 (499)
Q Consensus       488 ~W~~~i~~~~~  498 (499)
                      +||++|+++.+
T Consensus        79 ~W~~~I~~~~~   89 (89)
T cd01262          79 QWKKAIEDLQK   89 (89)
T ss_pred             HHHHHHHHHhC
Confidence            99999999753

3-Phosphoinositide dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain. PDK1 contains an N-terminal serine/threonine kinase domain followed by a PH domain. Following binding of the PH domain to PtdIns(3,4,5)P3 and PtdIns(3,4)P2, PDK1 activates kinases such as Akt (PKB). PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-32  Score=271.30  Aligned_cols=242  Identities=21%  Similarity=0.347  Sum_probs=190.5

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh--CCCCCccEEEEEEEcCC--
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQDTF--  128 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~Iv~l~~~~~~~~--  128 (499)
                      .....++..+||+|.||.||+|+.  +++.||||++.      ......+..|+++.+.  +.|+||++++..-....  
T Consensus       208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~  279 (534)
T KOG3653|consen  208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD  279 (534)
T ss_pred             cCCchhhHHHhhcCccceeehhhc--cCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence            355678899999999999999987  46999999974      3345567778888765  58999999998765444  


Q ss_pred             --eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEeeecCCCCeeeCCCCCEEEE
Q 010859          129 --SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---------GLIHRDIKPENLLLTADGHIKIA  197 (499)
Q Consensus       129 --~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~---------gIiHrDlKp~NILl~~~~~vkL~  197 (499)
                        .+++|++|.+.|+|.++++.+ .++......++..++.||+|||+-         .|+|||||..||||..|++..|+
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence              799999999999999999986 589999999999999999999963         49999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCC------CCCCcchhhhHHHHHHhcCCC--------
Q 010859          198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA------TFGNDLWALGCTLYQMLSGTS--------  263 (499)
Q Consensus       198 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~------~~~sDiwslG~ilyelltG~~--------  263 (499)
                      |||+|..+.+..        ........+||..|||||+|.+...      -.+.||||+|.+|+||++.-.        
T Consensus       359 DFGLAl~~~p~~--------~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  359 DFGLALRLEPGK--------PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             ccceeEEecCCC--------CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            999999876432        1223334799999999999976431      235799999999999998432        


Q ss_pred             ----CCCC-----CCHHHHHHHHH--hcCCCCCCCC-----ChHHHHHHHHhhccCCCCCCCCC
Q 010859          264 ----PFKD-----TSEWLIFQRII--ARDIRFPNYF-----SDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       264 ----Pf~~-----~~~~~~~~~i~--~~~~~~p~~~-----~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                          ||..     .+-.++...++  +..+.+|+.+     ...+++.++.|+..||+-|+||+
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                3321     11122222222  2445566543     35588999999999999999984

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.3e-30  Score=242.81  Aligned_cols=212  Identities=39%  Similarity=0.664  Sum_probs=186.4

Q ss_pred             eeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCh
Q 010859           63 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  142 (499)
Q Consensus        63 LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L  142 (499)
                      ||+|++|.||++....+++.+++|++.......  ....+.+|...++.+.|++|+++++++......+++||++.|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999987653221  345677899999999999999999999999999999999999999


Q ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-CCCEEEEecCCccccCCccccccCCCCCCC
Q 010859          143 FDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDD  220 (499)
Q Consensus       143 ~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~  220 (499)
                      .+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........          
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----------  148 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----------  148 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence            9999876 46899999999999999999999999999999999999999 89999999999876543210          


Q ss_pred             CccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 010859          221 KACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  299 (499)
Q Consensus       221 ~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~l  299 (499)
                      ......+...|++||.+... ..+.++|+|+||+++++|                               ..+.+++.+|
T Consensus       149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~  197 (215)
T cd00180         149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKM  197 (215)
T ss_pred             hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHH
Confidence            12345678899999999887 788999999999999999                               6789999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHP  322 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hp  322 (499)
                      |+.||.+||++     +++++|+
T Consensus       198 l~~~p~~R~~~-----~~l~~~~  215 (215)
T cd00180         198 LQKDPEKRPSA-----KEILEHL  215 (215)
T ss_pred             hhCCcccCcCH-----HHHhhCC
Confidence            99999999988     7888775

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-31  Score=285.95  Aligned_cols=247  Identities=25%  Similarity=0.445  Sum_probs=206.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEc---C----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKI---D----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  125 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~---~----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~  125 (499)
                      .++..+.+.||+|+||.|++|.-.   .    ....||||.+......  .....+..|..+|+.+ .||||+.+.+.+.
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            344567789999999999999743   1    1457999988655433  4556678899999998 5999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC
Q 010859          126 DTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT  189 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~  189 (499)
                      ....+++|+|||..|+|..++.+.+                .++......++.||+.|++||++..++||||-..|||++
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence            9999999999999999999998765                388999999999999999999999999999999999999


Q ss_pred             CCCCEEEEecCCccccCCccccccCCCCCCCCcccccc--CccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCC
Q 010859          190 ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG--TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  266 (499)
Q Consensus       190 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~G--t~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~  266 (499)
                      .+..+||+|||+|+...........         .-.|  ...|||||.+....++.++||||+|++|||+++ |..||.
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~---------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTK---------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEec---------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            9999999999999865443322100         0112  234999999999999999999999999999999 999999


Q ss_pred             CCC-HHHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          267 DTS-EWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       267 ~~~-~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      +.. ....++.+..+ ....|...++++.++++.|+..+|++||+..
T Consensus       524 ~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~  570 (609)
T KOG0200|consen  524 GIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS  570 (609)
T ss_pred             CCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence            854 55556656554 3478889999999999999999999999983

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.3e-30  Score=247.08  Aligned_cols=214  Identities=40%  Similarity=0.683  Sum_probs=184.2

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+......  .....+..|...++.++|+|++++++.+......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999999999999998765433  2345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          137 CEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       137 ~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      +++++|.+++..... +++..+..++.+++.+|.+||++|++|+||+|.||+++.++.++|+|||.+.......      
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------  152 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------  152 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence            999999999988766 8999999999999999999999999999999999999999999999999988654321      


Q ss_pred             CCCCCCccccccCccCCCcccc-CCCCCCCCCcchhhhHHHHHHhcCCCCCCC-CCH-HHHHHHHHhcC
Q 010859          216 AASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSE-WLIFQRIIARD  281 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l-~~~~~~~~sDiwslG~ilyelltG~~Pf~~-~~~-~~~~~~i~~~~  281 (499)
                         ........++..|++||++ ....++.++|+|+||+++|+|++|+.||.. .+. ..+.+.|..+.
T Consensus       153 ---~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      153 ---AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             ---cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence               0122346788899999999 666788899999999999999999999977 343 45666666554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=261.72  Aligned_cols=242  Identities=22%  Similarity=0.336  Sum_probs=188.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh--CCCCCccEEEEEEEc----C
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQD----T  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~Iv~l~~~~~~----~  127 (499)
                      ..+..+.+.||+|.||+||+|..  .|+.||||++...    +  .....+|.++.+.  |+|+||+.++..-..    -
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr----d--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR----D--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hheeEEEEEecCccccceeeccc--cCCceEEEEeccc----c--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            45789999999999999999998  4789999998643    1  2335556665544  699999999866432    2


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeeecCCCCeeeCCCCCEEEEec
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------GLIHRDIKPENLLLTADGHIKIADF  199 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~--------gIiHrDlKp~NILl~~~~~vkL~DF  199 (499)
                      ..+++|.+|-+.|+|+|++.+ ..++.+....++..++.||+|||..        .|.|||||..|||+..+|.+-|+|+
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            359999999999999999998 4799999999999999999999953        3999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCC------CCCCcchhhhHHHHHHhcC----------CC
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA------TFGNDLWALGCTLYQMLSG----------TS  263 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~------~~~sDiwslG~ilyelltG----------~~  263 (499)
                      |+|-.......+      -+......|||-.|||||+|...-.      -..+||||||.+++|++..          ++
T Consensus       361 GLAv~h~~~t~~------idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  361 GLAVRHDSDTDT------IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             eeeEEecccCCc------ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            999765543211      1233446799999999999975431      2457999999999998762          57


Q ss_pred             CCCCC-----CHHHHHHHHH--hcCCCCCCCCC-----hHHHHHHHHhhccCCCCCCCC
Q 010859          264 PFKDT-----SEWLIFQRII--ARDIRFPNYFS-----DAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       264 Pf~~~-----~~~~~~~~i~--~~~~~~p~~~~-----~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ||.+.     +.+++..-+.  +..+.+|+.+.     ..+..|++.|+-.+|.-|+||
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence            88642     3333333222  23455666554     235688999999999999998

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=278.10  Aligned_cols=246  Identities=19%  Similarity=0.320  Sum_probs=206.7

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCc----eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ..+-.++||+|+||+||+|.....|+    +||||++.....  ......+..|..+|.+++|||+++|++++.... +-
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            34567899999999999999875554    578888765432  233455777999999999999999999998776 88


Q ss_pred             EEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||++|+++|.|.++++.+ +++-......|..||++|+.|||.++++||||-..|+|+..-.++||+|||+|+.+.....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999865 5688999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                      ....        ...--.+-|||-|.+....++.++||||+||++||++| |..|+.+..-.++-..+..+ .+..|+..
T Consensus       854 ey~~--------~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiC  925 (1177)
T KOG1025|consen  854 EYSA--------PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPIC  925 (1177)
T ss_pred             cccc--------cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCc
Confidence            2111        11112346888899999999999999999999999999 99999998877776555443 46778899


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGP  312 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~  312 (499)
                      +-++..++.+||-.|+..||++.+
T Consensus       926 tiDVy~~mvkCwmid~~~rp~fke  949 (1177)
T KOG1025|consen  926 TIDVYMVMVKCWMIDADSRPTFKE  949 (1177)
T ss_pred             cHHHHHHHHHHhccCcccCccHHH
Confidence            999999999999999999999865

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=246.37  Aligned_cols=236  Identities=22%  Similarity=0.379  Sum_probs=185.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEE-EEcCCeEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFT-FQDTFSLY  131 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~-~~~~~~l~  131 (499)
                      .+.|.+.+.||+|.||.+.+|+++.+++.+++|.+.+...    ....+.+|...--.| .|.||+.-|++ |+..+.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            4679999999999999999999999999999999877643    334455565543334 58999988764 78888999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC--CCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~--~~vkL~DFG~a~~~~~~~  209 (499)
                      +++|||+-|+|..-+...| +-|...+.++.|+++||+|||+.++||||||.+||||-..  .+|||||||..+..+..-
T Consensus        99 F~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             EeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            9999999999999888765 8899999999999999999999999999999999998533  479999999987533211


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCC-----CCCCCCcchhhhHHHHHHhcCCCCCCCCC----HHHHHHHHH-h
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----PATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQRII-A  279 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-----~~~~~sDiwslG~ilyelltG~~Pf~~~~----~~~~~~~i~-~  279 (499)
                                   ...--+..|.+||++...     ...+.+|+|.||+|+|.++||.+||+...    .+..+.+-. .
T Consensus       178 -------------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  178 -------------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR  244 (378)
T ss_pred             -------------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence                         011224568999986432     25678899999999999999999998432    222222222 2


Q ss_pred             cCCCCCC---CCChHHHHHHHHhhccCCCCC
Q 010859          280 RDIRFPN---YFSDAARDLIDRLLDVDPSGR  307 (499)
Q Consensus       280 ~~~~~p~---~~~~~~~~Li~~lL~~dP~~R  307 (499)
                      .....|.   .+++.+..+.++-|..+|++|
T Consensus       245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             cCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence            3334554   478999999999999999999

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=7.9e-31  Score=294.79  Aligned_cols=206  Identities=20%  Similarity=0.252  Sum_probs=150.4

Q ss_pred             hCCC-CCccEEEEEE-------EcCCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeec
Q 010859          111 QLDH-PGVVRLFFTF-------QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDI  181 (499)
Q Consensus       111 ~l~h-p~Iv~l~~~~-------~~~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDl  181 (499)
                      .+.| +||++++++|       .....++++||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3445 5777777777       2334688889988 55999999753 46999999999999999999999999999999


Q ss_pred             CCCCeeeCCCCCEEEEecCCccccCCcccc---c-------------------cCC---CCCCCCccccccCccCCCccc
Q 010859          182 KPENLLLTADGHIKIADFGSVKPMQDSRIT---V-------------------LPN---AASDDKACTFVGTAAYVPPEV  236 (499)
Q Consensus       182 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~-------------------~~~---~~~~~~~~~~~Gt~~Y~aPE~  236 (499)
                      ||+||||+..|.+|++|||++.........   .                   ...   ..........+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999977666666666555432211000   0                   000   000011223578999999999


Q ss_pred             cCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCChHHHHHHHHhhccCCCCCCCCCCC
Q 010859          237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---YFSDAARDLIDRLLDVDPSGRPGAGPG  313 (499)
Q Consensus       237 l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~Li~~lL~~dP~~R~~~~~~  313 (499)
                      +.+..++.++|||||||+||||++|.+||.....  .+..+....  +|.   .-.+...+++.+||++||.+||++   
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~---  259 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV--LPPQILLNWPKEASFCLWLLHPEPSCRPSM---  259 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh--cChhhhhcCHHHHHHHHHhCCCChhhCcCh---
Confidence            9999999999999999999999999998764322  222222111  121   124567899999999999999999   


Q ss_pred             CHHHHhcCCCCCC
Q 010859          314 GYAVLKMHPFFKG  326 (499)
Q Consensus       314 ~~~~l~~Hpff~~  326 (499)
                        .++++||||..
T Consensus       260 --~eil~h~~~~~  270 (793)
T PLN00181        260 --SELLQSEFINE  270 (793)
T ss_pred             --HHHhhchhhhh
Confidence              88999999975

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.96  E-value=4e-30  Score=276.17  Aligned_cols=245  Identities=36%  Similarity=0.561  Sum_probs=197.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ....||..++.|..|+||.||+++++.|.+.+|+| +++..+.        .  +.++.....|++|             
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--------l--Rnilt~a~npfvv-------------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------L--RNILTFAGNPFVV-------------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--------h--hccccccCCccee-------------
Confidence            44579999999999999999999999999999995 4433211        1  1144555666665             


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                              ||=...++..++++.+.        +.|++|||+.||+|||+||+|.+|+.-||+|++|||+++..-...-+
T Consensus       136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                    45555566666666554        88999999999999999999999999999999999999864322111


Q ss_pred             ccCC-----CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010859          212 VLPN-----AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  286 (499)
Q Consensus       212 ~~~~-----~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~  286 (499)
                      .+..     ....-.....||||.|.|||++....|+..+|+|++|+|+|+.+.|..||.+.+.++++...+.....+|+
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE  279 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  279 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence            1110     11112223469999999999999999999999999999999999999999999999999999998888886


Q ss_pred             C---CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          287 Y---FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       287 ~---~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                      .   ++++++++|.+||+.+|..|.+..  +.-++++|+||+.+||..|..|..+
T Consensus       280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~--ga~evk~h~ff~~LDw~~llRqkae  332 (1205)
T KOG0606|consen  280 EDEALPPEAQDLIEQLLRQNPLCRLGTG--GALEVKQHGFFQLLDWKSLLRQKAE  332 (1205)
T ss_pred             cCcCCCHHHHHHHHHHHHhChHhhcccc--hhhhhhhccceeecccchhhhhhcc
Confidence            4   789999999999999999999885  5688999999999999977665443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=9e-27  Score=230.23  Aligned_cols=257  Identities=38%  Similarity=0.598  Sum_probs=210.2

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCeEEEEEe
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP-GVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+.............+.+|..+++.+.|+ +|+++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999997   78999999877655544566778899999999988 79999999988888999999


Q ss_pred             ccCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEecCCccccCCcccc
Q 010859          136 SCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~  211 (499)
                      ++.+++|.+++....   .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.++.+......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999998777764   799999999999999999999999999999999999999988 7999999999855432211


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCC---CCCCCCCcchhhhHHHHHHhcCCCCCCCCCH----HHHHHHHHhcCCC-
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIR-  283 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~~~~sDiwslG~ilyelltG~~Pf~~~~~----~~~~~~i~~~~~~-  283 (499)
                      ...    .......+||..|+|||.+.+   ..++...|+||+|++++++++|..||.....    ......+...... 
T Consensus       159 ~~~----~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         159 SSI----PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             ccc----cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            000    013457799999999999987   5788899999999999999999999987763    4444555444433 


Q ss_pred             CCCCCC--------hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          284 FPNYFS--------DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       284 ~p~~~~--------~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      +.....        ..+.+++.+++..+|..|.++     .....+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~-----~~~~~~~~~~  279 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS-----SSDLSHDLLA  279 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCH-----HHHhhchHhh
Confidence            222222        478999999999999999988     4555555544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2e-29  Score=270.96  Aligned_cols=260  Identities=26%  Similarity=0.424  Sum_probs=206.4

Q ss_pred             eeeeEeeecCceEEEEEEEcCCCceEEEEEEeCc---ccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           58 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKK---FITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        58 ~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~---~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ....++|.|+||.|+.+......+.++.|.....   ..........+..|..+-..+.|||++.....+++....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4678899999999999998887777777765432   1222222222555666677889999988777776666666669


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |||++ +|+..+...+++...++..++.|++.||.|||+.||.||||||+|++++.+|.+||+|||.+..+.-..     
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~-----  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW-----  474 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc-----
Confidence            99999 999999998889999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCC-CCCcchhhhHHHHHHhcCCCCCCCCCHHHHH--HH-------HHhcCCCC
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPAT-FGNDLWALGCTLYQMLSGTSPFKDTSEWLIF--QR-------IIARDIRF  284 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~-~~sDiwslG~ilyelltG~~Pf~~~~~~~~~--~~-------i~~~~~~~  284 (499)
                       .........++|+..|+|||++.+..|. ...||||.|++++.|++|+.||.........  +.       +..+...+
T Consensus       475 -e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~  553 (601)
T KOG0590|consen  475 -EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL  553 (601)
T ss_pred             -chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence             1112345578999999999999998875 4579999999999999999999866543321  11       11111122


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      -..++...+.+|.+||+.||.+|.++     ++|++.+||+.|+-
T Consensus       554 ~~~lp~~~~~~~~~~l~~~P~~R~ti-----~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  554 LSLLPRETRIIIYRMLQLDPTKRITI-----EQILNDEWIRSIEC  593 (601)
T ss_pred             HHhchhhHHHHHHHHccCChhheecH-----HHHhhChHhhhcce
Confidence            23578899999999999999999998     89999999998764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.7e-28  Score=223.82  Aligned_cols=158  Identities=25%  Similarity=0.267  Sum_probs=129.8

Q ss_pred             CChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCC
Q 010859          140 GELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  218 (499)
Q Consensus       140 g~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~  218 (499)
                      |+|.+++... +.+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++.....          
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence            6899999874 45999999999999999999999998      999999999999999  9998764321          


Q ss_pred             CCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHhcCCCC-------CCCCCh
Q 010859          219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRF-------PNYFSD  290 (499)
Q Consensus       219 ~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~-------p~~~~~  290 (499)
                           ...||+.|||||++.+..++.++|||||||++|+|++|+.||...... .....+.......       +..++.
T Consensus        63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (176)
T smart00750       63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSA  137 (176)
T ss_pred             -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHh
Confidence                 126899999999999999999999999999999999999999765442 2333333221111       222334


Q ss_pred             --HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          291 --AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       291 --~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                        ++.++|.+||..||.+||++     .+++.|+|+.
T Consensus       138 ~~~~~~~i~~cl~~~p~~Rp~~-----~~ll~~~~~~  169 (176)
T smart00750      138 ARSFADFMRVCASRLPQRREAA-----NHYLAHCRAL  169 (176)
T ss_pred             hhhHHHHHHHHHhcccccccCH-----HHHHHHHHHH
Confidence              69999999999999999998     8899999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-27  Score=229.04  Aligned_cols=249  Identities=15%  Similarity=0.267  Sum_probs=204.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCC-----ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE-
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~-----~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~-  125 (499)
                      +...+++...++-+|.||.||.|..++..     +.|-+|.+...  ..+.....+..|..++..+.|||+.++.++.. 
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            34567899999999999999999776432     33445544221  12334455666888888899999999988764 


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEE
Q 010859          126 DTFSLYMALESCEGGELFDQITSK--------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  197 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~--------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~  197 (499)
                      +....++++.+..-|+|..++...        ..++..+...++.|+..|++|||.+||+|.||-..|++|++.-.+||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence            556678888998889999988721        247788889999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHH
Q 010859          198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  276 (499)
Q Consensus       198 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~  276 (499)
                      |=.+++.+-+.++..+.+.+.        ....|||||.+....|+.++|+||||+++|||+| |+.|+..-+++++..-
T Consensus       439 DsaLSRDLFP~DYhcLGDnEn--------RPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNEN--------RPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             cchhccccCcccccccCCCCC--------CcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            999999887776665443221        2357999999999999999999999999999999 9999999999888776


Q ss_pred             HHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          277 IIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       277 i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +..+ .+..|.++|+++..++..||..+|++||+.
T Consensus       511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf  545 (563)
T KOG1024|consen  511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSF  545 (563)
T ss_pred             HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCH
Confidence            6654 345688999999999999999999999988

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=7.9e-27  Score=236.27  Aligned_cols=187  Identities=19%  Similarity=0.199  Sum_probs=140.9

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcC-CCceEEEEEEeCccc--chhhHHHHHHHHHHHHHhCCCCCccE-EEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVVR-LFFTFQ  125 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-t~~~vAiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~-l~~~~~  125 (499)
                      .....++|.+.+.||+|+||+||+|++.. +++.+|||++.....  ........+.+|..+|+.++|+|++. ++..  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            44557889999999999999999999876 688889998754321  12334566889999999999999985 5432  


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeec-CCCCeeeCCCCCEEEEecCCccc
Q 010859          126 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI-KPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDl-Kp~NILl~~~~~vkL~DFG~a~~  204 (499)
                        ...|+||||++|++|.. +...   .   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus        91 --~~~~LVmE~~~G~~L~~-~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-ARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-hCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence              45899999999999963 2211   1   1567899999999999999999999 99999999999999999999997


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCCC------CCCCCcch
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLW  249 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~------~~~~sDiw  249 (499)
                      +......  ..........+.+|++.|+|||.+....      .+..+|-|
T Consensus       162 ~~~~~~~--~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        162 FRRRGAL--YRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             cccCcch--hhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            7543211  0000112224678999999999986433      23345666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4e-26  Score=230.35  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=194.2

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCC-ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC----CCccEEEEEE-EcCCe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTG-TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH----PGVVRLFFTF-QDTFS  129 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~-~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----p~Iv~l~~~~-~~~~~  129 (499)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|+.........   ..+..|..++..+..    +++..+++.+ ..+.+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999998775 6789998765422221   146668888888862    6899999999 58888


Q ss_pred             EEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-----CCEEEEecCCc
Q 010859          130 LYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-----GHIKIADFGSV  202 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-----~~vkL~DFG~a  202 (499)
                      -|+||+.+ |.+|.++....  +.|+..++..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||+|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 77999988554  579999999999999999999999999999999999999865     35999999999


Q ss_pred             c--ccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHH---HHH
Q 010859          203 K--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF---QRI  277 (499)
Q Consensus       203 ~--~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~---~~i  277 (499)
                      +  .+........  .........+.||..|+|+.+..+...+.+.|+||++.++.+++.|.+||.+.......   .+.
T Consensus       175 r~~~~~~~~~~~~--~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  175 RRFKYVGDSGGNL--RPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             ccccccCCCCccc--ccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            8  3322211100  00111124577999999999999999999999999999999999999999876543222   222


Q ss_pred             HhcCCC--CCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          278 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       278 ~~~~~~--~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ......  +....+.++.++...+-..+...+|..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy  287 (322)
T KOG1164|consen  253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDY  287 (322)
T ss_pred             hhhhccccccCCChHHHHHHHHHhhccCCcCCCCH
Confidence            222111  344567788888888888888999865

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=5.3e-26  Score=208.72  Aligned_cols=251  Identities=19%  Similarity=0.280  Sum_probs=202.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC-CCccEEEEEEEcCCe
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFS  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~l~~~~~~~~~  129 (499)
                      -+....|.+++.||.|+||.+|+|....+|+.||||+=....     ....+..|..+.+.|++ .+|..+..++.+..+
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            455689999999999999999999999999999999854432     22335557778888865 788888888888889


Q ss_pred             EEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC---CCEEEEecCCcccc
Q 010859          130 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPM  205 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~---~~vkL~DFG~a~~~  205 (499)
                      -.+||+.+ |.+|.++.+-. ..|+..++..++-|++.-++|+|.++++||||||+|+|..-+   ..+.|+|||+|+.+
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999998 67888877633 469999999999999999999999999999999999998654   35899999999987


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC---CHHHHHHHHHhcCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARDI  282 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~---~~~~~~~~i~~~~~  282 (499)
                      .......   .-.-.......||+.|.|--.+.+...+..-|+-|+|.+|..+..|.+||++.   +..+-+++|.+...
T Consensus       165 ~d~~t~~---HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~  241 (341)
T KOG1163|consen  165 RDIRTRQ---HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM  241 (341)
T ss_pred             ccccccc---cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence            5432111   00113345678999999988888888889999999999999999999999875   44555677777666


Q ss_pred             CCC-----CCCChHHHHHHHHhhccCCCCCCCC
Q 010859          283 RFP-----NYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       283 ~~p-----~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..|     .++|.++.-.+.-|-..--++-|.-
T Consensus       242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            655     5789999999998887766666643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=8.6e-25  Score=209.07  Aligned_cols=243  Identities=21%  Similarity=0.311  Sum_probs=188.3

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      -.|.+++.||+|+||+++.|++.-++++||||.=..+.     ..-.+..|....+.| ..++|..+|.+-+...+=.+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            46999999999999999999999999999999754332     223356677666766 569999999988888888999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-----CEEEEecCCccccCC
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-----HIKIADFGSVKPMQD  207 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-----~vkL~DFG~a~~~~~  207 (499)
                      ||++ |.+|.++..=. .+|+...+..++.|++.-++|+|++.+|.|||||+|+||...+     .|.|+|||+|+.+..
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9998 66888877644 3599999999999999999999999999999999999997544     589999999998765


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC---CCHHHHHHHHHhcCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDIRF  284 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~---~~~~~~~~~i~~~~~~~  284 (499)
                      .....   .-.-....+..||+.||+--...|...+..-|+-|||-++++.|.|.+||.+   .+..+-+++|-...-.-
T Consensus       182 p~Tkq---HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  182 PKTKQ---HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             ccccc---cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            43110   0011334567899999999999999999999999999999999999999986   45566677765433222


Q ss_pred             -----CCCCChHHHHHHHHhhccCCCC
Q 010859          285 -----PNYFSDAARDLIDRLLDVDPSG  306 (499)
Q Consensus       285 -----p~~~~~~~~~Li~~lL~~dP~~  306 (499)
                           -.++|.++..-++-.-..+-.+
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E  285 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFE  285 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCccc
Confidence                 2345555554444433333333

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=2.6e-24  Score=200.26  Aligned_cols=142  Identities=20%  Similarity=0.228  Sum_probs=112.4

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhh-----------------------HHHHHHHHHHHHHhCCCCC
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-----------------------KTAYVKLERIVLDQLDHPG  116 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~hp~  116 (499)
                      ...||+|+||.||+|.+. +|+.||||++.........                       .......|..++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999765322111                       0123345888999998777


Q ss_pred             ccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCcEeeecCCCCeeeCCCCCEE
Q 010859          117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIK  195 (499)
Q Consensus       117 Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~L-H~~gIiHrDlKp~NILl~~~~~vk  195 (499)
                      +...+......  .++||||++|++|...+.+.+.+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            64333222222  389999999988776655557899999999999999999999 799999999999999998 57899


Q ss_pred             EEecCCcccc
Q 010859          196 IADFGSVKPM  205 (499)
Q Consensus       196 L~DFG~a~~~  205 (499)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=5.5e-24  Score=201.28  Aligned_cols=175  Identities=20%  Similarity=0.216  Sum_probs=136.8

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHH------HHHHHHHHHhCCCCCccEEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY------VKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~------~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      +..++|++.++||.|+||.||++.+  ++..+|+|++.......+.....      ..+|...+.++.||+|..+..++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            4457899999999999999999755  47789999997765555544333      577888999999999999988876


Q ss_pred             cC--------CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEE
Q 010859          126 DT--------FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  197 (499)
Q Consensus       126 ~~--------~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~  197 (499)
                      +.        ...+++|||++|.+|.+..    .+++    ....+++.+|..||+.|++|||+||+||+++.+| ++|+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence            43        3589999999999997763    2333    3466999999999999999999999999999998 9999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHh
Q 010859          198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML  259 (499)
Q Consensus       198 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyell  259 (499)
                      |||.........            +.          ..++....+..++|+||||+++..+.
T Consensus       177 Dfg~~~~~~e~~------------a~----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRK------------AK----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchh------------hH----------HHHHHHhHhcccccccceeEeehHHH
Confidence            999876542211            00          01334445667899999999887654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=5.1e-24  Score=207.33  Aligned_cols=234  Identities=27%  Similarity=0.415  Sum_probs=151.7

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC----------CCCccEEEEE--
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD----------HPGVVRLFFT--  123 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------hp~Iv~l~~~--  123 (499)
                      ....+..||.|+++.||.+++.+||+.+|+|+............+.+++|......+.          |-.++--++.  
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            5678999999999999999999999999999987665444455566665554333322          1112211121  


Q ss_pred             -------EEc---CC-----eEEEEEeccCCCChHHHHhh---cCCC---CHHHH-HHHHHHHHHHHHHHHHCCcEeeec
Q 010859          124 -------FQD---TF-----SLYMALESCEGGELFDQITS---KGHL---SEDEA-RFYTAEVVDALEYIHSMGLIHRDI  181 (499)
Q Consensus       124 -------~~~---~~-----~l~lv~E~~~gg~L~~~i~~---~~~l---~e~~~-~~i~~qil~aL~~LH~~gIiHrDl  181 (499)
                             ++.   ..     +.+++|+-+. ++|.+++..   ....   ....+ ..+..|++..+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                   111   11     2477888875 588777542   2222   12233 345589999999999999999999


Q ss_pred             CCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCC--------CCCCCCCcchhhhH
Q 010859          182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--------SPATFGNDLWALGC  253 (499)
Q Consensus       182 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--------~~~~~~sDiwslG~  253 (499)
                      +|+|++++.+|.++|+||+.....+..             ......+..|.+||....        ..++.+.|.|+||+
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~-------------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTR-------------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEE-------------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCce-------------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence            999999999999999999987643321             111234577999998643        24688899999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCC
Q 010859          254 TLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGR  307 (499)
Q Consensus       254 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R  307 (499)
                      +||.|+||+.||..........    ..+..-..+|..+++||..||+.||.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~----~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPE----WDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSG----GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCcccccc----ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999999999998654321111    0233333789999999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=2.1e-23  Score=194.40  Aligned_cols=144  Identities=21%  Similarity=0.201  Sum_probs=114.7

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh-----------------------hHHHHHHHHHHHHHhCCCC
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------------------NKTAYVKLERIVLDQLDHP  115 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~hp  115 (499)
                      +.+.||+|+||.||+|.+. +|+.||||++........                       ........|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999999987532110                       0122345788889999999


Q ss_pred             CccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCE
Q 010859          116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHI  194 (499)
Q Consensus       116 ~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~v  194 (499)
                      +|.....+....  .|+||||++|+++.........+++..+..++.|++.+|.+||+ +||+||||||+|||++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            875444333332  48999999988665543345678999999999999999999999 9999999999999998 8999


Q ss_pred             EEEecCCccccC
Q 010859          195 KIADFGSVKPMQ  206 (499)
Q Consensus       195 kL~DFG~a~~~~  206 (499)
                      +|+|||+|..+.
T Consensus       157 ~liDFG~a~~~~  168 (190)
T cd05145         157 YIIDVSQAVELD  168 (190)
T ss_pred             EEEEcccceecC
Confidence            999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7e-24  Score=206.98  Aligned_cols=267  Identities=25%  Similarity=0.417  Sum_probs=184.6

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCc-----------------------------------eEEEEEEeCcccc
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----------------------------------VYALKIMDKKFIT   94 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~-----------------------------------~vAiK~~~~~~~~   94 (499)
                      .++.++||+|+..||+|+-..||.|....+|.                                   +.|||.|-.-...
T Consensus       152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~  231 (598)
T KOG4158|consen  152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD  231 (598)
T ss_pred             cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence            57889999999999999999999997654221                                   2345543211111


Q ss_pred             h--hhHHHHHHHHH------HH--------HHh--------CCCCCccEEEEEEEcC-----------------------
Q 010859           95 K--ENKTAYVKLER------IV--------LDQ--------LDHPGVVRLFFTFQDT-----------------------  127 (499)
Q Consensus        95 ~--~~~~~~~~~E~------~~--------l~~--------l~hp~Iv~l~~~~~~~-----------------------  127 (499)
                      .  ........+|.      ..        .+.        -.|||||+++..|.++                       
T Consensus       232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g  311 (598)
T KOG4158|consen  232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG  311 (598)
T ss_pred             CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence            0  00111111110      00        011        2699999998776432                       


Q ss_pred             ----CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC--CCC--CEEEEec
Q 010859          128 ----FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT--ADG--HIKIADF  199 (499)
Q Consensus       128 ----~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~--~~~--~vkL~DF  199 (499)
                          ..+|+||...+. +|..++..+ ..+....+-+++|+++|+.|||++||.|||+|.+|||+.  +|+  .+.|+||
T Consensus       312 ~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  312 AGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             cCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence                358999998876 999998875 478888899999999999999999999999999999984  343  5899999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCC------CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHH
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI  273 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~------~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~  273 (499)
                      |++-.-.........    ....-...|...-||||+....+      .-.++|.|+.|.+.||++...-||....+..+
T Consensus       390 GCcLAd~~hGlqlpy----~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L  465 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPY----ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL  465 (598)
T ss_pred             ceeeecccccccccc----ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee
Confidence            998543332221111    11222446888999999986433      23578999999999999999999987544321


Q ss_pred             HHH-H-HhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          274 FQR-I-IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       274 ~~~-i-~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      -.+ - ...-+.+|+.+++.+++|+..+|+.||++|+++.-  .+.+++--.+
T Consensus       466 ~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i--AANvl~LsLw  516 (598)
T KOG4158|consen  466 DTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI--AANVLNLSLW  516 (598)
T ss_pred             chhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH--HHhHHHHHHh
Confidence            111 1 12334578899999999999999999999999842  2444443333

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.3e-23  Score=226.48  Aligned_cols=233  Identities=24%  Similarity=0.400  Sum_probs=177.7

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcc--cchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +|...+.||++.|=.|.+|++.+ | .|+||++-+..  +.-......+. |+. ...+++||.+++..+...+...|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHH-HHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            78999999999999999999865 4 49999987654  22222233333 333 5667999999998887788889999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      -+|... +|+|.+..+..+.+-+.+.|+.||+.||..+|..||+|||||.|||||+.=..+.|+||..-+..-      +
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY------L  172 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY------L  172 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc------C
Confidence            999977 999999988888999999999999999999999999999999999999999999999998765321      1


Q ss_pred             CCCCCCCCcccc----ccCccCCCccccCCC----------C-CCCCCcchhhhHHHHHHhc-CCCCCCCC---------
Q 010859          214 PNAASDDKACTF----VGTAAYVPPEVLNSS----------P-ATFGNDLWALGCTLYQMLS-GTSPFKDT---------  268 (499)
Q Consensus       214 ~~~~~~~~~~~~----~Gt~~Y~aPE~l~~~----------~-~~~~sDiwslG~ilyellt-G~~Pf~~~---------  268 (499)
                      +.+ .+....-|    .--..|.|||.+...          + .+++-||||+||+++||++ |++||.-.         
T Consensus       173 PeD-NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~  251 (1431)
T KOG1240|consen  173 PED-NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN  251 (1431)
T ss_pred             CCC-CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC
Confidence            111 11111111    122369999987431          1 4567799999999999998 89999521         


Q ss_pred             --CHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          269 --SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       269 --~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                        +....+++|          -+..++.||..|++.||.+|++|
T Consensus       252 ~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSA  285 (1431)
T KOG1240|consen  252 ADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSA  285 (1431)
T ss_pred             ccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCH
Confidence              111122221          23478999999999999999999

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3.4e-22  Score=185.39  Aligned_cols=201  Identities=14%  Similarity=0.147  Sum_probs=142.8

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhh-HHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +.+...|++|+||+||++..  .+.+++.+.+......... ....+.+|..+|++|. |++|.+++++    ...|++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34678999999999998876  6778887766544332111 1225778999999995 5889999886    3579999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeec-CCCCeeeCCCCCEEEEecCCccccCCcccc--
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI-KPENLLLTADGHIKIADFGSVKPMQDSRIT--  211 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDl-Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~--  211 (499)
                      ||+.|.+|.+.+..      . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|........-  
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999888654321      1 2357889999999999999999999 799999999999999999999854432100  


Q ss_pred             ccC-CCCCCCCccccccCccCCCccccCC--CCCCCCCcchhhhHHHHHHhcCCCCCCCCCH
Q 010859          212 VLP-NAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSE  270 (499)
Q Consensus       212 ~~~-~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDiwslG~ilyelltG~~Pf~~~~~  270 (499)
                      .+. .+-..-...-...++.|++|+...-  ...-...++++.|+-+|.++|+..|+-+.++
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            000 0000000011235788888886432  2222456888999999999999999866543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.87  E-value=7.9e-23  Score=220.41  Aligned_cols=288  Identities=32%  Similarity=0.471  Sum_probs=235.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ..+.+++.+.+-+-+|++|.++.+.-..+|..+++|+..+.-....+.......+..++-...+|.++..+..|.-...+
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            45678999999999999999999999999988888876554333332233333344444444568888777777777789


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +++++|+.|++|...+...+..+++-++.++..+..++++||...+.|||++|.|+|+..+|+.+++|||+......-..
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999995543321100


Q ss_pred             c-------------ccC------CC--CCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC
Q 010859          211 T-------------VLP------NA--ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  269 (499)
Q Consensus       211 ~-------------~~~------~~--~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~  269 (499)
                      .             ...      ..  .........+||+.|.+||.+.+...+..+|+|++|+++++.++|.+||....
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence            0             000      00  01123456789999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhcCCCCCC---CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCCC
Q 010859          270 EWLIFQRIIARDIRFPN---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL  340 (499)
Q Consensus       270 ~~~~~~~i~~~~~~~p~---~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p~~  340 (499)
                      ....++.|..+....|.   ..+.++++++.++|..+|.+|.++.  +..++..||||++++|+++..+..+..
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~--~~~e~k~~~~~~~~~~~~l~~q~~~~~ 1111 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK--GAAEVKGHPFFQDVDWENLALQKAEFV 1111 (1205)
T ss_pred             hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc--cccccccCCccCCCCccccccccCccC
Confidence            99999999998887765   4799999999999999999999984  446899999999999999988765543

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=2.5e-21  Score=182.28  Aligned_cols=135  Identities=16%  Similarity=0.157  Sum_probs=108.4

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-----CCCCccEEEEEEEcCC---eE
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-----DHPGVVRLFFTFQDTF---SL  130 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~l~~~~~~~~---~l  130 (499)
                      -.+.||+|+||.||.  ++.++.. +||++.....   .....+.+|+.+++.+     .||||+++|++++++.   .+
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            356899999999995  7777666 6998866422   2345678899999999     6799999999999874   44


Q ss_pred             E-EEEec--cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHH-HHHHHCCcEeeecCCCCeeeCCC----CCEEEEecCCc
Q 010859          131 Y-MALES--CEGGELFDQITSKGHLSEDEARFYTAEVVDAL-EYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSV  202 (499)
Q Consensus       131 ~-lv~E~--~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL-~~LH~~gIiHrDlKp~NILl~~~----~~vkL~DFG~a  202 (499)
                      + +||||  +.+|+|.+++.+. .+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+.+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            4 78999  5579999999764 56666  36688888888 99999999999999999999743    37999995544

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.86  E-value=4.3e-23  Score=209.28  Aligned_cols=170  Identities=29%  Similarity=0.443  Sum_probs=132.7

Q ss_pred             eEEEEEeccCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          129 SLYMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      ++|+.|++|...+|.+++.+..   ..+......++.|+..|++|   +|.+|||+||.||+...++.+||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            4799999999999999997553   35677889999999999999   99999999999999999999999999998765


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH-HHHHHHhcCCCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDIRF  284 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~  284 (499)
                      ....    ........+...+||..||+||.+.+..|+.++||||||+||||++.   +|....+.. .+..+..+  .+
T Consensus       407 ~~~~----~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g--~i  477 (516)
T KOG1033|consen  407 DKDE----TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDG--II  477 (516)
T ss_pred             ccCC----cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcC--CC
Confidence            4332    11122345667899999999999999999999999999999999997   333322211 22223333  33


Q ss_pred             CCC---CChHHHHHHHHhhccCCCCCCCC
Q 010859          285 PNY---FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       285 p~~---~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |+.   -.++-.+|+.+||.+.|.+||++
T Consensus       478 p~~~~~d~p~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  478 PPEFLQDYPEEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             ChHHhhcCcHHHHHHHHhcCCCcccCchH
Confidence            321   13456799999999999999966

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=1.6e-21  Score=214.13  Aligned_cols=227  Identities=26%  Similarity=0.377  Sum_probs=172.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDTFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~Iv~l~~~~~~~~~  129 (499)
                      .-..|.|-+.||+|+||.||.|...+ |+.||+|+=.....+.-      ..-.+++.+|+   -+.|..+...+.-.+.
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf------YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF------YICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee------eehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            34679999999999999999999987 99999998654433321      12233455555   3456666666666667


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-------CCCEEEEecCCc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-------DGHIKIADFGSV  202 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-------~~~vkL~DFG~a  202 (499)
                      -++|+||.+.|+|.++++..+.+++..+.+++.|++..+++||..||||+||||+|+||..       .--++|+|||.+
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            8899999999999999998888999999999999999999999999999999999999953       235999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCC-CCCCHHHHHHHHHhcC
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARD  281 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf-~~~~~~~~~~~i~~~~  281 (499)
                      ..+..-     ++   .......++|-.+-.+|++.|.+++..+|.|.|+.+++-||.|+.-= .+..-+.       ..
T Consensus       849 iDm~lf-----p~---~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~-------~~  913 (974)
T KOG1166|consen  849 IDMKLF-----PD---GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWM-------VK  913 (974)
T ss_pred             eeeeEc-----CC---CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCccee-------cc
Confidence            765321     11   23445678899999999999999999999999999999999987431 1100000       01


Q ss_pred             CCCCCCCChH-HHHHHHHhhc
Q 010859          282 IRFPNYFSDA-ARDLIDRLLD  301 (499)
Q Consensus       282 ~~~p~~~~~~-~~~Li~~lL~  301 (499)
                      ..+|..+..+ .-+|+..||.
T Consensus       914 ~~~~Ry~~~~~W~~~F~~lLN  934 (974)
T KOG1166|consen  914 TNFPRYWKRDMWNKFFDLLLN  934 (974)
T ss_pred             ccchhhhhHHHHHHHHHHHhC
Confidence            1134444333 4578888887

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=9e-21  Score=182.49  Aligned_cols=145  Identities=19%  Similarity=0.172  Sum_probs=115.6

Q ss_pred             CeeeeeEeeecCceEEEEEE-EcCCCceEEEEEEeCcccch---------------------hhHHHHHHHHHHHHHhCC
Q 010859           56 DFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITK---------------------ENKTAYVKLERIVLDQLD  113 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~-~~~t~~~vAiK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~  113 (499)
                      .|.+.+.||+|+||.||+|. +..+|+.||+|++.......                     ......+..|..++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 67789999999997543210                     001123567999999987


Q ss_pred             CC--CccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeeecCCCCeeeCC
Q 010859          114 HP--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG-LIHRDIKPENLLLTA  190 (499)
Q Consensus       114 hp--~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~g-IiHrDlKp~NILl~~  190 (499)
                      +.  .+.+++..    ...|+||||++|++|.........+....+..++.||+.+|.+||++| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            53  33444442    235899999999888776545556777788999999999999999999 99999999999999 


Q ss_pred             CCCEEEEecCCcccc
Q 010859          191 DGHIKIADFGSVKPM  205 (499)
Q Consensus       191 ~~~vkL~DFG~a~~~  205 (499)
                      ++.++|+|||.|...
T Consensus       184 ~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CCCEEEEEChhhhcc
Confidence            889999999998743

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.8e-21  Score=209.56  Aligned_cols=260  Identities=27%  Similarity=0.398  Sum_probs=208.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEc-CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~-~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...|.+.+.||+|+|+.|-++... .+...+|+|.+.... ........+..|..+-+.+. |+|++.+++...+....+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            457888889999999999999874 445567777665443 22233344455666666776 999999999999999999


Q ss_pred             EEEeccCCCChHHHH-hhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCcEeeecCCCCeeeCCCC-CEEEEecCCccccCC
Q 010859          132 MALESCEGGELFDQI-TSKG-HLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQD  207 (499)
Q Consensus       132 lv~E~~~gg~L~~~i-~~~~-~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~  207 (499)
                      ++++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++.++ .++++|||+|..+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999998 5554 6888999999999999999999 99999999999999999999 999999999987654


Q ss_pred             ccccccCCCCCCCCcccccc-CccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHH-HHHHhc----
Q 010859          208 SRITVLPNAASDDKACTFVG-TAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF-QRIIAR----  280 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~G-t~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~-~~i~~~----  280 (499)
                      ..       .........+| ++.|+|||.+.+. ......|+||+|+++..+++|..|+......... ......    
T Consensus       178 ~~-------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (601)
T KOG0590|consen  178 KN-------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF  250 (601)
T ss_pred             cC-------CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence            11       12333445678 9999999999884 4577889999999999999999999765443211 111111    


Q ss_pred             CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .......++..+.+++.++|..+|..|.+.     +++..+||+..
T Consensus       251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~-----~~~~~d~~~~~  291 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHKILKENPSNRLSI-----EELKLDNWLSS  291 (601)
T ss_pred             ccCccccCChhhhhcccccccCCchhcccc-----ccccccccccc
Confidence            233456788999999999999999999998     77999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=4.8e-19  Score=167.46  Aligned_cols=137  Identities=24%  Similarity=0.309  Sum_probs=114.2

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh-----hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +.||+|++|.||+|..  +|..+++|+.........     .......+|..++..+.|++|.....++.+....+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  678899998654322211     123446678889999999988777666777778899999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      |++|++|.+.+.....    ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998876432    8889999999999999999999999999999999 78999999999864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.4e-19  Score=169.15  Aligned_cols=239  Identities=17%  Similarity=0.275  Sum_probs=189.7

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +...+..++-.|.+.-.|+.|+++.  .|..+++|++.......... ..+..|.-.|+-+.||||+.+++.+...-++.
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~ris-rdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARIS-RDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhc-chhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            4455667788899999999999998  45678888886654443332 33555777788889999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCCCCCEEE--EecCCcccc
Q 010859          132 MALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKI--ADFGSVKPM  205 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~~~~vkL--~DFG~a~~~  205 (499)
                      ++..|++-|+|+.++.....  .+..++..++.+++.|+.|||+..  |----|....++|+++.+.+|  +|--++...
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe  343 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE  343 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence            99999999999999987643  678899999999999999999985  334457888999999876554  343332210


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCC---CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH--hc
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--AR  280 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~---~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~--~~  280 (499)
                                       ....-.|.|||||.+..++.   -.++|+|||+++|+||.|...||..-++.+.--+|-  ..
T Consensus       344 -----------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl  406 (448)
T KOG0195|consen  344 -----------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL  406 (448)
T ss_pred             -----------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc
Confidence                             01234689999999987764   357899999999999999999999888766544443  34


Q ss_pred             CCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       281 ~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ...+|++++.....|+.-|+..||.+||..
T Consensus       407 rv~ippgis~hm~klm~icmnedpgkrpkf  436 (448)
T KOG0195|consen  407 RVHIPPGISRHMNKLMNICMNEDPGKRPKF  436 (448)
T ss_pred             cccCCCCccHHHHHHHHHHhcCCCCcCCCc
Confidence            567899999999999999999999999976

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1e-18  Score=163.96  Aligned_cols=140  Identities=23%  Similarity=0.219  Sum_probs=109.0

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh-------------------hHHHHHHHHHHHHHhCCCCC-
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-------------------NKTAYVKLERIVLDQLDHPG-  116 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~hp~-  116 (499)
                      |.+.+.||+|+||.||+|... +|+.||||++........                   ........|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999875 799999999875431100                   01123456788888887764 


Q ss_pred             -ccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEE
Q 010859          117 -VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  195 (499)
Q Consensus       117 -Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vk  195 (499)
                       +...+.    ....++||||++|++|......      .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2356899999999998765321      45677889999999999999999999999999999999999


Q ss_pred             EEecCCccccCC
Q 010859          196 IADFGSVKPMQD  207 (499)
Q Consensus       196 L~DFG~a~~~~~  207 (499)
                      |+|||.+.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1.4e-18  Score=162.78  Aligned_cols=133  Identities=20%  Similarity=0.213  Sum_probs=106.8

Q ss_pred             EeeecCceEEEEEEEcCCCceEEEEEEeCcccch-----hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010859           62 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        62 ~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      .||+|+||.||+|..  +|..+++|+........     ......+.+|..+++.+.|+++.....++.+....++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  67899999865432211     12235567799999999888765444444566667999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       137 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      ++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|+||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988765321       8899999999999999999999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=1.9e-18  Score=160.13  Aligned_cols=140  Identities=20%  Similarity=0.265  Sum_probs=100.9

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHH---------------------HHHHHHHHHhCCCCC-
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---------------------VKLERIVLDQLDHPG-  116 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~hp~-  116 (499)
                      +++.||+|+||+||+|.+. +|+.||||++.............                     ...|...+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999986 79999999987643222211111                     134555555554332 


Q ss_pred             -ccEEEEEEEcCCeEEEEEeccCCCChHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCC
Q 010859          117 -VVRLFFTFQDTFSLYMALESCEGGELFDQ-ITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGH  193 (499)
Q Consensus       117 -Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~-i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~  193 (499)
                       +.+.+.+    ...++||||++|+.+... +... .. ...++.++.+++.++.++|. +||+||||||+||+++ ++.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence             4444443    235899999998554321 1111 11 16788999999999999999 9999999999999999 899


Q ss_pred             EEEEecCCccccC
Q 010859          194 IKIADFGSVKPMQ  206 (499)
Q Consensus       194 vkL~DFG~a~~~~  206 (499)
                      ++|+|||.+....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=6.4e-18  Score=181.99  Aligned_cols=139  Identities=18%  Similarity=0.223  Sum_probs=112.4

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc-----hhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..|...+.||+|+||+||++....  ..+++|+.......     .......+.+|..+++.++|++++..+.+..+...
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345678999999999999998743  44555543322111     11223456789999999999999988777777777


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      .++||||++|++|.+++.        ....++.|++.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999998875        357789999999999999999999999999999 678999999999874

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.2e-16  Score=154.09  Aligned_cols=137  Identities=20%  Similarity=0.245  Sum_probs=104.1

Q ss_pred             eEee-ecCceEEEEEEEcCCCceEEEEEEeCccc-----c-----hhhHHHHHHHHHHHHHhCCCCCc--cEEEEEEEc-
Q 010859           61 KIYG-VGSYSKVVRAKKIDTGTVYALKIMDKKFI-----T-----KENKTAYVKLERIVLDQLDHPGV--VRLFFTFQD-  126 (499)
Q Consensus        61 ~~LG-~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~-----~-----~~~~~~~~~~E~~~l~~l~hp~I--v~l~~~~~~-  126 (499)
                      .+|| .|+.|+||.+...  +..++||.+....+     .     .......+.+|..++..|.|++|  +..+.+... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 7888888888763  78899998865321     1     11233456779999999988775  566655432 


Q ss_pred             CCe---EEEEEeccCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          127 TFS---LYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       127 ~~~---l~lv~E~~~g-g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      ...   .++|||+++| .+|.+++.. +.+++..    +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence            222   3599999997 688888765 4566553    578999999999999999999999999999999999999998


Q ss_pred             cc
Q 010859          203 KP  204 (499)
Q Consensus       203 ~~  204 (499)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            64

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=1.2e-16  Score=141.21  Aligned_cols=132  Identities=23%  Similarity=0.232  Sum_probs=111.8

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCeEEEEEec
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTFSLYMALES  136 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~Iv~l~~~~~~~~~l~lv~E~  136 (499)
                      +++.||+|.++.||++....  ..+++|.......     ...+..|..+++.+.|  .++.+++.++...+..|++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46789999999999999844  7899998765432     3456778888888876  5899999988888889999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---GLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       137 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~---gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      ++|+.+..+       +......++.+++.+|.+||..   +++|+|++|+||+++..+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            998777554       5567788899999999999985   799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.68  E-value=2e-16  Score=163.69  Aligned_cols=196  Identities=21%  Similarity=0.343  Sum_probs=153.8

Q ss_pred             HHhCCCCCccEEEEEEEcCCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCc-EeeecCCCCe
Q 010859          109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGL-IHRDIKPENL  186 (499)
Q Consensus       109 l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gI-iHrDlKp~NI  186 (499)
                      |+.+.|.|+.++++...+...++.|.+||..|+|.+.+... -.++.--...++.+|+.||.|||.-.| .|+.+++.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            35678999999999999999999999999999999999874 457777778889999999999998766 9999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCC-------CCCCCcchhhhHHHHHHh
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-------ATFGNDLWALGCTLYQML  259 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-------~~~~sDiwslG~ilyell  259 (499)
                      +++....+||+|||+........        .........-...|.|||++.+..       .+.+.|+||+|++++|++
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~--------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETA--------EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeeeEEEEechhhhcccccccc--------cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            99999999999999987654300        001111122345799999997642       356789999999999999


Q ss_pred             cCCCCCCCC----CHHHHHHHHHh-cCCCC-CC-----CCChHHHHHHHHhhccCCCCCCCCCC
Q 010859          260 SGTSPFKDT----SEWLIFQRIIA-RDIRF-PN-----YFSDAARDLIDRLLDVDPSGRPGAGP  312 (499)
Q Consensus       260 tG~~Pf~~~----~~~~~~~~i~~-~~~~~-p~-----~~~~~~~~Li~~lL~~dP~~R~~~~~  312 (499)
                      +...||...    ...++...+.. +...+ |.     .+++++..+++.|+..+|.+||++..
T Consensus       153 ~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~  216 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQ  216 (484)
T ss_pred             hccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHH
Confidence            999999763    22345555555 22111 21     34567999999999999999999854

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=4.3e-17  Score=168.73  Aligned_cols=264  Identities=23%  Similarity=0.310  Sum_probs=204.9

Q ss_pred             CCCCCeeeeeEeee--cCceEEEEEEE--cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 010859           52 FSIQDFELGKIYGV--GSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~--G~~g~Vy~a~~--~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~  126 (499)
                      +....|.+.+.+|.  |.+|.||.+..  ..++..+|+|.-.... ........-.+|....+.+ .|++.++.+..+..
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCccccc
Confidence            33456889999999  99999999999  8999999999743322 2112222223355555555 59999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCcEeeecCCCCeeeCCC-CCEEEEecC
Q 010859          127 TFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVD----ALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFG  200 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~----aL~~LH~~gIiHrDlKp~NILl~~~-~~vkL~DFG  200 (499)
                      .+.+|+-+|+|. .+|..+...... +++..++.++.+...    ||.++|+.+|+|-|+||.||++..+ ...+++|||
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence            999999999995 699998887655 899999999999999    9999999999999999999999999 889999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC--CHHHHHHHHH
Q 010859          201 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT--SEWLIFQRII  278 (499)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~--~~~~~~~~i~  278 (499)
                      +...+....+....     .....-.|...|++||.+++ -++.+.|+++||-++.+..+|..++...  +.|..+....
T Consensus       269 ~v~~i~~~~~~~~~-----~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  269 LVSKISDGNFSSVF-----KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             eeEEccCCccccce-----eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            99887665422111     11122257788999999876 4677899999999999999988887655  4444443332


Q ss_pred             hcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          279 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       279 ~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                       ...++-...+.++...+..|++.+|..|+++     +.+++|++.....+
T Consensus       343 -ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~-----q~~~~l~~i~s~~~  387 (524)
T KOG0601|consen  343 -IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTA-----QILTALNVIHSKLF  387 (524)
T ss_pred             -CchhhhcCcchhhhhHHHHhcCcchhhhhHH-----HHHhccccccchhh
Confidence             2233444567778889999999999999998     88999999885443

>cd01251 PH_centaurin_alpha Centaurin alpha Pleckstrin homology (PH) domain

Probab=99.66  E-value=1.8e-16  Score=132.05  Aligned_cols=89  Identities=18%  Similarity=0.330  Sum_probs=72.0

Q ss_pred             EEEeeehhhhh-h--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEE-------E-cCCCcEEEEcCCceEE
Q 010859          410 MISMVKKLQKL-T--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ-------V-SSPSHFKIVTPKKVLS  478 (499)
Q Consensus       410 ~~g~~~k~~g~-~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~-------~-~~~~~f~i~~p~r~y~  478 (499)
                      |+||+.|++|. .  ||+|||+|++....||.++.....+|+|+|+.......|.       . +....|.|+||+|||+
T Consensus         1 KeG~L~K~g~~~~k~wkkRwFvL~~~~L~Yyk~~~d~~~~G~I~L~~~~~~~~v~~~~~~~~~~~~~~~F~i~t~~Rty~   80 (103)
T cd01251           1 KEGFMEKTGPKHTEGFKKRWFTLDDRRLMYFKDPLDAFAKGEVFLGSQEDGYEVREGLPPGTQGNHWYGVTLVTPERKFL   80 (103)
T ss_pred             CceeEEecCCCCCCCceeEEEEEeCCEEEEECCCCCcCcCcEEEeeccccceeEeccCCccccccccceEEEEeCCeEEE
Confidence            57999999974 2  9999999998888899998888999999998652212231       1 2224899999999999


Q ss_pred             EE-cCCccHHHHHHHHHHhcC
Q 010859          479 FE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       479 ~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      |. +.+.++++|+++|+.|++
T Consensus        81 l~a~s~~e~~~Wi~ai~~v~~  101 (103)
T cd01251          81 FACETEQDRREWIAAFQNVLS  101 (103)
T ss_pred             EECCCHHHHHHHHHHHHHHhc
Confidence            99 566999999999999874

Centaurin alpha Pleckstrin homology (PH) domain. Centaurin alpha is a phophatidlyinositide binding protein consisting of an N-terminal ArfGAP domain and two PH domains. In response to growth factor activation, PI3K phosphorylates phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 3,4,5-trisphosphate. Centaurin alpha 1 is recruited to the plasma membrane following growth factor stimulation by specific binding of its PH domain to phosphatidylinositol 3,4,5-trisphosphate. Centaurin alpha 2 is constitutively bound to the plasma membrane since it binds phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate with equal affinity. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specifici

>cd01264 PH_melted Melted pleckstrin homology (PH) domain

Probab=99.60  E-value=1.5e-15  Score=124.41  Aligned_cols=85  Identities=19%  Similarity=0.230  Sum_probs=69.0

Q ss_pred             EEEeeehhhh---hh--hccceEEeecCCeEEEECCCCCee-eeeeeccCCCCceEEEE---cC-----CCcEEEEcCCc
Q 010859          410 MISMVKKLQK---LT--SKKVQLILTNKPKLIYVDPSKLVV-KGNIIWSDNSNDLSIQV---SS-----PSHFKIVTPKK  475 (499)
Q Consensus       410 ~~g~~~k~~g---~~--~k~r~~ilt~~p~l~y~d~~~~~~-kg~i~~~~~~~~~~~~~---~~-----~~~f~i~~p~r  475 (499)
                      .+|+++|++|   ++  ||+|||+|+++-..||.+...... .|.|+|+.+.   .|..   ..     .+.|.|.||+|
T Consensus         2 ~~G~l~k~~g~~r~~K~WkrRwF~L~~~~L~y~K~~~~~~~~~g~IdL~~~~---sVk~~~~~~~~~~~~~~Fei~tp~r   78 (101)
T cd01264           2 IEGQLKEKKGRWRFIKRWKTRYFTLSGAQLLFQKGKSKDDPDDCSIDLSKIR---SVKAVAKKRRDRSLPKAFEIFTADK   78 (101)
T ss_pred             cceEEeecCccceeeecceeEEEEEeCCEEEEEeccCccCCCCceEEcccce---EEeeccccccccccCcEEEEEcCCc
Confidence            4799999999   44  999999999887778888754444 4999999983   4433   11     37999999999


Q ss_pred             eEEEE-cCCccHHHHHHHHHHhc
Q 010859          476 VLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       476 ~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      ||+|. |.+.++++|+++|+.++
T Consensus        79 t~~l~A~se~e~e~WI~~i~~a~  101 (101)
T cd01264          79 TYILKAKDEKNAEEWLQCLNIAV  101 (101)
T ss_pred             eEEEEeCCHHHHHHHHHHHHhhC
Confidence            99999 67799999999998763

Melted pleckstrin homology (PH) domain. The melted protein has a C-terminal PH domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>cd01233 Unc104 Unc-104 pleckstrin homology (PH) domain

Probab=99.55  E-value=8.2e-15  Score=121.60  Aligned_cols=86  Identities=16%  Similarity=0.219  Sum_probs=72.9

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--------cCCCcEEEEcCCceE
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--------SSPSHFKIVTPKKVL  477 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--------~~~~~f~i~~p~r~y  477 (499)
                      |+|+|++.|++|.+  ||+|||+|.+.-..||.+......+|.|+|+.+    .++.        ++++.|.|.||+|||
T Consensus         2 v~k~G~L~Kkg~~~k~WkkRwfvL~~~~L~yyk~~~~~~~~~~I~L~~~----~v~~~~~~~~~~~~~~~F~I~t~~rt~   77 (100)
T cd01233           2 VSKKGYLNFPEETNSGWTRRFVVVRRPYLHIYRSDKDPVERGVINLSTA----RVEHSEDQAAMVKGPNTFAVCTKHRGY   77 (100)
T ss_pred             cceeEEEEeeCCCCCCcEEEEEEEECCEEEEEccCCCccEeeEEEeccc----EEEEccchhhhcCCCcEEEEECCCCEE
Confidence            68999999999865  999999999887778888887899999999954    3322        246799999999999


Q ss_pred             EEE-cCCccHHHHHHHHHHhc
Q 010859          478 SFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       478 ~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      +|. +++.++++|+++|+..+
T Consensus        78 ~~~A~s~~e~~~Wi~ai~~~~   98 (100)
T cd01233          78 LFQALSDKEMIDWLYALNPLY   98 (100)
T ss_pred             EEEcCCHHHHHHHHHHhhhhh
Confidence            998 56689999999998765

Unc-104 pleckstrin homology (PH) domain. Unc-104 is a kinesin-like protein containing an N-terminal kinesin catalytic domain, followed by a forkhead associated domain with a C-terminal PH domain. These proteins are responsible for the transport of membrane vesicles along microtubules. The mechanism involves the binding of the PH domain to phosphatidiylinositol (4,5) P2-containing liposomes.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=2.8e-15  Score=158.80  Aligned_cols=146  Identities=21%  Similarity=0.315  Sum_probs=100.4

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch-------------------------------hhHHHHHH
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-------------------------------ENKTAYVK  103 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~-------------------------------~~~~~~~~  103 (499)
                      .+|+. +.||+|++|+||+|+.+++|+.||||+........                               ......+.
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 78999999999999999889999999997542100                               01112222


Q ss_pred             HHHHH------HHhC----CCCCccEEEEEEEc-CCeEEEEEeccCCCChHHH--HhhcC----CCCHHHHHHHHHHHHH
Q 010859          104 LERIV------LDQL----DHPGVVRLFFTFQD-TFSLYMALESCEGGELFDQ--ITSKG----HLSEDEARFYTAEVVD  166 (499)
Q Consensus       104 ~E~~~------l~~l----~hp~Iv~l~~~~~~-~~~l~lv~E~~~gg~L~~~--i~~~~----~l~e~~~~~i~~qil~  166 (499)
                      +|.++      +.++    .+...+.+-.++.+ ....++||||++|+.|.+.  +.+.+    .+.+..+..++.|++ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence            33332      2222    23333333333332 4457899999999999764  33433    255555666666665 


Q ss_pred             HHHHHHHCCcEeeecCCCCeeeCCCC----CEEEEecCCccccCCc
Q 010859          167 ALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDS  208 (499)
Q Consensus       167 aL~~LH~~gIiHrDlKp~NILl~~~~----~vkL~DFG~a~~~~~~  208 (499)
                            ..|++|+|+||.||+++.+|    .++++|||++..+...
T Consensus       278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                  59999999999999999988    9999999999877553

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.53  E-value=1.5e-13  Score=143.90  Aligned_cols=229  Identities=17%  Similarity=0.276  Sum_probs=157.1

Q ss_pred             eecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCChH
Q 010859           64 GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF  143 (499)
Q Consensus        64 G~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L~  143 (499)
                      +-++.+..-.|..+.++.+|.|.++....-   .....+.+-..-|+.++||||++++..+..+..+|+|+|.+.  .|.
T Consensus        21 ~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~   95 (690)
T KOG1243|consen   21 AFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLE   95 (690)
T ss_pred             cCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHH
Confidence            334444333577788899999998865522   334456666778999999999999999999999999999984  677


Q ss_pred             HHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 010859          144 DQITSKGHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  222 (499)
Q Consensus       144 ~~i~~~~~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~  222 (499)
                      .++++.+   ...+..-+.||+.||.||| +++++|++|.-.-|+++..|+.||++|-++.......          ...
T Consensus        96 ~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~----------~~~  162 (690)
T KOG1243|consen   96 TVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN----------APA  162 (690)
T ss_pred             HHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC----------ccc
Confidence            7777744   7778888999999999997 7789999999999999999999999999886433211          011


Q ss_pred             cccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhcc
Q 010859          223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV  302 (499)
Q Consensus       223 ~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~  302 (499)
                      ....---.|..|+.+....  -..|.|.|||++++++.|.  +....           +...+..+|.....+-.+.+.-
T Consensus       163 ~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~--~~~~~-----------~~~~~~~ipk~~~~~~~k~~~~  227 (690)
T KOG1243|consen  163 KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS--LLTKT-----------DLSNTGKIPKALIELYCKKLGA  227 (690)
T ss_pred             ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc--cCcch-----------hhhccCccchhHHHHHHHHhcc
Confidence            1112223467777665443  3469999999999999983  32221           1222333444444555455555


Q ss_pred             CCCCCCCCCCCCHHHH-hcCCCCCC
Q 010859          303 DPSGRPGAGPGGYAVL-KMHPFFKG  326 (499)
Q Consensus       303 dP~~R~~~~~~~~~~l-~~Hpff~~  326 (499)
                      .+..||..-. -+.+. +-|+||++
T Consensus       228 ~~~~r~n~~~-~~~~~~~~~gff~n  251 (690)
T KOG1243|consen  228 TELKRPNKLR-FILECRLLGGFFRN  251 (690)
T ss_pred             ccccccchhh-HHHHHHhccccccc
Confidence            5666665321 11222 23666664

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=9.2e-14  Score=145.44  Aligned_cols=142  Identities=23%  Similarity=0.332  Sum_probs=96.5

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhh--------------------------------HHH------H
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN--------------------------------KTA------Y  101 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~--------------------------------~~~------~  101 (499)
                      .+.||.|++|+||+|+.+ +|+.||||+..... ...-                                ...      .
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld  199 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD  199 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence            357999999999999875 69999999985431 1100                                000      1


Q ss_pred             HHHHHHHHHhC----C-CCCccEEEEEE-EcCCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHH-HHHHHHH
Q 010859          102 VKLERIVLDQL----D-HPGVVRLFFTF-QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVD-ALEYIHS  173 (499)
Q Consensus       102 ~~~E~~~l~~l----~-hp~Iv~l~~~~-~~~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~-aL~~LH~  173 (499)
                      +.+|...+.++    . +++| .+-.++ ......++||||++|++|.+..... ..+   ....++.+++. .+..+|.
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh
Confidence            22344444443    2 3333 222222 2234579999999999998876432 112   23445556655 4678999


Q ss_pred             CCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       174 ~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .|++|+|+||.||+++.+|.++|+|||++..+.+
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd01265 PH_PARIS-1 PARIS-1 pleckstrin homology (PH) domain

Probab=99.50  E-value=2.1e-14  Score=117.90  Aligned_cols=85  Identities=14%  Similarity=0.294  Sum_probs=66.7

Q ss_pred             EEeeehhhh--hh--hccceEEeecC-CeE-EEECCCCCeeeeeeeccCCCCceEEEEc-CCCcEEEEcCCceEEEE-cC
Q 010859          411 ISMVKKLQK--LT--SKKVQLILTNK-PKL-IYVDPSKLVVKGNIIWSDNSNDLSIQVS-SPSHFKIVTPKKVLSFE-DA  482 (499)
Q Consensus       411 ~g~~~k~~g--~~--~k~r~~ilt~~-p~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~~-~~~~f~i~~p~r~y~~~-d~  482 (499)
                      +|++.|++|  .+  ||+|||||++. +.| ||.++.....+|.|+|..+.  +..... .+..|.|.||+|||+|. ++
T Consensus         2 ~GyL~K~g~~~~~K~WkkRWFvL~~~~~~L~Yyk~~~d~~p~G~I~L~~~~--~~~~~~~~~~~F~i~t~~r~y~l~A~s   79 (95)
T cd01265           2 CGYLHKIEGKGPLRGRRSRWFALDDRTCYLYYYKDSQDAKPLGRVDLSGAA--FTYDPREEKGRFEIHSNNEVIALKASS   79 (95)
T ss_pred             cccEEEecCCCCCcCceeEEEEEcCCCcEEEEECCCCcccccceEECCccE--EEcCCCCCCCEEEEEcCCcEEEEECCC
Confidence            589999875  33  99999999974 445 77777788999999999862  221222 25799999999999999 55


Q ss_pred             CccHHHHHHHHHHhc
Q 010859          483 KQRASQWKKAIEALQ  497 (499)
Q Consensus       483 ~~~~~~W~~~i~~~~  497 (499)
                      +.++++|+++|+..+
T Consensus        80 ~~e~~~Wi~al~~~~   94 (95)
T cd01265          80 DKQMNYWLQALQSKR   94 (95)
T ss_pred             HHHHHHHHHHHHhhc
Confidence            689999999999753

PARIS-1 pleckstrin homology (PH) domain. PARIS-1 contains a PH domain and a TBC-type GTPase catalytic domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=1.3e-14  Score=150.35  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=192.1

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEc-CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCe
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~  129 (499)
                      ....+|..+..||.|.|+.|+.+... .++..|++|.+.+......... +-..|..+...+ .|.++++.+..|.....
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            34568999999999999999998866 7889999998866644443333 233466666655 58999999999988888


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-CCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-~~vkL~DFG~a~~~~~~  208 (499)
                      .|+-.|||+++++...+.-...+++...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||++..+.- 
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~-  419 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF-  419 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence            99999999998876655444458899999999999999999999999999999999999886 7889999999864221 


Q ss_pred             cccccCCCCCCCCccccccCccCC--CccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYV--PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~--aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~  286 (499)
                                  ....+.++..++  +|+.+....+..++|++|||..+++.++|.+.-.....   ...|..+......
T Consensus       420 ------------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~  484 (524)
T KOG0601|consen  420 ------------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNLP  484 (524)
T ss_pred             ------------ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCCC
Confidence                        111233344455  55555667788999999999999999998765443333   2334555555555


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      ....++..+.+.++..++..|+.+     .++..|.=|
T Consensus       485 ~~~~~~q~~~kv~~~~~~~~~~l~-----~~l~~~~~~  517 (524)
T KOG0601|consen  485 GLKLQLQVLLKVMINPDRKRRPSA-----VELSLHSEF  517 (524)
T ss_pred             chHHhhhhhhhhhcCCccccchhh-----hhhcccchh
Confidence            566889999999999999999988     556555544

>cd01238 PH_Tec Tec pleckstrin homology (PH) domain

Probab=99.49  E-value=4.3e-14  Score=118.42  Aligned_cols=85  Identities=19%  Similarity=0.217  Sum_probs=66.3

Q ss_pred             EEEEeeehhh-hh------hhccceEEeecCCeEEEECCCC--CeeeeeeeccCCCCceEEEE-----------cCCCcE
Q 010859          409 LMISMVKKLQ-KL------TSKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQV-----------SSPSHF  468 (499)
Q Consensus       409 ~~~g~~~k~~-g~------~~k~r~~ilt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~-----------~~~~~f  468 (499)
                      |++|++.|++ |.      .||+|||||++.-..||.++..  ...+|.|+|+.+   ..++.           .....|
T Consensus         1 ~k~g~l~Kr~~~~~~~~~~nwKkRwFvL~~~~L~Yyk~~~~~~~~~kG~I~L~~~---~~ve~~~~~~~~~~~~~~~~~F   77 (106)
T cd01238           1 ILESILVKRSQQKKKTSPLNYKERLFVLTKSKLSYYEGDFEKRGSKKGSIDLSKI---KCVETVKPEKNPPIPERFKYPF   77 (106)
T ss_pred             CcceeeeeeccCCCCCCCCCceeEEEEEcCCEEEEECCCcccccCcceeEECCcc---eEEEEecCCcCcccccccCccE
Confidence            5788888875 22      5999999998776667777653  479999999986   33332           124579


Q ss_pred             EEEcCCceEEEE-cCCccHHHHHHHHHHh
Q 010859          469 KIVTPKKVLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       469 ~i~~p~r~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                      .|+|++|||||. +.+.++++|+++|+.|
T Consensus        78 ~i~t~~r~~yl~A~s~~er~~WI~ai~~~  106 (106)
T cd01238          78 QVVHDEGTLYVFAPTEELRKRWIKALKQV  106 (106)
T ss_pred             EEEeCCCeEEEEcCCHHHHHHHHHHHHhC
Confidence            999999999998 5558999999999975

Tec pleckstrin homology (PH) domain. Proteins in the Tec family of cytoplasmic protein tyrosine kinases that includes Bruton's tyrosine kinase (BTK), BMX, IL2-inducible T-cell kinase (Itk) and Tec. These proteins generally have an N-terminal PH domain, followed by a Tek homology (TH) domain, a SH3 domain, a SH2 domain and a kinase domain. Tec PH domains tether these proteins to membranes following the activation of PI3K and its subsequent phosphorylation of phosphoinositides. The importance of PH domain membrane anchoring is confirmed by the discovery of a mutation of a critical arginine residue in the BTK PH domain, which causes X-linked agammaglobulinemia (XLA) in humans and a related disorder is mice. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few dis

>cd01257 PH_IRS Insulin receptor substrate (IRS) pleckstrin homology (PH) domain

Probab=99.48  E-value=1.2e-13  Score=113.83  Aligned_cols=87  Identities=16%  Similarity=0.175  Sum_probs=69.8

Q ss_pred             EEEEEeeehhhhhhhccceEEeecCC-----eEEEECCCC------CeeeeeeeccCCCCceEE-EEcCCCcEEEEcCCc
Q 010859          408 VLMISMVKKLQKLTSKKVQLILTNKP-----KLIYVDPSK------LVVKGNIIWSDNSNDLSI-QVSSPSHFKIVTPKK  475 (499)
Q Consensus       408 i~~~g~~~k~~g~~~k~r~~ilt~~p-----~l~y~d~~~------~~~kg~i~~~~~~~~~~~-~~~~~~~f~i~~p~r  475 (499)
                      |+++||+.|+  ..||||||||+..+     +|.|.+...      ...+|.|+|+.+.++... +.+....|.|.||.|
T Consensus         2 v~k~GyL~K~--K~~kkRwFVLr~~~~~~p~~Leyyk~ek~~~~~~~~p~~vI~L~~c~~v~~~~d~k~~~~f~i~t~dr   79 (101)
T cd01257           2 VRKSGYLRKQ--KSMHKRFFVLRAESSGGPARLEYYENEKKFLQKGSAPKRVIPLESCFNINKRADAKHRHLIALYTRDE   79 (101)
T ss_pred             ccEEEEEeEe--cCcEeEEEEEecCCCCCCceEEEECChhhccccCCCceEEEEccceEEEeeccccccCeEEEEEeCCc
Confidence            7899999998  68999999999863     786666643      678999999998332221 234457999999999


Q ss_pred             eEEEE-cCCccHHHHHHHHHHh
Q 010859          476 VLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       476 ~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                      +|+|. |.+.++++|+++|+++
T Consensus        80 ~f~l~aese~E~~~Wi~~i~~~  101 (101)
T cd01257          80 YFAVAAENEAEQDSWYQALLEL  101 (101)
T ss_pred             eEEEEeCCHHHHHHHHHHHhhC
Confidence            99999 6679999999999874

Insulin receptor substrate (IRS) pleckstrin homology (PH) domain. PH domains are only found in eukaryotes, and are often involved in targeting proteins to the plasma membrane via lipid binding. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, a well as cytoskeletal associated molecules and in lipid associated enzymes. The IRS PH domain targets IRS molecules to the plasma membrane, usually in response to insulin stimulation.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.47  E-value=7.9e-13  Score=122.64  Aligned_cols=141  Identities=16%  Similarity=0.180  Sum_probs=102.4

Q ss_pred             eeEeeecCceEEEEEEEcC------CCceEEEEEEeCcccc-------------------hhhHHHHHH----HHHHHHH
Q 010859           60 GKIYGVGSYSKVVRAKKID------TGTVYALKIMDKKFIT-------------------KENKTAYVK----LERIVLD  110 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~------t~~~vAiK~~~~~~~~-------------------~~~~~~~~~----~E~~~l~  110 (499)
                      ...||.|--+.||.|....      .+..+|||++......                   +.+....+.    .|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998654      3579999998542110                   111222333    6888888


Q ss_pred             hCCC--CCccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCcEeeecCCCCee
Q 010859          111 QLDH--PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI-HSMGLIHRDIKPENLL  187 (499)
Q Consensus       111 ~l~h--p~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~L-H~~gIiHrDlKp~NIL  187 (499)
                      ++..  -++..++.+    ..-++||||+.+..+....-+...++++.+..+..+++.+|..| |..||+|+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8743  345555554    45688999997654433222333466777888899999999999 8999999999999999


Q ss_pred             eCCCCCEEEEecCCcccc
Q 010859          188 LTADGHIKIADFGSVKPM  205 (499)
Q Consensus       188 l~~~~~vkL~DFG~a~~~  205 (499)
                      +. ++.+.|+|||.|...
T Consensus       158 ~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EE-CCcEEEEECCCceeC
Confidence            96 578999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd01247 PH_GPBP Goodpasture antigen binding protein (GPBP) Pleckstrin homology (PH) domain

Probab=99.46  E-value=1.3e-13  Score=112.06  Aligned_cols=83  Identities=12%  Similarity=0.183  Sum_probs=67.6

Q ss_pred             EEeeehhhhhh--hccceEEeecCCeEEEECCCCC--eeeeeeeccCCCCceEEEEcCCCcEEEEcCC-ceEEEE-cCCc
Q 010859          411 ISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKL--VVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-KVLSFE-DAKQ  484 (499)
Q Consensus       411 ~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~--~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-r~y~~~-d~~~  484 (499)
                      .||+.|.++++  ||+|||||.++-..||.++...  ..+|.|+|+.+  .+.+....+..|.|.++. |||+|. +.+.
T Consensus         2 ~G~L~K~~~~~k~Wk~RwFvL~~g~L~Yyk~~~~~~~~~~G~I~L~~~--~i~~~~~~~~~F~i~~~~~r~~~L~A~s~~   79 (91)
T cd01247           2 NGVLSKWTNYINGWQDRYFVLKEGNLSYYKSEAEKSHGCRGSIFLKKA--IIAAHEFDENRFDISVNENVVWYLRAENSQ   79 (91)
T ss_pred             ceEEEEeccccCCCceEEEEEECCEEEEEecCccCcCCCcEEEECccc--EEEcCCCCCCEEEEEeCCCeEEEEEeCCHH
Confidence            58999999977  9999999988888899997653  36899999986  233333446789997655 999999 5668


Q ss_pred             cHHHHHHHHHH
Q 010859          485 RASQWKKAIEA  495 (499)
Q Consensus       485 ~~~~W~~~i~~  495 (499)
                      ++++|+++|+.
T Consensus        80 e~~~Wi~al~~   90 (91)
T cd01247          80 SRLLWMDSVVR   90 (91)
T ss_pred             HHHHHHHHHhh
Confidence            99999999975

Goodpasture antigen binding protein (GPBP) Pleckstrin homology (PH) domain. The GPBP protein is a kinase that phosphorylates an N-terminal region of the alpha 3 chain of type IV collagen , which is commonly known as the goodpasture antigen. It has has an N-terminal PH domain and a C-terminal START domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cyt

>cd01236 PH_outspread Outspread Pleckstrin homology (PH) domain

Probab=99.45  E-value=9.9e-14  Score=114.76  Aligned_cols=86  Identities=16%  Similarity=0.210  Sum_probs=64.4

Q ss_pred             EEEeeehhhh-----------hhhccceEEeecCCeEEEE-CC-CCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCC
Q 010859          410 MISMVKKLQK-----------LTSKKVQLILTNKPKLIYV-DP-SKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPK  474 (499)
Q Consensus       410 ~~g~~~k~~g-----------~~~k~r~~ilt~~p~l~y~-d~-~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~  474 (499)
                      ++|||.|..+           ..||||||||+++..|+|. |. .....+|+|+++.+..+...+.  .+...|.|.||+
T Consensus         1 ~~g~l~~~~~~~~~~~~~~~~K~WkrRWFvL~~~~~L~y~~d~~~~~~p~G~IdL~~~~~V~~~~~~~~~~~~f~I~tp~   80 (104)
T cd01236           1 YCGWLLVAPDGTDFDNPVHRSKRWQRRWFILYDHGLLTYALDEMPTTLPQGTIDMNQCTDVVDAEARTGQKFSICILTPD   80 (104)
T ss_pred             CcceeEEcCCCCcccccceeeccccceEEEEeCCCEEEEeeCCCCCcccceEEEccceEEEeecccccCCccEEEEECCC
Confidence            3567766553           1289999999998888774 43 3457899999998733222221  224689999999


Q ss_pred             ceEEEE-cCCccHHHHHHHHHH
Q 010859          475 KVLSFE-DAKQRASQWKKAIEA  495 (499)
Q Consensus       475 r~y~~~-d~~~~~~~W~~~i~~  495 (499)
                      |||+|. |.+.++++|+++|+.
T Consensus        81 R~f~l~Aete~E~~~Wi~~l~~  102 (104)
T cd01236          81 KEHFIKAETKEEISWWLNMLMV  102 (104)
T ss_pred             ceEEEEeCCHHHHHHHHHHHHh
Confidence            999999 667999999999986

Outspread Pleckstrin homology (PH) domain. Outspread contains two PH domains and a C-terminal coiled-coil region. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, a well as cytoskeletal associated molecules and in lipid associated enzymes.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=3.5e-13  Score=122.54  Aligned_cols=127  Identities=20%  Similarity=0.206  Sum_probs=94.9

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCcc-EEEEEEEcCCeEEEEEeccC
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv-~l~~~~~~~~~l~lv~E~~~  138 (499)
                      ++.|+.|.++.||+++..  +..|++|+......    .......|..+++.+.+.+++ +++....  ..-++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999874  78899998754421    112345678888887654444 4554433  23479999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----EeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          139 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL-----IHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       139 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gI-----iHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      |.++...        ......++.+++.+|..||..++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9887543        11224567899999999999985     9999999999998 6789999999975

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd01235 PH_SETbf Set binding factor Pleckstrin Homology (PH) domain

Probab=99.42  E-value=5.2e-13  Score=111.05  Aligned_cols=84  Identities=24%  Similarity=0.304  Sum_probs=66.5

Q ss_pred             EEeeehhhhhh--hccceEEeec-CCeE-EEECCCCCeeeeeeeccCCCCceEEEEc-----------CCCcEEEEcCCc
Q 010859          411 ISMVKKLQKLT--SKKVQLILTN-KPKL-IYVDPSKLVVKGNIIWSDNSNDLSIQVS-----------SPSHFKIVTPKK  475 (499)
Q Consensus       411 ~g~~~k~~g~~--~k~r~~ilt~-~p~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~~-----------~~~~f~i~~p~r  475 (499)
                      +||+.|+++..  ||+|||||++ ...| ||.++.....+|.|+|+..   ..+...           ....|.|.|++|
T Consensus         2 ~G~L~K~g~~~k~WkkRwFvL~~~~~~L~Yy~~~~~~~~~g~I~L~~~---~~v~~~~~~~~~~~~~~~~~~f~i~t~~r   78 (101)
T cd01235           2 EGYLYKRGALLKGWKPRWFVLDPDKHQLRYYDDFEDTAEKGCIDLAEV---KSVNLAQPGMGAPKHTSRKGFFDLKTSKR   78 (101)
T ss_pred             eEEEEEcCCCCCCccceEEEEECCCCEEEEecCCCCCccceEEEccee---EEEeecCCCCCCCCCCCCceEEEEEeCCc
Confidence            79999999865  9999999996 3455 6666777899999999986   344321           123577789999


Q ss_pred             eEEEE-cCCccHHHHHHHHHHhc
Q 010859          476 VLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       476 ~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      +|+|. +.+.++++|+++|+.++
T Consensus        79 ~~~~~a~s~~e~~~Wi~ai~~~i  101 (101)
T cd01235          79 TYNFLAENINEAQRWKEKIQQCI  101 (101)
T ss_pred             eEEEECCCHHHHHHHHHHHHhhC
Confidence            99997 66689999999999864

Set binding factor Pleckstrin Homology (PH) domain. Set binding factor is a myotubularin-related pseudo-phosphatase consisting of a Denn domain, a Gram domain, an inactive phosphatase domain, a SID motif and a C-terminal PH domain. Its PH domain is predicted to bind lipids based upon its ability to respond to phosphatidylinositol 3-kinase .

>cd01266 PH_Gab Gab (Grb2-associated binder) pleckstrin homology (PH) domain

Probab=99.41  E-value=4.2e-13  Score=113.01  Aligned_cols=83  Identities=16%  Similarity=0.125  Sum_probs=66.9

Q ss_pred             EEeeehhhhh------hhccceEEeecCCe-------EEEECCCCCeeeeeeeccCCCCceEEEE-----cC-C---CcE
Q 010859          411 ISMVKKLQKL------TSKKVQLILTNKPK-------LIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SS-P---SHF  468 (499)
Q Consensus       411 ~g~~~k~~g~------~~k~r~~ilt~~p~-------l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~-~---~~f  468 (499)
                      +||+.|+++.      .||+|||||.+...       .||.|+...+.+|.|+|+.+   ..++.     .. .   ..|
T Consensus         2 eGwL~K~~~~~~~~~~~WkrRwFvL~~~~l~~~~~~L~Yyk~~~~~k~~g~I~L~~~---~~v~~~~~~~~~~~~~~~~f   78 (108)
T cd01266           2 EGWLKKSPPYKLLFRTKWVRRYFVLHCGDRERNLFALEYYKTSRKFKLEFVIDLESC---SQVDPGLLCTAGNCIFGYGF   78 (108)
T ss_pred             ceeeeeCCccccccccCcEEEEEEEeccccCCCcceEEEECCCCCCccceEEECCcc---EEEcccccccccCcccceEE
Confidence            6899998872      49999999998764       68888888899999999985   33322     11 1   249


Q ss_pred             EEEcCCceEEEE-cCCccHHHHHHHHHHh
Q 010859          469 KIVTPKKVLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       469 ~i~~p~r~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                      .|.||+|||+|. +.+.++++|+++|.++
T Consensus        79 ~i~t~~r~y~l~A~s~ee~~~Wi~~I~~~  107 (108)
T cd01266          79 DIETIVRDLYLVAKNEEEMTLWVNCICKL  107 (108)
T ss_pred             EEEeCCccEEEEECCHHHHHHHHHHHHhh
Confidence            999999999998 6668999999999875

Gab (Grb2-associated binder) pleckstrin homology (PH) domain. The Gab subfamily includes several Gab proteins, Drosophila DOS and C. elegans SOC-1. They are scaffolding adaptor proteins, which possess N-terminal PH domains and a C-terminus with proline-rich regions and multiple phosphorylation sites. Following activation of growth factor receptors, Gab proteins are tyrosine phosphorylated and activate PI3K, which generates 3-phosphoinositide lipids. By binding to these lipids via the PH domain, Gab proteins remain in proximity to the receptor, leading to further signaling. While not all Gab proteins depend on the PH domain for recruitment, it is required for Gab activity. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display str

>cd01260 PH_CNK Connector enhancer of KSR (Kinase suppressor of ras) (CNK) pleckstrin homology (PH) domain

Probab=99.40  E-value=3.3e-13  Score=111.22  Aligned_cols=86  Identities=19%  Similarity=0.204  Sum_probs=70.1

Q ss_pred             EEEeeehhhh--h----hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCC-ceEEEE-c
Q 010859          410 MISMVKKLQK--L----TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-KVLSFE-D  481 (499)
Q Consensus       410 ~~g~~~k~~g--~----~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-r~y~~~-d  481 (499)
                      .+|||.|+++  -    .||+|||+|+++-.+||.++.....+|.|+|+...+....+.++...|.|.+|+ |+|+|. |
T Consensus         2 ~~GwL~kk~~~~g~~~k~WkkrwfvL~~~~L~yyk~~~~~~~~~~I~L~~~~v~~~~~~~k~~~F~I~~~~~~~~~f~a~   81 (96)
T cd01260           2 CDGWLWKRKKPGGFMGQKWARRWFVLKGTTLYWYRSKQDEKAEGLIFLSGFTIESAKEVKKKYAFKVCHPVYKSFYFAAE   81 (96)
T ss_pred             ceeEEEEecCCCCccccCceeEEEEEECCEEEEECCCCCCccceEEEccCCEEEEchhcCCceEEEECCCCCcEEEEEeC
Confidence            4799988753  2    599999999998888999998889999999998622222234566799999998 999998 6


Q ss_pred             CCccHHHHHHHHHH
Q 010859          482 AKQRASQWKKAIEA  495 (499)
Q Consensus       482 ~~~~~~~W~~~i~~  495 (499)
                      .+.++++|+++|..
T Consensus        82 s~~e~~~Wi~ai~~   95 (96)
T cd01260          82 TLDDLSQWVNHLIT   95 (96)
T ss_pred             CHHHHHHHHHHHHh
Confidence            66899999999975

Connector enhancer of KSR (Kinase suppressor of ras) (CNK) pleckstrin homology (PH) domain. CNK is believed to regulate the activity and the subcellular localization of RAS activated RAF. CNK is composed of N-terminal SAM and PDZ domains along with a central or C-terminal PH domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, a well as cytoskelet

>cd01241 PH_Akt Akt pleckstrin homology (PH) domain

Probab=99.36  E-value=1e-12  Score=109.33  Aligned_cols=89  Identities=12%  Similarity=0.121  Sum_probs=66.7

Q ss_pred             EEEEEeeehhhhhh--hccceEEeec-CCeEEEECCCCCeeeeeeeccCCCC----ceEEEEcCCCcEEEE------cCC
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTN-KPKLIYVDPSKLVVKGNIIWSDNSN----DLSIQVSSPSHFKIV------TPK  474 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~-~p~l~y~d~~~~~~kg~i~~~~~~~----~~~~~~~~~~~f~i~------~p~  474 (499)
                      |+|+||+.|+++.+  ||+|||+|++ +-.+||.|......+|.||++...+    ...++......|.|.      ++.
T Consensus         1 v~k~G~L~K~g~~~~~Wk~R~f~L~~~~~l~~yk~~~~~~~~~~i~l~~~~v~~~~~~~~~~~~~~~F~i~~~~~~~~~~   80 (102)
T cd01241           1 VVKEGWLHKRGEYIKTWRPRYFLLKSDGSFIGYKEKPEDGDPFLPPLNNFSVAECQLMKTERPRPNTFIIRCLQWTTVIE   80 (102)
T ss_pred             CcEEEEEEeecCCCCCCeeEEEEEeCCCeEEEEecCCCccCccccccCCeEEeeeeeeeccCCCcceEEEEeccCCcccC
Confidence            47999999999977  9999999995 4556788865555568999887521    011122335689997      578


Q ss_pred             ceEEEEcCCccHHHHHHHHHHhc
Q 010859          475 KVLSFEDAKQRASQWKKAIEALQ  497 (499)
Q Consensus       475 r~y~~~d~~~~~~~W~~~i~~~~  497 (499)
                      |+|+ .|.+.++++|+++|+.|.
T Consensus        81 r~f~-a~s~ee~~eWi~ai~~v~  102 (102)
T cd01241          81 RTFH-VESPEEREEWIHAIQTVA  102 (102)
T ss_pred             EEEE-eCCHHHHHHHHHHHHhhC
Confidence            9987 477889999999999863

Akt pleckstrin homology (PH) domain. Akt (Protein Kinase B (PKB)) is a phosphatidylinositol 3'-kinase (PI3K)-dependent Ser/Thr kinase. The PH domain recruits Akt to the plasma membrane by binding to phosphoinositides (PtdIns-3,4-P2) and is required for activation. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>cd01244 PH_RasGAP_CG9209 RAS_GTPase activating protein (GAP)_CG9209 pleckstrin homology (PH) domain

Probab=99.36  E-value=1.3e-12  Score=106.99  Aligned_cols=80  Identities=18%  Similarity=0.088  Sum_probs=61.7

Q ss_pred             hhhhhhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc---CCCcEEEEcCCceEEEEc-CCccHHHHHH
Q 010859          416 KLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS---SPSHFKIVTPKKVLSFED-AKQRASQWKK  491 (499)
Q Consensus       416 k~~g~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~---~~~~f~i~~p~r~y~~~d-~~~~~~~W~~  491 (499)
                      ++.+..||+|||+||+.-..||.+|. ...+|.|||+....+..+...   ..+.|.|+||.|||||.. .+.++++|++
T Consensus        15 ~~~~~n~KkRwF~Lt~~~L~Y~k~~~-~~~~g~I~L~~i~~ve~v~~~~~~~~~~fqivt~~r~~yi~a~s~~E~~~Wi~   93 (98)
T cd01244          15 WKKVLHFKKRYFQLTTTHLSWAKDVQ-CKKSALIKLAAIKGTEPLSDKSFVNVDIITIVCEDDTMQLQFEAPVEATDWLN   93 (98)
T ss_pred             CccCcCCceeEEEECCCEEEEECCCC-CceeeeEEccceEEEEEcCCcccCCCceEEEEeCCCeEEEECCCHHHHHHHHH
Confidence            33345699999999977777777775 789999999986322222222   236899999999999995 4589999999


Q ss_pred             HHHHh
Q 010859          492 AIEAL  496 (499)
Q Consensus       492 ~i~~~  496 (499)
                      +|+++
T Consensus        94 al~k~   98 (98)
T cd01244          94 ALEKQ   98 (98)
T ss_pred             HHhcC
Confidence            99874

RAS_GTPase activating protein (GAP)_CG9209 pleckstrin homology (PH) domain. This protein consists of two C2 domains, followed by a RasGAP domain, a PH domain and a BTK domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=1.3e-12  Score=126.04  Aligned_cols=208  Identities=21%  Similarity=0.313  Sum_probs=145.9

Q ss_pred             HHhCCCCCccEEEEEEEcC-----CeEEEEEeccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cE
Q 010859          109 LDQLDHPGVVRLFFTFQDT-----FSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMG--LI  177 (499)
Q Consensus       109 l~~l~hp~Iv~l~~~~~~~-----~~l~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~g--Ii  177 (499)
                      |-.+-|-|||+++.++.+.     ....|+.||+..|+|.+++++.    ..+....-++++-||+.||.|||+..  |+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            3345699999999888654     3489999999999999998764    35888999999999999999999986  99


Q ss_pred             eeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHH
Q 010859          178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  257 (499)
Q Consensus       178 HrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilye  257 (499)
                      |+++...-|++..+|-||+.--.-.. ....-     ..........-.|-++|.|||.=.....+.++|||++|....+
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s-~h~s~-----~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDS-THPSV-----NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccc-cchhh-----hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence            99999999999999988864221110 00000     0000111222356788999997655566778999999999999


Q ss_pred             HhcCCCCCC-CCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          258 MLSGTSPFK-DTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       258 lltG~~Pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      |..|..--. +.+....-..|...-+...   ..--++++.+||+..|..||++     .+++.||-.-++.-.
T Consensus       275 mailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~a-----r~llfHpllfeVhsl  340 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDA-----RLLLFHPLLFEVHSL  340 (458)
T ss_pred             HHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcch-----hhhhcCceeeecchH
Confidence            988776532 2222222222222111111   1224678999999999999999     789999987666543

>cd01252 PH_cytohesin Cytohesin Pleckstrin homology (PH) domain

Probab=99.27  E-value=8.4e-12  Score=108.02  Aligned_cols=87  Identities=18%  Similarity=0.215  Sum_probs=69.2

Q ss_pred             EEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEE--EcCCCcEEEEcCC-----------
Q 010859          410 MISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ--VSSPSHFKIVTPK-----------  474 (499)
Q Consensus       410 ~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~--~~~~~~f~i~~p~-----------  474 (499)
                      ++||+.|++|..  ||+|||+|++.-..||.++.....+|.|+|+..  .+...  ...+..|.|.+|+           
T Consensus         2 k~G~L~K~~~~~~~WkkRwfvL~~~~L~yyk~~~~~~~~g~I~L~~~--~v~~~~~~~~~~~F~i~~~~~~~~i~~~~~~   79 (125)
T cd01252           2 REGWLLKQGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENV--SIREVEDPSKPFCFELFSPSDKQQIKACKTE   79 (125)
T ss_pred             cEEEEEEeCCCCCCeEeEEEEEECCEEEEEcCCCCCCceEEEECCCc--EEEEcccCCCCeeEEEECCcccccccccccc
Confidence            679999999865  999999999987778888877889999999964  12222  1245679888765           


Q ss_pred             ----------ceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          475 ----------KVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       475 ----------r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                                ++|+|. +.+.++++|+++|+.++.
T Consensus        80 ~~~~~~~~~~~~~~~~A~s~~e~~~Wi~al~~~~~  114 (125)
T cd01252          80 SDGRVVEGNHSVYRISAANDEEMDEWIKSIKASIS  114 (125)
T ss_pred             ccccccccCceEEEEECCCHHHHHHHHHHHHHHHh
Confidence                      689898 556899999999998763

Cytohesin Pleckstrin homology (PH) domain. Cytohesin is an ARF-Guanine nucleotide Exchange Factor (GEF), which has a Sec7-type Arf-GEFdomain and a pleckstrin homology domain. It specifically binds phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4, 5)P3) via its PH domain and it acts as a PI 3-kinase effector mediating biological responses such as cell adhesion and membrane trafficking. PH domains are only found in eukaryotes. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>cd01245 PH_RasGAP_CG5898 RAS GTPase-activating protein (GAP) CG5898 Pleckstrin homology (PH) domain

Probab=99.23  E-value=1.8e-11  Score=100.05  Aligned_cols=84  Identities=21%  Similarity=0.208  Sum_probs=65.9

Q ss_pred             EEeeehhhhh-h--hccceEEeec---CCeEE-EECCCCCeeeeeeeccCCCCceEEEE---cCCCcEEEEcCCc--eEE
Q 010859          411 ISMVKKLQKL-T--SKKVQLILTN---KPKLI-YVDPSKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTPKK--VLS  478 (499)
Q Consensus       411 ~g~~~k~~g~-~--~k~r~~ilt~---~p~l~-y~d~~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p~r--~y~  478 (499)
                      .|++.|++|. +  ||+|||+|++   ..+|+ |.++..++.+|.|+++.+ .+..+..   ..++.|.|.+|++  +|+
T Consensus         2 ~G~l~K~g~~~~K~wK~rwF~l~~~~s~~~l~yf~~~~~~~p~gli~l~~~-~V~~v~ds~~~r~~cFel~~~~~~~~y~   80 (98)
T cd01245           2 KGNLLKRTKSVTKLWKTLYFALILDGSRSHESLLSSPKKTKPIGLIDLSDA-YLYPVHDSLFGRPNCFQIVERALPTVYY   80 (98)
T ss_pred             CCccccCCCCcccccceeEEEEecCCCCceEEEEcCCCCCCccceeecccc-EEEEccccccCCCeEEEEecCCCCeEEE
Confidence            5788899885 4  9999999985   46674 555667899999999986 2122222   3358999999987  999


Q ss_pred             EEcCCccHHHHHHHHHH
Q 010859          479 FEDAKQRASQWKKAIEA  495 (499)
Q Consensus       479 ~~d~~~~~~~W~~~i~~  495 (499)
                      +.+.+.++++|+++|.+
T Consensus        81 ~~a~~~er~~Wi~~l~~   97 (98)
T cd01245          81 SCRSSEERDKWIESLQA   97 (98)
T ss_pred             EeCCHHHHHHHHHHHhc
Confidence            99888999999999975

RAS GTPase-activating protein (GAP) CG5898 Pleckstrin homology (PH) domain. This protein has a domain architecture of SH2-SH3-SH2-PH-C2-Ras_GAP. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, a well as cytoskeletal associated molecules and in lipid associated enzymes.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=8.1e-12  Score=131.53  Aligned_cols=166  Identities=23%  Similarity=0.388  Sum_probs=123.0

Q ss_pred             HHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCC
Q 010859          162 AEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS  240 (499)
Q Consensus       162 ~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~  240 (499)
                      .+++.||.|+|. .++||+.|.|++|.++.+|..||+.|+++....+..... ...+.........-...|.|||.+.+.
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p-~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYP-FSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccc-cccCCCCCChhhccCcccccchhhccc
Confidence            344599999995 489999999999999999999999999987655422211 111222222233456789999999998


Q ss_pred             CCCCCCcchhhhHHHHHHh-cCCCCCCCCCHHHHHHHH----HhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCH
Q 010859          241 PATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI----IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGY  315 (499)
Q Consensus       241 ~~~~~sDiwslG~ilyell-tG~~Pf~~~~~~~~~~~i----~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~  315 (499)
                      ..+.++|++||||++|.+. .|+.-+.+.+.......-    -......+..+|+++++=+.++|..++..||++     
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~-----  259 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL-----  259 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch-----
Confidence            8999999999999999999 566666654332222111    112334567899999999999999999999977     


Q ss_pred             HHHhcCCCCCCCCccccc
Q 010859          316 AVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       316 ~~l~~Hpff~~i~~~~~~  333 (499)
                      ..++.-|||.+..-..|+
T Consensus       260 ~~l~~~~ff~D~~~~aLr  277 (700)
T KOG2137|consen  260 DLLLSIPFFSDPGLKALR  277 (700)
T ss_pred             hhhhcccccCCchhhhhh
Confidence            778999999876554443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=7.5e-11  Score=111.75  Aligned_cols=140  Identities=21%  Similarity=0.231  Sum_probs=105.7

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC--CCccEEEEEEEcC---CeEEEEEe
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDT---FSLYMALE  135 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~Iv~l~~~~~~~---~~l~lv~E  135 (499)
                      +.||.|..+.||++...+ |+.|++|+.......  .....+..|..+++.+.+  ..+.+++.+....   ...|+|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            578999999999998744 689999987654321  123346778888888865  3456677666553   25789999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS------------------------------------------  173 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~------------------------------------------  173 (499)
                      |++|.+|.+.+.. +.++++....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888775542 357777777888888888888874                                          


Q ss_pred             --------------CCcEeeecCCCCeeeCC--CCCEEEEecCCccc
Q 010859          174 --------------MGLIHRDIKPENLLLTA--DGHIKIADFGSVKP  204 (499)
Q Consensus       174 --------------~gIiHrDlKp~NILl~~--~~~vkL~DFG~a~~  204 (499)
                                    ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          23599999999999998  56789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=1.4e-10  Score=104.54  Aligned_cols=134  Identities=19%  Similarity=0.200  Sum_probs=96.9

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhh-----HHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-----KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      ..+++|+-+.+|.+...  |..+++|.=-++......     ......+|..++.++.--+|.--+-++.+.....++||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            45789999999999663  445677753333222222     23344567788887765555444445567777889999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      |.+|..|.+.+...   .    -.++..+=.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99998888888765   1    44566666677789999999999999999997654 99999999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.20  E-value=2.6e-10  Score=116.39  Aligned_cols=202  Identities=24%  Similarity=0.281  Sum_probs=149.0

Q ss_pred             ceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE----cCCeEEEEEeccCC-CCh
Q 010859           68 YSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DTFSLYMALESCEG-GEL  142 (499)
Q Consensus        68 ~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~----~~~~l~lv~E~~~g-g~L  142 (499)
                      -.+.|+|....+|..|++|.+.-......++.   ..-.+.++++.|+|||++.++|.    .+..+++|++|.++ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~---t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKD---TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccc---hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            35899999999999999999843333333222   22456899999999999999887    35569999999986 577


Q ss_pred             HHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          143 FDQITS---------------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       143 ~~~i~~---------------~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .++.-.               ....+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|...|....+.+
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            765421               12478999999999999999999999999999999999999999999988887655433


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCC-CCCCCHHHH-HHHHHhcCCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLI-FQRIIARDIRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~P-f~~~~~~~~-~~~i~~~~~~~p  285 (499)
                      +.                 +       |-+.+   -.+-|.=.||.+++.|.||..- +........ ...|.       
T Consensus       446 d~-----------------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------  491 (655)
T KOG3741|consen  446 DP-----------------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------  491 (655)
T ss_pred             CC-----------------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------
Confidence            21                 0       11111   1245899999999999999643 222222222 22222       


Q ss_pred             CCCChHHHHHHHHhhccCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSG  306 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~  306 (499)
                      ..++.+++++|.-+...++++
T Consensus       492 ~~yS~D~rn~v~yl~s~~~~~  512 (655)
T KOG3741|consen  492 TTYSTDLRNVVEYLESLNFRE  512 (655)
T ss_pred             hhhhHHHHHHHHHHHhcCccc
Confidence            347899999999999999885

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.18  E-value=2.6e-10  Score=102.32  Aligned_cols=144  Identities=21%  Similarity=0.236  Sum_probs=106.4

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch-----hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .+.+|-+|+-+.|+.+..  .|+.+.||.--.+....     .-......+|..+|.++.--+|.--.-+|.|...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            677889999999999987  68888888532222222     22344566788888887655555444556677777889


Q ss_pred             EeccCC-CChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC---CEEEEecCCccc
Q 010859          134 LESCEG-GELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKP  204 (499)
Q Consensus       134 ~E~~~g-g~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~---~vkL~DFG~a~~  204 (499)
                      |||.+| .++.+++....  .-..+....++..|=..+.-||.++|+|+||..+||++.++|   .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 46777776542  223333378889999999999999999999999999998776   358999999764

>cd01254 PH_PLD Phospholipase D (PLD) pleckstrin homology (PH) domain

Probab=99.18  E-value=5.9e-11  Score=101.81  Aligned_cols=72  Identities=18%  Similarity=0.272  Sum_probs=61.1

Q ss_pred             hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcC----------------CCcEEEEcCCceEEEEcC-Cc
Q 010859          422 SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSS----------------PSHFKIVTPKKVLSFEDA-KQ  484 (499)
Q Consensus       422 ~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~----------------~~~f~i~~p~r~y~~~d~-~~  484 (499)
                      |++|||||.+.-.+||.||..+..+|+|.+...   ..++...                ...|.|.||+|+|.|... +.
T Consensus        33 w~kRWFvlr~s~L~Y~~~~~~~~~~~vil~D~~---f~v~~~~~~~~~~~~~~~~~~~~~~~~~i~t~~R~~~l~a~s~~  109 (121)
T cd01254          33 WQKRWFIVKESFLAYMDDPSSAQILDVILFDVD---FKVNGGGKEDISLAVELKDITGLRHGLKITNSNRSLKLKCKSSR  109 (121)
T ss_pred             CcceeEEEeCCEEEEEcCCCCCceeeEEEEcCC---ccEEeCCcccccccccccccCCCceEEEEEcCCcEEEEEeCCHH
Confidence            899999999988889999999999999999876   4555322                247999999999999955 58


Q ss_pred             cHHHHHHHHHHh
Q 010859          485 RASQWKKAIEAL  496 (499)
Q Consensus       485 ~~~~W~~~i~~~  496 (499)
                      ++++|+++|+++
T Consensus       110 ~~~~Wi~~i~~a  121 (121)
T cd01254         110 KLKQWMASIEDA  121 (121)
T ss_pred             HHHHHHHHHHhC
Confidence            999999999874

Phospholipase D (PLD) pleckstrin homology (PH) domain. PLD hydrolyzes phosphatidylcholine to phosphatidic acid (PtdOH), which can bind target proteins. PLD contains a PH domain, a PX domain and four conserved PLD signature domains. The PLD PH domain is specific for bisphosphorylated inositides. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>cd01246 PH_oxysterol_bp Oxysterol binding protein (OSBP) Pleckstrin homology (PH) domain

Probab=99.16  E-value=8.7e-11  Score=95.42  Aligned_cols=84  Identities=23%  Similarity=0.278  Sum_probs=68.5

Q ss_pred             EEeeehhhhhh--hccceEEeecCCeEEEECCCCC--eeeeeeeccCCCCceEEEEcCCCcEEEEcCC-ceEEEE-cCCc
Q 010859          411 ISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKL--VVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-KVLSFE-DAKQ  484 (499)
Q Consensus       411 ~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~--~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-r~y~~~-d~~~  484 (499)
                      +||+.|+++..  |++|+|+|.++-.+||.++...  ...|.|+++.+  .+.........|.|.+++ |+|+|. +.+.
T Consensus         2 ~G~L~k~~~~~~~W~~r~~vl~~~~L~~~~~~~~~~~~~~~~i~l~~~--~~~~~~~~~~~F~i~~~~~~~~~~~a~s~~   79 (91)
T cd01246           2 EGWLLKWTNYLKGWQKRWFVLDNGLLSYYKNKSSMRGKPRGTILLSGA--VISEDDSDDKCFTIDTGGDKTLHLRANSEE   79 (91)
T ss_pred             eEEEEEecccCCCceeeEEEEECCEEEEEecCccCCCCceEEEEeceE--EEEECCCCCcEEEEEcCCCCEEEEECCCHH
Confidence            69999988654  9999999998777788888766  88999999985  233333446899999988 999998 5568


Q ss_pred             cHHHHHHHHHHh
Q 010859          485 RASQWKKAIEAL  496 (499)
Q Consensus       485 ~~~~W~~~i~~~  496 (499)
                      ++.+|+.+|+.+
T Consensus        80 e~~~Wi~al~~a   91 (91)
T cd01246          80 ERQRWVDALELA   91 (91)
T ss_pred             HHHHHHHHHHhC
Confidence            999999999863

Oxysterol binding protein (OSBP) Pleckstrin homology (PH) domain. Oxysterol binding proteins are a multigene family that is conserved in yeast, flies, worms, mammals and plants. They all contain a C-terminal oxysterol binding domain, and most contain an N-terminal PH domain. OSBP PH domains bind to membrane phosphoinositides and thus likely play an important role in intracellular targeting. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=2.6e-09  Score=98.75  Aligned_cols=128  Identities=23%  Similarity=0.251  Sum_probs=83.9

Q ss_pred             EEEEEEEcCCCceEEEEEEeCccc-----------------------chhhHHHHHHHHHHHHHhCCCCC--ccEEEEEE
Q 010859           70 KVVRAKKIDTGTVYALKIMDKKFI-----------------------TKENKTAYVKLERIVLDQLDHPG--VVRLFFTF  124 (499)
Q Consensus        70 ~Vy~a~~~~t~~~vAiK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~hp~--Iv~l~~~~  124 (499)
                      .||.|... .|..+|+|+......                       ..........+|...|.++..-+  +.+++.+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999874 478999999864210                       11122344667899999997654  45555442


Q ss_pred             EcCCeEEEEEeccC--CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH-HHHCCcEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          125 QDTFSLYMALESCE--GGELFDQITSKGHLSEDEARFYTAEVVDALEY-IHSMGLIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       125 ~~~~~l~lv~E~~~--gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~-LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                          .-++||||++  |..+..+....  ++.+....++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                2369999998  65554433322  3356677888888886666 579999999999999999877 999999999


Q ss_pred             cccc
Q 010859          202 VKPM  205 (499)
Q Consensus       202 a~~~  205 (499)
                      |...
T Consensus       153 av~~  156 (188)
T PF01163_consen  153 AVDS  156 (188)
T ss_dssp             EEET
T ss_pred             ceec
Confidence            8754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd01250 PH_centaurin Centaurin Pleckstrin homology (PH) domain

Probab=99.04  E-value=2.8e-10  Score=93.03  Aligned_cols=84  Identities=17%  Similarity=0.176  Sum_probs=64.5

Q ss_pred             EEEeeehhhhh---hhccceEEeecCCeEEEECCCC--CeeeeeeeccCCCCceEEEEc---CCCcEEEEcCCceEEEE-
Q 010859          410 MISMVKKLQKL---TSKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQVS---SPSHFKIVTPKKVLSFE-  480 (499)
Q Consensus       410 ~~g~~~k~~g~---~~k~r~~ilt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~~---~~~~f~i~~p~r~y~~~-  480 (499)
                      ++|++.|+++.   .|++|+|+|.++-..||.|+..  ....|.|+++.+.  +.....   ....|.|.||+|+|+|. 
T Consensus         1 k~G~L~kk~~~~~~~W~kr~~~L~~~~l~~y~~~~~~~~~~~~~i~l~~~~--v~~~~~~~~~~~~f~i~~~~~~~~f~a   78 (94)
T cd01250           1 KQGYLYKRSSKSNKEWKKRWFVLKNGQLTYHHRLKDYDNAHVKEIDLRRCT--VRHNGKQPDRRFCFEVISPTKTWHFQA   78 (94)
T ss_pred             CcceEEEECCCcCCCceEEEEEEeCCeEEEEcCCcccccccceEEeccceE--EecCccccCCceEEEEEcCCcEEEEEC
Confidence            46899887642   4999999999777778877764  5678999998641  222222   35689999999999998 


Q ss_pred             cCCccHHHHHHHHHH
Q 010859          481 DAKQRASQWKKAIEA  495 (499)
Q Consensus       481 d~~~~~~~W~~~i~~  495 (499)
                      +.+.++++|+.+|+.
T Consensus        79 ~s~~~~~~Wi~al~~   93 (94)
T cd01250          79 DSEEERDDWISAIQE   93 (94)
T ss_pred             CCHHHHHHHHHHHhc
Confidence            556899999999975

Centaurin Pleckstrin homology (PH) domain. Centaurin beta and gamma consist of a PH domain, an ArfGAP domain and three ankyrin repeats. Centaurain gamma also has an N-terminal Ras homology domain. Centaurin alpha has a different domain architecture and its PH domain is in a different subfamily. Centaurin can bind to phosphatidlyinositol (3,4,5)P3. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.98  E-value=1.1e-08  Score=100.01  Aligned_cols=134  Identities=18%  Similarity=0.149  Sum_probs=91.0

Q ss_pred             ceEEEEEEEcCCCceEEEEEEeCcccc---hh-----hHHHHHHHHHHHHHhCCCCC--ccEEEEEEEc-----CCeEEE
Q 010859           68 YSKVVRAKKIDTGTVYALKIMDKKFIT---KE-----NKTAYVKLERIVLDQLDHPG--VVRLFFTFQD-----TFSLYM  132 (499)
Q Consensus        68 ~g~Vy~a~~~~t~~~vAiK~~~~~~~~---~~-----~~~~~~~~E~~~l~~l~hp~--Iv~l~~~~~~-----~~~l~l  132 (499)
                      ...|+.+..  .|+.|.||........   +.     .-.....+|...+.+|..-+  ...+..++..     ...-++
T Consensus        35 ~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         35 GRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            334556543  5678899966332211   00     00113556777666653222  2233333332     235789


Q ss_pred             EEeccCCC-ChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-------CCCEEEEecCCc
Q 010859          133 ALESCEGG-ELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-------DGHIKIADFGSV  202 (499)
Q Consensus       133 v~E~~~gg-~L~~~i~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-------~~~vkL~DFG~a  202 (499)
                      |||++++. +|.+++..  ....+......++.+++..+.-||.+||+|+|+++.|||++.       ++.+.|+||+.+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99999875 78888764  244667788899999999999999999999999999999975       467999999987


Q ss_pred             c
Q 010859          203 K  203 (499)
Q Consensus       203 ~  203 (499)
                      .
T Consensus       193 ~  193 (268)
T PRK15123        193 Q  193 (268)
T ss_pred             c
Confidence            5

>PF15409 PH_8: Pleckstrin homology domain

Probab=98.95  E-value=3.1e-09  Score=84.63  Aligned_cols=82  Identities=13%  Similarity=0.174  Sum_probs=66.4

Q ss_pred             Eeeehhhhhh---hccceEEe--ecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEcCC-cc
Q 010859          412 SMVKKLQKLT---SKKVQLIL--TNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAK-QR  485 (499)
Q Consensus       412 g~~~k~~g~~---~k~r~~il--t~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d~~-~~  485 (499)
                      |++-|++...   |.||+|+|  .++..-||.++.++.+.|.||++.+  ++++.. +...|.|.+...+|+|...+ .+
T Consensus         1 G~llKkrr~~lqG~~kRyFvL~~~~G~LsYy~~~~~~~~rGsi~v~~a--~is~~~-~~~~I~idsg~~i~hLKa~s~~~   77 (89)
T PF15409_consen    1 GWLLKKRRKPLQGWHKRYFVLDFEKGTLSYYRNQNSGKLRGSIDVSLA--VISANK-KSRRIDIDSGDEIWHLKAKSQED   77 (89)
T ss_pred             CcceeeccccCCCceeEEEEEEcCCcEEEEEecCCCCeeEeEEEccce--EEEecC-CCCEEEEEcCCeEEEEEcCCHHH
Confidence            4555544322   89999999  6777779999998899999999986  455554 45789999999999999654 89


Q ss_pred             HHHHHHHHHHh
Q 010859          486 ASQWKKAIEAL  496 (499)
Q Consensus       486 ~~~W~~~i~~~  496 (499)
                      .+.|+++++.+
T Consensus        78 f~~Wv~aL~~a   88 (89)
T PF15409_consen   78 FQRWVSALQKA   88 (89)
T ss_pred             HHHHHHHHHhc
Confidence            99999999985

>cd01219 PH_FGD FGD (faciogenital dysplasia protein) pleckstrin homology (PH) domain

Probab=98.86  E-value=1.1e-08  Score=84.96  Aligned_cols=87  Identities=23%  Similarity=0.331  Sum_probs=69.2

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeEEEECC-----CCCeeeeeeeccCCCCceEEEEc----CCCcEEEEcCCce
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDP-----SKLVVKGNIIWSDNSNDLSIQVS----SPSHFKIVTPKKV  476 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~-----~~~~~kg~i~~~~~~~~~~~~~~----~~~~f~i~~p~r~  476 (499)
                      .+++|++.|.++.+  ||.|+|+|-|.-.+||...     ..-..++.|+++.    ++++..    .++.|.|.++.|+
T Consensus         2 ~ikeG~L~K~~~~~~~~k~RyffLFnd~Ll~~~~~~~~~~~~y~~~~~i~l~~----~~v~~~~~~~~~~~F~I~~~~rs   77 (101)
T cd01219           2 LLKEGSVLKISSTTEKTEERYLFLFNDLLLYCVPRKMIGGSKFKVRARIDVSG----MQVCEGDNLERPHSFLVSGKQRC   77 (101)
T ss_pred             cccceEEEEEecCCCCceeEEEEEeCCEEEEEEcccccCCCcEEEEEEEeccc----EEEEeCCCCCcCceEEEecCCcE
Confidence            47899999998764  8999999999955455531     2347789999997    466554    3689999999999


Q ss_pred             EEEEc-CCccHHHHHHHHHHhcC
Q 010859          477 LSFED-AKQRASQWKKAIEALQN  498 (499)
Q Consensus       477 y~~~d-~~~~~~~W~~~i~~~~~  498 (499)
                      |++.. ++.+.++|+++|+++++
T Consensus        78 f~l~A~s~eEk~~W~~ai~~~i~  100 (101)
T cd01219          78 LELQARTQKEKNDWVQAIFSIID  100 (101)
T ss_pred             EEEEcCCHHHHHHHHHHHHHHhh
Confidence            99994 55899999999999875

FGD (faciogenital dysplasia protein) pleckstrin homology (PH) domain. FGD has a RhoGEF (DH) domain, followed by a PH domain, a FYVE domain and a C-terminal PH domain. FGD is a guanine nucleotide exchange factor that activates the Rho GTPase Cdc42. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>PF00169 PH: PH domain; InterPro: IPR001849 The pleckstrin homology (PH) domain is a domain of about 100 residues that occurs in a wide range of proteins involved in intracellular signalling or as constituents of the cytoskeleton [, , , , , , ]

Probab=98.86  E-value=9.8e-09  Score=84.64  Aligned_cols=86  Identities=21%  Similarity=0.305  Sum_probs=70.8

Q ss_pred             EEEEEeeehhhh--hhhccceEEeecCCeEEEECCC---CCeeeeeeeccCCCCceEEEE----------cCCCcEEEEc
Q 010859          408 VLMISMVKKLQK--LTSKKVQLILTNKPKLIYVDPS---KLVVKGNIIWSDNSNDLSIQV----------SSPSHFKIVT  472 (499)
Q Consensus       408 i~~~g~~~k~~g--~~~k~r~~ilt~~p~l~y~d~~---~~~~kg~i~~~~~~~~~~~~~----------~~~~~f~i~~  472 (499)
                      ++++|+|.|++.  ..||+|+|+|++.-.++|.++.   ....++.|+|...    .+..          ...+.|.|.+
T Consensus         1 ~~~~G~L~~~~~~~~~wk~r~~vL~~~~L~~~~~~~~~~~~~~~~~i~l~~~----~v~~~~~~~~~~~~~~~~~f~i~~   76 (104)
T PF00169_consen    1 CIKEGWLLKKSSSRKKWKKRYFVLRDSYLLYYKSSKDKSDSKPKGSIPLDDC----TVRPDPSSDFLSNKKRKNCFEITT   76 (104)
T ss_dssp             EEEEEEEEEEESSSSSEEEEEEEEETTEEEEESSTTTTTESSESEEEEGTTE----EEEEETSSTSTSTSSSSSEEEEEE
T ss_pred             CEEEEEEEEECCCCCCeEEEEEEEECCEEEEEecCccccceeeeEEEEecCc----eEEEcCccccccccCCCcEEEEEe
Confidence            578999999883  3499999999998888888887   6899999999984    3333          2357999999


Q ss_pred             CCc-eEEEE-cCCccHHHHHHHHHHhc
Q 010859          473 PKK-VLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       473 p~r-~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      +++ +|+|. +.+.++..|+++|++++
T Consensus        77 ~~~~~~~~~~~s~~~~~~W~~~i~~~~  103 (104)
T PF00169_consen   77 PNGKSYLFSAESEEERKRWIQAIQKAI  103 (104)
T ss_dssp             TTSEEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             CCCcEEEEEcCCHHHHHHHHHHHHHHh
Confidence            886 99999 45589999999999975

The pleckstrin homology domain commonly found in eukaryotic signalling proteins. The domain family possesses multiple functions including the abilities to bind inositol phosphates, and various proteins. PH domains have been found to possess inserted domains (such as in PLC gamma, syntrophins) and to be inserted within other domains. Mutations in Brutons tyrosine kinase (Btk) within its PH domain cause X-linked agammaglobulinaemia (XLA) in patients. Point mutations cluster into the positively charged end of the molecule around the predicted binding site for phosphatidylinositol lipids. The 3D structure of several PH domains has been determined []. All known cases have a common structure consisting of two perpendicular anti-parallel beta sheets, followed by a C-terminal amphipathic helix. The loops connecting the beta-strands differ greatly in length, making the PH domain relatively difficult to detect. There are no totally invariant residues within the PH domain. Proteins reported to contain one more PH domains belong to the following families: Pleckstrin, the protein where this domain was first detected, is the major substrate of protein kinase C in platelets. Pleckstrin is one of the rare proteins to contains two PH domains. Ser/Thr protein kinases such as the Akt/Rac family, the beta-adrenergic receptor kinases, the mu isoform of PKC and the trypanosomal NrkA family. Tyrosine protein kinases belonging to the Btk/Itk/Tec subfamily. Insulin Receptor Substrate 1 (IRS-1). Regulators of small G-proteins like guanine nucleotide releasing factor GNRP (Ras-GRF) (which contains 2 PH domains), guanine nucleotide exchange proteins like vav, dbl, SoS and Saccharomyces cerevisiae CDC24, GTPase activating proteins like rasGAP and BEM2/IPL2, and the human break point cluster protein bcr. Cytoskeletal proteins such as dynamin (see IPR001401 from INTERPRO), Caenorhabditis elegans kinesin-like protein unc-104 (see IPR001752 from INTERPRO), spectrin beta-chain, syntrophin (2 PH domains) and S. cerevisiae nuclear migration protein NUM1. Mammalian phosphatidylinositol-specific phospholipase C (PI-PLC) (see IPR000909 from INTERPRO) isoforms gamma and delta. Isoform gamma contains two PH domains, the second one is split into two parts separated by about 400 residues. Oxysterol binding proteins OSBP, S. cerevisiae OSH1 and YHR073w. Mouse protein citron, a putative rho/rac effector that binds to the GTP-bound forms of rho and rac. Several S. cerevisiae proteins involved in cell cycle regulation and bud formation like BEM2, BEM3, BUD4 and the BEM1-binding proteins BOI2 (BEB1) and BOI1 (BOB1). C. elegans protein MIG-10. C. elegans hypothetical proteins C04D8.1, K06H7.4 and ZK632.12. S. cerevisiae hypothetical proteins YBR129c and YHR155w. ; GO: 0005515 protein binding; PDB: 1DYN_B 2DYN_B 3SNH_A 3ZYS_C 1X05_A 2I5F_A 1ZM0_B 1XX0_A 2I5C_C 3A8P_D ....

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=4.7e-08  Score=92.24  Aligned_cols=126  Identities=20%  Similarity=0.289  Sum_probs=89.0

Q ss_pred             CCceEEEEEEeCcccch----hhHHHHHHHHHHHHHhCCCCC--ccEEEEEEEcC----CeEEEEEeccCC-CChHHHHh
Q 010859           79 TGTVYALKIMDKKFITK----ENKTAYVKLERIVLDQLDHPG--VVRLFFTFQDT----FSLYMALESCEG-GELFDQIT  147 (499)
Q Consensus        79 t~~~vAiK~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~--Iv~l~~~~~~~----~~l~lv~E~~~g-g~L~~~i~  147 (499)
                      .++.|-+|.+.......    .-......+|...+..|..-+  ....+.+....    ..-|+|+|++++ .+|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            35566666543321111    122334555666655553222  33344444331    345899999987 47999888


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC---CEEEEecCCccc
Q 010859          148 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKP  204 (499)
Q Consensus       148 ~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~---~vkL~DFG~a~~  204 (499)
                      ....++......++.++...+.-||.+||+|+|++|.|||++.++   .+.|+||+-++.
T Consensus       111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            755578888899999999999999999999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.79  E-value=5.5e-08  Score=92.90  Aligned_cols=138  Identities=22%  Similarity=0.232  Sum_probs=102.3

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc-------------------hhhHHHHHHHHHHHHHhCCCC--
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-------------------KENKTAYVKLERIVLDQLDHP--  115 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~-------------------~~~~~~~~~~E~~~l~~l~hp--  115 (499)
                      +.++..||.|--|.||.|.+. .|.++|||.=+.....                   -.......++|.++|..|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            457789999999999999986 5899999963221100                   011234456788888888543  


Q ss_pred             CccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEE
Q 010859          116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  195 (499)
Q Consensus       116 ~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vk  195 (499)
                      .+.+.+    +.+.-.+||||.+|-.|...-     ++.+.+..++..|+.-+..+-..||+|+|+.+=||+++++|.+.
T Consensus       172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPI----AWNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcc----ccccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            344443    345678999999997775532     24566667777777777777789999999999999999999999


Q ss_pred             EEecCCccc
Q 010859          196 IADFGSVKP  204 (499)
Q Consensus       196 L~DFG~a~~  204 (499)
                      ++||..+..
T Consensus       243 vIDwPQ~v~  251 (304)
T COG0478         243 VIDWPQAVP  251 (304)
T ss_pred             EEeCccccc
Confidence            999998754

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.74  E-value=9.9e-08  Score=95.63  Aligned_cols=232  Identities=16%  Similarity=0.200  Sum_probs=155.0

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHH-HhCCCCCccEEEEEE-------EcCCeE
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTF-------QDTFSL  130 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~Iv~l~~~~-------~~~~~l  130 (499)
                      .++.||+|+-+.+|-.-...   ..+.|++.+.-.....+      .+..| +.-.||-+-.=..+-       .....+
T Consensus        15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq------k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ------KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCccccCCccceeeecchhh---chhheeecCCCchHHHH------HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            56789999999999765432   34668887653322111      11223 333566443311111       122337


Q ss_pred             EEEEeccCCCCh-HHHHh---hc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          131 YMALESCEGGEL-FDQIT---SK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       131 ~lv~E~~~gg~L-~~~i~---~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      -+.|..+.|..= ..+..   +.   ..+..+-+...+..|+.+...||..|-+-+|+.++|+|+++++.|.|.|-..-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence            888988877432 22221   11   236788899999999999999999999999999999999999999999876543


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcC-CCCCCCC-------CH
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSG-TSPFKDT-------SE  270 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG-~~Pf~~~-------~~  270 (499)
                      .-.           .+.....-+|.+.|.+||.-.     +..-+...|.|.||++||+++.| +.||.+-       +.
T Consensus       166 i~~-----------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p  234 (637)
T COG4248         166 INA-----------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP  234 (637)
T ss_pred             ecc-----------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence            321           223344568999999999865     34456778999999999999996 9999752       22


Q ss_pred             HHHHHHHHhcCCC-----------CC-----CCCChHHHHHHHHhhcc--CCCCCCCCCC
Q 010859          271 WLIFQRIIARDIR-----------FP-----NYFSDAARDLIDRLLDV--DPSGRPGAGP  312 (499)
Q Consensus       271 ~~~~~~i~~~~~~-----------~p-----~~~~~~~~~Li~~lL~~--dP~~R~~~~~  312 (499)
                      .+.  .|-.+.+.           -|     .-+++++..|..+|+..  ++.-||+++.
T Consensus       235 ~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         235 LET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             chh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            221  22222111           11     23689999999999975  3668999853

>KOG0930 consensus Guanine nucleotide exchange factor Cytohesin, contains PH and Sec7 domains [Intracellular trafficking, secretion, and vesicular transport]

Probab=98.73  E-value=1.8e-08  Score=94.53  Aligned_cols=96  Identities=22%  Similarity=0.301  Sum_probs=72.4

Q ss_pred             ccccccCCCceEEEEEeeehhhh---hhhccceEEeecCCeEEEECC-CCCeeeeeeeccCCCCceEEEE-cCCCcEEEE
Q 010859          397 KWQQFLDPGESVLMISMVKKLQK---LTSKKVQLILTNKPKLIYVDP-SKLVVKGNIIWSDNSNDLSIQV-SSPSHFKIV  471 (499)
Q Consensus       397 ~~~~~~~~~~~i~~~g~~~k~~g---~~~k~r~~ilt~~p~l~y~d~-~~~~~kg~i~~~~~~~~~~~~~-~~~~~f~i~  471 (499)
                      .-|.|++++    .+||+-|.+|   +.||||||||||.=. ||.+- -..+.+|.|||...+ .-.|+. +.+..|++-
T Consensus       253 lthtffnpd----REGWLlKlgg~rvktWKrRWFiLtdNCL-YYFe~tTDKEPrGIIpLeNls-ir~VedP~kP~cfEly  326 (395)
T KOG0930|consen  253 LTHTFFNPD----REGWLLKLGGNRVKTWKRRWFILTDNCL-YYFEYTTDKEPRGIIPLENLS-IREVEDPKKPNCFELY  326 (395)
T ss_pred             chhhccCcc----ccceeeeecCCcccchhheeEEeeccee-eeeeeccCCCCCcceeccccc-eeeccCCCCCCeEEEe
Confidence            346677654    4799999988   679999999999754 55554 467899999999742 223333 667888886


Q ss_pred             cCCc----------------------eEEEEcCC-ccHHHHHHHHHHhcC
Q 010859          472 TPKK----------------------VLSFEDAK-QRASQWKKAIEALQN  498 (499)
Q Consensus       472 ~p~r----------------------~y~~~d~~-~~~~~W~~~i~~~~~  498 (499)
                      .|+-                      +|.|+.++ .+.++|+++|..++.
T Consensus       327 ~ps~~gq~IKACKTe~DGRvVEG~H~vYrIsA~~~Ee~~~Wi~sI~a~is  376 (395)
T KOG0930|consen  327 IPSNKGQVIKACKTEADGRVVEGNHSVYRISAPTPEEKDEWIKSIKAAIS  376 (395)
T ss_pred             cCCCCcCeeeeecccCCceeEeccceEEEeeCCCHHHHHHHHHHHHHHhc
Confidence            6643                      69999776 789999999998774

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=5.5e-08  Score=102.94  Aligned_cols=144  Identities=22%  Similarity=0.266  Sum_probs=91.7

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccch---------------------------h----hHHHH------HH
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK---------------------------E----NKTAY------VK  103 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~---------------------------~----~~~~~------~~  103 (499)
                      ..|+.+|-|+||.|+.+. |+.||||+........                           .    .....      ..
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            578999999999999865 9999999975421100                           0    00111      12


Q ss_pred             HHHHHHHhC-----CCCCccEEEEEEEcCCeEEEEEeccCCCChHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 010859          104 LERIVLDQL-----DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQ--ITSKGHLSEDEARFYTAEVVDALEYIHSMGL  176 (499)
Q Consensus       104 ~E~~~l~~l-----~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~--i~~~~~l~e~~~~~i~~qil~aL~~LH~~gI  176 (499)
                      +|...+.++     +.|+|.--.-+++-.+.-.++|||++|..+.+.  +... .++...+.....++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-GIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc-CCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            233333333     234433222333445567899999999888877  4443 345333222222221  122234899


Q ss_pred             EeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       177 iHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|.|.+|.||+++.+|++-+.|||....+.+.
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            99999999999999999999999998876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.66  E-value=4e-07  Score=85.31  Aligned_cols=141  Identities=21%  Similarity=0.247  Sum_probs=93.2

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHH------HHHHHHHHHhC---CCCCccEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY------VKLERIVLDQL---DHPGVVRLFF  122 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~------~~~E~~~l~~l---~hp~Iv~l~~  122 (499)
                      +...+|.+.+++-......|.+..-  +|..+++|.........+.....      ..++...+.++   .--....++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            4457899999998888887777654  67899999876543322222111      12233333333   2233333333


Q ss_pred             EEE-----cCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEE
Q 010859          123 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  197 (499)
Q Consensus       123 ~~~-----~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~  197 (499)
                      +..     -....+++|||++|..|.+...    +++    .+...+..++.-||+.|++|+|++|.|++++.+ .++++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI  176 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII  176 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence            322     2334568999999988866432    333    355667788999999999999999999999855 59999


Q ss_pred             ecCCcc
Q 010859          198 DFGSVK  203 (499)
Q Consensus       198 DFG~a~  203 (499)
                      ||+..+
T Consensus       177 D~~~k~  182 (229)
T PF06176_consen  177 DTQGKR  182 (229)
T ss_pred             ECcccc
Confidence            998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.64  E-value=6e-09  Score=108.99  Aligned_cols=242  Identities=20%  Similarity=0.237  Sum_probs=167.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-Iv~l~~~~~~~~~l~l  132 (499)
                      ..-|.+...+++|+++.+++.+...+...+ .+++...        .....++++|.+++||| .+..++.++.+....+
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            345778888999999999999876654444 5555332        23455788999999999 7777777788889999


Q ss_pred             EEeccCCC-ChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGG-ELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg-~L~~~i~-~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|+++.++ +-...+. ..-.+.+-+...+...-+.+|++||+.-=+|||    ||+..+ +..+..||+.+..+.... 
T Consensus       312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence            99999887 2222111 111234444555666778899999988778998    777654 688999999987654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  286 (499)
                                ...++.+|+.++|||+.....+....|.|++|.--.+|.-|-+|-...-.  ....+- .....|.    
T Consensus       386 ----------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g-~~p~s~~L~~~  452 (829)
T KOG0576|consen  386 ----------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIG-NGPNSPMLTDK  452 (829)
T ss_pred             ----------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCC-CCCCccccchh
Confidence                      34578899999999999999999999999999877788877777543110  000000 0000010    


Q ss_pred             -CCChHH-HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          287 -YFSDAA-RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       287 -~~~~~~-~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                       .+++.. .++...|+..-|..|+..     ..+..|.+|.+..
T Consensus       453 ~aw~~~~~~~~~~~~~~g~P~~pkv~-----mgacfsKvfngCp  491 (829)
T KOG0576|consen  453 SAWSPVFHRDFPAPCLNGLPPTPKVH-----MGACFSKVFNGCP  491 (829)
T ss_pred             hhcCcccccCCcccccCCCCCCCcch-----hhHHHHHHhccCc
Confidence             111111 246778888889888887     5678888888754

>cd01220 PH_CDEP Chondrocyte-derived ezrin-like domain containing protein (CDEP) Pleckstrin homology (PH) domain

Probab=98.63  E-value=2.1e-07  Score=76.65  Aligned_cols=87  Identities=11%  Similarity=0.179  Sum_probs=65.0

Q ss_pred             EEEEEeeehhhhhhhccceEEeecCCeEEEECC----CCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcCCceEE
Q 010859          408 VLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP----SKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTPKKVLS  478 (499)
Q Consensus       408 i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~----~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p~r~y~  478 (499)
                      .|++|++.|..+.-.++|+|.|=+.-.||+...    ..-...|.||+..    +.|+.     ..++.|.|.+|+|+|.
T Consensus         2 ~ikEG~L~K~~~k~~~~R~~FLFnD~LlY~~~~~~~~~~y~~~~~i~L~~----~~V~~~~~~~~~~~~F~I~~~~ks~~   77 (99)
T cd01220           2 FIRQGCLLKLSKKGLQQRMFFLFSDLLLYTSKSPTDQNSFRILGHLPLRG----MLTEESEHEWGVPHCFTIFGGQCAIT   77 (99)
T ss_pred             eeeEEEEEEEeCCCCceEEEEEccceEEEEEeecCCCceEEEEEEEEcCc----eEEeeccCCcCCceeEEEEcCCeEEE
Confidence            478999999776555556666666555555432    2336889999997    45554     2358999999999999


Q ss_pred             EEcCC-ccHHHHHHHHHHhcC
Q 010859          479 FEDAK-QRASQWKKAIEALQN  498 (499)
Q Consensus       479 ~~d~~-~~~~~W~~~i~~~~~  498 (499)
                      |..++ .+.++|+++|++++.
T Consensus        78 l~A~s~~Ek~~Wi~~i~~aI~   98 (99)
T cd01220          78 VAASTRAEKEKWLADLSKAIA   98 (99)
T ss_pred             EECCCHHHHHHHHHHHHHHhh
Confidence            99655 899999999999874

Chondrocyte-derived ezrin-like domain containing protein (CDEP) Pleckstrin homology (PH) domain. CDEP consists of a Ferm domain, a rhoGEF (DH) domain followed by two PH domains. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>cd01263 PH_anillin Anillin Pleckstrin homology (PH) domain

Probab=98.62  E-value=5e-08  Score=83.05  Aligned_cols=75  Identities=16%  Similarity=0.188  Sum_probs=55.6

Q ss_pred             hhccceEEeecCCeEEEECCCC---CeeeeeeeccCCCCceEE------EEcCCCcEEEEc--CC---------------
Q 010859          421 TSKKVQLILTNKPKLIYVDPSK---LVVKGNIIWSDNSNDLSI------QVSSPSHFKIVT--PK---------------  474 (499)
Q Consensus       421 ~~k~r~~ilt~~p~l~y~d~~~---~~~kg~i~~~~~~~~~~~------~~~~~~~f~i~~--p~---------------  474 (499)
                      .||||||||.++-..||.+|..   ....|.|+|..+. ...+      +...+++|.|.+  |+               
T Consensus        18 ~W~RRWFvL~g~~L~y~k~p~d~~~~~Plg~I~L~~c~-~~~v~~~~r~~c~Rp~tF~i~~~~~~~~~~~~~~~~~~~~~   96 (122)
T cd01263          18 AWHRRWCALEGGEIKYWKYPDDEKRKGPTGLIDLSTCT-SSEGASAVRDICARPNTFHLDVWRPKMETDDETLVSQCRRG   96 (122)
T ss_pred             CceEEEEEEeCCEEEEEcCCCccccCCceEEEEhhhCc-ccccccCChhhcCCCCeEEEEEecccccccccceeeccCCc
Confidence            4999999999655557766654   5677999999863 2445      345678999953  43               


Q ss_pred             --ceEEEE--cCCccHHHHHHHHHHh
Q 010859          475 --KVLSFE--DAKQRASQWKKAIEAL  496 (499)
Q Consensus       475 --r~y~~~--d~~~~~~~W~~~i~~~  496 (499)
                        |||++-  |...+.++|+++||++
T Consensus        97 ~~r~~~~lsaDt~eer~~W~~ain~~  122 (122)
T cd01263          97 IERLRVMLSADTKEERQTWLSLLNST  122 (122)
T ss_pred             eeEEEEEEecCCHHHHHHHHHHHhcC
Confidence              667644  6778999999999973

Anillin Pleckstrin homology (PH) domain. Anillin is an actin binding protein involved in cytokinesis. It has a C-terminal PH domain, which has been shown to be necessary, but not sufficient for targetting of anillin to ectopic septin containing foci . PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, a well as cytoskeletal associated molecules and in lipid associated enzymes.

>cd01237 Unc112 Unc-112 pleckstrin homology (PH) domain

Probab=98.62  E-value=5.4e-08  Score=79.76  Aligned_cols=74  Identities=12%  Similarity=0.145  Sum_probs=62.6

Q ss_pred             hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE---cCCCcEEEEcCC----ceEEEE-cCCccHHHHHHHH
Q 010859          422 SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTPK----KVLSFE-DAKQRASQWKKAI  493 (499)
Q Consensus       422 ~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p~----r~y~~~-d~~~~~~~W~~~i  493 (499)
                      ||+|||+|.+.-..||.++.....+|.|.++..++++..++   +.+..|.+.+|.    |+|+|. |.+.+..+|+.+.
T Consensus        20 ~KrrwF~lk~~~L~YyK~kee~~~~p~i~lnl~gcev~~dv~~~~~kf~I~l~~ps~~~~r~y~l~cdsEeqya~Wmaa~   99 (106)
T cd01237          20 YKQYWFTFRDTSISYYKSKEDSNGAPIGQLNLKGCEVTPDVNVAQQKFHIKLLIPTAEGMNEVWLRCDNEKQYAKWMAAC   99 (106)
T ss_pred             heeEEEEEeCCEEEEEccchhcCCCCeEEEecCceEEcccccccccceEEEEecCCccCCeEEEEECCCHHHHHHHHHHH
Confidence            89999999987777998888778899999999888887776   545666667898    999999 6679999999987


Q ss_pred             HH
Q 010859          494 EA  495 (499)
Q Consensus       494 ~~  495 (499)
                      .-
T Consensus       100 rl  101 (106)
T cd01237         100 RL  101 (106)
T ss_pred             HH
Confidence            54

Unc-112 pleckstrin homology (PH) domain. Unc-112 and related proteins contain two FERM domains with a PH domain between them. Both the PH and FERM domains have a PH-like fold. The FERM domains are likely responsible for the role of Unc-112 in organizing beta-integrin. The specific role of the Unc-112 PH domain is not known, but it is predicted to be involved in mediating membrane interactions. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>PRK09902 hypothetical protein; Provisional

Probab=98.60  E-value=5.9e-07  Score=83.89  Aligned_cols=139  Identities=16%  Similarity=0.200  Sum_probs=98.9

Q ss_pred             eecCceEEEEEEEcCCCceEEEEEEeCcc---cchhhHHHHHHHHHHHHHhCCCCC--ccEEEEEEE----cCCeEEEEE
Q 010859           64 GVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIVLDQLDHPG--VVRLFFTFQ----DTFSLYMAL  134 (499)
Q Consensus        64 G~G~~g~Vy~a~~~~t~~~vAiK~~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~--Iv~l~~~~~----~~~~l~lv~  134 (499)
                      |+||-|.|+.....  |..|-+|.-....   .........+.+|...|..|..-+  +.++...-.    -...-+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            77999999998753  4467788654111   111234556778888887774221  444442211    123478999


Q ss_pred             eccCC-CChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC--EEEEecCCccc
Q 010859          135 ESCEG-GELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKP  204 (499)
Q Consensus       135 E~~~g-g~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~--vkL~DFG~a~~  204 (499)
                      |-+.| .+|.+++...  .+.++.....++.++..++.-||+.|+.|+|+.+.||+++.+|.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 5788877653  34577778899999999999999999999999999999987777  99999987753

>PF15413 PH_11: Pleckstrin homology domain; PDB: 3MDB_D 3FEH_A 3LJU_X 3FM8_C

Probab=98.60  E-value=6.9e-08  Score=81.65  Aligned_cols=87  Identities=21%  Similarity=0.247  Sum_probs=53.0

Q ss_pred             EEEeeehhhhhh---hccceEEee-cCCeEEEEC-------------CCCCeeeeeeeccCCCCceEE-E------EcCC
Q 010859          410 MISMVKKLQKLT---SKKVQLILT-NKPKLIYVD-------------PSKLVVKGNIIWSDNSNDLSI-Q------VSSP  465 (499)
Q Consensus       410 ~~g~~~k~~g~~---~k~r~~ilt-~~p~l~y~d-------------~~~~~~kg~i~~~~~~~~~~~-~------~~~~  465 (499)
                      ++|++.|..-.|   ||+|||||. |+-.+||..             +.....+|....+........ .      ....
T Consensus         1 k~G~l~K~~~~~~kgWk~RwFiL~k~~~L~YyK~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (112)
T PF15413_consen    1 KEGYLYKWGNKFGKGWKKRWFILRKDGVLSYYKIPRDKKDVRIIGEESSRVIRKGDWSISRRSSRIQGIKDKNPFGEIHL   80 (112)
T ss_dssp             EEEEEEE--TTS-S--EEEEEEEE-TTEEEEESS-------------TT-SB-SEEEE---GGGT-EEEES-T--SS-SS
T ss_pred             CCceEEEecCCCCcCccccEEEEEeCCEEEEeecccccccccccccchhceEeecccCcccccccccccccCCcccCcCC
Confidence            579998877653   999999999 777777777             344445555543332111221 1      0113


Q ss_pred             CcEEEEcCCceEEEE-cCCccHHHHHHHHHHh
Q 010859          466 SHFKIVTPKKVLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       466 ~~f~i~~p~r~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                      +.|.|.||.|||+|. |.+.+..+|+++|.++
T Consensus        81 ~~~~i~T~~kt~~l~~~t~~d~~~Wi~aL~~~  112 (112)
T PF15413_consen   81 KVFSIFTPTKTFHLRCETREDRYDWIEALQEA  112 (112)
T ss_dssp             EEEEEE-SS-EEEEEESSHHHHHHHHHHHHH-
T ss_pred             CCcEEECCCcEEEEEECCHHHHHHHHHHHHhC
Confidence            578899999999999 6668999999999863

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.48  E-value=1.9e-06  Score=82.39  Aligned_cols=133  Identities=17%  Similarity=0.161  Sum_probs=82.4

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCC--ccEEEEEEEcCCeEEEEEeccC
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--Iv~l~~~~~~~~~l~lv~E~~~  138 (499)
                      ..||+|..+.||+.    .|..+++|......     ....+.+|..+++.+..-+  +.+.+.+..+.....+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999984    25578899875432     2233677888888875333  4667777777888899999999


Q ss_pred             CCC-hH--------------HHH-------hhc--CCCCHHH-HHHHHH----------HHHHH-HHHHH----HCCcEe
Q 010859          139 GGE-LF--------------DQI-------TSK--GHLSEDE-ARFYTA----------EVVDA-LEYIH----SMGLIH  178 (499)
Q Consensus       139 gg~-L~--------------~~i-------~~~--~~l~e~~-~~~i~~----------qil~a-L~~LH----~~gIiH  178 (499)
                      |.+ +.              ..+       ..-  ....... ...+..          .+... ..+|.    ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 11              111       110  0011110 001100          11111 12222    124789


Q ss_pred             eecCCCCeeeCCCCCEEEEecCCcc
Q 010859          179 RDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       179 rDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      +|+.|.||++++++ +.|+||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.45  E-value=9.5e-07  Score=98.55  Aligned_cols=202  Identities=24%  Similarity=0.348  Sum_probs=148.3

Q ss_pred             HHHHHHHHHHHhCCCCCccEEEEEEEcCCe----EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 010859          100 AYVKLERIVLDQLDHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG  175 (499)
Q Consensus       100 ~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~----l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~g  175 (499)
                      ...+.|...+..+.|+|++.++.+--....    +.+..++|.+.++...+..-+..+...++.+..+++.||.|+|++.
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            344556777888899999999887654332    3455689999999999999999999999999999999999999997


Q ss_pred             cEeeecCCC---CeeeCCCCCEEEE--ecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCC--Ccc
Q 010859          176 LIHRDIKPE---NLLLTADGHIKIA--DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDL  248 (499)
Q Consensus       176 IiHrDlKp~---NILl~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~--sDi  248 (499)
                      ..|.-+...   +--.+..+.+.+.  ||+.++.+....           ......-+..+.+||......+..+  .|+
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-----------~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL  375 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-----------KSFSDLLAEIRNADEDLKENTAKKSRLTDL  375 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcc-----------cchhhcCccccccccccccccchhhhhhHH
Confidence            777766655   4445566677777  898887654322           1123345667888998877766544  699


Q ss_pred             hhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          249 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       249 wslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      |.+|..+..+..|..+-....   ....++      +........+++.+|+.-++++|+++     .+++.|||.+-
T Consensus       376 ~~lgll~~~~~~~~~i~~~~~---~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~-----~~ll~~~f~~~  439 (1351)
T KOG1035|consen  376 WCLGLLLLQLSQGEDISEKSA---VPVSLL------DVLSTSELLDALPKCLDEDSEERLSA-----LELLTHPFLRF  439 (1351)
T ss_pred             HHHHHHHhhhhhcCccccccc---chhhhh------ccccchhhhhhhhhhcchhhhhccch-----hhhhhchhccc
Confidence            999999999998765532111   111111      11222378899999999999999999     77999999864

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.44  E-value=3.2e-06  Score=80.24  Aligned_cols=140  Identities=20%  Similarity=0.181  Sum_probs=92.7

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhH-------------------H--HHHHHHHHHHHhCCC--CC
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-------------------T--AYVKLERIVLDQLDH--PG  116 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~-------------------~--~~~~~E~~~l~~l~h--p~  116 (499)
                      ...|+.|--+.||+|.. .++..+|+|++..........                   .  .-...|...|+++..  -.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677888889999986 458899999986532221110                   0  112335555666532  22


Q ss_pred             ccEEEEEEEcCCeEEEEEeccCCCCh-HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCE
Q 010859          117 VVRLFFTFQDTFSLYMALESCEGGEL-FDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHI  194 (499)
Q Consensus       117 Iv~l~~~~~~~~~l~lv~E~~~gg~L-~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~v  194 (499)
                      +.+-+.++    .-.+||||+....+ .-.++. -.+..+++..+..+++..+.-|-. .|+||+||..-|||+. ++.+
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            33333333    23689999954311 111111 123444788899999999999876 9999999999999998 8899


Q ss_pred             EEEecCCccccC
Q 010859          195 KIADFGSVKPMQ  206 (499)
Q Consensus       195 kL~DFG~a~~~~  206 (499)
                      .|+|||.|....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999987543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.36  E-value=6.9e-06  Score=78.05  Aligned_cols=137  Identities=26%  Similarity=0.296  Sum_probs=80.6

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCC--CccEEEEEE---EcCCeEEEEE
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP--GVVRLFFTF---QDTFSLYMAL  134 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--~Iv~l~~~~---~~~~~l~lv~  134 (499)
                      ++.|+.|..+.||++....  ..+++|+....     .....+..|..+++.+...  .+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5689999999999999855  48999986443     3345566777777777432  244555533   2344589999


Q ss_pred             eccCCCChHH----------------HHh---hc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 010859          135 ESCEGGELFD----------------QIT---SK----GHLSEDE------ARFY---------------TAEVVD-ALE  169 (499)
Q Consensus       135 E~~~gg~L~~----------------~i~---~~----~~l~e~~------~~~i---------------~~qil~-aL~  169 (499)
                      ++++|..+..                .+.   ..    ..+....      ....               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                111   11    0111000      0000               111222 233


Q ss_pred             HHHH-------CCcEeeecCCCCeeeC-CCCCEEEEecCCcc
Q 010859          170 YIHS-------MGLIHRDIKPENLLLT-ADGHIKIADFGSVK  203 (499)
Q Consensus       170 ~LH~-------~gIiHrDlKp~NILl~-~~~~vkL~DFG~a~  203 (499)
                      .++.       ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3332       3599999999999999 66677899999875

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1090 consensus Predicted dual-specificity phosphatase [General function prediction only]

Probab=98.34  E-value=1.5e-07  Score=101.40  Aligned_cols=100  Identities=23%  Similarity=0.289  Sum_probs=76.8

Q ss_pred             cccccC-CCceEEEEEeeehhhhhh--hccceEEeec-CCeEEEECC-CCCeeeeeeeccCCCCceEEEEc---CCCcEE
Q 010859          398 WQQFLD-PGESVLMISMVKKLQKLT--SKKVQLILTN-KPKLIYVDP-SKLVVKGNIIWSDNSNDLSIQVS---SPSHFK  469 (499)
Q Consensus       398 ~~~~~~-~~~~i~~~g~~~k~~g~~--~k~r~~ilt~-~p~l~y~d~-~~~~~kg~i~~~~~~~~~~~~~~---~~~~f~  469 (499)
                      +.+|-. +.+.-+.+|.+.|+|.+-  ||.|||||.. .+.|+|+|- ...+.||.|.|-...++.-+-.|   .++-|.
T Consensus      1623 y~qf~s~~teNr~~eG~LyKrGA~lK~Wk~RwFVLd~~khqlrYYd~~edt~pkG~IdLaevesv~~~~~k~vdekgffd 1702 (1732)
T KOG1090|consen 1623 YRQFMSPPTENRIPEGYLYKRGAKLKLWKPRWFVLDPDKHQLRYYDDFEDTKPKGCIDLAEVESVALIGPKTVDEKGFFD 1702 (1732)
T ss_pred             hhhhcCCcccccCcccchhhcchhhcccccceeEecCCccceeeecccccccccchhhhhhhhhhcccCccccCccceee
Confidence            455543 355678899999999866  9999999987 888877665 56789999999876333221112   246789


Q ss_pred             EEcCCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          470 IVTPKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       470 i~~p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      ++|.+|+|.|..-+ +.|++|+++|+..+
T Consensus      1703 lktt~rvynf~a~nin~AqqWve~iqscl 1731 (1732)
T KOG1090|consen 1703 LKTTNRVYNFCAQNINLAQQWVECIQSCL 1731 (1732)
T ss_pred             eehhhHHHHHHhccchHHHHHHHHHHHhh
Confidence            99999999999666 89999999999865

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.34  E-value=2.5e-06  Score=90.31  Aligned_cols=140  Identities=21%  Similarity=0.301  Sum_probs=87.4

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh-----------------------------hHHHHH------HHH
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------------------------NKTAYV------KLE  105 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~-----------------------------~~~~~~------~~E  105 (499)
                      +.||..+.|+||+|+.+. |+.||||+-... +.+.                             .....+      .+|
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            578999999999999887 999999985432 1110                             000111      112


Q ss_pred             HH----HHHhCCCCC------ccEEEEEEEcCCeEEEEEeccCCCChHH--HHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 010859          106 RI----VLDQLDHPG------VVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIHS  173 (499)
Q Consensus       106 ~~----~l~~l~hp~------Iv~l~~~~~~~~~l~lv~E~~~gg~L~~--~i~~~~~l~e~~~~~i~~qil~aL~~LH~  173 (499)
                      .+    +.+.+.|-+      |.++|..+  ...-.++||||+|..+.+  .|.+.+ ++...+...+.+...  +-|=.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf~  319 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIFK  319 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHHh
Confidence            22    222233444      34444333  334789999999987754  455554 554433333322222  11235


Q ss_pred             CCcEeeecCCCCeeeCC----CCCEEEEecCCccccCC
Q 010859          174 MGLIHRDIKPENLLLTA----DGHIKIADFGSVKPMQD  207 (499)
Q Consensus       174 ~gIiHrDlKp~NILl~~----~~~vkL~DFG~a~~~~~  207 (499)
                      .|++|+|-+|.||++..    ++.+.+.|||+...+..
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            78999999999999994    56899999999876643

>cd01253 PH_beta_spectrin Beta-spectrin pleckstrin homology (PH) domain

Probab=98.34  E-value=1.7e-06  Score=72.21  Aligned_cols=76  Identities=16%  Similarity=0.244  Sum_probs=54.2

Q ss_pred             hhhccceEEeecCCeEEEECCCCC--eeeeeeeccCCCCceEEE---EcCCCcEEEEcC-CceEEEE-cCCccHHHHHHH
Q 010859          420 LTSKKVQLILTNKPKLIYVDPSKL--VVKGNIIWSDNSNDLSIQ---VSSPSHFKIVTP-KKVLSFE-DAKQRASQWKKA  492 (499)
Q Consensus       420 ~~~k~r~~ilt~~p~l~y~d~~~~--~~kg~i~~~~~~~~~~~~---~~~~~~f~i~~p-~r~y~~~-d~~~~~~~W~~~  492 (499)
                      -.|++|+++|++.-..||.|+...  ...|+||++-....+.+.   .+.++.|.|.++ +++|+|. +.+.++++|+.+
T Consensus        21 ~~Wk~r~~vL~~~~L~~ykd~~~~~~~~~~~~~i~l~~~~i~~~~~~~k~~~~F~l~~~~~~~~~f~a~s~e~~~~Wi~a  100 (104)
T cd01253          21 RSWDNVYGVLCGQSLSFYKDEKMAAENVHGEPPVDLTGAQCEVASDYTKKKHVFRLRLPDGAEFLFQAPDEEEMSSWVRA  100 (104)
T ss_pred             CCcceEEEEEeCCEEEEEecCcccccCCCCCCcEeccCCEEEecCCcccCceEEEEEecCCCEEEEECCCHHHHHHHHHH
Confidence            459999999999888899988643  445655655422222222   144688999765 6999998 555899999999


Q ss_pred             HHH
Q 010859          493 IEA  495 (499)
Q Consensus       493 i~~  495 (499)
                      |+.
T Consensus       101 L~~  103 (104)
T cd01253         101 LKS  103 (104)
T ss_pred             Hhc
Confidence            974

Beta-spectrin pleckstrin homology (PH) domain. Beta spectrin binds actin and functions as a major component of the cytoskeleton underlying cellular membranes. Beta spectrin consists of multiple spectrin repeats followed by a PH domain, which binds to Inositol-1,4,5-Trisphosphate. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. PH domains are often involved in targeting proteins to the plasma membrane via lipid binding. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.31  E-value=2.2e-05  Score=72.86  Aligned_cols=128  Identities=23%  Similarity=0.291  Sum_probs=87.7

Q ss_pred             CCeeeeeEeeecCc-eEEEEEEEcCCCceEEEEEEeC---cc-------cc-hh-------hHHHHHHHHHHHHHh---C
Q 010859           55 QDFELGKIYGVGSY-SKVVRAKKIDTGTVYALKIMDK---KF-------IT-KE-------NKTAYVKLERIVLDQ---L  112 (499)
Q Consensus        55 ~~y~~~~~LG~G~~-g~Vy~a~~~~t~~~vAiK~~~~---~~-------~~-~~-------~~~~~~~~E~~~l~~---l  112 (499)
                      .++++++.||.|+- |.||+++.  .|+.||+|+...   ..       .. .+       ....-+..|-....+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            79999999999999 99999987  678999999322   00       00 00       112234456554444   4


Q ss_pred             CCCCc--cEEEEEEEcC------------------CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 010859          113 DHPGV--VRLFFTFQDT------------------FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH  172 (499)
Q Consensus       113 ~hp~I--v~l~~~~~~~------------------~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH  172 (499)
                      ++.++  |++|+++--.                  -...||.||++...         .+    ...-+.+|+.-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence            56677  8888887211                  11356777765532         12    2334567788888899


Q ss_pred             HCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          173 SMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       173 ~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      ..||+-+|+++.|..     .-||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999986     3489999974

>smart00233 PH Pleckstrin homology domain

Probab=98.29  E-value=1.7e-06  Score=70.14  Aligned_cols=87  Identities=20%  Similarity=0.235  Sum_probs=67.2

Q ss_pred             EEEEeeehhhh---hhhccceEEeecCCeEEEECCCC---CeeeeeeeccCCCCceEEEEc-----CCCcEEEEcCCc-e
Q 010859          409 LMISMVKKLQK---LTSKKVQLILTNKPKLIYVDPSK---LVVKGNIIWSDNSNDLSIQVS-----SPSHFKIVTPKK-V  476 (499)
Q Consensus       409 ~~~g~~~k~~g---~~~k~r~~ilt~~p~l~y~d~~~---~~~kg~i~~~~~~~~~~~~~~-----~~~~f~i~~p~r-~  476 (499)
                      +++|+|.++.+   ..|++|+++|+++-..+|.++..   ....+.|+++..  .+.....     ....|.|.++++ +
T Consensus         2 ~~~G~l~~~~~~~~~~~~~~~~~L~~~~l~~~~~~~~~~~~~~~~~i~l~~~--~v~~~~~~~~~~~~~~f~l~~~~~~~   79 (102)
T smart00233        2 IKEGWLYKKSGGKKKSWKKRYFVLFNSTLLYYKSEKAKKDYKPKGSIDLSGI--TVREAPDPDSAKKPHCFEIKTADRRS   79 (102)
T ss_pred             ceeEEEEEeCCCccCCceEEEEEEECCEEEEEeCCCccccCCCceEEECCcC--EEEeCCCCccCCCceEEEEEecCCce
Confidence            57899988774   34999999999977777777654   567899999985  2222222     367899998887 9


Q ss_pred             EEEEcC-CccHHHHHHHHHHhc
Q 010859          477 LSFEDA-KQRASQWKKAIEALQ  497 (499)
Q Consensus       477 y~~~d~-~~~~~~W~~~i~~~~  497 (499)
                      |+|..+ ..++.+|+++|+.++
T Consensus        80 ~~f~~~s~~~~~~W~~~i~~~~  101 (102)
T smart00233       80 YLLQAESEEEREEWVDALRKAI  101 (102)
T ss_pred             EEEEcCCHHHHHHHHHHHHHhh
Confidence            999855 589999999999865

Domain commonly found in eukaryotic signalling proteins. The domain family possesses multiple functions including the abilities to bind inositol phosphates, and various proteins. PH domains have been found to possess inserted domains (such as in PLC gamma, syntrophins) and to be inserted within other domains. Mutations in Brutons tyrosine kinase (Btk) within its PH domain cause X-linked agammaglobulinaemia (XLA) in patients. Point mutations cluster into the positively charged end of the molecule around the predicted binding site for phosphatidylinositol lipids.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.25  E-value=5.6e-06  Score=74.52  Aligned_cols=130  Identities=22%  Similarity=0.280  Sum_probs=94.8

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCcc-EEEEEEEcCCeEEEEEe
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFSLYMALE  135 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv-~l~~~~~~~~~l~lv~E  135 (499)
                      -++.+.||+|.+|.||++..  .|..+|+|+-..+     .....+..|.++|..+.-.++. ++|.+-.+.    +.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhh
Confidence            35677899999999999988  4669999985433     3445577899999988776665 455544333    4499


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecC-CCCeeeCCCCCEEEEecCCccc
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK-PENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlK-p~NILl~~~~~vkL~DFG~a~~  204 (499)
                      |+.|-.|.+.-...       -+.-+..++++---|-..||-|+.|. |..++|..++.+-|+||..|+.
T Consensus        93 ~i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            99997886644321       13344556666556778899999998 7777777777999999999874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.14  E-value=2.1e-05  Score=76.04  Aligned_cols=134  Identities=18%  Similarity=0.087  Sum_probs=81.2

Q ss_pred             EeeecCc-eEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEeccCC
Q 010859           62 IYGVGSY-SKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEG  139 (499)
Q Consensus        62 ~LG~G~~-g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~lv~E~~~g  139 (499)
                      .|..|.. +.||++...  +..+.+|+.....      ...+..|..+++.+. +--+.+++.+.......++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3445555 789999753  4678889865432      223556777777773 33456777777776778999999998


Q ss_pred             CChHHHH-------------------hhcC----CCCHH------HHHHH-------------------HHHHHHHHHHH
Q 010859          140 GELFDQI-------------------TSKG----HLSED------EARFY-------------------TAEVVDALEYI  171 (499)
Q Consensus       140 g~L~~~i-------------------~~~~----~l~e~------~~~~i-------------------~~qil~aL~~L  171 (499)
                      .+|....                   ..-.    ++...      .....                   ..+++..|...
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            7765331                   0000    11100      00000                   11111111110


Q ss_pred             ----HHCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          172 ----HSMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       172 ----H~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                          ....++|+|+.|.|||++.++.+.|+||+.|.
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                12348999999999999988778899999875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.06  E-value=4.9e-05  Score=86.37  Aligned_cols=146  Identities=18%  Similarity=0.314  Sum_probs=91.2

Q ss_pred             eeeEeeecCceEEEEEEEcCCC--ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCc--cEEEEEEEcC---CeE
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGV--VRLFFTFQDT---FSL  130 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~--~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~I--v~l~~~~~~~---~~l  130 (499)
                      -++.|+.|.++.+|+......+  ..+++|+.......  .....+.+|..+|+.+. |+++  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            3677899999999998765432  46788875433211  12345778999999885 6654  7778777664   467


Q ss_pred             EEEEeccCCCChHH--------------------HHh---hc----------CC---CCHHHHHHHHHH-----------
Q 010859          131 YMALESCEGGELFD--------------------QIT---SK----------GH---LSEDEARFYTAE-----------  163 (499)
Q Consensus       131 ~lv~E~~~gg~L~~--------------------~i~---~~----------~~---l~e~~~~~i~~q-----------  163 (499)
                      |+||||++|..+.+                    .+.   .-          +.   ....++..+..+           
T Consensus       120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~  199 (822)
T PLN02876        120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP  199 (822)
T ss_pred             eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence            99999999854321                    111   10          00   001122221111           


Q ss_pred             ----HHHHHHHHHH-----------CCcEeeecCCCCeeeCCC-CC-EEEEecCCccccC
Q 010859          164 ----VVDALEYIHS-----------MGLIHRDIKPENLLLTAD-GH-IKIADFGSVKPMQ  206 (499)
Q Consensus       164 ----il~aL~~LH~-----------~gIiHrDlKp~NILl~~~-~~-vkL~DFG~a~~~~  206 (499)
                          +...+.+|..           ..+||+|++|.|||++.+ +. +-|.||+++..-.
T Consensus       200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence                2233455632           249999999999999853 34 5799999987543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.06  E-value=1.9e-07  Score=105.87  Aligned_cols=254  Identities=14%  Similarity=0.016  Sum_probs=167.9

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeC---cccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--C
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK---KFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--T  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~  127 (499)
                      .+.++++.--+|-|.++.--.-+.+..+  +.+|+...   ....+. ..+....|++.++...|+++...+.-..+  .
T Consensus      1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LseP-lkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEP-LKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred             HhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhH-HHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence            3456777666676666543222222222  34444422   111111 22333446666777889999888776654  3


Q ss_pred             CeEEEEEeccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeeecCCCCeeeCCCCCEEEEe
Q 010859          128 FSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMG-----LIHRDIKPENLLLTADGHIKIAD  198 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~g-----IiHrDlKp~NILl~~~~~vkL~D  198 (499)
                      ...|.+++||.+|.++..|.+.    ..+++.-+.....+.+.+..-+|+..     .+|++||+-|.+|..+..+|+++
T Consensus      1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred             hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence            4579999999999999998764    23444444445555577777777542     68999999999999999999999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 010859          199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  278 (499)
Q Consensus       199 FG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~  278 (499)
                      +|+.++..+.          ....+..++++.|++|++.+.-.++.++|+|..||-+|....|..+|........-..+.
T Consensus      1384 ~gLdKIknp~----------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiid 1453 (2724)
T KOG1826|consen 1384 GGLDKIKNPV----------LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIID 1453 (2724)
T ss_pred             cccccccCch----------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccc
Confidence            9999844322          233456788999999999988888888999999999999999988875432222111111


Q ss_pred             hc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          279 AR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       279 ~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .. ..+++...|.++-.....+|-..-..||+-     ...+.-+.|
T Consensus      1454 n~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q-----~isls~d~~ 1495 (2724)
T KOG1826|consen 1454 NHTFFSIEKLKPGDANVEALHRLLWKYMERPGQ-----YISLSRDHF 1495 (2724)
T ss_pred             ccccccccccCCCcccHHHHHHHHHHhhhcchh-----hhhcccccc
Confidence            11 234455556667666677777777889875     455555555

>cd01218 PH_phafin2 Phafin2 Pleckstrin Homology (PH) domain

Probab=98.03  E-value=3.8e-05  Score=63.66  Aligned_cols=88  Identities=18%  Similarity=0.255  Sum_probs=66.7

Q ss_pred             CceEEEEEeeehhhhhhhccceEEeecCCeEEEECC----CCCeeeeeeeccCCCCceEEEEc-C----CCcEEEEcCCc
Q 010859          405 GESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP----SKLVVKGNIIWSDNSNDLSIQVS-S----PSHFKIVTPKK  475 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~----~~~~~kg~i~~~~~~~~~~~~~~-~----~~~f~i~~p~r  475 (499)
                      |+-.+++|.+.|.-..-.+.|+|.|=+. .|+|-..    ..-+..+.|||..    +.++.. .    ++.|.|.+|.|
T Consensus         1 gR~li~eG~L~K~~rk~~~~R~ffLFnD-~LvY~~~~~~~~~~~~~~~i~L~~----~~v~~~~d~~~~~n~f~I~~~~k   75 (104)
T cd01218           1 GRVLVGEGVLTKMCRKKPKQRQFFLFND-ILVYGNIVISKKKYNKQHILPLEG----VQVESIEDDGIERNGWIIKTPTK   75 (104)
T ss_pred             CCEEEecCcEEEeecCCCceEEEEEecC-EEEEEEeecCCceeeEeeEEEccc----eEEEecCCcccccceEEEecCCe
Confidence            3456888988887766677799998888 5666543    1235568999997    455432 2    48999999999


Q ss_pred             eEEEEcCC-ccHHHHHHHHHHhc
Q 010859          476 VLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       476 ~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      ++.+..++ .+-.+|+++|++++
T Consensus        76 Sf~v~A~s~~eK~eWl~~i~~ai   98 (104)
T cd01218          76 SFAVYAATETEKREWMLHINKCV   98 (104)
T ss_pred             EEEEEcCCHHHHHHHHHHHHHHH
Confidence            99999655 78999999999876

Phafin2 Pleckstrin Homology (PH) domain. Phafin contains a PH domain and a FYVE domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>cd00821 PH Pleckstrin homology (PH) domain

Probab=98.01  E-value=1.5e-05  Score=63.86  Aligned_cols=83  Identities=20%  Similarity=0.281  Sum_probs=64.0

Q ss_pred             EEeeehhhh---hhhccceEEeecCCeEEEECCCC---CeeeeeeeccCCCCceEEEEc---CCCcEEEEcCC-ceEEEE
Q 010859          411 ISMVKKLQK---LTSKKVQLILTNKPKLIYVDPSK---LVVKGNIIWSDNSNDLSIQVS---SPSHFKIVTPK-KVLSFE  480 (499)
Q Consensus       411 ~g~~~k~~g---~~~k~r~~ilt~~p~l~y~d~~~---~~~kg~i~~~~~~~~~~~~~~---~~~~f~i~~p~-r~y~~~  480 (499)
                      +|+|.++.+   ..|++|+++|.+...++|.++..   ...++.|++...  .+.....   ....|.|.+++ ++|+|.
T Consensus         2 ~G~l~~~~~~~~~~w~~~~~~L~~~~l~~~~~~~~~~~~~~~~~i~l~~~--~v~~~~~~~~~~~~f~i~~~~~~~~~~~   79 (96)
T cd00821           2 EGYLLKKTGKLRKGWKRRWFVLFNDLLLYYKKKSSKKSYKPKGSIPLSGA--EVEESPDDSGRKNCFEIRTPDGRSYLLQ   79 (96)
T ss_pred             cchhhhhhChhhCCccEEEEEEECCEEEEEECCCCCcCCCCcceEEcCCC--EEEECCCcCCCCcEEEEecCCCcEEEEE
Confidence            577877665   35999999999887777777765   688899999974  2333333   25799999877 999998


Q ss_pred             cC-CccHHHHHHHHHH
Q 010859          481 DA-KQRASQWKKAIEA  495 (499)
Q Consensus       481 d~-~~~~~~W~~~i~~  495 (499)
                      .. ..++..|+++|+.
T Consensus        80 ~~s~~~~~~W~~~l~~   95 (96)
T cd00821          80 AESEEEREEWIEALQS   95 (96)
T ss_pred             eCCHHHHHHHHHHHhc
Confidence            55 4799999999986

Pleckstrin homology (PH) domain. PH domains are only found in eukaryotes. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	499
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-70
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-70
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-70
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-69
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-69
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-69
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-69
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-69
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-69
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-69
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-69
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-69
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-69
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-69
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-69
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-69
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-69
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-69
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-69
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-68
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-68
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-51
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-50
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-49
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-49
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-49
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-48
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-47
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-46
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-46
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-46
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-46
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-46
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-46
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-45
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-45
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-45
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-45
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-45
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-45
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-45
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-45
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-45
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-45
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-45
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-45
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-45
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-45
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-45
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-45
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-45
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-45
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-44
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-44
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-44
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-44
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-44
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-44
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-44
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-44
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-44
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-44
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-44
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-44
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-44
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-44
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-44
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-44
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-44
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-44
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-44
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-44
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-44
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-44
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-44
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-43
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-43
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-43
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-43
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-43
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-43
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-43
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-43
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-43
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-43
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-43
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-43
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-43
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-43
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-43
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-43
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-43
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-43
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-43
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-43
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-43
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-42
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-42
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-42
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-42
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-42
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-42
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-41
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-40
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-39
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-39
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-39
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-39
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-38
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-38
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-38
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-38
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-38
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-35
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-35
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-35
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-35
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-35
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-35
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-35
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-34
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-34
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-34
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-34
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-34
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-34
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-34
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-34
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-34
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-34
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-34
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-33
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-33
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-33
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-33
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-33
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-33
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-33
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-33
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-33
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-33
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-33
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-33
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-33
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-33
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-33
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-33
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-33
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-33
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-33
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-33
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-33
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-33
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-33
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-33
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-33
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-33
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-33
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-33
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-33
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-32
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-32
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-32
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-32
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-32
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-32
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-32
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-32
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-32
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-31
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-30
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-30
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-30
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-30
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-30
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-30
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-30
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-30
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-30
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-30
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-30
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-30
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-30
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-30
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-30
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-30
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-29
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-29
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-29
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-29
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-29
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-29
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-29
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-29
3soa_A	444	Full-Length Human Camkii Length = 444		6e-29
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-29
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-29
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-28
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-28
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-28
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-28
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-28
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-28
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-28
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-28
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-28
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-28
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-28
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-28
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-28
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-28
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-27
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-27
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-27
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-27
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-27
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-27
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-27
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-27
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-26
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-26
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-26
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-26
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-26
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-26
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-26
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-25
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-25
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-25
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-25
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-25
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-25
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-25
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-25
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-25
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-25
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-25
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-25
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-25
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-25
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-25
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-25
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-25
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-25
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-25
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-25
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-25
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-25
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-25
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-25
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-25
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-25
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-25
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-25
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-25
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-25
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-25
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-25
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-25
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-24
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-24
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-24
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-24
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-24
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-24
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-24
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-24
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-24
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-24
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-24
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-24
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-23
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-23
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-23
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-23
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-23
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-23
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-23
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-23
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-23
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-23
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-23
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-23
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-23
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-23
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-23
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-23
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-23
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-23
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-23
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-23
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-23
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-23
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-23
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-23
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-23
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-23
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-23
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-22
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-22
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-22
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-22
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-22
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-22
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-22
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-22
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-22
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-21
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-21
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-21
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-21
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-21
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-20
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-20
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-20
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-20
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-20
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-20
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-20
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-20
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-20
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-20
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-20
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-20
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-20
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-20
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-20
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-20
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-20
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-20
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-20
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-20
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-20
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-20
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-20
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-20
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-19
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-19
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-19
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-19
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-19
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-19
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		9e-19
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-19
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-18
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-18
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-18
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-18
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-18
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-18
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-18
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-18
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-18
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-18
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-17
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-17
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-17
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-17
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-17
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-17
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-17
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-17
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-17
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-17
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-17
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-17
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-17
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-17
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-17
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-17
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-17
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-17
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-17
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-17
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-17
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-17
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-17
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-17
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-17
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-17
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-17
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-17
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-17
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-17
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-17
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-17
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-17
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-17
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-16
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-16
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-16
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-15
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-14
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-13
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-13
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-13
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		9e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		9e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-11
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-10
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		8e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		7e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-08
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-08
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-07
1w1d_A	151	Crystal Structure Of The Pdk1 Pleckstrin Homology (		3e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-07
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		6e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-07
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-07
2vki_A	148	Structure Of The Pdk1 Ph Domain K465e Mutant Length		8e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-06

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  262 bits (669), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 175/289 (60%), Gaps = 9/289 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 200
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 342
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 261 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 309

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  261 bits (666), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 174/289 (60%), Gaps = 9/289 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANAFVGTAQYVSP 201
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 342
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 310

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  261 bits (666), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 174/289 (60%), Gaps = 9/289 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 200
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 342
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 261 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 309

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  260 bits (665), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 185
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 245
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 246 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 292

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  260 bits (665), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 174/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 204
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 265 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 311

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  260 bits (665), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 174/289 (60%), Gaps = 9/289 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 201
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 342
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 310

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  260 bits (665), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 179
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 286

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/288 (46%), Positives = 173/288 (60%), Gaps = 9/288 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 181
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 241
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLA 341
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL 
Sbjct: 242 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 289

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/288 (46%), Positives = 173/288 (60%), Gaps = 9/288 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 178
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 238
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLA 341
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL 
Sbjct: 239 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 286

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  259 bits (663), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 201
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  259 bits (663), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  259 bits (663), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 204
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 265 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 311

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  259 bits (663), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  259 bits (662), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 206
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARD 266
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 267 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 313

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  258 bits (660), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 132/286 (46%), Positives = 172/286 (60%), Gaps = 9/286 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 180
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 240
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPK 339
                     + R G     GY  LK HPFF+ + W+N+  QTPPK
Sbjct: 241 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 286

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  258 bits (659), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 172/287 (59%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S  V A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 201
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  258 bits (658), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 172/287 (59%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+F FQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 208
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 268
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 269 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 315

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  258 bits (658), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 174/287 (60%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + G L   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 203
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A+  +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  255 bits (652), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 171/287 (59%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E LIF +II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARD 263
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  255 bits (651), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 171/287 (59%), Gaps = 9/287 (3%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 294
           E+L    A   +DLWALGC +YQ+++G  PF+  +E LIF +II  +  FP  F      
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARD 263
Query: 295 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  198 bits (503), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 113/322 (35%), Positives = 169/322 (52%), Gaps = 22/322 (6%)
Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK-TAY 101
           R P E    + FEL ++ G G Y KV + +K+   +TG ++A+K++ K  I +  K TA+
Sbjct: 9   RGP-EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 102 VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 161
            K ER +L+++ HP +V L + FQ    LY+ LE   GGELF Q+  +G   ED A FY 
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDD 220
           AE+  AL ++H  G+I+RD+KPEN++L   GH+K+ DFG  K  + D  +T         
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--------- 178
Query: 221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
              TF GT  Y+ PE+L  S      D W+LG  +Y ML+G  PF   +      +I+  
Sbjct: 179 --HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 281 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
            +  P Y +               + R GAGPG    ++ HPFF+ I+W+ +  R   PP
Sbjct: 237 KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP 296
Query: 339 KLASEPMVQSGEGDDVHDSSWN 360
               +P++QS E     DS + 
Sbjct: 297 ---FKPLLQSEEDVSQFDSKFT 315

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 112/322 (34%), Positives = 168/322 (52%), Gaps = 22/322 (6%)
Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK-TAY 101
           R P E    + FEL ++ G G Y KV + +K+   +TG ++A+K++ K  I +  K TA+
Sbjct: 9   RGP-EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 102 VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 161
            K ER +L+++ HP +V L + FQ    LY+ LE   GGELF Q+  +G   ED A FY 
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDD 220
           AE+  AL ++H  G+I+RD+KPEN++L   GH+K+ DFG  K  + D  +T         
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--------- 178
Query: 221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
               F GT  Y+ PE+L  S      D W+LG  +Y ML+G  PF   +      +I+  
Sbjct: 179 --HXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 281 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
            +  P Y +               + R GAGPG    ++ HPFF+ I+W+ +  R   PP
Sbjct: 237 KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP 296
Query: 339 KLASEPMVQSGEGDDVHDSSWN 360
               +P++QS E     DS + 
Sbjct: 297 ---FKPLLQSEEDVSQFDSKFT 315

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 101/304 (33%), Positives = 164/304 (53%), Gaps = 20/304 (6%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           +S+QDF++ +  G GS+ +V   +    G  YA+K++ K+ + +  +  +   ER++L  
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           + HP ++R++ TFQD   ++M ++  EGGELF  +          A+FY AEV  ALEY+
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  +I+RD+KPEN+LL  +GHIKI DFG  K + D                   GT  Y
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-------------TYXLCGTPDY 169
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEV+++ P     D W+ G  +Y+ML+G +PF D++    +++I+  ++RFP +F+  
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG---QTPPKLASEPMVQS 348
                        S R G    G   +K HP+FK + W+ +     +TP     EP +Q 
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP----YEPPIQQ 285
Query: 349 GEGD 352
           G+GD
Sbjct: 286 GQGD 289

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  192 bits (487), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 57  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           FEL K+ G GS+ KV   KKI   D   +YA+K++ KK   K       K+ER +L +++
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVN 85
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 145
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMA 195
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PEV+N    T   D W+ G  +++ML+GT PF+          I+   +  P + S    
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 255
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                     P+ R GAGP G   +K H FF  IDW  +  R   PP
Sbjct: 256 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 302

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  191 bits (486), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 57  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           FEL K+ G GS+ KV   KKI   D   +YA+K++ KK   K       K+ER +L +++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVN 84
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMA 194
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PEV+N    T   D W+ G  +++ML+GT PF+          I+   +  P + S    
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                     P+ R GAGP G   +K H FF  IDW  +  R   PP
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  191 bits (484), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 57  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           FEL K+ G GS+ KV   KKI   D   +YA+K++ KK   K       K+ER +L +++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVN 84
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMA 194
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PEV+N    T   D W+ G  +++ML+GT PF+          I+   +  P + S    
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                     P+ R GAGP G   +K H FF  IDW  +  R   PP
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  187 bits (474), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/287 (34%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 57  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           FEL K+ G GS+ KV   +K+   D+G +YA+K++ KK   K       K+ER +L  ++
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVL-KKATLKVRDRVRTKMERDILADVN 88
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP VV+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+   L+++HS
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS 148
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAID----------HEKKAYSFCGTVEYMA 198
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PEV+N    +   D W+ G  +++ML+G+ PF+          I+   +  P + S    
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQ 258
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                     P+ R G+GP G   +K H F+  IDW  +  R   PP
Sbjct: 259 SLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPP 305

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  183 bits (465), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 125
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 231
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD     TF GT  Y
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 174
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 234
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
                       P  R G GP     +  H FF  I+W+++
Sbjct: 235 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 275

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 231
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD     TF GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 171
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 231
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD     TF GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 171
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  181 bits (459), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 231
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 171
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  181 bits (459), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 231
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 171
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  181 bits (459), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 231
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 171
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 127
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 231
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 176
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 236
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
                       P  R G GP     +  H FF  I+W+++
Sbjct: 237 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 277

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 95/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 154/290 (53%), Gaps = 23/290 (7%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
             +QDF+L ++ G GSY+KV+  +   T  +YA++++ K+ +  +    +V+ E+ V +Q
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 112 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D   TF GT  
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFCGTPN 218
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 280
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 277
Query: 281 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDW 329
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 102/294 (34%), Positives = 150/294 (51%), Gaps = 13/294 (4%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+   ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL    HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V A
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 168 LEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L+Y+HS   +++RD+K ENL+L  DGHIKI DFG  K       T+           TF 
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------TFC 310
Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           GT  Y+ PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP 
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 370
Query: 287 YFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                            P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 424

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +  T  GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWTLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/294 (34%), Positives = 150/294 (51%), Gaps = 13/294 (4%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+   ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  
Sbjct: 144 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 203
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL    HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V A
Sbjct: 204 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 263
Query: 168 LEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L+Y+HS   +++RD+K ENL+L  DGHIKI DFG  K       T+           TF 
Sbjct: 264 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------TFC 313
Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           GT  Y+ PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP 
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 373
Query: 287 YFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                            P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 374 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 427

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 153/290 (52%), Gaps = 23/290 (7%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
             +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 112 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D    F GT  
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSXFCGTPN 171
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 280
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 172 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 230
Query: 281 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDW 329
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 231 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 280

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 104/327 (31%), Positives = 166/327 (50%), Gaps = 28/327 (8%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
             +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 112 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D    F GT  
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSXFCGTPN 186
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 280
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 187 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 245
Query: 281 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ--TP 337
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW  +  +   P
Sbjct: 246 QIRIPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVP 305
Query: 338 PKLASEPMVQSGEGDDVHDSSWNPSHI 364
           P    +P +    G D  DS +    +
Sbjct: 306 P---FKPNISGEFGLDNFDSQFTNERV 329

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GG++F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +  T  GT  Y+ 
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWTLCGTPEYLA 192
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 252
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 253 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 288

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GG++F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  179 bits (453), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 153/290 (52%), Gaps = 23/290 (7%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
             +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 112 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D    F GT  
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSXFCGTPN 175
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 280
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 234
Query: 281 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDW 329
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 235 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  178 bits (451), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  178 bits (451), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G  P G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFATTDW 302

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P + +L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P + +L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  +  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +   ++
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM LE   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 199
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 260 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 295

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 227
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 288 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 323

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  175 bits (444), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++ +               T  GT  Y+ 
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA-------------TWTLCGTPEYLA 227
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 288 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 323

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +YQM +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  175 bits (443), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P + +L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  175 bits (443), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 149/289 (51%), Gaps = 13/289 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+H
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 125
Query: 173 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           S   +++RD+K ENL+L  DGHIKI DFG  K         + + A+    C   GT  Y
Sbjct: 126 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKXFC---GTPEY 175
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP      
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 235
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                       P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 236 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 284

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 149/289 (51%), Gaps = 13/289 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+H
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 127
Query: 173 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           S   +++RD+K ENL+L  DGHIKI DFG  K         + + A+    C   GT  Y
Sbjct: 128 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKXFC---GTPEY 177
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP      
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 237
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                       P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 238 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 286

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 199
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 260 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 295

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  174 bits (442), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 149/289 (51%), Gaps = 13/289 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+H
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 126
Query: 173 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           S   +++RD+K ENL+L  DGHIKI DFG  K         + + A+    C   GT  Y
Sbjct: 127 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKXFC---GTPEY 176
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP      
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 236
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                       P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 237 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 285

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  174 bits (441), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +  H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIXNHKWFATTDW 303

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLAGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 40  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 206
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 267 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLXGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 99/300 (33%), Positives = 159/300 (53%), Gaps = 20/300 (6%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLE 105
           E   I++FEL K+ G G+Y KV   +KI   DTG +YA+K++ K  I ++ KT  + + E
Sbjct: 49  EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 106 RIVLDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           R VL+ +   P +V L + FQ    L++ L+   GGELF  ++ +   +E E + Y  E+
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           V ALE++H +G+I+RDIK EN+LL ++GH+ + DFG  K            A   ++A  
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV---------ADETERAYD 219
Query: 225 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRII 278
           F GT  Y+ P+++    +      D W+LG  +Y++L+G SPF    +  S+  I +RI+
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 279 ARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
             +  +P   S              P  R G GP     +K H FF+ I+W ++  +  P
Sbjct: 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 339

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  +A+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L ++F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 26  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 85
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 86  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 192
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 252
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 253 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 289

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  +A+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L ++F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENL++   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  FE  K  G GS+ +V+  K  +TG  +A+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L ++F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  +E  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 34  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 93
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 94  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 200
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 260
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                       + R G    G   +K H +F   DW
Sbjct: 261 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 227
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 288 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 323

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 105/317 (33%), Positives = 162/317 (51%), Gaps = 21/317 (6%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD- 110
             I +FE  ++ G GS+ KV+ A+  +TG +YA+K++ K  I +++       E+ +L  
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
             +HP + +LF  FQ    L+  +E   GG+L   I       E  ARFY AE++ AL +
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H  G+I+RD+K +N+LL  +GH K+ADFG  K    + +T            TF GT  
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----------TATFCGTPD 189
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 290
           Y+ PE+L         D WA+G  LY+ML G +PF+  +E  +F+ I+  ++ +P +   
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249
Query: 291 XXXXXXXXXXXXXPSGRPGA-GPGGYAVLKMHPFFKGIDWK--NIRGQTPPKLASEPMVQ 347
                        P+ R G+   GG   +  HPFFK IDW   N R   PP     P ++
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP---FRPRIK 306
Query: 348 SGEGDDVHDSSWNPSHI 364
           S E  DV  S+++P  I
Sbjct: 307 SRE--DV--SNFDPDFI 319

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           P ++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      +   G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKAFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT   + 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEALA 206
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 293
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 294 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 329
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  168 bits (426), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 102/313 (32%), Positives = 160/313 (51%), Gaps = 19/313 (6%)
Query: 37  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           ++ +K F  +  Q     +DFE+ K+ G G++ +V   K  +   V+A+KI++K  + K 
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115
Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSED 155
            +TA  + ER VL   D   +  L + FQD  +LY+ ++   GG+L   ++  +  L E+
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLP 214
            ARFY AE+V A++ +H +  +HRDIKP+N+L+  +GHI++ADFGS +K M+D  +    
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV---- 231
Query: 215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTS 269
                 ++   VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S
Sbjct: 232 ------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285
Query: 270 EWLIFQRIIARDIR--FPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
               + +I+    R  FP   +               S     G  G    K HPFF GI
Sbjct: 286 LVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345
Query: 328 DWKNIRGQTPPKL 340
           DW NIR    P +
Sbjct: 346 DWDNIRNCEAPYI 358

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  168 bits (426), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 103/312 (33%), Positives = 160/312 (51%), Gaps = 17/312 (5%)
Query: 37  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           ++ +K F     +     +DFE+ K+ G G++ +V   K  +T  +YA+KI++K  + K 
Sbjct: 72  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 131
Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSED 155
            +TA  + ER VL   D   +  L + FQD   LY+ ++   GG+L   ++  +  L ED
Sbjct: 132 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED 191
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
            ARFY  E+V A++ IH +  +HRDIKP+N+LL  +GHI++ADFGS   M D   TV  +
Sbjct: 192 MARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSS 250
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 270
            A        VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S 
Sbjct: 251 VA--------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 302
Query: 271 WLIFQRIIARDIR--FPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID 328
              + +I+  + R  FP++ +               S     G  G    K H FF+G++
Sbjct: 303 VETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLN 362
Query: 329 WKNIRGQTPPKL 340
           W+NIR    P +
Sbjct: 363 WENIRNLEAPYI 374

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 103/312 (33%), Positives = 160/312 (51%), Gaps = 17/312 (5%)
Query: 37  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           ++ +K F     +     +DFE+ K+ G G++ +V   K  +T  +YA+KI++K  + K 
Sbjct: 56  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 115
Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSED 155
            +TA  + ER VL   D   +  L + FQD   LY+ ++   GG+L   ++  +  L ED
Sbjct: 116 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED 175
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
            ARFY  E+V A++ IH +  +HRDIKP+N+LL  +GHI++ADFGS   M D   TV  +
Sbjct: 176 MARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSS 234
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 270
            A        VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S 
Sbjct: 235 VA--------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 286
Query: 271 WLIFQRIIARDIR--FPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID 328
              + +I+  + R  FP++ +               S     G  G    K H FF+G++
Sbjct: 287 VETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLN 346
Query: 329 WKNIRGQTPPKL 340
           W+NIR    P +
Sbjct: 347 WENIRNLEAPYI 358

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 96/288 (33%), Positives = 143/288 (49%), Gaps = 13/288 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           + DF    + G GS+ KV+ A +  T  +YA+KI+ K  + +++      +E+ VL  LD
Sbjct: 18  LTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 114 HPG-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            P  + +L   FQ    LY  +E   GG+L   I   G   E +A FY AE+   L ++H
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
             G+I+RD+K +N++L ++GHIKIADFG  K      +T             F GT  Y+
Sbjct: 138 KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTR----------EFCGTPDYI 187
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PE++   P     D WA G  LY+ML+G  PF    E  +FQ I+  ++ +P   S   
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 247
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
                      P+ R G GP G   ++ H FF+ IDW+ +  R   PP
Sbjct: 248 VSICKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPP 295

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 145/291 (49%), Gaps = 14/291 (4%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVL 109
           H    DF   K+ G GS+ KV+ A+       YA+K++ KK I K+ +  ++  ER ++L
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
             + HP +V L F+FQ    LY  L+   GGELF  +  +    E  ARFY AE+  AL 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+HS+ +++RD+KPEN+LL + GHI + DFG  K           N   +    TF GT 
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK----------ENIEHNSTTSTFCGTP 203
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
            Y+ PEVL+  P     D W LG  LY+ML G  PF   +   ++  I+ + ++     +
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
Query: 290 XXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
                          + R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPP 313

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 141/285 (49%), Gaps = 11/285 (3%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           ++   + DF    + G GS+ KV+ +++  T  +YA+KI+ K  + +++      +E+ V
Sbjct: 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 394
Query: 109 LDQLDHPG-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           L     P  + +L   FQ    LY  +E   GG+L   I   G   E  A FY AE+   
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 454
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L ++ S G+I+RD+K +N++L ++GHIKIADFG  K      +T             F G
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK----------XFCG 504
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+ PE++   P     D WA G  LY+ML+G +PF+   E  +FQ I+  ++ +P  
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 564
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
            S              P  R G GP G   +K H FF+ IDW+ +
Sbjct: 565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 140/285 (49%), Gaps = 11/285 (3%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           ++   + DF    + G GS+ KV+ +++  T  +YA+KI+ K  + +++      +E+ V
Sbjct: 14  RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 73
Query: 109 LDQLDHPG-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           L     P  + +L   FQ    LY  +E   GG+L   I   G   E  A FY AE+   
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 133
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L ++ S G+I+RD+K +N++L ++GHIKIADFG  K           N         F G
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------ENIWDGVTTKXFCG 183
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+ PE++   P     D WA G  LY+ML+G +PF+   E  +FQ I+  ++ +P  
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 243
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
            S              P  R G GP G   +K H FF+ IDW+ +
Sbjct: 244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 94/293 (32%), Positives = 139/293 (47%), Gaps = 17/293 (5%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           Q    I+DFEL K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ V
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 109 LD-QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           L    +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++  
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 131
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+++HS G+++RD+K +N+LL  DGHIKIADFG  K           N   D K   F G
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------ENMLGDAKTNEFCG 181
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+ PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P +
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 241
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 338
                           P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 242 LEKEAKDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPP 290

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 107/313 (34%), Positives = 163/313 (52%), Gaps = 24/313 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+++ K+ G G++ +V   +   +  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P VV+LF  FQD   LYM +E   GG+L + + S   + E  A+FYTAEVV AL+ IHSM
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           GLIHRD+KP+N+LL   GH+K+ADFG+   M ++ +     A         VGT  Y+ P
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA---------VGTPDYISP 244
Query: 235 EVLNS--SPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 288
           EVL S      +G   D W++G  L++ML G +PF   S    + +I+     + FP   
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPED- 303
Query: 289 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKG--IDWKNIR---GQTPPKLASE 343
           +                     G  G   +K HPFFK    +W NIR       P+L+S+
Sbjct: 304 AEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSD 363
Query: 344 PMVQSGEGDDVHD 356
             + S   DD+ D
Sbjct: 364 --IDSSNFDDIED 374

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 150/312 (48%), Gaps = 19/312 (6%)
Query: 37  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           +Q ++    R  +      DFE+ K+ G G++S+V   K   TG VYA+KIM+K  + K 
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102
Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSED 155
            + +  + ER VL   D   + +L F FQD   LY+ +E   GG+L   ++  G  +  +
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
            ARFY AE+V A++ +H +G +HRDIKP+N+LL   GHI++ADFGS   ++         
Sbjct: 163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR--------- 213
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-------DLWALGCTLYQMLSGTSPFKDT 268
           A    ++   VGT  Y+ PE+L +     G        D WALG   Y+M  G +PF   
Sbjct: 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273
Query: 269 SEWLIFQRII--ARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKG 326
           S    + +I+     +  P                         G GG    + HPFF G
Sbjct: 274 STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFG 333
Query: 327 IDWKNIRGQTPP 338
           +DW  +R   PP
Sbjct: 334 LDWDGLRDSVPP 345

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 138/293 (47%), Gaps = 17/293 (5%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           Q    I+DF L K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ V
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 109 LD-QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           L    +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+++HS G+++RD+K +N+LL  DGHIKIADFG  K           N   D K   F G
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------ENMLGDAKTNXFCG 180
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+ PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P +
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 240
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 338
                           P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPP 289

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 19/292 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 243
Query: 235 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 288
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP+  
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD- 302
Query: 289 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 338
           +                     G  G   +K H FFK     W+ +R    P
Sbjct: 303 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 354

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 19/292 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 238
Query: 235 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 288
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP+  
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD- 297
Query: 289 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 338
           +                     G  G   +K H FFK     W+ +R    P
Sbjct: 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 349

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 19/292 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 243
Query: 235 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 288
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP+  
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD- 302
Query: 289 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 338
           +                     G  G   +K H FFK     W+ +R    P
Sbjct: 303 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 354

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 133/237 (56%), Gaps = 11/237 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I+DF++G + G GS++ V RA+ I TG   A+K++DKK + K      V+ E  +  QL 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 172
           HP ++ L+  F+D+  +Y+ LE C  GE+   + ++    SE+EAR +  +++  + Y+H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S G++HRD+   NLLLT + +IKIADFG    ++      +P+    +K  T  GT  Y+
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK------MPH----EKHYTLCGTPNYI 179
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
            PE+   S     +D+W+LGC  Y +L G  PF   +      +++  D   P++ S
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 152/315 (48%), Gaps = 25/315 (7%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 111 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 352
Query: 228 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 281
           T  Y+ PEVL    A   + D ++LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 410
Query: 282 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PPK 339
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q   PP 
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470
Query: 340 LASEPMVQSGEGDDV 354
           +     V + +  D+
Sbjct: 471 IPPRGEVNAADAFDI 485

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 152/315 (48%), Gaps = 25/315 (7%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 111 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 352
Query: 228 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 281
           T  Y+ PEVL    A   + D ++LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 410
Query: 282 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PPK 339
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q   PP 
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470
Query: 340 LASEPMVQSGEGDDV 354
           +     V + +  D+
Sbjct: 471 IPPRGEVNAADAFDI 485

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 152/315 (48%), Gaps = 25/315 (7%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 111 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 352
Query: 228 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 281
           T  Y+ PEVL    A   + D ++LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 410
Query: 282 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PPK 339
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q   PP 
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470
Query: 340 LASEPMVQSGEGDDV 354
           +     V + +  D+
Sbjct: 471 IPPRGEVNAADAFDI 485

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 152/315 (48%), Gaps = 25/315 (7%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 184 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 243
Query: 111 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 304 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 351
Query: 228 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 281
           T  Y+ PEVL    A   + D ++LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 409
Query: 282 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PPK 339
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q   PP 
Sbjct: 410 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 469
Query: 340 LASEPMVQSGEGDDV 354
           +     V + +  D+
Sbjct: 470 IPPRGEVNAADAFDI 484

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 120/243 (49%), Gaps = 14/243 (5%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+  F+I DF++G+  G G +  V  A++     + ALK++ K  + KE     ++ E  
Sbjct: 8   PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 67
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           +   L HP ++R++  F D   +Y+ LE    GEL+ ++   G   E  +  +  E+ DA
Sbjct: 68  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 127
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 226
           L Y H   +IHRDIKPENLL+   G +KIADFG SV              A   +     
Sbjct: 128 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH-------------APSLRRRXMC 174
Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           GT  Y+PPE++         DLW  G   Y+ L G  PF   S     +RI+  D++FP 
Sbjct: 175 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 234
Query: 287 YFS 289
           + S
Sbjct: 235 FLS 237

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 128/265 (48%), Gaps = 12/265 (4%)
Query: 44  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 103
           A  + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 104 LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
            E  +   L HP ++RL+  F D   +Y+ LE    GE++ ++       E     Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           + +AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------ 169
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
           T  GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  
Sbjct: 170 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 284 FPNYFSXXXXXXXXXXXXXXPSGRP 308
           FP++ +              PS RP
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/243 (32%), Positives = 119/243 (48%), Gaps = 14/243 (5%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+  F+I DF++ +  G G +  V  A++     + ALK++ K  + KE     ++ E  
Sbjct: 7   PKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           +   L HP ++R++  F D   +Y+ LE    GEL+ ++   G   E  +  +  E+ DA
Sbjct: 67  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 226
           L Y H   +IHRDIKPENLL+   G +KIADFG SV              A   +     
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH-------------APSLRRRXMC 173
Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           GT  Y+PPE++         DLW  G   Y+ L G  PF   S     +RI+  D++FP 
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233
Query: 287 YFS 289
           + S
Sbjct: 234 FLS 236

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 128/266 (48%), Gaps = 14/266 (5%)
Query: 44  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 103
           A  + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 104 LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
            E  +   L HP ++RL+  F D   +Y+ LE    GE++ ++       E     Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKA 222
           + +AL Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   + 
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRR 168
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
               GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   + 
Sbjct: 169 XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 228
Query: 283 RFPNYFSXXXXXXXXXXXXXXPSGRP 308
            FP++ +              PS RP
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 127/265 (47%), Gaps = 12/265 (4%)
Query: 44  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 103
           A  + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 104 LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
            E  +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           + +AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------ 169
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
           T  GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  
Sbjct: 170 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 284 FPNYFSXXXXXXXXXXXXXXPSGRP 308
           FP++ +              PS RP
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 148 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 195
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 255
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 256 TEGARDLISRLLKHNPSQRP 275

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 19  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 78
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 79  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 138
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 139 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 186
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 246
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 247 TEGARDLISRLLKHNPSQRP 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  142 bits (357), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 89/249 (35%), Positives = 134/249 (53%), Gaps = 23/249 (9%)
Query: 47  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           A  E   I ++ L K  G G+++KV  A+ + TG   A+KI+DK   T+ N T+  KL R
Sbjct: 7   ATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDK---TQLNPTSLQKLFR 63
Query: 107 IV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
            V  +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           V A++Y H   ++HRD+K ENLLL  D +IKIADFG       +  TV       +K  T
Sbjct: 124 VSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGF-----SNEFTV------GNKLDT 172
Query: 225 FVGTAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
           F G+  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++  
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229
Query: 281 DIRFPNYFS 289
             R P Y S
Sbjct: 230 KYRIPFYMS 238

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 128/261 (49%), Gaps = 14/261 (5%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 227
            Y HS  +IHRDIKPENLLL + G +KIADFG SV           P++  DD      G
Sbjct: 148 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH---------APSSRRDD----LCG 194
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 254
Query: 288 FSXXXXXXXXXXXXXXPSGRP 308
            +              PS RP
Sbjct: 255 VTEGARDLISRLLKHNPSQRP 275

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 172
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 232
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 233 TEGARDLISRLLKHNPSQRP 252

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 124/260 (47%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 174
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE +         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 234
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 235 TEGARDLISRLLKHNPSQRP 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGTLDY 172
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           +PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ +  
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 232
Query: 292 XXXXXXXXXXXXPSGRP 308
                       PS RP
Sbjct: 233 ARDLISRLLKHNPSQRP 249

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  141 bits (356), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 90/246 (36%), Positives = 133/246 (54%), Gaps = 23/246 (9%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 108
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N T+  KL R V 
Sbjct: 7   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK---TQLNPTSLQKLFREVR 63
Query: 109 -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 64  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 123
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++Y H   ++HRD+K ENLLL AD +IKIADFG       +  TV        K  TF G
Sbjct: 124 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTV------GGKLDTFCG 172
Query: 228 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 173 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 229
Query: 284 FPNYFS 289
            P Y S
Sbjct: 230 IPFYMS 235

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT------------TLSGT 170
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 231 TEGARDLISRLLKHNPSQRP 250

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 173
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 233
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 234 TEGARDLISRLLKHNPSQRP 253

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 121 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 168
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 228
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 229 TEGARDLISRLLKHNPSQRP 248

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 172
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 232
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 233 TEGARDLISRLLKHNPSQRP 252

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 128/261 (49%), Gaps = 14/261 (5%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 227
            Y HS  +IHRDIKPENLLL + G +KIADFG SV           P++  D    T  G
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRD----TLCG 169
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 229
Query: 288 FSXXXXXXXXXXXXXXPSGRP 308
            +              PS RP
Sbjct: 230 VTEGARDLISRLLKHNPSQRP 250

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 134/264 (50%), Gaps = 23/264 (8%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 108
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 109 -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCG 174
Query: 228 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 284 FPNYFSXXXXXXXXXXXXXXPSGR 307
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 134/264 (50%), Gaps = 23/264 (8%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 108
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 109 -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCG 174
Query: 228 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 284 FPNYFSXXXXXXXXXXXXXXPSGR 307
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIA+FG       SR T            T  GT
Sbjct: 124 SYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT------------TLCGT 171
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 231
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 232 TEGARDLISRLLKHNPSQRP 251

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL------------CGTLDY 172
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           +PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ +  
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 232
Query: 292 XXXXXXXXXXXXPSGRP 308
                       PS RP
Sbjct: 233 ARDLISRLLKHNPSQRP 249

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL------------CGT 169
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 174
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 234
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 235 TEGARDLISRLLKHNPSQRP 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 170
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 231 TEGARDLISRLLKHNPSQRP 250

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 127/258 (49%), Gaps = 14/258 (5%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           HS  +IHRDIKPENLLL + G +KIADFG SV           P++  DD      GT  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRDD----LCGTLD 174
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 290
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ + 
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 291 XXXXXXXXXXXXXPSGRP 308
                        PS RP
Sbjct: 235 GARDLISRLLKHNPSQRP 252

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 127/261 (48%), Gaps = 14/261 (5%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++ ++  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D+  +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 227
            Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     G
Sbjct: 122 SYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRAALCG 168
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDF 228
Query: 288 FSXXXXXXXXXXXXXXPSGRP 308
            +              PS RP
Sbjct: 229 VTEGARDLISRLLKHNPSQRP 249

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 169
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIA+FG       SR T            T  GT
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT------------TLCGT 172
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 232
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 233 TEGARDLISRLLKHNPSQRP 252

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 134/264 (50%), Gaps = 23/264 (8%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 108
           E   I ++ L K  G G+++KV  A+ I TG   A++I+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK---TQLNSSSLQKLFREVR 65
Query: 109 -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCG 174
Query: 228 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 284 FPNYFSXXXXXXXXXXXXXXPSGR 307
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 169
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 124/258 (48%), Gaps = 14/258 (5%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     GT  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRAALCGTLD 174
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 290
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ + 
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 291 XXXXXXXXXXXXXPSGRP 308
                        PS RP
Sbjct: 235 GARDLISRLLKHNPSQRP 252

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 128/231 (55%), Gaps = 16/231 (6%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           FE  +  G G++S+VV A++  TG ++A+K + KK +  + K + ++ E  VL ++ H  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL--KGKESSIENEIAVLRKIKHEN 81
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA+ Y+H MG+
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 177 IHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +HRD+KPENLL  +   +  I I+DFG  K M+             D   T  GT  YV 
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSK-ME----------GKGDVMSTACGTPGYVA 190
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEF 241

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 123/257 (47%), Gaps = 12/257 (4%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           ++++DFE+G+  G G +  V  A++     + ALK++ K  + K      ++ E  +   
Sbjct: 2   WALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 61
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT  Y
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGTLDY 169
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           +PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ +  
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 229
Query: 292 XXXXXXXXXXXXPSGRP 308
                       PS RP
Sbjct: 230 ARDLISRLLKHNPSQRP 246

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 89/246 (36%), Positives = 131/246 (53%), Gaps = 23/246 (9%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 108
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N T+  KL R V 
Sbjct: 10  EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK---TQLNPTSLQKLFREVR 66
Query: 109 -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 67  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 126
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++Y H   ++HRD+K ENLLL AD +IKIADFG       +  TV        K   F G
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTV------GGKLDAFCG 175
Query: 228 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
              Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 176 APPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 232
Query: 284 FPNYFS 289
            P Y S
Sbjct: 233 IPFYMS 238

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 124/260 (47%), Gaps = 12/260 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR   L             GT
Sbjct: 124 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL------------CGT 171
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 231
Query: 289 SXXXXXXXXXXXXXXPSGRP 308
           +              PS RP
Sbjct: 232 TEGARDLISRLLKHNPSQRP 251

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 125/261 (47%), Gaps = 14/261 (5%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 227
            Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     G
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRAALCG 168
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 288 FSXXXXXXXXXXXXXXPSGRP 308
            +              PS RP
Sbjct: 229 VTEGARDLISRLLKHNPSQRP 249

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/262 (33%), Positives = 133/262 (50%), Gaps = 23/262 (8%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--L 109
             I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V  +
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVRIM 60
Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
             L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A++
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G+ 
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCGSP 169
Query: 230 AYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 285
            Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R P
Sbjct: 170 PYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 226
Query: 286 NYFSXXXXXXXXXXXXXXPSGR 307
            Y S              PS R
Sbjct: 227 FYMSTDCENLLKKFLILNPSKR 248

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 132/264 (50%), Gaps = 23/264 (8%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 108
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 109 -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K   F G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDAFCG 174
Query: 228 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
              Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 APPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 284 FPNYFSXXXXXXXXXXXXXXPSGR 307
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 125/261 (47%), Gaps = 14/261 (5%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 227
            Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     G
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRXXLCG 168
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 288 FSXXXXXXXXXXXXXXPSGRP 308
            +              PS RP
Sbjct: 229 VTEGARDLISRLLKHNPSQRP 249

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 125/261 (47%), Gaps = 14/261 (5%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 227
            Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     G
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRXXLCG 171
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 231
Query: 288 FSXXXXXXXXXXXXXXPSGRP 308
            +              PS RP
Sbjct: 232 VTEGARDLISRLLKHNPSQRP 252

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           ++   + G G++S+V+ A+   T  + A+K + KK +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 177 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 133/264 (50%), Gaps = 23/264 (8%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 108
           E   I ++ L K  G G+++KV  A+ I TG   A++I+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK---TQLNSSSLQKLFREVR 65
Query: 109 -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K   F G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDEFCG 174
Query: 228 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 284 FPNYFSXXXXXXXXXXXXXXPSGR 307
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 122/241 (50%), Gaps = 12/241 (4%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DF++G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y HS  +IHRDIKPENLLL ++G +KIADFG       SR T            T  GT
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT------------TLCGT 173
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFV 233
Query: 289 S 289
           +
Sbjct: 234 T 234

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/236 (35%), Positives = 120/236 (50%), Gaps = 14/236 (5%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           HF+I DFE+G+  G G +  V  A++  +  + ALK++ K  I KE     ++ E  +  
Sbjct: 19  HFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
            L HP ++RL+  F D   +Y+ LE    GEL+ ++       E        E+ DAL Y
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H   +IHRDIKPENLLL   G +KIADFG SV              A   +  T  GT 
Sbjct: 139 CHGKKVIHRDIKPENLLLGLKGELKIADFGWSVH-------------APSLRRKTMCGTL 185
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 285
            Y+PPE++         DLW +G   Y++L G  PF+  S    ++RI+  D++FP
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFP 241

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 125/242 (51%), Gaps = 14/242 (5%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           +  ++++DF++G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 227
            Y HS  +IHRDIKPENLLL ++G +KIADFG SV           P++  D    T  G
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHA---------PSSRRD----TLCG 172
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF 232
Query: 288 FS 289
            +
Sbjct: 233 VT 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           ++   + G G++S+V+ A+   T  + A+K + K+ +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 177 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           ++   + G G++S+V+ A+   T  + A+K + K+ +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 177 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 118/219 (53%), Gaps = 14/219 (6%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 109
           E  +   FE+ +  G GS+ KV   +K DT  +YA+K M+K+   + N+   V  E  ++
Sbjct: 10  EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
             L+HP +V L+++FQD   ++M ++   GG+L   +    H  E+  + +  E+V AL+
Sbjct: 70  QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+ +  +IHRD+KP+N+LL   GH+ I DF            +LP    + +  T  GT 
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA--------AMLP---RETQITTMAGTK 178
Query: 230 AYVPPEVLNSSPA---TFGNDLWALGCTLYQMLSGTSPF 265
            Y+ PE+ +S      +F  D W+LG T Y++L G  P+
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           ++   + G G++S+V+ A+   T  + A+K + K+ +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 177 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 129/264 (48%), Gaps = 23/264 (8%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 108
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 109 -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
               L+HP +V+LF   +   +LY+  E   GGE+FD + + G   E EAR    ++V A
Sbjct: 66  IXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSA 125
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K   F G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF-----------TFGNKLDAFCG 174
Query: 228 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
              Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 APPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 284 FPNYFSXXXXXXXXXXXXXXPSGR 307
            P Y S              PS R
Sbjct: 232 IPFYXSTDCENLLKKFLILNPSKR 255

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/219 (35%), Positives = 119/219 (54%), Gaps = 16/219 (7%)
Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 121
           + G GS+ +V++ K   T   YA+K+++K    K   T+ +  E  +L +LDHP +++LF
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKA-SAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 122 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
              +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H   ++HRD+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 182 KPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 238
           KPEN+LL +   D  IKI DFG     Q        N    D+    +GTA Y+ PEVL 
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQ-------QNTKMKDR----IGTAYYIAPEVLR 196
Query: 239 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
            +      D+W+ G  LY +LSGT PF   +E+ I +R+
Sbjct: 197 GTYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 121/220 (55%), Gaps = 15/220 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 174
Query: 181 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 223
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 224 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 262

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 121/220 (55%), Gaps = 15/220 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 175
Query: 181 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 224
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 225 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 263

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 121/220 (55%), Gaps = 15/220 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 181 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 200
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 201 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 75/220 (34%), Positives = 122/220 (55%), Gaps = 15/220 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 157
Query: 181 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           +KPENLLL   + D +I+I DFG     + S+          DK    +GTA Y+ PEVL
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-------KMKDK----IGTAYYIAPEVL 206
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 207 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 245

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 118/217 (54%), Gaps = 16/217 (7%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+ +V++ K   T   YA+K+++K    K   T+ +  E  +L +LDHP +++LF  
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKA-SAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
            +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H   ++HRD+KP
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 184 ENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           EN+LL +   D  IKI DFG     Q        N    D+    +GTA Y+ PEVL  +
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQ-------NTKMKDR----IGTAYYIAPEVLRGT 198
Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
                 D+W+ G  LY +LSGT PF   +E+ I +R+
Sbjct: 199 YDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 118/217 (54%), Gaps = 16/217 (7%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+ +V++ K   T   YA+K+++K    K   T+ +  E  +L +LDHP +++LF  
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKA-SAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
            +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H   ++HRD+KP
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 184 ENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           EN+LL +   D  IKI DFG     Q        N    D+    +GTA Y+ PEVL  +
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQ-------NTKMKDR----IGTAYYIAPEVLRGT 198
Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
                 D+W+ G  LY +LSGT PF   +E+ I +R+
Sbjct: 199 YDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 192 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 237

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 191 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 126/237 (53%), Gaps = 20/237 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 113
           +++L +  G G++S V R  KI TG  YA KI++ K ++  +   + KLER   +   L 
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD---HQKLEREARICRLLK 61
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++++ + H 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 174 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTA 229
            G++HRD+KPENLLL +      +K+ADFG    +Q            D +A   F GT 
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-----------GDQQAWFGFAGTP 170
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
            Y+ PEVL   P     D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 227

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 186 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 231

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 182 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 227

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 126/237 (53%), Gaps = 20/237 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 113
           +++L +  G G++S V R  KI TG  YA KI++ K ++  +   + KLER   +   L 
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD---HQKLEREARICRLLK 61
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++++ + H 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 174 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTA 229
            G++HRD+KPENLLL +      +K+ADFG    +Q            D +A   F GT 
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-----------GDQQAWFGFAGTP 170
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
            Y+ PEVL   P     D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 227

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 119/220 (54%), Gaps = 15/220 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP + +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y H   ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRD 151
Query: 181 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KXKDKIGTAYYIAPEVL 200
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 201 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 127/264 (48%), Gaps = 44/264 (16%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-------------- 96
            ++++D E+GK    GSY  V  A   +  T YA+K++ KK + ++              
Sbjct: 14  QYTLKD-EIGK----GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 97  ---------NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS--LYMALESCEGGELFDQ 145
                         V  E  +L +LDHP VV+L     D     LYM  E    G + + 
Sbjct: 69  APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 146 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 205
            T K  LSED+ARFY  +++  +EY+H   +IHRDIKP NLL+  DGHIKIADFG     
Sbjct: 129 PTLKP-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGT 262
           +           SD      VGT A++ PE L+ +   F     D+WA+G TLY  + G 
Sbjct: 188 K----------GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
Query: 263 SPFKDTSEWLIFQRIIARDIRFPN 286
            PF D     +  +I ++ + FP+
Sbjct: 238 CPFMDERIMCLHSKIKSQALEFPD 261

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 78/235 (33%), Positives = 123/235 (52%), Gaps = 18/235 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLDH 114
           ++L +  G G++S V R  K+  G  YA KI++ K ++  +   + KLER   +   L H
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARD---HQKLEREARICRLLKH 80
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H M
Sbjct: 81  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 140
Query: 175 GLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           G++HRD+KPENLLL +      +K+ADFG    ++  +               F GT  Y
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF----------GFAGTPGY 190
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           + PEVL   P     DLWA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 245

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 113
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 86
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 174 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 195
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 113/236 (47%), Gaps = 10/236 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I  + LG   GVG++ KV   +   TG   A+KI++++ I   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++L+         +M +E   GGELFD I   G + E EAR    +++ A++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRD+KPEN+LL A  + KIADFG    M D         + +  A   +    Y  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
           PEV          D+W+ G  LY +L GT PF D     +F++I       P Y +
Sbjct: 190 PEV----------DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 113
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 174 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 172
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 113
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 174 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 171
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 227

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 113/236 (47%), Gaps = 10/236 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I  + LG   GVG++ KV   +   TG   A+KI++++ I   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++L+         +M +E   GGELFD I   G + E EAR    +++ A++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRD+KPEN+LL A  + KIADFG    M D         + +  A   +    Y  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAG 189
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
           PEV          D+W+ G  LY +L GT PF D     +F++I       P Y +
Sbjct: 190 PEV----------DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 113
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 174 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 172
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 113/217 (52%), Gaps = 15/217 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+Y +V+  K   TG   A+KI+ K  +T  + +  +  E  VL QLDHP +++L+  
Sbjct: 30  GSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEF 89
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           F+D  + Y+ +E   GGELFD+I  +   SE +A     +V+    Y+H   ++HRD+KP
Sbjct: 90  FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKP 149
Query: 184 ENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           ENLLL +   D  IKI DFG           +  +     K    +GTA Y+ PEVL   
Sbjct: 150 ENLLLESKSRDALIKIVDFG-----------LSAHFEVGGKMKERLGTAYYIAPEVLRKK 198
Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
                 D+W+ G  LY +L G  PF   ++  I +R+
Sbjct: 199 YDE-KCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 234

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 76/220 (34%), Positives = 114/220 (51%), Gaps = 15/220 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           K  G G+Y +V+  K   TG   A+KI+ K  +T  + +  +  E  VL QLDHP +++L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +  F+D  + Y+ +E   GGELFD+I  +   SE +A     +V+    Y+H   ++HRD
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 181 IKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           +KPENLLL +   D  IKI DFG           +  +     K    +GTA Y+ PEVL
Sbjct: 130 LKPENLLLESKSRDALIKIVDFG-----------LSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
                    D+W+ G  LY +L G  PF   ++  I +R+
Sbjct: 179 RKKYDE-KCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 217

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 124/237 (52%), Gaps = 18/237 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQL 112
           ++++L +  G G++S V R  K+  G  YA  I++ K ++  +   + KLER   +   L
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD---HQKLEREARICRLL 67
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 173 SMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            MG++HR++KPENLLL +      +K+ADFG    ++  +               F GT 
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF----------GFAGTP 177
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
            Y+ PEVL   P     DLWA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 121/232 (52%), Gaps = 20/232 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           FE+    G G+ S V R K+  T   YALK++ KK + K+     V+ E  VL +L HP 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDKK----IVRTEIGVLLRLSHPN 109
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +++L   F+    + + LE   GGELFD+I  KG+ SE +A     ++++A+ Y+H  G+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 177 IHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +HRD+KPENLL      D  +KIADFG  K ++   +             T  GT  Y  
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK-----------TVCGTPGYCA 218
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIARDIRF 284
           PE+L         D+W++G   Y +L G  PF D   +  +F+RI+  +  F
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF 270

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 113/236 (47%), Gaps = 10/236 (4%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I  + LG   GVG++ KV   K   TG   A+KI++++ I   +    ++ E   L    
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++L+        ++M +E   GGELFD I   G L E E+R    +++  ++Y H 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             ++HRD+KPEN+LL A  + KIADFG    M D         + +  A   +    Y  
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAG 194
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
           PEV          D+W+ G  LY +L GT PF D     +F++I       P Y +
Sbjct: 195 PEV----------DIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 142/295 (48%), Gaps = 18/295 (6%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 174
           VV L + ++   +L + L    GG+L   I   G     EAR  FY AE+   LE +H  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            +++RD+KPEN+LL   GHI+I+D G            +P   +       VGT  Y+ P
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTIKGR---VGTVGYMAP 354
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDI--RFPNYFSX 290
           EV+ +   TF  D WALGC LY+M++G SPF+   + +  + +  + +++   +   FS 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
Query: 291 XXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEP 344
                        P+ R G   G    +K HP FK +++K +  G   P    +P
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 142/295 (48%), Gaps = 18/295 (6%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 174
           VV L + ++   +L + L    GG+L   I   G     EAR  FY AE+   LE +H  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            +++RD+KPEN+LL   GHI+I+D G            +P   +       VGT  Y+ P
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTIKGR---VGTVGYMAP 354
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDI--RFPNYFSX 290
           EV+ +   TF  D WALGC LY+M++G SPF+   + +  + +  + +++   +   FS 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
Query: 291 XXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEP 344
                        P+ R G   G    +K HP FK +++K +  G   P    +P
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 121/226 (53%), Gaps = 18/226 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + F   ++ G G++S+V   K+  TG ++ALK + K   +   + + ++ E  VL ++ H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK---SPAFRDSSLENEIAVLKKIKH 65
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             +V L   ++ T   Y+ ++   GGELFD+I  +G  +E +A     +V+ A++Y+H  
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 175 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           G++HRD+KPENLL      +  I I DFG  K  Q+  ++          AC   GT  Y
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST---------AC---GTPGY 173
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
           V PEVL   P +   D W++G   Y +L G  PF + +E  +F++I
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 127/276 (46%), Gaps = 18/276 (6%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++  T  GT  Y+
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKTLCGTPNYI 209
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 293 XXXXXXXXXXXPSGRPGAG--------PGGYAVLKM 320
                      P+ RP             GYA +++
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 305

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 125/237 (52%), Gaps = 20/237 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 113
           +++L +  G G++S V R  K+ TG  YA KI++ K ++  +   + KLER   +   L 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARD---HQKLEREARICRLLK 61
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H 
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 174 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTA 229
           MG++HRD+KPENLLL +      +K+ADFG    +Q            D +A   F GT 
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-----------GDQQAWFGFAGTP 170
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
            Y+ PEVL         D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS 227

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 123/219 (56%), Gaps = 15/219 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G GS+ K +  K  + G  Y +K ++  +  +KE + +  + E  VL  + HP +V+   
Sbjct: 33  GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES--RREVAVLANMKHPNIVQYRE 90
Query: 123 TFQDTFSLYMALESCEGGELFDQITS-KGHL-SEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +F++  SLY+ ++ CEGG+LF +I + KG L  ED+   +  ++  AL+++H   ++HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           IK +N+ LT DG +++ DFG  +        VL +     +AC  +GT  Y+ PE+  + 
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIAR--------VLNSTVELARAC--IGTPYYLSPEICENK 200
Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 279
           P    +D+WALGC LY++ +    F+  S   +  +II+
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 176
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 292
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 176
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 292
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 176
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 292
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 176
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 292
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 293 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 18/276 (6%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++     GT  Y+
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKXLCGTPNYI 209
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 293 XXXXXXXXXXXPSGRPGAG--------PGGYAVLKM 320
                      P+ RP             GYA +++
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 305

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 18/276 (6%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++     GT  Y+
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKDLCGTPNYI 209
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 293 XXXXXXXXXXXPSGRPGAG--------PGGYAVLKM 320
                      P+ RP             GYA +++
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 305

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 18/276 (6%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 24  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 83
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 84  DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 143
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++     GT  Y+
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKDLCGTPNYI 193
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 292
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 194 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 253
Query: 293 XXXXXXXXXXXPSGRPGAG--------PGGYAVLKM 320
                      P+ RP             GYA +++
Sbjct: 254 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 289

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+ KV  A    T    ALK + ++ + K +    V+ E   L  L HP +++L+  
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
                 + M +E   GGELFD I  K  ++EDE R +  +++ A+EY H   ++HRD+KP
Sbjct: 78  ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN----S 239
           ENLLL  + ++KIADFG    M D                T  G+  Y  PEV+N    +
Sbjct: 137 ENLLLDDNLNVKIADFGLSNIMTDGNFLK-----------TSCGSPNYAAPEVINGKLYA 185
Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 289
            P     D+W+ G  LY ML G  PF D     +F+++ +     P++ S
Sbjct: 186 GPEV---DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLS 232

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 125/241 (51%), Gaps = 19/241 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--LDQLD 113
           +E+G+  G G ++ V + ++  TG  YA K + K+ ++   +  +  ++ER V  L ++ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D + Y+HS
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 174 MGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
             + H D+KPEN++L      +  IK+ DFG    ++           + ++     GT 
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----------AGNEFKNIFGTP 175
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYF 288
            +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  F   YF
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235
Query: 289 S 289
           S
Sbjct: 236 S 236

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 121/236 (51%), Gaps = 18/236 (7%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 113
           D++L +  G G++S V R  K      YA KI++ K ++  +   + KLER   +   L 
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARD---HQKLEREARICRLLK 88
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++++ +IH 
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 174 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
             ++HRD+KPENLLL +      +K+ADFG    +Q  +               F GT  
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF----------GFAGTPG 198
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           Y+ PEVL   P     D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS 254

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 125/241 (51%), Gaps = 19/241 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--LDQLD 113
           +E+G+  G G ++ V + ++  TG  YA K + K+ ++   +  +  ++ER V  L ++ 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D + Y+HS
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 174 MGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
             + H D+KPEN++L      +  IK+ DFG    ++           + ++     GT 
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----------AGNEFKNIFGTP 182
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYF 288
            +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  F   YF
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 242
Query: 289 S 289
           S
Sbjct: 243 S 243

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 30  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 89
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 90  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 149
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
            NL L  D  +KI DFG    ++             ++  T  GT  Y+ PEVL+    +
Sbjct: 150 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 303
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 259
Query: 304 PSGRP 308
           P+ RP
Sbjct: 260 PTARP 264

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 124/241 (51%), Gaps = 19/241 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--LDQLD 113
           +E+G+  G G ++ V + ++  TG  YA K + K+ +    +  +  ++ER V  L ++ 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D + Y+HS
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 174 MGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
             + H D+KPEN++L      +  IK+ DFG    ++           + ++     GT 
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----------AGNEFKNIFGTP 196
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYF 288
            +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  F   YF
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 256
Query: 289 S 289
           S
Sbjct: 257 S 257

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 145
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
            NL L  D  +KI DFG    ++             ++  T  GT  Y+ PEVL+    +
Sbjct: 146 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 303
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 255
Query: 304 PSGRP 308
           P+ RP
Sbjct: 256 PTARP 260

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 145
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
            NL L  D  +KI DFG    ++             ++  T  GT  Y+ PEVL+    +
Sbjct: 146 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 303
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 255
Query: 304 PSGRP 308
           P+ RP
Sbjct: 256 PTARP 260

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 81/238 (34%), Positives = 116/238 (48%), Gaps = 33/238 (13%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVV 118
           K  G GS+S   +     +   +A+KI+ K+    T++  TA    E        HP +V
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE-------GHPNIV 69
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
           +L   F D    ++ +E   GGELF++I  K H SE EA +   ++V A+ ++H +G++H
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 179 RDIKPENLLLTADG---HIKIADFG--SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           RD+KPENLL T +     IKI DFG   +KP         P+       C    T  Y  
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKP---------PDNQPLKTPCF---TLHYAA 177
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-------TSEWLIFQRIIARDIRF 284
           PE+LN +      DLW+LG  LY MLSG  PF+        TS   I ++I   D  F
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 10/245 (4%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 48  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 107
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 108 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 167
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
            NL L  D  +KI DFG    ++             ++     GT  Y+ PEVL+    +
Sbjct: 168 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 303
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 277
Query: 304 PSGRP 308
           P+ RP
Sbjct: 278 PTARP 282

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 10/245 (4%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 169
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
            NL L  D  +KI DFG    ++             ++     GT  Y+ PEVL+    +
Sbjct: 170 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 303
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 279
Query: 304 PSGRP 308
           P+ RP
Sbjct: 280 PTARP 284

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 118/220 (53%), Gaps = 16/220 (7%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           K  G G+Y +V+  +   T    A+KI+ K  ++  + +  ++ E  VL  LDHP +++L
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKL 101
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +  F+D  + Y+ +E  +GGELFD+I  +   +E +A     +V+  + Y+H   ++HRD
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 181 IKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           +KPENLLL +   D  IKI DFG     ++ +           K    +GTA Y+ PEVL
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQK-----------KMKERLGTAYYIAPEVL 210
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
                    D+W++G  L+ +L+G  PF   ++  I +++
Sbjct: 211 RKKYDE-KCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 10/245 (4%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 84  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 143
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
            NL L  D  +KI DFG    ++             ++     GT  Y+ PEVL+    +
Sbjct: 144 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 303
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253
Query: 304 PSGRP 308
           P+ RP
Sbjct: 254 PTARP 258

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 54  IQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK---TAYVKLERIVL 109
           ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
            Q+ HP ++ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +++D + 
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 170 YIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           Y+H+  + H D+KPEN++L        HIK+ DFG    ++D             +    
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----------EFKNI 178
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 120/231 (51%), Gaps = 24/231 (10%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++  V   ++  +G    +K ++K     +     ++ E  VL  LDHP ++++F  
Sbjct: 31  GSGAFGDVHLVEERSSGLERVIKTINKD--RSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV----VDALEYIHSMGLIHR 179
           F+D  ++Y+ +E+CEGGEL ++I S     +  +  Y AE+    ++AL Y HS  ++H+
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 180 DIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           D+KPEN+L    +    IKI DFG  +  +           SD+ +    GTA Y+ PEV
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFK-----------SDEHSTNAAGTALYMAPEV 197
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
                 TF  D+W+ G  +Y +L+G  PF  TS   + Q+   ++   PNY
Sbjct: 198 FKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE---PNY 244

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           GVGSYS+  R     T   YA+K++DK   +K + +  ++   I+L    HP ++ L   
Sbjct: 36  GVGSYSECKRCVHKATNMEYAVKVIDK---SKRDPSEEIE---ILLRYGQHPNIITLKDV 89
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           + D   +Y+  E   GGEL D+I  +   SE EA F    +   +EY+HS G++HRD+KP
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKP 149
Query: 184 ENLLLTADGH----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
            N+L   +      ++I DFG  K ++          A +    T   TA +V PEVL  
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLR----------AENGLLMTPCYTANFVAPEVLKR 199
Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKD 267
                G D+W+LG  LY ML+G +PF +
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           GVGSYS+  R     T   YA+K++DK   +K + +  ++   I+L    HP ++ L   
Sbjct: 36  GVGSYSECKRCVHKATNMEYAVKVIDK---SKRDPSEEIE---ILLRYGQHPNIITLKDV 89
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           + D   +Y+  E   GGEL D+I  +   SE EA F    +   +EY+HS G++HRD+KP
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKP 149
Query: 184 ENLLLTADGH----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 239
            N+L   +      ++I DFG  K ++          A +    T   TA +V PEVL  
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLR----------AENGLLMTPCYTANFVAPEVLKR 199
Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKD 267
                G D+W+LG  LY ML+G +PF +
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 120/231 (51%), Gaps = 26/231 (11%)
Query: 57  FELGKIYGVGSY--SKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +EL K  G G++  ++++R K+     + A+K +++     EN    VK E I    L H
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQ--ANELVAVKYIERGEKIDEN----VKREIINHRSLRH 74
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAM 134
Query: 175 GLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            + HRD+K EN LL  DG     +KIADFG  K    S +   P +A        VGT A
Sbjct: 135 QVAHRDLKLENTLL--DGSPAPRLKIADFGYSKA---SVLHSQPKSA--------VGTPA 181
Query: 231 YVPPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
           Y+ PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 123/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
            A+V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 48  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 105
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 106 RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 219
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/229 (34%), Positives = 115/229 (50%), Gaps = 22/229 (9%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +EL K  G G++      +   +  + A+K +++     E   A VK E I    L HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIAANVKREIINHRSLRHPN 76
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 177 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
            HRD+K EN LL  DG     +KI DFG       S+ +VL +        + VGT AY+
Sbjct: 137 CHRDLKLENTLL--DGSPAPRLKICDFGY------SKSSVLHSQPK-----STVGTPAYI 183
Query: 233 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 110
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 111 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 71  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 169 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 176
Query: 226 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 267
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 110
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 111 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 71  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 169 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 176
Query: 226 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 267
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 48  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 105
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 106 RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 219
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 48  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 105
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 106 RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 219
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 48  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 105
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 106 RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 219
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 110
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 111 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 71  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 169 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 176
Query: 226 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 267
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 48  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 105
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 106 RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 219
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 110
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 111 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 77  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 133
Query: 169 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 134 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 182
Query: 226 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 267
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 110
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 111 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 70  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 126
Query: 169 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 127 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 175
Query: 226 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 267
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/229 (34%), Positives = 115/229 (50%), Gaps = 22/229 (9%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +EL K  G G++      +   +  + A+K +++     EN    VK E I    L HP 
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPN 75
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 177 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
            HRD+K EN LL  DG     +KI DFG       S+ +VL +        + VGT AY+
Sbjct: 136 CHRDLKLENTLL--DGSPAPRLKICDFGY------SKSSVLHSQPK-----STVGTPAYI 182
Query: 233 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 231

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 131/260 (50%), Gaps = 34/260 (13%)
Query: 28  NNSSTNCPTVQRSKSFAF-------RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG 80
           NN+S    ++ R+K F F       ++        ++ + K  G G+  +V  A +  T 
Sbjct: 115 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 174
Query: 81  TVYALKIMDK-KFITKENKTA----YVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMA 133
              A++I+ K KF     + A     V+ E  +L +L+HP ++++  FF  +D    Y+ 
Sbjct: 175 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED---YYIV 231
Query: 134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--- 190
           LE  EGGELFD++     L E   + Y  +++ A++Y+H  G+IHRD+KPEN+LL++   
Sbjct: 232 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 291
Query: 191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---D 247
           D  IKI DFG  K + ++ +             T  GT  Y+ PEVL S      N   D
Sbjct: 292 DCLIKITDFGHSKILGETSLMR-----------TLCGTPTYLAPEVLVSVGTAGYNRAVD 340
Query: 248 LWALGCTLYQMLSGTSPFKD 267
            W+LG  L+  LSG  PF +
Sbjct: 341 CWSLGVILFICLSGYPPFSE 360

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 131/260 (50%), Gaps = 34/260 (13%)
Query: 28  NNSSTNCPTVQRSKSFAF-------RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG 80
           NN+S    ++ R+K F F       ++        ++ + K  G G+  +V  A +  T 
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 81  TVYALKIMDK-KFITKENKTA----YVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMA 133
              A++I+ K KF     + A     V+ E  +L +L+HP ++++  FF  +D    Y+ 
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED---YYIV 217
Query: 134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--- 190
           LE  EGGELFD++     L E   + Y  +++ A++Y+H  G+IHRD+KPEN+LL++   
Sbjct: 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 277
Query: 191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---D 247
           D  IKI DFG  K + ++ +             T  GT  Y+ PEVL S      N   D
Sbjct: 278 DCLIKITDFGHSKILGETSLMR-----------TLCGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 248 LWALGCTLYQMLSGTSPFKD 267
            W+LG  L+  LSG  PF +
Sbjct: 327 CWSLGVILFICLSGYPPFSE 346

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKEN-KTAYVKLERIVLDQLDH 114
           +EL ++ G G++S V R    +TG  +A+KI+D  KF +     T  +K E  +   L H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEY 170
           P +V L  T+     LYM  E  +G +L  +I  +       SE  A  Y  ++++AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 171 IHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
            H   +IHRD+KPEN+LL +  +   +K+ DFG    + +S +           A   VG
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLV----------AGGRVG 195
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 278
           T  ++ PEV+   P     D+W  G  L+ +LSG  PF  T E L F+ II
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGII 245

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/229 (34%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +EL K  G G++      +   +  + A+K +++     EN    VK E I    L HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPN 76
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 177 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
            HRD+K EN LL  DG     +KI  FG       S+ +VL +   D      VGT AY+
Sbjct: 137 CHRDLKLENTLL--DGSPAPRLKICAFGY------SKSSVLHSQPKDT-----VGTPAYI 183
Query: 233 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +E+ +  GVGSYS   R     T   +A+KI+DK   +K + T  ++   I+L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEEIE---ILLRYGQHPN 77
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           ++ L   + D   +Y+  E  +GGEL D+I  +   SE EA      +   +EY+H+ G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 177 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +HRD+KP N+L   +      I+I DFG  K ++          A +    T   TA +V
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLMTPCYTANFV 187
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
            PEVL         D+W+LG  LY ML+G +PF +
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++  V R  +  TG V+  K ++  +   +     VK E  +++QL HP ++ L   
Sbjct: 60  GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLHDA 116
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
           F+D + + + LE   GGELFD+I ++ + +SE E   Y  +  + L+++H   ++H DIK
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176
Query: 183 PENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           PEN++        +KI DFG    +    I  +  A           TA +  PE+++  
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-----------TAEFAAPEIVDRE 225
Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
           P  F  D+WA+G   Y +LSG SPF    +    Q +   D  F
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 173 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 179
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 288 FS 289
           FS
Sbjct: 240 FS 241

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 173 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 179
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 288 FS 289
           FS
Sbjct: 240 FS 241

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 22/237 (9%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           Q + L    G GS+ +V  A +  T    A K + K F+   ++    K E  ++  LDH
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDH 65
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P ++RL+ TF+D   +Y+ +E C GGELF+++  K    E +A     +V+ A+ Y H +
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 175 GLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            + HRD+KPEN L    + D  +K+ DFG     +  ++             T VGT  Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-----------TKVGTPYY 174
Query: 232 VPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           V P+VL      +G   D W+ G  +Y +L G  PF   ++  +  +I      FP 
Sbjct: 175 VSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 228

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 22/237 (9%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           Q + L    G GS+ +V  A +  T    A K + K F+   ++    K E  ++  LDH
Sbjct: 26  QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDH 82
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P ++RL+ TF+D   +Y+ +E C GGELF+++  K    E +A     +V+ A+ Y H +
Sbjct: 83  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 142
Query: 175 GLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            + HRD+KPEN L    + D  +K+ DFG     +  ++             T VGT  Y
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-----------TKVGTPYY 191
Query: 232 VPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           V P+VL      +G   D W+ G  +Y +L G  PF   ++  +  +I      FP 
Sbjct: 192 VSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 245

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +EL K  G G++      +   +  + A+K +++     EN    VK E I    L HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPN 76
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 177 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
            HRD+K EN LL  DG     +KI  FG       S+ +VL +        + VGT AY+
Sbjct: 137 CHRDLKLENTLL--DGSPAPRLKICAFGY------SKSSVLHSQPK-----STVGTPAYI 183
Query: 233 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 119/225 (52%), Gaps = 23/225 (10%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           +I G G + +V + ++  TG   A KI+  + +  + +   VK E  V++QLDH  +++L
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE---VKNEISVMNQLDHANLIQL 151
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHR 179
           +  F+    + + +E  +GGELFD+I  + + L+E +   +  ++ + + ++H M ++H 
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 180 DIKPENLL-LTADG-HIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           D+KPEN+L +  D   IKI DFG     KP +  ++                GT  ++ P
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--------------GTPEFLAP 257
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 279
           EV+N    +F  D+W++G   Y +LSG SPF   ++      I+A
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +E+ +  GVGSYS   R     T   +A+KI+DK   +K + T  ++   I+L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDK---SKRDPTEEIE---ILLRYGQHPN 77
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           ++ L   + D   +Y+  E  +GGEL D+I  +   SE EA      +   +EY+H+ G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 177 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +HRD+KP N+L   +      I+I DFG  K ++          A +    T   TA +V
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLXTPCYTANFV 187
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
            PEVL         D+W+LG  LY  L+G +PF +
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTPFAN 222

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 121/242 (50%), Gaps = 21/242 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 112
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP V+ L   +++   + +  E   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 173 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 287
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 288 FS 289
           FS
Sbjct: 241 FS 242

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 116/235 (49%), Gaps = 14/235 (5%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT 94
           P  Q     A R    + ++ +F + K  G G +S+V RA  +  G   ALK +    + 
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 95  KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKG 150
                A    E  +L QL+HP V++ + +F +   L + LE  + G+L   I      K 
Sbjct: 72  DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
            + E     Y  ++  ALE++HS  ++HRDIKP N+ +TA G +K+ D G +     S+ 
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-LGRFFSSKT 190
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T          A + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF
Sbjct: 191 TA---------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 118/228 (51%), Gaps = 16/228 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 114
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 115 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 277
           Y+ PE          +D+++LGC LY++L+G  PF  D+ + + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHV 232

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 114/227 (50%), Gaps = 25/227 (11%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIM-----DKKFITKENKTAYVKLERI-----VLDQLD 113
           G G+Y +V+  K+ +  +  A+K++     DK   + +NK      E I     +L  LD
Sbjct: 45  GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++LF  F+D    Y+  E  EGGELF+QI ++    E +A     +++  + Y+H 
Sbjct: 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK 164
Query: 174 MGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
             ++HRDIKPEN+LL       +IKI DFG           +    + D K    +GTA 
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFG-----------LSSFFSKDYKLRDRLGTAY 213
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
           Y+ PEVL         D+W+ G  +Y +L G  PF   ++  I +++
Sbjct: 214 YIAPEVLKKKYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 122/231 (52%), Gaps = 16/231 (6%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQL 112
           I  + +G + G GSY KV      +T    A+KI+ KK + +  N  A VK E  +L +L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 113 DHPGVVRLFFTF--QDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDAL 168
            H  V++L      ++   +YM +E C  G  E+ D +  K      +A  Y  +++D L
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGL 122
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           EY+HS G++H+DIKP NLLLT  G +KI+  G  + +           A+DD   T  G+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP--------FAADDTCRTSQGS 174
Query: 229 AAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
            A+ PPE+ N   + + F  D+W+ G TLY + +G  PF+  + + +F+ I
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 114
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 115 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            H  G+IHRD+KP N+L++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA-------VIGTAQ 184
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 277
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/229 (33%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           ++  K  G G++      +   T  + A+K +++     EN    V+ E I    L HP 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPN 77
Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           +VR          L + +E   GGEL+++I + G  SEDEARF+  +++  + Y HSM +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 177 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
            HRD+K EN LL  DG     +KI DFG       S+ +VL +        + VGT AY+
Sbjct: 138 CHRDLKLENTLL--DGSPAPRLKICDFGY------SKSSVLHSQPK-----STVGTPAYI 184
Query: 233 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
            PEVL          D+W+ G TLY ML G  PF+D  E   +++ I R
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 136/276 (49%), Gaps = 33/276 (11%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++ KV +AK  +TG + A K+++ K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 20  GDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYI-VEIEILATCDHPYIVKLLGA 76
Query: 124 FQDTFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +     L++ +E C GG + D I     +G L+E + +    ++++AL ++HS  +IHRD
Sbjct: 77  YYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRD 134
Query: 181 IKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV--- 236
           +K  N+L+T +G I++ADFG S K           N  +  K  +F+GT  ++ PEV   
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAK-----------NLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 237 --LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSXX 291
             +  +P  +  D+W+LG TL +M     P  + +   +  +I   D   +  P+ +S  
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 243
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
                       P  RP A     A L  HPF   I
Sbjct: 244 FRDFLKIALDKNPETRPSA-----AQLLEHPFVSSI 274

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 136/276 (49%), Gaps = 33/276 (11%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++ KV +AK  +TG + A K+++ K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 28  GDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYI-VEIEILATCDHPYIVKLLGA 84
Query: 124 FQDTFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
           +     L++ +E C GG + D I     +G L+E + +    ++++AL ++HS  +IHRD
Sbjct: 85  YYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRD 142
Query: 181 IKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV--- 236
           +K  N+L+T +G I++ADFG S K           N  +  K  +F+GT  ++ PEV   
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAK-----------NLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 237 --LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSXX 291
             +  +P  +  D+W+LG TL +M     P  + +   +  +I   D   +  P+ +S  
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
                       P  RP A     A L  HPF   I
Sbjct: 252 FRDFLKIALDKNPETRPSA-----AQLLEHPFVSSI 282

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 114
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 115 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 277
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 114
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 115 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 277
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 123/267 (46%), Gaps = 36/267 (13%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI---TKENKTAYVKLERIVLDQL 112
           ++ LG + G G +  V    ++      A+K++ +  +   +  + +    LE  +L ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 113 D----HPGVVRLFFTFQDTFSLYMALE-SCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
                HPGV+RL   F+      + LE      +LFD IT KG L E  +R +  +VV A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 168 LEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           +++ HS G++HRDIK EN+L+    G  K+ DFGS   + D   T             F 
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT------------DFD 199
Query: 227 GTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           GT  Y PPE +     ++ PAT    +W+LG  LY M+ G  PF+        Q I+  +
Sbjct: 200 GTRVYSPPEWISRHQYHALPAT----VWSLGILLYDMVCGDIPFERD------QEILEAE 249
Query: 282 IRFPNYFSXXXXXXXXXXXXXXPSGRP 308
           + FP + S              PS RP
Sbjct: 250 LHFPAHVSPDCCALIRRCLAPKPSSRP 276

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 114
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 115 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 277
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 173
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 174 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 211

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 114
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 88
Query: 115 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 148
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 149 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 201
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 277
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 249

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINAMLN 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 23/224 (10%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 111
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPY 172
Query: 232 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 63
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPYVA 175
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 113/222 (50%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N           GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--------KMXGTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 23/224 (10%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 111
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 60
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPY 172
Query: 232 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 119/245 (48%), Gaps = 29/245 (11%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN---------KTAYVKLE 105
           Q ++   + G G  S V R     TG  +A+KIM+   +T E          + A  +  
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME---VTAERLSPEQLEEVREATRRET 150
Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
            I+     HP ++ L  +++ +  +++  +    GELFD +T K  LSE E R     ++
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +A+ ++H+  ++HRD+KPEN+LL  +  I+++DFG    ++             +K    
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-----------EKLREL 259
Query: 226 VGTAAYVPPEVLNSS----PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 279
            GT  Y+ PE+L  S       +G   DLWA G  L+ +L+G+ PF    + L+ + I+ 
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
Query: 280 RDIRF 284
              +F
Sbjct: 320 GQYQF 324

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  +++ +  G G++  V R  +  TG  +A K +       E+    V+ E   +  L 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 106
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 172
           HP +V L   F+D   + M  E   GGELF+++  + + +SEDEA  Y  +V   L ++H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 173 SMGLIHRDIKPENLLLTA--DGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVG 227
               +H D+KPEN++ T      +K+ DFG    + P Q  ++T               G
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--------------G 212
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           TA +  PEV    P  +  D+W++G   Y +LSG SPF
Sbjct: 213 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 112/231 (48%), Gaps = 20/231 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKEN-KTAYVKLERIVLDQLDH 114
           +EL ++ G G +S V R    +TG  +A+KI+D  KF +     T  +K E  +   L H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEY 170
           P +V L  T+     LYM  E  +G +L  +I  +       SE  A  Y  ++++AL Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 171 IHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
            H   +IHRD+KP  +LL +  +   +K+  FG    + +S +           A   VG
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV----------AGGRVG 197
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 278
           T  ++ PEV+   P     D+W  G  L+ +LSG  PF  T E L F+ II
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGII 247

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  +++ +  G G++  V R  +  TG  +A K +       E+    V+ E   +  L 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 212
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 172
           HP +V L   F+D   + M  E   GGELF+++  + + +SEDEA  Y  +V   L ++H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 173 SMGLIHRDIKPENLLLTA--DGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVG 227
               +H D+KPEN++ T      +K+ DFG    + P Q  ++T               G
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--------------G 318
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           TA +  PEV    P  +  D+W++G   Y +LSG SPF
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 112/231 (48%), Gaps = 20/231 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKEN-KTAYVKLERIVLDQLDH 114
           +EL ++ G G +S V R    +TG  +A+KI+D  KF +     T  +K E  +   L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEY 170
           P +V L  T+     LYM  E  +G +L  +I  +       SE  A  Y  ++++AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 171 IHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
            H   +IHRD+KP  +LL +  +   +K+  FG    + +S +           A   VG
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV----------AGGRVG 195
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 278
           T  ++ PEV+   P     D+W  G  L+ +LSG  PF  T E L F+ II
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGII 245

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 122/247 (49%), Gaps = 24/247 (9%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           H   +++E  +I G G  S V R     T   YA+KI+D       +     +L    L 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 111 QLD-------HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
           ++D       HP +++L  T++     ++  +  + GELFD +T K  LSE E R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +++ +  +H + ++HRD+KPEN+LL  D +IK+ DFG    +              +K  
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-----------EKLR 181
Query: 224 TFVGTAAYVPPEV----LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
           +  GT +Y+ PE+    +N +   +G   D+W+ G  +Y +L+G+ PF    + L+ + I
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241
Query: 278 IARDIRF 284
           ++ + +F
Sbjct: 242 MSGNYQF 248

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 17  PEELFT----KLDRI-GKGSFGEVYKGIDNHTKEVVAIKIID--LEEAEDEIEDIQQEIT 69
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL Q D P + R F ++  +  L++ +E   GG   D +   G L E        E++  
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKG 128
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K   FVG
Sbjct: 129 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNXFVG 178
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
           T  ++ PEV+  S   F  D+W+LG T  ++  G  P  D
Sbjct: 179 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 218

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 114/222 (51%), Gaps = 19/222 (8%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+  +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 234 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 124/250 (49%), Gaps = 30/250 (12%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           H   +++E  +I G G  S V R     T   YA+KI+D       +     +L    L 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 111 QLD-------HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
           ++D       HP +++L  T++     ++  +  + GELFD +T K  LSE E R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDD 220
           +++ +  +H + ++HRD+KPEN+LL  D +IK+ DFG    + P +  R           
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR----------- 181
Query: 221 KACTFVGTAAYVPPEV----LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIF 274
           + C   GT +Y+ PE+    +N +   +G   D+W+ G  +Y +L+G+ PF    + L+ 
Sbjct: 182 EVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 275 QRIIARDIRF 284
           + I++ + +F
Sbjct: 239 RMIMSGNYQF 248

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 131/285 (45%), Gaps = 31/285 (10%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DFE   + G G++ +VV+A+       YA+K    K    E K + +  E ++L  L+H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----KIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 116 GVVRLFFTF-------------QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYT 161
            VVR +  +             +   +L++ +E CE G L+D I S+  +   DE     
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV------LPN 215
            ++++AL YIHS G+IHRD+KP N+ +    ++KI DFG  K +  S   +      LP 
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP- 181
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWL-I 273
             S D   + +GTA YV  EVL+ +       D+++LG   ++M+    PF    E + I
Sbjct: 182 -GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNI 237
Query: 274 FQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVL 318
            +++ +  I FP  F                   P   PG   +L
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 114/215 (53%), Gaps = 17/215 (7%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           ++ G G+Y+KV  A  +  G  YA+KI++K+     ++  + ++E +   Q  +  ++ L
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV-FREVETLYQCQ-GNKNILEL 76
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
              F+D    Y+  E  +GG +   I  + H +E EA     +V  AL+++H+ G+ HRD
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRD 136
Query: 181 IKPENLLLTADGH---IKIADF--GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           +KPEN+L  +      +KI DF  GS   + +S   +     +  +  T  G+A Y+ PE
Sbjct: 137 LKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPI-----TTPELTTPCGSAEYMAPE 191
Query: 236 VLN--SSPATFGN---DLWALGCTLYQMLSGTSPF 265
           V+   +  ATF +   DLW+LG  LY MLSG  PF
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 123/246 (50%), Gaps = 30/246 (12%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD- 113
           +++E  +I G G  S V R     T   YA+KI+D       +     +L    L ++D 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 114 ------HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
                 HP +++L  T++     ++  +  + GELFD +T K  LSE E R     +++ 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACT 224
           +  +H + ++HRD+KPEN+LL  D +IK+ DFG    + P +  R           + C 
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-----------EVC- 171
Query: 225 FVGTAAYVPPEV----LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 278
             GT +Y+ PE+    +N +   +G   D+W+ G  +Y +L+G+ PF    + L+ + I+
Sbjct: 172 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 229
Query: 279 ARDIRF 284
           + + +F
Sbjct: 230 SGNYQF 235

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 21/223 (9%)
Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
           + P+E F +    L K+ G GSY  V +A   +TG + A+K      +  E+    +  E
Sbjct: 25  KQPEEVFDV----LEKL-GEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKE 74
Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEV 164
             ++ Q D P VV+ + ++     L++ +E C  G + D I  +   L+EDE        
Sbjct: 75  ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQST 134
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           +  LEY+H M  IHRDIK  N+LL  +GH K+ADFG    + D             K   
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMA----------KRNX 184
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
            +GT  ++ PEV+         D+W+LG T  +M  G  P+ D
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 115 PGVVRLFFTFQD--TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDAL 168
           P +VR +    D    +LY+ +E CEGG+L   IT     + +L E+       ++  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 169 EYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +  H        ++HRD+KP N+ L    ++K+ DFG  + +             +D A 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD----------EDFAK 174
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            FVGT  Y+ PE +N       +D+W+LGC LY++ +   PF
Sbjct: 175 EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 115/222 (51%), Gaps = 23/222 (10%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++ KV +A+  +T  + A K++D K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYM-VEIDILASCDHPNIVKLLDA 102
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
           F    +L++ +E C GG + D +  +    L+E + +    + +DAL Y+H   +IHRD+
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 182 KPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL--- 237
           K  N+L T DG IK+ADFG S K           N  +  +  +F+GT  ++ PEV+   
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAK-----------NTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 238 --NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
                P  +  D+W+LG TL +M     P  + +   +  +I
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 22/227 (9%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 115 PGVVRLFFTFQD--TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDAL 168
           P +VR +    D    +LY+ +E CEGG+L   IT     + +L E+       ++  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 169 EYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +  H        ++HRD+KP N+ L    ++K+ DFG  +        +L +  S  K  
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--------ILNHDTSFAK-- 174
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           TFVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 22/227 (9%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 115 PGVVRLFFTFQD--TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDAL 168
           P +VR +    D    +LY+ +E CEGG+L   IT     + +L E+       ++  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 169 EYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +  H        ++HRD+KP N+ L    ++K+ DFG  +        +L +  S  KA 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--------ILNHDTSFAKA- 175
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
            FVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+
Sbjct: 176 -FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 21/221 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++ KV +A+  +T  + A K++D K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYM-VEIDILASCDHPNIVKLLDA 102
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
           F    +L++ +E C GG + D +  +    L+E + +    + +DAL Y+H   +IHRD+
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL---- 237
           K  N+L T DG IK+ADFG              N     +  +F+GT  ++ PEV+    
Sbjct: 162 KAGNILFTLDGDIKLADFG----------VSAKNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 238 -NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
               P  +  D+W+LG TL +M     P  + +   +  +I
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 110/217 (50%), Gaps = 18/217 (8%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 5   PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEIT 57
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 116
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNTFVG 166
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           T  ++ PEV+  S      D+W+LG T  ++  G  P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 23/222 (10%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G++ KV +A+  +T  + A K++D K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYM-VEIDILASCDHPNIVKLLDA 102
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
           F    +L++ +E C GG + D +  +    L+E + +    + +DAL Y+H   +IHRD+
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 182 KPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL--- 237
           K  N+L T DG IK+ADFG S K           N     +   F+GT  ++ PEV+   
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAK-----------NTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 238 --NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
                P  +  D+W+LG TL +M     P  + +   +  +I
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 43  FAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYV 102
           F    P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   +
Sbjct: 20  FQSMDPEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDI 72
Query: 103 KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 162
           + E  VL Q D P V + + ++     L++ +E   GG   D +   G L E +      
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILR 131
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           E++  L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K 
Sbjct: 132 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KR 181
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
            TFVGT  ++ PEV+  S      D+W+LG T  ++  G  P
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 31/285 (10%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DFE   + G G++ +VV+A+       YA+K    K    E K + +  E ++L  L+H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----KIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 116 GVVRLFFTF-------------QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYT 161
            VVR +  +             +   +L++ +E CE   L+D I S+  +   DE     
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV------LPN 215
            ++++AL YIHS G+IHRD+KP N+ +    ++KI DFG  K +  S   +      LP 
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP- 181
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWL-I 273
             S D   + +GTA YV  EVL+ +       D+++LG   ++M+    PF    E + I
Sbjct: 182 -GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNI 237
Query: 274 FQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVL 318
            +++ +  I FP  F                   P   PG   +L
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 54/281 (19%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN--KTAYVKLERIVLDQL 112
           + + L    G GSY  V  A +  T  + A+KIM+K  I + N      +K E  ++ +L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTA----- 162
            HP + RL+  ++D   + + +E C GG L D++      S G  + D  +         
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 163 ------------------------------EVVDALEYIHSMGLIHRDIKPENLLLTADG 192
                                         ++  AL Y+H+ G+ HRDIKPEN L + + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 193 --HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDL 248
              IK+ DFG  K           N        T  GT  +V PEVLN++  ++G   D 
Sbjct: 206 SFEIKLVDFGLSKEFYKL------NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 249 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF--PNY 287
           W+ G  L+ +L G  PF   ++     +++ + + F  PNY
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 18/217 (8%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 20  PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEIT 72
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 131
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K   FVG
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNXFVG 181
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           T  ++ PEV+  S      D+W+LG T  ++  G  P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 21/216 (9%)
Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRL 120
           + G G+Y  V   + +       ++I  K+   ++++ +    E I L + L H  +V+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSN----QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEAR--FYTAEVVDALEYIHSMGLI 177
             +F +   + + +E   GG L   + SK G L ++E    FYT ++++ L+Y+H   ++
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 178 HRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           HRDIK +N+L+ T  G +KI+DFG+ K +          A  +    TF GT  Y+ PE+
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRL----------AGINPCTETFTGTLQYMAPEI 194
Query: 237 LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 270
           ++  P  +G   D+W+LGCT+ +M +G  PF +  E
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A +  TG   A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 54  GEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL Y+H+ G+IHRDIK 
Sbjct: 111 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT+DG IK++DFG    +          +    K    VGT  ++ PEV++  P  
Sbjct: 170 DSILLTSDGRIKLSDFGFCAQV----------SKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 244 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
              D+W+LG  + +M+ G  P+ +       +RI
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 253

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A++  +G   A+K+MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 54  GEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  +GG L D I S+  L+E++       V+ AL Y+H+ G+IHRDIK 
Sbjct: 111 YLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT DG +K++DFG    +       +P      K    VGT  ++ PEV++ S   
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKD----VP------KRKXLVGTPYWMAPEVISRSLYA 219
Query: 244 FGNDLWALGCTLYQMLSGTSPF 265
              D+W+LG  + +M+ G  P+
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPY 241

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 18/217 (8%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 5   PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEIT 57
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 116
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K   FVG
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNXFVG 166
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           T  ++ PEV+  S      D+W+LG T  ++  G  P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 21/216 (9%)
Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRL 120
           + G G+Y  V   + +       ++I  K+   ++++ +    E I L + L H  +V+ 
Sbjct: 15  VLGKGTYGIVYAGRDLSN----QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEAR--FYTAEVVDALEYIHSMGLI 177
             +F +   + + +E   GG L   + SK G L ++E    FYT ++++ L+Y+H   ++
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 178 HRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           HRDIK +N+L+ T  G +KI+DFG+ K +          A  +    TF GT  Y+ PE+
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRL----------AGINPCTETFTGTLQYMAPEI 180
Query: 237 LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 270
           ++  P  +G   D+W+LGCT+ +M +G  PF +  E
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 216

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDH 114
           ++GKI G GSY  V + +  DTG + A+K    KF+  E+     K+   E  +L QL H
Sbjct: 7   KIGKI-GEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +V L   F+    L++  E C+   L +    +  + E   +  T + + A+ + H  
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             IHRD+KPEN+L+T    IK+ DFG       +R+   P+   DD+    V T  Y  P
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGF------ARLLTGPSDYYDDE----VATRWYRSP 171
Query: 235 EVLNSSPATFGN--DLWALGCTLYQMLSGT 262
           E+L      +G   D+WA+GC   ++LSG 
Sbjct: 172 ELLVGD-TQYGPPVDVWAIGCVFAELLSGV 200

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 177
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 178 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 230
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 231 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 265

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 258
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 258
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 258
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 177
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 178 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 230
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 231 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 265

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 192
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 193 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 245
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 246 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 280

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 258
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 178
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 179 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 231
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 232 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 266

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 193
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 194 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 246
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 247 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 281

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 220
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 221 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 273
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 274 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 308

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 95  KENKTAYVKLERIVLD--QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL 152
           +E +    + ER V +  QL H  +V +    ++    Y+ +E  EG  L + I S G L
Sbjct: 49  REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL 108
Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 212
           S D A  +T +++D +++ H M ++HRDIKP+N+L+ ++  +KI DFG  K + ++ +T 
Sbjct: 109 SVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT- 167
Query: 213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
                   +    +GT  Y  PE           D++++G  LY+ML G  PF
Sbjct: 168 --------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 193
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 194 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 246
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 247 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 281

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 178
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 179 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 231
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 232 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 266

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 178
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 179 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 231
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 232 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 266

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 173
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 174 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 226
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 227 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 212
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 213 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 265
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 266 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 300

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 192
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 193 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 245
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 246 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 280

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 225
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 226 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 278
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 279 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 313

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 220
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 221 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 273
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 274 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 308

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 176
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 177 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 229
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 230 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 264

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 21  PEELFT----KLERI-GKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEIT 73
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL Q D   V + + ++     L++ +E   GG   D + + G   E +      E++  
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKG 132
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 133 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNTFVG 182
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
           T  ++ PEV+  S      D+W+LG T  ++  G  P  D
Sbjct: 183 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 222

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 173
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 174 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 226
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 227 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 200
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 201 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 253
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 254 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 288

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 173
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 174 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 226
Query: 288 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
            S              PS RP      +  ++ HP+ + +
Sbjct: 227 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 117/228 (51%), Gaps = 34/228 (14%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           FEL ++ G G+Y +V + + + TG + A+K+MD   +T + +   +K E  +L +  H  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSHH- 80
Query: 117 VVRLFFTFQDTF----------SLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTAEV 164
             R   T+   F           L++ +E C  G + D I  +KG+ L E+   +   E+
Sbjct: 81  --RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           +  L ++H   +IHRDIK +N+LLT +  +K+ DFG V    D  +          +  T
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV---------GRRNT 188
Query: 225 FVGTAAYVPPEVL--NSSP-AT--FGNDLWALGCTLYQMLSGTSPFKD 267
           F+GT  ++ PEV+  + +P AT  F +DLW+LG T  +M  G  P  D
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 22/223 (9%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 113
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 114 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 170
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 171 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 193
Query: 230 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSE 270
            Y PPE +       G    +W+LG  LY M+ G  PF+   E
Sbjct: 194 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 235

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 27/255 (10%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           + DFE  +  G G +  V  AK       YA+K +  +   +E     V  E   L +L+
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLE 61
Query: 114 HPGVVRLFFTFQDTFS------------LYMALESCEGGELFDQITSKGHLSEDEARFYT 161
           HPG+VR F  + +  +            LY+ ++ C    L D +  +  + E E     
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 162 ---AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM--QDSRITVLPNA 216
               ++ +A+E++HS GL+HRD+KP N+  T D  +K+ DFG V  M   +   TVL   
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 217 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 276
            +  +    VGT  Y+ PE ++ +  +   D+++LG  L+++L    PF    E +   R
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERV---R 235
Query: 277 II--ARDIRFPNYFS 289
            +   R+++FP  F+
Sbjct: 236 TLTDVRNLKFPPLFT 250

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 160 GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 217 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 275
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 325
Query: 244 FGNDLWALGCTLYQMLSGTSPF 265
              D+W+LG  + +M+ G  P+
Sbjct: 326 PEVDIWSLGIMVIEMVDGEPPY 347

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 123/249 (49%), Gaps = 23/249 (9%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQ 111
           ++ +EL K  G G+Y  V ++    TG V A+K   K F   +N T   +  R  ++L +
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTE 64
Query: 112 LD-HPGVVRLFFTFQ--DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           L  H  +V L    +  +   +Y+  +  E       +     L     ++   +++  +
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR-------ITVLPNAAS--D 219
           +Y+HS GL+HRD+KP N+LL A+ H+K+ADFG  +   + R       +++  N  +  D
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 220 DK--ACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 276
           D+     +V T  Y  PE+ L S+  T G D+W+LGC L ++L G   F  +S     +R
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 277 IIARDIRFP 285
           II   I FP
Sbjct: 243 IIGV-IDFP 250

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 83  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 140 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 198
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 199 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 248
Query: 244 FGNDLWALGCTLYQMLSGTSPF 265
              D+W+LG  + +M+ G  P+
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPPY 270

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 31/285 (10%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DFE   + G G++ +VV+A+       YA+K    K    E K + +  E  +L  L+H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----KIRHTEEKLSTILSEVXLLASLNHQ 62
Query: 116 GVVRLFFTF-------------QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYT 161
            VVR +  +             +   +L++  E CE   L+D I S+  +   DE     
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV------LPN 215
            ++++AL YIHS G+IHR++KP N+ +    ++KI DFG  K +  S   +      LP 
Sbjct: 123 RQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP- 181
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWL-I 273
             S D   + +GTA YV  EVL+ +       D ++LG   ++ +    PF    E + I
Sbjct: 182 -GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNI 237
Query: 274 FQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVL 318
            +++ +  I FP  F                   P   PG   +L
Sbjct: 238 LKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 38  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 94
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 95  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 153
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 154 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 203
Query: 244 FGNDLWALGCTLYQMLSGTSPF 265
              D+W+LG  + +M+ G  P+
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPPY 225

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 40  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 96
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 97  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 155
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 156 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 205
Query: 244 FGNDLWALGCTLYQMLSGTSPF 265
              D+W+LG  + +M+ G  P+
Sbjct: 206 PEVDIWSLGIMVIEMVDGEPPY 227

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 33  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 89
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 90  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 148
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 149 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 244 FGNDLWALGCTLYQMLSGTSPF 265
              D+W+LG  + +M+ G  P+
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPPY 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 29  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 86  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 144
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 243
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 244 FGNDLWALGCTLYQMLSGTSPF 265
              D+W+LG  + +M+ G  P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY 216

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 114
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 115 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 221
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +E+ +  G G +  V+R    DTG   A+K   ++ ++ +N+  +  LE  ++ +L+HP 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK-QCRQELSPKNRERWC-LEIQIMKKLNHPN 74
Query: 117 VVRLFFTFQDTFSL------YMALESCEGGEL---FDQITSKGHLSEDEARFYTAEVVDA 167
           VV           L       +A+E CEGG+L    +Q  +   L E   R   +++  A
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI---KIADFGSVKPMQDSRITVLPNAASDDKACT 224
           L Y+H   +IHRD+KPEN++L         KI D G  K +    +            CT
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL------------CT 182
Query: 225 -FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            FVGT  Y+ PE+L     T   D W+ G   ++ ++G  PF
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           +E+ +  G G +  V+R    DTG   A+K   ++ ++ +N+  +  LE  ++ +L+HP 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK-QCRQELSPKNRERWC-LEIQIMKKLNHPN 73
Query: 117 VVRLFFTFQDTFSL------YMALESCEGGEL---FDQITSKGHLSEDEARFYTAEVVDA 167
           VV           L       +A+E CEGG+L    +Q  +   L E   R   +++  A
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI---KIADFGSVKPMQDSRITVLPNAASDDKACT 224
           L Y+H   +IHRD+KPEN++L         KI D G  K +    +            CT
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL------------CT 181
Query: 225 -FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            FVGT  Y+ PE+L     T   D W+ G   ++ ++G  PF
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 120
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 121 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 227
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 228 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 177
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 74
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 75  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 181
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 182 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 75
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 76  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 182
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 183 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 177
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 76
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 77  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 183
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 184 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 84
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 85  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 191
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 192 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 175
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 176 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 69
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 70  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 176
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 177 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DHPGVVRLF 121
           G G ++ V +     TG  YA K + K+   ++ +     L  I + +L    P V+ L 
Sbjct: 38  GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI--LHEIAVLELAKSCPRVINLH 95
Query: 122 FTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
             +++T  + + LE   GGE+F     +    +SE++      ++++ + Y+H   ++H 
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 180 DIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTF---VGTAAYVP 233
           D+KP+N+LL++    G IKI DFG  + +                AC     +GT  Y+ 
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKI--------------GHACELREIMGTPEYLA 201
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           PE+LN  P T   D+W +G   Y +L+ TSPF
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           H++     LG+    GS+ +V R +   TG   A+K +  +    E        E +   
Sbjct: 74  HWATHQLRLGR----GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE--------ELMACA 121
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
            L  P +V L+   ++   + + +E  EGG L   +  +G L ED A +Y  + ++ LEY
Sbjct: 122 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 181
Query: 171 IHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDD--KACTFVG 227
           +HS  ++H D+K +N+LL++DG H  + DFG    +Q       P+    D        G
Sbjct: 182 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ-------PDGLGKDLLTGDYIPG 234
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           T  ++ PEV+         D+W+  C +  ML+G  P+
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVL 109
           S++ +E   + G GSY  V++ +  DTG + A+K    KF+  ++     K+   E  +L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLL 78
Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
            QL H  +V L    +     Y+  E  +   L D       L     + Y  ++++ + 
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           + HS  +IHRDIKPEN+L++  G +K+ DFG       +R    P    DD+    V T 
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGF------ARTLAAPGEVYDDE----VATR 188
Query: 230 AYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 270
            Y  PE+L      +G   D+WA+GC + +M  G   F   S+
Sbjct: 189 WYRAPELL-VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 184 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 191
Query: 241 PATFGNDLWALGCTLYQMLSGTSPF 265
                 D+W+LG    +M+ G  P+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 116 GVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 175 GLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT  Y P
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTRVYSP 224
Query: 234 PEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 291
           PE +       G    +W+LG  LY M+ G  PF+   E      II   + F    S  
Sbjct: 225 PEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRVSSE 277
Query: 292 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 327
                       PS RP      +  ++ HP+ + +
Sbjct: 278 CQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 308

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           D+EL ++ G G+ + VV+A           K+  K+   ++ +T+  +L  E   + Q  
Sbjct: 11  DYELQEVIGSGA-TAVVQAAYCAPKKE---KVAIKRINLEKCQTSMDELLKEIQAMSQCH 66
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFD---QITSKGH-----LSEDEARFYTAEVV 165
           HP +V  + +F     L++ ++   GG + D    I +KG      L E        EV+
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + LEY+H  G IHRD+K  N+LL  DG ++IADFG       + +    +   +    TF
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV-----SAFLATGGDITRNKVRKTF 181
Query: 226 VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPF 265
           VGT  ++ PEV+       F  D+W+ G T  ++ +G +P+
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           D+EL ++ G G+ + VV+A           K+  K+   ++ +T+  +L  E   + Q  
Sbjct: 16  DYELQEVIGSGA-TAVVQAAYCAPKKE---KVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFD---QITSKGH-----LSEDEARFYTAEVV 165
           HP +V  + +F     L++ ++   GG + D    I +KG      L E        EV+
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + LEY+H  G IHRD+K  N+LL  DG ++IADFG V     +   +  N        TF
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG-VSAFLATGGDITRNKVRK----TF 186
Query: 226 VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPF 265
           VGT  ++ PEV+       F  D+W+ G T  ++ +G +P+
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           H++     LG+    GS+ +V R +   TG   A+K +  +    E        E +   
Sbjct: 93  HWATHQLRLGR----GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE--------ELMACA 140
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
            L  P +V L+   ++   + + +E  EGG L   +  +G L ED A +Y  + ++ LEY
Sbjct: 141 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 200
Query: 171 IHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           +HS  ++H D+K +N+LL++DG H  + DFG    +Q   +       S        GT 
Sbjct: 201 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGL-----GKSLLTGDYIPGTE 255
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            ++ PEV+         D+W+  C +  ML+G  P+
Sbjct: 256 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 175
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
               T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 176 EPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  +  + +G   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 60  GSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 117
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 177
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 178 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 224
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 278
           N        D+W++GC + ++L+G + F  T      Q+I+
Sbjct: 225 NWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIM 265

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHR+IK 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRNIKS 145
Query: 184 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 192
Query: 241 PATFGNDLWALGCTLYQMLSGTSPF 265
                 D+W+LG    +M+ G  P+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+ +V R K   TG   A+K +  +    E        E +    L  P +V L+  
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 118
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
            ++   + + +E  EGG L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 184 ENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 242
           +N+LL++DG    + DFG    +Q   +    +  + D      GT  ++ PEV+   P 
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLG--KSLLTGD---YIPGTETHMAPEVVMGKPC 233
Query: 243 TFGNDLWALGCTLYQMLSGTSPF 265
               D+W+  C +  ML+G  P+
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+ +V R K   TG   A+K +  +    E        E +    L  P +V L+  
Sbjct: 83  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 134
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
            ++   + + +E  EGG L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 194
Query: 184 ENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 242
           +N+LL++DG    + DFG    +Q   +    +  + D      GT  ++ PEV+   P 
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLG--KSLLTGD---YIPGTETHMAPEVVMGKPC 249
Query: 243 TFGNDLWALGCTLYQMLSGTSPF 265
               D+W+  C +  ML+G  P+
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+ +V R K   TG   A+K +  +    E        E +    L  P +V L+  
Sbjct: 81  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 132
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
            ++   + + +E  EGG L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K 
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 192
Query: 184 ENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 242
           +N+LL++DG    + DFG    +Q   +    +  + D      GT  ++ PEV+   P 
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGLG--KSLLTGD---YIPGTETHMAPEVVMGKPC 247
Query: 243 TFGNDLWALGCTLYQMLSGTSPF 265
               D+W+  C +  ML+G  P+
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 24/224 (10%)
Query: 54  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D E LG++ G G+  +V + +   TG V A+K M +    +ENK   + L+ +VL   
Sbjct: 24  INDLENLGEM-GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-VVLKSH 81
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEY 170
           D P +V+ F TF     +++A+E    G   +++  +  G + E      T  +V AL Y
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYY 139
Query: 171 I-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           +    G+IHRD+KP N+LL   G IK+ DFG    + D +       A D  A    G A
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-------AKDRSA----GCA 188
Query: 230 AYVPPEVLNSSPAT-----FGNDLWALGCTLYQMLSGTSPFKDT 268
           AY+ PE ++    T        D+W+LG +L ++ +G  P+K+ 
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 145
Query: 184 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +N+LL  DG +K+ DFG    + P Q  R                VGT  ++ PEV+   
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------SXMVGTPYWMAPEVVTRK 192
Query: 241 PATFGNDLWALGCTLYQMLSGTSPF 265
                 D+W+LG    +M+ G  P+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 184 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +N+LL  DG +K+ DFG    + P Q  R                VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------SXMVGTPYWMAPEVVTRK 191
Query: 241 PATFGNDLWALGCTLYQMLSGTSPF 265
                 D+W+LG    +M+ G  P+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N+       D+W++GC + ++L+G + F  T
Sbjct: 196 NAMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDSELKILDFGLCR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 184 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           +N+LL  DG +K+ DFG    + P Q  R                VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------SEMVGTPYWMAPEVVTRK 191
Query: 241 PATFGNDLWALGCTLYQMLSGTSPF 265
                 D+W+LG    +M+ G  P+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   FV T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMAGFVATRWYRAPEIML 191
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 115/260 (44%), Gaps = 47/260 (18%)
Query: 48  PQEHFSIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           P+++    D++L K + G+G   KV+      TG   ALK++      ++          
Sbjct: 21  PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---------- 70
Query: 107 IVLDQLDH-------PGVVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGH--LS 153
               ++DH       P +V +   +++       L + +E  EGGELF +I  +G    +
Sbjct: 71  ----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT 126
Query: 154 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRI 210
           E EA     ++  A++++HS  + HRD+KPENLL T+   D  +K+ DFG  K    + +
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
                        T   T  YV PEVL         D+W+LG  +Y +L G  PF   + 
Sbjct: 187 Q------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234
Query: 271 WLIF----QRIIARDIRFPN 286
             I     +RI      FPN
Sbjct: 235 QAISPGMKRRIRLGQYGFPN 254

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   FV T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMAGFVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   FV T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMAGFVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 115/260 (44%), Gaps = 47/260 (18%)
Query: 48  PQEHFSIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           P+++    D++L K + G+G   KV+      TG   ALK++      ++          
Sbjct: 2   PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---------- 51
Query: 107 IVLDQLDH-------PGVVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGH--LS 153
               ++DH       P +V +   +++       L + +E  EGGELF +I  +G    +
Sbjct: 52  ----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT 107
Query: 154 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRI 210
           E EA     ++  A++++HS  + HRD+KPENLL T+   D  +K+ DFG  K    + +
Sbjct: 108 EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 167
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
                        T   T  YV PEVL         D+W+LG  +Y +L G  PF   + 
Sbjct: 168 Q------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 215
Query: 271 WLIF----QRIIARDIRFPN 286
             I     +RI      FPN
Sbjct: 216 QAISPGMKRRIRLGQYGFPN 235

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + K F +    K  Y +L   +L  + H  V+ L  
Sbjct: 43  GSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 100
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 207
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 115 PGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDAL 168
           P +VR+   +++ ++    L +  E  +GGELF +I  +G    +E EA      + +A+
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAI 174
Query: 169 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   T 
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLTTP 223
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
             T  YV PEVL         D W+LG   Y +L G  PF
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 121
           + G G++++V     + T   YA+KI++K+      ++   +   ++     H  V+ L 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 122 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
             F++    Y+  E   GG +   I  + H +E EA     +V  AL+++H+ G+ HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 182 KPENLLLTADGH---IKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           KPEN+L         +KI DFG    +K   D      P         T  G+A Y+ PE
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL------TPCGSAEYMAPE 191
Query: 236 VLN--SSPATFGN---DLWALGCTLYQMLSGTSPF 265
           V+   S  A+  +   DLW+LG  LY +LSG  PF
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDSELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDSELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 191
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 51  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 108
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 215
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 50  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 107
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 214
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 43  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 100
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 207
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 43  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 100
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 207
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 42  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 99
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 160 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 206
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 202
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 30  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 87
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 147
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 148 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 194
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 195 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 54  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 111
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 218
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 42  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 99
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 160 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 206
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 60  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112
Query: 114 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 221
Query: 231 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 266
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 60  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 65
Query: 114 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 66  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 124 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 174
Query: 231 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 266
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 50  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 107
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 214
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 29  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 86
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 146
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 147 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 193
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 224

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 28  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 85
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 192
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 51  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 108
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 215
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 60  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112
Query: 114 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 221
Query: 231 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 266
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 191
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 110
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 217
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 191
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 28  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 85
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 192
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 183
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 104
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 211
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 212 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 60  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 84
Query: 114 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 85  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 143 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 193
Query: 231 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 266
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 112
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 219
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 220 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 54  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 111
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMXGYVATRWYRAPEIML 218
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 89
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 196
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 197 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 81
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 188
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 41  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 98
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 158
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 159 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 205
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 206 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 236

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 155
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 262
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 263 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 60  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 7   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 64
Query: 114 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 65  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 122
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 123 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 173
Query: 231 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 266
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 114
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 221
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 222 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 60  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 11  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 68
Query: 114 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 69  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 126
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 127 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 177
Query: 231 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 266
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 178 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 33/227 (14%)
Query: 60  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 84
Query: 114 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 85  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           IH  G++H D+KP N L+  DG +K+ DFG    MQ     V+ ++         VGT  
Sbjct: 143 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQ--------VGTVN 193
Query: 231 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 266
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI D+G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDYGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F ++   K AY +L   +L  + H  V+ L  
Sbjct: 34  GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR--LLKHMRHENVIGLLD 91
Query: 123 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
            F      D F+ +  +    G +L  ++     L ED  +F   +++  L YIH+ G+I
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 236
           HRD+KP NL +  D  +KI DFG  +              +D +    V T  Y  PEV 
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLAR-------------QADSEMXGXVVTRWYRAPEVI 197
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
           LN    T   D+W++GC + +M++G + FK
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 88
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 195
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 110
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN +        +
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVSX-------I 217
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 80
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 187
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 188 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 121
           + G G++++V     + T   YA+KI++K+     ++  + ++E +   Q  H  V+ L 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQ-GHRNVLELI 77
Query: 122 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
             F++    Y+  E   GG +   I  + H +E EA     +V  AL+++H+ G+ HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 182 KPENLLLTADGH---IKIADF---GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           KPEN+L         +KI DF     +K   D      P         T  G+A Y+ PE
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL------TPCGSAEYMAPE 191
Query: 236 VLN--SSPATFGN---DLWALGCTLYQMLSGTSPF 265
           V+   S  A+  +   DLW+LG  LY +LSG  PF
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 88
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 195
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 77
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 184
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 185 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 84
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 191
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 192 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+    V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGXVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 33/227 (14%)
Query: 60  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112
Query: 114 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VG   
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGAVN 221
Query: 231 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 266
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 95
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 202
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 203 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 51  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 108
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              +DD+    V T  Y  PE+ L
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMXGXVATRWYRAPEIML 215
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              + D+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTADEMTGYVATRWYRAPEIML 202
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI  FG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILGFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 91  KFITKEN----------KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG 140
           KFI KE           K   V LE  +L +++H  ++++   F++     + +E    G
Sbjct: 55  KFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG 114
Query: 141 -ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 199
            +LF  I     L E  A +   ++V A+ Y+    +IHRDIK EN+++  D  IK+ DF
Sbjct: 115 LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDF 174
Query: 200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQM 258
           GS   ++  ++             TF GT  Y  PEVL  +P      ++W+LG TLY +
Sbjct: 175 GSAAYLERGKLFY-----------TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223
Query: 259 LSGTSPFKDTSE 270
           +   +PF +  E
Sbjct: 224 VFEENPFCELEE 235

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              + D+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTADEMTGYVATRWYRAPEIML 202
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DFG  +              + D+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTADEMTGYVATRWYRAPEIML 202
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 110/225 (48%), Gaps = 30/225 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           L  I G G+ + V R +   TG ++A+K+ +     +       + E  VL +L+H  +V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE--VLKKLNHKNIV 70
Query: 119 RLFFTFQDTFSLY--MALESCEGGELF---DQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           +LF   ++T + +  + +E C  G L+   ++ ++   L E E      +VV  + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 174 MGLIHRDIKPENLL--LTADGH--IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            G++HR+IKP N++  +  DG    K+ DFG+ + ++D           D++  +  GT 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------DEQFVSLYGTE 179
Query: 230 AYVPPEVLNSS------PATFGN--DLWALGCTLYQMLSGTSPFK 266
            Y+ P++   +         +G   DLW++G T Y   +G+ PF+
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAF 121
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 223
            HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 122 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 173 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 231
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 232 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI D G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDAGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI D G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDRGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 113 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAF 119
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 223
            HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 120 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 171
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 139
Query: 172 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 140 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 187
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
           Y+ PE L  +  +  +D+W++G +L +M  G  P    S
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGS 226

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 173 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 169
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI DF   +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFYLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           L  I G G+ + V R +   TG ++A+K+ +     +       + E  VL +L+H  +V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE--VLKKLNHKNIV 70
Query: 119 RLFFTFQDTFSLY--MALESCEGGELF---DQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           +LF   ++T + +  + +E C  G L+   ++ ++   L E E      +VV  + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 174 MGLIHRDIKPENLL--LTADGH--IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            G++HR+IKP N++  +  DG    K+ DFG+ + ++D           D++     GT 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------DEQFVXLYGTE 179
Query: 230 AYVPPEVLNSS------PATFGN--DLWALGCTLYQMLSGTSPFK 266
            Y+ P++   +         +G   DLW++G T Y   +G+ PF+
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 123 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 237
           RD+KP NL +  D  +KI D G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDGGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 238 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 171
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 172 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 168
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 171
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 172 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 168
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 173 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 169
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 173 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 169
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 16  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 71
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 171
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 72  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 176
Query: 232 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
           + PEV+   +S+P +F +D++A G  LY++++G  P+ +
Sbjct: 177 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 215

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 171
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 172 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 195
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 18/224 (8%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G +  V R  +  +   Y  K +      K      VK E  +L+   H  ++ L  +
Sbjct: 14  GRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 124 FQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
           F+    L M  E   G ++F++I TS   L+E E   Y  +V +AL+++HS  + H DI+
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129
Query: 183 PENLLLTA--DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 240
           PEN++        IKI +FG  + ++            D+    F     Y  PEV    
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLK----------PGDNFRLLFTA-PEYYAPEVHQHD 178
Query: 241 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
             +   D+W+LG  +Y +LSG +PF   +   I + I+  +  F
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  L H  V+ L  
Sbjct: 37  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHLKHENVIGLLD 94
Query: 123 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
            F      + FS    + +  G +L + + S+  LS++  +F   +++  L+YIHS G+I
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQA-LSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 236
           HRD+KP N+ +  D  ++I DFG  +              +D++   +V T  Y  PE+ 
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR-------------QADEEMTGYVATRWYRAPEIM 200
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           LN        D+W++GC + ++L G + F
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  +  K F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---------IMRKLDHCNIV 76
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 183
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 171
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 123
Query: 172 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
                ++HRD+KP N+L+ + G IK+ DFG            +     D+ A  FVGT +
Sbjct: 124 REKHKIMHRDVKPSNILVNSRGEIKLCDFG------------VSGQLIDEMANEFVGTRS 171
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           Y+ PE L  +  +  +D+W++G +L +M  G  P
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  +  K F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---------IMRKLDHCNIV 76
Query: 119 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 183
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAF 121
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 223
            HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM---DKKFITKENKTAYVKLERI-VLDQ 111
           DF+L  + G G+Y  V  A    TG + A+K +   DK         A   L  I +L  
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF------ALRTLREIKILKH 65
Query: 112 LDHPGVVRLFF-----TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 166
             H  ++ +F      +F++   +Y+  E  +      ++ S   LS+D  +++  + + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLR 123
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S                FV
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 227 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 259
            T  Y  PEV L S+  +   D+W+ GC L ++ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 113 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAF 120
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 223
            HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E  +   + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           +HP +V+L         LY+  E       +  D     G +     + Y  +++  L +
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAF 118
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 223
            HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 119 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 179 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           ++ E+ ++ G G++  V +AK       +  K +  K I  E++     +E   L +++H
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSRVNH 61
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL---SEDEARFYTAEVVDALEYI 171
           P +V+L+    +   L M  E  EGG L++ +     L   +   A  +  +    + Y+
Sbjct: 62  PNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 172 HSM---GLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           HSM    LIHRD+KP NLLL A G + KI DFG+   +Q           +++K     G
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNK-----G 166
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
           +AA++ PEV   S  +   D+++ G  L+++++   PF +
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 206

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           ++ E+ ++ G G++  V +AK       +  K +  K I  E++     +E   L +++H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSRVNH 60
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL---SEDEARFYTAEVVDALEYI 171
           P +V+L+    +   L M  E  EGG L++ +     L   +   A  +  +    + Y+
Sbjct: 61  PNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 172 HSM---GLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           HSM    LIHRD+KP NLLL A G + KI DFG+   +Q           +++K     G
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNK-----G 165
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
           +AA++ PEV   S  +   D+++ G  L+++++   PF +
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  L H  V+ L  
Sbjct: 37  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHLKHENVIGLLD 94
Query: 123 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
            F      + FS    + +  G +L + I     LS++  +F   +++  L+YIHS G+I
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADL-NNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 236
           HRD+KP N+ +  D  ++I DFG  +              +D++   +V T  Y  PE+ 
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR-------------QADEEMTGYVATRWYRAPEIM 200
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           LN        D+W++GC + ++L G + F
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 63
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 184 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           ++E+ +  G G+Y  V  A++  TG   A+K +   F    N    ++ E  +L    H 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHD 113
Query: 116 GVVRLFFTFQDTF------SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
            ++ +    + T       S+Y+ L+  E  +L   I S   L+ +  R++  +++  L+
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+HS  +IHRD+KP NLL+  +  +KI DFG  + +  S       A        +V T 
Sbjct: 173 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS------PAEHQYFMTEYVATR 226
Query: 230 AYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPF 265
            Y  PE++ S    T   DLW++GC   +ML+    F
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM---DKKFITKENKTAYVKLERI-VLDQ 111
           DF+L  + G G+Y  V  A    TG + A+K +   DK         A   L  I +L  
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF------ALRTLREIKILKH 65
Query: 112 LDHPGVVRLFF-----TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 166
             H  ++ +F      +F++   +Y+  E  +      ++ S   LS+D  +++  + + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLR 123
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S                +V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 227 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 259
            T  Y  PEV L S+  +   D+W+ GC L ++ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           ++E+ +  G G+Y  V  A++  TG   A+K +   F    N    ++ E  +L    H 
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHD 114
Query: 116 GVVRLFFTFQDTF------SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
            ++ +    + T       S+Y+ L+  E  +L   I S   L+ +  R++  +++  L+
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+HS  +IHRD+KP NLL+  +  +KI DFG  + +  S       A        +V T 
Sbjct: 174 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS------PAEHQYFMTEYVATR 227
Query: 230 AYVPPEVLNS-SPATFGNDLWALGCTLYQMLS 260
            Y  PE++ S    T   DLW++GC   +ML+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 113 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 224
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  L H  V+ L  
Sbjct: 29  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHLKHENVIGLLD 86
Query: 123 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
            F      + FS    + +  G +L + I     LS++  +F   +++  L+YIHS G+I
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGADL-NNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGII 145
Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 236
           HRD+KP N+ +  D  ++I DFG  +              +D++   +V T  Y  PE+ 
Sbjct: 146 HRDLKPSNVAVNEDCELRILDFGLAR-------------QADEEMTGYVATRWYRAPEIM 192
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           LN        D+W++GC + ++L G + F
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 28  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 83
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 171
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 84  -LFMGYSTAPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  +IHRD+K  N+ L  D  +KI DFG          T     +   +     G+  +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA--------TEKSRWSGSHQFEQLSGSILW 188
Query: 232 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
           + PEV+   +S+P +F +D++A G  LY++++G  P+ +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 31/243 (12%)
Query: 39  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 17  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 73
Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 156
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 74  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 125
Query: 157 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 209
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 126 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 178
Query: 210 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 266
            TV    +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 179 -TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 237
Query: 267 DTS 269
           + +
Sbjct: 238 NIN 240

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
           DFE     G G+   V + +   +G      IM +K I  E K A    +  E  VL + 
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           + P +V  +  F     + + +E  +GG L   +     + E+     +  V+  L Y+ 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 173 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------MANSFVGTRSY 179
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           + PE L  +  +  +D+W++G +L ++  G  P 
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 28  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 83
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 171
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 84  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  +IHRD+K  N+ L  D  +KI DFG          T     +   +     G+  +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA--------TEKSRWSGSHQFEQLSGSILW 188
Query: 232 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
           + PEV+   +S+P +F +D++A G  LY++++G  P+ +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           K+ G GS+  V +AK  D+G + A+K  +  K F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---------IMRKLDHCNIV 76
Query: 119 RLFFTF------QDTFSLYMALESCEG-----GELFDQITSKGHLSEDEARFYTAEVVDA 167
           RL + F      +D   L + L+            + +  +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSR--AKQTLPVIYVKLYMYQLFRS 134
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 227 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 31/243 (12%)
Query: 39  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 18  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 74
Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 156
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 75  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 126
Query: 157 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 209
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 127 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 179
Query: 210 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 266
            TV    +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 180 -TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238
Query: 267 DTS 269
           + +
Sbjct: 239 NIN 241

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 115/257 (44%), Gaps = 42/257 (16%)
Query: 49  QEHFSIQDFELG-------KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY 101
           Q  F  Q  ELG       ++   G ++ V  A+ + +G  YALK   +    +E K   
Sbjct: 15  QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALK---RLLSNEEEKNRA 71
Query: 102 VKLERIVLDQLD-HPGVVRLFF----------TFQDTFSLYMALESCEGG--ELFDQITS 148
           +  E   + +L  HP +V+             T Q  F L   L  C+G   E   ++ S
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL--CKGQLVEFLKKMES 129
Query: 149 KGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQ 206
           +G LS D       +   A++++H     +IHRD+K ENLLL+  G IK+ DFGS     
Sbjct: 130 RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA---- 185
Query: 207 DSRITVLPN-------AASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLY 256
            + I+  P+        A  ++  T   T  Y  PE+++   + P     D+WALGC LY
Sbjct: 186 -TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244
Query: 257 QMLSGTSPFKDTSEWLI 273
            +     PF+D ++  I
Sbjct: 245 LLCFRQHPFEDGAKLRI 261

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 57  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVL 109
           +EL K Y      G G+Y  V  A    +G   A+K + + F ++   K AY +L  ++L
Sbjct: 38  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL--LLL 95
Query: 110 DQLDHPGVVRLFFTF------QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
             + H  V+ L   F      ++ +  Y+ +   +      Q       SE++ ++   +
Sbjct: 96  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL---QKIMGMEFSEEKIQYLVYQ 152
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           ++  L+YIHS G++HRD+KP NL +  D  +KI DFG  +              +D +  
Sbjct: 153 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------HADAEMT 199
Query: 224 TFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFK 266
            +V T  Y  PEV+ S        D+W++GC + +ML+G + FK
Sbjct: 200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 187
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 188 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 64
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 184
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 185 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 213

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM---DKKFITKENKTAYVKLERI-VLDQ 111
           DF+L  + G G+Y  V  A    TG + A+K +   DK         A   L  I +L  
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF------ALRTLREIKILKH 65
Query: 112 LDHPGVVRLFF-----TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 166
             H  ++ +F      +F++   +Y+  E  +      ++ S   LS+D  +++  + + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLR 123
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S                 V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 227 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 259
            T  Y  PEV L S+  +   D+W+ GC L ++ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 34/249 (13%)
Query: 52  FSIQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
            +I  F+LG  Y      G G    V  A   D     A+K   K  +T      +   E
Sbjct: 2   MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALRE 58
Query: 106 RIVLDQLDHPGVVRLFF--------------TFQDTFSLYMALESCEGGELFDQITSKGH 151
             ++ +LDH  +V++F               +  +  S+Y+  E  E       +  +G 
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGP 116
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRI 210
           L E+ AR +  +++  L+YIHS  ++HRD+KP NL + T D  +KI DFG  + M     
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD---- 172
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
              P+ +        + T  Y  P +L S +  T   D+WA GC   +ML+G + F    
Sbjct: 173 ---PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 270 EWLIFQRII 278
           E    Q I+
Sbjct: 230 ELEQMQLIL 238

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S  ++HRD+KP+NLL+  +G IK+ADFG       +R   +P      +  T      Y 
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGL------ARAFGVPVRTYTHEVVTL----WYR 177
Query: 233 PPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
            PE+ L     +   D+W+LGC   +M++  + F   SE
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 216

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 57  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVL 109
           +EL K Y      G G+Y  V  A    +G   A+K + + F ++   K AY +L  ++L
Sbjct: 20  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL--LLL 77
Query: 110 DQLDHPGVVRLFFTF------QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
             + H  V+ L   F      ++ +  Y+ +   +      Q       SE++ ++   +
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL---QKIMGLKFSEEKIQYLVYQ 134
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           ++  L+YIHS G++HRD+KP NL +  D  +KI DFG  +              +D +  
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------HADAEMT 181
Query: 224 TFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFK 266
            +V T  Y  PEV+ S        D+W++GC + +ML+G + FK
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S  ++HRD+KP+NLL+  +G IK+ADFG       +R   +P      +  T      Y 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGL------ARAFGVPVRTYTHEVVTL----WYR 170
Query: 233 PPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
            PE+ L     +   D+W+LGC   +M++  + F   SE
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +Q +E  +  G G+Y  V +AK  +T  + ALK + +     E   +    E  +L +L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           H  +VRL         L +  E C+    + FD  +  G L  +  + +  +++  L + 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  ++HRD+KP+NLL+  +G +K+ADFG  +      I V   +A        V T  Y
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLADFGLARAFG---IPVRCYSAE-------VVTLWY 167
Query: 232 VPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
            PP+VL  +   +   D+W+ GC   ++ +   P 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           ++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 115 PGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           P +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTFV 226
             ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
            TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 STAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 67/128 (52%), Gaps = 9/128 (7%)
Query: 139 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 198
           G +L+  + ++ HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI D
Sbjct: 129 GADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICD 187
Query: 199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQ 257
           FG  +          P+         +V T  Y  PE+ LNS   T   D+W++GC L +
Sbjct: 188 FGLAR-------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 240
Query: 258 MLSGTSPF 265
           MLS    F
Sbjct: 241 MLSNRPIF 248

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 122/269 (45%), Gaps = 25/269 (9%)
Query: 16  KDFDSKLRIEG----------NNNSSTNCPTVQRSKSFAFRA-PQEHFSI--QDFELGKI 62
           +  D+  R+EG          ++  ST  P  ++S     RA P++ + +  +D  LG+ 
Sbjct: 62  QSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQ 121
Query: 63  YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF 122
            G G++ +V   +     T+ A+K   ++ +  + K  +++  RI L Q  HP +VRL  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARI-LKQYSHPNIVRLIG 179
Query: 123 TFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
                  +Y+ +E  +GG+    + ++G  L          +    +EY+ S   IHRD+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 241
              N L+T    +KI+DFG  +   D     +  A+   +      TA    PE LN   
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADG----VXAASGGLRQVPVKWTA----PEALNYGR 291
Query: 242 ATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
            +  +D+W+ G  L++  S G SP+ + S
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 109
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 68
Query: 110 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 161
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 177
Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--TAYVKLERIVLDQLDHPGVVRLF 121
           G G+Y  V +A+  + G  +ALK   K  + KE++   +    E  +L +L H  +V+L+
Sbjct: 11  GEGTYGVVYKAQN-NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 122 FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
                   L +  E  +    +L D    +G L    A+ +  ++++ + Y H   ++HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 238
           D+KP+NLL+  +G +KIADFG  +                 K    V T  Y  P+VL  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 239 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           S   +   D+W++GC   +M++GT  F   SE     RI  R +  PN
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPN 221

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 109
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 68
Query: 110 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 161
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 177
Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 109
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 68
Query: 110 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 161
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 177
Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 50  EHFSIQDFELGKI--YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           ++F ++  +L  I   G G+Y  V + + + +G + A+K +     ++E K   + L+ I
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-I 102
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGH-LSEDEARFYTAEV 164
            +  +D P  V  +        +++ +E  +    + + Q+  KG  + ED        +
Sbjct: 103 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 162
Query: 165 VDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           V ALE++HS + +IHRD+KP N+L+ A G +K+ DFG    + DS       A + D  C
Sbjct: 163 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV------AKTIDAGC 216
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 258
                   + PE LN    +  +D+W+LG T+ ++
Sbjct: 217 KPYMAPERINPE-LNQKGYSVKSDIWSLGITMIEL 250

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 16  KDFDSKLRIEG----------NNNSSTNCPTVQRSKSFAFRA-PQEHFSI--QDFELGKI 62
           +  D+  R+EG          ++  ST  P  ++S     RA P++ + +  +D  LG+ 
Sbjct: 62  QSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQ 121
Query: 63  YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF 122
            G G++ +V   +     T+ A+K   ++ +  + K  +++  RI L Q  HP +VRL  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARI-LKQYSHPNIVRLIG 179
Query: 123 TFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
                  +Y+ +E  +GG+    + ++G  L          +    +EY+ S   IHRD+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 241
              N L+T    +KI+DFG  +   D        AAS       V   A   PE LN   
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADGVY-----AASGGLRQVPVKWTA---PEALNYGR 291
Query: 242 ATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
            +  +D+W+ G  L++  S G SP+ + S
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--TAYVKLERIVLDQLDHPGVVRLF 121
           G G+Y  V +A+  + G  +ALK   K  + KE++   +    E  +L +L H  +V+L+
Sbjct: 11  GEGTYGVVYKAQN-NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 122 FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
                   L +  E  +    +L D    +G L    A+ +  ++++ + Y H   ++HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 238
           D+KP+NLL+  +G +KIADFG  +                 K    + T  Y  P+VL  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 239 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           S   +   D+W++GC   +M++GT  F   SE     RI  R +  PN
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPN 221

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 31/243 (12%)
Query: 39  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 18  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 74
Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 156
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 75  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 126
Query: 157 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 209
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 127 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 179
Query: 210 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 266
            T     +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 180 -TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238
Query: 267 DTS 269
           + +
Sbjct: 239 NIN 241

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 14  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 69
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 171
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 70  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 122
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 123 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 174
Query: 232 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 175 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 47  APQEH--FSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 103
           +P++H  F+ +D  +LG+I G G+Y  V +     +G + A+K +      KE K   + 
Sbjct: 12  SPEQHWDFTAEDLKDLGEI-GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD 70
Query: 104 LERIVLDQLDHPGVVRLF---FTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEAR 158
           L+ +V+   D P +V+ +   F   D + + M L S    + +  + S     + E+   
Sbjct: 71  LD-VVMRSSDCPYIVQFYGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 159 FYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
             T   V AL ++  ++ +IHRDIKP N+LL   G+IK+ DFG    + DS       A 
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS------IAK 182
Query: 218 SDDKACTFVGTAAYVPPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPF 265
           + D  C       Y+ PE ++ S +  G    +D+W+LG TLY++ +G  P+
Sbjct: 183 TRDAGCR-----PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+  V + K      V  LK++D    T E   A+ + E  VL +  H  ++ LF  
Sbjct: 45  GSGSFGTVYKGKWHGDVAVKILKVVDP---TPEQFQAF-RNEVAVLRKTRHVNIL-LFMG 99
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYIHSMGL 176
           +    +L +  + CEG  L+       HL   E +F   +++D        ++Y+H+  +
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYK------HLHVQETKFQMFQLIDIARQTAQGMDYLHAKNI 153
Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           IHRD+K  N+ L     +KI DFG          TV    +   +     G+  ++ PEV
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLA--------TVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 237 L---NSSPATFGNDLWALGCTLYQMLSGTSPF 265
           +   +++P +F +D+++ G  LY++++G  P+
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 117/243 (48%), Gaps = 31/243 (12%)
Query: 39  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 10  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 66
Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 156
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 67  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 118
Query: 157 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 209
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG     + SR
Sbjct: 119 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSR 176
Query: 210 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 266
                  +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 177 ------WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 230
Query: 267 DTS 269
           + +
Sbjct: 231 NIN 233

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 17  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 72
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 171
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 177
Query: 232 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 67
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 171
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 68  -LFMGYSTAPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 172
Query: 232 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 17  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 72
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 171
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 177
Query: 232 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V AL  +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V AL  +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 114 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 225
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 67
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 171
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 172
Query: 232 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 49/222 (22%)
Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K     +          DK+C
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKY---------DKSC 179
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
                                  D+W+LG  +Y +L G  PF
Sbjct: 180 -----------------------DMWSLGVIMYILLCGYPPF 198

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 122 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLAR------- 174
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 175 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR------- 176
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR------- 172
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 122 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 174
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 175 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 118 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 170
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 171 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 88/170 (51%), Gaps = 19/170 (11%)
Query: 130 LYMALESCEGGELFDQITSKGHLSEDE---ARFYTAEVVDALEYIHSMGLIHRDIKPENL 186
           LY+ ++ C    L D +  +  L + E         ++ +A+E++HS GL+HRD+KP N+
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 187 LLTADGHIKIADFGSVKPM-----QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 241
             T D  +K+ DFG V  M     + + +T +P  A+       VGT  Y+ PE ++ + 
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQ---VGTKLYMSPEQIHGNN 252
Query: 242 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYFS 289
            +   D+++LG  L+++L     F    E +   RII   R+++FP  F+
Sbjct: 253 YSHKVDIFSLGLILFELLYS---FSTQMERV---RIITDVRNLKFPLLFT 296

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 172
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR------- 172
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 118 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 170
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 171 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR------- 176
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 140 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 192
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 193 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 176
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 125 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 177
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 178 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 126 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 178
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 179 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 117 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 169
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 170 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 176
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 128 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 180
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 181 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 172
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 176
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 122 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 174
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 175 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLAR------- 172
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +Q +E  +  G G+Y  V +AK  +T  + ALK + +     E   +    E  +L +L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           H  +VRL         L +  E C+    + FD  +  G L  +  + +  +++  L + 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  ++HRD+KP+NLL+  +G +K+A+FG  +      I V   +A        V T  Y
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG---IPVRCYSAE-------VVTLWY 167
Query: 232 VPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
            PP+VL  +   +   D+W+ GC   ++ +   P 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 22/228 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--TAYVKLERIVLDQLDHPGVVRLF 121
           G G+Y  V +A+  + G  +ALK   K  + KE++   +    E  +L +L H  +V+L+
Sbjct: 11  GEGTYGVVYKAQN-NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 122 FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
                   L +  E  +    +L D    +G L    A+ +  ++++ + Y H   ++HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 238
           D+KP+NLL+  +G +KIADFG  +                 K    V T  Y  P+VL  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 239 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           S   +   D+W++GC   +M++G   F   SE     RI  R +  PN
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIF-RILGTPN 221

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+Y+ V + K   T  + ALK  + +   +E        E  +L  L H  +V L   
Sbjct: 11  GEGTYATVYKGKSKLTDNLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
                SL +  E  +  +L   +   G++ +    + +  +++  L Y H   ++HRD+K
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127
Query: 183 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSP 241
           P+NLL+   G +K+ADFG       +R   +P    D++  T      Y PP++ L S+ 
Sbjct: 128 PQNLLINERGELKLADFGL------ARAKSIPTKTYDNEVVTL----WYRPPDILLGSTD 177
Query: 242 ATFGNDLWALGCTLYQMLSGTSPF 265
            +   D+W +GC  Y+M +G   F
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 127
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS         +  KA        +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---------TXXKASKGKLPIKW 178
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 266
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 36/223 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIM-DKKFITKENKTAYVKLERIVLDQLDHPGVVR 119
           K+ G GS+  V +AK +++  V   K++ DK+F  +E     +++ RIV     HP VV 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE-----LQIMRIV----KHPNVVD 96
Query: 120 LFFTF------QDTFSLYMALESC-----EGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           L   F      +D   L + LE            + ++  K  +     + Y  +++ +L
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL--KQTMPMLLIKLYMYQLLRSL 154
Query: 169 EYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
            YIHS+G+ HRDIKP+NLLL    G +K+ DFGS K +    I   PN +        + 
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL----IAGEPNVSX-------IC 203
Query: 228 TAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
           +  Y  PE +  ++  T   D+W+ GC + +++ G   F   S
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE----NKTAYVKLERIVLDQL 112
           +E     G G ++ V +A+  +T  + A+K +     ++     N+TA  +++  +L +L
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK--LLQEL 69
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP ++ L   F    ++ +  +  E         +   L+    + Y    +  LEY+H
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
              ++HRD+KP NLLL  +G +K+ADFG  K          PN A   +    V T  Y 
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS------PNRAYXHQ----VVTRWYR 179
Query: 233 PPEVL-NSSPATFGNDLWALGCTLYQML 259
            PE+L  +     G D+WA+GC L ++L
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 122
           G G+Y  V +AK    G + ALK +  +   ++       +  I +L +L HP +V L  
Sbjct: 30  GEGTYGVVYKAKD-SQGRIVALKRI--RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 123 TFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
                  L +  E  E    ++ D+  +K  L + + + Y  +++  + + H   ++HRD
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NS 239
           +KP+NLL+ +DG +K+ADFG       +R   +P  +   +  T      Y  P+VL  S
Sbjct: 145 LKPQNLLINSDGALKLADFGL------ARAFGIPVRSYTHEVVTL----WYRAPDVLMGS 194
Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
              +   D+W++GC   +M++G   F   ++
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 122
           G G+Y  V +AK    G + ALK +  +   ++       +  I +L +L HP +V L  
Sbjct: 30  GEGTYGVVYKAKD-SQGRIVALKRI--RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 123 TFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 180
                  L +  E  E    ++ D+  +K  L + + + Y  +++  + + H   ++HRD
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NS 239
           +KP+NLL+ +DG +K+ADFG       +R   +P  +   +  T      Y  P+VL  S
Sbjct: 145 LKPQNLLINSDGALKLADFGL------ARAFGIPVRSYTHEVVTL----WYRAPDVLMGS 194
Query: 240 SPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
              +   D+W++GC   +M++G   F   ++
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+  V  A+ +    V A+K M         K   +  E   L +L HP  ++    
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRD+K 
Sbjct: 84  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 240
            N+LL+  G +K+ DFGS   M                A  FVGT  ++ PEV   ++  
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMA--------------PANXFVGTPYWMAPEVILAMDEG 189
Query: 241 PATFGNDLWALGCTLYQMLSGTSPF 265
                 D+W+LG T  ++     P 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G GS+  V  A+ +    V A+K M         K   +  E   L +L HP  ++    
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122
Query: 124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 183
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRD+K 
Sbjct: 123 YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182
Query: 184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 240
            N+LL+  G +K+ DFGS   M                A  FVGT  ++ PEV   ++  
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMA--------------PANXFVGTPYWMAPEVILAMDEG 228
Query: 241 PATFGNDLWALGCTLYQMLSGTSPF 265
                 D+W+LG T  ++     P 
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 127
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++A   +K+ DFG  + M+DS        AS  K         +
Sbjct: 128 ESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 178
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 266
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+Y  V + + + +G + A+K +     ++E K   + L+ I +  +D P  V  +  
Sbjct: 16  GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISMRTVDCPFTVTFYGA 74
Query: 124 FQDTFSLYMALESCEGG--ELFDQITSKGH-LSEDEARFYTAEVVDALEYIHS-MGLIHR 179
                 +++ +E  +    + + Q+  KG  + ED        +V ALE++HS + +IHR
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 134
Query: 180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD-DKACTFVGTAAYVPPEVLN 238
           D+KP N+L+ A G +K+ DFG    + D       + A D D  C        + PE LN
Sbjct: 135 DVKPSNVLINALGQVKMCDFGISGYLVD-------DVAKDIDAGCKPYMAPERINPE-LN 186
Query: 239 SSPATFGNDLWALGCTLYQMLSGTSPF 265
               +  +D+W+LG T+ ++     P+
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPY 213

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 75  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 132
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 183
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 277
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 67
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 171
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  +IHRD+K  N+ L  D  +KI DFG     + SR       +   +     G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSR------WSGSHQFEQLSGSILW 172
Query: 232 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 98  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 155
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 156 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 206
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 266
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 73  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 130
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 131 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 181
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 266
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 127
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 178
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 266
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 67  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 124
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 175
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 266
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 127
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 178
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 266
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 72  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 129
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 130 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 180
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 266
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 176
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+          V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 125 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 177
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P+          V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 178 VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 31/218 (14%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH- 114
           D++L +  G G YS+V  A  I       +KI+      K+NK   +K E  +L+ L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKNK---IKREIKILENLRGG 91
Query: 115 PGVVRLFFTFQDTFSLYMAL--ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           P ++ L    +D  S   AL  E     + F Q+     L++ + RFY  E++ AL+Y H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 173 SMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQDSRITVLPNAASDDKACTFVGT 228
           SMG++HRD+KP N+++  +   +++ D+G  +   P Q+  +               V +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--------------VAS 194
Query: 229 AAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 8/217 (3%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P   F   D   G++ G G + + ++    +TG V  +K + +    +E +  ++K E  
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLK-EVK 59
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-YTAEVVD 166
           V+  L+HP V++          L    E  +GG L   I S         R  +  ++  
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--LPNAASDD--KA 222
            + Y+HSM +IHRD+   N L+  + ++ +ADFG  + M D +     L +    D  K 
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 259
            T VG   ++ PE++N        D+++ G  L +++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 15/227 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 450 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 507
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++A   +K+ DFG  + M+DS            KA        +
Sbjct: 508 ESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKW 558
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 277
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 15/227 (6%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 171
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 450 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 507
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS            KA        +
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKW 558
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 277
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVK 103
           + P +H + + +E+ K+ G GS+ +VV+A         ALK++  +K+F  +  +   + 
Sbjct: 89  QVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147
Query: 104 LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 161
                 D+ +   V+ +   FTF++   +   L S    EL  +   +G  S    R + 
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASD 219
             ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             +    
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS-------------SCYEH 253
Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 261
            +  T + +  Y  PEV+  +      D+W+LGC L ++L+G
Sbjct: 254 QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVK 103
           + P +H + + +E+ K+ G GS+ +VV+A         ALK++  +K+F  +  +   + 
Sbjct: 89  QVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147
Query: 104 LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 161
                 D+ +   V+ +   FTF++   +   L S    EL  +   +G  S    R + 
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASD 219
             ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             +    
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS-------------SCYEH 253
Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 261
            +  T + +  Y  PEV+  +      D+W+LGC L ++L+G
Sbjct: 254 QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 9/185 (4%)
Query: 82  VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGE 141
           + ALK+  +   +        + E     +L  P VV +    +    LY+      G +
Sbjct: 61  IVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVD 120
Query: 142 LFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 201
           L   +  +G L+   A     ++  AL+  H+ G  HRD+KPEN+L++AD    + DFG 
Sbjct: 121 LAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI 180
Query: 202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 261
                D ++T L N          VGT  Y  PE  + S AT+  D++AL C LY+ L+G
Sbjct: 181 ASATTDEKLTQLGNT---------VGTLYYXAPERFSESHATYRADIYALTCVLYECLTG 231
Query: 262 TSPFK 266
           + P++
Sbjct: 232 SPPYQ 236

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 109
           E F  Q F+     G GSY +V + +  + G +YA+K     F   +++    KL  +  
Sbjct: 52  ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR--KLAEVGS 109
Query: 110 DQL--DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVD 166
            +    HP  VRL   +++   LY+  E C G  L     + G  L E +   Y  + + 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           AL ++HS GL+H D+KP N+ L   G  K+ DFG           +L    +        
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFG-----------LLVELGTAGAGEVQE 217
Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 258
           G   Y+ PE+L  S  T   D+++LG T+ ++
Sbjct: 218 GDPRYMAPELLQGSYGT-AADVFSLGLTILEV 248

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 16/233 (6%)
Query: 40  SKSFAFRAPQEHFSIQDFELGKI--YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN 97
           +++  F+   E+F ++  +L  I   G G+Y  V + + + +G + A+K +     ++E 
Sbjct: 17  TENLYFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQ 76
Query: 98  KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGH-LSE 154
           K     L+ I    +D P  V  +        +++  E  +    + + Q+  KG  + E
Sbjct: 77  KRLLXDLD-ISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPE 135
Query: 155 DEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 213
           D        +V ALE++HS + +IHRD+KP N+L+ A G +K  DFG    + D      
Sbjct: 136 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVD------ 189
Query: 214 PNAASD-DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
            + A D D  C        + PE LN    +  +D+W+LG T  ++     P+
Sbjct: 190 -DVAKDIDAGCKPYXAPERINPE-LNQKGYSVKSDIWSLGITXIELAILRFPY 240

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF- 121
           G G +S V   + +  G  YALK I+  +   +E       + R+     +HP ++RL  
Sbjct: 38  GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL----FNHPNILRLVA 93
Query: 122 FTFQDT---FSLYMALESCEGGELFDQITS---KGH-LSEDEARFYTAEVVDALEYIHSM 174
           +  ++       ++ L   + G L+++I     KG+ L+ED+  +    +   LE IH+ 
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKP----MQDSR--ITVLPNAASDDKACTFVGT 228
           G  HRD+KP N+LL  +G   + D GS+      ++ SR  +T+   AA   + CT    
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA---QRCTI--- 207
Query: 229 AAYVPPEVLNSSPATF---GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 276
            +Y  PE+ +           D+W+LGC LY M+ G  P+      ++FQ+
Sbjct: 208 -SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQK 252

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 106/224 (47%), Gaps = 27/224 (12%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQL 112
           ++ ++  K  G G+   V  A     G   A+K + + F  + + K AY +L  ++L  +
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYREL--VLLKCV 80
Query: 113 DHPGVVRLF--FTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEV 164
           +H  ++ L   FT Q T      +Y+ +E  +       +    H+  D  R  +   ++
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQM 135
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           +  ++++HS G+IHRD+KP N+++ +D  +KI DFG  +            A ++     
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TACTNFMMTP 184
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           +V T  Y  PEV+         D+W++GC + +++ G   F+ T
Sbjct: 185 YVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGT 228

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G+Y+ V +     TG   ALK  + K  ++E   +    E  ++ +L H  +VRL+  
Sbjct: 14  GNGTYATVYKGLNKTTGVYVALK--EVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 124 FQDTFSLYMALESCEGG--ELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIH 178
                 L +  E  +    +  D  T   +   L  +  +++  +++  L + H   ++H
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILH 131
Query: 179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP-NAASDDKACTFVGTAAYVPPEVL 237
           RD+KP+NLL+   G +K+ DFG       +R   +P N  S +     V T  Y  P+VL
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGL------ARAFGIPVNTFSSE-----VVTLWYRAPDVL 180
Query: 238 -NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             S   +   D+W+ GC L +M++G   F  T++
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 115/239 (48%), Gaps = 28/239 (11%)
Query: 40  SKSFAFRAPQEHFSI-QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN- 97
           S+ ++ +     F++ + ++  K  G G+   V  A     G   A+K + + F  + + 
Sbjct: 6   SQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 65
Query: 98  KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALESCEGGELFDQITSKGH 151
           K AY +L  ++L  ++H  ++ L   FT Q T      +Y+ +E  +       +    H
Sbjct: 66  KRAYREL--VLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIH 118
Query: 152 LSEDEAR--FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 209
           +  D  R  +   +++  ++++HS G+IHRD+KP N+++ +D  +KI DFG  +      
Sbjct: 119 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------ 172
Query: 210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
                 A+++     +V T  Y  PEV+         D+W++GC + +++ G+  F+ T
Sbjct: 173 -----TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 226

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 114
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 22  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 76
Query: 115 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 164
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 134
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 188
Query: 225 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 270
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 189 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 110/233 (47%), Gaps = 35/233 (15%)
Query: 47  APQEHFSIQDFELGKIYGVGSYSKVV-------RAKKIDTGTVYALKIMDKKFITKENKT 99
           +PQ   + +D  L +I G G + +V        + +KI+     A+K   KK  T +NK 
Sbjct: 16  SPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINV----AVKTC-KKDCTLDNKE 70
Query: 100 AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEAR 158
            ++  E +++  LDHP +V+L    ++    ++ +E    GEL   +  +K  L      
Sbjct: 71  KFMS-EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLV 128
Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD-----SRITVL 213
            Y+ ++  A+ Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D     + +T L
Sbjct: 129 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           P                ++ PE +N    T  +D+W     ++++LS G  PF
Sbjct: 189 P--------------IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 114
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 21  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 75
Query: 115 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 164
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 133
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 187
Query: 225 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 270
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 188 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 114
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 22  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 76
Query: 115 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 164
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 134
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 188
Query: 225 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 270
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 189 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 114
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 22  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 76
Query: 115 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 164
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 134
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 188
Query: 225 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 270
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 189 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 56  DFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +  L +I G+G + KV RA  I D   V A +    + I++  +   V+ E  +   L H
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIEN--VRQEAKLFAMLKH 65
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS- 173
           P ++ L        +L + +E   GG L +++ S   +  D    +  ++   + Y+H  
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 174 --MGLIHRDIKPENLLLT--------ADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
             + +IHRD+K  N+L+         ++  +KI DFG  +     R T +  A       
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA------- 175
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
              G  A++ PEV+ +S  + G+D+W+ G  L+++L+G  PF+
Sbjct: 176 ---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 18  FDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRA--- 74
           ++S+L++     SS N       + + +    E F  ++ E GK+ G G++ KV+ A   
Sbjct: 9   YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWE-FPRENLEFGKVLGSGAFGKVMNATAY 67
Query: 75  --KKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY 131
              K       A+K++ +K  + E +    +L+  ++ QL  H  +V L      +  +Y
Sbjct: 68  GISKTGVSIQVAVKMLKEKADSSEREALMSELK--MMTQLGSHENIVNLLGACTLSGPIY 125
Query: 132 MALESCEGGELFDQITSKGH-LSEDEARF----------------------YTAEVVDAL 168
           +  E C  G+L + + SK    SEDE  +                      +  +V   +
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDDKACTFVG 227
           E++     +HRD+   N+L+T    +KI DFG  +  M DS   V  NA    K      
Sbjct: 186 EFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK------ 239
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
              ++ PE L     T  +D+W+ G  L+++ S G +P+
Sbjct: 240 ---WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 35/233 (15%)
Query: 47  APQEHFSIQDFELGKIYGVGSYSKVV-------RAKKIDTGTVYALKIMDKKFITKENKT 99
            PQ   + +D  L +I G G + +V        + +KI+     A+K   KK  T +NK 
Sbjct: 4   GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINV----AVKTC-KKDCTLDNKE 58
Query: 100 AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEAR 158
            ++  E +++  LDHP +V+L    ++    ++ +E    GEL   +  +K  L      
Sbjct: 59  KFMS-EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLV 116
Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD-----SRITVL 213
            Y+ ++  A+ Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D     + +T L
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           P                ++ PE +N    T  +D+W     ++++LS G  PF
Sbjct: 177 P--------------IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 106/232 (45%), Gaps = 35/232 (15%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVV-------RAKKIDTGTVYALKIMDKKFITKENKTA 100
           PQ   + +D  L +I G G + +V        + +KI+           KK  T +NK  
Sbjct: 1   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKEK 55
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARF 159
           ++  E +++  LDHP +V+L    ++    ++ +E    GEL   +  +K  L       
Sbjct: 56  FMS-EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVL 113
Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD-----SRITVLP 214
           Y+ ++  A+ Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D     + +T LP
Sbjct: 114 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 173
Query: 215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                           ++ PE +N    T  +D+W     ++++LS G  PF
Sbjct: 174 --------------IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 62  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 121
           + G G+   +V     D   V   +I+ + F   + +   ++      +  +HP V+R F
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLR------ESDEHPNVIRYF 84
Query: 122 FTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
            T +D    Y+A+E C    L + +  K   HL  +       +    L ++HS+ ++HR
Sbjct: 85  CTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITL-LQQTTSGLAHLHSLNIVHR 142
Query: 180 DIKPENLLLT---ADGHIK--IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           D+KP N+L++   A G IK  I+DFG  K +   R        S  +     GT  ++ P
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-------HSFSRRSGVPGTEGWIAP 195
Query: 235 EVLNSSPA---TFGNDLWALGCTLYQMLS-GTSPF 265
           E+L+       T+  D+++ GC  Y ++S G+ PF
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 114/263 (43%), Gaps = 50/263 (19%)
Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL- 112
           I D+ + +    G ++K++  +K      YALK  +K  + K+        ++I +    
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 113 -DHPGVVRLFFTFQDTFSLYMALESCEG--------GELFDQITSKGHLSEDEARF---- 159
            D    +++    ++ + L     +CEG          +++ + +   L  DE  F    
Sbjct: 88  DDFKNELQIITDIKNEYCL-----TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 160 -YTA------------EVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPM 205
            YT              V+++  YIH+   + HRD+KP N+L+  +G +K++DFG  + M
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTS 263
            D +I       S        GT  ++PPE  ++  +  G   D+W+LG  LY M     
Sbjct: 203 VDKKI-----KGSR-------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 264 PFK-DTSEWLIFQRIIARDIRFP 285
           PF    S   +F  I  ++I +P
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYP 273

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIM------DKKFITKENKTAYVKLERIVLDQLDHPGV 117
           GVG+Y  V +A+   +G   ALK +      +   I+   + A ++     L+  +HP V
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR----LEAFEHPNV 68
Query: 118 VRLFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           VRL      +       + +  E  +       D+    G L  +  +    + +  L++
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDF 127
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALFP----------VVVTLW 176
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           Y  PEVL  S      D+W++GC   +M      F   SE
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-----LDQLDHPGVV 118
           GVG+Y  V +A+   +G   ALK +             +   R V     L+  +HP VV
Sbjct: 18  GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77
Query: 119 RLFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           RL      +       + +  E  +       D+    G L  +  +    + +  L+++
Sbjct: 78  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFL 136
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  Y
Sbjct: 137 HANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTP----------VVVTLWY 185
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
             PEVL  S      D+W++GC   +M      F   SE
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVK 103
           + P +H + + +E+ K+ G G + +VV+A         ALK++  +K+F  +  +   + 
Sbjct: 89  QVPHDHVAYR-YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147
Query: 104 LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 161
                 D+ +   V+ +   FTF++   +   L S    EL  +   +G  S    R + 
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASD 219
             ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             +    
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS-------------SCYEH 253
Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 261
            +    + +  Y  PEV+  +      D+W+LGC L ++L+G
Sbjct: 254 QRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 114
           F++ ++ G G++  V   K+  TG   A+K  I D +F  +E +          L  L H
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD------LAVLHH 78
Query: 115 PGVVRL---FFTF--QDTFSLYM---------ALESCEGGELFDQITSKGHLSEDEARFY 160
           P +V+L   F+T   +D   +Y+          L  C       Q+     L     + +
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL----IKVF 134
Query: 161 TAEVVDALEYIH--SMGLIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAA 217
             +++ ++  +H  S+ + HRDIKP N+L+  ADG +K+ DFGS K +  S     PN A
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE----PNVA 190
Query: 218 SDDKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
                  ++ +  Y  PE +  +   T   D+W++GC   +M+ G   F+
Sbjct: 191 -------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
            LS D   ++  +++  L+YIHS  ++HRD+KP NLL+     +KI DFG  + + D   
Sbjct: 140 QLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLAR-IAD--- 195
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 265
              P           V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 196 ---PEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIM------DKKFITKENKTAYVKLERIVLDQLDHPGV 117
           GVG+Y  V +A+   +G   ALK +      +   I+   + A ++     L+  +HP V
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR----LEAFEHPNV 68
Query: 118 VRLFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           VRL      +       + +  E  +       D+    G L  +  +    + +  L++
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDF 127
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALAP----------VVVTLW 176
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           Y  PEVL  S      D+W++GC   +M      F   SE
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 39  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 92
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--------YTAEVVDALEYIH 172
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 93  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 173 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPMQDSRITVLPNAASD 219
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   +     N  + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 220 DKACTFVGTAAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLS-GTSPFKD 267
                  GT+ +  PE+L  S     T   D++++GC  Y +LS G  PF D
Sbjct: 211 S------GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 39  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 92
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--------YTAEVVDALEYIH 172
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 93  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 173 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPMQDSRITVLPNAASD 219
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   +     N  + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 220 DKACTFVGTAAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLS-GTSPFKD 267
                  GT+ +  PE+L  S     T   D++++GC  Y +LS G  PF D
Sbjct: 211 S------GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLD 113
           DF+  ++ G G + +V +AK          +I  K ++ K  K    K ER V  L +LD
Sbjct: 12  DFKEIELIGSGGFGQVFKAKH---------RIDGKTYVIKRVKYNNEKAEREVKALAKLD 62
Query: 114 HPGVVRLF-----FTFQ-----------DTFSLYMALESCEGGELFDQITSKGHLSEDE- 156
           H  +V        F +             T  L++ +E C+ G L   I  +     D+ 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 157 -ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
            A     ++   ++YIHS  LI+RD+KP N+ L     +KI DFG V  +++        
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-------- 174
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 272
              D K     GT  Y+ PE ++S       DL+ALG  L ++L       +TS++ 
Sbjct: 175 ---DGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 17  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLV 121
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 122 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 176
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 177 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIM------DKKFITKENKTAYVKLERIVLDQLDHPGV 117
           GVG+Y  V +A+   +G   ALK +      +   I+   + A ++     L+  +HP V
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR----LEAFEHPNV 68
Query: 118 VRLFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEY 170
           VRL      +       + +  E  +       D+    G L  +  +    + +  L++
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDF 127
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALDP----------VVVTLW 176
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           Y  PEVL  S      D+W++GC   +M      F   SE
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDD-----PEAAY 205
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 110
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 12  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 169
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 71  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 227
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 182
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 183 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 240

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 34  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 85  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 138
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 139 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 193
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 194 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 243

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 17  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 121
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 122 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 176
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 177 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 110
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 18  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 169
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 77  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 227
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 188
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 189 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 110
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 18  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 169
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 77  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 227
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM-----QEHRKVPF-- 188
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 189 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           D  + +  G GS+  V RA+    G+  A+KI+ ++    E    +++ E  ++ +L HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE-DEARFYTA--EVVDALEYIH 172
            +V          +L +  E    G L+  +   G   + DE R  +   +V   + Y+H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 173 SMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +    ++HRD+K  NLL+     +K+ DFG       SR+       S   A    GT  
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL------SRLKASXFLXSKXAA----GTPE 204
Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
           ++ PEVL   P+   +D+++ G  L+++ +   P+
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 110
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 12  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 169
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 71  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 227
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 182
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 183 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 240

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 107
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------- 159
           +     H  +V L         + +  E C  G+L + +  K  + E +  F        
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 160 ------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRIT 211
                 ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 VKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           D  + +  G GS+  V RA+    G+  A+KI+ ++    E    +++ E  ++ +L HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE-DEARFYTA--EVVDALEYIH 172
            +V          +L +  E    G L+  +   G   + DE R  +   +V   + Y+H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 173 SMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV---- 226
           +    ++HR++K  NLL+     +K+ DFG       SR+          KA TF+    
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL------SRL----------KASTFLSSKS 198
Query: 227 --GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 265
             GT  ++ PEVL   P+   +D+++ G  L+++ +   P+
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 107
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------- 159
           +     H  +V L         + +  E C  G+L + +  K  + E +  F        
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 160 ------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRIT 211
                 ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 VKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 110
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 8   KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 169
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 67  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 227
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM-----QEHRKVPF-- 178
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 179 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 44  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 94
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 95  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 148
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 149 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 203
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 204 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 253

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 110
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 8   KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 169
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 67  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 227
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 178
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 179 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 49/239 (20%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 21  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 74
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--------YTAEVVDALEYIH 172
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 75  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 173 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPM---QDSRITVLPNA 216
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   Q S  T L N 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 217 ASDDKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLS-GTSPFKD 267
           +         GT+ +  PE+L  S         T   D++++GC  Y +LS G  PF D
Sbjct: 193 S---------GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 55  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 112
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 113 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 169
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +    S + V            FV T  Y  PEV+         D+W++GC + 
Sbjct: 170 LDFGLARTAGTSFMMV-----------PFVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 218
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 219 EMIKGGVLFPGT 230

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 110
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 8   KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 169
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 67  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 227
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 178
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 179 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 106
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 107 -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 166 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-----PEAAY 205
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 107
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEAR------- 158
           +     H  +V L         + +  E C  G+L + +  K    L +++ R       
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 159 -FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRITVLPN 215
             ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   V  N
Sbjct: 155 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGN 213
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           A    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 214 ARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 30/239 (12%)
Query: 48  PQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           P   + I D +E+  + G GSY  V  A       V A+K + + F    +    ++ E 
Sbjct: 45  PHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EI 103
Query: 107 IVLDQLDHPGVVRLFFTF-----QDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARF 159
            +L++L+H  VV++         +    LY+ LE  +    +LF    +  +L+E   + 
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF---RTPVYLTELHIKT 160
Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---------------SVKP 204
               ++  ++Y+HS G++HRD+KP N L+  D  +K+ DFG                + P
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 205 MQDS-RITVLPNAASDDKACT-FVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLS 260
            +D   +   P+  +  +  T  V T  Y  PE +L     T   D+W++GC   ++L+
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 107
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEAR------- 158
           +     H  +V L         + +  E C  G+L + +  K    L +++ R       
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 159 -FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRITVLPN 215
             ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   V  N
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           A    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 ARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 120
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 21  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 74
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--------YTAEVVDALEYIH 172
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 75  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 173 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPMQDSRITVLPNAASD 219
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   +     N  + 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 220 DKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLS-GTSPFKD 267
                  GT+ +  PE+L  S         T   D++++GC  Y +LS G  PF D
Sbjct: 193 S------GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 127 TFSLYMALESCEGGELFDQITSKGHLSEDE--ARFYTAEVVDALEYIHSMGLIHRDIKPE 184
           T  L++ +E C+ G L   I  +     D+  A     ++   ++YIHS  LIHRD+KP 
Sbjct: 106 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPS 165
Query: 185 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF 244
           N+ L     +KI DFG V  +++           D K     GT  Y+ PE ++S     
Sbjct: 166 NIFLVDTKQVKIGDFGLVTSLKN-----------DGKRTRSKGTLRYMSPEQISSQDYGK 214
Query: 245 GNDLWALGCTLYQMLSGTSPFKDTSEWL 272
             DL+ALG  L ++L       +TS++ 
Sbjct: 215 EVDLYALGLILAELLHVCDTAFETSKFF 242

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 122 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
           + F+    + +A+   E     D + S   LS  E R Y   +  AL+ IH  G++HRD+
Sbjct: 87  YCFRKNDHVVIAMPYLEHESFLDILNS---LSFQEVREYMLNLFKALKRIHQFGIVHRDV 143
Query: 182 KPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKA-------CTFV------- 226
           KP N L         + DFG  +   D++I +L    S+ +        C+         
Sbjct: 144 KPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQV 203
Query: 227 ----GTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 272
               GT  +  PEVL   P  T   D+W+ G     +LSG  PF   S+ L
Sbjct: 204 APRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVV 165
           ++  L H  +VRL+        +Y+  E    G L D + S   G +   +   ++A++ 
Sbjct: 61  LMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 120
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + YI     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 121 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK---- 176
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  LY++++ G  P+
Sbjct: 177 -----WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 26/237 (10%)
Query: 44  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTA 100
           A R   +       ++ K+ GVG + +V   +    G      A+K +   +  K+ +  
Sbjct: 3   AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 62
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 160
               E  ++ Q DHP ++ L         + +  E  E G L         L +++ RF 
Sbjct: 63  LS--EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFT 114
Query: 161 TAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 213
             ++V  L       +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D      
Sbjct: 115 VIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD----- 169
Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           P AA   +         +  PE +     T  +D+W+ G  +++++S G  P+ D S
Sbjct: 170 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 224

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LXQVI-QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QML 259
           +M+
Sbjct: 217 EMV 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 26/224 (11%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
            ++ K+ GVG + +V   +    G      A+K +   +  K+ +      E  ++ Q D
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLS--EASIMGQFD 67
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL----- 168
           HP ++ L         + +  E  E G L         L +++ RF   ++V  L     
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGS 121
Query: 169 --EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
             +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D      P AA   +     
Sbjct: 122 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-----PEAAYTTRGGKI- 175
Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
               +  PE +     T  +D+W+ G  +++++S G  P+ D S
Sbjct: 176 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 218

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 26/237 (10%)
Query: 44  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTA 100
           A R   +       ++ K+ GVG + +V   +    G      A+K +   +  K+ +  
Sbjct: 18  AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 77
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 160
               E  ++ Q DHP ++ L         + +  E  E G L         L +++ RF 
Sbjct: 78  LS--EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFT 129
Query: 161 TAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 213
             ++V  L       +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D      
Sbjct: 130 VIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD----- 184
Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           P AA   +         +  PE +     T  +D+W+ G  +++++S G  P+ D S
Sbjct: 185 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 239

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 20/177 (11%)
Query: 95  KENKTAYVKL-ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH- 151
           K + TA   L E  V+ QL H  +V+L     ++   LY+  E    G L D + S+G  
Sbjct: 44  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 103
Query: 152 -LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
            L  D    ++ +V +A+EY+     +HRD+   N+L++ D   K++DFG  K    ++ 
Sbjct: 104 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 163
Query: 211 T-VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           T  LP                +  PE L  +  +  +D+W+ G  L+++ S G  P+
Sbjct: 164 TGKLP--------------VKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 112 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 169 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 218 EMIKGGVLFPGT 229

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 63/120 (52%), Gaps = 11/120 (9%)
Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAAS 218
           Y  ++  A+ +IHS+G+ HRDIKP+NLL+ + D  +K+ DFGS K        ++P+  S
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK-------KLIPSEPS 198
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 278
               C+    A   P  +L ++  T   DLW++GC   +++ G   F   +      RII
Sbjct: 199 VAXICSRFYRA---PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRII 255

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LXQVI-QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QML 259
           +M+
Sbjct: 217 EMV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LXQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QML 259
           +M+
Sbjct: 217 EMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 46  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 104 MDAN--LXQVI-QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 160
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 161 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 257 QML 259
           +M+
Sbjct: 210 EMV 212

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+L+  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 113
           +E+  + G GS+ +VV+A         A+KI+       +NK A++   +I +  L+   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108
Query: 114 -HPGVVRLF-------FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
            H   ++ +       F F++   L   + S    +L      +G +S +  R +  ++ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMC 167
Query: 166 DALEYIHS--MGLIHRDIKPENLLLT--ADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS             +     +
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS-------------SCQLGQR 214
Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
               + +  Y  PEVL   P     D+W+LGC L +M +G   F   +E
Sbjct: 215 IYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 113
           +E+  + G GS+ +VV+A         A+KI+       +NK A++   +I +  L+   
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 89
Query: 114 -HPGVVRLF-------FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
            H   ++ +       F F++   L   + S    +L      +G +S +  R +  ++ 
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMC 148
Query: 166 DALEYIHS--MGLIHRDIKPENLLLT--ADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS             +     +
Sbjct: 149 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS-------------SCQLGQR 195
Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
               + +  Y  PEVL   P     D+W+LGC L +M +G   F   +E
Sbjct: 196 IYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 95  KENKTAYVKL-ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH- 151
           K + TA   L E  V+ QL H  +V+L     ++   LY+  E    G L D + S+G  
Sbjct: 53  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 152 -LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
            L  D    ++ +V +A+EY+     +HRD+   N+L++ D   K++DFG  K    ++ 
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172
Query: 211 T-VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           T  LP                +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 173 TGKLP--------------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 25/159 (15%)
Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSL-----YMALESCEGGELFDQITSKGH-LSEDEARF 159
           R  L ++ HP +V++F   + T        Y+ +E   G  L     SKG  L   EA  
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL---KRSKGQKLPVAEAIA 186
Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
           Y  E++ AL Y+HS+GL++ D+KPEN++LT +  +K+ D G+V     SRI         
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV-----SRI--------- 231
Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 258
           +      GT  +  PE++ + P T   D++ +G TL  +
Sbjct: 232 NSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 113
           +E+  + G GS+ +VV+A         A+KI+       +NK A++   +I +  L+   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108
Query: 114 -HPGVVRLF-------FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
            H   ++ +       F F++   L   + S    +L      +G +S +  R +  ++ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMC 167
Query: 166 DALEYIHS--MGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASDDK 221
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS             +     +
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGS-------------SCQLGQR 214
Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
               + +  Y  PEVL   P     D+W+LGC L +M +G   F   +E
Sbjct: 215 IYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 40/233 (17%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKV------VRAKKIDTGTVYALKIMDKKFITKENKTAYV 102
           +++  I D ELG     G++  V      +R K+ID     A+K++ +   T++  T  +
Sbjct: 8   RDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDV----AIKVLKQG--TEKADTEEM 57
Query: 103 KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 162
             E  ++ QLD+P +VRL    Q   +L + +E   GG L   +  K    E+      A
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVA 113
Query: 163 EVVD----ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
           E++      ++Y+     +HRD+   N+LL    + KI+DFG  K +            +
Sbjct: 114 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL-----------GA 162
Query: 219 DDKACTFVGTA----AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
           DD   T          +  PE +N    +  +D+W+ G T+++ LS G  P+K
Sbjct: 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 95  KENKTAYVKL-ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH- 151
           K + TA   L E  V+ QL H  +V+L     ++   LY+  E    G L D + S+G  
Sbjct: 38  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 97
Query: 152 -LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
            L  D    ++ +V +A+EY+     +HRD+   N+L++ D   K++DFG  K    ++ 
Sbjct: 98  VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157
Query: 211 T-VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           T  LP                +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 158 TGKLP--------------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 32/227 (14%)
Query: 57  FELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            ++ ++ G G + +V   + K+      A+ I   K    E +      E  ++ Q DHP
Sbjct: 45  IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE------ 169
            VV L         + + +E  E G L         L + + +F   ++V  L       
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGAL------DAFLRKHDGQFTVIQLVGMLRGIAAGM 158
Query: 170 -YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y+  MG +HRD+   N+L+ ++   K++DFG            L     DD    +  T
Sbjct: 159 RYLADMGYVHRDLAARNILVNSNLVCKVSDFG------------LSRVIEDDPEAVYTTT 206
Query: 229 AAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
              +P     PE +     T  +D+W+ G  +++++S G  P+ D S
Sbjct: 207 GGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 253

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 33/237 (13%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 107
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------H 151
           +     H  +V L         + +  E C  G+L + +  K                  
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSR 209
           LS  +   ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS 
Sbjct: 163 LSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSN 221
Query: 210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 YIVKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFF 122
           G G+   VV A         A+K + + F  + + K AY +L  +++  ++H  ++ L  
Sbjct: 33  GSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLN 90
Query: 123 TFQDTFSL------YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
            F    SL      Y+ +E  +      Q+  +  L  +   +   +++  ++++HS G+
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDAN--LSQVI-QMELDHERMSYLLYQMLVGIKHLHSAGI 147
Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
           IHRD+KP N+++ +D  +KI DFG  +            A +      +V T  Y  PEV
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEV 196
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
           +         D+W++G  + +M+ G   F  T
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKGGVLFPGT 228

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 46/233 (19%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LERIVLDQLDHPGVVRL 120
           G G++ +V+  + ID    YA+K++  + I K  ++A ++   L++I  D +++  +V+ 
Sbjct: 44  GDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 121 FFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIH 178
              F     + +  E   G  L++ IT   +     ++ + Y  E++ AL Y+  M L H
Sbjct: 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTH 160
Query: 179 RDIKPENLLL--------------TADGH-----------IKIADFGSVKPMQDSRITVL 213
            D+KPEN+LL                DG            IK+ DFG             
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----------- 209
Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
                 D   + + T  Y  PEV+ +      +D+W+ GC L ++ +G+  F+
Sbjct: 210 --TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 105 ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYT 161
           E  V+ QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295
Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT-VLPNAASDD 220
            +V +A+EY+     +HRD+   N+L++ D   K++DFG  K    ++ T  LP      
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------ 349
Query: 221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                     +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 350 --------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 118/254 (46%), Gaps = 28/254 (11%)
Query: 40  SKSFAFRAPQEHFSIQDF-------ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF 92
           ++SF  +A Q    +Q++       E+G++ G G + +V   +    G V A++++D + 
Sbjct: 11  ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEV-AIRLIDIER 67
Query: 93  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGH 151
             ++   A+ K E +   Q  H  VV           L +    C+G  L+  +  +K  
Sbjct: 68  DNEDQLKAF-KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV 126
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT 211
           L  ++ R    E+V  + Y+H+ G++H+D+K +N+    +G + I DFG       S   
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF-----SISG 180
Query: 212 VLPNAASDDKACTFVGTAAYVPPEVL---------NSSPATFGNDLWALGCTLYQMLSGT 262
           VL     +DK     G   ++ PE++         +  P +  +D++ALG   Y++ +  
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 263 SPFK-DTSEWLIFQ 275
            PFK   +E +I+Q
Sbjct: 241 WPFKTQPAEAIIWQ 254

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QML 259
           +M+
Sbjct: 217 EMV 219

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 163
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 122
Query: 164 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 170
Query: 218 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 171 LDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 186 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 187 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 163
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 53  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 106
Query: 164 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 107 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 154
Query: 218 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 155 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 187 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 163
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 107
Query: 164 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 155
Query: 218 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 156 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 163
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 122
Query: 164 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 170
Query: 218 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 133 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 192
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 193 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 163
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 113
Query: 164 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 114 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 161
Query: 218 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 162 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           ++ +  + G GSY  V  A   +T    A+K +++ F    +    ++ E  +L++L   
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSD 85
Query: 116 GVVRLF-FTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
            ++RL+     D       LY+ LE  +  +L     +   L+E+  +     ++    +
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD---------- 220
           IH  G+IHRD+KP N LL  D  +K+ DFG  + +   + T + N   ++          
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 221 --KACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLS 260
             +  + V T  Y  PE +L     T   D+W+ GC   ++L+
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVV 165
           ++  L H  +VRL+        +Y+  E    G L D + S   G +   +   ++A++ 
Sbjct: 60  LMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 119
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + YI     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK---- 175
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +++W+ G  LY++++ G  P+
Sbjct: 176 -----WTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 163
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 49  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 102
Query: 164 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 103 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 150
Query: 218 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 151 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/256 (20%), Positives = 113/256 (44%), Gaps = 31/256 (12%)
Query: 44  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTA 100
           A R   +   +   ++ ++ G G + +V R +    G   +  A+K +   + T+  +  
Sbjct: 5   AVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY-TERQRRE 63
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 160
           ++  E  ++ Q +HP ++RL     ++  + +  E  E G L         L  ++ +F 
Sbjct: 64  FLS-EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFT 116
Query: 161 TAEVVDALE-------YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 213
             ++V  L        Y+  M  +HRD+   N+L+ ++   K++DFG  + ++++     
Sbjct: 117 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN----- 171
Query: 214 PNAASDDKACTFVG---TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
              +SD    + +G      +  PE +     T  +D W+ G  +++++S G  P+ D S
Sbjct: 172 ---SSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS 228
Query: 270 EWLIFQRIIARDIRFP 285
              +    I +D R P
Sbjct: 229 NQDVIN-AIEQDYRLP 243

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 90/192 (46%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++G  + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMG 216
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 112 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 169 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 257 QML 259
           +M+
Sbjct: 218 EMV 220

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 112 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 169 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 257 QML 259
           +M+
Sbjct: 218 EMV 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QML 259
           +M+
Sbjct: 217 EMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 52  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 109
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 110 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 166
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 167 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 215
Query: 257 QML 259
           +M+
Sbjct: 216 EMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QML 259
           +M+
Sbjct: 217 EMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 47  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 105 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 162 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 210
Query: 257 QML 259
           +M+
Sbjct: 211 EMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 91  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 149 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 206 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 257 QML 259
           +M+
Sbjct: 255 EMV 257

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 46  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 104 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 161 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 257 QML 259
           +M+
Sbjct: 210 EMV 212

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 47  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 105 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 162 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 210
Query: 257 QML 259
           +M+
Sbjct: 211 EMV 213

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 91  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 149 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 206 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 257 QML 259
           +M+
Sbjct: 255 EMV 257

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 19/235 (8%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A    E  V+  L H
Sbjct: 15  ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQH 69
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 172
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 70  DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
               IHRD++  N+L++A    KIADFG  + ++D+  T    A    K         + 
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---------WT 179
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
            PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P 
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPR 233

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 88/184 (47%), Gaps = 23/184 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 58  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 115
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 116 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 172
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         DLW++GC + 
Sbjct: 173 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 221
Query: 257 QMLS 260
           +M+ 
Sbjct: 222 EMVC 225

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 90/192 (46%), Gaps = 23/192 (11%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +       V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QMLSGTSPFKDT 268
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 19/235 (8%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A    E  V+  L H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQH 242
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 172
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
               IHRD++  N+L++A    KIADFG  + ++D+  T    A    K         + 
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---------WT 352
Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
            PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P 
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPR 406

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           ++ ++ G G + +V R +    G   +  A+K +   + T+  +  ++  E  ++ Q +H
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY-TERQRREFLS-EASIMGQFEH 74
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE----- 169
           P ++RL     ++  + +  E  E G L         L  ++ +F   ++V  L      
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGMLRGIASG 128
Query: 170 --YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
             Y+  M  +HRD+   N+L+ ++   K++DFG  + ++++        +SD    + +G
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN--------SSDPTYTSSLG 180
Query: 228 ---TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR 283
                 +  PE +     T  +D W+ G  +++++S G  P+ D S   +    I +D R
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN-AIEQDYR 239
Query: 284 FP 285
            P
Sbjct: 240 LP 241

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 88/184 (47%), Gaps = 23/184 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 47  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 104
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 105 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +      +V T  Y  PEV+         DLW++GC + 
Sbjct: 162 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 210
Query: 257 QMLS 260
           +M+ 
Sbjct: 211 EMVC 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 40/244 (16%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 107
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH---------------L 152
           +     H  +V L         + +  E C  G+L + +  K                 L
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 153 SEDEAR--------FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVK 203
            +++ R         ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLAR 206
Query: 204 P-MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 261
             M DS   V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G
Sbjct: 207 DIMNDSNYIVKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 257
Query: 262 TSPF 265
            +P+
Sbjct: 258 LNPY 261

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 40/233 (17%)
Query: 49  QEHFSIQDFELGKIYGVGSYSKV------VRAKKIDTGTVYALKIMDKKFITKENKTAYV 102
           +++  I D ELG     G++  V      +R K+ID     A+K++ +   T++  T  +
Sbjct: 334 RDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDV----AIKVLKQG--TEKADTEEM 383
Query: 103 KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 162
             E  ++ QLD+P +VRL    Q   +L + +E   GG L   +  K    E+      A
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVA 439
Query: 163 EVVD----ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
           E++      ++Y+     +HR++   N+LL    + KI+DFG  K +            +
Sbjct: 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL-----------GA 488
Query: 219 DDKACTFVGTA----AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
           DD   T          +  PE +N    +  +D+W+ G T+++ LS G  P+K
Sbjct: 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP +V+L   
Sbjct: 20  GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHPNLVQLLGV 75
Query: 124 FQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
                  Y+ +E    G L D +   ++  +S     +   ++  A+EY+     IHRD+
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 241
              N L+  +  +K+ADFG  + M     T    A    K         +  PE L  + 
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK---------WTAPESLAYNK 186
Query: 242 ATFGNDLWALGCTLYQMLS-GTSPF 265
            +  +D+WA G  L+++ + G SP+
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+ +E    G L D +   ++  +S     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 23/170 (13%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 163
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 107
Query: 164 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG  +        VL +  
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-------YVLDDEY 160
Query: 218 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
           +  +   F     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 161 TSSRGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 14/215 (6%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY-VKLERIVLDQLDHP 115
           F LG+  G GS+ ++     I T    A+K+ + K  TK  +  Y  K+ RI+      P
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIP 66
Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            V R F    D   L M L      +LF+  + K  LS         ++++ +E++HS  
Sbjct: 67  NV-RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS 123
Query: 176 LIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRI-TVLPNAASDDKACTFVGTAAY 231
            +HRDIKP+N L+        + I DFG  K  +D+     +P   + +      GTA Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN----LTGTARY 179
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
                      +  +DL +LG  L   L G+ P++
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+ +E    G L D +   ++  +S     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           ++E+  + G GSY  V  A   +     A+K +++ F    +    ++ E  +L++L   
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSD 87
Query: 116 GVVRL--FFTFQDTF---SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
            ++RL      +D      LY+ LE  +  +L     +   L+E   +     ++   ++
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ-DSRITVL-------------PNA 216
           IH  G+IHRD+KP N LL  D  +KI DFG  + +  D  I ++             P+ 
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 217 ASDDKACT-FVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLS 260
            +  K  T  V T  Y  PE +L     T   D+W+ GC   ++L+
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 32/297 (10%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 89
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 9   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 68
Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 148
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 69  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 127
Query: 149 KGH--------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
           K +              L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +
Sbjct: 128 KRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVV 187
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCT 254
           KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G  
Sbjct: 188 KICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 255 LYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
           L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 240 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 47  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVK 103
           A +  ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V 
Sbjct: 2   AMKSRYTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV- 59
Query: 104 LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARF 159
               VL Q  H  VVR F  + +   + +  E C GG L D I+       +  E E + 
Sbjct: 60  YAHAVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 117
Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
              +V   L YIHSM L+H DIKP N+ ++                     T +PNAAS+
Sbjct: 118 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASE 157
Query: 220 D 220
           +
Sbjct: 158 E 158

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK---- 175
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ 
Sbjct: 67  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 181
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 182 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 108/264 (40%), Gaps = 38/264 (14%)
Query: 43  FAFRAPQE-------HFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKF 92
           F F  P E          I   ++ ++ G G + +V        G      A+K +   +
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 93  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL 152
             K+ +      E  ++ Q DHP V+ L      +  + +  E  E G L         L
Sbjct: 74  TEKQRRDFLS--EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFL 125
Query: 153 SEDEARFYTAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 205
            +++ +F   ++V  L       +Y+  M  +HRD+   N+L+ ++   K++DFG  + +
Sbjct: 126 RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 185
Query: 206 QDSRITVLPNAASDDKACTFVGTAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 261
           +D          SD    + +G      +  PE +     T  +D+W+ G  +++++S G
Sbjct: 186 EDD--------TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 237
Query: 262 TSPFKDTSEWLIFQRIIARDIRFP 285
             P+ D +   +    I +D R P
Sbjct: 238 ERPYWDMTNQDVIN-AIEQDYRLP 260

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ 
Sbjct: 66  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 124
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 125 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 180
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 181 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 216

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 33/298 (11%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 89
           P  +  +   + A +  F      LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 8   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 67
Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 148
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 68  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 126
Query: 149 KGH---------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 193
           K +               L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    
Sbjct: 127 KRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186
Query: 194 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 253
           +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G 
Sbjct: 187 VKICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 254 TLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
            L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 239 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 175
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 175
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 69  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 127
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 128 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 183
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 184 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 219

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ 
Sbjct: 62  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 120
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 121 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 176
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 177 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 212

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIV 108
           ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V     V
Sbjct: 9   YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV-YAHAV 66
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEV 164
           L Q  H  VVR F  + +   + +  E C GG L D I+       +  E E +    +V
Sbjct: 67  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 220
              L YIHSM L+H DIKP N+ ++                     T +PNAAS++
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASEE 160

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ 
Sbjct: 67  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 181
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 182 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ 
Sbjct: 63  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 121
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 122 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 177
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 178 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 30/295 (10%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 89
           P  +  +   + A +  F      LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 66
Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 148
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 149 KGH------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
           K +            L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI
Sbjct: 126 KRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKI 185
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L+
Sbjct: 186 XDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 257 QMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
           ++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 EIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 71  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 129
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 130 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 185
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 186 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 221

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIV 108
           ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V     V
Sbjct: 7   YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV-YAHAV 64
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEV 164
           L Q  H  VVR F  + +   + +  E C GG L D I+       +  E E +    +V
Sbjct: 65  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 220
              L YIHSM L+H DIKP N+ ++                     T +PNAAS++
Sbjct: 123 GRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASEE 158

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 89
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66
Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 148
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 149 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 192
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 252
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 186 VVKICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 253 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 122
           G G+Y +V +A  IDT T   + I   +   +E       +  + +L +L H  ++ L  
Sbjct: 43  GEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 123 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
                  L++  E  E  +L   +     +S    + +  ++++ + + HS   +HRD+K
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 183 PENLLLTADGH-----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 236
           P+NLLL+         +KI DFG       +R   +P      +  T      Y PPE+ 
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGL------ARAFGIPIRQFTHEIITL----WYRPPEIL 209
Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           L S   +   D+W++ C   +ML  T  F   SE
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ 
Sbjct: 70  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 128
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 129 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 184
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 185 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 220

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ 
Sbjct: 56  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 114
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 115 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 170
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 171 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 206

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 175
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 166
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 55  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 114
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 115 GMAYLEEASVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 162
Query: 227 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 163 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIV 108
           ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V     V
Sbjct: 5   YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV-YAHAV 62
Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEV 164
           L Q  H  VVR F  + +   + +  E C GG L D I+       +  E E +    +V
Sbjct: 63  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 120
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 220
              L YIHSM L+H DIKP N+ ++                     T +PNAAS++
Sbjct: 121 GRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASEE 156

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 30/295 (10%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 89
           P  +  +   + A +  F      LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 66
Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 148
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 149 KGH------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
           K +            L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI
Sbjct: 126 KRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKI 185
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L+
Sbjct: 186 CDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 257 QMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
           ++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK- 175
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 176 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 166
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 117
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 118 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 165
Query: 227 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 89
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66
Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 148
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 149 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 192
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 252
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 186 VVKICDFGLARDIYKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 253 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALE 169
           +L HP +V+ +      + +Y+  E    G L + + S G  L   +      +V + + 
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT- 228
           ++ S   IHRD+   N L+  D  +K++DFG            +     DD+  + VGT 
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFG------------MTRYVLDDQYVSSVGTK 166
Query: 229 --AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
               +  PEV +    +  +D+WA G  ++++ S G  P+
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 166
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 55  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 114
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 115 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 162
Query: 227 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 163 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 182
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 166
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 75  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 134
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 135 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 182
Query: 227 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 183 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 229

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 166
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 53  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 112
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 160
Query: 227 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK- 175
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 176 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+ +E    G L D +   ++  ++     +   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK- 178
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 179 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 119/296 (40%), Gaps = 34/296 (11%)
Query: 38  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 92
           + ++   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 93  ITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH 151
              E++    +L +I++    H  VV L     +    L + +E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 119
Query: 152 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 195
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 255
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 256 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+ +E    G L D +   ++  ++     +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 182
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 89
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 9   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 68
Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 148
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 69  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 127
Query: 149 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 192
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 128 KRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 187
Query: 193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 252
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 188 VVKICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 239
Query: 253 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 240 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 298

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 89
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 44  PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 103
Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 148
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 104 EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 162
Query: 149 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 192
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 163 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222
Query: 193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 252
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 223 VVKICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 274
Query: 253 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 275 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 333

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 89
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66
Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 148
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 149 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 192
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 252
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 186 VVKICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 253 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 166
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 163
Query: 227 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HS G++HRD+KP N+++      +++ D+G  +   P Q+
Sbjct: 129 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE 188
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 189 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 19/119 (15%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVK---PMQD 207
           L++ + RFY  E++ AL+Y HS G++HRD+KP N+++      +++ D+G  +   P Q+
Sbjct: 134 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE 193
Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 194 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 117/296 (39%), Gaps = 34/296 (11%)
Query: 38  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 92
           + ++   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 93  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL-ESCEGGELFDQITSKGH 151
              E++    +L +I++    H  VV L           M + E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 152 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 195
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 255
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 256 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++     
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 84
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDEA 157
           HP ++ L    +    LY+A+E    G L D +                ++   LS  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 158 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLP 214
             + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                           ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 205 --------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 165
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 57  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 115
Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + +I     IHR+++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 116 EGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 171
Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 172 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 207

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++     
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 74
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDEA 157
           HP ++ L    +    LY+A+E    G L D +                ++   LS  + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 158 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLP 214
             + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                           ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 195 --------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 182
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 97/232 (41%), Gaps = 17/232 (7%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 276
Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 173
            +V+L          Y+  E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
              IHR++   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 387
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF 284
           PE L  +  +  +D+WA G  L+++ + G SP+       +++ ++ +D R 
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRM 438

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 179
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 180 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 123
           G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP +V+L   
Sbjct: 27  GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHPNLVQLLGV 82
Query: 124 FQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 181
                  Y+  E    G L D +   ++  ++     +   ++  A+EY+     IHRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 241
              N L+  +  +K+ADFG  + M     T    A    K         +  PE L  + 
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK---------WTAPESLAYNK 193
Query: 242 ATFGNDLWALGCTLYQMLS-GTSPF 265
            +  +D+WA G  L+++ + G SP+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 179
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 180 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 131
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 132 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 190
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 191 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK- 178
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 179 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 122
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 181
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 182 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 182
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK- 179
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 180 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 117/296 (39%), Gaps = 34/296 (11%)
Query: 38  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 92
           + ++   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 93  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL-ESCEGGELFDQITSKGH 151
              E++    +L +I++    H  VV L           M + E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 152 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 195
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 255
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 256 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 162
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK- 196
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 197 --------WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +       V T  Y  PEV+         DLW++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 216
Query: 257 QMLS 260
           +M+ 
Sbjct: 217 EMVC 220

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 34/296 (11%)
Query: 38  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 92
           +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 93  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL-ESCEGGELFDQITSKGH 151
              E++    +L +I++    H  VV L           M + E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 152 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 195
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 255
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 256 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 308
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/232 (21%), Positives = 97/232 (41%), Gaps = 17/232 (7%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 315
Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 173
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
              IHR++   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 426
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF 284
           PE L  +  +  +D+WA G  L+++ + G SP+       +++ ++ +D R 
Sbjct: 427 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRM 477

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDI 146
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 264 PF 265
           P+
Sbjct: 259 PY 260

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  ++ Q DHP ++ L      +  + +  E  E G L         L +++ +F   ++
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL------DTFLKKNDGQFTVIQL 126
Query: 165 VDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
           V  L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA
Sbjct: 127 VGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAA 181
Query: 218 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
              +         +  PE +     T  +D+W+ G  +++++S G  P+
Sbjct: 182 YTTRGGKI--PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++     
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 81
Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDEA 157
           HP ++ L    +    LY+A+E    G L D +                ++   LS  + 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 158 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLP 214
             + A+V   ++Y+     IHR++   N+L+  +   KIADFG  +  +      +  LP
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 201
Query: 215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                           ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 202 --------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 264 PF 265
           P+
Sbjct: 259 PY 260

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 79  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMALES 136
           TG + A+K + K     ++++ + K E  +L  L H  +++     +D    SL + +E 
Sbjct: 59  TGEMVAVKAL-KADAGPQHRSGW-KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
              G L D +  +  +   +   +  ++ + + Y+H+   IHRD+   N+LL  D  +KI
Sbjct: 117 VPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI 175
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  K + +           D  +  F     +  PE L      + +D+W+ G TLY
Sbjct: 176 GDFGLAKAVPEGHEXY--RVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 257 QMLS 260
           ++L+
Sbjct: 229 ELLT 232

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 84  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 136
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  +            A +       V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 257 QMLS 260
           +M+ 
Sbjct: 217 EMVC 220

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 30/254 (11%)
Query: 40  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITK 95
           S +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+
Sbjct: 3   SGAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TE 59
Query: 96  ENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHL 152
           E+   + + E  +L  L H  +V+           +L + +E    G L D +   K  +
Sbjct: 60  EHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 212
              +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        V
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------V 170
Query: 213 LPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
           LP     DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K 
Sbjct: 171 LPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KS 224
Query: 268 TSEWLIFQRIIARD 281
            S    F R+I  D
Sbjct: 225 KSPPAEFMRMIGND 238

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/269 (20%), Positives = 108/269 (40%), Gaps = 34/269 (12%)
Query: 22  LRIEGNNNSSTNCPTVQRSKSFAF-RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI--- 77
           +RI    +S+ + P +     +     P+  F      LGK  G G + +VV A+ +   
Sbjct: 47  VRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID 106
Query: 78  ----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 133
                     A+K++      K+      ++E + +    H  ++ L         LY+ 
Sbjct: 107 KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVI 165
Query: 134 LESCEGGELFDQITSK-----------GHLSEDEARF-----YTAEVVDALEYIHSMGLI 177
           +E    G L + + ++             + E++  F      T ++   +EY+ S   I
Sbjct: 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 225
Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           HRD+   N+L+T +  +KIADFG  + +         N     K         ++ PE L
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLARDIN--------NIDYYKKTTNGRLPVKWMAPEAL 277
Query: 238 NSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                T  +D+W+ G  ++++ + G SP+
Sbjct: 278 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 48  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 99
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 29  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 88
Query: 100 AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 149
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 89  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 146
Query: 150 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 147 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 206
Query: 201 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 259
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 207 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 260 S-GTSPF 265
           S G+SP+
Sbjct: 258 SLGSSPY 264

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 48  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 99
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 13  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 72
Query: 100 AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 149
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 73  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 150 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 201 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 259
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 191 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 260 S-GTSPF 265
           S G+SP+
Sbjct: 242 SLGSSPY 248

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 30/254 (11%)
Query: 40  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITK 95
           S +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+
Sbjct: 1   SGAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TE 57
Query: 96  ENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHL 152
           E+   + + E  +L  L H  +V+           +L + +E    G L D +   K  +
Sbjct: 58  EHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 212
              +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        V
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------V 168
Query: 213 LPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
           LP     DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K 
Sbjct: 169 LPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KS 222
Query: 268 TSEWLIFQRIIARD 281
            S    F R+I  D
Sbjct: 223 KSPPAEFMRMIGND 236

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G++ +VV A+ +             A+K++ K   T+E+ + 
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSD 86
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
            V    ++     H  ++ L         LY+ +E    G L + + ++           
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 264 PF 265
           P+
Sbjct: 259 PY 260

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 48  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 99
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 31  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 90
Query: 100 AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 149
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 91  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 148
Query: 150 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 149 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 208
Query: 201 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 259
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 209 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 260 S-GTSPF 265
           S G+SP+
Sbjct: 260 SLGSSPY 266

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERIVLDQLDHPGVV 118
           K+ G G +  V +   I  G    + +  K    K  + ++  V    + +  LDH  +V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLI 177
           RL      + SL +  +    G L D +   +G L       +  ++   + Y+   G++
Sbjct: 79  RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           HR++   N+LL +   +++ADFG           +LP    DDK   +  + A  P + +
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVAD--------LLP---PDDKQLLY--SEAKTPIKWM 184
Query: 238 NSSPATFG-----NDLWALGCTLYQMLS-GTSPF 265
                 FG     +D+W+ G T++++++ G  P+
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 48  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 99
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 36  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 95
Query: 100 AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 149
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 96  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 153
Query: 150 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 154 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 213
Query: 201 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 259
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 214 LARHIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 260 S-GTSPF 265
           S G+SP+
Sbjct: 265 SLGSSPY 271

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 104/236 (44%), Gaps = 18/236 (7%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           HF  +  +  +  G G + KV   +      +TG   A+K +  +  +  N  A +K E 
Sbjct: 5   HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEI 62
Query: 107 IVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 163
            +L  L H  +V+     T      + + +E    G L + +  +K  ++  +   Y  +
Sbjct: 63  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 122
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +   ++Y+ S   +HRD+   N+L+ ++  +KI DFG  K ++  +         DD+  
Sbjct: 123 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX---TVKDDRD- 178
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 279
                  +  PE L  S     +D+W+ G TL+++L+      D+S   +F ++I 
Sbjct: 179 ---SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD--SDSSPMALFLKMIG 229

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERIVLDQLDHPGVV 118
           K+ G G +  V +   I  G    + +  K    K  + ++  V    + +  LDH  +V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 119 RLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLI 177
           RL      + SL +  +    G L D +   +G L       +  ++   + Y+   G++
Sbjct: 97  RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 155
Query: 178 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 237
           HR++   N+LL +   +++ADFG           +LP    DDK   +  + A  P + +
Sbjct: 156 HRNLAARNVLLKSPSQVQVADFGVAD--------LLP---PDDKQLLY--SEAKTPIKWM 202
Query: 238 NSSPATFG-----NDLWALGCTLYQMLS-GTSPF 265
                 FG     +D+W+ G T++++++ G  P+
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 236

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 48  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 99
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 36  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 95
Query: 100 AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 149
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 96  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 153
Query: 150 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 154 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 213
Query: 201 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 259
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 214 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 260 S-GTSPF 265
           S G+SP+
Sbjct: 265 SLGSSPY 271

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 104/236 (44%), Gaps = 18/236 (7%)
Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           HF  +  +  +  G G + KV   +      +TG   A+K +  +  +  N  A +K E 
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEI 74
Query: 107 IVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 163
            +L  L H  +V+     T      + + +E    G L + +  +K  ++  +   Y  +
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +   ++Y+ S   +HRD+   N+L+ ++  +KI DFG  K ++  +         DD+  
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX---TVKDDRD- 190
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 279
                  +  PE L  S     +D+W+ G TL+++L+      D+S   +F ++I 
Sbjct: 191 ---SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD--SDSSPMALFLKMIG 241

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 129 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL 187
           SL + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L
Sbjct: 87  SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 146
Query: 188 LTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 245
           + ++ H+KIADFG  K  P+      V     S            +  PE L+ +  +  
Sbjct: 147 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---------PIFWYAPESLSDNIFSRQ 197
Query: 246 NDLWALGCTLYQMLS 260
           +D+W+ G  LY++ +
Sbjct: 198 SDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 42  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 97
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 4   AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 60
Query: 98  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSE 154
              + + E  +L  L H  +V+           +L + +E    G L D +   K  +  
Sbjct: 61  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 119
Query: 155 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 214
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 120 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 171
Query: 215 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 172 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 225
Query: 270 EWLIFQRIIARD 281
               F R+I  D
Sbjct: 226 PPAEFMRMIGND 237

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 129 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL 187
           SL + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L
Sbjct: 88  SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 147
Query: 188 LTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 245
           + ++ H+KIADFG  K  P+      V     S            +  PE L+ +  +  
Sbjct: 148 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---------PIFWYAPESLSDNIFSRQ 198
Query: 246 NDLWALGCTLYQMLS 260
           +D+W+ G  LY++ +
Sbjct: 199 SDVWSFGVVLYELFT 213

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 42  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 97
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 2   AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 58
Query: 98  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSE 154
              + + E  +L  L H  +V+           +L + +E    G L D +   K  +  
Sbjct: 59  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 117
Query: 155 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 214
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 118 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 169
Query: 215 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 170 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 223
Query: 270 EWLIFQRIIARD 281
               F R+I  D
Sbjct: 224 PPAEFMRMIGND 235

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 129 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL 187
           SL + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L
Sbjct: 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 159
Query: 188 LTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 245
           + ++ H+KIADFG  K  P+      V     S            +  PE L+ +  +  
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---------PIFWYAPESLSDNIFSRQ 210
Query: 246 NDLWALGCTLYQMLS 260
           +D+W+ G  LY++ +
Sbjct: 211 SDVWSFGVVLYELFT 225

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 40  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 96
Query: 136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 97  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 156
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 249
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 157 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 204
Query: 250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           + G  LY++ +     K  S    F R+I  D
Sbjct: 205 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 234

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 37  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 249
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 154 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           + G  LY++ +     K  S    F R+I  D
Sbjct: 202 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/250 (20%), Positives = 104/250 (41%), Gaps = 31/250 (12%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLER 106
           +   I   ++ ++ G G + +V        G      A+K +   +  K+ +      E 
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS--EA 59
Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 166
            ++ Q DHP V+ L      +  + +  E  E G L         L +++ +F   ++V 
Sbjct: 60  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFLRQNDGQFTVIQLVG 113
Query: 167 AL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
            L       +Y+  M  +HR +   N+L+ ++   K++DFG  + ++D          SD
Sbjct: 114 MLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDD--------TSD 165
Query: 220 DKACTFVGTAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ 275
               + +G      +  PE +     T  +D+W+ G  +++++S G  P+ D +   +  
Sbjct: 166 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 225
Query: 276 RIIARDIRFP 285
             I +D R P
Sbjct: 226 -AIEQDYRLP 234

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 55  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 111
Query: 136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 112 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 171
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 249
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 172 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 219
Query: 250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           + G  LY++ +     K  S    F R+I  D
Sbjct: 220 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 249

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 55  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 111
Query: 136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 112 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 171
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 249
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 172 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 219
Query: 250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           + G  LY++ +     K  S    F R+I  D
Sbjct: 220 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 249

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 42  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 97
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 29  AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 85
Query: 98  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSE 154
              + + E  +L  L H  +V+           +L + +E    G L D +   K  +  
Sbjct: 86  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 144
Query: 155 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 214
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 145 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 196
Query: 215 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 269
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 197 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 250
Query: 270 EWLIFQRIIARD 281
               F R+I  D
Sbjct: 251 PPAEFMRMIGND 262

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 264 PF 265
           P+
Sbjct: 259 PY 260

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 36  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 92
Query: 136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 93  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 152
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 249
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 153 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 200
Query: 250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           + G  LY++ +     K  S    F R+I  D
Sbjct: 201 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 35  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 91
Query: 136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 92  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 151
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 249
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 152 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 199
Query: 250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           + G  LY++ +     K  S    F R+I  D
Sbjct: 200 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 229

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 57/127 (44%), Gaps = 19/127 (14%)
Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
           YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP     
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLPQ---- 169
Query: 220 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 274
           DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S    F
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKSPPAEF 227
Query: 275 QRIIARD 281
            R+I  D
Sbjct: 228 MRMIGND 234

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 79  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SLYMALES 136
           TG + A+K + K     ++++ + K E  +L  L H  +++     +D    SL + +E 
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGW-KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
              G L D +  +  +   +   +  ++ + + Y+HS   IHR++   N+LL  D  +KI
Sbjct: 100 VPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKI 158
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  K + +           D  +  F     +  PE L      + +D+W+ G TLY
Sbjct: 159 GDFGLAKAVPEGHEYY--RVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 257 QMLS 260
           ++L+
Sbjct: 212 ELLT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 37  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 249
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 154 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           + G  LY++ +     K  S    F R+I  D
Sbjct: 202 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 101/242 (41%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           + +  I    N  +      ++       PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 INN--IDYYKNTTNGRLPVKWMA------PEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 264 PF 265
           P+
Sbjct: 259 PY 260

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G + +VV A+ +             A+K++      K+    
Sbjct: 15  PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 74
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 75  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 133
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 134 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARD 193
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 194 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 245
Query: 264 PF 265
           P+
Sbjct: 246 PY 247

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G + +VV A+ +             A+K++      K+    
Sbjct: 17  PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 76
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 77  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 135
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 136 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 195
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 196 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 247
Query: 264 PF 265
           P+
Sbjct: 248 PY 249

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 57/127 (44%), Gaps = 19/127 (14%)
Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
           YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP     
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLPQ---- 169
Query: 220 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 274
           DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S    F
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKSPPAEF 227
Query: 275 QRIIARD 281
            R+I  D
Sbjct: 228 MRMIGND 234

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 264 PF 265
           P+
Sbjct: 259 PY 260

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 64/135 (47%), Gaps = 14/135 (10%)
Query: 130 LYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL 188
           L + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L+
Sbjct: 85  LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 144
Query: 189 TADGHIKIADFGSVKPM---QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 245
            ++ H+KIADFG  K +   +D  +   P  +             +  PE L+ +  +  
Sbjct: 145 ESEAHVKIADFGLAKLLPLDKDXXVVREPGQS----------PIFWYAPESLSDNIFSRQ 194
Query: 246 NDLWALGCTLYQMLS 260
           +D+W+ G  LY++ +
Sbjct: 195 SDVWSFGVVLYELFT 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 62  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 120
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 121 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY--KAQTHGK--- 175
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 176 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 216

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHPGVV 118
           K+ G G++  V +   +  G    + +  K         A V+   E +++  +DHP +V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 119 RLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           RL       T  L   L     G L + +   K ++       +  ++   + Y+    L
Sbjct: 104 RLLGVCLSPTIQLVTQLMP--HGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 161
Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG---TAAYVP 233
           +HRD+   N+L+ +  H+KI DFG  + ++            D+K     G      ++ 
Sbjct: 162 VHRDLAARNVLVKSPNHVKITDFGLARLLE-----------GDEKEYNADGGKMPIKWMA 210
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
            E ++    T  +D+W+ G T++++++ G  P+
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G + +VV A+ +             A+K++      K+    
Sbjct: 20  PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 79
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 80  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 138
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 139 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 198
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 199 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 250
Query: 264 PF 265
           P+
Sbjct: 251 PY 252

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 62  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 120
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 121 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 175
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 176 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 216

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 37  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 249
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 154 KIGDFGLTK--------VLPQ----DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           + G  LY++ +     K  S    F R+I  D
Sbjct: 202 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 155
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V   
Sbjct: 71  VMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 129
Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K      
Sbjct: 130 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK-----W 182
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
              +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 58  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 171
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 172 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  ++IADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARD 206
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 264 PF 265
           P+
Sbjct: 259 PY 260

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/203 (21%), Positives = 84/203 (41%), Gaps = 38/203 (18%)
Query: 95  KENKTAYVKLERI-------VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 147
           K  K  Y + +R+       ++ Q  H  ++RL         + +  E  E G L     
Sbjct: 79  KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL----- 133
Query: 148 SKGHLSEDEARFYTAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
               L E +  F   ++V  L       +Y+ +M  +HRD+   N+L+ ++   K++DFG
Sbjct: 134 -DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192
Query: 201 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTL 255
                       L     DD   T+  +   +P     PE ++    T  +D+W+ G  +
Sbjct: 193 ------------LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240
Query: 256 YQMLS-GTSPFKDTSEWLIFQRI 277
           +++++ G  P+ + S   + + I
Sbjct: 241 WEVMTYGERPYWELSNHEVMKAI 263

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 78  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 136
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 137 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 191
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 192 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 232

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 78  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 136
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 137 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 191
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 192 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 232

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 56  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 114
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 115 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 169
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 170 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 210

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 76  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 134
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 135 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 189
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 190 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 230

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 61  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHPGVV 118
           K+ G G++  V +   +  G    + +  K         A V+   E +++  +DHP +V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 119 RLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           RL       T  L   L     G L + +   K ++       +  ++   + Y+    L
Sbjct: 81  RLLGVCLSPTIQLVTQL--MPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 138
Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG---TAAYVP 233
           +HRD+   N+L+ +  H+KI DFG  + ++            D+K     G      ++ 
Sbjct: 139 VHRDLAARNVLVKSPNHVKITDFGLARLLE-----------GDEKEYNADGGKMPIKWMA 187
Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
            E ++    T  +D+W+ G T++++++ G  P+
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 220

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 181
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 182 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 181
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 182 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 143 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 201
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 202 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 420 EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 478
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 479 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKW-- 534
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 535 ---PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 124 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 182
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 183 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 79  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SLYMALES 136
           TG + A+K + K     ++++ + K E  +L  L H  +++     +D    SL + +E 
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGW-KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 137 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
              G L D +  +  +   +   +  ++ + + Y+H+   IHR++   N+LL  D  +KI
Sbjct: 100 VPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKI 158
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG  K + +           D  +  F     +  PE L      + +D+W+ G TLY
Sbjct: 159 GDFGLAKAVPEGHEYY--RVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 257 QMLS 260
           ++L+
Sbjct: 212 ELLT 215

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 421 EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 479
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 480 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKW-- 535
Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 266
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 536 ---PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 575

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 210
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 265
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 20/113 (17%)
Query: 161 TAEVVDALEYIHS-MGLIHRDIKPENLLL-TADG-----HIKIADFGSVKPMQDSRITVL 213
           + +++  L+Y+H   G+IH DIKPEN+L+   D       IKIAD G+            
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----------- 185
Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
                D+     + T  Y  PEVL  +P   G D+W+  C ++++++G   F+
Sbjct: 186 --CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 20/113 (17%)
Query: 161 TAEVVDALEYIHS-MGLIHRDIKPENLLL-TADG-----HIKIADFGSVKPMQDSRITVL 213
           + +++  L+Y+H   G+IH DIKPEN+L+   D       IKIAD G+            
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----------- 185
Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
                D+     + T  Y  PEVL  +P   G D+W+  C ++++++G   F+
Sbjct: 186 --CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/247 (21%), Positives = 99/247 (40%), Gaps = 37/247 (14%)
Query: 55  QDFELGKIYGVGSYSKVVRAK-KIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQ 111
           Q F LG++ G G +  V  A+ K + G+    A+K++    I   +   +++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 112 LDHPGVVRL------------------FFTFQDTFSLYMALESCEGGELFDQITSKGHLS 153
            DHP V +L                     F     L+  L +   GE      +  +L 
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE------NPFNLP 135
Query: 154 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 213
                 +  ++   +EY+ S   IHRD+   N +L  D  + +ADFG  + +        
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-- 193
Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL 272
                  + C       ++  E L  +  T  +D+WA G T++++++ G +P+       
Sbjct: 194 ------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 273 IFQRIIA 279
           I+  +I 
Sbjct: 248 IYNYLIG 254

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 18/221 (8%)
Query: 57  FELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +EL  + G G      V  A+   TG    ++ ++ +  + E  T +++ E  V    +H
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNH 69
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH 172
           P +V    TF     L++       G   D I +     ++E    +    V+ AL+YIH
Sbjct: 70  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 129
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPM----QDSRITVLPNAASDDKACTFVGT 228
            MG +HR +K  ++L++ DG + ++   S   M    Q  R+         D     V  
Sbjct: 130 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV-------HDFPKYSVKV 182
Query: 229 AAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKD 267
             ++ PEVL  +   +   +D++++G T  ++ +G  PFKD
Sbjct: 183 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 223

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/228 (20%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLER--IVLDQ 111
           + E  K  G G +  V + + +   +V A+K  I+       E    + + +R   ++  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-YTAEVVDALEY 170
           L+HP +V+L+    +   + M    C  G+L+ ++  K H  +   +     ++   +EY
Sbjct: 80  LNHPNIVKLYGLMHNPPRMVMEFVPC--GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 171 IHSMG--LIHRDIKPENLLL-----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           + +    ++HRD++  N+ L      A    K+ADFG+             +  S     
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGT-------------SQQSVHSVS 184
Query: 224 TFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTS 269
             +G   ++ PE + +   ++    D ++    LY +L+G  PF + S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 18/221 (8%)
Query: 57  FELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +EL  + G G      V  A+   TG    ++ ++ +  + E  T +++ E  V    +H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNH 85
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH 172
           P +V    TF     L++       G   D I +     ++E    +    V+ AL+YIH
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPM----QDSRITVLPNAASDDKACTFVGT 228
            MG +HR +K  ++L++ DG + ++   S   M    Q  R+         D     V  
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV-------HDFPKYSVKV 198
Query: 229 AAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKD 267
             ++ PEVL  +   +   +D++++G T  ++ +G  PFKD
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDSRITVLPNAAS 218
           +++D + Y+H+  ++HRD+KP N+L+  +    G +KIAD G  +        + P A  
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADL 192
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           D    TF   A   P  +L +   T   D+WA+GC   ++L+    F    E
Sbjct: 193 DPVVVTFWYRA---PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL------ 205
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 260

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 184
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 135
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 38  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 94
Query: 136 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 194
               G L D +   K  +   +   YT+++   +EY+ +   IHR++   N+L+  +  +
Sbjct: 95  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRV 154
Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 249
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 155 KIGDFGLTK--------VLPQ----DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 202
Query: 250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           + G  LY++ +     K  S    F R+I  D
Sbjct: 203 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 232

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 155
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 84  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 143 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 194
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 195 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 155
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 81  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 140 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 191
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 192 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPF--GXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 135 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 183
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 184
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 155
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 77  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 187
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 155
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 85  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 144 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 195
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 196 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 138 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 186
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 155
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 170
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 224
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 279

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +     G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDI 146
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 264 PF 265
           P+
Sbjct: 259 PY 260

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 155
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 171
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 225
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 280

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 35/247 (14%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           +E+    G G++ KVV       G  + A+KI+       +N   Y +  R  +  L+H 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68
Query: 116 G---------VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL--SEDEARFYTAEV 164
                      V++   F+    + +  E   G   +D I   G L    D  R    ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN--------- 215
             ++ ++HS  L H D+KPEN+L     + +  +    K  +D R  + P+         
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN---PKIKRDERTLINPDIKVVDFGSA 184
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS--PFKDTSEWL- 272
              D+   T V T  Y  PEV+ +   +   D+W++GC L +   G +  P  D+ E L 
Sbjct: 185 TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 273 IFQRIIA 279
           + +RI+ 
Sbjct: 245 MMERILG 251

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 150
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 204
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 259

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 205
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 260

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 155
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 144
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 198
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 253

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 206
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 40/248 (16%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 102
           P+  F  ++  LGK  G G + KVV+A           T  A+K++ +     E +    
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 103 KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSE--- 154
           +    VL Q++HP V++L+        L + +E  + G L  F + + K   G+L     
Sbjct: 76  EFN--VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 155 ---------DEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 198
                    DE          +  ++   ++Y+  M L+HRD+   N+L+     +KI+D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISD 193
Query: 199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 258
           FG  + + +    V        K         ++  E L     T  +D+W+ G  L+++
Sbjct: 194 FGLSRDVYEEDSXV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 259 LS-GTSPF 265
           ++ G +P+
Sbjct: 246 VTLGGNPY 253

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 149
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 203
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 201
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 256

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 26/190 (13%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY---- 160
           E  ++ +L H  +V+L+    +   +Y+  E    G L D       L + E R      
Sbjct: 54  EAQIMKKLKHDKLVQLYAVVSEE-PIYIVTEYMNKGSLLD------FLKDGEGRALKLPN 106
Query: 161 ----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 216
                A+V   + YI  M  IHRD++  N+L+      KIADFG  + ++D+  T    A
Sbjct: 107 LVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGA 166
Query: 217 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ 275
               K         +  PE       T  +D+W+ G  L ++++ G  P+   +   + +
Sbjct: 167 KFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE 217
Query: 276 RIIARDIRFP 285
           + + R  R P
Sbjct: 218 Q-VERGYRMP 226

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 31  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 86
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 214
Query: 87  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 146
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 215 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 269
Query: 147 TSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 330 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 264 PF 265
           P+
Sbjct: 381 PY 382

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 31  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 86
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 214
Query: 87  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 146
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 215 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 269
Query: 147 TSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 330 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 264 PF 265
           P+
Sbjct: 381 PY 382

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/262 (22%), Positives = 113/262 (43%), Gaps = 28/262 (10%)
Query: 31  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 86
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 244 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 297
Query: 87  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 146
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 298 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 352
Query: 147 TSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 413 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463
Query: 264 PFKDTSEWLIFQRIIARDIRFP 285
           P+       +  + + R  R P
Sbjct: 464 PYPGMVNREVLDQ-VERGYRMP 484

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 206
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 138 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 186
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 40/248 (16%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 102
           P+  F  ++  LGK  G G + KVV+A           T  A+K++ +     E +    
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 103 KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSE--- 154
           +    VL Q++HP V++L+        L + +E  + G L  F + + K   G+L     
Sbjct: 76  EFN--VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 155 ---------DEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 198
                    DE          +  ++   ++Y+  M L+HRD+   N+L+     +KI+D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 258
           FG  + + +    V        K         ++  E L     T  +D+W+ G  L+++
Sbjct: 194 FGLSRDVYEEDSXV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 259 LS-GTSPF 265
           ++ G +P+
Sbjct: 246 VTLGGNPY 253

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 59  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 155
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 133 -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 243
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 100
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 101 YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 149
             ++E + +    H  ++ L         LY+ +     G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDI 146
Query: 150 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 264 PF 265
           P+
Sbjct: 259 PY 260

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+ +E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK- 180
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+ +E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 184
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 182
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 79  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 185
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 135 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 183
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/228 (20%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLER--IVLDQ 111
           + E  K  G G +  V + + +   +V A+K  I+       E    + + +R   ++  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-YTAEVVDALEY 170
           L+HP +V+L+    +   + M    C  G+L+ ++  K H  +   +     ++   +EY
Sbjct: 80  LNHPNIVKLYGLMHNPPRMVMEFVPC--GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 171 IHSMG--LIHRDIKPENLLL-----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           + +    ++HRD++  N+ L      A    K+ADFG              +  S     
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-------------SQQSVHSVS 184
Query: 224 TFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTS 269
             +G   ++ PE + +   ++    D ++    LY +L+G  PF + S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 40/248 (16%)
Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 102
           P+  F  ++  LGK  G G + KVV+A           T  A+K++ +     E +    
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 103 KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSE--- 154
           +    VL Q++HP V++L+        L + +E  + G L  F + + K   G+L     
Sbjct: 76  EFN--VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 155 ---------DEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 198
                    DE          +  ++   ++Y+  M L+HRD+   N+L+     +KI+D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 258
           FG  + + +    V        K         ++  E L     T  +D+W+ G  L+++
Sbjct: 194 FGLSRDVYEEDSYV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 259 LS-GTSPF 265
           ++ G +P+
Sbjct: 246 VTLGGNPY 253

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/168 (23%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 163
           E  ++ Q DHP ++RL           +  E  E G L   + T  G  +  +       
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           V   + Y+  +G +HRD+   N+L+ ++   K++DFG  + ++D      P+AA      
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAA------ 208
Query: 224 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
            +  T   +P     PE +     +  +D+W+ G  ++++L+ G  P+
Sbjct: 209 -YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/102 (25%), Positives = 46/102 (45%), Gaps = 7/102 (6%)
Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
            +  ++ + + Y+H+   IHR +   N+LL  D  +KI DFG  K + +           
Sbjct: 115 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 174
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 260
           D           +  PE L      + +D+W+ G TLY++L+
Sbjct: 175 DS-------PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 265
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 320

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/102 (25%), Positives = 46/102 (45%), Gaps = 7/102 (6%)
Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
            +  ++ + + Y+H+   IHR +   N+LL  D  +KI DFG  K + +           
Sbjct: 116 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 175
Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 260
           D           +  PE L      + +D+W+ G TLY++L+
Sbjct: 176 DS-------PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 32/129 (24%)
Query: 157 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------------TADGHIKIA 197
            R    ++  AL ++H   L H D+KPEN+L                      +  I++A
Sbjct: 134 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 193
Query: 198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 257
           DFGS     +   T+             V T  Y PPEV+         D+W++GC L++
Sbjct: 194 DFGSATFDHEHHTTI-------------VATRHYRPPEVILELGWAQPCDVWSIGCILFE 240
Query: 258 MLSGTSPFK 266
              G + F+
Sbjct: 241 YYRGFTLFQ 249

>pdb|1W1D|A Chain A, Crystal Structure Of The Pdk1 Pleckstrin Homology (Ph) Domain Bound To Inositol (1,3,4,5)-Tetrakisphosphate Length = 151

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 398 WQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSND 457
           W QF++    +L +  V K + L +++ QL+LT  P L YVDP   V+KG I W   S +
Sbjct: 43  WHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPW---SQE 98
Query: 458 LSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEAL 496
           L  +  +   F + TP +     D    A +W + I+ +
Sbjct: 99  LRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEV 137

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 157
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 211
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 266

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 32/129 (24%)
Query: 157 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------------TADGHIKIA 197
            R    ++  AL ++H   L H D+KPEN+L                      +  I++A
Sbjct: 157 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 216
Query: 198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 257
           DFGS     +   T+             V T  Y PPEV+         D+W++GC L++
Sbjct: 217 DFGSATFDHEHHTTI-------------VATRHYRPPEVILELGWAQPCDVWSIGCILFE 263
Query: 258 MLSGTSPFK 266
              G + F+
Sbjct: 264 YYRGFTLFQ 272

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 31  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 86
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 214
Query: 87  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 146
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 215 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFL 269
Query: 147 TSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 330 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 264 PF 265
           P+
Sbjct: 381 PY 382

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +    +A
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 177
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 178 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 29/246 (11%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           + +E+    G G++ +VV+   +D    G   ALKI+  K + K  + A  +LE  VL++
Sbjct: 33  ERYEIVSTLGEGTFGRVVQC--VDHRRGGARVALKII--KNVEKYKEAA--RLEINVLEK 86
Query: 112 LDHPG------VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE--DEARFYTAE 163
           ++          V++F  F     + ++ E   G   FD +    +L     + R    +
Sbjct: 87  INEKDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 164 VVDALEYIHSMGLIHRDIKPENLL-LTADGHI-----KIADFGSVKPMQDSRITVLPNAA 217
           +  A++++H   L H D+KPEN+L + +D  +     K  D  SVK     R+    +A 
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTA-VRVVDFGSAT 204
Query: 218 SD-DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK--DTSEWL-I 273
            D +   T V T  Y  PEV+     +   D+W++GC +++   G + F+  D  E L +
Sbjct: 205 FDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAM 264
Query: 274 FQRIIA 279
            +RI+ 
Sbjct: 265 MERILG 270

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 32/129 (24%)
Query: 157 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------------TADGHIKIA 197
            R    ++  AL ++H   L H D+KPEN+L                      +  I++A
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 257
           DFGS     +   T+             V T  Y PPEV+         D+W++GC L++
Sbjct: 185 DFGSATFDHEHHTTI-------------VATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 258 MLSGTSPFK 266
              G + F+
Sbjct: 232 YYRGFTLFQ 240

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A    E  V+  L H
Sbjct: 182 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQH 236
Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 172
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 237 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA--- 229
               IHRD++  N+L++A    KIADFG  +                      VG     
Sbjct: 296 QRNYIHRDLRAANILVSASLVCKIADFGLAR----------------------VGAKFPI 333
Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 286
            +  PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P 
Sbjct: 334 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPR 390

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 207
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 262

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 206
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+ +E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +    +A
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK- 177
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 178 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 150
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 204
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 259

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 206
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 58  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL------ 207
Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 262

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 163
           E  ++ Q DHP ++RL           +  E  E G L   + T  G  +  +       
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           V   + Y+  +G +HRD+   N+L+ ++   K++DFG  + ++D      P+AA      
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAAXTTTGG 214
Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                  +  PE +     +  +D+W+ G  ++++L+ G  P+
Sbjct: 215 KI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 106/242 (43%), Gaps = 23/242 (9%)
Query: 27  NNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 86
            N   T+ P  Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 162 TNVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 215
Query: 87  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 146
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 216 TLKPGNMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 270
Query: 147 TSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 204
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 271 KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRL 330
Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 331 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 381
Query: 264 PF 265
           P+
Sbjct: 382 PY 383

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 54  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 171
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 172 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 207

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 56  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 173
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 174 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +F+  K+ G G++  V +   I  G      + IM+ +  T       +  E  V+  +D
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 110 NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 168 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 216
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 254

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 52  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 169
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 170 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 205

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 23/210 (10%)
Query: 60  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR 119
           G   G G +  VV    ++  TV   K+     IT E        E  V+ +  H  +V 
Sbjct: 36  GNKMGEGGFG-VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAE-VVDALEYI 171
           L     D   L +       G L D+++          H+     R   A+   + + ++
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM-----RCKIAQGAANGINFL 149
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H    IHRDIK  N+LL      KI+DFG  +  +    TV+ +          VGT AY
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS--------RIVGTTAY 201
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSG 261
           + PE L     T  +D+++ G  L ++++G
Sbjct: 202 MAPEALRGE-ITPKSDIYSFGVVLLEIITG 230

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 28/203 (13%)
Query: 85  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL---FFTFQD--TFSLYMALESCE- 138
           + I+   F+ K      V  E  +L+   HP ++ L   F  F++     LY+  E    
Sbjct: 64  VNILSDSFLCKR-----VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT 118
Query: 139 --GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
                + DQ   +  +S    +++   ++  L  +H  G++HRD+ P N+LL  +  I I
Sbjct: 119 DLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTL 255
            DF   +  +D+         +D     +V    Y  PE V+     T   D+W+ GC +
Sbjct: 176 CDFNLAR--EDT---------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 256 YQMLSGTSPFKDTSEWLIFQRII 278
            +M +  + F+ ++ +    +I+
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIV 247

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 28/203 (13%)
Query: 85  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL---FFTFQD--TFSLYMALESCE- 138
           + I+   F+ K      V  E  +L+   HP ++ L   F  F++     LY+  E    
Sbjct: 64  VNILSDSFLCKR-----VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT 118
Query: 139 --GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
                + DQ   +  +S    +++   ++  L  +H  G++HRD+ P N+LL  +  I I
Sbjct: 119 DLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTL 255
            DF   +  +D+         +D     +V    Y  PE V+     T   D+W+ GC +
Sbjct: 176 CDFNLAR--EDT---------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 256 YQMLSGTSPFKDTSEWLIFQRII 278
            +M +  + F+ ++ +    +I+
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIV 247

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 184
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 18/219 (8%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--- 112
           +F +GK  G G++ ++   K + T    A+K+   K     ++   + LE     QL   
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSG 64
Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           D    V  F       ++ + L      +LFD        S         +++  +EY+H
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVH 122
Query: 173 SMGLIHRDIKPENLLLTADGH-----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           S  LI+RD+KPEN L+   G+     I I DFG  K   D   T       + K+ T  G
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPE-TKKHIPYREHKSLT--G 179
Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
           TA Y+          +  +DL ALG      L G+ P++
Sbjct: 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 189
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPF--GXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 182
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 182
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 102/247 (41%), Gaps = 35/247 (14%)
Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           +E+    G G++ KVV       G  + A+KI+       +N   Y +  R  +  L+H 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68
Query: 116 G---------VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL--SEDEARFYTAEV 164
                      V++   F+    + +  E   G   +D I   G L    D  R    ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN--------- 215
             ++ ++HS  L H D+KPEN+L     + +  +    K  +D R  + P+         
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN---PKIKRDERTLINPDIKVVDFGSA 184
Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS--PFKDTSEWL- 272
              D+   T V    Y  PEV+ +   +   D+W++GC L +   G +  P  D+ E L 
Sbjct: 185 TYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 273 IFQRIIA 279
           + +RI+ 
Sbjct: 245 MMERILG 251

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 23/210 (10%)
Query: 60  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR 119
           G   G G +  VV    ++  TV   K+     IT E        E  V+ +  H  +V 
Sbjct: 36  GNKMGEGGFG-VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAE-VVDALEYI 171
           L     D   L +       G L D+++          H+     R   A+   + + ++
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM-----RCKIAQGAANGINFL 149
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H    IHRDIK  N+LL      KI+DFG  +  +    TV+            VGT AY
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXX--------RIVGTTAY 201
Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSG 261
           + PE L     T  +D+++ G  L ++++G
Sbjct: 202 MAPEALRGE-ITPKSDIYSFGVVLLEIITG 230

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L   L     G L D +   K ++       +  ++ + + Y+
Sbjct: 73  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 131 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 179
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|2VKI|A Chain A, Structure Of The Pdk1 Ph Domain K465e Mutant Length = 148

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 398 WQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSND 457
           W QF++    +L +  V + + L +++ QL+LT  P L YVDP   V+KG I W   S +
Sbjct: 40  WHQFVE-NNLILKMGPVDERKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPW---SQE 95
Query: 458 LSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEAL 496
           L  +  +   F + TP +     D    A +W + I+ +
Sbjct: 96  LRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEV 134

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 162
           E  V+ ++ H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKIRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 73/190 (38%), Gaps = 25/190 (13%)
Query: 104 LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR----- 158
           +E +++ + +H  +VR       +   ++ LE   GG+L      K  L E   R     
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPS 136
Query: 159 --------FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
                       ++    +Y+     IHRDI   N LLT  G  ++A  G     QD   
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQD--- 193
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +  A+   K    +    ++PPE       T   D W+ G  L+++ S G  P+   S
Sbjct: 194 --IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251
Query: 270 EWLIFQRIIA 279
              + + + +
Sbjct: 252 NQEVLEFVTS 261

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/241 (21%), Positives = 97/241 (40%), Gaps = 39/241 (16%)
Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-- 107
           +H   +D  L +  G G++ KV  A+  +        ++  K +      A    +R   
Sbjct: 10  QHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 69
Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGH 151
           +L  L H  +V+ +    D   L M  E  + G+L   +                 +KG 
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS--- 208
           L   +     +++   + Y+ S   +HRD+   N L+ A+  +KI DFG  + +  +   
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 209 RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP 264
           R+   T+LP                ++PPE +     T  +D+W+ G  L+++ + G  P
Sbjct: 190 RVGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 265 F 265
           +
Sbjct: 236 W 236

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 86  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 144 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 192
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 114 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 171
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 82  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 230
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 140 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 188
Query: 231 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 61  KIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           K+ G G++  V +   I  G       A+K++ +    K NK   +  E  V+  +  P 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSPY 80
Query: 117 VVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 174
           V RL       T  L   L     G L D +  ++G L   +   +  ++   + Y+  +
Sbjct: 81  VSRLLGICLTSTVQLVTQLMPY--GCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP- 233
            L+HRD+   N+L+ +  H+KI DFG  + +             D     +      VP 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLL-------------DIDETEYHADGGKVPI 185
Query: 234 ----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                E +     T  +D+W+ G T++++++ G  P+
Sbjct: 186 KWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 74/190 (38%), Gaps = 25/190 (13%)
Query: 104 LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR----- 158
           +E +++ +L+H  +VR       +   ++ LE   GG+L      K  L E   R     
Sbjct: 83  MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPS 136
Query: 159 --------FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
                       ++    +Y+     IHRDI   N LLT  G  ++A  G     +D   
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--- 193
Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +  A+   K    +    ++PPE       T   D W+ G  L+++ S G  P+   S
Sbjct: 194 --IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251
Query: 270 EWLIFQRIIA 279
              + + + +
Sbjct: 252 NQEVLEFVTS 261
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	499
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-141
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-111
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-108
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-104
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-104
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-103
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-102
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-102
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-102
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-101
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-101
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-101
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-101
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-101
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-100
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-99
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-99
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-99
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-99
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-98
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-96
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-96
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-90
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-89
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-88
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-84
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-84
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-84
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-81
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-81
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-80
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-80
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-78
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-78
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-78
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-78
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-78
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-78
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-78
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-77
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-77
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-77
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-76
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-76
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-76
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-76
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-76
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-75
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-75
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-75
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-75
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-75
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-75
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-75
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-75
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-75
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-74
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-74
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-74
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-74
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-73
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-73
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-73
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-73
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-72
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-72
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-72
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-72
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-71
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-71
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-71
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-71
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-71
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-71
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-70
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-70
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-70
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-69
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-68
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-68
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-67
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-66
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-66
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-66
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-65
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-65
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-65
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-64
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-63
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-62
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-60
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-57
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-57
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-56
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-55
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-51
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-07
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-50
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-49
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-47
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-46
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-46
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-45
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-45
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-45
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-44
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-44
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-44
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-44
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-44
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-43
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-42
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-42
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-40
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-37
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-34
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-34
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-34
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-33
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-33
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-33
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-33
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-32
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-32
1w1g_A	151	HPDK1, 3-phosphoinositide dependent protein kinase	3e-32
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-32
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-32
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-32
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-31
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-31
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-30
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-30
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-30
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-30
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-29
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-29
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-29
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-29
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-29
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-29
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-28
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-27
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-27
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-27
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-26
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-25
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-22
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-22
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-21
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-20
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-19
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-18
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-17
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-16
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-15
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-14
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-14
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-14
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-13
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-13
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-12
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-11
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-10
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-10
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-10
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-10
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-09
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-09
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-09
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-09
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-09
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-07

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  407 bits (1049), Expect = e-141
 Identities = 144/317 (45%), Positives = 193/317 (60%), Gaps = 10/317 (3%)

Query: 28  NNSSTNCPTVQRSKSFAFRAPQ-EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 86
           + ++        S   A   PQ      +DF+ GKI G GS+S VV A+++ T   YA+K
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK 61

Query: 87  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 146
           I++K+ I KENK  YV  ER V+ +LDHP  V+L+FTFQD   LY  L   + GEL   I
Sbjct: 62  ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 121

Query: 147 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 206
              G   E   RFYTAE+V ALEY+H  G+IHRD+KPEN+LL  D HI+I DFG+ K   
Sbjct: 122 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK--- 178

Query: 207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
                VL   +   +A +FVGTA YV PE+L    A   +DLWALGC +YQ+++G  PF+
Sbjct: 179 -----VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 233

Query: 267 DTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFK 325
             +E+LIFQ+II  +  FP  F   ARDL+++LL +D + R G     GY  LK HPFF+
Sbjct: 234 AGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

Query: 326 GIDWKNIRGQTPPKLAS 342
            + W+N+  QTPPKL +
Sbjct: 294 SVTWENLHQQTPPKLTA 310

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  330 bits (849), Expect = e-111
 Identities = 107/303 (35%), Positives = 172/303 (56%), Gaps = 18/303 (5%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           +S+QDF++ +  G GS+ +V   +    G  YA+K++ K+ + +  +  +   ER++L  
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           + HP ++R++ TFQD   ++M ++  EGGELF  +          A+FY AEV  ALEY+
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  +I+RD+KPEN+LL  +GHIKI DFG  K                D   T  GT  Y
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAK-------------YVPDVTYTLCGTPDY 169

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 291
           + PEV+++ P     D W+ G  +Y+ML+G +PF D++    +++I+  ++RFP +F++ 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMVQSG 349
            +DL+ RL+  D S R G    G   +K HP+FK + W+ +  R    P    EP +Q G
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP---YEPPIQQG 286

Query: 350 EGD 352
           +GD
Sbjct: 287 QGD 289

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  324 bits (833), Expect = e-108
 Identities = 101/295 (34%), Positives = 156/295 (52%), Gaps = 15/295 (5%)

Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
              Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
           + +L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
              EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K                 +  T 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------------RVKGRTWTL 198

Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 285
            GT   + PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258

Query: 286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
           ++FS   +DL+  LL VD + R G    G   +K H +F   DW  I  R    P
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  314 bits (807), Expect = e-104
 Identities = 109/305 (35%), Positives = 163/305 (53%), Gaps = 16/305 (5%)

Query: 40  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFI-TK 95
           S   +     E    + FEL ++ G G Y KV + +K+   +TG ++A+K++ K  I   
Sbjct: 2   SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61

Query: 96  ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSED 155
              TA+ K ER +L+++ HP +V L + FQ    LY+ LE   GGELF Q+  +G   ED
Sbjct: 62  AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121

Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
            A FY AE+  AL ++H  G+I+RD+KPEN++L   GH+K+ DFG  K           +
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK----------ES 171

Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ 275
                   TF GT  Y+ PE+L  S      D W+LG  +Y ML+G  PF   +      
Sbjct: 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

Query: 276 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--R 333
           +I+   +  P Y +  ARDL+ +LL  + + R GAGPG    ++ HPFF+ I+W+ +  R
Sbjct: 232 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 291

Query: 334 GQTPP 338
              PP
Sbjct: 292 KVEPP 296

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  312 bits (803), Expect = e-104
 Identities = 106/302 (35%), Positives = 165/302 (54%), Gaps = 16/302 (5%)

Query: 42  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK 98
           +   +   E      FEL K+ G GS+ KV   KKI   D   +YA+K++ K  + K   
Sbjct: 11  THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVRD 69

Query: 99  TAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR 158
               K+ER +L +++HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +
Sbjct: 70  RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129

Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
           FY AE+  AL+++HS+G+I+RD+KPEN+LL  +GHIK+ DFG  K           +   
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK----------ESIDH 179

Query: 219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 278
           + KA +F GT  Y+ PEV+N    T   D W+ G  +++ML+GT PF+          I+
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

Query: 279 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQT 336
              +  P + S  A+ L+  L   +P+ R GAGP G   +K H FF  IDW  +  R   
Sbjct: 240 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIH 299

Query: 337 PP 338
           PP
Sbjct: 300 PP 301

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  313 bits (805), Expect = e-103
 Identities = 108/315 (34%), Positives = 157/315 (49%), Gaps = 25/315 (7%)

Query: 37  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           +Q ++    R  +      DFE+ K+ G G++S+V   K   TG VYA+KIM+K  + K 
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102

Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSED 155
            + +  + ER VL   D   + +L F FQD   LY+ +E   GG+L   ++  G  +  +
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162

Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
            ARFY AE+V A++ +H +G +HRDIKP+N+LL   GHI++ADFGS   +          
Sbjct: 163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL---------R 213

Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-------DLWALGCTLYQMLSGTSPFKDT 268
           A    ++   VGT  Y+ PE+L +     G        D WALG   Y+M  G +PF   
Sbjct: 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273

Query: 269 SEWLIFQRIIARDIRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
           S    + +I+                + ARD I RLL   P  R G   GG    + HPF
Sbjct: 274 STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGR--GGAGDFRTHPF 330

Query: 324 FKGIDWKNIRGQTPP 338
           F G+DW  +R   PP
Sbjct: 331 FFGLDWDGLRDSVPP 345

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  313 bits (803), Expect = e-102
 Identities = 105/313 (33%), Positives = 162/313 (51%), Gaps = 23/313 (7%)

Query: 37  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           ++ +K F  +  Q     +DFE+ K+ G G++ +V   K  +   V+A+KI++K  + K 
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115

Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSED 155
            +TA  + ER VL   D   +  L + FQD  +LY+ ++   GG+L   ++  +  L E+
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175

Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
            ARFY AE+V A++ +H +  +HRDIKP+N+L+  +GHI++ADFGS   +          
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---------M 226

Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 270
                ++   VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S 
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286

Query: 271 WLIFQRIIARDIRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
              + +I+    RF         S+ A+DLI RL+      R   G  G    K HPFF 
Sbjct: 287 VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHR--LGQNGIEDFKKHPFFS 343

Query: 326 GIDWKNIRGQTPP 338
           GIDW NIR    P
Sbjct: 344 GIDWDNIRNCEAP 356

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  311 bits (798), Expect = e-102
 Identities = 110/312 (35%), Positives = 158/312 (50%), Gaps = 23/312 (7%)

Query: 37  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           + R K    +        +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K 
Sbjct: 51  LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110

Query: 97  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 156
           + +A+   ER ++   + P VV+LF+ FQD   LYM +E   GG+L   + S   + E  
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKW 169

Query: 157 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 216
           ARFYTAEVV AL+ IHSMG IHRD+KP+N+LL   GH+K+ADFG+   M         N 
Sbjct: 170 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---------NK 220

Query: 217 ASDDKACTFVGTAAYVPPEVLNSSPATFGN----DLWALGCTLYQMLSGTSPFKDTSEWL 272
               +  T VGT  Y+ PEVL S           D W++G  LY+ML G +PF   S   
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280

Query: 273 IFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 328
            + +I+     + FP+    S  A++LI   L  D   R   G  G   +K H FFK   
Sbjct: 281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVR--LGRNGVEEIKRHLFFKNDQ 337

Query: 329 WK--NIRGQTPP 338
           W    +R    P
Sbjct: 338 WAWETLRDTVAP 349

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  309 bits (793), Expect = e-102
 Identities = 110/348 (31%), Positives = 175/348 (50%), Gaps = 24/348 (6%)

Query: 5   QSHGREMLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYG 64
             H  E         +    +G +            ++       E   I++FEL K+ G
Sbjct: 4   HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLG 63

Query: 65  VGSYSKVVRAKKI---DTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDH-PGVVR 119
            G+Y KV   +KI   DTG +YA+K++ K  I  K   T + + ER VL+ +   P +V 
Sbjct: 64  TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 123

Query: 120 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
           L + FQ    L++ L+   GGELF  ++ +   +E E + Y  E+V ALE++H +G+I+R
Sbjct: 124 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183

Query: 180 DIKPENLLLTADGHIKIADFGSVK-PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 238
           DIK EN+LL ++GH+ + DFG  K  + D            ++A  F GT  Y+ P+++ 
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVAD----------ETERAYDFCGTIEYMAPDIVR 233

Query: 239 SSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRFPNYFSDAA 292
              +      D W+LG  +Y++L+G SPF    +  S+  I +RI+  +  +P   S  A
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293

Query: 293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
           +DLI RLL  DP  R G GP     +K H FF+ I+W ++  +    P
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 341

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  306 bits (787), Expect = e-101
 Identities = 105/289 (36%), Positives = 154/289 (53%), Gaps = 12/289 (4%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
            ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
             HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  +++RDIK ENL+L  DGHIKI DFG  K             +      TF GT  Y
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----------EGISDGATMKTFCGTPEY 171

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 291
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
           A+ L+  LL  DP  R G GP     +  H FF  I+W+++  +   PP
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  304 bits (780), Expect = e-101
 Identities = 97/296 (32%), Positives = 141/296 (47%), Gaps = 23/296 (7%)

Query: 44  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 103
               P+  F+I DF++G+  G G +  V  A++     + ALK++ K  + KE     ++
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62

Query: 104 LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
            E  +   L HP ++R++  F D   +Y+ LE    GEL+ ++   G   E  +  +  E
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKA 222
           + DAL Y H   +IHRDIKPENLL+   G +KIADFG SV      R T           
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----------M 172

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
           C   GT  Y+PPE++         DLW  G   Y+ L G  PF   S     +RI+  D+
Sbjct: 173 C---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229

Query: 283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
           +FP + SD ++DLI +LL   P  R          +  HP+ K     N R   PP
Sbjct: 230 KFPPFLSDGSKDLISKLLRYHPPQRLPL-----KGVMEHPWVK----ANSRRVLPP 276

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  312 bits (802), Expect = e-101
 Identities = 88/319 (27%), Positives = 151/319 (47%), Gaps = 21/319 (6%)

Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
            +      F   ++ G G + +V   +   TG +YA K ++KK + K        +E+ +
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238

Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEV 164
           L ++    +V L + F+    L + +    GG++   I +         E  A FYTA++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           V  LE++H   +I+RD+KPEN+LL  DG+++I+D G                A   K   
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV----------ELKAGQTKTKG 348

Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIAR 280
           + GT  ++ PE+L      F  D +ALG TLY+M++   PF+   E +    + QR++ +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408

Query: 281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPK 339
            + +P+ FS A++D  + LL  DP  R G   G    L+ HP F+ I W+ +  G   P 
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

Query: 340 LASEPMVQSGEGDDVHDSS 358
               P  ++    ++ D  
Sbjct: 469 F--VPDSRTVYAKNIQDVG 485

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  306 bits (787), Expect = e-101
 Identities = 106/313 (33%), Positives = 161/313 (51%), Gaps = 14/313 (4%)

Query: 29  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 88
           N++   P     +     +   H    DF   K+ G GS+ KV+ A+       YA+K++
Sbjct: 12  NANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL 71

Query: 89  DKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 147
            KK I K+ +  ++  ER VL + + HP +V L F+FQ    LY  L+   GGELF  + 
Sbjct: 72  QKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ 131

Query: 148 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 207
            +    E  ARFY AE+  AL Y+HS+ +++RD+KPEN+LL + GHI + DFG  K    
Sbjct: 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---- 187

Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
                  N   +    TF GT  Y+ PEVL+  P     D W LG  LY+ML G  PF  
Sbjct: 188 ------ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241

Query: 268 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 327
            +   ++  I+ + ++     +++AR L++ LL  D + R GA    +  +K H FF  I
Sbjct: 242 RNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA-KDDFMEIKSHVFFSLI 300

Query: 328 DWKNI--RGQTPP 338
           +W ++  +  TPP
Sbjct: 301 NWDDLINKKITPP 313

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  303 bits (778), Expect = e-101
 Identities = 91/290 (31%), Positives = 141/290 (48%), Gaps = 17/290 (5%)

Query: 47  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 166
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T               
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------DLC 168

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT 336
           + ++ ARDLI RLL  +PS RP         +  HP+      K    Q 
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPML-----REVLEHPWITANSSKPSNCQN 273

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  305 bits (783), Expect = e-100
 Identities = 98/306 (32%), Positives = 150/306 (49%), Gaps = 13/306 (4%)

Query: 36  TVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK 95
           T      F     ++   + DF    + G GS+ KV+ +++  T  +YA+KI+ K  + +
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60

Query: 96  ENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE 154
           ++      +E+ VL      P + +L   FQ    LY  +E   GG+L   I   G   E
Sbjct: 61  DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE 120

Query: 155 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 214
             A FY AE+   L ++ S G+I+RD+K +N++L ++GHIKIADFG  K           
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------E 170

Query: 215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 274
           N        TF GT  Y+ PE++   P     D WA G  LY+ML+G +PF+   E  +F
Sbjct: 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

Query: 275 QRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-- 332
           Q I+  ++ +P   S  A  +   L+   P  R G GP G   +K H FF+ IDW+ +  
Sbjct: 231 QSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 290

Query: 333 RGQTPP 338
           +   PP
Sbjct: 291 KEIQPP 296

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  305 bits (784), Expect = 1e-99
 Identities = 107/313 (34%), Positives = 160/313 (51%), Gaps = 13/313 (4%)

Query: 29  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 88
           + S +  +       +   P+   ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+
Sbjct: 122 SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL 181

Query: 89  DKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS 148
            K+ I  +++ A+   E  VL    HP +  L ++FQ    L   +E   GGELF  ++ 
Sbjct: 182 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR 241

Query: 149 KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 207
           +   SED ARFY AE+V AL+Y+HS   +++RD+K ENL+L  DGHIKI DFG  K    
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---- 297

Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 267
                           TF GT  Y+ PEVL  +      D W LG  +Y+M+ G  PF +
Sbjct: 298 ------EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

Query: 268 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 327
                +F+ I+  +IRFP      A+ L+  LL  DP  R G G      +  H FF GI
Sbjct: 352 QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411

Query: 328 DWKNI--RGQTPP 338
            W+++  +  +PP
Sbjct: 412 VWQHVYEKKLSPP 424

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  303 bits (779), Expect = 1e-99
 Identities = 83/298 (27%), Positives = 145/298 (48%), Gaps = 23/298 (7%)

Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
            E  +   FE+ +  G GS+ KV   +K DT  +YA+K M+K+   + N+   V  E  +
Sbjct: 9   NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI 68

Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           +  L+HP +V L+++FQD   ++M ++   GG+L   +    H  E+  + +  E+V AL
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           +Y+ +  +IHRD+KP+N+LL   GH+ I DF     +             + +  T  GT
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-----------ETQITTMAGT 177

Query: 229 AAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDI 282
             Y+ PE+ +S      +F  D W+LG T Y++L G  P+     TS   I        +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237

Query: 283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
            +P+ +S     L+ +LL+ +P  R        + ++  P+   I+W  +  +   P 
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQR----FSQLSDVQNFPYMNDINWDAVFQKRLIPG 291

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  309 bits (794), Expect = 2e-99
 Identities = 96/314 (30%), Positives = 151/314 (48%), Gaps = 20/314 (6%)

Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 109
           +  +   F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238

Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDA 167
           ++++   VV L + ++   +L + L    GG+L   I   G     E  A FY AE+   
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           LE +H   +++RD+KPEN+LL   GHI+I+D G    + +                  VG
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-----------GQTIKGRVG 347

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIR 283
           T  Y+ PEV+ +   TF  D WALGC LY+M++G SPF+   + +    + + +      
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLAS 342
           +   FS  AR L  +LL  DP+ R G   G    +K HP FK +++K +  G   P    
Sbjct: 408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPF-- 465

Query: 343 EPMVQSGEGDDVHD 356
           +P  Q+    DV D
Sbjct: 466 KPDPQAIYCKDVLD 479

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  302 bits (775), Expect = 2e-99
 Identities = 96/295 (32%), Positives = 153/295 (51%), Gaps = 14/295 (4%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
                 I +FE  ++ G GS+ KV+ A+  +TG +YA+K++ K  I +++       E+ 
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75

Query: 108 VLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 166
           +L    +HP + +LF  FQ    L+  +E   GG+L   I       E  ARFY AE++ 
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           AL ++H  G+I+RD+K +N+LL  +GH K+ADFG  K              +     TF 
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK----------EGICNGVTTATFC 185

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
           GT  Y+ PE+L         D WA+G  LY+ML G +PF+  +E  +F+ I+  ++ +P 
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RGQTPP 338
           +  + A  ++   +  +P+ R G+   GG   +  HPFFK IDW  +  R   PP
Sbjct: 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP 300

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  309 bits (793), Expect = 6e-98
 Identities = 102/321 (31%), Positives = 155/321 (48%), Gaps = 26/321 (8%)

Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
             H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242

Query: 109 LDQL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
           L  +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHAS 350

Query: 226 VGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIA 279
           VGT  Y+ PEVL          D ++LGC L+++L G SPF     KD  E  I +  + 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLT 408

Query: 280 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPP 338
             +  P+ FS   R L++ LL  D + R G    G   +K  PFF+ +DW+ +   + PP
Sbjct: 409 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

Query: 339 KLASEPMVQSGEGDDVHDSSW 359
            L   P        D  D   
Sbjct: 469 PL--IPPRGEVNAADAFDIGS 487

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  297 bits (763), Expect = 1e-97
 Identities = 98/295 (33%), Positives = 148/295 (50%), Gaps = 17/295 (5%)

Query: 47  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           + Q    I+DF L K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+
Sbjct: 9   SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68

Query: 107 IVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
            VL    +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             L+++HS G+++RD+K +N+LL  DGHIKIADFG  K           N   D K  TF
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------ENMLGDAKTNTF 178

Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 285
            GT  Y+ PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 238

Query: 286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
            +    A+DL+ +L   +P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 239 RWLEKEAKDLLVKLFVREPEKRLGVRGD----IRQHPLFREINWEELERKEIDPP 289

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  296 bits (761), Expect = 3e-97
 Identities = 102/303 (33%), Positives = 162/303 (53%), Gaps = 23/303 (7%)

Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
            +   +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62

Query: 109 LDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            +Q  +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  A
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L Y+H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D   TF G
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFCG 172

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF---------KDTSEWLIFQRII 278
           T  Y+ PE+L      F  D WALG  +++M++G SPF            +E  +FQ I+
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232

Query: 279 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RGQ 335
            + IR P   S  A  ++   L+ DP  R G  P  G+A ++ HPFF+ +DW  +  +  
Sbjct: 233 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 292

Query: 336 TPP 338
            PP
Sbjct: 293 VPP 295

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  295 bits (757), Expect = 4e-96
 Identities = 101/304 (33%), Positives = 161/304 (52%), Gaps = 23/304 (7%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
                 +QDF+L ++ G GSY+KV+  +   T  +YA++++ K+ +  +    +V+ E+ 
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104

Query: 108 VLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 166
           V +Q  +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 164

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           AL Y+H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D   TF 
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFC 214

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF---------KDTSEWLIFQRI 277
           GT  Y+ PE+L      F  D WALG  +++M++G SPF            +E  +FQ I
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

Query: 278 IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RG 334
           + + IR P   S  A  ++   L+ DP  R G  P  G+A ++ HPFF+ +DW  +  + 
Sbjct: 275 LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQ 334

Query: 335 QTPP 338
             PP
Sbjct: 335 VVPP 338

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  303 bits (778), Expect = 5e-96
 Identities = 102/338 (30%), Positives = 159/338 (47%), Gaps = 14/338 (4%)

Query: 4   IQSHGREMLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIY 63
           +   G E     +    + +I G    +    T      F     ++   + DF    + 
Sbjct: 291 VPPEGSEGNEELRQKFERAKI-GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVL 349

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFF 122
           G GS+ KV+ +++  T  +YA+KI+ K  + +++      +E+ VL      P + +L  
Sbjct: 350 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409

Query: 123 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 182
            FQ    LY  +E   GG+L   I   G   E  A FY AE+   L ++ S G+I+RD+K
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 469

Query: 183 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 242
            +N++L ++GHIKIADFG  K           N        TF GT  Y+ PE++   P 
Sbjct: 470 LDNVMLDSEGHIKIADFGMCK----------ENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519

Query: 243 TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV 302
               D WA G  LY+ML+G +PF+   E  +FQ I+  ++ +P   S  A  +   L+  
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 579

Query: 303 DPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
            P  R G GP G   +K H FF+ IDW+ +  +   PP
Sbjct: 580 HPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  275 bits (706), Expect = 4e-90
 Identities = 90/275 (32%), Positives = 147/275 (53%), Gaps = 18/275 (6%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            I+DF++G + G GS++ V RA+ I TG   A+K++DKK + K      V+ E  +  QL
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 171
            HP ++ L+  F+D+  +Y+ LE C  GE+   + ++    SE+EAR +  +++  + Y+
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           HS G++HRD+   NLLLT + +IKIADFG + +                +K  T  GT  
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-----------HEKHYTLCGTPN 177

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD 290
           Y+ PE+   S     +D+W+LGC  Y +L G  PF   +      +++  D   P++ S 
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237

Query: 291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            A+DLI +LL  +P+ R        + +  HPF  
Sbjct: 238 EAKDLIHQLLRRNPADRLSL-----SSVLDHPFMS 267

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  274 bits (703), Expect = 2e-89
 Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 24/289 (8%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S + +  G+  G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L
Sbjct: 13  SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            H  VV     F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
              +IHRD+K  NL L  D  +KI DFG + K   D            ++     GT  Y
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-----------GERKKVLCGTPNY 181

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 291
           + PEVL+    +F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +  
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
           A  LI ++L  DP+ RP         L    FF         G  P +L
Sbjct: 242 AASLIQKMLQTDPTARPTI-----NELLNDEFFT-------SGYIPARL 278

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  273 bits (701), Expect = 2e-88
 Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 24/296 (8%)

Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
               +  S + +  G+  G G ++K       DT  V+A KI+ K  + K ++   + +E
Sbjct: 32  EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             +   L H  VV     F+D   +++ LE C    L +    +  L+E EAR+Y  ++V
Sbjct: 92  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACT 224
              +Y+H   +IHRD+K  NL L  D  +KI DFG + K   D            ++   
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-----------GERKKV 200

Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 284
             GT  Y+ PEVL+    +F  D+W++GC +Y +L G  PF+ +     + RI   +   
Sbjct: 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 260

Query: 285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
           P + +  A  LI ++L  DP+ RP         L    FF         G  P +L
Sbjct: 261 PKHINPVAASLIQKMLQTDPTARPTI-----NELLNDEFFT-------SGYIPARL 304

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  261 bits (670), Expect = 2e-84
 Identities = 81/295 (27%), Positives = 137/295 (46%), Gaps = 36/295 (12%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            DFE   + G G++ +VV+A+       YA+K +       E K + +  E ++L  L+H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNH 61

Query: 115 PGVVRLFFTFQDTFS-------------LYMALESCEGGELFDQITSKG-HLSEDEARFY 160
             VVR +  + +  +             L++ +E CE G L+D I S+  +   DE    
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS----RITVLPNA 216
             ++++AL YIHS G+IHRD+KP N+ +    ++KI DFG  K +  S    ++      
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 217 ASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIF 274
            S D   + +GTA YV  EVL+ +   +    D+++LG   ++M+             I 
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEMIYP--FSTGMERVNIL 238

Query: 275 QRIIARDIRFPNYF----SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           +++ +  I FP  F        + +I  L+D DP+ RPGA       L    +  
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-----RTLLNSGWLP 288

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  261 bits (670), Expect = 3e-84
 Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 24/311 (7%)

Query: 18  FDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI 77
           F S  +++    S     +          +  E F  Q F+     G GSY +V + +  
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79

Query: 78  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC 137
           + G +YA+K     F   +++   +           HP  VRL   +++   LY+  E C
Sbjct: 80  EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139

Query: 138 EGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 196
            G  L     + G  L E +   Y  + + AL ++HS GL+H D+KP N+ L   G  K+
Sbjct: 140 -GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKL 198

Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 256
            DFG +  +            +        G   Y+ PE+L         D+++LG T+ 
Sbjct: 199 GDFGLLVEL-----------GTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTIL 246

Query: 257 QMLSGTSPFKDTSEWLIFQRIIARDI--RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGG 314
           ++            W   Q++    +   F    S   R ++  +L+ DP  R  A    
Sbjct: 247 EVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATA---- 299

Query: 315 YAVLKMHPFFK 325
              L   P  +
Sbjct: 300 -EALLALPVLR 309

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  262 bits (672), Expect = 4e-84
 Identities = 64/350 (18%), Positives = 126/350 (36%), Gaps = 70/350 (20%)

Query: 29  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 88
           ++ +N   + +         ++   I D+ + +    G ++K++  +K      YALK  
Sbjct: 11  SNYSNLIYLNKYVK------EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKY 62

Query: 89  DKKFITKENKTAY--------------VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL 134
           +K  + K+                    K E  ++  + +   +       +   +Y+  
Sbjct: 63  EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122

Query: 135 ESCEGGELFDQITSKGHL--------SEDEARFYTAEVVDALEYIHS-MGLIHRDIKPEN 185
           E  E   +         L             +     V+++  YIH+   + HRD+KP N
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182

Query: 186 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 245
           +L+  +G +K++DFG                  D K     GT  ++PPE  ++  +  G
Sbjct: 183 ILMDKNGRVKLSDFG------------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG 230

Query: 246 N--DLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDIRFP----------------- 285
              D+W+LG  LY M     PF    S   +F  I  ++I +P                 
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290

Query: 286 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 333
             N+ S+   D +   L  +P+ R  +          H +    + +++R
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITS-----EDALKHEWLADTNIEDLR 335

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  253 bits (649), Expect = 2e-81
 Identities = 83/279 (29%), Positives = 139/279 (49%), Gaps = 24/279 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            ++++ +  G G++S V R     TG  +A KI++ K ++  +    ++ E  +  +L H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQH 64

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 175 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           G++HR++KPENLLL +      +K+ADFG    + D            +    F GT  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-----------SEAWHGFAGTPGY 173

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF-- 288
           + PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P   +  
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233

Query: 289 -SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
            +  A+ LID +L V+P  R  A       LK  P+   
Sbjct: 234 VTPEAKSLIDSMLTVNPKKRITA----DQALK-VPWICN 267

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  252 bits (646), Expect = 6e-81
 Identities = 88/295 (29%), Positives = 145/295 (49%), Gaps = 30/295 (10%)

Query: 53  SIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA---YVKLERIV 108
            ++D  E+G+  G G ++ V + ++  TG  YA K + K+ ++   +      ++ E  +
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           L ++ HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D +
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 169 EYIHSMGLIHRDIKPENLLLT----ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKAC 223
            Y+HS  + H D+KPEN++L      +  IK+ DFG + K    +               
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK------------ 169

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
              GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229

Query: 284 FP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG 334
           F   YF   S+ A+D I RLL  DP  R          L+ H + K I  +N+RG
Sbjct: 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTI----AQSLE-HSWIKAIRRRNVRG 279

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  252 bits (645), Expect = 1e-80
 Identities = 81/296 (27%), Positives = 140/296 (47%), Gaps = 33/296 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI------V 108
           +++E  +I G G  S V R     T   YA+KI+D       +     +L         +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 109 LDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           L ++  HP +++L  T++     ++  +  + GELFD +T K  LSE E R     +++ 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           +  +H + ++HRD+KPEN+LL  D +IK+ DFG    +              +K     G
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----------GEKLREVCG 185

Query: 228 TAAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           T +Y+ PE++  S            D+W+ G  +Y +L+G+ PF    + L+ + I++ +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245

Query: 282 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 333
            +F     + +SD  +DL+ R L V P  R  A       L  HPFF+    + +R
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA----EEALA-HPFFQQYVVEEVR 296

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  251 bits (644), Expect = 2e-80
 Identities = 86/279 (30%), Positives = 142/279 (50%), Gaps = 27/279 (9%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + F   ++ G G++S+V   K+  TG ++ALK + K    +++    ++ E  VL ++ H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKH 65

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             +V L   ++ T   Y+ ++   GGELFD+I  +G  +E +A     +V+ A++Y+H  
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 175 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           G++HRD+KPENLL      +  I I DFG  K  Q+  ++            T  GT  Y
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS------------TACGTPGY 173

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF-- 288
           V PEVL   P +   D W++G   Y +L G  PF + +E  +F++I      F   ++  
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233

Query: 289 -SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
            S++A+D I  LL+ DP+ R          L  HP+  G
Sbjct: 234 ISESAKDFICHLLEKDPNERYTC----EKALS-HPWIDG 267

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  249 bits (637), Expect = 1e-78
 Identities = 89/304 (29%), Positives = 146/304 (48%), Gaps = 26/304 (8%)

Query: 30  SSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD 89
           S T    + R   F        FS  ++++ +  G G++S V R     TG  +A KI++
Sbjct: 6   SMTGGQQMGRGSEFMMN-ASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63

Query: 90  KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK 149
            K ++  +    ++ E  +  +L HP +VRL  + Q+    Y+  +   GGELF+ I ++
Sbjct: 64  TKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122

Query: 150 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQ 206
              SE +A     ++++++ Y HS G++HR++KPENLLL +      +K+ADFG    + 
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 266
           D            +    F GT  Y+ PEVL   P +   D+WA G  LY +L G  PF 
Sbjct: 183 D-----------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231

Query: 267 DTSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 322
           D  +  ++ +I A    +P   +   +  A+ LID +L V+P  R  A       LK  P
Sbjct: 232 DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA----DQALK-VP 286

Query: 323 FFKG 326
           +   
Sbjct: 287 WICN 290

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  246 bits (630), Expect = 2e-78
 Identities = 90/282 (31%), Positives = 146/282 (51%), Gaps = 31/282 (10%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + + +  + G GS+ +V++ K   T   YA+K+++K     ++ +  +  E  +L +LDH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDH 80

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +++LF   +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 175 GLIHRDIKPENLLLTA---DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            ++HRD+KPEN+LL +   D  IKI DFG S    Q++++               +GTA 
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK------------DRIGTAY 188

Query: 231 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--- 285
           Y+ PEVL  +   +    D+W+ G  LY +LSGT PF   +E+ I +R+      F    
Sbjct: 189 YIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

Query: 286 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
               SD A+DLI ++L   PS R  A       L+ HP+ + 
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITA----TQCLE-HPWIQK 282

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  246 bits (630), Expect = 4e-78
 Identities = 78/303 (25%), Positives = 137/303 (45%), Gaps = 29/303 (9%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA---YVKLERIVLDQ 111
             +++G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +L Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           + H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +++D + Y+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 172 HSMGLIHRDIKPENLLLTA----DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 226
           H+  + H D+KPEN++L        HIK+ DFG + +                       
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK------------NIF 179

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP- 285
           GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      I +    F  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239

Query: 286 NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 342
            +F   S+ A+D I +LL  +   R          L+ HP+   +D +    +    +  
Sbjct: 240 EFFSHTSELAKDFIRKLLVKETRKRLTI----QEALR-HPWITPVDNQQAMVRRESVVNL 294

Query: 343 EPM 345
           E  
Sbjct: 295 ENF 297

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  244 bits (626), Expect = 4e-78
 Identities = 84/281 (29%), Positives = 127/281 (45%), Gaps = 31/281 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           Q + L    G GS+ +V  A +  T    A K + K F+   ++    K E  ++  LDH
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDH 65

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P ++RL+ TF+D   +Y+ +E C GGELF+++  K    E +A     +V+ A+ Y H +
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 175 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            + HRD+KPEN L      D  +K+ DFG     +                 T VGT  Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-----------GKMMRTKVGTPYY 174

Query: 232 VPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---- 285
           V P+VL      +G   D W+ G  +Y +L G  PF   ++  +  +I      FP    
Sbjct: 175 VSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW 231

Query: 286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
              S  A  LI RLL   P  R  +       L+ H +F+ 
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITS----LQALE-HEWFEK 267

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  247 bits (632), Expect = 6e-78
 Identities = 83/287 (28%), Positives = 136/287 (47%), Gaps = 32/287 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-----VL 109
           Q ++   + G G  S V R     TG  +A+KIM+        +      E       +L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 110 DQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
            Q+  HP ++ L  +++ +  +++  +    GELFD +T K  LSE E R     +++A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            ++H+  ++HRD+KPEN+LL  +  I+++DFG    ++             +K     GT
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-----------GEKLRELCGT 262

Query: 229 AAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
             Y+ PE+L  S            DLWA G  L+ +L+G+ PF    + L+ + I+    
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322

Query: 283 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           +F     +  S   +DLI RLL VDP  R  A       L+ HPFF+
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTA----EQALQ-HPFFE 364

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  246 bits (629), Expect = 6e-78
 Identities = 87/293 (29%), Positives = 137/293 (46%), Gaps = 33/293 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-----VL 109
            ++ + K  G G+  +V  A +  T    A+KI+ K+     +         +     +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
            +L+HP ++++   F      Y+ LE  EGGELFD++     L E   + Y  +++ A++
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 170 YIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + +                T  
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----------TSLMRTLC 177

Query: 227 GTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI 282
           GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +  ++  +  +I +   
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237

Query: 283 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 331
            F        S+ A DL+ +LL VDP  R          L+ HP+ +  D K 
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTT----EEALR-HPWLQDEDMKR 285

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  245 bits (628), Expect = 9e-78
 Identities = 84/306 (27%), Positives = 142/306 (46%), Gaps = 30/306 (9%)

Query: 53  SIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA---YVKLERIV 108
           ++ D+ + G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           L ++ HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 169 EYIHSMGLIHRDIKPENLLLT----ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKAC 223
            Y+HS+ + H D+KPEN++L         IKI DFG + K    +               
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK------------ 175

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
              GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235

Query: 284 FP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK 339
           F   YF   S  A+D I RLL  DP  R          L+ HP+ K  D +    +    
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTI----QDSLQ-HPWIKPKDTQQALSRKASA 290

Query: 340 LASEPM 345
           +  E  
Sbjct: 291 VNMEKF 296

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  247 bits (633), Expect = 3e-77
 Identities = 86/293 (29%), Positives = 139/293 (47%), Gaps = 33/293 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-----VL 109
            ++ + K  G G+  +V  A +  T    A++I+ K+     +         +     +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
            +L+HP ++++   F      Y+ LE  EGGELFD++     L E   + Y  +++ A++
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 170 YIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T  
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TLC 302

Query: 227 GTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI 282
           GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +  ++  +  +I +   
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362

Query: 283 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 331
            F        S+ A DL+ +LL VDP  R          L+ HP+ +  D K 
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTT----EEALR-HPWLQDEDMKR 410

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  243 bits (623), Expect = 3e-77
 Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 33/287 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + + + K  G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L  
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQ 85

Query: 115 P--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
               ++RL+        +YM +E C   +L   +  K  +   E + Y   +++A+  IH
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
             G++H D+KP N L+  DG +K+ DFG    MQ    +V+ +        + VGT  Y+
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD--------SQVGTVNYM 195

Query: 233 PPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR 280
           PPE +    ++  N           D+W+LGC LY M  G +PF+   ++      II  
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255

Query: 281 D--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           +  I FP+      +D++   L  DP  R          L  HP+ +
Sbjct: 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQ 297

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  244 bits (625), Expect = 6e-77
 Identities = 78/289 (26%), Positives = 135/289 (46%), Gaps = 29/289 (10%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQ 111
             +++G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +L Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           + HP ++ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +++D + Y+
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 172 HSMGLIHRDIKPENLLLTA----DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 226
           H+  + H D+KPEN++L        HIK+ DFG + +                       
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK------------NIF 179

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP- 285
           GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A    F  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239

Query: 286 NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 331
            +F   S+ A+D I +LL  +   R          L+ HP+   +D + 
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTI----QEALR-HPWITPVDTQQ 283

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  242 bits (620), Expect = 2e-76
 Identities = 82/337 (24%), Positives = 134/337 (39%), Gaps = 62/337 (18%)

Query: 39  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK 98
           R   +           + + L    G GSY  V  A +  T  + A+KIM+K  I + N 
Sbjct: 11  RENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69

Query: 99  TAYVKLER--IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----- 151
               +++    ++ +L HP + RL+  ++D   + + +E C GG L D++          
Sbjct: 70  KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129

Query: 152 -----------------------------------LSEDEARFYTAEVVDALEYIHSMGL 176
                                                E        ++  AL Y+H+ G+
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189

Query: 177 IHRDIKPENLLLTADG--HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            HRDIKPEN L + +    IK+ DFG       S+     N        T  GT  +V P
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGL------SKEFYKLNNGEYYGMTTKAGTPYFVAP 243

Query: 235 EVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYF 288
           EVLN++  ++G   D W+ G  L+ +L G  PF   ++     +++ + + F     N  
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL 303

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           S  ARDL+  LL+ +   R  A       L+ HP+  
Sbjct: 304 SPLARDLLSNLLNRNVDERFDA----MRALQ-HPWIS 335

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  241 bits (617), Expect = 3e-76
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 30/287 (10%)

Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 109
           +    + + + +  G G +  V R  +  +   Y  K +  K   +      VK E  +L
Sbjct: 1   KELY-EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISIL 55

Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDAL 168
           +   H  ++ L  +F+    L M  E   G ++F++I +    L+E E   Y  +V +AL
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 169 EYIHSMGLIHRDIKPENLLLTA--DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTF 225
           +++HS  + H DI+PEN++        IKI +FG + +        +L            
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL------------ 163

Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 285
                Y  PEV      +   D+W+LG  +Y +LSG +PF   +   I + I+  +  F 
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223

Query: 286 -NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 328
              F   S  A D +DRLL  +   R  A       L+ HP+ K   
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTA----SEALQ-HPWLKQKI 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  241 bits (617), Expect = 4e-76
 Identities = 79/306 (25%), Positives = 134/306 (43%), Gaps = 33/306 (10%)

Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
              + +   ELG+    G ++ V +     TG  YA K + K+   ++ +   +  E  V
Sbjct: 27  NNFYILTSKELGR----GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAV 81

Query: 109 LDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVV 165
           L+     P V+ L   +++T  + + LE   GGE+F     +    +SE++      +++
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141

Query: 166 DALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFG-SVKPMQDSRITVLPNAASDDK 221
           + + Y+H   ++H D+KP+N+LL      G IKI DFG S K      +           
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---------- 191

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
               +GT  Y+ PE+LN  P T   D+W +G   Y +L+ TSPF        +  I   +
Sbjct: 192 --EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249

Query: 282 IRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP 337
           + +    F   S  A D I  LL  +P  RP A       L  H + +  D++N+     
Sbjct: 250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA----EICLS-HSWLQQWDFENLFHPEE 304

Query: 338 PKLASE 343
              +S+
Sbjct: 305 TSSSSQ 310

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  241 bits (618), Expect = 6e-76
 Identities = 77/299 (25%), Positives = 146/299 (48%), Gaps = 23/299 (7%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           S++ +   +  G GS+ K +  K  + G  Y +K ++   ++ + +    + E  VL  +
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR-EVAVLANM 80

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEY 170
            HP +V+   +F++  SLY+ ++ CEGG+LF +I +       ED+   +  ++  AL++
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +H   ++HRDIK +N+ LT DG +++ DFG  + +           ++ + A   +GT  
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN----------STVELARACIGTPY 190

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFS 289
           Y+ PE+  + P    +D+WALGC LY++ +    F+  S   +  +II+        ++S
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS 250

Query: 290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQS 348
              R L+ +L   +P  RP       ++L+   F      K I     P+L +E     
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVN----SILE-KGFIA----KRIEKFLSPQLIAEEFCLK 300

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  244 bits (625), Expect = 7e-76
 Identities = 86/279 (30%), Positives = 141/279 (50%), Gaps = 23/279 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           ++++L +  G G++S V R  K+  G  YA  I++ K ++  +    ++ E  +   L H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKH 69

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H M
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 175 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           G++HR++KPENLLL        +K+ADFG    ++                  F GT  Y
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG----------EQQAWFGFAGTPGY 179

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NY 287
           + PEVL   P     DLWA G  LY +L G  PF D  +  ++Q+I A    FP    + 
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
            +  A+DLI+++L ++PS R  A       LK HP+   
Sbjct: 240 VTPEAKDLINKMLTINPSKRITA----AEALK-HPWISH 273

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  241 bits (616), Expect = 1e-75
 Identities = 92/310 (29%), Positives = 147/310 (47%), Gaps = 32/310 (10%)

Query: 27  NNNSSTNCPTVQRSKSFAFRAPQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYAL 85
           ++ +++  P         +       ++ DF E+    G G+ S V R K+  T   YAL
Sbjct: 24  SSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYAL 83

Query: 86  KIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQ 145
           K++ K           V+ E  VL +L HP +++L   F+    + + LE   GGELFD+
Sbjct: 84  KVLKKT-----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR 138

Query: 146 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFG-S 201
           I  KG+ SE +A     ++++A+ Y+H  G++HRD+KPENLL      D  +KIADFG S
Sbjct: 139 IVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198

Query: 202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 261
                   +             T  GT  Y  PE+L         D+W++G   Y +L G
Sbjct: 199 KIVEHQVLMK------------TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

Query: 262 TSPFKD-TSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYA 316
             PF D   +  +F+RI+  +  F   ++   S  A+DL+ +L+ +DP  R       + 
Sbjct: 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTT----FQ 302

Query: 317 VLKMHPFFKG 326
            L+ HP+  G
Sbjct: 303 ALQ-HPWVTG 311

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  241 bits (616), Expect = 1e-75
 Identities = 88/308 (28%), Positives = 138/308 (44%), Gaps = 30/308 (9%)

Query: 35  PTVQRSKSFAFRAPQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI 93
           P +            +    +D +EL ++ G G +S V R    +TG  +A+KI+D    
Sbjct: 3   PGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKF 62

Query: 94  TKENKTAYVKLER--IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH 151
           T     +   L+R   +   L HP +V L  T+     LYM  E  +G +L  +I  +  
Sbjct: 63  TSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 122

Query: 152 ----LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKP 204
                SE  A  Y  ++++AL Y H   +IHRD+KP  +LL +      +K+  FG    
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           + +          S   A   VGT  ++ PEV+   P     D+W  G  L+ +LSG  P
Sbjct: 183 LGE----------SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

Query: 265 FKDTSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM 320
           F  T E  +F+ II    +     +   S++A+DL+ R+L +DP+ R       Y  L  
Sbjct: 233 FYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITV----YEALN- 286

Query: 321 HPFFKGID 328
           HP+ K  D
Sbjct: 287 HPWLKERD 294

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  245 bits (627), Expect = 1e-75
 Identities = 91/293 (31%), Positives = 144/293 (49%), Gaps = 29/293 (9%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + + +  + G GS+ +V++ K   T   YA+K+++K     ++ +  +  E  +L +LDH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDH 80

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +++LF   +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 175 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            ++HRD+KPEN+LL     D  IKI DFG     Q            + K    +GTA Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-----------NTKMKDRIGTAYY 189

Query: 232 VPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---- 285
           + PEVL  +   +    D+W+ G  LY +LSGT PF   +E+ I +R+      F     
Sbjct: 190 IAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

Query: 286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
              SD A+DLI ++L   PS R  A       L+ HP+ +    +       P
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITA----TQCLE-HPWIQKYSSETPTISDLP 294

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  240 bits (614), Expect = 1e-75
 Identities = 82/352 (23%), Positives = 145/352 (41%), Gaps = 39/352 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + + + K  G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQ 66

Query: 115 P--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
               ++RL+        +YM +E C   +L   +  K  +   E + Y   +++A+  IH
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
             G++H D+KP N L+  DG +K+ DFG    MQ    +V+ +        + VGT  Y+
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD--------SQVGTVNYM 176

Query: 233 PPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR 280
           PPE +    ++  N           D+W+LGC LY M  G +PF+   ++      II  
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236

Query: 281 D--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 338
           +  I FP+      +D++   L  DP  R          L  HP+ +             
Sbjct: 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQ----IQTHPVNQM 287

Query: 339 KLASEPMVQSGEGDDVHDSSWNPSH--IGDISAKINDGNGGASSSEGSITRL 388
              +   ++   G  V  +S N        +    + G    SSS  +  + 
Sbjct: 288 AKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 339

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  237 bits (608), Expect = 2e-75
 Identities = 81/283 (28%), Positives = 135/283 (47%), Gaps = 33/283 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             F   +  G G++  V   ++  +G    +K ++K       +   ++ E  VL  LDH
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ--IEAEIEVLKSLDH 79

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEY 170
           P ++++F  F+D  ++Y+ +E+CEGGEL ++I S       LSE        ++++AL Y
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 171 IHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
            HS  ++H+D+KPEN+L         IKI DFG  +  +            D+ +    G
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-----------DEHSTNAAG 188

Query: 228 TAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 285
           TA Y+ PEV     +      D+W+ G  +Y +L+G  PF  TS   + Q+   ++  + 
Sbjct: 189 TALYMAPEVFKRDVTFKC---DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245

Query: 286 NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
                 +  A DL+ ++L  DP  RP A      VL  H +FK
Sbjct: 246 VECRPLTPQAVDLLKQMLTKDPERRPSA----AQVLH-HEWFK 283

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  244 bits (624), Expect = 3e-75
 Identities = 86/279 (30%), Positives = 141/279 (50%), Gaps = 24/279 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             ++  ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDH
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +++L+  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 175 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            ++HRD+KPENLLL +   D +I+I DFG     +              K    +GTA Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-----------SKKMKDKIGTAYY 194

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NY 287
           + PEVL+ +      D+W+ G  LY +LSG  PF   +E+ I +++      F       
Sbjct: 195 IAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
            S++A+DLI ++L   PS R  A       L  H + + 
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISA----RDALD-HEWIQT 287

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  243 bits (623), Expect = 6e-75
 Identities = 91/325 (28%), Positives = 154/325 (47%), Gaps = 30/325 (9%)

Query: 27  NNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 86
              +      +Q +      + + H S + ++  K  G G+Y +V+  +   T    A+K
Sbjct: 10  GRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK 68

Query: 87  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 146
           I+ K  ++  + +  +  E  VL  LDHP +++L+  F+D  + Y+ +E  +GGELFD+I
Sbjct: 69  IIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI 127

Query: 147 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVK 203
             +   +E +A     +V+  + Y+H   ++HRD+KPENLLL     D  IKI DFG   
Sbjct: 128 IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187

Query: 204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSG 261
             ++             K    +GTA Y+ PEVL      +    D+W++G  L+ +L+G
Sbjct: 188 VFEN-----------QKKMKERLGTAYYIAPEVLRKK---YDEKCDVWSIGVILFILLAG 233

Query: 262 TSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV 317
             PF   ++  I +++      F        S+ A+DLI ++L  D   R  A       
Sbjct: 234 YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA----QQA 289

Query: 318 LKMHPFFKGIDWKNIRGQTPPKLAS 342
           L+ HP+ K +  K   G   P LA+
Sbjct: 290 LE-HPWIKEMCSKKESGIELPSLAN 313

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  238 bits (610), Expect = 6e-75
 Identities = 92/286 (32%), Positives = 134/286 (46%), Gaps = 34/286 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLD 113
             +E+ +  GVGSYS   R     T   +A+KI+DK    K +       E  I+L    
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS---KRD----PTEEIEILLRYGQ 74

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP ++ L   + D   +Y+  E  +GGEL D+I  +   SE EA      +   +EY+H+
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 174 MGLIHRDIKPENLLLTADGH----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
            G++HRD+KP N+L   +      I+I DFG  K ++          A +    T   TA
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLMTPCYTA 184

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDIRFP- 285
            +V PEVL         D+W+LG  LY ML+G +PF    D +   I  RI +       
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244

Query: 286 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 328
              N  SD A+DL+ ++L VDP  R  A      VL+ HP+    D
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTA----ALVLR-HPWIVHWD 285

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  238 bits (609), Expect = 7e-75
 Identities = 69/325 (21%), Positives = 124/325 (38%), Gaps = 42/325 (12%)

Query: 39  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK 98
           ++      A  E    Q +      G G++  V  A   +      +K + K+ + ++  
Sbjct: 8   KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67

Query: 99  TAYVKLERI-----VLDQLDHPGVVRLFFTFQDTFSLYMALES-CEGGELFDQITSKGHL 152
               KL ++     +L +++H  ++++   F++     + +E    G +LF  I     L
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127

Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 212
            E  A +   ++V A+ Y+    +IHRDIK EN+++  D  IK+ DFGS   ++      
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER----- 182

Query: 213 LPNAASDDKACTFVGTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
                      TF GT  Y  PEVL       P     ++W+LG TLY ++   +PF + 
Sbjct: 183 ------GKLFYTFCGTIEYCAPEVLMGNPYRGPEL---EMWSLGVTLYTLVFEENPFCE- 232

Query: 269 SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 328
                 +  +   I  P   S     L+  LL   P  R          L   P+     
Sbjct: 233 -----LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRT-----TLEKLVTDPWVT--- 279

Query: 329 WKNIRGQTPPKLASEPMVQSGEGDD 353
               +         E + +  + + 
Sbjct: 280 ----QPVNLADYTWEEVFRVNKPES 300

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  236 bits (603), Expect = 2e-74
 Identities = 95/305 (31%), Positives = 142/305 (46%), Gaps = 52/305 (17%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY------------ 101
           +  + L    G GSY  V  A   +  T YA+K++ KK + ++                 
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71

Query: 102 -----------VKLERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITS 148
                      V  E  +L +LDHP VV+L       +   LYM  E    G + + + +
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130

Query: 149 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS 208
              LSED+ARFY  +++  +EY+H   +IHRDIKP NLL+  DGHIKIADFG     +  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG- 189

Query: 209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF---GNDLWALGCTLYQMLSGTSPF 265
                    SD      VGT A++ PE L+ +   F     D+WA+G TLY  + G  PF
Sbjct: 190 ---------SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 266 KDTSEWLIFQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGR---PGAGPGGYAVLKM 320
            D     +  +I ++ + FP+    ++  +DLI R+LD +P  R   P         +K+
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPE--------IKL 292

Query: 321 HPFFK 325
           HP+  
Sbjct: 293 HPWVT 297

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  235 bits (601), Expect = 3e-74
 Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 45/289 (15%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            DF+  ++ G G + +V +AK    G  Y +K +       E      + E   L +LDH
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEK----AEREVKALAKLDH 63

Query: 115 PGVVRLFFTFQDTFS----------------LYMALESCEGGELFDQI--TSKGHLSEDE 156
             +V     +                     L++ +E C+ G L   I       L +  
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 157 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 216
           A     ++   ++YIHS  LI+RD+KP N+ L     +KI DFG V  ++          
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---------- 173

Query: 217 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 276
            +D K     GT  Y+ PE ++S       DL+ALG  L ++L       +TS+   F  
Sbjct: 174 -NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTD 230

Query: 277 IIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           +  RD    + F    + L+ +LL   P  RP        +L+      
Sbjct: 231 L--RDGIISDIFDKKEKTLLQKLLSKKPEDRPNT----SEILR-TLTVW 272

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  238 bits (609), Expect = 4e-74
 Identities = 83/280 (29%), Positives = 135/280 (48%), Gaps = 28/280 (10%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             +++ +  G G++  V R  +  TG V+  K ++       +K   VK E  +++QL H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYT-VKNEISIMNQLHH 107

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHS 173
           P ++ L   F+D + + + LE   GGELFD+I ++ + +SE E   Y  +  + L+++H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 174 MGLIHRDIKPENLLLTA--DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 230
             ++H DIKPEN++        +KI DFG + K   D  + V               TA 
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT------------TATAE 215

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF- 288
           +  PE+++  P  F  D+WA+G   Y +LSG SPF    +    Q +   D  F  + F 
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 275

Query: 289 --SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
             S  A+D I  LL  +P  R       +  L+ HP+ KG
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTV----HDALE-HPWLKG 310

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  237 bits (607), Expect = 6e-74
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 33/288 (11%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
            + + + K  G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112

Query: 114 HP--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
                ++RL+        +YM +E C   +L   +  K  +   E + Y   +++A+  I
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ +        + VG   Y
Sbjct: 172 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD--------SQVGAVNY 222

Query: 232 VPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIA 279
           +PPE +    ++  N           D+W+LGC LY M  G +PF+   ++      II 
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282

Query: 280 RD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            +  I FP+      +D++   L  DP  R          L  HP+ +
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQ 325

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  235 bits (601), Expect = 3e-73
 Identities = 51/329 (15%), Positives = 95/329 (28%), Gaps = 72/329 (21%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--- 112
               G + G       + A   +TG  + + +         N    +K E + L  L   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 113 ----------------------DHPGVVRLFFTFQDT-----FSLYMALESC---EGGEL 142
                                     ++R+    +D      F LY  ++S     G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 143 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 202
               ++   L        T +V+  L  +H  GL+H  ++P +++L   G + +  F  +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWAL 251
                                    +  + PPE+              +  TF  D WAL
Sbjct: 254 VRDGARV--------------VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299

Query: 252 GCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG 311
           G  +Y +     P    +     + I     R         R L++  L      R    
Sbjct: 300 GLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355

Query: 312 PGGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
                 ++  P +     + +R +    L
Sbjct: 356 ----QAME-TPEY-----EQLRTELSAAL 374

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  239 bits (612), Expect = 3e-73
 Identities = 81/316 (25%), Positives = 135/316 (42%), Gaps = 35/316 (11%)

Query: 28  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI 87
              +     +  +     R  +     + +   +  G G+Y +V+  K+ +  +  A+K+
Sbjct: 10  GRENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68

Query: 88  MDKKFITKENKTAY----------VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC 137
           + K    K   +            +  E  +L  LDHP +++LF  F+D    Y+  E  
Sbjct: 69  IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128

Query: 138 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHI 194
           EGGELF+QI ++    E +A     +++  + Y+H   ++HRDIKPEN+LL    +  +I
Sbjct: 129 EGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188

Query: 195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCT 254
           KI DFG                  D K    +GTA Y+ PEVL         D+W+ G  
Sbjct: 189 KIVDFGLSSFFSK-----------DYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVI 236

Query: 255 LYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGA 310
           +Y +L G  PF   ++  I +++      F        SD A++LI  +L  D + R  A
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296

Query: 311 GPGGYAVLKMHPFFKG 326
                  L    + K 
Sbjct: 297 ----EEALN-SRWIKK 307

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  232 bits (595), Expect = 4e-73
 Identities = 91/321 (28%), Positives = 150/321 (46%), Gaps = 29/321 (9%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQL 112
           I  + +G + G GSY KV      +T    A+KI+ KK + +  N  A VK E  +L +L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63

Query: 113 DHPGVVRLF--FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDAL 168
            H  V++L      ++   +YM +E C  G  E+ D +  +      +A  Y  +++D L
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGL 122

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           EY+HS G++H+DIKP NLLLT  G +KI+  G  + +            +DD   T  G+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA--------ADDTCRTSQGS 174

Query: 229 AAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 286
            A+ PPE+ N      G   D+W+ G TLY + +G  PF+  + + +F+ I       P 
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG 234

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMV 346
                  DL+  +L+ +P+ R          ++ H +F+         + PP  A  P+ 
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKR-----FSIRQIRQHSWFR--------KKHPPAEAPVPIP 281

Query: 347 QSGEGDDVHDSSWNPSHIGDI 367
            S +  D   S     ++ D+
Sbjct: 282 PSPDTKDRWRSMTVVPYLEDL 302

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  230 bits (590), Expect = 9e-73
 Identities = 88/277 (31%), Positives = 134/277 (48%), Gaps = 25/277 (9%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I  + LG   GVG++ KV   +   TG   A+KI++++ I   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++L+         +M +E   GGELFD I   G + E EAR    +++ A++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAYV 232
             ++HRD+KPEN+LL A  + KIADFG            L N  SD +   T  G+  Y 
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFG------------LSNMMSDGEFLRTSCGSPNYA 177

Query: 233 PPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
            PEV++    + P     D+W+ G  LY +L GT PF D     +F++I       P Y 
Sbjct: 178 APEVISGRLYAGPEV---DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL 234

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           + +   L+  +L VDP  R          ++ H +FK
Sbjct: 235 NRSVATLLMHMLQVDPLKR-----ATIKDIREHEWFK 266

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  229 bits (586), Expect = 4e-72
 Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 28/284 (9%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
            +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELK 63

Query: 114 HPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDA 167
           HP +VR +    D  +  LY+ +E CEGG+L   IT     + +L E+       ++  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 168 LEYIHSMGL-----IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           L+  H         +HRD+KP N+ L    ++K+ DFG  + +                A
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----------HDTSFA 173

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
            TFVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+  +  +I     
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233

Query: 283 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            R P  +SD   ++I R+L++    RP        +L+ +P   
Sbjct: 234 RRIPYRYSDELNEIITRMLNLKDYHRPSV----EEILE-NPLIL 272

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  230 bits (588), Expect = 7e-72
 Identities = 94/315 (29%), Positives = 144/315 (45%), Gaps = 35/315 (11%)

Query: 47  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 106
              E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N T+  KL R
Sbjct: 7   CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK---TQLNPTSLQKLFR 63

Query: 107 --IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
              ++  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           V A++Y H   ++HRD+K ENLLL AD +IKIADFG                    K   
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-----------GGKLDA 172

Query: 225 FVGTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
           F G   Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++  
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229

Query: 281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 340
             R P Y S    +L+ R L ++P  R          +    +          G    +L
Sbjct: 230 KYRIPFYMSTDCENLLKRFLVLNPIKRGTL-----EQIMKDRWIN-------AGHEEDEL 277

Query: 341 ASEPMVQSGEGDDVH 355
                 +    D   
Sbjct: 278 KPFVEPELDISDQKR 292

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  229 bits (586), Expect = 9e-72
 Identities = 83/292 (28%), Positives = 124/292 (42%), Gaps = 36/292 (12%)

Query: 31  STNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK 90
               P    + +             ++ LG + G G +  V    ++      A+K++ +
Sbjct: 7   LQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR 66

Query: 91  KFITKENKTAY---VKLE----RIVLDQLDHPGVVRLFFTFQDTFSLYMALE-SCEGGEL 142
             +   +  +      LE      V     HPGV+RL   F+      + LE      +L
Sbjct: 67  NRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL 126

Query: 143 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS 201
           FD IT KG L E  +R +  +VV A+++ HS G++HRDIK EN+L+    G  K+ DFGS
Sbjct: 127 FDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186

Query: 202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLY 256
              + D   T             F GT  Y PPE ++       PA     +W+LG  LY
Sbjct: 187 GALLHDEPYT------------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLY 230

Query: 257 QMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
            M+ G  PF+        Q I+  ++ FP + S     LI R L   PS RP
Sbjct: 231 DMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRCLAPKPSSRP 276

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  229 bits (587), Expect = 9e-72
 Identities = 92/312 (29%), Positives = 134/312 (42%), Gaps = 42/312 (13%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGV 117
             K  G GS+S   +     +   +A+KI+ K+        A  + E   L   + HP +
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNI 68

Query: 118 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 177
           V+L   F D    ++ +E   GGELF++I  K H SE EA +   ++V A+ ++H +G++
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128

Query: 178 HRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
           HRD+KPENLL T    +  IKI DFG  +               +    T   T  Y  P
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCFTLHYAAP 178

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-------IFQRIIARDIRFP-- 285
           E+LN +      DLW+LG  LY MLSG  PF+     L       I ++I   D  F   
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238

Query: 286 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASE 343
                S  A+DLI  LL VDP+ R         +   + + +         Q        
Sbjct: 239 AWKNVSQEAKDLIQGLLTVDPNKRLKM----SGLRY-NEWLQD------GSQLSSNPLMT 287

Query: 344 PMVQSGEGDDVH 355
           P +    G  VH
Sbjct: 288 PDILGSSGAAVH 299

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  229 bits (586), Expect = 1e-71
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 40/301 (13%)

Query: 55  QDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL- 112
             ++L + + G G++++V     + T   YA+KI++K+     ++   V  E  +L Q  
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR---VFREVEMLYQCQ 68

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            H  V+ L   F++    Y+  E   GG +   I  + H +E EA     +V  AL+++H
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 173 SMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           + G+ HRD+KPEN+L         +KI DF     ++ +      +  S  +  T  G+A
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC---SPISTPELLTPCGSA 185

Query: 230 AYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPF---------------KDTS 269
            Y+ PEV+ +            DLW+LG  LY +LSG  PF                   
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 270 EWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           + ++F+ I      FP     + S AA+DLI +LL  D   R  A      VL+ HP+ +
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA----AQVLQ-HPWVQ 300

Query: 326 G 326
           G
Sbjct: 301 G 301

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  229 bits (586), Expect = 1e-71
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 34/292 (11%)

Query: 29  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 88
             S   P      +      ++      +++G + G G +  V    ++      A+K +
Sbjct: 17  RGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76

Query: 89  DKKFITKENKTAY---VKLERIVLDQLDH--PGVVRLFFTFQDTFSLYMALESCEG-GEL 142
           +K  I+   +      V +E ++L ++     GV+RL   F+   S  + LE  E   +L
Sbjct: 77  EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136

Query: 143 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS 201
           FD IT +G L E+ AR +  +V++A+ + H+ G++HRDIK EN+L+  + G +K+ DFGS
Sbjct: 137 FDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196

Query: 202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLY 256
              ++D+  T             F GT  Y PPE +         A     +W+LG  LY
Sbjct: 197 GALLKDTVYT------------DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLY 240

Query: 257 QMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
            M+ G  PF+        + II   + F    S   + LI   L + PS RP
Sbjct: 241 DMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 286

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  227 bits (582), Expect = 1e-71
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 33/283 (11%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K      +   +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN 63

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +G+ HRDIKPENLLL    ++KI+DFG +     ++R  +L             GT  YV
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN---------KMCGTLPYV 174

Query: 233 PPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDIRFP- 285
            PE+L        P     D+W+ G  L  ML+G  P+   S+    +     +      
Sbjct: 175 APELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230

Query: 286 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV--LKMHPFFK 325
                 A   L+ ++L  +PS R         +  +K   ++ 
Sbjct: 231 WKKIDSAPLALLHKILVENPSAR-------ITIPDIKKDRWYN 266

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  229 bits (586), Expect = 1e-71
 Identities = 85/317 (26%), Positives = 144/317 (45%), Gaps = 38/317 (11%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K      +   +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN 63

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +G+ HRDIKPENLLL    ++KI+DFG +     ++R  +L             GT  YV
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN---------KMCGTLPYV 174

Query: 233 PPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDIRFP- 285
            PE+L        P     D+W+ G  L  ML+G  P+   S+    +     +      
Sbjct: 175 APELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230

Query: 286 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV--LKMHPFFKGIDWKNI-RGQTPPKLA 341
                 A   L+ ++L  +PS R         +  +K   ++     K + +G   P++ 
Sbjct: 231 WKKIDSAPLALLHKILVENPSAR-------ITIPDIKKDRWYN----KPLKKGAKRPRVT 279

Query: 342 SEPMVQSGEGDDVHDSS 358
           S  + +S  G   H  S
Sbjct: 280 SGGVSESPSGFSKHIQS 296

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  230 bits (589), Expect = 2e-71
 Identities = 78/279 (27%), Positives = 136/279 (48%), Gaps = 28/279 (10%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
                +I G G + +V + ++  TG   A KI+  +    ++K   VK E  V++QLDH 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEE-VKNEISVMNQLDHA 146

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
            +++L+  F+    + + +E  +GGELFD+I  + + L+E +   +  ++ + + ++H M
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 175 GLIHRDIKPENLLLT--ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            ++H D+KPEN+L        IKI DFG + +     ++ V              GT  +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN------------FGTPEF 254

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF-- 288
           + PEV+N    +F  D+W++G   Y +LSG SPF   ++      I+A         F  
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD 314

Query: 289 -SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
            S+ A++ I +LL  + S R  A       LK HP+   
Sbjct: 315 ISEEAKEFISKLLIKEKSWRISA----SEALK-HPWLSD 348

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  227 bits (581), Expect = 6e-71
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 18/268 (6%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + +   +  G G +S V   + +  G  YALK +      ++      + E  +    +H
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRLFNH 85

Query: 115 PGVVRLFFTFQD----TFSLYMALESCEGGELFDQI----TSKGHLSEDEARFYTAEVVD 166
           P ++RL              ++ L   + G L+++I         L+ED+  +    +  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            LE IH+ G  HRD+KP N+LL  +G   + D GS+       +     A +        
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDWAAQR 204

Query: 227 GTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDI 282
            T +Y  PE+ +       +   D+W+LGC LY M+ G  P+    +        +   +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264

Query: 283 RFPNY--FSDAARDLIDRLLDVDPSGRP 308
             P     S A   L++ ++ VDP  RP
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQRP 292

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  226 bits (579), Expect = 1e-70
 Identities = 79/294 (26%), Positives = 138/294 (46%), Gaps = 19/294 (6%)

Query: 26  GNNNSSTNCPTVQRSKSFAFRAPQEHFS-IQDFELGKIYGVGSYSKVVRAKKIDTGTVYA 84
              +     P V + +      P   ++ + +F + K  G G +S+V RA  +  G   A
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61

Query: 85  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD 144
           LK +    +      A    E  +L QL+HP V++ + +F +   L + LE  + G+L  
Sbjct: 62  LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121

Query: 145 QI----TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
            I      K  + E     Y  ++  ALE++HS  ++HRDIKP N+ +TA G +K+ D G
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 181

Query: 201 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 260
             +             +    A + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +
Sbjct: 182 LGRFFS----------SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231

Query: 261 GTSPF--KDTSEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA 310
             SPF     + + + ++I   D      +++S+  R L++  ++ DP  RP  
Sbjct: 232 LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  233 bits (595), Expect = 4e-70
 Identities = 82/327 (25%), Positives = 139/327 (42%), Gaps = 33/327 (10%)

Query: 15  EKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQD-----FELGKIYGVGSYS 69
             D D + +I     + ++         +    PQ      D     +++ +  G G++ 
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFG 171

Query: 70  KVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS 129
            V R  +  TG  +A K +       E+    V+ E   +  L HP +V L   F+D   
Sbjct: 172 VVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228

Query: 130 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL 188
           + M  E   GGELF+++  +   +SEDEA  Y  +V   L ++H    +H D+KPEN++ 
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288

Query: 189 T--ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 245
           T      +K+ DFG +        + V              GTA +  PEV    P  + 
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVT------------TGTAEFAAPEVAEGKPVGYY 336

Query: 246 NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLD 301
            D+W++G   Y +LSG SPF   ++    + + + D     + F   S+  +D I +LL 
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396

Query: 302 VDPSGRPGAGPGGYAVLKMHPFFKGID 328
            DP+ R       +  L+ HP+    +
Sbjct: 397 ADPNTRMTI----HQALE-HPWLTPGN 418

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  228 bits (584), Expect = 2e-69
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 32/305 (10%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           I  + LG   GVG++ KV   K   TG   A+KI++++ I   +    ++ E   L    
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +++L+        ++M +E   GGELFD I   G L E E+R    +++  ++Y H 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAYV 232
             ++HRD+KPEN+LL A  + KIADFG            L N  SD +   T  G+  Y 
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFG------------LSNMMSDGEFLRTSCGSPNYA 182

Query: 233 PPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
            PEV++    + P     D+W+ G  LY +L GT PF D     +F++I       P Y 
Sbjct: 183 APEVISGRLYAGPEV---DIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQS 348
           + +   L+  +L VDP  R          ++ H +FK       +         +P   S
Sbjct: 240 NPSVISLLKHMLQVDPMKR-----ATIKDIREHEWFK-------QDLPKYLFPEDPSYSS 287

Query: 349 GEGDD 353
              DD
Sbjct: 288 TMIDD 292

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  222 bits (568), Expect = 1e-68
 Identities = 87/283 (30%), Positives = 135/283 (47%), Gaps = 26/283 (9%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
                 I  + + +  G GS+ KV  A    T    ALK + ++ + K +    V+ E  
Sbjct: 2   AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
            L  L HP +++L+        + M +E   GGELFD I  K  ++EDE R +  +++ A
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFV 226
           +EY H   ++HRD+KPENLLL  + ++KIADFG            L N  +D     T  
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG------------LSNIMTDGNFLKTSC 168

Query: 227 GTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
           G+  Y  PEV+N    + P     D+W+ G  LY ML G  PF D     +F+++ +   
Sbjct: 169 GSPNYAAPEVINGKLYAGPEV---DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY 225

Query: 283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
             P++ S  A+ LI R++  DP  R          ++  P+F 
Sbjct: 226 VMPDFLSPGAQSLIRRMIVADPMQR-----ITIQEIRRDPWFN 263

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  221 bits (565), Expect = 5e-68
 Identities = 91/317 (28%), Positives = 134/317 (42%), Gaps = 43/317 (13%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
              ++  K  G G++      +   T  + A+K +++     EN    V+ E I    L 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLR 74

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           HP +VR          L + +E   GGEL+++I + G  SEDEARF+  +++  + Y HS
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 174 MGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           M + HRD+K EN LL       +KI DFG  K                 +  + VGT AY
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------HSQPKSTVGTPAY 183

Query: 232 VPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----QRIIARDIR 283
           + PEVL             D+W+ G TLY ML G  PF+D  E   +    QRI++    
Sbjct: 184 IAPEVLLRQEYDGKIA---DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240

Query: 284 FPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLA 341
            P+    S     LI R+   DP+ R          +K H +F     KN+    P  L 
Sbjct: 241 IPDDIRISPECCHLISRIFVADPATR-----ISIPEIKTHSWFL----KNL----PADLM 287

Query: 342 SEPMVQSGEGDDVHDSS 358
           +E    S   +      
Sbjct: 288 NESNTGSQFQEPEQPMQ 304

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  221 bits (564), Expect = 2e-67
 Identities = 43/310 (13%), Positives = 82/310 (26%), Gaps = 56/310 (18%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---- 112
              G + G       + A   +TG  + + +         N    +K E + L  L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 113 ---------------------DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQIT 147
                                    ++R+    +D +                   + + 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 148 SK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK 203
           S       L        T +V+  L  +H  GL+H  ++P +++L   G + +  F  + 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-----TFGNDLWALGCTLYQM 258
               S ++                        +L          TF  D W LG  +Y +
Sbjct: 260 RDGASAVS---------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 259 LSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVL 318
                P  D +     + I       P       R L++  L      R           
Sbjct: 311 WCADLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLP-----LQA 361

Query: 319 KMHPFFKGID 328
              P ++ + 
Sbjct: 362 METPEYEQLR 371

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  216 bits (552), Expect = 1e-66
 Identities = 58/308 (18%), Positives = 116/308 (37%), Gaps = 59/308 (19%)

Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
            +  S   + L  I G G+ + V R +   TG ++A+K+ +     +         E  V
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEV 60

Query: 109 LDQLDHPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITSKGH---LSEDEARFYTAE 163
           L +L+H  +V+LF   ++T +    + +E C  G L+  +    +   L E E      +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLT----ADGHIKIADFGSVKPMQDSRITVLPNAASD 219
           VV  + ++   G++HR+IKP N++           K+ DFG+ + ++D           D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------D 169

Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGN--------DLWALGCTLYQMLSGTSPFKDT--- 268
           ++  +  GT  Y+ P++   +     +        DLW++G T Y   +G+ PF+     
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 269 --------------------------SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV 302
                                     +  + +   +                ++  +L+ 
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 303 DPSGRPGA 310
           D     G 
Sbjct: 290 DQEKCWGF 297

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  215 bits (549), Expect = 2e-66
 Identities = 74/295 (25%), Positives = 128/295 (43%), Gaps = 31/295 (10%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           + DFE  +  G G +  V  AK       YA+K +         +      E   L +L+
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV--MREVKALAKLE 61

Query: 114 HPGVVRLFFTFQD------------TFSLYMALESCEGGELFDQITSKGHLSEDEARF-- 159
           HPG+VR F  + +               LY+ ++ C    L D +  +  + E E     
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 160 -YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ--DSRITVLPNA 216
               ++ +A+E++HS GL+HRD+KP N+  T D  +K+ DFG V  M   +   TVL   
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 217 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 276
            +  +    VGT  Y+ PE ++ +  +   D+++LG  L+++L    PF    E +    
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLT 238

Query: 277 IIARDIRFP---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 328
            + R+++FP            ++  +L   P  RP A       +  +  F+ +D
Sbjct: 239 DV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-----INIIENAVFEDLD 287

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  216 bits (552), Expect = 3e-66
 Identities = 80/291 (27%), Positives = 122/291 (41%), Gaps = 44/291 (15%)

Query: 55  QDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTAYVKLERIVLDQL 112
            D++L K + G+G   KV+      TG   ALK++       +E                
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE--------VDHHWQAS 79

Query: 113 DHPGVVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +V +   +++       L + +E  EGGELF +I  +G    +E EA     ++  
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 167 ALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++++HS  + HRD+KPENLL T    D  +K+ DFG  K    + +             
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ------------ 187

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRIIA 279
           T   T  YV PEVL         D+W+LG  +Y +L G  PF   +       + +RI  
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247

Query: 280 RDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
               FPN      S+ A+ LI  LL  DP+ R          +  HP+   
Sbjct: 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI----TQFMN-HPWINQ 293

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  215 bits (548), Expect = 2e-65
 Identities = 49/344 (14%), Positives = 98/344 (28%), Gaps = 66/344 (19%)

Query: 30  SSTNCPTVQRSKSFAFRAPQEHFSI-----QDFELGKIYGVGSYSKVVRAKKIDTGTVYA 84
                     +  +   A     S+     +  +L +   VG  S V   + ++    +A
Sbjct: 32  EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91

Query: 85  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ------------------- 125
           LK+         ++   +        +L            +                   
Sbjct: 92  LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151

Query: 126 -------DTFSLYMALESCEG------GELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
                     +  + + +           L      +G          TA+++     + 
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S GL+H    P+NL +  DG + + D  ++  +               +         Y 
Sbjct: 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV-------------GTRGPASSVPVTYA 258

Query: 233 PPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IFQRIIARDIRFPNY- 287
           P E LN+S    T   + W LG ++Y++     PF   +  +   ++R   R     +  
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA 318

Query: 288 ------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
                   D  + LI R L+ D   R          ++  P F 
Sbjct: 319 FGSCTPLPDFVKTLIGRFLNFDRRRRLLPL----EAME-TPEFL 357

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  213 bits (545), Expect = 9e-65
 Identities = 58/308 (18%), Positives = 115/308 (37%), Gaps = 59/308 (19%)

Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
            +  S   + L  I G G+ + V R +   TG ++A+K+ +     +         E  V
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD--VQMREFEV 60

Query: 109 LDQLDHPGVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAE 163
           L +L+H  +V+LF   ++  T    + +E C  G L+  +    +   L E E      +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLT----ADGHIKIADFGSVKPMQDSRITVLPNAASD 219
           VV  + ++   G++HR+IKP N++           K+ DFG+ + ++D           D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------D 169

Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGN--------DLWALGCTLYQMLSGTSPFKDT--- 268
           ++  +  GT  Y+ P++   +     +        DLW++G T Y   +G+ PF+     
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 269 --------------------------SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV 302
                                     +  + +   +                ++  +L+ 
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 303 DPSGRPGA 310
           D     G 
Sbjct: 290 DQEKCWGF 297

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  215 bits (548), Expect = 9e-65
 Identities = 75/309 (24%), Positives = 129/309 (41%), Gaps = 39/309 (12%)

Query: 37  VQRSKSFAFRAPQEHFSI-----QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKK 91
           +  S S       E  S+       F    + G G+   +V           A+K +  +
Sbjct: 1   MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPE 59

Query: 92  FITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG 150
             +  ++      E  +L + D HP V+R F T +D    Y+A+E C    L + +  K 
Sbjct: 60  CFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112

Query: 151 H-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKP 204
                 E      +    L ++HS+ ++HRD+KP N+L++           I+DFG  K 
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172

Query: 205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLS- 260
           +   R        S  +     GT  ++ PE+L+       T+  D+++ GC  Y ++S 
Sbjct: 173 LAVGR-------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

Query: 261 GTSPFKDTSEWLIFQRIIARDIRFPNYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAV 317
           G+ PF  + +      + A  +   +        AR+LI++++ +DP  RP A      V
Sbjct: 226 GSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAK----HV 281

Query: 318 LKMHPFFKG 326
           LK HPFF  
Sbjct: 282 LK-HPFFWS 289

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  209 bits (535), Expect = 2e-64
 Identities = 64/287 (22%), Positives = 106/287 (36%), Gaps = 19/287 (6%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            +F   +  G G +  V +  K   G +YA+K   K      ++   ++          H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEY 170
             VVR F  + +   + +  E C GG L D I+       +  E E +    +V   L Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV-----LPNAASDDKACTF 225
           IHSM L+H DIKP N+ ++       A     +    S   +     L +          
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190

Query: 226 VGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R 283
            G + ++  EVL  +       D++AL  T+          ++  +W     I    + R
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQGRLPR 247

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK 330
            P   S    +L+  ++  DP  RP A     A++K H        K
Sbjct: 248 IPQVLSQEFTELLKVMIHPDPERRPSA----MALVK-HSVLLSASRK 289

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  211 bits (538), Expect = 1e-63
 Identities = 79/323 (24%), Positives = 139/323 (43%), Gaps = 48/323 (14%)

Query: 27  NNNSSTNCPTVQRSKSFAFRA---PQEHFSIQDFEL-GKIYGVGSYSKVVRAKKIDTGTV 82
           +  +    P  Q+   F  ++    +++  I D+++  ++ G+G   KV++     T   
Sbjct: 30  HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89

Query: 83  YALKIMDKKFITKENKTAYVKLE-RIVLDQLDHPGVVRLFFTFQDTFS----LYMALESC 137
           +ALK++      +         E  +       P +VR+   +++ ++    L + +E  
Sbjct: 90  FALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141

Query: 138 EGGELFDQITSKGHL--SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADG 192
           +GGELF +I  +G    +E EA      + +A++Y+HS+ + HRD+KPENLL T    + 
Sbjct: 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201

Query: 193 HIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWAL 251
            +K+ DFG + +    + +T            T   T  YV PEVL         D+W+L
Sbjct: 202 ILKLTDFGFAKETTSHNSLT------------TPCYTPYYVAPEVLGPEKYDKSCDMWSL 249

Query: 252 GCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYF----SDAARDLIDRLLDVD 303
           G  +Y +L G  PF           +  RI      FPN      S+  + LI  LL  +
Sbjct: 250 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 309

Query: 304 PSGRPGAGPGGYAVLKMHPFFKG 326
           P+ R          +  HP+   
Sbjct: 310 PTQRMTI----TEFMN-HPWIMQ 327

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  209 bits (534), Expect = 1e-62
 Identities = 80/308 (25%), Positives = 118/308 (38%), Gaps = 57/308 (18%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD- 113
                 KI G GS   VV       G   A+K M   F           +E  +L + D 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDI------ALMEIKLLTESDD 67

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE-------VVD 166
           HP V+R + +      LY+ALE C    L D + SK    E+               +  
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 167 ALEYIHSMGLIHRDIKPENLLLT-------------ADGHIKIADFGSVKPMQDSRITVL 213
            + ++HS+ +IHRD+KP+N+L++              +  I I+DFG  K +   + +  
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGN-------DLWALGCTLYQMLS-GTSPF 265
            N           GT+ +  PE+L  S             D++++GC  Y +LS G  PF
Sbjct: 187 TNLN------NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 266 KDTSEWLIFQRIIARDIRFPNY-------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVL 318
            D         II                    A DLI +++D DP  RP A      VL
Sbjct: 241 GDKYS--RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM----KVL 294

Query: 319 KMHPFFKG 326
           + HP F  
Sbjct: 295 R-HPLFWP 301

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  199 bits (509), Expect = 5e-60
 Identities = 76/315 (24%), Positives = 127/315 (40%), Gaps = 38/315 (12%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 115
             + ++   G ++ V  A+ + +G  YALK +      +E K   +  E   + +L  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHP 86

Query: 116 GVVRLFFTFQDTFS-------LYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVV 165
            +V+                  ++ L     G+L + +    S+G LS D       +  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 166 DALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLPNAASDD 220
            A++++H     +IHRD+K ENLLL+  G IK+ DFGS   +    D   +    A  ++
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 221 KACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
           +  T   T  Y  PE+++     P     D+WALGC LY +     PF+D +      RI
Sbjct: 207 EI-TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRI 261

Query: 278 IARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ 335
           +      P +         LI  +L V+P  R         V+         +    R  
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSI----AEVVH-QLQ----EIAAARNV 312

Query: 336 TPPKLASEPMVQSGE 350
            P    +E + Q+G 
Sbjct: 313 NPKSPITELLEQNGG 327

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  201 bits (513), Expect = 1e-57
 Identities = 71/312 (22%), Positives = 116/312 (37%), Gaps = 54/312 (17%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           +   +E+ +  G G +  V+R    DTG   A+K   ++   K  +     LE  ++ +L
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER--WCLEIQIMKKL 69

Query: 113 DHPGVVRLFFTFQDTFSL------YMALESCEGGELFDQITSKGH---LSEDEARFYTAE 163
           +HP VV           L       +A+E CEGG+L   +    +   L E   R   ++
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDD 220
           +  AL Y+H   +IHRD+KPEN++L         KI D G  K +              +
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-----------GE 178

Query: 221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 280
               FVGT  Y+ PE+L     T   D W+ G   ++ ++G  PF    + + +   +  
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 281 DIRF--------------------PNYFSDAARDLIDRL----LDVDPSGRPGAGPGGYA 316
                                   PN+ S      ++R     L      R     G   
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR-----GTDP 293

Query: 317 VLKMHPFFKGID 328
                  F+ +D
Sbjct: 294 QNPNVGCFQALD 305

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  190 bits (485), Expect = 6e-57
 Identities = 67/294 (22%), Positives = 117/294 (39%), Gaps = 68/294 (23%)

Query: 54  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQ 111
           I D+++  ++ G+G   KV++     T   +ALK++      +         E  +    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 67

Query: 112 LDHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHL--SEDEARFYTAEVV 165
              P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127

Query: 166 DALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +A++Y+HS+ + HRD+KPENLL T    +  +K+ DFG                      
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------- 165

Query: 223 CTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWL----IFQR 276
                       E        +    D+W+LG  +Y +L G  PF           +  R
Sbjct: 166 ---------FAKETTGEK---YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213

Query: 277 IIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
           I      FP    +  S+  + LI  LL  +P+ R          +  HP+   
Sbjct: 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI----TEFMN-HPWIMQ 262

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  190 bits (484), Expect = 2e-56
 Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 31/312 (9%)

Query: 20  SKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDT 79
            +L  E  +N         +   + +R      + Q   +G+    GS+ +V R K   T
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR-VGR----GSFGEVHRMKDKQT 82

Query: 80  GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG 139
           G   A+K +  +    E        E +    L  P +V L+   ++   + + +E  EG
Sbjct: 83  GFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134

Query: 140 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIAD 198
           G L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K +N+LL++DG    + D
Sbjct: 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCD 194

Query: 199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 258
           FG         +       S        GT  ++ PEV+   P     D+W+  C +  M
Sbjct: 195 FGHAL-----CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 259 LSGTSPFKDTSEW-LIFQRIIARD----IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 313
           L+G  P+       L  +  IA +       P   +      I   L  +P  R  A   
Sbjct: 250 LNGCHPWTQYFRGPLCLK--IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASA--- 304

Query: 314 GYAVLKMHPFFK 325
               L+      
Sbjct: 305 --MELRRKVGKA 314

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  188 bits (478), Expect = 3e-55
 Identities = 41/284 (14%), Positives = 86/284 (30%), Gaps = 42/284 (14%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLE 105
               +   +  + G G++++V  A + D         + LK+       +          
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG---TQL 117

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-----TSKGHLSEDEARFY 160
              L        ++ +          +  E    G L + I     T +  + +     +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLT-----------ADGHIKIADFGSVKPMQDSR 209
              ++  +E +H   +IH DIKP+N +L                + + D G    M+   
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KD 267
                             T+ +   E+L++ P  +  D + +  T+Y ML GT      +
Sbjct: 238 --------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289

Query: 268 TSEWLIFQRIIARDIRFPNYF-SDAARDLIDRLLDVDPSGRPGA 310
             E             F      D   +    +L++       +
Sbjct: 290 GGECKPEG-------LFRRLPHLDMWNEFFHVMLNIPDCHHLPS 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  177 bits (450), Expect = 2e-51
 Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 19/254 (7%)

Query: 83  YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL 142
           +         ++  +      ++   +D       V           LY+ ++ C    L
Sbjct: 89  WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENL 148

Query: 143 FDQITSKGHLSEDE---ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 199
            D +  +  L + E         ++ +A+E++HS GL+HRD+KP N+  T D  +K+ DF
Sbjct: 149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 208

Query: 200 GSVKPMQDS--RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 257
           G V  M       TVL    +       VGT  Y+ PE ++ +  +   D+++LG  L++
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

Query: 258 MLSGTSPFKDTSE-WLIFQRIIARDIRFPNYF---SDAARDLIDRLLDVDPSGRPGAGPG 313
           +L     F    E   I   +  R+++FP  F         ++  +L   P+ RP A   
Sbjct: 269 LL---YSFSTQMERVRIITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA--- 320

Query: 314 GYAVLKMHPFFKGI 327
              +++ +  F+ +
Sbjct: 321 -TDIIE-NAIFENL 332

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 23/83 (27%), Positives = 33/83 (39%), Gaps = 2/83 (2%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            DFE  +  G G +  V  AK       YA+K +         +   V  E   L +L+H
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK--VMREVKALAKLEH 63

Query: 115 PGVVRLFFTFQDTFSLYMALESC 137
           PG+VR F  + +T       E  
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMD 86

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  172 bits (438), Expect = 4e-50
 Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 33/291 (11%)

Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-- 106
           +  +   +     + G G+Y  V   + +      A+K      I + +      L    
Sbjct: 16  EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKE-----IPERDSRYSQPLHEEI 70

Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEA--RFYTAE 163
            +   L H  +V+   +F +   + + +E   GG L   + SK G L ++E    FYT +
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 164 VVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +++ L+Y+H   ++HRDIK +N+L+ T  G +KI+DFG+ K +                 
Sbjct: 131 ILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN----------PCT 180

Query: 223 CTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWL--IFQRII 278
            TF GT  Y+ PE+++  P  +G   D+W+LGCT+ +M +G  PF +  E    +F ++ 
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVG 239

Query: 279 ARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 327
              +    P   S  A+  I +  + DP  R  A       L +  F K  
Sbjct: 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACA-----NDLLVDEFLKVS 285

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  170 bits (433), Expect = 2e-49
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 28/281 (9%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F+  + ++GK    GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 20  PEELFTKLE-KIGK----GSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEIT 72

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           VL Q D P V + + ++     L++ +E   GG   D +     L E +      E++  
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKG 131

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++           K  TFVG
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----------IKRNTFVG 181

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIARDI--RF 284
           T  ++ PEV+  S      D+W+LG T  ++  G  P  +     ++F  +I ++     
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--LIPKNNPPTL 239

Query: 285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
              +S   ++ ++  L+ +PS RP A       L  H F  
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRPTA-----KELLKHKFIL 275

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  164 bits (417), Expect = 5e-47
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 32/287 (11%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P E + I   ELG     G++ KV +AK  +TG + A K+++      E +     +E  
Sbjct: 17  PNEVWEIVG-ELGD----GAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIE 68

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVD 166
           +L   DHP +V+L   +     L++ +E C GG +   +      L+E + +    ++++
Sbjct: 69  ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 128

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           AL ++HS  +IHRD+K  N+L+T +G I++ADFG       +            K  +F+
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL----------QKRDSFI 178

Query: 227 GTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           GT  ++ PEV+              D+W+LG TL +M     P  + +   +  +I   D
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238

Query: 282 ---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
              +  P+ +S   RD +   LD +P  RP A     A L  HPF  
Sbjct: 239 PPTLLTPSKWSVEFRDFLKIALDKNPETRPSA-----AQLLEHPFVS 280

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  162 bits (412), Expect = 3e-46
 Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 38/308 (12%)

Query: 38  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN 97
           + S +  +   ++ + +Q+     I G G+ + V  A         A+K ++      + 
Sbjct: 3   EDSSALPWSINRDDYELQE----VI-GSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQT 55

Query: 98  KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-------- 149
               +  E   + Q  HP +V  + +F     L++ ++   GG + D I           
Sbjct: 56  SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS 115

Query: 150 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDS 208
           G L E        EV++ LEY+H  G IHRD+K  N+LL  DG ++IADFG S      +
Sbjct: 116 GVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS------A 169

Query: 209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKD 267
            +    +   +    TFVGT  ++ PEV+       F  D+W+ G T  ++ +G +P+  
Sbjct: 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229

Query: 268 TSE----WLIFQ------RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV 317
                   L  Q          +D      +  + R +I   L  DP  RP A      +
Sbjct: 230 YPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA----EL 285

Query: 318 LKMHPFFK 325
           L+ H FF+
Sbjct: 286 LR-HKFFQ 292

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  162 bits (411), Expect = 6e-46
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 27/281 (9%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+           KI G GS   V  A++  +G   A+K+MD   + K+ +   +  E +
Sbjct: 43  PRLLLDS----YVKI-GEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVV 94

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           ++    H  VV ++ ++     L++ +E  +GG L D I S+  L+E++       V+ A
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQA 153

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L Y+H+ G+IHRDIK +++LLT DG +K++DFG    +               K  + VG
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----------PKRKSLVG 203

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF 284
           T  ++ PEV++ S      D+W+LG  + +M+ G  P+   S     +R+       ++ 
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN 263

Query: 285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            +  S   RD ++R+L  DP  R  A       L  HPF  
Sbjct: 264 SHKVSPVLRDFLERMLVRDPQERATA-----QELLDHPFLL 299

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  160 bits (408), Expect = 1e-45
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 27/291 (9%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
             I D E     G G+  +V + +   TG V A+K M +    +ENK   + L+ +VL  
Sbjct: 22  AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-VVLKS 80

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
            D P +V+ F TF     +++A+E         +   +G + E      T  +V AL Y+
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 172 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
               G+IHRD+KP N+LL   G IK+ DFG    + D +                 G AA
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-----------AKDRSAGCAA 189

Query: 231 YVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI-R 283
           Y+ PE ++    T  +     D+W+LG +L ++ +G  P+K+  +++ +  +++  +   
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249

Query: 284 FPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
            P    FS   +  +   L  D   RP      Y  L  H F K  +   +
Sbjct: 250 LPGHMGFSGDFQSFVKDCLTKDHRKRP-----KYNKLLEHSFIKRYETLEV 295

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  160 bits (406), Expect = 2e-45
 Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 27/281 (9%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P++ ++       KI G G+   V  A  + TG   A++ M+   + ++ K   +  E +
Sbjct: 18  PKKKYTR----FEKI-GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEIL 69

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           V+ +  +P +V    ++     L++ +E   GG L D + ++  + E +      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQA 128

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           LE++HS  +IHRDIK +N+LL  DG +K+ DFG    +   +           K  T VG
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----------SKRSTMVG 178

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF 284
           T  ++ PEV+         D+W+LG    +M+ G  P+ + +       I       ++ 
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238

Query: 285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           P   S   RD ++R L++D   R  A       L  H F K
Sbjct: 239 PEKLSAIFRDFLNRCLEMDVEKRGSA-----KELLQHQFLK 274

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  161 bits (408), Expect = 7e-45
 Identities = 73/381 (19%), Positives = 128/381 (33%), Gaps = 63/381 (16%)

Query: 44  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 103
           +F      + +    +GK  G      V  A+   TG    ++ ++ +  + E  T    
Sbjct: 19  SFLPEGGCYELLT-VIGK--GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 104 LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYT 161
            E  V    +HP +V    TF     L++       G   D I +     ++E    +  
Sbjct: 76  -ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL 134

Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
             V+ AL+YIH MG +HR +K  ++L++ DG + ++   S   M              D 
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS---HGQRQRVVHDF 191

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKD------------ 267
               V    ++ PEVL  +   +    D++++G T  ++ +G  PFKD            
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251

Query: 268 ----------------------------------TSEWLIFQRIIARDIRFPNYFSDAAR 293
                                             T+         +    +   FS    
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 294 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 353
             +++ L  +P  RP A     + L  H FFK I  +      P  L     + + EG  
Sbjct: 312 HFVEQCLQRNPDARPSA-----STLLNHSFFKQIK-RRASEALPELLRPVTPITNFEGSQ 365

Query: 354 VHDSSWNPSHIGDISAKINDG 374
             D S     + ++     D 
Sbjct: 366 SQDHSGIFGLVTNLEELEVDD 386

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  159 bits (404), Expect = 1e-44
 Identities = 75/301 (24%), Positives = 120/301 (39%), Gaps = 30/301 (9%)

Query: 35  PTVQRSKSFAFRAPQEHFSIQD----FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK 90
           P   R+ S       E F   D    F   +  G GS+  V  A+ +    V A+K M  
Sbjct: 30  PAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY 89

Query: 91  KFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG 150
                  K   +  E   L +L HP  ++    +    + ++ +E C G         K 
Sbjct: 90  SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 149

Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
            L E E    T   +  L Y+HS  +IHRD+K  N+LL+  G +K+ DFGS         
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS--------- 200

Query: 211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 267
                A+    A +FVGT  ++ PEV+ +      +   D+W+LG T  ++     P  +
Sbjct: 201 -----ASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255

Query: 268 TSEWLIFQRIIARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
            +       I   +   ++  + +S+  R+ +D  L   P  RP +      VL  H F 
Sbjct: 256 MNAMSALYHIAQNESPALQSGH-WSEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFV 309

Query: 325 K 325
            
Sbjct: 310 L 310

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  157 bits (399), Expect = 3e-44
 Identities = 84/284 (29%), Positives = 129/284 (45%), Gaps = 33/284 (11%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P+E F + +    K+ G GSY  V +A   +TG + A+K +    +  + +   +  E  
Sbjct: 27  PEEVFDVLE----KL-GEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQE--IIKEIS 76

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 166
           ++ Q D P VV+ + ++     L++ +E C  G + D I      L+EDE        + 
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            LEY+H M  IHRDIK  N+LL  +GH K+ADFG    + D+            K  T +
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM----------AKRNTVI 186

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD---- 281
           GT  ++ PEV+         D+W+LG T  +M  G  P+ D      IF  +I  +    
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--MIPTNPPPT 244

Query: 282 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            R P  +SD   D + + L   P  R  A       L  HPF +
Sbjct: 245 FRKPELWSDNFTDFVKQCLVKSPEQRATA-----TQLLQHPFVR 283

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  156 bits (396), Expect = 3e-44
 Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 28/292 (9%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
               D E     G G+Y  V + + + +G + A+K +     ++E K   + L+ I +  
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISMRT 62

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSK-GHLSEDEARFYTAEVVDAL 168
           +D P  V  +        +++ +E  +    + + Q+  K   + ED        +V AL
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 169 EYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           E++HS + +IHRD+KP N+L+ A G +K+ DFG    + D                   G
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-----------AKDIDAG 171

Query: 228 TAAYVPPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI 282
              Y+ PE +N      G    +D+W+LG T+ ++     P+    + +   ++++    
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231

Query: 283 -RFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
            + P + FS    D   + L  +   RP      Y  L  HPFF   + K  
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERP-----TYPELMQHPFFTLHESKGT 278

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  156 bits (397), Expect = 4e-44
 Identities = 71/264 (26%), Positives = 115/264 (43%), Gaps = 30/264 (11%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM------DKKFITK---ENKTAYVKLERI 107
           + L ++ G G    V  A+      + ALK+M      D  F T+   E +TA       
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTA------- 88

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
              +L  P VV +    +    LY+ +    G +L   +  +G L+   A     ++  A
Sbjct: 89  --GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           L+  H+ G  HRD+KPEN+L++AD    + DFG      D ++T         +    VG
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT---------QLGNTVG 197

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---IARDIRF 284
           T  Y+ PE  + S AT+  D++AL C LY+ L+G+ P++     ++   I   I R    
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTV 257

Query: 285 PNYFSDAARDLIDRLLDVDPSGRP 308
                 A   +I R +  +P  R 
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDRY 281

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  155 bits (395), Expect = 6e-44
 Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 32/266 (12%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM------DKKFITK---ENKTAYVKLERI 107
           +++    G G  S V  A+        A+K +       ++ + +   E   +       
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS------- 65

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
              QL H  +V +    ++    Y+ +E  EG  L + I S G LS D A  +T +++D 
Sbjct: 66  --SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           +++ H M ++HRDIKP+N+L+ ++  +KI DFG  K + ++ +T         +    +G
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT---------QTNHVLG 174

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDIRFPN 286
           T  Y  PE           D++++G  LY+ML G  PF  +T+  +  + I         
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT 234

Query: 287 YF----SDAARDLIDRLLDVDPSGRP 308
                   +  ++I R  + D + R 
Sbjct: 235 DVRKDIPQSLSNVILRATEKDKANRY 260

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  155 bits (394), Expect = 7e-44
 Identities = 54/277 (19%), Positives = 107/277 (38%), Gaps = 29/277 (10%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 118
                G GS+  V +    +T    A   +  + +TK  +    K E  +L  L HP +V
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIV 88

Query: 119 RLFFTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           R + +++ T      + +  E    G L   +     +     R +  +++  L+++H+ 
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 175 G--LIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
              +IHRD+K +N+ +T   G +KI D G     + S             A   +GT  +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------------FAKAVIGTPEF 196

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPNYF 288
           + PE+          D++A G  + +M +   P+ +        R +   ++   F    
Sbjct: 197 MAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
               +++I+  +  +   R          L  H FF+
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQ 287

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  155 bits (393), Expect = 5e-43
 Identities = 72/343 (20%), Positives = 125/343 (36%), Gaps = 67/343 (19%)

Query: 38  QRSKSFAFRAPQEH---FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT 94
           QR +  AF   ++        DFE     G G+   V +     +G V A K++  +   
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--I 70

Query: 95  KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE 154
           K      +  E  VL + + P +V  +  F     + + +E  +GG L   +   G + E
Sbjct: 71  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 130

Query: 155 DEARFYTAEVVDALEYIHSMG-LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 213
                 +  V+  L Y+     ++HRD+KP N+L+ + G IK+ DFG    + DS     
Sbjct: 131 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 185

Query: 214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 273
                   A +FVGT +Y+ PE L  +  +  +D+W++G +L +M  G  P        +
Sbjct: 186 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

Query: 274 FQRIIARDIRF--------------------------------------------PNYFS 289
                 +                                                   FS
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298

Query: 290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
              +D +++ L  +P+ R          L +H F K  D + +
Sbjct: 299 LEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDAEEV 336

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  153 bits (389), Expect = 1e-42
 Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 36/304 (11%)

Query: 48  PQEHFSIQ--DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
           P++H+     D +     G G+Y  V +     +G + A+K +      KE K   + L+
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLD 72

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSK--GHLSEDEARFYT 161
            +V+   D P +V+ +         ++ +E       + +  + S     + E+     T
Sbjct: 73  -VVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 162 AEVVDALEYIHSMG-LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 220
              V AL ++     +IHRDIKP N+LL   G+IK+ DFG    + DS            
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI----------- 180

Query: 221 KACTFVGTAAYVPPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPFKD--TSEWLIF 274
                 G   Y+ PE ++ S +  G    +D+W+LG TLY++ +G  P+    +    + 
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240

Query: 275 QRIIARDI-RFPNY----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW 329
           Q ++  D  +  N     FS +  + ++  L  D S RP      Y  L  HPF    + 
Sbjct: 241 Q-VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-----KYKELLKHPFILMYEE 294

Query: 330 KNIR 333
           + + 
Sbjct: 295 RAVE 298

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  150 bits (382), Expect = 8e-42
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 42/295 (14%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P   F + +  +G     G+Y +V + + + TG + A+K+MD   +T + +    +   +
Sbjct: 22  PAGIFELVE-LVGN----GTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINM 73

Query: 108 VLDQLDHPGVVRLFFTF------QDTFSLYMALESCEGGELFD--QITSKGHLSEDEARF 159
           +     H  +   +  F           L++ +E C  G + D  + T    L E+   +
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
              E++  L ++H   +IHRDIK +N+LLT +  +K+ DFG    +  +           
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV---------- 183

Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTS-EWLI 273
            +  TF+GT  ++ PEV+              DLW+LG T  +M  G  P  D      +
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243

Query: 274 FQRIIARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
           F   I R+         +S   +  I+  L  + S RP         L  HPF +
Sbjct: 244 FL--IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT-----EQLMKHPFIR 291

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  150 bits (381), Expect = 8e-42
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 35/270 (12%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM------DKKFITK---ENKTAYVKLERI 107
           +ELG+I G G  S+V  A+ +      A+K++      D  F  +   E + A       
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA------- 66

Query: 108 VLDQLDHPGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
               L+HP +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+
Sbjct: 67  --AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
              AL + H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   A       
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA------- 177

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDI 282
             +GTA Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q  +  D 
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDP 236

Query: 283 RFPNYF----SDAARDLIDRLLDVDPSGRP 308
             P+      S     ++ + L  +P  R 
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRY 266

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  151 bits (383), Expect = 9e-40
 Identities = 61/266 (22%), Positives = 103/266 (38%), Gaps = 48/266 (18%)

Query: 57  FELGKIYGVGSYSKVVRAK--KIDTGTVYALKIM----DKKFITKENKTAYVKLERIVLD 110
           +E+      G    +  A    ++   V  LK +    D +             ER  L 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAM------AMAERQFLA 134

Query: 111 QLDHPGVVRLFFTFQDT-----FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
           ++ HP +V++F   + T        Y+ +E   G  L         L   EA  Y  E++
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEIL 192

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM-QDSRITVLPNAASDDKACT 224
            AL Y+HS+GL++ D+KPEN++LT +  +K+ D G+V  +     +              
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL-------------- 237

Query: 225 FVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
             GT  +  PE++    + AT   D++ +G TL  +                  +   D 
Sbjct: 238 -YGTPGFQAPEIVRTGPTVAT---DIYTVGRTLAALTLDLPTRNGRYV----DGLPEDDP 289

Query: 283 RFPNYFSDAARDLIDRLLDVDPSGRP 308
               Y  D+   L+ R +D DP  R 
Sbjct: 290 VLKTY--DSYGRLLRRAIDPDPRQRF 313

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  138 bits (351), Expect = 2e-37
 Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 59/326 (18%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAY--VKLERIVLDQLDHP 115
           +GKI G GSY  V + +  DTG + A+K  ++ +      K A   +++    L QL HP
Sbjct: 8   IGKI-GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRM----LKQLKHP 62

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 174
            +V L   F+    L++  E C+   +  ++   +  + E   +  T + + A+ + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVP 233
             IHRD+KPEN+L+T    IK+ DFG       +R+   P+           V T  Y  
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGF------ARLLTGPS-----DYYDDEVATRWYRS 170

Query: 234 PEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI----------- 277
           PE+L          D+WA+GC   ++LSG   +   S+    +LI + +           
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230

Query: 278 ----IARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 321
                   ++ P+              S  A  L+   L +DP+ R         +L  H
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC----EQLLH-H 285

Query: 322 PFFKGIDWKNIRGQTPPKLASEPMVQ 347
           P+F+ I       +   K A     Q
Sbjct: 286 PYFENIREIEDLAKEHDKPAENLYFQ 311

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  137 bits (348), Expect = 7e-37
 Identities = 81/335 (24%), Positives = 130/335 (38%), Gaps = 71/335 (21%)

Query: 35  PTVQRSKSFAFRAPQEHF-SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF 92
                S          +F S++ +E LG + G GSY  V++ +  DTG + A+K    KF
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMEKYENLGLV-GEGSYGMVMKCRNKDTGRIVAIK----KF 58

Query: 93  ITKE-----NKTAY--VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELF 143
           +  +      K A   +KL    L QL H  +V L    +     Y+  E  +    +  
Sbjct: 59  LESDDDKMVKKIAMREIKL----LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL 114

Query: 144 DQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK 203
           +       L     + Y  ++++ + + HS  +IHRDIKPEN+L++  G +K+ DFG   
Sbjct: 115 E--LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF-- 170

Query: 204 PMQDSRITVLPNAASDDKACT-FVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSG 261
               +R    P      +     V T  Y  PE+L          D+WA+GC + +M  G
Sbjct: 171 ----ARTLAAPG-----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

Query: 262 TSPFKDTSE----WLIFQRI---------------IARDIRFPNY------------FSD 290
              F   S+    + I   +               +   +R P               S+
Sbjct: 222 EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSE 281

Query: 291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
              DL  + L +DP  RP        +L  H FF+
Sbjct: 282 VVIDLAKKCLHIDPDKRPFC----AELLH-HDFFQ 311

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  131 bits (331), Expect = 1e-34
 Identities = 64/265 (24%), Positives = 113/265 (42%), Gaps = 34/265 (12%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           ++ E+ ++ G G++  V +AK        A+K ++ +   K         E   L +++H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIV-----ELRQLSRVNH 60

Query: 115 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEY 170
           P +V+L+         + + +E  EGG L++ +       + +   A  +  +    + Y
Sbjct: 61  PNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 171 IHSM---GLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           +HSM    LIHRD+KP NLLL A G  +KI DFG+   +Q                    
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------------K 164

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI-FQRIIARDIR-- 283
           G+AA++ PEV   S  +   D+++ G  L+++++   PF +           +    R  
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRP 308
                      L+ R    DPS RP
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRP 249

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  131 bits (331), Expect = 2e-34
 Identities = 84/326 (25%), Positives = 131/326 (40%), Gaps = 77/326 (23%)

Query: 53  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLE 105
            +  +E L KI G G++ +V +A+   TG   ALK  +M+ +   KE    TA   +K+ 
Sbjct: 15  EVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKI- 69

Query: 106 RIVLDQLDHPGVVRLF--------FTFQDTFSLYMALESCEG--GELFDQITSKGHLSED 155
              L  L H  VV L            +   S+Y+  + CE     L          +  
Sbjct: 70  ---LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLS 124

Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           E +     +++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L  
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAK 178

Query: 216 AASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE- 270
            +  ++    V T  Y PPE+L    +  P     DLW  GC + +M + +   +  +E 
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPI---DLWGAGCIMAEMWTRSPIMQGNTEQ 235

Query: 271 -----------------W-----------LIFQRIIARDIR--FPNYF-SDAARDLIDRL 299
                            W           L   +   R ++     Y     A DLID+L
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295

Query: 300 LDVDPSGRPGAGPGGYAVLKMHPFFK 325
           L +DP+ R  +       L  H FF 
Sbjct: 296 LVLDPAQRIDSD----DALN-HDFFW 316

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  130 bits (328), Expect = 4e-34
 Identities = 79/347 (22%), Positives = 135/347 (38%), Gaps = 69/347 (19%)

Query: 28  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK 86
           ++  T     Q   S +  A     SI  +  + K+ G G+Y +V +A    T    A+K
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKL-GEGTYGEVYKAIDTVTNETVAIK 65

Query: 87  --IMDKKFITKE--NKTAY--VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG 140
              ++ +   +E    TA   V L    L +L H  ++ L         L++  E  E  
Sbjct: 66  RIRLEHE---EEGVPGTAIREVSL----LKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117

Query: 141 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-----DGHIK 195
           +L   +     +S    + +  ++++ + + HS   +HRD+KP+NLLL+         +K
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLK 177

Query: 196 IADFGSVKPMQDSRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPA-TFGNDLWALGC 253
           I DFG       +R   +P      +  T  + T  Y PPE+L  S   +   D+W++ C
Sbjct: 178 IGDFGL------ARAFGIPI-----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226

Query: 254 TLYQMLSGTSPFKDTSE------------------W----------LIFQRIIARDIR-- 283
              +ML  T  F   SE                  W            F +   + ++  
Sbjct: 227 IWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV 286

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK 330
                 D   DL+  +L++DP  R  A       L+ HP+F   D+ 
Sbjct: 287 LGALLDDEGLDLLTAMLEMDPVKRISA----KNALE-HPYFSHNDFD 328

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  128 bits (324), Expect = 1e-33
 Identities = 53/261 (20%), Positives = 112/261 (42%), Gaps = 22/261 (8%)

Query: 56  DFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           D  + +  G GS+  V RA+     G+  A+KI+ ++    E    +++ E  ++ +L H
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRH 93

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQI---TSKGHLSEDEARFYTAEVVDALEYI 171
           P +V          +L +  E    G L+  +    ++  L E        +V   + Y+
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 172 HSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           H+    ++HR++K  NLL+     +K+ DFG  +    + ++            +  GT 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK----------SAAGTP 203

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNY 287
            ++ PEVL   P+   +D+++ G  L+++ +   P+ + +   +   +  +  R   P  
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263

Query: 288 FSDAARDLIDRLLDVDPSGRP 308
            +     +I+     +P  RP
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRP 284

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  128 bits (323), Expect = 2e-33
 Identities = 74/316 (23%), Positives = 119/316 (37%), Gaps = 64/316 (20%)

Query: 53  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK----IMDKKFITKENKTAY--VKLE 105
           +   +E + +I GVG+Y  V +A+   +G   ALK                +    V L 
Sbjct: 7   ATSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 106 RIVLDQLDHPGVVRLF-----FTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEAR 158
           R  L+  +HP VVRL              + +  E  +       D+    G L  +  +
Sbjct: 66  R-RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIK 123

Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 218
               + +  L+++H+  ++HRD+KPEN+L+T+ G +K+ADFG            L    S
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG------------LARIYS 171

Query: 219 DDKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLI 273
              A T  V T  Y  PEVL  S      D+W++GC   +M      F   SE      I
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

Query: 274 FQ----------------------RIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPG 309
           F                           R ++   P    ++   L+  +L  +P  R  
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRIS 290

Query: 310 AGPGGYAVLKMHPFFK 325
           A    +  L+ H +  
Sbjct: 291 A----FRALQ-HSYLH 301

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  128 bits (323), Expect = 3e-33
 Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 64/313 (20%)

Query: 53  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLE 105
             + +E L  + G G ++ V +A+  +T  + A+K   +  +   K+  N+TA   +KL 
Sbjct: 8   RAKRYEKLDFL-GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL- 65

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAE 163
              L +L HP ++ L   F    ++ +  +  E     +     +   L+    + Y   
Sbjct: 66  ---LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLM 120

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
            +  LEY+H   ++HRD+KP NLLL  +G +K+ADFG  K          PN     +A 
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS------PN-----RAY 169

Query: 224 T-FVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----------- 270
           T  V T  Y  PE+L  +     G D+WA+GC L ++L         S+           
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229

Query: 271 ----------------WLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGP 312
                           ++ F+      +   F     D   DLI  L   +P  R  A  
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA-AGDDLLDLIQGLFLFNPCARITA-- 286

Query: 313 GGYAVLKMHPFFK 325
                LK   +F 
Sbjct: 287 --TQALK-MKYFS 296

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  126 bits (318), Expect = 4e-33
 Identities = 40/261 (15%), Positives = 74/261 (28%), Gaps = 46/261 (17%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
           + L   +G     +  +A         AL  +D + +  ++         + L ++D PG
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 117 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
           V R+           +  E   GG L +        S   A      +  A +  H  G+
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 177 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 236
                 P  + ++ DG + +A                                  +P   
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------TMPDA- 179

Query: 237 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD-- 294
              +P     D+  +G +LY +L    P  +                 P   +D  RD  
Sbjct: 180 ---NPQD---DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233

Query: 295 -----LIDRLLDVDPSGRPGA 310
                +  R +  D   R  +
Sbjct: 234 FQISAVAARSVQGDGGIRSAS 254

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  127 bits (322), Expect = 1e-32
 Identities = 78/311 (25%), Positives = 124/311 (39%), Gaps = 67/311 (21%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 114
           +   K+ G GS+  V +AK  D+G + A+K  + DK+F  +E     +++    + +LDH
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-----LQI----MRKLDH 106

Query: 115 PGVVRL---FFTFQDTFS---LYMALESCEG---GELFDQITSKGHLSEDEARFYTAEVV 165
             +VRL   F++  +      L + L+               +K  L     + Y  ++ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 166 DALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
            +L YIHS G+ HRDIKP+NLLL  D   +K+ DFGS K +      V           +
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-----------S 215

Query: 225 FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII----- 278
           ++ +  Y  PE+   ++  T   D+W+ GC L ++L G   F   S       II     
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275

Query: 279 ------------ARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGG 314
                         + +FP                  A  L  RLL+  P+ R       
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP---- 331

Query: 315 YAVLKMHPFFK 325
                 H FF 
Sbjct: 332 LEACA-HSFFD 341

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  125 bits (316), Expect = 2e-32
 Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 69/311 (22%)

Query: 59  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAY--VKLERIVLDQLDH 114
           L K+ G G+Y+ V + K   T  + ALK +  +   +E    TA   V L    L  L H
Sbjct: 7   LDKL-GEGTYATVYKGKSKLTDNLVALKEI--RLEHEEGAPCTAIREVSL----LKDLKH 59

Query: 115 PGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
             +V L        SL +  E  +    +  D       ++    + +  +++  L Y H
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD--DCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF---VGTA 229
              ++HRD+KP+NLL+   G +K+ADFG       +R   +P         T+   V T 
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGL------ARAKSIPTK-------TYDNEVVTL 164

Query: 230 AYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRII------ 278
            Y PP++L  S   +   D+W +GC  Y+M +G   F  ++       IF RI+      
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF-RILGTPTEE 223

Query: 279 ----------ARDIRFPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAV 317
                      +   +P Y                 DL+ +LL  +   R  A       
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA----EDA 279

Query: 318 LKMHPFFKGID 328
           +K HPFF  + 
Sbjct: 280 MK-HPFFLSLG 289

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  125 bits (315), Expect = 2e-32
 Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 68/320 (21%)

Query: 53  SIQDFE-LGKIYGVGSYSKVVRAKKI-DTGTVYALK--IMDKKFITKE--NKTAY--VKL 104
           + Q +E + +I G G+Y KV +A+ + + G   ALK   +      +E    +    V +
Sbjct: 9   ADQQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAV 64

Query: 105 ERIVLDQLDHPGVVRLF-----FTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEA 157
            R  L+  +HP VVRLF             L +  E  +       D++   G +  +  
Sbjct: 65  LR-HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETI 122

Query: 158 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 217
           +    +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG            L    
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG------------LARIY 170

Query: 218 SDDKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WL 272
           S   A T  V T  Y  PEVL  S      DLW++GC   +M      F+ +S+      
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230

Query: 273 IFQ----------------------RIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 308
           I                           A+ I     +   +  +DL+ + L  +P+ R 
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRI 289

Query: 309 GAGPGGYAVLKMHPFFKGID 328
            A    Y+ L  HP+F+ ++
Sbjct: 290 SA----YSALS-HPYFQDLE 304

>1w1g_A HPDK1, 3-phosphoinositide dependent protein kinase-1; transferase, PKB, pleckstrin homology domain, inositol phosphate, signal transduction; HET: 4PT; 1.45A {Homo sapiens} SCOP: b.55.1.1 PDB: 1w1d_A* 1w1h_A 2vki_A Length = 151

 Score =  119 bits (299), Expect = 3e-32
 Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 4/131 (3%)

Query: 368 SAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQL 427
               N        SE     L    +  + W QF++    +L +  V K + L +++ QL
Sbjct: 13  DLDSNSFELDLQFSEDEKRLLLEKQAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQL 71

Query: 428 ILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRAS 487
           +LT  P L YVDP   V+KG I W   S +L  +  +   F + TP +     D    A 
Sbjct: 72  LLTEGPHLYYVDPVNKVLKGEIPW---SQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAH 128

Query: 488 QWKKAIEALQN 498
           +W + I+ +  
Sbjct: 129 KWCRKIQEVWR 139

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  124 bits (313), Expect = 4e-32
 Identities = 82/334 (24%), Positives = 139/334 (41%), Gaps = 71/334 (21%)

Query: 35  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK-I-MDKKF 92
                 ++  F+   E +      L K+ G G+Y  V +AK    G + ALK I +D + 
Sbjct: 6   HHSSGRENLYFQGLMEKYQK----LEKV-GEGTYGVVYKAKDS-QGRIVALKRIRLDAE- 58

Query: 93  ITKE--NKTAY--VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQI 146
              E    TA   + L    L +L HP +V L         L +  E  E    ++ D  
Sbjct: 59  --DEGIPSTAIREISL----LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD-- 110

Query: 147 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 206
            +K  L + + + Y  +++  + + H   ++HRD+KP+NLL+ +DG +K+ADFG      
Sbjct: 111 ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL----- 165

Query: 207 DSRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSP 264
            +R   +P      ++ T  V T  Y  P+VL  S   +   D+W++GC   +M++G   
Sbjct: 166 -ARAFGIPV-----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219

Query: 265 FKDTSE----WLIFQRI---------------IARDIRFPNY-----------FSDAARD 294
           F   ++      IF  +               + +   F  +           F     D
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGID 279

Query: 295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 328
           L+  +L  DP+ R  A       +  HP+FK +D
Sbjct: 280 LLSNMLCFDPNKRISA----RDAMN-HPYFKDLD 308

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  123 bits (311), Expect = 5e-32
 Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 69/316 (21%)

Query: 54  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLER 106
           ++ +  L KI G G+Y  V +A+  + G  +ALK   ++K+    E    T    + +  
Sbjct: 1   MEKYHGLEKI-GEGTYGVVYKAQN-NYGETFALKKIRLEKE---DEGIPSTTIREISI-- 53

Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 164
             L +L H  +V+L+        L +  E  +    +L D    +G L    A+ +  ++
Sbjct: 54  --LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQL 109

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           ++ + Y H   ++HRD+KP+NLL+  +G +KIADFG       +R   +P      +  T
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL------ARAFGIPV-----RKYT 158

Query: 225 F-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE------------ 270
             + T  Y  P+VL  S   +   D+W++GC   +M++GT  F   SE            
Sbjct: 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218

Query: 271 ------W----------LIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGP 312
                 W            F                 ++  DL+ ++L +DP+ R  A  
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG-LDESGIDLLSKMLKLDPNQRITA-- 275

Query: 313 GGYAVLKMHPFFKGID 328
                L+ H +FK  +
Sbjct: 276 --KQALE-HAYFKENN 288

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  123 bits (311), Expect = 6e-32
 Identities = 78/314 (24%), Positives = 128/314 (40%), Gaps = 69/314 (21%)

Query: 54  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK-I-MDKKFITKE--NKTAY--VKLER 106
           +Q +E L KI G G+Y  V +AK  +T  + ALK + +D      E    +A   + L  
Sbjct: 1   MQKYEKLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICL-- 54

Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 164
             L +L H  +VRL         L +  E C+    + FD     G L  +  + +  ++
Sbjct: 55  --LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQL 110

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           +  L + HS  ++HRD+KP+NLL+  +G +K+A+FG       +R   +P      +  +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL------ARAFGIPV-----RCYS 159

Query: 225 F-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSP-FKDTSE----WLIFQ-- 275
             V T  Y PP+VL  +   +   D+W+ GC   ++ +   P F           IF+  
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

Query: 276 ----------------------RIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAG 311
                                       +    P   +   RDL+  LL  +P  R  A 
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK-LNATGRDLLQNLLKCNPVQRISA- 277

Query: 312 PGGYAVLKMHPFFK 325
                 L+ HP+F 
Sbjct: 278 ---EEALQ-HPYFS 287

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  122 bits (309), Expect = 8e-32
 Identities = 56/273 (20%), Positives = 106/273 (38%), Gaps = 35/273 (12%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL----ERIVLD 110
            + E  K  G G +  V + + +   +V A+K +       E +          E  ++ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 111 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDAL 168
            L+HP +V+L+           M +E    G+L+ ++  K H +          ++   +
Sbjct: 79  NLNHPNIVKLYGLMHN---PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135

Query: 169 EYIHSMG--LIHRDIKPENLLLTADG-----HIKIADFGSVKPMQDSRITVLPNAASDDK 221
           EY+ +    ++HRD++  N+ L +         K+ADFG       S+        S   
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL------SQQ-------SVHS 182

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLI--FQRI 277
               +G   ++ PE + +   ++    D ++    LY +L+G  PF + S   I     I
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

Query: 278 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 308
               +R   P       R++I+     DP  RP
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  124 bits (313), Expect = 2e-31
 Identities = 84/335 (25%), Positives = 135/335 (40%), Gaps = 83/335 (24%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 114
           +   K+ G GS+  V +AK +++  V A+K  + DK+F  +E     +++    +  + H
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNRE-----LQI----MRIVKH 91

Query: 115 PGVVRLFFTF------QDTFSLYMALESCEGGELFDQ---------ITSKGHLSEDEARF 159
           P VV L   F      +D   L + LE         +            K  +     + 
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLE------YVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAAS 218
           Y  +++ +L YIHS+G+ HRDIKP+NLLL    G +K+ DFGS K +      V      
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV------ 199

Query: 219 DDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
                +++ +  Y  PE+   ++  T   D+W+ GC + +++ G   F   S       I
Sbjct: 200 -----SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254

Query: 278 I-----------------ARDIRFPNY------------FSDAARDLIDRLLDVDPSGRP 308
           I                   + +FP                  A DLI RLL+  PS R 
Sbjct: 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL 314

Query: 309 GAGPGGYAVLKMHPFFKGI---DWKNIRGQTPPKL 340
            A       L  HPFF  +   + +   G+  P L
Sbjct: 315 TA----IEALC-HPFFDELRTGEARMPNGRELPPL 344

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  121 bits (306), Expect = 4e-31
 Identities = 74/319 (23%), Positives = 124/319 (38%), Gaps = 69/319 (21%)

Query: 53  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAY--VKLERI 107
           S   F+ L K+ G G+Y+ V +     TG   ALK +  K  ++E    TA   + L   
Sbjct: 3   SSSQFKQLEKL-GNGTYATVYKGLNKTTGVYVALKEV--KLDSEEGTPSTAIREISL--- 56

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG-----ELFDQITSKGHLSEDEARFYTA 162
            + +L H  +VRL+        L +  E  +       +      +   L  +  +++  
Sbjct: 57  -MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +++  L + H   ++HRD+KP+NLL+   G +K+ DFG       +R   +P        
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL------ARAFGIPV-----NT 164

Query: 223 CTF-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE---------- 270
            +  V T  Y  P+VL  S   +   D+W+ GC L +M++G   F  T++          
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224

Query: 271 --------W----------LIFQRIIARDIR------FPNYFSDAARDLIDRLLDVDPSG 306
                   W             Q+   RD+R                D +  LL ++P  
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284

Query: 307 RPGAGPGGYAVLKMHPFFK 325
           R  A       L  HP+F 
Sbjct: 285 RLSA----KQALH-HPWFA 298

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  121 bits (305), Expect = 1e-30
 Identities = 73/328 (22%), Positives = 124/328 (37%), Gaps = 76/328 (23%)

Query: 52  FSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALK-------IMDKKFITKENKTAYVK 103
           ++I   F+L  + G G+Y  V  A    TG + A+K        +      +E     +K
Sbjct: 7   YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE-----IK 61

Query: 104 LERIVLDQLDHPGVVRL--------FFTFQDTFSLYMALESCEGGELFD----QITSKGH 151
           +    L    H  ++ +        F  F +   +Y+  E      L      ++ S   
Sbjct: 62  I----LKHFKHENIITIFNIQRPDSFENFNE---VYIIQE------LMQTDLHRVISTQM 108

Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT 211
           LS+D  +++  + + A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S   
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168

Query: 212 VLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
                        FV T  Y  PEV L S+  +   D+W+ GC L ++      F     
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

Query: 271 ----WLIFQ------------RIIARDIR-------------FPNYFSDA---ARDLIDR 298
                LIF              I +   R                 F        DL+ R
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288

Query: 299 LLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
           +L  DP+ R  A       L+ HP+ + 
Sbjct: 289 MLVFDPAKRITAK----EALE-HPYLQT 311

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  119 bits (301), Expect = 2e-30
 Identities = 60/296 (20%), Positives = 123/296 (41%), Gaps = 37/296 (12%)

Query: 36  TVQRSKSFAFRAPQEHFSIQDFE-------LGKIYGVGSYSKVVRAK-KIDTGTVYALKI 87
           ++  ++SF  +A Q    +Q+++       +G++ G G + +V   +     G V A+++
Sbjct: 7   SLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH---GEV-AIRL 62

Query: 88  MDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 147
           +D +   ++   A+ K E +   Q  H  VV           L +    C+G  L+  + 
Sbjct: 63  IDIERDNEDQLKAF-KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121

Query: 148 S-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 206
             K  L  ++ R    E+V  + Y+H+ G++H+D+K +N+    +G + I DFG      
Sbjct: 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL----- 175

Query: 207 DSRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPATFGN---------DLWALGCTLY 256
              I+ +  A   +       G   ++ PE++                  D++ALG   Y
Sbjct: 176 -FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234

Query: 257 QMLSGTSPFKD-TSEWLIFQRIIARDIRF---PNYFSDAARDLIDRLLDVDPSGRP 308
           ++ +   PFK   +E +I+Q  +   ++             D++      +   RP
Sbjct: 235 ELHAREWPFKTQPAEAIIWQ--MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERP 288

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  118 bits (297), Expect = 2e-30
 Identities = 59/269 (21%), Positives = 108/269 (40%), Gaps = 31/269 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDK-KFITKENKTAYVKLERIVLDQL 112
            +  L +I G+G + KV RA      G   A+K                V+ E  +   L
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP ++ L        +L + +E   GG L   ++ K  +  D    +  ++   + Y+H
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLH 122

Query: 173 SMG---LIHRDIKPENLLLTADGH--------IKIADFGSVKPMQDSRITVLPNAASDDK 221
                 +IHRD+K  N+L+             +KI DFG  +    +             
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM---------- 172

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
             +  G  A++ PEV+ +S  + G+D+W+ G  L+++L+G  PF+      +   +    
Sbjct: 173 --SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230

Query: 282 IR--FPNYFSDAARDLIDRLLDVDPSGRP 308
           +    P+   +    L++   + DP  RP
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRP 259

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  119 bits (301), Expect = 2e-30
 Identities = 76/356 (21%), Positives = 139/356 (39%), Gaps = 89/356 (25%)

Query: 33  NCPTVQRSKSFA---FRAPQEH---------FSIQD-FELGKIYGVGSYSKVVRAKKIDT 79
           + P   R++ +       P+E+         +  QD ++L +  G G YS+V  A  I  
Sbjct: 1   SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 60

Query: 80  GTVYALKIM---DKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD--TFSLYMA 133
                +KI+    KK I +E     +K+    L+ L   P ++ L    +D  + +  + 
Sbjct: 61  NEKVVVKILKPVKKKKIKRE-----IKI----LENLRGGPNIITLADIVKDPVSRTPALV 111

Query: 134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADG 192
            E     +      +   L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++     
Sbjct: 112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 168

Query: 193 HIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPPEVL-NSSPATFGNDLWA 250
            +++ D+G            L       +     V +  +  PE+L +     +  D+W+
Sbjct: 169 KLRLIDWG------------LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 216

Query: 251 LGCTLYQMLSGTSPF-------------------KDTSEWLIFQRI-IARD--------- 281
           LGC L  M+    PF                   +D  +++    I +            
Sbjct: 217 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 276

Query: 282 -IRFPNYF--------SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 328
             R+  +         S  A D +D+LL  D   R  A       ++ HP+F  + 
Sbjct: 277 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR----EAME-HPYFYTVV 327

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  120 bits (302), Expect = 4e-30
 Identities = 81/325 (24%), Positives = 128/325 (39%), Gaps = 85/325 (26%)

Query: 55  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAY--VKLE 105
             +E+ + Y      G G+Y  V  A    TG   A+K + + F +  + K  Y  ++L 
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL- 81

Query: 106 RIVLDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFD----QITSKGHL 152
              L  + H  V+ L            F D   +Y+         L       I     L
Sbjct: 82  ---LKHMKHENVIGLLDVFTPARSLEEFND---VYLVTH------LMGADLNNIVKCQKL 129

Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 212
           ++D  +F   +++  L+YIHS  +IHRD+KP NL +  D  +KI DFG            
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG------------ 177

Query: 213 LPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE- 270
           L    +D+    +V T  Y  PE+ LN        D+W++GC + ++L+G + F  T   
Sbjct: 178 LARHTADEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236

Query: 271 ---WLIFQ-----------RIIARDIR-------------FPNYFSDA---ARDLIDRLL 300
               LI +           +I +   R             F N F  A   A DL++++L
Sbjct: 237 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 296

Query: 301 DVDPSGRPGAGPGGYAVLKMHPFFK 325
            +D   R  A       L  H +F 
Sbjct: 297 VLDSDKRITAA----QALA-HAYFA 316

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  118 bits (298), Expect = 1e-29
 Identities = 81/326 (24%), Positives = 135/326 (41%), Gaps = 85/326 (26%)

Query: 55  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAY--VKLE 105
             +E+  +Y      G G+Y  V  A    TG   A+K + + F ++   K AY  ++L 
Sbjct: 19  TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL- 77

Query: 106 RIVLDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFD----QITSKGHL 152
              L  + H  V+ L            F D    Y+ +              ++     L
Sbjct: 78  ---LKHMRHENVIGLLDVFTPDETLDDFTD---FYLVMP------FMGTDLGKLMKHEKL 125

Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 212
            ED  +F   +++  L YIH+ G+IHRD+KP NL +  D  +KI DFG  +   DS +T 
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMT- 183

Query: 213 LPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE- 270
                       +V T  Y  PEV LN    T   D+W++GC + +M++G + FK +   
Sbjct: 184 -----------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232

Query: 271 ---WLIFQ-----------RIIARDIR-------------FPNYFSDA---ARDLIDRLL 300
                I +           R+ + + +             F +  ++A   A +L++++L
Sbjct: 233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 292

Query: 301 DVDPSGRPGAGPGGYAVLKMHPFFKG 326
            +D   R  AG      L  HP+F+ 
Sbjct: 293 VLDAEQRVTAG----EALA-HPYFES 313

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  116 bits (293), Expect = 2e-29
 Identities = 59/272 (21%), Positives = 109/272 (40%), Gaps = 17/272 (6%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           P   F   D   G++ G G + + ++    +TG V  +K + +    +E +  ++K E  
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLK-EVK 59

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 166
           V+  L+HP V++          L    E  +GG L   I +        +   +  ++  
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG----SVKPMQDSRITVLPNAASDDKA 222
            + Y+HSM +IHRD+   N L+  + ++ +ADFG     V                  K 
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179

Query: 223 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
            T VG   ++ PE++N        D+++ G  L +++   +   D   +L        ++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD---YLPRTMDFGLNV 236

Query: 283 R------FPNYFSDAARDLIDRLLDVDPSGRP 308
           R       P     +   +  R  D+DP  RP
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  115 bits (290), Expect = 2e-29
 Identities = 38/273 (13%), Positives = 93/273 (34%), Gaps = 33/273 (12%)

Query: 50  EHFSI--QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           +H  I  +              ++ + + +   G    +K++  +  +      + + E 
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNE-EC 58

Query: 107 IVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT--A 162
             L    HP V+ +             +       G L++ +    +   D+++      
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 163 EVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 220
           ++   + ++H++   +    +   ++++  D   +I+        Q              
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP------------ 166

Query: 221 KACTFVGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 277
                +   A+V PE L   P        D+W+    L+++++   PF D S   I  ++
Sbjct: 167 ---GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223

Query: 278 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 308
               +R   P   S     L+   ++ DP+ RP
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRP 256

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  115 bits (290), Expect = 4e-29
 Identities = 56/268 (20%), Positives = 114/268 (42%), Gaps = 33/268 (12%)

Query: 56  DFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
              +G+  G GS+  V + K     G V A+K+++    T +   A+   E  VL +  H
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWH---GDV-AVKMLNVTAPTPQQLQAFKN-EVGVLRKTRH 79

Query: 115 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 172
             ++    ++     ++    + CEG  L+  +  S+      +      +    ++Y+H
Sbjct: 80  VNILLFMGYSTAPQLAIVT--QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           +  +IHRD+K  N+ L  D  +KI DFG       +      + +   +  +  G+  ++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSRWSGSHQFEQLS--GSILWM 189

Query: 233 PPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---------R 280
            PEV+   +S+P +F +D++A G  LY++++G  P+ + +      +II           
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIEMVGRGSLSPD 246

Query: 281 DIRFPNYFSDAARDLIDRLLDVDPSGRP 308
             +  +      + L+   L      RP
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERP 274

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  116 bits (292), Expect = 6e-29
 Identities = 81/319 (25%), Positives = 134/319 (42%), Gaps = 72/319 (22%)

Query: 55  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAY--VKLE 105
             +EL K Y      G G+Y  V  A    +G   A+K + + F ++   K AY  + L 
Sbjct: 18  TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL- 76

Query: 106 RIVLDQLDHPGVVRLFFTFQ-----DTFS-LYMALESCEGGELFDQITSKGHLSEDEARF 159
              L  + H  V+ L   F        F   Y+ +   +  +L   +  K   SE++ ++
Sbjct: 77  ---LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQY 130

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
              +++  L+YIHS G++HRD+KP NL +  D  +KI DFG  +   D+ +T        
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMT-------- 181

Query: 220 DKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIF 274
                +V T  Y  PEV L+        D+W++GC + +ML+G + FK          I 
Sbjct: 182 ----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

Query: 275 Q-----------RIIARDIR-------------FPNYFSDA---ARDLIDRLLDVDPSGR 307
           +           ++  +  +             F   F  A   A DL++++L++D   R
Sbjct: 238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297

Query: 308 PGAGPGGYAVLKMHPFFKG 326
             A       L  HPFF+ 
Sbjct: 298 LTAA----QALT-HPFFEP 311

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  116 bits (292), Expect = 7e-29
 Identities = 78/345 (22%), Positives = 126/345 (36%), Gaps = 83/345 (24%)

Query: 38  QRSKSFAFRAPQEHFSI--QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALK--- 86
                 A  A      +  Q F++G  Y      G G+Y  V  A         A+K   
Sbjct: 2   HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61

Query: 87  ----IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DTFS-LYMALESC 137
                   +   +E     +K+    L +  H  ++ +    +    +    +Y+  +  
Sbjct: 62  PFEHQTYCQRTLRE-----IKI----LLRFRHENIIGINDIIRAPTIEQMKDVYIVQD-- 110

Query: 138 EGGELFD----QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 193
               L +    ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     
Sbjct: 111 ----LMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166

Query: 194 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALG 252
           +KI DFG       +R+   P+         +V T  Y  PE+ LNS   T   D+W++G
Sbjct: 167 LKICDFGL------ARVAD-PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219

Query: 253 CTLYQMLSGTSPFKDTSE----WLIF-----------QRIIARDIR-------------F 284
           C L +MLS    F           I              II    R             +
Sbjct: 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 279

Query: 285 PNYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
              F +A   A DL+D++L  +P  R          L  HP+ + 
Sbjct: 280 NRLFPNADSKALDLLDKMLTFNPHKRIEVE----QALA-HPYLEQ 319

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  118 bits (296), Expect = 7e-29
 Identities = 76/385 (19%), Positives = 137/385 (35%), Gaps = 111/385 (28%)

Query: 38  QRSKSFAFRAPQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
               + +   P   + I D +E+  + G GSY  V  A       V A+K + + F   E
Sbjct: 35  SSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---E 91

Query: 97  N----KTAY--VKLERIVLDQLDHPGVVRLF--------FTFQDTFSLYMALESCEGGEL 142
           +    K     + +    L++L+H  VV++           F +   LY+ LE  +  + 
Sbjct: 92  DLIDCKRILREIAI----LNRLNHDHVVKVLDIVIPKDVEKFDE---LYVVLEIADS-DF 143

Query: 143 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-- 200
                +  +L+E   +     ++  ++Y+HS G++HRD+KP N L+  D  +K+ DFG  
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

Query: 201 -SVKPMQDSRITVLPNAASDDKACTFVGTAA--------YV------PPEV-LNSSPATF 244
            +V   ++    +  +   DD                  +V       PE+ L     T 
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263

Query: 245 GNDLWALGCTLYQMLS-----------------GTSPFKDTSEW---------------- 271
             D+W++GC   ++L+                 G+S F  + +                 
Sbjct: 264 AIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ 323

Query: 272 --LIFQRI--------------IARD----------IRFPNYFSDA---ARDLIDRLLDV 302
             +IF  +               A+                 F  +   A  L+ R+L  
Sbjct: 324 LNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVF 383

Query: 303 DPSGRPGAGPGGYAVLKMHPFFKGI 327
           +P+ R          L  HPFFK +
Sbjct: 384 NPNKRITIN----ECLA-HPFFKEV 403

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  113 bits (286), Expect = 3e-28
 Identities = 77/335 (22%), Positives = 123/335 (36%), Gaps = 85/335 (25%)

Query: 52  FSIQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALK------IMDKKFITKENKT 99
            +I  F+LG  Y      G G    V  A   D     A+K          K   +E   
Sbjct: 2   MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE--- 58

Query: 100 AYVKLERIVLDQLDHPGVVRLF-------------FTFQDTFS-LYMALESCEGGELFD- 144
             +K+    + +LDH  +V++F                    + +Y+  E  E     D 
Sbjct: 59  --IKI----IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DL 108

Query: 145 -QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSV 202
             +  +G L E+ AR +  +++  L+YIHS  ++HRD+KP NL +   D  +KI DFG  
Sbjct: 109 ANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL- 167

Query: 203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSG 261
                +R  + P+ +        + T  Y  P + L+ +  T   D+WA GC   +ML+G
Sbjct: 168 -----AR-IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

Query: 262 TSPFKDTSE----WLIFQRI----------IARDIR-------------FPNYFSDA--- 291
            + F    E     LI + I          +   I                         
Sbjct: 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE 281

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
           A D ++++L   P  R  A       L  HP+   
Sbjct: 282 AVDFLEQILTFSPMDRLTAE----EALS-HPYMSI 311

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  114 bits (287), Expect = 4e-28
 Identities = 63/338 (18%), Positives = 114/338 (33%), Gaps = 68/338 (20%)

Query: 38  QRSKSFAFRAPQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
            + ++       E  ++Q  + + +    GSY  V      +   V A+K +        
Sbjct: 4   AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGR 62

Query: 97  NKTAYVKL--------ERIVLDQLDHPGVVRLFFTF----QDTFS-LYMALESCEGGELF 143
                           E  +L+   HP ++ L   F    +     LY+  E     +L 
Sbjct: 63  TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA 121

Query: 144 DQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 202
             I   +  +S    +++   ++  L  +H  G++HRD+ P N+LL  +  I I DF   
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN-- 179

Query: 203 KPMQDSRITVLPNAASDDKACT-FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLS 260
                     L    + D   T +V    Y  PE+ +     T   D+W+ GC + +M +
Sbjct: 180 ----------LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

Query: 261 GTSPF--KDTSE--WLIFQ-----------RIIARDIR--------------FPNYFSDA 291
             + F           I +              +   R              +      A
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA 289

Query: 292 ---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
              A DLI ++L+ +P  R          L+ HP+F+ 
Sbjct: 290 DPVALDLIAKMLEFNPQRRISTE----QALR-HPYFES 322

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  113 bits (284), Expect = 1e-27
 Identities = 76/342 (22%), Positives = 125/342 (36%), Gaps = 99/342 (28%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 114
           + LGK  G GS+  V     I++G  +ALK  + D ++  +E           ++  LDH
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD---------IMKVLDH 59

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGG--------------------------------EL 142
             +++L   F  T                                             E 
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 143 FDQ---------ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DG 192
                       I S   +  +    Y  ++  A+ +IHS+G+ HRDIKP+NLL+ + D 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWAL 251
            +K+ DFGS K +  S  +V            ++ +  Y  PE+ L ++  T   DLW++
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV-----------AYICSRFYRAPELMLGATEYTPSIDLWSI 228

Query: 252 GCTLYQMLSGTSPFKDTSE----WLI-----------------------FQRIIARDIR- 283
           GC   +++ G   F   +       I                       F  + A+D R 
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288

Query: 284 -FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 324
             P      A DL++++L  +P  R       Y  +  HPFF
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINP----YEAMA-HPFF 325

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  114 bits (286), Expect = 1e-27
 Identities = 66/323 (20%), Positives = 117/323 (36%), Gaps = 55/323 (17%)

Query: 54  IQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY-- 101
           I++  +   Y      G GSY  V  A   +T    A+K +++ F   E+          
Sbjct: 19  IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILRE 75

Query: 102 VKLERIVLDQLDHPGVVRL--------FFTFQDTFSLYMALESCEGGELFDQITSKGHLS 153
           + +    L++L    ++RL           F +   LY+ LE  +  +L     +   L+
Sbjct: 76  ITI----LNRLKSDYIIRLYDLIIPDDLLKFDE---LYIVLEIADS-DLKKLFKTPIFLT 127

Query: 154 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRI 210
           E+  +     ++    +IH  G+IHRD+KP N LL  D  +K+ DFG   ++   +D+ I
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 211 TVLPNAASDDKACTFVGTAA---YV------PPEV-LNSSPATFGNDLWALGCTLYQMLS 260
                   +              +V       PE+ L     T   D+W+ GC   ++L+
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 261 GTSPFKDTSEWL--IFQ-RIIARDIRFPNYFSDAARDLIDRL-LDVDPSGRPGA------ 310
                 +       +F            N      +   D+L +  +  G P        
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307

Query: 311 -GPGGYAVLKMHPFFKGIDWKNI 332
             P     +K+ P  K I+ K  
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQK 330

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  112 bits (283), Expect = 1e-27
 Identities = 72/330 (21%), Positives = 125/330 (37%), Gaps = 88/330 (26%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY--VKLERIV 108
           + ++  K  G G+   V  A         A+K + + F   +N+T    AY  + L    
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVL---- 77

Query: 109 LDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF 159
           +  ++H  ++ L            FQD   +Y+ +E  +   L   I  +  L  +   +
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQD---VYIVMELMDA-NLCQVI--QMELDHERMSY 131

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
              +++  ++++HS G+IHRD+KP N+++ +D  +KI DFG            L   A  
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------LARTAGT 179

Query: 220 DKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 278
               T +V T  Y  PEV+         D+W++GC + +M+ G   F  T     + ++I
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239

Query: 279 -----------------ARD----------IRFPNYFSDA---------------ARDLI 296
                             R             F   F D                ARDL+
Sbjct: 240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299

Query: 297 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
            ++L +D S R          L+ HP+   
Sbjct: 300 SKMLVIDASKRISVD----EALQ-HPYINV 324

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  111 bits (281), Expect = 2e-27
 Identities = 69/344 (20%), Positives = 128/344 (37%), Gaps = 81/344 (23%)

Query: 37  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 96
           +  + + A          + F++ ++ G G++  V   K+  TG   A+K   K      
Sbjct: 6   MSLNAAAAADERSRKEMDR-FQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQDPR 61

Query: 97  NKTAYVKLERIVLDQLDHPGVVRL---FFT-----FQDTFSLYMALESCEGGELFDQ--- 145
            +   +++ +  L  L HP +V+L   F+T      +D + L + +E             
Sbjct: 62  FRNRELQIMQD-LAVLHHPNIVQLQSYFYTLGERDRRDIY-LNVVME------YVPDTLH 113

Query: 146 ------ITSKGHLSEDEARFYTAEVVDALEYIH--SMGLIHRDIKPENLLL-TADGHIKI 196
                    +        + +  +++ ++  +H  S+ + HRDIKP N+L+  ADG +K+
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173

Query: 197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTL 255
            DFGS K +  S   V            ++ +  Y  PE+   +   T   D+W++GC  
Sbjct: 174 CDFGSAKKLSPSEPNV-----------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222

Query: 256 YQMLSGTSPFKDTSEWLIFQRII-------ARDIR----------------------FPN 286
            +M+ G   F+  +       I+          +R                      F +
Sbjct: 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282

Query: 287 YFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 327
           +       A DL+  LL   P  R       Y  L  HP+F  +
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERMKP----YEALC-HPYFDEL 321

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  111 bits (279), Expect = 1e-26
 Identities = 81/417 (19%), Positives = 148/417 (35%), Gaps = 109/417 (26%)

Query: 55  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY--V 102
             F + K Y      G G+   V  A         A+K + + F   +N+T    AY  +
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYREL 112

Query: 103 KLERIVLDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFDQITSKGHLS 153
            L    +  ++H  ++ L            FQD   +Y+ +E  +   L   I  +  L 
Sbjct: 113 VL----MKCVNHKNIISLLNVFTPQKTLEEFQD---VYLVMELMDA-NLCQVIQME--LD 162

Query: 154 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 213
            +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI DFG            L
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------L 210

Query: 214 PNAASDDKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 272
              A      T +V T  Y  PEV+         D+W++GC + +M+     F       
Sbjct: 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270

Query: 273 IFQRII-----------------ARD----------IRFPNYFSDA-------------- 291
            + ++I                  R+          + FP  F D+              
Sbjct: 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 330

Query: 292 -ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGE 350
            ARDL+ ++L +DP+ R          L+ HP+     W +           +   +  +
Sbjct: 331 QARDLLSKMLVIDPAKRISVD----DALQ-HPYINV--WYDP--AEVEAPPPQIYDKQLD 381

Query: 351 GDDVHDSSW-----------NPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDS 396
             +     W                  +       +G A +S  S+   +S++   S
Sbjct: 382 EREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSSSVNDISS 438

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  109 bits (274), Expect = 3e-26
 Identities = 77/349 (22%), Positives = 128/349 (36%), Gaps = 96/349 (27%)

Query: 56  DFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY--VK 103
           D  + + Y      G G+Y  V ++    TG V A+K +   F   +N T     +  + 
Sbjct: 4   DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIM 60

Query: 104 LERIVLDQL-DHPGVVRLFFTFQ-DTFS-LYMALESCEGGELFD----QITSKGHLSEDE 156
           +    L +L  H  +V L    + D    +Y+  +        +     +     L    
Sbjct: 61  I----LTELSGHENIVNLLNVLRADNDRDVYLVFD------YMETDLHAVIRANILEPVH 110

Query: 157 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVL 213
            ++   +++  ++Y+HS GL+HRD+KP N+LL A+ H+K+ADFG   S   ++     + 
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 214 PNAASDDKACT--------FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSP 264
            +   + +           +V T  Y  PE+ L S+  T G D+W+LGC L ++L G   
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230

Query: 265 F--KDT----------------------------------------SEWLIFQRIIARDI 282
           F    T                                         +            
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290

Query: 283 RFPNYFSDA-----ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
                   A     A DL+D+LL  +P+ R  A       LK HPF   
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISAN----DALK-HPFVSI 334

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  106 bits (266), Expect = 3e-25
 Identities = 68/347 (19%), Positives = 117/347 (33%), Gaps = 102/347 (29%)

Query: 53  SIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
            + ++E  K+ G G+Y  V +A  K       YALK      I     +     E  +L 
Sbjct: 20  DLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQ-----IEGTGISMSACREIALLR 73

Query: 111 QLDHPGVVRLF--FTFQDTFSLYMALESCE--------GGELFDQITSKGHLSEDEARFY 160
           +L HP V+ L   F       +++  +  E                     L     +  
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFG-------SVKPMQDSR 209
             +++D + Y+H+  ++HRD+KP N+L+  +    G +KIAD G        +KP+ D  
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 210 ITVLPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPF 265
             V+              T  Y  PE+L    + + A    D+WA+GC   ++L+    F
Sbjct: 194 PVVV--------------TFWYRAPELLLGARHYTKAI---DIWAIGCIFAELLTSEPIF 236

Query: 266 KDTSEWLIFQRIIARD--------------------IRFPNY------------------ 287
               E +        D                     + P +                  
Sbjct: 237 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLI 296

Query: 288 ---------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
                        A  L+ +LL +DP  R  +       ++  P+F 
Sbjct: 297 KYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS----EQAMQ-DPYFL 338

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  103 bits (260), Expect = 5e-25
 Identities = 62/315 (19%), Positives = 109/315 (34%), Gaps = 65/315 (20%)

Query: 36  TVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK 95
           ++QR+ +            +D  L +  G G Y +V R      G   A+KI    F ++
Sbjct: 1   SMQRTVA------------RDITLLECVGKGRYGEVWRGSW--QGENVAVKI----FSSR 42

Query: 96  ENKTAYVKLERIVLDQLDHPGVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGH 151
           + K+ + + E      L H  ++        +   +  L++     E G L+D +     
Sbjct: 43  DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-T 101

Query: 152 LSEDEARFYTAEVVDALEYIHS--------MGLIHRDIKPENLLLTADGHIKIADFGSVK 203
           L           +   L ++H           + HRD+K +N+L+  +G   IAD G   
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL-- 159

Query: 204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN------DLWALGCTLYQ 257
               + +        D      VGT  Y+ PEVL+ +            D+WA G  L++
Sbjct: 160 ----AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215

Query: 258 MLSGTSPFKDTSEWLI-FQRIIARDIRF-----------------PNYFSDAA----RDL 295
           +           ++   F  ++  D  F                   +FSD        L
Sbjct: 216 VARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKL 275

Query: 296 IDRLLDVDPSGRPGA 310
           +      +PS R  A
Sbjct: 276 MKECWYQNPSARLTA 290

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  104 bits (262), Expect = 8e-25
 Identities = 77/379 (20%), Positives = 131/379 (34%), Gaps = 110/379 (29%)

Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LER 106
           E +    + L +  G G +S V  AK +   T  A+KI+            Y +    E 
Sbjct: 14  EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-------RGDKVYTEAAEDEI 66

Query: 107 IVLDQL--------DHPG---VVRLF--FTFQDTFSLYMALESCE--GGELFDQITSKGH 151
            +L ++        D  G   +++L   F  +    +++ +   E  G  L   I    H
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM-VFEVLGENLLALIKKYEH 125

Query: 152 --LSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLL------TADGHIKIADFGSV 202
             +     +  + +++  L+Y+H   G+IH DIKPEN+L+           IKIAD G+ 
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN- 184

Query: 203 KPMQDSRITVLPNAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 260
                         A   D+     + T  Y  PEVL  +P   G D+W+  C ++++++
Sbjct: 185 --------------ACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

Query: 261 GTSPF--KDTSEWLIFQRIIARDIR----FPNYFSDAAR--------------------- 293
           G   F   +   +      IA+ I      P+Y     +                     
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290

Query: 294 ---------------------DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 332
                                D +  +L +DP  R  AG      L  HP+ K       
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG-----LVNHPWLKD-----T 340

Query: 333 RGQTPPKLASEPMVQSGEG 351
            G    ++    +  SG  
Sbjct: 341 LGMEEIRVPDRELYGSGSD 359

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 98.3 bits (245), Expect = 9e-23
 Identities = 62/297 (20%), Positives = 107/297 (36%), Gaps = 55/297 (18%)

Query: 55  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ++ K  G G Y +V   K +   G   A+K+    F T E  + + + E      + 
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKV----FFTTEEASWFRETEIYQTVLMR 89

Query: 114 HPGVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
           H  ++               LY+  +  E G L+D + S   L            V  L 
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLC 148

Query: 170 YIHS--------MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
           ++H+          + HRD+K +N+L+  +G   IAD G       +   +      D  
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL------AVKFISDTNEVDIP 202

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTSPFKDTSEWLI-- 273
             T VGT  Y+PPEVL+ S            D+++ G  L+++           E+ +  
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

Query: 274 ------------FQRIIARD-IR--FPNYFSDAA-----RDLIDRLLDVDPSGRPGA 310
                        + I+    +R  FPN +S          L+      +P+ R  A
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 56/296 (18%), Positives = 104/296 (35%), Gaps = 53/296 (17%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +   L +  G G + +V R K    G   A+KI    F ++E ++ + + E      L H
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKI----FSSREERSWFREAEIYQTVMLRH 95

Query: 115 PGVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
             ++               L++  +  E G LFD +     ++ +            L +
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAH 154

Query: 171 IHS--------MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +H           + HRD+K +N+L+  +G   IAD G       +          D   
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL------AVRHDSATDTIDIAP 208

Query: 223 CTFVGTAAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTS----------PFK 266
              VGT  Y+ PEVL+ S            D++A+G   +++    S          P+ 
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 267 -----DTSEWLIFQRIIARDIR--FPNYFSD-----AARDLIDRLLDVDPSGRPGA 310
                D S   + + +  + +R   PN +           ++      + + R  A
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 40/254 (15%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LERIVLDQL- 112
           +E+  + G GS+ +VV+A         A+KI+       +NK A++    +E  +L+ + 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108

Query: 113 -----DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVV 165
                    +V L   F     L +  E      L+D + +     +S +  R +  ++ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 166 DALEYIHS--MGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAAS--D 219
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS               +    
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS---------------SCQLG 212

Query: 220 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 279
            +   ++ +  Y  PEVL   P     D+W+LGC L +M +G   F   +E     +I+ 
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

Query: 280 RDIRFPNYFSDAAR 293
                P +  D A 
Sbjct: 273 VLGIPPAHILDQAP 286

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 63/261 (24%), Positives = 108/261 (41%), Gaps = 56/261 (21%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LERIVLDQL- 112
           +E+ K+ G GS+ +VV+A         ALK++        N+  + +    E  +L+ L 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-------RNEKRFHRQAAEEIRILEHLR 151

Query: 113 -----DHPGVVRL--FFTFQD----TF-----SLYMALESCEGGELFDQITSKGHLSEDE 156
                +   V+ +   FTF++    TF     +LY         EL  +   +G  S   
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLY---------ELIKKNKFQG-FSLPL 201

Query: 157 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLP 214
            R +   ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS------------- 248

Query: 215 NAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 272
             +     +  T++ +  Y  PEV+  +      D+W+LGC L ++L+G        E  
Sbjct: 249 --SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306

Query: 273 IFQRIIARDIRFPNYFSDAAR 293
               +I           DA++
Sbjct: 307 QLACMIELLGMPSQKLLDASK 327

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 46/233 (19%), Positives = 87/233 (37%), Gaps = 34/233 (14%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLD 113
           + +L ++ G G Y  V +          A+K+         N+  ++  E+ +  +  ++
Sbjct: 14  NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSF-----ANRQNFIN-EKNIYRVPLME 65

Query: 114 HPGVVRLF-----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
           H  + R        T        + +E    G L   ++         +      V   L
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGL 124

Query: 169 EYIHSM---------GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
            Y+H+           + HRD+   N+L+  DG   I+DFG    +  +R+        D
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV--RPGEED 182

Query: 220 DKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLSGTSPF 265
           + A + VGT  Y+ PEVL  +        A    D++ALG   +++    +  
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 63/343 (18%), Positives = 113/343 (32%), Gaps = 93/343 (27%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK--------LERIV 108
           F + +  G G++ +V+  + ID    YA+K++        N   Y +        L++I 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-------RNIKKYTRSAKIEADILKKIQ 89

Query: 109 LDQLDHPGVVRLF--FTFQD----TFSLYMALESCEGGELFDQITSKGH--LSEDEARFY 160
            D +++  +V+    F + D     F          G  L++ IT   +     ++ + Y
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFEPL-------GPSLYEIITRNNYNGFHIEDIKLY 142

Query: 161 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS-- 218
             E++ AL Y+  M L H D+KPEN+LL      K                    +    
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 219 ----------DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT 268
                      D   + + T  Y  PEV+ +      +D+W+ GC L ++ +G+  F+  
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 269 SEWLIFQRIIARDIRFPNYFSDAAR----------------------------------- 293
                   + +     P      A                                    
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 294 -----------DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
                      D +  +L +DP+ RP       A L  H F +
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSP-----AELLKHKFLE 360

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 46/234 (19%), Positives = 87/234 (37%), Gaps = 34/234 (14%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
             +L ++   G +  V +A+        A+KI       ++ ++   + E   L  + H 
Sbjct: 25  PLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP----IQDKQSWQNEYEVYSLPGMKHE 78

Query: 116 GVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
            +++              L++     E G L D + +   +S +E       +   L Y+
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYL 137

Query: 172 HSMGL----------IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
           H               HRDIK +N+LL  +    IADFG     +  +     +      
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ---- 193

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 270
               VGT  Y+ PEVL  +     +     D++A+G  L+++ S  +      +
Sbjct: 194 ----VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 72/354 (20%), Positives = 111/354 (31%), Gaps = 117/354 (33%)

Query: 57  FELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYV---KLERIVLDQL 112
           +E+    G G++ KVV         +  ALKI+        N   Y    +LE  VL ++
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKI 73

Query: 113 ------DHPGVVRLF--FTFQD----TFSLYMALESCEGGELFDQITSKGH--LSEDEAR 158
                 +    V +   F F       F L        G   F+ +             R
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGHMCIAFELL-------GKNTFEFLKENNFQPYPLPHVR 126

Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-------------------IKIADF 199
               ++  AL ++H   L H D+KPEN+L                         I++ADF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 200 GSVKPMQDSRITVLPNAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 257
           GS               A+   +   T V T  Y PPEV+         D+W++GC L++
Sbjct: 187 GS---------------ATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231

Query: 258 MLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR------------------------ 293
              G + F+          +       P++     R                        
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291

Query: 294 --------------------DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 327
                               DL+ R+L+ DP+ R          L  HPFF G+
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL----AEALL-HPFFAGL 340

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 25/262 (9%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           D  LG+  G G++ +V   +     T+ A+K   ++ +  + K  +++ E  +L Q  HP
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQ-EARILKQYSHP 172

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSM 174
            +VRL         +Y+ +E  +GG+    + ++G  L          +    +EY+ S 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP- 233
             IHRD+   N L+T    +KI+DFG  +   D                   G    VP 
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-------------SGGLRQVPV 279

Query: 234 ----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR--FPN 286
               PE LN    +  +D+W+ G  L++  S G SP+ + S     + +  +  R   P 
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPE 338

Query: 287 YFSDAARDLIDRLLDVDPSGRP 308
              DA   L+++    +P  RP
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRP 360

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 20/216 (9%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQL 112
            D  +    G G Y +V            A+K +      KE+     +   E  V+ ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEI 273

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEY 170
            HP +V+L          Y+  E    G L D +       +S     +   ++  A+EY
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +     IHR++   N L+  +  +K+ADFG  + M     T     A          TA 
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-----AHAGAKFPIKWTA- 387

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
              PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 388 ---PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 73/348 (20%), Positives = 116/348 (33%), Gaps = 105/348 (30%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYV---KLERIVLDQL 112
           +E+    G G++ KVV       G  + A+KI+       +N   Y    + E  VL+ L
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68

Query: 113 ------DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEV 164
                      V++   F+    + +  E   G   +D I   G      D  R    ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGH-------------------IKIADFGSVKPM 205
             ++ ++HS  L H D+KPEN+L     +                   IK+ DFGS    
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS---- 183

Query: 206 QDSRITVLPNAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS 263
                      A+  D+   T V T  Y  PEV+ +   +   D+W++GC L +   G +
Sbjct: 184 -----------ATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232

Query: 264 PFKDTSEWLIFQRIIA----------RDIRFPNYFSD----------------------- 290
            F           +            +  R   YF                         
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292

Query: 291 -----------AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 327
                         DLI ++L+ DP+ R          LK HPFF  +
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITL----REALK-HPFFDLL 335

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 28/244 (11%)

Query: 29  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYA 84
            +           +F  R P + F  +  +  +  G G++  V   +    + +TG V A
Sbjct: 16  TTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA 74

Query: 85  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGEL 142
           +K +  +  T+E+   + + E  +L  L H  +V+           +L + +E    G L
Sbjct: 75  VKKL--QHSTEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131

Query: 143 FDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 201
            D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG 
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG- 190

Query: 202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLY 256
                      L      DK    V      P     PE L  S  +  +D+W+ G  LY
Sbjct: 191 -----------LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239

Query: 257 QMLS 260
           ++ +
Sbjct: 240 ELFT 243

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 46/234 (19%), Positives = 96/234 (41%), Gaps = 29/234 (12%)

Query: 56  DFELGKIYGVGSYSKVVRAK-KIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLDQ 111
           +F+  K+ G G++  V +     +   V    A+K + ++  + +     +  E  V+  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILD-EAYVMAS 73

Query: 112 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 169
           +D+P V RL       T  + +  +    G L D +   K ++       +  ++   + 
Sbjct: 74  VDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+    L+HRD+   N+L+    H+KI DFG  K +             ++K   +    
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----------EEK--EYHAEG 178

Query: 230 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 277
             VP      E +     T  +D+W+ G T++++++ G+ P+       I   +
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 52/250 (20%), Positives = 100/250 (40%), Gaps = 35/250 (14%)

Query: 39  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFIT 94
            ++ +A + P   F  +  +     G G++  V   +      +TG + A+K +      
Sbjct: 8   HAQLYACQDPTI-FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL------ 60

Query: 95  KENKTAYVK---LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TS 148
           + +     +    E  +L  L    +V+           SL + +E    G L D +   
Sbjct: 61  QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120

Query: 149 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS 208
           +  L       Y++++   +EY+ S   +HRD+   N+L+ ++ H+KIADFG        
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG-------- 172

Query: 209 RITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GT 262
               L      DK    V      P     PE L+ +  +  +D+W+ G  LY++ +   
Sbjct: 173 ----LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228

Query: 263 SPFKDTSEWL 272
                ++E+L
Sbjct: 229 KSCSPSAEFL 238

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 27/222 (12%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
            F  +  +  +  G G++  V   +    + +TG V A+K +  +  T+E+   + + E 
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER-EI 62

Query: 107 IVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 163
            +L  L H  +V+           +L + +E    G L D +   K  +   +   YT++
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +   +EY+ +   IHRD+   N+L+  +  +KI DFG            L      DK  
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG------------LTKVLPQDKEF 170

Query: 224 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS 260
             V      P     PE L  S  +  +D+W+ G  LY++ +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 27/238 (11%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
           F  +  +  +  G G + KV           TG + A+K + K     ++++ + + E  
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQ-EID 85

Query: 108 VLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
           +L  L H  +++           SL + +E    G L D +  +  +   +   +  ++ 
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQIC 144

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           + + Y+H+   IHRD+   N+LL  D  +KI DFG            L  A  +      
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG------------LAKAVPEGHEYYR 192

Query: 226 VGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 277
           V      P     PE L      + +D+W+ G TLY++L+   S     +++L    I
Sbjct: 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 22/215 (10%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
              L    G G + +V       T  V A+K +      K    +      E  V+ +L 
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLR 237

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYI 171
           H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A++   + Y+
Sbjct: 238 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
             M  +HRD++  N+L+  +   K+ADFG  + ++D+  T     A          TA  
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-----ARQGAKFPIKWTA-- 349

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 350 --PEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 26/222 (11%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           HF  +  +  +  G G + KV   +      +TG   A+K + K      +     K E 
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKK-EI 74

Query: 107 IVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 163
            +L  L H  +V+     T      + + +E    G L + +  +K  ++  +   Y  +
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +   ++Y+ S   +HRD+   N+L+ ++  +KI DFG            L  A   DK  
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG------------LTKAIETDKEY 182

Query: 224 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS 260
             V      P     PE L  S     +D+W+ G TL+++L+
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 31/235 (13%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKLERIVLD 110
           +F+  K+ G G++  V +   I  G      V A+K + ++  + +     +  E  V+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKEL-REATSPKANKEILD-EAYVMA 72

Query: 111 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDAL 168
            +D+P V RL       T  + +  +    G L D +   K ++       +  ++   +
Sbjct: 73  SVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y+    L+HRD+   N+L+    H+KI DFG  K +             ++K   +   
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----------EEK--EYHAE 177

Query: 229 AAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 277
              VP      E +     T  +D+W+ G T++++++ G+ P+       I   +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 22/215 (10%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
              L    G G + +V       T  V A+K +      K    +      E  V+ +L 
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLR 320

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYI 171
           H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A++   + Y+
Sbjct: 321 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
             M  +HRD++  N+L+  +   K+ADFG  + ++D+  T     A          TA  
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-----ARQGAKFPIKWTA-- 432

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 433 --PEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 27/224 (12%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLDQL 112
             ELG+  G G +  V +   +         A+K   K   +   +  +++ E + + Q 
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQ-EALTMRQF 448

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 171
           DHP +V+L     +   +++ +E C  GEL   +   K  L       Y  ++  AL Y+
Sbjct: 449 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
            S   +HRDI   N+L++++  +K+ DFG  + M+DS                +  +   
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------------TYYKASKGK 553

Query: 232 VP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           +P     PE +N    T  +D+W  G  ++++L  G  PF+   
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 28/231 (12%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAK-KIDTGTVY-ALKIMDKKFITKENKTAYVKLE 105
            +++  I D ELG     G++  V +   ++    +  A+K++ K+   K +    ++ E
Sbjct: 7   KRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMR-E 60

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEV 164
             ++ QLD+P +VRL    Q   +L + +E   GG L   +   +  +          +V
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG            L  A   D +  
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG------------LSKALGADDSYY 167

Query: 225 FVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
              +A   P     PE +N    +  +D+W+ G T+++ LS G  P+K   
Sbjct: 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 71/365 (19%), Positives = 111/365 (30%), Gaps = 117/365 (32%)

Query: 64  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-----DHPG-- 116
           G G +S V  +  I      A+K++  K      +TA    E  +L  +     + P   
Sbjct: 46  GWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETA--LDEIRLLKSVRNSDPNDPNRE 101

Query: 117 -VVRLFFTFQDTFSLY--------MALESCEGGELFDQITSKGH--LSEDEARFYTAEVV 165
            VV+L     D F +         M  E   G  L   I    +  L     +    +V+
Sbjct: 102 MVVQLL----DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 166 DALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---------------- 208
             L+Y+H+   +IH DIKPEN+LL+ +              Q S                
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 209 -------------------RITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPATFGNDL 248
                              +I  L NA    K  T  + T  Y   EVL  S      D+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276

Query: 249 WALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIR----FP-----------NYFSD- 290
           W+  C  +++ +G   F      E+   +  IA  I      P            +F+  
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336

Query: 291 ------------------------------AARDLIDRLLDVDPSGRPGAGPGGYAVLKM 320
                                            D +  +L++ P  R  A       L+ 
Sbjct: 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA----ECLR- 391

Query: 321 HPFFK 325
           HP+  
Sbjct: 392 HPWLN 396

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 24/224 (10%)

Query: 56  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 112
              + KI G G   +V     +      V  A+K + K   T+  +  ++  E  ++ Q 
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLS-EASIMGQF 107

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 171
           DHP ++RL           +  E  E G L   + T  G  +  +       V   + Y+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
             +G +HRD+   N+L+ ++   K++DFG    +  SR+        DD    +  T   
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFG----L--SRVL------EDDPDAAYTTTGGK 215

Query: 232 VP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           +P     PE +     +  +D+W+ G  ++++L+ G  P+ + +
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 31/226 (13%)

Query: 56  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 112
             ELG+  G G +  V +      +   +  A+K   K   +   +  +++ E + + Q 
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQ-EALTMRQF 73

Query: 113 DHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 169
           DHP +V+L    T      +++ +E C  GEL   +   K  L       Y  ++  AL 
Sbjct: 74  DHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+ S   +HRDI   N+L++++  +K+ DFG  + M+DS                +  + 
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------------TYYKASK 176

Query: 230 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +P     PE +N    T  +D+W  G  ++++L  G  PF+   
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 28/232 (12%)

Query: 45  FRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-KIDTGTVY-ALKIMDKKFITKENKTAYV 102
               +++  I D ELG     G++  V +   ++    +  A+K++ K+   K +    +
Sbjct: 330 LFLKRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM 384

Query: 103 KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYT 161
           + E  ++ QLD+P +VRL    Q   +L + +E   GG L   +   +  +         
Sbjct: 385 R-EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442

Query: 162 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 221
            +V   ++Y+     +HR++   N+LL    + KI+DFG            L  A   D 
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG------------LSKALGADD 490

Query: 222 ACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 267
           +     +A   P     PE +N    +  +D+W+ G T+++ LS G  P+K 
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 47/225 (20%), Positives = 98/225 (43%), Gaps = 25/225 (11%)

Query: 56  DFELGKIYGVGSYSKVVRAK-KIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLDQ 111
                K+ G G + +V +   K  +G      A+K + K   T++ +  ++  E  ++ Q
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLG-EAGIMGQ 102

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEY 170
             H  ++RL         + +  E  E G L   +    G  S  +       +   ++Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           + +M  +HRD+   N+L+ ++   K++DFG    +  SR+        DD   T+  +  
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFG----L--SRVL------EDDPEATYTTSGG 210

Query: 231 YVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
            +P     PE ++    T  +D+W+ G  ++++++ G  P+ + S
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 31/229 (13%)

Query: 55  QDFELGKIYGVGSYSKVVRAK-KIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQ 111
           +D  L +  G GS+  V R +    +G     A+K +    +++         E   +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 112 LDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDAL 168
           LDH  ++RL+          + M  E    G L D++   +GH        Y  +V + +
Sbjct: 78  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG- 227
            Y+ S   IHRD+   NLLL     +KI DFG ++ +            +DD        
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----------NDDHYVMQEHR 184

Query: 228 ------TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
                  A    PE L +   +  +D W  G TL++M + G  P+   +
Sbjct: 185 KVPFAWCA----PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 44/234 (18%), Positives = 93/234 (39%), Gaps = 29/234 (12%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVY----ALKIMDKKFITKENKTAYVKLERIVLDQ 111
           +    K+ G G +  V +   I  G        +K++ +    +++  A      + +  
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTD-HMLAIGS 71

Query: 112 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 169
           LDH  +VRL       +  L +  +    G L D +   +G L       +  ++   + 
Sbjct: 72  LDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+   G++HR++   N+LL +   +++ADFG    +             DDK      + 
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP-----------DDKQLL--YSE 176

Query: 230 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 277
           A  P      E ++    T  +D+W+ G T++++++ G  P+       +   +
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 30/221 (13%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQL 112
            D  +    G G Y +V            A+K +      KE+     +   E  V+ ++
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEI 66

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEY 170
            HP +V+L          Y+  E    G L D  +  ++  +S     +   ++  A+EY
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           +     IHRD+   N L+  +  +K+ADFG  + M     T                  A
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--------------AHAGA 172

Query: 231 YVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
             P     PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQL 112
            +    +  G G +  V     ++   V A+K +      +E   +      E  V+ +L
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI------REGAMSEEDFIEEAEVMMKL 60

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 171
            HP +V+L+    +   + +  E  E G L D + T +G  + +       +V + + Y+
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
               +IHRD+   N L+  +  IK++DFG       +R         DD+  +  GT   
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGM------TRFV------LDDQYTSSTGTKFP 168

Query: 232 V---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
           V    PEV + S  +  +D+W+ G  ++++ S G  P+
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 47/224 (20%), Positives = 96/224 (42%), Gaps = 24/224 (10%)

Query: 56  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 112
           +  + K+ G G + +V     K      +  A+K + K   T++ +  ++  E  ++ Q 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLG-EASIMGQF 103

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 171
           DHP ++RL      +  + +  E  E G L   +       +  +       +   ++Y+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
             MG +HRD+   N+L+ ++   K++DFG    +   R+        DD    +      
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFG----L--GRVL------EDDPEAAYTTRGGK 211

Query: 232 VP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
           +P     PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 31/226 (13%)

Query: 56  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 112
           D  L +I G G + +V            +  A+K   KK  T +NK  ++  E +++  L
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMS-EAVIMKNL 70

Query: 113 DHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 169
           DHP +V+L      +     ++ +E    GEL   +  +K  L       Y+ ++  A+ 
Sbjct: 71  DHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D                 +  + 
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------------DYYKASV 173

Query: 230 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
             +P     PE +N    T  +D+W     ++++LS G  PF    
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 26/228 (11%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAK-KIDTGTVY-ALKIMDKKFITKENKTAYVKLE 105
            ++  +++D ELG     G++  V +   ++       A+KI+  +      K   +  E
Sbjct: 14  DRKLLTLEDKELGS----GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-E 68

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             V+ QLD+P +VR+    +   S  + +E  E G L   +    H+ +        +V 
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 127

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             ++Y+     +HRD+   N+LL    + KI+DFG            L  A   D+    
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG------------LSKALRADENYYK 175

Query: 226 VGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 267
             T    P     PE +N    +  +D+W+ G  +++  S G  P++ 
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 22/218 (10%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 115
           F +GK  G G++ ++   K + T    A+K+   K     ++   + LE     QL    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSGD 65

Query: 116 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           G+ ++++         M LE    S E  +LFD        S         +++  +EY+
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLE--DLFDL--CDRTFSLKTVLMIAIQLISRMEYV 121

Query: 172 HSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           HS  LI+RD+KPEN L+   G+     I I DF   K   D   T       + K+    
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE-TKKHIPYREHKS--LT 178

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           GTA Y+          +  +DL ALG      L G+ P
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 26/217 (11%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           +  L K  G G +  V   K      V A+K++      KE   +  +   E   + +L 
Sbjct: 9   EITLLKELGSGQFGVVKLGKWKGQYDV-AVKMI------KEGSMSEDEFFQEAQTMMKLS 61

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 172
           HP +V+ +      + +Y+  E    G L + + S G  L   +      +V + + ++ 
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S   IHRD+   N L+  D  +K++DFG    M  +R         DD+  + VGT   V
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFG----M--TRYV------LDDQYVSSVGTKFPV 169

Query: 233 ---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
               PEV +    +  +D+WA G  ++++ S G  P+
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 50/293 (17%), Positives = 110/293 (37%), Gaps = 33/293 (11%)

Query: 5   QSHGREMLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFE------ 58
            S G + +   ++  + L  +  + +             +   P+   ++Q         
Sbjct: 30  GSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL 89

Query: 59  ---LGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
                ++ G G +  V     +D        A+K +  +       + ++  E I++   
Sbjct: 90  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT-EGIIMKDF 147

Query: 113 DHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEY 170
            HP V+ L     +   S  + L   + G+L + I     + +  +   +  +V   +++
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 207

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           + S   +HRD+   N +L     +K+ADFG  + M D            +       T A
Sbjct: 208 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----------KEFDSVHNKTGA 256

Query: 231 YVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 277
            +P      E L +   T  +D+W+ G  L+++++ G  P+ D + + I   +
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 22/218 (10%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 115
           +++G+  G GS+  +     +      A+K   ++     +    ++ E      L    
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 66

Query: 116 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           G+  +++  Q+     + ++    S E  +L D        S         +++  ++ I
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGPSLE--DLLDL--CGRKFSVKTVAMAAKQMLARVQSI 122

Query: 172 HSMGLIHRDIKPENLLL----TADGH-IKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
           H   L++RDIKP+N L+    + + + I + DFG VK  +D   T       + K     
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV-TKQHIPYREKKN--LS 179

Query: 227 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           GTA Y+          +  +DL ALG      L G+ P
Sbjct: 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 22/217 (10%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 115
           + LG+  G GS+  +     I  G   A+K+   K      K   + +E  +   +    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGV 65

Query: 116 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           G+  + +   +     M +E    S E  +LF+        S         +++  +EYI
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLE--DLFNF--CSRKFSLKTVLLLADQMISRIEYI 121

Query: 172 HSMGLIHRDIKPENLLL--TADGH-IKIADFGSVKPMQDSRI-TVLPNAASDDKACTFVG 227
           HS   IHRD+KP+N L+     G+ + I DFG  K  +D+R    +P      +     G
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY----RENKNLTG 177

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           TA Y           +  +DL +LG  L     G+ P
Sbjct: 178 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 70.7 bits (174), Expect = 8e-14
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 46/229 (20%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI-----MDKKFITKENKTAYVKLER 106
            ++++ +L +  G G +  V+         V A+K        + F+           E 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQAFLA----------EA 65

Query: 107 IVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAE 163
            V+ QL H  +V+L     ++   LY+  E    G L D  +   +  L  D    ++ +
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           V +A+EY+     +HRD+   N+L++ D   K++DFG    +  ++         +  + 
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG----L--TK---------EASST 170

Query: 224 TFVG------TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
              G      TA    PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 171 QDTGKLPVKWTA----PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 72.4 bits (178), Expect = 9e-14
 Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 40/224 (17%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
             +L K  G G + +V  A       V A+K M      K    +      E  V+  L 
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM------KPGSMSVEAFLAEANVMKTLQ 241

Query: 114 HPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALE 169
           H  +V+L    T +    +Y+  E    G L D + S         +   ++A++ + + 
Sbjct: 242 HDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG-- 227
           +I     IHRD++  N+L++A    KIADFG            L     D++     G  
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFG------------LARVIEDNEYTAREGAK 346

Query: 228 -----TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                TA    PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 347 FPIKWTA----PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 45/231 (19%), Positives = 94/231 (40%), Gaps = 24/231 (10%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
              ++ G G +  V     +D        A+K +  +       + ++  E I++    H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT-EGIIMKDFSH 85

Query: 115 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 172
           P V+ L     +   S  + L   + G+L + I     + +  +   +  +V   ++Y+ 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S   +HRD+   N +L     +K+ADFG    +  +R     +    +       T A +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFG----L--AR-----DMYDKEYYSVHNKTGAKL 194

Query: 233 P-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 277
           P      E L +   T  +D+W+ G  L+++++ G  P+ D + + I   +
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 20/216 (9%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 115
           F LG+  G GS+ ++     I T    A+K+ + K      K   +  E  +   L    
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKIYRILQGGT 63

Query: 116 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           G+  + +   +     + ++    S E  +LF+       LS         ++++ +E++
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGPSLE--DLFNFC--SRKLSLKTVLMLADQMINRVEFV 119

Query: 172 HSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           HS   +HRDIKP+N L+        + I DFG  K  +D+  T       ++K     GT
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS-THQHIPYRENKN--LTGT 176

Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           A Y           +  +DL +LG  L   L G+ P
Sbjct: 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 46/241 (19%), Positives = 96/241 (39%), Gaps = 27/241 (11%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKL 104
           P E          ++ G G +  V   + ID        A+K +  +    +   A+++ 
Sbjct: 17  PHERVVTH---SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLR- 71

Query: 105 ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTA 162
           E +++  L+HP V+ L           ++ L     G+L   I + + + +  +   +  
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 222
           +V   +EY+     +HRD+   N +L     +K+ADFG  + + D            +  
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD-----------REYY 180

Query: 223 CTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR 276
                  A +P      E L +   T  +D+W+ G  L+++L+ G  P++    + +   
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240

Query: 277 I 277
           +
Sbjct: 241 L 241

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
           D    K  G G +  V   K      V A+K++      KE   +  +   E  V+  L 
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMI------KEGSMSEDEFIEEAKVMMNLS 77

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 172
           H  +V+L+        +++  E    G L + +   +      +      +V +A+EY+ 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S   +HRD+   N L+   G +K++DFG       SR         DD+  + VG+   V
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGL------SRY------VLDDEYTSSVGSKFPV 185

Query: 233 ---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
              PPEVL  S  +  +D+WA G  ++++ S G  P+
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 20/154 (12%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALK-----IMDKKFITKENKTAYVKLERIVL 109
           ++ +L +  G G +  V+         V A+K        + F+           E  V+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQAFLA----------EASVM 240

Query: 110 DQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVD 166
            QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
           A+EY+     +HRD+   N+L++ D   K++DFG
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 35/232 (15%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           Q F LG++ G G +  V  A+           A+K++    I   +   +++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81

Query: 112 LDHPGVVRLF------FTFQDTFSLYMALESCEGGELFD------QITSKGHLSEDEARF 159
            DHP V +L                 + L   + G+L           +  +L       
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 160 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 219
           +  ++   +EY+ S   IHRD+   N +L  D  + +ADFG  + +              
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR------- 194

Query: 220 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                  G A+ +P      E L  +  T  +D+WA G T++++++ G +P+
Sbjct: 195 ------QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 40/224 (17%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 113
             +L +  G G + +V          V A+K +      K+   +      E  ++ QL 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMSPDAFLAEANLMKQLQ 66

Query: 114 HPGVVRLF--FTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALE 169
           H  +VRL+   T +    +Y+  E  E G L D  +  S   L+ ++     A++ + + 
Sbjct: 67  HQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG-- 227
           +I     IHRD++  N+L++     KIADFG            L     D++     G  
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFG------------LARLIEDNEYTAREGAK 171

Query: 228 -----TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                TA    PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 172 FPIKWTA----PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 42/236 (17%), Positives = 84/236 (35%), Gaps = 36/236 (15%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 105
             + +   + +  G GS+  V         K +  T  A+K    +  +   +  ++  E
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFLN-E 78

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL----------FDQITSKGHLSED 155
             V+ + +   VVRL           + +E    G+L                    S  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +      E+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++       
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--- 195

Query: 216 AASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                      G    +P     PE L     T  +D+W+ G  L+++ +    P+
Sbjct: 196 ----------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 41/232 (17%), Positives = 80/232 (34%), Gaps = 32/232 (13%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTV--------YALKI--------MDKKFITKENKTA 100
           ++L       +   +  A    T T         ++LK+         ++ F  +  K  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 101 YVKLERIVLDQLDHPGV--VRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSE 154
            V   +  L       +     F   QD +  ++ L     S +     D  + K  LSE
Sbjct: 104 QVNKWKK-LYSTPLLAIPTCMGFGVHQDKYR-FLVLPSLGRSLQ--SALDV-SPKHVLSE 158

Query: 155 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRITV 212
                    ++DALE++H    +H ++  EN+ +       + +A +G       S   V
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
              A  +       G   ++  ++      +  +DL +LG  + + L G  P
Sbjct: 219 ---AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 48/228 (21%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
            LGKI G G +  V+              A+K M     ++     ++  E   +    H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKDFSH 95

Query: 115 PGVVRLF-----FTFQDTFSLYMALESCEGGELFD------QITSKGHLSEDEARFYTAE 163
           P V+RL       + Q      + L   + G+L          T   H+       +  +
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           +   +EY+ +   +HRD+   N +L  D  + +ADFG  K +                  
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----------- 204

Query: 224 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
              G  A +P      E L     T  +D+WA G T++++ + G +P+
Sbjct: 205 --QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 41/232 (17%), Positives = 85/232 (36%), Gaps = 35/232 (15%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVY-------ALKIMDKKFITKENKTAYVKLERIV 108
           D    +  G G+++K+ +  + + G           LK++DK    +    ++ +    +
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFE-AASM 65

Query: 109 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDA 167
           + +L H  +V  +          +  E  + G L   +  +K  ++         ++  A
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGH--------IKIADFGSVKPMQDSRITVLPNAASD 219
           + ++    LIH ++  +N+LL  +          IK++D G    +    I         
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER----- 180

Query: 220 DKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 269
                      +VPPE + N        D W+ G TL+++ S G  P     
Sbjct: 181 ---------IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 29/104 (27%), Positives = 41/104 (39%), Gaps = 5/104 (4%)

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRITVLPNAASDD 220
            ++D LEYIH    +H DIK  NLLL       + + D+G               AA   
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG-VHKAYAADPK 218

Query: 221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           +     GT  +   +  N    +   DL  LG  + Q L+G  P
Sbjct: 219 RC--HDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 5/104 (4%)

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRITVLPNAASDD 220
            ++D LEYIH    +H DIK  NLLL       + +AD+G       +         +  
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG-NHKQYQENPR 217

Query: 221 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 264
           K     GT  +   +       +  +D+  LG  + + L G  P
Sbjct: 218 KG--HNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 46/236 (19%), Positives = 90/236 (38%), Gaps = 36/236 (15%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 105
               ++  L +  G G++ +V   +        +    A+K    +  +++++  ++  E
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLM-E 83

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD-------QITSKGHLSEDEAR 158
            +++ + +H  +VR       +   ++ +E   GG+L         + +    L+  +  
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143

Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPN 215
               ++    +Y+     IHRDI   N LLT  G     KI DFG    M  +R     +
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----M--AR-----D 192

Query: 216 AASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                      G  A +P     PE       T   D W+ G  L+++ S G  P+
Sbjct: 193 IYRAS--YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 47/236 (19%), Positives = 90/236 (38%), Gaps = 36/236 (15%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 105
               ++  L +  G G++ +V   +        +    A+K    +  +++++  ++  E
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLM-E 124

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD-------QITSKGHLSEDEAR 158
            +++ + +H  +VR       +   ++ LE   GG+L         + +    L+  +  
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184

Query: 159 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPN 215
               ++    +Y+     IHRDI   N LLT  G     KI DFG    M  +R     +
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----M--AR-----D 233

Query: 216 AASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
                      G  A +P     PE       T   D W+ G  L+++ S G  P+
Sbjct: 234 IYRAG--YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 25/168 (14%)

Query: 56  DFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
             +LGK  G G++ +V+ A      K  T    A+K++ K+  T     A +  E  +L 
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMS-ELKILI 85

Query: 111 QLD-HPGVVRLF-FTFQDTFSLYMALESCEGGELFD----------------QITSKGHL 152
            +  H  VV L     +    L + +E C+ G L                  +   K  L
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
           + +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI DFG
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 27/204 (13%)

Query: 22  LRIEGNNNSSTNCPTVQRSKSFAFRAPQE-HFSIQDFELGKIYGVGSYSKVVRAK----- 75
           +RI    +S+ + P +     +      +  F      LGK  G G + +VV A+     
Sbjct: 47  VRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID 106

Query: 76  --KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM 132
             K       A+K++ K   T+++ +  V  E  ++  +  H  ++ L         LY+
Sbjct: 107 KDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKMIGKHKNIINLLGACTQDGPLYV 164

Query: 133 ALESCEGGELFD----------------QITSKGHLSEDEARFYTAEVVDALEYIHSMGL 176
            +E    G L +                    +  ++  +    T ++   +EY+ S   
Sbjct: 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 224

Query: 177 IHRDIKPENLLLTADGHIKIADFG 200
           IHRD+   N+L+T +  +KIADFG
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFG 248

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 42/169 (24%), Positives = 67/169 (39%), Gaps = 22/169 (13%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           F   + + GK  G G++ KVV A      K D     A+K M K     + K A +  E 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMS-EL 100

Query: 107 IVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFD--------------QITSKGH 151
            ++  L  H  +V L         + +  E C  G+L +                 +   
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 152 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
            S  +   ++++V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 39/175 (22%), Positives = 72/175 (41%), Gaps = 31/175 (17%)

Query: 55  QDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 109
           ++  LGK  G G + KVV+A           T  A+K++ K+  +       +  E  VL
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS-EFNVL 80

Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD------------------------Q 145
            Q++HP V++L+        L + +E  + G L                           
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 146 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
              +  L+  +   +  ++   ++Y+  M L+HRD+   N+L+     +KI+DFG
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 21/174 (12%)

Query: 46  RAPQEHFSIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVK 103
                     D +   + G G++ +V++A  KK       A+K M K++ +K++   +  
Sbjct: 16  PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAG 74

Query: 104 LERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFD----------------QI 146
            E  VL +L  HP ++ L    +    LY+A+E    G L D                  
Sbjct: 75  -ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 147 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
           ++   LS  +   + A+V   ++Y+     IHRD+   N+L+  +   KIADFG
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 187

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 45/173 (26%), Positives = 63/173 (36%), Gaps = 26/173 (15%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           F       GK  G G++ KVV A      K D     A+K M K       + A +  E 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK-MLKPSAHLTEREALMS-EL 77

Query: 107 IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGEL----------FDQITSKGHLSED 155
            VL  L +H  +V L           +  E C  G+L          F    +   + ED
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 156 EARFYT--------AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
           +              +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 42/201 (20%), Positives = 81/201 (40%), Gaps = 28/201 (13%)

Query: 25  EGNNNSSTNCPTVQRSKSFAFRAPQEH-FSIQDFELGKIYGVGSYSKVVRAK-------K 76
             +++ S + P +     +      +  F      LGK  G G++ +VV A+       K
Sbjct: 5   HHHHHHSQD-PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK 63

Query: 77  IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALE 135
                  A+K++ K   T+++ +  V  E  ++  +  H  ++ L         LY+ +E
Sbjct: 64  PKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121

Query: 136 SCEGGELFD----------------QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 179
               G L +                    +  ++  +    T ++   +EY+ S   IHR
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

Query: 180 DIKPENLLLTADGHIKIADFG 200
           D+   N+L+T +  +KIADFG
Sbjct: 182 DLAARNVLVTENNVMKIADFG 202

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 57/284 (20%), Positives = 103/284 (36%), Gaps = 55/284 (19%)

Query: 20  SKLRIEGNNNSSTNCPTVQRSKSFAFRAPQE-HFSIQDFELGKIYGVGSYSKVVRAK--- 75
           + L  E   +     P  QR             +   + E  +  G G++ +V +A+   
Sbjct: 11  TTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70

Query: 76  --KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 133
               +  T+ A+K M K+  + + +  + + E  ++ + D+P +V+L         + + 
Sbjct: 71  LLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMAEFDNPNIVKLLGVCAVGKPMCLL 128

Query: 134 LESCEGGEL------------------------FDQITSKGHLSEDEARFYTAEVVDALE 169
            E    G+L                                 LS  E      +V   + 
Sbjct: 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD--KACTFVG 227
           Y+     +HRD+   N L+  +  +KIADFG    +  SR     N  S D  K      
Sbjct: 189 YLSERKFVHRDLATRNCLVGENMVVKIADFG----L--SR-----NIYSADYYK----AD 233

Query: 228 TAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 265
               +P     PE +  +  T  +D+WA G  L+++ S G  P+
Sbjct: 234 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.0 bits (139), Expect = 2e-09
 Identities = 39/213 (18%), Positives = 64/213 (30%), Gaps = 53/213 (24%)

Query: 38  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN 97
           +    F+   P E          KI G G + +V +   I   T  A+KI+  +     N
Sbjct: 8   KGPVPFSHCLPTEKLQR----CEKI-GEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVN 60

Query: 98  KTAYVKLERIV--------------LDQLDHPGVVRLF---------------------- 121
            +     E I+                     G + L                       
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 122 -----FTFQDTFS---LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH- 172
                    D F    L++ LE   GG   +Q+ +K   S   A+    ++  +L     
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEA 179

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 205
           S+   HRD+   N+LL      K+    + K  
Sbjct: 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 48/206 (23%), Positives = 71/206 (34%), Gaps = 54/206 (26%)

Query: 26  GNNNS-STNCPTVQRSKSFAFRAPQEHFSIQD-------FELGKIYGVGSYSKVVRAKKI 77
           G+  S +TN      S S+          + D       F+   + G G + KV +   +
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV-L 60

Query: 78  DTGTVYALKIMD-------KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFS 129
             G   ALK          ++F T          E   L    HP +V L  F  +    
Sbjct: 61  RDGAKVALKRRTPESSQGIEEFET----------EIETLSFCRHPHLVSLIGFCDERNEM 110

Query: 130 L----YMA---LESCEGGELFDQITSKGHLS--------EDEARFYTAEVVDALEYIHSM 174
           +    YM    L+      L+        +S           AR         L Y+H+ 
Sbjct: 111 ILIYKYMENGNLKRH----LYGSDLPTMSMSWEQRLEICIGAAR--------GLHYLHTR 158

Query: 175 GLIHRDIKPENLLLTADGHIKIADFG 200
            +IHRD+K  N+LL  +   KI DFG
Sbjct: 159 AIIHRDVKSINILLDENFVPKITDFG 184

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 35/171 (20%), Positives = 62/171 (36%), Gaps = 23/171 (13%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 105
             S+      +  G   + KV +         +     A+K + K       +  +   E
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRH-E 62

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL----------------FDQITSK 149
            ++  +L HP VV L         L M    C  G+L                 D  T K
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 150 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
             L   +     A++   +EY+ S  ++H+D+   N+L+    ++KI+D G
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 173

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 49/241 (20%), Positives = 90/241 (37%), Gaps = 42/241 (17%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 105
           H   +D  L    G G++ KV  A+           + A+K +  K  ++  +  + + E
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQR-E 93

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL---------------FDQITSKG 150
             +L  L H  +VR F    +   L M  E    G+L                 +  + G
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 151 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 210
            L   +     ++V   + Y+  +  +HRD+   N L+     +KI DFG  + +  +  
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213

Query: 211 TVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSP 264
                          VG    +P     PE +     T  +D+W+ G  L+++ + G  P
Sbjct: 214 YR-------------VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

Query: 265 F 265
           +
Sbjct: 261 W 261

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 51/242 (21%), Positives = 93/242 (38%), Gaps = 43/242 (17%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 105
           H   +D  L +  G G++ KV  A+           + A+K +  K  T   +  + + E
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQR-E 67

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD----------------QITSK 149
             +L  L H  +V+ +    D   L M  E  + G+L                     +K
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 150 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 209
           G L   +     +++   + Y+ S   +HRD+   N L+ A+  +KI DFG  + +  + 
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 210 ITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTS 263
                           VG    +P     PE +     T  +D+W+ G  L+++ + G  
Sbjct: 188 YYR-------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

Query: 264 PF 265
           P+
Sbjct: 235 PW 236

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 56.1 bits (136), Expect = 8e-09
 Identities = 34/144 (23%), Positives = 60/144 (41%), Gaps = 19/144 (13%)

Query: 168 LEYIH---SMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKA 222
           L Y+H      +IHRD+K  N+LL  +    + DFG  K    +D+ +T           
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT----------- 192

Query: 223 CTFV-GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
            T V GT  ++ PE L++  ++   D++  G  L ++++G   F D +       ++  D
Sbjct: 193 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLD 250

Query: 282 IRFPNYFSDAARDLIDRLLDVDPS 305
                        L+D  L  +  
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYK 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 26/173 (15%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK-------KIDTGTVYALKIMDKKFITKENKTAYVKL 104
                  LGK  G G++ +VV A+       K +  T  A+K++ K   T+++ +  +  
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS- 123

Query: 105 ERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFD----------------QIT 147
           E  ++  +  H  ++ L         LY+ +E    G L +                   
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 148 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
            +  LS  +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 236

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 31/172 (18%)

Query: 58  ELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           E GK+ G G++ KV+ A      K       A+K M K+      + A +  E  ++ QL
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALMS-ELKMMTQL 105

Query: 113 -DHPGVVRLFFTFQDTFSLYMALESCEGGEL-----------------------FDQITS 148
             H  +V L      +  +Y+  E C  G+L                        ++   
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 149 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 200
              L+ ++   +  +V   +E++     +HRD+   N+L+T    +KI DFG
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 21/181 (11%)

Query: 136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 195
           S    E   +   K  L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233

Query: 196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWA 250
           I DFG  + +      V                 A +P     PE +     T  +D+W+
Sbjct: 234 ICDFGLARDIYKDPDYV-------------RKGDARLPLKWMAPETIFDRVYTIQSDVWS 280

Query: 251 LGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGR 307
            G  L+++ S G SP+        F R +    R   P+Y +      +      +PS R
Sbjct: 281 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340

Query: 308 P 308
           P
Sbjct: 341 P 341

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 39/176 (22%), Positives = 63/176 (35%), Gaps = 13/176 (7%)

Query: 56  DFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
             +LGK  G G++ +V+ A      K  T    A+K M K+  T     A +  E  +L 
Sbjct: 23  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMS-ELKILI 80

Query: 111 QLD-HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 168
            +  H  VV L     +    L + +E C+ G L   + SK +        Y  +     
Sbjct: 81  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP----YKTKGARFR 136

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           +    +G I  D+K     +T+      + F   K + D      P     D    
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 3e-07
 Identities = 82/559 (14%), Positives = 159/559 (28%), Gaps = 183/559 (32%)

Query: 4   IQSHGREMLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQD--FELGK 61
           I++  R+   M + +  +     N+N       V R         Q +  ++    EL  
Sbjct: 98  IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR--------LQPYLKLRQALLELRP 149

Query: 62  -----IYGVGSYSK------VVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERI 107
                I GV    K      V  + K+       ++ L +                    
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL------------KNCNSPET 197

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALES--CEGGELFDQITSKGHLSEDEARFYTAEVV 165
           VL+ L                 L   ++       +    I  + H  + E R       
Sbjct: 198 VLEMLQ---------------KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS-- 240

Query: 166 DALEYIHSMGLIHRDIKPEN-----------LLLTADGHIKIADFGSVKPMQDSRITVLP 214
               Y + + L+  +++              LL T     ++ DF S        +    
Sbjct: 241 --KPYENCL-LVLLNVQNAKAWNAFNLSCKILLTTRF--KQVTDFLSAATTTHISLDHHS 295

Query: 215 NAASDDKACTFVGTAAYV-------PPEVLNSSP--------------ATFGN----DLW 249
              + D+  + +    Y+       P EVL ++P              AT+ N    +  
Sbjct: 296 MTLTPDEVKSLL--LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353

Query: 250 ALGCTLYQMLSGTSP------FKDTSEWLIFQRIIARDIRFP---------NYFSDAARD 294
            L   +   L+   P      F   S   +F          P         +        
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLS---VFPP----SAHIPTILLSLIWFDVIKSDVMV 406

Query: 295 LID-----RLLDVDPSGRPGAGPGGYAVLK--------MHPFFKGIDWKNIRGQTPPKLA 341
           +++      L++  P     + P  Y  LK        +H        ++I         
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH--------RSIVDHYNIPKT 458

Query: 342 SEPMVQSGEGDDVHDSSWNPSHIG--------------------D---ISAKINDGNGGA 378
            +            D  +  SHIG                    D   +  KI   +  A
Sbjct: 459 FDS---DDLIPPYLDQYFY-SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRH-DSTA 513

Query: 379 SSSEGSITRLASIDSFDSKWQQFL---DPGESVLMISMVKKLQK-----LTSKK---VQL 427
            ++ GSI  L ++      ++ ++   DP    L+ +++  L K     + SK    +++
Sbjct: 514 WNASGSI--LNTLQQLK-FYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRI 570

Query: 428 ILTNKPKLIYVDPSKLVVK 446
            L  + + I+ +  K V +
Sbjct: 571 ALMAEDEAIFEEAHKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 3e-05
 Identities = 55/350 (15%), Positives = 109/350 (31%), Gaps = 87/350 (24%)

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
               ++DI         D  +   +F   K +QD   ++L     D              
Sbjct: 14  HQYQYKDILSVFE----DAFVD--NF-DCKDVQDMPKSILSKEEIDH------------- 53

Query: 234 PEVLNSSPATFGND--LWAL---GCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 288
             ++ S  A  G     W L      + Q        +   ++L+    I  + R P+  
Sbjct: 54  --IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV-LRINYKFLMSP--IKTEQRQPSMM 108

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW-KNIR-------------G 334
           +    +  DRL + +           Y V ++ P+ K       +R             G
Sbjct: 109 TRMYIEQRDRLYNDNQVFAK------YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG 162

Query: 335 QTPPKLASE----PMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLAS 390
           +T   +A +      VQ      +    W           +N  N   +S E  +  L  
Sbjct: 163 KT--WVALDVCLSYKVQCKMDFKIF---W-----------LNLKN--CNSPETVLEMLQK 204

Query: 391 IDS-FDSKWQQFLDPGESV-LMISMVK-KLQKLTSKKVQ----LILTN--KPKLI-YVDP 440
           +    D  W    D   ++ L I  ++ +L++L   K      L+L N    K     + 
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL 264

Query: 441 S-KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQW 489
           S K+++              +  ++ +H  +      L+ ++ K    ++
Sbjct: 265 SCKILL----TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 9/103 (8%)

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           + ++H    IHRDIK  N+LL      KI+DFG  +  +    TV+ +          VG
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR--------IVG 197

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 270
           T AY+ PE L     T  +D+++ G  L ++++G     +  E
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	499
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
1w1g_A	151	HPDK1, 3-phosphoinositide dependent protein kinase	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
2cod_A	115	Centaurin-delta 1; ARF GAP and RHO GAP with ankyri	99.52
1x1f_A	149	Signal-transducing adaptor protein 1; docking prot	99.51
2rsg_A	94	Collagen type IV alpha-3-binding protein; pleckstr	99.5
2dn6_A	115	KIAA0640 protein; PH domain, structural genomics,	99.44
2dhk_A	119	TBC1 domain family member 2; PH domain, paris-1, s	99.43
1eaz_A	125	Tandem PH domain containing protein-1; lipid-bindi	99.43
1v5p_A	126	Pleckstrin homology domain-containing, family A; T	99.42
1v5u_A	117	SBF1, SET binding factor 1; MTMR5, the pleckstrin	99.41
1pls_A	113	Pleckstrin homology domain; phosphorylation; NMR {	99.41
1btk_A	169	Bruton'S tyrosine kinase; transferase, PH domain,	99.4
2d9v_A	130	Pleckstrin homology domain-containing protein fami	99.39
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
1wi1_A	126	Calcium-dependent activator protein for secretion,	99.37
1v88_A	130	Oxysterol binding protein-related protein 8; vesic	99.37
2lul_A	164	Tyrosine-protein kinase TEC; structural genomics,	99.37
1fao_A	126	Dual adaptor of phosphotyrosine and 3- phosphoinos	99.37
1x1g_A	129	Pleckstrin 2; PH domain, structural genomics, rike	99.37
2d9x_A	120	Oxysterol binding protein-related protein 11; PH d	99.37
2i5f_A	109	Pleckstrin; PH domain, protein-inositol phosphate	99.36
1u5d_A	108	SKAP55, SRC kinase-associated phosphoprotein of 55	99.35
2rlo_A	128	Centaurin-gamma 1; split PH domain, alternative sp	99.35
1upq_A	123	PEPP1; PH domain, phosphoinositide binding, signal	99.35
2dkp_A	128	Pleckstrin homology domain-containing family A mem	99.34
1dyn_A	125	Dynamin; signal transduction protein; 2.20A {Homo	99.34
3aj4_A	112	Pleckstrin homology domain-containing family B ME;	99.34
1x05_A	129	Pleckstrin; PH domain, structural genomics, NPPSFA	99.34
3rcp_A	103	Pleckstrin homology domain-containing family A ME;	99.34
1u5f_A	148	SRC-associated adaptor protein; PH domain of SKAP-	99.33
1v89_A	118	Hypothetical protein KIAA0053; pleckstrin homology	99.33
1wg7_A	150	Dedicator of cytokinesis protein 9; pleckstrin hom	99.33
1fgy_A	127	GRP1; PH domain, signaling protein; HET: 4IP; 1.50	99.33
1unq_A	125	RAC-alpha serine/threonine kinase; transferase, pl	99.32
1wgq_A	109	FYVE, rhogef and PH domain containing 6; ethanol d	99.31
2da0_A	114	130-kDa phosphatidylinositol 4,5-biphosphate- depe	99.31
2d9y_A	117	Pleckstrin homology domain-containing protein fami	99.29
2yry_A	122	Pleckstrin homology domain-containing family A mem	99.28
1u5e_A	211	SRC-associated adaptor protein; novel dimerization	99.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
2j59_M	168	RHO-GTPase activating protein 10; ARF, ARF1, ARFBD	99.25
2w2x_D	124	1-phosphatidylinositol-4,5-bisphosphate phosphodie	99.24
3tfm_A	228	Myosin X; split PH domain, motor protein; 2.53A {R	99.24
2cof_A	107	Protein KIAA1914; PH domain, structural genomics,	99.23
2p0d_A	129	RHO GTPase-activating protein 9; protein-phosphoin	99.21
2y7b_A	134	Actin-binding protein anillin; cell cycle; 1.90A {	99.2
3lju_X	386	ARF-GAP with dual PH domain-containing protein 1;	99.19
1qqg_A	264	IRS-1, insulin receptor substrate 1; beta-sandwhic	99.18
4a6h_A	120	Phosphatidylinositol 4,5-bisphosphate-binding Pro	99.16
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3cxb_B	112	Pleckstrin homology domain-containing family M mem	99.14
2coc_A	112	FYVE, rhogef and PH domain containing protein 3; s	99.11
1wjm_A	123	Beta-spectrin III; PH domain, signal transduction,	99.1
2r09_A	347	Cytohesin-3; autoinhibition, GRP1, PIP3, ARF, 3-ph	99.06
1btn_A	106	Beta-spectrin; signal transduction protein; HET: I	99.05
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
3a8p_A	263	T-lymphoma invasion and metastasis-inducing protei	99.01
2q13_A	385	DCC-interacting protein 13 alpha; APPL1, BAR domai	98.92
3lju_X	386	ARF-GAP with dual PH domain-containing protein 1;	98.87
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
4h8s_A	407	DCC-interacting protein 13-beta; BAR domain, pleck	98.79
1dro_A	122	Beta-spectrin; cytoskeleton; NMR {Drosophila melan	98.78
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	98.77
2d9w_A	127	Docking protein 2; PH domain, structural genomics,	98.77
2rov_A	117	RHO-associated protein kinase 2; ATP-binding, coil	98.76
3pp2_A	124	RHO GTPase-activating protein 27; PH domain, GTPas	98.75
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
2dtc_A	126	RAL guanine nucleotide exchange factor ralgps1A; P	98.53
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.5
3tca_A	291	Amyloid beta A4 precursor protein-binding family 1	98.5
2ys3_A	137	UNC-112-related protein 2; PH domain, kindlin-3, s	98.45
2fjl_A	150	1-phosphatidylinositol-4,5-bisphosphate phosphodie	98.43
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.4
2coa_A	125	Protein kinase C, D2 type; protein kinase D2, PH d	98.4
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.32
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.16
2d9z_A	129	Protein kinase C, NU type; PH domain, structural g	98.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.09
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.08
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.77
3a8n_A	279	TIAM-1, T-lymphoma invasion and metastasis-inducin	97.67
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.66
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.55
3hk0_A	256	Growth factor receptor-bound protein 10; GRB10, RA	97.53
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.34
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.28
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.16
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.15
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.13
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.04
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.02
4gmv_A	281	RAS-associated and pleckstrin homology domains-CO	96.97
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.92
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.89
3mpx_A	434	FYVE, rhogef and PH domain-containing protein 5; s	96.76
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.75
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.7
1v5m_A	136	SH2 and PH domain-containing adapter protein APS;	96.69
3tfm_A	228	Myosin X; split PH domain, motor protein; 2.53A {R	96.28
1v61_A	132	RAC/CDC42 guanine nucleotide exchange factor (GEF)	96.19
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.89
4f7h_A	173	Fermitin family homolog 2; beta-barrel, membrane b	95.71
3ml4_A	224	Protein DOK-7; tyrosine phosphorylation, adapter p	95.62
4bbk_A	165	Kindlin-1, fermitin family homolog 1; PH domain, c	95.55
1zc3_B	113	Exocyst complex protein EXO84; exocytosis, small G	95.41
1dbh_A	354	Protein (human SOS 1); guanine nucleotide exchange	94.84
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.66
1xcg_A	368	PDZ-rhogef, RHO guanine nucleotide exchange factor	93.51
3t06_A	418	PDZ-rhogef, RHO guanine nucleotide exchange factor	93.46
2z0q_A	346	XPLN, RHO guanine nucleotide exchange factor 3; DH	93.31
2dfk_A	402	Collybistin II; DH domain, PH domain, cell cycle;	93.1
3jzy_A	510	Intersectin 2; C2 domain, structural genomics cons	91.33
2pz1_A	466	RHO guanine nucleotide exchange factor 4; helical	90.98
2lg1_A	185	A-kinase anchor protein 13; metal binding protein;	90.48
1mai_A	131	Phospholipase C delta-1; pleckstrin, inositol tris	90.22
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.88
1txd_A	385	RHO guanine nucleotide exchange factor 12; helical	89.33
3qwm_A	140	Iqsec1, IQ motif and SEC7 domain-containing protei	89.17
3odw_A	536	RHO guanine nucleotide exchange factor 1; regulati	88.04
2vrw_B	406	P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP	88.03
1kz7_A	353	Guanine nucleotide exchange factor DBS; guanine nu	86.76
3p6a_A	377	RHO guanine nucleotide exchange factor 1; regulati	86.42
1nty_A	311	Triple functional domain protein; DBL, pleckstrin,	85.81
2rgn_B	354	RHOA/RAC/CDC42 exchange factor; heterotrimeric G-p	85.64
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.31
3ky9_A	587	Proto-oncogene VAV; calponin homology domain, DBL	84.44
1foe_A	377	T-lymphoma invasion and metastasis inducing protei	81.74

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.1e-77  Score=642.67  Aligned_cols=423  Identities=27%  Similarity=0.443  Sum_probs=327.6

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHH---HHHHhCCCCCccEEEEEEEc
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER---IVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~---~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      ..++++||+++++||+|+||+||+|+++.||+.||||++.+..+........+.+|+   .+++.++|||||+++++|++
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            467899999999999999999999999999999999999887665555455555554   45567799999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          127 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      ...+|+|||||+||+|.+++.+.+.|++..+++|++||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+.
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHhcCCCCCCCC---CHHHHHHHHHhcCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARDI  282 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyelltG~~Pf~~~---~~~~~~~~i~~~~~  282 (499)
                      .            ....++|||+.|||||++. +..|+.++||||||||||+|++|++||.+.   +...+.+.+....+
T Consensus       344 ~------------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~  411 (689)
T 3v5w_A          344 K------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV  411 (689)
T ss_dssp             S------------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC
T ss_pred             C------------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Confidence            3            2344789999999999996 467999999999999999999999999763   45567788889999


Q ss_pred             CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCCCCccCCCCCCCCCCCCCCC
Q 010859          283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEPMVQSGEGDDVHDSSWNP  361 (499)
Q Consensus       283 ~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~  361 (499)
                      .+|..+|+++++||.+||+.||.+|+|+...+++++++||||+++||+.+..+ .+|++.|........ +..+.+.|..
T Consensus       412 ~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~-~~fD~~~fd~  490 (689)
T 3v5w_A          412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAA-DAFDIGSFDE  490 (689)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTT-BCCC------
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcC-CCCCCccCCc
Confidence            99999999999999999999999999987678899999999999999998654 345554433221110 0000111111


Q ss_pred             C---CCCCcc--ccccCCCCCC-CCC------CC-------ccccccc----ccccCcccccccCCCceEEEEEeeehhh
Q 010859          362 S---HIGDIS--AKINDGNGGA-SSS------EG-------SITRLAS----IDSFDSKWQQFLDPGESVLMISMVKKLQ  418 (499)
Q Consensus       362 ~---~~~~~~--~~~~~~~~~~-~~~------~~-------~~~~~~~----~~~~~~~~~~~~~~~~~i~~~g~~~k~~  418 (499)
                      .   ......  ...-.+.+.. ++.      ..       ...+...    .+.....+.++. .|+.+++.|.+.|++
T Consensus       491 e~~~~~~~~~~d~~~f~~Fs~~~~~~~q~e~~et~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~G~~~k~~  569 (689)
T 3v5w_A          491 EDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKAKNKQLGHEEDYA-LGKDCIMHGYMSKMG  569 (689)
T ss_dssp             ---CCCCCCHHHHTTTTTCCEECHHHHHHHHHTTTHHHHHHHHHHHHHHHHHHHHHTSCCSCTT-SSSCCCEEEEEEEC-
T ss_pred             cccCCCCCCchHHHHHhCCCccCccchhhhhhhhhhhhhccchhhHHHhHHHhhhhhccccccc-cCCcceeecccccCC
Confidence            0   000000  0000000000 000      00       0000000    001111234455 378899999999999


Q ss_pred             hhh---hccceEEe-----------ecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEcCCc
Q 010859          419 KLT---SKKVQLIL-----------TNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQ  484 (499)
Q Consensus       419 g~~---~k~r~~il-----------t~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d~~~  484 (499)
                      |+|   |++|+|.|           +..+++||+|+..++.||+|||+++   +.++.+++++|+|+||+        +.
T Consensus       570 g~f~~~~~rR~~~l~p~r~e~~~e~~~~~~l~~~~~v~~v~k~~i~~~~~---l~~~~k~~k~f~~~t~~--------~~  638 (689)
T 3v5w_A          570 NPFLTQWQRRYFYLFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKC---LLLKIRGGKQFILQCDS--------DP  638 (689)
T ss_dssp             ------CEEEEEEEETTEEEEECTTSCCCEEEEGGGEEEEEEEESSSCEE---EEEEETTTEEEEEECSS--------HH
T ss_pred             CcccchhhhhccccCCCcccccccCCCCcceeeeccccccccCcCCCCcc---eeeeecCCcEEEEECCC--------hH
Confidence            987   79999999           3456789999999999999999997   99999999999999997        33


Q ss_pred             cHHHHHHHHHHhc
Q 010859          485 RASQWKKAIEALQ  497 (499)
Q Consensus       485 ~~~~W~~~i~~~~  497 (499)
                      .+.+|+++|.++.
T Consensus       639 ~~~~W~~~i~~~~  651 (689)
T 3v5w_A          639 ELVQWKKELRDAY  651 (689)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            5899999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.1e-74  Score=569.77  Aligned_cols=282  Identities=49%  Similarity=0.853  Sum_probs=263.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      +...+||++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|+++..+
T Consensus        28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            45568999999999999999999999999999999999987766666777899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+.... 
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~-  186 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-  186 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT-
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998765322 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                             ......+++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+++++|....+.+|..+++
T Consensus       187 -------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~  259 (311)
T 4aw0_A          187 -------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP  259 (311)
T ss_dssp             -------TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCH
T ss_pred             -------CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCH
Confidence                   2234567899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL  340 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~-~~~~~l~~Hpff~~i~~~~~~~~~~p~~  340 (499)
                      ++++||.+||+.||++|||+.+ .+...|++||||++++|+.+..++||.+
T Consensus       260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l  310 (311)
T 4aw0_A          260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL  310 (311)
T ss_dssp             HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred             HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence            9999999999999999999976 5677899999999999999998888764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.2e-69  Score=535.85  Aligned_cols=280  Identities=37%  Similarity=0.698  Sum_probs=246.9

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      ++...++|++++.||+|+||+||+|++.   .+++.||||++.+....... ...+.+|+.+|++++|||||+++++|++
T Consensus        19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEE
T ss_pred             ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            3445679999999999999999999984   46889999999876544332 2346779999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          127 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      +..+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998643


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  286 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~  286 (499)
                      ..          .....+++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|....+.+|.
T Consensus       178 ~~----------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~  247 (304)
T 3ubd_A          178 DH----------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ  247 (304)
T ss_dssp             -------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred             CC----------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC
Confidence            22          23345789999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKL  340 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~  340 (499)
                      .+|+++++||.+||+.||++|||+...+++++++||||+++||+.+..+ .+|++
T Consensus       248 ~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~  302 (304)
T 3ubd_A          248 FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPF  302 (304)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSS
T ss_pred             cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCc
Confidence            9999999999999999999999997778899999999999999998654 34433

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1e-65  Score=503.95  Aligned_cols=256  Identities=35%  Similarity=0.556  Sum_probs=221.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|+++..+|+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            35899999999999999999999999999999999998877666667788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||||| +|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....    
T Consensus        91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----  165 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----  165 (275)
T ss_dssp             EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC----
Confidence            99999 6799999999999999999999999999999999999999999999999999999999999999865432    


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChH
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  291 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  291 (499)
                             ....+.+||+.|||||++.+..+ +.++|||||||++|+|++|++||.+.+...+++.|....+.+|..+|++
T Consensus       166 -------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~  238 (275)
T 3hyh_A          166 -------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPG  238 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred             -------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence                   23346799999999999998876 5799999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      +++||.+||+.||++|||+     +++++||||+
T Consensus       239 ~~~li~~~L~~dP~~R~s~-----~eil~hpw~k  267 (275)
T 3hyh_A          239 AAGLIKRMLIVNPLNRISI-----HEIMQDDWFK  267 (275)
T ss_dssp             HHHHHHHHSCSSGGGSCCH-----HHHHHCHHHH
T ss_pred             HHHHHHHHccCChhHCcCH-----HHHHcCcccc
Confidence            9999999999999999988     8999999996

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8e-65  Score=512.69  Aligned_cols=258  Identities=28%  Similarity=0.527  Sum_probs=230.0

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++.+...... ....+.+|+.+|++++|||||+++++|+++..+|+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            46899999999999999999999999999999999988765443 45678889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          133 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |||||+||+|.+++...  ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+.... 
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            99999999999999754  357999999999999999999999999999999999999999999999999998764321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFS  289 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~  289 (499)
                               ....+++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+...++.+|....+ .+|..+|
T Consensus       180 ---------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s  250 (350)
T 4b9d_A          180 ---------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS  250 (350)
T ss_dssp             ---------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred             ---------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCC
Confidence                     223467999999999999999999999999999999999999999999999999999988775 4677899


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +++++||.+||+.||++|||+     +++++||||+.
T Consensus       251 ~~~~~li~~~L~~dP~~R~s~-----~e~l~hp~~~~  282 (350)
T 4b9d_A          251 YDLRSLVSQLFKRNPRDRPSV-----NSILEKGFIAK  282 (350)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH-----HHHHTSHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCH-----HHHhcCHHhhc
Confidence            999999999999999999988     89999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-64  Score=507.19  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=230.0

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ..|++++.||+|+||+||+|+++.||+.||||++.+....   ....+.+|+.+|+.++|||||+++++|+++..+|+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5699999999999999999999999999999999865332   2345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |||+||+|.+++.+ +++++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+...      
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~------  223 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------  223 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS------
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC------
Confidence            99999999998876 57999999999999999999999999999999999999999999999999999876432      


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---CCCCCCCChH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDA  291 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~  291 (499)
                          .....+++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+....++.|....   +..+..+|++
T Consensus       224 ----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~  299 (346)
T 4fih_A          224 ----VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPS  299 (346)
T ss_dssp             ----SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHH
T ss_pred             ----CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHH
Confidence                233457899999999999999999999999999999999999999999999999988887753   3344578999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +++||.+||+.||++|||+     +++++||||+.
T Consensus       300 ~~dli~~~L~~dP~~R~ta-----~e~l~Hp~~~~  329 (346)
T 4fih_A          300 LKGFLDRLLVRDPAQRATA-----AELLKHPFLAK  329 (346)
T ss_dssp             HHHHHHHHSCSSTTTSCCH-----HHHTTCGGGGG
T ss_pred             HHHHHHHHcCCChhHCcCH-----HHHhcCHhhcC
Confidence            9999999999999999998     99999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-62  Score=507.78  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=230.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +.|++++.||+|+||+||+|+++.||+.||||++.+....   ....+.+|+.+|+.++|||||+++++|++...+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            5699999999999999999999999999999999875432   2345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |||+||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+...      
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~------  300 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------  300 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS------
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC------
Confidence            99999999998875 56999999999999999999999999999999999999999999999999999876432      


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---CCCCCCCChH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDA  291 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~  291 (499)
                          .....+++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+....+..|....   +..+..+|++
T Consensus       301 ----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~  376 (423)
T 4fie_A          301 ----VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPS  376 (423)
T ss_dssp             ----CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHH
T ss_pred             ----CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHH
Confidence                233457899999999999999999999999999999999999999999999999988887653   3455678999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +++||.+||+.||++|||+     +++++||||+.
T Consensus       377 ~~dli~~~L~~dP~~R~ta-----~ell~Hp~~~~  406 (423)
T 4fie_A          377 LKGFLDRLLVRDPAQRATA-----AELLKHPFLAK  406 (423)
T ss_dssp             HHHHHHHHSCSSTTTSCCH-----HHHTTCGGGGG
T ss_pred             HHHHHHHHcCCChhHCcCH-----HHHhcCHHhcC
Confidence            9999999999999999998     99999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.9e-62  Score=493.17  Aligned_cols=257  Identities=26%  Similarity=0.389  Sum_probs=225.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||+++++...        .+|+.+|+.++|||||++|++|++...+|+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            457899999999999999999999999999999999875432        358999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~  211 (499)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+.+......
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999999999999999999999999999999999999999999999987 6999999999876543211


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---CCCCCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFPNYF  288 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~  288 (499)
                           .......+++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+...++.+|.....   .+|..+
T Consensus       208 -----~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  282 (336)
T 4g3f_A          208 -----KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC  282 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred             -----cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence                 011223457899999999999999999999999999999999999999999888778888887654   467889


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHH-------------hcCCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVL-------------KMHPFFKGI  327 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l-------------~~Hpff~~i  327 (499)
                      |+++++||.+||+.||.+|||+     ++|             ++|||+...
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa-----~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASA-----MELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             CHHHHHHHHHHccCCHhHCcCH-----HHHHHHHHHHHhhhhhccCCCcCCC
Confidence            9999999999999999999998     555             579998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-61  Score=477.91  Aligned_cols=251  Identities=21%  Similarity=0.379  Sum_probs=219.9

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCeEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----TFSLYM  132 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~----~~~l~l  132 (499)
                      |++.+.||+|+||+||+|.++.++..||+|++.+...... ....+.+|+.+|++++|||||+++++|++    +..+|+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            4788899999999999999999999999999987655443 34667889999999999999999999975    456999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCC-CCCEEEEecCCccccCCcc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~~~  209 (499)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|  |+||||||+||||+. +|++||+|||+|+....  
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--  184 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  184 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence            9999999999999999899999999999999999999999999  999999999999984 79999999999975322  


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH-HHHHHHHHhcCC--CCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIARDI--RFPN  286 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~-~~~~~~i~~~~~--~~p~  286 (499)
                                ....+++||+.|||||++.+ .|+.++|||||||++|+|+||++||.+.+. ..+++.+.....  .+|.
T Consensus       185 ----------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  253 (290)
T 3fpq_A          185 ----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK  253 (290)
T ss_dssp             ----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred             ----------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCc
Confidence                      23457899999999999875 599999999999999999999999987544 445555555432  3566


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+++++++||.+||+.||++|||+     +++++||||+.
T Consensus       254 ~~~~~~~~li~~~L~~dP~~R~s~-----~e~l~Hp~~~~  288 (290)
T 3fpq_A          254 VAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQE  288 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGC-
T ss_pred             cCCHHHHHHHHHHccCChhHCcCH-----HHHhcCccccC
Confidence            789999999999999999999988     99999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-60  Score=487.49  Aligned_cols=261  Identities=27%  Similarity=0.406  Sum_probs=226.0

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------CC
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------TF  128 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~------~~  128 (499)
                      ++|++++.||+|+||+||+|+++.||+.||||++.+..... .....+.+|+.+|+.++|||||++++++..      ..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            57999999999999999999999999999999997664433 334567789999999999999999999764      46


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+|||||+ |+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999996 689999999999999999999999999999999999999999999999999999999999999876432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--  285 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--  285 (499)
                      ..      .......+++||+.|||||++.+. .++.++||||||||+|+|++|++||.+.+...+++.|.......+  
T Consensus       212 ~~------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          212 PA------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             ----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cc------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            21      122345578999999999998875 569999999999999999999999999999999988875322211  


Q ss_pred             -----------------------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          286 -----------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       286 -----------------------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                                                   ..++++++|||.+||+.||.+|||+     +++++||||+...
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~  352 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA-----AAALRHPFLAKYH  352 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSGGGTTTC
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH-----HHHhcCHhhCcCC
Confidence                                         2468999999999999999999998     8999999998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.4e-60  Score=469.26  Aligned_cols=265  Identities=27%  Similarity=0.475  Sum_probs=205.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      ++||++++.||+|+||+||+|+++.+|+.||||++....  .+.....+.+|+.+|+.++|||||+++++|.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            468999999999999999999999999999999997653  3444566888999999999999999999997544     


Q ss_pred             -------eEEEEEeccCCCChHHHHhhcCCC---CHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEe
Q 010859          129 -------SLYMALESCEGGELFDQITSKGHL---SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD  198 (499)
Q Consensus       129 -------~l~lv~E~~~gg~L~~~i~~~~~l---~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~D  198 (499)
                             .+|+|||||+||+|.+++...+.+   ++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   489999999999999999877553   4567899999999999999999999999999999999999999999


Q ss_pred             cCCccccCCccccc--cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHH
Q 010859          199 FGSVKPMQDSRITV--LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQ  275 (499)
Q Consensus       199 FG~a~~~~~~~~~~--~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~  275 (499)
                      ||+|+.+.......  ...........+.+||+.|||||++.+..|+.++|||||||++|||++   ||.+..+. ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            99999876543211  011112234456799999999999999999999999999999999996   88654332 2233


Q ss_pred             HHHhcCCCCCC---CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          276 RIIARDIRFPN---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       276 ~i~~~~~~~p~---~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      .+.  ...+|.   ..++.+.+||.+||+.||.+|||+     +++++||||++++|.
T Consensus       239 ~~~--~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~eil~h~~~~~~~~p  289 (299)
T 4g31_A          239 DVR--NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-----INIIENAVFEDLDFP  289 (299)
T ss_dssp             HHH--TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGCCC---
T ss_pred             HHh--cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCH-----HHHhcCHhhCCCCCC
Confidence            333  334443   346778999999999999999998     899999999999984

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-57  Score=460.98  Aligned_cols=281  Identities=37%  Similarity=0.645  Sum_probs=254.7

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +.+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+|+.++||||++++++|++...+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            46789999999999999999999999999999999998765544455667788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....   
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---  158 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---  158 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT---
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC---
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999753221   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChH
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  291 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  291 (499)
                             .....+++||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+....++.+......+|..++++
T Consensus       159 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  231 (337)
T 1o6l_A          159 -------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE  231 (337)
T ss_dssp             -------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             -------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence                   1234467999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  342 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~  342 (499)
                      +++||.+||+.||.+||++...+++++++||||.+++|+.+... ..|++.|
T Consensus       232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p  283 (337)
T 1o6l_A          232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP  283 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCC
Confidence            99999999999999999876667799999999999999988653 3444433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.1e-58  Score=466.65  Aligned_cols=282  Identities=33%  Similarity=0.609  Sum_probs=253.8

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      ..+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+..|+.++..+ +||+|++++++|++..
T Consensus        15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            456789999999999999999999999999999999999876554555566778899999887 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999753221


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  288 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  288 (499)
                                .....+++||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+...++++|....+.+|..+
T Consensus       175 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~  244 (353)
T 2i0e_A          175 ----------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM  244 (353)
T ss_dssp             ----------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred             ----------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence                      2234467999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLA  341 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~  341 (499)
                      ++++.+||.+||+.||.+||++...+++++++||||++++|+.+... .+|++.
T Consensus       245 s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~  298 (353)
T 2i0e_A          245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYK  298 (353)
T ss_dssp             CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcC
Confidence            99999999999999999999987778899999999999999998653 344443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.6e-58  Score=467.01  Aligned_cols=283  Identities=33%  Similarity=0.646  Sum_probs=248.7

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      ..+.+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+..|+.+++.+ +||||++++++|++..
T Consensus        18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            356789999999999999999999999999999999999887655566667788899999988 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999753221


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  288 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  288 (499)
                                .....+++||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++++|....+.+|..+
T Consensus       178 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~  247 (353)
T 3txo_A          178 ----------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL  247 (353)
T ss_dssp             ------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred             ----------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence                      2334567999999999999988899999999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCC-CCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAG-PGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  342 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~-~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~  342 (499)
                      ++++.+||.+||+.||.+||++. ..+.+++++||||++++|+.+... ..|++.|
T Consensus       248 ~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p  303 (353)
T 3txo_A          248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRP  303 (353)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccC
Confidence            99999999999999999999983 356789999999999999998643 3444433

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.7e-58  Score=495.82  Aligned_cols=261  Identities=28%  Similarity=0.481  Sum_probs=238.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++.+..   ......+.+|+.+|+.++|||||+++++|++...+|+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            578999999999999999999999999999999997753   33456688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC--CCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~--~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+++.. .+.|++..++.|+.||+.||+|||++||+||||||+|||++.+  +++||+|||+|+.+...  
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence            999999999999864 4679999999999999999999999999999999999999865  89999999999876432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                               ....+.+||+.|||||++.+..|+.++||||||||+|+|++|++||.+.+..+++.+|....+.+|    .
T Consensus       311 ---------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  381 (573)
T 3uto_A          311 ---------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS  381 (573)
T ss_dssp             ---------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGT
T ss_pred             ---------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccccc
Confidence                     233467999999999999999999999999999999999999999999999999999999887776    4


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                      .+|+++++||.+||+.||.+|||+     +++++||||+..+|....
T Consensus       382 ~~s~~~~dli~~~L~~dp~~R~t~-----~e~l~Hpw~~~~~~~~~~  423 (573)
T 3uto_A          382 GISEDGKDFIRKLLLADPNTRMTI-----HQALEHPWLTPGNAPGRD  423 (573)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSTTTSCCCCTTTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcCcCCCCCCCch
Confidence            689999999999999999999998     899999999988886543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.7e-58  Score=468.90  Aligned_cols=262  Identities=28%  Similarity=0.443  Sum_probs=212.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCe
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~  129 (499)
                      .++|++++.||+|+||+||+|+++   .+++.||+|++.+..     ....+.+|+.+|+.+ +|||||+++++|++...
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            367999999999999999999985   467899999986542     234567799999988 69999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-CCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-~~vkL~DFG~a~~~~~~  208 (499)
                      +|+|||||+||+|.+++.   .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+.....
T Consensus        95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            999999999999999984   49999999999999999999999999999999999999877 89999999999876543


Q ss_pred             cccccCC------------------CCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCC-C
Q 010859          209 RITVLPN------------------AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKD-T  268 (499)
Q Consensus       209 ~~~~~~~------------------~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~-~  268 (499)
                      .......                  ........+.+||+.|||||++.+. .|+.++||||+|||+|+|++|++||.. .
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            3211100                  0011234567999999999999876 489999999999999999999999954 4


Q ss_pred             CHHHHHHHHHhc--------------------------------------CC----------------CCCCCCChHHHH
Q 010859          269 SEWLIFQRIIAR--------------------------------------DI----------------RFPNYFSDAARD  294 (499)
Q Consensus       269 ~~~~~~~~i~~~--------------------------------------~~----------------~~p~~~~~~~~~  294 (499)
                      ++..++..|...                                      ..                .....+|++++|
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            555555444320                                      00                112357899999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      ||.+||+.||.+||||     +++++||||++++
T Consensus       332 Ll~~lL~~dP~~R~ta-----~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          332 LLDKLLDLNPASRITA-----EEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHTCSCTTTSCCH-----HHHHTSGGGTTC-
T ss_pred             HHHHHCcCChhHCcCH-----HHHhcCcccCCCC
Confidence            9999999999999999     8999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-57  Score=469.66  Aligned_cols=283  Identities=35%  Similarity=0.697  Sum_probs=248.7

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      ..+..++|+++++||+|+||.||+|+++.+++.||+|++.+...........+..|+.++..+ +||||++++++|++..
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            356688999999999999999999999999999999999987766665566677899888776 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+|||||+||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999753221


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC---------CHHHHHHHHHh
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---------SEWLIFQRIIA  279 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~---------~~~~~~~~i~~  279 (499)
                                .....+++||+.|+|||++.+..++.++|||||||++|+|++|++||...         .....++.+..
T Consensus       207 ----------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          207 ----------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             ----------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             ----------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence                      23345789999999999999999999999999999999999999999632         34557788889


Q ss_pred             cCCCCCCCCChHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 010859          280 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  342 (499)
Q Consensus       280 ~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~-~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~  342 (499)
                      ..+.+|..+++++++||.+||+.||.+||++.. .+++++++||||++++|+.+... .+|++.|
T Consensus       277 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p  341 (396)
T 4dc2_A          277 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP  341 (396)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCC
T ss_pred             cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcC
Confidence            999999999999999999999999999999853 46799999999999999998654 3444443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3e-57  Score=455.14  Aligned_cols=272  Identities=36%  Similarity=0.711  Sum_probs=251.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+.+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||++++++|++...+
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            35678999999999999999999999999999999999876554445566778899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....   
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999986432   


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                                ...+.+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....+.++....+.+|..+++
T Consensus       159 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~  228 (318)
T 1fot_A          159 ----------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE  228 (318)
T ss_dssp             ----------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred             ----------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence                      2335789999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ++.+||.+||+.||.+||++...+++++++||||++++|+.+...
T Consensus       229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~  273 (318)
T 1fot_A          229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSR  273 (318)
T ss_dssp             HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTT
T ss_pred             HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhC
Confidence            999999999999999999776666799999999999999998654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.2e-57  Score=463.07  Aligned_cols=282  Identities=36%  Similarity=0.648  Sum_probs=245.7

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHH-HHhCCCCCccEEEEEEEcCC
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      .....++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|..+ ++.++||||++++++|++..
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            35678899999999999999999999999999999999998876665555666667776 57789999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999853221


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  288 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  288 (499)
                                .....+++||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+...++++|......+|..+
T Consensus       193 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  262 (373)
T 2r5t_A          193 ----------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI  262 (373)
T ss_dssp             ----------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSS
T ss_pred             ----------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCC
Confidence                      2234568999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  342 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~  342 (499)
                      +.++++||.+||+.||.+||++. .+++++++||||++++|+.+... .+|++.|
T Consensus       263 ~~~~~~li~~lL~~dp~~R~~~~-~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p  316 (373)
T 2r5t_A          263 TNSARHLLEGLLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNP  316 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTTT-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CHHHHHHHHHHcccCHHhCCCCC-CCHHHHhCCccccCCCHHHHHhCCCCCCCCC
Confidence            99999999999999999999996 36789999999999999998654 3444433

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.3e-56  Score=453.73  Aligned_cols=275  Identities=36%  Similarity=0.708  Sum_probs=249.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCe
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~  129 (499)
                      .+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||++++++|++...
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            45678999999999999999999999999999999999988776666777788899999887 89999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... 
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-  163 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-  163 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999999753221 


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC---------CCHHHHHHHHHhc
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---------TSEWLIFQRIIAR  280 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~---------~~~~~~~~~i~~~  280 (499)
                               .....+.+||+.|+|||++.+..++.++|+|||||++|+|++|+.||..         ......++.+...
T Consensus       164 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  234 (345)
T 3a8x_A          164 ---------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  234 (345)
T ss_dssp             ---------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred             ---------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence                     1234467999999999999999999999999999999999999999975         3455677888889


Q ss_pred             CCCCCCCCChHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCC
Q 010859          281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       281 ~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~-~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ...+|..++.++++||.+||+.||.+||++.. .+++++++||||++++|+.+...
T Consensus       235 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~  290 (345)
T 3a8x_A          235 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQK  290 (345)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhC
Confidence            99999999999999999999999999999853 46789999999999999988653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-56  Score=454.75  Aligned_cols=273  Identities=36%  Similarity=0.644  Sum_probs=252.2

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ....+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||++++++|++...
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            34567899999999999999999999999999999999987655555556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....  
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--  193 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999986532  


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  289 (499)
                                 ...+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+++|....+.+|..++
T Consensus       194 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  262 (350)
T 1rdq_E          194 -----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS  262 (350)
T ss_dssp             -----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCC
T ss_pred             -----------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence                       223578999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      +++.+||.+||+.||.+||+....+++++++||||++++|..+...
T Consensus       263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~  308 (350)
T 1rdq_E          263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR  308 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTT
T ss_pred             HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhc
Confidence            9999999999999999999965556799999999999999988643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.9e-57  Score=450.22  Aligned_cols=257  Identities=20%  Similarity=0.348  Sum_probs=223.3

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      .+..++|.+.+.||+|+||+||+|++.     .++..||||++...   .......+.+|+.+|++++|||||++++++.
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            455689999999999999999999875     36889999999754   3344566888999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC
Q 010859          126 DTFSLYMALESCEGGELFDQITSK-------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG  192 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~-------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~  192 (499)
                      +...+|+|||||++|+|.+++.+.             ..+++..+..++.||+.||.|||+++|+||||||+||||+.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999764             3599999999999999999999999999999999999999999


Q ss_pred             CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHH
Q 010859          193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEW  271 (499)
Q Consensus       193 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~  271 (499)
                      ++||+|||+|+........        ......+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~--------~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~  237 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN  237 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCE--------EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             cEEECCcccceecCCCCce--------eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999865443211        12234579999999999999999999999999999999998 99999999999


Q ss_pred             HHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          272 LIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       272 ~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ++...+..+. +..|..+|+++.+|+.+||+.||++|||+     +++  |++++
T Consensus       238 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-----~~i--~~~L~  285 (299)
T 4asz_A          238 EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNI-----KGI--HTLLQ  285 (299)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHH--HHHHH
T ss_pred             HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH-----HHH--HHHHH
Confidence            9988888765 56888999999999999999999999988     666  34554

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.8e-57  Score=457.52  Aligned_cols=272  Identities=35%  Similarity=0.631  Sum_probs=245.6

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      ..+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+..|+.++..+ +||||++++++|++..
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            346689999999999999999999999999999999999876554444556677788888876 9999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999754221


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  288 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  288 (499)
                                .....+++||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+...++++|......+|..+
T Consensus       172 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~  241 (345)
T 1xjd_A          172 ----------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL  241 (345)
T ss_dssp             ----------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred             ----------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence                      1234567999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ++++++||.+||+.||.+||++.    .++++||||++++|+.+...
T Consensus       242 s~~~~~li~~lL~~dp~~R~~~~----~~i~~hp~f~~~~w~~l~~~  284 (345)
T 1xjd_A          242 EKEAKDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERK  284 (345)
T ss_dssp             CHHHHHHHHHHSCSSGGGSBTTB----SCGGGSGGGTTCCHHHHHTT
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCh----HHHHcCccccCCCHHHHhhC
Confidence            99999999999999999999983    27999999999999998653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-56  Score=451.36  Aligned_cols=254  Identities=21%  Similarity=0.327  Sum_probs=216.6

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      .+..+||.+.+.||+|+||+||+|+.+     .+++.||||++...   .......+.+|+.+|++++|||||++++++.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            455679999999999999999999875     46889999999654   3344566888999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC
Q 010859          126 DTFSLYMALESCEGGELFDQITSK---------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  190 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~---------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~  190 (499)
                      +...+|+|||||++|+|.+++.+.               +++++.++..|+.||+.||.|||+++|+||||||+||||+.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999999754               35899999999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCC
Q 010859          191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  269 (499)
Q Consensus       191 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~  269 (499)
                      ++++||+|||+|+.+.....        .......+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~--------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~  265 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDY--------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS  265 (329)
T ss_dssp             TTEEEECCCC------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred             CCcEEEcccccceeccCCCc--------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence            99999999999987643321        122335689999999999999999999999999999999999 999999999


Q ss_pred             HHHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          270 EWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       270 ~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ..+.+..+..+ .+.+|..+|+++.+|+.+||+.||++|||+     ++|+.
T Consensus       266 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-----~ei~~  312 (329)
T 4aoj_A          266 NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSI-----KDVHA  312 (329)
T ss_dssp             HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCH-----HHHHH
T ss_pred             HHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCH-----HHHHH
Confidence            98888888775 467889999999999999999999999988     66654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5e-56  Score=441.94  Aligned_cols=259  Identities=20%  Similarity=0.319  Sum_probs=209.8

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..+++++++.||+|+||+||+|+..   ..||||+++..... ......+.+|+.+|++++|||||++++++.+ ..+|
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            45678999999999999999999864   36999998654333 3345678889999999999999999998754 5689


Q ss_pred             EEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||||+||+|.+++... +++++..+..|+.||+.||.|||++||+||||||+||||+.++++||+|||+|+...... 
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~-  186 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS-  186 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC-
Confidence            999999999999999754 679999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCC---CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR----  283 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~----  283 (499)
                             ......+.+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.+.......+......    
T Consensus       187 -------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          187 -------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             -------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence                   1223346789999999999853   45899999999999999999999999987766555555544332    


Q ss_pred             --CCCCCChHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCC
Q 010859          284 --FPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPF  323 (499)
Q Consensus       284 --~p~~~~~~~~~Li~~lL~~dP~~R~~~~~-~~~~~l~~Hpf  323 (499)
                        +|..+|+++.+||.+||+.||++|||+.+ ...-++++|++
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence              34578999999999999999999999833 11113456665

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-55  Score=485.32  Aligned_cols=283  Identities=33%  Similarity=0.607  Sum_probs=254.7

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      ..+.+++|+++++||+|+||.||+|+++.+++.||||++.+...........+..|+.++..+ +||+|++++++|++..
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            456788999999999999999999999999999999999876554555556677889899887 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999853221


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  288 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  288 (499)
                                .....+++||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++++|....+.+|..+
T Consensus       496 ----------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  565 (674)
T 3pfq_A          496 ----------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM  565 (674)
T ss_dssp             ----------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTS
T ss_pred             ----------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccC
Confidence                      2234568999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  342 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~  342 (499)
                      ++++++||.+||+.||.+||++...+.++|++||||++++|+.+... .+|++.|
T Consensus       566 s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p  620 (674)
T 3pfq_A          566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP  620 (674)
T ss_dssp             CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCC
T ss_pred             CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCC
Confidence            99999999999999999999997777899999999999999998654 3444433

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.1e-55  Score=449.65  Aligned_cols=280  Identities=30%  Similarity=0.576  Sum_probs=248.6

Q ss_pred             CCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           49 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      ...+..++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||++++++|++..
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            34567899999999999999999999999999999999998765555555667888999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+...
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC---CCCCCCCcchhhhHHHHHHhcCCCCCCC---CCHHHHHHHHHhcCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDI  282 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~~~~sDiwslG~ilyelltG~~Pf~~---~~~~~~~~~i~~~~~  282 (499)
                                 ....+++||+.|+|||++.+   ..++.++|||||||++|+|++|+.||..   .........+.....
T Consensus       169 -----------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  237 (384)
T 4fr4_A          169 -----------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV  237 (384)
T ss_dssp             -----------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred             -----------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence                       23446789999999999864   4589999999999999999999999974   345566777788888


Q ss_pred             CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCCC
Q 010859          283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  343 (499)
Q Consensus       283 ~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~~  343 (499)
                      .+|..+++++.+||.+||+.||.+||++    ++++++||||++++|+.+... ..|++.|.
T Consensus       238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~----~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~  295 (384)
T 4fr4_A          238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVFQKRLIPGFIPN  295 (384)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCS----HHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred             CCCCcCCHHHHHHHHHHhcCCHhHhccc----HHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence            9999999999999999999999999984    489999999999999998653 34444443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.4e-56  Score=442.36  Aligned_cols=254  Identities=20%  Similarity=0.334  Sum_probs=221.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      +...++++++.||+|+||+||+|+..     .+++.||||++....  .......+.+|+.+|++++|||||++++++.+
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            55678999999999999999999863     467899999986542  22234567889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC
Q 010859          127 TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  190 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~  190 (499)
                      ...+|+|||||++|+|.+++...                +.+++..+..++.||+.||.|||+++|+||||||+||||+.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            99999999999999999999643                35899999999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCC
Q 010859          191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  269 (499)
Q Consensus       191 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~  269 (499)
                      ++++||+|||+|+.+.....        .....+.+||+.|||||++.+..++.++|||||||++|||+| |..||.+.+
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~--------~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADY--------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGC--------BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             CCCEEECCcccceeccCCCc--------eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999987644321        122345689999999999999999999999999999999998 899999999


Q ss_pred             HHHHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          270 EWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       270 ~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ..++.+.+..+. .+.|+.+|+++.+|+.+||+.||.+||++     .+|++
T Consensus       253 ~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~-----~ei~~  299 (308)
T 4gt4_A          253 NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF-----KDIHS  299 (308)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            999888887754 56788999999999999999999999988     66654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.1e-55  Score=459.74  Aligned_cols=274  Identities=36%  Similarity=0.645  Sum_probs=241.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++++.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++..++||||++++++|++...+
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            45568999999999999999999999999999999999875444444444577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+....
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999999987 4789999999999999999999999999999999999999999999999999997654321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DI  282 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~  282 (499)
                               .......+||+.|+|||++.     ...++.++|||||||++|+|++|++||.+.+..+.+.+|...  .+
T Consensus       230 ---------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  300 (437)
T 4aw2_A          230 ---------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF  300 (437)
T ss_dssp             ---------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             ---------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence                     11233568999999999986     556899999999999999999999999999999999888753  45


Q ss_pred             CCCCC---CChHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          283 RFPNY---FSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       283 ~~p~~---~~~~~~~Li~~lL~~dP~~--R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                      .+|..   +++++++||++||+.+|++  |+++     +++++||||++++|+.+....||
T Consensus       301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~-----~eil~Hpff~~i~w~~l~~~~~p  356 (437)
T 4aw2_A          301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGI-----EDFKKHPFFSGIDWDNIRNCEAP  356 (437)
T ss_dssp             CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTT-----HHHHTSGGGTTCCTTTGGGSCCS
T ss_pred             cCCcccccCCHHHHHHHHHHhcccccccCCCCH-----HHHhCCCccCCCCHHHHhhCCCC
Confidence            66654   8999999999999998888  8887     99999999999999999765554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-55  Score=456.09  Aligned_cols=276  Identities=38%  Similarity=0.672  Sum_probs=241.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++++.||+|+||.||+|+++.+|+.||||++.+...........+..|+.++..++||||++++++|++...+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            45678999999999999999999999999999999999875544444455577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999999999998754 79999999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccC-------CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLN-------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--  280 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-------~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--  280 (499)
                               .......+||+.|+|||++.       ...++.++|||||||++|+|++|++||.+.+....+.+|...  
T Consensus       217 ---------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          217 ---------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             ---------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             ---------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence                     11233578999999999986       356899999999999999999999999999999998888763  


Q ss_pred             CCCCC---CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          281 DIRFP---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       281 ~~~~p---~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                      .+.+|   ..+|+++++||.+||+ +|.+|++.  .+++++++||||++++|+.+....||
T Consensus       288 ~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr--~~~~ei~~Hpff~~i~w~~l~~~~~p  345 (412)
T 2vd5_A          288 HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGR--GGAGDFRTHPFFFGLDWDGLRDSVPP  345 (412)
T ss_dssp             HCCCC----CCCHHHHHHHHTTSS-CGGGCTTT--TTHHHHHTSGGGTTCCSTTSTTSCCS
T ss_pred             CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhcCCCcCCCCHHHHhhcCCC
Confidence            34455   5799999999999999 99999864  25699999999999999999765444

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.3e-55  Score=458.75  Aligned_cols=283  Identities=37%  Similarity=0.643  Sum_probs=243.0

Q ss_pred             CCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           49 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      ...+..++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|..+++.++||||++++++|.+..
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~  221 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD  221 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence            34567789999999999999999999999999999999998765444445556677999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999999999988899999999999999999999998 9999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  287 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~  287 (499)
                      .          .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..
T Consensus       302 ~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~  371 (446)
T 4ejn_A          302 D----------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT  371 (446)
T ss_dssp             ---------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred             C----------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            1          123346789999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLA  341 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~  341 (499)
                      +++++.+||.+||+.||.+||+....+++++++||||++++|+.+... .+|++.
T Consensus       372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~  426 (446)
T 4ejn_A          372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFK  426 (446)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCcc
Confidence            999999999999999999999665556699999999999999987653 344433

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-54  Score=436.63  Aligned_cols=276  Identities=38%  Similarity=0.715  Sum_probs=239.3

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccch-hhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      ..+..++|++++.||+|+||.||+|++.   .+|+.||+|++.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3456789999999999999999999986   689999999998764432 233455677999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          126 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      +...+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999998754


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  285 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p  285 (499)
                      ...          .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......++......+|
T Consensus       172 ~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p  241 (327)
T 3a62_A          172 IHD----------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP  241 (327)
T ss_dssp             -----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred             ccC----------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            321          1223456899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ..+++++.+||.+||+.||.+||++...+++++++||||++++|+.+...
T Consensus       242 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~  291 (327)
T 3a62_A          242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR  291 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTT
T ss_pred             CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhc
Confidence            99999999999999999999999987667899999999999999987653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.4e-54  Score=460.90  Aligned_cols=283  Identities=29%  Similarity=0.549  Sum_probs=252.5

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|+++++||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||++++++|++...+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            46678999999999999999999999999999999999877655555556778899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          131 YMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      |+||||++||+|.+++...    ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999998764    369999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC----CHHHHHHHHHhcCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIARDI  282 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~----~~~~~~~~i~~~~~  282 (499)
                      ...          .....++||+.|+|||++.+..++.++|||||||++|+|++|++||.+.    ....+.+.+.....
T Consensus       341 ~~~----------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~  410 (543)
T 3c4z_A          341 AGQ----------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV  410 (543)
T ss_dssp             TTC----------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred             CCC----------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence            321          2234568999999999999999999999999999999999999999875    45677888888889


Q ss_pred             CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCCC
Q 010859          283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  343 (499)
Q Consensus       283 ~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~~  343 (499)
                      .+|..+++++++||.+||+.||.+||++.+.+.+++++||||++++|+.+... ..|++.|.
T Consensus       411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~  472 (543)
T 3c4z_A          411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD  472 (543)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCC
Confidence            99999999999999999999999999987777799999999999999998653 34444443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.5e-55  Score=452.64  Aligned_cols=268  Identities=38%  Similarity=0.624  Sum_probs=237.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|++...+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            35578999999999999999999999999999999999875444444445577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||+||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.... 
T Consensus       145 ~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-  222 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-  222 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred             EEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-
Confidence            9999999999999998764 69999999999999999999999999999999999999999999999999998654322 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCC----CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc--CCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRF  284 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~  284 (499)
                              .....+.+||+.|+|||++.+..    ++.++|||||||++|+|++|++||.+.+....+.+|...  .+.+
T Consensus       223 --------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  294 (410)
T 3v8s_A          223 --------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF  294 (410)
T ss_dssp             --------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             --------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence                    11234678999999999997665    788999999999999999999999999999999998864  3555


Q ss_pred             CC--CCChHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          285 PN--YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       285 p~--~~~~~~~~Li~~lL~~dP~~--R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                      |.  .+++++++||.+||+.+|.+  |+++     +++++||||++++|+.+.
T Consensus       295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~-----~ei~~Hp~f~~~~w~~~~  342 (410)
T 3v8s_A          295 PDDNDISKEAKNLICAFLTDREVRLGRNGV-----EEIKRHLFFKNDQWAWET  342 (410)
T ss_dssp             CTTCCCCHHHHHHHHHHSSCGGGCTTSSCH-----HHHHTSGGGCCSSCCSTT
T ss_pred             CCcccccHHHHHHHHHHccChhhhCCCCCH-----HHHhcCccccCCCHHHHh
Confidence            54  68999999999999988888  8877     999999999999998654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.1e-54  Score=431.61  Aligned_cols=261  Identities=32%  Similarity=0.543  Sum_probs=239.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++++.||+|+||.||+|++..+|+.||||++.+..... .....+.+|+.+|+.++||||+++++++.+...+
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            345789999999999999999999999999999999998765433 3445677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......  
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--  167 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--  167 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999765432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCC-CCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT-FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~-~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  289 (499)
                               ......+||+.|+|||++.+..+. .++|||||||++|+|++|++||.+.+......++....+.+|..++
T Consensus       168 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s  238 (328)
T 3fe3_A          168 ---------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS  238 (328)
T ss_dssp             ---------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred             ---------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence                     233467899999999999887764 7899999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      +++.+||.+||+.||.+|||+     +++++||||+...
T Consensus       239 ~~~~~li~~~L~~dP~~R~t~-----~eil~h~~~~~~~  272 (328)
T 3fe3_A          239 TDCENLLKRFLVLNPIKRGTL-----EQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHHHHHCCSSTTTSCCH-----HHHTTCTTTTTTC
T ss_pred             HHHHHHHHHHCCCChhHCcCH-----HHHhcCHhhcCCC
Confidence            999999999999999999998     9999999998654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.1e-54  Score=462.75  Aligned_cols=282  Identities=32%  Similarity=0.544  Sum_probs=250.9

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||.||+|+++.+|+.||+|++.+..+........+.+|+.+|+.++||||++++++|++...+
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            46678999999999999999999999999999999999877655555566778899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |+||||++||+|.+++...+.  +++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+...
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999999987644  999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC----HHHHHHHHHhcCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQRIIARDIRF  284 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~----~~~~~~~i~~~~~~~  284 (499)
                                 ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+    ...+.+.+......+
T Consensus       340 -----------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~  408 (576)
T 2acx_A          340 -----------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY  408 (576)
T ss_dssp             -----------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC
T ss_pred             -----------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC
Confidence                       12335689999999999999899999999999999999999999998753    456677778888889


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  343 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~~~~  343 (499)
                      |..+++++++||.+||+.||.+||++...+++++++||||++++|+.+... .+|++.|.
T Consensus       409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~  468 (576)
T 2acx_A          409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPD  468 (576)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCC
Confidence            999999999999999999999999876667799999999999999998653 34444443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-53  Score=434.36  Aligned_cols=263  Identities=29%  Similarity=0.521  Sum_probs=239.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+......   .....+.+|+.+|+.++||||++++++|.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            4679999999999999999999999999999999987654322   1345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC----CEEEEecCCccccC
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  206 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~----~vkL~DFG~a~~~~  206 (499)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    ++||+|||+++.+.
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999999888999999999999999999999999999999999999998877    79999999998654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  285 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-  285 (499)
                      ..           ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..|....+.++ 
T Consensus       171 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  239 (361)
T 2yab_A          171 DG-----------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE  239 (361)
T ss_dssp             TT-----------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             CC-----------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            32           123456899999999999999999999999999999999999999999999999999998888776 


Q ss_pred             ---CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 010859          286 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  332 (499)
Q Consensus       286 ---~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~  332 (499)
                         ..+++++++||.+||+.||.+|||+     +++++||||++++|...
T Consensus       240 ~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~~~~~~~  284 (361)
T 2yab_A          240 EFFSQTSELAKDFIRKLLVKETRKRLTI-----QEALRHPWITPVDTQQA  284 (361)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTSCSSHHHH
T ss_pred             hhccCCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCcCcCCCchhhh
Confidence               5689999999999999999999998     89999999999998754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-54  Score=439.81  Aligned_cols=255  Identities=24%  Similarity=0.382  Sum_probs=216.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCC-----CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC-CCccEEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQ  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t-----~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~l~~~~~  125 (499)
                      +..++|++++.||+|+||+||+|.+..+     ++.||||.+.....  ......+.+|+.+|.++.| ||||++++++.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            4568999999999999999999998654     36799999876532  2334567789999999965 89999999986


Q ss_pred             c-CCeEEEEEeccCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee
Q 010859          126 D-TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL  188 (499)
Q Consensus       126 ~-~~~l~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl  188 (499)
                      + ...+|+|||||++|+|.+++.+.                ..+++..+..|+.||+.||+|||+++|+||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            5 56799999999999999999753                348999999999999999999999999999999999999


Q ss_pred             CCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCC
Q 010859          189 TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD  267 (499)
Q Consensus       189 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~  267 (499)
                      +.++++||+|||+|+.+....        ......+.+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~--------~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDP--------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCT--------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CCCCCEEECcchhhhhcccCC--------CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999998764332        1123346789999999999999999999999999999999998 9999998


Q ss_pred             CCHH-HHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          268 TSEW-LIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       268 ~~~~-~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      .+.. ...+.+..+ .+.+|+.+++++.+|+.+||+.||++|||+     ++|++|
T Consensus       291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~-----~eil~~  341 (353)
T 4ase_A          291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  341 (353)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCH-----HHHHHH
Confidence            7643 344444443 467889999999999999999999999988     778776

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=414.07  Aligned_cols=263  Identities=30%  Similarity=0.523  Sum_probs=236.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.+......   .....+.+|+.+++.++||||+++++++.+...+
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4679999999999999999999999999999999987643321   1345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC----CEEEEecCCccccC
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  206 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~----~vkL~DFG~a~~~~  206 (499)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.+.
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999999888899999999999999999999999999999999999999887    89999999998654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  285 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-  285 (499)
                      ..           ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....+.++ 
T Consensus       170 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (326)
T 2y0a_A          170 FG-----------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  238 (326)
T ss_dssp             TT-----------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             CC-----------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc
Confidence            32           122356799999999999999999999999999999999999999999999888888888777766 


Q ss_pred             ---CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 010859          286 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  332 (499)
Q Consensus       286 ---~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~  332 (499)
                         ..++..+.+||.+||+.||.+|||+     +++++||||++.+|...
T Consensus       239 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~~~  283 (326)
T 2y0a_A          239 EYFSNTSALAKDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQA  283 (326)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSTTTSCCSHHHH
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCH-----HHHhcCCCccCCcchhh
Confidence               4689999999999999999999998     89999999998887543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.1e-53  Score=425.65  Aligned_cols=258  Identities=33%  Similarity=0.537  Sum_probs=232.2

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            45689999999999999999999999999999999998765444444456888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~---  161 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---  161 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC---
Confidence            999999 6799999988889999999999999999999999999999999999999999999999999999865432   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                              ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.......+.+....+.+|..+++
T Consensus       162 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  233 (336)
T 3h4j_B          162 --------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP  233 (336)
T ss_dssp             --------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCH
T ss_pred             --------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCH
Confidence                    22345689999999999988776 789999999999999999999999877666666666677888999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ++.+||.+||+.||.+|||+     +++++||||+.
T Consensus       234 ~~~~li~~~L~~dP~~Rpt~-----~eil~hp~~~~  264 (336)
T 3h4j_B          234 GAQSLIRRMIVADPMQRITI-----QEIRRDPWFNV  264 (336)
T ss_dssp             HHHHHHHTTSCSSGGGSCCH-----HHHTTCHHHHT
T ss_pred             HHHHHHHHHcCCChhHCcCH-----HHHHhChhhcc
Confidence            99999999999999999998     99999999974

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-51  Score=430.27  Aligned_cols=257  Identities=33%  Similarity=0.572  Sum_probs=232.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999998765433 3345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC---CCCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~---~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+...... 
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-  167 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-  167 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-
Confidence            99999999999999988999999999999999999999999999999999999998   45789999999997654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  286 (499)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....++.+..+.+.+|.    
T Consensus       168 ---------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  238 (444)
T 3soa_A          168 ---------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD  238 (444)
T ss_dssp             ---------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred             ---------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc
Confidence                     2233578999999999999999999999999999999999999999999999999999998887764    


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+++++++||.+||+.||.+||++     +++++||||++
T Consensus       239 ~~s~~~~~li~~~L~~dP~~Rpta-----~e~L~hp~~~~  273 (444)
T 3soa_A          239 TVTPEAKDLINKMLTINPSKRITA-----AEALKHPWISH  273 (444)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSCTTHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCH-----HHHhcCccccC
Confidence            689999999999999999999998     89999999974

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-51  Score=408.21  Aligned_cols=255  Identities=28%  Similarity=0.452  Sum_probs=227.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++......   ....+.+|..+++.++||||++++++|.+...+|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            46899999999999999999999999999999999765332   245577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||++||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......    
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  170 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  170 (297)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----
T ss_pred             EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc----
Confidence            9999999999999875 69999999999999999999999999999999999999999999999999998654321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCh
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  290 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~  290 (499)
                            ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...   ....|..+++
T Consensus       171 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T 3fxz_A          171 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (297)
T ss_dssp             ------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCH
T ss_pred             ------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCH
Confidence                  2334568999999999999999999999999999999999999999998887766665543   3455778999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      .+.+||.+||+.||.+||++     +++++||||+..
T Consensus       245 ~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~  276 (297)
T 3fxz_A          245 IFRDFLNRCLEMDVEKRGSA-----KELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHHHHSCSSTTTSCCH-----HHHTTCGGGGGC
T ss_pred             HHHHHHHHHccCChhHCcCH-----HHHhhChhhccc
Confidence            99999999999999999998     999999999853

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.2e-51  Score=418.58  Aligned_cols=256  Identities=32%  Similarity=0.576  Sum_probs=232.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999998765543 3345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC---CEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~---~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++......  
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~--  184 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--  184 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--
Confidence            99999999999999888899999999999999999999999999999999999998654   5999999999865432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  286 (499)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..+....+.+|.    
T Consensus       185 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (362)
T 2bdw_A          185 ---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD  255 (362)
T ss_dssp             ---------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred             ---------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                     1223568999999999999999999999999999999999999999999999999999988887764    


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+++++++||.+||+.||.+||++     +++++||||.+
T Consensus       256 ~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~  290 (362)
T 2bdw_A          256 TVTPEAKSLIDSMLTVNPKKRITA-----DQALKVPWICN  290 (362)
T ss_dssp             GSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCcccCC
Confidence            579999999999999999999998     89999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.1e-51  Score=402.34  Aligned_cols=260  Identities=33%  Similarity=0.609  Sum_probs=236.8

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..+..++|++++.||+|+||.||+|.+..++..||+|++.+...........+.+|..+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            35678999999999999999999999999999999999977655444456678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--  161 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  161 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999865332  


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  289 (499)
                                .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.....+.+......+|..++
T Consensus       162 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T 3fdn_A          162 ----------SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT  231 (279)
T ss_dssp             ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred             ----------ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCC
Confidence                      1223568999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +++.+||.+||+.||.+||++     +++++||||++
T Consensus       232 ~~~~~li~~~l~~~p~~Rps~-----~e~l~h~~~~~  263 (279)
T 3fdn_A          232 EGARDLISRLLKHNPSQRPML-----REVLEHPWITA  263 (279)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCH-----HHHHHCHHHHH
T ss_pred             HHHHHHHHHHhccChhhCCCH-----HHHhhCccccC
Confidence            999999999999999999998     99999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-51  Score=434.23  Aligned_cols=261  Identities=32%  Similarity=0.549  Sum_probs=239.4

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      .....++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            34667899999999999999999999999999999999987654444455678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999999865432 


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  288 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  288 (499)
                                ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+.++..+.+..|..+
T Consensus       170 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  239 (476)
T 2y94_A          170 ----------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL  239 (476)
T ss_dssp             ----------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTC
T ss_pred             ----------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccC
Confidence                      22345689999999999988775 6889999999999999999999999998899999999999999999


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ++++.+||.+||+.||.+|||+     +++++||||+.
T Consensus       240 s~~~~~Li~~~L~~dP~~Rpt~-----~eil~hp~~~~  272 (476)
T 2y94_A          240 NPSVISLLKHMLQVDPMKRATI-----KDIREHEWFKQ  272 (476)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCH-----HHHHTCHHHHT
T ss_pred             CHHHHHHHHHHcCCCchhCcCH-----HHHHhCHHhhh
Confidence            9999999999999999999998     89999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-51  Score=418.37  Aligned_cols=280  Identities=38%  Similarity=0.695  Sum_probs=239.5

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccc-hhhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQL-DHPGVVRLFFTF  124 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~  124 (499)
                      ..+..++|++++.||+|+||.||+|++.   .+|+.||||++.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            4566789999999999999999999995   58999999998754321 112223355688889988 699999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          125 QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      .+...+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCC--CCCCCCCcchhhhHHHHHHhcCCCCCCCC----CHHHHHHHHH
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRII  278 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDiwslG~ilyelltG~~Pf~~~----~~~~~~~~i~  278 (499)
                      +....         ......++||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...    ....+.+.+.
T Consensus       209 ~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  279 (355)
T 1vzo_A          209 FVADE---------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  279 (355)
T ss_dssp             CCGGG---------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             cccCC---------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence            54321         122335789999999999986  34788999999999999999999999743    3455666777


Q ss_pred             hcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          279 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       279 ~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                      .....+|..++..+.+||.+||+.||.+||++...+++++++||||..++|+.+..+..|
T Consensus       280 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~  339 (355)
T 1vzo_A          280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP  339 (355)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCC
Confidence            788889999999999999999999999999766556799999999999999998776544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.9e-51  Score=403.55  Aligned_cols=261  Identities=34%  Similarity=0.618  Sum_probs=238.5

Q ss_pred             CCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           49 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      ...+..++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|..+++.++||||+++++++.+..
T Consensus         8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A            8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            45677899999999999999999999999999999999997764444444566888999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999998654321


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  288 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  288 (499)
                                  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......+|..+
T Consensus       168 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T 2vgo_A          168 ------------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL  235 (284)
T ss_dssp             ------------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTS
T ss_pred             ------------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcC
Confidence                        22356799999999999999999999999999999999999999999999888889998899999999


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +.++.+||.+||+.||.+||++     +++++||||+.
T Consensus       236 ~~~~~~li~~~l~~~p~~Rps~-----~~ll~h~~~~~  268 (284)
T 2vgo_A          236 SDGSKDLISKLLRYHPPQRLPL-----KGVMEHPWVKA  268 (284)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCH-----HHHHTCHHHHH
T ss_pred             CHHHHHHHHHHhhcCHhhCCCH-----HHHhhCHHHHh
Confidence            9999999999999999999998     89999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-51  Score=412.80  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=230.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            47899999999999999999999999999999998643    23345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC--CCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~--~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.+...  
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--  157 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence            9999999999999875 46999999999999999999999999999999999999987  789999999999876432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  286 (499)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+....+.++.    
T Consensus       158 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (321)
T 1tki_A          158 ---------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK  228 (321)
T ss_dssp             ---------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             ---------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence                     2234568999999999999988999999999999999999999999999999999999998887763    


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .++.++.+||.+||..||.+|||+     +++++||||+.
T Consensus       229 ~~s~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~  263 (321)
T 1tki_A          229 EISIEAMDFVDRLLVKERKSRMTA-----SEALQHPWLKQ  263 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH-----HHHhcChhhcc
Confidence            689999999999999999999998     89999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-50  Score=400.99  Aligned_cols=257  Identities=27%  Similarity=0.426  Sum_probs=219.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            46899999999999999999999999999999999876533 33445677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....    
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~----  154 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP----  154 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC----
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc----
Confidence            999986 66665554 578999999999999999999999999999999999999999999999999999865422    


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCC-CCCCCHHHHHHHHHhcCC--------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIARDI--------  282 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~P-f~~~~~~~~~~~i~~~~~--------  282 (499)
                            .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.......+.....        
T Consensus       155 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          155 ------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             ------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred             ------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence                  12233568999999999997766 79999999999999999987777 666676666666654210        


Q ss_pred             ---------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          283 ---------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       283 ---------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                           ..+..+++++++||.+||+.||.+|||+     +++++||||+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~  289 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYFSDF  289 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTC
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH-----HHHhcCcccccC
Confidence                                 1123478999999999999999999998     999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.4e-51  Score=419.79  Aligned_cols=270  Identities=23%  Similarity=0.362  Sum_probs=223.7

Q ss_pred             CCCCeeeeeEeeec--CceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           53 SIQDFELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        53 ~~~~y~~~~~LG~G--~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ..++|++++.||+|  +||.||+|+++.+|+.||||++...... ......+.+|+.+++.++||||++++++|.+...+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            35789999999999  9999999999999999999999876543 34556778899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |+|||||++|+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            9999999999999999876  67999999999999999999999999999999999999999999999999998755332


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC--CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  281 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----  281 (499)
                      ....   ..........+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......+....     
T Consensus       182 ~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          182 GQRQ---RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             TEEC---SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             cccc---cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            1110   001122234589999999999987  578999999999999999999999998766554443332211     


Q ss_pred             -----------------------------------------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          282 -----------------------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       282 -----------------------------------------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                                                               ..++..+++++.+||.+||+.||.+|||+     +++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~ell~  333 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA-----STLLN  333 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH-----HHHTT
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH-----HHHhc
Confidence                                                     12455689999999999999999999998     89999


Q ss_pred             CCCCCCCCccc
Q 010859          321 HPFFKGIDWKN  331 (499)
Q Consensus       321 Hpff~~i~~~~  331 (499)
                      ||||+++.|..
T Consensus       334 hp~f~~~~~~~  344 (389)
T 3gni_B          334 HSFFKQIKRRA  344 (389)
T ss_dssp             SGGGGGC---C
T ss_pred             CHHHHHHhhcc
Confidence            99999887753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-50  Score=405.23  Aligned_cols=261  Identities=26%  Similarity=0.401  Sum_probs=218.8

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      -..++|++++.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            34689999999999999999999995 589999999975532 2334456778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  173 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-  173 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred             EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence            99999985 888887765 459999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC------
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR------  283 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~------  283 (499)
                               ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......      
T Consensus       174 ---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  244 (311)
T 3niz_A          174 ---------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW  244 (311)
T ss_dssp             ---------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred             ---------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence                     22234578999999999876 56899999999999999999999999988776666665431100      


Q ss_pred             ------------------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          284 ------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       284 ------------------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                                              +...+++++.+||.+||+.||.+|||+     +++++||||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~  310 (311)
T 3niz_A          245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA-----RDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTSCTT
T ss_pred             hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH-----HHHhcCcccccCCcc
Confidence                                    123468899999999999999999998     999999999998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-50  Score=404.35  Aligned_cols=263  Identities=29%  Similarity=0.512  Sum_probs=237.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.+......   .....+.+|+.+++.++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4679999999999999999999999999999999987643322   1345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC----CEEEEecCCccccC
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  206 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~----~vkL~DFG~a~~~~  206 (499)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    ++||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999999888899999999999999999999999999999999999999888    79999999998654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  285 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-  285 (499)
                      ..           .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....+.++ 
T Consensus       171 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          171 DG-----------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE  239 (321)
T ss_dssp             TT-----------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             cc-----------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence            32           122356799999999999999999999999999999999999999999999888888888777665 


Q ss_pred             ---CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 010859          286 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  332 (499)
Q Consensus       286 ---~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~  332 (499)
                         ..++..+.+||.+||+.||.+||++     +++++||||.+++|...
T Consensus       240 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~hp~~~~~~~~~~  284 (321)
T 2a2a_A          240 EFFSHTSELAKDFIRKLLVKETRKRLTI-----QEALRHPWITPVDNQQA  284 (321)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSTTTSCCH-----HHHHHSTTTSCSSHHHH
T ss_pred             hhhcccCHHHHHHHHHHcCCChhhCcCH-----HHHhcCccccCCCcccc
Confidence               4689999999999999999999998     89999999999888654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.2e-51  Score=411.19  Aligned_cols=263  Identities=25%  Similarity=0.368  Sum_probs=218.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++.+...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            45578999999999999999999999999999999998765332 22344566799999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC-----CCCCEEEEecCCcccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-----ADGHIKIADFGSVKPM  205 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~-----~~~~vkL~DFG~a~~~  205 (499)
                      |+||||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||+++..
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999999985 9999999988899999999999999999999999999999999999994     4456999999999865


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-  283 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~-  283 (499)
                      ....          ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+...... 
T Consensus       188 ~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          188 GIPI----------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             C---------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             CCcc----------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            4221          223345789999999999875 4899999999999999999999999999988877777642110 


Q ss_pred             -----------------C------------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          284 -----------------F------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       284 -----------------~------------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                                       +            +..+++++.+||.+||+.||.+|||+     +++++||||++++|+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA-----KNALEHPYFSHNDFD  328 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSSCSC
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH-----HHHhCCcccCCCCCC
Confidence                             0            11267899999999999999999998     999999999999996

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-50  Score=415.82  Aligned_cols=267  Identities=29%  Similarity=0.467  Sum_probs=212.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC--eE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF--SL  130 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~--~l  130 (499)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.+.... ........+|+.+++.+. ||||++++++|....  .+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            57899999999999999999999999999999999765333 334455677999999997 999999999997544  79


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||+ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+.....
T Consensus        87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            99999997 599998876 4799999999999999999999999999999999999999999999999999987643211


Q ss_pred             ccc-----------CCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 010859          211 TVL-----------PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  278 (499)
Q Consensus       211 ~~~-----------~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~  278 (499)
                      ...           ...........++||+.|+|||++.+ ..++.++||||||||+|+|++|++||.+.+....+..|.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            000           00011223456799999999999976 678999999999999999999999999999888877775


Q ss_pred             hcCC-----------------------------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          279 ARDI-----------------------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       279 ~~~~-----------------------------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      ..-.                                               ..+..+++++.+||.+||+.||.+|||+ 
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~-  323 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA-  323 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH-
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH-
Confidence            3110                                               0112578999999999999999999998 


Q ss_pred             CCCHHHHhcCCCCCCCC
Q 010859          312 PGGYAVLKMHPFFKGID  328 (499)
Q Consensus       312 ~~~~~~l~~Hpff~~i~  328 (499)
                          +++++||||+.+.
T Consensus       324 ----~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          324 ----NDALKHPFVSIFH  336 (388)
T ss_dssp             ----HHHTTSTTTTTTC
T ss_pred             ----HHHhCCHHHHHhc
Confidence                9999999998654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1e-50  Score=413.04  Aligned_cols=261  Identities=32%  Similarity=0.499  Sum_probs=226.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh--hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ..++|++++.||+|+||+||+|.++.+|+.||||++.+......  .....+.+|+.+++.++||||+++++++.+...+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34689999999999999999999999999999999975432211  1345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC---EEEEecCCcc
Q 010859          131 YMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVK  203 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~---vkL~DFG~a~  203 (499)
                      |+|||||+||+|.+.+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999998887643    35899999999999999999999999999999999999987654   9999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR  283 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~  283 (499)
                      ......          ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ....+..+....+.
T Consensus       182 ~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~  250 (351)
T 3c0i_A          182 QLGESG----------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYK  250 (351)
T ss_dssp             ECCTTS----------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCC
T ss_pred             EecCCC----------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCC
Confidence            764321          1233568999999999999999999999999999999999999999885 45667777777766


Q ss_pred             CC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          284 FP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       284 ~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      ++    ..+++++++||.+||+.||.+||++     +++++||||++.++
T Consensus       251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          251 MNPRQWSHISESAKDLVRRMLMLDPAERITV-----YEALNHPWLKERDR  295 (351)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHTHHH
T ss_pred             CCccccccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcChhhcCCcc
Confidence            65    4689999999999999999999998     89999999986543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-51  Score=408.57  Aligned_cols=248  Identities=21%  Similarity=0.278  Sum_probs=193.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----eE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----SL  130 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~----~l  130 (499)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++....    ......+.|+..+..++|||||++++++.++.    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4799999999999999999987  68999999986532    22223344565667889999999999997653    68


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------GLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~--------gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      |+|||||+||+|.+++.+. .++++.+..++.|++.||.|||++        +|+||||||+||||+.++++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999999875 699999999999999999999987        9999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCC------CCCCCCcchhhhHHHHHHhcCCCCCCCC--------
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS------PATFGNDLWALGCTLYQMLSGTSPFKDT--------  268 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~------~~~~~sDiwslG~ilyelltG~~Pf~~~--------  268 (499)
                      +........      ......+.+||+.|||||++.+.      .++.++|||||||++|||+||.+||...        
T Consensus       156 ~~~~~~~~~------~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          156 VRHDSATDT------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             EEEETTTTE------ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             ccccCCCCc------eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            876543211      11223356899999999999765      3567899999999999999998766422        


Q ss_pred             -------CHHHHHHHHHhcC--CCCCCCC-----ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          269 -------SEWLIFQRIIARD--IRFPNYF-----SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       269 -------~~~~~~~~i~~~~--~~~p~~~-----~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                             ........+....  +.+|...     +..+.+|+.+||+.||++|||+     .++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ei~~  290 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKK  290 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH-----HHHHH
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH-----HHHHH
Confidence                   1223333343332  2344432     2468899999999999999998     55653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-50  Score=423.68  Aligned_cols=274  Identities=24%  Similarity=0.331  Sum_probs=208.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE-----cCC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-----DTF  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~-----~~~  128 (499)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            4789999999999999999999999999999999976532 3344566788999999999999999999994     336


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.....
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            7999999985 699999998888999999999999999999999999999999999999999999999999999876532


Q ss_pred             cccccC-----------------CCCCCCCccccccCccCCCcccc-CCCCCCCCCcchhhhHHHHHHhc----------
Q 010859          209 RITVLP-----------------NAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLS----------  260 (499)
Q Consensus       209 ~~~~~~-----------------~~~~~~~~~~~~Gt~~Y~aPE~l-~~~~~~~~sDiwslG~ilyellt----------  260 (499)
                      ......                 ...........+||+.|+|||++ .+..++.++||||||||+|+|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            211000                 00001234567999999999986 56679999999999999999999          


Q ss_pred             -CCCCCCCCCH--------------------HHHHHHHHhcC-------------------------------CCCCCCC
Q 010859          261 -GTSPFKDTSE--------------------WLIFQRIIARD-------------------------------IRFPNYF  288 (499)
Q Consensus       261 -G~~Pf~~~~~--------------------~~~~~~i~~~~-------------------------------~~~p~~~  288 (499)
                       |+++|.+.+.                    ...+..|...-                               .......
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7888877542                    22222222100                               0011345


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      ++++.+||.+||+.||.+|||+     +++++||||++++|.....
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~-----~e~L~Hp~f~~~~~~~~e~  410 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITI-----NECLAHPFFKEVRIAEVET  410 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTCCGGGCC
T ss_pred             CHHHHHHHHHHhccCccccCCH-----HHHhcCHhhhhcCCCccCC
Confidence            8999999999999999999998     8999999999999987654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8e-51  Score=412.47  Aligned_cols=256  Identities=34%  Similarity=0.560  Sum_probs=224.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.+....       ..+|+.++.++ +||||++++++|++...+|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            56899999999999999999999999999999999876432       23466677666 79999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC----CCEEEEecCCccccCCc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDS  208 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~----~~vkL~DFG~a~~~~~~  208 (499)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++.+...
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            99999999999999998899999999999999999999999999999999999998543    35999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC---CCHHHHHHHHHhcCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDIRFP  285 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~---~~~~~~~~~i~~~~~~~p  285 (499)
                      .          ....+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+   .+...++..+..+.+.++
T Consensus       174 ~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  243 (342)
T 2qr7_A          174 N----------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS  243 (342)
T ss_dssp             T----------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred             C----------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence            1          223457899999999999888889999999999999999999999986   456778888888877765


Q ss_pred             ----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          286 ----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       286 ----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                          ..+++++++||.+||..||.+||++     +++++||||.  +|+.+.
T Consensus       244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~--~~~~~~  288 (342)
T 2qr7_A          244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTA-----ALVLRHPWIV--HWDQLP  288 (342)
T ss_dssp             STTTTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHTTSHHHH--TGGGSC
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCCeec--Cccccc
Confidence                4689999999999999999999998     8999999995  576654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-50  Score=405.67  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=209.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            5789999999999999999999999999999999976532  22234567799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          134 LESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      |||++ |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            99998 5999988754      3599999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  281 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----  281 (499)
                      ..          ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+....     
T Consensus       161 ~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  230 (317)
T 2pmi_A          161 PV----------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE  230 (317)
T ss_dssp             CC----------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCT
T ss_pred             Cc----------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            21          122356799999999999764 68999999999999999999999999999888777765421     


Q ss_pred             -----------------------------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          282 -----------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       282 -----------------------------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                                                   ...+..++.++.+||.+||+.||.+|||+     +++++||||++..+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA-----KQALHHPWFAEYYHH  303 (317)
T ss_dssp             TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGGGGCC-
T ss_pred             hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH-----HHHhCChhhhcccch
Confidence                                         01123578899999999999999999998     899999999976654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-50  Score=399.86  Aligned_cols=258  Identities=36%  Similarity=0.624  Sum_probs=221.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh-----------------------hHHHHHHHHHHH
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------------------NKTAYVKLERIV  108 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~-----------------------~~~~~~~~E~~~  108 (499)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++.+......                       .....+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            456899999999999999999999999999999999987643221                       123457789999


Q ss_pred             HHhCCCCCccEEEEEEEc--CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCe
Q 010859          109 LDQLDHPGVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  186 (499)
Q Consensus       109 l~~l~hp~Iv~l~~~~~~--~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NI  186 (499)
                      ++.++||||+++++++.+  ...+|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999999986  6789999999999999886543 5799999999999999999999999999999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCC---CCCCCcchhhhHHHHHHhcCCC
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTS  263 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~---~~~~sDiwslG~ilyelltG~~  263 (499)
                      |++.++.+||+|||+++.+....          ......+||+.|+|||++.+..   ++.++|||||||++|+|++|+.
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSD----------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSS----------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             EECCCCCEEEecCCCcccccccc----------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            99999999999999998654321          1223468999999999998765   3778899999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          264 PFKDTSEWLIFQRIIARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       264 Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ||.+.+.......+......+|.  .+++++.+||.+||+.||.+||++     +++++||||+
T Consensus       239 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~-----~e~l~hp~~~  297 (298)
T 2zv2_A          239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV-----PEIKLHPWVT  297 (298)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH-----HHHTTCHHHH
T ss_pred             CCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCH-----HHHhcCcccc
Confidence            99998888888888777766664  689999999999999999999998     8999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.3e-50  Score=405.76  Aligned_cols=259  Identities=29%  Similarity=0.467  Sum_probs=220.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|++..+++.||+|++......  .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            58999999999999999999999999999999999765322  2234577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....   
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  160 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---  160 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc---
Confidence            99999999999999888899999999999999999999999999999999999999999999999999986543211   


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHhcCCCCC--CCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRFP--NYFS  289 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~~  289 (499)
                           .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.. ..+..........+  ..++
T Consensus       161 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (323)
T 3tki_A          161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID  235 (323)
T ss_dssp             -----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred             -----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCC
Confidence                 122335789999999999987765 77899999999999999999999876553 23333333332222  5689


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      +++.+||.+||+.||.+||++     +++++||||...
T Consensus       236 ~~~~~li~~~L~~dP~~R~t~-----~eil~h~~~~~~  268 (323)
T 3tki_A          236 SAPLALLHKILVENPSARITI-----PDIKKDRWYNKP  268 (323)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHTTCTTTTCC
T ss_pred             HHHHHHHHHHccCChhhCcCH-----HHHhhChhhccc
Confidence            999999999999999999998     999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-50  Score=412.87  Aligned_cols=257  Identities=30%  Similarity=0.529  Sum_probs=230.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++....   ......+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999997653   22344678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC--CCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~--~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.+...  
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--  204 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  204 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence            99999999999998654 6999999999999999999999999999999999999974  478999999999865432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++    .
T Consensus       205 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  275 (387)
T 1kob_A          205 ---------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS  275 (387)
T ss_dssp             ---------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred             ---------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                     122356899999999999999999999999999999999999999999999888888888776655    3


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      .+++++.+||.+||+.||.+||++     +++++||||++..+
T Consensus       276 ~~s~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~  313 (387)
T 1kob_A          276 SVSPEAKDFIKNLLQKEPRKRLTV-----HDALEHPWLKGDHS  313 (387)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSTTTSSCCT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH-----HHHhhCccccCCcc
Confidence            579999999999999999999998     89999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-49  Score=394.23  Aligned_cols=261  Identities=30%  Similarity=0.535  Sum_probs=239.8

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            34578999999999999999999999999999999998876666666677888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  169 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--  169 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--
Confidence            999999999999999888889999999999999999999999999999999999999999999999999998654221  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChH
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  291 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  291 (499)
                              .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+......+|..+++.
T Consensus       170 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T 2rku_A          170 --------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV  241 (294)
T ss_dssp             --------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred             --------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHH
Confidence                    223346799999999999998899999999999999999999999999998888888888889999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      +.+||.+||+.||.+||++     +++++||||...
T Consensus       242 ~~~li~~~l~~~p~~Rps~-----~~ll~~~~~~~~  272 (294)
T 2rku_A          242 AASLIQKMLQTDPTARPTI-----NELLNDEFFTSG  272 (294)
T ss_dssp             HHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHTS
T ss_pred             HHHHHHHHcccChhhCcCH-----HHHhhChheecC
Confidence            9999999999999999998     889999999754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=396.71  Aligned_cols=259  Identities=35%  Similarity=0.654  Sum_probs=207.3

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|..+++.++||||+++++++.+...+|+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            35789999999999999999999999999999999976544444445667889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--  166 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--  166 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence            99999999999999875 679999999999999999999999999999999999999999999999999998654221  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChH
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  291 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  291 (499)
                              .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....+.+|..++.+
T Consensus       167 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (278)
T 3cok_A          167 --------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE  238 (278)
T ss_dssp             ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHH
T ss_pred             --------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHH
Confidence                    122346799999999999998999999999999999999999999998776666666666777888899999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +.+||.+||+.||.+||++     +++++||||..
T Consensus       239 ~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~  268 (278)
T 3cok_A          239 AKDLIHQLLRRNPADRLSL-----SSVLDHPFMSR  268 (278)
T ss_dssp             HHHHHHHHSCSSGGGSCCH-----HHHTTSTTTC-
T ss_pred             HHHHHHHHcccCHhhCCCH-----HHHhcCccccC
Confidence            9999999999999999998     99999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.9e-50  Score=407.71  Aligned_cols=257  Identities=35%  Similarity=0.537  Sum_probs=213.1

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...++|++.+.||+|+||.||+|++..+++.||||++....     ....+.+|+.+++.++||||+++++++.+...+|
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            33567999999999999999999999999999999997642     2345677999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC---CCCEEEEecCCccccCCc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~---~~~vkL~DFG~a~~~~~~  208 (499)
                      +||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.....
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            99999999999999998888999999999999999999999999999999999999975   789999999999865322


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHhcCCCCC--
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRFP--  285 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~p--  285 (499)
                                 ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+....+.++  
T Consensus       205 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~  273 (349)
T 2w4o_A          205 -----------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP  273 (349)
T ss_dssp             -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT
T ss_pred             -----------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc
Confidence                       1223568999999999999999999999999999999999999999776544 46677777665544  


Q ss_pred             --CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          286 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       286 --~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                        ..++.++.+||.+||+.||++||++     +++++||||.+..+
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTT-----FQALQHPWVTGKAA  314 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSTTTTSTTC
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCH-----HHHhcCcccCCCcc
Confidence              4689999999999999999999998     89999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-49  Score=390.36  Aligned_cols=260  Identities=32%  Similarity=0.567  Sum_probs=234.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++........ ....+.+|..+++.++||||+++++++.+....|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH-HHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            5789999999999999999999999999999999987654333 345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC---EEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~---vkL~DFG~a~~~~~~~~  210 (499)
                      |||+++++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++......  
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--  161 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--  161 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence            999999999999998888999999999999999999999999999999999999987665   999999999765432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                               .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|    .
T Consensus       162 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T 3kk8_A          162 ---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD  232 (284)
T ss_dssp             ---------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred             ---------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence                     122346799999999999999999999999999999999999999999999998888888877666    3


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      .+++++.+||.+||+.||.+||++     +++++||||.+..+.
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          233 TVTPEAKSLIDSMLTVNPKKRITA-----DQALKVPWICNRERV  271 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSHHHHSCCCG
T ss_pred             ccCHHHHHHHHHHcccChhhCCCH-----HHHhcCccccCChhH
Confidence            689999999999999999999998     999999999876543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1e-50  Score=430.30  Aligned_cols=262  Identities=33%  Similarity=0.546  Sum_probs=236.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...++|++.+.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            33578999999999999999999999999999999998876655555677888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee---CCCCCEEEEecCCccccCCc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+.+...
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999988899999999999999999999999999999999999999   46789999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC---
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---  285 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p---  285 (499)
                                 ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+....+.++   
T Consensus       183 -----------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  250 (484)
T 3nyv_A          183 -----------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ  250 (484)
T ss_dssp             -----------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG
T ss_pred             -----------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence                       22345689999999999976 689999999999999999999999999999999999998877665   


Q ss_pred             -CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          286 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       286 -~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                       ..+++++++||.+||+.||.+|||+     +++++||||+...++
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~-----~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISA-----RDALDHEWIQTYTKE  291 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSHHHHHHTC-
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCH-----HHHhhChhhcccccc
Confidence             4689999999999999999999998     999999999865543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-49  Score=397.39  Aligned_cols=262  Identities=28%  Similarity=0.400  Sum_probs=219.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.+|..+++.++||||+++++++.+...+|+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            4789999999999999999999999999999999866533 233445567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......    
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  156 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS----  156 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc----
Confidence            9999999999998888889999999999999999999999999999999999999999999999999998654321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  281 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----------  281 (499)
                            ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+....           
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          157 ------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             ------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence                  12235689999999999876 568999999999999999999999999988877665554310           


Q ss_pred             --------CCCC------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          282 --------IRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       282 --------~~~p------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                              ...|            ..++.++.+||.+||+.||.+|||+     +++++||||+++.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC-----EQLLHHPYFENIREIE  295 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH-----HHHHTSGGGTTCC---
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH-----HHHhcChHHHhccCHH
Confidence                    1111            3578899999999999999999998     9999999999987654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-49  Score=402.21  Aligned_cols=261  Identities=30%  Similarity=0.535  Sum_probs=240.2

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ....+|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            34578999999999999999999999999999999998876666666777888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--  195 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--  195 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--
Confidence            999999999999999988889999999999999999999999999999999999999999999999999998654221  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChH
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  291 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  291 (499)
                              ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....+.+|..++++
T Consensus       196 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (335)
T 2owb_A          196 --------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV  267 (335)
T ss_dssp             --------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred             --------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHH
Confidence                    223356899999999999998899999999999999999999999999998888888888899999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      +.+||.+||+.||.+||++     +++++||||...
T Consensus       268 ~~~li~~~l~~dp~~Rps~-----~ell~~~~~~~~  298 (335)
T 2owb_A          268 AASLIQKMLQTDPTARPTI-----NELLNDEFFTSG  298 (335)
T ss_dssp             HHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHTS
T ss_pred             HHHHHHHHccCChhHCcCH-----HHHhcCccccCC
Confidence            9999999999999999998     889999999754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.2e-50  Score=395.27  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=216.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||+||+|++ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            46899999999999999999999 67999999999765432 22234567799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc---
Confidence            999986 999988764 679999999999999999999999999999999999999999999999999997653211   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---------  282 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~---------  282 (499)
                             ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.....         
T Consensus       155 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          155 -------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             -------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence                   122345789999999999764 589999999999999999999999999988877776654100         


Q ss_pred             --------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          283 --------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       283 --------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                          .++..+++++.+||.+||+.||++||++     +++++||||++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~  287 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFKEN  287 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGGC-
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH-----HHHhcCcchhhc
Confidence                                1224578999999999999999999998     899999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.2e-50  Score=409.44  Aligned_cols=255  Identities=33%  Similarity=0.509  Sum_probs=214.2

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...++|++++.||+|+||+||+|++..+++.||+|++.+.....    ..+.+|+.+++.++||||+++++++.+...+|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            34578999999999999999999999999999999997654332    34667999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC--EEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~--vkL~DFG~a~~~~~~~  209 (499)
                      +|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... 
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            99999999999999988889999999999999999999999999999999999999987765  999999998743221 


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCC-CcchhhhHHHHHHhcCCCCCCCCCH----HHHHHHHHhcCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRF  284 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~-sDiwslG~ilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~  284 (499)
                                ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.    ....+.+....+.+
T Consensus       172 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  241 (361)
T 3uc3_A          172 ----------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI  241 (361)
T ss_dssp             -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC
T ss_pred             ----------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC
Confidence                      22335689999999999988777555 8999999999999999999987544    45566677777777


Q ss_pred             CC--CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          285 PN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       285 p~--~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      |.  .+++++.+||.+||+.||.+|||+     +++++||||..
T Consensus       242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~ell~hp~f~~  280 (361)
T 3uc3_A          242 PDDIRISPECCHLISRIFVADPATRISI-----PEIKTHSWFLK  280 (361)
T ss_dssp             CTTSCCCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSHHHHT
T ss_pred             CCcCCCCHHHHHHHHHHccCChhHCcCH-----HHHHhCcchhc
Confidence            76  579999999999999999999998     99999999953

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.1e-50  Score=402.98  Aligned_cols=251  Identities=35%  Similarity=0.591  Sum_probs=203.2

Q ss_pred             CCeeee---eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010859           55 QDFELG---KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        55 ~~y~~~---~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l  130 (499)
                      ++|++.   +.||+|+||.||+|.++.+|+.||||++.+.      ......+|+.+++.+. ||||+++++++.+...+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            567775   7899999999999999999999999998654      2344667899999996 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC---CEEEEecCCccccCC
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQD  207 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~---~vkL~DFG~a~~~~~  207 (499)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999999999999999988999999999999999999999999999999999999998766   899999999986543


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC-------HHHHHHHHHhc
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-------EWLIFQRIIAR  280 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~-------~~~~~~~i~~~  280 (499)
                      ..          ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+       .......+..+
T Consensus       162 ~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          162 DN----------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             --------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             CC----------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            21          22345689999999999999999999999999999999999999998644       35667777777


Q ss_pred             CCCCCC----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 DIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ~~~~p~----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+.++.    .+++++++||.+||+.||.+||++     +++++||||++
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~ell~h~w~~~  276 (325)
T 3kn6_A          232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKM-----SGLRYNEWLQD  276 (325)
T ss_dssp             CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCT-----TTSTTCGGGCT
T ss_pred             CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCH-----HHHhcChhhcc
Confidence            777663    589999999999999999999999     77999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.4e-49  Score=414.10  Aligned_cols=274  Identities=24%  Similarity=0.381  Sum_probs=217.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-----~  128 (499)
                      .++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            478999999999999999999999999999999997653 2334456678899999999999999999999776     5


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            7999999996 599999998888999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCC------------CCCCCCccccccCccCCCcccc-CCCCCCCCCcchhhhHHHHHHhc-----------CCCC
Q 010859          209 RITVLPN------------AASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLS-----------GTSP  264 (499)
Q Consensus       209 ~~~~~~~------------~~~~~~~~~~~Gt~~Y~aPE~l-~~~~~~~~sDiwslG~ilyellt-----------G~~P  264 (499)
                      .......            ..........+||+.|+|||++ .+..++.++||||||||+|+|++           |.++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            2110000            0001234578999999999986 56679999999999999999998           5555


Q ss_pred             CCCCC-----------------HHHHHHHHHh------------------------cCCCCC-------CCCChHHHHHH
Q 010859          265 FKDTS-----------------EWLIFQRIIA------------------------RDIRFP-------NYFSDAARDLI  296 (499)
Q Consensus       265 f~~~~-----------------~~~~~~~i~~------------------------~~~~~p-------~~~~~~~~~Li  296 (499)
                      |.+.+                 ....+..|..                        .....+       ..+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            55543                 1222222221                        111111       35799999999


Q ss_pred             HHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          297 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       297 ~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                      .+||+.||.+|||+     +++++||||++++|.....
T Consensus       343 ~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~~~~~e~  375 (432)
T 3n9x_A          343 ESMLKFNPNKRITI-----DQALDHPYLKDVRKKKLEN  375 (432)
T ss_dssp             HHHSCSSTTTSCCH-----HHHHTCGGGTTTCCTTTC-
T ss_pred             HHHhcCCcccCCCH-----HHHhcChhhhhccCcccCc
Confidence            99999999999998     9999999999999876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.4e-50  Score=398.94  Aligned_cols=266  Identities=32%  Similarity=0.493  Sum_probs=217.9

Q ss_pred             CCCeeee-eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010859           54 IQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        54 ~~~y~~~-~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~  131 (499)
                      .+.|++. +.||+|+||.||+|.+..+++.||||++.+..   ......+.+|+.++.++ +||||+++++++.+...+|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            4679985 78999999999999999999999999997653   22345577799988884 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC---EEEEecCCccccCCc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDS  208 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~---vkL~DFG~a~~~~~~  208 (499)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999998888999999999999999999999999999999999999998776   999999999765432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC-----CCCCCCCcchhhhHHHHHHhcCCCCCCCCC--------------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTS--------------  269 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDiwslG~ilyelltG~~Pf~~~~--------------  269 (499)
                      ....   ..........+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+              
T Consensus       168 ~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          168 GDCS---PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             Cccc---cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            1100   001122335679999999999875     457889999999999999999999998764              


Q ss_pred             -HHHHHHHHHhcCCCCCC----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          270 -EWLIFQRIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       270 -~~~~~~~i~~~~~~~p~----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                       .......+....+.+|.    .+++++++||.+||+.||.+||++     +++++||||++..+.
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA-----AQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSTTCC-----
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH-----HHHhcChhhcCCCCc
Confidence             24466777777777773    689999999999999999999998     999999999987654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.6e-50  Score=421.48  Aligned_cols=253  Identities=24%  Similarity=0.420  Sum_probs=212.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~------  127 (499)
                      .++|++++.||+|+||+||+|.+..+|+.||||++.+... .......+.+|+.+|+.++||||++++++|...      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            5789999999999999999999999999999999987633 333455677899999999999999999999654      


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|+||||+++ +|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            468999999976 67777754  499999999999999999999999999999999999999999999999999986533


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-----  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-----  282 (499)
                      .           ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+.+|.....     
T Consensus       217 ~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          217 S-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  285 (464)
T ss_dssp             C-----------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             C-----------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            2           223457899999999999999999999999999999999999999999998888777764210     


Q ss_pred             ----------------------CCCCCC---------------ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          283 ----------------------RFPNYF---------------SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       283 ----------------------~~p~~~---------------~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                            .+|..+               ++++++||.+||+.||.+|||+     +++++||||+
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~~~  360 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DDALQHPYIN  360 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTG
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH-----HHHhcChhhh
Confidence                                  111111               5679999999999999999998     9999999998


Q ss_pred             C
Q 010859          326 G  326 (499)
Q Consensus       326 ~  326 (499)
                      .
T Consensus       361 ~  361 (464)
T 3ttj_A          361 V  361 (464)
T ss_dssp             G
T ss_pred             h
Confidence            4

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.3e-49  Score=388.36  Aligned_cols=253  Identities=32%  Similarity=0.543  Sum_probs=229.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.+....   ....+.+|..+++.++||||+++++++.+...+|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            46799999999999999999999999999999999765332   245577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee---CCCCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++..+...  
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--  162 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--  162 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--
Confidence            9999999999999988889999999999999999999999999999999999999   77889999999999765432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  286 (499)
                               .......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+.......+......+|.    
T Consensus       163 ---------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (277)
T 3f3z_A          163 ---------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL  232 (277)
T ss_dssp             ---------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             ---------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh
Confidence                     223356799999999998765 889999999999999999999999999999999999988888875    


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+++++.+||.+||+.||.+||++     .++++||||+.
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~-----~~~l~h~~~~~  267 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITS-----LQALEHEWFEK  267 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCH-----HHHTTSHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCH-----HHHhcCHHHhc
Confidence            689999999999999999999998     89999999974

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.7e-50  Score=390.53  Aligned_cols=260  Identities=33%  Similarity=0.547  Sum_probs=228.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+...+
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            45678999999999999999999999999999999999765443344456678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999997654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  289 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~  289 (499)
                                ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.....+.+......+|..++
T Consensus       166 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (276)
T 2h6d_A          166 ----------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN  235 (276)
T ss_dssp             ---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred             ----------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcC
Confidence                      2234579999999999988765 68899999999999999999999999988888888888888999999


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .++.+||.+||+.||.+||++     +++++||||+.
T Consensus       236 ~~l~~li~~~l~~~p~~Rps~-----~~~l~h~~~~~  267 (276)
T 2h6d_A          236 RSVATLLMHMLQVDPLKRATI-----KDIREHEWFKQ  267 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             HHHHHHHHHHccCChhhCCCH-----HHHHhChhhcc
Confidence            999999999999999999998     89999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.4e-49  Score=422.03  Aligned_cols=258  Identities=30%  Similarity=0.477  Sum_probs=229.0

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh----------hHHHHHHHHHHHHHhCCCCCccEEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE----------NKTAYVKLERIVLDQLDHPGVVRLFF  122 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~Iv~l~~  122 (499)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+......          .....+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            35789999999999999999999999999999999987644321          33466788999999999999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC---CEEEEec
Q 010859          123 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADF  199 (499)
Q Consensus       123 ~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~---~vkL~DF  199 (499)
                      ++.+...+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999999888999999999999999999999999999999999999999876   6999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  279 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~  279 (499)
                      |+|+.+...           ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus       194 g~a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          194 GLSSFFSKD-----------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             TTCEECCTT-----------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCEEcCCC-----------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            999865432           22335689999999999874 589999999999999999999999999999999999999


Q ss_pred             cCCCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          280 RDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       280 ~~~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ..+.++    ..+++++++||.+||+.||.+|||+     +++++||||+..
T Consensus       262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~~~~~  308 (504)
T 3q5i_A          262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA-----EEALNSRWIKKY  308 (504)
T ss_dssp             CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHHT
T ss_pred             CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCH-----HHHhcCHhhhhc
Confidence            888776    5789999999999999999999998     999999999754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=394.28  Aligned_cols=259  Identities=24%  Similarity=0.348  Sum_probs=215.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch--hhHHHHHHHHHHHHHhC---CCCCccEEEEEEEc
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQL---DHPGVVRLFFTFQD  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~hp~Iv~l~~~~~~  126 (499)
                      ...++|++++.||+|+||+||+|++..+|+.||+|++.......  ........+|..+++.+   +||||+++++++.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34679999999999999999999999999999999997543221  11122345566666665   59999999999987


Q ss_pred             CC-----eEEEEEeccCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEec
Q 010859          127 TF-----SLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  199 (499)
Q Consensus       127 ~~-----~l~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DF  199 (499)
                      ..     .+|+||||+. ++|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            55     5899999997 599999987654  999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  279 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~  279 (499)
                      |+++.....           ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+......++..
T Consensus       165 g~a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          165 GLARIYSYQ-----------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             SCTTTSTTC-----------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             ccccccCCC-----------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999865322           223457899999999999999999999999999999999999999999999888877765


Q ss_pred             cCCC---------------------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          280 RDIR---------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       280 ~~~~---------------------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ....                           ....+++++.+||.+||+.||.+|||+     +++++||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~h~~~~~~  303 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA-----FRALQHSYLHKD  303 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSTTC---
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH-----HHHhcCccccCC
Confidence            2111                           113478999999999999999999999     899999999853

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.4e-49  Score=398.62  Aligned_cols=263  Identities=29%  Similarity=0.494  Sum_probs=228.4

Q ss_pred             CCeeee-eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEE
Q 010859           55 QDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        55 ~~y~~~-~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      +.|.+. +.||+|+||.||+|.+..+|+.||+|++.+..... .....+.+|+.+++.+ .||||+++++++.+...+|+
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            568887 89999999999999999999999999998764333 2345577799999988 56999999999999999999


Q ss_pred             EEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC---CCCEEEEecCCccccCC
Q 010859          133 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQD  207 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~---~~~vkL~DFG~a~~~~~  207 (499)
                      ||||+++|+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999998654  67999999999999999999999999999999999999998   78999999999986543


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--  285 (499)
                      .           ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......++  
T Consensus       187 ~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  255 (327)
T 3lm5_A          187 A-----------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE  255 (327)
T ss_dssp             ------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             c-----------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence            2           122356899999999999999999999999999999999999999999999888888877665544  


Q ss_pred             --CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 010859          286 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       286 --~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~  334 (499)
                        ..+++.+.+||.+||+.||.+||++     +++++||||++++|+++..
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~~ll~h~~~~~~~~~~~~~  301 (327)
T 3lm5_A          256 TFSSVSQLATDFIQSLLVKNPEKRPTA-----EICLSHSWLQQWDFENLFH  301 (327)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTCGGGCCCCTTCC--
T ss_pred             hhcccCHHHHHHHHHHcCCChhhCcCH-----HHHhCCHhhcccccccccC
Confidence              3589999999999999999999998     9999999999999987754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.4e-50  Score=401.87  Aligned_cols=258  Identities=24%  Similarity=0.386  Sum_probs=213.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||+||+|++..+++.||+|++......  .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            46899999999999999999999999999999998654321  1111234588999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....    
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~----  153 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP----  153 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC----
Confidence            999974 9999888754 5999999999999999999999999999999999999999999999999999754322    


Q ss_pred             cCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---------  282 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~---------  282 (499)
                            .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....         
T Consensus       154 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          154 ------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ------ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence                  122234578999999999876 5689999999999999999999999999998887776654211         


Q ss_pred             ----------CC-----------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          283 ----------RF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       283 ----------~~-----------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                .+           +..+++++.+||.+||+.||.+|||+     +++++||||.++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA-----EDAMKHPFFLSLGE  290 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGGGGCS
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH-----HHHhcChhhhhccc
Confidence                      11           12468899999999999999999998     99999999997654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.8e-49  Score=401.83  Aligned_cols=252  Identities=25%  Similarity=0.456  Sum_probs=219.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-----CCCccEEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----HPGVVRLFFTFQ  125 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~Iv~l~~~~~  125 (499)
                      ....++|++++.||+|+||+||+|++..+++.||||++...    .........|..+++.+.     ||||+++++++.
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            34568999999999999999999999999999999998643    233445667888999886     999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-------------
Q 010859          126 DTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-------------  190 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-------------  190 (499)
                      ....+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.             
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999999 889999998764  5999999999999999999999999999999999999975             


Q ss_pred             ------------CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHH
Q 010859          191 ------------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM  258 (499)
Q Consensus       191 ------------~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyel  258 (499)
                                  ++.+||+|||+|+....             .....+||+.|+|||++.+..++.++|||||||++|+|
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD-------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTS-------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCEEEEeccCceecCC-------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                        78999999999975332             22356899999999999999999999999999999999


Q ss_pred             hcCCCCCCCCCHHHHHHHHHhcCCCCCC----------------------------------------------CCChHH
Q 010859          259 LSGTSPFKDTSEWLIFQRIIARDIRFPN----------------------------------------------YFSDAA  292 (499)
Q Consensus       259 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~----------------------------------------------~~~~~~  292 (499)
                      ++|+.||.+.+.......+......+|.                                              ..++++
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            9999999999888777766654333331                                              123678


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      .+||.+||+.||.+|||+     +++++||||+
T Consensus       333 ~~li~~~L~~dP~~Rpta-----~elL~hp~f~  360 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSP-----AELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCH-----HHHTTSGGGC
T ss_pred             HHHHHHHhcCChhhCCCH-----HHHhcCcccC
Confidence            899999999999999999     9999999995

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-49  Score=405.27  Aligned_cols=255  Identities=27%  Similarity=0.425  Sum_probs=215.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      .++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            4689999999999999999999999999999999866533 3344566778999999999999999999998653     


Q ss_pred             -eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 -~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                       .+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence             469999999 7899998876 5799999999999999999999999999999999999999999999999999986432


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~----  282 (499)
                                   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..|.....    
T Consensus       181 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          181 -------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  247 (367)
T ss_dssp             -------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             -------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence                         2235689999999999876 6799999999999999999999999999988877776654211    


Q ss_pred             ---------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          283 ---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       283 ---------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                                 .+....++++.+||.+||+.||.+|||+     +++++||||+.+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~-----~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTC-
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH-----HHHhcChHHHhhcC
Confidence                                       1224568999999999999999999998     89999999997654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=406.74  Aligned_cols=256  Identities=29%  Similarity=0.505  Sum_probs=222.9

Q ss_pred             Ceee--eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           56 DFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        56 ~y~~--~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .|.+  .+.||+|+||.||+|.+..+|+.||+|++.....   .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            4555  6789999999999999999999999999976532   3445678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee--CCCCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl--~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++.+.... 
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            9999999999988654 469999999999999999999999999999999999999  567899999999998764321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                                .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......++    .
T Consensus       244 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  313 (373)
T 2x4f_A          244 ----------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ  313 (373)
T ss_dssp             ----------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGT
T ss_pred             ----------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhc
Confidence                      22345799999999999998999999999999999999999999999999999999988776665    4


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      .+++++.+||.+||+.||.+||++     +++++||||++..+.
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~-----~e~l~hp~~~~~~~~  352 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISA-----SEALKHPWLSDHKLH  352 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHCHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcCcCCCchh
Confidence            689999999999999999999998     999999999987654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.9e-49  Score=388.39  Aligned_cols=265  Identities=30%  Similarity=0.509  Sum_probs=231.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc------hhhHHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT------KENKTAYVKLERIVLDQLD-HPGVVRLFFTFQ  125 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~  125 (499)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++......      .......+.+|..+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            358999999999999999999999999999999999765311      1223455678999999995 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          126 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      +...+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999999865


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccC------CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  279 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~------~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~  279 (499)
                      ...           .......||+.|+|||++.      ...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       175 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          175 DPG-----------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             CTT-----------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCC-----------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            432           1223567999999999984      45678899999999999999999999999998888888888


Q ss_pred             cCCCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          280 RDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       280 ~~~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                      ..+.++    ..++.++.+||.+||+.||.+||++     +++++||||++..++.++
T Consensus       244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGCTTC-----
T ss_pred             CCcccCcccccccCHHHHHHHHHHccCCcccCCCH-----HHHHhChHhhhccchhhc
Confidence            776665    3579999999999999999999998     899999999998887654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-49  Score=422.13  Aligned_cols=257  Identities=32%  Similarity=0.548  Sum_probs=225.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|+++.++..||+|++.+....... ...+.+|+.+++.++||||++++++|.+...+|+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            45799999999999999999999999999999999876543332 35577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC---CCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~---~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|+.+...  
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--  192 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--  192 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence            9999999999999988899999999999999999999999999999999999999764   45999999999865432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                               ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+....+.++    .
T Consensus       193 ---------~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  262 (494)
T 3lij_A          193 ---------KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK  262 (494)
T ss_dssp             ---------BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred             ---------ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence                     22335689999999999874 689999999999999999999999999999999999998887765    3


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      .+++++++||.+||+.||.+|||+     +++++||||+...
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~  299 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISA-----QQALEHPWIKEMC  299 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTCHHHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhhCccH-----HHHhcCcccccCc
Confidence            589999999999999999999998     8999999998643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-49  Score=421.27  Aligned_cols=257  Identities=35%  Similarity=0.584  Sum_probs=228.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+...... ....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            5789999999999999999999999999999999976543222 345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC---CCCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~---~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.+...  
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--  177 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--  177 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--
Confidence            99999999999998888999999999999999999999999999999999999995   4567999999999865432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                               ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+....+.++    .
T Consensus       178 ---------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (486)
T 3mwu_A          178 ---------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR  247 (486)
T ss_dssp             -------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG
T ss_pred             ---------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC
Confidence                     22335689999999999976 488999999999999999999999999999999999988876654    3


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      .+++++++||.+||+.||.+|||+     +++++||||+...
T Consensus       248 ~~s~~~~~li~~~L~~dp~~R~t~-----~~~l~hp~~~~~~  284 (486)
T 3mwu_A          248 TISDDAKDLIRKMLTFHPSLRITA-----TQCLEHPWIQKYS  284 (486)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCH-----HHHHHCHHHHHTC
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCHhhccCc
Confidence            589999999999999999999998     8999999998654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-49  Score=389.32  Aligned_cols=263  Identities=31%  Similarity=0.563  Sum_probs=232.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .++|++++.||+|+||.||+|++..+|+.||+|++........   .....+.+|..+++.++||||+++++++.+...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3579999999999999999999999999999999987644322   1356678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC----CEEEEecCCccccC
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  206 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~----~vkL~DFG~a~~~~  206 (499)
                      |+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999998888899999999999999999999999999999999999999877    89999999998654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  285 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-  285 (499)
                      ...           ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++ 
T Consensus       164 ~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T 3bhy_A          164 AGN-----------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE  232 (283)
T ss_dssp             -------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred             CCC-----------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence            321           22345799999999999999999999999999999999999999999998888888887766655 


Q ss_pred             ---CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 010859          286 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  332 (499)
Q Consensus       286 ---~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~  332 (499)
                         ..++..+.+||.+||+.||.+||++     +++++||||+.+.+...
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~~~~~~~  277 (283)
T 3bhy_A          233 EYFSNTSELAKDFIRRLLVKDPKRRMTI-----AQSLEHSWIKAIRRRNV  277 (283)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSGGGSCCH-----HHHHHCHHHHHHHHCCC
T ss_pred             hhcccCCHHHHHHHHHHccCCHhHCcCH-----HHHHhCHHHHHHHHHhh
Confidence               4689999999999999999999998     89999999998766543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-49  Score=402.54  Aligned_cols=266  Identities=30%  Similarity=0.475  Sum_probs=225.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc--hhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+....  .......+.+|+.+++.++||||+++++++.+...+|
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            36899999999999999999999999999999999765332  2334567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 010859          132 MALESCEGGELFDQITS----------------------------------------KGHLSEDEARFYTAEVVDALEYI  171 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~i~~qil~aL~~L  171 (499)
                      +|||||+||+|.+++..                                        ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998852                                        11246788999999999999999


Q ss_pred             HHCCcEeeecCCCCeeeCCCC--CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCC--CCCCCCCc
Q 010859          172 HSMGLIHRDIKPENLLLTADG--HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGND  247 (499)
Q Consensus       172 H~~gIiHrDlKp~NILl~~~~--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sD  247 (499)
                      |++||+||||||+|||++.++  .+||+|||+++.+.....      ..........||+.|+|||++.+  ..++.++|
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN------GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC------C--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc------cccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999999999999998776  899999999986533210      01112345689999999999975  67889999


Q ss_pred             chhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 010859          248 LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  323 (499)
Q Consensus       248 iwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpf  323 (499)
                      ||||||++|+|++|+.||.+.+.......+......++.    .+++++.+||.+||+.||.+||++     +++++|||
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~hp~  333 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA-----MRALQHPW  333 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH-----HHHHHSHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH-----HHHhcChh
Confidence            999999999999999999999999988888887766553    479999999999999999999998     89999999


Q ss_pred             CCCCCcc
Q 010859          324 FKGIDWK  330 (499)
Q Consensus       324 f~~i~~~  330 (499)
                      |+++.+.
T Consensus       334 ~~~~~~~  340 (345)
T 3hko_A          334 ISQFSDK  340 (345)
T ss_dssp             HHTTSSC
T ss_pred             hccChHh
Confidence            9987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-48  Score=392.76  Aligned_cols=253  Identities=29%  Similarity=0.466  Sum_probs=224.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      .|...+.||+|+||.||+|++..+|+.||||++.....   .....+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            48889999999999999999999999999999976532   234557789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      |++|++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....      
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------  195 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------  195 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS------
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc------
Confidence            9999999998875 469999999999999999999999999999999999999999999999999998654321      


Q ss_pred             CCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---CCCCCCChHH
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFPNYFSDAA  292 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~  292 (499)
                          ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....   ..+..+++++
T Consensus       196 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  271 (321)
T 2c30_A          196 ----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVL  271 (321)
T ss_dssp             ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHH
T ss_pred             ----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHH
Confidence                123356899999999999999999999999999999999999999999988887777766532   2334689999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      .+||.+||+.||.+||++     +++++||||...
T Consensus       272 ~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~  301 (321)
T 2c30_A          272 RDFLERMLVRDPQERATA-----QELLDHPFLLQT  301 (321)
T ss_dssp             HHHHHHHSCSSTTTSCCH-----HHHHTSGGGGGC
T ss_pred             HHHHHHHccCChhhCcCH-----HHHhcChhhccC
Confidence            999999999999999998     899999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.2e-50  Score=404.66  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=221.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh-----hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      .++|++++.||+|+||.||+|++..+|+.||||++.+......     .....+.+|+.+++.++||||++++++|.+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4689999999999999999999999999999999987654322     12334566999999999999999999999999


Q ss_pred             eEEEEEeccCCC-ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg-~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .+|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            999999999766 9999999988999999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  286 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~  286 (499)
                      .           ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....      ........|.
T Consensus       183 ~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~  245 (335)
T 3dls_A          183 G-----------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPY  245 (335)
T ss_dssp             T-----------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSS
T ss_pred             C-----------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCc
Confidence            2           22345789999999999988876 7889999999999999999999976432      3445566777


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+++++.+||.+||+.||.+||++     +++++||||+.
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~-----~ell~hp~~~~  280 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTL-----EKLVTDPWVTQ  280 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHCTTTTC
T ss_pred             ccCHHHHHHHHHHccCChhhCcCH-----HHHhcCccccC
Confidence            899999999999999999999998     99999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.9e-49  Score=386.96  Aligned_cols=254  Identities=32%  Similarity=0.578  Sum_probs=219.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.+...  ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            4689999999999999999999999999999999977542  22345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee---CCCCCEEEEecCCccccC
Q 010859          134 LESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl---~~~~~vkL~DFG~a~~~~  206 (499)
                      |||+++|+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..+.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999999988543    679999999999999999999999999999999999999   456789999999997654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  285 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-  285 (499)
                      ..           ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.....+.+......++ 
T Consensus       179 ~~-----------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (285)
T 3is5_A          179 SD-----------EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV  246 (285)
T ss_dssp             -------------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred             Cc-----------ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence            32           12235679999999999864 678899999999999999999999999988888777776655544 


Q ss_pred             --CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          286 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       286 --~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                        ..+++++.+||.+||+.||.+||++     +++++||||+.
T Consensus       247 ~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~f~~  284 (285)
T 3is5_A          247 ECRPLTPQAVDLLKQMLTKDPERRPSA-----AQVLHHEWFKQ  284 (285)
T ss_dssp             --CCCCHHHHHHHHHHTCSCTTTSCCH-----HHHHTSGGGGC
T ss_pred             ccCcCCHHHHHHHHHHccCChhhCcCH-----HHHhcCHHhhc
Confidence              3478999999999999999999998     99999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.5e-49  Score=390.81  Aligned_cols=253  Identities=34%  Similarity=0.580  Sum_probs=226.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.....   .....+.+|..+++.++||||+++++++.+...+|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            4689999999999999999999999999999999976532   2234577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee---CCCCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.....   
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---  161 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---  161 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---
Confidence            9999999999999888889999999999999999999999999999999999999   7788999999999875332   


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....+.++    .
T Consensus       162 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (304)
T 2jam_A          162 ---------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD  232 (304)
T ss_dssp             ---------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTT
T ss_pred             ---------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccc
Confidence                     123356799999999999999999999999999999999999999999999888888888765544    5


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+++++.+||.+||+.||.+||++     +++++||||++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~  267 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTC-----EKALSHPWIDG  267 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSHHHHS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH-----HHHhcCccccC
Confidence            689999999999999999999998     89999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.3e-49  Score=409.01  Aligned_cols=251  Identities=30%  Similarity=0.515  Sum_probs=211.0

Q ss_pred             CCCCCeeee-eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHH-HhCCCCCccEEEEEEEc---
Q 010859           52 FSIQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQD---  126 (499)
Q Consensus        52 ~~~~~y~~~-~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~Iv~l~~~~~~---  126 (499)
                      ...++|.+. +.||+|+||+||+|.++.+|+.||||++...        ....+|+.++ +..+||||++++++|..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            446789887 7899999999999999999999999998643        2345577665 55689999999999875   


Q ss_pred             -CCeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC---CCCEEEEecC
Q 010859          127 -TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFG  200 (499)
Q Consensus       127 -~~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~---~~~vkL~DFG  200 (499)
                       ...+|+|||||+||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             678999999999999999998754  5999999999999999999999999999999999999998   7899999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH----HHHH
Q 010859          201 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQR  276 (499)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~----~~~~  276 (499)
                      +++.....           ....+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...    ....
T Consensus       210 ~a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  278 (400)
T 1nxk_A          210 FAKETTSH-----------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  278 (400)
T ss_dssp             TCEECC----------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH
T ss_pred             cccccCCC-----------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH
Confidence            99865321           22346789999999999999999999999999999999999999998765322    4556


Q ss_pred             HHhcCCCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          277 IIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       277 i~~~~~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +....+.+|    ..++.++.+||.+||+.||.+|||+     +++++||||.+
T Consensus       279 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~eil~hp~~~~  327 (400)
T 1nxk_A          279 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  327 (400)
T ss_dssp             HHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             HHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCccccC
Confidence            667777766    4689999999999999999999998     99999999974

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-48  Score=387.93  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=222.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...++|++++.||+|+||.||+|++..+++.||+|++.............+.+|..+++.++||||+++++++.+...+|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            34578999999999999999999999999999999998766666666777889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......  
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  165 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--  165 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc--
Confidence            999999999999999988899999999999999999999999999999999999999999999999999998654321  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-----CCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----FPN  286 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~  286 (499)
                             .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......+.......     ++.
T Consensus       166 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T 4eqm_A          166 -------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK  238 (294)
T ss_dssp             ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCT
T ss_pred             -------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhccc
Confidence                   12233568999999999999999999999999999999999999999998887766555544322     346


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .+|+.+.++|.+||+.||.+||+.     .+.+.+.|.
T Consensus       239 ~~~~~l~~li~~~l~~dp~~R~~~-----~~~l~~~l~  271 (294)
T 4eqm_A          239 DIPQSLSNVILRATEKDKANRYKT-----IQEMKDDLS  271 (294)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCSS-----HHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcCCHhHcccc-----HHHHHHHHH
Confidence            789999999999999999999976     444555543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.1e-50  Score=399.38  Aligned_cols=261  Identities=26%  Similarity=0.435  Sum_probs=222.3

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----  128 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~----  128 (499)
                      ..++|++++.||+|+||.||+|++..+++.||||++.............+.+|..+++.++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3578999999999999999999999999999999998776555556667888999999999999999999987654    


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            35999999999999999998889999999999999999999999999999999999999999999999999999866443


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC---
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---  285 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p---  285 (499)
                      ..       ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+   
T Consensus       170 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          170 GN-------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             -------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             cc-------ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            21       11223356899999999999999999999999999999999999999999988887777766554433   


Q ss_pred             -CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          286 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       286 -~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                       ..++.++.+||.+||+.||.+||++     ++++.|+|++
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~-----~~~l~~~l~~  278 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQT-----AAEMRADLVR  278 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSS-----HHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhh-----HHHHHHHHHH
Confidence             4589999999999999999999998     8899999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.2e-48  Score=397.95  Aligned_cols=255  Identities=32%  Similarity=0.567  Sum_probs=227.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc--h---hhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--K---ENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~--~---~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++......  .   ......+.+|..+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            5799999999999999999999999999999999765321  1   12245567899999998 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC------CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS------SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  282 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~------~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~  282 (499)
                                 ......+||+.|+|||++.+      ..++.++|||||||++|+|++|..||.+.+.......+....+
T Consensus       254 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          254 -----------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             -----------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             -----------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence                       12335689999999999853      3578899999999999999999999999998888888888777


Q ss_pred             CCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          283 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       283 ~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      .++    ..++.++.+||.+||+.||.+||++     +++++||||+
T Consensus       323 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~ell~hp~f~  364 (365)
T 2y7j_A          323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTA-----EQALQHPFFE  364 (365)
T ss_dssp             CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGC
T ss_pred             CCCCcccccCCHHHHHHHHHHcCCChhHCcCH-----HHHhcCcccC
Confidence            665    4689999999999999999999998     9999999996

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.2e-49  Score=397.83  Aligned_cols=262  Identities=26%  Similarity=0.352  Sum_probs=220.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  126 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-------  126 (499)
                      .++|++++.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            579999999999999999999999999999999986654332 223445679999999999999999999987       


Q ss_pred             -CCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          127 -TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       127 -~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                       ...+|+||||+++ +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence             4569999999986 777777654 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR  283 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~  283 (499)
                      +.....      .........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus       174 ~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          174 FSLAKN------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  247 (351)
T ss_dssp             CCCCSS------SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccc------ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            643221      11233345689999999999876 45899999999999999999999999999988887777653332


Q ss_pred             CCCC--------------------------------CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          284 FPNY--------------------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       284 ~p~~--------------------------------~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      ++..                                .++++.+||.+||+.||.+||++     +++++||||....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~  319 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-----DDALNHDFFWSDP  319 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGSSS
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH-----HHHhCCCCcCCCC
Confidence            2221                                26789999999999999999998     9999999997543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=388.35  Aligned_cols=262  Identities=31%  Similarity=0.552  Sum_probs=226.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch-hhHHHHHHHHHHHHHhCCCCCccEEEEEE--EcCCeE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTF--QDTFSL  130 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~--~~~~~l  130 (499)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|..+++.++||||+++++++  .+...+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            578999999999999999999999999999999997653322 23456688899999999999999999998  455689


Q ss_pred             EEEEeccCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |+||||++++ |.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999876 7777765  356999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCC--CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~  286 (499)
                      .        .........||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.+.+.....+.+....+.+|.
T Consensus       163 ~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  234 (305)
T 2wtk_C          163 A--------ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG  234 (305)
T ss_dssp             C--------SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS
T ss_pred             c--------cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC
Confidence            1        112233567999999999998654  377899999999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      .+++++.+||.+||+.||.+||++     +++++||||+....
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSI-----RQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCH-----HHHHHSHHHHSCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCCCH-----HHHhcCcccccCCC
Confidence            999999999999999999999988     89999999987544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-49  Score=391.63  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=210.0

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++++.||+|+||+||+|++..+|+.||||++.............+..+..+.+..+||||+++++++.+...+|+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            34789999999999999999999999999999999876554444444444444444555699999999999999999999


Q ss_pred             EEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~---  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC---
Confidence            99999 56998888765 45999999999999999999999999999999999999999999999999998765432   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCCCCCCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFS  289 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~  289 (499)
                              .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....   ..+....  ..++..++
T Consensus       211 --------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~  278 (311)
T 3p1a_A          211 --------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLS  278 (311)
T ss_dssp             ------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSC
T ss_pred             --------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCC
Confidence                    12234579999999999886 6899999999999999999997777654332   2333322  12456789


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +++.+||.+||+.||.+||++     +++++||||+.
T Consensus       279 ~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  310 (311)
T 3p1a_A          279 SELRSVLVMMLEPDPKLRATA-----EALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGSC
T ss_pred             HHHHHHHHHHcCCChhhCcCH-----HHHHhCccccC
Confidence            999999999999999999998     99999999974

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-49  Score=397.36  Aligned_cols=263  Identities=25%  Similarity=0.365  Sum_probs=217.1

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh--hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++........  .....+.+|+.+++.++||||++++++|.+...+
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            35789999999999999999999999999999999875432221  1123466799999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999999986 898888765 469999999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-----
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----  283 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----  283 (499)
                                ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+.++......     
T Consensus       167 ----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          167 ----------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             ----------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ----------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence                      223356899999999999764 5889999999999999999999999999988888777652110     


Q ss_pred             C-----------------------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          284 F-----------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       284 ~-----------------------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                      +                       ...++.++.+||.+||+.||.+|||+     +++++||||++..+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFSNRPGPT  302 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSGGGTSSSCCC
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH-----HHHhcChhhhcCCCCC
Confidence            0                       13457899999999999999999998     8999999999765543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.3e-49  Score=396.00  Aligned_cols=263  Identities=28%  Similarity=0.416  Sum_probs=222.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .+++|++++.||+|+||.||+|++..+|+.||+|++...... ......+.+|..+++.++||||+++++++.+...+|+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            468999999999999999999999999999999999765433 3334556789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....   
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  178 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---  178 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc---
Confidence            99999999998888877889999999999999999999999999999999999999999999999999997654321   


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC----------
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----------  281 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~----------  281 (499)
                             ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+....          
T Consensus       179 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          179 -------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             -------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence                   122345799999999999875 68999999999999999999999999998877666554311          


Q ss_pred             ---------CCCC------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          282 ---------IRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       282 ---------~~~p------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                               ..+|            ..+++++.+||.+||+.||.+||++     +++++||||+...|.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~  317 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC-----AELLHHDFFQMDGFAE  317 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHGGGHHH
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH-----HHHhcCchhccCChhh
Confidence                     1111            2478999999999999999999999     8899999998766543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.7e-48  Score=399.51  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=210.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      .++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            5789999999999999999999999999999999986543 2334456778999999999999999999998665     


Q ss_pred             -eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 -~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                       .+|+||||+++ +|.+.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             cceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence             79999999975 88888864  599999999999999999999999999999999999999999999999999976532


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR----  283 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~----  283 (499)
                      .           ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......    
T Consensus       180 ~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          180 S-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  248 (371)
T ss_dssp             ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHH
T ss_pred             c-----------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            1           1223568999999999999999999999999999999999999999999988877776542110    


Q ss_pred             --------------------------------CCC------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          284 --------------------------------FPN------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       284 --------------------------------~p~------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                                      +|.      ..+.++++||.+||+.||.+|||+     +++++||||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~~  323 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-----DEALQHPYIN  323 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHHSHHHH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH-----HHHhCCcchh
Confidence                                            011      015679999999999999999998     8999999998


Q ss_pred             CC
Q 010859          326 GI  327 (499)
Q Consensus       326 ~i  327 (499)
                      ..
T Consensus       324 ~~  325 (371)
T 2xrw_A          324 VW  325 (371)
T ss_dssp             TT
T ss_pred             hh
Confidence            53

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4e-49  Score=410.86  Aligned_cols=261  Identities=33%  Similarity=0.540  Sum_probs=215.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch-----hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.+.....     ......+.+|+.+|+.++||||+++++++... 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            468999999999999999999999999999999998764321     12223467899999999999999999998654 


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC---CEEEEecCCcccc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPM  205 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~---~vkL~DFG~a~~~  205 (499)
                      .+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+|+..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            5899999999999999999888999999999999999999999999999999999999997654   5999999999875


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCC---CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHhcC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD  281 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~~~~  281 (499)
                      ...           ....+.+||+.|+|||++.+   ..++.++|||||||++|+|++|++||.+.... .....+....
T Consensus       293 ~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~  361 (419)
T 3i6u_A          293 GET-----------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  361 (419)
T ss_dssp             C----------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred             CCC-----------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence            432           22345789999999999863   56788999999999999999999999875433 3444555555


Q ss_pred             CCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          282 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       282 ~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                      +.++    ..+++++.+||.+||+.||.+||++     +++++||||++.+|..
T Consensus       362 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~~~~  410 (419)
T 3i6u_A          362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMKR  410 (419)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGCCHHHHH
T ss_pred             CCCCchhhcccCHHHHHHHHHHccCChhHCcCH-----HHHhCCcccCChhHHH
Confidence            5543    4689999999999999999999998     8999999999877754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.4e-49  Score=399.89  Aligned_cols=263  Identities=27%  Similarity=0.448  Sum_probs=225.5

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||.||+|.+..+|+.||+|++....  .......+.+|..+++.++||||+++++++.+...+
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence            455689999999999999999999999999999999997653  334456678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++..+... 
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999999999888899999999999999999999985 9999999999999999999999999998754321 


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHH--------------
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ--------------  275 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~--------------  275 (499)
                                 .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......              
T Consensus       186 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3eqc_A          186 -----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  254 (360)
T ss_dssp             -----------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred             -----------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence                       1234689999999999999999999999999999999999999998776544322              


Q ss_pred             ----------------------------HHHhcC-CCCC-CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          276 ----------------------------RIIARD-IRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       276 ----------------------------~i~~~~-~~~p-~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                                  .+.... ...| ..++.++.+||.+||+.||.+|||+     +++++||||+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~  329 (360)
T 3eqc_A          255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-----KQLMVHAFIK  329 (360)
T ss_dssp             -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSHHHH
T ss_pred             CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH-----HHHhhChHhh
Confidence                                        122211 1122 3478999999999999999999998     9999999999


Q ss_pred             CCCcccc
Q 010859          326 GIDWKNI  332 (499)
Q Consensus       326 ~i~~~~~  332 (499)
                      +.+|+.+
T Consensus       330 ~~~~~~~  336 (360)
T 3eqc_A          330 RSDAEEV  336 (360)
T ss_dssp             HHHHSCC
T ss_pred             cchHhhh
Confidence            8776544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.6e-48  Score=379.09  Aligned_cols=259  Identities=29%  Similarity=0.460  Sum_probs=222.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.....  ......+.+|..+++.++||||+++++++.+....|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            4689999999999999999999999999999999976532  23345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.....   
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---  160 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---  160 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc---
Confidence            99999999999998888899999999999999999999999999999999999999999999999999976543211   


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHhcCCCC--CCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRF--PNYFS  289 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~~  289 (499)
                           .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.. ..+..+.......  +..++
T Consensus       161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (276)
T 2yex_A          161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID  235 (276)
T ss_dssp             -----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred             -----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcC
Confidence                 112335689999999999987765 77899999999999999999999876543 2333333332222  24689


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      +++.+||.+||+.||.+||++     +++++||||++.
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~~  268 (276)
T 2yex_A          236 SAPLALLHKILVENPSARITI-----PDIKKDRWYNKP  268 (276)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHTTCTTTTCC
T ss_pred             HHHHHHHHHHCCCCchhCCCH-----HHHhcCccccCh
Confidence            999999999999999999998     999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-48  Score=392.09  Aligned_cols=263  Identities=26%  Similarity=0.431  Sum_probs=212.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      .++|++++.||+|+||.||+|+++.+|+.||||++....  .......+.+|+.+|+.++||||++++++|.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            468999999999999999999999999999999997653  3344566888999999999999999999986543     


Q ss_pred             ----------------------------------------------------eEEEEEeccCCCChHHHHhhcCC---CC
Q 010859          129 ----------------------------------------------------SLYMALESCEGGELFDQITSKGH---LS  153 (499)
Q Consensus       129 ----------------------------------------------------~l~lv~E~~~gg~L~~~i~~~~~---l~  153 (499)
                                                                          .+|+|||||+||+|.+++.+...   .+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999987643   56


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC--CCCCCCCccccccCccC
Q 010859          154 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP--NAASDDKACTFVGTAAY  231 (499)
Q Consensus       154 e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~--~~~~~~~~~~~~Gt~~Y  231 (499)
                      +..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........  ...........+||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            6679999999999999999999999999999999999999999999999876543211000  00011233456899999


Q ss_pred             CCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC---CCCChHHHHHHHHhhccCCCCCC
Q 010859          232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---NYFSDAARDLIDRLLDVDPSGRP  308 (499)
Q Consensus       232 ~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~~~~~~~Li~~lL~~dP~~R~  308 (499)
                      +|||++.+..++.++|||||||++|+|++|..|+...  ......+...  .+|   ...++++.+||.+||+.||.+||
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNL--KFPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhcc--CCCcccccCChhHHHHHHHHccCCCCcCC
Confidence            9999999999999999999999999999987775321  1222222222  333   34578899999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 010859          309 GAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       309 ~~~~~~~~~l~~Hpff~~i  327 (499)
                      ++     +++++||||+++
T Consensus       319 s~-----~~~l~~~~f~~~  332 (332)
T 3qd2_B          319 EA-----TDIIENAIFENL  332 (332)
T ss_dssp             CH-----HHHHHSTTCCCC
T ss_pred             CH-----HHHhhchhhhcC
Confidence            98     999999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.8e-48  Score=379.58  Aligned_cols=251  Identities=26%  Similarity=0.389  Sum_probs=213.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .++|++++.||+|+||+||+|.+..+++.||+|++........ ....+.+|...+..+ +||||+++++++.+...+|+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4689999999999999999999999999999999987644333 344566688888888 99999999999999999999


Q ss_pred             EEeccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-----------------
Q 010859          133 ALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-----------------  191 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-----------------  191 (499)
                      ||||++|++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.+                 
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999999865    679999999999999999999999999999999999999844                 


Q ss_pred             --CCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCC
Q 010859          192 --GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDT  268 (499)
Q Consensus       192 --~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~  268 (499)
                        ..+||+|||++......              ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP--------------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS--------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             CceEEEEcccccccccCCc--------------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence              47999999999865432              134699999999999876 5668999999999999999999887655


Q ss_pred             CHHHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          269 SEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       269 ~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ..   ...+... ...+|..+++++.+||.+||+.||.+||++     +++++||||.+.
T Consensus       235 ~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~  286 (289)
T 1x8b_A          235 DQ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSA-----MALVKHSVLLSA  286 (289)
T ss_dssp             HH---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTCTTC---
T ss_pred             hH---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCH-----HHHhhChHhhhh
Confidence            43   3334433 345778899999999999999999999998     999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-48  Score=399.23  Aligned_cols=252  Identities=28%  Similarity=0.484  Sum_probs=213.8

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE-------
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-------  125 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~-------  125 (499)
                      ..++|++++.||+|+||+||+|++..+|+.||||++......       ..+|+.+++.++||||++++++|.       
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            357899999999999999999999999999999998754222       235899999999999999999984       


Q ss_pred             -------------------------------cCCeEEEEEeccCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHH
Q 010859          126 -------------------------------DTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEY  170 (499)
Q Consensus       126 -------------------------------~~~~l~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~i~~qil~aL~~  170 (499)
                                                     +...+|+||||+++ +|.+.+.    ..+.+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                           34459999999985 7766654    45679999999999999999999


Q ss_pred             HHHCCcEeeecCCCCeeeC-CCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCC-CCCCCcc
Q 010859          171 IHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDL  248 (499)
Q Consensus       171 LH~~gIiHrDlKp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDi  248 (499)
                      ||++||+||||||+|||++ .++.+||+|||+|+.+...           ......+||+.|+|||++.+.. ++.++||
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-----------EPSVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-----------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-----------CCCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            9999999999999999997 6889999999999865432           2233568899999999987754 8999999


Q ss_pred             hhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-----------------CC------------CCCCCCChHHHHHHHHh
Q 010859          249 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-----------------DI------------RFPNYFSDAARDLIDRL  299 (499)
Q Consensus       249 wslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~Li~~l  299 (499)
                      |||||++|+|++|++||.+.+....+..+...                 ..            .+|..+++++.+||.+|
T Consensus       226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            99999999999999999999988877776541                 11            14566899999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      |+.||.+|||+     +++++||||+.+.
T Consensus       306 L~~dP~~R~t~-----~e~l~hp~f~~~~  329 (383)
T 3eb0_A          306 LRYEPDLRINP-----YEAMAHPFFDHLR  329 (383)
T ss_dssp             CCSSGGGSCCH-----HHHHTSGGGHHHH
T ss_pred             ccCChhhCCCH-----HHHhcCHHHHHHH
Confidence            99999999998     8999999998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.2e-48  Score=392.70  Aligned_cols=252  Identities=28%  Similarity=0.405  Sum_probs=223.6

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ..|++++.||+|+||+||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            46999999999999999999999999999999998765555555667888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||+. |+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....      
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence            9997 588887753 46799999999999999999999999999999999999999999999999999976432      


Q ss_pred             CCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC--CCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYF  288 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~  288 (499)
                              ....+||+.|+|||++.   +..++.++|||||||++|+|++|++||.+.+.......+......  .+..+
T Consensus       207 --------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (348)
T 1u5q_A          207 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW  278 (348)
T ss_dssp             --------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred             --------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Confidence                    12468999999999984   567899999999999999999999999998887777777665432  34578


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ++.+.+||.+||+.||.+||++     +++++||||..
T Consensus       279 ~~~l~~li~~~l~~dP~~Rps~-----~~ll~h~~~~~  311 (348)
T 1u5q_A          279 SEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVLR  311 (348)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHTTCHHHHS
T ss_pred             CHHHHHHHHHHcccChhhCcCH-----HHHhhChhhhc
Confidence            9999999999999999999998     99999999964

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.5e-48  Score=401.62  Aligned_cols=255  Identities=29%  Similarity=0.446  Sum_probs=213.4

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-----  127 (499)
                      ...+|++++.||+|+||+||+|++..+++ ||+|++......       ..+|+.+++.++||||++++++|...     
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            35689999999999999999999988766 888887654322       22588999999999999999999543     


Q ss_pred             -CeEEEEEeccCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC-CCCCEEEEecCC
Q 010859          128 -FSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGS  201 (499)
Q Consensus       128 -~~l~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~-~~~~vkL~DFG~  201 (499)
                       ..+|+||||+++ +|...+.    ..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus       110 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             CEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence             348999999987 4444333    346799999999999999999999999999999999999999 789999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~  280 (499)
                      |+.+...           ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus       189 a~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~  257 (394)
T 4e7w_A          189 AKILIAG-----------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV  257 (394)
T ss_dssp             CEECCTT-----------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             cccccCC-----------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9865432           223356899999999998765 5899999999999999999999999999888777766542


Q ss_pred             -----------------CCC------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          281 -----------------DIR------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       281 -----------------~~~------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                                       ...            ++..+++++.+||.+||+.||.+||++     +++++||||+++.|..
T Consensus       258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA-----IEALCHPFFDELRTGE  332 (394)
T ss_dssp             HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSGGGSTTTSSC
T ss_pred             hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH-----HHHhcChhhhhhcccc
Confidence                             111            334588999999999999999999998     8999999999988765


Q ss_pred             c
Q 010859          332 I  332 (499)
Q Consensus       332 ~  332 (499)
                      .
T Consensus       333 ~  333 (394)
T 4e7w_A          333 A  333 (394)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.4e-49  Score=398.42  Aligned_cols=264  Identities=23%  Similarity=0.440  Sum_probs=232.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhh--------------HHHHHHHHHHHHHhCCCCC
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN--------------KTAYVKLERIVLDQLDHPG  116 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~hp~  116 (499)
                      ....++|++++.||+|+||.||+|.+  +|+.||+|++.........              ....+.+|+.+++.++|||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            45578999999999999999999999  8999999999765333221              1266788999999999999


Q ss_pred             ccEEEEEEEcCCeEEEEEeccCCCChHHH------Hhh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCee
Q 010859          117 VVRLFFTFQDTFSLYMALESCEGGELFDQ------ITS--KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLL  187 (499)
Q Consensus       117 Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~------i~~--~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NIL  187 (499)
                      |+++++++.+...+|+||||+++|+|.++      +..  .+.+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999998      665  5679999999999999999999999 99999999999999


Q ss_pred             eCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCC-CCcchhhhHHHHHHhcCCCCC
Q 010859          188 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATF-GNDLWALGCTLYQMLSGTSPF  265 (499)
Q Consensus       188 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~-~sDiwslG~ilyelltG~~Pf  265 (499)
                      ++.++.+||+|||++......            ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  252 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF  252 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EcCCCcEEEeccccccccccc------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999865332            22346799999999999887 5665 899999999999999999999


Q ss_pred             CCCCH-HHHHHHHHhcCCCCC-------------------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          266 KDTSE-WLIFQRIIARDIRFP-------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       266 ~~~~~-~~~~~~i~~~~~~~p-------------------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ...+. ......+......+|                   ..+++++.+||.+||+.||.+||++     +++++||||+
T Consensus       253 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-----~e~l~hp~f~  327 (348)
T 2pml_X          253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS-----EDALKHEWLA  327 (348)
T ss_dssp             CCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSGGGT
T ss_pred             CCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH-----HHHhcCcccc
Confidence            98877 777788887777777                   6789999999999999999999998     9999999999


Q ss_pred             CCCccccc
Q 010859          326 GIDWKNIR  333 (499)
Q Consensus       326 ~i~~~~~~  333 (499)
                      +.+|..+.
T Consensus       328 ~~~~~~~~  335 (348)
T 2pml_X          328 DTNIEDLR  335 (348)
T ss_dssp             TCCHHHHH
T ss_pred             CCCHHHHH
Confidence            99987654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.9e-48  Score=403.51  Aligned_cols=255  Identities=29%  Similarity=0.452  Sum_probs=214.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  126 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~------  126 (499)
                      ...+|++++.||+|+||.||+|++..+|+.||||++......       ..+|+.+|+.++||||++++++|..      
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            345799999999999999999999999999999998754221       2358999999999999999998843      


Q ss_pred             CCeEEEEEeccCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-CCEEEEecCC
Q 010859          127 TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS  201 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-~~vkL~DFG~  201 (499)
                      ...+++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence            2347899999986 6766554    34679999999999999999999999999999999999999965 5689999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~  280 (499)
                      |+.+...           ......+||+.|+|||++.+. .++.++||||||||+|+|++|++||.+.+....+.++...
T Consensus       204 a~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~  272 (420)
T 1j1b_A          204 AKQLVRG-----------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV  272 (420)
T ss_dssp             CEECCTT-----------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             hhhcccC-----------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9865432           122356899999999998765 6899999999999999999999999999887777666541


Q ss_pred             -----------------CCC------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          281 -----------------DIR------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       281 -----------------~~~------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                                       .+.            ++..+++++.+||.+||+.||.+||++     +++++||||+++.+..
T Consensus       273 lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFFDELRDPN  347 (420)
T ss_dssp             HCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGGGGCTT
T ss_pred             hCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH-----HHHhCCHhhccccccc
Confidence                             122            234578999999999999999999998     8999999998776543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.7e-48  Score=387.06  Aligned_cols=253  Identities=27%  Similarity=0.474  Sum_probs=213.3

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEc--CCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD--TFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~--~~~  129 (499)
                      ..++|++++.||+|+||+||+|++..+++.||+|++...      ....+.+|+.+++.+. ||||+++++++.+  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            457899999999999999999999999999999998643      2345778999999997 9999999999987  678


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~  208 (499)
                      .++||||+++++|.+++..   +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999999999988754   89999999999999999999999999999999999999777 8999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCC-CHHHHHHHHHh-------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIA-------  279 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~-~~~~~~~~i~~-------  279 (499)
                                 ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... +.......+..       
T Consensus       185 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~  253 (330)
T 3nsz_A          185 -----------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  253 (330)
T ss_dssp             -----------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             -----------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence                       12335689999999999977 66899999999999999999999999543 33333322221       


Q ss_pred             ------cCCCC------------------------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          280 ------RDIRF------------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       280 ------~~~~~------------------------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                            ....+                        +..+++++.+||.+||+.||.+|||+     +++++||||+++.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----REAMEHPYFYTVVK  328 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSGGGTTCC-
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH-----HHHhcCccHhhhcc
Confidence                  11111                        22379999999999999999999998     99999999999876


Q ss_pred             c
Q 010859          330 K  330 (499)
Q Consensus       330 ~  330 (499)
                      +
T Consensus       329 ~  329 (330)
T 3nsz_A          329 D  329 (330)
T ss_dssp             -
T ss_pred             C
Confidence            5

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.2e-48  Score=390.93  Aligned_cols=269  Identities=24%  Similarity=0.385  Sum_probs=219.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-----~  128 (499)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...  ........+.+|+.+++.++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            47899999999999999999999999999999999643  2333445567899999999999999999988654     6


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            7999999997 599998876 46999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  281 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~------  281 (499)
                      ................++||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....      
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            2111111111122345689999999998754 678999999999999999999999999988766655443210      


Q ss_pred             ------------------CC--------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          282 ------------------IR--------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       282 ------------------~~--------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                                        ..        .+..+++++.+||.+||+.||.+||++     +++++||||+.+.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA-----KEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTTCCTT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH-----HHHhcCccccccCCcc
Confidence                              00        113678999999999999999999998     8999999999877643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-48  Score=398.00  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=203.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~------  127 (499)
                      .++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3789999999999999999999999999999999876532 233445677899999999999999999999754      


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|+|||++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 6799998876 5799999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~----  282 (499)
                                   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..|.....    
T Consensus       185 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          185 -------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             -------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence                         1235689999999999877 6789999999999999999999999999988777776654110    


Q ss_pred             -------------------CC--------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          283 -------------------RF--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       283 -------------------~~--------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                         ..        ....++++.+||.+||+.||.+|||+     +++++||||+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~-----~e~L~hp~~~~~~~  320 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTTCC
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH-----HHHhcChhhhhccC
Confidence                               00        12468899999999999999999998     89999999997653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-47  Score=378.36  Aligned_cols=254  Identities=21%  Similarity=0.369  Sum_probs=218.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCe
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----TFS  129 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~----~~~  129 (499)
                      ...|++.+.||+|+||.||+|.+..++..||+|++........ ....+.+|..+++.++||||+++++++..    ...
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            3469999999999999999999999999999999987654433 45667789999999999999999999875    466


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeC-CCCCEEEEecCCccccC
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLT-ADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~-~~~~vkL~DFG~a~~~~  206 (499)
                      +|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            9999999999999999998888999999999999999999999999  99999999999998 78999999999997543


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH-HHHHHHhc--CCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIAR--DIR  283 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~-~~~~i~~~--~~~  283 (499)
                      .            .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... ....+...  ...
T Consensus       184 ~------------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (290)
T 1t4h_A          184 A------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS  250 (290)
T ss_dssp             T------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred             c------------cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc
Confidence            2            22335679999999999875 48899999999999999999999998855444 44444332  223


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ++...++++.+||.+||+.||.+||++     +++++||||++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~h~~f~~  288 (290)
T 1t4h_A          251 FDKVAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQE  288 (290)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGC-
T ss_pred             cCCCCCHHHHHHHHHHccCChhhCCCH-----HHHhhCccccc
Confidence            456788999999999999999999988     99999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.2e-48  Score=383.21  Aligned_cols=260  Identities=30%  Similarity=0.519  Sum_probs=222.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++....   ......+.+|..+++.++||||+++++++.+...+|+|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            478999999999999999999999999999999986542   22345577799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  171 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL---  171 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH---
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc---
Confidence            999999999998875 4569999999999999999999999999999999999999999999999999875432110   


Q ss_pred             cCCCCCCCCccccccCccCCCcccc-----CCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---CC
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RF  284 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l-----~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~  284 (499)
                             .......||+.|+|||++     .+..++.++|||||||++|+|++|..||...+.......+.....   ..
T Consensus       172 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (302)
T 2j7t_A          172 -------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT  244 (302)
T ss_dssp             -------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred             -------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCC
Confidence                   112346799999999998     467789999999999999999999999999988877777766543   23


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  331 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~  331 (499)
                      |..++.++.+||.+||..||.+||++     +++++||||+++.+..
T Consensus       245 ~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~  286 (302)
T 2j7t_A          245 PSKWSVEFRDFLKIALDKNPETRPSA-----AQLLEHPFVSSITSNK  286 (302)
T ss_dssp             GGGSCHHHHHHHHHHSCSCTTTSCCH-----HHHTTSTTTTTCCCCH
T ss_pred             ccccCHHHHHHHHHHcccChhhCCCH-----HHHhcChHHhhhccch
Confidence            56789999999999999999999998     8999999999988764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.6e-47  Score=391.05  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=218.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----Ce
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----FS  129 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-----~~  129 (499)
                      ++|++++.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            58999999999999999999999999999999986532  333445677899999999999999999999755     46


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            9999999974 999988764 69999999999999999999999999999999999999999999999999998664332


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC------
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI------  282 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~------  282 (499)
                      .       ........+||+.|+|||++. +..++.++|||||||++|+|++|++||.+.+.......+.....      
T Consensus       183 ~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          183 D-------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             C-------BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             C-------ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            1       112234568999999999864 55589999999999999999999999999887777666653110      


Q ss_pred             -------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          283 -------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       283 -------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                               .++..+++++.+||.+||+.||.+|||+     +++++||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~~  320 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-----EQALAHPYLEQY  320 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGTTT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcchhhc
Confidence                                     0124578999999999999999999998     999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1e-47  Score=401.38  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=215.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC------CCCCccEEEEEEEc
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL------DHPGVVRLFFTFQD  126 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~Iv~l~~~~~~  126 (499)
                      ...+|++++.||+|+||+||+|.+..+++.||||++....    .....+.+|+.+++.+      +|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3568999999999999999999999999999999996542    2234455677777665      67899999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC--EEEEecCCc
Q 010859          127 TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSV  202 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~--vkL~DFG~a  202 (499)
                      ...+|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999999996 59999988764  4999999999999999999999999999999999999999987  999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  282 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~  282 (499)
                      .....             ...+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..+.....
T Consensus       250 ~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~  316 (429)
T 3kvw_A          250 CYEHQ-------------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG  316 (429)
T ss_dssp             EETTC-------------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             eecCC-------------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            75322             23356899999999999999999999999999999999999999999998887766653200


Q ss_pred             C-----------------------------------------------------------CCCCCChHHHHHHHHhhccC
Q 010859          283 R-----------------------------------------------------------FPNYFSDAARDLIDRLLDVD  303 (499)
Q Consensus       283 ~-----------------------------------------------------------~p~~~~~~~~~Li~~lL~~d  303 (499)
                      .                                                           ++...++++.+||.+||+.|
T Consensus       317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d  396 (429)
T 3kvw_A          317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD  396 (429)
T ss_dssp             CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence            0                                                           11234788999999999999


Q ss_pred             CCCCCCCCCCCHHHHhcCCCCCC
Q 010859          304 PSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       304 P~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      |.+|||+     +++++||||+.
T Consensus       397 P~~Rpta-----~e~L~Hpw~~~  414 (429)
T 3kvw_A          397 PAVRMTP-----GQALRHPWLRR  414 (429)
T ss_dssp             TTTSCCH-----HHHHTSTTTC-
T ss_pred             hhhCCCH-----HHHhCChhhcc
Confidence            9999999     99999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=380.74  Aligned_cols=260  Identities=31%  Similarity=0.487  Sum_probs=222.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++.....     ...+.+|..+++.++||||+++++++.+...+|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            35789999999999999999999999999999999976432     2346779999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            999999999999987 45679999999999999999999999999999999999999999999999999997654321  


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---CCCCCCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYF  288 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~  288 (499)
                              .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....   +..|..+
T Consensus       180 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
T 3com_A          180 --------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW  251 (314)
T ss_dssp             --------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred             --------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccC
Confidence                    12235679999999999999999999999999999999999999999888776655554432   3346678


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  332 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~  332 (499)
                      +.++.+||.+||..||.+||++     +++++||||++..+...
T Consensus       252 ~~~l~~li~~~l~~dp~~Rpt~-----~~ll~~~~~~~~~~~~~  290 (314)
T 3com_A          252 SDNFTDFVKQCLVKSPEQRATA-----TQLLQHPFVRSAKGVSI  290 (314)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCH-----HHHTTSHHHHTCCCGGG
T ss_pred             CHHHHHHHHHHccCChhhCcCH-----HHHHhCHHHhcCCcchH
Confidence            9999999999999999999998     99999999998776543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.2e-48  Score=388.28  Aligned_cols=260  Identities=33%  Similarity=0.541  Sum_probs=218.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc-----hhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      .++|++++.||+|+||.||+|.+..+++.||||++.+....     .......+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            46899999999999999999999999999999999765432     1122334678999999999999999999998765


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC---EEEEecCCcccc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPM  205 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~---vkL~DFG~a~~~  205 (499)
                       .|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999999999999998888999999999999999999999999999999999999987664   999999999865


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHhcC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD  281 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~~~~  281 (499)
                      ....           .....+||+.|+|||++.   ...++.++|||||||++|+|++|..||...... .....+....
T Consensus       168 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  236 (322)
T 2ycf_A          168 GETS-----------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  236 (322)
T ss_dssp             CCCH-----------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred             cccc-----------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence            4321           123567999999999973   566889999999999999999999999865433 3344455555


Q ss_pred             CCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          282 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       282 ~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      ..++    ..++.++.+||.+||+.||.+||++     +++++||||++.+|.
T Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-----~~~l~h~~~~~~~~~  284 (322)
T 2ycf_A          237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK  284 (322)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGCCHHHH
T ss_pred             cccCchhhhhcCHHHHHHHHHHcccCHhhCCCH-----HHHhhCcCcCCHHHH
Confidence            4442    4689999999999999999999998     899999999987765

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.9e-47  Score=391.63  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=217.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE---
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL---  130 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l---  130 (499)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++......   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3689999999999999999999999999999999976543 334456677899999999999999999999877655   


Q ss_pred             ---EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          131 ---YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       131 ---~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                         |+||||+. ++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             eeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence               99999997 589888754  499999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~----  282 (499)
                                   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....    
T Consensus       197 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  263 (371)
T 4exu_A          197 -------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT  263 (371)
T ss_dssp             ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             -------------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence                         2235689999999999987 6789999999999999999999999999988777766654110    


Q ss_pred             ---------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          283 ---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       283 ---------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                                                 ..+..+++++.+||.+||+.||.+||++     +++++||||+.+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~  333 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-----AQALTHPFFEPFRDP  333 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTTCCG
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH-----HHHhcCcccccCCCc
Confidence                                       0123568999999999999999999998     999999999976543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.8e-48  Score=379.84  Aligned_cols=259  Identities=34%  Similarity=0.574  Sum_probs=229.2

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||.||+|++..+++.||+|++.+..... .....+.+|..+++.++||||+++++++.+...+|+|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            468999999999999999999999999999999997654332 2345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC---CCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~---~~vkL~DFG~a~~~~~~~~  210 (499)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++......  
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--  177 (287)
T 2wei_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--  177 (287)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC--
T ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC--
Confidence            9999999999999888889999999999999999999999999999999999999764   47999999998765332  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                               .......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+.......+....+.++    .
T Consensus       178 ---------~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (287)
T 2wei_A          178 ---------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR  247 (287)
T ss_dssp             ---------SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGT
T ss_pred             ---------CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhh
Confidence                     122345799999999998764 88899999999999999999999999999888888888766554    4


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      .+++++.+||.+||..||.+||++     +++++||||+..+++
T Consensus       248 ~~~~~~~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~~~~  286 (287)
T 2wei_A          248 TISDDAKDLIRKMLTFHPSLRITA-----TQCLEHPWIQKYSSE  286 (287)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHSHHHHHHCCC
T ss_pred             hcCHHHHHHHHHHcccChhhCcCH-----HHHhcCHHHhccccC
Confidence            689999999999999999999998     999999999876553

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.2e-48  Score=378.86  Aligned_cols=258  Identities=29%  Similarity=0.509  Sum_probs=226.0

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCeE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSL  130 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~--~~~~l  130 (499)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++....... .....+.+|..+++.++||||+++++++.  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            3579999999999999999999999999999999998765433 34566788999999999999999999874  46789


Q ss_pred             EEEEeccCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          131 YMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~~LH~~g-----IiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                      |+||||+++++|.+++...    ..+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999998754    34999999999999999999999999     99999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  281 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~  281 (499)
                      ++......          .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus       163 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~  232 (279)
T 2w5a_A          163 ARILNHDT----------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK  232 (279)
T ss_dssp             HHHC---C----------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             heeecccc----------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence            97654321          11234679999999999999889999999999999999999999999998888888887766


Q ss_pred             C-CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          282 I-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       282 ~-~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      . .+|..++.++.+||.+||+.||.+||++     +++++|+|+.+
T Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~ll~~~~~~~  273 (279)
T 2w5a_A          233 FRRIPYRYSDELNEIITRMLNLKDYHRPSV-----EEILENPLILE  273 (279)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSTTCCG
T ss_pred             cccCCcccCHHHHHHHHHHcCCCcccCCCH-----HHHHhChhhhh
Confidence            5 5778899999999999999999999988     99999999974

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=389.08  Aligned_cols=257  Identities=28%  Similarity=0.468  Sum_probs=214.4

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCeE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTFSL  130 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~Iv~l~~~~~~~~~l  130 (499)
                      ..++|++++.||+|+||.||+|.+ .+++.||||++...... ......+.+|+.+|+.+.|  |||+++++++.+...+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            456799999999999999999998 46899999999866433 3344667889999999976  9999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||+ .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.... 
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~-  161 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-  161 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc-
Confidence            999995 5789999999988999999999999999999999999999999999999996 6889999999998764322 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCC-----------CCCCCCCcchhhhHHHHHHhcCCCCCCCCCH-HHHHHHHH
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRII  278 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----------~~~~~~sDiwslG~ilyelltG~~Pf~~~~~-~~~~~~i~  278 (499)
                             ........+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||..... ......+.
T Consensus       162 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  234 (343)
T 3dbq_A          162 -------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  234 (343)
T ss_dssp             ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             -------ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence                   1112335689999999999864           6688899999999999999999999987543 34444444


Q ss_pred             h--cCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          279 A--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       279 ~--~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .  ....+|...+.++.+||.+||+.||.+||++     +++++||||+.
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~  279 (343)
T 3dbq_A          235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI  279 (343)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHS
T ss_pred             cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCH-----HHHHhCccccc
Confidence            3  3456788889999999999999999999998     99999999973

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.8e-47  Score=380.88  Aligned_cols=252  Identities=21%  Similarity=0.380  Sum_probs=213.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++.+.||+|+||+||+|++  +|+.||+|++...... ......+.+|+.++++++||||+++++++.+...+
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            45568999999999999999999987  6889999999766443 33445677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          131 YMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~---l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      |+||||+++|+|.+++.+.+.   +++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999999987654   999999999999999999999999  999999999999999999999999999754


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH--hcCCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIR  283 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~--~~~~~  283 (499)
                      ....          ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.  .....
T Consensus       190 ~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  259 (309)
T 3p86_A          190 ASTF----------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE  259 (309)
T ss_dssp             ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             cccc----------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            3221          12335689999999999999999999999999999999999999999998887776664  34567


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      +|..+++++.+||.+||+.||.+||++     +++++
T Consensus       260 ~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~ll~  291 (309)
T 3p86_A          260 IPRNLNPQVAAIIEGCWTNEPWKRPSF-----ATIMD  291 (309)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            788999999999999999999999998     66664

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.9e-50  Score=410.20  Aligned_cols=250  Identities=18%  Similarity=0.231  Sum_probs=207.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHH---HHHhCCCCCccEEE-------EE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI---VLDQLDHPGVVRLF-------FT  123 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hp~Iv~l~-------~~  123 (499)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            468999999999999999999999999999999998765555556677888994   55556899999998       77


Q ss_pred             EEcCC-----------------eEEEEEeccCCCChHHHHhhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCcEee
Q 010859          124 FQDTF-----------------SLYMALESCEGGELFDQITSKGHLSE-------DEARFYTAEVVDALEYIHSMGLIHR  179 (499)
Q Consensus       124 ~~~~~-----------------~l~lv~E~~~gg~L~~~i~~~~~l~e-------~~~~~i~~qil~aL~~LH~~gIiHr  179 (499)
                      +.+.+                 ..|+||||+ +|+|.+++...+.+++       ..+..++.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            76654                 289999999 5799999987665666       7888899999999999999999999


Q ss_pred             ecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCC-----------CCCCCCcc
Q 010859          180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----------PATFGNDL  248 (499)
Q Consensus       180 DlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-----------~~~~~sDi  248 (499)
                      ||||+|||++.++.+||+|||+|+....             .....+| +.|+|||++.+.           .++.++||
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-------------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC-------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC-------------cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            9999999999999999999999985321             2335678 999999999887           79999999


Q ss_pred             hhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          249 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       249 wslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      |||||++|+|++|+.||.+.+.......+.    ..+..+++++.+||.+||+.||.+||++     .++++||||+++
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~f~~~  366 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQL  366 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCH-----HHHHTSHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCH-----HHHhhChHHHHH
Confidence            999999999999999998766544333322    3346789999999999999999999998     899999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.8e-47  Score=394.71  Aligned_cols=256  Identities=28%  Similarity=0.470  Sum_probs=216.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC--CCCccEEEEEEEcCCeEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--HPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~l~~~~~~~~~l~  131 (499)
                      ..+|++++.||+|+||.||+|.+.. ++.||||++...... ......+.+|+.+|+.+.  ||||+++++++.....+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            3569999999999999999999865 899999999876443 334566788999999996  599999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+..... 
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~-  209 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT-  209 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc-
Confidence            9999 56789999999988999999999999999999999999999999999999995 68999999999987643221 


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCC-----------CCCCCCCcchhhhHHHHHHhcCCCCCCCCC-HHHHHHHHHh
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIA  279 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----------~~~~~~sDiwslG~ilyelltG~~Pf~~~~-~~~~~~~i~~  279 (499)
                             .......+||+.|+|||++.+           ..++.++||||||||+|+|++|+.||.+.. ....+..+..
T Consensus       210 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          210 -------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             -----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             -------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence                   112335689999999999865           368889999999999999999999998764 3345555554


Q ss_pred             c--CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          280 R--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       280 ~--~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .  ...+|...+.++.+||.+||+.||.+||++     +++++||||+.
T Consensus       283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~ell~hp~~~~  326 (390)
T 2zmd_A          283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI  326 (390)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHS
T ss_pred             ccccCCCCccchHHHHHHHHHHcccChhhCCCH-----HHHhhCcCccc
Confidence            4  345677889999999999999999999998     89999999974

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2e-47  Score=391.57  Aligned_cols=255  Identities=22%  Similarity=0.369  Sum_probs=220.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEc-------CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFF  122 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~  122 (499)
                      .+..++|++++.||+|+||.||+|++.       .++..||+|++....  .......+.+|+.+++.+ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            456789999999999999999999975       345679999986552  334456688899999999 8999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCe
Q 010859          123 TFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  186 (499)
Q Consensus       123 ~~~~~~~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NI  186 (499)
                      ++.+...+|+||||+++|+|.+++...+                .+++..+..++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998653                479999999999999999999999999999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCC
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  265 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf  265 (499)
                      |++.++++||+|||+++.+.....        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDY--------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCT--------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             EECCCCCEEEccccCCcccCcccc--------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999986543221        112234567899999999999999999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          266 KDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       266 ~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+.+....+..+... ....|..++.++.+||.+||+.||.+||++     +++++
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~  357 (370)
T 2psq_A          307 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  357 (370)
T ss_dssp             TTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            998887777766654 356778899999999999999999999998     66654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.8e-48  Score=388.39  Aligned_cols=274  Identities=20%  Similarity=0.340  Sum_probs=206.6

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCc---eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      .+..++|++++.||+|+||.||+|++..++.   .||+|++....... .....+.+|..+++.++||||+++++++.+.
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            3456789999999999999999999887765   89999987654333 3356677899999999999999999999877


Q ss_pred             CeE------EEEEeccCCCChHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEE
Q 010859          128 FSL------YMALESCEGGELFDQITSKG------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  195 (499)
Q Consensus       128 ~~l------~lv~E~~~gg~L~~~i~~~~------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vk  195 (499)
                      ...      |+||||+++|+|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            655      99999999999999986542      599999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHH
Q 010859          196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  274 (499)
Q Consensus       196 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~  274 (499)
                      |+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.....
T Consensus       178 l~Dfg~a~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~  249 (323)
T 3qup_A          178 VADFGLSRKIYSGDY--------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY  249 (323)
T ss_dssp             ECCCCC-------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             Eeecccccccccccc--------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence            999999986543321        112224467889999999999999999999999999999999 99999998888877


Q ss_pred             HHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCC--CCHHHHhcCCCCCCCCccccc
Q 010859          275 QRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       275 ~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~--~~~~~l~~Hpff~~i~~~~~~  333 (499)
                      ..+... ....|..+++++.+||.+||+.||.+||++.+  ..+++++.|||+.+...+.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~  311 (323)
T 3qup_A          250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY  311 (323)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred             HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence            777665 35677889999999999999999999999644  345889999999876655443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-47  Score=377.50  Aligned_cols=257  Identities=24%  Similarity=0.395  Sum_probs=204.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++++.||+|+||+||+|++..+|+.||+|++...... .........+...++.++||||+++++++.+....|
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            4568999999999999999999999999999999999765322 233344445556688899999999999999999999


Q ss_pred             EEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          132 MALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      +||||++| +|.+++..    .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999975 88776653    46799999999999999999999998 99999999999999999999999999997654


Q ss_pred             CccccccCCCCCCCCccccccCccCCCcccc----CCCCCCCCCcchhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHh-c
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIA-R  280 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l----~~~~~~~~sDiwslG~ilyelltG~~Pf~~-~~~~~~~~~i~~-~  280 (499)
                      ...           ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.. .........+.. .
T Consensus       162 ~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (290)
T 3fme_A          162 DDV-----------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP  230 (290)
T ss_dssp             -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred             ccc-----------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence            321           22234799999999996    556788999999999999999999999986 344444444443 3


Q ss_pred             CCCCC-CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ~~~~p-~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ....+ ..+++++.+||.+||+.||.+||++     +++++||||+.
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~e~l~hp~f~~  272 (290)
T 3fme_A          231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTY-----PELMQHPFFTL  272 (290)
T ss_dssp             CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHhhcChhhCcCH-----HHHHhCccccc
Confidence            33333 4689999999999999999999998     99999999974

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=381.10  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=214.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE--------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--------  125 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~--------  125 (499)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++...   .......+.+|..+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            47899999999999999999999999999999998754   3344566778999999999999999999884        


Q ss_pred             ------cCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC-CCCCEEEEe
Q 010859          126 ------DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIAD  198 (499)
Q Consensus       126 ------~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~-~~~~vkL~D  198 (499)
                            +...+|+||||++ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  4468999999997 599998865 5799999999999999999999999999999999999997 567999999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010859          199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  277 (499)
Q Consensus       199 FG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i  277 (499)
                      ||+++.......       .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.....+.+
T Consensus       165 fg~~~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          165 FGLARIMDPHYS-------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             CTTCBCC---------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CccccccCCCcc-------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999987643211       1122335678999999998765 67899999999999999999999999999888777766


Q ss_pred             HhcCCC------------------------------CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          278 IARDIR------------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       278 ~~~~~~------------------------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ......                              ++..++.++.+||.+||+.||.+||++     +++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~  312 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA-----EEALSHPYMSIY  312 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSHHHHTT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH-----HHHhCCcccccc
Confidence            543211                              124589999999999999999999998     999999999987


Q ss_pred             Ccc
Q 010859          328 DWK  330 (499)
Q Consensus       328 ~~~  330 (499)
                      +|.
T Consensus       313 ~~p  315 (320)
T 2i6l_A          313 SFP  315 (320)
T ss_dssp             CC-
T ss_pred             cCc
Confidence            764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.3e-47  Score=376.09  Aligned_cols=255  Identities=29%  Similarity=0.474  Sum_probs=226.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .+.|++++.||+|+||.||+|.+..+++.||+|++......  .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            35799999999999999999999999999999999765432  2345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+....    
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----  173 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----  173 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB----
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc----
Confidence            999999999998875 579999999999999999999999999999999999999999999999999997654321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCChHH
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAA  292 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~  292 (499)
                            .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ..++..++..+
T Consensus       174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  247 (303)
T 3a7i_A          174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL  247 (303)
T ss_dssp             ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHH
T ss_pred             ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHH
Confidence                  12235689999999999999999999999999999999999999999988877766665543 35677899999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+||.+||+.||.+||++     +++++||||..
T Consensus       248 ~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~  276 (303)
T 3a7i_A          248 KEFVEACLNKEPSFRPTA-----KELLKHKFILR  276 (303)
T ss_dssp             HHHHHHHCCSSGGGSCCH-----HHHTTCHHHHH
T ss_pred             HHHHHHHcCCChhhCcCH-----HHHhhChhhhc
Confidence            999999999999999998     89999999963

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.4e-47  Score=383.54  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=215.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEE-cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCC------CccEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKK-IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP------GVVRLFFTF  124 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~-~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------~Iv~l~~~~  124 (499)
                      ...++|++++.||+|+||.||+|.+ ..+|+.||+|++...    ......+.+|..+++.++|+      +|+++++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            4457999999999999999999999 568899999998643    23345567788888887654      599999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC------------
Q 010859          125 QDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA------------  190 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~------------  190 (499)
                      .+...+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.            
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999999 789999998765  6899999999999999999999999999999999999987            


Q ss_pred             -------CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCC
Q 010859          191 -------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS  263 (499)
Q Consensus       191 -------~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~  263 (499)
                             ++.+||+|||+++....             .....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  232 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE-------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT  232 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS-------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccccccCCCceEeeCcccccCcc-------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence                   66899999999975322             2235689999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCC--------------------------------------------CCCChHHHHHHHHh
Q 010859          264 PFKDTSEWLIFQRIIARDIRFP--------------------------------------------NYFSDAARDLIDRL  299 (499)
Q Consensus       264 Pf~~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~~~~~~~Li~~l  299 (499)
                      ||...+.......+......+|                                            ...++++.+||.+|
T Consensus       233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  312 (339)
T 1z57_A          233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM  312 (339)
T ss_dssp             SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence            9999887766555433222221                                            12356789999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      |+.||.+|||+     +++++||||+.+.
T Consensus       313 L~~dP~~Rpt~-----~ell~hp~f~~~~  336 (339)
T 1z57_A          313 LEYDPAKRITL-----REALKHPFFDLLK  336 (339)
T ss_dssp             TCSSTTTSCCH-----HHHTTSGGGGGGG
T ss_pred             hCcCcccccCH-----HHHhcCHHHHHHh
Confidence            99999999998     9999999998643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=384.65  Aligned_cols=252  Identities=23%  Similarity=0.432  Sum_probs=212.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--eE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SL  130 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~--~l  130 (499)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++.......  ....+.+|..+++.++||||+++++++.+..  .+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            4578999999999999999999999999999999997543322  2455678999999999999999999998655  78


Q ss_pred             EEEEeccCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee----CCCCCEEEEecCCcc
Q 010859          131 YMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSVK  203 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~---l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl----~~~~~vkL~DFG~a~  203 (499)
                      |+||||+++++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999999986533   9999999999999999999999999999999999999    777889999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccC--------CCCCCCCCcchhhhHHHHHHhcCCCCCCCCC----HH
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--------SSPATFGNDLWALGCTLYQMLSGTSPFKDTS----EW  271 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~--------~~~~~~~sDiwslG~ilyelltG~~Pf~~~~----~~  271 (499)
                      .+...           ......+||+.|+|||++.        +..++.++|||||||++|+|++|+.||....    ..
T Consensus       165 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          165 ELEDD-----------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             ECCTT-----------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             ecCCC-----------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            65432           2223567999999999985        5678999999999999999999999997432    24


Q ss_pred             HHHHHHHhcCC-------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCC
Q 010859          272 LIFQRIIARDI-------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP  322 (499)
Q Consensus       272 ~~~~~i~~~~~-------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hp  322 (499)
                      ....++.....                         .++..++..+.+||.+||+.||++||++     +++++||
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~-----~ell~h~  304 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQFFAET  304 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-----HHHHHHH
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH-----HHhhhcc
Confidence            45555554332                         1122345688999999999999999998     8899887

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.8e-47  Score=384.51  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=216.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS----  129 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~----  129 (499)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|..+++.++||||+++++++.+...    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            3689999999999999999999999999999999976543 33445567789999999999999999999987654    


Q ss_pred             --EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 --LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 --l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                        +|+||||+. ++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              599999997 599888754  499999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  281 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----  281 (499)
                                   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....     
T Consensus       179 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          179 -------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT  245 (353)
T ss_dssp             ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred             -------------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence                         1234689999999999877 678999999999999999999999999988777666654310     


Q ss_pred             --------------------------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          282 --------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       282 --------------------------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                                ...+..+++++.+||.+||+.||.+||++     +++++||||+.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~f~~~~~  314 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-----AQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTTCC
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH-----HHHhcCcchhhccC
Confidence                                      11234678999999999999999999998     89999999987654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3e-47  Score=385.62  Aligned_cols=259  Identities=26%  Similarity=0.400  Sum_probs=218.2

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCC-ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCC------ccEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTG-TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG------VVRLFFTF  124 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~-~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~------Iv~l~~~~  124 (499)
                      ...++|++++.||+|+||+||+|.+..++ +.||+|++...    ......+.+|+.+++.+.|++      ++.+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            44689999999999999999999998877 68999998653    233455677888888886655      99999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee--------------
Q 010859          125 QDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL--------------  188 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl--------------  188 (499)
                      .....+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||+              
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence            9999999999999 567878777653  69999999999999999999999999999999999999              


Q ss_pred             -----CCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCC
Q 010859          189 -----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS  263 (499)
Q Consensus       189 -----~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~  263 (499)
                           +.++.+||+|||+++....             .....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  237 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHE-------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT  237 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTS-------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccccCCCcEEEeecCccccccc-------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence                 5678999999999975322             2235689999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCC--------------------------------------------CCChHHHHHHHHh
Q 010859          264 PFKDTSEWLIFQRIIARDIRFPN--------------------------------------------YFSDAARDLIDRL  299 (499)
Q Consensus       264 Pf~~~~~~~~~~~i~~~~~~~p~--------------------------------------------~~~~~~~~Li~~l  299 (499)
                      ||.+.+.......+......+|.                                            ..+.++.+||.+|
T Consensus       238 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  317 (355)
T 2eu9_A          238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM  317 (355)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence            99998877665554432222221                                            1245788999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          300 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       300 L~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                      |+.||.+|||+     +++++||||++++|+...
T Consensus       318 L~~dP~~Rpt~-----~e~l~hp~f~~~~~~~~~  346 (355)
T 2eu9_A          318 LEFDPAQRITL-----AEALLHPFFAGLTPEERS  346 (355)
T ss_dssp             TCSSTTTSCCH-----HHHTTSGGGGGCCHHHHC
T ss_pred             hcCChhhCcCH-----HHHhcChhhcCCChhhcc
Confidence            99999999998     899999999999987654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=379.62  Aligned_cols=260  Identities=28%  Similarity=0.462  Sum_probs=217.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc----
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD----  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~----  126 (499)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++.....    ....+.+|+.+++.+ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            346799999999999999999999999999999999976432    224567788899988 79999999999986    


Q ss_pred             --CCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          127 --TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       127 --~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                        ...+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999999864  56999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  277 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i  277 (499)
                      .......          ......+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+
T Consensus       177 ~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          177 AQLDRTV----------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             C-----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             eecCcCc----------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            7653221          1233568999999999987     566889999999999999999999999998887776666


Q ss_pred             HhcCCC--CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          278 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       278 ~~~~~~--~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      ......  .+..++..+.+||.+||..||.+||++     +++++||||++..+.
T Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~hp~~~~~~~~  296 (326)
T 2x7f_A          247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT-----EQLMKHPFIRDQPNE  296 (326)
T ss_dssp             HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSHHHHCCTTH
T ss_pred             hcCccccCCccccCHHHHHHHHHHhccChhhCCCH-----HHHhhChHHhhCccc
Confidence            554332  245689999999999999999999998     999999999876554

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.5e-48  Score=383.35  Aligned_cols=270  Identities=28%  Similarity=0.462  Sum_probs=200.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.++||||+++++++.+...+
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            3556899999999999999999999999999999998865422  22334567789999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          131 YMALESCEGGELFDQITS--------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~--------~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      |+||||+++++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999999874        456999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  281 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~  281 (499)
                      .........     ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................
T Consensus       169 ~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          169 AFLATGGDI-----TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             HHCC--------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             heeccCCCc-----cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            765432110     01122335689999999999875 568899999999999999999999999877665554444332


Q ss_pred             C----------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 010859          282 I----------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  332 (499)
Q Consensus       282 ~----------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~  332 (499)
                      .          ..+..++.++.+||.+||+.||.+||++     +++++||||+...++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~  299 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA-----AELLRHKFFQKAKNKEF  299 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSTTC--------
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCH-----HHHhhChhhhcCCCCcc
Confidence            2          2234678999999999999999999998     99999999998766543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.9e-47  Score=378.80  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=219.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEc-CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC---CCCCccEEEEEEE----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQ----  125 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~-~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~Iv~l~~~~~----  125 (499)
                      .++|++++.||+|+||.||+|++. .+|+.||+|++........ ....+.+|..+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            478999999999999999999995 6789999999975433221 112234566666555   8999999999987    


Q ss_pred             -cCCeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          126 -DTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       126 -~~~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                       ....+|+||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5678999999998 59999998753  4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-  281 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-  281 (499)
                      +......           ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.... 
T Consensus       168 ~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (326)
T 1blx_A          168 RIYSFQM-----------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  236 (326)
T ss_dssp             CCCCGGG-----------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccCCC-----------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence            7654221           2235679999999999999999999999999999999999999999999888777776420 


Q ss_pred             --------------------------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          282 --------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       282 --------------------------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                                                ..++..++.++.+||.+||+.||.+||++     +++++||||+++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYFQDLERC  306 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTCCCC
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH-----HHHhcCccccccchh
Confidence                                      01335688999999999999999999998     899999999988764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.2e-47  Score=380.96  Aligned_cols=251  Identities=19%  Similarity=0.309  Sum_probs=216.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCce---EEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV---YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~---vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      .+..++|++.+.||+|+||.||+|.+..+++.   ||||++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            45678999999999999999999999866654   9999997542  233455678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      ..+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999999755 579999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  284 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  284 (499)
                      .....       ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ....
T Consensus       203 ~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~  275 (325)
T 3kul_A          203 DDPDA-------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA  275 (325)
T ss_dssp             ----C-------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             cCccc-------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC
Confidence            43211       111223456888999999998889999999999999999999 99999999988888777665 4567


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |..+++++.+||.+||..||.+||++
T Consensus       276 ~~~~~~~l~~li~~~l~~dp~~Rps~  301 (325)
T 3kul_A          276 PMGCPHALHQLMLDCWHKDRAQRPRF  301 (325)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCcCHHHHHHHHHHccCChhhCcCH
Confidence            78899999999999999999999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.7e-47  Score=386.76  Aligned_cols=257  Identities=23%  Similarity=0.351  Sum_probs=203.1

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC---
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF---  128 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~---  128 (499)
                      ...++|++++.||+|+||.||+|++..+|+.||||++........    ....+...++.++||||++++++|....   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN----RELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCC----HHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccH----HHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            446899999999999999999999999999999999866433222    2344666778889999999999986533   


Q ss_pred             ----eEEEEEeccCCCChHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH--HCCcEeeecCCCCeeeCC-CCCEEEE
Q 010859          129 ----SLYMALESCEGGELFDQI----TSKGHLSEDEARFYTAEVVDALEYIH--SMGLIHRDIKPENLLLTA-DGHIKIA  197 (499)
Q Consensus       129 ----~l~lv~E~~~gg~L~~~i----~~~~~l~e~~~~~i~~qil~aL~~LH--~~gIiHrDlKp~NILl~~-~~~vkL~  197 (499)
                          .+|+||||+++ +|...+    .....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence                38999999987 554433    35567999999999999999999999  999999999999999997 8999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHH
Q 010859          198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR  276 (499)
Q Consensus       198 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~  276 (499)
                      |||+++.+...           ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......
T Consensus       175 Dfg~a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  243 (360)
T 3e3p_A          175 DFGSAKKLSPS-----------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE  243 (360)
T ss_dssp             CCTTCBCCCTT-----------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             eCCCceecCCC-----------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence            99999865432           1223567999999999987654 89999999999999999999999999988877777


Q ss_pred             HHhcCC--------------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          277 IIARDI--------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       277 i~~~~~--------------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      +.....                                ..+...++++.+||.+||+.||.+|||+     +++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f  318 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP-----YEALCHPYF  318 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH-----HHHTTSGGG
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH-----HHHhcCccc
Confidence            654210                                1122256789999999999999999998     899999999


Q ss_pred             CCCCc
Q 010859          325 KGIDW  329 (499)
Q Consensus       325 ~~i~~  329 (499)
                      +++..
T Consensus       319 ~~~~~  323 (360)
T 3e3p_A          319 DELHD  323 (360)
T ss_dssp             GGGGC
T ss_pred             cccCC
Confidence            97653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-48  Score=399.03  Aligned_cols=258  Identities=18%  Similarity=0.239  Sum_probs=200.6

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC--CCCCccEEE-------EEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DHPGVVRLF-------FTF  124 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~Iv~l~-------~~~  124 (499)
                      ..+|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|..+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34699999999999999999999999999999999987665555666777785444444  699988865       444


Q ss_pred             EcC-----------------CeEEEEEeccCCCChHHHHhhcC-CCCHHHH------HHHHHHHHHHHHHHHHCCcEeee
Q 010859          125 QDT-----------------FSLYMALESCEGGELFDQITSKG-HLSEDEA------RFYTAEVVDALEYIHSMGLIHRD  180 (499)
Q Consensus       125 ~~~-----------------~~l~lv~E~~~gg~L~~~i~~~~-~l~e~~~------~~i~~qil~aL~~LH~~gIiHrD  180 (499)
                      ...                 ..+|+|||||+ |+|.+++...+ .+++...      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            433                 34899999998 79999998743 3444444      56779999999999999999999


Q ss_pred             cCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCC--CCCCCCCcchhhhHHHHHH
Q 010859          181 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQM  258 (499)
Q Consensus       181 lKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDiwslG~ilyel  258 (499)
                      |||+|||++.+|.+||+|||+|+.....             .....||+.|+|||++.+  ..++.++|||||||++|+|
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el  286 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTR-------------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV  286 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCE-------------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCC-------------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence            9999999999999999999999865321             114567799999999987  6799999999999999999


Q ss_pred             hcCCCCCCCCCHHHH--HH-----HHHhcCCCCC--CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          259 LSGTSPFKDTSEWLI--FQ-----RIIARDIRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       259 ltG~~Pf~~~~~~~~--~~-----~i~~~~~~~p--~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      ++|+.||.+......  +.     ......+.+|  ..+++++.+||.+||+.||++||++     +++++||||+++.|
T Consensus       287 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~  361 (371)
T 3q60_A          287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP-----LEAMETPEFLQLQN  361 (371)
T ss_dssp             HHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH-----HHHTTSHHHHHHHH
T ss_pred             HhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCHHHHHHHH
Confidence            999999987643210  00     0011223333  4789999999999999999999998     99999999998876


Q ss_pred             c
Q 010859          330 K  330 (499)
Q Consensus       330 ~  330 (499)
                      .
T Consensus       362 ~  362 (371)
T 3q60_A          362 E  362 (371)
T ss_dssp             H
T ss_pred             H
Confidence            5

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.4e-47  Score=392.49  Aligned_cols=252  Identities=25%  Similarity=0.347  Sum_probs=209.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC--------CCCccEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--------HPGVVRLFFT  123 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp~Iv~l~~~  123 (499)
                      ...++|++++.||+|+||+||+|++..+++.||||++...    ......+.+|+.+++.+.        ||||++++++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            3357899999999999999999999999999999999653    334455777888888884        7889999999


Q ss_pred             EE----cCCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeCCCC----
Q 010859          124 FQ----DTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADG----  192 (499)
Q Consensus       124 ~~----~~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~~~~----  192 (499)
                      |.    +...+|+||||+ +++|.+.+...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++    
T Consensus       110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            98    667899999999 55777777654  4699999999999999999999998 999999999999999775    


Q ss_pred             ---------------------------------------------CEEEEecCCccccCCccccccCCCCCCCCcccccc
Q 010859          193 ---------------------------------------------HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG  227 (499)
Q Consensus       193 ---------------------------------------------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~G  227 (499)
                                                                   .+||+|||+|+....             .....+|
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-------------~~~~~~g  255 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-------------HFTEDIQ  255 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-------------CSCSCCS
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-------------cCccCCC
Confidence                                                         799999999986532             1234579


Q ss_pred             CccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC------HHHHHHHHHhc---------------------
Q 010859          228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS------EWLIFQRIIAR---------------------  280 (499)
Q Consensus       228 t~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~------~~~~~~~i~~~---------------------  280 (499)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+      .......+...                     
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  335 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK  335 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence            999999999999999999999999999999999999998654      22333333221                     


Q ss_pred             ---------------------CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 ---------------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ---------------------~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                           .+.++...++++.+||.+||+.||.+|||+     +++++||||++
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~  397 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA-----AECLRHPWLNS  397 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH-----HHHHTSGGGGC
T ss_pred             ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH-----HHHhhCccccC
Confidence                                 112233345678999999999999999998     99999999973

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9e-47  Score=368.51  Aligned_cols=251  Identities=20%  Similarity=0.342  Sum_probs=220.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++++.||+|+||.||+|.+. +++.||+|++.......    ..+.+|..++++++||||+++++++.+...+|
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            44679999999999999999999987 47789999997654332    34778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            999999999999999754 5699999999999999999999999999999999999999999999999999986544321


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                      .         ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ....|..+
T Consensus       162 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T 4hcu_A          162 T---------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA  232 (269)
T ss_dssp             H---------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred             c---------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcC
Confidence            1         1224467889999999998899999999999999999999 99999999998888887765 45567788


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ++++.+||.+||+.||.+||++     +++++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~-----~~ll~~  260 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAF-----SRLLRQ  260 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCH-----HHHHHH
Confidence            9999999999999999999998     666653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-46  Score=386.82  Aligned_cols=255  Identities=28%  Similarity=0.413  Sum_probs=213.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CC-----CccEEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HP-----GVVRLFFTFQ  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~Iv~l~~~~~  125 (499)
                      ...++|++++.||+|+||+||+|.+..+++.||||++...    .........|..+++.+. |+     +|+++++++.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            3468999999999999999999999999999999999653    223445666777877774 44     4999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeeecCCCCeeeC--CCCCEEEEec
Q 010859          126 DTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH--SMGLIHRDIKPENLLLT--ADGHIKIADF  199 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH--~~gIiHrDlKp~NILl~--~~~~vkL~DF  199 (499)
                      ....+|+||||+.+ +|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+||
T Consensus       127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999999965 999999875  45999999999999999999999  57999999999999995  4678999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  279 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~  279 (499)
                      |+|+....             .....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus       206 G~a~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~  272 (382)
T 2vx3_A          206 GSSCQLGQ-------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE  272 (382)
T ss_dssp             TTCEETTC-------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cCceeccc-------------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99986532             22356899999999999999999999999999999999999999999998888777765


Q ss_pred             cCCCCC------------------CC----------------------------------------------CChHHHHH
Q 010859          280 RDIRFP------------------NY----------------------------------------------FSDAARDL  295 (499)
Q Consensus       280 ~~~~~p------------------~~----------------------------------------------~~~~~~~L  295 (499)
                      .....|                  ..                                              .++++.+|
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  352 (382)
T 2vx3_A          273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL  352 (382)
T ss_dssp             HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred             HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence            211100                  00                                              00378999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          296 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       296 i~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      |.+||+.||.+|||+     +++++||||++..+
T Consensus       353 i~~mL~~dP~~Rpta-----~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          353 ILRMLDYDPKTRIQP-----YYALQHSFFKKTAD  381 (382)
T ss_dssp             HHHHTCSCTTTSCCH-----HHHTTSGGGCC---
T ss_pred             HHHhcCCChhhCCCH-----HHHhcCcccccCCC
Confidence            999999999999999     99999999986543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=392.53  Aligned_cols=260  Identities=20%  Similarity=0.332  Sum_probs=223.1

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEE-----EcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      .+..++|++++.||+|+||+||+|+     +..+++.||||++....  .......+.+|+.+++.++||||+++++++.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4556899999999999999999999     45678899999986432  2334455777999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC---CEE
Q 010859          126 DTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIK  195 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~-------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~---~vk  195 (499)
                      +....|+|||||+||+|.+++...+       .+++..++.++.||+.||.|||++||+||||||+|||++.+|   .+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999998653       489999999999999999999999999999999999999655   599


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHH
Q 010859          196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  274 (499)
Q Consensus       196 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~  274 (499)
                      |+|||+|+.+....        .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.....
T Consensus       225 L~DFG~a~~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~  296 (367)
T 3l9p_A          225 IGDFGMARDIYRAG--------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  296 (367)
T ss_dssp             ECCCHHHHHHHHHS--------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ECCCcccccccccc--------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999997553221        1122335678999999999998899999999999999999998 99999999988888


Q ss_pred             HHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          275 QRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       275 ~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ..+.... ...|..++.++.+||.+||+.||.+||++     +++++|.++-
T Consensus       297 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~l~~~  343 (367)
T 3l9p_A          297 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-----AIILERIEYC  343 (367)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCH-----HHHHHHHHHH
Confidence            8777654 55677899999999999999999999988     8899887764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-46  Score=378.17  Aligned_cols=267  Identities=24%  Similarity=0.294  Sum_probs=217.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .++|++++.||+|+||.||+|++..+|+.||||++......     ..+.+|+.+++.+ +||||+++++++.+....|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            46899999999999999999999999999999998765322     2366799999999 99999999999999999999


Q ss_pred             EEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC-----EEEEecCCccccC
Q 010859          133 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKPMQ  206 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~-----vkL~DFG~a~~~~  206 (499)
                      ||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+|+.+.
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 89999999864 67999999999999999999999999999999999999999887     9999999998764


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC---CHHHHHHHHHhcCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARDIR  283 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~---~~~~~~~~i~~~~~~  283 (499)
                      ......   ..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.   .....++.+......
T Consensus       162 ~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          162 DPETKK---HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             CTTTCC---BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             cCCCCc---cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            432110   00011234678999999999999999999999999999999999999999874   444555666544433


Q ss_pred             CC-----CCCChHHHHHHHHhhccCCCCCCCCCC--CCHHHHh---cCCCCCCCCcc
Q 010859          284 FP-----NYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVLK---MHPFFKGIDWK  330 (499)
Q Consensus       284 ~p-----~~~~~~~~~Li~~lL~~dP~~R~~~~~--~~~~~l~---~Hpff~~i~~~  330 (499)
                      .|     ..+| ++.+||.+||..||.+||++.+  ..+.++.   ...+...++|.
T Consensus       239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence            33     2355 9999999999999999999843  1111111   24455678887

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.8e-47  Score=393.18  Aligned_cols=258  Identities=26%  Similarity=0.377  Sum_probs=196.3

Q ss_pred             CCeee-eeEeeecCceEEEEEEEc--CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCe
Q 010859           55 QDFEL-GKIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFS  129 (499)
Q Consensus        55 ~~y~~-~~~LG~G~~g~Vy~a~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~--~~~~  129 (499)
                      +.|++ +++||+|+||+||+|+++  .+++.||||++......     ..+.+|+.+|+.++||||++++++|.  ....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            45777 568999999999999976  56899999998755332     24667999999999999999999994  4778


Q ss_pred             EEEEEeccCCCChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee----CCCCCEEE
Q 010859          130 LYMALESCEGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKI  196 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl----~~~~~vkL  196 (499)
                      +|+||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999999975 888887632         249999999999999999999999999999999999999    67789999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHH----
Q 010859          197 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW----  271 (499)
Q Consensus       197 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~----  271 (499)
                      +|||+|+.+.....       ........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..    
T Consensus       174 ~Dfg~a~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          174 ADMGFARLFNSPLK-------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             CCTTCCC-----------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             EECCCceecCCCCc-------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            99999987643211       11233457899999999999874 4899999999999999999999999876542    


Q ss_pred             -----HHHHHHHhcCC-C-------------------------------------CCCCCChHHHHHHHHhhccCCCCCC
Q 010859          272 -----LIFQRIIARDI-R-------------------------------------FPNYFSDAARDLIDRLLDVDPSGRP  308 (499)
Q Consensus       272 -----~~~~~i~~~~~-~-------------------------------------~p~~~~~~~~~Li~~lL~~dP~~R~  308 (499)
                           ..+..+...-. .                                     .....++++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence                 33444432100 0                                     0011277899999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCcc
Q 010859          309 GAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       309 ~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      |+     +++++||||.+..+.
T Consensus       327 ta-----~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          327 TS-----EQAMQDPYFLEDPLP  343 (405)
T ss_dssp             CH-----HHHHTSGGGTSSSCC
T ss_pred             CH-----HHHhcChhhccCCCC
Confidence            98     999999999976554

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=375.17  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=214.3

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||+||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++.+...+
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            35678999999999999999999999999999999998543   344556678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999999999987 4679999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccC----CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH-----HHHHHHhc
Q 010859          210 ITVLP----NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-----IFQRIIAR  280 (499)
Q Consensus       210 ~~~~~----~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~-----~~~~i~~~  280 (499)
                      .....    ...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ......  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--  240 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--  240 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--
Confidence            21100    0001122236789999999999999999999999999999999999999987532211     011111  


Q ss_pred             CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          281 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       281 ~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ...+|..+++++.+||.+||+.||.+||++     +++++
T Consensus       241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~l~~  275 (310)
T 3s95_A          241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSF-----VKLEH  275 (310)
T ss_dssp             HHTCCTTCCTTHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cccCCCCCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            123577889999999999999999999998     66664

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.2e-47  Score=384.90  Aligned_cols=256  Identities=22%  Similarity=0.378  Sum_probs=210.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc--------hhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--------KENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      .++|++++.||+|+||.||+|.+.. |+.||||++......        .......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            4789999999999999999999865 999999998654322        2223466788999999999999999999984


Q ss_pred             -----cCCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEec
Q 010859          126 -----DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  199 (499)
Q Consensus       126 -----~~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DF  199 (499)
                           ....+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence                 3457999999998 5888888755 46999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  278 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~  278 (499)
                      |+++.....           ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus       179 g~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  247 (362)
T 3pg1_A          179 NLAREDTAD-----------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV  247 (362)
T ss_dssp             TC--------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             Ccccccccc-----------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999754322           22335689999999999877 678999999999999999999999999998888777765


Q ss_pred             hcCC--------------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          279 ARDI--------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       279 ~~~~--------------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ....                                ..+..+++.+.+||.+||+.||.+|||+     +++++||||++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~  322 (362)
T 3pg1_A          248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST-----EQALRHPYFES  322 (362)
T ss_dssp             HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGTT
T ss_pred             HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH-----HHHHcCchhhh
Confidence            4110                                1123568899999999999999999998     99999999997


Q ss_pred             C
Q 010859          327 I  327 (499)
Q Consensus       327 i  327 (499)
                      +
T Consensus       323 ~  323 (362)
T 3pg1_A          323 L  323 (362)
T ss_dssp             T
T ss_pred             c
Confidence            5

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.7e-47  Score=379.90  Aligned_cols=256  Identities=18%  Similarity=0.305  Sum_probs=213.4

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCce----EEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~----vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      ..+..++|++++.||+|+||+||+|.+..+++.    ||+|++.....  ......+.+|..+++.++||||+++++++.
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   85 (325)
T 3kex_A            8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP   85 (325)
T ss_dssp             CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            345678999999999999999999999988887    66666543321  111223556888999999999999999886


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          126 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      + ...|+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus        86 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           86 G-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             B-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             C-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            4 5689999999999999999875 5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CC
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DI  282 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~  282 (499)
                      +....        .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus       165 ~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  236 (325)
T 3kex_A          165 LPPDD--------KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL  236 (325)
T ss_dssp             SCCCT--------TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC
T ss_pred             cCccc--------ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC
Confidence            64432        1122335678889999999998899999999999999999999 99999988877777666654 45


Q ss_pred             CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       283 ~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ..|..++.++.+||.+||+.||.+||++     .++++|
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~el~~~  270 (325)
T 3kex_A          237 AQPQICTIDVYMVMVKCWMIDENIRPTF-----KELANE  270 (325)
T ss_dssp             CCCTTBCTTTTHHHHHHTCSCTTTSCCH-----HHHHHH
T ss_pred             CCCCcCcHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            6777899999999999999999999998     666654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-46  Score=372.11  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=206.5

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|..+++.++||||+++++++.+...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            44578999999999999999999999999999999999766555555567788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-  188 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-  188 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999997654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---CCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNY  287 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~  287 (499)
                              ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....   ..++..
T Consensus       189 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (309)
T 2h34_A          189 --------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPG  260 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTT
T ss_pred             --------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCC
Confidence                    112235679999999999999999999999999999999999999999877654444443322   134567


Q ss_pred             CChHHHHHHHHhhccCCCCCC-CC
Q 010859          288 FSDAARDLIDRLLDVDPSGRP-GA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~-~~  310 (499)
                      +|+++.+||.+||+.||.+|| ++
T Consensus       261 ~~~~l~~li~~~l~~dP~~Rp~s~  284 (309)
T 2h34_A          261 IPVAFDAVIARGMAKNPEDRYVTC  284 (309)
T ss_dssp             CCTHHHHHHHHHTCSSGGGSCSSH
T ss_pred             CCHHHHHHHHHhccCCHHHHHHhH
Confidence            899999999999999999999 55

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=371.22  Aligned_cols=259  Identities=26%  Similarity=0.469  Sum_probs=216.1

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|....+||+|+||.||+|.+..+++.||+|++....   ......+.+|..+++.++||||+++++++.+...+|
T Consensus        19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            44456666679999999999999999999999999997652   233455778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-CCCEEEEecCCccccCC
Q 010859          132 MALESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQD  207 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-~~~vkL~DFG~a~~~~~  207 (499)
                      +||||+++++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            999999999999999865   24679999999999999999999999999999999999987 89999999999986543


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCC--CCCCCcchhhhHHHHHHhcCCCCCCCCCHHH-HH-H-HHHhcCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IF-Q-RIIARDI  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--~~~~sDiwslG~ilyelltG~~Pf~~~~~~~-~~-~-~i~~~~~  282 (499)
                      ..          .......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||....... .. . .......
T Consensus       176 ~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (295)
T 2clq_A          176 IN----------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP  245 (295)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC
T ss_pred             CC----------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc
Confidence            21          1223567999999999987643  7889999999999999999999997644322 21 1 2233455


Q ss_pred             CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       283 ~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      .+|..+++++.+||.+||+.||.+||++     +++++||||+...
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~  286 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACA-----NDLLVDEFLKVSS  286 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCH-----HHHHTSGGGCC--
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCH-----HHHhcChhhhhcc
Confidence            7788899999999999999999999998     9999999998543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.6e-46  Score=370.04  Aligned_cols=267  Identities=31%  Similarity=0.520  Sum_probs=212.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  126 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-------  126 (499)
                      .++|++++.||+|+||.||+|++..+|+.||||++...    ......+.+|..+++.++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            36899999999999999999999999999999998643    3345667789999999999999999998865       


Q ss_pred             ------CCeEEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEec
Q 010859          127 ------TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  199 (499)
Q Consensus       127 ------~~~l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DF  199 (499)
                            ...+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence                  467899999999999999998653 5889999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccC----CCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCC-CHHHH
Q 010859          200 GSVKPMQDSRITVLP----NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLI  273 (499)
Q Consensus       200 G~a~~~~~~~~~~~~----~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~-~~~~~  273 (499)
                      |++............    ............||+.|+|||++.+. .++.++|||||||++|+|++   ||... +....
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            999876432110000    00011233456899999999999865 68999999999999999998   66543 33445


Q ss_pred             HHHHHhcCCCCCC----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 010859          274 FQRIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  332 (499)
Q Consensus       274 ~~~i~~~~~~~p~----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~  332 (499)
                      ...+......+|.    ..+..+.+||.+||+.||.+||++     +++++||||....++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~  295 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-----RTLLNSGWLPVKHQDEV  295 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH-----HHHHHSSCSCCCCHHHH
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH-----HHHhCCCCcCCCChHHH
Confidence            5566655555554    456779999999999999999998     99999999987766543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.7e-47  Score=385.84  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=215.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEE-----EcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  124 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~  124 (499)
                      .+..++|++++.||+|+||.||+|+     +..+++.||||++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3556899999999999999999999     55677999999997542  233345678899999999 789999999999


Q ss_pred             EcCC-eEEEEEeccCCCChHHHHhhcCC----------------------------------------------------
Q 010859          125 QDTF-SLYMALESCEGGELFDQITSKGH----------------------------------------------------  151 (499)
Q Consensus       125 ~~~~-~l~lv~E~~~gg~L~~~i~~~~~----------------------------------------------------  151 (499)
                      .+.. .+|+|||||+||+|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8754 49999999999999999986543                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCC
Q 010859          152 --------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  217 (499)
Q Consensus       152 --------------l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  217 (499)
                                    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....        
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~--------  247 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--------  247 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT--------
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc--------
Confidence                          8999999999999999999999999999999999999999999999999998654321        


Q ss_pred             CCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHH-HHHHh-cCCCCCCCCChHHHH
Q 010859          218 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF-QRIIA-RDIRFPNYFSDAARD  294 (499)
Q Consensus       218 ~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~-~~i~~-~~~~~p~~~~~~~~~  294 (499)
                      .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....... ..+.. .....|..+++++.+
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  327 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ  327 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1122335678999999999999999999999999999999998 99999887644333 33333 345678889999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          295 LIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       295 Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ||.+||+.||.+||++     +++++|
T Consensus       328 li~~~l~~dP~~Rps~-----~ell~~  349 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTF-----SELVEH  349 (359)
T ss_dssp             HHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHccCChhhCCCH-----HHHHHH
Confidence            9999999999999998     677654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-46  Score=375.21  Aligned_cols=258  Identities=22%  Similarity=0.369  Sum_probs=221.8

Q ss_pred             CCCCCCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEE
Q 010859           48 PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF  122 (499)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~  122 (499)
                      +...+..++|++++.||+|+||.||+|.+.     .++..||+|++....  .......+.+|..+++.++||||+++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence            344566789999999999999999999984     456899999986542  2334566788999999999999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 010859          123 TFQDTFSLYMALESCEGGELFDQITSKGH------------------------LSEDEARFYTAEVVDALEYIHSMGLIH  178 (499)
Q Consensus       123 ~~~~~~~l~lv~E~~~gg~L~~~i~~~~~------------------------l~e~~~~~i~~qil~aL~~LH~~gIiH  178 (499)
                      ++.+...+|+||||+++|+|.+++...+.                        +++..++.++.||+.||.|||++||+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            99999999999999999999999987543                        899999999999999999999999999


Q ss_pred             eecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHH
Q 010859          179 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM  258 (499)
Q Consensus       179 rDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyel  258 (499)
                      |||||+|||++.++.+||+|||+++........        .......||+.|+|||++.+..++.++|||||||++|+|
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  245 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSY--------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI  245 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCE--------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccc--------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHH
Confidence            999999999999999999999999866433211        122345678999999999988899999999999999999


Q ss_pred             hc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          259 LS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       259 lt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ++ |..||.+.+.......+... ....|..+++++.+||.+||+.||.+||++     +++++
T Consensus       246 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~l~~  304 (314)
T 2ivs_A          246 VTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF-----ADISK  304 (314)
T ss_dssp             HTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            99 99999998877777666654 355778899999999999999999999988     66654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.9e-46  Score=367.01  Aligned_cols=271  Identities=19%  Similarity=0.278  Sum_probs=219.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l  130 (499)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++......     ..+.+|..+++.+ +|++|+++++++.+....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            4457899999999999999999999999999999998754322     2356688899998 799999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC-----EEEEecCCccc
Q 010859          131 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKP  204 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~-----vkL~DFG~a~~  204 (499)
                      |+||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 899999998754 5999999999999999999999999999999999999988776     99999999987


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC---CHHHHHHHHHhcC
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARD  281 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~---~~~~~~~~i~~~~  281 (499)
                      ........   ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.   .....+..+....
T Consensus       161 ~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          161 YRDPVTKQ---HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             SBCTTTCC---BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             cccccccc---cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            65432110   00112344678999999999999999999999999999999999999999874   4445555554432


Q ss_pred             CC-----CCCCCChHHHHHHHHhhccCCCCCCCCCC--CCHHHH---hcCCCCCCCCccc
Q 010859          282 IR-----FPNYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVL---KMHPFFKGIDWKN  331 (499)
Q Consensus       282 ~~-----~p~~~~~~~~~Li~~lL~~dP~~R~~~~~--~~~~~l---~~Hpff~~i~~~~  331 (499)
                      ..     ++..+++++.+||.+||+.||.+||++.+  ..++++   +.......+||+.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  297 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL  297 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence            22     23478999999999999999999999843  111112   2344555566653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=378.81  Aligned_cols=255  Identities=20%  Similarity=0.327  Sum_probs=221.5

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      .+..++|++++.||+|+||.||+|++.     .+++.||+|++....  .......+.+|..+++.++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            455689999999999999999999997     456899999987543  2334566788999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeec
Q 010859          126 DTFSLYMALESCEGGELFDQITSK------------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDI  181 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDl  181 (499)
                      +...+|+||||+++|+|.+++...                        ..+++..++.++.||+.||.|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999999999999999999999864                        56999999999999999999999999999999


Q ss_pred             CCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-
Q 010859          182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-  260 (499)
Q Consensus       182 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-  260 (499)
                      ||+|||++.++.+||+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ 
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADY--------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGC--------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCcc--------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence            99999999999999999999986543221        112234578999999999998889999999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCC-CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          261 GTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       261 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      |..||.+.+.......+..... .+|..+++++.+||.+||+.||.+||++     +++++
T Consensus       273 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~  328 (343)
T 1luf_A          273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF-----CSIHR  328 (343)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCH-----HHHHH
Confidence            9999999998888887776553 5778899999999999999999999998     55653

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.6e-47  Score=380.82  Aligned_cols=256  Identities=30%  Similarity=0.516  Sum_probs=222.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh---hHHHHHHHHHHHHHhCC--CCCccEEEEEEEc
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLD--HPGVVRLFFTFQD  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hp~Iv~l~~~~~~  126 (499)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++........   .....+.+|..+++.+.  ||||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            346789999999999999999999999999999999987643321   11123456888898885  5999999999999


Q ss_pred             CCeEEEEEeccCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC-CCCCEEEEecCCccc
Q 010859          127 TFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVKP  204 (499)
Q Consensus       127 ~~~l~lv~E~~~g-g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~-~~~~vkL~DFG~a~~  204 (499)
                      ....|+|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            9999999999986 89999999888999999999999999999999999999999999999999 678999999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR  283 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~  283 (499)
                      ....            ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....      .+......
T Consensus       200 ~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~  261 (320)
T 3a99_A          200 LKDT------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF  261 (320)
T ss_dssp             CCSS------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC
T ss_pred             cccc------------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccc
Confidence            5432            2234679999999999876665 678899999999999999999997642      34556777


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      ++..+++++.+||.+||+.||.+||++     +++++||||+++.+.
T Consensus       262 ~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          262 FRQRVSSECQHLIRWCLALRPSDRPTF-----EEIQNHPWMQDVLLP  303 (320)
T ss_dssp             CSSCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSCCCH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCH-----HHHhcCHhhcCccCc
Confidence            888999999999999999999999998     999999999987654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-46  Score=371.02  Aligned_cols=246  Identities=19%  Similarity=0.300  Sum_probs=212.7

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCC-------ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTG-------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  124 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~-------~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~  124 (499)
                      +..++|++.+.||+|+||.||+|.+..++       ..||+|++....   ......+.+|..+++.++||||+++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            45689999999999999999999998887       479999986542   33445678899999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC--------EE
Q 010859          125 QDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--------IK  195 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~--------vk  195 (499)
                      .+....|+||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 999999999999999999999999999999999999998887        99


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcC-CCCCCCCCHHHH
Q 010859          196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSG-TSPFKDTSEWLI  273 (499)
Q Consensus       196 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG-~~Pf~~~~~~~~  273 (499)
                      |+|||++.....              .....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||...+. ..
T Consensus       162 l~Dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~  226 (289)
T 4fvq_A          162 LSDPGISITVLP--------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QR  226 (289)
T ss_dssp             ECCCCSCTTTSC--------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HH
T ss_pred             eccCcccccccC--------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HH
Confidence            999999875432              224578999999999987 6789999999999999999995 555555544 44


Q ss_pred             HHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          274 FQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       274 ~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ...+......+|...++++.+||.+||+.||.+||++     +++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~  268 (289)
T 4fvq_A          227 KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSF-----RAIIR  268 (289)
T ss_dssp             HHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             HHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            4455566777888889999999999999999999998     67765

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2e-46  Score=375.41  Aligned_cols=269  Identities=19%  Similarity=0.301  Sum_probs=228.7

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  124 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~  124 (499)
                      .....++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|..+++.++||||+++++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            3455689999999999999999999987     467899999987543  223344577899999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCE
Q 010859          125 QDTFSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI  194 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~----------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~v  194 (499)
                      .+....|+||||+++|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence            9999999999999999999998753          357999999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHH
Q 010859          195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLI  273 (499)
Q Consensus       195 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~  273 (499)
                      ||+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+....
T Consensus       178 kl~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  249 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDY--------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV  249 (322)
T ss_dssp             EECCTTCCCGGGGGGC--------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred             EECcCccccccccccc--------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence            9999999986543221        112234567899999999998889999999999999999999 9999999988888


Q ss_pred             HHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC------CCCCCCCccccc
Q 010859          274 FQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH------PFFKGIDWKNIR  333 (499)
Q Consensus       274 ~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H------pff~~i~~~~~~  333 (499)
                      ...+.... ...|..++.++.+||.+||+.||.+||++     +++++|      ++|+.++|....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~e~l~~L~~~~~~~~~~~~~~~~~  311 (322)
T 1p4o_A          250 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIISSIKEEMEPGFREVSFYYSE  311 (322)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHGGGSCTTHHHHCSTTST
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHHHHHHhhccCCccccccccc
Confidence            77776654 45677899999999999999999999998     566654      788777665443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-46  Score=380.73  Aligned_cols=251  Identities=31%  Similarity=0.493  Sum_probs=185.8

Q ss_pred             CCCCCeeeee-EeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----
Q 010859           52 FSIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----  126 (499)
Q Consensus        52 ~~~~~y~~~~-~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~----  126 (499)
                      ...++|++.+ +||+|+||.||+|.++.+|+.||||++....       .........++.++||||+++++++..    
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            3467899965 6999999999999999999999999986531       112223335677899999999999976    


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC---CCEEEEecCC
Q 010859          127 TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGS  201 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~---~~vkL~DFG~  201 (499)
                      ...+|+|||||+||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            556999999999999999998764  69999999999999999999999999999999999999864   5599999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHH----HHHH
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRI  277 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~----~~~i  277 (499)
                      ++.....            .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......    ...+
T Consensus       178 ~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (336)
T 3fhr_A          178 AKETTQN------------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI  245 (336)
T ss_dssp             CEEC----------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred             ceecccc------------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh
Confidence            9754321            22356789999999999888899999999999999999999999987665443    2333


Q ss_pred             HhcCCCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          278 IARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       278 ~~~~~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ....+.+|    ..+++++.+||.+||+.||.+||++     +++++||||++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  293 (336)
T 3fhr_A          246 RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI-----TQFMNHPWINQ  293 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCccccc
Confidence            33344444    4689999999999999999999998     99999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-46  Score=381.05  Aligned_cols=256  Identities=23%  Similarity=0.359  Sum_probs=222.3

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCC-------CceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLF  121 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t-------~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~  121 (499)
                      ..+..++|++++.||+|+||.||+|++..+       +..||+|++....  .......+.+|+.+++.+ +||||++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            345568999999999999999999998643       3579999997652  334456677899999999 999999999


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCC
Q 010859          122 FTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  185 (499)
Q Consensus       122 ~~~~~~~~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~N  185 (499)
                      +++.+...+|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            99999999999999999999999998753                49999999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCC
Q 010859          186 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  264 (499)
Q Consensus       186 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~P  264 (499)
                      ||++.++.+||+|||+|+.......        ........||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDY--------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCT--------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             EEEcCCCcEEEcccCcccccccccc--------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999986643221        122234567899999999999999999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          265 FKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       265 f~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      |.+.+.....+.+... ....|..+++++.+||.+||+.||.+||++     +++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~  345 (382)
T 3tt0_A          294 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  345 (382)
T ss_dssp             STTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            9999888887777665 456778899999999999999999999998     66765

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.1e-46  Score=363.44  Aligned_cols=252  Identities=20%  Similarity=0.326  Sum_probs=218.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||.||+|.+. ++..||+|++......    ...+.+|..+++.++||||+++++++.+...+
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            345689999999999999999999876 5678999999765433    23467899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998764 49999999999999999999999999999999999999999999999999998654432


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~  287 (499)
                      ..         ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.... ...|..
T Consensus       159 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (268)
T 3sxs_A          159 YV---------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL  229 (268)
T ss_dssp             EE---------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             hh---------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCc
Confidence            11         1223456788999999998889999999999999999999 999999998888877776654 445677


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      .++++.+||.+||+.||.+||++     +++++|
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~~  258 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTF-----QQLLSS  258 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             ChHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            89999999999999999999998     667653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4e-46  Score=366.40  Aligned_cols=252  Identities=21%  Similarity=0.335  Sum_probs=217.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||.||+|.+. ++..||+|++.......    ..+.+|..+++.++||||+++++++.+...+
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            455689999999999999999999886 57789999997654332    3467899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999999999987 4679999999999999999999999999999999999999999999999999998664432


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      ..         ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+... ....|..
T Consensus       175 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (283)
T 3gen_A          175 YT---------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL  245 (283)
T ss_dssp             HH---------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             cc---------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCc
Confidence            11         1223457889999999998889999999999999999998 99999999988888877765 3456778


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      .++.+.+||.+||+.||.+||++     +++++|
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~~  274 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTF-----KILLSN  274 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCH-----HHHHHH
Confidence            89999999999999999999998     667654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-47  Score=377.31  Aligned_cols=254  Identities=31%  Similarity=0.552  Sum_probs=211.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhh---HHHHHHHHHHHHHhC----CCCCccEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN---KTAYVKLERIVLDQL----DHPGVVRLFFTF  124 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~---~~~~~~~E~~~l~~l----~hp~Iv~l~~~~  124 (499)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++.........   ....+.+|..+++++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999999999999999999765433211   122344578888887    899999999999


Q ss_pred             EcCCeEEEEEec-cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC-CCCCEEEEecCCc
Q 010859          125 QDTFSLYMALES-CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSV  202 (499)
Q Consensus       125 ~~~~~l~lv~E~-~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~-~~~~vkL~DFG~a  202 (499)
                      .+....|+|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            999999999999 78999999999888899999999999999999999999999999999999999 7899999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  281 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~  281 (499)
                      ......            ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...      ..+....
T Consensus       188 ~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~  249 (312)
T 2iwi_A          188 ALLHDE------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAE  249 (312)
T ss_dssp             EECCSS------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTC
T ss_pred             hhcccC------------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhc
Confidence            865432            2235679999999999876665 45899999999999999999999764      2355677


Q ss_pred             CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          282 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       282 ~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      ..+|..++.++.+||.+||+.||.+||++     +++++||||+...
T Consensus       250 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~~~~~~~~  291 (312)
T 2iwi_A          250 LHFPAHVSPDCCALIRRCLAPKPSSRPSL-----EEILLDPWMQTPA  291 (312)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHHSTTTCC--
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhcCch
Confidence            88899999999999999999999999998     9999999998643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.8e-46  Score=381.88  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=210.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-----------CCCccE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----------HPGVVR  119 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~Iv~  119 (499)
                      .+..++|++++.||+|+||+||+|++..+++.||||++....    .....+.+|+.+++.+.           ||||++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            455689999999999999999999999999999999997542    23445667888888775           899999


Q ss_pred             EEEEEEcCC----eEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeC---
Q 010859          120 LFFTFQDTF----SLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLT---  189 (499)
Q Consensus       120 l~~~~~~~~----~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~---  189 (499)
                      +++++....    .+++||||+ +++|.+++...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++   
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence            999998654    799999999 88999999864  4599999999999999999999998 999999999999995   


Q ss_pred             ---CCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCC
Q 010859          190 ---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK  266 (499)
Q Consensus       190 ---~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~  266 (499)
                         ..+.+||+|||+++.....             ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  236 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH-------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  236 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC-------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCcCcceEEEcccccccccCCC-------------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence               3448999999999765321             224579999999999999999999999999999999999999998


Q ss_pred             CCC------HHHHHHHHH------------------------------------------hcCCCCCCCCChHHHHHHHH
Q 010859          267 DTS------EWLIFQRII------------------------------------------ARDIRFPNYFSDAARDLIDR  298 (499)
Q Consensus       267 ~~~------~~~~~~~i~------------------------------------------~~~~~~p~~~~~~~~~Li~~  298 (499)
                      +.+      .......+.                                          ...+.+|..++.++.+||.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  316 (373)
T 1q8y_A          237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP  316 (373)
T ss_dssp             --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence            654      222222222                                          22334555667889999999


Q ss_pred             hhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          299 LLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       299 lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      ||+.||.+||++     +++++||||++.
T Consensus       317 ~L~~dP~~Rpt~-----~ell~hp~f~~~  340 (373)
T 1q8y_A          317 MLQLDPRKRADA-----GGLVNHPWLKDT  340 (373)
T ss_dssp             GGCSSTTTCBCH-----HHHHTCGGGTTC
T ss_pred             HhccCccccCCH-----HHHhhChhhhcc
Confidence            999999999998     999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.4e-46  Score=383.33  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=216.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||.||+|++..+++.||||++....  .......+.+|..+|+.++||||+++++++.+...+
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            345679999999999999999999999999999999986542  223334567799999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999999998654 59999999999999999999999999999999999999999999999999998643322


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      ..        .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ....|..
T Consensus       268 ~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (377)
T 3cbl_A          268 YA--------ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL  339 (377)
T ss_dssp             EE--------CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             ee--------ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            11        11122346778999999998889999999999999999998 99999998887777666553 4567888


Q ss_pred             CChHHHHHHHHhhccCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +++++.+||.+||+.||.+||++
T Consensus       340 ~~~~l~~li~~cl~~dP~~Rps~  362 (377)
T 3cbl_A          340 CPDAVFRLMEQCWAYEPGQRPSF  362 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHHcCCCchhCcCH
Confidence            99999999999999999999988

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=368.25  Aligned_cols=260  Identities=28%  Similarity=0.442  Sum_probs=203.0

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      -....++|++++.||+|+||.||+|.+..+|+.||||++...... ......+..+..+++.++||||+++++++.+...
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            345578999999999999999999999999999999999766432 2233444455567888999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 LYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +|+||||+ ++.+..+... .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++..+..
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            99999999 5555555543 46799999999999999999999995 999999999999999999999999999976533


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHhcC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD  281 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~-~~~~~~~~~i~~~~  281 (499)
                      ..           ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.. .........+....
T Consensus       178 ~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  246 (318)
T 2dyl_A          178 DK-----------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE  246 (318)
T ss_dssp             --------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC
T ss_pred             Cc-----------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC
Confidence            21           223457999999999994     45688899999999999999999999987 45556666666554


Q ss_pred             CC-CC--CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          282 IR-FP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       282 ~~-~p--~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      .. +|  ..+++++.+||.+||+.||.+||++     +++++||||++.
T Consensus       247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~  290 (318)
T 2dyl_A          247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKY-----NKLLEHSFIKRY  290 (318)
T ss_dssp             CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH-----HHHTTSHHHHHH
T ss_pred             CCCCCccCCCCHHHHHHHHHHccCChhHCcCH-----HHHhhCHHHHhc
Confidence            33 33  3589999999999999999999998     999999999753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.9e-46  Score=361.06  Aligned_cols=250  Identities=23%  Similarity=0.438  Sum_probs=205.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch-hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      +..++|++.+.||+|+||.||+|.+  +|+.||+|++....... ......+.+|..+++.++||||+++++++.+...+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            4568999999999999999999997  48899999986643322 22345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeeecCCCCeeeCC--------CCCEEEEec
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG---LIHRDIKPENLLLTA--------DGHIKIADF  199 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~g---IiHrDlKp~NILl~~--------~~~vkL~DF  199 (499)
                      |+||||+++++|.+++.. +.+++..++.++.|++.||.|||++|   |+||||||+|||++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999998864 57999999999999999999999999   999999999999986        678999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  279 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~  279 (499)
                      |++......            ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus       161 g~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  228 (271)
T 3dtc_A          161 GLAREWHRT------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM  228 (271)
T ss_dssp             CC-------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT
T ss_pred             Ccccccccc------------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc
Confidence            999765332            12245799999999999998999999999999999999999999999888777776665


Q ss_pred             cC--CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          280 RD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       280 ~~--~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ..  ..+|..+++++.+||.+||+.||.+||++     +++++|
T Consensus       229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~  267 (271)
T 3dtc_A          229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF-----TNILDQ  267 (271)
T ss_dssp             SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCH-----HHHHHH
Confidence            54  45677899999999999999999999998     667653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.8e-46  Score=365.90  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=205.7

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCC---CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      +..++|++++.||+|+||.||+|.+..+   +..||+|++...  ........+.+|..+++.++||||+++++++. +.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence            4467999999999999999999999754   456999987543  23334566778999999999999999999985 45


Q ss_pred             eEEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .+|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            7899999999999999998654 699999999999999999999999999999999999999999999999999987643


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  285 (499)
                      ...         .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ...+|
T Consensus       169 ~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (281)
T 1mp8_A          169 STY---------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  239 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             ccc---------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence            221         11223467889999999998899999999999999999996 99999998887777777654 35678


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ..+++++.+||.+||..||.+||++     .++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  269 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRF-----TELKA  269 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            8899999999999999999999988     55654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-45  Score=358.82  Aligned_cols=250  Identities=20%  Similarity=0.334  Sum_probs=218.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++.+.||+|+||.||+|.+. +++.||+|++.......    ..+.+|..+++.++||||+++++++.+...+|
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            34579999999999999999999986 57889999997654332    45778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999999999875 5699999999999999999999999999999999999999999999999999986543221


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  288 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  288 (499)
                               .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+... ....|..+
T Consensus       160 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  230 (267)
T 3t9t_A          160 ---------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA  230 (267)
T ss_dssp             ---------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred             ---------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccC
Confidence                     11223467889999999998889999999999999999999 99999999888888777765 34567788


Q ss_pred             ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       289 ~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      +..+.+||.+||+.||.+||++     +++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~-----~~ll~  257 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAF-----SRLLR  257 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            9999999999999999999998     66654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.1e-46  Score=379.95  Aligned_cols=278  Identities=17%  Similarity=0.167  Sum_probs=209.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCC-----CceEEEEEEeCcccchhhHH--------HHHHHHHHHHHhCCCCCccE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKT--------AYVKLERIVLDQLDHPGVVR  119 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t-----~~~vAiK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~hp~Iv~  119 (499)
                      ..++|++++.||+|+||.||+|.+..+     ++.||||++...........        .....|...++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            356899999999999999999999765     58899999876532111111        11233555677889999999


Q ss_pred             EEEEEEcC----CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC--CCC
Q 010859          120 LFFTFQDT----FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT--ADG  192 (499)
Q Consensus       120 l~~~~~~~----~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~--~~~  192 (499)
                      +++++...    ..+|+||||| |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            99998764    5689999999 99999999876 6799999999999999999999999999999999999999  889


Q ss_pred             CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH
Q 010859          193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL  272 (499)
Q Consensus       193 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~  272 (499)
                      .+||+|||+|+.+.......   ..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHK---AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCC---CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             eEEEEECCcceecccCCccc---ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            99999999998765432111   111222345679999999999999999999999999999999999999998643222


Q ss_pred             HHHHHHh----cC------CC-CCCCCChHHHHHHHHhhccCCCCCCCCCC--CCHHHH---hcCCCCCCCCcccccC
Q 010859          273 IFQRIIA----RD------IR-FPNYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVL---KMHPFFKGIDWKNIRG  334 (499)
Q Consensus       273 ~~~~i~~----~~------~~-~p~~~~~~~~~Li~~lL~~dP~~R~~~~~--~~~~~l---~~Hpff~~i~~~~~~~  334 (499)
                      .......    ..      .. .+..+++++.+||..||..||.+||++.+  ..+.++   ...++...++|....+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~  346 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVEN  346 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-----
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccC
Confidence            1111111    00      01 12567999999999999999999999843  111111   1345666777775543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-46  Score=375.55  Aligned_cols=256  Identities=23%  Similarity=0.397  Sum_probs=215.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  124 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~  124 (499)
                      .+..++|++++.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            455689999999999999999999973     466789999997543  222345677899999999 899999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeec
Q 010859          125 QDTFSLYMALESCEGGELFDQITSKG-----------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDI  181 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDl  181 (499)
                      .+...+|+||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999998653                       2799999999999999999999999999999


Q ss_pred             CCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-
Q 010859          182 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-  260 (499)
Q Consensus       182 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-  260 (499)
                      ||+|||++.++.+||+|||++..+....        .........||+.|+|||++.+..++.++|||||||++|+|++ 
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  270 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDS--------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  270 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCT--------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCc--------cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence            9999999999999999999998654321        1112234578899999999998899999999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHHhc--CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          261 GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       261 G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      |..||.+......+..+...  ....|..+++++.+||.+||+.||.+||++     +++++|
T Consensus       271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~~  328 (344)
T 1rjb_A          271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-----PNLTSF  328 (344)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCH-----HHHHHH
Confidence            99999887655555555544  345677889999999999999999999998     677754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-45  Score=371.73  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=215.6

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceE--EEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  127 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~v--AiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~  127 (499)
                      .+..++|++.+.||+|+||.||+|++..+|..+  |+|.+....  .......+.+|+.+++++ +||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            355689999999999999999999999999866  999886532  223345577899999999 899999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC
Q 010859          128 FSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  191 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~  191 (499)
                      ..+|+||||+++|+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence            99999999999999999998654                69999999999999999999999999999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCH
Q 010859          192 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  270 (499)
Q Consensus       192 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~  270 (499)
                      +.+||+|||+++.....           .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus       179 ~~~kL~Dfg~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             GCEEECCTTCEESSCEE-----------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CeEEEcccCcCcccccc-----------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            99999999998743211           11223467889999999988889999999999999999998 9999999988


Q ss_pred             HHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          271 WLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       271 ~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ......+... ....|..+++++.+||.+||+.||.+||++     +++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  293 (327)
T 1fvr_A          248 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILV  293 (327)
T ss_dssp             HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            8877776654 355677899999999999999999999998     66665

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.9e-46  Score=364.99  Aligned_cols=247  Identities=21%  Similarity=0.346  Sum_probs=218.1

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++.+.||+|+||.||+|.+..++..||+|++....    .....+.+|..+++.++||||+++++++.+...+
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            345689999999999999999999999999999999986542    2345577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |+||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999999999864  44999999999999999999999999999999999999999999999999999876433


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      .         ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ....|.
T Consensus       165 ~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 3kfa_A          165 T---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE  235 (288)
T ss_dssp             S---------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             c---------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCC
Confidence            2         112234567889999999998899999999999999999999 99999988877766666554 456778


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .+++++.+||.+||..||.+||++
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~  259 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSF  259 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCH
Confidence            899999999999999999999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.7e-46  Score=366.82  Aligned_cols=251  Identities=20%  Similarity=0.314  Sum_probs=205.9

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEE----EcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      ..+..++|++++.||+|+||+||+|+    +..+++.||||++...   .......+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34667899999999999999999999    5678999999998654   2334456788999999999999999999985


Q ss_pred             c--CCeEEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          126 D--TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       126 ~--~~~l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      .  ...+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  456999999999999999998754 4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-----------
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-----------  271 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-----------  271 (499)
                      +........       ........||+.|+|||++.+..++.++|||||||++|+|++|..||......           
T Consensus       162 ~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  234 (295)
T 3ugc_A          162 KVLPQDKEF-------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG  234 (295)
T ss_dssp             C--------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCT
T ss_pred             ccccCCcce-------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcccc
Confidence            876433211       11223446788899999999999999999999999999999999998754321           


Q ss_pred             -----HHHHHHH-hcCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          272 -----LIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       272 -----~~~~~i~-~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                           .....+. ......|..+++++.+||.+||+.||.+||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  279 (295)
T 3ugc_A          235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF  279 (295)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCH
Confidence                 1112222 23456678899999999999999999999998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.2e-46  Score=373.26  Aligned_cols=254  Identities=19%  Similarity=0.302  Sum_probs=208.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceE----EEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVY----ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~v----AiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      +..++|++++.||+|+||+||+|++..+++.+    |+|.+....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            45678999999999999999999998888766    555553321  223345677899999999999999999999876


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      . .++|+||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+.
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            5 78999999999999999874 579999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  284 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  284 (499)
                      ....        ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+... ....
T Consensus       169 ~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (327)
T 3poz_A          169 AEEK--------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ  240 (327)
T ss_dssp             TTCC---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred             CCcc--------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC
Confidence            3321        112234567889999999999999999999999999999999 99999988877766665544 3566


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      |..++.++.+|+.+||+.||.+||++     .++++|
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~  272 (327)
T 3poz_A          241 PPICTIDVYMIMVKCWMIDADSRPKF-----RELIIE  272 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSCGGGSCCH-----HHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCCCH-----HHHHHH
Confidence            77899999999999999999999998     666643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.6e-45  Score=362.70  Aligned_cols=254  Identities=30%  Similarity=0.501  Sum_probs=206.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|..+++.++||||+++++++.+...+|
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            45679999999999999999999999999999999998755555556677888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          132 MALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +||||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999998864    45699999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC--CHHHHHHHHHhcCCC-C
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT--SEWLIFQRIIARDIR-F  284 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~--~~~~~~~~i~~~~~~-~  284 (499)
                      ..          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.  +.......+....+. .
T Consensus       189 ~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  258 (310)
T 2wqm_A          189 KT----------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL  258 (310)
T ss_dssp             --------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC
T ss_pred             CC----------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC
Confidence            21          1223467999999999999999999999999999999999999999764  334455555544332 2


Q ss_pred             -CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          285 -PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       285 -p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                       +..+++++.+||.+||..||.+||++     +++++
T Consensus       259 ~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~il~  290 (310)
T 2wqm_A          259 PSDHYSEELRQLVNMCINPDPEKRPDV-----TYVYD  290 (310)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cccccCHHHHHHHHHHcCCChhhCCCH-----HHHHH
Confidence             25689999999999999999999998     66664

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1e-45  Score=368.34  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=217.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEE-----cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  124 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~  124 (499)
                      .+..++|++++.||+|+||.||+|.+     ..+++.||+|++.....  ......+.+|+.+++.+ +||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            34467999999999999999999995     45788999999975532  23446678899999999 999999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCe
Q 010859          125 QDTFSLYMALESCEGGELFDQITSKG------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  186 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~~------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NI  186 (499)
                      .+....|+||||+++|+|.+++...+                  .+++..++.++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999998654                  489999999999999999999999999999999999


Q ss_pred             eeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCC
Q 010859          187 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  265 (499)
Q Consensus       187 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf  265 (499)
                      |++.++.+||+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  248 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSN--------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTT--------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             EEcCCCCEEEcccccccccccccc--------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999987654321        112234568889999999998899999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHHhcC--CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          266 KDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       266 ~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+.........+....  ...|..++.++.+||.+||+.||.+||++     +++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  300 (313)
T 1t46_A          249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-----KQIVQ  300 (313)
T ss_dssp             TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCH-----HHHHH
Confidence            8876555444444433  34467789999999999999999999998     66664

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.4e-45  Score=370.24  Aligned_cols=256  Identities=21%  Similarity=0.366  Sum_probs=218.8

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEc-------CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLF  121 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~  121 (499)
                      ..+..++|++++.||+|+||.||+|++.       .++..||+|++....  .......+.+|..+++.+ +||||++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            3455689999999999999999999986       467889999987543  333456677899999999 899999999


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCC
Q 010859          122 FTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  185 (499)
Q Consensus       122 ~~~~~~~~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~N  185 (499)
                      +++.+...+|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            99999999999999999999999998654                38999999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCC
Q 010859          186 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  264 (499)
Q Consensus       186 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~P  264 (499)
                      ||++.++.+||+|||+++........        .......||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  259 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYY--------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  259 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSE--------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             EEEcCCCCEEEccccccccccccccc--------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999866432211        11223467889999999988889999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          265 FKDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       265 f~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      |.+.+.......+.... ...|..++.++.+||.+||..||.+||++     +++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  311 (334)
T 2pvf_A          260 YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  311 (334)
T ss_dssp             STTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            99998888777766553 56778899999999999999999999998     55654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.7e-45  Score=358.92  Aligned_cols=250  Identities=21%  Similarity=0.360  Sum_probs=210.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHH----HHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~----~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++...........    ..+.+|..+++.++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            3556899999999999999999999999999999999876543332221    567889999999999999999999987


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCCCCC-----EEEEe
Q 010859          127 TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGH-----IKIAD  198 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~~~~-----vkL~D  198 (499)
                      ..  ++||||+++|+|.+.+... ..+++..+..++.|++.||.|||++|  |+||||||+|||++.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            76  6899999999999888655 46999999999999999999999999  999999999999988876     99999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCccCCCccccC--CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH--HH
Q 010859          199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IF  274 (499)
Q Consensus       199 FG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~--~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~--~~  274 (499)
                      ||+++....             ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||...+...  ..
T Consensus       173 fg~~~~~~~-------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  239 (287)
T 4f0f_A          173 FGLSQQSVH-------------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI  239 (287)
T ss_dssp             CTTCBCCSS-------------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH
T ss_pred             CCccccccc-------------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH
Confidence            999874322             233568999999999984  4557889999999999999999999998754332  23


Q ss_pred             HHHHhc--CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          275 QRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       275 ~~i~~~--~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ..+...  ...+|..+++++.+||.+||+.||.+||++     +++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~  282 (287)
T 4f0f_A          240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF-----SYIVK  282 (287)
T ss_dssp             HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            334333  345778899999999999999999999998     66653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.6e-46  Score=372.91  Aligned_cols=261  Identities=24%  Similarity=0.364  Sum_probs=194.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCe
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      .+..++|++++.||+|+||.||+|.+..+|+.||||++...... . ....+..|.. +++.++||||+++++++.+...
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-K-EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-H-HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-h-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            45678999999999999999999999999999999999765322 2 2233334444 7788899999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          130 LYMALESCEGGELFDQITS-----KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~-----~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      +|+||||+++ +|.+++..     .+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999999985 88887763     56799999999999999999999999 99999999999999999999999999997


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCcccc----CCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-HHHHHHH
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRII  278 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l----~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-~~~~~i~  278 (499)
                      .+....           ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.+.+.. .....+.
T Consensus       175 ~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (327)
T 3aln_A          175 QLVDSI-----------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV  243 (327)
T ss_dssp             C-----------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC
T ss_pred             eccccc-----------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh
Confidence            654321           12234799999999998    4566899999999999999999999999875432 2222222


Q ss_pred             hcC-CCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          279 ARD-IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       279 ~~~-~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      ... ..++    ..+++++.+||.+||+.||.+||++     +++++||||....+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~~~~  295 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY-----KELLKHPFILMYEER  295 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHHHHHS
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH-----HHHHhChHHHHhHhh
Confidence            221 1222    3589999999999999999999998     899999999865543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-45  Score=362.07  Aligned_cols=251  Identities=20%  Similarity=0.303  Sum_probs=213.3

Q ss_pred             CCCCCCeeeee-EeeecCceEEEEEEE--cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           51 HFSIQDFELGK-IYGVGSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        51 ~~~~~~y~~~~-~LG~G~~g~Vy~a~~--~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      .+..++|++.+ .||+|+||.||+|.+  ..+++.||+|++..... .......+.+|..+++.++||||+++++++ ..
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            34567899999 999999999999954  56789999999976532 233356678899999999999999999999 55


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            67899999999999999999888899999999999999999999999999999999999999999999999999987644


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  285 (499)
                      ....       ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+... ...+|
T Consensus       170 ~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T 1xbb_A          170 DENY-------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP  242 (291)
T ss_dssp             TCSE-------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             CCCc-------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            3211       011223457789999999988888999999999999999999 99999999888877776654 35677


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..+++++.+||.+||+.||.+||++
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~  267 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGF  267 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCH
Confidence            8899999999999999999999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.2e-45  Score=356.62  Aligned_cols=246  Identities=15%  Similarity=0.263  Sum_probs=214.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--C
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--F  128 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~--~  128 (499)
                      .+..++|++.+.||+|+||.||+|++.  |+.||+|++........ ....+.+|..+++.++||||+++++++.+.  .
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHH-HHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            456789999999999999999999984  88999999977643333 345678899999999999999999999887  7


Q ss_pred             eEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          129 SLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      .+|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            8999999999999999998765  4899999999999999999999999  99999999999999999999999998754


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCCCCCC---CCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc-
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF---GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-  280 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~---~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~-  280 (499)
                      ..               .....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||.+.+.......+... 
T Consensus       163 ~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  227 (271)
T 3kmu_A          163 FQ---------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG  227 (271)
T ss_dssp             TS---------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC
T ss_pred             ec---------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC
Confidence            22               12357899999999998766554   799999999999999999999999888877776654 


Q ss_pred             -CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 010859          281 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  319 (499)
Q Consensus       281 -~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~  319 (499)
                       ...+|..+++++.+||.+||+.||.+||++     ++++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il  262 (271)
T 3kmu_A          228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKF-----DMIV  262 (271)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHH
Confidence             455778899999999999999999999998     5565

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-45  Score=360.39  Aligned_cols=256  Identities=20%  Similarity=0.300  Sum_probs=218.3

Q ss_pred             CCCCCeeeee-EeeecCceEEEEEEEc--CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           52 FSIQDFELGK-IYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        52 ~~~~~y~~~~-~LG~G~~g~Vy~a~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      +..++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .......+.+|+.+++.++||||+++++++. ..
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   82 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE   82 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence            4457888887 9999999999999864  468889999997652  3345566788999999999999999999995 45


Q ss_pred             eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .+|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            699999999999999999754 5699999999999999999999999999999999999999999999999999987643


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p  285 (499)
                      ....       ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+.... ..+|
T Consensus       163 ~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~  235 (287)
T 1u59_A          163 DDSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP  235 (287)
T ss_dssp             CSCE-------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC
T ss_pred             Ccce-------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCC
Confidence            3211       112223467899999999988889999999999999999998 999999988877777776643 5678


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP  322 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hp  322 (499)
                      ..+++++.+||.+||..||.+||++     +++++|.
T Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~~l  267 (287)
T 1u59_A          236 PECPPELYALMSDCWIYKWEDRPDF-----LTVEQRM  267 (287)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCH-----HHHHHHH
T ss_pred             CCcCHHHHHHHHHHcCCChhhCcCH-----HHHHHHH
Confidence            8999999999999999999999988     6777653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.9e-45  Score=365.06  Aligned_cols=258  Identities=28%  Similarity=0.468  Sum_probs=213.1

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC--CCCccEEEEEEEcCCe
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--HPGVVRLFFTFQDTFS  129 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~l~~~~~~~~~  129 (499)
                      +..++|++++.||+|+||.||+|.+. +++.||+|++...... ......+.+|+.+++.+.  ||||+++++++.+...
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            44568999999999999999999985 4899999999765433 334566778999999997  5999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence            999999 55789999999988999999999999999999999999999999999999996 5899999999998654322


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCC-----------CCCCCCCcchhhhHHHHHHhcCCCCCCCCCH-HHHHHHH
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRI  277 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----------~~~~~~sDiwslG~ilyelltG~~Pf~~~~~-~~~~~~i  277 (499)
                      .        .......+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||..... ......+
T Consensus       181 ~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          181 T--------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             -----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             c--------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            1        112235679999999999876           4678899999999999999999999987643 3344444


Q ss_pred             Hhc--CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          278 IAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       278 ~~~--~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ...  ...+|...+.++.+||.+||+.||.+||++     +++++||||+.
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~h~~~~~  298 (313)
T 3cek_A          253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI  298 (313)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHC
T ss_pred             HhcccccCCcccchHHHHHHHHHHccCCcccCcCH-----HHHhcCccccC
Confidence            443  345677889999999999999999999998     99999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.8e-45  Score=377.43  Aligned_cols=253  Identities=19%  Similarity=0.321  Sum_probs=205.8

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      ..+..++|++.+.||+|+||.||+|++.   .++..||||++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            3455679999999999999999999987   567789999986542  33445667889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          127 TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      ...+|+||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999999999998764 6999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR  283 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~  283 (499)
                      ......       ........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.....+.+... ...
T Consensus       198 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~  270 (373)
T 2qol_A          198 EDDPEA-------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP  270 (373)
T ss_dssp             -----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC
T ss_pred             ccCCcc-------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            432210       111122346788999999999899999999999999999998 99999998888877776654 344


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      .|..++.++.+||.+||+.||.+||++.
T Consensus       271 ~~~~~~~~l~~li~~cl~~dp~~RPs~~  298 (373)
T 2qol_A          271 PPMDCPAALYQLMLDCWQKDRNNRPKFE  298 (373)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCccccHHHHHHHHHHhCcChhhCcCHH
Confidence            5667899999999999999999999983

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-45  Score=366.71  Aligned_cols=251  Identities=18%  Similarity=0.299  Sum_probs=210.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCC----ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~----~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      .+...+|++.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            456689999999999999999999987654    359999987543  23344567789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          127 TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      ...+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999765 57999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR  283 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~  283 (499)
                      ......       ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+... ...
T Consensus       198 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~  270 (333)
T 1mqb_A          198 EDDPEA-------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP  270 (333)
T ss_dssp             --------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             cccccc-------ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC
Confidence            432210       111223456889999999998899999999999999999999 99999998888887777665 455


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .|..++.++.+||.+||+.||.+||++
T Consensus       271 ~~~~~~~~l~~li~~~l~~~p~~Rps~  297 (333)
T 1mqb_A          271 TPMDCPSAIYQLMMQCWQQERARRPKF  297 (333)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCH
Confidence            677899999999999999999999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-45  Score=371.60  Aligned_cols=260  Identities=19%  Similarity=0.323  Sum_probs=217.9

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEE-----EcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      .+..++|++++.||+|+||.||+|+     +..++..||+|++....  .......+.+|..+++.++||||+++++++.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            3556899999999999999999999     56788999999986432  2334456778999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC---CCEE
Q 010859          126 DTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIK  195 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~-------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~---~~vk  195 (499)
                      +....|+||||+++|+|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998753       48999999999999999999999999999999999999954   4699


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHH
Q 010859          196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  274 (499)
Q Consensus       196 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~  274 (499)
                      |+|||++........        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.....
T Consensus       184 l~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  255 (327)
T 2yfx_A          184 IGDFGMARDIYRASY--------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  255 (327)
T ss_dssp             ECCCHHHHHHHC--------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ECccccccccccccc--------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence            999999975533211        122235678999999999988889999999999999999998 99999998888777


Q ss_pred             HHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          275 QRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       275 ~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ..+... ....|..++..+.+||.+||+.||.+||++     +++++|.++-
T Consensus       256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~l~~~  302 (327)
T 2yfx_A          256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-----AIILERIEYC  302 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCH-----HHHHHHHHHH
Confidence            777654 345677899999999999999999999988     8899988764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=370.14  Aligned_cols=255  Identities=19%  Similarity=0.306  Sum_probs=208.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcc--cchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      +..++|++++.||+|+||.||+|.+..+++.+|+|+..|..  .........+.+|..+++.++||||+++++++.+.. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            45689999999999999999999999988876444433221  112234456778999999999999999999998765 


Q ss_pred             EEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .++|++|+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            88999999999999999864 56999999999999999999999999999999999999999999999999999876433


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ..        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.....+.+... ....|.
T Consensus       171 ~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  242 (327)
T 3lzb_A          171 EK--------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  242 (327)
T ss_dssp             -----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             cc--------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            21        112224467889999999999999999999999999999999 99999998877776666554 356677


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .++.++.+||.+||..||.+||++     +++++
T Consensus       243 ~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  271 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDADSRPKF-----RELII  271 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            899999999999999999999998     66664

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.3e-46  Score=369.14  Aligned_cols=256  Identities=24%  Similarity=0.382  Sum_probs=215.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEE-----cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  124 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~  124 (499)
                      .+..++|++++.||+|+||.||+|.+     ..+++.||+|++....  .......+.+|..+++.+ +||||+++++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            34568999999999999999999985     4577899999997653  233445677899999999 789999999998


Q ss_pred             EcCC-eEEEEEeccCCCChHHHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCee
Q 010859          125 QDTF-SLYMALESCEGGELFDQITSKGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  187 (499)
Q Consensus       125 ~~~~-~l~lv~E~~~gg~L~~~i~~~~~----------------l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NIL  187 (499)
                      .... .+|+||||+++|+|.+++.....                +++..++.++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7654 59999999999999999987654                899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCC
Q 010859          188 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  266 (499)
Q Consensus       188 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~  266 (499)
                      ++.++.+||+|||+++.+....        .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDP--------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCT--------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ECCCCCEEECCCccccccccCc--------cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999998654321        1122335678999999999999899999999999999999998 999998


Q ss_pred             CCCHHHH-HHHHHh-cCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          267 DTSEWLI-FQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       267 ~~~~~~~-~~~i~~-~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      +...... ...+.. .....|..+++++.+||.+||+.||.+||++     +++++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  304 (316)
T 2xir_A          253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  304 (316)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            7664333 333333 3456778899999999999999999999988     777754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.5e-45  Score=358.19  Aligned_cols=270  Identities=20%  Similarity=0.291  Sum_probs=211.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEE-EEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~-~~~~~~~~l~l  132 (499)
                      .++|++++.||+|+||.||+|++..+++.||+|++.......     .+.+|..+++.+.|++++..+ .++.+....|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC-----CHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch-----HHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            468999999999999999999999999999999876543222     356688899999887766554 45577888999


Q ss_pred             EEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee---CCCCCEEEEecCCccccCCc
Q 010859          133 ALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 8899999985 4579999999999999999999999999999999999999   78899999999999876543


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH---HHHHHHHHhcCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRFP  285 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~p  285 (499)
                      .....   ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.   ......+.......|
T Consensus       162 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          162 RTHQH---IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTCCB---CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccCcc---CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            21100   001233467899999999999999999999999999999999999999986432   233344444333333


Q ss_pred             -----CCCChHHHHHHHHhhccCCCCCCCCCC--CCHHHHh---cCCCCCCCCcccc
Q 010859          286 -----NYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVLK---MHPFFKGIDWKNI  332 (499)
Q Consensus       286 -----~~~~~~~~~Li~~lL~~dP~~R~~~~~--~~~~~l~---~Hpff~~i~~~~~  332 (499)
                           ..+|+++.+||.+||+.||.+||++.+  ..+++++   ..++-..+||+.+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence                 678999999999999999999999843  1111111   2556666777754

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=370.31  Aligned_cols=260  Identities=18%  Similarity=0.186  Sum_probs=204.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcC---CCceEEEEEEeCcccchhh--------HHHHHHHHHHHHHhCCCCCccEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKEN--------KTAYVKLERIVLDQLDHPGVVRL  120 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~---t~~~vAiK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~Iv~l  120 (499)
                      ...++|++++.||+|+||.||+|.+..   ++..||+|++.........        ....+.+|...++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            345789999999999999999999987   8899999999765321111        11224467788999999999999


Q ss_pred             EEEEEc----CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC--CE
Q 010859          121 FFTFQD----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG--HI  194 (499)
Q Consensus       121 ~~~~~~----~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~--~v  194 (499)
                      ++++.+    ...+|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999987    78899999999 999999999888899999999999999999999999999999999999999887  99


Q ss_pred             EEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC--CCHHH
Q 010859          195 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD--TSEWL  272 (499)
Q Consensus       195 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~--~~~~~  272 (499)
                      ||+|||+|+.+.......   ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+  .+...
T Consensus       193 kL~Dfg~a~~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHK---QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             EECCCTTCEESSGGGCCC---CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             EEEeCCCceecccccccc---cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            999999998765432110   0112223467899999999999999999999999999999999999999965  23332


Q ss_pred             HHHHHHhcCCCCCC---------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          273 IFQRIIARDIRFPN---------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       273 ~~~~i~~~~~~~p~---------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ...........+|.         .+++++.+||.+||..||.+||++     +++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~  321 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY-----QALKK  321 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH-----HHHHH
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH-----HHHHH
Confidence            22222222222332         789999999999999999999998     55653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.6e-45  Score=368.27  Aligned_cols=255  Identities=21%  Similarity=0.381  Sum_probs=216.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCc-----eEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----VYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  124 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~-----~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~  124 (499)
                      .+..++|++++.||+|+||.||+|.+..+++     .||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3456899999999999999999999987765     79999987543  233456678899999999 899999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC
Q 010859          125 QDTFSLYMALESCEGGELFDQITSK--------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  190 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~--------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~  190 (499)
                      .+...+|+||||+++|+|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence            9999999999999999999998753              35899999999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCC
Q 010859          191 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  269 (499)
Q Consensus       191 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~  269 (499)
                      ++.+||+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSN--------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTT--------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCeEEECccccccccccccc--------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            99999999999986543211        112234567889999999998899999999999999999998 999998876


Q ss_pred             HHHHHHHHHhcC--CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          270 EWLIFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       270 ~~~~~~~i~~~~--~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .......+....  ...|...++++.+||.+||+.||.+||++     +++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  319 (333)
T 2i1m_A          272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF-----QQICS  319 (333)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             hhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCH-----HHHHH
Confidence            555555555443  34567789999999999999999999998     66654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-44  Score=359.47  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=207.7

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEE----EcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      ..+....|++++.||+|+||.||+|+    +..+++.||+|++....  .......+.+|..+++.++||||+++++++.
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            44556789999999999999999999    56789999999997543  2233456788999999999999999999998


Q ss_pred             cC--CeEEEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          126 DT--FSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       126 ~~--~~l~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      +.  ..+|+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence            76  679999999999999999954 467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC--------------
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT--------------  268 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~--------------  268 (499)
                      .........       ........||..|+|||++.+..++.++|||||||++|+|++|..|+...              
T Consensus       174 ~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (302)
T 4e5w_A          174 KAIETDKEY-------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ  246 (302)
T ss_dssp             EECCTTCCE-------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred             ccccCCCcc-------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence            876543211       11233457899999999999888999999999999999999999986432              


Q ss_pred             CHHHHH-HHHHh-cCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          269 SEWLIF-QRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       269 ~~~~~~-~~i~~-~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ...... ..+.. ....+|..+++++.+||.+||+.||.+||++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  290 (302)
T 4e5w_A          247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF  290 (302)
T ss_dssp             GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCH
Confidence            111112 22222 3455678899999999999999999999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.3e-45  Score=363.34  Aligned_cols=257  Identities=20%  Similarity=0.341  Sum_probs=208.1

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcC---CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      ..+..++|++++.||+|+||.||+|.+..   ++..||+|++...... ......+.+|..+++.++||||+++++++.+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            34556789999999999999999998865   5668999998765433 3334567789999999999999999999976


Q ss_pred             CC-----eEEEEEeccCCCChHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEE
Q 010859          127 TF-----SLYMALESCEGGELFDQIT------SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  195 (499)
Q Consensus       127 ~~-----~l~lv~E~~~gg~L~~~i~------~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vk  195 (499)
                      ..     ..|+||||+++|+|.+++.      ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence            54     3599999999999999984      335699999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHH
Q 010859          196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  274 (499)
Q Consensus       196 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~  274 (499)
                      |+|||+++.+.....        ........|++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.....
T Consensus       188 l~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  259 (313)
T 3brb_A          188 VADFGLSKKIYSGDY--------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY  259 (313)
T ss_dssp             ECSCSCC------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             EeecCcceecccccc--------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence            999999986543221        112234567889999999999999999999999999999999 99999998887777


Q ss_pred             HHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          275 QRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       275 ~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ..+... ...+|..+++++.+||.+||..||.+||++     +++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~  301 (313)
T 3brb_A          260 DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF-----SVLRL  301 (313)
T ss_dssp             HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            776654 456778899999999999999999999998     66654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.6e-45  Score=356.76  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=213.1

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcC---CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      ..+..++|++.+.||+|+||+||+|.+..   ++..||+|++.+..  .......+.+|..+++.++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            34567899999999999999999999764   34469999987653  23345667889999999999999999999876


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          127 TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                      . ..|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            5 568999999999999999765 45999999999999999999999999999999999999999999999999999865


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR  283 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~  283 (499)
                      ....         ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+... ...
T Consensus       164 ~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~  234 (281)
T 3cc6_A          164 EDED---------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP  234 (281)
T ss_dssp             ------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC
T ss_pred             cccc---------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC
Confidence            4322         111234467889999999998889999999999999999998 99999887776666665543 456


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .|..+++.+.+||.+||..||.+||++     +++++
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell~  266 (281)
T 3cc6_A          235 KPDLCPPVLYTLMTRCWDYDPSDRPRF-----TELVC  266 (281)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCCchhCcCH-----HHHHH
Confidence            678899999999999999999999998     66654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-44  Score=380.09  Aligned_cols=240  Identities=24%  Similarity=0.407  Sum_probs=209.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-e
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-S  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-~  129 (499)
                      .+..++|++++.||+|+||.||+|.+.  |+.||||++....     ....+.+|+.+|+.++||||+++++++.+.. .
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            456789999999999999999999884  7899999997543     2345778999999999999999999976654 7


Q ss_pred             EEEEEeccCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +|+|||||++|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999987654  79999999999999999999999999999999999999999999999999975322


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  285 (499)
                      .             .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+..+ ....|
T Consensus       342 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p  408 (450)
T 1k9a_A          342 T-------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP  408 (450)
T ss_dssp             ------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred             c-------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            1             113367889999999999999999999999999999998 99999988777777766654 45678


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..+++++.+||.+||..||.+||++
T Consensus       409 ~~~~~~l~~li~~cl~~dp~~Rpt~  433 (450)
T 1k9a_A          409 DGCPPAVYDVMKNCWHLDAATRPTF  433 (450)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCH
Confidence            8999999999999999999999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.4e-44  Score=353.04  Aligned_cols=245  Identities=22%  Similarity=0.358  Sum_probs=212.1

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||.||+|.+. ++..||+|++......    ...+.+|..+++.++||||+++++++.++ ..
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   82 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PI   82 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcCC-Cc
Confidence            344579999999999999999999975 5678999998765322    34577899999999999999999998754 58


Q ss_pred             EEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |+||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999999997643  6999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ...         ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.....+.+... ....|.
T Consensus       163 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (279)
T 1qpc_A          163 EYT---------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD  233 (279)
T ss_dssp             CEE---------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             ccc---------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcc
Confidence            211         1223457889999999988889999999999999999999 99999999888877777654 345677


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .++.++.+||.+||..||.+||++
T Consensus       234 ~~~~~l~~li~~~l~~~p~~Rps~  257 (279)
T 1qpc_A          234 NCPEELYQLMRLCWKERPEDRPTF  257 (279)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cccHHHHHHHHHHhccChhhCCCH
Confidence            899999999999999999999988

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=383.46  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=201.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...+|.+.+.||+|+||+||. ....+|+.||||++.......      ..+|+.+|+.+ +||||+++++++.+...+|
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~------~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSF------ADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEE------CHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHH------HHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            345799999999999999764 445679999999997653322      34688899998 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-----CCEEEEecCCcccc
Q 010859          132 MALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-----GHIKIADFGSVKPM  205 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-----~~vkL~DFG~a~~~  205 (499)
                      +|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+     ..+||+|||+|+.+
T Consensus        95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9999996 59999998653 46666788999999999999999999999999999999532     35889999999876


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD  281 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~  281 (499)
                      .....       ........+||+.|+|||++.   ...++.++|||||||++|+|++ |..||...........+....
T Consensus       174 ~~~~~-------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  246 (432)
T 3p23_A          174 AVGRH-------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS  246 (432)
T ss_dssp             -------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC
T ss_pred             cCCCc-------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC
Confidence            53321       112334578999999999997   4567889999999999999999 999997665544332222211


Q ss_pred             CCC---CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 010859          282 IRF---PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  330 (499)
Q Consensus       282 ~~~---p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~  330 (499)
                      ...   +...+..+.+||.+||+.||.+||++     +++++||||.+++|.
T Consensus       247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~evl~hp~f~~~~~~  293 (432)
T 3p23_A          247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSA-----KHVLKHPFFWSLEKQ  293 (432)
T ss_dssp             CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHTSTTTCCHHHH
T ss_pred             ccccCccccccHHHHHHHHHHHhCCHhhCCCH-----HHHHhCccccChHHH
Confidence            111   12345668999999999999999998     999999999988873

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5e-45  Score=366.36  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=198.7

Q ss_pred             CCCCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           48 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      +...+..++|++++.||+|+||+||+|++.  ++.||||++...    .........|+.+++.++||||+++++++.+.
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            334456789999999999999999999874  789999998653    22233445588889999999999999999874


Q ss_pred             C----eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CcEeeecCCCCeeeCCCCC
Q 010859          128 F----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM----------GLIHRDIKPENLLLTADGH  193 (499)
Q Consensus       128 ~----~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~----------gIiHrDlKp~NILl~~~~~  193 (499)
                      .    .+|+|||||++|+|.+++... .+++..++.++.||+.||.|||+.          ||+||||||+|||++.++.
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence            3    489999999999999999774 599999999999999999999999          9999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCC-----CCCCCCcchhhhHHHHHHhcCCCCCCCC
Q 010859          194 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----PATFGNDLWALGCTLYQMLSGTSPFKDT  268 (499)
Q Consensus       194 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-----~~~~~sDiwslG~ilyelltG~~Pf~~~  268 (499)
                      +||+|||+|+.+....        ........+||+.|+|||++.+.     .++.++|||||||++|+|++|+.||.+.
T Consensus       170 ~kL~DFg~a~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          170 ACIADFGLALKFEAGK--------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             EEECCCTTCEEECTTS--------CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred             EEEccCCccccccccc--------CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            9999999998664332        11223346899999999999873     4566789999999999999999999764


Q ss_pred             CH----------------HHHHHHHHhcCC--CCCCC-----CChHHHHHHHHhhccCCCCCCCC
Q 010859          269 SE----------------WLIFQRIIARDI--RFPNY-----FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       269 ~~----------------~~~~~~i~~~~~--~~p~~-----~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..                ......+.....  .++..     .++++.+||.+||+.||.+|||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (322)
T 3soc_A          242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA  306 (322)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence            32                122222222211  11221     23459999999999999999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-44  Score=379.50  Aligned_cols=246  Identities=22%  Similarity=0.345  Sum_probs=213.7

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..+..++|++.+.||+|+||.||+|.+. ++..||||++.....    ....+.+|+.+|+.++||||+++++++. ...
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            3456689999999999999999999986 467899999976432    2455778999999999999999999986 557


Q ss_pred             EEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 LYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            89999999999999999754  3689999999999999999999999999999999999999999999999999987643


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  285 (499)
                      ....         ......+|..|+|||++....++.++|||||||++|+|++ |+.||.+.+..+..+.+... ....|
T Consensus       337 ~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~  407 (454)
T 1qcf_A          337 NEYT---------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP  407 (454)
T ss_dssp             HHHH---------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC
T ss_pred             Ccee---------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            3211         1123356789999999998899999999999999999999 99999999888887777654 34567


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..+++++.+||.+||..||.+||++
T Consensus       408 ~~~~~~l~~li~~cl~~dp~~RPt~  432 (454)
T 1qcf_A          408 ENCPEELYNIMMRCWKNRPEERPTF  432 (454)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCH
Confidence            7899999999999999999999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.2e-45  Score=366.59  Aligned_cols=251  Identities=20%  Similarity=0.296  Sum_probs=211.3

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEE----EcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      .-+..++|++++.||+|+||.||+|+    +..+++.||+|++...   .......+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   94 (327)
T 3lxl_A           18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSY   94 (327)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence            34556899999999999999999999    5678999999998764   3344566788999999999999999999886


Q ss_pred             --cCCeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          126 --DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       126 --~~~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                        +...+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence              566799999999999999999863 56999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH-----------
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-----------  271 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~-----------  271 (499)
                      .........       ........||+.|+|||++.+..++.++|||||||++|+|++|..||......           
T Consensus       175 ~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  247 (327)
T 3lxl_A          175 KLLPLDKDY-------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV  247 (327)
T ss_dssp             EECCTTCSE-------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred             eecccCCcc-------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence            876433211       11223456889999999999888999999999999999999999999754432           


Q ss_pred             ----HHHHHHHh-cCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          272 ----LIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       272 ----~~~~~i~~-~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                          .....+.. .....|..+++++.+||.+||+.||.+||++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  291 (327)
T 3lxl_A          248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF  291 (327)
T ss_dssp             CHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence                11222222 2345677899999999999999999999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3e-44  Score=354.87  Aligned_cols=249  Identities=21%  Similarity=0.306  Sum_probs=205.7

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEE-EEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~-~~~~~~~~l~l  132 (499)
                      .++|++++.||+|+||.||+|++..+|+.||+|++......     ..+.+|..+++.+.|++++..+ .++.+....|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            47899999999999999999999999999999998765332     2367799999999887765544 44567888999


Q ss_pred             EEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC---CCCCEEEEecCCccccCCc
Q 010859          133 ALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~---~~~~vkL~DFG~a~~~~~~  208 (499)
                      ||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 8899999974 45799999999999999999999999999999999999994   7889999999999876543


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHhcCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFP  285 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p  285 (499)
                      .....   ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+   ....+..+.......|
T Consensus       162 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          162 RTHQH---IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTCCB---CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccc---cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            21100   00112346789999999999999999999999999999999999999998643   2334444444444443


Q ss_pred             -----CCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          286 -----NYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       286 -----~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                           ..+|+++.+||.+||+.||.+||++.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  269 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYS  269 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHH
Confidence                 67899999999999999999999983

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-44  Score=354.39  Aligned_cols=248  Identities=21%  Similarity=0.355  Sum_probs=210.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCc---eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE-
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL-  130 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l-  130 (499)
                      -.|.+.+.||+|+||+||+|.+..++.   .||+|++...  ........+.+|..+++.++||||+++++++.+.... 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            357788999999999999999876655   7999998653  2334456677899999999999999999999876655 


Q ss_pred             EEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999999873 568999999999999999999999999999999999999999999999999998664432


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      ..      .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+... ....|..
T Consensus       179 ~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T 3pls_A          179 YY------SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY  252 (298)
T ss_dssp             GG------CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTT
T ss_pred             cc------ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCcc
Confidence            11      1223335678999999999999999999999999999999999 66667777766666665554 3556778


Q ss_pred             CChHHHHHHHHhhccCCCCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +++++.+||.+||+.||.+||++
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~  275 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTF  275 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             chHHHHHHHHHHccCChhhCcCH
Confidence            99999999999999999999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.3e-45  Score=360.01  Aligned_cols=257  Identities=23%  Similarity=0.365  Sum_probs=208.6

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcC-CCc--eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKID-TGT--VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-t~~--~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      .+..++|++++.||+|+||+||+|++.. +++  .||+|++.............+.+|..+++.++||||+++++++.+.
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            3446799999999999999999998653 333  6899998776555555667788899999999999999999999876


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      . .++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            5 89999999999999998764 569999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC--CC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD--IR  283 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~--~~  283 (499)
                      .....       ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+....  ..
T Consensus       173 ~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (291)
T 1u46_A          173 QNDDH-------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP  245 (291)
T ss_dssp             C-CCE-------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred             ccccc-------hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC
Confidence            33211       112224567889999999988888999999999999999999 999999999888888877654  34


Q ss_pred             CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       284 ~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+..++.++.+||.+||..||.+||++     +++++
T Consensus       246 ~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  277 (291)
T 1u46_A          246 RPEDCPQDIYNVMVQCWAHKPEDRPTF-----VALRD  277 (291)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCcCcCHHHHHHHHHHccCCcccCcCH-----HHHHH
Confidence            556899999999999999999999988     66764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-44  Score=384.80  Aligned_cols=252  Identities=21%  Similarity=0.352  Sum_probs=219.2

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+...+|++.+.||+|+||.||+|.++.++..||||++.....    ....+.+|+.+|+.++||||+++++++.+...+
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            3456789999999999999999999999999999999875432    234577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999999999864  45899999999999999999999999999999999999999999999999999876433


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ...         ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.....+.+... ....|.
T Consensus       372 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  442 (495)
T 1opk_A          372 TYT---------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE  442 (495)
T ss_dssp             CEE---------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             cee---------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            211         1123456789999999998889999999999999999999 99999998877766665543 345678


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+++++.+||.+||+.||.+||++     +++++
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~-----~el~~  471 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSF-----AEIHQ  471 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCH-----HHHHH
Confidence            899999999999999999999998     55653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=378.06  Aligned_cols=246  Identities=24%  Similarity=0.442  Sum_probs=205.0

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--eE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SL  130 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~--~l  130 (499)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++......  .....+.+|..+++.++||||+++++++.+..  .+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            357899999999999999999999999999999999754332  22445667999999999999999999998755  78


Q ss_pred             EEEEeccCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee----CCCCCEEEEecCCcc
Q 010859          131 YMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSVK  203 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~---l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl----~~~~~vkL~DFG~a~  203 (499)
                      |+|||||+||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999999986533   9999999999999999999999999999999999999    777889999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCC--------CCCCCCCcchhhhHHHHHHhcCCCCCCC----CCHH
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--------SPATFGNDLWALGCTLYQMLSGTSPFKD----TSEW  271 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--------~~~~~~sDiwslG~ilyelltG~~Pf~~----~~~~  271 (499)
                      ......           .....+||+.|+|||++.+        ..++.++|||||||++|+|++|+.||..    ....
T Consensus       165 ~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          165 ELEDDE-----------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             ECCCGG-----------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             EccCCC-----------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            654322           2235679999999999865        4577889999999999999999999964    2334


Q ss_pred             HHHHHHHhcCCC-------------------------CCCCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          272 LIFQRIIARDIR-------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       272 ~~~~~i~~~~~~-------------------------~p~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      ....++......                         ++..++..+.+||.+||+.||++||++.
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (396)
T 4eut_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (396)
T ss_dssp             HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence            555555554321                         1123456789999999999999999983

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-45  Score=369.34  Aligned_cols=253  Identities=20%  Similarity=0.252  Sum_probs=207.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|++....   ......+.+|..+++.++||||+++++++.+...+|
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            34679999999999999999999964 68999999876542   234556788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          132 MALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~----~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +||||+++|+|.+++....    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999999987653    589999999999999999999999999999999999999999999999999976433


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHH-------HHHHhc
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF-------QRIIAR  280 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~-------~~i~~~  280 (499)
                      ..        .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......       ......
T Consensus       192 ~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          192 LD--------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             SS--------CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             cc--------ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            21        112233567999999999998888999999999999999999999999765432111       011111


Q ss_pred             C------C----CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          281 D------I----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       281 ~------~----~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      .      .    .++...+..+.+|+.+||+.||.+||++     +++++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~  309 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-----GDVLWK  309 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH-----HHHHHH
Confidence            1      1    1122345678999999999999999998     667654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.6e-44  Score=355.18  Aligned_cols=251  Identities=21%  Similarity=0.374  Sum_probs=197.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++++.||+|+||+||+|++.   ..||+|++...... ......+.+|+.+++.++||||++++++. ....+
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            456789999999999999999999864   35999999765433 34456678899999999999999999955 55678


Q ss_pred             EEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      ++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999999999644 569999999999999999999999999999999999999999999999999997654321


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccC---CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHH-hcCCC--
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIR--  283 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~-~~~~~--  283 (499)
                              .........||+.|+|||++.   +..++.++|||||||++|+|++|+.||.+.+.......+. .....  
T Consensus       175 --------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (289)
T 3og7_A          175 --------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD  246 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred             --------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence                    112233567999999999986   5668889999999999999999999998866555444443 33222  


Q ss_pred             ---CCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 010859          284 ---FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  319 (499)
Q Consensus       284 ---~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~  319 (499)
                         ++..+++++.+||.+||+.||.+||++     ++++
T Consensus       247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell  280 (289)
T 3og7_A          247 LSKVRSNCPKRMKRLMAECLKKKRDERPSF-----PRIL  280 (289)
T ss_dssp             TTSSCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             hhhccccCCHHHHHHHHHHccCChhhCCCH-----HHHH
Confidence               234688999999999999999999988     5565

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-44  Score=355.42  Aligned_cols=244  Identities=27%  Similarity=0.406  Sum_probs=210.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  126 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-------  126 (499)
                      ..+|++++.||+|+||.||+|.+..+|+.||+|++....       ..+.+|..+++.++||||+++++++..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            368999999999999999999999999999999997642       135578999999999999999998864       


Q ss_pred             ---------CCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEE
Q 010859          127 ---------TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  195 (499)
Q Consensus       127 ---------~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vk  195 (499)
                               ...+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                     45689999999999999999754  5799999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHH
Q 010859          196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ  275 (499)
Q Consensus       196 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~  275 (499)
                      |+|||++.......           ......||+.|+|||++.+..++.++|||||||++|+|++|..||...  .....
T Consensus       163 l~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~  229 (284)
T 2a19_B          163 IGDFGLVTSLKNDG-----------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT  229 (284)
T ss_dssp             ECCCTTCEESSCCS-----------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred             ECcchhheeccccc-----------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence            99999998654321           223457999999999999989999999999999999999999998532  22233


Q ss_pred             HHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          276 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       276 ~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                      .+..  ..++..++.++.+||.+||+.||.+||++     .++++|.+.
T Consensus       230 ~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~l~~  271 (284)
T 2a19_B          230 DLRD--GIISDIFDKKEKTLLQKLLSKKPEDRPNT-----SEILRTLTV  271 (284)
T ss_dssp             HHHT--TCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHH
T ss_pred             Hhhc--ccccccCCHHHHHHHHHHccCChhhCcCH-----HHHHHHHHH
Confidence            3332  34677899999999999999999999988     889988764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.2e-44  Score=356.66  Aligned_cols=249  Identities=20%  Similarity=0.341  Sum_probs=208.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCC---ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEE-EcCCe
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF-QDTFS  129 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~-~~~~~  129 (499)
                      ..+|++.+.||+|+||.||+|.+..++   ..+|+|.+...  ........+.+|..+++.++||||+++++++ ..+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            457999999999999999999976443   45899988653  2334456677899999999999999999985 56678


Q ss_pred             EEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999999999764 56899999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  286 (499)
                      ...      .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+.... ...|.
T Consensus       182 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (298)
T 3f66_A          182 EYY------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  255 (298)
T ss_dssp             GGC------BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred             chh------ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc
Confidence            211      1122334578899999999999899999999999999999999 788888877766666666554 34577


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .+++++.+||.+||+.||.+||++
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~  279 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSF  279 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCH
Confidence            889999999999999999999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-44  Score=354.42  Aligned_cols=240  Identities=23%  Similarity=0.404  Sum_probs=203.0

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCe
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFS  129 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-~~~  129 (499)
                      .+..++|++++.||+|+||.||+|.+  +|+.||+|++....     ....+.+|..+++.++||||+++++++.+ ...
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            45578999999999999999999987  48899999986542     33457789999999999999999998754 457


Q ss_pred             EEEEEeccCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          130 LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      +|+||||+++++|.+++...+.  +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999999999987643  89999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  285 (499)
                      .             .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+... ....|
T Consensus       170 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (278)
T 1byg_A          170 T-------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP  236 (278)
T ss_dssp             -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC
T ss_pred             c-------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCc
Confidence            1             123467899999999998899999999999999999998 99999988777776666554 45677


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..+++++.+||.+||..||.+||++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~  261 (278)
T 1byg_A          237 DGCPPAVYEVMKNCWHLDAAMRPSF  261 (278)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCH
Confidence            8899999999999999999999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.3e-44  Score=378.63  Aligned_cols=273  Identities=19%  Similarity=0.288  Sum_probs=221.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC-CCccEEEEEEEcCCeEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~l~~~~~~~~~l~  131 (499)
                      ..++|++++.||+|+||.||+|++..+++.||||++.......     .+..|..+++.+.| ++|..+..++......|
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            3578999999999999999999999999999999987653322     25678899999977 56667777778888999


Q ss_pred             EEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee---CCCCCEEEEecCCccccCC
Q 010859          132 MALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl---~~~~~vkL~DFG~a~~~~~  207 (499)
                      +||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.+..
T Consensus        80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999999 8899999985 4679999999999999999999999999999999999999   5789999999999987654


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHhcCC--
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDI--  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~---~~~~~~~i~~~~~--  282 (499)
                      ......   .........+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+..   ....+.++.....  
T Consensus       159 ~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          159 TSTHQH---IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             TTTCCB---CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             Cccccc---cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            321100   00122336789999999999999999999999999999999999999998743   3344444443322  


Q ss_pred             ---CCCCCCChHHHHHHHHhhccCCCCCCCCCC--C---CHHHHhcCCCCCCCCcccccC
Q 010859          283 ---RFPNYFSDAARDLIDRLLDVDPSGRPGAGP--G---GYAVLKMHPFFKGIDWKNIRG  334 (499)
Q Consensus       283 ---~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~--~---~~~~l~~Hpff~~i~~~~~~~  334 (499)
                         .++..++.++.+||.+||+.||.+||++.+  .   .+.....|+|+..+||+.+..
T Consensus       236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~  295 (483)
T 3sv0_A          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKY  295 (483)
T ss_dssp             CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred             cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence               233678999999999999999999999854  1   112223699999999997644

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.2e-44  Score=374.59  Aligned_cols=253  Identities=30%  Similarity=0.438  Sum_probs=197.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .+.|.+.+.||+|+||+||.+ ...+|+.||||++....      ...+.+|+.+++.+ +||||+++++++.+...+|+
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l   86 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI   86 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence            355677899999999999875 44679999999986542      23456788888875 89999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCC-------HHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-------------C
Q 010859          133 ALESCEGGELFDQITSKGHLS-------EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-------------G  192 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~-------e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-------------~  192 (499)
                      |||||. |+|.+++...+...       +..+..++.||+.||.|||++||+||||||+|||++.+             +
T Consensus        87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence            999996 59999998764332       33457799999999999999999999999999999754             4


Q ss_pred             CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCC-------CCCCCCCcchhhhHHHHHHhc-CCCC
Q 010859          193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSP  264 (499)
Q Consensus       193 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-------~~~~~~sDiwslG~ilyellt-G~~P  264 (499)
                      ++||+|||+|+.+......      ........+||+.|+|||++.+       ..++.++|||||||++|+|++ |..|
T Consensus       166 ~~kL~DFG~a~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSS------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             EEEECCCTTCEECCC--------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             EEEEcccccceecCCCCcc------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence            8999999999876543211      0112335689999999999976       568999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCC-------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          265 FKDTSEWLIFQRIIARDIRFPN-------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       265 f~~~~~~~~~~~i~~~~~~~p~-------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      |.+.....  ..+......++.       .+++++.+||.+||+.||.+||++     +++++||||.+.
T Consensus       240 f~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~eil~hp~f~~~  302 (434)
T 2rio_A          240 FGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-----MKVLRHPLFWPK  302 (434)
T ss_dssp             TCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSCH
T ss_pred             CCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH-----HHHHhCCccCCc
Confidence            98765433  344554444332       245789999999999999999998     899999999753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=361.59  Aligned_cols=261  Identities=24%  Similarity=0.377  Sum_probs=205.8

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE----cC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DT  127 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~----~~  127 (499)
                      +..++|++++.||+|+||.||+|++..+|+.||+|++...   .......+.+|..+++.++||||+++++++.    ..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            3457899999999999999999999999999999998653   3344566788999999999999999999986    34


Q ss_pred             CeEEEEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          128 FSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      ..+|+||||+++|+|.+++..    .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            579999999999999998876    4679999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCCCC---CCCCCcchhhhHHHHHHhcCCCCCCCCCH--HHHHHHHH
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTSPFKDTSE--WLIFQRII  278 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~---~~~~sDiwslG~ilyelltG~~Pf~~~~~--~~~~~~i~  278 (499)
                      ........... ...........||+.|+|||++.+..   ++.++|||||||++|+|++|+.||.....  ......+.
T Consensus       183 ~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          183 QACIHVEGSRQ-ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             ESCEEEESHHH-HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hcccccccccc-cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            54321100000 00001112456899999999997654   68899999999999999999999954211  01111111


Q ss_pred             h-cCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          279 A-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       279 ~-~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      . .....+..++.++.+||.+||+.||.+||++     +++++|
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  300 (317)
T 2buj_A          262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI-----PLLLSQ  300 (317)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             ccCCCCccccCCHHHHHHHHHHhhcChhhCCCH-----HHHHHH
Confidence            1 1233345789999999999999999999998     777764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.8e-44  Score=353.69  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=197.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh--CCCCCccEEEEEEEc---
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQD---  126 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~Iv~l~~~~~~---  126 (499)
                      ...++|++++.||+|+||+||+|++  +|+.||||++...      .......|.+++..  ++||||+++++++.+   
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~   76 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH   76 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence            3467999999999999999999987  6899999998643      12233446666655  799999999988643   


Q ss_pred             -CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeeecCCCCeeeCCCCCEEEE
Q 010859          127 -TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH--------SMGLIHRDIKPENLLLTADGHIKIA  197 (499)
Q Consensus       127 -~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH--------~~gIiHrDlKp~NILl~~~~~vkL~  197 (499)
                       ...+|+||||+++|+|.+++.. +.+++..+..++.||+.||.|||        ++||+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence             4569999999999999999965 46999999999999999999999        9999999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCC------CCCCCCcchhhhHHHHHHhcC----------
Q 010859          198 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS------PATFGNDLWALGCTLYQMLSG----------  261 (499)
Q Consensus       198 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~------~~~~~sDiwslG~ilyelltG----------  261 (499)
                      |||+|+.........      .......+||+.|+|||++.+.      .++.++|||||||++|+|++|          
T Consensus       156 Dfg~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQL------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             CCTTCEEEETTTTEE------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             eCCCeeecccccccc------cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            999997654332111      1122345899999999999876      345689999999999999999          


Q ss_pred             CCCCCCC----CHHHHHHHHHhcC---CCCCC-----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          262 TSPFKDT----SEWLIFQRIIARD---IRFPN-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       262 ~~Pf~~~----~~~~~~~~i~~~~---~~~p~-----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ..||...    ........+....   ..+|.     ..++++.+||.+||+.||.+||++     +++++
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~i~~  295 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA-----LRIKK  295 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH-----HHHHH
T ss_pred             cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH-----HHHHH
Confidence            8898653    2223333333222   22222     245779999999999999999998     66653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-44  Score=363.70  Aligned_cols=246  Identities=16%  Similarity=0.212  Sum_probs=202.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCC--------CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccE------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDT--------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR------  119 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t--------~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~------  119 (499)
                      .++|++.+.||+|+||.||+|++..+        ++.||+|++.+.        ..+.+|..+++.++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            47999999999999999999999884        889999998754        23667899999999999987      


Q ss_pred             ---------EEEEEEc-CCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCee
Q 010859          120 ---------LFFTFQD-TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  187 (499)
Q Consensus       120 ---------l~~~~~~-~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NIL  187 (499)
                               +++++.. ...+|+||||+ +++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5666665 78899999999 89999999876  78999999999999999999999999999999999999


Q ss_pred             eCCCC--CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCC
Q 010859          188 LTADG--HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF  265 (499)
Q Consensus       188 l~~~~--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf  265 (499)
                      ++.++  .+||+|||+++.+........   ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVA---YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCC---CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EcCCCCceEEEecCcceeeccCCCcccc---ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99998  899999999987654321110   1122334568999999999999999999999999999999999999999


Q ss_pred             CCCC--HHHHHHHH---HhcCCCCC------CCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          266 KDTS--EWLIFQRI---IARDIRFP------NYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       266 ~~~~--~~~~~~~i---~~~~~~~p------~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      .+..  ........   ......++      ..+++++.+||.+||+.||.+||++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  325 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA  325 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence            8763  33332222   22222222      24689999999999999999999983

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.8e-43  Score=386.18  Aligned_cols=246  Identities=21%  Similarity=0.317  Sum_probs=208.1

Q ss_pred             Ceee-eeEeeecCceEEEEEEE--cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           56 DFEL-GKIYGVGSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        56 ~y~~-~~~LG~G~~g~Vy~a~~--~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      .+.+ .+.||+|+||.||+|.+  ..+++.||||++...... ......+.+|+.+|+.++|||||++++++.++ .+|+
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~l  446 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWML  446 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEE
Confidence            3444 34899999999999955  466789999999765332 33446678899999999999999999999754 5899


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...... 
T Consensus       447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~-  525 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-  525 (635)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc-
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999876443211 


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCh
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSD  290 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  290 (499)
                            ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.....+.+... ...+|..+++
T Consensus       526 ------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~  599 (635)
T 4fl3_A          526 ------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR  599 (635)
T ss_dssp             ---------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence                  112223457889999999999999999999999999999998 99999999998888877765 3567889999


Q ss_pred             HHHHHHHHhhccCCCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ++.+||.+||..||++||++
T Consensus       600 ~l~~li~~cl~~dP~~RPs~  619 (635)
T 4fl3_A          600 EMYDLMNLCWTYDVENRPGF  619 (635)
T ss_dssp             HHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHcCCCHhHCcCH
Confidence            99999999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=358.64  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=189.8

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEE-----
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQ-----  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~-----  125 (499)
                      +...+|++.+.||+|+||.||+|++..+|+.||+|++...   .......+.+|..+++.+. ||||+++++++.     
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            3446899999999999999999999999999999998554   2334456778999999995 999999999983     


Q ss_pred             ---cCCeEEEEEeccCCCChHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeCCCCCEEEE
Q 010859          126 ---DTFSLYMALESCEGGELFDQITS---KGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIA  197 (499)
Q Consensus       126 ---~~~~l~lv~E~~~gg~L~~~i~~---~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~~~~~vkL~  197 (499)
                         ....+|+||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence               4556899999996 699988865   467999999999999999999999999  9999999999999999999999


Q ss_pred             ecCCccccCCccccccCC--CCCCCCccccccCccCCCcccc---CCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH
Q 010859          198 DFGSVKPMQDSRITVLPN--AASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL  272 (499)
Q Consensus       198 DFG~a~~~~~~~~~~~~~--~~~~~~~~~~~Gt~~Y~aPE~l---~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~  272 (499)
                      |||+++............  ..........+||+.|+|||++   .+..++.++|||||||++|+|++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            999998765432110000  0001122356799999999998   56678899999999999999999999998765543


Q ss_pred             HHHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          273 IFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       273 ~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      .....  .....+...+..+.+||.+||+.||.+||++     +++++|
T Consensus       261 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~  302 (337)
T 3ll6_A          261 IVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSI-----AEVVHQ  302 (337)
T ss_dssp             -------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCH-----HHHHHH
T ss_pred             hhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            32221  1233445678899999999999999999988     778765

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.4e-44  Score=353.06  Aligned_cols=230  Identities=30%  Similarity=0.526  Sum_probs=192.4

Q ss_pred             CCCCCeeee-eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHH-HhCCCCCccEEEEEEEc---
Q 010859           52 FSIQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQD---  126 (499)
Q Consensus        52 ~~~~~y~~~-~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~Iv~l~~~~~~---  126 (499)
                      ...++|.+. +.||+|+||.||+|.+..+++.||+|++...        ....+|+.++ +.++||||+++++++.+   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            346789888 7899999999999999999999999998643        2345577766 66799999999999987   


Q ss_pred             -CCeEEEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC---CCCEEEEecC
Q 010859          127 -TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFG  200 (499)
Q Consensus       127 -~~~l~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~---~~~vkL~DFG  200 (499)
                       ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             778999999999999999998764  6999999999999999999999999999999999999998   7899999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHH----H
Q 010859          201 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ----R  276 (499)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~----~  276 (499)
                      ++....                                +..++.++|||||||++|+|++|+.||.+.+......    .
T Consensus       166 ~a~~~~--------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  213 (299)
T 3m2w_A          166 FAKETT--------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  213 (299)
T ss_dssp             TCEECT--------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS
T ss_pred             cccccc--------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH
Confidence            986432                                2346678999999999999999999998766544321    1


Q ss_pred             HHhcCCCCC----CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          277 IIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       277 i~~~~~~~p----~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +......+|    ..+++++.+||.+||+.||.+||++     +++++||||.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-----~e~l~hp~~~~  262 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  262 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHT
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCH-----HHHhcChhhcc
Confidence            222334444    5689999999999999999999988     99999999975

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.9e-44  Score=374.46  Aligned_cols=250  Identities=20%  Similarity=0.332  Sum_probs=210.9

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++.+.||+|+||.||+|.+.. +..||||++......    ...+.+|+.+|+.++||||+++++++.+ ..+
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            3556789999999999999999999875 467999998765332    3457789999999999999999999876 678


Q ss_pred             EEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999999999753  46999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ..         .......||..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+..+ ....|.
T Consensus       334 ~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  404 (452)
T 1fmk_A          334 EY---------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP  404 (452)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             ce---------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            21         11223457889999999998899999999999999999999 99999999888887777654 356678


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+++.+.+||.+||+.||.+||++     +++++
T Consensus       405 ~~~~~l~~li~~cl~~dP~~Rpt~-----~~l~~  433 (452)
T 1fmk_A          405 ECPESLHDLMCQCWRKEPEERPTF-----EYLQA  433 (452)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            899999999999999999999998     66654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=366.06  Aligned_cols=240  Identities=16%  Similarity=0.216  Sum_probs=196.9

Q ss_pred             CCCCCeeeeeEeeecCceEEEEE-----EEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC---CCCccEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRA-----KKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFT  123 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a-----~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~Iv~l~~~  123 (499)
                      +..++|++.+.||+|+||+||+|     .+..+++.||+|++....      ...+..|..+++.+.   |+||++++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            44578999999999999999999     467889999999986542      234566777788776   9999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC--------
Q 010859          124 FQDTFSLYMALESCEGGELFDQITS-----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--------  190 (499)
Q Consensus       124 ~~~~~~l~lv~E~~~gg~L~~~i~~-----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~--------  190 (499)
                      +......|+|||||+||+|.+++..     .+.+++..++.++.||+.||+|||++||+||||||+|||++.        
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999999974     456999999999999999999999999999999999999998        


Q ss_pred             ---CCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC
Q 010859          191 ---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD  267 (499)
Q Consensus       191 ---~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~  267 (499)
                         ++.+||+|||+|+.+....        ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFP--------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSC--------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccCCEEEeeCchhhhhhccC--------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence               8999999999997653211        11233456899999999999999999999999999999999999999965


Q ss_pred             CCHHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhccCCCCCCCC
Q 010859          268 TSEWLIFQRIIARDIRFPN-YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       268 ~~~~~~~~~i~~~~~~~p~-~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .....     ......++. ..++.+.+++..||..+|.+|++.
T Consensus       288 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~  326 (365)
T 3e7e_A          288 NEGGE-----CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPS  326 (365)
T ss_dssp             EETTE-----EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred             CCCCc-----eeechhccccCcHHHHHHHHHHHcCCCCCCcchH
Confidence            43210     001111111 246779999999999999999765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.6e-44  Score=357.43  Aligned_cols=251  Identities=21%  Similarity=0.305  Sum_probs=206.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEE----cCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--C
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKK----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--T  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~----~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~  127 (499)
                      ...|++++.||+|+||+||+|..    ..+|+.||||++....  .......+.+|+.+++.++||||+++++++.+  .
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            34459999999999999988754    4578999999997652  23445667889999999999999999999987  4


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            6899999999999999999875 499999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHH--------------H
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--------------I  273 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~--------------~  273 (499)
                      ....       ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......              .
T Consensus       187 ~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  259 (318)
T 3lxp_A          187 GHEY-------YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR  259 (318)
T ss_dssp             TCSE-------EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred             cccc-------cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence            3211       112234568899999999998889999999999999999999999997643211              1


Q ss_pred             HHHHHh--cCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 010859          274 FQRIIA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  319 (499)
Q Consensus       274 ~~~i~~--~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~  319 (499)
                      ......  .....|..++.++.+||.+||+.||.+||++     ++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell  302 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF-----ENLI  302 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCH-----HHHH
Confidence            112222  2445678899999999999999999999998     5565

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-44  Score=368.05  Aligned_cols=253  Identities=20%  Similarity=0.335  Sum_probs=201.6

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCC---ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCeE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTFSL  130 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~-~~~~l  130 (499)
                      ..|++.+.||+|+||.||+|.+..++   ..||+|.+...  ........+.+|..+++.++||||+++++++. .+...
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            46899999999999999999986443   46899988643  23344566788999999999999999999864 56688


Q ss_pred             EEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          131 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999865 458999999999999999999999999999999999999999999999999998654322


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      ..      .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+... ....|..
T Consensus       247 ~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~  320 (373)
T 3c1x_A          247 FD------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY  320 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTT
T ss_pred             cc------cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            11      1112234567889999999999999999999999999999999 78899887766666555554 3456778


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ++..+.+||.+||+.||.+||++     +++++
T Consensus       321 ~~~~l~~li~~cl~~dp~~RPs~-----~ell~  348 (373)
T 3c1x_A          321 CPDPLYEVMLKCWHPKAEMRPSF-----SELVS  348 (373)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            99999999999999999999998     55553

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=351.98  Aligned_cols=242  Identities=26%  Similarity=0.469  Sum_probs=199.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++.+.||+|+||.||+|++  +++.||+|++...     .....+.+|+.++++++||||+++++++.+.  .|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cE
Confidence            4467999999999999999999987  4789999998543     3345677899999999999999999988754  78


Q ss_pred             EEEeccCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeeecCCCCeeeCCCCC-EEEEecCCccc
Q 010859          132 MALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHS---MGLIHRDIKPENLLLTADGH-IKIADFGSVKP  204 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~~LH~---~gIiHrDlKp~NILl~~~~~-vkL~DFG~a~~  204 (499)
                      +||||++||+|.+++...+   .+++..+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999998764   37899999999999999999999   89999999999999998887 79999999975


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC--HHHHHHHHHh-cC
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRIIA-RD  281 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~--~~~~~~~i~~-~~  281 (499)
                      ....             .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....  .......+.. ..
T Consensus       156 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  222 (307)
T 2eva_A          156 IQTH-------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR  222 (307)
T ss_dssp             ----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC
T ss_pred             cccc-------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC
Confidence            4321             123469999999999999999999999999999999999999998543  3333333332 34


Q ss_pred             CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          282 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       282 ~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      ..++..++..+.+||.+||+.||.+||++     +++++
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  256 (307)
T 2eva_A          223 PPLIKNLPKPIESLMTRCWSKDPSQRPSM-----EEIVK  256 (307)
T ss_dssp             CCCBTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCcccccCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            45667899999999999999999999998     55654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=382.02  Aligned_cols=248  Identities=21%  Similarity=0.303  Sum_probs=208.4

Q ss_pred             CCCCeeeee-EeeecCceEEEEEEEc--CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           53 SIQDFELGK-IYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        53 ~~~~y~~~~-~LG~G~~g~Vy~a~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..+++.+.+ .||+|+||.||+|.++  .++..||||++....  .......+.+|+.+|+.++||||+++++++.+ ..
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            445677777 8999999999999876  356679999987642  22345667889999999999999999999987 46


Q ss_pred             EEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999999999754 45999999999999999999999999999999999999999999999999999876432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ...       ........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+..+ ...+|.
T Consensus       490 ~~~-------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  562 (613)
T 2ozo_A          490 DSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  562 (613)
T ss_dssp             -------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT
T ss_pred             Cce-------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            210       111123346789999999998899999999999999999998 99999999888888777765 356788


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      .+++++.+||.+||..||.+||++
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~  586 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDF  586 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH
Confidence            899999999999999999999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-44  Score=362.67  Aligned_cols=256  Identities=18%  Similarity=0.245  Sum_probs=205.6

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ....++|++.+.||+|+||.||+|.+ .+|+.||||++........  ...+.+|..+++.++||||+++++++.+....
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            34567999999999999999999985 4689999999876532221  22467799999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          131 YMALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSM---GLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~----~l~e~~~~~i~~qil~aL~~LH~~---gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      |+||||+++|+|.+++....    .+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999999999998653    399999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCC----CHHHHHHHHHh
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIA  279 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~----~~~~~~~~i~~  279 (499)
                      ......         ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...    ...........
T Consensus       183 ~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          183 LMDYKD---------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCSSS---------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             ccCccc---------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            664322         12233456999999999998888999999999999999999999999521    11001111111


Q ss_pred             cC---------------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 010859          280 RD---------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  323 (499)
Q Consensus       280 ~~---------------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpf  323 (499)
                      ..               ..++...+..+.+|+.+||+.||.+||++     +++++|-.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~~L~  307 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM-----SEVVRMLE  307 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH-----HHHHHHHH
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH-----HHHHHHhc
Confidence            10               11122234779999999999999999998     77886653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-43  Score=352.54  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCccc-chhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      .|..++.||+|+||.||+|.+  +++.||+|++..... ........+.+|..+++.++||||+++++++.+...+|+||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            355679999999999999986  688999999976432 23445567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          135 ESCEGGELFDQITS---KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       135 E~~~gg~L~~~i~~---~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  188 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-  188 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS-
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc-
Confidence            99999999999874   34699999999999999999999999999999999999999999999999999986543211 


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHH----HHHHhcCC-----
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----QRIIARDI-----  282 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~----~~i~~~~~-----  282 (499)
                             ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.........    ..+.....     
T Consensus       189 -------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          189 -------TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             -------CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             -------cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence                   112234679999999999876 4788999999999999999999999875443221    22221111     


Q ss_pred             ------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          283 ------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       283 ------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                            ..+...+..+.+|+.+||+.||.+||++     +++++
T Consensus       261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~l~~  299 (307)
T 2nru_A          261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI-----KKVQQ  299 (307)
T ss_dssp             SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             ccccccccchHHHHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence                  1223345779999999999999999998     66654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-43  Score=353.21  Aligned_cols=248  Identities=24%  Similarity=0.335  Sum_probs=195.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh--CCCCCccEEEEEEEcC---
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQDT---  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~Iv~l~~~~~~~---  127 (499)
                      ..++|++++.||+|+||.||+|++.  |+.||||++....      ......|.+++..  ++||||+++++++.+.   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3478999999999999999999884  8999999985431      1223345555554  4899999999999877   


Q ss_pred             -CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeeecCCCCeeeCCCCCEEEEe
Q 010859          128 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------GLIHRDIKPENLLLTADGHIKIAD  198 (499)
Q Consensus       128 -~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~--------gIiHrDlKp~NILl~~~~~vkL~D  198 (499)
                       ..+|+||||+++|+|.+++... .+++..+..++.|++.||.|||++        ||+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence             7899999999999999999765 699999999999999999999999        999999999999999999999999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCC------CcchhhhHHHHHHhcC----------C
Q 010859          199 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG------NDLWALGCTLYQMLSG----------T  262 (499)
Q Consensus       199 FG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~------sDiwslG~ilyelltG----------~  262 (499)
                      ||+|+.+......      ........+||+.|+|||++.+...+..      +|||||||++|+|++|          .
T Consensus       186 fg~a~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          186 LGLAVKFISDTNE------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CTTCEECC---------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CCCceeecccccc------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            9999766433211      1112235689999999999988777665      8999999999999999          7


Q ss_pred             CCCCCCC----HHHHHHHHHh---cCCCCCC-----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          263 SPFKDTS----EWLIFQRIIA---RDIRFPN-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       263 ~Pf~~~~----~~~~~~~i~~---~~~~~p~-----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .||....    .......+..   ....+|.     .+++++.+||.+||+.||.+||++     +++++
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~  324 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA-----LRVKK  324 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH-----HHHHH
Confidence            7776431    2222333222   1223333     345679999999999999999998     66664

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.2e-43  Score=377.43  Aligned_cols=250  Identities=20%  Similarity=0.336  Sum_probs=215.7

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      .+..++|++.+.||+|+||.||+|.+.. +..||||++......    ...+.+|+.+|+.++||||+++++++.+ ..+
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            3556789999999999999999999875 467999999765432    3457789999999999999999999876 678


Q ss_pred             EEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999999753  46999999999999999999999999999999999999999999999999999876432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ...         ......++..|+|||++.+..++.++|||||||+||+|++ |+.||.+....+....+... ....|.
T Consensus       417 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  487 (535)
T 2h8h_A          417 EYT---------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP  487 (535)
T ss_dssp             HHH---------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cee---------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            211         1123457889999999998899999999999999999999 99999999888887777654 345678


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .++.++.+||.+||+.||++||++     ++|+.
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~-----~~l~~  516 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTF-----EYLQA  516 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            899999999999999999999988     66654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=355.63  Aligned_cols=250  Identities=21%  Similarity=0.357  Sum_probs=190.2

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHH--HHhCCCCCccEEEEEEE--
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLDHPGVVRLFFTFQ--  125 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~--l~~l~hp~Iv~l~~~~~--  125 (499)
                      ..+..++|++++.||+|+||.||+|++  +++.||||++....      ......|..+  +..++||||+++++.+.  
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence            346789999999999999999999976  78999999986542      1222334444  44589999999997553  


Q ss_pred             ---cCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEeeecCCCCeeeCCCCC
Q 010859          126 ---DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---------GLIHRDIKPENLLLTADGH  193 (499)
Q Consensus       126 ---~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~---------gIiHrDlKp~NILl~~~~~  193 (499)
                         ....+|+|||||++|+|.+++... .+++..+..++.||+.||.|||++         ||+||||||+|||++.++.
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence               234689999999999999999775 469999999999999999999999         9999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCC-------CCCCCCCcchhhhHHHHHHhcCCCCCC
Q 010859          194 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLSGTSPFK  266 (499)
Q Consensus       194 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-------~~~~~~sDiwslG~ilyelltG~~Pf~  266 (499)
                      +||+|||+++.+........  ..........+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRP--GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             EEECCCTTCEECSSSSCC-----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             EEEeeccceeecccccccCc--cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            99999999987654321110  011223345689999999999987       345678999999999999999977653


Q ss_pred             CCCH-----------------HHHHHHHHh---cCCCCCCCC------ChHHHHHHHHhhccCCCCCCCC
Q 010859          267 DTSE-----------------WLIFQRIIA---RDIRFPNYF------SDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       267 ~~~~-----------------~~~~~~i~~---~~~~~p~~~------~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ....                 ......+..   ....+|..+      ++++.+||.+||+.||.+|||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA  306 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch
Confidence            3211                 111222222   123344443      3479999999999999999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=353.56  Aligned_cols=250  Identities=20%  Similarity=0.320  Sum_probs=207.4

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEE----EcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  126 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~  126 (499)
                      .+..++|++++.||+|+||.||+|+    +..+|+.||+|++...   .......+.+|+.+++.++||||+++++++..
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            4567789999999999999999999    4668999999998754   23345567889999999999999999999876


Q ss_pred             CC--eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          127 TF--SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       127 ~~--~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      ..  .+|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            44  789999999999999999876 459999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHH------------
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW------------  271 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~------------  271 (499)
                      .........       .......||..|+|||++.+..++.++|||||||++|+|++|..||......            
T Consensus       194 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 2w1i_A          194 VLPQDKEYY-------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ  266 (326)
T ss_dssp             ECCSSCSEE-------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred             hcccccccc-------ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence            765432110       1122346788899999998888999999999999999999999998643211            


Q ss_pred             ----HHHHHHHh-cCCCCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          272 ----LIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       272 ----~~~~~i~~-~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                          ...+.+.. .....|..+++++.+||.+||+.||.+||++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  310 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF  310 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence                11111211 2355678899999999999999999999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.5e-45  Score=367.43  Aligned_cols=245  Identities=17%  Similarity=0.221  Sum_probs=196.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc-----hhhHHHHHHHHHHHHHhCC---------CCCc
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLD---------HPGV  117 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------hp~I  117 (499)
                      +..++|++++.||+|+||+||+|++  +|+.||||++.+....     .......+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3457899999999999999999998  7899999999876432     2223355777888888775         7888


Q ss_pred             cEEEEEEE------------------------------cCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHH
Q 010859          118 VRLFFTFQ------------------------------DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA  167 (499)
Q Consensus       118 v~l~~~~~------------------------------~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~a  167 (499)
                      +++.+++.                              +...+|+|||||++|++.+.+.+ +.+++..++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            77776642                              26789999999999988777755 569999999999999999


Q ss_pred             HHHHH-HCCcEeeecCCCCeeeCCCC--------------------CEEEEecCCccccCCccccccCCCCCCCCccccc
Q 010859          168 LEYIH-SMGLIHRDIKPENLLLTADG--------------------HIKIADFGSVKPMQDSRITVLPNAASDDKACTFV  226 (499)
Q Consensus       168 L~~LH-~~gIiHrDlKp~NILl~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~  226 (499)
                      |.||| ++||+||||||+|||++.++                    .+||+|||+|+....               ...+
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------------~~~~  238 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------------GIVV  238 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------------TEEE
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------------CcEE
Confidence            99999 99999999999999999887                    899999999986532               1458


Q ss_pred             cCccCCCccccCCCCCCCCCcchhhhHH-HHHHhcCCCCCCCCCH-HHHHHHHHhc-CCC------CCCCCChHHHHHHH
Q 010859          227 GTAAYVPPEVLNSSPATFGNDLWALGCT-LYQMLSGTSPFKDTSE-WLIFQRIIAR-DIR------FPNYFSDAARDLID  297 (499)
Q Consensus       227 Gt~~Y~aPE~l~~~~~~~~sDiwslG~i-lyelltG~~Pf~~~~~-~~~~~~i~~~-~~~------~p~~~~~~~~~Li~  297 (499)
                      ||+.|+|||++.+.. +.++||||||++ .+++++|..||.+... ......+... ...      .+..+++++++||.
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence            999999999998777 889999998777 8889999999954321 1122333321 111      12246889999999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHh-cCCCCC
Q 010859          298 RLLDVDPSGRPGAGPGGYAVLK-MHPFFK  325 (499)
Q Consensus       298 ~lL~~dP~~R~~~~~~~~~~l~-~Hpff~  325 (499)
                      +||+.|     |+     ++++ +||||+
T Consensus       318 ~~L~~d-----sa-----~e~l~~Hp~f~  336 (336)
T 2vuw_A          318 TMLNFS-----SA-----TDLLCQHSLFK  336 (336)
T ss_dssp             HGGGSS-----SH-----HHHHHHCGGGC
T ss_pred             HHhccC-----CH-----HHHHhcCCCcC
Confidence            999977     66     8999 999995

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.8e-44  Score=387.25  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=209.4

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  126 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~------  126 (499)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.++||||+++++++.+      
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            3589999999999999999999999999999999986542  23345567889999999999999999998765      


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCC---EEEEecC
Q 010859          127 TFSLYMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFG  200 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~---vkL~DFG  200 (499)
                      ....|+|||||+||+|.+++...+   .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            677899999999999999998754   5999999999999999999999999999999999999997765   9999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH---
Q 010859          201 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---  277 (499)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i---  277 (499)
                      ++......           ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+...   
T Consensus       170 ~a~~~~~~-----------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~  238 (676)
T 3qa8_A          170 YAKELDQG-----------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE  238 (676)
T ss_dssp             CCCBTTSC-----------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred             cccccccc-----------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence            99865432           1223568999999999999999999999999999999999999999875443221100   


Q ss_pred             -----------HhcCCCC----------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          278 -----------IARDIRF----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       278 -----------~~~~~~~----------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                 ..+...+          +..+++.+.+||.+||..||.+||++     +++++||||+.+
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa-----~elL~hp~F~~l  304 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD-----PQNPNVGCFQAL  304 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC-----TTCCCCTTHHHH
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH-----HHHhcCHHHHHH
Confidence                       0111111          22356889999999999999999999     679999999863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=351.74  Aligned_cols=256  Identities=20%  Similarity=0.318  Sum_probs=208.0

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..+..++|++++.||+|+||.||+|.+..   .+|+|++....... .....+.+|..+++.++||||+++++++.+...
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            34567899999999999999999999854   59999987543222 122335568889999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999999998764 699999999999999999999999999999999999998 789999999998765322


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCC---------CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNS---------SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  279 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---------~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~  279 (499)
                      ...     ..........||+.|+|||++.+         ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus       183 ~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  257 (319)
T 2y4i_B          183 QAG-----RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT  257 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred             ccc-----ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence            110     11223345579999999999864         3478899999999999999999999999988877777665


Q ss_pred             cCCCC--CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          280 RDIRF--PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       280 ~~~~~--p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .....  +..++.++.+||.+||..||.+||++     +++++
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~l~~  295 (319)
T 2y4i_B          258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTF-----TKLMD  295 (319)
T ss_dssp             TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCH-----HHHHH
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            53322  23688999999999999999999988     66664

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-42  Score=379.31  Aligned_cols=247  Identities=25%  Similarity=0.437  Sum_probs=210.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCC---CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      +..++|++++.||+|+||.||+|.+..+   +..||+|++...  ........+.+|..+++.++||||+++++++.+ .
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~  463 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N  463 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence            3457899999999999999999998754   457999987543  233344667789999999999999999999854 5


Q ss_pred             eEEEEEeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            6899999999999999998654 699999999999999999999999999999999999999999999999999987643


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p  285 (499)
                      ...         .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.... ..+|
T Consensus       544 ~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~  614 (656)
T 2j0j_A          544 STY---------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  614 (656)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred             Ccc---------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            221         11223467889999999998899999999999999999997 999999999888888777653 5678


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..+++++.+||.+||..||.+||++
T Consensus       615 ~~~~~~l~~li~~~l~~dP~~RPs~  639 (656)
T 2j0j_A          615 PNCPPTLYSLMTKCWAYDPSRRPRF  639 (656)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCH
Confidence            8999999999999999999999998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-43  Score=367.12  Aligned_cols=251  Identities=18%  Similarity=0.244  Sum_probs=197.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC-CCc---------------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGV---------------  117 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~I---------------  117 (499)
                      ...|.+++.||+|+||+||+|++..+|+.||||++.............+.+|..+++.+.| ++.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3569999999999999999999999999999999875444333345567889988988877 221               


Q ss_pred             ------cEEEEEEEc-----CCeEEEEEeccCCCChHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEee
Q 010859          118 ------VRLFFTFQD-----TFSLYMALESCEGGELFDQITS-------KGHLSEDEARFYTAEVVDALEYIHSMGLIHR  179 (499)
Q Consensus       118 ------v~l~~~~~~-----~~~l~lv~E~~~gg~L~~~i~~-------~~~l~e~~~~~i~~qil~aL~~LH~~gIiHr  179 (499)
                            ..++.++..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  111112222     23467888876 5699988841       2347888999999999999999999999999


Q ss_pred             ecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCcccc----------CCCCCCCCCcch
Q 010859          180 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL----------NSSPATFGNDLW  249 (499)
Q Consensus       180 DlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l----------~~~~~~~~sDiw  249 (499)
                      ||||+||||+.++.+||+|||+++.....             ....+| +.|+|||++          .+..++.++|||
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE-------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc-------------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence            99999999999999999999998754321             335678 999999999          556688899999


Q ss_pred             hhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          250 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       250 slG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      ||||++|+|++|+.||.+.+.......+..    ....+|+++.+||.+||+.||.+||++     .++++||||+.+.
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~~~l~~~~~~~~~  371 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQLR  371 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCH-----HHHHhCHHHHHHH
Confidence            999999999999999988765443333322    234678999999999999999999998     8999999998653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.3e-42  Score=346.66  Aligned_cols=248  Identities=21%  Similarity=0.301  Sum_probs=199.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHh--CCCCCccEEEEEEEcCC---
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQDTF---  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~Iv~l~~~~~~~~---  128 (499)
                      .++|++.+.||+|+||.||+|++  +|+.||||++...      ....+.+|..++..  ++||||+++++++....   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            46899999999999999999998  5899999998643      22345567778777  79999999999998776   


Q ss_pred             -eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeeecCCCCeeeCCCCCEEEEec
Q 010859          129 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH--------SMGLIHRDIKPENLLLTADGHIKIADF  199 (499)
Q Consensus       129 -~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH--------~~gIiHrDlKp~NILl~~~~~vkL~DF  199 (499)
                       .+|+||||+++|+|.+++.+. .+++..+..++.||+.||.|||        ++||+||||||+|||++.++.+||+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             899999999999999999764 6999999999999999999999        899999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCccCCCccccCCCC------CCCCCcchhhhHHHHHHhcC----------CC
Q 010859          200 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSG----------TS  263 (499)
Q Consensus       200 G~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~------~~~~sDiwslG~ilyelltG----------~~  263 (499)
                      |++..........      .......+||+.|+|||++.+..      ++.++|||||||++|+|++|          ..
T Consensus       192 g~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          192 GLAVRHDSATDTI------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             TTCEEEETTTTEE------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             CCceecccccccc------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9997654332110      01223568999999999998763      23679999999999999999          88


Q ss_pred             CCCCCC-----HHHHHHHHHhcC--CCCCCC-----CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          264 PFKDTS-----EWLIFQRIIARD--IRFPNY-----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       264 Pf~~~~-----~~~~~~~i~~~~--~~~p~~-----~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ||....     .......+....  ..+|..     .+..+.+||.+||+.||.+||++     +++++|
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~i~~~  330 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKKT  330 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH-----HHHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH-----HHHHHH
Confidence            997642     233334443322  223332     23578999999999999999998     666653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.9e-41  Score=333.68  Aligned_cols=219  Identities=18%  Similarity=0.170  Sum_probs=185.7

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|..+++.++||||+++++++.+.+.+|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999999999999999998776555555667788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +||||++|++|.+++.+.  .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.          
T Consensus       108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----------  175 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----------  175 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC----------
T ss_pred             EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc----------
Confidence            999999999999998653  46667889999999999999999999999999999999999999975442          


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHH---HHHhcCCC----C
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ---RIIARDIR----F  284 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~---~i~~~~~~----~  284 (499)
                                          ++       .++.++|||||||++|+|++|+.||.+.+......   +.......    +
T Consensus       176 --------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T 3uqc_A          176 --------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI  228 (286)
T ss_dssp             --------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHH
T ss_pred             --------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhc
Confidence                                22       36788999999999999999999998865432110   11111111    2


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +..+++++.+||.+||+.||.+| |+
T Consensus       229 ~~~~~~~l~~li~~~l~~dP~~R-s~  253 (286)
T 3uqc_A          229 DRDIPFQISAVAARSVQGDGGIR-SA  253 (286)
T ss_dssp             CTTSCHHHHHHHHHHHCTTSSCC-CH
T ss_pred             ccCCCHHHHHHHHHHcccCCccC-CH
Confidence            35689999999999999999999 88

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-41  Score=373.85  Aligned_cols=238  Identities=26%  Similarity=0.368  Sum_probs=199.2

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcC-CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe-
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS-  129 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~-  129 (499)
                      ...++|++++.||+|+||.||+|.+.. +|+.||||++....  .......+.+|+.+++.++||||+++++++..... 
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            445899999999999999999999986 79999999886532  23344567789999999999999999999987655 


Q ss_pred             ----EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          130 ----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       130 ----l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                          .|+||||++|++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence                7999999999999988765  69999999999999999999999999999999999999875 9999999999865


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  285 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p  285 (499)
                      ...              ...+||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+....           ..|
T Consensus       232 ~~~--------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~  285 (681)
T 2pzi_A          232 NSF--------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLP  285 (681)
T ss_dssp             TCC--------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCC
T ss_pred             ccC--------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------ccc
Confidence            321              3567999999999987654 88999999999999999999998753210           111


Q ss_pred             C-----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          286 N-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       286 ~-----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      .     ..++.+.+||.+||+.||.+||++     .+.+.|+|+.
T Consensus       286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~-----~~~l~~~l~~  325 (681)
T 2pzi_A          286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTT-----AEEMSAQLTG  325 (681)
T ss_dssp             TTCHHHHHCHHHHHHHHHHTCSSGGGSCSS-----HHHHHHHHHH
T ss_pred             ccccccccCHHHHHHHhhhccCChhhCCCH-----HHHHHHHHHH
Confidence            1     135789999999999999999998     7788888774

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1e-35  Score=320.59  Aligned_cols=192  Identities=15%  Similarity=0.164  Sum_probs=141.8

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccch-------hhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-------ENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~-------~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ...++.|+.|.+..++..-+|+.||+|++.+.....       +.....+.+|+++|+++ .|+||++++++++++..+|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            334678888888888888899999999998764321       33445688899999999 6999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||||+|++|.++|.+.+++++.   .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....   
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~---  392 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD---  392 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC---
Confidence            999999999999999999989875   47899999999999999999999999999999999999999999865432   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF  265 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf  265 (499)
                             .....+.+||+.|||||++.+. +..++|+||+|+++|+|.++..+|
T Consensus       393 -------~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          393 -------CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             -------CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence                   2334578999999999999875 566899999999999987765443

>1w1g_A HPDK1, 3-phosphoinositide dependent protein kinase-1; transferase, PKB, pleckstrin homology domain, inositol phosphate, signal transduction; HET: 4PT; 1.45A {Homo sapiens} SCOP: b.55.1.1 PDB: 1w1d_A* 1w1h_A 2vki_A

Probab=100.00  E-value=1.2e-33  Score=244.05  Aligned_cols=106  Identities=30%  Similarity=0.531  Sum_probs=101.1

Q ss_pred             cccccccCcccccccCCCceEEEEEeeehhhhhhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCc
Q 010859          388 LASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSH  467 (499)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~  467 (499)
                      +.+.|++++.||+|+ +||.|+++|+|.|++|+|||+||||||+.|+|||+||..|++||+|||++.   ++|+.++++.
T Consensus        33 ~~~~q~~~~~w~~f~-~ge~Ilk~G~v~KrkGl~~kkR~liLT~~PrL~Yvdp~~~~~KGeIpls~~---l~ve~k~~~~  108 (151)
T 1w1g_A           33 LLEKQAGGNPWHQFV-ENNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQE---LRPEAKNFKT  108 (151)
T ss_dssp             HHHHHHHHCTTGGGT-TTCCEEEEEEEEEEETTEEEEEEEEEETTTEEEEEETTTTEEEEEECCCTT---CEEEESSSSE
T ss_pred             hhhhccccchhhccC-CCCcEEEEEEEEecccCcceeEEEEEcCCceEEEEcCccccccceEecCCC---eeEEEcCCCE
Confidence            445677889999998 799999999999999999999999999999999999999999999999986   9999999999


Q ss_pred             EEEEcCCceEEEEcCCccHHHHHHHHHHhc
Q 010859          468 FKIVTPKKVLSFEDAKQRASQWKKAIEALQ  497 (499)
Q Consensus       468 f~i~~p~r~y~~~d~~~~~~~W~~~i~~~~  497 (499)
                      |+|+||+|||+|+|++++|++||++|++++
T Consensus       109 F~I~Tp~RtY~~~d~~~~AqeWv~aI~~~~  138 (151)
T 1w1g_A          109 FFVHTPNRTYYLMDPSGNAHKWCRKIQEVW  138 (151)
T ss_dssp             EEEEETTEEEEEECTTSCHHHHHHHHHHHH
T ss_pred             EEEECCCceEEEEcCccCHHHHHHHHHHHH
Confidence            999999999999999999999999999986

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=8.5e-29  Score=265.17  Aligned_cols=194  Identities=15%  Similarity=0.084  Sum_probs=146.2

Q ss_pred             eeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh-----hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010859           58 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        58 ~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ...+.||+|+||.||+|.  ..+..+|+|..........     .....+.+|..++++++||||+++..++.+....|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            456799999999999994  4678999998765433322     123457889999999999999944444445666799


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||||+|++|.+++..        +..++.||+.||.|||++||+||||||+|||++.  ++||+|||+|+.........
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999999876        6789999999999999999999999999999998  99999999998765422100


Q ss_pred             cCCCCCCCCccccccCccCCCccccCC--CCCCCCCcchhhhHHHHHHhcCCCCCC
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFK  266 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDiwslG~ilyelltG~~Pf~  266 (499)
                      ..   ......+++||+.|||||++..  ..|+..+|+|+...-..+.+.++.+|.
T Consensus       487 ~~---~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VD---LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HH---HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cc---hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            00   0001246799999999999986  567888899999988888887777664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.4e-26  Score=227.85  Aligned_cols=145  Identities=17%  Similarity=0.179  Sum_probs=115.5

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh---------------hHHHHHHHHHHHHHhCCCCCccEEEEE
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---------------NKTAYVKLERIVLDQLDHPGVVRLFFT  123 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hp~Iv~l~~~  123 (499)
                      +++.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|..+++.++|   ++++..
T Consensus        94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~  169 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV  169 (282)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred             ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence            339999999999999999 8899999999965322111               234567789999999985   444444


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          124 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       124 ~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      +.. ...|+||||++||+|.+ +..      ..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|+
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred             Eec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence            433 45699999999999988 421      34567999999999999999999999999999999 9999999999986


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCC
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS  239 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~  239 (499)
                                             ++..|+|||++..
T Consensus       241 -----------------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          241 -----------------------EVGEEGWREILER  253 (282)
T ss_dssp             -----------------------ETTSTTHHHHHHH
T ss_pred             -----------------------ECCCCCHHHHHHH
Confidence                                   3456789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=4.9e-22  Score=192.87  Aligned_cols=140  Identities=19%  Similarity=0.236  Sum_probs=109.3

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCce--EEEEEEeCcccc---------------------hhhHHHHHHHHHHHHHhCC
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFIT---------------------KENKTAYVKLERIVLDQLD  113 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~--vAiK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~  113 (499)
                      |++.+.||+|+||.||+|.+..+|+.  ||||++......                     .......+.+|..+|+.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999888999  999997553211                     0111235677999999998


Q ss_pred             CCCc--cEEEEEEEcCCeEEEEEeccCC-C----ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeeecCCCC
Q 010859          114 HPGV--VRLFFTFQDTFSLYMALESCEG-G----ELFDQITSKGHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPEN  185 (499)
Q Consensus       114 hp~I--v~l~~~~~~~~~l~lv~E~~~g-g----~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDlKp~N  185 (499)
                      |+++  ..++..    ...|+||||+.+ |    +|.+....   .++..+..++.||+.||.||| ++||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            7754  344432    246899999942 3    66665432   345678899999999999999 9999999999999


Q ss_pred             eeeCCCCCEEEEecCCcccc
Q 010859          186 LLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       186 ILl~~~~~vkL~DFG~a~~~  205 (499)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=5.4e-19  Score=179.53  Aligned_cols=139  Identities=17%  Similarity=0.165  Sum_probs=101.0

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc-----------h----hhH----HHHHHHHHHHHHhCCCCCc
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----------K----ENK----TAYVKLERIVLDQLDHPGV  117 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~-----------~----~~~----~~~~~~E~~~l~~l~hp~I  117 (499)
                      |++++.||.|+||.||+|.+. +|+.||||+++.....           .    ...    ......|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 6999999998643111           0    000    0112346666777755444


Q ss_pred             cEEEEEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-----
Q 010859          118 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-----  192 (499)
Q Consensus       118 v~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-----  192 (499)
                      .-..-+....  .++||||++|++|.++..      .+.+..++.||+.+|.+||++|||||||||.|||++++|     
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            2211111122  379999999988866432      234567889999999999999999999999999999877     


Q ss_pred             -----CEEEEecCCccc
Q 010859          193 -----HIKIADFGSVKP  204 (499)
Q Consensus       193 -----~vkL~DFG~a~~  204 (499)
                           .+.|+||+.+..
T Consensus       248 ~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TSEEEEEEECCCTTCEE
T ss_pred             cccccceEEEEeCCccc
Confidence                 389999998754

>2cod_A Centaurin-delta 1; ARF GAP and RHO GAP with ankyrin repeat and PH domains (ARAP) 2, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.52  E-value=1.3e-14  Score=122.36  Aligned_cols=90  Identities=16%  Similarity=0.218  Sum_probs=78.6

Q ss_pred             CceEEEEEeeehhhh-h--hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEc
Q 010859          405 GESVLMISMVKKLQK-L--TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFED  481 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g-~--~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d  481 (499)
                      +..++++|||.|+++ .  .||+|||||++....||.++.....+|.|+|+..   ..++......|.|+|++|+|+|..
T Consensus         5 ~~~~~~~G~L~K~~~~~~~~WkkR~fvL~~~~L~yy~~~~~~~~~g~i~l~~~---~~v~~~~~~~F~i~~~~r~~~l~a   81 (115)
T 2cod_A            5 SSGKVKSGWLDKLSPQGKRMFQKRWVKFDGLSISYYNNEKEMYSKGIIPLSAI---STVRVQGDNKFEVVTTQRTFVFRV   81 (115)
T ss_dssp             CSCCCEEEEEEECCSSSSSCCEEEEEEECSSEEEEEESSCCSSCCCEEETTTE---EEEEEETTTEEEEEESSCCEEEEC
T ss_pred             CCCccEEEEEEEcCCCCCCCCceEEEEEECCEEEEEcCCCCcccCCEEECCcc---eEEEeCCCCEEEEEeCCcEEEEEC
Confidence            345789999999987 3  3999999999998889999988899999999986   677777789999999999999994


Q ss_pred             -CCccHHHHHHHHHHhc
Q 010859          482 -AKQRASQWKKAIEALQ  497 (499)
Q Consensus       482 -~~~~~~~W~~~i~~~~  497 (499)
                       .+.++++|+++|+.++
T Consensus        82 ~s~~e~~~Wi~~l~~~~   98 (115)
T 2cod_A           82 EKEEERNDWISILLNAL   98 (115)
T ss_dssp             SSHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHH
Confidence             5589999999999875

>1x1f_A Signal-transducing adaptor protein 1; docking protein BRDG1, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.51  E-value=9.4e-15  Score=128.78  Aligned_cols=89  Identities=13%  Similarity=0.210  Sum_probs=74.0

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE---cCCCcEEEEcCCceEEEEc-
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTPKKVLSFED-  481 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p~r~y~~~d-  481 (499)
                      ++++||+.|+++.+  ||+|||||.+.-.+||.|+.....+|.|+|+..++ +..+.   +....|.|.||+|+|+|.. 
T Consensus        18 v~keG~L~Kkg~~~k~WkrRWFvLk~~~L~Yyk~~~d~~~~g~I~L~~~~~-~~~~~~~~~~~~~F~I~t~~r~~~f~A~   96 (149)
T 1x1f_A           18 LYFEGFLLIKRSGYREYEHYWTELRGTTLFFYTDKKSIIYVDKLDIVDLTC-LTEQNSTEKNCAKFTLVLPKEEVQLKTE   96 (149)
T ss_dssp             EEEEEEEEEECTTCCSCEEEEEEEETTEEEEESCSSCSSCSEECCCSSCCE-EEECCCTTSCCCEEEEECSSCCEEEECS
T ss_pred             ccEEEEEEEeCCCCCCceeEEEEEcCCEEEEEeCCCccccCcEEECCCceE-EeeccCCCCcCcEEEEEcCCCEEEEEcC
Confidence            89999999999876  99999999999777888888888899999998621 11121   2246899999999999995 


Q ss_pred             CCccHHHHHHHHHHhc
Q 010859          482 AKQRASQWKKAIEALQ  497 (499)
Q Consensus       482 ~~~~~~~W~~~i~~~~  497 (499)
                      ...++++|+++|+.+.
T Consensus        97 s~ee~~eWi~aI~~v~  112 (149)
T 1x1f_A           97 NTESGEEWRGFILTVT  112 (149)
T ss_dssp             SHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHH
Confidence            4589999999999875

>2rsg_A Collagen type IV alpha-3-binding protein; pleckstrin homology, lipid transport; NMR {Homo sapiens}

Probab=99.50  E-value=2.3e-14  Score=116.31  Aligned_cols=88  Identities=18%  Similarity=0.232  Sum_probs=71.6

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeEEEECCCC--CeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEE-cC
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFE-DA  482 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~-d~  482 (499)
                      |.|+|+|.|+++++  ||+|||||+++-..||.++..  ...+|.|++..+  .+.+....+..|.|.||+|+|+|. +.
T Consensus         1 V~k~G~L~K~g~~~k~WkkR~FvL~~~~L~Yy~~~~~~~~~~~~~i~l~~~--~~~~~~~~~~~F~i~~~~r~~~l~A~s   78 (94)
T 2rsg_A            1 VERCGVLSKWTNYIHGWQDRWVVLKNNALSYYKSEDETEYGCRGSICLSKA--VITPHDFDECRFDISVNDSVWYLRAQD   78 (94)
T ss_dssp             CCEEEEEEEESSSTTCEEEEEEEEETTEEEEESSTTGGGTCCSEEEETTTC--EEEECSSCSSEEEEEETTEEEEEECCS
T ss_pred             CCEEEEEEEeCCCCCCceEEEEEEECCEEEEEEecccccccceeeEeccee--eeecCcccceeEEEEeCCeEEEEECCC
Confidence            46899999999876  999999999877767776654  346799999875  334444556899999999999999 55


Q ss_pred             CccHHHHHHHHHHhc
Q 010859          483 KQRASQWKKAIEALQ  497 (499)
Q Consensus       483 ~~~~~~W~~~i~~~~  497 (499)
                      +.++++|+++|++++
T Consensus        79 ~~e~~~Wi~aLq~Ak   93 (94)
T 2rsg_A           79 PDHRQQWIDAIEQHK   93 (94)
T ss_dssp             SCCTHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHhhc
Confidence            689999999999863

>2dn6_A KIAA0640 protein; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.44  E-value=1.9e-13  Score=114.99  Aligned_cols=90  Identities=18%  Similarity=0.235  Sum_probs=75.2

Q ss_pred             CceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcCCceE
Q 010859          405 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTPKKVL  477 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p~r~y  477 (499)
                      ++.++++|||.|+++..  ||+|||||++.-..||.++.....+|.|+|...   ..++.     .....|.|.|++|+|
T Consensus         5 ~~~~~~~G~L~K~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~---~~v~~~~~~~~~~~~F~i~~~~r~~   81 (115)
T 2dn6_A            5 SSGVLKQGYMMKKGHRRKNWTERWFVLKPNIISYYVSEDLKDKKGDILLDEN---CCVESLPDKDGKKCLFLVKCFDKTF   81 (115)
T ss_dssp             CCSCSEEEEEEEECTTSSCEEEEEEEECSSCEEEESSTTCSSEEEEECCCTT---CEEEEECCCTTCCSEEEEECSSCEE
T ss_pred             CCCceEEEEEEecCCCCCCcEEeEEEEECCEEEEeCCCCCcccCcEEEecCc---EEEEECCCCCCCeeEEEEEeCCCEE
Confidence            45679999999998754  999999999988888888888899999999975   34433     234689999999999


Q ss_pred             EEEc-CCccHHHHHHHHHHhc
Q 010859          478 SFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       478 ~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      +|.. .+.++++|+++|+.++
T Consensus        82 ~l~a~s~~e~~~Wi~ai~~~~  102 (115)
T 2dn6_A           82 EISASDKKKKQEWIQAIHSTI  102 (115)
T ss_dssp             EEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEcCCHHHHHHHHHHHHHHH
Confidence            9994 5589999999999875

>2dhk_A TBC1 domain family member 2; PH domain, paris-1, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.43  E-value=9e-14  Score=118.07  Aligned_cols=88  Identities=15%  Similarity=0.159  Sum_probs=70.9

Q ss_pred             eEEEEEeeehhhh--hh--hccceEEeecCC-eE-EEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCCceEE
Q 010859          407 SVLMISMVKKLQK--LT--SKKVQLILTNKP-KL-IYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPKKVLS  478 (499)
Q Consensus       407 ~i~~~g~~~k~~g--~~--~k~r~~ilt~~p-~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~r~y~  478 (499)
                      .++++|||.|+++  ..  ||+|||||++.+ .| ||.++.....+|.|+|+.+   ..+..  +....|.|+|++|+|+
T Consensus         7 ~~~~~G~L~K~g~~~~~k~WkkRwfvL~~~~~~L~Yy~~~~~~~~~g~I~L~~~---~~~~~~~~~~~~F~i~~~~r~~~   83 (119)
T 2dhk_A            7 GKKLCGYLSKFGGKGPIRGWKSRWFFYDERKCQLYYSRTAQDANPLDSIDLSSA---VFDCKADAEEGIFEIKTPSRVIT   83 (119)
T ss_dssp             CCCCEEEEEECSCSSSSCCCEEEEEEEETTTTEEEEESSTTCCSCSEEEEGGGC---EEEECTTGGGCEEEEECSSCCEE
T ss_pred             CCcEEEEEEecCCCCCCCCceeEEEEEECCccEEEEECCCCCcccccEEECCCC---EEEecCCCCCCEEEEEeCCcEEE
Confidence            3578999999985  43  999999999973 44 6667777789999999986   33322  3457999999999999


Q ss_pred             EE-cCCccHHHHHHHHHHhc
Q 010859          479 FE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       479 ~~-d~~~~~~~W~~~i~~~~  497 (499)
                      |. +.+.++++|+++|+.++
T Consensus        84 l~a~s~~e~~~Wi~al~~~~  103 (119)
T 2dhk_A           84 LKAATKQAMLYWLQQLQMKR  103 (119)
T ss_dssp             EECSSHHHHHHHHHHHHHHH
T ss_pred             EECCCHHHHHHHHHHHHHHH
Confidence            99 55689999999999875

>1eaz_A Tandem PH domain containing protein-1; lipid-binding protein, lipid degradation, phosphatidylinositol (3, 4)-bisphosphate, signalling; HET: CIT; 1.40A {Homo sapiens} SCOP: b.55.1.1

Probab=99.43  E-value=1.5e-13  Score=117.36  Aligned_cols=90  Identities=16%  Similarity=0.159  Sum_probs=76.0

Q ss_pred             CceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcCCc
Q 010859          405 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTPKK  475 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p~r  475 (499)
                      +..++++|||.|+++.+  ||+|||||++.-..||.++.....+|.|+|+..   ..+..       +....|.|.|++|
T Consensus        11 ~~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~l~~~---~~v~~~~~~~~~~~~~~F~i~~~~r   87 (125)
T 1eaz_A           11 DSAVIKAGYCVKQGAVMKNWKRRYFQLDENTIGYFKSELEKEPLRVIPLKEV---HKVQECKQSDIMMRDNLFEIVTTSR   87 (125)
T ss_dssp             -CCCSEEEEEEEECTTTCCEEEEEEEECSSEEEEESSTTCSSCSEEEEGGGC---CEEEECTTHHHHTCSSEEEEECSSC
T ss_pred             CCCccEEEEEEEeCCCCCCcceEEEEEeCCEEEEEcCCCCCcceeEEEcccc---eEEeeccccccCCcCCEEEEEeCCc
Confidence            45679999999998855  999999999987778888887889999999986   44544       3467999999999


Q ss_pred             eEEEE-cCCccHHHHHHHHHHhc
Q 010859          476 VLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       476 ~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      +|+|. +.+.++++|+++|+.++
T Consensus        88 ~~~l~a~s~~e~~~W~~al~~~i  110 (125)
T 1eaz_A           88 TFYVQADSPEEMHSWIKAVSGAI  110 (125)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCHHHHHHHHHHHHHHH
Confidence            99998 55689999999999875

>1v5p_A Pleckstrin homology domain-containing, family A; TAPP2, the pleckstrin homology domain, structural genomics; NMR {Mus musculus} SCOP: b.55.1.1

Probab=99.42  E-value=2.7e-13  Score=116.21  Aligned_cols=87  Identities=11%  Similarity=0.163  Sum_probs=68.1

Q ss_pred             EEEEeeehhh-hhh--hccceEEeec--CCeEEE-EC----CCCCeeeeeeeccCCCCceEEEEc-------CCCcEEEE
Q 010859          409 LMISMVKKLQ-KLT--SKKVQLILTN--KPKLIY-VD----PSKLVVKGNIIWSDNSNDLSIQVS-------SPSHFKIV  471 (499)
Q Consensus       409 ~~~g~~~k~~-g~~--~k~r~~ilt~--~p~l~y-~d----~~~~~~kg~i~~~~~~~~~~~~~~-------~~~~f~i~  471 (499)
                      .++||+.|++ +..  ||||||||+.  +-.||| .|    +...+.+|.|+|+..   ..|...       ....|.|+
T Consensus        16 ~~~G~L~K~g~~~~k~WkrRwFvL~~~~~~~L~Y~k~~~~~~~~~~~~G~I~L~~~---~~V~~~~~~~~~~~~~~F~i~   92 (126)
T 1v5p_A           16 RICGFLDIEDNENSGKFLRRYFILDTQANCLLWYMDNPQNLAVGAGAVGSLQLTYI---SKVSIATPKQKPKTPFCFVIN   92 (126)
T ss_dssp             CEECCEEEECTTCSSCEEEEEEEEETTTTEEEEESSCTTTSCTTCCCSEEEETTTC---CEEEECCTTTSCSCSSEEEEE
T ss_pred             ceEEEEEEeCCCCCCCccceEEEEecCCCCEEEEECCCCCCCCCceeeEEEECCCc---cEEecCCcccCCCCCEEEEEE
Confidence            5799999997 433  9999999993  556777 45    456788999999975   344432       23589999


Q ss_pred             cCCceEEEEc-CCccHHHHHHHHHHhcC
Q 010859          472 TPKKVLSFED-AKQRASQWKKAIEALQN  498 (499)
Q Consensus       472 ~p~r~y~~~d-~~~~~~~W~~~i~~~~~  498 (499)
                      ||.|||+|.. .+.++++|+++|+.+..
T Consensus        93 t~~r~y~l~A~s~~e~~~Wi~al~~a~~  120 (126)
T 1v5p_A           93 ALSQRYFLQANDQKDLKDWVEALNQASK  120 (126)
T ss_dssp             CSSCEEEEECSSHHHHHHHHHHHHHTTT
T ss_pred             CCCEEEEEECCCHHHHHHHHHHHHHHHh
Confidence            9999999994 55899999999998753

>1v5u_A SBF1, SET binding factor 1; MTMR5, the pleckstrin homology domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: b.55.1.1

Probab=99.41  E-value=1.5e-13  Score=115.90  Aligned_cols=90  Identities=17%  Similarity=0.193  Sum_probs=73.1

Q ss_pred             ceEEEEEeeehhhhhh--hccceEEee--cCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----------cCCCcEEE
Q 010859          406 ESVLMISMVKKLQKLT--SKKVQLILT--NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----------SSPSHFKI  470 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~--~k~r~~ilt--~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----------~~~~~f~i  470 (499)
                      +.++++|||.|+++..  ||+|||||+  +.-..||.++.....+|.|+|+..   ..+..           .....|.|
T Consensus         6 ~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~~~L~yy~~~~~~~~~g~i~L~~~---~~v~~~~~~~~~~~~~~~~~~F~i   82 (117)
T 1v5u_A            6 SGRSYEGILYKKGAFMKPWKARWFVLDKTKHQLRYYDHRMDTECKGVIDLAEV---EAVAPGTPTIGAPKTVDEKAFFDV   82 (117)
T ss_dssp             CSSSEEEEEEECCCSSSCCEEEEEEEETTTTEEEEESSSSCSSCCCEEEGGGE---EEEECCCCCTTSCSSSCTTTCEEE
T ss_pred             CCccEEEEEEecCCCCCCceeeEEEEECCCCEEEEeecCCCCccceEEEccCc---EEEeecCccccccccCCCCeEEEE
Confidence            3468999999998854  999999999  556667777777889999999985   44442           12369999


Q ss_pred             EcCCceEEEEc-CCccHHHHHHHHHHhcC
Q 010859          471 VTPKKVLSFED-AKQRASQWKKAIEALQN  498 (499)
Q Consensus       471 ~~p~r~y~~~d-~~~~~~~W~~~i~~~~~  498 (499)
                      .|++|+|+|.. .+.++++|+++|+.++.
T Consensus        83 ~~~~r~~~l~a~s~~e~~~Wi~al~~~i~  111 (117)
T 1v5u_A           83 KTTRRVYNFCAQDVPSAQQWVDRIQSCLS  111 (117)
T ss_dssp             EESSCEEEEECSSHHHHHHHHHHHHTTCC
T ss_pred             ECCCceEEEECCCHHHHHHHHHHHHHHhc
Confidence            99999999994 45899999999999873

>1pls_A Pleckstrin homology domain; phosphorylation; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.41  E-value=1.7e-13  Score=115.00  Aligned_cols=91  Identities=19%  Similarity=0.128  Sum_probs=73.5

Q ss_pred             eEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEE--EcCCCcEEEEcCC-ceEEEEc
Q 010859          407 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ--VSSPSHFKIVTPK-KVLSFED  481 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~--~~~~~~f~i~~p~-r~y~~~d  481 (499)
                      .++++|||.|+++.+  ||+|||||++....||.++.....+|.|+|+....+....  .+....|.|.|++ |+|+|..
T Consensus         4 ~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~~~~~~~~~~~~~~~F~i~~~~~r~~~l~a   83 (113)
T 1pls_A            4 KRIREGYLVKKGSVFNTWKPMWVVLLEDGIEFYKKKSDNSPKGMIPLKGSTLTSPCQDFGKRMFVFKITTTKQQDHFFQA   83 (113)
T ss_dssp             CCSEEEEEEEESSSSSCCEEEEEEEETTEEEEESSTTCSSCSEEEESSSCCEESSCCSSCCSSSEEEEEETTTEEEEEEC
T ss_pred             CCcEEEEEEEeCCCCCCceEEEEEEECCEEEEEeCCCCCCcceEEEcCCCEEEEecCCCCCCccEEEEEcCCCCEEEEEC
Confidence            468999999998755  9999999999887788888888999999999872211011  2345699999986 9999994


Q ss_pred             -CCccHHHHHHHHHHhc
Q 010859          482 -AKQRASQWKKAIEALQ  497 (499)
Q Consensus       482 -~~~~~~~W~~~i~~~~  497 (499)
                       .+.++++|+++|+.++
T Consensus        84 ~s~~e~~~Wi~ai~~~~  100 (113)
T 1pls_A           84 AFLEERDAWVRDINKAI  100 (113)
T ss_dssp             SSHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHH
Confidence             5589999999999875

>1btk_A Bruton'S tyrosine kinase; transferase, PH domain, BTK motif, zinc binding, X-linked agammaglobulinemia, tyrosine-protein kinase; 1.60A {Homo sapiens} SCOP: b.55.1.1 PDB: 1b55_A* 2z0p_A* 1bwn_A*

Probab=99.40  E-value=1.7e-13  Score=123.77  Aligned_cols=88  Identities=18%  Similarity=0.199  Sum_probs=69.8

Q ss_pred             EEEEEeeehhhh-------hhhccceEEeecCCeEEEEC----CCCCeeeeeeeccCCCCceEEEEc---C------C--
Q 010859          408 VLMISMVKKLQK-------LTSKKVQLILTNKPKLIYVD----PSKLVVKGNIIWSDNSNDLSIQVS---S------P--  465 (499)
Q Consensus       408 i~~~g~~~k~~g-------~~~k~r~~ilt~~p~l~y~d----~~~~~~kg~i~~~~~~~~~~~~~~---~------~--  465 (499)
                      ++++|||.|+++       ..||+|||||++.-..||.+    ......+|.|+|+..   ..++..   .      .  
T Consensus         3 vikeG~L~Kr~~~~~~~~~k~WKkRwFVL~~~~L~Yyk~~~~~~~~~~~~G~I~L~~~---~~ve~~~~~~~~~~~~~~~   79 (169)
T 1btk_A            3 VILESIFLKRSQQKKKTSPLNFKKCLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKI---TCVETVVPEKNPPPERQIP   79 (169)
T ss_dssp             CCEEEEEEEECCCSSTTCCCCEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEEGGGE---EEEEECCCCSSCCGGGCC-
T ss_pred             eEEEEEEEEecCCCCCcccCCCceEEEEEcCCEEEEEecCCccCCCCceeeEEECcce---EEEEeccCCCCcchhcccc
Confidence            689999999752       23999999999886667776    456789999999975   334432   1      1  


Q ss_pred             -------------------CcEEEEcCCceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          466 -------------------SHFKIVTPKKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       466 -------------------~~f~i~~p~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                                         ..|.|+||+|||||. +.+.++++|+++|..++.
T Consensus        80 ~~~~~~~~~~~~~i~~~~~~~F~I~t~~rt~yl~A~s~~E~~eWi~aI~~~i~  132 (169)
T 1btk_A           80 RRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIR  132 (169)
T ss_dssp             --------CCTTHHHHCCCEEEEEEETTCCEEEEESCHHHHHHHHHHHHHHHT
T ss_pred             cccCcccccccccccccccccEEEEeCCceEEEEcCCHHHHHHHHHHHHHHHH
Confidence                               479999999999999 455899999999999873

>2d9v_A Pleckstrin homology domain-containing protein family B member 1; PH domain, phret1, structural genomics, NPPSFA; NMR {Mus musculus}

Probab=99.39  E-value=3.6e-13  Score=116.27  Aligned_cols=92  Identities=14%  Similarity=0.155  Sum_probs=69.8

Q ss_pred             ceEEEEEeeehhhhhh--hccceEEe-ecCCeEEEECCCCCeeeeeeeccCCCCceE-------EE----EcCCCcEEEE
Q 010859          406 ESVLMISMVKKLQKLT--SKKVQLIL-TNKPKLIYVDPSKLVVKGNIIWSDNSNDLS-------IQ----VSSPSHFKIV  471 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~--~k~r~~il-t~~p~l~y~d~~~~~~kg~i~~~~~~~~~~-------~~----~~~~~~f~i~  471 (499)
                      ..++++|||.|+++.+  ||+||||| +++-..||.|+.....+|.|+++.....+.       +.    ......|.|.
T Consensus         6 ~~v~~~G~L~K~g~~~k~WkkRwFVL~~~~~L~Yyk~~~~~~~~g~i~l~~~~~~i~~~~~~~~v~~~~~~~~~~~F~I~   85 (130)
T 2d9v_A            6 SGLVRGGWLWRQSSILRRWKRNWFALWLDGTLGYYHDETAQDEEDRVVIHFNVRDIKVGQECQDVQPPEGRSRDGLLTVN   85 (130)
T ss_dssp             CCEEEEEEEEEECSSSCCEEEEEEEEETTTEEEEESSSSTTSEEEEEECTTTEEEEEEGGGCSSCCCCSSCCTTTEEEEE
T ss_pred             CceeEEEEEEeecCccCCceeeEEEEccCCEEEEEeCCCCCCcCceEecccceeEEeccccccccCCCCCCCcCcEEEEE
Confidence            4589999999998865  99999999 566666777777678899998875310011       11    1234689999


Q ss_pred             cC-CceEEEE-cCCccHHHHHHHHHHhc
Q 010859          472 TP-KKVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       472 ~p-~r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      |+ +|||+|. +.+.++++|+++|+.++
T Consensus        86 ~~~~r~~~l~A~s~~e~~~Wi~al~~a~  113 (130)
T 2d9v_A           86 LREGSRLHLCAETRDDAIAWKTALMEAN  113 (130)
T ss_dssp             ETTSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eCCCCEEEEEcCCHHHHHHHHHHHHHHH
Confidence            95 5999999 55589999999999876

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.39  E-value=1.2e-12  Score=126.36  Aligned_cols=140  Identities=16%  Similarity=0.140  Sum_probs=111.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~l  132 (499)
                      +.+|++...+|.|+.+.||++..  .+..+++|+........   ...+.+|..+++.+. +..+.+++.++.+....|+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            46799999999999999999975  36899999986532111   124677888888874 6678889999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS---------------------------------------  173 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~---------------------------------------  173 (499)
                      ||||++|.+|.+.+.     +......++.++..+|..||+                                       
T Consensus        88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999876531     223345788999999999998                                       


Q ss_pred             --------------------CCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          174 --------------------MGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       174 --------------------~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                                          ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                458999999999999875556799999875

>1wi1_A Calcium-dependent activator protein for secretion, CAPS; PH domain, PIP2 binding site, structural genomics; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.37  E-value=6.2e-13  Score=112.14  Aligned_cols=86  Identities=14%  Similarity=0.192  Sum_probs=72.6

Q ss_pred             EEEEEeeehhhh-h--hhccceEEeecCCeEEEE----CCCCCeeeeeeeccCCCCceEEEE--------cCCCcEEEEc
Q 010859          408 VLMISMVKKLQK-L--TSKKVQLILTNKPKLIYV----DPSKLVVKGNIIWSDNSNDLSIQV--------SSPSHFKIVT  472 (499)
Q Consensus       408 i~~~g~~~k~~g-~--~~k~r~~ilt~~p~l~y~----d~~~~~~kg~i~~~~~~~~~~~~~--------~~~~~f~i~~  472 (499)
                      ..++||+.|+++ .  .||||||||++.-..||.    |..+.+..|.|+|...    +|+.        ..+..|.|++
T Consensus         8 ~~~~G~L~KqG~~~~K~WKrRwFVL~~~~LyYfk~~~~~~~~~~p~G~I~L~g~----tV~~~~~~~~~~~~k~~F~~v~   83 (126)
T 1wi1_A            8 MKHSGYLWAIGKNVWKRWKKRFFVLVQVSQYTFAMCSYREKKAEPQELLQLDGY----TVDYTDPQPGLEGGRAFFNAVK   83 (126)
T ss_dssp             EEEEEEEEEECSSSCCSCEEEEEEEEEEETTEEEEEECCSSSSCCSEEEECSSC----EEEECCCCSSCCSCSSEEEEEC
T ss_pred             CceeEEEEEeCCCcccccceEEEEEeCCEEEEEEcccccccCCCCceEEECCCc----EEEEecCCcccccCceEEEEec
Confidence            689999999987 3  499999999999777887    8888999999999975    4331        2346799999


Q ss_pred             CCceEEEE-cCCccHHHHHHHHHHhc
Q 010859          473 PKKVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       473 p~r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      ++++|+|. |.+.++..|+++|..+.
T Consensus        84 ~~~ty~~~Adseee~~~WikAi~~A~  109 (126)
T 1wi1_A           84 EGDTVIFASDDEQDRILWVQAMYRAT  109 (126)
T ss_dssp             SSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCceEEEEcCCHHHHHHHHHHHHHHh
Confidence            99999999 67799999999999875

>1v88_A Oxysterol binding protein-related protein 8; vesicle transport, pleckstrin homology domain, phosphatidylinositol binding, structural genomics; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.37  E-value=1.9e-13  Score=117.80  Aligned_cols=93  Identities=17%  Similarity=0.175  Sum_probs=71.5

Q ss_pred             ceEEEEEeeehhhhhh-hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCC----------
Q 010859          406 ESVLMISMVKKLQKLT-SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK----------  474 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~-~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~----------  474 (499)
                      ..++++|||.|++++- ||+|||||.++-.+||.++.....+|.|+|..+.+......+....|.|.+|.          
T Consensus         6 ~~v~k~GwL~K~g~~k~WkrRWfVLk~~~L~yyk~~~~~~p~G~I~L~~~~v~~~~~~~~~~~F~i~~~~~~~i~~~~g~   85 (130)
T 1v88_A            6 SGIVMADWLKIRGTLKSWTKLWCVLKPGVLLIYKTQKNGQWVGTVLLNACEIIERPSKKDGFCFKLFHPLEQSIWAVKGP   85 (130)
T ss_dssp             SSCCEEEEEEECCSSSSCEEEEEEEETTEEEEESCSSSCCCCEEEECSSCEECCCCTTTSSCEEEEECTTCCCCSCSSCT
T ss_pred             CceEEEeEEEEeCCCCCceEEEEEEECCEEEEECCCCCCCceEEEEcCCCEEEECCCCCCCeEEEEEcCCccccccccCC
Confidence            3478999999977432 99999999998888888988888999999998621101111233699998763          


Q ss_pred             --------------ceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          475 --------------KVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       475 --------------r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                                    |+|+|. |.+.++++|+++|+.+++
T Consensus        86 ~~~~~g~~~~~~~~~~~~f~A~s~~e~~~Wi~ai~~a~~  124 (130)
T 1v88_A           86 KGEAVGSITQPLPSSYLIIRATSESDGRCWMDALELALK  124 (130)
T ss_dssp             TSCSCSCCCSCCCSSCCEEECSSHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccCCceEEEEECCCHHHHHHHHHHHHHHHh
Confidence                          458888 666899999999999864

>2lul_A Tyrosine-protein kinase TEC; structural genomics, northeast structural genomics consortiu PSI-biology, protein structure initiative, transferase; NMR {Homo sapiens}

Probab=99.37  E-value=9.7e-13  Score=118.22  Aligned_cols=91  Identities=18%  Similarity=0.185  Sum_probs=71.4

Q ss_pred             CceEEEEEeeehhhh---h----hhccceEEeecCCeEEEECCC-CCeeeeeeeccCCCCceEEEE----------cCCC
Q 010859          405 GESVLMISMVKKLQK---L----TSKKVQLILTNKPKLIYVDPS-KLVVKGNIIWSDNSNDLSIQV----------SSPS  466 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g---~----~~k~r~~ilt~~p~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~----------~~~~  466 (499)
                      +..+|++|+|.|++.   .    .||+|||||++.-..||.++. ....+|.|+|...   ..++.          ....
T Consensus        12 ~~~~i~EG~L~Kr~~~kk~~~~knWKkRwFVL~~~~L~Yyk~~~~~~~~~G~I~L~~~---~~v~~~~~~~~~~~~~~~~   88 (164)
T 2lul_A           12 NFNTILEEILIKRSQQKKKTSPLNYKERLFVLTKSMLTYYEGRAEKKYRKGFIDVSKI---KCVEIVKNDDGVIPCQNKY   88 (164)
T ss_dssp             CSSEEEEEEEEEECCCCSSSCCCCEEEEEEEEESSEEEEECCCSSSCCCCCEEEGGGC---CEEEECCCCSSSCCSSSCS
T ss_pred             CCCeeEEEEEEEecCCCCCCCCCCceeEEEEEECCEEEEEeccCcccccccEEEEeee---EEEEeccccccCcccccce
Confidence            446899999999763   1    399999999998766777764 3457899999976   33433          2235


Q ss_pred             cEEEEcCCceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          467 HFKIVTPKKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       467 ~f~i~~p~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      .|.|.||+|||||. +.+.++++|+++|++++.
T Consensus        89 ~f~i~t~~rt~~l~A~s~~e~~~Wi~aL~~~i~  121 (164)
T 2lul_A           89 PFQVVHDANTLYIFAPSPQSRDLWVKKLKEEIK  121 (164)
T ss_dssp             EEEEECSSCEEEEECSSHHHHHHHHHHHHHHHT
T ss_pred             eEEEecCCcEEEEECCCHHHHHHHHHHHHHHHH
Confidence            79999999999999 455899999999999874

>1fao_A Dual adaptor of phosphotyrosine and 3- phosphoinositides; pleckstrin, inositol tetrakisphosphate signal transduction protein, adaptor protein; HET: 4IP; 1.80A {Homo sapiens} SCOP: b.55.1.1 PDB: 1fb8_A

Probab=99.37  E-value=5.3e-13  Score=114.30  Aligned_cols=90  Identities=13%  Similarity=0.062  Sum_probs=74.0

Q ss_pred             eEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCCceEEEEc-
Q 010859          407 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPKKVLSFED-  481 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~r~y~~~d-  481 (499)
                      .++++|||.|+++..  ||+|||||++.-..||.++.....+|.|+|..+.. +.+..  +.+..|.|.||+|+|+|.. 
T Consensus        17 ~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~~-v~~~~~~~~~~~F~i~~~~r~~~l~a~   95 (126)
T 1fao_A           17 LGTKEGYLTKQGGLVKTWKTRWFTLHRNELKYFKDQMSPEPIRILDLTECSA-VQFDYSQERVNCFCLVFPFRTFYLCAK   95 (126)
T ss_dssp             TTCEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEEGGGCCE-EEEECSSSSSSEEEEEETTEEEEEECS
T ss_pred             CccEEEEEEEcCCCCCCcccEEEEEECCEEEEeCCCCCCCceeEEEccceEE-EEecccCCCCCEEEEEeCCcEEEEECC
Confidence            468999999998755  99999999998777888888889999999998721 22221  3347899999999999994 


Q ss_pred             CCccHHHHHHHHHHhc
Q 010859          482 AKQRASQWKKAIEALQ  497 (499)
Q Consensus       482 ~~~~~~~W~~~i~~~~  497 (499)
                      .+.++++|+++|+.++
T Consensus        96 s~~e~~~Wi~al~~~i  111 (126)
T 1fao_A           96 TGVEADEWIKILRWKL  111 (126)
T ss_dssp             SHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHH
Confidence            5589999999999875

>1x1g_A Pleckstrin 2; PH domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.37  E-value=8.7e-13  Score=113.36  Aligned_cols=94  Identities=18%  Similarity=0.248  Sum_probs=73.6

Q ss_pred             CCceEEEEEeeehhhhhh--hccceEEeec-CCeEEEECC--CCCeeeeeeeccCCCCceEEEEc----------CCCcE
Q 010859          404 PGESVLMISMVKKLQKLT--SKKVQLILTN-KPKLIYVDP--SKLVVKGNIIWSDNSNDLSIQVS----------SPSHF  468 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g~~--~k~r~~ilt~-~p~l~y~d~--~~~~~kg~i~~~~~~~~~~~~~~----------~~~~f  468 (499)
                      ....++++|||.|+++..  ||+|||||++ ...|+|.+.  .....+|.|+|..+. +..++..          ....|
T Consensus        14 ~~~~~~~~G~L~K~g~~~~~Wk~R~fvL~~d~~~L~yy~~~~~~~~~~g~i~L~~~~-v~~~~~~~~p~~~~~~~~~~~F   92 (129)
T 1x1g_A           14 LSGTVVKQGYLAKQGHKRKNWKVRRFVLRKDPAFLHYYDPSKEENRPVGGFSLRGSL-VSALEDNGVPTGVKGNVQGNLF   92 (129)
T ss_dssp             TCSEEEEEEEEEEECSSSSSEEEEEEEEEESSCEEEEECSSSCCSSCSCCEESTTCC-CEECCSSSSCSSCSSCCCSSCE
T ss_pred             cCCCEEEEEEEEEECCCCCCeeeEEEEEeCCCCeEEEeCCCCcCCccceEEECcCCE-EEEeCCCCCcccccCCCCCceE
Confidence            355799999999998754  9999999995 577766655  577899999999752 1233222          35799


Q ss_pred             EEEcCC-ceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          469 KIVTPK-KVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       469 ~i~~p~-r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      .|.|++ |+|+|. +.+.++++|+++|+.+++
T Consensus        93 ~I~~~~~r~~~l~a~s~~e~~~Wi~al~~~~~  124 (129)
T 1x1g_A           93 KVITKDDTHYYIQASSKAERAEWIEAIKKLTS  124 (129)
T ss_dssp             EECCTTCCCEEECCSSHHHHHHHHHHHHHHSS
T ss_pred             EEEcCCCCEEEEEcCCHHHHHHHHHHHHHHHh
Confidence            999996 889998 556899999999999864

>2d9x_A Oxysterol binding protein-related protein 11; PH domain, OSBP-related protein 11, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=99.37  E-value=1.9e-13  Score=116.21  Aligned_cols=89  Identities=11%  Similarity=0.180  Sum_probs=69.7

Q ss_pred             eEEEEEeeehhhhhh--hccceEEeec-CCeEEEE-CCCC--CeeeeeeeccCCCCceEEEEcCCCcEEEEcCC-ceEEE
Q 010859          407 SVLMISMVKKLQKLT--SKKVQLILTN-KPKLIYV-DPSK--LVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-KVLSF  479 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~--~k~r~~ilt~-~p~l~y~-d~~~--~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-r~y~~  479 (499)
                      .++++|||.|+++..  ||+|||||+. ...|+|. ++..  ...+|.|+|..+  .+.+.......|.|.||+ |+|+|
T Consensus         7 ~~~~~G~L~K~~~~~~~Wk~R~fvL~~~~~~L~Yyk~~~~~~~~~~g~I~L~~~--~v~~~~~~~~~F~i~~~~~r~~~l   84 (120)
T 2d9x_A            7 GENVYGYLMKYTNLVTGWQYRFFVLNNEAGLLEYFVNEQSRNQKPRGTLQLAGA--VISPSDEDSHTFTVNAASGEQYKL   84 (120)
T ss_dssp             CCCCEEEEEEEEETTTEEEEEEEEECTTTCEEEEESSGGGSSSCCSEEEECTTC--CEECCSSSSSCEEECCSSSCCEEE
T ss_pred             CCcEEEEEEecCCCCCCceEEEEEEECCCCEEEEEecCcccCCCccceEEcceE--EEEecCCCCCEEEEEcCCCCEEEE
Confidence            467899999998755  9999999995 4566555 5443  267999999986  233333556899999996 99999


Q ss_pred             E-cCCccHHHHHHHHHHhc
Q 010859          480 E-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       480 ~-d~~~~~~~W~~~i~~~~  497 (499)
                      . +.+.++++|+++|+.++
T Consensus        85 ~a~s~~e~~~Wi~al~~~~  103 (120)
T 2d9x_A           85 RATDAKERQHWVSRLQICT  103 (120)
T ss_dssp             CCSSHHHHHHHHHHHHHHH
T ss_pred             ECCCHHHHHHHHHHHHHHH
Confidence            8 55689999999999875

>2i5f_A Pleckstrin; PH domain, protein-inositol phosphate complex, lipid binding protein; HET: 5IP; 1.35A {Homo sapiens} SCOP: b.55.1.1 PDB: 2i5c_A* 1zm0_A

Probab=99.36  E-value=1.4e-12  Score=108.52  Aligned_cols=91  Identities=18%  Similarity=0.183  Sum_probs=70.5

Q ss_pred             ceEEEEEeeehhhhhh--hccceEEeecC-CeEE-EECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcCC
Q 010859          406 ESVLMISMVKKLQKLT--SKKVQLILTNK-PKLI-YVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTPK  474 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~--~k~r~~ilt~~-p~l~-y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p~  474 (499)
                      +.++++|||.|+++..  ||+|||||++. ..|+ |.++.....+|.|+|..+. +..+..       .....|.|.|++
T Consensus         5 ~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~~~L~yyk~~~~~~~~g~i~L~~~~-v~~~~~~~~~~~~~~~~~F~i~~~~   83 (109)
T 2i5f_A            5 GVIIKQGCLLKQGHRRKNWKVRKFILREDPAYLHYYDPAGAEDPLGAIHLRGCV-VTSVESNSNGRKSEEENLFEIITAD   83 (109)
T ss_dssp             CCEEEEEEEEEECTTTCCEEEEEEEEETTTTEEEEECTTSCSSCSEEEECTTCE-EEEECC--------CCSEEEEECTT
T ss_pred             CceeEEEEEEEcCCCCCCceEEEEEEeCCCcEEEEECCCCCCCccEEEECCCCE-EEEccCCcccccCCCceEEEEEeCC
Confidence            3589999999998755  99999999996 3664 5466677899999999851 112211       146799999986


Q ss_pred             -ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          475 -KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       475 -r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                       |+|+|. +.+.++++|+++|+.++
T Consensus        84 ~~~~~l~a~s~~e~~~Wi~ai~~~~  108 (109)
T 2i5f_A           84 EVHYFLQAATPKERTEWIKAIQMAS  108 (109)
T ss_dssp             CCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEcCCHHHHHHHHHHHHHHh
Confidence             779998 55589999999999875

>1u5d_A SKAP55, SRC kinase-associated phosphoprotein of 55 kDa; PH domain, signaling protein; 1.70A {Homo sapiens} SCOP: b.55.1.1

Probab=99.35  E-value=1.1e-12  Score=108.64  Aligned_cols=87  Identities=18%  Similarity=0.281  Sum_probs=72.5

Q ss_pred             eEEEEEeeehhhh------hhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--------cCCCcEEEEc
Q 010859          407 SVLMISMVKKLQK------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--------SSPSHFKIVT  472 (499)
Q Consensus       407 ~i~~~g~~~k~~g------~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--------~~~~~f~i~~  472 (499)
                      .++++|||.|+++      ..||+|||+|++.-..||.++.....+|.|+|+..    .+..        +....|.|.|
T Consensus         2 ~v~~~G~L~K~~~~~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~----~v~~~~~~~~~~~~~~~F~i~~   77 (108)
T 1u5d_A            2 SVIKQGYLEKKSKDHSFFGSEWQKRWCVVSRGLFYYYANEKSKQPKGTFLIKGY----SVRMAPHLRRDSKKESCFELTS   77 (108)
T ss_dssp             CEEEEEEEEEEEECSSSSCEEEEEEEEEEETTEEEEESSTTCSSCSEEEECTTC----EEEECGGGCSSGGGGGEEEEEC
T ss_pred             CccEEEEEEEcCCCCCccccCceeeEEEEeCCEEEEecCCCCCCCCEEEEecce----EEEeCCccccccCCcceEEEEc
Confidence            4799999999884      34999999999887778888888889999999986    2332        2347899999


Q ss_pred             CC-ceEEEEc-CCccHHHHHHHHHHhc
Q 010859          473 PK-KVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       473 p~-r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      |+ |+|+|.. .+.++++|+++|+.++
T Consensus        78 ~~~r~~~l~a~s~~e~~~Wi~ai~~~i  104 (108)
T 1u5d_A           78 QDRRTYEFTATSPAEARDWVDQISFLL  104 (108)
T ss_dssp             SSSCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence            97 9999995 5589999999999876

>2rlo_A Centaurin-gamma 1; split PH domain, alternative splicing, ANK repeat, cytoplasm, GTP-binding, GTPase activation, metal-binding, nucleotide-binding; NMR {Homo sapiens}

Probab=99.35  E-value=6.6e-13  Score=114.21  Aligned_cols=91  Identities=20%  Similarity=0.162  Sum_probs=63.8

Q ss_pred             eEEEEEeeehhhh--hh--hccceEEeecCCeEEEECCC-----C-------------CeeeeeeeccCCCCc------e
Q 010859          407 SVLMISMVKKLQK--LT--SKKVQLILTNKPKLIYVDPS-----K-------------LVVKGNIIWSDNSND------L  458 (499)
Q Consensus       407 ~i~~~g~~~k~~g--~~--~k~r~~ilt~~p~l~y~d~~-----~-------------~~~kg~i~~~~~~~~------~  458 (499)
                      .++++|||.|++|  +.  ||+|||||++...|+|.+..     .             ....|.||+..+...      .
T Consensus         3 ~~~k~G~L~K~~g~~~~k~WkkRwFvL~~~~~l~Y~~~~~d~~~~~~~~~i~l~~~~~~~~~~~i~l~~~~~~~~~~~~~   82 (128)
T 2rlo_A            3 IPIKQSFLLKRSGNSLNKEWKKKYVTLSSNGFLLYHPSINDYIHSTHGKEMDLLRTTVKVPGKRPPRAISAFGPSASGSA   82 (128)
T ss_dssp             CEEEEEEEEEECSCSTTCCEEEEEEEEETTTEEEEESSHHHHHHTCSCEEEESSSCEEECSSCCCCCSSCCCSCCSCCCC
T ss_pred             cceeEEEEEEecCCCccCCccEEEEEEeCCCEEEEecchhhhccccCCCeeeeeeeEEecCCCccccccccccccccccc
Confidence            4689999999954  44  99999999998889888641     0             112234444432110      0


Q ss_pred             EEEEcCCCcEEEEcCC-ceEEEEc-CCccHHHHHHHHHHhc
Q 010859          459 SIQVSSPSHFKIVTPK-KVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       459 ~~~~~~~~~f~i~~p~-r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      .........|.|+||+ |||+|.. .+.++++|+++|+.++
T Consensus        83 ~~~~~~~~~F~I~t~~~r~~~l~A~s~~e~~~Wi~ai~~~i  123 (128)
T 2rlo_A           83 GQAEEENFEFLIVSSTGQTWHFEAASFEERDAWVQAIESQI  123 (128)
T ss_dssp             SSCCCCCCCEEEECTTSCEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             cccccCCceEEEEcCCCCEEEEEcCCHHHHHHHHHHHHHHH
Confidence            0011345799999998 9999994 5589999999999875

>1upq_A PEPP1; PH domain, phosphoinositide binding, signal transduction; 1.48A {Homo sapiens} SCOP: b.55.1.1 PDB: 1upr_A*

Probab=99.35  E-value=2e-12  Score=110.11  Aligned_cols=91  Identities=16%  Similarity=0.253  Sum_probs=74.5

Q ss_pred             CCceEEEEEeeehhhh-hh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc-------CCCcEEEEcC
Q 010859          404 PGESVLMISMVKKLQK-LT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS-------SPSHFKIVTP  473 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g-~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~-------~~~~f~i~~p  473 (499)
                      ++..++++|||.|+++ .+  ||+|||||++.-..||.++.....+|.|+|...    .+...       ....|.|.++
T Consensus         7 p~~~~~~~G~L~K~~~~~~~~WkkR~fvL~~~~L~yy~~~~~~~~~g~i~l~~~----~v~~~~~~~~~~~~~~f~i~~~   82 (123)
T 1upq_A            7 PNLPVHIRGWLHKQDSSGLRLWKRRWFVLSGHCLFYYKDSREESVLGSVLLPSY----NIRPDGPGAPRGRRFTFTAEHP   82 (123)
T ss_dssp             TTSCEEEEEEEEEECSSSSCCEEEEEEEEETTEEEEESSTTCCSCCEEEEGGGC----EEEECCSSCTTSSSSEEEEECT
T ss_pred             CCCCceEEEEEEeeCCCCCCCceeEEEEEeCCEEEEECCCCCcccceEEECCCC----EEEECCCCccCCCcEEEEEECC
Confidence            4566899999999985 33  999999999887778888888899999999875    34332       3467888888


Q ss_pred             C-ceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          474 K-KVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       474 ~-r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      + |+|+|. +.+.++++|+++|+.++.
T Consensus        83 ~~r~~~l~a~s~~e~~~Wi~al~~a~~  109 (123)
T 1upq_A           83 GMRTYVLAADTLEDLRGWLRALGRASR  109 (123)
T ss_dssp             TSCCEEEECSSHHHHHHHHHHHHHHHC
T ss_pred             CCeEEEEECCCHHHHHHHHHHHHHHHh
Confidence            7 999998 556899999999999763

>2dkp_A Pleckstrin homology domain-containing family A member 5; PH domain, pleckstrin homology domain-containing protein family A member 5; NMR {Homo sapiens}

Probab=99.34  E-value=1.3e-12  Score=112.00  Aligned_cols=90  Identities=20%  Similarity=0.262  Sum_probs=74.0

Q ss_pred             CCceEEEEEeeehhhh-hh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcC
Q 010859          404 PGESVLMISMVKKLQK-LT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTP  473 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g-~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p  473 (499)
                      +++.++++|||.|+++ ..  ||+|||||++.-..||.++.....+|.|+|...    .+..       +....|.|.++
T Consensus        17 ~~~~~~~~G~L~K~~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~----~v~~~~~~~~~~~~~~F~i~~~   92 (128)
T 2dkp_A           17 PNAPVVRRGWLYKQDSTGMKLWKKRWFVLSDLCLFYYRDEKEEGILGSILLPSF----QIALLTSEDHINRKYAFKAAHP   92 (128)
T ss_dssp             TTSCCCEEEEEEEECCSSSCCEEEEEEEEETTEEEEESSTTCCSEEEEECGGGS----EEEECCGGGCCSSCSEEEEECS
T ss_pred             CCCCcEEEEEEEEeCCCCCCCceeEEEEEeCCEEEEECCCCCcccceEEEcCce----EEEEcCCcccCCCCeEEEEEcC
Confidence            4667899999999886 33  999999999887778888888899999999864    3333       33468999998


Q ss_pred             C-ceEEEEc-CCccHHHHHHHHHHhc
Q 010859          474 K-KVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       474 ~-r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      + |+|+|.. .+.++++|+++|+.+.
T Consensus        93 ~~r~~~l~a~s~~e~~~Wi~al~~a~  118 (128)
T 2dkp_A           93 NMRTYYFCTDTGKEMELWMKAMLDAA  118 (128)
T ss_dssp             SSCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCEEEEEcCCHHHHHHHHHHHHHHH
Confidence            5 9999994 5689999999998864

>1dyn_A Dynamin; signal transduction protein; 2.20A {Homo sapiens} SCOP: b.55.1.1 PDB: 2dyn_A 3zys_C 2ys1_A

Probab=99.34  E-value=2.8e-12  Score=106.83  Aligned_cols=85  Identities=18%  Similarity=0.198  Sum_probs=70.5

Q ss_pred             EEEEEeeehh-hhhh---hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cCCCcEEEEcCC---
Q 010859          408 VLMISMVKKL-QKLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SSPSHFKIVTPK---  474 (499)
Q Consensus       408 i~~~g~~~k~-~g~~---~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~~~~f~i~~p~---  474 (499)
                      +++.||+.|. +|+.   ||+||||||+.-..||.|....+.+|.|||..    +.+..      ..+..|.|..|+   
T Consensus        12 VirkGWL~k~~~g~~k~~wk~rWFVLt~~~L~yyKd~~eke~~G~IpL~~----~~vr~v~~~~~~rk~~F~l~~~d~r~   87 (125)
T 1dyn_A           12 VIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDN----LKLRDVEKGFMSSKHIFALFNTEQRN   87 (125)
T ss_dssp             EEEEEEEEESCCCGGGTSSEEEEEEEESSEEEEESSTTCSCEEEEEECTT----EEEEECCSCSSSSCEEEEEEETTSSC
T ss_pred             eEEEEEEEEecCccccCCceeeEEEEeccceeeecCCcccccceEEECCC----ceEeccCCCCCCCceEEEEECCCCcc
Confidence            8999999995 4422   99999999999999999999999999999976    45544      234699998774   


Q ss_pred             -----ceEEEEcCC-ccHHHHHHHHHHh
Q 010859          475 -----KVLSFEDAK-QRASQWKKAIEAL  496 (499)
Q Consensus       475 -----r~y~~~d~~-~~~~~W~~~i~~~  496 (499)
                           |+|.|...+ .++++|+.+|.++
T Consensus        88 v~~~h~~y~LsA~t~ee~~~Wi~s~~ra  115 (125)
T 1dyn_A           88 VYKDYRQLELACETQEEVDSWKASFLRA  115 (125)
T ss_dssp             SSTTCSSEEEEESSHHHHHHHHHHHHHT
T ss_pred             ccccceEEEEeCCCHHHHHHHHHHHHhC
Confidence                 499999665 8999999999654

>3aj4_A Pleckstrin homology domain-containing family B ME; antiparallel beta sheet, protein transport; HET: SEP EDO; 1.00A {Homo sapiens} PDB: 3via_A 2dhi_A

Probab=99.34  E-value=2.2e-13  Score=114.12  Aligned_cols=91  Identities=13%  Similarity=0.206  Sum_probs=69.8

Q ss_pred             EEEEEeeehhhhhh--hccceEEe-ecCCeEEEECCCCCeeeeeeeccCCCCce----EEE---E---cC-CCcEEEEcC
Q 010859          408 VLMISMVKKLQKLT--SKKVQLIL-TNKPKLIYVDPSKLVVKGNIIWSDNSNDL----SIQ---V---SS-PSHFKIVTP  473 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~il-t~~p~l~y~d~~~~~~kg~i~~~~~~~~~----~~~---~---~~-~~~f~i~~p  473 (499)
                      ++++|||.|+++.+  ||+||||| .++-..||.++.....+|.|++...+..+    .+.   .   ++ +..|.|.||
T Consensus         5 ~~~~G~L~K~g~~~k~WkkR~fvL~~~~~L~yyk~~~~~~~~g~i~l~~~~i~l~~~~~v~~v~~~~~~~~~~~F~i~~~   84 (112)
T 3aj4_A            5 FVKSGWLLRQSTILKRWKKNWFDLWSDGHLIYYDDQTRQNIEDKVHMPMDCINIRTGQECRDTQPPDGKSKDCMLQIVCR   84 (112)
T ss_dssp             CSEEEEEEEECSSSCCEEEEEEEECTTSEEEEESSTTCCSEEEEEEHHHHEEEEEEGGGCCSCCCSTTCCGGGEEEEEET
T ss_pred             eeEEEEEEeeCCCCCCeeceEEEEeeCCEEEEEcCCCCCCCCccccccccceeecccccccccCCCCCCCcCcEEEEEec
Confidence            68999999998855  99999999 55666688888878999999998642000    111   1   12 348999876


Q ss_pred             -CceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          474 -KKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       474 -~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                       +|+|+|. +.+.++++|+++|++++.
T Consensus        85 ~~r~~~l~a~s~~e~~~Wi~al~~a~~  111 (112)
T 3aj4_A           85 DGKTISLCAESTDDCLAWKFTLQDSRT  111 (112)
T ss_dssp             TSCEEEEECSSHHHHHHHHHHHHHHHT
T ss_pred             CCcEEEEEeCCHHHHHHHHHHHHHHhh
Confidence             8999999 456899999999999763

>1x05_A Pleckstrin; PH domain, structural genomics, NPPSFA, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.55.1.1 PDB: 1xx0_A

Probab=99.34  E-value=2.7e-12  Score=110.34  Aligned_cols=92  Identities=18%  Similarity=0.219  Sum_probs=71.1

Q ss_pred             ceEEEEEeeehhhhhh--hccceEEeecCC-eE-EEECCCCCeeeeeeeccCCCCceEEEEc-------CCCcEEEEcCC
Q 010859          406 ESVLMISMVKKLQKLT--SKKVQLILTNKP-KL-IYVDPSKLVVKGNIIWSDNSNDLSIQVS-------SPSHFKIVTPK  474 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~--~k~r~~ilt~~p-~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~~-------~~~~f~i~~p~  474 (499)
                      ..++++|||.|+++..  ||+|||||++.+ .| ||.++.....+|.|+|..+.+ ..+...       ....|.|.|++
T Consensus        16 ~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~~~L~yy~~~~~~~~~g~i~L~~~~v-~~~~~~~~~~~~~~~~~F~i~~~~   94 (129)
T 1x05_A           16 GVIIKQGCLLKQGHRRKNWKVRKFILREDPAYLHYYDPAGAEDPLGAIHLRGCVV-TSVESNSNGRKSEEENLFEIITAD   94 (129)
T ss_dssp             SEEEEEEEEEECCSSCCCCEEEEEEEEETTTEEEEECSSCCSSCSEEEECTTCEE-EECCCCCCSSSCSSCSEEEEECTT
T ss_pred             CCceEEEEEEecCCCCCCCeeEEEEEeCCCCEEEEECCCCCCcceeEEEccCCEE-EEccCCccccccCCCeEEEEEcCC
Confidence            4589999999998754  999999999974 56 555666788999999998511 111111       45789999985


Q ss_pred             -ceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          475 -KVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       475 -r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                       |+|+|. +.+.++++|+++|+.+++
T Consensus        95 ~~~~~l~a~s~~e~~~Wi~al~~~~~  120 (129)
T 1x05_A           95 EVHYFLQAATPKERTEWIKAIQMASR  120 (129)
T ss_dssp             CCCCEEECSSHHHHHHHHHHHHHHHT
T ss_pred             CCEEEEECCCHHHHHHHHHHHHHHHH
Confidence             889998 555899999999999763

>3rcp_A Pleckstrin homology domain-containing family A ME; FAPP1, PH domain, lipid-binding, membrane, membrane protein; 1.90A {Homo sapiens} PDB: 2kcj_A

Probab=99.34  E-value=8.2e-13  Score=108.86  Aligned_cols=86  Identities=12%  Similarity=0.195  Sum_probs=67.2

Q ss_pred             EEeeehhhhhh--hccceEEeecCCeEEEECCCC--CeeeeeeeccCCCCceEEEEcCCCcEEEEcC-CceEEEE-cCCc
Q 010859          411 ISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQVSSPSHFKIVTP-KKVLSFE-DAKQ  484 (499)
Q Consensus       411 ~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p-~r~y~~~-d~~~  484 (499)
                      +|||.|+++..  ||+|||||+++-..||.++..  ...+|.|+|+.+  .+.+.......|.|.+| +|+|+|. +.+.
T Consensus         2 eG~L~K~g~~~k~Wk~R~fvL~~~~L~Yy~~~~~~~~~~~g~i~L~~~--~v~~~~~~~~~F~i~~~~~r~~~l~a~s~~   79 (103)
T 3rcp_A            2 EGVLYKWTNYLTGWQPRWFVLDNGILSYYDSQDDVCKGSKGSIKMAVC--EIKVHSADNTRMELIIPGEQHFYMKAVNAA   79 (103)
T ss_dssp             EEEEEEECCTTTCEEEEEEEEETTEEEEESSCC---CCCSCEEEGGGC--EEECCTTCSSEEEEEETTTEEEEEECSSHH
T ss_pred             ceEEEEccCCCCCeeceEEEEECCEEEEEecCCcccCCcccEEEeeee--EEEEcCCCCceEEEEeCCCCEEEEECCCHH
Confidence            79999999866  999999999765556666653  358999999753  22223345689999998 7999999 4558


Q ss_pred             cHHHHHHHHHHhcC
Q 010859          485 RASQWKKAIEALQN  498 (499)
Q Consensus       485 ~~~~W~~~i~~~~~  498 (499)
                      ++++|+++|+.++.
T Consensus        80 e~~~Wi~al~~a~~   93 (103)
T 3rcp_A           80 ERQRWLVALGSSKA   93 (103)
T ss_dssp             HHHHHHHHHHTTSC
T ss_pred             HHHHHHHHHHHHHH
Confidence            99999999998763

>1u5f_A SRC-associated adaptor protein; PH domain of SKAP-HOM, artefactual dimerization induced by V derived sequence, signaling protein; 1.90A {Mus musculus} SCOP: b.55.1.1 PDB: 1u5g_A

Probab=99.33  E-value=1.2e-12  Score=115.57  Aligned_cols=88  Identities=16%  Similarity=0.293  Sum_probs=73.0

Q ss_pred             eEEEEEeeehhhh------hhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--------cCCCcEEEEc
Q 010859          407 SVLMISMVKKLQK------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--------SSPSHFKIVT  472 (499)
Q Consensus       407 ~i~~~g~~~k~~g------~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--------~~~~~f~i~~  472 (499)
                      .++++|||.|+++      ..||+|||||+++...||.++.....+|.|+|+..    .+..        +....|.|.|
T Consensus        16 ~~~~~G~L~K~g~~~~~~~k~WkkR~fvL~~~~L~yyk~~~~~~~~g~i~L~~~----~v~~~~~~~~~~~~~~~F~I~~   91 (148)
T 1u5f_A           16 FVIKAGYLEKRRKDHSFLGFEWQKRWCALSKTVFYYYGSDKDKQQKGEFAIDGY----DVRMNNTLRKDGKKDCCFEICA   91 (148)
T ss_dssp             SEEEEEEEEEECCCSSCSSCSEEEEEEEEETTEEEEESSTTCSSCSEEEECTTC----EEEECTTSCSSTTGGGEEEEEC
T ss_pred             CccEEEEEEEeCCCCCCcCCCceeEEEEEECCEEEEEcCCCCcccceEEEcCCc----EEEECCCcccCCCCccEEEEEC
Confidence            4799999999884      25999999999988888888888889999999986    2331        2236899999


Q ss_pred             CC-ceEEEEc-CCccHHHHHHHHHHhcC
Q 010859          473 PK-KVLSFED-AKQRASQWKKAIEALQN  498 (499)
Q Consensus       473 p~-r~y~~~d-~~~~~~~W~~~i~~~~~  498 (499)
                      ++ |+|+|.. .+.++++|+++|+.++.
T Consensus        92 ~~~r~~~l~a~s~~e~~~Wi~al~~~i~  119 (148)
T 1u5f_A           92 PDKRIYQFTAASPKDAEEWVQQLKFILQ  119 (148)
T ss_dssp             TTSCEEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             CCCcEEEEECCCHHHHHHHHHHHHHHHH
Confidence            87 9999994 56899999999999864

>1v89_A Hypothetical protein KIAA0053; pleckstrin homology domain, phosphatidylinositol binding, structural genomics; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.33  E-value=7.5e-13  Score=111.64  Aligned_cols=89  Identities=11%  Similarity=0.227  Sum_probs=73.3

Q ss_pred             ceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cCCCcEEEEc-----
Q 010859          406 ESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SSPSHFKIVT-----  472 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~~~~f~i~~-----  472 (499)
                      +.++++|||.|+++..  ||+|||||++.-..||.++.....+|.|+|..+   ..++.      .....|.|.|     
T Consensus         6 ~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~---~v~~~~~~~~~~~~~~f~i~~~~~~~   82 (118)
T 1v89_A            6 SGPIKMGWLKKQRSIVKNWQQRYFVLRAQQLYYYKDEEDTKPQGCMYLPGC---TIKEIATNPEEAGKFVFEIIPASWDQ   82 (118)
T ss_dssp             SCEEEEEEEEEECSSSSCEEEEEEEEETTEEEEESSSSCCSCSEEECSTTE---EEEEECCCSSCCCCCEEEEEESCCSS
T ss_pred             CCCcEEEEEEecCCCCCCccEEEEEEECCEEEEEeCCCCCCceEEEECCCC---EEEEcCcCcccCCcceEEEECCcccc
Confidence            4589999999998765  999999999987778888888889999999975   22222      2356899998     


Q ss_pred             ---CCceEEEE-cCCccHHHHHHHHHHhc
Q 010859          473 ---PKKVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       473 ---p~r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                         +.|+|+|. +.+.++++|+++|+.++
T Consensus        83 ~~~~~~~~~l~a~s~~e~~~Wi~al~~~~  111 (118)
T 1v89_A           83 NRMGQDSYVLMASSQAEMEEWVKFLRRVA  111 (118)
T ss_dssp             CCSSCCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccCCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence               78999999 55689999999999976

>1wg7_A Dedicator of cytokinesis protein 9; pleckstrin homology domain, zizimin1, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.33  E-value=7.6e-13  Score=117.01  Aligned_cols=92  Identities=12%  Similarity=0.099  Sum_probs=71.6

Q ss_pred             ceEEEEEeeehhh------hhh--hccceEEeecC-----CeEEEECCC-CCeeeeeeeccCCCCceEEEEcCCCcEEEE
Q 010859          406 ESVLMISMVKKLQ------KLT--SKKVQLILTNK-----PKLIYVDPS-KLVVKGNIIWSDNSNDLSIQVSSPSHFKIV  471 (499)
Q Consensus       406 ~~i~~~g~~~k~~------g~~--~k~r~~ilt~~-----p~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~  471 (499)
                      ..++++|||.|++      +..  ||+|||||++.     -.+||.++. ....+|.|+|..+..+.....+....|.|.
T Consensus        16 ~~~~~~G~L~K~~~~~~~~~~~k~Wk~RwfvL~~~~~g~~~L~yy~~~~~~~~~~g~I~L~~~~~~~~~~~~~~~~F~i~   95 (150)
T 1wg7_A           16 GGITKHGWLYKGNMNSAISVTMRSFKRRFFHLIQLGDGSYNLNFYKDEKISKEPKGSIFLDSCMGVVQNNKVRRFAFELK   95 (150)
T ss_dssp             CCCCCEEEEEECCCCSSHHHHHSSCEEEEEEEEECSSSCEEEEEESSSCCSSCCSEEECTTTCCEECCCCSSCTTEEEEE
T ss_pred             CCeeEEEEEEEecCCccccccccCeeEEEEEEecCCCCceEEEEECCCCCCCCcCcEEecccCEEEecCCCCCceEEEEE
Confidence            4578999999987      333  99999999997     555777776 678999999998632211112445799999


Q ss_pred             cCC-ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          472 TPK-KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       472 ~p~-r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      |++ |+|+|. +.+.++++|+.+|+.++
T Consensus        96 ~~~~r~~~l~A~s~~e~~~Wi~al~~ai  123 (150)
T 1wg7_A           96 MQDKSSYLLAADSEVEMEEWITILNKIL  123 (150)
T ss_dssp             CSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eCCCcEEEEEeCCHHHHHHHHHHHHHHH
Confidence            995 999999 45589999999999875

>1fgy_A GRP1; PH domain, signaling protein; HET: 4IP; 1.50A {Mus musculus} SCOP: b.55.1.1 PDB: 1fgz_A 1u2b_A 1fhw_A* 1fhx_A* 1u29_A* 1u27_A*

Probab=99.33  E-value=7.7e-13  Score=113.20  Aligned_cols=89  Identities=19%  Similarity=0.195  Sum_probs=71.4

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEE-EcCCCcEEEEcCC----------
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ-VSSPSHFKIVTPK----------  474 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~-~~~~~~f~i~~p~----------  474 (499)
                      ++++|||.|+++..  ||+|||||++.-..||.++.....+|.|+|+.+.+ ..+. .+.+..|.|.+|+          
T Consensus         5 ~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~v-~~~~~~~~~~~f~i~~~~~~~~~~~~~~   83 (127)
T 1fgy_A            5 PDREGWLLKLGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSI-REVLDPRKPNCFELYNPSHKGQVIKACK   83 (127)
T ss_dssp             CSEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEECTTCEE-EEECCSSCSSEEEEECSSSTTCCCCCEE
T ss_pred             CceEeEEEEECCCCCCeEEEEEEEECCEEEEeCCCCCCCcceEEECCceEE-EEccCCCCCceEEEecCCcccccccccc
Confidence            68999999998755  99999999998777888888889999999998611 1111 1345789998764          


Q ss_pred             ------------ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          475 ------------KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       475 ------------r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                                  |+|+|. +.+.++++|+++|+.++
T Consensus        84 ~~~~~~~v~~~~r~~~l~a~s~~e~~~Wi~al~~~i  119 (127)
T 1fgy_A           84 TEADGRVVEGNHVVYRISAPSPEEKEEWMKSIKASI  119 (127)
T ss_dssp             ECTTSCEEECCCSEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccCCcceecCCceEEEEECCCHHHHHHHHHHHHHHh
Confidence                        899998 45689999999999876

>1unq_A RAC-alpha serine/threonine kinase; transferase, pleckstrin homology domain, PKB, AKT, phosphoinositide, serine/threonine-protein kinase; HET: 4IP; 0.98A {Homo sapiens} SCOP: b.55.1.1 PDB: 1h10_A* 1unr_A 2uzs_A* 2uzr_A 2uvm_A* 1unp_A 2x18_A* 1p6s_A

Probab=99.32  E-value=3.8e-13  Score=115.06  Aligned_cols=92  Identities=15%  Similarity=0.207  Sum_probs=71.6

Q ss_pred             ceEEEEEeeehhhhhh--hccceEEeecC-CeEEEECCCCCeeeeeeeccCCCCc-eE---EEEcCCCcEEEE----cCC
Q 010859          406 ESVLMISMVKKLQKLT--SKKVQLILTNK-PKLIYVDPSKLVVKGNIIWSDNSND-LS---IQVSSPSHFKIV----TPK  474 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~--~k~r~~ilt~~-p~l~y~d~~~~~~kg~i~~~~~~~~-~~---~~~~~~~~f~i~----~p~  474 (499)
                      ..++++|||.|+++..  ||+|||||++. -.+||.++.....+|.|||...... ..   .+.+....|.|.    ++.
T Consensus         6 ~~~~~~G~L~K~g~~~k~WkkRwfvL~~~~~L~yy~~~~~~~~~g~i~L~~~~~~~~~~~~~~~~~~~~F~I~~~~~~~~   85 (125)
T 1unq_A            6 VAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTV   85 (125)
T ss_dssp             GCEEEEEEEEEECSSSCCEEEEEEEEETTSEEEEESSCCCSHHHHTSCSEEEECTTCEEEEECSSSTTEEEEEEEETTEE
T ss_pred             CCeeEEeeEEeccCCccCccCcEEEEecCCEEEEEeCCCCCCCCceeEccceeEEeeeecccccCCCCEEEEEecCCCCc
Confidence            4589999999998755  99999999965 4557777777788999999875221 11   222556799998    568


Q ss_pred             ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          475 KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       475 r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      |+|+|. +.+.++++|+++|+.++
T Consensus        86 ~~~~~~a~s~~e~~~Wi~al~~~~  109 (125)
T 1unq_A           86 IERTFHVETPEEREEWTTAIQTVA  109 (125)
T ss_dssp             EEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eeEEEEeCCHHHHHHHHHHHHHHH
Confidence            999999 45589999999999875

>1wgq_A FYVE, rhogef and PH domain containing 6; ethanol decreased 4; pleckstrin homoloy domain, signal transduction, structural genomics; NMR {Mus musculus} SCOP: b.55.1.1

Probab=99.31  E-value=7.7e-13  Score=110.27  Aligned_cols=89  Identities=13%  Similarity=0.172  Sum_probs=71.5

Q ss_pred             ceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE----cCCCcEEEEcCC-ceEE
Q 010859          406 ESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV----SSPSHFKIVTPK-KVLS  478 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~~p~-r~y~  478 (499)
                      +.++++|||.|+++..  ||+|||||++.-..||.++.....+|.|+|+..   ..+..    +.+..|.|.|++ |+|+
T Consensus         6 ~~~~~~G~L~K~~~~~~~Wk~RwfvL~~~~L~yyk~~~~~~~~~~i~L~~~---~~~~~~~~~~~~~~F~i~~~~~~~~~   82 (109)
T 1wgq_A            6 SGSTMSGYLYRSKGSKKPWKHLWFVIKNKVLYTYAASEDVAALESQPLLGF---TVTLVKDENSESKVFQLLHKGMVFYV   82 (109)
T ss_dssp             CSCSCEEEEEEESSTTSCCEEEEEEEETTEEEEESCTTCSSCSEEEECSSE---EEEECCCSSCSSSEEEEEETTEEEEE
T ss_pred             CCCeEEEEEEeCCCCCCCceeEEEEEeCCEEEEECCCCcCccCceEECCCC---EEEECCCCCCCCcEEEEEeCCCeEEE
Confidence            3467899999998754  999999999877778888887889999999986   22222    124689999874 8899


Q ss_pred             EE-cCCccHHHHHHHHHHhc
Q 010859          479 FE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       479 ~~-d~~~~~~~W~~~i~~~~  497 (499)
                      |. +.+.++++|+++|+.+.
T Consensus        83 ~~a~s~~e~~~Wi~al~~a~  102 (109)
T 1wgq_A           83 FKADDAHSTQRWIDAFQEGT  102 (109)
T ss_dssp             EECSSHHHHHHHHHHHHHHH
T ss_pred             EECCCHHHHHHHHHHHHHHh
Confidence            99 55689999999999875

>2da0_A 130-kDa phosphatidylinositol 4,5-biphosphate- dependent ARF1 GTPase-activating protein...; PH domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=99.31  E-value=1.5e-12  Score=109.62  Aligned_cols=88  Identities=9%  Similarity=0.108  Sum_probs=68.0

Q ss_pred             eEEEEEeeehhhh-h--hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEc-C
Q 010859          407 SVLMISMVKKLQK-L--TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFED-A  482 (499)
Q Consensus       407 ~i~~~g~~~k~~g-~--~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d-~  482 (499)
                      .++++|||.|+++ +  .||+|||||++.-..||.++..... |.|++..+  .+.+....+..|.|.||+|+|+|.. .
T Consensus         9 ~~~~~G~L~K~~~~~~k~WkkR~fvL~~~~L~yyk~~~~~~~-~~i~l~~~--~v~~~~~~~~~F~I~~~~r~~~l~a~s   85 (114)
T 2da0_A            9 GSEKKGYLLKKSDGIRKVWQRRKCSVKNGILTISHATSNRQP-AKLNLLTC--QVKPNAEDKKSFDLISHNRTYHFQAED   85 (114)
T ss_dssp             CSCEEEEEEEECSSSCCCEEEEEEEEETTEEEECCSSCCSCC-EEEETTTS--EEEECSSSSSCEEEEETTEEEEEECSS
T ss_pred             CccEEEEEEEeCCCCCCCceeEEEEEeCCEEEEEcCCCCCCC-CEEEeeee--EEEECCCCCCEEEEEcCCcEEEEEcCC
Confidence            3689999999987 3  4999999998877777777665444 55555443  2444445567999999999999994 5


Q ss_pred             CccHHHHHHHHHHhc
Q 010859          483 KQRASQWKKAIEALQ  497 (499)
Q Consensus       483 ~~~~~~W~~~i~~~~  497 (499)
                      +.++++|+++|+.++
T Consensus        86 ~~e~~~Wi~al~~~~  100 (114)
T 2da0_A           86 EQDYVAWISVLTNSK  100 (114)
T ss_dssp             HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHH
Confidence            589999999999875

>2d9y_A Pleckstrin homology domain-containing protein family A member 6; PH domain, PEPP-3, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=99.29  E-value=4.8e-12  Score=106.59  Aligned_cols=91  Identities=15%  Similarity=0.181  Sum_probs=73.1

Q ss_pred             CCceEEEEEeeehhhh-hh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEc-
Q 010859          404 PGESVLMISMVKKLQK-LT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVT-  472 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g-~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~-  472 (499)
                      +++.++++|||.|+++ ..  ||+|||||++.-..||.++.....+|.|+|...    .+..       ..+..|.|.+ 
T Consensus         7 p~~~~~~~G~L~K~~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~----~v~~~~~~~~~~~~~~F~i~~~   82 (117)
T 2d9y_A            7 GNAPVTKAGWLFKQASSGVKQWNKRWFVLVDRCLFYYKDEKEESILGSIPLLSF----RVAAVQPSDNISRKHTFKAEHA   82 (117)
T ss_dssp             SSCCCCEEEEEEEECTTSSSCEEEEEEEEETTEEEEESSTTCCSCCEEEECSSC----EEEECCTTTTCCCSSEEEEECS
T ss_pred             CCCCeeEEEEEEEeCCCCCCCceEEEEEECCCEEEEECCCCCCCcCCEEEeCCe----EEEEcCccccCCCccEEEEEcC
Confidence            4566899999999874 33  999999999887778888888899999999985    2322       2245899975 


Q ss_pred             CCceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          473 PKKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       473 p~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      ++|+|+|. +.+.++++|+++|+.++.
T Consensus        83 ~~r~~~l~a~s~~e~~~Wi~al~~~~~  109 (117)
T 2d9y_A           83 GVRTYFFSAESPEEQEAWIQAMGEAAR  109 (117)
T ss_dssp             SSCEEEEECSSHHHHHHHHHHHHHTTC
T ss_pred             CCcEEEEEcCCHHHHHHHHHHHHHHHh
Confidence            56999999 456899999999999763

>2yry_A Pleckstrin homology domain-containing family A member 6; PH domain, PEPP-3, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=99.28  E-value=7e-12  Score=106.49  Aligned_cols=94  Identities=17%  Similarity=0.199  Sum_probs=73.8

Q ss_pred             CCceEEEEEeeehhhh-h--hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE----cCCCcEEEEcC-Cc
Q 010859          404 PGESVLMISMVKKLQK-L--TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV----SSPSHFKIVTP-KK  475 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g-~--~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~~p-~r  475 (499)
                      ++..++++|||.|+++ .  .||+|||||++.-..||.++.....+|.|+|....+ ..+..    +.+..|.|.++ +|
T Consensus        18 ~~~~~~~~G~L~K~~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~v-~~~~~~~~~~~~~~F~i~~~~~r   96 (122)
T 2yry_A           18 PNAPVTKAGWLFKQASSGVKQWNKRWFVLVDRCLFYYKDEKEESILGSIPLLSFRV-AAVQPSDNISRKHTFKAEHAGVR   96 (122)
T ss_dssp             TTCCEEEEEEEEEECCSSSCCEEEEEEEEETTEEEEESSTTCCSCCEEEESTTCCC-EECCTTCSCSSSSEEEEECSSSC
T ss_pred             CCCCccEEEEEEEECCCCCCCcEEEEEEEeCCEEEEECCCCCCCcccEEEcCCCEE-EEcCccccCCcccEEEEecCCCc
Confidence            4667999999999874 3  399999999987777887888889999999998631 12211    23469999765 79


Q ss_pred             eEEEEc-CCccHHHHHHHHHHhcC
Q 010859          476 VLSFED-AKQRASQWKKAIEALQN  498 (499)
Q Consensus       476 ~y~~~d-~~~~~~~W~~~i~~~~~  498 (499)
                      +|+|.. .+.++++|+++|+.+.+
T Consensus        97 ~~~l~a~s~~e~~~Wi~al~~a~~  120 (122)
T 2yry_A           97 TYFFSAESPEEQEAWIQAMGEAAR  120 (122)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHHHC
T ss_pred             EEEEEcCCHHHHHHHHHHHHHHHh
Confidence            999995 55899999999998764

>1u5e_A SRC-associated adaptor protein; novel dimerization domain, PH domain, signaling protein; 2.60A {Mus musculus} SCOP: b.55.1.1 PDB: 2otx_A

Probab=99.28  E-value=4.6e-12  Score=118.47  Aligned_cols=89  Identities=16%  Similarity=0.203  Sum_probs=73.6

Q ss_pred             eEEEEEeeehhhhh------hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcC
Q 010859          407 SVLMISMVKKLQKL------TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTP  473 (499)
Q Consensus       407 ~i~~~g~~~k~~g~------~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p  473 (499)
                      .++++|||.|+++.      .||+|||||+++...||.++.....+|.|+|...   ..+..       +....|.|.||
T Consensus       105 ~v~k~G~L~Kkg~~~~~~~k~WkkRwfVL~~~~L~Yyk~~~~~~p~g~I~L~~~---~~v~~~~~~~~~~k~~~F~I~t~  181 (211)
T 1u5e_A          105 FVIKAGYLEKRRKDHSFLGFEWQKRWCALSKTVFYYYGSDKDKQQKGEFAIDGY---DVRMNNTLRKDGKKDCCFEICAP  181 (211)
T ss_dssp             SEEEEEEEEEEEHHHHTTTCCCEEEEEEEETTEEEEESSTTCSSCSEEEECTTC---EEEECGGGCSSTTGGGEEEEECS
T ss_pred             CccEEEEEEEECCCCCcCCCCcEeEEEEEECCEEEEEcCCCCccceEEEEeCCc---EEEEcCCccccCCCCCEEEEEcC
Confidence            48999999998863      5999999999988888888888889999999986   33332       22468999998


Q ss_pred             C-ceEEEEc-CCccHHHHHHHHHHhcC
Q 010859          474 K-KVLSFED-AKQRASQWKKAIEALQN  498 (499)
Q Consensus       474 ~-r~y~~~d-~~~~~~~W~~~i~~~~~  498 (499)
                      + |+|+|.. .+.++++|+++|+.+++
T Consensus       182 ~~r~~~l~A~s~~e~~~Wi~aL~~ai~  208 (211)
T 1u5e_A          182 DKRIYQFTAASPKDAEEWVQQLKFILQ  208 (211)
T ss_dssp             SSCEEEEECSSHHHHHHHHHHHHHHHH
T ss_pred             CCCEEEEEcCCHHHHHHHHHHHHHHHH
Confidence            6 9999995 55899999999999863

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.26  E-value=1.3e-11  Score=118.29  Aligned_cols=135  Identities=16%  Similarity=0.171  Sum_probs=99.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCC--ccEEEEEEEcCCeEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFTFQDTFSLY  131 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--Iv~l~~~~~~~~~l~  131 (499)
                      ..+|.+..+.+.|+.+.||++.. .+|..+++|+.....      ...+..|..+++.+.+.+  +.+++.+..+.+..|
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            35677655555677799999964 567889999975431      123566888888875434  556888888888899


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG------------------------------------  175 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~g------------------------------------  175 (499)
                      +||||++|.+|.  ..   ..+   ...++.++...|..||+..                                    
T Consensus        92 ~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999999998883  21   122   2356677777788887643                                    


Q ss_pred             ----------------------cEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          176 ----------------------LIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       176 ----------------------IiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                                            ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                  9999999999999876666799999875

>2j59_M RHO-GTPase activating protein 10; ARF, ARF1, ARFBD, arhgap21, myristate, transport, nucleotide-binding, rhogap protein, hydrolase; HET: GTP; 2.1A {Homo sapiens} SCOP: b.55.1.1 PDB: 2dhj_A

Probab=99.25  E-value=6.3e-12  Score=113.29  Aligned_cols=91  Identities=15%  Similarity=0.196  Sum_probs=62.4

Q ss_pred             EEEEEeee----------hhhhhh--hccceEEeecCCeEEEECCCC--CeeeeeeeccCCCCceEEEE---cCCCcEEE
Q 010859          408 VLMISMVK----------KLQKLT--SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQV---SSPSHFKI  470 (499)
Q Consensus       408 i~~~g~~~----------k~~g~~--~k~r~~ilt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~---~~~~~f~i  470 (499)
                      ++++|||.          |+++..  ||+|||||++.-..||.++..  ...+|.|+|+.....+.+..   +..+.|.|
T Consensus         3 v~~eG~L~~k~~~~~~gkK~g~~~k~WkkRwfvL~~~~L~yyk~~~~~~~~~~g~i~l~~~~~~~~~~~~~~~~~~~F~I   82 (168)
T 2j59_M            3 AAKEGWLHFRPLVTDKGKRVGGSIRPWKQMYVVLRGHSLYLYKDKREQTTPSEEEQPISVNACLIDISYSETKRKNVFRL   82 (168)
T ss_dssp             CCEEEEEEEEECC------------CCEEEEEEEETTEEEEESCTTCC--------CEECSSCEEEECSSSCSCSSEEEE
T ss_pred             CcEEEEEeeeeecccCCcccCCCCCCceEEEEEEeCCEEEEEECCcccccccCCceEecccceEEEeccccCCCCCEEEE
Confidence            57899998          554444  999999999987778888743  57889999998533333332   34679999


Q ss_pred             EcCCceEEEEc-CCccHHHHHHHHHHhcC
Q 010859          471 VTPKKVLSFED-AKQRASQWKKAIEALQN  498 (499)
Q Consensus       471 ~~p~r~y~~~d-~~~~~~~W~~~i~~~~~  498 (499)
                      .|++|+|+|.. .+.++++|+++|+.++.
T Consensus        83 ~t~~r~~~l~A~s~~e~~~Wi~ai~~~~~  111 (168)
T 2j59_M           83 TTSDCECLFQAEDRDDMLAWIKTIQESSN  111 (168)
T ss_dssp             ECSSCEEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             EeCCceEEEEcCCHHHHHHHHHHHHHHHh
Confidence            99999999994 55899999999998763

>2w2x_D 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2; hydrolase, phospholipase C, phosphoinositides, RHO gtpases, RAC, SH2 domain; HET: GSP; 2.30A {Homo sapiens} PDB: 2w2w_A* 2w2x_C* 2k2j_A

Probab=99.24  E-value=9.3e-13  Score=112.66  Aligned_cols=87  Identities=8%  Similarity=0.087  Sum_probs=66.4

Q ss_pred             eEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCC---------CeeeeeeeccCCCCceEEEE------cCCCcEE
Q 010859          407 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSK---------LVVKGNIIWSDNSNDLSIQV------SSPSHFK  469 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~---------~~~kg~i~~~~~~~~~~~~~------~~~~~f~  469 (499)
                      .++++|||.|+++..  ||+|||||++.-..||.++..         ...+|.|+|+.+    .++.      +.+..|.
T Consensus        11 ~~~k~G~L~K~g~~~k~Wk~RwfVL~~~~L~yyk~~~~~~~e~~plg~~~~G~I~L~~~----~v~~~~~~~~~k~~~F~   86 (124)
T 2w2x_D           11 EHKQQGELYMWDSIDQKWTRHFCAIADAKLSFSDDIEQTMEEDNPLGSLCRGILDLNTY----NVVKAPQGKNQKSFVFI   86 (124)
T ss_dssp             --CCEEEEEEEETTTTEEEEEEEEEETTEEEEEEEHHHHHHCSSCCCCSCSEEEEGGGE----EEEECTTCBTTBSEEEE
T ss_pred             hcceeEEEEEECCCCCCceEeEEEEECCEEEEEcccccccccccccCCccccEEECCCC----EEEEccCCcCCCCEEEE
Confidence            368999999988755  999999999887767776421         345899999985    3332      2345899


Q ss_pred             EEcC---CceEEEE-cCCccHHHHHHHHHHhc
Q 010859          470 IVTP---KKVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       470 i~~p---~r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      |.++   .|+|+|. |...++++|+++|.++.
T Consensus        87 I~~~~~~~~~~~~~A~s~ee~~~Wi~ai~~a~  118 (124)
T 2w2x_D           87 LEPKQQGDPPVEFATDKVEELFEWFQSIREIT  118 (124)
T ss_dssp             EEECC--CCCEEEEECCCHHHHHHHHHHHHHH
T ss_pred             EECCCCCCceEEEEECCHHHHHHHHHHHHHHH
Confidence            9876   4899988 56689999999999875

>3tfm_A Myosin X; split PH domain, motor protein; 2.53A {Rattus norvegicus}

Probab=99.24  E-value=1.1e-11  Score=117.53  Aligned_cols=93  Identities=13%  Similarity=0.215  Sum_probs=76.0

Q ss_pred             CceEEEEEeeehhhh-------hhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceE
Q 010859          405 GESVLMISMVKKLQK-------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVL  477 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g-------~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y  477 (499)
                      ...++++||+.|+++       ..||+|||||+++-..||.++.....+|.|+|+.+.. +.........|.|.|++|+|
T Consensus        55 ~~~~~k~G~L~K~g~~~~~~~~k~WkkRwfvL~~~~L~Yyk~~~~~~~~g~I~L~~~~~-v~~~~~k~~~F~I~t~~r~~  133 (228)
T 3tfm_A           55 KQEALKQGWLHNNGGGSSTLSRRNWKKRWFVLRQSKLMYFENDSEEKLKGTVEVRSAKE-IIDNTNKENGIDIIMADRTF  133 (228)
T ss_dssp             CCCSSEEEEEEECGGGCSSSCGGGCEEEEEEECSSEEEEESSTTCCSEEEEEEGGGCSE-EEEETTTTSEEEEECSSCEE
T ss_pred             CCCcceEEEEEEECCCcCCcccCCceEEEEEEeCCEEEEEeCCCCcceeEEEEcCCCEE-eccCCCCCcEEEEEcCCcEE
Confidence            344789999999987       4599999999988777888888789999999998722 22222445789999999999


Q ss_pred             EEE-cCCccHHHHHHHHHHhcC
Q 010859          478 SFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       478 ~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      +|. +.+.++++|+++|++++.
T Consensus       134 ~l~A~s~~e~~~Wv~aL~~~i~  155 (228)
T 3tfm_A          134 HLIAESPEDASQWFSVLSQVHS  155 (228)
T ss_dssp             EEECSSHHHHHHHHHHHHHHHT
T ss_pred             EEEcCCHHHHHHHHHHHHHHHh
Confidence            999 555899999999999864

>2cof_A Protein KIAA1914; PH domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.23  E-value=5.2e-12  Score=104.94  Aligned_cols=90  Identities=11%  Similarity=0.097  Sum_probs=68.2

Q ss_pred             eEEEEEeeehhhhhhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEE--EcCCCcEEEEcC-CceEEEE-cC
Q 010859          407 SVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ--VSSPSHFKIVTP-KKVLSFE-DA  482 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~--~~~~~~f~i~~p-~r~y~~~-d~  482 (499)
                      .++++|||.|+....||+|||||++.-..||.++.. ..+|.|+++..+..+.+.  .+.+..|.|.|+ .|+|+|. +.
T Consensus         7 ~~~~~G~L~K~~~k~Wk~RwfvL~~~~L~yyk~~~~-~~~~~~~i~l~~~~v~~~~~~~~~~~F~i~~~~~r~~~l~A~s   85 (107)
T 2cof_A            7 GLETSSYLNVLVNSQWKSRWCSVRDNHLHFYQDRNR-SKVAQQPLSLVGCEVVPDPSPDHLYSFRILHKGEELAKLEAKS   85 (107)
T ss_dssp             CCTTCCEEEEEETTEEEEEEEEECSSCEEEECSSTT-CSEEEEEECTTTCEEECCCBTTBSCEEEEEETTEEEEEEECSS
T ss_pred             CCcEeEEEEEecCCCcceEEEEEECCEEEEEeCCcc-cCCCeeEEeccceEEEECCCCCCCeEEEEEeCCCeEEEEEcCC
Confidence            457889999984445999999999986667777754 566777777654323222  234579999999 8999999 55


Q ss_pred             CccHHHHHHHHHHhc
Q 010859          483 KQRASQWKKAIEALQ  497 (499)
Q Consensus       483 ~~~~~~W~~~i~~~~  497 (499)
                      +.++++|+++|+.+.
T Consensus        86 ~~e~~~Wi~al~~~~  100 (107)
T 2cof_A           86 SEEMGHWLGLLLSES  100 (107)
T ss_dssp             HHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHHH
Confidence            689999999999875

>2p0d_A RHO GTPase-activating protein 9; protein-phosphoinositide complex, pleckstrin homology domain, ligand binding protein; HET: I3P; 1.81A {Homo sapiens} PDB: 2p0f_A 2p0h_A*

Probab=99.21  E-value=2.9e-11  Score=104.05  Aligned_cols=90  Identities=13%  Similarity=0.181  Sum_probs=69.8

Q ss_pred             ceEEEEEeeehh----hh----hhhccceEEeecCCeEEEECCC-----------CCeeeeeeeccCCCCceEEE---Ec
Q 010859          406 ESVLMISMVKKL----QK----LTSKKVQLILTNKPKLIYVDPS-----------KLVVKGNIIWSDNSNDLSIQ---VS  463 (499)
Q Consensus       406 ~~i~~~g~~~k~----~g----~~~k~r~~ilt~~p~l~y~d~~-----------~~~~kg~i~~~~~~~~~~~~---~~  463 (499)
                      ..++++|+|.|+    +|    -.||+|||||++...+||.|+.           .....|.|+|..+.  +...   .+
T Consensus        10 ~~~~k~G~L~kk~~~~~G~~~~k~Wk~rwfvL~~~~L~yykd~~~~~~~~~~~~~~~~p~g~I~L~~~~--v~~~~~~~k   87 (129)
T 2p0d_A           10 HEVEKSGLLNMTKIAQGGRKLRKNWGPSWVVLTGNSLVFYREPPPTAPSSGWGPAGSRPESSVDLRGAA--LAHGRHLSS   87 (129)
T ss_dssp             CSEEEEEEEEEEEEEETTEECCCCCEEEEEEEESSEEEEESCC--------------CCSEEEECTTCE--EEECTTSCS
T ss_pred             cceeEEEEEEEeeeccCCCcCCCCceEEEEEEeCCEEEEEcCcccccccccccccCCCCccEEEeCCcE--EEECCCCCC
Confidence            358899999984    45    3499999999999999999983           45788999999762  1111   13


Q ss_pred             CCCcEEEEcCC-ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          464 SPSHFKIVTPK-KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       464 ~~~~f~i~~p~-r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      .++.|.|.|++ |+|+|. +.+.++++|+++|+.++
T Consensus        88 r~~~F~l~t~~~~~yl~qA~s~~e~~~Wi~aI~~~i  123 (129)
T 2p0d_A           88 RRNVLHIRTIPGHEFLLQSDHETELRAWHRALRTVI  123 (129)
T ss_dssp             SSSEEEEECTTSCEEEEECSCHHHHHHHHHHHHHHH
T ss_pred             CCcEEEEEcCCCCEEEEECCCHHHHHHHHHHHHHHH
Confidence            35799999985 889998 56689999999999876

>2y7b_A Actin-binding protein anillin; cell cycle; 1.90A {Homo sapiens}

Probab=99.20  E-value=5.7e-12  Score=108.93  Aligned_cols=93  Identities=13%  Similarity=0.185  Sum_probs=69.6

Q ss_pred             CceEEEEEeeehh--hhhh--hccceEEeecCCeEEEECC---CCCeeeeeeeccCCCC-ceEEEE----cCCCcEEEEc
Q 010859          405 GESVLMISMVKKL--QKLT--SKKVQLILTNKPKLIYVDP---SKLVVKGNIIWSDNSN-DLSIQV----SSPSHFKIVT  472 (499)
Q Consensus       405 ~~~i~~~g~~~k~--~g~~--~k~r~~ilt~~p~l~y~d~---~~~~~kg~i~~~~~~~-~~~~~~----~~~~~f~i~~  472 (499)
                      +..++++|||.|+  ++..  ||+|||||++.-..||.++   .....+|.|+|..+.. .+....    +.+..|.|.|
T Consensus         2 ~~~v~~~G~L~K~~~~~~~~~WkrRwfvL~~~~L~yyk~~~d~~~~~p~g~I~L~~~~~~~v~~~~~~~~~~~~~F~i~~   81 (134)
T 2y7b_A            2 NSSVEERGFLTIFEDVSGFGAWHRRWCVLSGNCISYWTYPDDEKRKNPIGRINLANCTSRQIEPANREFCARRNTFELIT   81 (134)
T ss_dssp             CCCCCEEEEEEEEEEETTEEEEEEEEEEEETTEEEEESSHHHHTTSCCSEEEEGGGBCSSSCEECCTTTCCCTTEEEEEE
T ss_pred             CCCceEEeeEEEEcCCCCCCCcEEEEEEEECCEEEEECCCCcccccCceEEEEhhhCccccccccchhhccCCCEEEEEe
Confidence            4457899999998  5544  9999999998855566643   3378899999998632 122221    3467999987


Q ss_pred             --CC------------------ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          473 --PK------------------KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       473 --p~------------------r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                        |+                  |+|+|. +.+.++++|+++|+.++
T Consensus        82 ~~p~~~~~~~~~~~~~~~~~~~r~~~l~A~s~~e~~~Wi~al~~~i  127 (134)
T 2y7b_A           82 VRPQREDDRETLVSQCRDTLCVTKNWLSADTKEERDLWMQKLNQVL  127 (134)
T ss_dssp             EEECCTTCCCCSSEEEETTEEEEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cCCCcccccccccccccCCCceEEEEEECCCHHHHHHHHHHHHHHH
Confidence              55                  589999 55689999999999875

>3lju_X ARF-GAP with dual PH domain-containing protein 1; structural genomics consortium, GTPase activation, SGC, binding, nucleus, phosphoprotein; HET: IP9; 1.70A {Homo sapiens} PDB: 3feh_A* 3fm8_C 3mdb_C*

Probab=99.19  E-value=1.4e-11  Score=125.59  Aligned_cols=91  Identities=15%  Similarity=0.333  Sum_probs=74.9

Q ss_pred             eEEEEEeeehhhhhh---hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cC---CCcEEEEcCC
Q 010859          407 SVLMISMVKKLQKLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SS---PSHFKIVTPK  474 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~---~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~---~~~f~i~~p~  474 (499)
                      .++++||+.|+++.+   ||+|||||++.-..||.++.....+|.|+|........+..      +.   ...|.|+||+
T Consensus       268 ~~~k~G~L~K~g~~~~k~WKkRwFVL~~~~L~YYk~~~d~~~~G~I~L~~~~~~~~v~~~~~~~~~~~~~~~~F~I~t~~  347 (386)
T 3lju_X          268 NYLKEGYMEKTGPKQTEGFRKRWFTMDDRRLMYFKDPLDAFARGEVFIGSKESGYTVLHGFPPSTQGHHWPHGITIVTPD  347 (386)
T ss_dssp             CCSEEEEEEECCTTSCSCCEEEEEEEETTEEEEESSTTCSBCSEEEECCCGGGTCEEEESCCTTCCSCCSCEEEEEECSS
T ss_pred             ccceeeeEEEECCCCCCCCcccEEEEECCEEEEEecCCCcccceEEEeecceeeeeecccCCccccccCCCcEEEEEeCC
Confidence            478999999998765   99999999988888999988888999999987643333332      11   3569999999


Q ss_pred             ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          475 KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       475 r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      |||+|. +.+.++++|+++|+.++
T Consensus       348 rty~l~A~s~~e~~~Wi~aL~~~i  371 (386)
T 3lju_X          348 RKFLFACETESDQREWVAAFQKAV  371 (386)
T ss_dssp             CEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             eEEEEEcCCHHHHHHHHHHHHHHH
Confidence            999999 55589999999999987

>1qqg_A IRS-1, insulin receptor substrate 1; beta-sandwhich, signal transduction; 2.30A {Homo sapiens} SCOP: b.55.1.2 b.55.1.2 PDB: 1irs_A*

Probab=99.18  E-value=1.7e-11  Score=118.39  Aligned_cols=89  Identities=18%  Similarity=0.256  Sum_probs=69.9

Q ss_pred             CceEEEEEeeehhhhhhhccceEEeecCC------eEEEECC-CC-----CeeeeeeeccCCCCceEEEE----cCCCcE
Q 010859          405 GESVLMISMVKKLQKLTSKKVQLILTNKP------KLIYVDP-SK-----LVVKGNIIWSDNSNDLSIQV----SSPSHF  468 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~~k~r~~ilt~~p------~l~y~d~-~~-----~~~kg~i~~~~~~~~~~~~~----~~~~~f  468 (499)
                      .+.++++|||.|+  ..||||||||.+..      +|+|++. ..     ...+|.|+|+.+   ..|..    +....|
T Consensus         7 ~~~v~k~G~L~K~--K~WkkRwFVL~~~~~~G~~~~L~YYk~~~~~~~~~~~p~g~I~L~~~---~~V~~~~~~~~~~~F   81 (264)
T 1qqg_A            7 FSDVRKVGYLRKP--KSMHKRFFVLRAASEAGGPARLEYYENEKKWRHKSSAPKRSIPLESC---FNINKRADSKNKHLV   81 (264)
T ss_dssp             --CEEEEEEEECT--TTCCEEEEEEECCBTTTBSSEEEEESSHHHHHTTCSCCSEEEEGGGE---EEEEEECCSSCSSEE
T ss_pred             CCCccEEEEEEEC--CCCEeEEEEEECCCCCCCCCEEEEECCCccccccccCcceEEEeece---EEEEeccCCCCCcEE
Confidence            3458999999999  57999999999872      7755554 33     479999999986   44433    345799


Q ss_pred             EEEcCCceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          469 KIVTPKKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       469 ~i~~p~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      .|.|+.|+|+|. |.+.++++|+++|+.++.
T Consensus        82 ~I~t~~rty~l~A~se~e~~~Wi~aL~~~~~  112 (264)
T 1qqg_A           82 ALYTRDEHFAIAADSEAEQDSWYQALLQLHN  112 (264)
T ss_dssp             EEEESSCEEEEECSSHHHHHHHHHHHHHHC-
T ss_pred             EEEECCEEEEEEeCCHHHHHHHHHHHHHHHH
Confidence            999999999999 555899999999999763

>4a6h_A Phosphatidylinositol 4,5-bisphosphate-binding Pro SLM1; signaling protein; HET: I4C; 1.45A {Saccharomyces cerevisiae} PDB: 3nsu_A* 4a6f_A* 4a6k_A* 4a6f_B* 4a5k_A

Probab=99.16  E-value=3.6e-11  Score=101.89  Aligned_cols=91  Identities=14%  Similarity=0.179  Sum_probs=68.2

Q ss_pred             CCceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCC---CCeeeeeeeccCCCCceEEEEc-----------CCCc
Q 010859          404 PGESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPS---KLVVKGNIIWSDNSNDLSIQVS-----------SPSH  467 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~---~~~~kg~i~~~~~~~~~~~~~~-----------~~~~  467 (499)
                      +.. ++++|||.|++++.  |++|||||++.-..||.+..   .....|.|+|..+  .+.....           ....
T Consensus         3 p~~-~~k~G~L~Kk~~~~k~W~~rwfVL~~~~L~yyK~~~~~~d~~P~gsI~L~~c--~v~~~~~~~~~~~~~~~~~~~~   79 (120)
T 4a6h_A            3 PFT-EIKSGFLERRSKFLKSYSKGYYVLTPNFLHEFKTADRKKDLVPVMSLALSEC--TVTEHSRKNSTSSPNSTGSDAK   79 (120)
T ss_dssp             CCC-CSEEEEEEEEETTTTEEEEEEEEECSSEEEEESSCCTTTCCSCSEEEEGGGE--EEEEECCCCC---------CCE
T ss_pred             CCc-ccEEEEEEEcCCCCCCCccEEEEEeCCEEEEEcCCCcCcCCCceEEEECCCC--EEEEcccccccccccccCCCcE
Confidence            345 79999999999755  99999999999555666654   4558899999764  2222111           3458


Q ss_pred             EEEEcCC-------ceEEEEc-CCccHHHHHHHHHHhc
Q 010859          468 FKIVTPK-------KVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       468 f~i~~p~-------r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      |.|.++.       ++|+|.. ...++++|+++|..+.
T Consensus        80 F~i~~~~~~~~~~~~~y~f~A~s~~e~~~Wv~aI~~~~  117 (120)
T 4a6h_A           80 FVLHAKQNGIIRRGHNWVFKADSYESMMSWFDNLKILT  117 (120)
T ss_dssp             EEEEESSSSSSCTTCEEEEECSSHHHHHHHHHHHHHHC
T ss_pred             EEEEeCCCCcccCceEEEEEcCCHHHHHHHHHHHHHHh
Confidence            9998654       6999995 5589999999999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=9.2e-11  Score=118.56  Aligned_cols=141  Identities=17%  Similarity=0.243  Sum_probs=106.2

Q ss_pred             eeeeEeeecCceEEEEEEEcCCCceEEEEEEe--CcccchhhHHHHHHHHHHHHHhCC--CCCccEEEEEEEcC---CeE
Q 010859           58 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD--KKFITKENKTAYVKLERIVLDQLD--HPGVVRLFFTFQDT---FSL  130 (499)
Q Consensus        58 ~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~l~~~~~~~---~~l  130 (499)
                      .-++.|+.|.++.||++...  +..+++|+..  .....  .....+.+|..+++.+.  +..+.+++.++.+.   +..
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            35678899999999998763  4688899764  22111  12345677888988886  45578888888776   458


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-------------------------------------  173 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-------------------------------------  173 (499)
                      |+||||++|..+.+..  ...++......++.+++.+|..||+                                     
T Consensus       117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9999999998775422  1247888899999999999999997                                     


Q ss_pred             ---------------------CCcEeeecCCCCeeeCCCCC--EEEEecCCccc
Q 010859          174 ---------------------MGLIHRDIKPENLLLTADGH--IKIADFGSVKP  204 (499)
Q Consensus       174 ---------------------~gIiHrDlKp~NILl~~~~~--vkL~DFG~a~~  204 (499)
                                           .+++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 36899999999999998763  69999999864

>3cxb_B Pleckstrin homology domain-containing family M member 2; SIFA, SKIP, complex, virulence, cytoplasm, membrane, polymorphism, signaling protein; 2.60A {Homo sapiens} PDB: 3hw2_B

Probab=99.14  E-value=4.1e-11  Score=100.44  Aligned_cols=89  Identities=11%  Similarity=0.183  Sum_probs=68.1

Q ss_pred             EEEeeehhhh------hhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCc--eE-EEEcCCCcEEEEc-CCceEEE
Q 010859          410 MISMVKKLQK------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSND--LS-IQVSSPSHFKIVT-PKKVLSF  479 (499)
Q Consensus       410 ~~g~~~k~~g------~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~--~~-~~~~~~~~f~i~~-p~r~y~~  479 (499)
                      ++|||.|++|      -.||+|||||.++-..||.|......+|.|++....+.  .. ...+.++.|.|.+ +.++|+|
T Consensus         2 keG~L~kK~g~~~~~~k~Wk~rwfvL~~~~L~~yk~~~~~~p~~~i~l~~~~~~~~~~~~~~~r~~~F~l~~~~~~~y~f   81 (112)
T 3cxb_B            2 KEGMLHYKAGTSYLGKEHWKTCFVVLSNGILYQYPDRTDVIPLLSVNMGGEQCGGCRRANTTDRPHAFQVILSDRPCLEL   81 (112)
T ss_dssp             EEEEEEECCSCCCSSCCCCEEEEEEEETTEEEEESSSSCCSCSEEEETTC-CEEEEEECCCSSCTTEEEEEETTSCCEEE
T ss_pred             ceEEEEEeCCCCCCCCCCceEEEEEEECCEEEEECCCCCCCccceEEecCCEEEeeeccCCCCCCeEEEEEcCCCCEEEE
Confidence            6899986643      23999999999988888888887888999999965221  00 1124468999985 5899999


Q ss_pred             E-cCCccHHHHHHHHHHhcC
Q 010859          480 E-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       480 ~-d~~~~~~~W~~~i~~~~~  498 (499)
                      . +.+.++++|+++|+.++.
T Consensus        82 ~A~s~ee~~~Wi~ai~~~~~  101 (112)
T 3cxb_B           82 SAESEAEMAEWMQHLCQAVS  101 (112)
T ss_dssp             ECSSHHHHHHHHHHHHHHHT
T ss_pred             EcCCHHHHHHHHHHHHHHhh
Confidence            9 455899999999998763

>2coc_A FYVE, rhogef and PH domain containing protein 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.11  E-value=4.5e-11  Score=99.96  Aligned_cols=85  Identities=13%  Similarity=0.130  Sum_probs=67.5

Q ss_pred             EEEEeeehhhh-hhhccceEEeecC-C-eEE-EECCCCCeeeeeeeccCCCCceEEE-------EcCCCcEEEEcCCceE
Q 010859          409 LMISMVKKLQK-LTSKKVQLILTNK-P-KLI-YVDPSKLVVKGNIIWSDNSNDLSIQ-------VSSPSHFKIVTPKKVL  477 (499)
Q Consensus       409 ~~~g~~~k~~g-~~~k~r~~ilt~~-p-~l~-y~d~~~~~~kg~i~~~~~~~~~~~~-------~~~~~~f~i~~p~r~y  477 (499)
                      +..|+|.|+++ .-||||||||.+. | .|| |.++.....+|.|||...    .|.       ...+..|.|.+++|+|
T Consensus         9 ~~~G~L~k~~~~~~WkkrWfVL~~~~~~~Ly~Yk~~~d~~p~g~I~L~g~----~V~~~~~~~~~~~~~~Fki~~~~~~y   84 (112)
T 2coc_A            9 LLCGPLRLSESGETWSEVWAAIPMSDPQVLHLQGGSQDGRLPRTIPLPSC----KLSVPDPEERLDSGHVWKLQWAKQSW   84 (112)
T ss_dssp             SSEEEEEEESSSSCEEEEEEECCTTCTTCEEEECCTTCSSSCSEECGGGC----EEECCCSSSCCSSSEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCCCceEEEEEEECCCccEEEEECCCCccCcceEEEcCCC----EEEecCcccccCCCCEEEEecCCeEE
Confidence            45699988655 3499999999985 3 454 778888899999999975    333       1235699999999999


Q ss_pred             EEE-cCCccHHHHHHHHHHhc
Q 010859          478 SFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       478 ~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      +|. |.+.++++|+++|+.+.
T Consensus        85 ~f~A~s~e~~~~Wl~al~~A~  105 (112)
T 2coc_A           85 YLSASSAELQQQWLETLSTAA  105 (112)
T ss_dssp             EEEESSHHHHHHHHHHHHHHH
T ss_pred             EEEcCCHHHHHHHHHHHHHHh
Confidence            999 56689999999999864

>1wjm_A Beta-spectrin III; PH domain, signal transduction, structural genomics, spectrin beta chain, brain 2, KIAA0302; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.10  E-value=2.7e-11  Score=103.22  Aligned_cols=91  Identities=19%  Similarity=0.207  Sum_probs=67.2

Q ss_pred             eEEEEEeeehhhhh----------hhccceEEeecCCeEEEECCCCC----eeeeeeeccCCCCceEEE---EcCCCcEE
Q 010859          407 SVLMISMVKKLQKL----------TSKKVQLILTNKPKLIYVDPSKL----VVKGNIIWSDNSNDLSIQ---VSSPSHFK  469 (499)
Q Consensus       407 ~i~~~g~~~k~~g~----------~~k~r~~ilt~~p~l~y~d~~~~----~~kg~i~~~~~~~~~~~~---~~~~~~f~  469 (499)
                      .+.++|+|.|++..          .||+|||||.+.-..||.|+...    ..+|+++++.....+.+.   .+.++.|.
T Consensus         7 ~v~~eG~L~kk~~~~~~gk~~~~~~Wk~rwfvL~~~~L~yyk~~~~~~~~~~~~~~~~i~l~~~~~~~~~~~~~r~~~F~   86 (123)
T 1wjm_A            7 GEQMEGMLCRKQEMEAFGKKAANRSWQNVYCVLRRGSLGFYKDAKAASAGVPYHGEVPVSLARAQGSVAFDYRKRKHVFK   86 (123)
T ss_dssp             CCCEEEEEEEEEEEEETTEECSCCCCEEEEEEEETTEEEEESSHHHHTTTCBSSSCCCEECTTCEEEECTTCSSCSSEEE
T ss_pred             CeEEEEEEEEEEEEeCCCccCCCCCccEEEEEEECCEEEEEEcccccccCcccCCCceEEccCcEEeecccccCCCCEEE
Confidence            36789999987643          39999999999877777776432    346776666543223322   24467999


Q ss_pred             EEcCC-ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          470 IVTPK-KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       470 i~~p~-r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      |.|++ |+|+|. +.+.++++|+++|+.++
T Consensus        87 i~~~~~~~~~f~A~s~~e~~~Wi~ai~~~~  116 (123)
T 1wjm_A           87 LGLQDGKEYLFQAKDEAEMSSWLRVVNAAI  116 (123)
T ss_dssp             EECSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEcCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence            99986 999999 45589999999999875

>2r09_A Cytohesin-3; autoinhibition, GRP1, PIP3, ARF, 3-phosphoinositide, pleckst homology domain, guanine-nucleotide releasing factor, signa protein; HET: 4IP PGE PE5; 1.90A {Mus musculus} SCOP: a.118.3.1 b.55.1.1 PDB: 2r0d_A*

Probab=99.06  E-value=7.4e-11  Score=118.74  Aligned_cols=88  Identities=19%  Similarity=0.207  Sum_probs=71.7

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcC----------
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTP----------  473 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p----------  473 (499)
                      ++++||+.|++|..  ||+|||||++.-..||.++.....+|.|+|..+.  +....  +.+..|.|.+|          
T Consensus       213 ~~k~G~L~K~g~~~k~WkkRwFVL~~~~L~Yyk~~~~~~p~G~I~L~~~~--v~~~~~~~~~~~F~I~~~~~~~~~~~~~  290 (347)
T 2r09_A          213 PDREGWLLKLGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLS--IREVEDPRKPNCFELYNPSHKGQVIKAC  290 (347)
T ss_dssp             CCEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEECTTCE--EEEECCSSCSSEEEEECSSSTTCCCCCE
T ss_pred             cccCCeeEecCCCcccceeEEEEEcCCEEEEEcCCCccCCcEEEEcCCeE--EEEccCCCCCCEEEEEeCCccccccccc
Confidence            48999999999864  9999999999877788888878899999999762  22211  34678999987          


Q ss_pred             ------------CceEEEEc-CCccHHHHHHHHHHhc
Q 010859          474 ------------KKVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       474 ------------~r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                                  .|+|+|.. .+.++++|+++|+.++
T Consensus       291 k~~~~g~~v~~~~r~y~l~A~s~ee~~~Wi~aI~~ai  327 (347)
T 2r09_A          291 KTEADGRVVEGNHVVYRISAPSPEEKEEWMKSIKASI  327 (347)
T ss_dssp             EECTTSCEEECCCSCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cccccccccccCceEEEEECCCHHHHHHHHHHHHHHH
Confidence                        49999994 5589999999999876

>1btn_A Beta-spectrin; signal transduction protein; HET: I3P; 2.00A {Mus musculus} SCOP: b.55.1.1 PDB: 1mph_A

Probab=99.05  E-value=9.2e-11  Score=96.79  Aligned_cols=86  Identities=13%  Similarity=0.206  Sum_probs=60.0

Q ss_pred             EEeeehhh--------hhh--hccceEEeecCCeEEEECCCC----CeeeeeeeccCCCCceEEEE---cCCCcEEEEcC
Q 010859          411 ISMVKKLQ--------KLT--SKKVQLILTNKPKLIYVDPSK----LVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTP  473 (499)
Q Consensus       411 ~g~~~k~~--------g~~--~k~r~~ilt~~p~l~y~d~~~----~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p  473 (499)
                      +|||.|++        +..  ||+|||||++.-..||.|+..    ...++.++++.....+.+..   +.++.|.|.|+
T Consensus         2 eG~L~kk~~~~~~gk~~~~~~Wk~rwfvL~~~~L~yyk~~~~~~~~~~~~~~~~i~l~~~~~~~~~~~~~~~~~F~i~~~   81 (106)
T 1btn_A            2 EGFLNRKHEWEAHNKKASSRSWHNVYCVINNQEMGFYKDAKSAASGIPYHSEVPVSLKEAICEVALDYKKKKHVFKLRLS   81 (106)
T ss_dssp             EEEEEEEEEECSTTCBCSCCCCEEEEEEEETTEEEEESSHHHHHHTCCSSSCCCEECTTCEEEECSSCCSSSSEEEEECT
T ss_pred             ccEEEEEEEEeCCCccCCCCChhEEEEEEECCEEEEEeCCcccccCCCCCCcceEECCCCEEEEcccccCCccEEEEEec
Confidence            68888876        333  999999999876667777642    33345555554322223221   34679999987


Q ss_pred             C-ceEEEEc-CCccHHHHHHHHHHh
Q 010859          474 K-KVLSFED-AKQRASQWKKAIEAL  496 (499)
Q Consensus       474 ~-r~y~~~d-~~~~~~~W~~~i~~~  496 (499)
                      + |+|+|.. .+.++++|+++|+.+
T Consensus        82 ~~~~~~~~A~s~~e~~~Wi~ai~~A  106 (106)
T 1btn_A           82 DGNEYLFQAKDDEEMNTWIQAISSA  106 (106)
T ss_dssp             TSCEEEEECSSHHHHHHHHHHHHHC
T ss_pred             CCCEEEEECCCHHHHHHHHHHHhcC
Confidence            5 9999995 558999999999863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=1.4e-10  Score=114.44  Aligned_cols=193  Identities=16%  Similarity=0.201  Sum_probs=122.5

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCC--ccEEEEEEEcCC---eEEEE
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPG--VVRLFFTFQDTF---SLYMA  133 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~--Iv~l~~~~~~~~---~l~lv  133 (499)
                      ++.++.|....||++.     ..+++|+....     .....+.+|..+|+.+ .+..  +.+++....+..   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            3458999999999873     56899985422     3345677899888877 3322  344554443333   34899


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS----------------------------------------  173 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~----------------------------------------  173 (499)
                      |++++|.+|......  .++.++...++.++...|..||+                                        
T Consensus        95 m~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999999888754432  47888888899999999999986                                        


Q ss_pred             ------------------CCcEeeecCCCCeeeCC--CCCEEEEecCCccccCCccc-cccCCC---CCCCCccccccCc
Q 010859          174 ------------------MGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRI-TVLPNA---ASDDKACTFVGTA  229 (499)
Q Consensus       174 ------------------~gIiHrDlKp~NILl~~--~~~vkL~DFG~a~~~~~~~~-~~~~~~---~~~~~~~~~~Gt~  229 (499)
                                        ..++|+|++|.||+++.  .+.+.|+||+.+....+..- ......   ........+....
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                              13699999999999998  45678999999875322110 000000   0000000000000


Q ss_pred             cCCC-ccccCCCCCCCCCcchhhhHHHHHHhcCCCCCC
Q 010859          230 AYVP-PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK  266 (499)
Q Consensus       230 ~Y~a-PE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~  266 (499)
                      .... |+.....  ....++|++|.++|.+.+|..+|.
T Consensus       253 ~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          253 KHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence            1112 2221111  112489999999999999998863

>3a8p_A T-lymphoma invasion and metastasis-inducing protein 2; guanine nucleotide exchange factor, alternative splicing, cell projection, coiled coil; 2.10A {Mus musculus} PDB: 3a8q_A

Probab=99.01  E-value=6.6e-10  Score=107.22  Aligned_cols=88  Identities=18%  Similarity=0.178  Sum_probs=68.4

Q ss_pred             ceEEEEEeee--------hhhhh------hhccceEEeecCCeEEEECC------CCCeeeeeeeccCCCCceEEEE---
Q 010859          406 ESVLMISMVK--------KLQKL------TSKKVQLILTNKPKLIYVDP------SKLVVKGNIIWSDNSNDLSIQV---  462 (499)
Q Consensus       406 ~~i~~~g~~~--------k~~g~------~~k~r~~ilt~~p~l~y~d~------~~~~~kg~i~~~~~~~~~~~~~---  462 (499)
                      ..++++||+.        |.++.      .||+|||||++.-..||.|+      .....+|.|+|..+    .+..   
T Consensus         9 ~~v~K~G~L~~k~~~~~~K~g~~~~~~~K~WkrRWfVL~~~~L~yyK~~~~~~~~~~~~p~g~I~L~~~----~v~~~~~   84 (263)
T 3a8p_A            9 GVVRKAGWLFFKPLVTLQKERKLELVARRKWKQYWVTLKGCTLLFYETYGKNSTEQNSAPRCALFAEDS----IVQSVPE   84 (263)
T ss_dssp             -CEEEEEEEEEEEEEEEEGGGEEEECTTCCCEEEEEEEETTEEEEESSCCC------CCCSEEEECTTC----EEEECTT
T ss_pred             CCeEEEEEeeecccccccCCCCccCccCCCceEEEEEEcCCEEEEEecCcccccccccCccceEEcCCc----EEEECCc
Confidence            3589999998        66665      39999999999877788874      34567899999854    2322   


Q ss_pred             --cCCCcEEEEc-CCceEEEE-cCCccHHHHHHHHHHhc
Q 010859          463 --SSPSHFKIVT-PKKVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       463 --~~~~~f~i~~-p~r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                        +.++.|.|.| ++|+|+|. |.+.++++|+++|+.+.
T Consensus        85 ~~kk~~~F~I~t~~~r~y~f~A~s~ee~~~Wi~aI~~a~  123 (263)
T 3a8p_A           85 HPKKEHVFCLSNSCGDVYLFQATSQTDLENWVTAIHSAC  123 (263)
T ss_dssp             CSSCSSEEEEECTTSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCCCCEEEEEcCCCcEEEEEcCCHHHHHHHHHHHHHHH
Confidence              3467999999 58999999 55689999999999865

>2q13_A DCC-interacting protein 13 alpha; APPL1, BAR domain, PH domain, BAR-PH domain, protein transpo; 2.05A {Homo sapiens} PDB: 2z0o_A 2elb_A

Probab=98.92  E-value=4.3e-10  Score=115.01  Aligned_cols=90  Identities=10%  Similarity=0.097  Sum_probs=67.7

Q ss_pred             eEEEEEeeehhhhh-----hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-cCCCcEEEEcCC--ceEE
Q 010859          407 SVLMISMVKKLQKL-----TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-SSPSHFKIVTPK--KVLS  478 (499)
Q Consensus       407 ~i~~~g~~~k~~g~-----~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-~~~~~f~i~~p~--r~y~  478 (499)
                      .++++||+.|+++.     .||||||+|.++-..||.+ ......|.|++..+.+ ..++. .....|.|.||+  |||+
T Consensus       277 ~~~k~G~L~K~~~~~~~~~~WkkRwfvL~~~~L~y~k~-~~~~~~~~i~l~~~~v-~~~~~~~r~~~F~i~t~~~~~~~~  354 (385)
T 2q13_A          277 LTRKAGYLNARNKTGLVSSTWDRQFYFTQGGNLMSQAR-GDVAGGLAMDIDNCSV-MAVDCEDRRYCFQITSFDGKKSSI  354 (385)
T ss_dssp             CSCCEEEEEEC--------CCEEEEEEEETTEEEEECS-SCSSCEEEEECTTCEE-EEECCTTCSSEEEEECTTSCBCCC
T ss_pred             CccEEEEEEEecCCCCCcCCceeEEEEEECCEEEEecC-CCcCCCceEEccceEE-EeccccCCCceEEEEeCCCCeEEE
Confidence            46899999998753     3999999999886666666 4556779999987621 12221 334689999998  9999


Q ss_pred             EE-cCCccHHHHHHHHHHhcC
Q 010859          479 FE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       479 ~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      |. +.+.++++|+++|+.++.
T Consensus       355 l~A~s~~e~~~Wi~ai~~~~~  375 (385)
T 2q13_A          355 LQAESKKDHEEWICTINNISK  375 (385)
T ss_dssp             EECSSHHHHHHHHHHHHHHHT
T ss_pred             EEeCCHHHHHHHHHHHHHHHH
Confidence            99 556899999999999764

>3lju_X ARF-GAP with dual PH domain-containing protein 1; structural genomics consortium, GTPase activation, SGC, binding, nucleus, phosphoprotein; HET: IP9; 1.70A {Homo sapiens} PDB: 3feh_A* 3fm8_C 3mdb_C*

Probab=98.87  E-value=1.6e-09  Score=110.36  Aligned_cols=84  Identities=8%  Similarity=0.078  Sum_probs=66.2

Q ss_pred             EEEEeeehhhhhh--hccceEEe--ecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----cCCCcEEEE----cCCc
Q 010859          409 LMISMVKKLQKLT--SKKVQLIL--TNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIV----TPKK  475 (499)
Q Consensus       409 ~~~g~~~k~~g~~--~k~r~~il--t~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~----~p~r  475 (499)
                      +++|||.|+++..  ||+|||||  .++-..||.++...+.+|.|+|...    .+..     .++..|.|.    +++|
T Consensus       147 ~keG~L~KrG~~~k~WkrRwFVL~~~~~~L~Yy~~~~~~~p~g~I~L~~~----~~~~~~~~~~~~~~f~I~~~~~~~~R  222 (386)
T 3lju_X          147 YREGFLWKRGRDNGQFLSRKFVLTEREGALKYFNRNDAKEPKAVMKIEHL----NATFQPAKIGHPHGLQVTYLKDNSTR  222 (386)
T ss_dssp             EEEEEEEEECSSSCCEEEEEEEEETTTTEEEEEC-----CCSEEEEGGGE----EEEECHHHHTSTTCEEEEEEETTEEE
T ss_pred             ccccceeeeccccCCceEEEEEEEcCCCEEEEECCCCccCcccEEEeecc----EEEEcccccCCCceEEEEEecCCCce
Confidence            8999999999865  99999999  6676778888888999999999973    3333     466789887    8899


Q ss_pred             eEEEEcC-CccHHHHHHHHHHh
Q 010859          476 VLSFEDA-KQRASQWKKAIEAL  496 (499)
Q Consensus       476 ~y~~~d~-~~~~~~W~~~i~~~  496 (499)
                      +|+|... ..++.+|+++|..+
T Consensus       223 ~y~l~A~s~~e~~~Wi~aIr~a  244 (386)
T 3lju_X          223 NIFIYHEDGKEIVDWFNALRAA  244 (386)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCHHHHHHHHHhhhhc
Confidence            9999954 58999999999875

>4h8s_A DCC-interacting protein 13-beta; BAR domain, pleckstrin homology domain, adaptor protein, RAB signaling protein; 3.50A {Homo sapiens}

Probab=98.79  E-value=2.7e-09  Score=109.82  Aligned_cols=91  Identities=9%  Similarity=0.079  Sum_probs=67.2

Q ss_pred             CceEEEEEeeehh---hh--hhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCC--c
Q 010859          405 GESVLMISMVKKL---QK--LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPK--K  475 (499)
Q Consensus       405 ~~~i~~~g~~~k~---~g--~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~--r  475 (499)
                      ...+.|+|||.|+   |+  ..|+||||+|.++-..||. .......|.|+|..+  .++...  .....|.|.||+  |
T Consensus       298 ~~~~~k~G~L~k~~~~g~~~~~W~rrwfvl~~~~l~y~~-~~~~~~~~~~~l~~~--~v~~~~~~~r~~cF~i~~~~~~~  374 (407)
T 4h8s_A          298 RNLIQKAGYLNLRNKTGLVTTTWERLYFFTQGGNLMCQP-RGAVAGGLIQDLDNC--SVMAVDCEDRRYCFQITTPNGKS  374 (407)
T ss_dssp             CSCSCCEEEEEEEEECSSSCEEEEEEEEEECSSCEECCC-TTCSSCCCCBCSSCC--EEEEECCTTCSSEEEEECTTSSC
T ss_pred             CCcceeeceeeeeccCCCCCCCceEEEEEEECCEEEEEe-CCCCCCCeEEECCce--EEEECCCCCCCceEEEEecCCCc
Confidence            3457899999887   33  2399999999876554554 455667789998875  233222  234589999985  7


Q ss_pred             eEEEE-cCCccHHHHHHHHHHhcC
Q 010859          476 VLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       476 ~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      ||+|. +.+.++++|+++|++++.
T Consensus       375 ~~~l~A~s~~e~~~Wi~ai~~a~~  398 (407)
T 4h8s_A          375 GIILQAESRKENEEWICAINNISR  398 (407)
T ss_dssp             CEEEECSSSHHHHHHHHHHHHHHS
T ss_pred             eEEEEcCCHHHHHHHHHHHHHHHH
Confidence            99998 667899999999999864

>1dro_A Beta-spectrin; cytoskeleton; NMR {Drosophila melanogaster} SCOP: b.55.1.1

Probab=98.78  E-value=2.9e-09  Score=90.39  Aligned_cols=91  Identities=10%  Similarity=0.117  Sum_probs=65.8

Q ss_pred             EEEEEeeehhhh----------hhhccceEEeecCCeEEEECCCCCeee--------eeeeccCCCCceEEEE-cCCCcE
Q 010859          408 VLMISMVKKLQK----------LTSKKVQLILTNKPKLIYVDPSKLVVK--------GNIIWSDNSNDLSIQV-SSPSHF  468 (499)
Q Consensus       408 i~~~g~~~k~~g----------~~~k~r~~ilt~~p~l~y~d~~~~~~k--------g~i~~~~~~~~~~~~~-~~~~~f  468 (499)
                      +.++|+|.|++.          -.||+|||||.+.-..||.|+.....+        |.|++..+.+....+. +.++.|
T Consensus         8 v~k~G~L~rK~~~~~~gkk~~~~~Wk~rw~vL~~~~L~~yk~~~~~~~~~~~~~~~~~~i~L~~~~v~~~~d~~kr~~~F   87 (122)
T 1dro_A            8 EGHEGYVTRKHEWDSTTKKASNRSWDKVYMAAKAGRISFYKDQKGYKSNPELTFRGEPSYDLQNAAIEIASDYTKKKHVL   87 (122)
T ss_dssp             SSEEEEEEEECSCCCCCCTTCCCCCEEEEEEESSSCCBEESSSSHHHHCTTCCSSCCCBCCCSSCCCEECCSSSSSTTEE
T ss_pred             eEEEEEEEEEEEEeCCCccCCCCCccEEEEEEECCEEEEEeCCcccccCCCcccCCCceEECCCCEEEeCCCCCCCCeEE
Confidence            468889866431          349999999999988899998654432        4566765422111111 446899


Q ss_pred             EEEc-CCceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          469 KIVT-PKKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       469 ~i~~-p~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      .|.| ++|+|+|. +.+.++++|+++|+.++.
T Consensus        88 ~l~t~~~~~~lfqA~s~~e~~~Wi~ai~~~i~  119 (122)
T 1dro_A           88 RVKLANGALFLLQAHDDTEMSQWVTSLKAQSD  119 (122)
T ss_dssp             EEECSSSCEEEEECSSSHHHHHHHHHHHHHHT
T ss_pred             EEEEcCCCEEEEECCCHHHHHHHHHHHHHHHH
Confidence            9997 67999999 566899999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=98.77  E-value=4.1e-09  Score=109.72  Aligned_cols=92  Identities=14%  Similarity=0.218  Sum_probs=64.2

Q ss_pred             eEEEEEeeehhhhhh--hccceEEee-cCCeEEEECCCCCeeeeeeeccCCCCc---e-EEEEcCCCcEEEEcCCceEE-
Q 010859          407 SVLMISMVKKLQKLT--SKKVQLILT-NKPKLIYVDPSKLVVKGNIIWSDNSND---L-SIQVSSPSHFKIVTPKKVLS-  478 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~--~k~r~~ilt-~~p~l~y~d~~~~~~kg~i~~~~~~~~---~-~~~~~~~~~f~i~~p~r~y~-  478 (499)
                      .|+|+||+.|+++.+  ||+|||||+ ++..+||.++.....+|.||++..+..   + ..+...++.|.|.+++.++. 
T Consensus         5 ~v~keG~L~K~g~~~k~Wk~r~fvL~~~~~l~yyk~~~~~~~~~~i~l~~~~~~~~~~~~~~~~~~~~f~I~~~~~~~~~   84 (446)
T 4ejn_A            5 AIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVI   84 (446)
T ss_dssp             CEEEEEEEEEEETTTTEEEEEEEEEETTSBEEEESSCC-------CCCGGGBCTTCEEEEECSSSTTEEEEEEEETTEEE
T ss_pred             eEEEEeeEEeeccccccccceEEEEeeCCEEEEEecCCCCCccCcccccCccccceeecCCCCCCCceeEEEcCCCceee
Confidence            489999999999877  999999998 677778999888888999999985321   1 22223367999998764443 


Q ss_pred             ---EE-cCCccHHHHHHHHHHhcC
Q 010859          479 ---FE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       479 ---~~-d~~~~~~~W~~~i~~~~~  498 (499)
                         +. +...++++|+.+|+.++.
T Consensus        85 ~r~~~~~~~ee~e~W~~ai~~~i~  108 (446)
T 4ejn_A           85 ERTFHVETPEEREEWTTAIQTVAD  108 (446)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             eeEEecCCHHHHHHHHHHHHhhhh
Confidence               33 455789999999998763

>2d9w_A Docking protein 2; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.77  E-value=1.2e-08  Score=84.68  Aligned_cols=90  Identities=17%  Similarity=0.199  Sum_probs=70.7

Q ss_pred             CceEEEEEeeehhhh-hh---hccceEEeec-----CCeEEEECCCCC-----eeeeeeeccCCCCceEEEEcCC-----
Q 010859          405 GESVLMISMVKKLQK-LT---SKKVQLILTN-----KPKLIYVDPSKL-----VVKGNIIWSDNSNDLSIQVSSP-----  465 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g-~~---~k~r~~ilt~-----~p~l~y~d~~~~-----~~kg~i~~~~~~~~~~~~~~~~-----  465 (499)
                      +|-++++|+|.+..- .|   ||||||||+.     .-||-|.|-...     .-+..|.|+.+   ++|...+.     
T Consensus         9 ~e~~vk~G~L~~q~q~~fgkKWrk~w~vLy~~S~~GvaRLE~yd~~ek~~r~~~~rrVIrLsdC---isV~~~~~e~~~p   85 (127)
T 2d9w_A            9 GDGAVKQGFLYLQQQQTFGKKWRRFGASLYGGSDCALARLELQEGPEKPRRCEAARKVIRLSDC---LRVAEAGGEASSP   85 (127)
T ss_dssp             CCCSSEEEEEEECBCSSSSCBCCEEEEEEECCSSSSCCEEEEECCCSCSSSCSCCEEEECGGGE---EEEEECCSCSSSC
T ss_pred             cCccccceEEEecccchhhhhhheeEEEEecCCCCCceeeeeeeccCccccCCCCceEEEhhhC---CeEecccCccCCC
Confidence            566899999987662 33   9999999996     468855554322     34788999998   77777432     


Q ss_pred             ---CcEEEEcCCceEEEEcCCccHHHHHHHHHHhc
Q 010859          466 ---SHFKIVTPKKVLSFEDAKQRASQWKKAIEALQ  497 (499)
Q Consensus       466 ---~~f~i~~p~r~y~~~d~~~~~~~W~~~i~~~~  497 (499)
                         ..|.|.|+.|+|.|.....+..+|+.+|-++.
T Consensus        86 k~~~aF~l~T~er~~~laAe~~E~~~Wi~~ic~~a  120 (127)
T 2d9w_A           86 RDTSAFFLETKERLYLLAAPAAERGDWVQAICLLA  120 (127)
T ss_dssp             SSCEEEEEEESSCEEEEEECHHHHHHHHHHHHHHH
T ss_pred             CcceEEEEEeCCcEEEEEeCcHHHHHHHHHHHHHh
Confidence               68999999999999977778999999998863

>2rov_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus}

Probab=98.76  E-value=3.9e-09  Score=88.86  Aligned_cols=85  Identities=13%  Similarity=0.112  Sum_probs=64.4

Q ss_pred             EEEeeeh--hhhh---hhccceEEeecCCeEEEECCCC---CeeeeeeeccCCCCceEEEEc------------CCCcEE
Q 010859          410 MISMVKK--LQKL---TSKKVQLILTNKPKLIYVDPSK---LVVKGNIIWSDNSNDLSIQVS------------SPSHFK  469 (499)
Q Consensus       410 ~~g~~~k--~~g~---~~k~r~~ilt~~p~l~y~d~~~---~~~kg~i~~~~~~~~~~~~~~------------~~~~f~  469 (499)
                      .+|||.+  ++|.   .|++|+|||++.-.+||.+...   ...+|.|+++..   +.|+..            .+..|.
T Consensus         3 ~eGwl~~pk~~~~~k~~Wkkr~~vL~~~kL~~y~~~~~~~~~~p~~~Idl~~~---~~V~~V~~~d~i~~~~~~~p~iF~   79 (117)
T 2rov_A            3 LEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKL---FHVRPVTQTDVYRADAKEIPRIFQ   79 (117)
T ss_dssp             SEEEEECCCCSSSSCCCCCEEEEEEETTEEEEESCHHHHHTTCCSEEECGGGE---EEEEECCTTTCSSSCTTTGGGEEE
T ss_pred             eEEEEEeecCCCccCCCcEEEEEEEECCEEEEEECCCCcccCCceEEEECccc---EEEEEcccccccccccccCCcEEE
Confidence            3799985  6664   5999999999987767766542   366899999875   554442            135799


Q ss_pred             EEc------CCceEEEEc-CCccHHHHHHHHHHhc
Q 010859          470 IVT------PKKVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       470 i~~------p~r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      |.+      |+|+|+|.. .+.+.++|+.+|.+.+
T Consensus        80 I~~~~~~~~~~~~l~l~A~s~~e~~~WV~aL~~~i  114 (117)
T 2rov_A           80 ILYANEGISSAKNLLLLANSTEEQQKWVSRLVKKI  114 (117)
T ss_dssp             EEECSSSSTTCEEEEEECSSHHHHHHHHHHHHHHC
T ss_pred             EEeCCCCCCCCcEEEEEeCCHHHHHHHHHHHHHHh
Confidence            975      469999985 5689999999999876

>3pp2_A RHO GTPase-activating protein 27; PH domain, GTPase activator, pleckstrin homology domain, STR genomics consortium, SGC, hydrolase activator; HET: CIT; 1.42A {Homo sapiens}

Probab=98.75  E-value=7.6e-09  Score=88.15  Aligned_cols=90  Identities=12%  Similarity=0.111  Sum_probs=65.9

Q ss_pred             eEEEEEeeehhh--------h-hhhccceEEeecCCeEEEECCCCC------------eeeeeeeccCCCCceEEE---E
Q 010859          407 SVLMISMVKKLQ--------K-LTSKKVQLILTNKPKLIYVDPSKL------------VVKGNIIWSDNSNDLSIQ---V  462 (499)
Q Consensus       407 ~i~~~g~~~k~~--------g-~~~k~r~~ilt~~p~l~y~d~~~~------------~~kg~i~~~~~~~~~~~~---~  462 (499)
                      .+.++|+|.++.        + -.|++|||||++.-.+||.|+...            ...|-|+|..+  .+.+-   .
T Consensus         7 ~v~keG~L~rK~~~~~gkk~~~r~W~~~w~VL~~~~L~~yKd~~~~~~~~~~~~~~~~~~~~~i~L~~a--~v~~~~~d~   84 (124)
T 3pp2_A            7 TLDKAGVLHRTKTADKGKRLRKKHWSASWTVLEGGVLTFFKDSKTSAAGGLRQPSKFSTPEYTVELRGA--TLSWAPKDK   84 (124)
T ss_dssp             --CEEEEEEEEEEEETTEECSSCCCEEEEEEEETTEEEEESCSBCC---CBCCGGGGCSEEEEEECTTC--EEEECCGGG
T ss_pred             cEEEEEEEEEEEeccCCccCCCCCceEEEEEEECCEEEEEecCccccccCccCcccccCCcceEEcCCC--EEEeccccc
Confidence            367888887641        2 369999999999888899987654            34577777765  22221   1


Q ss_pred             -cCCCcEEEEcC-CceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          463 -SSPSHFKIVTP-KKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       463 -~~~~~f~i~~p-~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                       +.++.|.|.|+ +++|.|. +.+.++++|+++|+.++.
T Consensus        85 ~krk~vF~l~t~~~~~ylfqA~s~~e~~~Wi~aI~~aI~  123 (124)
T 3pp2_A           85 SSRKNVLELRSRDGSEYLIQHDSEAIISTWHKAIAQGIQ  123 (124)
T ss_dssp             CSSSSEEEEECTTSCEEEEECSCHHHHHHHHHHHHHHHC
T ss_pred             CCCceEEEEECCCCCEEEEECCCHHHHHHHHHHHHHHHh
Confidence             34689999986 5899998 556899999999999874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=6e-07  Score=88.53  Aligned_cols=133  Identities=14%  Similarity=0.213  Sum_probs=94.3

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCC---CccEEEEEEE-cCCeEEEEEe
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP---GVVRLFFTFQ-DTFSLYMALE  135 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---~Iv~l~~~~~-~~~~l~lv~E  135 (499)
                      ++.++.|....||++     |..+++|+-..     ......+..|..+|+.+.+.   .+.+++.+.. ..+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456799999999998     57889998422     23345678899999988642   2455555553 4556789999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-----------------------------------------  174 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~-----------------------------------------  174 (499)
                      +++|..|....-  ..++......++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988866322  1245555555666666666666542                                         


Q ss_pred             -------------------CcEeeecCCCCeeeCC---CCCE-EEEecCCccc
Q 010859          175 -------------------GLIHRDIKPENLLLTA---DGHI-KIADFGSVKP  204 (499)
Q Consensus       175 -------------------gIiHrDlKp~NILl~~---~~~v-kL~DFG~a~~  204 (499)
                                         .++|+|++|.|||++.   ++.+ .|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               3599999999999987   4564 8999998864

>2dtc_A RAL guanine nucleotide exchange factor ralgps1A; PH domain, protein binding, structural genomics, NPPSFA; 1.70A {Mus musculus}

Probab=98.53  E-value=1.2e-07  Score=80.27  Aligned_cols=85  Identities=19%  Similarity=0.266  Sum_probs=64.6

Q ss_pred             EEEEeeehhhhh----hhccceEEeecCCeEEEECCC---------CCeeeeeeeccCCCCceEEEE----cCCCcEEEE
Q 010859          409 LMISMVKKLQKL----TSKKVQLILTNKPKLIYVDPS---------KLVVKGNIIWSDNSNDLSIQV----SSPSHFKIV  471 (499)
Q Consensus       409 ~~~g~~~k~~g~----~~k~r~~ilt~~p~l~y~d~~---------~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~  471 (499)
                      |...++-|+|+.    .||+|||||++.-.+||..+.         +.+..|.|||...    .|+.    +.++.|.|.
T Consensus         7 L~rk~llK~G~k~~~ksWkr~W~vL~g~~L~yf~~~~~~~~~~~~~~~~P~~~i~L~g~----~V~~~e~~~~~~~F~L~   82 (126)
T 2dtc_A            7 LRRKTLLKEGRKPALSSWTRYWVVLSGATLLYYGAKSLRGTDRKHYKSTPGKKVSIVGW----MVQLPDDPEHPDIFQLN   82 (126)
T ss_dssp             EEEEEEEBTTBCCSSCCCEEEEEEEETTEEEEEEBSSSCCSSGGGBCSSCSEEEECTTC----EEECCCCTTSTTEEEEE
T ss_pred             eeeeehhhcCCcccccCcccEEEEEeCCEEEEEcccccccccccccccCCCceEEeCCC----EEEecCCCCCCCEEEEe
Confidence            344455566663    399999999998877777552         4567899999875    3333    456899999


Q ss_pred             cC--CceEEEEc-CCccHHHHHHHHHHhc
Q 010859          472 TP--KKVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       472 ~p--~r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      +|  +.+|.|.. ...++..|+++|..++
T Consensus        83 ~~~~G~~Y~fqA~s~~~~~~W~~ai~~a~  111 (126)
T 2dtc_A           83 NPDKGNVYKFQTGSRFHAILWHKHLDDAC  111 (126)
T ss_dssp             CTTSCSEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eCCCCCEEEEeCCCHHHHHHHHHHHHHHH
Confidence            76  89999995 4589999999999876

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.50  E-value=1.5e-06  Score=83.63  Aligned_cols=137  Identities=17%  Similarity=0.161  Sum_probs=97.4

Q ss_pred             CeeeeeEeeecCce-EEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEE
Q 010859           56 DFELGKIYGVGSYS-KVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        56 ~y~~~~~LG~G~~g-~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .|++. .+..|..| .||+......+..+.+|+-...      ....+..|..+|+.+. +--+.+++.+..+.+..|+|
T Consensus        26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            44543 34455554 7999888777888999986432      3445777888888774 32366788888899999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---------------------------------------  174 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~---------------------------------------  174 (499)
                      ||+++|.++.+.....    ......+..++...|..||..                                       
T Consensus        99 me~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             EECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             EEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            9999998877654432    122334555566666666642                                       


Q ss_pred             -------------------CcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          175 -------------------GLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       175 -------------------gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                                         .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                               15899999999999877767799999875

>3tca_A Amyloid beta A4 precursor protein-binding family 1-interacting protein; RA domain, RBD, PH domain; 2.35A {Mus musculus}

Probab=98.50  E-value=6.2e-08  Score=94.78  Aligned_cols=87  Identities=11%  Similarity=0.095  Sum_probs=66.8

Q ss_pred             EEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE----------cCCCcEEEEcCC--
Q 010859          409 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV----------SSPSHFKIVTPK--  474 (499)
Q Consensus       409 ~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~----------~~~~~f~i~~p~--  474 (499)
                      ..+|||.|+++..  ||+|||||.+....||.++.....+|.|++.... ...+..          ..+..|.|.+|+  
T Consensus       169 ~~~G~L~k~~~~~k~WkkR~fvL~~~~L~yyk~~~~~~~~~~i~l~~l~-~~~v~~~~~~~~~~~~~~~~~F~i~~~~~~  247 (291)
T 3tca_A          169 ELEGALYLKEDGKKSWKRRYFLLRASGIYYVPKGKTKTSRDLACFIQFE-NVNIYYGIQCKMKYKAPTDHCFVLKHPQIQ  247 (291)
T ss_dssp             CCEEEEEEECTTSSCEEEEEEEECSSEEEECCTTCCSSTTTCEEEEEGG-GCEEEEECSHHHHHCCSSSCEEEEECTTCC
T ss_pred             ceEEEEEEeCCCCCCceEEEEEEeCCEEEEEecCccccccCceeeccce-eEEEEecCccccccCCCCCeEEEEEcCCCC
Confidence            5789999988754  9999999998877788888888889999886531 123322          124689998864  


Q ss_pred             ----ceEEEE-cCCccHHHHHHHHHHh
Q 010859          475 ----KVLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       475 ----r~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                          |+|+|. +.+.++..|+.+|.-+
T Consensus       248 ~~~~~~~~l~A~s~~e~~~Wi~air~A  274 (291)
T 3tca_A          248 KESQYIKYLCCDDARTLSQWVMGIRIA  274 (291)
T ss_dssp             SCCTTSEEEECSSHHHHHHHHHHHHHH
T ss_pred             CCCceEEEEECCCHHHHHHHHHHHHHH
Confidence                679999 5568999999999754

>2ys3_A UNC-112-related protein 2; PH domain, kindlin-3, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.45  E-value=1.4e-07  Score=79.98  Aligned_cols=73  Identities=8%  Similarity=0.155  Sum_probs=57.2

Q ss_pred             hccceEEeecCCeEEEECCCCC--eeeeeeeccCCCCceEEEE---cCCCcEEEEcCC----ceEEEE-cCCccHHHHHH
Q 010859          422 SKKVQLILTNKPKLIYVDPSKL--VVKGNIIWSDNSNDLSIQV---SSPSHFKIVTPK----KVLSFE-DAKQRASQWKK  491 (499)
Q Consensus       422 ~k~r~~ilt~~p~l~y~d~~~~--~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p~----r~y~~~-d~~~~~~~W~~  491 (499)
                      ||+|||+|.+.-..||.++...  +..|.|+|..+  ++..++   ..+..|.+.+|.    |+|+|. |.+.+..+|+.
T Consensus        28 ~KrrWFvlk~~~L~YyK~kee~~~ePig~I~L~gc--eV~pd~~~~~~kf~ikl~iPs~~g~r~y~l~cdsEeqy~~WMa  105 (137)
T 2ys3_A           28 YRQHWVVFKETTLSYYKSQDEAPGDPIQQLNLKGC--EVVPDVNVSGQKFCIKLLVPSPEGMSEIYLRCQDEQQYARWMA  105 (137)
T ss_dssp             SCCCEEEECSSCEEEESSTTTTTSCCSCCBCTTTC--EEEECCBGGGTBEEEEEEEECSSSEEEEEEEESSHHHHHHHHH
T ss_pred             ceeEEEEEeCCEEEEECCchhccCCCceEEECCCC--EEeccccccCCceEEEEEccCCCCceEEEEECCCHHHHHHHHH
Confidence            8999999999977788788875  88999999986  344443   223344556675    999999 66799999999


Q ss_pred             HHHHh
Q 010859          492 AIEAL  496 (499)
Q Consensus       492 ~i~~~  496 (499)
                      ++..+
T Consensus       106 A~rlA  110 (137)
T 2ys3_A          106 GCRLA  110 (137)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            98764

>2fjl_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 1; beta-barrel, hydrolase; NMR {Rattus norvegicus} SCOP: b.55.1.1

Probab=98.43  E-value=1.3e-07  Score=81.68  Aligned_cols=88  Identities=15%  Similarity=0.212  Sum_probs=63.2

Q ss_pred             EEEEeeehhhhhh--hccceEEeecCCeEEEEC-------------------C-------C-----C-------------
Q 010859          409 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVD-------------------P-------S-----K-------------  442 (499)
Q Consensus       409 ~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d-------------------~-------~-----~-------------  442 (499)
                      +|.|+|.|+.+..  |++|+|||++. +|||..                   |       .     .             
T Consensus         2 ~k~G~L~~~~~~~~~w~~~~fvL~~~-~L~y~~e~s~~~~~~~~e~~~~~~~~~~~~~~~n~~fh~~~~~~~e~~~~~l~   80 (150)
T 2fjl_A            2 IKNGILYLEDPVNHEWYPHYFVLTSS-KIYYSEETSSDQGNEDEEEPKEASGSTELHSSLEVLFQGPNPAILEPEREHLD   80 (150)
T ss_dssp             CEEEEEEEEETTTTEEEEEEEEEETT-EEEECCCCSCSSCCSCCCCSCCCCCSCCCCCCSSSGGGSSCSTTSCTTCSSSC
T ss_pred             CcceEEEeecCCCCCceEeEEEEECC-EEEEEeeccccccccCcccccccCCchhhcccchhccccCCccccchhHhccc
Confidence            5899999999866  99999999954 555533                   1       0     0             


Q ss_pred             ------CeeeeeeeccCCCCceEEEEc--CCCcEEEEcC---CceEEEE-cCCccHHHHHHHHHHhc
Q 010859          443 ------LVVKGNIIWSDNSNDLSIQVS--SPSHFKIVTP---KKVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       443 ------~~~kg~i~~~~~~~~~~~~~~--~~~~f~i~~p---~r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                            .-++|.|++..+.+++....+  ....|.|.+|   .|+|.|. |...++.+|+++|.++.
T Consensus        81 E~~~lG~l~kG~IdL~gc~V~~~~~~~~~~~~vF~I~~~~~~~~~~~laAds~Eem~dW~kaIreaa  147 (150)
T 2fjl_A           81 ENSPLGDLLRGVLDVPACQIAIRPEGKNNRLFVFSISMPSVAQWSLDVAADSQEELQDWVKKIREVA  147 (150)
T ss_dssp             TTTTTTTCCCEEECSTTCEEEEETTCSSSCSCEEEEECTTTSSCCEEEEESSHHHHHHHHHHHHHHH
T ss_pred             ccccccccccceEecCccEEEeccCCCCCCceEEEEeCCCCCCceEEEEeCCHHHHHHHHHHHHHHH
Confidence                  012799999987222211122  2469999887   4699999 56689999999999975

>2coa_A Protein kinase C, D2 type; protein kinase D2, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=98.40  E-value=4.8e-07  Score=75.07  Aligned_cols=91  Identities=19%  Similarity=0.201  Sum_probs=73.4

Q ss_pred             CceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc----------CCCcEEEEc
Q 010859          405 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS----------SPSHFKIVT  472 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~----------~~~~f~i~~  472 (499)
                      +..+||+||+.+..-.-  +||+-+.|...-..+|.+....+.=-||||+..   +.++..          ..+.|+|.|
T Consensus         5 ~s~vlkeGW~VH~t~~d~~rKRHYWrLD~K~Itlf~~e~~~~~ykeIpL~eI---l~v~~~~~~~~l~~~~~~hcFEi~T   81 (125)
T 2coa_A            5 SSGTLREGWVVHYSNKDTLRKRHYWRLDCKCITLFQNNTTNRYYKEIPLSEI---LTVESAQNFSLVPPGTNPHCFEIVT   81 (125)
T ss_dssp             CCSCSEEEEEEECCSSSCCCEEEEEEECSSEEEEESSSSCSSCSEEEETTTC---CEEEESCCCSSSCTTSCCEEEEEEC
T ss_pred             CCceeecceEEEEccCCccccceeeEecCCeEEEEecCCCCceeeeeehhHe---ecccccccccccCCCCCCceEEEEe
Confidence            45689999998765433  788889999999999998877777788999986   888874          336799999


Q ss_pred             CCceEEEEc----CCcc--------HHHHHHHHHHhcC
Q 010859          473 PKKVLSFED----AKQR--------ASQWKKAIEALQN  498 (499)
Q Consensus       473 p~r~y~~~d----~~~~--------~~~W~~~i~~~~~  498 (499)
                      .++|||+-+    +..+        |..|..+|..++-
T Consensus        82 ~~~~yyVg~~~~~~p~~~sg~g~~~a~~W~~aIrqALm  119 (125)
T 2coa_A           82 ANATYFVGEMPGGTPGGPSGQGAEAARGWETAIRQALM  119 (125)
T ss_dssp             SSCCCCEECCSCCCSSSCCCCCSHHHHHHHHHHHHHGG
T ss_pred             CCeEEEEccCCCCCCCCcCccccHHHHHHHHHHHhhcc
Confidence            999999985    2223        8999999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.32  E-value=7.9e-07  Score=90.79  Aligned_cols=81  Identities=16%  Similarity=0.129  Sum_probs=48.8

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCccc-chh---hHHHHHHHHHHHHHhCCC--CCc-cEEEEEEEcCCeEE
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKE---NKTAYVKLERIVLDQLDH--PGV-VRLFFTFQDTFSLY  131 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--p~I-v~l~~~~~~~~~l~  131 (499)
                      -.+.||.|..+.||++....+++.|++|....... ..+   ........|..+++.+..  |.. .+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            46689999999999997766678999998653211 000   112334567778776632  333 355543  344468


Q ss_pred             EEEeccCCCC
Q 010859          132 MALESCEGGE  141 (499)
Q Consensus       132 lv~E~~~gg~  141 (499)
                      +|||+++|..
T Consensus       112 lvmE~l~g~~  121 (397)
T 2olc_A          112 TVMEDLSHLK  121 (397)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEEeCCCcc
Confidence            9999998743

>2d9z_A Protein kinase C, NU type; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.14  E-value=2.6e-06  Score=70.84  Aligned_cols=90  Identities=20%  Similarity=0.224  Sum_probs=71.8

Q ss_pred             CceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc----------CCCcEEEEc
Q 010859          405 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS----------SPSHFKIVT  472 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~----------~~~~f~i~~  472 (499)
                      +..+||+||+.+..-.-  +||+-+.|...-..+|.+....+.=-||||+..   +.++..          +++.|+|.|
T Consensus         5 ~s~vlkeGWmVH~t~~d~~rKRHYWrLD~K~Itlf~~e~~~k~ykeIpLseI---L~v~~~~~~~~~~~~~~phcFEi~T   81 (129)
T 2d9z_A            5 SSGMVKEGWMVHYTSRDNLRKRHYWRLDSKCLTLFQNESGSKYYKEIPLSEI---LRISSPRDFTNISQGSNPHCFEIIT   81 (129)
T ss_dssp             CTTSEEEEEEEEEESSCCCCEEEEEEEESSCEEEESCSSCCSCCCEECTTTC---CEECCTTCCCCSSSCSCCCSEEEEC
T ss_pred             CCceeecceEEEEccCCccccceeeEecCCeEEEEecCCCCceeceeeHHHh---cccccccCccccCCCCCCceEEEEE
Confidence            55689999988655433  788888999999999998777777778999986   777773          237899999


Q ss_pred             CCceEEEEc-C-----------C----ccHHHHHHHHHHhc
Q 010859          473 PKKVLSFED-A-----------K----QRASQWKKAIEALQ  497 (499)
Q Consensus       473 p~r~y~~~d-~-----------~----~~~~~W~~~i~~~~  497 (499)
                      .++|||+-+ +           +    ..|..|..+|..++
T Consensus        82 ~~~~y~Vge~~~~~~~~~~~~~sg~g~~~a~~We~aIrqAL  122 (129)
T 2d9z_A           82 DTMVYFVGENNGDSSHNPVLAATGVGLDVAQSWEKAIRQAL  122 (129)
T ss_dssp             SSCEEEECBCCSCCSCCTTTTTTTCBHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEccCCCCCCCCccccccccchHHHHHHHHHHHHhc
Confidence            999999974 2           1    35889999999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.09  E-value=2.9e-06  Score=85.13  Aligned_cols=86  Identities=9%  Similarity=-0.052  Sum_probs=54.3

Q ss_pred             eeeeEe-eecCceEEEEEEEc--C----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-C--CCccEEEEEEEcC
Q 010859           58 ELGKIY-GVGSYSKVVRAKKI--D----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-H--PGVVRLFFTFQDT  127 (499)
Q Consensus        58 ~~~~~L-G~G~~g~Vy~a~~~--~----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--p~Iv~l~~~~~~~  127 (499)
                      ...+.| +.|....+|++...  .    ++..+++|+..............+..|..+++.+. +  -.+.+++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            446778 88999999998753  1    25689999764432000000123556777777663 2  2466777777655


Q ss_pred             ---CeEEEEEeccCCCChH
Q 010859          128 ---FSLYMALESCEGGELF  143 (499)
Q Consensus       128 ---~~l~lv~E~~~gg~L~  143 (499)
                         ...|+|||+++|..+.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence               3568999999986654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.08  E-value=2.2e-05  Score=77.71  Aligned_cols=135  Identities=15%  Similarity=0.146  Sum_probs=76.9

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-----CCCCccEEE---EEEEcCCeEE
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-----DHPGVVRLF---FTFQDTFSLY  131 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~l~---~~~~~~~~l~  131 (499)
                      ++.|+.|..+.||++...  +..+++|+....   .    ..+..|..+++.|     ..|.++...   .+..+.+..|
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---E----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC---H----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC---H----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            456677889999999763  345999998652   1    1122344444333     235544310   0123466789


Q ss_pred             EEEeccCCCChH--------------HHHhhc-CCC--C-----------HH--------H-------------------
Q 010859          132 MALESCEGGELF--------------DQITSK-GHL--S-----------ED--------E-------------------  156 (499)
Q Consensus       132 lv~E~~~gg~L~--------------~~i~~~-~~l--~-----------e~--------~-------------------  156 (499)
                      ++|+|++|..+.              ..++.. ..+  +           ..        .                   
T Consensus       108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  187 (346)
T 2q83_A          108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL  187 (346)
T ss_dssp             EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred             EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence            999999986542              111110 001  0           00        0                   


Q ss_pred             ----HHHHHHHHHHHHHHHH-------------HCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          157 ----ARFYTAEVVDALEYIH-------------SMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       157 ----~~~i~~qil~aL~~LH-------------~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                          +..+..++..++.+|+             ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                1112223344566665             2579999999999999888899999999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.77  E-value=7e-05  Score=76.95  Aligned_cols=32  Identities=22%  Similarity=0.308  Sum_probs=27.9

Q ss_pred             HHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       172 H~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      +...++|+|++|.|||++.++ +.|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            356799999999999998876 99999998864

>3a8n_A TIAM-1, T-lymphoma invasion and metastasis-inducing protein 1; guanine nucleotide exchange factor, guanine-nucleotide releasing factor, lipoprotein; 4.50A {Mus musculus}

Probab=97.67  E-value=4.8e-06  Score=80.13  Aligned_cols=77  Identities=13%  Similarity=0.139  Sum_probs=55.1

Q ss_pred             hhccceEEeecCCeEEEECCCCC------eeeeeeeccCCCCceEEE-EcCCCcEEEEcC-CceEEEEc-CCccHHHHHH
Q 010859          421 TSKKVQLILTNKPKLIYVDPSKL------VVKGNIIWSDNSNDLSIQ-VSSPSHFKIVTP-KKVLSFED-AKQRASQWKK  491 (499)
Q Consensus       421 ~~k~r~~ilt~~p~l~y~d~~~~------~~kg~i~~~~~~~~~~~~-~~~~~~f~i~~p-~r~y~~~d-~~~~~~~W~~  491 (499)
                      .|++||+||.+.-.+||.|....      ..+|-|++..+.++...+ .+.++.|.|.|+ +++|.|.. ...+++.|++
T Consensus        38 ~Wkk~w~VLkg~~L~fYKde~~~~~~~~~~p~~~I~L~ga~v~~a~d~~kKk~vF~L~t~~g~~yLFQA~s~eEm~~WI~  117 (279)
T 3a8n_A           38 KWKHYWVSLKGCTLFFYETDGRSGIDHNSVPKHAVWVENSIVQAVPEHPKKDFVFCLSNSLGDAFLFQTTSQTELENWIT  117 (279)
T ss_dssp             CCEEEEEEEETTEECCBCCC--------CCCSSCCBCCSCEECCCTTSSSSCSCCCEEETTTEEEECCCSCHHHHHHHHH
T ss_pred             CCeEEEEEEeCCEEEEEecccccccccccCCCceEeccCcEEEeccccCCCCcEEEEEcCCCCEEEEeCCCHHHHHHHHH
Confidence            49999999998888888887532      235568888762221112 244679999875 78899884 5589999999


Q ss_pred             HHHHhc
Q 010859          492 AIEALQ  497 (499)
Q Consensus       492 ~i~~~~  497 (499)
                      +|+.+.
T Consensus       118 aI~~a~  123 (279)
T 3a8n_A          118 AIHSAC  123 (279)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.66  E-value=0.0003  Score=69.31  Aligned_cols=76  Identities=12%  Similarity=0.032  Sum_probs=58.7

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEEEEEe
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      -.+.|+.|....+|++..  ++..+++|+....      ....+..|...|+.|.   ...+.+++.+.......|+|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            356789999999999975  4678999987543      2455677888887773   3557788888888889999999


Q ss_pred             ccCCCCh
Q 010859          136 SCEGGEL  142 (499)
Q Consensus       136 ~~~gg~L  142 (499)
                      +++|..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.55  E-value=0.00017  Score=70.35  Aligned_cols=132  Identities=17%  Similarity=0.061  Sum_probs=73.0

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEecc-
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSLYMALESC-  137 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-v~l~~~~~~~~~l~lv~E~~-  137 (499)
                      ++.|+.|....+|++      ..+++|+........    .....|..+++.+...++ .+++...  ...-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            778999999999999      568999876431110    112346666665532222 3555443  33346899999 


Q ss_pred             CCCChHHH------------------HhhcC-CC----C-HHHHHHHHHH--------------HHHHHHHHH----H--
Q 010859          138 EGGELFDQ------------------ITSKG-HL----S-EDEARFYTAE--------------VVDALEYIH----S--  173 (499)
Q Consensus       138 ~gg~L~~~------------------i~~~~-~l----~-e~~~~~i~~q--------------il~aL~~LH----~--  173 (499)
                      +|.+|...                  ++..+ .+    + ...+..+...              +...+..+.    .  
T Consensus        91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~  170 (301)
T 3dxq_A           91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP  170 (301)
T ss_dssp             TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence            66544210                  01111 01    1 1111111111              111112111    1  


Q ss_pred             --CCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          174 --MGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       174 --~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                        ..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              23799999999999 5677899999998763

>3hk0_A Growth factor receptor-bound protein 10; GRB10, RA, PH, RAS-associating, pleckstrin-homology, adapter phosphoprotein, SH2 domain; 2.60A {Homo sapiens}

Probab=97.53  E-value=0.00014  Score=69.23  Aligned_cols=91  Identities=12%  Similarity=0.096  Sum_probs=59.3

Q ss_pred             CceEEEEEeeehhhh--hhhccceEEeecCCeEEEECCCCCeeeee---eeccCCCCceEEEE--cC------CCcEEEE
Q 010859          405 GESVLMISMVKKLQK--LTSKKVQLILTNKPKLIYVDPSKLVVKGN---IIWSDNSNDLSIQV--SS------PSHFKIV  471 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g--~~~k~r~~ilt~~p~l~y~d~~~~~~kg~---i~~~~~~~~~~~~~--~~------~~~f~i~  471 (499)
                      +..--.+|++.++++  ..||||||+|.+....||.+......++.   ++++..  .+..-.  ++      +..|.|.
T Consensus       129 s~~P~~~G~L~~ke~~~K~WkkRyfvLr~sgLy~~~k~~sk~~r~l~~~~~L~~~--~vy~~~~~kKk~kaPt~~~F~ik  206 (256)
T 3hk0_A          129 SSSPEIQGFLHVKELGKKSWKKLYVCLRRSGLYCSTKGTSAAPRHLQLLADLEDS--NIFSLIAGRKQYNAPTDHGLCIK  206 (256)
T ss_dssp             TSCEEEEEEEEEECTTSSCEEEEEEEEETTEEEEESSTTCCCGGGEEEEECCTTE--EEEEESSTHHHHCCSSSEEEEEE
T ss_pred             CCCCcceeEEEEecCCCCcceEEEEEEeCCEEEEEecCCCCccccceEEEEcCCC--EEEEecccccccCCCCCCEEEEE
Confidence            444567899987753  55999999999877655444433334343   588763  222221  11      3577877


Q ss_pred             cCC------ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          472 TPK------KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       472 ~p~------r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      .+.      .+|+|. |.+.++++|+.+|..+.
T Consensus       207 ~~k~~~~~~~~~~lcaede~~~~~W~~aIr~ak  239 (256)
T 3hk0_A          207 PNKVRNETKELRLLCAEDEQTRTSWMTAFRLLK  239 (256)
T ss_dssp             ETTCSSCCTTCEEEEESSHHHHHHHHHHHHHHH
T ss_pred             cccccCCCceEEEEEeCCHHHHHHHHHHHHHHH
Confidence            332      359999 55589999999998753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.34  E-value=0.00083  Score=61.95  Aligned_cols=123  Identities=16%  Similarity=0.111  Sum_probs=80.9

Q ss_pred             CChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH-HCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCC
Q 010859          140 GELFDQITSK-GHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  217 (499)
Q Consensus       140 g~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  217 (499)
                      .+|.+++... .+++|++++.++.|.+.+|.-+- ...-..+=+-|..|++..+|.|-+.+ +.+.              
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence            4788888754 67999999999999999988762 12222333457889999999888663 2110              


Q ss_pred             CCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 010859          218 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID  297 (499)
Q Consensus       218 ~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~  297 (499)
                              .....+.|||... ...+.+.=|+|||++||..+--..|=                 .-+..+|+.+..||.
T Consensus        98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~  151 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLID  151 (229)
T ss_dssp             -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHH
T ss_pred             --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHH
Confidence                    1234577888763 34556678999999999988422221                 123458999999999


Q ss_pred             HhhccC
Q 010859          298 RLLDVD  303 (499)
Q Consensus       298 ~lL~~d  303 (499)
                      .|....
T Consensus       152 ~Mt~~~  157 (229)
T 2yle_A          152 HMANTV  157 (229)
T ss_dssp             HHTTCC
T ss_pred             HHHhcc
Confidence            998663

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.28  E-value=0.00061  Score=70.19  Aligned_cols=75  Identities=11%  Similarity=0.018  Sum_probs=49.2

Q ss_pred             eeeEeeecCceEEEEEEEcC-------CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeE
Q 010859           59 LGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSL  130 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~-------t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-v~l~~~~~~~~~l  130 (499)
                      -++.|+.|....||++....       ++..|++|+.....  .   ...+..|..+++.+...++ .++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            35678899999999998753       35789999884321  1   1223358777777743333 567766643    


Q ss_pred             EEEEeccCCCCh
Q 010859          131 YMALESCEGGEL  142 (499)
Q Consensus       131 ~lv~E~~~gg~L  142 (499)
                      .+|+||++|.+|
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            289999987443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.16  E-value=0.00089  Score=67.74  Aligned_cols=140  Identities=16%  Similarity=0.166  Sum_probs=82.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcC-------CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD  126 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~-------t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~  126 (499)
                      ++.+ ++.|..|-...+|++....       ++..|.+|+....    ......+.+|..+++.|. +.-..++++++.+
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence            3444 4567788889999998743       3578999985321    112344557888887774 2223566776654


Q ss_pred             CCeEEEEEeccCCCChHHH----------H-------hhc----C-CC--CHHHHHHHHHHHHH----------------
Q 010859          127 TFSLYMALESCEGGELFDQ----------I-------TSK----G-HL--SEDEARFYTAEVVD----------------  166 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~----------i-------~~~----~-~l--~e~~~~~i~~qil~----------------  166 (499)
                      .    +||||++|..|...          +       ...    + ..  -...+..+..++-.                
T Consensus       126 g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          126 G----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             E----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             c----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence            2    89999998655310          1       111    1 11  13455555544422                


Q ss_pred             ---HHHHHH----H----CCcEeeecCCCCeeeCCC----CCEEEEecCCcc
Q 010859          167 ---ALEYIH----S----MGLIHRDIKPENLLLTAD----GHIKIADFGSVK  203 (499)
Q Consensus       167 ---aL~~LH----~----~gIiHrDlKp~NILl~~~----~~vkL~DFG~a~  203 (499)
                         .+..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..|.
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               233332    2    248999999999999876    789999999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.15  E-value=0.0019  Score=63.25  Aligned_cols=141  Identities=16%  Similarity=0.108  Sum_probs=76.9

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-----CCCccEEE---EEEEcC
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----HPGVVRLF---FTFQDT  127 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~Iv~l~---~~~~~~  127 (499)
                      +..-++.|+.|....||++...  +..+++|+..... .    ...+..|..+++.+.     -|.++...   .+....
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~-~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~   95 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-E----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   95 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             cceEeeccCCCcccceEEEEeC--CccEEEEEeCCCC-C----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence            3345667888999999999763  3378999986531 1    112334555555442     23333210   011234


Q ss_pred             CeEEEEEeccCCCChHH--------------HHhhc-CC--------CCHHHHHH---------------HHHHHHHHHH
Q 010859          128 FSLYMALESCEGGELFD--------------QITSK-GH--------LSEDEARF---------------YTAEVVDALE  169 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~--------------~i~~~-~~--------l~e~~~~~---------------i~~qil~aL~  169 (499)
                      +..+++|++++|..+..              .+... ..        .....-..               +...+...+.
T Consensus        96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~  175 (322)
T 2ppq_A           96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  175 (322)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence            56799999999865311              01110 00        11000000               0112344455


Q ss_pred             HHHH-------CCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          170 YIHS-------MGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       170 ~LH~-------~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      .++.       .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            5553       369999999999999877656899999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.13  E-value=0.001  Score=66.81  Aligned_cols=76  Identities=17%  Similarity=0.020  Sum_probs=43.6

Q ss_pred             eeeEeeecCceEEEEEEEcC--------CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCe
Q 010859           59 LGKIYGVGSYSKVVRAKKID--------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFS  129 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~--------t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-Iv~l~~~~~~~~~  129 (499)
                      -++.|+.|....+|++....        .+..+++|+.....   .. ......|..+++.+...+ ..+++..+  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cc-eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            35577888889999998653        13688999865421   10 111345777777664323 34666554  22 


Q ss_pred             EEEEEeccCCCCh
Q 010859          130 LYMALESCEGGEL  142 (499)
Q Consensus       130 l~lv~E~~~gg~L  142 (499)
                       ++||||++|..+
T Consensus       110 -~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 -GRIEEWLYGDPL  121 (369)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -cEEEEEecCCcC
Confidence             689999988543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.04  E-value=0.0015  Score=64.11  Aligned_cols=135  Identities=16%  Similarity=0.147  Sum_probs=75.1

Q ss_pred             eEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCC--ccEEEEE-----EEcCCeEEEE
Q 010859           61 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFT-----FQDTFSLYMA  133 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--Iv~l~~~-----~~~~~~l~lv  133 (499)
                      ..|+ |....||++.. .+|+.+++|+.......    ...+..|..+++.+...+  +.+++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 88889998764 34668999998633211    233455666666552111  3333322     1234567899


Q ss_pred             EeccCCCChH----H-------H---Hhh---c------CCCCHHHH----H------------------HHHHHHHHHH
Q 010859          134 LESCEGGELF----D-------Q---ITS---K------GHLSEDEA----R------------------FYTAEVVDAL  168 (499)
Q Consensus       134 ~E~~~gg~L~----~-------~---i~~---~------~~l~e~~~----~------------------~i~~qil~aL  168 (499)
                      |++++|..+.    +       .   +..   .      ..++....    .                  ..+.+++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999875431    0       0   110   0      01111110    1                  1111222222


Q ss_pred             HHH----HHCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          169 EYI----HSMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       169 ~~L----H~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      +-+    ....++|+|++|.|||++ + .+.|+||+.+.
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            222    123589999999999998 4 89999999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.02  E-value=0.00098  Score=65.84  Aligned_cols=31  Identities=32%  Similarity=0.597  Sum_probs=27.2

Q ss_pred             CCcEeeecCCCCeeeCCC----CCEEEEecCCccc
Q 010859          174 MGLIHRDIKPENLLLTAD----GHIKIADFGSVKP  204 (499)
Q Consensus       174 ~gIiHrDlKp~NILl~~~----~~vkL~DFG~a~~  204 (499)
                      ..++|||+++.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999875    6899999998864

>4gmv_A RAS-associated and pleckstrin homology domains-CO protein 1; RA-PH, coiled-coil region, RAS-association domain, pleckstri homology domain; 2.40A {Homo sapiens} PDB: 4gn1_A

Probab=96.97  E-value=0.00087  Score=64.47  Aligned_cols=86  Identities=10%  Similarity=0.040  Sum_probs=54.7

Q ss_pred             EEEEeeehhhh--hhhccceEEeecCCeEEEECCCCCee---eeeeeccCCCCceEEEE------c--CCCcEEEEcC--
Q 010859          409 LMISMVKKLQK--LTSKKVQLILTNKPKLIYVDPSKLVV---KGNIIWSDNSNDLSIQV------S--SPSHFKIVTP--  473 (499)
Q Consensus       409 ~~~g~~~k~~g--~~~k~r~~ilt~~p~l~y~d~~~~~~---kg~i~~~~~~~~~~~~~------~--~~~~f~i~~p--  473 (499)
                      -.+|++.++++  ..||||||+|.+....||.+......   .+-++++..  +++.-.      +  .+..|.|..|  
T Consensus       159 e~~G~L~~k~~~~k~WkkRyfvLr~sgLyy~~K~~sk~~r~l~~l~~L~~~--~VY~~~~~kkk~kaPt~~~F~ik~~~~  236 (281)
T 4gmv_A          159 EIEGVLWLKDDGKKSWKKRYFLLRASGIYYVPKGKAKVSRDLVCFLQLDHV--NVYYGQDYRNKYKAPTDYCLVLKHPQI  236 (281)
T ss_dssp             CCEEEEEEECTTSSCEEEEEEEECSSCEEEC---------CCEEEECGGGC--EEEEESSHHHHTCCSCSCEEEEECTTC
T ss_pred             ccEEEEEEECCCCCCCeEEEEEEeCCEEEEEeCCCCCccccceEEEEcCCc--EEEEecccccccCCCCCcEEEEecCcc
Confidence            36788887754  45999999999988765555433334   344577763  233321      1  1458888754  


Q ss_pred             ----CceEEEE-cCCccHHHHHHHHHHh
Q 010859          474 ----KKVLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       474 ----~r~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                          +.+|+|. |.+..+..|+.+|.-+
T Consensus       237 ~~~~~~~~~~caede~~~~~Wv~Air~a  264 (281)
T 4gmv_A          237 QKKSQYIKYLCCDDVRTLHQWVNGIRIA  264 (281)
T ss_dssp             CSCCTTCEEEECSSHHHHHHHHHHHHHH
T ss_pred             CCCCCceEEEEeCCHHHHHHHHHHHHHH
Confidence                3689999 5557999999999754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.92  E-value=0.012  Score=56.77  Aligned_cols=79  Identities=16%  Similarity=0.075  Sum_probs=52.7

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-C--CCccEEEEEEEcCCeEEE
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-H--PGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--p~Iv~l~~~~~~~~~l~l  132 (499)
                      ...-++.+|.|..+.||+++. .+|+.|.+|+......   .....+..|...|+.|. .  --+.+++.+  +.  -++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence            355678899999999999986 4689999997543321   11234667888887773 2  124455543  22  378


Q ss_pred             EEeccCCCCh
Q 010859          133 ALESCEGGEL  142 (499)
Q Consensus       133 v~E~~~gg~L  142 (499)
                      ||||++++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.89  E-value=0.0032  Score=62.57  Aligned_cols=31  Identities=29%  Similarity=0.366  Sum_probs=27.6

Q ss_pred             CCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          174 MGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       174 ~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      ..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3589999999999999888899999988764

>3mpx_A FYVE, rhogef and PH domain-containing protein 5; structural genomics consortium, DH domain, SGC, L binding protein; 2.80A {Homo sapiens}

Probab=96.76  E-value=0.002  Score=66.29  Aligned_cols=101  Identities=17%  Similarity=0.227  Sum_probs=69.7

Q ss_pred             cccccCCCceEEEEEeeehhhhhhhccceEEeecCCeEEEEC--CCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCc
Q 010859          398 WQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVD--PSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKK  475 (499)
Q Consensus       398 ~~~~~~~~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d--~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r  475 (499)
                      |..++.+|...+++|.+.+..+.-.+.|+++|-+.-.++..-  .++-..|+.||++....+.......+..|.|.++++
T Consensus       234 ~~~l~~~~r~li~~g~l~~~~~~~~~~r~~fLF~d~Ll~~k~~~~~~y~~k~~i~L~~l~v~~~~~~~~~~~f~i~~~~~  313 (434)
T 3mpx_A          234 QGDLLQPGREFLKEGTLMKVTGKNRRPRHLFLMNDVLLYTYPQKDGKYRLKNTLAVANMKVSRPVMEKVPYALKIETSES  313 (434)
T ss_dssp             CCCCCCTTCCEEECCEEEEEETTEEEEEEEEEESSEEEEEEECTTSCEEEEEEEEC-----CCCCCTTSCSEEEEECSSC
T ss_pred             ccccccCCcceEecceEEEEeCCCceEEEEEEECCEEEEEEecCCCeEEEEEEEEcCCcEEEecCCCCCCeeEEEecCCe
Confidence            456677888889999988766555677888888875555442  235678899999974221111113368999999999


Q ss_pred             eEEEEcCC-ccHHHHHHHHHHhcC
Q 010859          476 VLSFEDAK-QRASQWKKAIEALQN  498 (499)
Q Consensus       476 ~y~~~d~~-~~~~~W~~~i~~~~~  498 (499)
                      +|.|...+ .+.++|+++|++++.
T Consensus       314 ~~~l~a~s~~ek~~W~~~i~~ai~  337 (434)
T 3mpx_A          314 CLMLSASSCAERDEWYGCLSRALP  337 (434)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHC--
T ss_pred             EEEEecCCHHHHHHHHHHHHHHHH
Confidence            99999655 899999999998763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.70  E-value=0.0085  Score=62.09  Aligned_cols=76  Identities=14%  Similarity=0.144  Sum_probs=48.6

Q ss_pred             eeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEecc
Q 010859           59 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSLYMALESC  137 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-v~l~~~~~~~~~l~lv~E~~  137 (499)
                      -++.|+.|-...+|++....++..|++|+.......-    .....|..+++.|...++ .+++.++.  +.  +||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence            3567888999999999876545789999875431100    012457888888764444 46777763  22  499999


Q ss_pred             CCCCh
Q 010859          138 EGGEL  142 (499)
Q Consensus       138 ~gg~L  142 (499)
                      +|..|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87544

>1v5m_A SH2 and PH domain-containing adapter protein APS; adaptor protein, pleckstrin homology domain, cellular signaling, structural genomics; NMR {Mus musculus} SCOP: b.55.1.1

Probab=96.69  E-value=0.001  Score=55.40  Aligned_cols=75  Identities=17%  Similarity=0.246  Sum_probs=57.4

Q ss_pred             hhhccceEEeecC-----CeE-EEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcCCc-eEEEEcC-Cc
Q 010859          420 LTSKKVQLILTNK-----PKL-IYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTPKK-VLSFEDA-KQ  484 (499)
Q Consensus       420 ~~~k~r~~ilt~~-----p~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p~r-~y~~~d~-~~  484 (499)
                      --|+|++|+|-..     -.| ||..|...+.|..|+++..   ..|..       -+.++|.|.+.++ -|+|+.. +.
T Consensus        40 ~~W~k~RLvL~k~g~G~~y~LEfy~PPkssKpK~~i~cs~I---~EVR~tt~LEmPD~~nTFVlK~~n~~eyi~ea~d~~  116 (136)
T 1v5m_A           40 AQWQKCRLLLRRAVAGERFRLEFFVPPKASRPKVSIPLSAI---IEVRTTMPLEMPEKDNTFVLKVENGAEYILETIDSL  116 (136)
T ss_dssp             CCCEEEEEEEEECSSSCCEEEEEESSTTSSSCSSCEETTTC---CBCCCCCCSSSCCCTTEECCBCTTSCBEEEECSSHH
T ss_pred             cchhheeeEEEEccCCCceEEEEecCCcccCCccccchhhh---hhhhhccccccCCccceEEEEecCCcEEEEEcCCHH
Confidence            3488888888752     344 8888999999999999965   22222       4678999999988 7888844 47


Q ss_pred             cHHHHHHHHHHhc
Q 010859          485 RASQWKKAIEALQ  497 (499)
Q Consensus       485 ~~~~W~~~i~~~~  497 (499)
                      ++..|+..|..-+
T Consensus       117 q~~sWla~Ir~C~  129 (136)
T 1v5m_A          117 QKHSWVADIQGCV  129 (136)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhc
Confidence            9999999997643

>3tfm_A Myosin X; split PH domain, motor protein; 2.53A {Rattus norvegicus}

Probab=96.28  E-value=0.0032  Score=58.89  Aligned_cols=74  Identities=12%  Similarity=0.159  Sum_probs=51.7

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCce-EEEEcC-CCcEEEEcCCceEEEEcCC
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDL-SIQVSS-PSHFKIVTPKKVLSFEDAK  483 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~-~~~~~~-~~~f~i~~p~r~y~~~d~~  483 (499)
                      .-+.|++.|++|+.  ||||||||+++...||.....-.+.|-.--...  .. ..-.++ .++|+|.+++.-+|+.+..
T Consensus        21 ~~~~g~l~~~~~~~~~w~~rw~vl~~~~~~~~~~~~~~~k~G~L~K~g~--~~~~~~~k~WkkRwfvL~~~~L~Yyk~~~   98 (228)
T 3tfm_A           21 PYFHSFLYMNGGLMNSWKRRWCVLKDETFLWFRSKQEALKQGWLHNNGG--GSSTLSRRNWKKRWFVLRQSKLMYFENDS   98 (228)
T ss_dssp             CCEEEEEEECCTTTCCCEEEEEEEETTEEEEESSCCCSSEEEEEEECGG--GCSSSCGGGCEEEEEEECSSEEEEESSTT
T ss_pred             CceEEEEeecCcccccceEEEEEEeCCEEEEeccCCCcceEEEEEEECC--CcCCcccCCceEEEEEEeCCEEEEEeCCC
Confidence            35789999999986  999999999998888888777667676532211  00 000011 3678888888888887654

>1v61_A RAC/CDC42 guanine nucleotide exchange factor (GEF) 6; pleckstrin homology domain, structural genomics; NMR {Mus musculus} SCOP: b.55.1.1

Probab=96.19  E-value=0.011  Score=49.95  Aligned_cols=89  Identities=13%  Similarity=0.258  Sum_probs=62.1

Q ss_pred             CceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCC---CCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcCC
Q 010859          405 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPS---KLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTPK  474 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~---~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p~  474 (499)
                      |+. +..|.|..+.|-.  .+-|.|+|-+.-.||..-..   .-.+||.+|++.    +.|..     ..++.|.|.-+.
T Consensus        26 G~i-i~~s~v~~~~~~~~~~~eR~l~LF~~~Ll~~s~~~~~~~f~~kgklPL~g----~~V~~~ed~~~~~~aFeI~g~~  100 (132)
T 1v61_A           26 GNV-IFMSQVVMQHGACEEKEERYFLLFSSVLIMLSASPRMSGFMYQGKIPIAG----MVVNRLDEIEGSDCMFEITGST  100 (132)
T ss_dssp             CCC-SCEEEEEBCCSSSSCCCEEEEEECSSCEEEEECSSSSSCCEEEEEECTTT----CBCSTTCSSSSSCCCEEEECSS
T ss_pred             CCe-EEEeeEEEEEcccCcceEEEEEEcCCeEEEEEecCCCceEEEEEEEecce----eEEEeccccccCccEEEEecCC
Confidence            543 3444455443322  35699999887776666433   348999999997    45443     245799998765


Q ss_pred             -ceEEEEcCC-ccHHHHHHHHHHhcC
Q 010859          475 -KVLSFEDAK-QRASQWKKAIEALQN  498 (499)
Q Consensus       475 -r~y~~~d~~-~~~~~W~~~i~~~~~  498 (499)
                       +++.+...+ .+.++|+++|+.+++
T Consensus       101 ~~~i~v~~~s~eE~~~Wl~~L~~~i~  126 (132)
T 1v61_A          101 VERIVVHCNNNQDFQEWMEQLNRLTK  126 (132)
T ss_dssp             SCEEEECCCCSHHHHHHHHHHHHHHT
T ss_pred             CceEEEEeCCHHHHHHHHHHHHHHHh
Confidence             888888765 789999999998764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.89  E-value=0.023  Score=58.10  Aligned_cols=76  Identities=16%  Similarity=0.020  Sum_probs=47.2

Q ss_pred             eeeEeeecCceEEEEEEEcCC-------CceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010859           59 LGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        59 ~~~~LG~G~~g~Vy~a~~~~t-------~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l  130 (499)
                      -++.|..|-...+|++.....       +..|++|+.....   +. .....+|..+++.+. +.-..++++.+.  +  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADFP--E--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence            355677888899999987521       5789999864421   11 111345777776663 222345565443  2  


Q ss_pred             EEEEeccCCCCh
Q 010859          131 YMALESCEGGEL  142 (499)
Q Consensus       131 ~lv~E~~~gg~L  142 (499)
                      ++||||++|..|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            688999998654

>4f7h_A Fermitin family homolog 2; beta-barrel, membrane binding, integrin activation, cytoplas membrane, cell adhesion; HET: SRT; 1.90A {Homo sapiens} PDB: 2lko_A*

Probab=95.71  E-value=0.013  Score=51.02  Aligned_cols=71  Identities=14%  Similarity=0.207  Sum_probs=51.6

Q ss_pred             hccceEEeecCCeEEEECCCC--CeeeeeeeccCCCCceEEEE-cCCCcEEE--EcC----CceEEEE-cCCccHHHHHH
Q 010859          422 SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQV-SSPSHFKI--VTP----KKVLSFE-DAKQRASQWKK  491 (499)
Q Consensus       422 ~k~r~~ilt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~-~~~~~f~i--~~p----~r~y~~~-d~~~~~~~W~~  491 (499)
                      ||+|||++-|.-..||..+..  .+..|.|+|.-+  ++.+++ .+...|.|  ..|    .+.|+|. |.+....+|..
T Consensus        66 yKryWFv~kd~~LsyYKskEe~~geP~~~I~LrGC--EVtpDVnva~~Kf~IkL~vP~~~gm~e~~Lrcd~E~qya~WMA  143 (173)
T 4f7h_A           66 YKQYWCTFKDTSISCYKSKEESSGTPAHQMNLRGC--EVTPDVNISGQKFNIKLLIPVAEGMNEIWLRCDNEKQYAHWMA  143 (173)
T ss_dssp             CEEEEEEEETTEEEEESCGGGCSSCCSEEEECTTC--EEEEEEETTTTEEEEEEEEEETTEEEEEEEEESSHHHHHHHHH
T ss_pred             ceeEEEEEeCCEEEEEcCHhHhcCCCceEEecCce--EEeccccccccceeEEEeccCCCCcceeeeecCCHHHHHHHHH
Confidence            899999999988777777765  678899999976  555554 22344433  233    4778888 67789999987


Q ss_pred             HHH
Q 010859          492 AIE  494 (499)
Q Consensus       492 ~i~  494 (499)
                      |..
T Consensus       144 Acr  146 (173)
T 4f7h_A          144 ACR  146 (173)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            754

>3ml4_A Protein DOK-7; tyrosine phosphorylation, adapter protein, dimerization, SIG protein; HET: PTR; 2.60A {Mus musculus}

Probab=95.62  E-value=0.011  Score=53.89  Aligned_cols=87  Identities=17%  Similarity=0.278  Sum_probs=65.3

Q ss_pred             eEEEEEeeehhhhhhhccceEEeec-CC-----eE-EEECCCC----CeeeeeeeccCCCCceEEEE-----cCCCcEEE
Q 010859          407 SVLMISMVKKLQKLTSKKVQLILTN-KP-----KL-IYVDPSK----LVVKGNIIWSDNSNDLSIQV-----SSPSHFKI  470 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~~k~r~~ilt~-~p-----~l-~y~d~~~----~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i  470 (499)
                      ..+-+|.|+.+.|..||+||+||-. .|     +| +|.|...    ...|..|.|..-   +-+|.     +..++.-|
T Consensus         8 ~~v~eg~vk~r~~KkWk~rw~vlrk~s~~adcl~L~vYkd~~dr~k~~~~KaslsL~~~---~GlE~g~~ldk~s~TlAI   84 (224)
T 3ml4_A            8 AALVEGQVKLRDGKKWKSRWLVLRKPSPVADCLLMLVYKDKCERSKGLRERSSLTLEDI---CGLEPALPYEGLAHTLAI   84 (224)
T ss_dssp             CCSEEEEEEEC---CCEEEEEEEECSSTTSSCEEEEEESSSHHHHSCCCCSEEEEECCE---EEEEEEEEETTEEEEEEE
T ss_pred             ceeEEEeeeeecCCceeeEEEEEEcCCCchheEEEEEEcChhhhhcCCcccceeehHHh---cCccccccccCcccEEEE
Confidence            3566799999999999999999987 44     33 7878753    445777888765   55555     44578888


Q ss_pred             EcCCceEEEE-cCCccHHHHHHHHHHh
Q 010859          471 VTPKKVLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       471 ~~p~r~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                      .+...|+.|. |....+.+|...|...
T Consensus        85 Ic~d~~~vLAFds~e~l~~W~~~l~~s  111 (224)
T 3ml4_A           85 ICLSQAVMLGFDSHEAMCAWDTRIRYA  111 (224)
T ss_dssp             EESSCEEEEECSSHHHHHHHHHHHHHH
T ss_pred             EecCcEEEEEeCCHHHHHHHHHHHhhc
Confidence            9999999998 7778999999988754

>4bbk_A Kindlin-1, fermitin family homolog 1; PH domain, cell adhesion; 2.10A {Mus musculus}

Probab=95.55  E-value=0.013  Score=50.49  Aligned_cols=71  Identities=13%  Similarity=0.217  Sum_probs=52.1

Q ss_pred             hccceEEeecCCeEEEECCCC--CeeeeeeeccCCCCceEEEEc-CCCcE--EEEcC----CceEEEE-cCCccHHHHHH
Q 010859          422 SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQVS-SPSHF--KIVTP----KKVLSFE-DAKQRASQWKK  491 (499)
Q Consensus       422 ~k~r~~ilt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~~-~~~~f--~i~~p----~r~y~~~-d~~~~~~~W~~  491 (499)
                      ||+|||++.|.-..||+++..  ....|.|+|..+  ++.+++. +.+.|  ++..|    ...++|. |.+....+|.-
T Consensus        45 fKryWfv~kDt~LsyYKSkEe~~geP~~~inLrGC--EVtPDVnva~~Kf~ikL~ip~~~gm~e~~LrcdsE~QYa~WMA  122 (165)
T 4bbk_A           45 CKQYWFVFKDTSIAYFKNKELEQGEPIEKLNLRGC--EIVPDVNVSGRKFGIKLLIPVADGMNEVYLRCDHEDQYARWMA  122 (165)
T ss_dssp             CEEEEEEEETTEEEEESSGGGTTSCCSEEEECTTC--EEEEEEETTTTEEEEEEEEEETTEEEEEEEEESSHHHHHHHHH
T ss_pred             ceeEEEEEeCCEEEEEcCHHHhcCCCceEEecCcc--EEecccccccceeeEEEecCCCCcceeeeeecCCHHHHHHHHH
Confidence            899999999998888888865  678899999976  5666653 33444  33233    3567777 67789999987


Q ss_pred             HHH
Q 010859          492 AIE  494 (499)
Q Consensus       492 ~i~  494 (499)
                      |..
T Consensus       123 Acr  125 (165)
T 4bbk_A          123 ACI  125 (165)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            754

>1zc3_B Exocyst complex protein EXO84; exocytosis, small GTPase, GTP-binding protein,, signaling protein; HET: GNP; 2.00A {Rattus norvegicus} SCOP: b.55.1.1 PDB: 1zc4_B*

Probab=95.41  E-value=0.089  Score=43.20  Aligned_cols=89  Identities=13%  Similarity=0.165  Sum_probs=61.9

Q ss_pred             CCceEEEEEeeehhhhhh---hccceEEeecCCeEEEECCC-----CCeeeeeeeccCCCCceEEEE-----cCCCcEEE
Q 010859          404 PGESVLMISMVKKLQKLT---SKKVQLILTNKPKLIYVDPS-----KLVVKGNIIWSDNSNDLSIQV-----SSPSHFKI  470 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g~~---~k~r~~ilt~~p~l~y~d~~-----~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i  470 (499)
                      +|.-++++|.+.+...-.   .++++|.|-|. .|+|..+.     ..+....+||..    +.++.     .-.+.|.|
T Consensus         4 pgR~lv~eG~l~el~~~~~k~~~~v~~FLfND-~Ll~a~~~~~~~~~~~~~~~~~L~~----~~v~d~~d~~~~~n~f~i   78 (113)
T 1zc3_B            4 PGQYLVYNGDLVEYEADHMAQLQRVHGFLMND-CLLVATWLPQRRGMYRYNALYPLDR----LAVVNVKDNPPMKDMFKL   78 (113)
T ss_dssp             -CCCEEEEEEEEEEETTTCCEEEEEEEEEESS-EEEEEEEECCTTSCEEEEEEEETTT----CEEEEECCBTTBSSEEEE
T ss_pred             CCeEEEEeCcEEEEccccCCCCccEEEEecCC-EEEEEEEeccCcccEEEEEEEEccc----CEEEECCCCcccceEEEE
Confidence            577888889887754322   34566666665 55555552     136677888887    45543     23689999


Q ss_pred             EcCCceEEEEcC-CccHHHHHHHHHHhc
Q 010859          471 VTPKKVLSFEDA-KQRASQWKKAIEALQ  497 (499)
Q Consensus       471 ~~p~r~y~~~d~-~~~~~~W~~~i~~~~  497 (499)
                      .++.+++.+... ..+-.+|+.+|++++
T Consensus        79 ~~~~~s~~~~aes~~eK~~Wl~~~~~a~  106 (113)
T 1zc3_B           79 LMFPESRIFQAENAKIKREWLEVLEETK  106 (113)
T ss_dssp             EETTEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EeCCceEEEEcCCHHHHHHHHHHHHHHH
Confidence            999999888754 478899999999875

>1dbh_A Protein (human SOS 1); guanine nucleotide exchange factor, gene regulation; 2.30A {Homo sapiens} SCOP: a.87.1.1 b.55.1.1 PDB: 1pms_A 1awe_A

Probab=94.84  E-value=0.13  Score=51.10  Aligned_cols=91  Identities=12%  Similarity=0.222  Sum_probs=65.8

Q ss_pred             ccCCCceEEEEEeeehhhhhhhccceEEeecCCeEEEECC-----------CCCeeeeeeeccCCCCceEEEEc-----C
Q 010859          401 FLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP-----------SKLVVKGNIIWSDNSNDLSIQVS-----S  464 (499)
Q Consensus       401 ~~~~~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~-----------~~~~~kg~i~~~~~~~~~~~~~~-----~  464 (499)
                      ++.++...+++|.+.+. | ..+.|.++|-+.-.++....           ..-..|+.||++.    +.+...     .
T Consensus       240 l~~~~r~li~eG~l~~~-g-~~~~~~~fLF~d~Ll~~k~~~~~~~~~~~~~~~y~~k~~i~l~~----~~v~~~~d~~~~  313 (354)
T 1dbh_A          240 IGQCCNEFIMEGTLTRV-G-AKHERHIFLFDGLMICCKSNHGQPRLPGASNAEYRLKEKFFMRK----VQINDKDDTNEY  313 (354)
T ss_dssp             GGGTCCCEEEEEEEEET-T-CSSCEEEEEESSEEEEEEECTTCCCCTTSCCCSEEEEEEEESCS----CEEEECCCSSSC
T ss_pred             cccccceEEEEeeEEEE-e-cCceEEEEEeCCEEEEEecCCCCCCCCCCCCcceeEEEEEeccc----eEEEeCCccccc
Confidence            44557778999998887 3 45678888877754444432           1335789999997    455442     1


Q ss_pred             CCcEEEEcCC-ceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          465 PSHFKIVTPK-KVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       465 ~~~f~i~~p~-r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      ++.|.|..++ ++|.|...+ .+.++|+++|.++.
T Consensus       314 ~~~F~i~~~~~~~~~l~a~s~~ek~~W~~~i~~~~  348 (354)
T 1dbh_A          314 KHAFEIILKDENSVIFSAKSAEEKNNWMAALISLQ  348 (354)
T ss_dssp             CSEEEECCTTSCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CccEEEecCCCCEEEEEeCCHHHHHHHHHHHHHHH
Confidence            4789998874 899999665 78999999999875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.66  E-value=0.21  Score=50.48  Aligned_cols=29  Identities=24%  Similarity=0.410  Sum_probs=24.9

Q ss_pred             cEeeecCCCCeee------CCCCCEEEEecCCccc
Q 010859          176 LIHRDIKPENLLL------TADGHIKIADFGSVKP  204 (499)
Q Consensus       176 IiHrDlKp~NILl------~~~~~vkL~DFG~a~~  204 (499)
                      ++|+|+.+.|||+      ++++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4457799999998863

>1xcg_A PDZ-rhogef, RHO guanine nucleotide exchange factor 11; X-RAY crystallography, regulation of RHOA GTPase, protein complex; 2.50A {Homo sapiens} SCOP: a.87.1.1 b.55.1.1 PDB: 3kz1_A*

Probab=93.51  E-value=0.22  Score=49.60  Aligned_cols=95  Identities=8%  Similarity=0.113  Sum_probs=62.6

Q ss_pred             ccccCCCceEEEEEeeehhh-hhhhccceEEeecCCeEEEECCC------------------CCeeeeeeeccCCCCceE
Q 010859          399 QQFLDPGESVLMISMVKKLQ-KLTSKKVQLILTNKPKLIYVDPS------------------KLVVKGNIIWSDNSNDLS  459 (499)
Q Consensus       399 ~~~~~~~~~i~~~g~~~k~~-g~~~k~r~~ilt~~p~l~y~d~~------------------~~~~kg~i~~~~~~~~~~  459 (499)
                      ..+..++...+++|.+.+.. +...+.|+++|-+.-.++....+                  +-..++.||++.    +.
T Consensus       244 ~~l~~~~R~li~~G~l~~~~~~~~~~~~~~fLF~d~Ll~~k~~~~k~~~~~~~~~~~~~~~~~~~~~~~i~l~~----~~  319 (368)
T 1xcg_A          244 KSLDLTTRKMIHEGPLTWRISKDKTLDLHVLLLEDLLVLLQKQDEKLLLKCHSKTAVGSSDSKQTFSPVLKLNA----VL  319 (368)
T ss_dssp             GGCCGGGSCEEEEEEEEECCSSSCCCEEEEEEESSEEEEEEECSSCEECCC-------------CCCSEEEGGG----EE
T ss_pred             hhcccccceEEeecceEeeecCCCeeEEEEEcccccHHHhhcccccceeeeccccccCCCCcccCcCCceEccc----ee
Confidence            33434566788999887543 22356677777776555544321                  123478899986    45


Q ss_pred             EEE--cCCCcEEEEcC-----CceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          460 IQV--SSPSHFKIVTP-----KKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       460 ~~~--~~~~~f~i~~p-----~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      ++.  ...+.|.|.+.     .++|.|...+ .+.+.|+++|++++
T Consensus       320 v~~~~~~~~~f~i~~~~~~g~~~~~~l~a~s~~ek~~W~~~i~~ai  365 (368)
T 1xcg_A          320 IRSVATDKRAFFIICTSKLGPPQIYELVALTSSDKNTWMELLEEAV  365 (368)
T ss_dssp             EEECSSCSSEEEEEECCSSSTTCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eecccCCCceEEEEEecCCCCceEEEEEcCCHHHHHHHHHHHHHHH
Confidence            554  34568887643     4899999765 78999999999876

>3t06_A PDZ-rhogef, RHO guanine nucleotide exchange factor 11; DH-PH RHOA complex, pdzrhogef, guanine nucleotide exchange F RHOA, signaling protein; 2.84A {Homo sapiens}

Probab=93.46  E-value=0.22  Score=50.64  Aligned_cols=90  Identities=8%  Similarity=0.124  Sum_probs=63.0

Q ss_pred             CCceEEEEEeeehhhh-hhhccceEEeecCCeEEEECCC------------------CCeeeeeeeccCCCCceEEEE--
Q 010859          404 PGESVLMISMVKKLQK-LTSKKVQLILTNKPKLIYVDPS------------------KLVVKGNIIWSDNSNDLSIQV--  462 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g-~~~k~r~~ilt~~p~l~y~d~~------------------~~~~kg~i~~~~~~~~~~~~~--  462 (499)
                      ++...+++|.+.+..+ .-++.|+++|-+.-.++....+                  ....|+.|+++.    +.+..  
T Consensus       291 ~~r~li~eG~l~~~~~~~~~~~~~~fLF~d~Ll~~k~~~~k~~~~~~~~~~~~~~~~~~~~k~~i~l~~----~~v~~~~  366 (418)
T 3t06_A          291 TTRKMIHEGPLTWRISKDKTLDLHVLLLEDLLVLLQKQDEKLLLKCHSKTAVGSSDSKQTFSPVLKLNA----VLIRSVA  366 (418)
T ss_dssp             GGSCEEEEEEEEECCBTTBCCEEEEEEESSEEEEEEECSSCEECCC-------------CCCSEEEGGG----EEEEECS
T ss_pred             ccceeEEeceEEEEeCCCCeEEEEEEecCCEEEEEEEcCCceEEeecccccccCCCcccccCCceechh----ceecccc
Confidence            4566889999876543 2356788888887777665332                  234568899987    44443  


Q ss_pred             cCCCcEEEEcC-----CceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          463 SSPSHFKIVTP-----KKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       463 ~~~~~f~i~~p-----~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      ...+.|+|...     .++|.|...+ .+.+.|+++|++++
T Consensus       367 ~~~~~f~l~~~~~~~~~~~~~l~A~s~~ek~~W~~~I~~a~  407 (418)
T 3t06_A          367 TDKRAFFIICTSKLGPPQIYELVALTSSDKNTWMELLEEAV  407 (418)
T ss_dssp             SCSSEEEEEECCSSSTTCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccCceEEEEecCCCCCceEEEEEcCCHHHHHHHHHHHHHHH
Confidence            34568888642     3899999765 78999999999986

>2z0q_A XPLN, RHO guanine nucleotide exchange factor 3; DH-PH domain, alternative splicing, cytoplasm, guanine- nucleotide releasing factor; 1.79A {Mus musculus} PDB: 3eo2_A

Probab=93.31  E-value=0.16  Score=50.30  Aligned_cols=90  Identities=14%  Similarity=0.222  Sum_probs=62.4

Q ss_pred             ccCCCceEEEEEeeehhhhhhhccceEEeecCCeEEEECC--CC----CeeeeeeeccCCCCceEEEEcC----------
Q 010859          401 FLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP--SK----LVVKGNIIWSDNSNDLSIQVSS----------  464 (499)
Q Consensus       401 ~~~~~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~--~~----~~~kg~i~~~~~~~~~~~~~~~----------  464 (499)
                      .+.++...+++|.+.+.+|   +.|.++|=+.-.++....  +.    ...|+-||++.    +.++...          
T Consensus       225 l~~~~r~li~~G~l~~~~~---~~~~~fLF~d~Ll~~k~~~~~~~~~~~v~k~~i~l~~----l~v~~~~d~~~~~~~s~  297 (346)
T 2z0q_A          225 LIDSSRVLCCHGELKNNRG---VKLHVFLFQEVLVITRAVTHNEQLCYQLYRQPIPVKD----LTLEDLQDGEVRLGGSL  297 (346)
T ss_dssp             HHHTCCCEEEEEEEEETTS---CEEEEEEESSEEEEEEEEEETTEEEEEESSCCEEGGG----CEEEECCTTTSCCCSCC
T ss_pred             cccCCeEEEEeceeEECCC---cEEEEEECCCcEEEEEEeccCCceeeeeecCCcchhh----ceeeecCCCccccCccc
Confidence            4446777889999987666   677777777654444321  11    12578899987    4555432          


Q ss_pred             ----------CCcEEEEc----CCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          465 ----------PSHFKIVT----PKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       465 ----------~~~f~i~~----p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                                ++.|.|..    ++++|.|...+ .+.+.|+++|++++
T Consensus       298 ~g~~~~~~~~~~~F~i~~~~~~~~~~~~l~a~s~~ek~~W~~~i~~ai  345 (346)
T 2z0q_A          298 RGAFSNNERVKNFFRVSFKNGSQSQTHSLQANDTFNKQQWLNCIRQAK  345 (346)
T ss_dssp             --CCSHHHHTSSEEEEEECCGGGCEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cccccCCcccccceEEEEecCCCCceEEEEECCHHHHHHHHHHHHHhh
Confidence                      35799963    47899999665 78999999999875

>2dfk_A Collybistin II; DH domain, PH domain, cell cycle; 2.15A {Rattus norvegicus} SCOP: a.87.1.1 b.55.1.1

Probab=93.10  E-value=0.36  Score=48.78  Aligned_cols=93  Identities=15%  Similarity=0.224  Sum_probs=64.7

Q ss_pred             ccCCCceEEEEEeeehhhhh--hhccceEEeecCCeEEEECC----CCCeeeeeeeccCCCCceEEEEcC----------
Q 010859          401 FLDPGESVLMISMVKKLQKL--TSKKVQLILTNKPKLIYVDP----SKLVVKGNIIWSDNSNDLSIQVSS----------  464 (499)
Q Consensus       401 ~~~~~~~i~~~g~~~k~~g~--~~k~r~~ilt~~p~l~y~d~----~~~~~kg~i~~~~~~~~~~~~~~~----------  464 (499)
                      ++.++...+++|.+.+..+.  -.+.|.++|-+.-.++....    .....|+.||++.    +.+....          
T Consensus       250 l~~~~r~Li~~G~l~~~~~~~~k~~~r~~fLF~d~Ll~~k~~~~~~~~~~~k~~i~l~~----~~v~~~~d~~~~~~~~~  325 (402)
T 2dfk_A          250 ILDRSSELIYTGEMAWIYQPYGRNQQRVFFLFDHQMVLCKKDLIRRDILYYKGRIDMDK----YEVIDIEDGRDDDFNVS  325 (402)
T ss_dssp             GGGTCCCEEEEEEEEEESSTTCCCEEEEEEEETTEEEEEEECSSCTTCEEEEEEEEGGG----EEEEECCSEECSSSCCE
T ss_pred             ccccccceEEeceEEEEeccCCceEEEEEEeeCCEEEEEEeccccCCceEEeeeeeccc----eEEEecCCCCccccccc
Confidence            34456668889988765431  24568888887766655532    2356899999986    4554421          


Q ss_pred             -CCcEEEEcC--CceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          465 -PSHFKIVTP--KKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       465 -~~~f~i~~p--~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                       ++.|.|..+  .++|.|...+ .+.+.|+++|.+.+
T Consensus       326 ~~~~F~i~~~~~~~~~~l~a~s~~eK~~Wi~~i~~a~  362 (402)
T 2dfk_A          326 MKNAFKLHNKETEEVHLFFAKKLEEKIRWLRAFREER  362 (402)
T ss_dssp             ESSEEEEEESSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cceeEEEEECCCCeEEEEEeCCHHHHHHHHHHHHHHH
Confidence             368999865  5789998655 78999999998754

>3jzy_A Intersectin 2; C2 domain, structural genomics consortium (SGC), endocytosis; 1.56A {Homo sapiens} PDB: 3qbv_B* 1ki1_B

Probab=91.33  E-value=0.037  Score=57.88  Aligned_cols=87  Identities=18%  Similarity=0.250  Sum_probs=0.0

Q ss_pred             CceEEEEEeeehhhhhhhccceEEeecCCeEEEECCCCC--------------------eeeeeeeccCCCCceEEEE--
Q 010859          405 GESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKL--------------------VVKGNIIWSDNSNDLSIQV--  462 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~~~~--------------------~~kg~i~~~~~~~~~~~~~--  462 (499)
                      +...+++|.+.|.++  .+.|+++|-+.-.++.. +.+.                    ..|+.|+++..    .+..  
T Consensus       250 ~r~li~eG~l~~~~~--~~~~~~fLF~d~Ll~~k-~~~~~~~~~g~~~~f~~~~~~~~~v~k~~i~l~~~----~v~~~~  322 (510)
T 3jzy_A          250 PRKLLHSGKLYKTKS--NKELHGFLFNDFLLLTY-MVKQFAVSSGSEKLFSSKSNAQFKMYKTPIFLNEV----LVKLPT  322 (510)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             cceeEEeceEEEcCC--CcEEEEEcccceeEEee-ecccccccCCcccccCcccccceeEEcCceehhhe----EEeccC
Confidence            456778888876543  46777777766554443 2211                    24788998874    3332  


Q ss_pred             ---cCCCcEEEEcCCceEEEEcCC-ccHHHHHHHHHHhcC
Q 010859          463 ---SSPSHFKIVTPKKVLSFEDAK-QRASQWKKAIEALQN  498 (499)
Q Consensus       463 ---~~~~~f~i~~p~r~y~~~d~~-~~~~~W~~~i~~~~~  498 (499)
                         ..+..|.|..+.|+|.|..++ .+.++|+++|++++.
T Consensus       323 d~~~~~~~F~i~~~~~~~~l~a~s~~ek~~W~~~i~~ai~  362 (510)
T 3jzy_A          323 DPSSDEPVFHISHIDRVYTLRTDNINERTAWVQKIKAASE  362 (510)
T ss_dssp             ----------------------------------------
T ss_pred             CCCccccceeeeccceeEEeccCCHHHHHHHHHHHHHHHH
Confidence               235799999999999999655 789999999998653

>2pz1_A RHO guanine nucleotide exchange factor 4; helical bundle, beta barrel, beta sandwich, signaling protei; 2.25A {Homo sapiens} PDB: 2dx1_A 3nmz_D 3nmx_D

Probab=90.98  E-value=0.74  Score=47.38  Aligned_cols=91  Identities=12%  Similarity=0.173  Sum_probs=62.9

Q ss_pred             CCCceEEEEEeeehhhhh--hhccceEEeecCCeEEEECC----CCCeeeeeeeccCCCCceEEEEcC-----------C
Q 010859          403 DPGESVLMISMVKKLQKL--TSKKVQLILTNKPKLIYVDP----SKLVVKGNIIWSDNSNDLSIQVSS-----------P  465 (499)
Q Consensus       403 ~~~~~i~~~g~~~k~~g~--~~k~r~~ilt~~p~l~y~d~----~~~~~kg~i~~~~~~~~~~~~~~~-----------~  465 (499)
                      .++...+++|.+.+..+.  -.+.|+++|-+.-.++....    .....|+.||++.    +.+....           +
T Consensus       329 ~~~r~li~~G~l~~~~~~~~~~~~r~~fLF~d~Ll~~k~~~~~~~~~~~k~~i~l~~----~~v~~~~d~~~~~~~~~~~  404 (466)
T 2pz1_A          329 VRSSELIYSGELTRVTQPQAKSQQRMFFLFDHQLIYCKKDLLRRDVLYYKGRLDMDG----LEVVDLEDGKDRDLHVSIK  404 (466)
T ss_dssp             HHCSCEEEEEEEEEECTTTCCEEEEEEEEETTEEEEEEECSSCTTCEEEEEEEETTT----CEEEECCSBSCCSSCCCBC
T ss_pred             cccceeEEeeeEEEEecCCCCeeEEEEEEECCEEEEEEeccccCCceEEeeeeeccc----eEEEeCCCCcccccccccc
Confidence            345567888988765431  24568888887766555532    2456799999987    4554321           2


Q ss_pred             CcEEEEcC--CceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          466 SHFKIVTP--KKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       466 ~~f~i~~p--~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      +.|.|..+  .++|.|...+ .+.+.|+++|.+.+
T Consensus       405 ~~F~i~~~~~~~~~~l~a~s~~eK~~W~~~i~~a~  439 (466)
T 2pz1_A          405 NAFRLHRGATGDSHLLCTRKPEQKQRWLKAFARER  439 (466)
T ss_dssp             EEEEEECSSSCCEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             eeEEEEeCCCCeEEEEEeCCHHHHHHHHHHHHHHH
Confidence            57999865  5789888655 78999999998864

>2lg1_A A-kinase anchor protein 13; metal binding protein; NMR {Homo sapiens}

Probab=90.48  E-value=0.46  Score=42.52  Aligned_cols=88  Identities=11%  Similarity=0.107  Sum_probs=54.2

Q ss_pred             CceEEEEEeee-hhhhhhhccceEEeecCCeEEEECCCCCee--------eeeeeccCCCCceEEEE--cCCCcEEEEcC
Q 010859          405 GESVLMISMVK-KLQKLTSKKVQLILTNKPKLIYVDPSKLVV--------KGNIIWSDNSNDLSIQV--SSPSHFKIVTP  473 (499)
Q Consensus       405 ~~~i~~~g~~~-k~~g~~~k~r~~ilt~~p~l~y~d~~~~~~--------kg~i~~~~~~~~~~~~~--~~~~~f~i~~p  473 (499)
                      +...+++|.+. |...--++.|.++|-+.-.++.. +...+.        ..-|++..    +.|..  ...+.|++...
T Consensus        68 ~R~Ll~eG~L~~k~~~~~~~d~~~fLf~D~Ll~~~-~~~~ky~~~~~~~~~pvi~L~~----~~vre~a~d~~~~fli~~  142 (185)
T 2lg1_A           68 RKKLVRDGSVFLKNAAGRLKEVQAVLLTDILVFLQ-EKDQKYIFASLDQKSTVISLKK----LIVREVAHEEKGLFLISM  142 (185)
T ss_dssp             TSCEEEEEEEEEECTTCCEEEEEEEEESSEEECCE-EETTEEECCCCSSSCSEEESSS----CEEECCSSCSSEEEEECC
T ss_pred             CCceeeeceEEEeccCCCeeeEEEEeecCEEEEEE-ecCCEEEEEcccCCCCeEeecc----eEEeccCCCCCeEEEEEe
Confidence            45689999986 32211346677666665333332 211111        24577776    34544  34466766642


Q ss_pred             ----CceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          474 ----KKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       474 ----~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                          .+.|-|...+ .+...|+++|.+++
T Consensus       143 ~~~g~~~yel~a~s~~er~~W~~~I~~Ai  171 (185)
T 2lg1_A          143 GMTDPEMVEVHASSKEERNSWIQIIQDTI  171 (185)
T ss_dssp             SSSCCCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cCCCCeEEEEEcCCHHHHHHHHHHHHHHH
Confidence                4899999765 89999999999865

>1mai_A Phospholipase C delta-1; pleckstrin, inositol trisphosphate, signal transduction protein, hydrolase; HET: I3P; 1.90A {Rattus norvegicus} SCOP: b.55.1.1

Probab=90.22  E-value=0.55  Score=39.42  Aligned_cols=74  Identities=14%  Similarity=0.199  Sum_probs=52.6

Q ss_pred             hccceEEeecCCeEEEEC--CC-CCeeeeeeeccCCCCceEEEEcC--------------CCcEEEEcCC--ceEEEEcC
Q 010859          422 SKKVQLILTNKPKLIYVD--PS-KLVVKGNIIWSDNSNDLSIQVSS--------------PSHFKIVTPK--KVLSFEDA  482 (499)
Q Consensus       422 ~k~r~~ilt~~p~l~y~d--~~-~~~~kg~i~~~~~~~~~~~~~~~--------------~~~f~i~~p~--r~y~~~d~  482 (499)
                      .|.|.|+|++...++|..  |. ....++.|+++..   -.|....              ...|.|+-.+  ++-+|..+
T Consensus        28 ~k~r~f~l~~~~~~~w~~s~~~~~~~~~~~i~i~~I---~eIr~G~~s~~~~~~~~~~~~~~~FsIiy~~~~k~LdlvA~  104 (131)
T 1mai_A           28 RRERFYKLQEDCKTIWQESRKVMRSPESQLFSIEDI---QEVRMGHRTEGLEKFARDIPEDRCFSIVFKDQRNTLDLIAP  104 (131)
T ss_dssp             EEEEEEEECTTSSEEEECCCCTTCCTTTTEEEGGGE---EEEEESSCSHHHHHHCTTSCGGGEEEEEESSSCCCEEEECS
T ss_pred             ceeEEEEECCCCCEEEeCCcCCCCCCcCcEEEHhhh---HHHHCCCCCHHHHhhhhcCCccceEEEEECCCCceEEEEeC
Confidence            367999999977777773  32 2346799999974   4555532              1358887554  57788765


Q ss_pred             C-ccHHHHHHHHHHhcC
Q 010859          483 K-QRASQWKKAIEALQN  498 (499)
Q Consensus       483 ~-~~~~~W~~~i~~~~~  498 (499)
                      + .+|+.|+..|+.++.
T Consensus       105 s~~e~~~Wv~gL~~L~~  121 (131)
T 1mai_A          105 SPADAQHWVQGLRKIIH  121 (131)
T ss_dssp             SHHHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHHH
Confidence            5 899999999998763

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.88  E-value=0.44  Score=43.65  Aligned_cols=116  Identities=15%  Similarity=0.143  Sum_probs=79.9

Q ss_pred             CCCCCccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC
Q 010859          112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  191 (499)
Q Consensus       112 l~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~  191 (499)
                      ..||+++.. .+-.+++.+.+.++.-+.+-=+..+.+   ++......++.+|+....++  ..-+|--|+|+||+++.+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~---~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS---FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG---SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh---cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence            368999977 455666777777776543322333443   78899999999998877444  445888999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcch-hhhHHHHHHhcCCCCCC
Q 010859          192 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLW-ALGCTLYQMLSGTSPFK  266 (499)
Q Consensus       192 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiw-slG~ilyelltG~~Pf~  266 (499)
                      +.+++.-.|+-..+                           +|.-     .+ ..|.| .+=|++..+++++..|.
T Consensus       116 ~~p~i~~RGik~~l---------------------------~P~~-----~~-ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          116 GLPIAKTRGLQNVV---------------------------DPLP-----VS-EAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             SCEEESCCEETTTB---------------------------SCCC-----CC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCEEEEEccCccCC---------------------------CCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999877764322                           2211     11 12333 47788899999888873

>1txd_A RHO guanine nucleotide exchange factor 12; helical bundle (DH), beta sandwich (PH), signaling protein; 2.13A {Homo sapiens} SCOP: a.87.1.1 b.55.1.1 PDB: 1x86_A

Probab=89.33  E-value=0.59  Score=46.82  Aligned_cols=90  Identities=7%  Similarity=0.082  Sum_probs=56.2

Q ss_pred             CCceEEEEEeeehhhh-hhhccceEEeecCCeEEEECCC------------------CCeeeeeeeccCCCCceEEEEc-
Q 010859          404 PGESVLMISMVKKLQK-LTSKKVQLILTNKPKLIYVDPS------------------KLVVKGNIIWSDNSNDLSIQVS-  463 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g-~~~k~r~~ilt~~p~l~y~d~~------------------~~~~kg~i~~~~~~~~~~~~~~-  463 (499)
                      ++...+++|.+.++.+ .-.+.|.++|-+.-.++....+                  ....++.|+++.    +.++.. 
T Consensus       253 ~~R~li~eG~l~~~~~~~~~~~~~~fLF~d~Ll~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~l~~----~~v~~~~  328 (385)
T 1txd_A          253 TKRKMIHEGPLVWKVNRDKTIDLYTLLLEDILVLLQKQDDRLVLRCHSKILASTADSKHTFSPVIKLST----VLVRQVA  328 (385)
T ss_dssp             GGSCEEEEEEEEEESSSSCBCCEEEEEESSEEEEEEEETTEEECCC-------------CCCSEEEGGG----EEEEECC
T ss_pred             ccceEEEECcEEEEcCCCCeEEEEEEecCCeeEEEEecCCeeEEeeccccccccCCCCcCCCCceeccc----ccccccc
Confidence            4566788898874422 2245677777666554433211                  123578899986    455442 


Q ss_pred             -CCCcEEEEc----CCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          464 -SPSHFKIVT----PKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       464 -~~~~f~i~~----p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                       ..+.|++.+    +.++|.|...+ .+.+.|+++|.+++
T Consensus       329 ~d~~~~f~i~~~~~~~~~~~l~a~s~~ek~~W~~~i~~~i  368 (385)
T 1txd_A          329 TDNKALFVISMSDNGAQIYELVAQTVSEKTVWQDLICRMA  368 (385)
T ss_dssp             C-CCEEEEEEECSSCEEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cCCceEEEEEEcCCCceEEEEEcCCHHHHHHHHHHHHHHH
Confidence             234555543    35899998665 78999999999875

>3qwm_A Iqsec1, IQ motif and SEC7 domain-containing protein 1; structural genomics, structural genomics consortium, SGC; 2.39A {Homo sapiens}

Probab=89.17  E-value=3.7  Score=34.68  Aligned_cols=79  Identities=11%  Similarity=0.210  Sum_probs=57.0

Q ss_pred             ehhhhhhhccceEEeecCCeEEEE---CC---CCCeeeeeeeccCCCCceEEEEc----CCCcEEEEcC--C----ceEE
Q 010859          415 KKLQKLTSKKVQLILTNKPKLIYV---DP---SKLVVKGNIIWSDNSNDLSIQVS----SPSHFKIVTP--K----KVLS  478 (499)
Q Consensus       415 ~k~~g~~~k~r~~ilt~~p~l~y~---d~---~~~~~kg~i~~~~~~~~~~~~~~----~~~~f~i~~p--~----r~y~  478 (499)
                      .|..+.-...|+|.|=|.-.||-+   ++   ++-..++-+|+..    +++..-    -++.|.|..+  +    ++..
T Consensus        26 ~K~~~kg~qqR~~FLFND~LL~TK~~~kkk~~~~Y~vr~~~~L~g----m~V~~~e~e~~p~~~~l~s~~~G~~~k~~i~  101 (140)
T 3qwm_A           26 NKPQKLGLHQREIFLFNDLLVVTKIFQKKKNSVTYSFRQSFSLYG----MQVLLFENQYYPNGIRLTSSVPGADIKVLIN  101 (140)
T ss_dssp             TSCCCTTTTEEEEEEESSCEEEEECCC---CCCCCCCEEEECCTT----EEEEEECCSSCTTEEEEEECCTTSCCEEEEE
T ss_pred             cccccccccceEEEEecchhhheeecccCCCCCceEEEEEeeecc----eEEEcccCCCCceEEEEEecCCCCcceEEEE
Confidence            466555567899988887776654   11   3467788999886    666653    3578888754  3    7788


Q ss_pred             EEcCC-ccHHHHHHHHHHhc
Q 010859          479 FEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       479 ~~d~~-~~~~~W~~~i~~~~  497 (499)
                      |..++ .++..|+++|.+.+
T Consensus       102 ~~A~s~~ER~rwi~dL~esI  121 (140)
T 3qwm_A          102 FNAPNPQDRKKFTDDLRESI  121 (140)
T ss_dssp             EECSSHHHHHHHHHHHHHHH
T ss_pred             EECCCHHHHHHHHHHHHHHH
Confidence            88665 79999999998875

>3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A

Probab=88.04  E-value=1.7  Score=45.71  Aligned_cols=96  Identities=6%  Similarity=0.112  Sum_probs=62.3

Q ss_pred             cccccCCCceEEEEEeeehhhhh-hhccceEEeecCCeEEEECCCC------------------CeeeeeeeccCCCCce
Q 010859          398 WQQFLDPGESVLMISMVKKLQKL-TSKKVQLILTNKPKLIYVDPSK------------------LVVKGNIIWSDNSNDL  458 (499)
Q Consensus       398 ~~~~~~~~~~i~~~g~~~k~~g~-~~k~r~~ilt~~p~l~y~d~~~------------------~~~kg~i~~~~~~~~~  458 (499)
                      |..+...+...|++|.+.++.+- -++.|+++|-+.-.|+......                  ...++.|+++.    +
T Consensus       402 ~~~ldl~~R~LI~eG~l~~~~~~~k~~~r~~fLF~D~LL~~k~k~~ky~~k~~~~~~~~~~d~k~~~~~~i~L~~----l  477 (536)
T 3odw_A          402 FKNLDITKKKLVHEGPLTWRVTKDKAVEVHVLLLDDLLLLLQRQDERLLLKSHSRTLTPTPDGKTMLRPVLRLTS----A  477 (536)
T ss_dssp             SSSCCCTTSCEEEEEEEEEESCC---CEEEEEEESSEEEEEEEETTEEECCCC------------CCCSEEEGGG----E
T ss_pred             hcccccccceeeeecceEEEecCCCeeEEEEEEcCCEEEEEEEcCCeEEEeecccccccccccccccCceeeccc----c
Confidence            44444456778999988665432 3567888887776666553211                  12345688886    4


Q ss_pred             EEEE--cCCCcEEEEc----CCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          459 SIQV--SSPSHFKIVT----PKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       459 ~~~~--~~~~~f~i~~----p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      .++.  ...+.|++..    +.++|.|...+ .+.+.|++.|++++
T Consensus       478 ~v~e~~~d~~~ffli~~~~~~~~~~~L~A~S~eEK~~W~~~I~~aI  523 (536)
T 3odw_A          478 MTREVATDHKAFYVLFTWDQEAQIYELVAQTVSERKNWCALITETA  523 (536)
T ss_dssp             EEEECTTCTTEEEEEEC---CCCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eeecccccCCceEEEecCCCCceEEEEECCCHHHHHHHHHHHHHHH
Confidence            5554  2345666643    46899999766 78999999999876

>2vrw_B P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP-binding, metal-binding, phosphoprotein, exchange factor, RAC, GTPase, membrane domain; 1.85A {Mus musculus} PDB: 3bji_A 1f5x_A

Probab=88.03  E-value=1  Score=45.39  Aligned_cols=90  Identities=11%  Similarity=0.115  Sum_probs=59.6

Q ss_pred             CCCceEEEEEeeehhh--hhhhccceEEeecCCeEEEECCC-CCeeeeeeeccCCCCceEEEEc---------CCCcEEE
Q 010859          403 DPGESVLMISMVKKLQ--KLTSKKVQLILTNKPKLIYVDPS-KLVVKGNIIWSDNSNDLSIQVS---------SPSHFKI  470 (499)
Q Consensus       403 ~~~~~i~~~g~~~k~~--g~~~k~r~~ilt~~p~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~~---------~~~~f~i  470 (499)
                      ..|+ .+++|.+.+..  +...+.|.++|-+.-.++....+ .-..|+.||++.    +.+...         ..+.|.|
T Consensus       230 ~~gr-li~~G~l~~~~~~~~~~~~~~~fLF~d~Ll~~k~k~~~y~~k~~i~l~~----~~v~~~~~~~~~~~~~~~~F~i  304 (406)
T 2vrw_B          230 NYGR-PKIDGELKITSVERRSKTDRYAFLLDKALLICKRRGDSYDLKASVNLHS----FQVRDDSSGERDNKKWSHMFLL  304 (406)
T ss_dssp             GGCS-EEEEEEEEEECSSCCSCEEEEEEEESSEEEEEEEETTEEEEEEEEETTT----EEEEC--------CTTCEEEEE
T ss_pred             ccCc-ccccccEEEEecCCCccceEEEEecCCEEEEEEecCCceEEEEEecccc----eeeeecCCCCccCCccceeeEE
Confidence            3466 56778776543  22346688877776554444322 346789999986    444432         1368988


Q ss_pred             Ec--CCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          471 VT--PKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       471 ~~--p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      ..  +.++|.|...+ .+.++|+++|++++
T Consensus       305 ~~~~~~~~~~l~a~s~~ek~~W~~~i~~ai  334 (406)
T 2vrw_B          305 IEDQGAQGYELFFKTRELKKKWMEQFEMAI  334 (406)
T ss_dssp             EETTCSCEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             EecCCCceEEEeCCCHHHHHHHHHHHHHHH
Confidence            74  67899998655 78899999998875

>1kz7_A Guanine nucleotide exchange factor DBS; guanine nucleotide exchange factor (GEF), small G-protein, signaling protein; 2.40A {Mus musculus} SCOP: a.87.1.1 b.55.1.1 PDB: 1lb1_A 1kzg_A 1rj2_A

Probab=86.76  E-value=1.7  Score=42.95  Aligned_cols=72  Identities=17%  Similarity=0.254  Sum_probs=50.2

Q ss_pred             hccceEEeecCCeEEEECC----------CCCeeeeeeeccCCCCceEEEE---cCCCcEEEEc--CCceEEEEcCC-cc
Q 010859          422 SKKVQLILTNKPKLIYVDP----------SKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVT--PKKVLSFEDAK-QR  485 (499)
Q Consensus       422 ~k~r~~ilt~~p~l~y~d~----------~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~--p~r~y~~~d~~-~~  485 (499)
                      .+.|.+.|=+.-.++....          ..-..|+-|+++.    +.+..   ..++.|.|..  +.++|.|...+ .+
T Consensus       237 ~~~r~~fLF~d~Ll~~k~~~~~~~~~~~~~~y~~k~~i~l~~----~~v~e~~~~~~~~F~i~~~~~~~~~~l~a~s~~e  312 (353)
T 1kz7_A          237 PMQRHLFLHEKAVLFCKKREENGEGYEKAPSYSYKQSLNMTA----VGITENVKGDTKKFEIWYNAREEVYIIQAPTPEI  312 (353)
T ss_dssp             CEEEEEEEESSEEEEEEEECCCCSSCCCSCEEEEEEEEEGGG----EEEECCBTTBTTEEEEEETTTTEEEEEECSSHHH
T ss_pred             cceeEEEEECCEEEEEEeccccccCCCCCCeEEEEEEeEccc----ceeeEcCCCCCceEEEEECCCCcEEEEECCCHHH
Confidence            4567777777655554432          1235688999986    45543   2467999975  56789888655 78


Q ss_pred             HHHHHHHHHHhc
Q 010859          486 ASQWKKAIEALQ  497 (499)
Q Consensus       486 ~~~W~~~i~~~~  497 (499)
                      .++|+++|++++
T Consensus       313 k~~W~~~i~~ai  324 (353)
T 1kz7_A          313 KAAWVNAIRKVL  324 (353)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            899999999865

>3p6a_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 2.50A {Homo sapiens} PDB: 3odo_A

Probab=86.42  E-value=2  Score=42.67  Aligned_cols=96  Identities=7%  Similarity=0.114  Sum_probs=60.7

Q ss_pred             cccccCCCceEEEEEeeehhhh-hhhccceEEeecCCeEEEECCCC------------------CeeeeeeeccCCCCce
Q 010859          398 WQQFLDPGESVLMISMVKKLQK-LTSKKVQLILTNKPKLIYVDPSK------------------LVVKGNIIWSDNSNDL  458 (499)
Q Consensus       398 ~~~~~~~~~~i~~~g~~~k~~g-~~~k~r~~ilt~~p~l~y~d~~~------------------~~~kg~i~~~~~~~~~  458 (499)
                      |.....++...+++|.+..+.+ --++.|+++|=+.-.++....+.                  ....+.|+++.    +
T Consensus       249 ~~~l~~~~r~li~eG~l~~~~~~~~~~~~~~fLF~d~Ll~~k~k~~k~~~k~~~~~~~~~~~~k~~~~~~i~l~~----~  324 (377)
T 3p6a_A          249 FKNLDITKKKLVHEGPLTWRVTKDKAVEVHVLLLDDLLLLLQRQDERLLLKSHSRTLTPTPDGKTMLRPVLRLTS----A  324 (377)
T ss_dssp             STTCCCTTSCEEEEEEEEEESSSSCEEEEEEEEESSEEEEEEEETTEEECCCCCCC---------CSCSEEEGGG----E
T ss_pred             hcccccccceEEEECCcEEEecCCCeEEEEEEeeCCEEEEEEEcCceeEEeecccccccCccccCCCCCeEechh----h
Confidence            5444445667899999865432 23466888777766665553221                  11234688887    4


Q ss_pred             EEEE--cCCCcEE-EEc---CCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          459 SIQV--SSPSHFK-IVT---PKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       459 ~~~~--~~~~~f~-i~~---p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      .++.  ...+.|+ |.+   +.++|.|...+ .+.+.|++.|++++
T Consensus       325 ~v~e~~~~~~~~~~i~~~~~~~~~~~l~A~s~~ek~~W~~~I~~ai  370 (377)
T 3p6a_A          325 MTREVATDHKAFYVLFTWDQEAQIYELVAQTVSERKNWCALITETA  370 (377)
T ss_dssp             EEEECTTCTTEEEEEETTCTTCCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             hccccccccceeEEEecCCCCCeeEEEecCCHHHHHHHHHHHHHHH
Confidence            4444  2234455 444   56899998765 78999999999876

>1nty_A Triple functional domain protein; DBL, pleckstrin, GEF, RHO, GTPase, guanine-nucleotide releas factor, phosphorylation, signaling protein; 1.70A {Homo sapiens} SCOP: a.87.1.1 b.55.1.1 PDB: 2nz8_B 2kr9_A

Probab=85.81  E-value=1.8  Score=41.73  Aligned_cols=71  Identities=17%  Similarity=0.342  Sum_probs=49.2

Q ss_pred             ccceEEeecCCeEEEECC------CCCeeeeeeeccCCCCceEEEE---cCCCcEEEEc-----CCceEEEEcCC-ccHH
Q 010859          423 KKVQLILTNKPKLIYVDP------SKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVT-----PKKVLSFEDAK-QRAS  487 (499)
Q Consensus       423 k~r~~ilt~~p~l~y~d~------~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~-----p~r~y~~~d~~-~~~~  487 (499)
                      +.|.+.|=+.-.++....      ..-..|+.|+++.    +.+..   ..+..|.|..     +.++|.|...+ .+.+
T Consensus       222 ~~r~~fLF~d~Ll~~k~~~~~~~~~~y~~k~~i~l~~----~~v~e~~~~~~~~F~i~~~~~~~~~~~~~l~a~s~~ek~  297 (311)
T 1nty_A          222 RERHLFLFEMSLVFSKEVKDSSGRSKYLYKSKLFTSE----LGVTEHVEGDPCKFALWVGRTPTSDNKIVLKASSIENKQ  297 (311)
T ss_dssp             EEEEEEEESSEEEEEEEEECTTCCEEEEEEEEEEGGG----EEEECCCTTCTTEEEEEESSSCCTTTCEEEECSSHHHHH
T ss_pred             ceeEEEeccCeEEEEEeeccCCCCceeEEeeeeeccc----eeeEEccCCCCceEEEEeCCCCCCCceEEEECCCHHHHH
Confidence            567787777644443321      1235789999986    55553   2356899865     45788888665 7899


Q ss_pred             HHHHHHHHhc
Q 010859          488 QWKKAIEALQ  497 (499)
Q Consensus       488 ~W~~~i~~~~  497 (499)
                      .|+++|++++
T Consensus       298 ~W~~~i~~~i  307 (311)
T 1nty_A          298 DWIKHIREVI  307 (311)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999876

>2rgn_B RHOA/RAC/CDC42 exchange factor; heterotrimeric G-protein, small molecular weight G-protein, complex, protein-protein complex, rhogef, galphaq; HET: GDP; 3.50A {Homo sapiens}

Probab=85.64  E-value=1.2  Score=43.98  Aligned_cols=72  Identities=17%  Similarity=0.284  Sum_probs=49.8

Q ss_pred             hccceEEeecCCeEEEECCC---------CCeeeeeeeccCCCCceEEEE---cCCCcEEEEc--C---CceEEEEcCC-
Q 010859          422 SKKVQLILTNKPKLIYVDPS---------KLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVT--P---KKVLSFEDAK-  483 (499)
Q Consensus       422 ~k~r~~ilt~~p~l~y~d~~---------~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~--p---~r~y~~~d~~-  483 (499)
                      .+.|.++|=+.-.++..-..         .-..|+-||++.    +.+..   ..+..|.|..  |   ..+|.|...+ 
T Consensus       228 ~~~r~~fLF~d~Ll~~k~~~~~~~~~~~~~y~~k~~i~l~~----~~v~~~~~~~~~~F~i~~~~~~~~~~~~~l~a~s~  303 (354)
T 2rgn_B          228 GRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSC----LGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADP  303 (354)
T ss_dssp             CCEEEEEEESSEEEEEEECC--------CCEEEEEEEEGGG----EEEEESGGGCTTEEEEEEECSSSCEEEEEEEESSH
T ss_pred             CceEEEEEeCCcEEEEEeccCCCCCCCCCceEEcceeeccc----eeeeeccCCCCceEEEEecCCCCCceEEEEECCCH
Confidence            35577777776554443221         346789999986    56654   3457899964  3   3788888665 


Q ss_pred             ccHHHHHHHHHHhc
Q 010859          484 QRASQWKKAIEALQ  497 (499)
Q Consensus       484 ~~~~~W~~~i~~~~  497 (499)
                      .+.+.|+++|.+++
T Consensus       304 ~ek~~W~~~i~~ai  317 (354)
T 2rgn_B          304 AISQAWIKHVAQIL  317 (354)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHH
Confidence            78999999998875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.31  E-value=2.1  Score=39.27  Aligned_cols=84  Identities=13%  Similarity=-0.004  Sum_probs=61.6

Q ss_pred             CCCCccEEEEEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC
Q 010859          113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG  192 (499)
Q Consensus       113 ~hp~Iv~l~~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~  192 (499)
                      .||++ . -..-.+++.+.+.++.-+++.=+..+.   .++......++.+|+.... -|...-+|--|+|+||+++.++
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~~  121 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRAL  121 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTTC
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCCC
Confidence            68888 3 334467778888777664444444554   3788899999888887555 1235568889999999999999


Q ss_pred             CEEEEecCCc
Q 010859          193 HIKIADFGSV  202 (499)
Q Consensus       193 ~vkL~DFG~a  202 (499)
                      .+++.-.|.-
T Consensus       122 ~p~i~hRGi~  131 (219)
T 4ano_A          122 EPFFLHVGVK  131 (219)
T ss_dssp             CEEESCCEET
T ss_pred             cEEEEEcCCc
Confidence            9999888763

>3ky9_A Proto-oncogene VAV; calponin homology domain, DBL homology domain, pleckst homology domain, C1 domain, guanine-nucleotide releasing FA metal-binding; 2.73A {Homo sapiens} PDB: 2d86_A

Probab=84.44  E-value=1.7  Score=46.15  Aligned_cols=91  Identities=12%  Similarity=0.096  Sum_probs=61.3

Q ss_pred             cCCCceEEEEEeeehhhh--hhhccceEEeecCCeEEEECC-CCCeeeeeeeccCCCCceEEEEcC---------CCcEE
Q 010859          402 LDPGESVLMISMVKKLQK--LTSKKVQLILTNKPKLIYVDP-SKLVVKGNIIWSDNSNDLSIQVSS---------PSHFK  469 (499)
Q Consensus       402 ~~~~~~i~~~g~~~k~~g--~~~k~r~~ilt~~p~l~y~d~-~~~~~kg~i~~~~~~~~~~~~~~~---------~~~f~  469 (499)
                      ...|+ .++.|.+.+..+  ...+.|+++|-+.-.++.... .+-..|+.||++.    +.++...         ++.|.
T Consensus       401 ~~~gr-ll~~G~l~~~~~~~~~~~~r~~fLF~d~Ll~~k~~~~~y~~k~~i~L~~----~~v~~~~~~~~~~~~~~~~f~  475 (587)
T 3ky9_A          401 AHYGR-PKIDGELKITSVERRSKMDRYAFLLDKALLICKRRGDSYDLKDFVNLHS----FQVRDDSSGDRDNKKWSHMFL  475 (587)
T ss_dssp             GGGCC-EEEEEEEEEECSSCCSCEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG----EEEEEC-----CCCTTCEEEE
T ss_pred             hhcCc-eEEEeeEEEEeccCCCcceEEEEEECCEEEEEEecCCEEEeeeeechhh----ceeeecCCCCcccccccceeE
Confidence            33466 567888865432  234668888887766655433 3456889999997    5555432         25799


Q ss_pred             EEcCC--ceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          470 IVTPK--KVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       470 i~~p~--r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      |....  ++|.|...+ .+.++|+++|++++
T Consensus       476 i~~~~~~~~~~L~A~S~eeK~~Wi~~I~~ai  506 (587)
T 3ky9_A          476 LIEDQGAQGYELFFKTRELKKKWMEQFEMAI  506 (587)
T ss_dssp             EEETTC---CEEEESSHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCceEEEEeCCHHHHHHHHHHHHHHh
Confidence            98754  899988655 78999999999875

>1foe_A T-lymphoma invasion and metastasis inducing protein 1; DBL homology domain, pleckstrin homology domain, GTPase, guanine nucleotide exchange factor; 2.80A {Mus musculus} SCOP: a.87.1.1 b.55.1.1

Probab=81.74  E-value=6.6  Score=38.85  Aligned_cols=50  Identities=14%  Similarity=0.236  Sum_probs=36.8

Q ss_pred             eeeeeeeccCCCCceEEEEcC------CCcEEEE--------cCCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          444 VVKGNIIWSDNSNDLSIQVSS------PSHFKIV--------TPKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       444 ~~kg~i~~~~~~~~~~~~~~~------~~~f~i~--------~p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      ..|+.||++.    +.+....      ...|.|.        +|.++|.|...+ .+.+.|+++|++++
T Consensus       301 ~~k~~i~l~~----~~v~~~~~~~~~~~~~f~i~~~~~~~~~~~~~~~~l~A~s~~eK~~W~~~i~~~i  365 (377)
T 1foe_A          301 RFRHMIPTEA----LQVRALPSADAEANAVCEIVHVKSESEGRPERVFHLCCSSPESRKDFLKSVHSIL  365 (377)
T ss_dssp             CCEEEEEGGG----EEEECCCCTTTTSCCEEEEEECCBTGGGBCCEEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             eEeeeccccc----eEEEecCCCccchhhHHHHHhccccccCCCcceEEEEeCCHHHHHHHHHHHHHHh
Confidence            5678899986    5665422      1236675        478999999665 78999999999875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	499
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-96
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-86
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-84
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-81
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-80
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-78
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-75
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-74
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-74
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-73
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-73
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-73
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-72
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-71
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-71
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-71
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-70
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-69
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-69
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-68
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-67
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-67
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-66
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-59
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-56
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-56
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-55
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-54
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-53
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-53
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-52
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-52
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-52
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-51
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-50
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-48
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-48
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-46
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-44
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-38
d1w1ha_	147	b.55.1.1 (A:) 3-phosphoinositide dependent protein	1e-15
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-15

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  290 bits (743), Expect = 5e-96
 Identities = 138/288 (47%), Positives = 183/288 (63%), Gaps = 9/288 (3%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDHP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
             V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           +IHRD+KPEN+LL  D HI+I DFG+ K +               +A +FVGTA YV PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--------KQARANSFVGTAQYVSPE 180

Query: 236 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL 295
           +L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARDL
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240

Query: 296 IDRLLDVDPSGRPGAG-PGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 342
           +++LL +D + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 288

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  263 bits (673), Expect = 5e-86
 Identities = 88/276 (31%), Positives = 137/276 (49%), Gaps = 17/276 (6%)

Query: 51  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
            ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +  
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 170
            L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 171 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
            HS  +IHRDIKPENLLL + G +KIADFG                A   +  T  GT  
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSV------------HAPSSRRTTLCGTLD 169

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD 290
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ ++
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229

Query: 291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
            ARDLI RLL  +PS RP         +  HP+   
Sbjct: 230 GARDLISRLLKHNPSQRPML-----REVLEHPWITA 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  262 bits (670), Expect = 1e-84
 Identities = 107/303 (35%), Positives = 173/303 (57%), Gaps = 18/303 (5%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
           +S+QDF++ +  G GS+ +V   +    G  YA+K++ K+ + +  +  +   ER++L  
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
           + HP ++R++ TFQD   ++M ++  EGGELF  +          A+FY AEV  ALEY+
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           HS  +I+RD+KPEN+LL  +GHIKI DFG  K +              D   T  GT  Y
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-------------PDVTYTLCGTPDY 167

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 291
           + PEV+++ P     D W+ G  +Y+ML+G +PF D++    +++I+  ++RFP +F++ 
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 227

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMVQSG 349
            +DL+ RL+  D S R G    G   +K HP+FK + W+ +  R    P    EP +Q G
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP---YEPPIQQG 284

Query: 350 EGD 352
           +GD
Sbjct: 285 QGD 287

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (644), Expect = 7e-81
 Identities = 96/288 (33%), Positives = 145/288 (50%), Gaps = 17/288 (5%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQL 112
           I+DF L K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ VL    
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++  L+++H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S G+++RD+K +N+LL  DGHIKIADFG  K               D K  TF GT  Y+
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML----------GDAKTNTFCGTPDYI 170

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA 292
            PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P +    A
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230

Query: 293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
           +DL+ +L   +P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 231 KDLLVKLFVREPEKRLGV----RGDIRQHPLFREINWEELERKEIDPP 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (638), Expect = 9e-80
 Identities = 105/288 (36%), Positives = 153/288 (53%), Gaps = 12/288 (4%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 113 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S  +++RDIK ENL+L  DGHIKI DFG  K                    TF GT  Y+
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----------DGATMKTFCGTPEYL 172

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA 292
            PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

Query: 293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 338
           + L+  LL  DP  R G GP     +  H FF  I+W+++  +   PP
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  247 bits (631), Expect = 3e-78
 Identities = 97/315 (30%), Positives = 151/315 (47%), Gaps = 24/315 (7%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV---L 109
           ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+   +
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
              D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  LE
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           ++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VGT 
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVGTH 169

Query: 230 AYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRFP 285
            Y+ PEVL          D ++LGC L+++L G SPF+         I +  +   +  P
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 229

Query: 286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPPKLASE 343
           + FS   R L++ LL  D + R G    G   +K  PFF+ +DW+ +  Q   PP +   
Sbjct: 230 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI--- 286

Query: 344 PMVQSGEGDDVHDSS 358
           P        D  D  
Sbjct: 287 PPRGEVNAADAFDIG 301

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  240 bits (613), Expect = 1e-75
 Identities = 81/297 (27%), Positives = 136/297 (45%), Gaps = 27/297 (9%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            +++ +  G G++  V R  +  TG V+  K ++  +   +     VK E  +++QL HP
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHP 86

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
            ++ L   F+D + + + LE   GGELFD+I ++ + +SE E   Y  +  + L+++H  
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 175 GLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
            ++H DIKPEN++        +KI DFG    +             D+       TA + 
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-----------DEIVKVTTATAEFA 195

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYF 288
            PE+++  P  F  D+WA+G   Y +LSG SPF    +    Q +   D  F     +  
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPM 345
           S  A+D I  LL  +P  R             HP+ KG D  N+  + P    ++  
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTV-----HDALEHPWLKG-DHSNLTSRIPSSRYNKIR 306

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 3e-74
 Identities = 76/287 (26%), Positives = 132/287 (45%), Gaps = 27/287 (9%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            +E+    G G++ KV +A+  +T  + A K++D K    E +     +E  +L   DHP
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 174
            +V+L   F    +L++ +E C GG +   +      L+E + +    + +DAL Y+H  
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            +IHRD+K  N+L T DG IK+ADFG                 +  +  +F+GT  ++ P
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----------TIQRRDSFIGTPYWMAP 179

Query: 235 EVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPN 286
           EV+        P  +  D+W+LG TL +M     P  + +   +  +I   +   +  P+
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 239

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 333
            +S   +D + + L+ +   R        + L  HPF      K IR
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTT-----SQLLQHPFVTVDSNKPIR 281

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  235 bits (600), Expect = 8e-74
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 26/293 (8%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  +++ +  G G++  V R  +  TG  +A K +       E+    V+ E   +  L 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR 81

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIH 172
           HP +V L   F+D   + M  E   GGELF+++  +   +SEDEA  Y  +V   L ++H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 173 SMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
               +H D+KPEN++ T      +K+ DFG    +                     GTA 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-----------KQSVKVTTGTAE 190

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---- 286
           +  PEV    P  +  D+W++G   Y +LSG SPF   ++    + + + D    +    
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK 339
             S+  +D I +LL  DP+ R             HP+    +      Q P  
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTI-----HQALEHPWLTPGNAPGRDSQIPSS 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  234 bits (597), Expect = 2e-73
 Identities = 101/293 (34%), Positives = 157/293 (53%), Gaps = 15/293 (5%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 107
            Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ 
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 108 VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           +L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
            EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++                 T  G
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------------WTLCG 200

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
           T   + PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 338
           FS   +DL+  LL VD + R G    G   +K H +F   DW  I  R    P
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  231 bits (590), Expect = 2e-73
 Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 33/288 (11%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL------ERIV 108
           +++E  +I G G  S V R     T   YA+KI+D       +     +L      E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 109 LDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           L ++  HP +++L  T++     ++  +  + GELFD +T K  LSE E R     +++ 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           +  +H + ++HRD+KPEN+LL  D +IK+ DFG    +              +K     G
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----------GEKLREVCG 171

Query: 228 TAAYVPPEVL------NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
           T +Y+ PE++      N        D+W+ G  +Y +L+G+ PF    + L+ + I++ +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231

Query: 282 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            +F     + +SD  +DL+ R L V P  R  A          HPFF+
Sbjct: 232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQ 274

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (586), Expect = 8e-73
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 19/276 (6%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++D++L +  G G+Y +V  A    T    A+KI+D K      +   +K E  +   L+
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN 61

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
           +G+ HRDIKPENLLL    ++KI+DFG           V      +       GT  YV 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLAT--------VFRYNNRERLLNKMCGTLPYVA 173

Query: 234 PEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF---S 289
           PE+L          D+W+ G  L  ML+G  P+   S+             + N +    
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233

Query: 290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            A   L+ ++L  +PS R          +K   ++ 
Sbjct: 234 SAPLALLHKILVENPSARITI-----PDIKKDRWYN 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  229 bits (586), Expect = 2e-72
 Identities = 91/295 (30%), Positives = 145/295 (49%), Gaps = 27/295 (9%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
             ++   + G G++S+V+ A+   T  + A+K + KK +  E K   ++ E  VL ++ H
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 175 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           G++HRD+KPENLL      D  I I+DFG  K                    T  GT  Y
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-----------GSVLSTACGTPGY 175

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NY 287
           V PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F     + 
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW--KNIRGQTPPKL 340
            SD+A+D I  L++ DP  R             HP+  G     KNI      ++
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTC-----EQALQHPWIAGDTALDKNIHQSVSEQI 285

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  228 bits (582), Expect = 1e-71
 Identities = 71/285 (24%), Positives = 112/285 (39%), Gaps = 28/285 (9%)

Query: 50  EHFSIQD----FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
           E F   D    F   +  G GS+  V  A+ +    V A+K M         K   +  E
Sbjct: 6   ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
              L +L HP  ++    +    + ++ +E C G         K  L E E    T   +
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL 125

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             L Y+HS  +IHRD+K  N+LL+  G +K+ DFGS   M  +               +F
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--------------SF 171

Query: 226 VGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
           VGT  ++ PEV+   +        D+W+LG T  ++     P  + +       I   + 
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231

Query: 283 RF--PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
                 ++S+  R+ +D  L   P  RP +      VL  H F  
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVL 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (580), Expect = 3e-71
 Identities = 70/322 (21%), Positives = 120/322 (37%), Gaps = 64/322 (19%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           DFE     G G+   V +     +G V A K++  +   K      +  E  VL + + P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM- 174
            +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+    
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            ++HRD+KP N+L+ + G IK+ DFG    + DS               +FVGT +Y+ P
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN------------SFVGTRSYMSP 172

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRF------- 284
           E L  +  +  +D+W++G +L +M  G  P          L+F   +  D          
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 285 ----------------------------------PNYFSDAARDLIDRLLDVDPSGRPGA 310
                                                FS   +D +++ L  +P+ R   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 311 GPGGYAVLKMHPFFKGIDWKNI 332
                  L +H F K  D + +
Sbjct: 293 -----KQLMVHAFIKRSDAEEV 309

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 5e-71
 Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 22/274 (8%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           + +   +  G G+   V  A  + TG   A++ M+ +   ++ K   +  E +V+ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKN 76

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
           P +V    ++     L++ +E   GG L D +T      E +      E + ALE++HS 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN 135

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            +IHRDIK +N+LL  DG +K+ DFG    +               K  T VGT  ++ P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----------EQSKRSTMVGTPYWMAP 185

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA 291
           EV+         D+W+LG    +M+ G  P+ + +       I      +++ P   S  
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
            RD ++R LD+D   R  A       L  H F K
Sbjct: 246 FRDFLNRCLDMDVEKRGSA-----KELLQHQFLK 274

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (575), Expect = 1e-70
 Identities = 106/312 (33%), Positives = 166/312 (53%), Gaps = 20/312 (6%)

Query: 38  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT 94
              ++       E   I++FEL K+ G G+Y KV   +KI   DTG +YA+K++ K  I 
Sbjct: 7   HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66

Query: 95  KENK-TAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL 152
           ++ K T + + ER VL+ +   P +V L + FQ    L++ L+   GGELF  ++ +   
Sbjct: 67  QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 126

Query: 153 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 212
           +E E + Y  E+V ALE++H +G+I+RDIK EN+LL ++GH+ + DFG  K         
Sbjct: 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE- 185

Query: 213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKDTSE 270
                   +A  F GT  Y+ P+++    +      D W+LG  +Y++L+G SPF    E
Sbjct: 186 --------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237

Query: 271 ----WLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 326
                 I +RI+  +  +P   S  A+DLI RLL  DP  R G GP     +K H FF+ 
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

Query: 327 IDWKNIRGQTPP 338
           I+W ++  +  P
Sbjct: 298 INWDDLAAKKVP 309

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 3e-69
 Identities = 81/305 (26%), Positives = 138/305 (45%), Gaps = 30/305 (9%)

Query: 49  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---E 105
           QE+     ++ G+  G G ++ V + ++  TG  YA K + K+      +    +    E
Sbjct: 5   QENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             +L ++ HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  +++
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDK 221
           + + Y+HS+ + H D+KPEN++L         IKI DFG    +              ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNE 172

Query: 222 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 281
                GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232

Query: 282 IRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQ 335
             F +      S  A+D I RLL  DP  R             HP+ K  D +       
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQALSSAW 287

Query: 336 TPPKL 340
           + P+ 
Sbjct: 288 SHPQF 292

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 4e-69
 Identities = 76/280 (27%), Positives = 128/280 (45%), Gaps = 28/280 (10%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHP 63

Query: 116 GVVRLFFTFQDTFS--LYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALE 169
            +VR +    D  +  LY+ +E CEGG+L   IT     + +L E+       ++  AL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 170 YIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
             H        ++HRD+KP N+ L    ++K+ DFG  + +                A  
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD----------TSFAKA 173

Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R 283
           FVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+  +  +I      R
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 233

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
            P  +SD   ++I R+L++    RP         +  +P 
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSV-----EEILENPL 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 5e-68
 Identities = 52/279 (18%), Positives = 108/279 (38%), Gaps = 29/279 (10%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 116
            +     G GS+  V +    +T    A   +  + +TK  +  + + E  +L  L HP 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE-EAEMLKGLQHPN 69

Query: 117 VVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           +VR + +++ T      + +  E    G L   +     +     R +  +++  L+++H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 173 SMG--LIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           +    +IHRD+K +N+ +T   G +KI D G     + S                 +GT 
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK------------AVIGTP 177

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPN 286
            ++ PE+          D++A G  + +M +   P+ +        R +   ++   F  
Sbjct: 178 EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236

Query: 287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
                 +++I+  +  +   R          L  H FF+
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQ 270

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 3e-67
 Identities = 73/289 (25%), Positives = 121/289 (41%), Gaps = 31/289 (10%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            + + +  G G +  V R  +  +   Y  K +  K   +      VK E  +L+   H 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIARHR 61

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSM 174
            ++ L  +F+    L M  E   G ++F++I +    L+E E   Y  +V +AL+++HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 175 GLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
            + H DI+PEN++        IKI +FG  + ++             D          Y 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-----------GDNFRLLFTAPEYY 170

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYF 288
            PEV      +   D+W+LG  +Y +LSG +PF   +   I + I+  +  F        
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG----IDWKNIR 333
           S  A D +DRLL  +   R  A     +    HP+ K     +  K IR
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTA-----SEALQHPWLKQKIERVSTKVIR 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  214 bits (546), Expect = 7e-67
 Identities = 67/263 (25%), Positives = 120/263 (45%), Gaps = 15/263 (5%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            +ELG+I G G  S+V  A+ +      A+K++        +     + E      L+HP
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 116 GVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
            +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL + 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 172 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 231
           H  G+IHRD+KP N++++A   +K+ DFG  + + DS         S  +    +GTA Y
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS-------GNSVTQTAAVIGTAQY 180

Query: 232 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY---- 287
           + PE          +D+++LGC LY++L+G  PF   S   +  + +  D   P+     
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240

Query: 288 FSDAARDLIDRLLDVDPSGRPGA 310
            S     ++ + L  +P  R   
Sbjct: 241 LSADLDAVVLKALAKNPENRYQT 263

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 3e-66
 Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 31/280 (11%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 112
            +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 113 D--HPGVVRLFFTFQDTFSLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALE 169
                GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 170 YIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           + H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGT 172

Query: 229 AAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
             Y PPE +           +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 226

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 327
            S   + LI   L + PS RP         ++ HP+ + +
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTF-----EEIQNHPWMQDV 261

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 7e-63
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 41/290 (14%)

Query: 54  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           I D++   ++ G+G   KV++     T   +ALK++      +           +     
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV-------ELHWRAS 62

Query: 113 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 166
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 167 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------SHNSLT 171

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIA 279
           T   T  YV PEVL         D+W+LG  +Y +L G  PF           +  RI  
Sbjct: 172 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231

Query: 280 RDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
               FPN      S+  + LI  LL  +P+ R             HP+  
Sbjct: 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIM 276

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 2e-62
 Identities = 56/263 (21%), Positives = 109/263 (41%), Gaps = 23/263 (8%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
              +G+  G GS+  V + K        A+K+++    T +   A+   E  VL +  H 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHV 64

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 174
            ++  F  +     L +  + CEG  L+  +   +      +      +    ++Y+H+ 
Sbjct: 65  NILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            +IHRD+K  N+ L  D  +KI DFG           V    +   +     G+  ++ P
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLAT--------VKSRWSGSHQFEQLSGSILWMAP 175

Query: 235 EVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY---- 287
           EV+   + +P +F +D++A G  LY++++G  P+ + +       ++ R    P+     
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 288 --FSDAARDLIDRLLDVDPSGRP 308
                A + L+   L      RP
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERP 258

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 1e-59
 Identities = 56/288 (19%), Positives = 112/288 (38%), Gaps = 23/288 (7%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
            ++  +++D ELG     G++  V +   +        A+KI+  +      K   +  E
Sbjct: 4   DRKLLTLEDKELGS----GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-E 58

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 165
             V+ QLD+P +VR+    +   S  + +E  E G L   +    H+ +        +V 
Sbjct: 59  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             ++Y+     +HRD+   N+LL    + KI+DFG  K ++                   
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-------KAQTHG 170

Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IR 283
                +  PE +N    +  +D+W+ G  +++  S G  P++      +   +   + + 
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 230

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKGIDW 329
            P        DL++     D   RPG      AV     + ++  ++ 
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFA----AVELRLRNYYYDVVNE 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-59
 Identities = 56/264 (21%), Positives = 108/264 (40%), Gaps = 25/264 (9%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
            ++++ +L +  G G +  V+       G   A+K +      +         E  V+ Q
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA-----FLAEASVMTQ 56

Query: 112 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDAL 168
           L H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +A+
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           EY+     +HRD+   N+L++ D   K++DFG  K    ++              T    
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-------------DTGKLP 163

Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDIRFPN 286
             +  PE L     +  +D+W+ G  L+++ S G  P+       +  R+     +  P+
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223

Query: 287 YFSDAARDLIDRLLDVDPSGRPGA 310
               A  +++     +D + RP  
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSF 247

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-58
 Identities = 67/314 (21%), Positives = 128/314 (40%), Gaps = 52/314 (16%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIV--L 109
           + Q +E     G G+Y KV +A+ + + G   ALK +  +   +    + ++   ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 110 DQLDHPGVVRLFFTFQDTFS-----LYMALESCEGGEL-FDQITSKGHLSEDEARFYTAE 163
           +  +HP VVRLF     + +     L +  E  +     +     +  +  +  +    +
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           ++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG  +                    
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-----------QMALT 173

Query: 224 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---- 279
           + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+     +I+     
Sbjct: 174 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233

Query: 280 -----------------------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYA 316
                                     +F     +  +DL+ + L  +P+ R  A      
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----Y 288

Query: 317 VLKMHPFFKGIDWK 330
               HP+F+ ++  
Sbjct: 289 SALSHPYFQDLERC 302

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 7e-58
 Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 25/285 (8%)

Query: 48  PQEHFSIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLE 105
            +++  I D ELG     G++  V +   +        A+K++ +   T++  T  +  E
Sbjct: 6   KRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMRE 59

Query: 106 RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEV 164
             ++ QLD+P +VRL    Q   +L + +E   GG L   +  K   +          +V
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
              ++Y+     +HRD+   N+LL    + KI+DFG  K +         + +       
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG-------ADDSYYTARSA 171

Query: 225 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDI 282
                 +  PE +N    +  +D+W+ G T+++ LS G  P+K      +   I   + +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231

Query: 283 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK 325
             P         L+          RP        V +     ++ 
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFL----TVEQRMRACYYS 272

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-56
 Identities = 59/263 (22%), Positives = 98/263 (37%), Gaps = 15/263 (5%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVL 109
             +D  L +  G GS+  V R +           A+K +    +++         E   +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 110 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDAL 168
             LDH  ++RL+        + M  E    G L D++    GH        Y  +V + +
Sbjct: 66  HSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 169 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
            Y+ S   IHRD+   NLLL     +KI DFG ++ +         N             
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-------NDDHYVMQEHRKVP 177

Query: 229 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--P 285
            A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R   P
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237

Query: 286 NYFSDAARDLIDRLLDVDPSGRP 308
                   +++ +     P  RP
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRP 260

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 4e-56
 Identities = 71/314 (22%), Positives = 115/314 (36%), Gaps = 53/314 (16%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
            +  +E     G G++ +V +A+   TG   ALK +  +   KE        E  +L  L
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL 66

Query: 113 DHPGVVRLFFTFQDTFS--------LYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
            H  VV L    +   S        +Y+  + CE              +  E +     +
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG  +    ++ +        ++   
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ------PNRYTN 180

Query: 225 FVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---- 279
            V T  Y PPE+L          DLW  GC + +M + +   +  +E      I      
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 280 ----------------------------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG 311
                                       +D          A DLID+LL +DP+ R  + 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS- 299

Query: 312 PGGYAVLKMHPFFK 325
                    H FF 
Sbjct: 300 ----DDALNHDFFW 309

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 9e-56
 Identities = 60/289 (20%), Positives = 115/289 (39%), Gaps = 42/289 (14%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           F  ++ E GK+ G G++ KV+ A      K       A+K++ +K  + E +   +  E 
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA--LMSEL 91

Query: 107 IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-------------- 151
            ++ QL  H  +V L      +  +Y+  E C  G+L + + SK                
Sbjct: 92  KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 152 ---------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 202
                    L+ ++   +  +V   +E++     +HRD+   N+L+T    +KI DFG  
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 261
           + +      V+                 ++ PE L     T  +D+W+ G  L+++ S G
Sbjct: 212 RDIMSDSNYVVR--------GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263

Query: 262 TSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 308
            +P+        F ++I    +   P Y ++    ++      D   RP
Sbjct: 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-55
 Identities = 76/327 (23%), Positives = 123/327 (37%), Gaps = 63/327 (19%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            +   K+ G GS+  V +AK  D+G + A+K + +    K         E  ++ +LDH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73

Query: 116 GVVRLFFTF------QDTFSLYMALESCEGG---ELFDQITSKGHLSEDEARFYTAEVVD 166
            +VRL + F      +D   L + L+               +K  L     + Y  ++  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
           +L YIHS G+ HRDIKP+NLLL  D   +K+ DFGS K +              +   ++
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----------GEPNVSY 182

Query: 226 VGTAAYVPP-EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII------ 278
           + +  Y  P  +  ++  T   D+W+ GC L ++L G   F   S       II      
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 279 -----------ARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGGY 315
                        + +FP                  A  L  RLL+  P+ R        
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP----- 297

Query: 316 AVLKMHPFFKGIDWKNIRGQTPPKLAS 342
                H FF  +   N++        +
Sbjct: 298 LEACAHSFFDELRDPNVKLPNGRDTPA 324

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 5e-55
 Identities = 64/299 (21%), Positives = 102/299 (34%), Gaps = 46/299 (15%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHP 115
           E     G G ++ V +A+  +T  + A+K +     ++           E  +L +L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            ++ L   F    ++ +  +  E         +   L+    + Y    +  LEY+H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           ++HRD+KP NLLL  +G +K+ADFG  K                      V T  Y  PE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN----------RAYTHQVVTRWYRAPE 170

Query: 236 VLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--------- 285
           +L        G D+WA+GC L ++L         S+     RI                 
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 286 -------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
                              +   D   DLI  L   +P  R  A            +F 
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFS 284

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 9e-55
 Identities = 52/257 (20%), Positives = 103/257 (40%), Gaps = 17/257 (6%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           +D    K  G G +  V   K        A+K++ +  ++++        E  V+  L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHS 173
             +V+L+        +++  E    G L + +   +      +      +V +A+EY+ S
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
              +HRD+   N L+   G +K++DFG  + + D   T          +        + P
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSP 169

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNYFSDA 291
           PEVL  S  +  +D+WA G  ++++ S G  P++  +     + I     +  P+  S+ 
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 292 ARDLIDRLLDVDPSGRP 308
              ++          RP
Sbjct: 230 VYTIMYSCWHEKADERP 246

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (464), Expect = 1e-54
 Identities = 52/263 (19%), Positives = 94/263 (35%), Gaps = 17/263 (6%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
               D  +    G G Y +V            A+K + +  +  E        E  V+ +
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKE 69

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALE 169
           + HP +V+L          Y+  E    G L D +       +S     +   ++  A+E
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+     IHRD+   N L+  +  +K+ADFG  + M     T                  
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH---------AGAKFPI 180

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNY 287
            +  PE L  +  +  +D+WA G  L+++ +         +      ++ +D R   P  
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240

Query: 288 FSDAARDLIDRLLDVDPSGRPGA 310
             +   +L+      +PS RP  
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSF 263

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 51/258 (19%), Positives = 109/258 (42%), Gaps = 17/258 (6%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
           +    +  G G +  V     ++     A+K + +  +++E+       E  V+ +L HP
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEED----FIEEAEVMMKLSHP 60

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 174
            +V+L+    +   + +  E  E G L D + ++  L + +       +V + + Y+   
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            +IHRD+   N L+  +  IK++DFG  + + D + T          +        +  P
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASP 171

Query: 235 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNYFSDAA 292
           EV + S  +  +D+W+ G  ++++ S G  P+++ S   + + I     +  P   S   
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231

Query: 293 RDLIDRLLDVDPSGRPGA 310
             +++      P  RP  
Sbjct: 232 YQIMNHCWKERPEDRPAF 249

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  181 bits (459), Expect = 5e-54
 Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 47/300 (15%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
            +   +  G G+Y  V +A+  + G  +ALK +  +   +   +  ++ E  +L +L H 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
            +V+L+        L +  E  +          +G L    A+ +  ++++ + Y H   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 176 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 235
           ++HRD+KP+NLL+  +G +KIADFG  +                 K    + T  Y  P+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI----------PVRKYTHEIVTLWYRAPD 170

Query: 236 VL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------------- 279
           VL  S   +   D+W++GC   +M++GT  F   SE     RI                 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 280 --------------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 325
                             F     ++  DL+ ++L +DP+ R  A          H +FK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFK 285

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-53
 Identities = 54/278 (19%), Positives = 110/278 (39%), Gaps = 24/278 (8%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
              +  +L +  G G + +V      +  T  A+K + +  ++ +        E  ++ Q
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDA----FLAEANLMKQ 64

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALE 169
           L H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ + + 
Sbjct: 65  LQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           +I     IHRD++  N+L++     KIADFG  + ++D+                     
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---------EYTAREGAKFPI 174

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
            +  PE +N    T  +D+W+ G  L ++++ G  P+   +   + Q +     +  P+ 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM-HPFF 324
             +    L+       P  RP        +  +   FF
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFD----YLRSVLEDFF 268

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (457), Expect = 2e-53
 Identities = 51/288 (17%), Positives = 106/288 (36%), Gaps = 41/288 (14%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           +   + E  +  G G++ +V +A+       +  T+ A+K++ ++           + E 
Sbjct: 10  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREA 67

Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--------------- 151
            ++ + D+P +V+L         + +  E    G+L + + S                  
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 152 ---------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 202
                    LS  E      +V   + Y+     +HRD+   N L+  +  +KIADFG  
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 261
           + +  +                      ++PPE +  +  T  +D+WA G  L+++ S G
Sbjct: 188 RNIYSADYY--------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 262 TSPFKDTSEWLIFQRIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRP 308
             P+   +   +   +   +I   P        +L+       P+ RP
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 287

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 4e-53
 Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 47/305 (15%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59

Query: 114 HPGVVRLFFTFQDTFSLYMALESCE-GGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L         LY+  E      + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S  ++HRD+KP+NLL+  +G IK+ADFG  +                      V T  Y 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------PVRTYTHEVVTLWYR 169

Query: 233 PPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-----------AR 280
            PE+L      +   D+W+LGC   +M++  + F   SE     RI              
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

Query: 281 DIRFPNY------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 322
               P+Y                    +  R L+ ++L  DP+ R  A          HP
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHP 284

Query: 323 FFKGI 327
           FF+ +
Sbjct: 285 FFQDV 289

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 8e-53
 Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 30/275 (10%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
              D +   + G G++ +V++A+    G      I   K    ++       E  VL +L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 113 -DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSED 155
             HP ++ L    +    LY+A+E    G L D +                ++   LS  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 156 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 215
           +   + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +         
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------- 179

Query: 216 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF 274
                K         ++  E LN S  T  +D+W+ G  L++++S G +P+   +   ++
Sbjct: 180 ---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 275 QRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
           +++     +  P    D   DL+ +     P  RP
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 9e-53
 Identities = 52/282 (18%), Positives = 106/282 (37%), Gaps = 24/282 (8%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 111
              +   L    G G + +V       T  V A+K +    ++ E        E  V+ +
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA----FLQEAQVMKK 68

Query: 112 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALE 169
           L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A++   + 
Sbjct: 69  LRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T                  
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---------ARQGAKFPI 178

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 287
            +  PE       T  +D+W+ G  L ++ + G  P+       +  ++     +  P  
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238

Query: 288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM-HPFFKGID 328
             ++  DL+ +    +P  RP        +      +F   +
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFE----YLQAFLEDYFTSTE 276

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-52
 Identities = 50/307 (16%), Positives = 108/307 (35%), Gaps = 16/307 (5%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLD 113
           +F+  K+ G G++  V +   I  G    + +  K+    T       +  E  V+  +D
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 173
           +P V RL      +    +      G  L      K ++       +  ++   + Y+  
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
             L+HRD+   N+L+    H+KI DFG  K +             +  A        ++ 
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVPIKWMA 181

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDA 291
            E +     T  +D+W+ G T++++++ G+ P+       I   +   + +  P   +  
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241

Query: 292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEG 351
              ++ +   +D   RP        ++           + +  Q   ++       S   
Sbjct: 242 VYMIMVKCWMIDADSRPKFR----ELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFY 297

Query: 352 DDVHDSS 358
             + D  
Sbjct: 298 RALMDEE 304

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 14/260 (5%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 114 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIH 172
           HP +V+L     +   +++ +E C  GEL   +  +   L       Y  ++  AL Y+ 
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 173 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
           S   +HRDI   N+L++++  +K+ DFG  + M+DS            KA        ++
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWM 176

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRII-ARDIRFPNYFSD 290
            PE +N    T  +D+W  G  ++++L  G  PF+      +  RI     +  P     
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236

Query: 291 AARDLIDRLLDVDPSGRPGA 310
               L+ +    DPS RP  
Sbjct: 237 TLYSLMTKCWAYDPSRRPRF 256

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 4e-52
 Identities = 65/314 (20%), Positives = 108/314 (34%), Gaps = 54/314 (17%)

Query: 50  EHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 108
           + F +   +      G G+Y  V  A         A+K +       +        E  +
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKI 59

Query: 109 LDQLDHPGVVRLF-----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 163
           L +  H  ++ +       T +    +Y+            ++    HLS D   ++  +
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGAD--LYKLLKTQHLSNDHICYFLYQ 117

Query: 164 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           ++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +          P+        
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-------PDHDHTGFLT 170

Query: 224 TFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 282
            +V T  Y  PE++ NS   T   D+W++GC L +MLS    F           I+    
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230

Query: 283 -------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAG 311
                                          R        A DL+D++L  +P  R    
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV- 289

Query: 312 PGGYAVLKMHPFFK 325
                    HP+ +
Sbjct: 290 ----EQALAHPYLE 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (447), Expect = 4e-52
 Identities = 51/268 (19%), Positives = 105/268 (39%), Gaps = 13/268 (4%)

Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLER 106
           +   I   ++ ++ G G + +V        G      A+K +   +  K+ +      E 
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD--FLSEA 78

Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD-QITSKGHLSEDEARFYTAEVV 165
            ++ Q DHP V+ L      +  + +  E  E G L      + G  +  +       + 
Sbjct: 79  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138

Query: 166 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 225
             ++Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D       +  +   A   
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT-----SDPTYTSALGG 193

Query: 226 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR 283
                +  PE +     T  +D+W+ G  +++++S G  P+ D +   +   I     + 
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253

Query: 284 FPNYFSDAARDLIDRLLDVDPSGRPGAG 311
            P     A   L+      D + RP  G
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFG 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 8e-52
 Identities = 74/326 (22%), Positives = 125/326 (38%), Gaps = 60/326 (18%)

Query: 52  FSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           + ++  +   +  G G+Y  V  A    TG   A+K + + F ++       + E  +L 
Sbjct: 14  WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLK 72

Query: 111 QLDHPGVVRLFFTFQ------DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 164
            + H  V+ L   F       D    Y+ +     G    ++     L ED  +F   ++
Sbjct: 73  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 165 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 224
           +  L YIH+ G+IHRD+KP NL +  D  +KI DFG  +               D +   
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-------------DSEMTG 177

Query: 225 FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 283
           +V T  Y  PEV LN    T   D+W++GC + +M++G + FK +      + I+     
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 284 FPNYF-------------------------------SDAARDLIDRLLDVDPSGRPGAGP 312
            P  F                               S  A +L++++L +D   R  A  
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-- 295

Query: 313 GGYAVLKMHPFFKGIDWKNIRGQTPP 338
                   HP+F+ +       Q   
Sbjct: 296 ---GEALAHPYFESLHDTEDEPQVQK 318

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (439), Expect = 7e-51
 Identities = 51/298 (17%), Positives = 98/298 (32%), Gaps = 33/298 (11%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP- 115
           + LG+  G GS+  +     I  G   A+K+   K    +     + +E  +   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
           G+  + +   +     M +E                 S         +++  +EYIHS  
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 176 LIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 232
            IHRD+KP+N L+        + I DFG  K  +D+R           +     GTA Y 
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP---YRENKNLTGTARYA 180

Query: 233 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--------F 284
                     +  +DL +LG  L     G+ P++        Q+      +         
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK-------GIDWKNIR 333
              +       ++    +    +P        + ++  + F +         DW  ++
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYS----YLRQLFRNLFHRQGFSYDYVFDWNMLK 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (435), Expect = 2e-50
 Identities = 66/302 (21%), Positives = 114/302 (37%), Gaps = 47/302 (15%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 114
           Q +E  +  G G+Y  V +AK  +T  + ALK +      +   ++ ++ E  +L +L H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60

Query: 115 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 174
             +VRL         L +  E C+        +  G L  +  + +  +++  L + HS 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 175 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 234
            ++HRD+KP+NLL+  +G +K+A+FG  +                      V T  Y PP
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGI----------PVRCYSAEVVTLWYRPP 170

Query: 235 EVLNSSPA-TFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIARDIRFPNY----- 287
           +VL  +   +   D+W+ GC   ++ +   P F         +RI               
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 288 ------------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 323
                                    +   RDL+  LL  +P  R  A          HP+
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPY 285

Query: 324 FK 325
           F 
Sbjct: 286 FS 287

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-50
 Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 37/286 (12%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           F       GK  G G++ KVV A      K D     A+K++       E +   +  E 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSEL 77

Query: 107 IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-------------- 151
            VL  L +H  +V L           +  E C  G+L + +  K                
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 152 ----LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 207
               L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG  + +++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FK 266
               V+                 ++ PE + +   TF +D+W+ G  L+++ S  S  + 
Sbjct: 198 DSNYVVKG--------NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 267 DTSEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA 310
                  F ++I    R   P +      D++    D DP  RP  
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  170 bits (430), Expect = 3e-49
 Identities = 67/320 (20%), Positives = 119/320 (37%), Gaps = 68/320 (21%)

Query: 53  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 112
           +  D++L +  G G YS+V  A  I       +KI+      K      +K E  +L+ L
Sbjct: 33  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENL 86

Query: 113 -DHPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 169
              P ++ L    +D  S    +  E     +          L++ + RFY  E++ AL+
Sbjct: 87  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALD 143

Query: 170 YIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 228
           Y HSMG++HRD+KP N+++  +   +++ D+G  +                 +    V +
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-----------GQEYNVRVAS 192

Query: 229 AAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 287
             +  PE+ ++     +  D+W+LGC L  M+    PF    +       IA+ +   + 
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252

Query: 288 F--------------------------------------SDAARDLIDRLLDVDPSGRPG 309
           +                                      S  A D +D+LL  D   R  
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312

Query: 310 AGPGGYAVLKMHPFFKGIDW 329
           A          HP+F  +  
Sbjct: 313 A-----REAMEHPYFYTVVK 327

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 1e-48
 Identities = 52/299 (17%), Positives = 110/299 (36%), Gaps = 36/299 (12%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
            + +   + +  G GS+  V         K +  T  A+K +++    +E        E 
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEA 74

Query: 107 IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----------LSEDE 156
            V+ + +   VVRL           + +E    G+L   + S              S  +
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 157 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 216
                 E+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++        
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----- 189

Query: 217 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGT-SPFKDTSEWLIFQ 275
               K    +    ++ PE L     T  +D+W+ G  L+++ +    P++  S   + +
Sbjct: 190 ---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246

Query: 276 RIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM-----HPFFKGID 328
            ++   +   P+   D   +L+      +P  RP        ++        P F+ + 
Sbjct: 247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL----EIISSIKEEMEPGFREVS 301

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  166 bits (422), Expect = 2e-48
 Identities = 45/266 (16%), Positives = 91/266 (34%), Gaps = 22/266 (8%)

Query: 57  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 115
           +++G+  G GS+  +     +      A+K   ++    +     ++ E      L    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYKLLAGCT 61

Query: 116 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 175
           G+  +++  Q+     + ++                 S         +++  ++ IH   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 176 LIHRDIKPENLLLTA-----DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 230
           L++RDIKP+N L+          I + DFG VK  +D             +     GTA 
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK---QHIPYREKKNLSGTAR 178

Query: 231 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRFP-- 285
           Y+          +  +DL ALG      L G+ P++          ++RI  +    P  
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 286 ---NYFSDAARDLIDRLLDVDPSGRP 308
                F +     +    ++     P
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATP 264

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 4e-48
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 34/284 (11%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 106
           F     +LGK  G G++ +V+ A      K  T    A+K++ +     E++ A +   +
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELK 68

Query: 107 IVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-------------- 151
           I++    H  VV L     +    L + +E C+ G L   + SK +              
Sbjct: 69  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 152 --LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 209
             L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI DFG  + +    
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD- 187

Query: 210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGT-SPFKDT 268
                      +         ++ PE +     T  +D+W+ G  L+++ S   SP+   
Sbjct: 188 -------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240

Query: 269 SEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA 310
                F R +    R   P+Y +      +      +PS RP  
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 9e-48
 Identities = 59/282 (20%), Positives = 109/282 (38%), Gaps = 34/282 (12%)

Query: 52  FSIQDFELGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKL 104
                  LGK  G G++ +VV A+ I          T  A+K++ K   T+++ +  +  
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISE 68

Query: 105 ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TS 148
             ++     H  ++ L         LY+ +E    G L + +                  
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 149 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS 208
           +  LS  +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +   
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 267
                       K         ++ PE L     T  +D+W+ G  L+++ + G SP+  
Sbjct: 189 D--------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240

Query: 268 TSEWLIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRP 308
                +F+ +     +  P+  ++    ++       PS RP
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 2e-46
 Identities = 71/311 (22%), Positives = 121/311 (38%), Gaps = 56/311 (18%)

Query: 52  FSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 110
           + + + ++     G G+Y  V  A    TG   A+K + + F +  +     + E  +L 
Sbjct: 14  WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLK 72

Query: 111 QLDHPGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 166
            + H  V+ L   F    SL     + L +   G   + I     L++D  +F   +++ 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 167 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 226
            L+YIHS  +IHRD+KP NL +  D  +KI DFG  +               DD+   +V
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-------------DDEMTGYV 179

Query: 227 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 285
            T  Y  PE+ LN        D+W++GC + ++L+G + F  T      + I+       
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239

Query: 286 NYF-------------------------------SDAARDLIDRLLDVDPSGRPGAGPGG 314
                                             +  A DL++++L +D   R  A    
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA---- 295

Query: 315 YAVLKMHPFFK 325
            A    H +F 
Sbjct: 296 -AQALAHAYFA 305

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 3e-46
 Identities = 52/257 (20%), Positives = 107/257 (41%), Gaps = 15/257 (5%)

Query: 59  LGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
             ++ G G +  V     +D        A+K +++  IT   + +    E I++    HP
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 88

Query: 116 GVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHS 173
            V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 174 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 233
              +HRD+   N +L     +K+ADFG  + M D          S            ++ 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK------EFDSVHNKTGAKLPVKWMA 202

Query: 234 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNYFSDA 291
            E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y  D 
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262

Query: 292 ARDLIDRLLDVDPSGRP 308
             +++ +        RP
Sbjct: 263 LYEVMLKCWHPKAEMRP 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 4e-46
 Identities = 44/261 (16%), Positives = 96/261 (36%), Gaps = 16/261 (6%)

Query: 55  QDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLD 110
                 K+ G G + +V +     +        A+K +   +  K+        E  ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMG 64

Query: 111 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALE 169
           Q  H  ++RL         + +  E  E G L   +  K G  S  +       +   ++
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 170 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 229
           Y+ +M  +HRD+   N+L+ ++   K++DFG  + ++D       +  +           
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-------DPEATYTTSGGKIPI 177

Query: 230 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNY 287
            +  PE ++    T  +D+W+ G  ++++++               + I    R   P  
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237

Query: 288 FSDAARDLIDRLLDVDPSGRP 308
              A   L+ +    + + RP
Sbjct: 238 CPSAIYQLMMQCWQQERARRP 258

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-45
 Identities = 57/320 (17%), Positives = 118/320 (36%), Gaps = 68/320 (21%)

Query: 54  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 113
           ++ ++  K  G G+   V  A         A+K + + F  + +     + E +++  ++
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 74

Query: 114 HPGVVRLFFTF------QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 167
           H  ++ L   F      ++   +Y+ +E  +          +  L  +   +   +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131

Query: 168 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 227
           ++++HS G+IHRD+KP N+++ +D  +KI DFG  +                     +V 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----------SFMMTPYVV 180

Query: 228 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-------- 279
           T  Y  PEV+         D+W++GC + +M+     F        + ++I         
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240

Query: 280 -------------------RDIRFPNYF---------------SDAARDLIDRLLDVDPS 305
                                + FP  F               +  ARDL+ ++L +DP+
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300

Query: 306 GRPGAGPGGYAVLKMHPFFK 325
            R             HP+  
Sbjct: 301 KRISV-----DDALQHPYIN 315

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 6e-44
 Identities = 53/295 (17%), Positives = 104/295 (35%), Gaps = 53/295 (17%)

Query: 56  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 115
              L +  G G + +V R K    G   A+KI   +    E ++ + + E      L H 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHE 57

Query: 116 GVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 171
            ++               L++  +  E G LFD + ++  ++ +            L ++
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHL 116

Query: 172 HS--------MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 223
           H           + HRD+K +N+L+  +G   IAD G       +  T+      D    
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------DIAPN 170

Query: 224 TFVGTAAYVPPEVLNSS------PATFGNDLWALGCTLYQMLSGTSPFKDTSEW------ 271
             VGT  Y+ PEVL+ S       +    D++A+G   +++    S      ++      
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 272 ---------LIFQRIIARDIR--FPNYFS-----DAARDLIDRLLDVDPSGRPGA 310
                     + + +  + +R   PN +           ++      + + R  A
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (354), Expect = 4e-38
 Identities = 59/362 (16%), Positives = 121/362 (33%), Gaps = 78/362 (21%)

Query: 50  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--- 106
           E +    + L +  G G +S V  AK +   T  A+KI+    +  E     +KL +   
Sbjct: 8   EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67

Query: 107 ----IVLDQLDHPGVVRLFFTFQDTFS--LYMALESCEGG---ELFDQITSKGHLSEDEA 157
                  D +    +++L   F       +++ +     G       +      +     
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 158 RFYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 216
           +  + +++  L+Y+    G+IH DIKPEN+L+      +      +  + ++        
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY----- 182

Query: 217 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS------- 269
             D+     + T  Y  PEVL  +P   G D+W+  C ++++++G   F+          
Sbjct: 183 --DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240

Query: 270 -----------------------------------------EWLIFQRIIARDIRFPNYF 288
                                                    ++   + ++    +F    
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300

Query: 289 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQS 348
           +    D +  +L +DP  R  A       L  HP+      K+  G    ++    +  S
Sbjct: 301 AKEISDFLSPMLQLDPRKRADA-----GGLVNHPWL-----KDTLGMEEIRVPDRELYGS 350

Query: 349 GE 350
           G 
Sbjct: 351 GS 352

>d1w1ha_ b.55.1.1 (A:) 3-phosphoinositide dependent protein kinase-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 147

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: 3-phosphoinositide dependent protein kinase-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.1 bits (176), Expect = 1e-15
 Identities = 34/136 (25%), Positives = 59/136 (43%), Gaps = 6/136 (4%)

Query: 363 HIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTS 422
           +I D+ +   + +   S  E  +          + W QF++    +L +  V K + L +
Sbjct: 6   YIHDLDSNSFELDLQFSEDEKRLLLEKQAGG--NPWHQFVE-NNLILKMGPVDKRKGLFA 62

Query: 423 KKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDA 482
           ++ QL+LT  P L YVDP   V+KG I WS        +  +   F + TP +     D 
Sbjct: 63  RRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQEL---RPEAKNFKTFFVHTPNRTYYLMDP 119

Query: 483 KQRASQWKKAIEALQN 498
              A +W + I+ +  
Sbjct: 120 SGNAHKWCRKIQEVWR 135

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.5 bits (177), Expect = 2e-15
 Identities = 21/159 (13%), Positives = 48/159 (30%), Gaps = 28/159 (17%)

Query: 58  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---------------V 102
            +GK+ G G  S V      +      +K       + +                     
Sbjct: 3   AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 103 KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 162
           + E   L +L    V +++          + +E                +  +       
Sbjct: 62  RNEFRALQKLQGLAVPKVY----AWEGNAVLME-------LIDAKELYRVRVENPDEVLD 110

Query: 163 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 201
            +++ +   +  G++H D+   N+L++ +  I I DF  
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 148

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	499
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1w1ha_	147	3-phosphoinositide dependent protein kinase-1 {Hum	99.91
d2coaa1	112	Protein kinase c, d2 type {Human (Homo sapiens) [T	99.58
d2coda1	102	Centaurin-delta 1 {Human (Homo sapiens) [TaxId: 96	99.51
d1faoa_	100	Dual adaptor of phosphotyrosine and 3-phosphoinosi	99.44
d1eaza_	103	Tapp1 {Human (Homo sapiens) [TaxId: 9606]}	99.33
d1btka_	169	Bruton's tyrosine kinase {Human (Homo sapiens) [Ta	99.24
d1qqga1	103	Insulin receptor substrate 1, IRS-1 {Human (Homo s	99.22
d2dyna_	111	Dynamin {Human (Homo sapiens) [TaxId: 9606]}	99.21
d1x1fa1	136	Signal-transducing adaptor protein 1, STAP-1 {Huma	99.21
d1v89a_	118	Rho-GTPase-activating protein 25 (KIAA0053) {Human	99.2
d1u5da1	106	Src kinase-associated phosphoprotein SKAP55 (SCAP1	99.16
d1v88a_	130	Oxysterol binding protein-related protein 8 (ORP-8	99.16
d1wg7a_	150	Dedicator of cytokinesis protein 9, DOCK9 {Human (	99.14
d1plsa_	113	Pleckstrin {Human (Homo sapiens) [TaxId: 9606]}	99.13
d2fjla1	101	Phosphoinositide phospholipase C, PLC-gamma-1 {Rat	99.12
d1v5ua_	117	SET binding factor 1, Sbf1 {Mouse (Mus musculus) [	99.11
d1omwa2	119	G-protein coupled receptor kinase 2 (beta-adrenerg	99.11
d1u5fa1	111	Src-associated adaptor protein Skap2 {Mouse (Mus m	99.11
d1unqa_	118	Rac-alpha serine/threonine kinase {Human (Homo sap	99.1
d2elba2	101	DCC-interacting protein 13-alpha, APPL1 {Human (Ho	99.1
d2i5fa1	104	Pleckstrin {Human (Homo sapiens) [TaxId: 9606]}	99.07
d2coca1	99	FYVE, RhoGEF and PH domain containing protein 3, F	99.06
d1fgya_	127	Grp1 {Mouse (Mus musculus) [TaxId: 10090]}	99.05
d1upqa_	107	Phosphoinositol 3-phosphate binding protein-1, PEP	99.03
d1u5ea1	209	Src-associated adaptor protein Skap2 {Mouse (Mus m	99.03
d1wgqa_	109	FYVE, RhoGEF and PH domain containing protein 6, F	99.03
d1wi1a_	126	Calcium-dependent activator protein for secretion,	99.01
d1x1ga1	116	Pleckstrin-2 {Human (Homo sapiens) [TaxId: 9606]}	98.97
d2j59m1	133	Rho GTPase-activating protein 21 {Human (Homo sapi	98.94
d2cofa1	95	KIAA1914 {Human (Homo sapiens) [TaxId: 9606]}	98.91
d1v5pa_	126	Tapp2 {Mouse (Mus musculus) [TaxId: 10090]}	98.88
d1v5ma_	136	SH2 and PH domain-containing adapter protein APS {	98.84
d1droa_	122	beta-spectrin {Fruit fly (Drosophila melanogaster)	98.63
d1btna_	106	beta-spectrin {Mouse (Mus musculus), brain [TaxId:	98.5
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.43
d1wjma_	123	beta-spectrin {Human (Homo sapiens), brain 2 isofo	98.41
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.97
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.87
d1v61a_	132	Rac/CDC42 GEF 6, alpha-pix {Mouse (Mus musculus) [	97.84
d1maia_	119	Phospholipase C delta-1 {Rat (Rattus norvegicus) [	97.71
d1zc3b1	109	Exocyst complex protein EXO84 {Rat (Rattus norvegi	97.26
d2dfka2	162	Rho guanine nucleotide exchange factor 9, Collybis	97.25
d1dbha2	133	Son of sevenless-1 (sos-1) {Human (Homo sapiens) [	97.23
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.89
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.83
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.41
d1ki1b2	142	GEF of intersectin {Human (Homo sapiens) [TaxId: 9	95.11
d1ntya2	121	Triple functional domain protein TRIO {Human (Homo	94.74
d1fhoa_	119	UNC-89 {Nematode (Caenorhabditis elegans) [TaxId:	94.42
d1xcga2	140	Rho guanine nucleotide exchange factor 11, PDZ-Rho	94.3
d1txda2	114	Rho guanine nucleotide exchange factor 12 {Human (	91.84
d1kz7a2	147	Dbl's big sister, Dbs {Mouse (Mus musculus) [TaxId	86.08

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-68  Score=526.87  Aligned_cols=283  Identities=49%  Similarity=0.864  Sum_probs=257.5

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      +...++|++++.||+|+||+||+|+++.+|+.||||++.+.....+.....+.+|+.+|++++|||||+++++|+++..+
T Consensus         4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~   83 (288)
T d1uu3a_           4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL   83 (288)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred             CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence            44568999999999999999999999999999999999887666666677888999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+.... 
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-  162 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-  162 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998765322 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                             ......+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++++|....+.+|..+++
T Consensus       163 -------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  235 (288)
T d1uu3a_         163 -------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP  235 (288)
T ss_dssp             --------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCH
T ss_pred             -------cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCH
Confidence                   1223446789999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCCCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLA  341 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~-~~~~~l~~Hpff~~i~~~~~~~~~~p~~~  341 (499)
                      ++++||.+||+.||.+|||+.+ .....+++||||++++|+.+..+.||.++
T Consensus       236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~  287 (288)
T d1uu3a_         236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT  287 (288)
T ss_dssp             HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence            9999999999999999999976 45667899999999999999999888653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-66  Score=520.51  Aligned_cols=280  Identities=37%  Similarity=0.648  Sum_probs=258.3

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      +++++||++++.||+|+||.||+|+++.||+.||||++.+...........+.+|+.+|+.++||||++++++|++...+
T Consensus         1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            35789999999999999999999999999999999999987665566667788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||+||+|.+++.+.+.++++.++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....  
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--  158 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--  158 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999865432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                              .....+++||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+...+++.+....+.+|..+|+
T Consensus       159 --------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~  230 (337)
T d1o6la_         159 --------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP  230 (337)
T ss_dssp             --------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred             --------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCH
Confidence                    233456899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKL  340 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~-~~p~~  340 (499)
                      ++++||.+||++||.+|++....+++++++||||++++|+.+..+ .+|++
T Consensus       231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~  281 (337)
T d1o6la_         231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPF  281 (337)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred             HHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCC
Confidence            999999999999999999876667899999999999999998654 33433

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-64  Score=503.51  Aligned_cols=271  Identities=37%  Similarity=0.712  Sum_probs=252.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ++++||++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+...+|
T Consensus         1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            46789999999999999999999999999999999998776655566677889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      +|||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+....    
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----  156 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----  156 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999986543    


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChH
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  291 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  291 (499)
                               ...+.+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+..+++......+|..++++
T Consensus       157 ---------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  227 (316)
T d1fota_         157 ---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED  227 (316)
T ss_dssp             ---------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ---------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHH
Confidence                     22357899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      +++||.+||+.||.+|++....+++++++||||++++|+.+..+
T Consensus       228 ~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~  271 (316)
T d1fota_         228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSR  271 (316)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTT
T ss_pred             HHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhC
Confidence            99999999999999998665556699999999999999988653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-65  Score=493.45  Aligned_cols=258  Identities=34%  Similarity=0.616  Sum_probs=242.1

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ++++++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++|||||++++++.++..+
T Consensus         2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence            46789999999999999999999999999999999999877655556667788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....   
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---  158 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---  158 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999976532   


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                               ......+||+.|||||++.+..++.++|||||||++|+|++|++||.+.+....++++....+.+|+.+|+
T Consensus       159 ---------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  229 (263)
T d2j4za1         159 ---------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE  229 (263)
T ss_dssp             ---------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCH
T ss_pred             ---------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCH
Confidence                     22346789999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ++++||.+||+.||++|||+     +++++||||+
T Consensus       230 ~~~~li~~~L~~dp~~R~t~-----~eil~hp~~~  259 (263)
T d2j4za1         230 GARDLISRLLKHNPSQRPML-----REVLEHPWIT  259 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH-----HHHHTCHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCH-----HHHHcCcCcC
Confidence            99999999999999999998     9999999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-62  Score=497.95  Aligned_cols=272  Identities=36%  Similarity=0.646  Sum_probs=250.8

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  130 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l  130 (499)
                      ...+++|++++.||+|+||+||+|+++.||+.||||++.+...........+.+|+.+|+.++|||||+++++|.+...+
T Consensus        37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            34578999999999999999999999999999999999877655555667788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      |+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+..   
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---  193 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence            99999999999999999989999999999999999999999999999999999999999999999999999987542   


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  290 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~  290 (499)
                                ...+.+||+.|||||++.+..++.++|||||||++|+|++|++||.+.+....+.+|....+.+|..+++
T Consensus       194 ----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  263 (350)
T d1rdqe_         194 ----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSS  263 (350)
T ss_dssp             ----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCH
T ss_pred             ----------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCH
Confidence                      2235789999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ++.+||.+||+.||.+|+.....+++++++||||++++|+.+..+
T Consensus       264 ~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~  308 (350)
T d1rdqe_         264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR  308 (350)
T ss_dssp             HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTT
T ss_pred             HHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhc
Confidence            999999999999999997433334599999999999999988654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-62  Score=490.62  Aligned_cols=268  Identities=35%  Similarity=0.637  Sum_probs=243.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHH-HhCCCCCccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~Iv~l~~~~~~~~~l~l  132 (499)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+...........+..|..++ +.++|||||+++++|.+...+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            47999999999999999999999999999999999876554444445555566655 57899999999999999999999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....    
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~----  156 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----  156 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT----
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc----
Confidence            9999999999999999899999999999999999999999999999999999999999999999999999865432    


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCChHH
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA  292 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  292 (499)
                            .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...++.+|....+.+|..+|+++
T Consensus       157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~  230 (320)
T d1xjda_         157 ------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA  230 (320)
T ss_dssp             ------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             ------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHH
Confidence                  12334568999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          293 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       293 ~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      ++||.+||+.||.+||++.    .++++||||++++|+.+..+
T Consensus       231 ~dli~~~L~~dP~~R~s~~----~~l~~hpff~~~~~~~l~~~  269 (320)
T d1xjda_         231 KDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERK  269 (320)
T ss_dssp             HHHHHHHSCSSGGGSBTTB----SCGGGSGGGTTCCHHHHHTT
T ss_pred             HHHHHHhcccCCCCCcCHH----HHHHhCchhccCCHHHHHhc
Confidence            9999999999999999983    26999999999999988654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6e-62  Score=495.16  Aligned_cols=272  Identities=32%  Similarity=0.573  Sum_probs=239.1

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHH---HHHHHhCCCCCccEEEEEEEcCC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE---RIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      +++++|++++.||+|+||.||+|+++.||+.||||++.+...........+.+|   ..+++.++|||||+++++|.+..
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            367999999999999999999999999999999999987655444433444444   55677778999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+...
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCH---HHHHHHHHhcCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRF  284 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~  284 (499)
                                  .....+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+.   ......+......+
T Consensus       161 ------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  228 (364)
T d1omwa3         161 ------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL  228 (364)
T ss_dssp             ------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCC
T ss_pred             ------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCC
Confidence                        233568999999999986 45689999999999999999999999986543   34455556667788


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  335 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~  335 (499)
                      |..+|+++++||.+||+.||.+|||+...+++++++||||++++|..+..+
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~  279 (364)
T d1omwa3         229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQ  279 (364)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTT
T ss_pred             CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcC
Confidence            899999999999999999999999976667799999999999999987654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-62  Score=476.74  Aligned_cols=257  Identities=29%  Similarity=0.452  Sum_probs=221.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+....  .....+.+|+.+|++++|||||++++++.++..+|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            68999999999999999999999999999999999876432  2234578899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.+.....   
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~---  158 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---  158 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence            99999999999999888999999999999999999999999999999999999999999999999999987643221   


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHH-HHHHhcCCC--CCCCCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF-QRIIARDIR--FPNYFS  289 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~-~~i~~~~~~--~p~~~~  289 (499)
                           .....+.+||+.|||||++.+..+ +.++|||||||++|+|++|++||...++.... ..+......  .+..+|
T Consensus       159 -----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  233 (271)
T d1nvra_         159 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID  233 (271)
T ss_dssp             -----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred             -----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCC
Confidence                 123346789999999999988775 67899999999999999999999876554333 333332222  224689


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      +++.+||.+||+.||++|||+     +++++||||+
T Consensus       234 ~~~~~li~~~L~~dP~~R~t~-----~eil~hpwf~  264 (271)
T d1nvra_         234 SAPLALLHKILVENPSARITI-----PDIKKDRWYN  264 (271)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHTTCTTTT
T ss_pred             HHHHHHHHHHcCCChhHCcCH-----HHHhcCHhhC
Confidence            999999999999999999998     8999999997

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-61  Score=476.18  Aligned_cols=253  Identities=28%  Similarity=0.461  Sum_probs=228.3

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+....   ....+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            4799999999999999999999999999999999865332   3456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccC
Q 010859          135 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  214 (499)
Q Consensus       135 E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  214 (499)
                      |||+||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....     
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-----  170 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----  170 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-----
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-----
Confidence            99999999998776 469999999999999999999999999999999999999999999999999998764321     


Q ss_pred             CCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---CCCCCCCCChH
Q 010859          215 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA  291 (499)
Q Consensus       215 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~  291 (499)
                           ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+...   .+..|..+|++
T Consensus       171 -----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  245 (293)
T d1yhwa1         171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI  245 (293)
T ss_dssp             -----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHH
T ss_pred             -----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHH
Confidence                 2334678999999999999999999999999999999999999999999888777776654   34556789999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          292 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       292 ~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +++||.+||+.||.+|||+     +++++||||+.
T Consensus       246 ~~~li~~~L~~dP~~R~s~-----~eil~Hp~~~~  275 (293)
T d1yhwa1         246 FRDFLNRCLDMDVEKRGSA-----KELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHTCSSTTTSCCH-----HHHTTCGGGGG
T ss_pred             HHHHHHHHccCChhHCcCH-----HHHhcCHhhCC
Confidence            9999999999999999988     89999999973

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-60  Score=471.04  Aligned_cols=263  Identities=30%  Similarity=0.525  Sum_probs=234.8

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+......   .....+.+|+.+|++++|||||+++++|++...+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            569999999999999999999999999999999987654332   23566888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC----CEEEEecCCccccCC
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQD  207 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~----~vkL~DFG~a~~~~~  207 (499)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+|+....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999999888999999999999999999999999999999999999998876    599999999987643


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--  285 (499)
                      .           ....+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++  
T Consensus       170 ~-----------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1jksa_         170 G-----------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE  238 (293)
T ss_dssp             S-----------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             C-----------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            2           233457899999999999999999999999999999999999999999999999999998887766  


Q ss_pred             --CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          286 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       286 --~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                        ..+|+++++||.+||+.||.+|||+     +++++||||++.+|+...
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~~~~~~~l  283 (293)
T d1jksa_         239 YFSNTSALAKDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQAL  283 (293)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSTTTCC-------
T ss_pred             hcCCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCChhHhh
Confidence              5689999999999999999999998     899999999999987653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-61  Score=477.35  Aligned_cols=255  Identities=34%  Similarity=0.601  Sum_probs=216.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .+.|++++.||+|+||+||+|+++.+|+.||||++.+.....  ....+.+|+.+|+.++|||||+++++|+++..+|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            466999999999999999999999999999999998765433  234577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC---CCCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~---~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+.   .++++||+|||+|+.....  
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--  163 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--  163 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence            99999999999999988999999999999999999999999999999999999995   4789999999999865432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                               ....+.+||+.|||||++.+..++.++|||||||++|+|++|++||.+.+.......+....+.++    .
T Consensus       164 ---------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (307)
T d1a06a_         164 ---------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD  234 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred             ---------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence                     233467899999999999999999999999999999999999999999999999999998876654    4


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+|+++++||.+||+.||++|||+     +++++||||++
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~  269 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTC-----EQALQHPWIAG  269 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSTTTTS
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCH-----HHHhcCHhhCC
Confidence            689999999999999999999998     89999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-60  Score=481.73  Aligned_cols=261  Identities=28%  Similarity=0.482  Sum_probs=236.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+..   ......+.+|+.+|++++|||||+++++|+++..+|+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            579999999999999999999999999999999997653   33456688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC--CCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~--~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+|+.+...  
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--  179 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  179 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence            999999999999854 467999999999999999999999999999999999999964  578999999999876432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  286 (499)
                               ....+.+||+.|||||++.+..++.++|||||||++|+|++|++||.+.+..+.+..|....+.++.    
T Consensus       180 ---------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  250 (350)
T d1koaa2         180 ---------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS  250 (350)
T ss_dssp             ---------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGG
T ss_pred             ---------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                     2334678999999999999999999999999999999999999999999999999999988877664    


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  333 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~  333 (499)
                      .+|+++++||.+||+.||++|||+     +++++||||+..+|....
T Consensus       251 ~~s~~~~~li~~~L~~dP~~R~t~-----~eil~hp~~~~~~~~~~~  292 (350)
T d1koaa2         251 GISEDGKDFIRKLLLADPNTRMTI-----HQALEHPWLTPGNAPGRD  292 (350)
T ss_dssp             GCCHHHHHHHHHHCCSSGGGSCCH-----HHHHHSTTTSCTTCCSCC
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCCCCCch
Confidence            589999999999999999999998     999999999987765443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-60  Score=464.73  Aligned_cols=255  Identities=29%  Similarity=0.528  Sum_probs=219.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLY  131 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~--~~~l~  131 (499)
                      .+||++++.||+|+||+||+|+++.||+.||+|++.+..... .....+.+|+.+|++++|||||++++++.+  +..+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            479999999999999999999999999999999998775543 345667889999999999999999999965  55699


Q ss_pred             EEEeccCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          132 MALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~~LH~~g-----IiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      +|||||+||+|.+++.+    .+.+++..++.++.||+.||.|||++|     |+||||||+||||+.+|.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999998864    357999999999999999999999976     999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  282 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~  282 (499)
                      +.+....          ....+.+||+.|||||++.+..++.++|||||||++|+|++|++||.+.+..++..+|....+
T Consensus       162 ~~~~~~~----------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~  231 (269)
T d2java1         162 RILNHDT----------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF  231 (269)
T ss_dssp             HHC---------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             eecccCC----------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence            8764321          223467899999999999999999999999999999999999999999999999999888765


Q ss_pred             -CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          283 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       283 -~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                       .+|..+|+++.+||.+||+.||.+|||+     +++++|||.
T Consensus       232 ~~~~~~~s~~l~~li~~~L~~dp~~Rps~-----~ell~hp~i  269 (269)
T d2java1         232 RRIPYRYSDELNEIITRMLNLKDYHRPSV-----EEILENPLI  269 (269)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSTTC
T ss_pred             CCCCcccCHHHHHHHHHHcCCChhHCcCH-----HHHHhCCcC
Confidence             4778899999999999999999999988     999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-60  Score=469.51  Aligned_cols=254  Identities=29%  Similarity=0.496  Sum_probs=226.2

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  134 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~  134 (499)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+..   ......+.+|+.+|+.++|||||+++++|.++..+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            46999999999999999999999999999999998653   223345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          135 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       135 E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......    
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~----  164 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----  164 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence            99999999998765 4569999999999999999999999999999999999999999999999999997653321    


Q ss_pred             CCCCCCCCccccccCccCCCccccC-----CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---CCC
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFP  285 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p  285 (499)
                            ....+.+||+.|+|||++.     +..++.++|||||||++|+|++|++||.+.+..+.+.++.....   ..|
T Consensus       165 ------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (288)
T d2jfla1         165 ------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP  238 (288)
T ss_dssp             ------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSG
T ss_pred             ------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence                  1223578999999999984     45688999999999999999999999999998888888887653   445


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ..+|+++++||.+||+.||.+|||+     +++++||||+.
T Consensus       239 ~~~s~~~~~li~~~L~~dp~~R~t~-----~ell~hp~~~~  274 (288)
T d2jfla1         239 SRWSSNFKDFLKKCLEKNVDARWTT-----SQLLQHPFVTV  274 (288)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSGGGCC
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCC
Confidence            6899999999999999999999998     89999999974

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-59  Score=476.30  Aligned_cols=255  Identities=30%  Similarity=0.533  Sum_probs=232.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+...   .....+.+|+.+|++++|||||+++++|.++..+|+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4679999999999999999999999999999999987532   2345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeC--CCCCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT--ADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~--~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+.+.+.+ ++++.+++.++.||+.||.|||++||+||||||+||||+  .++++||+|||+|+.+...  
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--  182 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  182 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence            99999999999877654 699999999999999999999999999999999999998  5689999999999876432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  286 (499)
                               ....+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+.+|....+.+|    .
T Consensus       183 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  253 (352)
T d1koba_         183 ---------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS  253 (352)
T ss_dssp             ---------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred             ---------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                     234467899999999999999999999999999999999999999999999999999999887766    4


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                      .+|+++++||.+||+.||.+|||+     +++++||||++.
T Consensus       254 ~~s~~~~~li~~~L~~dp~~R~s~-----~eil~Hp~~~~~  289 (352)
T d1koba_         254 SVSPEAKDFIKNLLQKEPRKRLTV-----HDALEHPWLKGD  289 (352)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSTTTSSC
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhCCC
Confidence            689999999999999999999998     899999999873

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-61  Score=480.56  Aligned_cols=261  Identities=27%  Similarity=0.451  Sum_probs=223.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++++.||+|+||+||+|+++.+|+.||+|++.+..  .......+.+|+.+|+.++|||||+++++|.++..+|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            44689999999999999999999999999999999998653  2334566788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.+...  
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999999999998899999999999999999999997 59999999999999999999999999999865321  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHH----------------
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----------------  274 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~----------------  274 (499)
                                ...+++||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+.....                
T Consensus       159 ----------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         159 ----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             ----------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             ----------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence                      234679999999999999999999999999999999999999999876532211                


Q ss_pred             --------------------------HHHHhc-CCCCC-CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          275 --------------------------QRIIAR-DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       275 --------------------------~~i~~~-~~~~p-~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                                ..+... ...+| ..+|.+++|||.+||+.||.+|||+     +++++||||+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta-----~e~L~Hpf~~~  303 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-----KQLMVHAFIKR  303 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHH
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCH-----HHHhhCHhhCc
Confidence                                      001110 01122 2368899999999999999999999     99999999987


Q ss_pred             CCccc
Q 010859          327 IDWKN  331 (499)
Q Consensus       327 i~~~~  331 (499)
                      .+|+.
T Consensus       304 ~~~~~  308 (322)
T d1s9ja_         304 SDAEE  308 (322)
T ss_dssp             HHHSC
T ss_pred             CCccc
Confidence            76653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-59  Score=465.50  Aligned_cols=252  Identities=27%  Similarity=0.384  Sum_probs=229.5

Q ss_pred             CeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           56 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      .|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|++++|||||+++++|.+...+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999988776666667778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      ||.||+|..++...+++++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+....        
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--------  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------  167 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--------
Confidence            999999988888888899999999999999999999999999999999999999999999999999975432        


Q ss_pred             CCCCCCccccccCccCCCccccCC---CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCh
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF--PNYFSD  290 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~  290 (499)
                            ....+||+.|||||++.+   ..|+.++|||||||++|+|++|+.||.+.+....+.++.......  +..+|+
T Consensus       168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~  241 (309)
T d1u5ra_         168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE  241 (309)
T ss_dssp             ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCH
T ss_pred             ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCH
Confidence                  235689999999999864   458899999999999999999999999999888888887765433  346899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ++++||.+||+.||.+|||+     +++++||||..
T Consensus       242 ~~~~li~~~L~~dP~~Rpt~-----~ell~Hp~~~~  272 (309)
T d1u5ra_         242 YFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVLR  272 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH-----HHHTTCHHHHS
T ss_pred             HHHHHHHHHCcCChhHCcCH-----HHHHhCHHhcC
Confidence            99999999999999999998     89999999963

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-59  Score=453.24  Aligned_cols=250  Identities=21%  Similarity=0.381  Sum_probs=219.1

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCeEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----TFSLYM  132 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~----~~~l~l  132 (499)
                      |++.+.||+|+||+||+|+++.+++.||+|++........ ....+.+|+.+|++++|||||+++++|.+    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            4788899999999999999999999999999987655443 35567889999999999999999999875    456899


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeecCCCCeeeC-CCCCEEEEecCCccccCCcc
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDlKp~NILl~-~~~~vkL~DFG~a~~~~~~~  209 (499)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+....  
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--  167 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  167 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence            9999999999999999889999999999999999999999999  99999999999997 478999999999975432  


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC-HHHHHHHHHhcC--CCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARD--IRFPN  286 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~-~~~~~~~i~~~~--~~~p~  286 (499)
                                ....+.+||+.|||||++.+ .++.++|||||||++|+|++|+.||.+.. ...+.+.+..+.  ..++.
T Consensus       168 ----------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  236 (270)
T d1t4ha_         168 ----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK  236 (270)
T ss_dssp             ----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred             ----------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence                      23346789999999999876 58999999999999999999999997654 445556665543  23556


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      ..++++++||.+||+.||++|||+     +++++||||+
T Consensus       237 ~~~~~~~~li~~~l~~dp~~R~s~-----~ell~Hp~fk  270 (270)
T d1t4ha_         237 VAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQ  270 (270)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCH-----HHHhCCcccC
Confidence            789999999999999999999988     9999999996

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-58  Score=452.12  Aligned_cols=257  Identities=30%  Similarity=0.517  Sum_probs=231.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh------hHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE------NKTAYVKLERIVLDQLD-HPGVVRLFFTFQD  126 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~------~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~  126 (499)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+......      .....+.+|+.+|++++ ||||++++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4799999999999999999999999999999999987654332      23345778999999996 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          127 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      +..+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccC------CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  280 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~------~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~  280 (499)
                      ..           ......+||+.|+|||++.      ...++.++||||+||++|+|++|+.||.+.+.....+.+...
T Consensus       162 ~~-----------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~  230 (277)
T d1phka_         162 PG-----------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  230 (277)
T ss_dssp             TT-----------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             CC-----------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence            32           2234578999999999984      344788999999999999999999999999999999999988


Q ss_pred             CCCCCC----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          281 DIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       281 ~~~~p~----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ...++.    .+|+++++||.+||+.||.+||++     +++++||||+.
T Consensus       231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~-----~eil~h~~~~~  275 (277)
T d1phka_         231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQQ  275 (277)
T ss_dssp             CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGCT
T ss_pred             CCCCCCcccccCCHHHHHHHHHHccCChhHCcCH-----HHHHcCHHHHH
Confidence            776553    689999999999999999999998     99999999985

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-58  Score=460.99  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=231.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|.++.||+.||||++.+..    .....+.+|+.+|+.++|||||+++++|+++..+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999997653    2234577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC--CCEEEEecCCccccCCccc
Q 010859          134 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~--~~vkL~DFG~a~~~~~~~~  210 (499)
                      ||||+||+|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.....  
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            99999999999998765 79999999999999999999999999999999999999855  48999999999865432  


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  286 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  286 (499)
                               ....+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+.+|....+.+|.    
T Consensus       158 ---------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (321)
T d1tkia_         158 ---------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK  228 (321)
T ss_dssp             ---------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             ---------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc
Confidence                     2334678999999999999999999999999999999999999999999999999999999888875    


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      .+|+++++||.+||+.||.+|||+     +++++||||+.
T Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~-----~eil~hp~~~~  263 (321)
T d1tkia_         229 EISIEAMDFVDRLLVKERKSRMTA-----SEALQHPWLKQ  263 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhcc
Confidence            689999999999999999999988     89999999964

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-57  Score=451.18  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=216.5

Q ss_pred             eeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchh--hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010859           58 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  135 (499)
Q Consensus        58 ~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E  135 (499)
                      +.+++||+|+||+||+|+++.+|+.||||++.+......  .....+.+|+.+|+.++|||||+++++|.++..+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            357899999999999999999999999999876543322  123457789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCC
Q 010859          136 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  215 (499)
Q Consensus       136 ~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  215 (499)
                      ||.++++..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......      
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------  154 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------  154 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc------
Confidence            99998888777777789999999999999999999999999999999999999999999999999998654321      


Q ss_pred             CCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 010859          216 AASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----------  283 (499)
Q Consensus       216 ~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----------  283 (499)
                          ....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.++.+++.+|......           
T Consensus       155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 ----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             ----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             ----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence                22345689999999999865 45799999999999999999999999999998888877652100           


Q ss_pred             ---------C--------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          284 ---------F--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       284 ---------~--------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                               +        ...+++++.+||.+||+.||++||||     +++++||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa-----~e~L~Hp~f~~~  286 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFSNR  286 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSGGGTSS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH-----HHHhCCHhhCCC
Confidence                     0        12468899999999999999999999     899999999853

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=446.06  Aligned_cols=252  Identities=31%  Similarity=0.538  Sum_probs=221.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhH---HHHHHHHHHHHHhCC--CCCccEEEEEEEcCC
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK---TAYVKLERIVLDQLD--HPGVVRLFFTFQDTF  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~---~~~~~~E~~~l~~l~--hp~Iv~l~~~~~~~~  128 (499)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+........   ...+.+|+.+|++++  |||||+++++|.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            368999999999999999999999999999999998765433211   122456899999886  899999999999999


Q ss_pred             eEEEEEeccCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCC-CCEEEEecCCccccC
Q 010859          129 SLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQ  206 (499)
Q Consensus       129 ~l~lv~E~~~g-g~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~-~~vkL~DFG~a~~~~  206 (499)
                      .+|+||||+.+ +++.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            99999999976 6888899888899999999999999999999999999999999999999855 799999999997643


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCC-CCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  285 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p  285 (499)
                      .            ....+++||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.      ..+......+|
T Consensus       163 ~------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~  224 (273)
T d1xwsa_         163 D------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR  224 (273)
T ss_dssp             S------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS
T ss_pred             c------------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC
Confidence            2            23346789999999999987664 67789999999999999999999864      34677888999


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                      ..+|+++++||.+||+.||++|||+     +++++||||+++-
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~s~-----~eil~hp~~~~~~  262 (273)
T d1xwsa_         225 QRVSSECQHLIRWCLALRPSDRPTF-----EEIQNHPWMQDVL  262 (273)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSCC
T ss_pred             CCCCHHHHHHHHHHccCCHhHCcCH-----HHHhcCHhhCCCC
Confidence            9999999999999999999999988     8999999998754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=449.31  Aligned_cols=280  Identities=38%  Similarity=0.692  Sum_probs=240.8

Q ss_pred             CCCCCCCeeeeeEeeecCceEEEEEEEc---CCCceEEEEEEeCcccch-hhHHHHHHHHHHHHHhCCC-CCccEEEEEE
Q 010859           50 EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDH-PGVVRLFFTF  124 (499)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~t~~~vAiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h-p~Iv~l~~~~  124 (499)
                      ++..+++|++++.||+|+||+||+|++.   .+|+.||||++.+..... ......+.+|+.+|++++| |||+++++++
T Consensus        19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~   98 (322)
T d1vzoa_          19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   98 (322)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence            4456799999999999999999999984   478999999997654322 2334456779999999976 8999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccc
Q 010859          125 QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  204 (499)
Q Consensus       125 ~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~  204 (499)
                      .+...+|++|||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCCC--CCCCCCcchhhhHHHHHHhcCCCCCCCCCHH----HHHHHHH
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRII  278 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDiwslG~ilyelltG~~Pf~~~~~~----~~~~~i~  278 (499)
                      +....         .....+..||+.|+|||.+.+.  .++.++|||||||+||+|++|+.||.+.+..    .+.+...
T Consensus       179 ~~~~~---------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~  249 (322)
T d1vzoa_         179 FVADE---------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  249 (322)
T ss_dssp             CCGGG---------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             hcccc---------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence            64432         1233467899999999999765  3678999999999999999999999876543    3344455


Q ss_pred             hcCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 010859          279 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  338 (499)
Q Consensus       279 ~~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~~~~~~~~~p  338 (499)
                      .....+|..+++++.+||.+||+.||.+|||+...+++++++||||++++|+.+..+..|
T Consensus       250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~  309 (322)
T d1vzoa_         250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP  309 (322)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCC
Confidence            667788889999999999999999999999876556799999999999999999875544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=441.62  Aligned_cols=258  Identities=29%  Similarity=0.452  Sum_probs=217.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||+||+|+++.+|+.||||++...... +.....+.+|+.+|++++|||||+++++|++...+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            47999999999999999999999999999999999665322 23345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHh-h-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          134 LESCEGGELFDQIT-S-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       134 ~E~~~gg~L~~~i~-~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      ||||.++ +.+++. . .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....   
T Consensus        80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~---  155 (298)
T d1gz8a_          80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---  155 (298)
T ss_dssp             EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---
T ss_pred             EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC---
Confidence            9999764 444443 2 356999999999999999999999999999999999999999999999999999865432   


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-------
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-------  283 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~-------  283 (499)
                             .......+||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+....+.++......       
T Consensus       156 -------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         156 -------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             -------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             -------cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence                   22334568999999999987666 578999999999999999999999999988877776542110       


Q ss_pred             -----------CC-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 010859          284 -----------FP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  328 (499)
Q Consensus       284 -----------~p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~  328 (499)
                                 ++           ..+++++++||.+||+.||++|||+     +++++||||++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~-----~ell~H~ff~~~~  290 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHPFFQDVT  290 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGTTCC
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH-----HHHhCCHhhccCC
Confidence                       11           2467899999999999999999998     8999999998763

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-57  Score=452.46  Aligned_cols=250  Identities=30%  Similarity=0.509  Sum_probs=214.0

Q ss_pred             CCCCeeeee-EeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHH-hCCCCCccEEEEEEEc----
Q 010859           53 SIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVRLFFTFQD----  126 (499)
Q Consensus        53 ~~~~y~~~~-~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~l~~~~~~----  126 (499)
                      .+++|++++ +||+|+||+||+|+++.||+.||||++.+.        ..+.+|+.++. .++|||||+++++|++    
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            468999875 699999999999999999999999998653        23556887754 5589999999999976    


Q ss_pred             CCeEEEEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC---CCCEEEEecCC
Q 010859          127 TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGS  201 (499)
Q Consensus       127 ~~~l~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~---~~~vkL~DFG~  201 (499)
                      +..+|+|||||+||+|.+++.+.  ..|++.+++.|+.||+.||+|||++||+||||||+|||++.   ++++||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            56799999999999999999875  36999999999999999999999999999999999999986   46799999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHH----HHH
Q 010859          202 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----QRI  277 (499)
Q Consensus       202 a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~----~~i  277 (499)
                      |+.....           ....+.+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+.....    ..+
T Consensus       161 a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i  229 (335)
T d2ozaa1         161 AKETTSH-----------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI  229 (335)
T ss_dssp             CEECCCC-----------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred             eeeccCC-----------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence            9865432           2234578999999999999999999999999999999999999999877654433    334


Q ss_pred             HhcCCCCCC----CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          278 IARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       278 ~~~~~~~p~----~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      ....+.+|.    .+|+++++||.+||+.||++|||+     +++++||||..
T Consensus       230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~  277 (335)
T d2ozaa1         230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  277 (335)
T ss_dssp             CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSHHHHT
T ss_pred             hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCH-----HHHHcCHHhhC
Confidence            445666664    589999999999999999999988     89999999963

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.4e-56  Score=436.45  Aligned_cols=250  Identities=27%  Similarity=0.458  Sum_probs=215.9

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----e
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----S  129 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~----~  129 (499)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++|||||++++++.+..    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999999999999999998876666666677889999999999999999999997643    4


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.++......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            89999999999999999998999999999999999999999999999999999999999999999999999987654322


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  285 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----  285 (499)
                             .......+.+||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+....+.++.......|    
T Consensus       166 -------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         166 -------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             --------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred             -------ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence                   112344567899999999999999999999999999999999999999999999888888887765543    


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      ..+|+++.+||.+||+.||.+||++
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~s  263 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQT  263 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhH
Confidence            5689999999999999999999965

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-56  Score=438.85  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=217.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCC-CceEEEEEEeCcccchhhHHHHHHHHHHHHHhC---CCCCccEEEEEEEc---
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQD---  126 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t-~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~Iv~l~~~~~~---  126 (499)
                      .++|++++.||+|+||+||+|++..+ ++.||||++.+....... ...+.+|+.+|+.|   +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            47899999999999999999999766 667999999765433222 22244566666554   89999999999853   


Q ss_pred             --CCeEEEEEeccCCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          127 --TFSLYMALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       127 --~~~l~lv~E~~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                        ...+|++||||.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              457999999999877654443 33569999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--
Q 010859          204 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--  281 (499)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~--  281 (499)
                      .....           ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+.++....  
T Consensus       165 ~~~~~-----------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  233 (305)
T d1blxa_         165 IYSFQ-----------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  233 (305)
T ss_dssp             CCCGG-----------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             hhccc-----------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            64332           23346789999999999999999999999999999999999999999999988888776420  


Q ss_pred             -------------------------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          282 -------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       282 -------------------------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                               ..++..+++++++||.+||+.||++|||+     +++++||||+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa-----~e~L~Hpff~~i~~  301 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYFQDLER  301 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTCCC
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH-----HHHhcChhhcCchh
Confidence                                     12345678999999999999999999998     89999999998875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.2e-55  Score=432.46  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=219.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||+||+|+++ +|+.||||++...... +.....+.+|+.+|++++|||||+++++|.+...+|++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            479999999999999999999986 7899999999776432 33345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|.......    
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~----  154 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV----  154 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc----
Confidence            9999987777777777889999999999999999999999999999999999999999999999999998654321    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-----------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  281 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~-----------  281 (499)
                            ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.++..++.++....           
T Consensus       155 ------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         155 ------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence                  223456799999999998754 57899999999999999999999999999888877765411           


Q ss_pred             ------------------CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          282 ------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       282 ------------------~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                                        ..++..+++++.|||++||+.||++|||+     +++++||||+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~-----~ell~Hp~f~~  286 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFKE  286 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGGC
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCc
Confidence                              11234578999999999999999999998     89999999973

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-54  Score=430.10  Aligned_cols=253  Identities=20%  Similarity=0.338  Sum_probs=206.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCc---eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      +..++|++.+.||+|+||+||+|+++.+|+   .||||.+....  .......+.+|+.+|++++|||||++++++.+..
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            456789999999999999999999987765   58888875542  2334456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .+|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+..
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999988774 5699999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p  285 (499)
                      ....     ..........||+.|||||++.+..++.++|||||||++|||+| |++||.+.+...+...+... .+..|
T Consensus       181 ~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~  255 (299)
T d1jpaa_         181 DTSD-----PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP  255 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred             CCCc-----ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            3211     01112223568999999999999999999999999999999998 89999999998888887664 35677


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAG  311 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~  311 (499)
                      ..+++++.+||.+||+.||.+||++.
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~  281 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFG  281 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHH
Confidence            88999999999999999999999983

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=435.50  Aligned_cols=255  Identities=23%  Similarity=0.394  Sum_probs=216.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCc-----eEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----VYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~-----~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~  125 (499)
                      +..++|++++.||+|+||+||+|++..+++     .||+|.+.....  ......+.+|..+|+++ +|||||++++++.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            345799999999999999999999876654     699998865432  22334567788899887 8999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecC
Q 010859          126 DTFSLYMALESCEGGELFDQITSK-----------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK  182 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~-----------------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlK  182 (499)
                      +...+|+|||||+||+|.+++...                       +.+++..++.|+.||+.||.|||++||+|||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            999999999999999999999754                       248999999999999999999999999999999


Q ss_pred             CCCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-C
Q 010859          183 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G  261 (499)
Q Consensus       183 p~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G  261 (499)
                      |+|||++.++++||+|||+|+......        ......+.+||+.|||||++.+..++.++|||||||++|||+| |
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~--------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDS--------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCT--------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             hhccccccCCeEEEeeccccccccCCC--------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence            999999999999999999998654322        1122335678999999999999999999999999999999998 8


Q ss_pred             CCCCCCCCHHHHHHHHHhcC--CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          262 TSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       262 ~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ++||.+.+....+.+++...  +..|..+|+++++||.+||+.||++|||+     ++|++|
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~-----~ei~~~  320 (325)
T d1rjba_         264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-----PNLTSF  320 (325)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            99999877666666666654  45678899999999999999999999998     778764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-54  Score=429.15  Aligned_cols=261  Identities=26%  Similarity=0.333  Sum_probs=216.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-------
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  126 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~-------  126 (499)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+.... +.....+.+|+.+|+.++||||+++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            58999999999999999999999999999999998766433 2334456779999999999999999998855       


Q ss_pred             -CCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCcccc
Q 010859          127 -TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  205 (499)
Q Consensus       127 -~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~  205 (499)
                       ...+|+|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence             3468999999988777666666678999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Q 010859          206 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF  284 (499)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  284 (499)
                      ......      ......+.+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.++......+......+
T Consensus       168 ~~~~~~------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         168 SLAKNS------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             CC-----------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccccc------ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            543211      12233456899999999998765 68999999999999999999999999999888877766532222


Q ss_pred             CC--------------------------------CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 010859          285 PN--------------------------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  326 (499)
Q Consensus       285 p~--------------------------------~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~  326 (499)
                      +.                                ..++++.|||.+||+.||++|||+     +++++||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa-----~elL~Hpff~~  310 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-----DDALNHDFFWS  310 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGSS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH-----HHHHcChhhcc
Confidence            21                                136788999999999999999999     89999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-54  Score=426.03  Aligned_cols=251  Identities=20%  Similarity=0.322  Sum_probs=216.8

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++++.||+|+||+||+|+++.+|+.||||++.+....    ...+.+|+.+|++++|||||+++++|.+...+|
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            3457999999999999999999999999999999998765332    345778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|||||++|+|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999999998754  568999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCC-CCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~P-f~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      .         .......||+.|+|||++.+..++.++|||||||++|||++|..| |.+.+.....+.+... .+.+|..
T Consensus       170 ~---------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         170 Y---------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG  240 (287)
T ss_dssp             S---------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             c---------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCcc
Confidence            1         122234689999999999999999999999999999999996555 5566665555555443 4567889


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      +|+++.+||.+||+.||++|||+     +++++
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~-----~ei~~  268 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSF-----AEIHQ  268 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCH-----HHHHH
Confidence            99999999999999999999998     66754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=424.36  Aligned_cols=254  Identities=20%  Similarity=0.310  Sum_probs=213.8

Q ss_pred             eEeeecCceEEEEEEEc--CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010859           61 KIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        61 ~~LG~G~~g~Vy~a~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv~E~~~  138 (499)
                      +.||+|+||+||+|.+.  .+++.||||++...... ......+.+|+.+|++++|||||++++++.++ ..|+|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            57999999999999865  45678999999765432 33445678899999999999999999999765 5789999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccccCCCCC
Q 010859          139 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  218 (499)
Q Consensus       139 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~  218 (499)
                      +|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+......       
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-------  163 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-------  163 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-------
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-------
Confidence            9999999999889999999999999999999999999999999999999999999999999999876543211       


Q ss_pred             CCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCChHHHHHH
Q 010859          219 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLI  296 (499)
Q Consensus       219 ~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li  296 (499)
                      ........||+.|||||++.+..++.++|||||||++|||+| |++||.+.+..++...+..+ .+.+|..+|+++.+||
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM  243 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence            112234579999999999999999999999999999999998 99999999988888877764 4678889999999999


Q ss_pred             HHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          297 DRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       297 ~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      .+||+.||++||++.+  +.+.++|+|++
T Consensus       244 ~~cl~~dp~~RPs~~~--i~~~L~~~~~~  270 (277)
T d1xbba_         244 NLCWTYDVENRPGFAA--VELRLRNYYYD  270 (277)
T ss_dssp             HHHTCSSTTTSCCHHH--HHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHH--HHHHhhCHHhh
Confidence            9999999999999822  22235677764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-54  Score=417.35  Aligned_cols=249  Identities=20%  Similarity=0.339  Sum_probs=209.5

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|+++ +++.||||++.+....    ...+.+|+.++++++|||||++++++.++..+|+|
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            468999999999999999999986 4678999998765333    23477899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      ||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~--  156 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--  156 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc--
Confidence            9999999999988755 5689999999999999999999999999999999999999999999999999987644321  


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCh
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSD  290 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  290 (499)
                             .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.....+.+..+ ....|..+++
T Consensus       157 -------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~  229 (263)
T d1sm2a_         157 -------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  229 (263)
T ss_dssp             ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCH
T ss_pred             -------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCH
Confidence                   12234679999999999999999999999999999999999 68888888888888877764 4556788999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ++.+||.+||+.||++||++     +++++|
T Consensus       230 ~l~~li~~cl~~~p~~Rps~-----~~il~~  255 (263)
T d1sm2a_         230 HVYQIMNHCWKERPEDRPAF-----SRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCH-----HHHHHH
Confidence            99999999999999999998     777764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-54  Score=433.00  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=213.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----  128 (499)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|....     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            4789999999999999999999999999999999976543 3444566788999999999999999999998654     


Q ss_pred             -eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 -~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                       .+|+||||| +.+|..++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             579999999 557776665 45799999999999999999999999999999999999999999999999999986532


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~----  282 (499)
                                   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.....    
T Consensus       174 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         174 -------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             -------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             -------------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence                         2345789999999999865 4578999999999999999999999999888776655543211    


Q ss_pred             ---------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          283 ---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       283 ---------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                                                 ..+..+++++.+||.+||+.||.+|||+     +++++||||+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEALAHPYFESLHD  309 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTC-
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH-----HHHhcChhhCcCCC
Confidence                                       1224578999999999999999999998     99999999998764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-53  Score=416.78  Aligned_cols=258  Identities=26%  Similarity=0.393  Sum_probs=224.0

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||++++++|.+...+++|
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            4789999999999999999999999999999999977643 444567788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccccc
Q 010859          134 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  213 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~  213 (499)
                      |+++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+......    
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----  155 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----  155 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC----
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC----
Confidence            9999999999988888899999999999999999999999999999999999999999999999999998764322    


Q ss_pred             CCCCCCCCccccccCccCCCccccCCCC-CCCCCcchhhhHHHHHHhcCCCCC-CCCCHHHHHHHHHhcCC---------
Q 010859          214 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDI---------  282 (499)
Q Consensus       214 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDiwslG~ilyelltG~~Pf-~~~~~~~~~~~i~~~~~---------  282 (499)
                            .......+++.|+|||++.+.. ++.++|||||||++|+|++|+.|| .+.+..+.++++.....         
T Consensus       156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             ------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence                  2223456788999999987665 689999999999999999999885 55666666666543111         


Q ss_pred             --------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          283 --------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       283 --------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                          ..+..+++++.+||.+||+.||.+||||     +++++||||+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa-----~e~L~Hp~f~~~  289 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYFSDF  289 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGSSC
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH-----HHHhcChhhcCC
Confidence                                1233568899999999999999999999     899999999863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-54  Score=422.55  Aligned_cols=261  Identities=20%  Similarity=0.292  Sum_probs=222.4

Q ss_pred             CCCCeeeeeE-eeecCceEEEEEEEcC--CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           53 SIQDFELGKI-YGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        53 ~~~~y~~~~~-LG~G~~g~Vy~a~~~~--t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..++|.+.+. ||+|+||+||+|.++.  ++..||||++.+..  .......+.+|+.+|++++|||||++++++.++ .
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~   82 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A   82 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-e
Confidence            3468899985 9999999999998764  45579999997542  233455678899999999999999999999765 5


Q ss_pred             EEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            89999999999999987654 57999999999999999999999999999999999999999999999999999877543


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  286 (499)
                      ...       .......+||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+ .+.+|.
T Consensus       163 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  235 (285)
T d1u59a_         163 DSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  235 (285)
T ss_dssp             SCE-------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred             ccc-------cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            211       122335579999999999998899999999999999999998 99999998888888887765 467889


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                      .+|+++.+||.+||+.||++||++.+  +.+.++|+|++
T Consensus       236 ~~~~~l~~li~~cl~~~p~~RPs~~~--i~~~L~~~~~~  272 (285)
T d1u59a_         236 ECPPELYALMSDCWIYKWEDRPDFLT--VEQRMRACYYS  272 (285)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHH--HHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHH--HHHHHHHHHHH
Confidence            99999999999999999999999832  34447788774

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-54  Score=414.61  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=222.1

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~lv  133 (499)
                      .++|++++.||+|+||+||+|+++ +++.||||++.+.....    ..+.+|+.++++++||||+++++++.++..+|+|
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            479999999999999999999985 68899999998764432    3577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccccc
Q 010859          134 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  212 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  212 (499)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.....  
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--  155 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--  155 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc--
Confidence            999999999998654 46799999999999999999999999999999999999999999999999999987654321  


Q ss_pred             cCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCh
Q 010859          213 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSD  290 (499)
Q Consensus       213 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~  290 (499)
                             .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++.+++..+ ....|...++
T Consensus       156 -------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~  228 (258)
T d1k2pa_         156 -------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE  228 (258)
T ss_dssp             -------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             -------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccH
Confidence                   12234679999999999999999999999999999999998 89999999999988888775 4567888999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          291 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       291 ~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ++.+||.+||+.||++|||+     +++++|
T Consensus       229 ~l~~li~~cl~~dP~~RPt~-----~eil~~  254 (258)
T d1k2pa_         229 KVYTIMYSCWHEKADERPTF-----KILLSN  254 (258)
T ss_dssp             HHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCH-----HHHHHH
Confidence            99999999999999999988     788876

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=430.64  Aligned_cols=250  Identities=30%  Similarity=0.449  Sum_probs=211.6

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE------cCC
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ------DTF  128 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~------~~~  128 (499)
                      -+|+.+++||+|+||+||+|+++.+|+.||||++.+....       ..+|+.+|+.++||||++++++|.      +..
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            4799999999999999999999999999999999765322       235899999999999999999984      344


Q ss_pred             eEEEEEeccCCCChHH---HHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEecCCccc
Q 010859          129 SLYMALESCEGGELFD---QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKP  204 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~---~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~~  204 (499)
                      ++|+|||||+++.+..   +......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            6899999998753322   233456799999999999999999999999999999999999999875 899999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCccCCCccccCC-CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhc---
Q 010859          205 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---  280 (499)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~---  280 (499)
                      +...           ....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+.++...   
T Consensus       173 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         173 LVRG-----------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  241 (350)
T ss_dssp             CCTT-----------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccCC-----------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            5432           23345789999999999865 46899999999999999999999999999888877776531   


Q ss_pred             --------------CCCC------------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          281 --------------DIRF------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       281 --------------~~~~------------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                    ...+            ...+++++.+||.+||+.||++|||+     +++++||||+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~f~~~  309 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFFDEL  309 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGGG
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhccc
Confidence                          1111            23478999999999999999999999     899999999865

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-53  Score=427.40  Aligned_cols=253  Identities=26%  Similarity=0.454  Sum_probs=212.2

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEc--CCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD--TFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~--~~~  129 (499)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+..      ...+.+|+.+|+.+. ||||++++++|..  ...
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            3578999999999999999999999999999999986542      345778999999985 9999999999974  457


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC-CEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~-~vkL~DFG~a~~~~~~  208 (499)
                      +|+|||||.+++|..+.   +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999999997763   4599999999999999999999999999999999999998765 6999999999865432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCH-HHHHHHHHh-------
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIA-------  279 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~-~~~~~~i~~-------  279 (499)
                                 ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ......+..       
T Consensus       184 -----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~  252 (328)
T d3bqca1         184 -----------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  252 (328)
T ss_dssp             -----------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             -----------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence                       233466899999999998765 479999999999999999999999976543 222222211       


Q ss_pred             ------cCC------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          280 ------RDI------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       280 ------~~~------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                            ...                        ..+..+++++.|||++||+.||.+|||+     +++++||||+++.|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----REAMEHPYFYTVVK  327 (328)
T ss_dssp             HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTSCC
T ss_pred             hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCCC
Confidence                  000                        0112478999999999999999999999     99999999999998


Q ss_pred             c
Q 010859          330 K  330 (499)
Q Consensus       330 ~  330 (499)
                      +
T Consensus       328 ~  328 (328)
T d3bqca1         328 D  328 (328)
T ss_dssp             C
T ss_pred             C
Confidence            5

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=419.68  Aligned_cols=254  Identities=22%  Similarity=0.353  Sum_probs=219.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++++.||+|+||+||+|+++ +++.||||++......    ...+.+|+.+|++++|||||++++++.+ ..+|
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence            34579999999999999999999985 5788999999765332    2457789999999999999999998765 4679


Q ss_pred             EEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|||||++|+|.+++...  .++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            999999999999977644  359999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                      .         .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.....+.+..+ ....|..
T Consensus       164 ~---------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~  234 (272)
T d1qpca_         164 Y---------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN  234 (272)
T ss_dssp             E---------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             c---------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence            1         12234579999999999998899999999999999999999 56777888888888877764 4567889


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc--CCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK  325 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~--Hpff~  325 (499)
                      +++++.+||.+||+.||++|||+     +++++  |+||.
T Consensus       235 ~~~~l~~li~~cl~~~P~~Rpt~-----~ei~~~L~~~ft  269 (272)
T d1qpca_         235 CPEELYQLMRLCWKERPEDRPTF-----DYLRSVLEDFFT  269 (272)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCCHhHCcCH-----HHHHHHhhhhhh
Confidence            99999999999999999999998     77876  77875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=420.15  Aligned_cols=252  Identities=21%  Similarity=0.348  Sum_probs=207.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++++.||+|+||+||+|+..   ..||||++....... .....+.+|+.+|++++|||||++++++. +..+|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence            34578999999999999999999753   469999997654433 34566788999999999999999999765 45689


Q ss_pred             EEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCccc
Q 010859          132 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  210 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~  210 (499)
                      +|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+...... 
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~-  158 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-  158 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC-
Confidence            999999999999999754 569999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccCCCCCCCCccccccCccCCCccccCC---CCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-----
Q 010859          211 TVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-----  282 (499)
Q Consensus       211 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~-----  282 (499)
                             ......+.+||+.|||||++.+   ..++.++|||||||++|||+||+.||.+.+.......+.....     
T Consensus       159 -------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~  231 (276)
T d1uwha_         159 -------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL  231 (276)
T ss_dssp             --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred             -------CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc
Confidence                   1123346789999999999864   3478899999999999999999999998776655544444332     


Q ss_pred             -CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          283 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       283 -~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                       ..+..+|+++.+||.+||+.||++|||+     +++++|
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~~il~~  266 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERPLF-----PQILAS  266 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             hhccccchHHHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence             2456789999999999999999999998     677654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=423.46  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=212.5

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----e
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----S  129 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~-----~  129 (499)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+.+|+.+|+.++||||+++++++....     .
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            46999999999999999999999999999999997643  3344556778999999999999999999997543     3


Q ss_pred             EEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          130 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|++ +|+.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        86 ~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          86 VYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            4555 556689999999764 69999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccC-CCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC------
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI------  282 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~------  282 (499)
                      .       ........+||+.|+|||++. +..++.++||||+||++|+|++|++||.+.+.............      
T Consensus       164 ~-------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         164 D-------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             C-------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             c-------cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            1       122334678999999999984 45678999999999999999999999999887666555432100      


Q ss_pred             -------------------------CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          283 -------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       283 -------------------------~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                               .....+++++++||.+||+.||.+|||+     +++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta-----~e~L~hpf~~~~  301 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-----EQALAHPYLEQY  301 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTT
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhccC
Confidence                                     0123568899999999999999999998     999999999853

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=426.09  Aligned_cols=255  Identities=23%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------C
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------T  127 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~------~  127 (499)
                      +++|++++.||+|+||+||+|+++.||+.||||++.+.... ......+.+|+.+|+.++|||||+++++|..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            47899999999999999999999999999999999877543 3445567889999999999999999999963      4


Q ss_pred             CeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          128 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+|+|||||.+ ++.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++....
T Consensus        95 ~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence            689999999976 5555554  4599999999999999999999999999999999999999999999999999876433


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC----
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR----  283 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~----  283 (499)
                      .           ......+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+......++......    
T Consensus       172 ~-----------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         172 S-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             c-----------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            2           2334668999999999999999999999999999999999999999999887777666531110    


Q ss_pred             ------------------C---------C-----------CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 010859          284 ------------------F---------P-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  325 (499)
Q Consensus       284 ------------------~---------p-----------~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~  325 (499)
                                        .         +           ...++++.+||++||+.||++||||     +++++||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta-----~elL~Hpw~~  315 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DDALQHPYIN  315 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTG
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH-----HHHhcCcccC
Confidence                              0         0           1136789999999999999999999     9999999998


Q ss_pred             CCC
Q 010859          326 GID  328 (499)
Q Consensus       326 ~i~  328 (499)
                      ..-
T Consensus       316 ~~~  318 (355)
T d2b1pa1         316 VWY  318 (355)
T ss_dssp             GGC
T ss_pred             CCC
Confidence            643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=409.68  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=207.7

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCC---ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  129 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~  129 (499)
                      ..++|++++.||+|+||+||+|++..++   ..||||.+...  ........+.+|..+|++++|||||++++++.+ ..
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~   81 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP   81 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-Ce
Confidence            3478999999999999999999987553   46888887443  234445668889999999999999999999964 57


Q ss_pred             EEEEEeccCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          130 LYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       130 l~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      +|+|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.+...
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            8999999999999998765 457999999999999999999999999999999999999999999999999999875432


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~  286 (499)
                      .         .......+||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++..++..+. .++|.
T Consensus       162 ~---------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~  232 (273)
T d1mp8a_         162 T---------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP  232 (273)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             c---------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            2         122335678999999999999999999999999999999998 999999999888888887754 57888


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      .+|+++.+||.+||+.||.+|||+     ++|++|
T Consensus       233 ~~~~~~~~li~~cl~~dp~~Rps~-----~ei~~~  262 (273)
T d1mp8a_         233 NCPPTLYSLMTKCWAYDPSRRPRF-----TELKAQ  262 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence            999999999999999999999998     777654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=424.13  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=214.8

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  128 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~-----~  128 (499)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+.+|+.++|||||+++++|...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            368999999999999999999999999999999998764433 3345577899999999999999999999633     3


Q ss_pred             eEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          129 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      ..+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|..... 
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence            44666777889999998865 4799999999999999999999999999999999999999999999999999875432 


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCC-CCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC---
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF---  284 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---  284 (499)
                                  ...+..||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.......   
T Consensus       174 ------------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         174 ------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  241 (348)
T ss_dssp             ------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ------------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence                        23456899999999997665 46889999999999999999999999999888877776532221   


Q ss_pred             ----------------------------CCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 010859          285 ----------------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  327 (499)
Q Consensus       285 ----------------------------p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff~~i  327 (499)
                                                  ...++++++|||.+||+.||.+|||+     +++++||||+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~elL~Hp~f~~~  307 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQY  307 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTT
T ss_pred             HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH-----HHHhcCHhhCCC
Confidence                                        12478999999999999999999998     999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=406.71  Aligned_cols=250  Identities=18%  Similarity=0.300  Sum_probs=206.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCC----ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~----~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      +..+.|++.++||+|+||+||+|.++.++    ..||||++.....  ......+.+|+.+|++++|||||++++++.+.
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            44578999999999999999999987665    4799999965432  23344577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccC
Q 010859          128 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  206 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~  206 (499)
                      ..+|+|||||.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999999987655 579999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 010859          207 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  284 (499)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  284 (499)
                      ....       .........||+.|||||++.+..++.++|||||||++|||++ |.+||.+.+..+.++.+..+ ....
T Consensus       162 ~~~~-------~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~  234 (283)
T d1mqba_         162 DDPE-------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT  234 (283)
T ss_dssp             -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCCc-------cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC
Confidence            4321       1112234578999999999999999999999999999999999 56666777777777776654 4567


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |..++.++.+||.+||+.||++||++
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~RPt~  260 (283)
T d1mqba_         235 PMDCPSAIYQLMMQCWQQERARRPKF  260 (283)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCH
T ss_pred             chhhHHHHHHHHHHHCcCCHhHCcCH
Confidence            78899999999999999999999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=410.71  Aligned_cols=255  Identities=20%  Similarity=0.343  Sum_probs=214.5

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  131 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~~l~  131 (499)
                      +..++|++++.||+|+||+||+|+++.+ +.||||++......    ...+.+|+.+|++++|||||++++++.+ ..+|
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            4458999999999999999999999765 57999999765433    2457789999999999999999999865 4579


Q ss_pred             EEEeccCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcc
Q 010859          132 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       132 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~  209 (499)
                      +|||||++|+|..++...  +.+++.++..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+....
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999999999999887643  569999999999999999999999999999999999999999999999999998664332


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  287 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  287 (499)
                               ........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+... ...+|..
T Consensus       168 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  238 (285)
T d1fmka3         168 ---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE  238 (285)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ---------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc
Confidence                     122234679999999999999999999999999999999999 56677778887788777654 4568889


Q ss_pred             CChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc--CCCCCC
Q 010859          288 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKG  326 (499)
Q Consensus       288 ~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~--Hpff~~  326 (499)
                      +++++++||.+||+.||++||++     +++++  |+||..
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~-----~~i~~~L~~~~~~  274 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTF-----EYLQAFLEDYFTS  274 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHTTTSC
T ss_pred             cCHHHHHHHHHHcccCHhHCcCH-----HHHHHHHhhhhcC
Confidence            99999999999999999999988     77876  888875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=414.97  Aligned_cols=253  Identities=19%  Similarity=0.310  Sum_probs=211.1

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCc----eEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      ...||++++.||+|+||+||+|.+..+|+    .||+|.+....  .......+.+|+.+|++++|||||++++++.++ 
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            34689999999999999999999998887    47777765432  223345678899999999999999999999875 


Q ss_pred             eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      ..+++|||+.+|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+..
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            567888999999999887765 5799999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcC-CCCC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFP  285 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p  285 (499)
                      ...        ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+..+. +..|
T Consensus       164 ~~~--------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p  235 (317)
T d1xkka_         164 EEK--------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP  235 (317)
T ss_dssp             TCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred             ccc--------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            321        122334579999999999999999999999999999999998 899999988877777776644 5678


Q ss_pred             CCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          286 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       286 ~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ..+++++.+||.+||+.||.+|||+     .+++.|
T Consensus       236 ~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~~  266 (317)
T d1xkka_         236 PICTIDVYMIMVKCWMIDADSRPKF-----RELIIE  266 (317)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             cccCHHHHHHHHHhCCCChhhCcCH-----HHHHHH
Confidence            8899999999999999999999998     778877

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=407.58  Aligned_cols=251  Identities=23%  Similarity=0.369  Sum_probs=206.4

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcC-CC--ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKID-TG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  128 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-t~--~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~  128 (499)
                      +..+||++++.||+|+||+||+|+... ++  ..||||++.+...........+.+|+.+|++++|||||++++++.+. 
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence            345789999999999999999998653 33  36899999877666666667788999999999999999999999764 


Q ss_pred             eEEEEEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCC
Q 010859          129 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  207 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~  207 (499)
                      .+|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            678999999999999877654 5699999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHhcCC--CC
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI--RF  284 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~~~~--~~  284 (499)
                      ....       ........||..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+...++.....  +.
T Consensus       164 ~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (273)
T d1u46a_         164 NDDH-------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR  236 (273)
T ss_dssp             -CCE-------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred             CCCc-------ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC
Confidence            3211       122234568889999999999999999999999999999998 8999999999999998887654  45


Q ss_pred             CCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          285 PNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       285 p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      |..+|+++.+||.+||..||++|||+
T Consensus       237 ~~~~~~~l~~li~~cl~~dp~~RPt~  262 (273)
T d1u46a_         237 PEDCPQDIYNVMVQCWAHKPEDRPTF  262 (273)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cccccHHHHHHHHHHcCCChhHCcCH
Confidence            67899999999999999999999988

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=407.97  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=201.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcC-----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~  125 (499)
                      +..++|++++.||+|+||.||+|++..     +++.||||++......  .....+..|..++.++ +|+||+.+++++.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            345789999999999999999999764     4578999998654322  2233344555555554 7899999999876


Q ss_pred             c-CCeEEEEEeccCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeee
Q 010859          126 D-TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL  188 (499)
Q Consensus       126 ~-~~~l~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl  188 (499)
                      . ...+|+|||||++|+|.+++...                ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  167 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence            5 55799999999999999999753                248999999999999999999999999999999999999


Q ss_pred             CCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcC-CCCCCC
Q 010859          189 TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKD  267 (499)
Q Consensus       189 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG-~~Pf~~  267 (499)
                      +.++++||+|||+|+......        ......+.+||+.|+|||++.+..++.++|||||||++|||++| .+||.+
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~--------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDP--------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CGGGCEEECC------CCSCT--------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCCcEEEccCcchhhccccc--------cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            999999999999998654322        12234467899999999999999999999999999999999986 678887


Q ss_pred             CCHHHHHHHHHh--cCCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          268 TSEWLIFQRIIA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       268 ~~~~~~~~~i~~--~~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      .+....+..++.  ..+.+|+.+++++.+||.+||+.||++|||+     +++++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~eil~~  290 (299)
T d1ywna1         240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  290 (299)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            665444444433  3466788899999999999999999999998     778765

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=409.07  Aligned_cols=252  Identities=24%  Similarity=0.369  Sum_probs=216.0

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCce--EEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  128 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~--vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~~~~  128 (499)
                      +..++|++.+.||+|+||+||+|+++.+|..  ||||.+....  .......+.+|+.+|+++ +|||||++++++.++.
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            4568999999999999999999999988875  5667665332  223345578899999998 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCC
Q 010859          129 SLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG  192 (499)
Q Consensus       129 ~l~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~  192 (499)
                      .+|+|||||+||+|.+++.+.                ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999998654                5699999999999999999999999999999999999999999


Q ss_pred             CEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcC-CCCCCCCCHH
Q 010859          193 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKDTSEW  271 (499)
Q Consensus       193 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG-~~Pf~~~~~~  271 (499)
                      .+||+|||+|+.....           .......||..|+|||.+.+..++.++|||||||++|||++| .+||.+.+..
T Consensus       165 ~~kl~DfG~a~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~  233 (309)
T d1fvra_         165 VAKIADFGLSRGQEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  233 (309)
T ss_dssp             CEEECCTTCEESSCEE-----------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             ceEEcccccccccccc-----------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999764322           122356799999999999999999999999999999999996 5689999988


Q ss_pred             HHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          272 LIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       272 ~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      ++.+.+..+ .+.+|..+++++++||.+||+.||++||++     +++++|
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~~  279 (309)
T d1fvra_         234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILVS  279 (309)
T ss_dssp             HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            888887664 566788899999999999999999999998     778876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-51  Score=405.79  Aligned_cols=248  Identities=21%  Similarity=0.314  Sum_probs=216.6

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  127 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~  127 (499)
                      ..++|++++.||+|+||+||+|+.+     .+++.||||++....  .......+.+|+.+|+.++||||+++++++.+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            3578999999999999999999975     356899999986543  233456678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCC
Q 010859          128 FSLYMALESCEGGELFDQITSKG------------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP  183 (499)
Q Consensus       128 ~~l~lv~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp  183 (499)
                      ..++++|||+++|+|.+++....                        .+++..+..++.||+.||+|||++||+||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999986532                        388999999999999999999999999999999


Q ss_pred             CCeeeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcC-C
Q 010859          184 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-T  262 (499)
Q Consensus       184 ~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG-~  262 (499)
                      +|||++.++++||+|||+|+.+....        ......+.+||+.|+|||++.+..++.++|||||||++|||++| .
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSAD--------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGG--------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             cceEECCCCcEEEccchhheeccCCc--------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            99999999999999999998664432        12233467899999999999999999999999999999999998 4


Q ss_pred             CCCCCCCHHHHHHHHHhcCC-CCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          263 SPFKDTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       263 ~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                      +||.+.+..+....+..+.. ..|..+++++.+||.+||+.||++|||+
T Consensus       241 ~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~  289 (301)
T d1lufa_         241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF  289 (301)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence            78999999998888887654 4688899999999999999999999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=400.63  Aligned_cols=244  Identities=23%  Similarity=0.395  Sum_probs=207.6

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCeE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTFSL  130 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~-~~~~l  130 (499)
                      +..++|++++.||+|+||.||+|++  +|+.||||++++..     ..+.+.+|+.++++++||||+++++++. +...+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            5678999999999999999999998  47899999986542     2345778999999999999999999885 45678


Q ss_pred             EEEEeccCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCc
Q 010859          131 YMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  208 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~  208 (499)
                      |+||||+++|+|.+++.+.+  .+++..++.++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++.... 
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence            99999999999999997643  489999999999999999999999999999999999999999999999999985432 


Q ss_pred             cccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHh-cCCCCCC
Q 010859          209 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDIRFPN  286 (499)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~~~~~~~~~~~i~~-~~~~~p~  286 (499)
                                  ......||+.|+|||++.+..++.++|||||||++|||+| |++||...+.......+.. ..+++|.
T Consensus       156 ------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~  223 (262)
T d1byga_         156 ------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD  223 (262)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT
T ss_pred             ------------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence                        2234578999999999998999999999999999999998 8999999888888887765 4567889


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          287 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       287 ~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      .+++++.+||.+||+.||.+|||+     +++++
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~-----~~l~~  252 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSF-----LQLRE  252 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCH-----HHHHH
Confidence            999999999999999999999998     55554

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-51  Score=403.65  Aligned_cols=254  Identities=24%  Similarity=0.369  Sum_probs=214.3

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEcCCC-------ceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKIDTG-------TVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFT  123 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~t~-------~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~  123 (499)
                      +..++|++++.||+|+||.||+|++..++       ..||||++.+...  ......+.+|...+.++ +|||||+++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            45689999999999999999999987654       4799999876532  23344566677777776 89999999999


Q ss_pred             EEcCCeEEEEEeccCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCee
Q 010859          124 FQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  187 (499)
Q Consensus       124 ~~~~~~l~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NIL  187 (499)
                      +.++..+|+|||||++|+|.+++....                .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            999999999999999999999997542                4899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCC
Q 010859          188 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  266 (499)
Q Consensus       188 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~  266 (499)
                      ++.++.+||+|||+++......        ........+||+.|+|||++.+..++.++|||||||++|||++ |.+||.
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHID--------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCC--------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ecCCCCeEeccchhhccccccc--------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence            9999999999999998765432        1223446789999999999999999999999999999999998 799999


Q ss_pred             CCCHHHHHHHHHhc-CCCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          267 DTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       267 ~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                      +.+....++.+..+ .+.+|..+++++.+||.+||+.||++|||+     .++++
T Consensus       240 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~-----~eil~  289 (299)
T d1fgka_         240 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  289 (299)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCH-----HHHHH
Confidence            99988888777654 466788999999999999999999999998     66653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=401.62  Aligned_cols=263  Identities=19%  Similarity=0.306  Sum_probs=226.1

Q ss_pred             CCCCCCeeeeeEeeecCceEEEEEEEcC-----CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010859           51 HFSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  125 (499)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~  125 (499)
                      .+..++|++++.||+|+||+||+|.++.     +++.||||++.+..  .......+.+|+.++++++|||||++++++.
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            3456899999999999999999998853     46789999987543  3334456788999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEE
Q 010859          126 DTFSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  195 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~----------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vk  195 (499)
                      .+..+++|||||++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++|
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence            999999999999999999988643          2478999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcC-CCCCCCCCHHHHH
Q 010859          196 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKDTSEWLIF  274 (499)
Q Consensus       196 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG-~~Pf~~~~~~~~~  274 (499)
                      |+|||+|+.+.....        .......+||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+
T Consensus       174 l~DFGla~~~~~~~~--------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~  245 (308)
T d1p4oa_         174 IGDFGMTRDIYETDY--------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  245 (308)
T ss_dssp             ECCTTCCCGGGGGGC--------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             EeecccceeccCCcc--------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999987654321        1223456799999999999999999999999999999999998 6899999999988


Q ss_pred             HHHHhcC-CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc------CCCCCCCC
Q 010859          275 QRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM------HPFFKGID  328 (499)
Q Consensus       275 ~~i~~~~-~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~------Hpff~~i~  328 (499)
                      +.+..+. ...|..+++.+.+||.+||+.||++|||+     +++++      +|+|+.++
T Consensus       246 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-----~~il~~L~~~~~~~~~~~~  301 (308)
T d1p4oa_         246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIISSIKEEMEPGFREVS  301 (308)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHGGGSCTTHHHHC
T ss_pred             HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-----HHHHHHHHHhcCCCCcCCC
Confidence            8887754 45678899999999999999999999988     66665      67775433

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-50  Score=397.54  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=216.7

Q ss_pred             CCCCCeeeeeEeeecCceEEEEEEEc-----CCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010859           52 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  125 (499)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~l~~~~~  125 (499)
                      +..++|++++.||+|+||.||+|+..     .+++.||||++.+..  .......+.+|..+++.+ +|||||++++++.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            44589999999999999999999863     467899999997653  233445677899999988 6999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCee
Q 010859          126 DTFSLYMALESCEGGELFDQITSKG------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  187 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L~~~i~~~~------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NIL  187 (499)
                      +...+|+|||||++|+|.+++.+..                  .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            9999999999999999999987543                  5899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhc-CCCCCC
Q 010859          188 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  266 (499)
Q Consensus       188 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyellt-G~~Pf~  266 (499)
                      ++.++.+||+|||+++.......        .......+||+.|+|||++.+..++.++|||||||++|||+| |.+||.
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSN--------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTT--------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ccccCcccccccchheeccCCCc--------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence            99999999999999987654321        122235689999999999999999999999999999999998 777787


Q ss_pred             CCCHHHHHHHHHhcC--CCCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 010859          267 DTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  319 (499)
Q Consensus       267 ~~~~~~~~~~i~~~~--~~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~  319 (499)
                      +.+....+.+++...  ...|..+|+++.+||.+||+.||.+||++     ++++
T Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-----~~il  299 (311)
T d1t46a_         250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-----KQIV  299 (311)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCH-----HHHH
Confidence            777766666665543  34567789999999999999999999998     6665

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-49  Score=391.74  Aligned_cols=259  Identities=20%  Similarity=0.263  Sum_probs=204.7

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCeEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-Iv~l~~~~~~~~~l~lv  133 (499)
                      ++|++++.||+|+||+||+|++..+|+.||||++......     ..+..|..+++.++|++ |+.++.++.+....++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4699999999999999999999999999999998765322     23567999999997765 55666777888999999


Q ss_pred             EeccCCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC---CCCEEEEecCCccccCCcc
Q 010859          134 LESCEGGELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSR  209 (499)
Q Consensus       134 ~E~~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~---~~~vkL~DFG~a~~~~~~~  209 (499)
                      |||+.+ +|...+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.+....
T Consensus        82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            999954 6666554 4567999999999999999999999999999999999999864   4579999999999876543


Q ss_pred             ccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCCHHHHHHHH---HhcCC----
Q 010859          210 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---IARDI----  282 (499)
Q Consensus       210 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~~~~~~~~i---~~~~~----  282 (499)
                      ....   .......+.+||+.|||||++.+..++.++|||||||++|+|++|+.||...........+   .....    
T Consensus       161 ~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         161 THQH---IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TCCB---CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccc---eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            2111   1122345678999999999999999999999999999999999999999876554332222   22111    


Q ss_pred             -CCCCCCChHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 010859          283 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  324 (499)
Q Consensus       283 -~~p~~~~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~Hpff  324 (499)
                       .++..+|+++.+||.+||..||++||++.+  +.++++|+|.
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~--i~~~l~~~~~  278 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSY--LRQLFRNLFH  278 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH--HHHHHHHHHH
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHH--HHHHHHHHHH
Confidence             234578999999999999999999998732  3456677655

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.7e-47  Score=377.39  Aligned_cols=247  Identities=19%  Similarity=0.293  Sum_probs=205.7

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC-CCccEEEEEEEcCCeEEEE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLYMA  133 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~l~~~~~~~~~l~lv  133 (499)
                      ++|++++.||+|+||+||+|++..+|+.||||++......     ..+.+|..+++.+.| +||+.+++++.+....|+|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            5799999999999999999999999999999998765322     225568888888865 8999999999999999999


Q ss_pred             EeccCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCC-----CCCEEEEecCCccccCC
Q 010859          134 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-----DGHIKIADFGSVKPMQD  207 (499)
Q Consensus       134 ~E~~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~-----~~~vkL~DFG~a~~~~~  207 (499)
                      |||| +++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.+..
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 679999887654 6999999999999999999999999999999999999974     57899999999987654


Q ss_pred             ccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHhcCC--
Q 010859          208 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDI--  282 (499)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~---~~~~~~~i~~~~~--  282 (499)
                      .....   ........+++||+.|||||++.+..++.++|||||||++|+|++|..||.+..   ......++.....  
T Consensus       159 ~~~~~---~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         159 PVTKQ---HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             TTTCC---BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             Ccccc---ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            32111   011223446799999999999999999999999999999999999999997543   3334444433221  


Q ss_pred             ---CCCCCCChHHHHHHHHhhccCCCCCCCC
Q 010859          283 ---RFPNYFSDAARDLIDRLLDVDPSGRPGA  310 (499)
Q Consensus       283 ---~~p~~~~~~~~~Li~~lL~~dP~~R~~~  310 (499)
                         .++..+|+++.+++..|+..+|++||+.
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y  266 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDY  266 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence               2335689999999999999999999975

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=384.69  Aligned_cols=252  Identities=19%  Similarity=0.313  Sum_probs=206.9

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCC---ceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCeEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTFSLYM  132 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~-~~~~l~l  132 (499)
                      +.+.++||+|+||+||+|++..++   ..||||++++.  ........+.+|+.+|++++|||||++++++. .+..+++
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            345789999999999999987654   36899998643  34445567889999999999999999999875 4678999


Q ss_pred             EEeccCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCCccccCCcccc
Q 010859          133 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  211 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~a~~~~~~~~~  211 (499)
                      |||||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||+.++.+||+|||+++........
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999999988755 45788899999999999999999999999999999999999999999999999876543211


Q ss_pred             ccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHhc-CCCCCCCCC
Q 010859          212 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR-DIRFPNYFS  289 (499)
Q Consensus       212 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~~  289 (499)
                            .........||+.|+|||.+.+..++.++|||||||++|||+||..||.. .+.......+..+ .+..|..++
T Consensus       187 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~  260 (311)
T d1r0pa_         187 ------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP  260 (311)
T ss_dssp             ------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCC
T ss_pred             ------cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCc
Confidence                  11223345799999999999999999999999999999999997666654 3444455555543 455778899


Q ss_pred             hHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 010859          290 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  321 (499)
Q Consensus       290 ~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~H  321 (499)
                      +++.+||.+||+.||++||++     .++++|
T Consensus       261 ~~l~~li~~cl~~dP~~RPs~-----~ei~~~  287 (311)
T d1r0pa_         261 DPLYEVMLKCWHPKAEMRPSF-----SELVSR  287 (311)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence            999999999999999999998     777765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=373.14  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=192.3

Q ss_pred             CCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----eE
Q 010859           55 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----SL  130 (499)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~l~~~~~~~~----~l  130 (499)
                      .+|.+.+.||+|+||+||+|+.  +|+.||||++....    ......+.|+..+..++|||||++++++.+..    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            5799999999999999999986  68999999986432    22222334555556789999999999987543    68


Q ss_pred             EEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCcEeeecCCCCeeeCCCCCEEEEecCCc
Q 010859          131 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS--------MGLIHRDIKPENLLLTADGHIKIADFGSV  202 (499)
Q Consensus       131 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~--------~gIiHrDlKp~NILl~~~~~vkL~DFG~a  202 (499)
                      |+|||||++|+|.+++.+. .+++.....++.|++.||.|||+        +||+||||||+||||+.++++||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999999875 69999999999999999999996        59999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCccCCCccccCCCC------CCCCCcchhhhHHHHHHhcCCCCCCCC--------
Q 010859          203 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSGTSPFKDT--------  268 (499)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~------~~~~sDiwslG~ilyelltG~~Pf~~~--------  268 (499)
                      +........      ........+||+.|+|||++.+..      ++.++|||||||+||||+||.+||...        
T Consensus       156 ~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         156 VRHDSATDT------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             EEEETTTTE------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             ccccCCCcc------eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            876543211      112334578999999999987653      466899999999999999999887431        


Q ss_pred             -------CHHHHHHHHHhcCC--CCCCCC-----ChHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 010859          269 -------SEWLIFQRIIARDI--RFPNYF-----SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  320 (499)
Q Consensus       269 -------~~~~~~~~i~~~~~--~~p~~~-----~~~~~~Li~~lL~~dP~~R~~~~~~~~~~l~~  320 (499)
                             +.....+.+.....  .+|..+     +.++.+|+.+||+.||++|||+     .++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~ei~~  290 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKK  290 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH-----HHHHH
T ss_pred             hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH-----HHHHH
Confidence                   12222233332222  233322     2458899999999999999998     66654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.2e-46  Score=378.56  Aligned_cols=255  Identities=25%  Similarity=0.367  Sum_probs=198.0

Q ss_pred             CCCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-----------CCCccEEE
Q 010859           53 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----------HPGVVRLF  121 (499)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~Iv~l~  121 (499)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++...    ......+|+.+++.++           |+||++++
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            33569999999999999999999999999999999976532    2344566777777664           68899998


Q ss_pred             EEEE--cCCeEEEEEeccCCCChHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeecCCCCeeeCCCCC--
Q 010859          122 FTFQ--DTFSLYMALESCEGGELFDQ---ITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGH--  193 (499)
Q Consensus       122 ~~~~--~~~~l~lv~E~~~gg~L~~~---i~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDlKp~NILl~~~~~--  193 (499)
                      +++.  .....+++|+++..+.....   ......+++..++.++.||+.||.|||+ +||+||||||+||||+.++.  
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            8875  45667777777665443322   2234579999999999999999999998 89999999999999987653  


Q ss_pred             ----EEEEecCCccccCCccccccCCCCCCCCccccccCccCCCccccCCCCCCCCCcchhhhHHHHHHhcCCCCCCCCC
Q 010859          194 ----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  269 (499)
Q Consensus       194 ----vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDiwslG~ilyelltG~~Pf~~~~  269 (499)
                          ++|+|||.|.....             .....+||+.|+|||++.+..++.++|+|||||++++|++|+.||...+
T Consensus       167 ~~~~~kl~dfg~s~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE-------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             TEEEEEECCCTTCEETTB-------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             ccceeeEeeccccccccc-------------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence                99999999875432             2235689999999999999999999999999999999999999997543


Q ss_pred             HH------HHHHHHHh------------------------------------------cCCCCCCCCChHHHHHHHHhhc
Q 010859          270 EW------LIFQRIIA------------------------------------------RDIRFPNYFSDAARDLIDRLLD  301 (499)
Q Consensus       270 ~~------~~~~~i~~------------------------------------------~~~~~p~~~~~~~~~Li~~lL~  301 (499)
                      ..      .....+..                                          ....++...++++.|||.+||+
T Consensus       234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~  313 (362)
T d1q8ya_         234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ  313 (362)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred             cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence            21      11111110                                          1112223356789999999999


Q ss_pred             cCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 010859          302 VDPSGRPGAGPGGYAVLKMHPFFKGIDW  329 (499)
Q Consensus       302 ~dP~~R~~~~~~~~~~l~~Hpff~~i~~  329 (499)
                      .||.+||||     +++++||||++..+
T Consensus       314 ~dP~~Rpta-----~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         314 LDPRKRADA-----GGLVNHPWLKDTLG  336 (362)
T ss_dssp             SSTTTCBCH-----HHHHTCGGGTTCTT
T ss_pred             CChhHCcCH-----HHHhcCcccCCCCC
Confidence            999999999     89999999996543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=3.3e-26  Score=209.93  Aligned_cols=137  Identities=17%  Similarity=0.180  Sum_probs=108.1

Q ss_pred             eeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccc---------------hhhHHHHHHHHHHHHHhCCCCCccEEE
Q 010859           57 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---------------KENKTAYVKLERIVLDQLDHPGVVRLF  121 (499)
Q Consensus        57 y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hp~Iv~l~  121 (499)
                      +.+++.||+|+||+||+|++. +|+.||||++......               ..........|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            458999999999999999985 6899999987532111               011123345577889999999999888


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeecCCCCeeeCCCCCEEEEecCC
Q 010859          122 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  201 (499)
Q Consensus       122 ~~~~~~~~l~lv~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDlKp~NILl~~~~~vkL~DFG~  201 (499)
                      ++..    .+++|||+++..+.+       +++..+..++.|++.||.|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    279999998865533       5666778899999999999999999999999999999865 589999999


Q ss_pred             ccccC
Q 010859          202 VKPMQ  206 (499)
Q Consensus       202 a~~~~  206 (499)
                      |....
T Consensus       149 a~~~~  153 (191)
T d1zara2         149 SVEVG  153 (191)
T ss_dssp             CEETT
T ss_pred             cccCC
Confidence            97653

>d1w1ha_ b.55.1.1 (A:) 3-phosphoinositide dependent protein kinase-1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: 3-phosphoinositide dependent protein kinase-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.9e-25  Score=192.69  Aligned_cols=103  Identities=30%  Similarity=0.555  Sum_probs=96.2

Q ss_pred             cccCcccccccCCCceEEEEEeeehhhhhhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEE
Q 010859          392 DSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIV  471 (499)
Q Consensus       392 ~~~~~~~~~~~~~~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~  471 (499)
                      |...++||.|+. |+.|+|+||+.|++|++|||||||||+++++||.|+.++..||+|+|+.+   +.++.++++.|.|+
T Consensus        33 q~~~~~~~~~~~-g~~ilK~G~L~Kr~~~~wkkR~FvL~~~~L~YYkd~~~~~~kG~I~L~~~---~~v~~~~~~~F~I~  108 (147)
T d1w1ha_          33 QAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQE---LRPEAKNFKTFFVH  108 (147)
T ss_dssp             HHHHCTTGGGTT-TCCEEEEEEEEECCTTSCEEEEEEEETTTEEEEEETTTTEEEEEECCCTT---CEEEEEETTEEEEE
T ss_pred             ccCCCccccccC-CCeEEEEEEEEeecCCcceEEEEEEcCCeeEEEeCCCcccccceEEeccc---cccccccCceEEEe
Confidence            445677999995 89999999999999999999999999999999999999999999999987   88999999999999


Q ss_pred             cCCceEEEEcCCccHHHHHHHHHHhcC
Q 010859          472 TPKKVLSFEDAKQRASQWKKAIEALQN  498 (499)
Q Consensus       472 ~p~r~y~~~d~~~~~~~W~~~i~~~~~  498 (499)
                      ||+|||+|.+++++|++|+++|++|++
T Consensus       109 t~~Rty~l~a~~~d~~~Wv~aI~~v~~  135 (147)
T d1w1ha_         109 TPNRTYYLMDPSGNAHKWCRKIQEVWR  135 (147)
T ss_dssp             CSSCEEEEECTTSCHHHHHHHHHHHHH
T ss_pred             cCceEEEEEcChHHHHHHHHHHHHHHH
Confidence            999999999988999999999999863

>d2coaa1 b.55.1.1 (A:8-119) Protein kinase c, d2 type {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Protein kinase c, d2 type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=5.3e-16  Score=128.51  Aligned_cols=86  Identities=20%  Similarity=0.225  Sum_probs=71.9

Q ss_pred             EEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc----------CCCcEEEEcCCce
Q 010859          409 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS----------SPSHFKIVTPKKV  476 (499)
Q Consensus       409 ~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~----------~~~~f~i~~p~r~  476 (499)
                      ||+||+.|+++..  ||+|||||++.-..||.|+.....+|+|||+..   +.++..          ++..|.|.||+||
T Consensus         2 lk~GwL~k~~~~~~~wkkRwFvL~~~~L~YYk~~~~~~p~g~I~L~~~---~~v~~~~~~~~~~~~~~~~~F~I~T~~rt   78 (112)
T d2coaa1           2 LREGWVVHYSNKDTLRKRHYWRLDCKCITLFQNNTTNRYYKEIPLSEI---LTVESAQNFSLVPPGTNPHCFEIVTANAT   78 (112)
T ss_dssp             SEEEEEEECCSSSCCCEEEEEEECSSEEEEESSSSCSSCSEEEETTTC---CEEEESCCCSSSCTTSCCEEEEEECSSCC
T ss_pred             ceEEEEEEECCCCCCeeEEEEEEEcceEEEEeccCCCccceEEeeecc---ccccccccccccccCCCccEEEEEeCCeE
Confidence            7999999999866  999999999988889999999999999999986   455541          3356999999999


Q ss_pred             EEEEcC------------CccHHHHHHHHHHhc
Q 010859          477 LSFEDA------------KQRASQWKKAIEALQ  497 (499)
Q Consensus       477 y~~~d~------------~~~~~~W~~~i~~~~  497 (499)
                      |||...            +.++++|+++|++++
T Consensus        79 yy~~~~~~~~~~~~s~~~~~~~~~W~~aI~~A~  111 (112)
T d2coaa1          79 YFVGEMPGGTPGGPSGQGAEAARGWETAIRQAL  111 (112)
T ss_dssp             CCEECCSCCCSSSCCCCCSHHHHHHHHHHHHHG
T ss_pred             EEEecCCccccccccccChHHHHHHHHHHHHhh
Confidence            999642            235889999999864

>d2coda1 b.55.1.1 (A:8-109) Centaurin-delta 1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Centaurin-delta 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=9.8e-15  Score=118.49  Aligned_cols=86  Identities=16%  Similarity=0.261  Sum_probs=77.3

Q ss_pred             EEEEeeehhhhhh---hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEE-cCCc
Q 010859          409 LMISMVKKLQKLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFE-DAKQ  484 (499)
Q Consensus       409 ~~~g~~~k~~g~~---~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~-d~~~  484 (499)
                      |++||+.|+++.+   |++|||+|+++...||.++......|.|+|..+   ..+.....+.|.|+||+|+|+|. +.+.
T Consensus         2 ik~G~L~K~~~~~~~~W~kr~fvL~~~~L~~~~~~~~~~~~~~i~L~~~---~~~~~~~~~~f~i~~~~~~~~l~a~s~~   78 (102)
T d2coda1           2 VKSGWLDKLSPQGKRMFQKRWVKFDGLSISYYNNEKEMYSKGIIPLSAI---STVRVQGDNKFEVVTTQRTFVFRVEKEE   78 (102)
T ss_dssp             CEEEEEEECCSSSSSCCEEEEEEECSSEEEEEESSCCSSCCCEEETTTE---EEEEEETTTEEEEEESSCCEEEECSSHH
T ss_pred             cEEEEEEEECCCCCCCceEEEEEEECCEEEEEeccCcceeEEEEEchhc---eeeccccceeEEEEcCCcEEEEEeCCHH
Confidence            7899999988643   899999999999999999999999999999975   67777788999999999999999 4568


Q ss_pred             cHHHHHHHHHHhc
Q 010859          485 RASQWKKAIEALQ  497 (499)
Q Consensus       485 ~~~~W~~~i~~~~  497 (499)
                      ++++|+++|+.++
T Consensus        79 e~~~Wi~ai~~~i   91 (102)
T d2coda1          79 ERNDWISILLNAL   91 (102)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999999876

>d1faoa_ b.55.1.1 (A:) Dual adaptor of phosphotyrosine and 3-phosphoinositides DAPP1/PHISH {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Dual adaptor of phosphotyrosine and 3-phosphoinositides DAPP1/PHISH
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=5.6e-14  Score=113.52  Aligned_cols=90  Identities=13%  Similarity=0.076  Sum_probs=74.0

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCCceEEEE-cC
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPKKVLSFE-DA  482 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~r~y~~~-d~  482 (499)
                      ..|+||+.|+++..  ||+|||||+++-..||.++.....+|.|+|+.+.+ +....  +..+.|.|.||+|+|+|. +.
T Consensus         4 ~~KeG~L~K~~~~~k~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~~-v~~~~~~~~~~~F~i~~~~r~~~l~a~s   82 (100)
T d1faoa_           4 GTKEGYLTKQGGLVKTWKTRWFTLHRNELKYFKDQMSPEPIRILDLTECSA-VQFDYSQERVNCFCLVFPFRTFYLCAKT   82 (100)
T ss_dssp             TCEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEEGGGCCE-EEEECSSSSSSEEEEEETTEEEEEECSS
T ss_pred             ccEEEEEEEeCCCCCCceEEEEEEECCEEEEEeccCCccCceEEechheEE-EEeccccccccccccccCCeEEEEEeCC
Confidence            36899999998876  99999999998887888888888999999998622 22222  335689999999999999 55


Q ss_pred             CccHHHHHHHHHHhcC
Q 010859          483 KQRASQWKKAIEALQN  498 (499)
Q Consensus       483 ~~~~~~W~~~i~~~~~  498 (499)
                      +.++++|+++|+..++
T Consensus        83 ~~~~~~Wi~ai~~~i~   98 (100)
T d1faoa_          83 GVEADEWIKILRWKLS   98 (100)
T ss_dssp             HHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHh
Confidence            6899999999998763

>d1eaza_ b.55.1.1 (A:) Tapp1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Tapp1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=8.1e-13  Score=106.68  Aligned_cols=88  Identities=16%  Similarity=0.161  Sum_probs=74.4

Q ss_pred             eEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcCCceE
Q 010859          407 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTPKKVL  477 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p~r~y  477 (499)
                      .|+|+||+.|+++..  |++|||+|++...+||.++.....+|.|++...   ..+..       +....|.|.+++|+|
T Consensus         2 ~vik~G~L~K~~~~~~~Wkkr~fvL~~~~l~yy~~~~~~~~~~~i~l~~~---~~~~~~~~~~~~~~~~~f~i~~~~~~~   78 (103)
T d1eaza_           2 AVIKAGYCVKQGAVMKNWKRRYFQLDENTIGYFKSELEKEPLRVIPLKEV---HKVQECKQSDIMMRDNLFEIVTTSRTF   78 (103)
T ss_dssp             CCSEEEEEEEECTTTCCEEEEEEEECSSEEEEESSTTCSSCSEEEEGGGC---CEEEECTTHHHHTCSSEEEEECSSCEE
T ss_pred             ceEEEEEEEEECCCCCCeeEEEEEEECCEEEEEecccCcccceEEEccce---EEeeccccccccccceEEEEEeCCEEE
Confidence            378999999987755  999999999998889998888899999999986   23322       335689999999999


Q ss_pred             EEE-cCCccHHHHHHHHHHhc
Q 010859          478 SFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       478 ~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      +|. +.+.++++|+++|+.++
T Consensus        79 ~~~a~s~~e~~~W~~aI~~ai   99 (103)
T d1eaza_          79 YVQADSPEEMHSWIKAVSGAI   99 (103)
T ss_dssp             EEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEeCCHHHHHHHHHHHHHHH
Confidence            998 56689999999999876

>d1btka_ b.55.1.1 (A:) Bruton's tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Bruton's tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=2.9e-12  Score=113.56  Aligned_cols=89  Identities=18%  Similarity=0.192  Sum_probs=70.1

Q ss_pred             eEEEEEeeehhhh---h----hhccceEEeecCCeEEEECCCC----CeeeeeeeccCCCCceEEEE-------------
Q 010859          407 SVLMISMVKKLQK---L----TSKKVQLILTNKPKLIYVDPSK----LVVKGNIIWSDNSNDLSIQV-------------  462 (499)
Q Consensus       407 ~i~~~g~~~k~~g---~----~~k~r~~ilt~~p~l~y~d~~~----~~~kg~i~~~~~~~~~~~~~-------------  462 (499)
                      .||++|++.|++.   .    .||+|||||++....||.++..    ...+|.|++...   ..++.             
T Consensus         2 ~vi~eG~L~Kr~~~k~k~~~~~WkrRwFVL~~~~L~Yyk~~~~~~~~~~~kG~I~L~~~---~~v~~~~~~~~~~~~~~~   78 (169)
T d1btka_           2 AVILESIFLKRSQQKKKTSPLNFKKCLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKI---TCVETVVPEKNPPPERQI   78 (169)
T ss_dssp             CCCEEEEEEEECCCSSTTCCCCEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEEGGGE---EEEEECCCCSSCCGGGCC
T ss_pred             cEEEEEEEEEecCCCCCcCcCCceEEEEEEECCEEeeeccccccccccCccceEeccce---EEEEeecccCCCCccccc
Confidence            3789999998763   2    3999999999987778877643    468899999974   33332             


Q ss_pred             -----------------cCCCcEEEEcCCceEEEEc-CCccHHHHHHHHHHhcC
Q 010859          463 -----------------SSPSHFKIVTPKKVLSFED-AKQRASQWKKAIEALQN  498 (499)
Q Consensus       463 -----------------~~~~~f~i~~p~r~y~~~d-~~~~~~~W~~~i~~~~~  498 (499)
                                       +....|.|+|+.|||+|.. .+.++++|+++|++++.
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~F~I~t~~rt~~l~A~s~eE~~~WI~aL~~~i~  132 (169)
T d1btka_          79 PRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIR  132 (169)
T ss_dssp             ---------CCTTHHHHCCCEEEEEEETTCCEEEEESCHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccCcceEEEeCCcEEEEECCCHHHHHHHHHHHHHHHH
Confidence                             1235899999999999994 55899999999999875

>d1qqga1 b.55.1.2 (A:12-114) Insulin receptor substrate 1, IRS-1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Phosphotyrosine-binding domain (PTB)
domain: Insulin receptor substrate 1, IRS-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.22  E-value=1.2e-11  Score=99.90  Aligned_cols=84  Identities=17%  Similarity=0.273  Sum_probs=65.1

Q ss_pred             EEEEEeeehhhhhhhccceEEeecC------CeEEEEC-C-----CCCeeeeeeeccCCCCceEEEE----cCCCcEEEE
Q 010859          408 VLMISMVKKLQKLTSKKVQLILTNK------PKLIYVD-P-----SKLVVKGNIIWSDNSNDLSIQV----SSPSHFKIV  471 (499)
Q Consensus       408 i~~~g~~~k~~g~~~k~r~~ilt~~------p~l~y~d-~-----~~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~  471 (499)
                      |+|+||+.|++  .||+|||+|.+.      ++|+|.+ +     .....+|.|++..+   ..+..    +....|.|.
T Consensus         2 v~k~GyL~K~k--~WkkR~fvL~~~~~~~~~~~L~yy~~~~~~~~~~~~~~~~i~l~~~---~~~~~~~~~~~~~~f~i~   76 (103)
T d1qqga1           2 VRKVGYLRKPK--SMHKRFFVLRAASEAGGPARLEYYENEKKWRHKSSAPKRSIPLESC---FNINKRADSKNKHLVALY   76 (103)
T ss_dssp             EEEEEEEECTT--TCCEEEEEEECCBTTTBSSEEEEESSHHHHHTTCSCCSEEEEGGGE---EEEEEECCSSCSSEEEEE
T ss_pred             cceeEEEEEcC--CCCEEEEEEecccccCCccEEEEEcchhhhhcccccccceEeccee---eEEeecccCCCceEEEEE
Confidence            78999999985  499999999874      4565554 2     34556799999875   33333    335689999


Q ss_pred             cCCceEEEE-cCCccHHHHHHHHHHh
Q 010859          472 TPKKVLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       472 ~p~r~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                      |++|+|+|. +.+.++++|+++|.++
T Consensus        77 t~~r~~~l~A~s~~e~~~Wi~al~~l  102 (103)
T d1qqga1          77 TRDEHFAIAADSEAEQDSWYQALLQL  102 (103)
T ss_dssp             ESSCEEEEECSSHHHHHHHHHHHHHH
T ss_pred             eCCeEEEEEcCCHHHHHHHHHHHHhh
Confidence            999999999 4558999999999986

>d2dyna_ b.55.1.1 (A:) Dynamin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Dynamin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=1.4e-11  Score=101.02  Aligned_cols=90  Identities=16%  Similarity=0.134  Sum_probs=68.8

Q ss_pred             eEEEEEeeehhhh-h---hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE---cCCCcEEEEcC------
Q 010859          407 SVLMISMVKKLQK-L---TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTP------  473 (499)
Q Consensus       407 ~i~~~g~~~k~~g-~---~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p------  473 (499)
                      .|+++|||.|+++ +   .||+|||||+++-..||.|+.....+|.|++.... +..++.   .....|.|.+|      
T Consensus         2 ~vik~GwL~k~~~~~~~~~WkkRwFvL~~~~L~yyk~~~~~~~~~~i~l~~~~-v~~~~~~~~~~~~~F~l~~~~~~~~~   80 (111)
T d2dyna_           2 LVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDNLK-LRDVEKGFMSSKHIFALFNTEQRNVY   80 (111)
T ss_dssp             CEEEEEEEEETTCCTTTTSSEEEEEEEESSEEEEESSTTCCCEEEEEECTTEE-EEEECCCSTTCSEEEEEEESSCSCSB
T ss_pred             eEEEEeeEEEECCCCCcCCceEEEEEEECCEEEEEcchhhcccccccccccce-eEeeccccccccccEEeeeccccccc
Confidence            4899999999864 2   29999999998876678888888999999998631 112222   23457998765      


Q ss_pred             --CceEEEEc-CCccHHHHHHHHHHhc
Q 010859          474 --KKVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       474 --~r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                        .|+|+|.. .+.++.+|+++|.++.
T Consensus        81 ~~~r~~~l~a~s~ed~~~W~~al~~A~  107 (111)
T d2dyna_          81 KDYRQLELACETQEEVDSWKASFLRAG  107 (111)
T ss_dssp             TTBSSEEEEESSHHHHHHHHHHHHHTT
T ss_pred             cCceeEEEECCCHHHHHHHHHHHHHhc
Confidence              48999994 5589999999999864

>d1x1fa1 b.55.1.1 (A:8-143) Signal-transducing adaptor protein 1, STAP-1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Signal-transducing adaptor protein 1, STAP-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=1.1e-11  Score=105.60  Aligned_cols=88  Identities=11%  Similarity=0.201  Sum_probs=73.6

Q ss_pred             eEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcCCceEEE
Q 010859          407 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTPKKVLSF  479 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p~r~y~~  479 (499)
                      -+-++||+.|+++..  ||+|||||++.-..||.++.....+|.|+++.+   +.+..     +....|.|.|++|+|+|
T Consensus        10 ~~~~eG~L~k~~~~~k~WkkrwfvL~~~~L~yY~~~~d~~~~~~i~L~~~---~~~~~~~~~~~~~~~F~i~~~~~~~~f   86 (136)
T d1x1fa1          10 PLYFEGFLLIKRSGYREYEHYWTELRGTTLFFYTDKKSIIYVDKLDIVDL---TCLTEQNSTEKNCAKFTLVLPKEEVQL   86 (136)
T ss_dssp             CEEEEEEEEEECTTCCSCEEEEEEEETTEEEEESCSSCSSCSEECCCSSC---CEEEECCCTTSCCCEEEEECSSCCEEE
T ss_pred             CccEEEEEEEECCCCCCeEEEEEEEcCCEeEEEeecccccccccccccce---eeeeeecccccccceeeecCCCceEEE
Confidence            367899999988764  999999999988878888988899999999986   33332     23478999999999999


Q ss_pred             Ec-CCccHHHHHHHHHHhc
Q 010859          480 ED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       480 ~d-~~~~~~~W~~~i~~~~  497 (499)
                      .. ...++.+|+++|..|+
T Consensus        87 ~Aes~~e~~~Wi~~I~~v~  105 (136)
T d1x1fa1          87 KTENTESGEEWRGFILTVT  105 (136)
T ss_dssp             ECSSHHHHHHHHHHHHHHH
T ss_pred             EeCCHHHHHHHHHHHHHHH
Confidence            95 4589999999999876

>d1v89a_ b.55.1.1 (A:) Rho-GTPase-activating protein 25 (KIAA0053) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho-GTPase-activating protein 25 (KIAA0053)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=1.1e-11  Score=102.46  Aligned_cols=90  Identities=11%  Similarity=0.228  Sum_probs=72.5

Q ss_pred             CceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cCCCcEEEEcCC--
Q 010859          405 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SSPSHFKIVTPK--  474 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~~~~f~i~~p~--  474 (499)
                      ++.++++|||.|+++..  ||+|||+|+++...||.++.....+|.|+|..+   .-.+.      +....|.|.+++  
T Consensus         5 ~s~~~k~G~L~K~~~~~k~WkkR~fvL~~~~l~y~~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~~f~l~~~~~~   81 (118)
T d1v89a_           5 SSGPIKMGWLKKQRSIVKNWQQRYFVLRAQQLYYYKDEEDTKPQGCMYLPGC---TIKEIATNPEEAGKFVFEIIPASWD   81 (118)
T ss_dssp             SSCEEEEEEEEEECSSSSCEEEEEEEEETTEEEEESSSSCCSCSEEECSTTE---EEEEECCCSSCCCCCEEEEEESCCS
T ss_pred             CCCCeEEEEEEEECCCCCCcEEEEEEEECCEEEEecccCcccccceeccCce---EEEEeccccccCCCcEEEEecCCCc
Confidence            44589999999988766  899999999987778888888999999999975   22222      223578887654  


Q ss_pred             ------ceEEEE-cCCccHHHHHHHHHHhc
Q 010859          475 ------KVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       475 ------r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                            |+|+|. |.+.++++|+++|+++.
T Consensus        82 ~~~~~~~~~~~~a~s~ee~~~Wi~aI~~a~  111 (118)
T d1v89a_          82 QNRMGQDSYVLMASSQAEMEEWVKFLRRVA  111 (118)
T ss_dssp             SCCSSCCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ceecCCcEEEEEcCCHHHHHHHHHHHHHHH
Confidence                  789998 66799999999999976

>d1u5da1 b.55.1.1 (A:108-213) Src kinase-associated phosphoprotein SKAP55 (SCAP1) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Src kinase-associated phosphoprotein SKAP55 (SCAP1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=2.2e-11  Score=98.62  Aligned_cols=89  Identities=16%  Similarity=0.254  Sum_probs=69.9

Q ss_pred             EEEEEeeehhhh------hhhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cCCCcEEEEcC-C
Q 010859          408 VLMISMVKKLQK------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SSPSHFKIVTP-K  474 (499)
Q Consensus       408 i~~~g~~~k~~g------~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~~~~f~i~~p-~  474 (499)
                      |||+|+|.|+++      ..|++|||+|++.-.+||.++.....+|.|++...  .+....      +....|.|.|+ +
T Consensus         1 vik~G~L~k~~~~~~~~~~~Wkkr~~vL~~~~L~y~~~~~~~~~~~~i~l~~~--~~~~~~~~~~~~~~~~~f~i~~~~~   78 (106)
T d1u5da1           1 VIKQGYLEKKSKDHSFFGSEWQKRWCVVSRGLFYYYANEKSKQPKGTFLIKGY--SVRMAPHLRRDSKKESCFELTSQDR   78 (106)
T ss_dssp             EEEEEEEEEEEECSSSSCEEEEEEEEEEETTEEEEESSTTCSSCSEEEECTTC--EEEECGGGCSSGGGGGEEEEECSSS
T ss_pred             CeEEEEEEEECCCCCCCcCCcEEEEEEEECCEEEEEecccccccccccccCCc--eEeeccccccccCCceeEEEEcCCC
Confidence            699999988663      22899999999988888888888889999999875  111111      23358999886 5


Q ss_pred             ceEEEEcC-CccHHHHHHHHHHhcC
Q 010859          475 KVLSFEDA-KQRASQWKKAIEALQN  498 (499)
Q Consensus       475 r~y~~~d~-~~~~~~W~~~i~~~~~  498 (499)
                      |+|+|... +.++++|+++|+.|+.
T Consensus        79 ~~~~f~a~s~~e~~~W~~ai~~~i~  103 (106)
T d1u5da1          79 RTYEFTATSPAEARDWVDQISFLLK  103 (106)
T ss_dssp             CCEEEECSSHHHHHHHHHHHHHHHH
T ss_pred             cEEEEEeCCHHHHHHHHHHHHHHHH
Confidence            89999954 5899999999999863

>d1v88a_ b.55.1.1 (A:) Oxysterol binding protein-related protein 8 (ORP-8, KIAA1451) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Oxysterol binding protein-related protein 8 (ORP-8, KIAA1451)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=5.7e-12  Score=106.24  Aligned_cols=92  Identities=17%  Similarity=0.176  Sum_probs=67.1

Q ss_pred             eEEEEEeeehhhhhh-hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCC-----------
Q 010859          407 SVLMISMVKKLQKLT-SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-----------  474 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~-~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-----------  474 (499)
                      -|+++|||+|++.+- ||+|||||.+.-..||.++.....+|.|+|..+.++.....+....|.|.+|.           
T Consensus         7 ~~~~~GwLkk~~~~k~WkkRwfvL~~~~L~yyk~~~~~~~~g~i~L~~~~v~~~~~~~~~~~f~i~~~~~~~~~~~~~~~   86 (130)
T d1v88a_           7 GIVMADWLKIRGTLKSWTKLWCVLKPGVLLIYKTQKNGQWVGTVLLNACEIIERPSKKDGFCFKLFHPLEQSIWAVKGPK   86 (130)
T ss_dssp             SCCEEEEEEECCSSSSCEEEEEEEETTEEEEESCSSSCCCCEEEECSSCEECCCCTTTSSCEEEEECTTCCCCSCSSCTT
T ss_pred             CCeEeCeEEeCCCCCCceEEEEEEeCCEEEEEcCCCCCcceeEEECCCeEEEEccccCCCceEEEEcCCCcceecccCcc
Confidence            379999997765433 99999999988777888998889999999997521111112334567765532           


Q ss_pred             -------------ceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          475 -------------KVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       475 -------------r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                                   +.|+|. +.+.++++|+++|+.++.
T Consensus        87 ~~~~~~~~~~~~~~~~~l~A~s~~e~~~Wi~al~~~i~  124 (130)
T d1v88a_          87 GEAVGSITQPLPSSYLIIRATSESDGRCWMDALELALK  124 (130)
T ss_dssp             SCSCSCCCSCCCSSCCEEECSSHHHHHHHHHHHHHHHT
T ss_pred             cccceeEEecCCcEEEEEECCCHHHHHHHHHHHHHHhh
Confidence                         335666 556899999999999874

>d1wg7a_ b.55.1.1 (A:) Dedicator of cytokinesis protein 9, DOCK9 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Dedicator of cytokinesis protein 9, DOCK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=1.3e-11  Score=106.87  Aligned_cols=91  Identities=13%  Similarity=0.119  Sum_probs=68.9

Q ss_pred             eEEEEEeeehhhh------h--hhccceEEeecCC-----eEEEECCC-CCeeeeeeeccCCCCceEEEEcCCCcEEEEc
Q 010859          407 SVLMISMVKKLQK------L--TSKKVQLILTNKP-----KLIYVDPS-KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVT  472 (499)
Q Consensus       407 ~i~~~g~~~k~~g------~--~~k~r~~ilt~~p-----~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~  472 (499)
                      .|+|+|||.|++.      .  .||+|||||++..     .+||.|.. ....+|.|++..+..+..........|.|.+
T Consensus        17 ~v~k~G~L~K~~~~~~~~~~~k~WkkR~fvL~~~~~~~~~L~yy~~~~~~~~~~g~i~l~~~~~~~~~~~~~~~~F~i~~   96 (150)
T d1wg7a_          17 GITKHGWLYKGNMNSAISVTMRSFKRRFFHLIQLGDGSYNLNFYKDEKISKEPKGSIFLDSCMGVVQNNKVRRFAFELKM   96 (150)
T ss_dssp             CCCCEEEEEECCCCSSHHHHHSSCEEEEEEEEECSSSCEEEEEESSSCCSSCCSEEECTTTCCEECCCCSSCTTEEEEEC
T ss_pred             CEeEEEEEEEecCCCCcccccccceEEEEEEEcCcCCceeEEEEeccccccccccccccccccccccCccccceEEEEEc
Confidence            4799999998752      1  2999999999753     45777654 4678999999987332233334457899988


Q ss_pred             C-CceEEEE-cCCccHHHHHHHHHHhc
Q 010859          473 P-KKVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       473 p-~r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      + +|+|+|. +.+.++++|+++|+.++
T Consensus        97 ~~~~~~~l~A~s~~e~~~Wi~aL~~~i  123 (150)
T d1wg7a_          97 QDKSSYLLAADSEVEMEEWITILNKIL  123 (150)
T ss_dssp             SSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCeEEEEEeCCHHHHHHHHHHHHHHH
Confidence            7 5899999 55689999999999875

>d1plsa_ b.55.1.1 (A:) Pleckstrin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Pleckstrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.13  E-value=2.1e-11  Score=100.01  Aligned_cols=90  Identities=19%  Similarity=0.138  Sum_probs=71.7

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEE--EcCCCcEEEEc-CCceEEEEcC
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ--VSSPSHFKIVT-PKKVLSFEDA  482 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~--~~~~~~f~i~~-p~r~y~~~d~  482 (499)
                      +|++|||.|+++..  |++|||+|++.-.+||.++.....+|.|++..+.....+.  ......|.|.+ ++|+|+|...
T Consensus         5 ~ikeG~L~k~~~~~k~WkkryfvL~~~~L~~y~~~~~~~p~~~i~l~~~~~~~~~~~~~~~~~~f~l~~~~~~~~~~~a~   84 (113)
T d1plsa_           5 RIREGYLVKKGSVFNTWKPMWVVLLEDGIEFYKKKSDNSPKGMIPLKGSTLTSPCQDFGKRMFVFKITTTKQQDHFFQAA   84 (113)
T ss_dssp             CSEEEEEEEESSSSSCCEEEEEEEETTEEEEESSTTCSSCSEEEESSSCCEESSCCSSCCSSSEEEEEETTTEEEEEECS
T ss_pred             ceEEEEEEEeCCCCCCceEEEEEEECCEEEEEecCCccccceEEECccCeEEeeecccCCcceEEEEecCCCeEEEEECC
Confidence            68999999987644  9999999999988899899888999999999862211111  13346788876 6799999954


Q ss_pred             -CccHHHHHHHHHHhc
Q 010859          483 -KQRASQWKKAIEALQ  497 (499)
Q Consensus       483 -~~~~~~W~~~i~~~~  497 (499)
                       +.++.+|+++|+.++
T Consensus        85 s~~e~~~Wi~ai~~ai  100 (113)
T d1plsa_          85 FLEERDAWVRDINKAI  100 (113)
T ss_dssp             SHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHH
Confidence             589999999999875

>d2fjla1 b.55.1.1 (A:1-37,A:87-150) Phosphoinositide phospholipase C, PLC-gamma-1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Phosphoinositide phospholipase C, PLC-gamma-1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.12  E-value=4.8e-11  Score=95.85  Aligned_cols=87  Identities=15%  Similarity=0.197  Sum_probs=69.9

Q ss_pred             EEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--c--CCCcEEEEcC---CceEEE
Q 010859          409 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--S--SPSHFKIVTP---KKVLSF  479 (499)
Q Consensus       409 ~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~--~~~~f~i~~p---~r~y~~  479 (499)
                      +|+|+|.|++...  |++|||+|+++...||.++.....+|.|++..+.  +....  .  ....|.|.++   .|+|+|
T Consensus         2 iK~G~L~k~~~~~k~W~kR~fvL~~~~L~yy~~~~~~~~~~~i~l~~~~--v~~~~~~~~~~~~~f~i~~~~~~~~~~~~   79 (101)
T d2fjla1           2 IKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDLLRGVLDVPACQ--IAIRPEGKNNRLFVFSISMPSVAQWSLDV   79 (101)
T ss_dssp             CEEEEEEEEETTTTEEEEEEEEEETTEEEECCCCSCTCCCEEECSTTCE--EEEETTCSSSCSCEEEEECTTTSSCCEEE
T ss_pred             ceEEEEEEEcCCCCCCeEEEEEEECCEEEEEeccccceecceEEcCCce--eEeeeeecccccceeEEeccccccEEEEE
Confidence            6899999998766  9999999999888788888888999999998751  22111  2  2357898876   489999


Q ss_pred             E-cCCccHHHHHHHHHHhc
Q 010859          480 E-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       480 ~-d~~~~~~~W~~~i~~~~  497 (499)
                      . +.+.++.+|+++|+++.
T Consensus        80 ~a~s~~e~~~Wi~ai~~~~   98 (101)
T d2fjla1          80 AADSQEELQDWVKKIREVA   98 (101)
T ss_dssp             EESSHHHHHHHHHHHHHHH
T ss_pred             EeCCHHHHHHHHHHHHHHH
Confidence            8 56689999999999975

>d1v5ua_ b.55.1.1 (A:) SET binding factor 1, Sbf1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: SET binding factor 1, Sbf1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.11  E-value=3.9e-11  Score=98.82  Aligned_cols=89  Identities=19%  Similarity=0.242  Sum_probs=68.9

Q ss_pred             eEEEEEeeehhhhhh--hccceEEeec-CCeE-EEECCCCCeeeeeeeccCCCCceEEEEc-----------CCCcEEEE
Q 010859          407 SVLMISMVKKLQKLT--SKKVQLILTN-KPKL-IYVDPSKLVVKGNIIWSDNSNDLSIQVS-----------SPSHFKIV  471 (499)
Q Consensus       407 ~i~~~g~~~k~~g~~--~k~r~~ilt~-~p~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~~-----------~~~~f~i~  471 (499)
                      .++++|||.|+++..  ||+|||||.. ...| ||.++.....+|.|+++..   ..+...           ....|.++
T Consensus         7 ~~~~eG~L~k~~~~~k~WkkR~fvL~~~~~~L~~~~~~~~~~p~g~i~l~~~---~~v~~~~~~~~~~~~~~~~~~~~~~   83 (117)
T d1v5ua_           7 GRSYEGILYKKGAFMKPWKARWFVLDKTKHQLRYYDHRMDTECKGVIDLAEV---EAVAPGTPTIGAPKTVDEKAFFDVK   83 (117)
T ss_dssp             SSSEEEEEEECCCSSSCCEEEEEEEETTTTEEEEESSSSCSSCCCEEEGGGE---EEEECCCCCTTSCSSSCTTTCEEEE
T ss_pred             CCeEEEEEEEECCCCCCceEEEEEEeCCCCEEEecccccccCcceEEEecce---EEEeecccccccccccccceEEEee
Confidence            468999999987644  9999999985 4555 4556667888999999864   333331           12468888


Q ss_pred             cCCceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          472 TPKKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       472 ~p~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      +++|+|+|. |.+.++++|+++|+.++.
T Consensus        84 ~~~~~~~~~a~s~~e~~~Wv~~l~~ai~  111 (117)
T d1v5ua_          84 TTRRVYNFCAQDVPSAQQWVDRIQSCLS  111 (117)
T ss_dssp             ESSCEEEEECSSHHHHHHHHHHHHTTCC
T ss_pred             CCCcEEEEEeCCHHHHHHHHHHHHHHHh
Confidence            999999999 566899999999999873

>d1omwa2 b.55.1.1 (A:550-668) G-protein coupled receptor kinase 2 (beta-adrenergic receptor kinase 1) {Cow (Bos taurus) [TaxId: 9913]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: G-protein coupled receptor kinase 2 (beta-adrenergic receptor kinase 1)
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.11  E-value=2.9e-11  Score=100.32  Aligned_cols=92  Identities=11%  Similarity=0.079  Sum_probs=66.4

Q ss_pred             CCceEEEEEeeehhhhhh---hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEc-CCceEEE
Q 010859          404 PGESVLMISMVKKLQKLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVT-PKKVLSF  479 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g~~---~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~-p~r~y~~  479 (499)
                      .|.-++++|+|.|++|.+   |++|||||+++-..||.++  ...+|.|++.....+-.........|+|.+ ++|+|+|
T Consensus         6 ~~~~~i~eG~L~K~g~~~~~~WkkR~fvL~~~~L~yy~~~--~~~~~~i~l~~~~~v~~~~~~~~~~f~i~~~~~~~~~f   83 (119)
T d1omwa2           6 LGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEG--EAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFVL   83 (119)
T ss_dssp             TTSCCCEEEEEEECC------CEEEEEEEETTEEEEECTT--SCCCEEEEGGGEEEEEEEESSSCEEEEEEETTSCEEEE
T ss_pred             cCCCeEEEEEEEEECCCCCCCeEEEEEEEEcCeEEEEecc--cccCccceeccccccccccccccceEEEEcCCCcEEEE
Confidence            366789999999998633   9999999998765566544  456789999865221122224456788876 5799999


Q ss_pred             Ec-CCccHHHHHHHHHHhc
Q 010859          480 ED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       480 ~d-~~~~~~~W~~~i~~~~  497 (499)
                      .. .+.++++|+++|.+++
T Consensus        84 ~a~s~~e~~~W~~al~~a~  102 (119)
T d1omwa2          84 QCDSDPELVQWKKELRDAY  102 (119)
T ss_dssp             ECSSHHHHHHHHHHHHHHH
T ss_pred             ECCCHHHHHHHHHHHHHHH
Confidence            94 5589999999998864

>d1u5fa1 b.55.1.1 (A:109-219) Src-associated adaptor protein Skap2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Src-associated adaptor protein Skap2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.11  E-value=6.8e-11  Score=96.53  Aligned_cols=89  Identities=17%  Similarity=0.235  Sum_probs=71.9

Q ss_pred             eEEEEEeeehhhh---h---hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcC
Q 010859          407 SVLMISMVKKLQK---L---TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTP  473 (499)
Q Consensus       407 ~i~~~g~~~k~~g---~---~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p  473 (499)
                      .++++|||.|++.   +   .|++|||||++.-..||.++.....+|.|++...   ..+..       .....|.|.++
T Consensus         8 ~v~k~G~L~k~~~~~~~~~~~W~~r~~vL~~~~L~~y~~~~~~~p~g~i~L~~~---~~~~~~~~~~~~~~~~~f~i~~~   84 (111)
T d1u5fa1           8 FVIKAGYLEKRRKDHSFLGFEWQKRWCALSKTVFYYYGSDKDKQQKGEFAIDGY---DVRMNNTLRKDGKKDCCFEICAP   84 (111)
T ss_dssp             SEEEEEEEEEECCCSSCSSCSEEEEEEEEETTEEEEESSTTCSSCSEEEECTTC---EEEECTTSCSSTTGGGEEEEECT
T ss_pred             CeeEEEEEEEECCCCCCCcCCceEEEEEEECCEEEeeccccccCcceEEEeccc---EEEeeccccccccccceEEEEcc
Confidence            4899999998753   2   3899999999998888989888888999999975   22222       23478999886


Q ss_pred             -CceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          474 -KKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       474 -~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                       +|+|+|. +.+.++++|+++|+.+++
T Consensus        85 ~~~~~~~~a~s~~e~~~W~~ai~~~i~  111 (111)
T d1u5fa1          85 DKRIYQFTAASPKDAEEWVQQLKFILQ  111 (111)
T ss_dssp             TSCEEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             CCcEEEEEcCCHHHHHHHHHHHHHHhC
Confidence             6899998 566899999999999864

>d1unqa_ b.55.1.1 (A:) Rac-alpha serine/threonine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rac-alpha serine/threonine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=1.6e-11  Score=101.39  Aligned_cols=93  Identities=14%  Similarity=0.191  Sum_probs=69.2

Q ss_pred             CceEEEEEeeehhhhhh--hccceEEeecCCeE-EEECCCCCeeeeeeeccCCCCc--eEEE--EcCCCcEEEEcC----
Q 010859          405 GESVLMISMVKKLQKLT--SKKVQLILTNKPKL-IYVDPSKLVVKGNIIWSDNSND--LSIQ--VSSPSHFKIVTP----  473 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l-~y~d~~~~~~kg~i~~~~~~~~--~~~~--~~~~~~f~i~~p----  473 (499)
                      +..|+++|||.|+++..  ||+|||||++...| ||.+......+|.||+......  ..+.  .+..+.|.|.++    
T Consensus         4 ~~~v~k~G~L~K~~~~~k~Wk~RwfvL~~~~~l~~~~~~~~~~~~~~i~l~~~~~~~~~~~~~~~~~~~~f~i~~~~~~~   83 (118)
T d1unqa_           4 DVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTT   83 (118)
T ss_dssp             GGCEEEEEEEEEECSSSCCEEEEEEEEETTSEEEEESSCCCSHHHHTSCSEEEECTTCEEEEECSSSTTEEEEEEEETTE
T ss_pred             cCCEEEEEEEEEECCCCCCcEEEEEEEeccceeEEEeeccCccccccccccceEEeecccccccccCCceEEEEeccccc
Confidence            45699999999998866  99999999986655 6677777788899998643211  1222  234578998753    


Q ss_pred             CceEEEE-cCCccHHHHHHHHHHhc
Q 010859          474 KKVLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       474 ~r~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      .++|+|. +.+.++++|+++|+.++
T Consensus        84 ~~~~~f~a~s~~e~~~Wi~ai~~~~  108 (118)
T d1unqa_          84 VIERTFHVETPEEREEWTTAIQTVA  108 (118)
T ss_dssp             EEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eeEEEEEeCCHHHHHHHHHHHHHHH
Confidence            4668887 55689999999999875

>d2elba2 b.55.1.1 (A:274-374) DCC-interacting protein 13-alpha, APPL1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: DCC-interacting protein 13-alpha, APPL1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=1.3e-11  Score=99.45  Aligned_cols=89  Identities=12%  Similarity=0.054  Sum_probs=62.7

Q ss_pred             eEEEEEeeehhh--hh---hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcC--CceEEE
Q 010859          407 SVLMISMVKKLQ--KL---TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTP--KKVLSF  479 (499)
Q Consensus       407 ~i~~~g~~~k~~--g~---~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p--~r~y~~  479 (499)
                      .+.|+|+|.|+.  |.   .|+||||||+++ .|+|........+|.|++..+.+....+......|.|.++  +|+|+|
T Consensus         4 ~~~k~G~L~k~~~~g~~~k~W~kRwfvL~~~-~L~y~~~~~~~~~~~i~l~~~~v~~~~~~~~~~~f~i~~~~~~~~~~l   82 (101)
T d2elba2           4 LTRKAGYLNARNKTGLVSSTWDRQFYFTQGG-NLMSQARGDVAGGLAMDIDNCSVMAVDCEDRRYCFQITSFDGKKSSIL   82 (101)
T ss_dssp             CSCCEEEEEECSCCC----CCCEEEEEEETT-EEEEECTTCCCE----EEEECCCCCCCCCCSSSSSEECCCSSSCCCCE
T ss_pred             CccEeEEEEEeccCCCCccccEEEEEEEeCC-EEEEEccCCcccceEEEecccccccccccCCcceEEEEeecccceEEE
Confidence            467899998873  43   299999999986 5666666667888999997653333333344568999875  599999


Q ss_pred             E-cCCccHHHHHHHHHHh
Q 010859          480 E-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       480 ~-d~~~~~~~W~~~i~~~  496 (499)
                      . +.+.++++|++||++|
T Consensus        83 ~A~s~~e~~~Wi~al~~v  100 (101)
T d2elba2          83 QAESKKDHEEWICTINNI  100 (101)
T ss_dssp             ECSSHHHHHHHHHHHHHT
T ss_pred             ECCCHHHHHHHHHHHHhc
Confidence            9 5558999999999985

>d2i5fa1 b.55.1.1 (A:244-347) Pleckstrin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Pleckstrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.07  E-value=2.3e-10  Score=91.83  Aligned_cols=88  Identities=19%  Similarity=0.257  Sum_probs=66.1

Q ss_pred             EEEEEeeehhhhhh--hccceEEeecCCeE-EEEC-CCCCeeeeeeeccCCCCceEEEE---------cCCCcEEEEcC-
Q 010859          408 VLMISMVKKLQKLT--SKKVQLILTNKPKL-IYVD-PSKLVVKGNIIWSDNSNDLSIQV---------SSPSHFKIVTP-  473 (499)
Q Consensus       408 i~~~g~~~k~~g~~--~k~r~~ilt~~p~l-~y~d-~~~~~~kg~i~~~~~~~~~~~~~---------~~~~~f~i~~p-  473 (499)
                      |+|+|+|.|+++..  ||+|||+|.+...+ ||.+ +.....+|.|++...   ..+..         .....|.|.++ 
T Consensus         2 v~k~G~L~k~~~~~k~WkkR~fvL~~~~~~l~~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~   78 (104)
T d2i5fa1           2 IIKQGCLLKQGHRRKNWKVRKFILREDPAYLHYYDPAGAEDPLGAIHLRGC---VVTSVESNSNGRKSEEENLFEIITAD   78 (104)
T ss_dssp             EEEEEEEEEECTTTCCEEEEEEEEETTTTEEEEECTTSCSSCSEEEECTTC---EEEEECC--------CCSEEEEECTT
T ss_pred             EEEEEEEEEECCCCCCcEEEEEEEECCeeEEEEEcCccccCccceEeecce---EEEEeccCcccccccCccEEEEECCC
Confidence            79999999998754  89999999986554 4444 456678899999875   22221         23458888876 


Q ss_pred             CceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          474 KKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       474 ~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      .|+|+|. +.+.++++|+++|+.+++
T Consensus        79 ~~~~~~~a~s~~e~~~W~~ai~~a~r  104 (104)
T d2i5fa1          79 EVHYFLQAATPKERTEWIKAIQMASR  104 (104)
T ss_dssp             CCEEEEECSSHHHHHHHHHHHHHHHC
T ss_pred             CeEEEEEcCCHHHHHHHHHHHHHHhC
Confidence            5889988 556899999999998753

>d2coca1 b.55.1.1 (A:8-106) FYVE, RhoGEF and PH domain containing protein 3, FGD3 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: FYVE, RhoGEF and PH domain containing protein 3, FGD3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.06  E-value=4.6e-11  Score=95.33  Aligned_cols=87  Identities=11%  Similarity=0.076  Sum_probs=64.3

Q ss_pred             EEEeeehhhh-hhhccceEEeecC-C-eE-EEECCCCCeeeeeeeccCCCCceEEEE----cCCCcEEEEcCCceEEEE-
Q 010859          410 MISMVKKLQK-LTSKKVQLILTNK-P-KL-IYVDPSKLVVKGNIIWSDNSNDLSIQV----SSPSHFKIVTPKKVLSFE-  480 (499)
Q Consensus       410 ~~g~~~k~~g-~~~k~r~~ilt~~-p-~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~~p~r~y~~~-  480 (499)
                      ..|+|.|+.+ ..|+||||||+++ + .| ||.++.....+|.|++....+ ..+..    +....|.|.+++|+|+|. 
T Consensus         3 ~~G~L~~~~~~k~W~krwfvL~~~~~~~ly~~~~~~~~~~~~~i~l~~~~~-~~~~~~~~~~~~~~F~i~~~~r~~~l~A   81 (99)
T d2coca1           3 LCGPLRLSESGETWSEVWAAIPMSDPQVLHLQGGSQDGRLPRTIPLPSCKL-SVPDPEERLDSGHVWKLQWAKQSWYLSA   81 (99)
T ss_dssp             SEEEEEEESSSSCEEEEEEECCTTCTTCEEEECCTTCSSSCSEECGGGCEE-ECCCSSSCCSSSEEEEEEETTEEEEEEE
T ss_pred             eEEEEEccCCCCCccEEEEEEecCCccEEEEECcCccccccccccccceee-eecccccccCCceEEEEEcCCcEEEEEC
Confidence            4688887665 4699999999985 3 35 445567788899999997511 11111    223479999999999999 


Q ss_pred             cCCccHHHHHHHHHHhc
Q 010859          481 DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       481 d~~~~~~~W~~~i~~~~  497 (499)
                      +.+.++++|+++|+.+.
T Consensus        82 ~s~~e~~~Wi~aL~~Aa   98 (99)
T d2coca1          82 SSAELQQQWLETLSTAA   98 (99)
T ss_dssp             SSHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhc
Confidence            55689999999999863

>d1fgya_ b.55.1.1 (A:) Grp1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Grp1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.05  E-value=8.2e-11  Score=98.26  Aligned_cols=88  Identities=17%  Similarity=0.109  Sum_probs=67.7

Q ss_pred             EEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-cCC--------------------
Q 010859          409 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-SSP--------------------  465 (499)
Q Consensus       409 ~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-~~~--------------------  465 (499)
                      .|+|||.|+++..  ||+|||||++.-..||.++.....+|.|+|..+.+ ..+.. ...                    
T Consensus         6 ~keG~L~K~~~~~k~WkrR~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~v-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (127)
T d1fgya_           6 DREGWLLKLGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSI-REVLDPRKPNCFELYNPSHKGQVIKACKT   84 (127)
T ss_dssp             SEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEECTTCEE-EEECCSSCSSEEEEECSSSTTCCCCCEEE
T ss_pred             ceEEEEEEECCCCCCcEEEEEEEECCEEEEEccCCCccccceEeCCCeEE-EEccCCCCCceEEEecccccccccccccc
Confidence            5899999998766  99999999988777888988889999999987511 11110 111                    


Q ss_pred             --CcEEEEcCCceEEEEcC-CccHHHHHHHHHHhc
Q 010859          466 --SHFKIVTPKKVLSFEDA-KQRASQWKKAIEALQ  497 (499)
Q Consensus       466 --~~f~i~~p~r~y~~~d~-~~~~~~W~~~i~~~~  497 (499)
                        ..|.+.++.|+|+|... +.++++|+.+|++++
T Consensus        85 ~~~~~~~~~~~~~~~f~a~s~~e~~~Wi~aL~~~i  119 (127)
T d1fgya_          85 EADGRVVEGNHVVYRISAPSPEEKEEWMKSIKASI  119 (127)
T ss_dssp             CTTSCEEECCCSEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccceeEeeCCCeEEEEECCCHHHHHHHHHHHHHHH
Confidence              23455678899999954 589999999999986

>d1upqa_ b.55.1.1 (A:) Phosphoinositol 3-phosphate binding protein-1, PEPP1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Phosphoinositol 3-phosphate binding protein-1, PEPP1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.03  E-value=3e-10  Score=91.73  Aligned_cols=91  Identities=15%  Similarity=0.236  Sum_probs=70.4

Q ss_pred             CCceEEEEEeeehhhhh---hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcC-C
Q 010859          404 PGESVLMISMVKKLQKL---TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTP-K  474 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g~---~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p-~  474 (499)
                      ++..++++||+.|+++.   .|++|||+|.++..+||.++.....++.|++....  +....     +....|.|.++ +
T Consensus         5 p~~~~~~~G~L~k~~~~~~k~W~kr~~vL~~~~L~~y~~~~~~~~~~~i~l~~~~--v~~~~~~~~~~~~~~~~i~~~~~   82 (107)
T d1upqa_           5 PNLPVHIRGWLHKQDSSGLRLWKRRWFVLSGHCLFYYKDSREESVLGSVLLPSYN--IRPDGPGAPRGRRFTFTAEHPGM   82 (107)
T ss_dssp             TTSCEEEEEEEEEECSSSSCCEEEEEEEEETTEEEEESSTTCCSCCEEEEGGGCE--EEECCSSCTTSSSSEEEEECTTS
T ss_pred             cCCceeEEEEEEEeCCCCCCCeeEEEEEEECCEEEEecCcccccccceecccceE--EEEeccCcccCcceEEEEEcCCC
Confidence            35568999999987542   29999999999888889999888899999998751  21111     12347788776 6


Q ss_pred             ceEEEE-cCCccHHHHHHHHHHh
Q 010859          475 KVLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       475 r~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                      |+|+|. +.+.++++|+++|+.+
T Consensus        83 ~~~~~~a~s~~e~~~Wi~al~~A  105 (107)
T d1upqa_          83 RTYVLAADTLEDLRGWLRALGRA  105 (107)
T ss_dssp             CCEEEECSSHHHHHHHHHHHHHH
T ss_pred             eEEEEEcCCHHHHHHHHHHHHHH
Confidence            899999 4558999999999986

>d1u5ea1 b.55.1.1 (A:14-222) Src-associated adaptor protein Skap2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Src-associated adaptor protein Skap2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.03  E-value=1.8e-10  Score=105.18  Aligned_cols=89  Identities=17%  Similarity=0.209  Sum_probs=71.6

Q ss_pred             ceEEEEEeeehhhhh------hhccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEc
Q 010859          406 ESVLMISMVKKLQKL------TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVT  472 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~------~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~  472 (499)
                      ..++++|||.|+++.      .|++|||+|+++-.+||.+......+|.|+|..+   ..+..       +....|.|.|
T Consensus       102 ~~~~k~G~L~K~~~~~~~~~~~Wkkr~fvL~~~~L~yy~~~~~~~~~~~i~L~~~---~~~~~~~~~~~~~~~~~F~i~~  178 (209)
T d1u5ea1         102 PFVIKAGYLEKRRKDHSFLGFEWQKRWCALSKTVFYYYGSDKDKQQKGEFAIDGY---DVRMNNTLRKDGKKDCCFEICA  178 (209)
T ss_dssp             SSEEEEEEEEEEEHHHHTTTCCCEEEEEEEETTEEEEESSTTCSSCSEEEECTTC---EEEECGGGCSSTTGGGEEEEEC
T ss_pred             CCeeEEEEEEEecCCCCCccccceEEEEEEECCEEEEEecCCCCccceEEEecce---eeeeccccccccCCCcEEEEEc
Confidence            358999999987641      3999999999988888899888899999999975   22211       1235899999


Q ss_pred             C-CceEEEEc-CCccHHHHHHHHHHhc
Q 010859          473 P-KKVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       473 p-~r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      | +|+|+|.. .+.++++|+++|+.++
T Consensus       179 ~~~r~~~f~a~s~~e~~~Wi~al~~~i  205 (209)
T d1u5ea1         179 PDKRIYQFTAASPKDAEEWVQQLKFIL  205 (209)
T ss_dssp             SSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCCEEEEEcCCHHHHHHHHHHHHHHH
Confidence            8 59999995 5589999999999886

>d1wgqa_ b.55.1.1 (A:) FYVE, RhoGEF and PH domain containing protein 6, Fgd6 (KIAA1362) {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: FYVE, RhoGEF and PH domain containing protein 6, Fgd6 (KIAA1362)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.03  E-value=1.3e-10  Score=94.47  Aligned_cols=92  Identities=12%  Similarity=0.162  Sum_probs=71.6

Q ss_pred             CceEEEEEeeehhhhhh--hccceEEeecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcC-CceEEE
Q 010859          405 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTP-KKVLSF  479 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p-~r~y~~  479 (499)
                      .+..+++|||.|+++..  |++|||+|++.-.+||.++.....++.|++..... ..+..  +.++.|.|.++ +++|+|
T Consensus         5 ~~~~~~~G~L~k~~~~~~~W~kr~~vL~~~~L~~~k~~~~~~~~~~i~l~~~~~-~~~~~~~~~~~~F~i~~~~~~~~~f   83 (109)
T d1wgqa_           5 SSGSTMSGYLYRSKGSKKPWKHLWFVIKNKVLYTYAASEDVAALESQPLLGFTV-TLVKDENSESKVFQLLHKGMVFYVF   83 (109)
T ss_dssp             CCSCSCEEEEEEESSTTSCCEEEEEEEETTEEEEESCTTCSSCSEEEECSSEEE-EECCCSSCSSSEEEEEETTEEEEEE
T ss_pred             CCCCcEEEEEEEECCCCCCceEEEEEEeCCEEEEeccccccccccccccceeee-eecccccccceeeeeecccceEEEE
Confidence            34468899999887643  99999999998888888988888999999987511 11111  23578999876 578888


Q ss_pred             E-cCCccHHHHHHHHHHhc
Q 010859          480 E-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       480 ~-d~~~~~~~W~~~i~~~~  497 (499)
                      . +.+.++++|+++|+.+.
T Consensus        84 ~a~s~~~~~~Wi~ai~~a~  102 (109)
T d1wgqa_          84 KADDAHSTQRWIDAFQEGT  102 (109)
T ss_dssp             ECSSHHHHHHHHHHHHHHH
T ss_pred             ECCCHHHHHHHHHHHHHHh
Confidence            7 56689999999999976

>d1wi1a_ b.55.1.1 (A:) Calcium-dependent activator protein for secretion, CAPS {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Calcium-dependent activator protein for secretion, CAPS
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.01  E-value=2.3e-10  Score=95.59  Aligned_cols=90  Identities=13%  Similarity=0.079  Sum_probs=64.3

Q ss_pred             ceEEEEEeeehhhh-hh--hccceEEeecC-CeEEEECCC---CCeeeeeeeccCCCCceEEEE-------cCCCcEEEE
Q 010859          406 ESVLMISMVKKLQK-LT--SKKVQLILTNK-PKLIYVDPS---KLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIV  471 (499)
Q Consensus       406 ~~i~~~g~~~k~~g-~~--~k~r~~ilt~~-p~l~y~d~~---~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~  471 (499)
                      +.+.++|||.|+++ .+  ||||||||.+. ..+||.+..   ....+|.|++...   ..+..       +....|.|.
T Consensus         6 ~~~~~~G~L~K~g~~~~k~WkkRwfvL~~~~~~~yy~~~~~~~~~~~~~~i~l~~~---~~~~~~~~~~~~~~~~~~~i~   82 (126)
T d1wi1a_           6 SGMKHSGYLWAIGKNVWKRWKKRFFVLVQVSQYTFAMCSYREKKAEPQELLQLDGY---TVDYTDPQPGLEGGRAFFNAV   82 (126)
T ss_dssp             CCEEEEEEEEEECSSSCCSCEEEEEEEEEEETTEEEEEECCSSSSCCSEEEECSSC---EEEECCCCSSCCSCSSEEEEE
T ss_pred             CCCcEEEEEEEECCCCCCCceEEEEEEeCCceEEEEEcccccccccceeeeeecee---eeeeccccccccccceeEEec
Confidence            34789999999875 33  99999999974 455554332   3345788999875   22111       112346677


Q ss_pred             cCCceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          472 TPKKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       472 ~p~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      +++|+|+|. +.+.++++|+++|..++.
T Consensus        83 ~~~r~~~f~A~s~~e~~~Wv~al~~a~~  110 (126)
T d1wi1a_          83 KEGDTVIFASDDEQDRILWVQAMYRATG  110 (126)
T ss_dssp             CSSCEEEEECSSHHHHHHHHHHHHHHHT
T ss_pred             cCCeEEEEEECCHHHHHHHHHHHHHHHH
Confidence            899999999 556899999999998763

>d1x1ga1 b.55.1.1 (A:8-123) Pleckstrin-2 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Pleckstrin-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=3e-10  Score=93.07  Aligned_cols=90  Identities=20%  Similarity=0.300  Sum_probs=65.5

Q ss_pred             ceEEEEEeeehhhhhh--hccceEEeecCCe-EEEECC--CCCeeeeeeeccCCCCceEEEE----------cCCCcEEE
Q 010859          406 ESVLMISMVKKLQKLT--SKKVQLILTNKPK-LIYVDP--SKLVVKGNIIWSDNSNDLSIQV----------SSPSHFKI  470 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~--~k~r~~ilt~~p~-l~y~d~--~~~~~kg~i~~~~~~~~~~~~~----------~~~~~f~i  470 (499)
                      ..|+++|++.|+++..  ||+|||+|++... ++|.+.  .....+|.|++..+.. ..+..          .....|.|
T Consensus         9 ~~v~k~G~L~K~~~~~k~WkkR~fvL~~~~~~~~~~~~~~~~~~p~~~i~L~~~~i-~~~~~~~~~~~~~~~~~~~~f~i   87 (116)
T d1x1ga1           9 GTVVKQGYLAKQGHKRKNWKVRRFVLRKDPAFLHYYDPSKEENRPVGGFSLRGSLV-SALEDNGVPTGVKGNVQGNLFKV   87 (116)
T ss_dssp             SEEEEEEEEEEECSSSSSEEEEEEEEEESSCEEEEECSSSCCSSCSCCEESTTCCC-EECCSSSSCSSCSSCCCSSCEEE
T ss_pred             CCEEEEEEEEEEcCCCCCCceEEEEEECCCcEEEEeccccccccceeEEEcCCCEE-EEecccCcccccccccccceeEE
Confidence            3689999999987654  9999999988554 555543  3457789999987521 12221          11246889


Q ss_pred             EcCC-ceEEEE-cCCccHHHHHHHHHHh
Q 010859          471 VTPK-KVLSFE-DAKQRASQWKKAIEAL  496 (499)
Q Consensus       471 ~~p~-r~y~~~-d~~~~~~~W~~~i~~~  496 (499)
                      .+++ |+|+|. +.+.++++|+++|++|
T Consensus        88 ~~~~~~~~~f~a~s~ee~~~Wi~ai~~~  115 (116)
T d1x1ga1          88 ITKDDTHYYIQASSKAERAEWIEAIKKL  115 (116)
T ss_dssp             CCTTCCCEEECCSSHHHHHHHHHHHHHH
T ss_pred             EeCCCeEEEEECCCHHHHHHHHHHHHhh
Confidence            8875 678888 5568999999999986

>d2j59m1 b.55.1.1 (M:931-1063) Rho GTPase-activating protein 21 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho GTPase-activating protein 21
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.94  E-value=1.1e-09  Score=92.46  Aligned_cols=87  Identities=15%  Similarity=0.205  Sum_probs=58.9

Q ss_pred             EEEeee----------hhhhhh--hccceEEeecCCeEEEECCCCC----eeeeeeeccCCCCceEEEE---cCCCcEEE
Q 010859          410 MISMVK----------KLQKLT--SKKVQLILTNKPKLIYVDPSKL----VVKGNIIWSDNSNDLSIQV---SSPSHFKI  470 (499)
Q Consensus       410 ~~g~~~----------k~~g~~--~k~r~~ilt~~p~l~y~d~~~~----~~kg~i~~~~~~~~~~~~~---~~~~~f~i  470 (499)
                      |+|||.          |.++.+  |++|||||.++-..||.++...    ...|.|+|..+  .+.+..   +.+..|.|
T Consensus         3 KeG~L~~k~~~~~~~kk~~~~~k~Wkkr~fvL~~~~L~~y~~~~~~~~~~~~~~~i~L~~~--~v~~~~~~~~r~~~F~i   80 (133)
T d2j59m1           3 KEGWLHFRPLVTDKGKRVGGSIRPWKQMYVVLRGHSLYLYKDKREQTTPSEEEQPISVNAC--LIDISYSETKRKNVFRL   80 (133)
T ss_dssp             EEEEEEEEECC------------CCEEEEEEEETTEEEEESCTTCC--------CEECSSC--EEEECSSSCSCSSEEEE
T ss_pred             ceEEEEeeccccccccccCCCCCCceEEEEEEeCCEEEEEeccccccccccccccceecce--EEEEcccccccCceeEE
Confidence            688886          233333  9999999998777777765432    45677888875  222222   23457999


Q ss_pred             EcCCceEEEEc-CCccHHHHHHHHHHhcC
Q 010859          471 VTPKKVLSFED-AKQRASQWKKAIEALQN  498 (499)
Q Consensus       471 ~~p~r~y~~~d-~~~~~~~W~~~i~~~~~  498 (499)
                      .|++|+|+|.. .+.++++|+.+|+.+.+
T Consensus        81 ~~~~~~~~f~A~s~~e~~~Wi~ai~~a~~  109 (133)
T d2j59m1          81 TTSDCECLFQAEDRDDMLAWIKTIQESSN  109 (133)
T ss_dssp             ECSSCEEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             ecCCCEEEEEeCCHHHHHHHHHHHHHHHh
Confidence            99999999994 56899999999998753

>d2cofa1 b.55.1.1 (A:8-102) KIAA1914 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: KIAA1914
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.91  E-value=2.6e-10  Score=90.37  Aligned_cols=86  Identities=12%  Similarity=0.098  Sum_probs=64.6

Q ss_pred             EEeeehhhhhhhccceEEeecCCeEEEECCC-CCeeeeeeeccCCCCceEEEEcCCCcEEEEc-CCceEEEE-cCCccHH
Q 010859          411 ISMVKKLQKLTSKKVQLILTNKPKLIYVDPS-KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVT-PKKVLSFE-DAKQRAS  487 (499)
Q Consensus       411 ~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~-p~r~y~~~-d~~~~~~  487 (499)
                      +|++.|.+.--||+|||+|.++-.+||.++. ....+|.|++..+.++.....+.+..|.|.+ .+|+|+|. +.+.+++
T Consensus         4 s~yl~~~~~~~WkkR~fvL~~~~L~yyk~~~~~~~~~~~i~l~~~~v~~~~~~~~~~~f~~~~~~~~~~~l~A~s~~e~~   83 (95)
T d2cofa1           4 SSYLNVLVNSQWKSRWCSVRDNHLHFYQDRNRSKVAQQPLSLVGCEVVPDPSPDHLYSFRILHKGEELAKLEAKSSEEMG   83 (95)
T ss_dssp             CCEEEEEETTEEEEEEEEECSSCEEEECSSTTCSEEEEEECTTTCEEECCCBTTBSCEEEEEETTEEEEEEECSSHHHHH
T ss_pred             ccchhhhcCCCceEEEEEEECCEEEEEecccccccccccccccceEEEecccccceecceeccccceeEEeeCCCHHHHH
Confidence            5778777777799999999988888888875 4467899999875221122224456788765 57999999 5568999


Q ss_pred             HHHHHHHHh
Q 010859          488 QWKKAIEAL  496 (499)
Q Consensus       488 ~W~~~i~~~  496 (499)
                      +|+++|..+
T Consensus        84 ~Wi~~L~~~   92 (95)
T d2cofa1          84 HWLGLLLSE   92 (95)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999999875

>d1v5pa_ b.55.1.1 (A:) Tapp2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Tapp2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.88  E-value=3.8e-10  Score=94.19  Aligned_cols=87  Identities=13%  Similarity=0.172  Sum_probs=60.3

Q ss_pred             EEEEeeehhhh---hhhccceEEeec-CCeE-EEECCCCCeeeeeeec-----cCCCCceEEEE-------cCCCcEEEE
Q 010859          409 LMISMVKKLQK---LTSKKVQLILTN-KPKL-IYVDPSKLVVKGNIIW-----SDNSNDLSIQV-------SSPSHFKIV  471 (499)
Q Consensus       409 ~~~g~~~k~~g---~~~k~r~~ilt~-~p~l-~y~d~~~~~~kg~i~~-----~~~~~~~~~~~-------~~~~~f~i~  471 (499)
                      .++|+|.|++.   ..|+||||||.. .+.| ||.+......+|.||+     ...   ..+..       +....|.|.
T Consensus        16 ~~~GyL~k~~~~~~k~WkrRwFvL~~~~~~L~yy~~~~~~~~~g~~~l~~i~~~~~---~~~~~~~~~~~~~~~~~~~~~   92 (126)
T d1v5pa_          16 RICGFLDIEDNENSGKFLRRYFILDTQANCLLWYMDNPQNLAVGAGAVGSLQLTYI---SKVSIATPKQKPKTPFCFVIN   92 (126)
T ss_dssp             CEECCEEEECTTCSSCEEEEEEEEETTTTEEEEESSCTTTSCTTCCCSEEEETTTC---CEEEECCTTTSCSCSSEEEEE
T ss_pred             ceeeeEEEECCCCCCCeeEEEEEEEcCCCeEEEeeccccccccceeecccceeeee---eccccccccccccccceEEEc
Confidence            45799987653   249999999974 4566 5555544455555554     443   22322       112578888


Q ss_pred             cCCceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          472 TPKKVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       472 ~p~r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      |++|+|+|. +.+.++++|+++|+++.+
T Consensus        93 ~~~r~~~l~Aes~~e~~~Wi~aL~~A~~  120 (126)
T d1v5pa_          93 ALSQRYFLQANDQKDLKDWVEALNQASK  120 (126)
T ss_dssp             CSSCEEEEECSSHHHHHHHHHHHHHTTT
T ss_pred             CCCeeEEEECCCHHHHHHHHHHHHHHhc
Confidence            999999999 556899999999999764

>d1v5ma_ b.55.1.1 (A:) SH2 and PH domain-containing adapter protein APS {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: SH2 and PH domain-containing adapter protein APS
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.84  E-value=6e-10  Score=94.54  Aligned_cols=90  Identities=14%  Similarity=0.142  Sum_probs=66.2

Q ss_pred             EEEEEeeehh--------h-h-hhhccceEEeecCC-----eE-EEECCCCCeeeeeeeccCCCCceEEEE----cCCCc
Q 010859          408 VLMISMVKKL--------Q-K-LTSKKVQLILTNKP-----KL-IYVDPSKLVVKGNIIWSDNSNDLSIQV----SSPSH  467 (499)
Q Consensus       408 i~~~g~~~k~--------~-g-~~~k~r~~ilt~~p-----~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~----~~~~~  467 (499)
                      |.|+|+|.++        + | -.||+|||||.+..     +| ||.++.....+|.|++........+..    +.++.
T Consensus        18 v~keG~L~~~~~~~~~~~~~~~~~WkkrwfvL~~~~~~~~~~L~yy~~~~~~k~~g~i~l~~~~~~~~~~~~~~~~~~~~   97 (136)
T d1v5ma_          18 IQREGALRFMVADDAASGPGGTAQWQKCRLLLRRAVAGERFRLEFFVPPKASRPKVSIPLSAIIEVRTTMPLEMPEKDNT   97 (136)
T ss_dssp             CCEEEEEEEEECSCCCSSSCCSCCCEEEEEEEEECSSSCCEEEEEESSTTSSSCSSCEETTTCCBCCCCCCSSSCCCTTE
T ss_pred             eeEEEEEEeeccccccCCCCCCCCceEEEEEEeCCcccchhhhhhhCcccccCcCcceecccceeeeeeccccCCCCCcE
Confidence            5688888542        1 2 33999999999853     45 677788899999999986422111111    34578


Q ss_pred             EEEEcCCc-eEEEE-cCCccHHHHHHHHHHhc
Q 010859          468 FKIVTPKK-VLSFE-DAKQRASQWKKAIEALQ  497 (499)
Q Consensus       468 f~i~~p~r-~y~~~-d~~~~~~~W~~~i~~~~  497 (499)
                      |.|.|+++ +|+|. |.+.++++|+++|++++
T Consensus        98 F~l~t~~~~~y~f~A~s~~e~~~Wv~ai~~ai  129 (136)
T d1v5ma_          98 FVLKVENGAEYILETIDSLQKHSWVADIQGCV  129 (136)
T ss_dssp             ECCBCTTSCBEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEEcCCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence            99999875 68886 66799999999999987

>d1droa_ b.55.1.1 (A:) beta-spectrin {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: beta-spectrin
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.63  E-value=5.7e-09  Score=86.29  Aligned_cols=90  Identities=11%  Similarity=0.184  Sum_probs=62.6

Q ss_pred             EEEEeeehhhh----------hhhccceEEeecCCeEEEECCCCCeeeeeeeccCC------CCceEEEE---cCCCcEE
Q 010859          409 LMISMVKKLQK----------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDN------SNDLSIQV---SSPSHFK  469 (499)
Q Consensus       409 ~~~g~~~k~~g----------~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i~~~~~------~~~~~~~~---~~~~~f~  469 (499)
                      .++|+|.|++.          -.|+||||||.++-.+||.++.....++.|.+...      ...+....   +....|.
T Consensus         9 ~~eG~L~rk~~~~~~~kk~~~~~W~kr~~vL~~~~L~yy~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~   88 (122)
T d1droa_           9 GHEGYVTRKHEWDSTTKKASNRSWDKVYMAAKAGRISFYKDQKGYKSNPELTFRGEPSYDLQNAAIEIASDYTKKKHVLR   88 (122)
T ss_dssp             SEEEEEEEECSCCCCCCTTCCCCCEEEEEEESSSCCBEESSSSHHHHCTTCCSSCCCBCCCSSCCCEECCSSSSSTTEEE
T ss_pred             ceEEEEEEeecccccCcccCCCCceEEEEEEeCCEEEEEcCcccccccCcccccccceEeccceEEEeccccccccceEE
Confidence            57788875531          23999999999988889988865444454443321      11122211   3456899


Q ss_pred             EEcCC-ceEEEE-cCCccHHHHHHHHHHhcC
Q 010859          470 IVTPK-KVLSFE-DAKQRASQWKKAIEALQN  498 (499)
Q Consensus       470 i~~p~-r~y~~~-d~~~~~~~W~~~i~~~~~  498 (499)
                      |.+++ ++|+|. +.+.++++|+++|+.+.+
T Consensus        89 l~~~~~~~~~f~a~s~~d~~~Wv~al~~~~~  119 (122)
T d1droa_          89 VKLANGALFLLQAHDDTEMSQWVTSLKAQSD  119 (122)
T ss_dssp             EECSSSCEEEEECSSSHHHHHHHHHHHHHHT
T ss_pred             EECCCCcEEEEECCCHHHHHHHHHHHHHHHh
Confidence            99875 889888 667899999999999864

>d1btna_ b.55.1.1 (A:) beta-spectrin {Mouse (Mus musculus), brain [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: beta-spectrin
species: Mouse (Mus musculus), brain [TaxId: 10090]

Probab=98.50  E-value=5.8e-08  Score=77.76  Aligned_cols=75  Identities=13%  Similarity=0.208  Sum_probs=53.6

Q ss_pred             hhhccceEEeecCCeEEEECCC------CCeeeeeeeccCCCCceEEEE---cCCCcEEEEcC-CceEEEE-cCCccHHH
Q 010859          420 LTSKKVQLILTNKPKLIYVDPS------KLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTP-KKVLSFE-DAKQRASQ  488 (499)
Q Consensus       420 ~~~k~r~~ilt~~p~l~y~d~~------~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p-~r~y~~~-d~~~~~~~  488 (499)
                      ..|++|||+|+++...||.++.      .....|.|++..+  .+....   +.++.|.|.++ +++|+|. +.+.++.+
T Consensus        21 ~~Wk~r~~vL~~~~L~~yk~~~~~~~~~~~~~~~~i~l~~~--~~~~~~~~~~~~~~f~i~~~~~~~~~~~a~s~~e~~~   98 (106)
T d1btna_          21 RSWHNVYCVINNQEMGFYKDAKSAASGIPYHSEVPVSLKEA--ICEVALDYKKKKHVFKLRLSDGNEYLFQAKDDEEMNT   98 (106)
T ss_dssp             CCCEEEEEEEETTEEEEESSHHHHHHTCCSSSCCCEECTTC--EEEECSSCCSSSSEEEEECTTSCEEEEECSSHHHHHH
T ss_pred             CCCcEEEEEEECCEEEEEeChhhcccccccCcceeEEeccc--eeeeccccccCcceEeecccCCCEEEEECCCHHHHHH
Confidence            3499999999987776777753      2445567777754  122221   33468999987 5899988 55689999


Q ss_pred             HHHHHHHh
Q 010859          489 WKKAIEAL  496 (499)
Q Consensus       489 W~~~i~~~  496 (499)
                      |+++|+.+
T Consensus        99 W~~ai~~A  106 (106)
T d1btna_          99 WIQAISSA  106 (106)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHHHhC
Confidence            99999863

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.43  E-value=3.7e-07  Score=85.04  Aligned_cols=140  Identities=15%  Similarity=0.136  Sum_probs=92.3

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~l~~~~~~~~~l~l  132 (499)
                      ++.|+..+..+-++.+.||++.  .++..+.+|+.......   ....+.+|..+++.+. +--+.+++.+..+++..|+
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            4567777776666667999885  35667889987544221   1223556777776663 3335677888888899999


Q ss_pred             EEeccCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q 010859          133 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------------------------------------  174 (499)
Q Consensus       133 v~E~~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~~LH~~--------------------------------------  174 (499)
                      ||++++|..+.+.....     .....++.++...|..||+.                                      
T Consensus        88 v~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            99999998775543211     11222333333444444421                                      


Q ss_pred             ---------------------CcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          175 ---------------------GLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       175 ---------------------gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                                           .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 25899999999999877666799999875

>d1wjma_ b.55.1.1 (A:) beta-spectrin {Human (Homo sapiens), brain 2 isoform [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: beta-spectrin
species: Human (Homo sapiens), brain 2 isoform [TaxId: 9606]

Probab=98.41  E-value=2.7e-08  Score=82.05  Aligned_cols=87  Identities=17%  Similarity=0.166  Sum_probs=55.2

Q ss_pred             EEEEeeehhhh----------hhhccceEEeecCCeEEEECCCCCeeeeee------eccCCCCceEEEE---cCCCcEE
Q 010859          409 LMISMVKKLQK----------LTSKKVQLILTNKPKLIYVDPSKLVVKGNI------IWSDNSNDLSIQV---SSPSHFK  469 (499)
Q Consensus       409 ~~~g~~~k~~g----------~~~k~r~~ilt~~p~l~y~d~~~~~~kg~i------~~~~~~~~~~~~~---~~~~~f~  469 (499)
                      ..+|+|.++.+          ..||+|||+|.+.-..||.++......+.+      .+..+  ......   +.+..|.
T Consensus         9 ~~eG~L~rk~~~~~~~kr~~~k~Wkkrw~vL~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~f~   86 (123)
T d1wjma_           9 QMEGMLCRKQEMEAFGKKAANRSWQNVYCVLRRGSLGFYKDAKAASAGVPYHGEVPVSLARA--QGSVAFDYRKRKHVFK   86 (123)
T ss_dssp             CEEEEEEEEEEEEETTEECSCCCCEEEEEEEETTEEEEESSHHHHTTTCBSSSCCCEECTTC--EEEECTTCSSCSSEEE
T ss_pred             eeEEEEEEEeeccccCcccCCCCCcEEEEEEECCEEEEEecchhccccccccccccccccce--eEEecccccccCcEEE
Confidence            44677665432          239999999998876677655332222333      23322  111111   2335688


Q ss_pred             EEcC-CceEEEEc-CCccHHHHHHHHHHhc
Q 010859          470 IVTP-KKVLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       470 i~~p-~r~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      |.++ +++|+|.. .+.++.+|+++|+.++
T Consensus        87 i~~~~~~~~~l~a~s~~e~~~Wi~aI~~a~  116 (123)
T d1wjma_          87 LGLQDGKEYLFQAKDEAEMSSWLRVVNAAI  116 (123)
T ss_dssp             EECSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEcCCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence            8875 68999994 5689999999999876

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.97  E-value=7.2e-06  Score=81.24  Aligned_cols=81  Identities=17%  Similarity=0.167  Sum_probs=47.5

Q ss_pred             eeEeeecCceEEEEEEEcCCCceEEEEEEeCcc-cch---hhHHHHHHHHHHHHHhCC-C-C-CccEEEEEEEcCCeEEE
Q 010859           60 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF-ITK---ENKTAYVKLERIVLDQLD-H-P-GVVRLFFTFQDTFSLYM  132 (499)
Q Consensus        60 ~~~LG~G~~g~Vy~a~~~~t~~~vAiK~~~~~~-~~~---~~~~~~~~~E~~~l~~l~-h-p-~Iv~l~~~~~~~~~l~l  132 (499)
                      .+.||.|....||++.+..+++.+++|.-.... ...   .........|...|+.+. + | .+.+++.+  +...-++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            557899999999999988888899999653211 000   011223445776776552 2 3 34555544  3444578


Q ss_pred             EEeccCCCCh
Q 010859          133 ALESCEGGEL  142 (499)
Q Consensus       133 v~E~~~gg~L  142 (499)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.87  E-value=3.1e-05  Score=71.16  Aligned_cols=135  Identities=13%  Similarity=0.110  Sum_probs=80.4

Q ss_pred             EeeecC-ceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCeEEEEEeccC
Q 010859           62 IYGVGS-YSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTFSLYMALESCE  138 (499)
Q Consensus        62 ~LG~G~-~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~Iv~l~~~~~~~~~l~lv~E~~~  138 (499)
                      .+..|. -+.||++.. .++..+.+|.......      ..+..|...++.+..  -.+.+++.+..+....|+||++++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            445555 368998875 4577788997654321      124556666666532  235677888888889999999999


Q ss_pred             CCChHHH--------------HhhcC-------CCC--HHHH----H-HHH---------------HHHHHHHHHHHHC-
Q 010859          139 GGELFDQ--------------ITSKG-------HLS--EDEA----R-FYT---------------AEVVDALEYIHSM-  174 (499)
Q Consensus       139 gg~L~~~--------------i~~~~-------~l~--e~~~----~-~i~---------------~qil~aL~~LH~~-  174 (499)
                      |.++...              +.+-.       .+.  ....    . .+.               ......+..+... 
T Consensus        90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  169 (255)
T d1nd4a_          90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM  169 (255)
T ss_dssp             SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred             ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence            8665321              11100       000  0000    0 000               0011223333332 


Q ss_pred             ------CcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          175 ------GLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       175 ------gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                            .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                  26999999999999887667899999875

>d1v61a_ b.55.1.1 (A:) Rac/CDC42 GEF 6, alpha-pix {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rac/CDC42 GEF 6, alpha-pix
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.84  E-value=9.8e-06  Score=67.38  Aligned_cols=91  Identities=15%  Similarity=0.242  Sum_probs=66.6

Q ss_pred             CceEEEEEeeehhhh--hhhccceEEeecCCeEEEECC---CCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcC-Cce
Q 010859          405 GESVLMISMVKKLQK--LTSKKVQLILTNKPKLIYVDP---SKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTP-KKV  476 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g--~~~k~r~~ilt~~p~l~y~d~---~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p-~r~  476 (499)
                      |+ +++.|++.+..+  .-+|.|+|+|-+.-.+|+...   ..-..+|.||+....+. .++.  ..+..|.|.+| .++
T Consensus        26 G~-li~~g~~~~~~~~~~~~k~R~~fLF~~~Ll~~k~~~~~~~~~~k~~i~l~~~~v~-~~~~~~~~~~~f~i~~~~~~~  103 (132)
T d1v61a_          26 GN-VIFMSQVVMQHGACEEKEERYFLLFSSVLIMLSASPRMSGFMYQGKIPIAGMVVN-RLDEIEGSDCMFEITGSTVER  103 (132)
T ss_dssp             CC-CSCEEEEEBCCSSSSCCCEEEEEECSSCEEEEECSSSSSCCEEEEEECTTTCBCS-TTCSSSSSCCCEEEECSSSCE
T ss_pred             cC-EEEEEEEEEEEecCCCcceEEEEEeCCEEEEEEEcCCCceeEEeeecchhhcccc-ccccccCccceEEEeCCCCCE
Confidence            65 566788877654  347889999999999888742   24667999999985322 1111  23467999987 589


Q ss_pred             EEEEcC-CccHHHHHHHHHHhc
Q 010859          477 LSFEDA-KQRASQWKKAIEALQ  497 (499)
Q Consensus       477 y~~~d~-~~~~~~W~~~i~~~~  497 (499)
                      |.|... +.+.++|+++|++++
T Consensus       104 ~~l~a~s~eek~~Wv~~L~~~i  125 (132)
T d1v61a_         104 IVVHCNNNQDFQEWMEQLNRLT  125 (132)
T ss_dssp             EEECCCCSHHHHHHHHHHHHHH
T ss_pred             EEEEcCCHHHHHHHHHHHHHHH
Confidence            998854 588999999999986

>d1maia_ b.55.1.1 (A:) Phospholipase C delta-1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Phospholipase C delta-1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.71  E-value=3.3e-05  Score=62.70  Aligned_cols=74  Identities=12%  Similarity=0.161  Sum_probs=52.9

Q ss_pred             hccceEEeecCCeE-EEECCC--CCeeeeeeeccCCCCceEEEEcC--------------CCcEEEE--cCCceEEEEcC
Q 010859          422 SKKVQLILTNKPKL-IYVDPS--KLVVKGNIIWSDNSNDLSIQVSS--------------PSHFKIV--TPKKVLSFEDA  482 (499)
Q Consensus       422 ~k~r~~ilt~~p~l-~y~d~~--~~~~kg~i~~~~~~~~~~~~~~~--------------~~~f~i~--~p~r~y~~~d~  482 (499)
                      .++|+|.|+...++ +|.++.  ....+|.||++..   ..|....              ...|.|+  ++.||++|..+
T Consensus        26 ~k~R~f~L~~d~~~i~~~~~~~~~~~~~~~i~i~~I---~~V~~G~~s~~~~~~~~~~~~~~~FsIv~~~~~r~l~l~a~  102 (119)
T d1maia_          26 RRERFYKLQEDCKTIWQESRKVMRSPESQLFSIEDI---QEVRMGHRTEGLEKFARDIPEDRCFSIVFKDQRNTLDLIAP  102 (119)
T ss_dssp             EEEEEEEECTTSSEEEECCCCTTCCTTTTEEEGGGE---EEEEESSCSHHHHHHCTTSCGGGEEEEEESSSCCCEEEECS
T ss_pred             CEEEEEEEcCCCCEEEEeCCCCCCCccceEEEHHHc---eEEEcCCCCchhhhcccCCCcCceEEEEEcCCCcEEEEEEC
Confidence            46799999876555 554332  3345799999974   5555521              1248887  67899999976


Q ss_pred             C-ccHHHHHHHHHHhcC
Q 010859          483 K-QRASQWKKAIEALQN  498 (499)
Q Consensus       483 ~-~~~~~W~~~i~~~~~  498 (499)
                      + .++..|+.+|+.+++
T Consensus       103 s~~~~~~Wv~~L~~L~~  119 (119)
T d1maia_         103 SPADAQHWVQGLRKIIH  119 (119)
T ss_dssp             SHHHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHhC
Confidence            5 899999999998764

>d1zc3b1 b.55.1.1 (B:171-279) Exocyst complex protein EXO84 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Exocyst complex protein EXO84
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.26  E-value=0.00085  Score=53.00  Aligned_cols=89  Identities=12%  Similarity=0.139  Sum_probs=64.4

Q ss_pred             CceEEEEEeeehhhhhh---hccceEEeecCCeEEEEC-C---CCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEc
Q 010859          405 GESVLMISMVKKLQKLT---SKKVQLILTNKPKLIYVD-P---SKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVT  472 (499)
Q Consensus       405 ~~~i~~~g~~~k~~g~~---~k~r~~ilt~~p~l~y~d-~---~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~  472 (499)
                      |..+|++|.+.+...-.   .++|.+.|=+.-.++..- +   +.-..++.||++..    .++.     .-.+.|.|.+
T Consensus         1 GR~li~eG~l~~~~~~~~k~~~~~~~fLF~d~Ll~~k~~~~~~~~~~~~~~~~l~~~----~v~~~~d~~~~~n~f~i~~   76 (109)
T d1zc3b1           1 GQYLVYNGDLVEYEADHMAQLQRVHGFLMNDCLLVATWLPQRRGMYRYNALYPLDRL----AVVNVKDNPPMKDMFKLLM   76 (109)
T ss_dssp             CCCEEEEEEEEEEETTTCCEEEEEEEEEESSEEEEEEEECCTTSCEEEEEEEETTTC----EEEEECCBTTBSSEEEEEE
T ss_pred             CCEEEEeeeEEEEccCCCCcceeEEEEEecCEEEEEEEcCCcceEEEeeeEEeccce----EEEEeecccccceEEEEcc
Confidence            55678899888754333   356677777777766642 2   24577899999874    4433     1246899999


Q ss_pred             CCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          473 PKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       473 p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      +.++|.|...+ .+..+|+++|++++
T Consensus        77 ~~~~~~~~a~s~~eK~~W~~~l~~a~  102 (109)
T d1zc3b1          77 FPESRIFQAENAKIKREWLEVLEETK  102 (109)
T ss_dssp             TTEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCEEEEEECCHHHHHHHHHHHHHHH
Confidence            99999998554 89999999999876

>d2dfka2 b.55.1.1 (A:240-401) Rho guanine nucleotide exchange factor 9, Collybistin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho guanine nucleotide exchange factor 9, Collybistin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.25  E-value=0.00087  Score=57.07  Aligned_cols=93  Identities=15%  Similarity=0.219  Sum_probs=69.0

Q ss_pred             ccCCCceEEEEEeeehhhh--hhhccceEEeecCCeEEEEC----CCCCeeeeeeeccCCCCceEEEEcC----------
Q 010859          401 FLDPGESVLMISMVKKLQK--LTSKKVQLILTNKPKLIYVD----PSKLVVKGNIIWSDNSNDLSIQVSS----------  464 (499)
Q Consensus       401 ~~~~~~~i~~~g~~~k~~g--~~~k~r~~ilt~~p~l~y~d----~~~~~~kg~i~~~~~~~~~~~~~~~----------  464 (499)
                      .+.++...+++|.+.+..+  .-++.|.|+|-+.-.+|+.-    ...-..++.|+++.    +.++...          
T Consensus        20 L~~~~r~Li~eG~L~~~~~~~~k~~~r~~fLF~d~Ll~~k~~~~~~~~y~~k~~i~L~~----~~v~~~~~~~~~~~~~~   95 (162)
T d2dfka2          20 ILDRSSELIYTGEMAWIYQPYGRNQQRVFFLFDHQMVLCKKDLIRRDILYYKGRIDMDK----YEVIDIEDGRDDDFNVS   95 (162)
T ss_dssp             GGGTCCCEEEEEEEEEESSTTCCCEEEEEEEETTEEEEEEECSSCTTCEEEEEEEEGGG----EEEEECCSEECSSSCCE
T ss_pred             ccccCceEEEEEEEEEEEcCCCCceeEEEEEeCCeEEEEEecCCCCCceEEccccchhh----ceeeecccccccccCcc
Confidence            4455667899999987643  33678999999999988863    23568899999987    4555421          


Q ss_pred             -CCcEEEEc--CCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          465 -PSHFKIVT--PKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       465 -~~~f~i~~--p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                       ++.|.|+.  .+++|.|...+ .+...|+++|.+.+
T Consensus        96 ~~~~f~i~~~~~~~~~~~~A~s~~eK~~W~~~l~~~~  132 (162)
T d2dfka2          96 MKNAFKLHNKETEEVHLFFAKKLEEKIRWLRAFREER  132 (162)
T ss_dssp             ESSEEEEEESSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccceEEEEECCCCeEEEEEeCCHHHHHHHHHHHHHHH
Confidence             25699973  46899999554 89999999998753

>d1dbha2 b.55.1.1 (A:418-550) Son of sevenless-1 (sos-1) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Son of sevenless-1 (sos-1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.23  E-value=0.00072  Score=55.53  Aligned_cols=92  Identities=12%  Similarity=0.222  Sum_probs=69.1

Q ss_pred             cccCCCceEEEEEeeehhhhhhhccceEEeecCCeEEEECC-----------CCCeeeeeeeccCCCCceEEEEc-----
Q 010859          400 QFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP-----------SKLVVKGNIIWSDNSNDLSIQVS-----  463 (499)
Q Consensus       400 ~~~~~~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~-----------~~~~~kg~i~~~~~~~~~~~~~~-----  463 (499)
                      .++.+|...+++|.+.|.++  .+.|+++|-|.-.+|+.-.           ..-.+|+.||++.    +.+...     
T Consensus        19 ~l~~~gr~li~eG~l~~~~~--~k~r~~fLF~d~Li~~k~~~~~~~~~~~~~~~y~~k~~i~l~~----~~v~~~~~~~~   92 (133)
T d1dbha2          19 DIGQCCNEFIMEGTLTRVGA--KHERHIFLFDGLMICCKSNHGQPRLPGASNAEYRLKEKFFMRK----VQINDKDDTNE   92 (133)
T ss_dssp             CGGGTCCCEEEEEEEEETTC--SSCEEEEEESSEEEEEEECTTCCCCTTSCCCSEEEEEEEESCS----CEEEECCCSSS
T ss_pred             CccccCcEEEEEeEEEEecC--CCeEEEEEecCeEEEEEecccccccccCCCccEEEEeeeeccc----ccccccCCCcc
Confidence            35667888999999988754  4789999998877777532           1235789999998    455442     


Q ss_pred             CCCcEEEEcC-CceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          464 SPSHFKIVTP-KKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       464 ~~~~f~i~~p-~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      -++.|.|.++ .+.|.|...+ .+..+|+++|.++.
T Consensus        93 ~~~~f~i~~~~~~~~~l~a~s~~eK~~W~~~l~~~~  128 (133)
T d1dbha2          93 YKHAFEIILKDENSVIFSAKSAEEKNNWMAALISLQ  128 (133)
T ss_dssp             CCSEEEECCTTSCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cccceeEEcCCCcEEEEEECCHHHHHHHHHHHHHHH
Confidence            1468998774 6789888655 89999999999865

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.89  E-value=0.0015  Score=63.85  Aligned_cols=79  Identities=10%  Similarity=0.090  Sum_probs=52.4

Q ss_pred             CCCeeeeeEeeecCceEEEEEEEcC-------CCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCCCCCc-cEEEEEEE
Q 010859           54 IQDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQ  125 (499)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~a~~~~-------t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-v~l~~~~~  125 (499)
                      .+++++ +.|+.|-.-.+|++....       ..+.|.+++.....    . .....+|..+++.+.-.++ .+++++|.
T Consensus        42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            345554 678889999999998753       34668888875321    1 2235568888887743344 47777775


Q ss_pred             cCCeEEEEEeccCCCCh
Q 010859          126 DTFSLYMALESCEGGEL  142 (499)
Q Consensus       126 ~~~~l~lv~E~~~gg~L  142 (499)
                      +    .+||||++|..|
T Consensus       116 ~----g~I~efi~g~~l  128 (395)
T d1nw1a_         116 G----GRLEEYIPSRPL  128 (395)
T ss_dssp             T----EEEECCCCEEEC
T ss_pred             C----ceEEEEeccccC
Confidence            4    578999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.83  E-value=0.00067  Score=64.67  Aligned_cols=69  Identities=14%  Similarity=0.115  Sum_probs=42.0

Q ss_pred             ceEEEEEEEcCCCceEEEEEEeCcccchhhHHHHHHHHHHHHHhCC---CC--CccEE--EEEEEcCCeEEEEEeccCCC
Q 010859           68 YSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HP--GVVRL--FFTFQDTFSLYMALESCEGG  140 (499)
Q Consensus        68 ~g~Vy~a~~~~t~~~vAiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp--~Iv~l--~~~~~~~~~l~lv~E~~~gg  140 (499)
                      --.||++.. ++|+.|++|+.+...-.    ...+..|...+..|.   -|  ..+..  -..+......+.+++++.|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            368999986 56889999998654322    233555666665552   12  11111  12234566788999999874


Q ss_pred             C
Q 010859          141 E  141 (499)
Q Consensus       141 ~  141 (499)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.41  E-value=0.0068  Score=56.81  Aligned_cols=30  Identities=27%  Similarity=0.400  Sum_probs=26.9

Q ss_pred             CCcEeeecCCCCeeeCCCCCEEEEecCCcc
Q 010859          174 MGLIHRDIKPENLLLTADGHIKIADFGSVK  203 (499)
Q Consensus       174 ~gIiHrDlKp~NILl~~~~~vkL~DFG~a~  203 (499)
                      .|+||+|+.+.||+++.+...-|+||+.|.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999875

>d1ki1b2 b.55.1.1 (B:1439-1580) GEF of intersectin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: GEF of intersectin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.11  E-value=0.0098  Score=48.95  Aligned_cols=86  Identities=16%  Similarity=0.243  Sum_probs=56.8

Q ss_pred             ceEEEEEeeehhhhhhhccceEEeecCCeEEEECCC-----------------CCeeeeeeeccCCCCceEEEEc-----
Q 010859          406 ESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS-----------------KLVVKGNIIWSDNSNDLSIQVS-----  463 (499)
Q Consensus       406 ~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~~-----------------~~~~kg~i~~~~~~~~~~~~~~-----  463 (499)
                      ...|++|.+.|..+  .+.|.+.|=+.-.+|..-..                 .-+.++.|+++.    +.+...     
T Consensus        23 R~li~eG~L~k~~~--~k~r~~FLFnD~Ll~tK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~l~~----l~v~~~~d~~~   96 (142)
T d1ki1b2          23 RKFLHSGKLYKAKN--NKELYGFLFNDFLLLTQITKPLGSSGTDKVFSPKSNLQYMYKTPIFLNE----VLVKLPTDPSG   96 (142)
T ss_dssp             CCEEEECCCBCSSS--CCCCEEEEESSEEEEEEEECC-------CCSCSSCCEEEECSSCEEGGG----EEEECCSSSCC
T ss_pred             eEEEEeeEEEEecC--CCEEEEEEecCEEEEEEeccccceeccccccccCCceeEEEEcccchhh----heeeccCCccc
Confidence            44789998876543  36788877777665542111                 123456678875    444442     


Q ss_pred             CCCcEEEEcCCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          464 SPSHFKIVTPKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       464 ~~~~f~i~~p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      ....|.+..++++|.|..++ .+...|+++|++++
T Consensus        97 ~~~~~~~~~~~~~~~l~a~s~~ek~~W~~~I~~Ai  131 (142)
T d1ki1b2          97 DEPIFHISHIDRVYTLRAESINERTAWVQKIKAAS  131 (142)
T ss_dssp             C---CEEEETTEEEECBCSSHHHHHHHHHHHHHHH
T ss_pred             ceeEEEecCCCEEEEEEeCCHHHHHHHHHHHHHHH
Confidence            23467777899999999665 89999999999875

>d1ntya2 b.55.1.1 (A:1415-1535) Triple functional domain protein TRIO {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Triple functional domain protein TRIO
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.74  E-value=0.054  Score=42.82  Aligned_cols=89  Identities=17%  Similarity=0.315  Sum_probs=61.4

Q ss_pred             CCceEEEEEeeeh----hhhhhhccceEEeecCCeEEEEC--CC----CCeeeeeeeccCCCCceEEEE---cCCCcEEE
Q 010859          404 PGESVLMISMVKK----LQKLTSKKVQLILTNKPKLIYVD--PS----KLVVKGNIIWSDNSNDLSIQV---SSPSHFKI  470 (499)
Q Consensus       404 ~~~~i~~~g~~~k----~~g~~~k~r~~ilt~~p~l~y~d--~~----~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i  470 (499)
                      .|+ .|++|.+..    ....-.+.|.+.|=+.-.+|..-  ..    ....+..|+++.    +.++.   .....|.|
T Consensus        10 ~G~-Ll~~g~l~v~~~~~~~~k~~~R~~FLF~d~Ll~~K~k~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~f~i   84 (121)
T d1ntya2          10 QGE-LILQESFQVWDPKTLIRKGRERHLFLFEMSLVFSKEVKDSSGRSKYLYKSKLFTSE----LGVTEHVEGDPCKFAL   84 (121)
T ss_dssp             GCC-EEEEEEEEEECSSSSSCCEEEEEEEEESSEEEEEEEEECTTCCEEEEEEEEEEGGG----EEEECCCTTCTTEEEE
T ss_pred             CCc-EEEEeEEEEEcccccCCCCcEEEEEeeCCeEEEEEEecCCCCCceeEEEeeEEecc----eEEEEcCCCCCceEEE
Confidence            476 577787752    22222467888888887777642  11    346888899987    55554   34578988


Q ss_pred             E-----cCCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          471 V-----TPKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       471 ~-----~p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      .     .+.+.|.|...+ .+.++|+++|++++
T Consensus        85 ~~~~~~~~~~~~~l~a~s~~eK~~W~~~I~~~i  117 (121)
T d1ntya2          85 WVGRTPTSDNKIVLKASSIENKQDWIKHIREVI  117 (121)
T ss_dssp             EESSSCCTTTCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCceEEEEECCCHHHHHHHHHHHHHHH
Confidence            4     356789888655 78999999999976

>d1fhoa_ b.55.1.1 (A:) UNC-89 {Nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: UNC-89
species: Nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=94.42  E-value=0.033  Score=44.29  Aligned_cols=90  Identities=9%  Similarity=0.008  Sum_probs=60.2

Q ss_pred             CCceEEEEEeeehhhhhhhccceEEeecCCeEEEECCC-----CCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCC--
Q 010859          404 PGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS-----KLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPK--  474 (499)
Q Consensus       404 ~~~~i~~~g~~~k~~g~~~k~r~~ilt~~p~l~y~d~~-----~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~--  474 (499)
                      .|++++.-++....+.--.|.|++.|=+.-.||+....     .-..|+.|+++..    .++.  .+...|.|...+  
T Consensus         7 ~G~ll~~~~f~v~~~~~k~k~R~vFLF~~~ll~~K~~~~~~~~~y~~K~~i~l~~~----~v~e~~gd~~~F~i~~~~~~   82 (119)
T d1fhoa_           7 LGRIIRHDAFQVWEGDEPPKLRYVFLFRNKIMFTEQDASTSPPSYTHYSSIRLDKY----NIRQHTTDEDTIVLQPQEPG   82 (119)
T ss_dssp             CCCSSEEEEEEECSTTCSCEEEEEEEETTEEEEEEECCSSSSCCCSSCCEEESSSC----EEEEECTTCCEEEEECCSTT
T ss_pred             CCceEEEeEEEEEeCCCCceEEEEEEEcCeEEEEEeccCCCCceEEEecEEECCce----EEEEcCCCCcEEEEEeCCCC
Confidence            47777777766655544456788888888887776432     2457999999974    4433  567899997433  


Q ss_pred             c-----eEEEEc-CCccHHHHHHHHHHhc
Q 010859          475 K-----VLSFED-AKQRASQWKKAIEALQ  497 (499)
Q Consensus       475 r-----~y~~~d-~~~~~~~W~~~i~~~~  497 (499)
                      +     ++.+.. .+...+.|+++|.+.+
T Consensus        83 ~~~~~~~~~~~a~s~~~K~~Wv~~I~e~~  111 (119)
T d1fhoa_          83 LPSFRIKPKDFETSEYVRKAWLRDIAEEQ  111 (119)
T ss_dssp             CCCBCCCCCSSSSCSHHHHHHHHHHHTCC
T ss_pred             CCcceEEEEEecCCHHHHHHHHHHHHHHH
Confidence            2     233333 3355789999998754

>d1xcga2 b.55.1.1 (A:942-1081) Rho guanine nucleotide exchange factor 11, PDZ-RhoGEF {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho guanine nucleotide exchange factor 11, PDZ-RhoGEF
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.30  E-value=0.059  Score=43.81  Aligned_cols=96  Identities=8%  Similarity=0.190  Sum_probs=58.9

Q ss_pred             cccccCCCceEEEEEeee-hhhhhhhccceEEeecCCeEEEECCCC------------------CeeeeeeeccCCCCce
Q 010859          398 WQQFLDPGESVLMISMVK-KLQKLTSKKVQLILTNKPKLIYVDPSK------------------LVVKGNIIWSDNSNDL  458 (499)
Q Consensus       398 ~~~~~~~~~~i~~~g~~~-k~~g~~~k~r~~ilt~~p~l~y~d~~~------------------~~~kg~i~~~~~~~~~  458 (499)
                      |..+..++...|++|.+. |...--.+.|+++|=+.-.+|..-...                  ....+.++++.    +
T Consensus        15 ~~~l~~~~R~Li~eG~L~~k~~~~k~k~r~~FLF~D~Ll~tk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~----~   90 (140)
T d1xcga2          15 FKSLDLTTRKMIHEGPLTWRISKDKTLDLHVLLLEDLLVLLQKQDEKLLLKCHSKTAVGSSDSKQTFSPVLKLNA----V   90 (140)
T ss_dssp             GGGCCGGGSCEEEEEEEEECCSSSCCCEEEEEEESSEEEEEEECSSCEECCC-------------CCCSEEEGGG----E
T ss_pred             hcccCcccceEEEEeeEEEEecCCCceEEEEEEecCeEEEEEecccceeeccccccccccccceeeecceEecce----E
Confidence            444444567789999996 443333456777777765555432211                  12234455554    3


Q ss_pred             EEEE--cCCCcEEEEc-----CCceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          459 SIQV--SSPSHFKIVT-----PKKVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       459 ~~~~--~~~~~f~i~~-----p~r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      .++.  ...+.|.|..     +.++|.|...+ .+..+|+++|++++
T Consensus        91 ~~~~~~~~~~~f~li~~~~~~~~~~~~l~A~s~~eK~~Wi~~i~~aI  137 (140)
T d1xcga2          91 LIRSVATDKRAFFIICTSKLGPPQIYELVALTSSDKNTWMELLEEAV  137 (140)
T ss_dssp             EEEECSSCSSEEEEEECCSSSTTCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCeEEEEEcCCCCCceEEEEEcCCHHHHHHHHHHHHHHH
Confidence            3433  3456788753     34778888654 89999999999976

>d1txda2 b.55.1.1 (A:1020-1133) Rho guanine nucleotide exchange factor 12 {Human (Homo sapiens), gamma isoform [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho guanine nucleotide exchange factor 12
species: Human (Homo sapiens), gamma isoform [TaxId: 9606]

Probab=91.84  E-value=0.29  Score=37.96  Aligned_cols=85  Identities=9%  Similarity=0.106  Sum_probs=49.3

Q ss_pred             EEEEeeehhhhhh-hccceEEeecCCeEEEECCC------------------CCeeeeeeeccCCCCceEEEEc--C-CC
Q 010859          409 LMISMVKKLQKLT-SKKVQLILTNKPKLIYVDPS------------------KLVVKGNIIWSDNSNDLSIQVS--S-PS  466 (499)
Q Consensus       409 ~~~g~~~k~~g~~-~k~r~~ilt~~p~l~y~d~~------------------~~~~kg~i~~~~~~~~~~~~~~--~-~~  466 (499)
                      |++|-+..+.+-- .+-|.+.|=+.-.|+.....                  ....+.-|+++.    +.+...  + ..
T Consensus         2 i~eG~L~~~~~~~k~~er~vFLF~d~Ll~~k~~~~k~~~~~~~~~~~~~~~~~~~~~~~i~l~~----l~v~e~~~d~~~   77 (114)
T d1txda2           2 IHEGPLVWKVNRDKTIDLYTLLLEDILVLLQKQDDRLVLRCHSKILASTADSKHTFSPVIKLST----VLVRQVATDNKA   77 (114)
T ss_dssp             EEEEEEEEESSSSCBCCEEEEEESSEEEEEEEETTEEECCC-------------CCCSEEEGGG----EEEEECCC-CCE
T ss_pred             ceeeeEEEEecCCCceEEEEEEecCeEEEEEecccccccccccccccccccceeeecCcEEccc----EEEEEcCCCCCC
Confidence            5677665322211 23466666665555544222                  123445688886    455542  3 34


Q ss_pred             cEEEEcCC---ceEEEEcCC-ccHHHHHHHHHHhc
Q 010859          467 HFKIVTPK---KVLSFEDAK-QRASQWKKAIEALQ  497 (499)
Q Consensus       467 ~f~i~~p~---r~y~~~d~~-~~~~~W~~~i~~~~  497 (499)
                      .|.|.+.+   ..|.|...+ .+-+.|+++|.++.
T Consensus        78 ~fli~~~~~~~~~y~l~A~s~~eK~~W~~~I~~~~  112 (114)
T d1txda2          78 LFVISMSDNGAQIYELVAQTVSEKTVWQDLICRMA  112 (114)
T ss_dssp             EEEEEECSSCEEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEEEecCCCceEEEEEcCCHHHHHHHHHHHHHHh
Confidence            56665533   578888665 78999999999875

>d1kz7a2 b.55.1.1 (A:819-965) Dbl's big sister, Dbs {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Dbl's big sister, Dbs
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=86.08  E-value=0.89  Score=36.77  Aligned_cols=71  Identities=17%  Similarity=0.270  Sum_probs=49.9

Q ss_pred             ccceEEeecCCeEEEECC----------CCCeeeeeeeccCCCCceEEEEc---CCCcEEEE--cCCceEEEEcCC-ccH
Q 010859          423 KKVQLILTNKPKLIYVDP----------SKLVVKGNIIWSDNSNDLSIQVS---SPSHFKIV--TPKKVLSFEDAK-QRA  486 (499)
Q Consensus       423 k~r~~ilt~~p~l~y~d~----------~~~~~kg~i~~~~~~~~~~~~~~---~~~~f~i~--~p~r~y~~~d~~-~~~  486 (499)
                      +.|.+.|=+.-.+|+...          ..-.+|+.|+++.    +.+...   +...|.+.  +|...|.|...+ ..-
T Consensus        41 ~~R~~FLF~~~Li~cK~~~~~~~~~~~~~~y~~k~~~~~~~----~~v~~~~~~~~~~f~~~~~~~~~~~~l~a~s~eeK  116 (147)
T d1kz7a2          41 MQRHLFLHEKAVLFCKKREENGEGYEKAPSYSYKQSLNMTA----VGITENVKGDTKKFEIWYNAREEVYIIQAPTPEIK  116 (147)
T ss_dssp             EEEEEEEESSEEEEEEEECCCCSSCCCSCEEEEEEEEEGGG----EEEECCBTTBTTEEEEEETTTTEEEEEECSSHHHH
T ss_pred             ceEEEEEecCcEEEEEecccCCcccccCceEEEeeEEecCC----ceeEecCCCCcceEEEEeCCCCcEEEEEeCCHHHH
Confidence            457777777766666431          1246789999986    555542   34566665  578889998665 789


Q ss_pred             HHHHHHHHHhc
Q 010859          487 SQWKKAIEALQ  497 (499)
Q Consensus       487 ~~W~~~i~~~~  497 (499)
                      +.|+++|++++
T Consensus       117 ~~W~~~I~~~l  127 (147)
T d1kz7a2         117 AAWVNAIRKVL  127 (147)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999999865